index,subject_en,subject_cui,start_id,predicate_en,object_en,object_cui,end_id,source_count,research_count,AFFECTS,influence_relation,evidence_level
1,PARP1,C1538577,en_4,CAUSES,DNA Damage,C0012860,en_835,2,1,AFFECTS,Excitatory,3
2,AGTR1,C1439284,en_5,CAUSES,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Excitatory,3
3,AGTR1,C1439284,en_5,CAUSES,Increased blood vessel permeability,C0232374,en_3278,1,1,AFFECTS,Excitatory,3
4,APBB1,C1412459,en_8,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
5,DHPS,C1367701,en_30,CAUSES,Increased pressure,C0520818,en_4193,1,1,AFFECTS,Excitatory,6
6,EPO gene,C1366564,en_5664,CAUSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,6
7,GALNT3,C1414953,en_37,CAUSES,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Excitatory,3
8,GALNT3,C1414953,en_37,CAUSES,Hyperphosphatemia,C0085681,en_2686,1,1,AFFECTS,Excitatory,3
9,IL1RAP,C1416397,en_50,CAUSES,Nephrotic Syndrome,C0027726,en_1654,1,1,AFFECTS,Excitatory,3
10,KCNH2,C1416572,en_55,CAUSES,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,Excitatory,3
11,NELL1,C1417676,en_62,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
12,NELL1,C1417676,en_62,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
13,NHS,C1417725,en_64,CAUSES,Does pull,C0580846,en_4341,1,1,AFFECTS,Excitatory,3
14,P2RX7,C1418215,en_66,CAUSES,Malaria,C0024530,en_1493,1,1,AFFECTS,Excitatory,3
15,RIT2,C1419388,en_73,CAUSES,Antimicrobial activity,C1271650,en_5452,2,1,AFFECTS,Excitatory,3
16,SOD1,C1420306,en_81,CAUSES,Amyotrophic Lateral Sclerosis,C0002736,en_310,1,1,AFFECTS,Excitatory,3
17,SREBF1,C1420398,en_82,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
18,VEGFA,C1823619,en_89,CAUSES,Brain Injuries,C0270611,en_3552,1,1,AFFECTS,Excitatory,3
19,VEGFA,C1823619,en_89,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
20,OGT,C1417945,en_94,CAUSES,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Excitatory,3
21,APOL1,C1412485,en_95,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
22,SPINT2,C1420362,en_108,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
23,SETD2,C1822686,en_128,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
24,TLR7 gene,C1336639,en_5634,CAUSES,Low Level,C4321351,en_6342,1,1,AFFECTS,Excitatory,6
25,TET2,C1825692,en_139,CAUSES,Clonal Expansion,C1516670,en_5861,1,1,AFFECTS,Excitatory,3
26,ACE2,C1422064,en_5723,CAUSES,Breast Feeding,C0006147,en_512,1,1,AFFECTS,Excitatory,3
27,ACE2,C1422064,en_5723,CAUSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
28,ACE2,C1422064,en_5723,CAUSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
29,ACE2,C1422064,en_5723,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
30,ACE2,C1422064,en_5723,CAUSES,Down-Regulation,C0013081,en_844,1,1,AFFECTS,Excitatory,3
31,ACE2,C1422064,en_5723,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
32,ACE2,C1422064,en_5723,CAUSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
33,ACE2,C1422064,en_5723,CAUSES,Pneumonia,C0032285,en_1833,3,3,AFFECTS,Excitatory,9
34,ACE2,C1422064,en_5723,CAUSES,Pregnancy,C0032961,en_1872,1,1,AFFECTS,Excitatory,3
35,ACE2,C1422064,en_5723,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
36,ACE2,C1422064,en_5723,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
37,ACE2,C1422064,en_5723,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
38,ACE2,C1422064,en_5723,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
39,ACE2,C1422064,en_5723,CAUSES,Violent,C0242151,en_3394,1,1,AFFECTS,Excitatory,3
40,ACE2,C1422064,en_5723,CAUSES,Myocardial dysfunction,C0340515,en_3816,2,1,AFFECTS,Excitatory,3
41,IFIH1,C1537399,en_147,CAUSES,Aicardi's syndrome,C0175713,en_2969,1,1,AFFECTS,Excitatory,3
42,C16orf58,C1824415,en_149,CAUSES,Stress,C0038435,en_2165,1,1,AFFECTS,Excitatory,3
43,MAP1LC3A,C1417005,en_153,CAUSES,Vesicle,C0333262,en_3759,1,1,AFFECTS,Excitatory,3
44,SCGB3A2,C1425493,en_160,CAUSES,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Excitatory,3
45,NEAT1,C2681866,en_164,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
46,NIPAL4,C1836267,en_167,CAUSES,Ichthyoses,C0020757,en_1257,1,1,AFFECTS,Excitatory,3
47,"C5,C5AR1",C1367710;C1824180,en_170,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
48,CA2|SLC25A20,C1413043;C1413076,en_172,CAUSES,Thrombosis,C0040053,en_2233,4,1,AFFECTS,Excitatory,3
49,"GABPA,NFE2L2",C1414905;C1417701,en_177,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
50,"GABPA,NFE2L2",C1414905;C1417701,en_177,CAUSES,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Excitatory,3
51,"GATA4,FEZF2",C1414995;C1825291,en_182,CAUSES,Adequate anesthesia,C0475812,en_4147,1,1,AFFECTS,Excitatory,3
52,"MT1JP,NCAPG2",C1826313;C1826383,en_183,CAUSES,Cell Death,C0007587,en_587,3,1,AFFECTS,Excitatory,3
53,"MT1JP,NCAPG2",C1826313;C1826383,en_183,CAUSES,Necrosis,C0027540,en_1645,1,1,AFFECTS,Excitatory,3
54,"Abortion, Habitual",C0000809,en_207,CAUSES,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Excitatory,3
55,Accidents,C0000924,en_211,CAUSES,physical disorders,C0683323,en_4659,1,1,AFFECTS,Excitatory,3
56,Acetylcysteine,C0001047,en_219,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,8
57,Acinetobacter,C0001138,en_225,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
58,Acquired Immunodeficiency Syndrome,C0001175,en_226,CAUSES,Cessation of life,C0011065,en_762,4,3,AFFECTS,Excitatory,9
59,Acquired Immunodeficiency Syndrome,C0001175,en_226,CAUSES,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,Excitatory,3
60,"Pancreatitis, Acute",C0001339,en_231,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,6
61,Adenosine,C0001443,en_236,CAUSES,anti-inflammatory response,C1154987,en_5310,1,1,AFFECTS,Excitatory,3
62,Adenoviruses,C0001483,en_239,CAUSES,Eye Infections,C0015403,en_953,2,1,AFFECTS,Excitatory,3
63,Adenoviruses,C0001483,en_239,CAUSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
64,Immunologic Adjuvants,C0001551,en_242,CAUSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
65,Adrenal Cortex Hormones,C0001617,en_247,CAUSES,Diabetes,C0011847,en_797,2,1,AFFECTS,Excitatory,3
66,Adrenal Cortex Hormones,C0001617,en_247,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
67,Aerosols,C0001712,en_254,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
68,Ageusia,C0001800,en_259,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
69,Ageusia,C0001800,en_259,CAUSES,Malnutrition,C0162429,en_2910,1,1,AFFECTS,Excitatory,3
70,Air,C0001861,en_264,CAUSES,Dysbarism,C0004760,en_446,1,1,AFFECTS,Excitatory,3
71,Air,C0001861,en_264,CAUSES,Subcutaneous Emphysema,C0038536,en_2175,1,1,AFFECTS,Excitatory,3
72,Air Pollution,C0001873,en_265,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
73,Air Pollution,C0001873,en_265,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
74,Air Pollution,C0001873,en_265,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
75,alcohol use disorder,C0001956,en_270,CAUSES,Alcohol withdrawal syndrome,C0236663,en_3339,1,1,AFFECTS,Excitatory,6
76,Ethanol,C0001962,en_271,CAUSES,Present,C0150312,en_2833,1,1,AFFECTS,Excitatory,6
77,Ethanol,C0001962,en_271,CAUSES,heavy drinking,C0687132,en_4684,1,1,AFFECTS,Excitatory,6
78,Methanol,C0001963,en_272,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
79,Allergens,C0002092,en_279,CAUSES,Asthma,C0004096,en_418,1,1,AFFECTS,Excitatory,3
80,Allergens,C0002092,en_279,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
81,Allergens,C0002092,en_279,CAUSES,Pulmonary Eosinophilia,C0034068,en_1931,1,1,AFFECTS,Excitatory,3
82,Alopecia Areata,C0002171,en_283,CAUSES,Immune Tolerance,C0020963,en_1272,1,1,AFFECTS,Excitatory,3
83,Alzheimer's Disease,C0002395,en_291,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
84,Alzheimer's Disease,C0002395,en_291,CAUSES,Senile Plaques,C0333463,en_3764,1,1,AFFECTS,Excitatory,3
85,Amantadine,C0002403,en_292,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
86,Aminolevulinic Acid,C0002563,en_302,CAUSES,Plethora,C0232370,en_3277,1,1,AFFECTS,Excitatory,3
87,Amyotrophic Lateral Sclerosis,C0002736,en_310,CAUSES,Degenerative abnormality,C0011164,en_770,1,1,AFFECTS,Excitatory,3
88,Analgesics,C0002771,en_312,CAUSES,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Excitatory,3
89,Analgesics,C0002771,en_312,CAUSES,Gout,C0018099,en_1091,1,1,AFFECTS,Excitatory,3
90,Analgesics,C0002771,en_312,CAUSES,Tendinitis,C0039503,en_2213,1,1,AFFECTS,Excitatory,3
91,Analgesics,C0002771,en_312,CAUSES,"Diabetes Insipidus, Nephrogenic",C0162283,en_2902,1,1,AFFECTS,Excitatory,3
92,Androgens,C0002844,en_315,CAUSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
93,General Anesthesia,C0002915,en_320,CAUSES,Little's Disease,C0023882,en_1451,2,1,AFFECTS,Excitatory,3
94,Anesthetics,C0002932,en_322,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
95,"Angioplasty, Balloon",C0002996,en_326,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
96,Angiotensin II,C0003009,en_328,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
97,Angiotensin II,C0003009,en_328,CAUSES,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Excitatory,3
98,Angiotensin II,C0003009,en_328,CAUSES,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Excitatory,3
99,Angiotensin II,C0003009,en_328,CAUSES,Increased blood vessel permeability,C0232374,en_3278,1,1,AFFECTS,Excitatory,3
100,Angiotensin II,C0003009,en_328,CAUSES,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Excitatory,3
101,Angiotensin II,C0003009,en_328,CAUSES,Systemic disease,C0442893,en_4062,1,1,AFFECTS,Excitatory,3
102,Angiotensin II,C0003009,en_328,CAUSES,Cardiac Hypertrophy,C1383860,en_5688,1,1,AFFECTS,Excitatory,3
103,"Receptor, Angiotensin II",C0003011,en_329,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
104,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
105,Angiotensins,C0003018,en_332,CAUSES,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Excitatory,3
106,Angiotensins,C0003018,en_332,CAUSES,Vasodilation,C0042401,en_2342,1,1,AFFECTS,Excitatory,3
107,Angiotensins,C0003018,en_332,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,3
108,Animal Diseases,C0003047,en_333,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
109,Anosmia,C0003126,en_337,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
110,"Anti-Infective Agents, Local",C0003205,en_341,CAUSES,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
111,Anti-Inflammatory Agents,C0003209,en_342,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,7
112,Anti-Inflammatory Agents,C0003209,en_342,CAUSES,Underlying,C4722602,en_6385,1,1,AFFECTS,Excitatory,8
113,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
114,Antibiotics,C0003232,en_344,CAUSES,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Excitatory,3
115,Antibodies,C0003241,en_347,CAUSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
116,Antibodies,C0003241,en_347,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
117,Antibodies,C0003241,en_347,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
118,Antibodies,C0003241,en_347,CAUSES,Immune response,C0301872,en_3696,2,2,AFFECTS,Excitatory,6
119,Antibodies,C0003241,en_347,CAUSES,"Passive immunity, function",C0678210,en_4555,2,1,AFFECTS,Excitatory,3
120,Antibodies,C0003241,en_347,CAUSES,PATIENT SYMPTOMS,C1317600,en_5529,1,1,AFFECTS,Excitatory,3
121,Antibodies,C0003241,en_347,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
122,Antibodies,C0003241,en_347,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
123,"Antibodies, Anti-Idiotypic",C0003242,en_348,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,7
124,Monoclonal Antibodies,C0003250,en_350,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
125,Monoclonal Antibodies,C0003250,en_350,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
126,Antidepressive Agents,C0003289,en_356,CAUSES,Sleep disturbances,C0037317,en_2121,1,1,AFFECTS,Excitatory,3
127,Antifibrinolytic Agents,C0003304,en_359,CAUSES,Lysis,C0024348,en_1476,1,1,AFFECTS,Excitatory,6
128,Antigens,C0003320,en_365,CAUSES,Abscess,C0000833,en_210,1,1,AFFECTS,Excitatory,3
129,Antigens,C0003320,en_365,CAUSES,Maximal Voluntary Ventilation,C0024967,en_1511,2,1,AFFECTS,Excitatory,3
130,Antigens,C0003320,en_365,CAUSES,Cytokine storm,C0919747,en_5119,3,1,AFFECTS,Excitatory,3
131,Antigens,C0003320,en_365,CAUSES,Organ failure,C0948600,en_5171,4,1,AFFECTS,Excitatory,3
132,Antigens,C0003320,en_365,CAUSES,Allergic Reaction,C1527304,en_5919,1,1,AFFECTS,Excitatory,3
133,"Antigens, Viral",C0003342,en_366,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
134,Antimalarials,C0003374,en_369,CAUSES,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
135,Antimalarials,C0003374,en_369,CAUSES,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
136,Antineoplastic Agents,C0003392,en_371,CAUSES,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Excitatory,3
137,Antipyretics,C0003419,en_375,CAUSES,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Excitatory,3
138,Antipyretics,C0003419,en_375,CAUSES,Gout,C0018099,en_1091,1,1,AFFECTS,Excitatory,3
139,Antipyretics,C0003419,en_375,CAUSES,Tendinitis,C0039503,en_2213,1,1,AFFECTS,Excitatory,3
140,Antipyretics,C0003419,en_375,CAUSES,"Diabetes Insipidus, Nephrogenic",C0162283,en_2902,1,1,AFFECTS,Excitatory,3
141,Anxiety,C0003467,en_380,CAUSES,Epilepsy,C0014544,en_917,1,1,AFFECTS,Excitatory,6
142,Arbovirus Infections,C0003723,en_391,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
143,Arboviruses,C0003725,en_392,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
144,Arboviruses,C0003725,en_392,CAUSES(SPEC),Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
145,cardiac arrhythmia,C0003811,en_397,CAUSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
146,cardiac arrhythmia,C0003811,en_397,CAUSES,Heart failure,C0018801,en_1135,2,2,AFFECTS,Excitatory,6
147,cardiac arrhythmia,C0003811,en_397,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
148,cardiac arrhythmia,C0003811,en_397,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,3
149,Arteriosclerosis,C0003850,en_399,CAUSES,Lower limb ischemia,C0340565,en_3818,1,1,AFFECTS,Excitatory,3
150,Rheumatoid Arthritis,C0003873,en_402,CAUSES(SPEC),Edema,C0013604,en_877,1,1,AFFECTS,Excitatory,3
151,Rheumatoid Arthritis,C0003873,en_402,CAUSES(SPEC),Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
152,Ascorbic Acid,C0003968,en_405,CAUSES,Diarrhea,C0011991,en_810,1,1,AFFECTS,Excitatory,3
153,Ascorbic Acid,C0003968,en_405,CAUSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
154,Ascorbic Acid,C0003968,en_405,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
155,Ascorbic Acid Deficiency,C0003969,en_406,CAUSES,Scurvy,C0036474,en_2074,1,1,AFFECTS,Excitatory,3
156,Aspergillus,C0004034,en_411,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
157,Aspergillus,C0004034,en_411,CAUSES,Infectious disease of lung,C0876973,en_5058,2,1,AFFECTS,Excitatory,3
158,Aspergillus fumigatus,C0004037,en_412,CAUSES,Invasive mycosis,C1262313,en_5421,1,1,AFFECTS,Excitatory,3
159,Aspirin,C0004057,en_414,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
160,Asthenia,C0004093,en_416,CAUSES,Chronic Fatigue Syndrome,C0015674,en_967,4,2,AFFECTS,Excitatory,6
161,Asthma,C0004096,en_418,CAUSES,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Excitatory,3
162,Asthma,C0004096,en_418,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
163,Asthma,C0004096,en_418,CAUSES(SPEC),Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
164,Asthma,C0004096,en_418,CAUSES(SPEC),Hypercapnic respiratory failure,C0398353,en_3947,1,1,AFFECTS,Excitatory,3
165,Asthma,C0004096,en_418,CAUSES(SPEC),Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
166,Atherosclerosis,C0004153,en_421,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
167,Atherosclerosis,C0004153,en_421,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
168,Atrial Fibrillation,C0004238,en_423,CAUSES,Heart failure,C0018801,en_1135,2,2,AFFECTS,Excitatory,6
169,Atrial Fibrillation,C0004238,en_423,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
170,Autoantibodies,C0004358,en_426,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
171,Autoantibodies,C0004358,en_426,CAUSES,Adverse reactions,C0559546,en_4315,1,1,AFFECTS,Excitatory,3
172,Autoantibodies,C0004358,en_426,CAUSES,cell injury,C0599732,en_4467,1,1,AFFECTS,Excitatory,3
173,Autoantibodies,C0004358,en_426,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
174,Autoimmune Diseases,C0004364,en_428,CAUSES,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Excitatory,3
175,Autoimmune Diseases,C0004364,en_428,CAUSES,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,2,1,AFFECTS,Excitatory,3
176,Autoimmune Diseases,C0004364,en_428,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
177,Autoimmunity,C0004368,en_430,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
178,Bacteria,C0004611,en_440,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
179,Bacteria,C0004611,en_440,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
180,Bacteria,C0004611,en_440,CAUSES,Infection,C3714514,en_6235,3,3,AFFECTS,Excitatory,9
181,Bacteria,C0004611,en_440,CAUSES,Periodontal Diseases,C0031090,en_1774,1,1,AFFECTS,Excitatory,3
182,Bacteria,C0004611,en_440,CAUSES,Periodontitis,C0031099,en_1775,1,1,AFFECTS,Excitatory,3
183,Bacteria,C0004611,en_440,CAUSES,Peritonitis,C0031154,en_1778,2,1,AFFECTS,Excitatory,3
184,Bacteria,C0004611,en_440,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
185,Bacteria,C0004611,en_440,CAUSES,Respiratory Tract Infections,C0035243,en_2017,2,2,AFFECTS,Excitatory,6
186,Bacteria,C0004611,en_440,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
187,Bacteria,C0004611,en_440,CAUSES,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Excitatory,3
188,Bacteria,C0004611,en_440,CAUSES,Animal Development,C0870137,en_5000,5,2,AFFECTS,Excitatory,6
189,Bacteria,C0004611,en_440,CAUSES,Infectious disease of lung,C0876973,en_5058,2,1,AFFECTS,Excitatory,3
190,Bacteria,C0004611,en_440,CAUSES,Nosocomial pneumonia,C0949083,en_5175,3,1,AFFECTS,Excitatory,3
191,Bacterial Infections,C0004623,en_441,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
192,Bacterial Infections,C0004623,en_441,CAUSES,Influenza,C0021400,en_1311,1,1,AFFECTS,Excitatory,3
193,"Pneumonia, Bacterial",C0004626,en_442,CAUSES,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Excitatory,7
194,Bacterial Proteins,C0004627,en_443,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
195,Bacteriophages,C0004651,en_444,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
196,BCG Vaccine,C0004886,en_448,CAUSES,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,8
197,BCG Vaccine,C0004886,en_448,CAUSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
198,Bed rest,C0004910,en_449,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
199,Bed rest,C0004910,en_449,CAUSES,Muscular Atrophy,C0026846,en_1604,3,2,AFFECTS,Excitatory,6
200,Bed rest,C0004910,en_449,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
201,Bed rest,C0004910,en_449,CAUSES,associated disease,C0243083,en_3459,1,1,AFFECTS,Excitatory,3
202,Benzalkonium Chloride,C0005026,en_454,CAUSES,NEPHROTOXICITY,C0599918,en_4485,1,1,AFFECTS,Excitatory,3
203,Benzene,C0005036,en_455,CAUSES,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Excitatory,3
204,Beryllium,C0005139,en_458,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
205,Biological Products,C0005522,en_469,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
206,Biological Response Modifiers,C0005525,en_470,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,7
207,Biological Response Modifiers,C0005525,en_470,CAUSES,Autoimmune Diseases,C0004364,en_428,2,1,AFFECTS,Excitatory,3
208,Biological Response Modifiers,C0005525,en_470,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,3
209,Bleomycin,C0005740,en_481,CAUSES,Fibrosis,C0016059,en_994,2,2,AFFECTS,Excitatory,6
210,Bleomycin,C0005740,en_481,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Excitatory,3
211,Blood coagulation,C0005778,en_484,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
212,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
213,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
214,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
215,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Obstruction,C0028778,en_1702,1,1,AFFECTS,Excitatory,3
216,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
217,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Disease of capillaries,C0155765,en_2890,1,1,AFFECTS,Excitatory,3
218,Blood Coagulation Disorders,C0005779,en_485,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
219,Body Fluids,C0005889,en_496,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
220,Bradykinin,C0006100,en_507,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
221,Bronchiolitis,C0006271,en_517,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,8
222,Bronchoalveolar Lavage Fluid,C0006279,en_518,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
223,Bronchoscopy,C0006290,en_520,CAUSES,Coughing,C0010200,en_723,1,1,AFFECTS,Excitatory,3
224,Cachexia,C0006625,en_531,CAUSES,Anorexia,C0003123,en_336,1,1,AFFECTS,Excitatory,3
225,Cachexia,C0006625,en_531,CAUSES,Malaise,C0231218,en_3251,1,1,AFFECTS,Excitatory,3
226,Malignant Neoplasms,C0006826,en_545,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,6
227,Malignant Neoplasms,C0006826,en_545,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
228,Malignant Neoplasms,C0006826,en_545,CAUSES,Advanced cancer,C0877373,en_5070,1,1,AFFECTS,Excitatory,3
229,Candida,C0006836,en_546,CAUSES,Fungemia,C0085082,en_2640,2,1,AFFECTS,Excitatory,3
230,Candida,C0006836,en_546,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
231,Cannabidiol,C0006863,en_548,CAUSES(SPEC),Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
232,Captopril,C0006938,en_553,CAUSES,Death (finding),C1306577,en_5521,2,1,AFFECTS,Excitatory,3
233,Carbohydrates,C0007004,en_554,CAUSES,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Excitatory,6
234,Carbon Dioxide,C0007012,en_556,CAUSES,Acidosis,C0001122,en_222,1,1,AFFECTS,Excitatory,3
235,Carbon Dioxide,C0007012,en_556,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,6
236,Carbon Tetrachloride,C0007022,en_557,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
237,Carcinogens,C0007090,en_558,CAUSES,Somatic mutation,C0544886,en_4268,1,1,AFFECTS,Excitatory,3
238,Carcinogens,C0007090,en_558,CAUSES,Mammary Neoplasms,C1458155,en_5786,1,1,AFFECTS,Excitatory,3
239,Cardiovascular Diseases,C0007222,en_569,CAUSES,Cessation of life,C0011065,en_762,5,5,AFFECTS,Excitatory,21
240,Cardiovascular Diseases,C0007222,en_569,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,6
241,Cardiovascular Diseases,C0007222,en_569,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
242,Cardiovascular Diseases,C0007222,en_569,CAUSES,Cardiac complication,C0161816,en_2898,1,1,AFFECTS,Excitatory,3
243,Cardiovascular Diseases,C0007222,en_569,CAUSES,Hospital admission,C0184666,en_3063,2,1,AFFECTS,Excitatory,6
244,Cardiovascular Diseases,C0007222,en_569,CAUSES,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,Excitatory,6
245,Cardiovascular Diseases,C0007222,en_569,CAUSES(SPEC),Cessation of life,C0011065,en_762,3,1,AFFECTS,Excitatory,3
246,Carrier Proteins,C0007292,en_573,CAUSES,uptake,C0243144,en_3467,3,1,AFFECTS,Excitatory,3
247,Celiac Disease,C0007570,en_582,CAUSES,Dietary restriction NOS,C0425422,en_4004,1,1,AFFECTS,Excitatory,7
248,Cell Death,C0007587,en_587,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
249,CNS disorder,C0007682,en_597,CAUSES,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Excitatory,3
250,CNS disorder,C0007682,en_597,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,6
251,Cerebral Palsy,C0007789,en_605,CAUSES,Physical disability,C0520817,en_4192,1,1,AFFECTS,Excitatory,3
252,Cesarean section,C0007876,en_610,CAUSES,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Excitatory,3
253,Chlamydia,C0008148,en_626,CAUSES,Infertility,C0021359,en_1305,1,1,AFFECTS,Excitatory,3
254,Chlamydia,C0008148,en_626,CAUSES,"Pregnancy, Ectopic",C0032987,en_1875,1,1,AFFECTS,Excitatory,3
255,Chlamydia,C0008148,en_626,CAUSES,Pelvic Inflammatory Disease,C0242172,en_3395,1,1,AFFECTS,Excitatory,3
256,Chloroquine,C0008269,en_631,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
257,Chloroquine,C0008269,en_631,CAUSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
258,Chloroquine,C0008269,en_631,CAUSES,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,7
259,Cholelithiasis,C0008350,en_638,CAUSES,Inflammatory disorder,C1290884,en_5483,2,1,AFFECTS,Excitatory,3
260,Cholelithiasis,C0008350,en_638,CAUSES(SPEC),Pancreatitis,C0030305,en_1745,2,1,AFFECTS,Excitatory,3
261,Chronic Disease,C0008679,en_643,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
262,Chronic Disease,C0008679,en_643,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
263,Chronic Disease,C0008679,en_643,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
264,Chronic Disease,C0008679,en_643,CAUSES,Health Care,C0086388,en_2715,1,1,AFFECTS,Excitatory,3
265,Cicatrix,C0008767,en_645,CAUSES,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Excitatory,3
266,Cisplatin,C0008838,en_648,CAUSES,Injury,C0175677,en_2968,3,1,AFFECTS,Excitatory,3
267,Cocaine,C0009170,en_665,CAUSES(SPEC),Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Excitatory,3
268,Ulcerative Colitis,C0009324,en_676,CAUSES,Diarrhea,C0011991,en_810,1,1,AFFECTS,Excitatory,3
269,Ulcerative Colitis,C0009324,en_676,CAUSES,Stomach ache,C0221512,en_3228,1,1,AFFECTS,Excitatory,3
270,Collagen,C0009325,en_677,CAUSES,Fever,C0015967,en_985,2,1,AFFECTS,Excitatory,3
271,Collagen,C0009325,en_677,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Excitatory,3
272,Collagen,C0009325,en_677,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
273,Communicable Diseases,C0009450,en_685,CAUSES,Appendicitis,C0003615,en_387,1,1,AFFECTS,Excitatory,3
274,Communicable Diseases,C0009450,en_685,CAUSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,3
275,Communicable Diseases,C0009450,en_685,CAUSES,Cessation of life,C0011065,en_762,10,8,AFFECTS,Excitatory,24
276,Communicable Diseases,C0009450,en_685,CAUSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
277,Communicable Diseases,C0009450,en_685,CAUSES,Respiratory Insufficiency,C0035229,en_2012,1,1,AFFECTS,Excitatory,3
278,Communicable Diseases,C0009450,en_685,CAUSES,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,Excitatory,3
279,Communicable Diseases,C0009450,en_685,CAUSES,Septicemia,C0036690,en_2086,2,1,AFFECTS,Excitatory,3
280,Communicable Diseases,C0009450,en_685,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
281,Comorbidity,C0009488,en_690,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
282,Complement System Proteins,C0009498,en_691,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
283,Complication,C0009566,en_697,CAUSES,Cessation of life,C0011065,en_762,7,6,AFFECTS,Excitatory,24
284,Complication,C0009566,en_697,CAUSES,Disease,C0012634,en_826,3,3,AFFECTS,Excitatory,9
285,Complication,C0009566,en_697,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
286,Complication,C0009566,en_697,CAUSES,Weaning,C0043084,en_2386,1,1,AFFECTS,Excitatory,3
287,Complication,C0009566,en_697,CAUSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
288,Complication,C0009566,en_697,CAUSES,CARDIAC EVENT,C0741923,en_4791,1,1,AFFECTS,Excitatory,6
289,Complication,C0009566,en_697,CAUSES,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,3
290,Complication,C0009566,en_697,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
291,Conalbumin,C0009629,en_700,CAUSES,Cleans drug injection equipment finding,C0542277,en_4254,2,1,AFFECTS,Excitatory,3
292,Coronary Arteriosclerosis,C0010054,en_717,CAUSES,Cessation of life,C0011065,en_762,3,1,AFFECTS,Excitatory,6
293,Coronary Arteriosclerosis,C0010054,en_717,CAUSES,acute care,C0679878,en_4616,2,1,AFFECTS,Excitatory,3
294,Coronary heart disease,C0010068,en_718,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
295,Coronary heart disease,C0010068,en_718,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
296,Coughing,C0010200,en_723,CAUSES,Cessation of life,C0011065,en_762,4,2,AFFECTS,Excitatory,6
297,Coughing,C0010200,en_723,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
298,Coxiella burnetii,C0010240,en_726,CAUSES,Acute Q fever,C0519066,en_4183,1,1,AFFECTS,Excitatory,3
299,Coxsackie Viruses,C0010247,en_727,CAUSES,Eye Infections,C0015403,en_953,1,1,AFFECTS,Excitatory,3
300,Creatinine,C0010294,en_730,CAUSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
301,Critical Illness,C0010340,en_733,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
302,Critical Illness,C0010340,en_733,CAUSES,Ischemia,C0022116,en_1363,1,1,AFFECTS,Excitatory,3
303,Critical Illness,C0010340,en_733,CAUSES,Syndrome,C0039082,en_2197,4,2,AFFECTS,Excitatory,6
304,Cryptococcus,C0010415,en_736,CAUSES,Fungemia,C0085082,en_2640,2,1,AFFECTS,Excitatory,3
305,Cyclosporine,C0010592,en_740,CAUSES,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,Excitatory,3
306,"Cytopathogenic Effect, Viral",C0010827,en_753,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
307,Tissue damage,C0010957,en_756,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
308,Tissue damage,C0010957,en_756,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
309,Tissue damage,C0010957,en_756,CAUSES,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Excitatory,3
310,Tissue damage,C0010957,en_756,CAUSES,Non-productive cough,C0850149,en_4940,2,1,AFFECTS,Excitatory,3
311,Tissue damage,C0010957,en_756,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
312,Decubitus ulcer,C0011127,en_767,CAUSES,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Excitatory,3
313,Deglutition Disorders,C0011168,en_772,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
314,Dehydration,C0011175,en_773,CAUSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
315,Dengue Fever,C0011311,en_778,CAUSES,Immune response,C0301872,en_3696,2,1,AFFECTS,Excitatory,3
316,Dengue Virus,C0011315,en_779,CAUSES,Virus Diseases,C0042769,en_2362,3,2,AFFECTS,Excitatory,6
317,Dexamethasone,C0011777,en_796,CAUSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
318,Diabetes,C0011847,en_797,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
319,Diabetes,C0011847,en_797,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
320,Diabetes,C0011847,en_797,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
321,Diabetes,C0011847,en_797,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
322,Diabetes,C0011847,en_797,CAUSES,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Excitatory,3
323,Diabetes,C0011847,en_797,CAUSES,Kidney Failure,C0035078,en_1994,1,1,AFFECTS,Excitatory,3
324,Diabetes,C0011847,en_797,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,6
325,Diabetes,C0011847,en_797,CAUSES(SPEC),Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
326,Diabetes,C0011847,en_797,CAUSES(SPEC),End stage renal failure,C1261469,en_5418,1,1,AFFECTS,Excitatory,3
327,Diabetes Mellitus,C0011849,en_798,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
328,Diabetes Mellitus,C0011849,en_798,CAUSES,Insulin Resistance,C0021655,en_1325,2,1,AFFECTS,Excitatory,3
329,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,CAUSES,Immune Tolerance,C0020963,en_1272,1,1,AFFECTS,Excitatory,3
330,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,CAUSES,Diabetic cardiomyopathy,C0853897,en_4959,1,1,AFFECTS,Excitatory,3
331,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,3
332,Heroin,C0011892,en_805,CAUSES,overdose,C4018909,en_6291,1,1,AFFECTS,Excitatory,3
333,Heroin,C0011892,en_805,CAUSES,Addictive Behavior,C0085281,en_2658,1,1,AFFECTS,Excitatory,3
334,Diarrhea,C0011991,en_810,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
335,Diarrhea,C0011991,en_810,CAUSES,Hospital admission,C0184666,en_3063,1,1,AFFECTS,Excitatory,6
336,Diet,C0012155,en_811,CAUSES,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Excitatory,3
337,Diet,C0012155,en_811,CAUSES,Obesity,C0028754,en_1699,2,2,AFFECTS,Excitatory,6
338,Diet,C0012155,en_811,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
339,Diet,C0012155,en_811,CAUSES,"Steatohepatitis, non-alcoholic",C0878674,en_5075,1,1,AFFECTS,Excitatory,3
340,Dinoprostone,C0012472,en_818,CAUSES,mental dysfunction,C0679224,en_4591,1,1,AFFECTS,Excitatory,3
341,Disasters,C0012618,en_825,CAUSES,Malnutrition,C0162429,en_2910,1,1,AFFECTS,Excitatory,3
342,Disasters,C0012618,en_825,CAUSES,Acute inflammatory disease,C1290885,en_5484,1,1,AFFECTS,Excitatory,3
343,"Discharge, Body Substance",C2926602,en_6145,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
344,Disease,C0012634,en_826,CAUSES,Acute Disease,C0001314,en_230,1,1,AFFECTS,Excitatory,3
345,Disease,C0012634,en_826,CAUSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
346,Disease,C0012634,en_826,CAUSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
347,Disease,C0012634,en_826,CAUSES,Complication,C0009566,en_697,4,3,AFFECTS,Excitatory,9
348,Disease,C0012634,en_826,CAUSES,Critical Illness,C0010340,en_733,8,4,AFFECTS,Excitatory,12
349,Disease,C0012634,en_826,CAUSES,Cessation of life,C0011065,en_762,19,15,AFFECTS,Excitatory,61
350,Disease,C0012634,en_826,CAUSES,Diagnosis,C0011900,en_806,2,2,AFFECTS,Excitatory,6
351,Disease,C0012634,en_826,CAUSES,Dyspnea,C0013404,en_866,2,1,AFFECTS,Excitatory,3
352,Disease,C0012634,en_826,CAUSES,Edema,C0013604,en_877,2,2,AFFECTS,Excitatory,6
353,Disease,C0012634,en_826,CAUSES,Fatigue,C0015672,en_966,1,1,AFFECTS,Excitatory,3
354,Disease,C0012634,en_826,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
355,Disease,C0012634,en_826,CAUSES,Health Services,C0018747,en_1125,1,1,AFFECTS,Excitatory,3
356,Disease,C0012634,en_826,CAUSES,Hospitalization,C0019993,en_1206,3,3,AFFECTS,Excitatory,9
357,Disease,C0012634,en_826,CAUSES,Infection,C3714514,en_6235,6,4,AFFECTS,Excitatory,12
358,Disease,C0012634,en_826,CAUSES,Inflammation,C0021368,en_1307,4,4,AFFECTS,Excitatory,16
359,Disease,C0012634,en_826,CAUSES,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,Excitatory,3
360,Disease,C0012634,en_826,CAUSES,Leukocytosis,C0023518,en_1421,1,1,AFFECTS,Excitatory,3
361,Disease,C0012634,en_826,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
362,Disease,C0012634,en_826,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,6
363,Disease,C0012634,en_826,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
364,Disease,C0012634,en_826,CAUSES,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Excitatory,3
365,Disease,C0012634,en_826,CAUSES,Pneumonia,C0032285,en_1833,13,8,AFFECTS,Excitatory,24
366,Disease,C0012634,en_826,CAUSES,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Excitatory,3
367,Disease,C0012634,en_826,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
368,Disease,C0012634,en_826,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,11,6,AFFECTS,Excitatory,18
369,Disease,C0012634,en_826,CAUSES,Respiratory Tract Infections,C0035243,en_2017,4,1,AFFECTS,Excitatory,3
370,Disease,C0012634,en_826,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,3
371,Disease,C0012634,en_826,CAUSES,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Excitatory,3
372,Disease,C0012634,en_826,CAUSES,Sleep,C0037313,en_2119,2,1,AFFECTS,Excitatory,3
373,Disease,C0012634,en_826,CAUSES,Syndrome,C0039082,en_2197,4,3,AFFECTS,Excitatory,9
374,Disease,C0012634,en_826,CAUSES,Virus Diseases,C0042769,en_2362,5,3,AFFECTS,Excitatory,9
375,Disease,C0012634,en_826,CAUSES,Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Excitatory,3
376,Disease,C0012634,en_826,CAUSES,Hospital admission,C0184666,en_3063,2,1,AFFECTS,Excitatory,3
377,Disease,C0012634,en_826,CAUSES,Fatal Outcome,C0206277,en_3157,1,1,AFFECTS,Excitatory,6
378,Disease,C0012634,en_826,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,8
379,Disease,C0012634,en_826,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
380,Disease,C0012634,en_826,CAUSES,Lung infiltration,C0235896,en_3332,1,1,AFFECTS,Excitatory,3
381,Disease,C0012634,en_826,CAUSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
382,Disease,C0012634,en_826,CAUSES,Acute respiratory failure,C0264490,en_3533,2,2,AFFECTS,Excitatory,14
383,Disease,C0012634,en_826,CAUSES,Immune response,C0301872,en_3696,2,2,AFFECTS,Excitatory,6
384,Disease,C0012634,en_826,CAUSES,Hypercapnic respiratory failure,C0398353,en_3947,1,1,AFFECTS,Excitatory,3
385,Disease,C0012634,en_826,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,3
386,Disease,C0012634,en_826,CAUSES,Primary immune deficiency disorder,C0398686,en_3951,1,1,AFFECTS,Excitatory,3
387,Disease,C0012634,en_826,CAUSES,Respiratory distress,C0476273,en_4149,3,2,AFFECTS,Excitatory,9
388,Disease,C0012634,en_826,CAUSES,Acute abdominal pain,C0740577,en_4779,1,1,AFFECTS,Excitatory,3
389,Disease,C0012634,en_826,CAUSES,Infection Problem,C0740689,en_4780,1,1,AFFECTS,Excitatory,3
390,Disease,C0012634,en_826,CAUSES,Cytokine storm,C0919747,en_5119,3,2,AFFECTS,Excitatory,9
391,Disease,C0012634,en_826,CAUSES,Bilateral pneumonia,C1142578,en_5287,1,1,AFFECTS,Excitatory,7
392,Disease,C0012634,en_826,CAUSES,Respiratory Failure,C1145670,en_5292,13,10,AFFECTS,Excitatory,34
393,Disease,C0012634,en_826,CAUSES,Inflammatory Response,C1155266,en_5321,2,2,AFFECTS,Excitatory,6
394,Disease,C0012634,en_826,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,5,3,AFFECTS,Excitatory,9
395,Disease,C0012634,en_826,CAUSES,End stage renal failure,C1261469,en_5418,1,1,AFFECTS,Excitatory,3
396,Disease,C0012634,en_826,CAUSES,Introduction procedure,C1293116,en_5496,1,1,AFFECTS,Excitatory,3
397,Disease,C0012634,en_826,CAUSES,Immune System Suppression,C1373218,en_5686,1,1,AFFECTS,Excitatory,6
398,Disease,C0012634,en_826,CAUSES,Symptoms,C1457887,en_5784,5,3,AFFECTS,Excitatory,9
399,Disease,C0012634,en_826,CAUSES,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,Excitatory,6
400,Disease,C0012634,en_826,CAUSES,Severe infection,C5139167,en_6407,1,1,AFFECTS,Excitatory,7
401,Disease,C0012634,en_826,CAUSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,14
402,Disease Outbreaks,C0012652,en_827,CAUSES,Disease,C0012634,en_826,9,7,AFFECTS,Excitatory,21
403,Disease Outbreaks,C0012652,en_827,CAUSES,Infection,C3714514,en_6235,2,2,AFFECTS,Excitatory,6
404,Disease Outbreaks,C0012652,en_827,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
405,Disease Outbreaks,C0012652,en_827,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
406,Disease Outbreaks,C0012652,en_827,CAUSES,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Excitatory,3
407,Disease Outbreaks,C0012652,en_827,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
408,Disseminated Intravascular Coagulation,C0012739,en_829,CAUSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,7
409,Disseminated Intravascular Coagulation,C0012739,en_829,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
410,Disseminated Intravascular Coagulation,C0012739,en_829,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
411,DNA,C0012854,en_834,CAUSES,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Excitatory,6
412,DNA,C0012854,en_834,CAUSES,Thickened,C0205400,en_3130,1,1,AFFECTS,Excitatory,3
413,DNA,C0012854,en_834,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
414,"DNA, Mitochondrial",C0012929,en_837,CAUSES,Hereditary Diseases,C0019247,en_1180,1,1,AFFECTS,Excitatory,3
415,Docosahexaenoic Acids,C0012968,en_838,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
416,Dopamine,C0013030,en_842,CAUSES,Depressive disorder,C0011581,en_788,2,1,AFFECTS,Excitatory,3
417,Pharmacotherapy,C0013216,en_855,CAUSES,Peripheral Neuropathy,C0031117,en_1776,1,1,AFFECTS,Excitatory,3
418,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
419,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
420,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Complication,C0009566,en_697,2,2,AFFECTS,Excitatory,6
421,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
422,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Drug abuse,C0013146,en_851,1,1,AFFECTS,Excitatory,3
423,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Fever,C0015967,en_985,1,1,AFFECTS,Excitatory,3
424,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
425,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Phlebitis,C0031542,en_1792,1,1,AFFECTS,Excitatory,3
426,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
427,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Seizures,C0036572,en_2076,1,1,AFFECTS,Excitatory,3
428,Pharmaceutical Preparations,C0013227,en_856,CAUSES,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,2,AFFECTS,Excitatory,6
429,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
430,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Acute Lung Injury,C0242488,en_3416,3,2,AFFECTS,Excitatory,6
431,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Congenital webbing,C0332875,en_3755,1,1,AFFECTS,Excitatory,3
432,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Chronic liver disease NOS,C0341439,en_3823,1,1,AFFECTS,Excitatory,3
433,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Maximum,C0806909,en_4887,1,1,AFFECTS,Excitatory,3
434,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Excitatory,3
435,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,Excitatory,3
436,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Adverse event,C0877248,en_5069,3,2,AFFECTS,Excitatory,6
437,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Excitatory,3
438,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Death (finding),C1306577,en_5521,2,1,AFFECTS,Excitatory,3
439,Pharmaceutical Preparations,C0013227,en_856,CAUSES,hearing impairment,C1384666,en_5689,2,2,AFFECTS,Excitatory,6
440,Pharmaceutical Preparations,C0013227,en_856,CAUSES,imbalance,C1397014,en_5692,1,1,AFFECTS,Excitatory,3
441,Pharmaceutical Preparations,C0013227,en_856,CAUSES,Antiinflammatory Effect,C1516019,en_5851,1,1,AFFECTS,Excitatory,3
442,Dust,C0013330,en_861,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
443,Dyspnea,C0013404,en_866,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
444,Dyspnea,C0013404,en_866,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
445,Dyspnea,C0013404,en_866,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,6
446,Dyspnea,C0013404,en_866,CAUSES,Hospital admission,C0184666,en_3063,2,1,AFFECTS,Excitatory,3
447,Embolism,C0013922,en_887,CAUSES,Cerebral Infarction,C0007785,en_603,1,1,AFFECTS,Excitatory,3
448,Embolism,C0013922,en_887,CAUSES,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,Excitatory,3
449,Endotoxins,C0014264,en_903,CAUSES,Acute Lung Injury,C0242488,en_3416,2,2,AFFECTS,Excitatory,6
450,Enterobacter,C0014344,en_907,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
451,Enterobacteriaceae,C0014346,en_908,CAUSES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Excitatory,3
452,Enterovirus,C0014383,en_910,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
453,Enzymes,C0014442,en_912,CAUSES,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Excitatory,6
454,Enzymes,C0014442,en_912,CAUSES,Cell Death,C0007587,en_587,3,3,AFFECTS,Excitatory,9
455,Epidemic,C0014499,en_914,CAUSES,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Excitatory,3
456,Epidemic,C0014499,en_914,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
457,Epidemic,C0014499,en_914,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
458,Epidemic,C0014499,en_914,CAUSES,Influenza,C0021400,en_1311,1,1,AFFECTS,Excitatory,3
459,Epidemic,C0014499,en_914,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
460,Ergosterol,C0014705,en_925,CAUSES,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Excitatory,3
461,Escherichia coli,C0014834,en_929,CAUSES,Superinfection,C0038826,en_2184,1,1,AFFECTS,Excitatory,6
462,Escherichia coli,C0014834,en_929,CAUSES,Urinary tract infection,C0042029,en_2320,1,1,AFFECTS,Excitatory,6
463,Escherichia coli,C0014834,en_929,CAUSES,Intestinal tract infectious disease NOS,C0178238,en_2979,1,1,AFFECTS,Excitatory,3
464,Evolution,C0015219,en_937,CAUSES,Syndrome,C0039082,en_2197,2,1,AFFECTS,Excitatory,3
465,Exercise,C0015259,en_940,CAUSES,Distress,C0231303,en_3256,1,1,AFFECTS,Excitatory,7
466,Exercise,C0015259,en_940,CAUSES,Muscle hypertrophy,C0236033,en_3337,2,1,AFFECTS,Excitatory,3
467,Exercise,C0015259,en_940,CAUSES,Functional capacity,C1998319,en_6082,1,1,AFFECTS,Excitatory,7
468,Exocytosis,C0015283,en_943,CAUSES,Antibody -dependent cell cytotoxicity,C0003272,en_353,2,1,AFFECTS,Excitatory,3
469,Exocytosis,C0015283,en_943,CAUSES,Apoptosis,C0162638,en_2922,2,1,AFFECTS,Excitatory,3
470,Exudate,C0015388,en_950,CAUSES,Airway Obstruction,C0001883,en_266,1,1,AFFECTS,Excitatory,6
471,Fatigue,C0015672,en_966,CAUSES,Cessation of life,C0011065,en_762,4,2,AFFECTS,Excitatory,6
472,Fatigue,C0015672,en_966,CAUSES,Chronic Fatigue Syndrome,C0015674,en_967,4,2,AFFECTS,Excitatory,6
473,Fatigue,C0015672,en_966,CAUSES,[D]Musculoskeletal pain,C0026858,en_1608,1,1,AFFECTS,Excitatory,3
474,Fatigue,C0015672,en_966,CAUSES,Sleep,C0037313,en_2119,1,1,AFFECTS,Excitatory,3
475,Fatigue,C0015672,en_966,CAUSES,Evaluation,C0220825,en_3201,1,1,AFFECTS,Excitatory,6
476,Chronic Fatigue Syndrome,C0015674,en_967,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
477,Fatty Acids,C0015684,en_969,CAUSES,Extravasation,C0015376,en_949,1,1,AFFECTS,Excitatory,3
478,Fatty Acids,C0015684,en_969,CAUSES,Lysis,C0024348,en_1476,1,1,AFFECTS,Excitatory,3
479,"Fatty Acids, Nonesterified",C0015688,en_970,CAUSES,Instability,C1444783,en_5750,1,1,AFFECTS,Excitatory,3
480,Fentanyl,C0015846,en_978,CAUSES,Respiratory Depression,C0235063,en_3320,2,1,AFFECTS,Excitatory,3
481,Fetal Distress,C0015930,en_983,CAUSES,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Excitatory,3
482,Fetal Distress,C0015930,en_983,CAUSES,Maternal-Fetal Transmission,C0282474,en_3647,1,1,AFFECTS,Excitatory,3
483,Fibrinolytic Agents,C0016018,en_991,CAUSES,"Stroke, Acute",C0751956,en_4854,1,1,AFFECTS,Excitatory,3
484,Fibromyalgia,C0016053,en_993,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
485,Fibrosis,C0016059,en_994,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,6
486,Fibrosis,C0016059,en_994,CAUSES,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,Excitatory,3
487,Filarioidea,C0016091,en_995,CAUSES(SPEC),Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
488,Food,C0016452,en_1011,CAUSES,Mental disorders,C0004936,en_452,1,1,AFFECTS,Excitatory,3
489,Food,C0016452,en_1011,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
490,Food,C0016452,en_1011,CAUSES,Abnormal shape,C0332482,en_3751,2,1,AFFECTS,Excitatory,3
491,Food Allergy,C0016470,en_1013,CAUSES,Allergic Reaction,C1527304,en_5919,1,1,AFFECTS,Excitatory,3
492,Formaldehyde,C0016564,en_1014,CAUSES,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Excitatory,3
493,Influenza in Birds,C0016627,en_1015,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
494,Free Radicals,C0016693,en_1018,CAUSES,Tissue damage,C0010957,en_756,2,1,AFFECTS,Excitatory,3
495,Free Radicals,C0016693,en_1018,CAUSES,Oxidative Stress,C0242606,en_3422,2,1,AFFECTS,Excitatory,3
496,fungus,C0016832,en_1023,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
497,fungus,C0016832,en_1023,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
498,fungus,C0016832,en_1023,CAUSES,AIRWAY DISEASE,C0699949,en_4711,1,1,AFFECTS,Excitatory,3
499,gamma-Aminobutyric Acid,C0016904,en_1026,CAUSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
500,Gases,C0017110,en_1034,CAUSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
501,Gastritis,C0017152,en_1036,CAUSES,"Abdomen, Acute",C0000727,en_205,1,1,AFFECTS,Excitatory,3
502,Gastrointestinal Hemorrhage,C0017181,en_1040,CAUSES,Liver Cirrhosis,C0023890,en_1454,1,1,AFFECTS,Excitatory,6
503,Gel,C0017243,en_1043,CAUSES,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,Excitatory,3
504,"Gene Products, env",C0017278,en_1046,CAUSES,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,3
505,gene therapy,C0017296,en_1048,CAUSES,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Excitatory,6
506,Genes,C0017337,en_1052,CAUSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
507,Genes,C0017337,en_1052,CAUSES,Disease,C0012634,en_826,3,1,AFFECTS,Excitatory,3
508,Genes,C0017337,en_1052,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
509,Genes,C0017337,en_1052,CAUSES,Aicardi's syndrome,C0175713,en_2969,1,1,AFFECTS,Excitatory,3
510,Genes,C0017337,en_1052,CAUSES,Malignant neoplasm of kidney,C0740457,en_4778,1,1,AFFECTS,Excitatory,3
511,Synthetic Genes,C0017374,en_1053,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
512,Synthetic Genes,C0017374,en_1053,CAUSES,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,3
513,"Genes, Viral",C0017376,en_1054,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
514,Genome,C0017428,en_1059,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
515,Genome,C0017428,en_1059,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
516,Gingivitis,C0017574,en_1060,CAUSES,Periodontitis,C0031099,en_1775,1,1,AFFECTS,Excitatory,3
517,Gingivitis,C0017574,en_1060,CAUSES,Tooth Loss,C0080233,en_2626,1,1,AFFECTS,Excitatory,6
518,Glucocorticoids,C0017710,en_1068,CAUSES,Osteoporosis,C0029456,en_1726,1,1,AFFECTS,Excitatory,3
519,Glucocorticoids,C0017710,en_1068,CAUSES,"Osteoporosis, Postmenopausal",C0029458,en_1727,1,1,AFFECTS,Excitatory,3
520,Glucose,C0017725,en_1072,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
521,Glutamates,C0017789,en_1074,CAUSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
522,Glutamates,C0017789,en_1074,CAUSES,T-Cell Proliferation,C1155046,en_5314,2,1,AFFECTS,Excitatory,3
523,Glycoproteins,C0017968,en_1085,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
524,Glycyrrhetinic Acid,C0017986,en_1087,CAUSES,Liddle's syndrome,C0221043,en_3211,1,1,AFFECTS,Excitatory,3
525,Gout,C0018099,en_1091,CAUSES,Preventive Intervention,C1514416,en_5833,1,1,AFFECTS,Excitatory,3
526,Gram-Negative Bacteria,C0018150,en_1093,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
527,Heart Arrest,C0018790,en_1131,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
528,Cardiac Catheterization Procedures,C0018795,en_1132,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
529,Heart Diseases,C0018799,en_1134,CAUSES,Complication,C0009566,en_697,3,2,AFFECTS,Excitatory,6
530,Heart Diseases,C0018799,en_1134,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,6
531,Heart Diseases,C0018799,en_1134,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
532,Heart failure,C0018801,en_1135,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,6
533,Heart failure,C0018801,en_1135,CAUSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,3
534,Heart failure,C0018801,en_1135,CAUSES,Hospitalization,C0019993,en_1206,3,2,AFFECTS,Excitatory,6
535,Heart failure,C0018801,en_1135,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
536,Heart failure,C0018801,en_1135,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
537,Helminthiasis,C0018889,en_1146,CAUSES,"Tuberculosis, Lymph Node",C0041316,en_2296,1,1,AFFECTS,Excitatory,3
538,Hematopoiesis,C0018951,en_1152,CAUSES,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,3
539,Heme,C0018966,en_1154,CAUSES,Methemoglobinemia,C0025637,en_1554,1,1,AFFECTS,Excitatory,3
540,Hemodialysis,C0019004,en_1155,CAUSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
541,Hemorrhage,C0019080,en_1161,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
542,Tacaribe Complex Viruses,C0019094,en_1163,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
543,"Heparin, Low-Molecular-Weight",C0019139,en_1167,CAUSES,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Excitatory,3
544,Heparitin Sulfate,C0019143,en_1168,CAUSES,Degenerative abnormality,C0011164,en_770,2,1,AFFECTS,Excitatory,3
545,Hepatitis B Virus,C0019169,en_1174,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
546,Hepatitis B Virus,C0019169,en_1174,CAUSES,Liver damage,C0151763,en_2867,1,1,AFFECTS,Excitatory,3
547,Hepatitis Viruses,C0019186,en_1175,CAUSES,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,Excitatory,3
548,Primary carcinoma of the liver cells,C0019204,en_1178,CAUSES,Liver diseases,C0023895,en_1455,4,1,AFFECTS,Excitatory,3
549,Hesperidin,C0019392,en_1183,CAUSES,Drowsiness,C0013144,en_850,1,1,AFFECTS,Excitatory,3
550,HEXOKINASE,C0019472,en_1184,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
551,HIV Antibodies,C0019683,en_1191,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
552,HLA Antigens,C0019721,en_1195,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
553,homocysteine,C0019878,en_1203,CAUSES,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Excitatory,3
554,homocysteine,C0019878,en_1203,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
555,"Hydrocephalus, Normal Pressure",C0020258,en_1218,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
556,Hydrogen,C0020275,en_1220,CAUSES,Complication,C0009566,en_697,3,1,AFFECTS,Excitatory,3
557,Hydrogen,C0020275,en_1220,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
558,Hydrogen Peroxide,C0020281,en_1221,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
559,Hydrogen Peroxide,C0020281,en_1221,CAUSES,Oxidative Stress,C0242606,en_3422,2,1,AFFECTS,Excitatory,3
560,Hydroxychloroquine,C0020336,en_1226,CAUSES,Pigmentation,C0031911,en_1809,2,1,AFFECTS,Excitatory,3
561,Hydroxychloroquine,C0020336,en_1226,CAUSES,Retinal depigmentation,C0151891,en_2870,1,1,AFFECTS,Excitatory,3
562,Hydroxychloroquine,C0020336,en_1226,CAUSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
563,Hydroxychloroquine,C0020336,en_1226,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,3
564,Hydroxychloroquine,C0020336,en_1226,CAUSES,Retinal toxicity,C0877104,en_5063,1,1,AFFECTS,Excitatory,3
565,Hydroxychloroquine,C0020336,en_1226,CAUSES,Worse,C1457868,en_5783,1,1,AFFECTS,Excitatory,8
566,hypercholesterolemia,C0020443,en_1231,CAUSES,Arteriosclerosis,C0003850,en_399,1,1,AFFECTS,Excitatory,3
567,Hypersensitivity,C0020517,en_1238,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
568,Hypersensitivity,C0020517,en_1238,CAUSES(SPEC),Allergic rhinitis NOS,C0002103,en_280,2,1,AFFECTS,Excitatory,3
569,Hypertensive disease,C0020538,en_1239,CAUSES,Blood Pressure,C0005823,en_492,1,1,AFFECTS,Excitatory,3
570,Hypertensive disease,C0020538,en_1239,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
571,Hypertensive disease,C0020538,en_1239,CAUSES,Cessation of life,C0011065,en_762,5,3,AFFECTS,Excitatory,12
572,Hypertensive disease,C0020538,en_1239,CAUSES(SPEC),Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
573,Hypertensive disease,C0020538,en_1239,CAUSES(SPEC),End stage renal failure,C1261469,en_5418,1,1,AFFECTS,Excitatory,3
574,IgG3,C0020859,en_1266,CAUSES,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Excitatory,3
575,Immobilization,C0020944,en_1269,CAUSES,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,Excitatory,3
576,Immunity,C0020964,en_1273,CAUSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
577,Immunization,C0020971,en_1277,CAUSES,Uveitis,C0042164,en_2325,1,1,AFFECTS,Excitatory,3
578,Immunoglobulins,C0021027,en_1282,CAUSES,Malaria,C0024530,en_1493,1,1,AFFECTS,Excitatory,3
579,Immunologic Factors,C0021054,en_1285,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
580,Immunotherapy,C0021083,en_1290,CAUSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
581,Immunotherapy,C0021083,en_1290,CAUSES,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Excitatory,3
582,Infarction,C0021308,en_1301,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
583,Infection,C3714514,en_6235,CAUSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
584,Infection,C3714514,en_6235,CAUSES,Common Cold,C0009443,en_684,1,1,AFFECTS,Excitatory,3
585,Infection,C3714514,en_6235,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
586,Infection,C3714514,en_6235,CAUSES,Disease,C0012634,en_826,3,2,AFFECTS,Excitatory,6
587,Infection,C3714514,en_6235,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
588,Infection,C3714514,en_6235,CAUSES,Immune System Diseases,C0021053,en_1284,1,1,AFFECTS,Excitatory,3
589,Infection,C3714514,en_6235,CAUSES,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,Excitatory,3
590,Infection,C3714514,en_6235,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
591,Infection,C3714514,en_6235,CAUSES,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Excitatory,6
592,Infection,C3714514,en_6235,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,3,AFFECTS,Excitatory,9
593,Infection,C3714514,en_6235,CAUSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
594,Infection,C3714514,en_6235,CAUSES,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Excitatory,3
595,Infection,C3714514,en_6235,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
596,Infection,C3714514,en_6235,CAUSES,Vasculitis,C0042384,en_2338,1,1,AFFECTS,Excitatory,3
597,Infection,C3714514,en_6235,CAUSES,Respiratory complication,C0161818,en_2899,1,1,AFFECTS,Excitatory,3
598,Infection,C3714514,en_6235,CAUSES,Malaise,C0231218,en_3251,1,1,AFFECTS,Excitatory,3
599,Infection,C3714514,en_6235,CAUSES,Acute respiratory failure,C0264490,en_3533,4,1,AFFECTS,Excitatory,3
600,Infection,C3714514,en_6235,CAUSES,Nosocomial pneumonia,C0949083,en_5175,1,1,AFFECTS,Excitatory,3
601,Infection,C3714514,en_6235,CAUSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,3
602,Infection,C3714514,en_6235,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
603,Infection,C3714514,en_6235,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
604,Infectious disorder of kidney,C0021313,en_1302,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
605,Human Papillomavirus,C0021344,en_1303,CAUSES,Malignant neoplasm of cervix uteri,C0007847,en_608,1,1,AFFECTS,Excitatory,3
606,Infertility,C0021359,en_1305,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
607,Inflammation,C0021368,en_1307,CAUSES,Anemia,C0002871,en_316,1,1,AFFECTS,Excitatory,6
608,Inflammation,C0021368,en_1307,CAUSES,Blood Coagulation Disorders,C0005779,en_485,5,2,AFFECTS,Excitatory,6
609,Inflammation,C0021368,en_1307,CAUSES,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Excitatory,3
610,Inflammation,C0021368,en_1307,CAUSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,3
611,Inflammation,C0021368,en_1307,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
612,Inflammation,C0021368,en_1307,CAUSES,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Excitatory,3
613,Inflammation,C0021368,en_1307,CAUSES,Disease,C0012634,en_826,4,4,AFFECTS,Excitatory,15
614,Inflammation,C0021368,en_1307,CAUSES,Disseminated Intravascular Coagulation,C0012739,en_829,2,2,AFFECTS,Excitatory,6
615,Inflammation,C0021368,en_1307,CAUSES,Growth,C0018270,en_1098,2,1,AFFECTS,Excitatory,3
616,Inflammation,C0021368,en_1307,CAUSES,Hypertensive disease,C0020538,en_1239,2,1,AFFECTS,Excitatory,3
617,Inflammation,C0021368,en_1307,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
618,Inflammation,C0021368,en_1307,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
619,Inflammation,C0021368,en_1307,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
620,Inflammation,C0021368,en_1307,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,3,AFFECTS,Excitatory,9
621,Inflammation,C0021368,en_1307,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,3
622,Inflammation,C0021368,en_1307,CAUSES,Superinfection,C0038826,en_2184,3,1,AFFECTS,Excitatory,3
623,Inflammation,C0021368,en_1307,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
624,Inflammation,C0021368,en_1307,CAUSES,Virus Diseases,C0042769,en_2362,3,2,AFFECTS,Excitatory,6
625,Inflammation,C0021368,en_1307,CAUSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
626,Inflammation,C0021368,en_1307,CAUSES,Dyslipidemias,C0242339,en_3406,2,1,AFFECTS,Excitatory,3
627,Inflammation,C0021368,en_1307,CAUSES,Immune response,C0301872,en_3696,2,1,AFFECTS,Excitatory,3
628,Inflammation,C0021368,en_1307,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,3
629,Inflammation,C0021368,en_1307,CAUSES,Acute respiratory distress,C0748355,en_4831,5,2,AFFECTS,Excitatory,6
630,Inflammation,C0021368,en_1307,CAUSES,Cytokine storm,C0919747,en_5119,3,2,AFFECTS,Excitatory,6
631,Inflammation,C0021368,en_1307,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,7
632,Inflammation,C0021368,en_1307,CAUSES,Macrophage activation syndrome,C1096155,en_5233,2,1,AFFECTS,Excitatory,3
633,Inflammation,C0021368,en_1307,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
634,Inflammation,C0021368,en_1307,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
635,Inflammation,C0021368,en_1307,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
636,Inflammation,C0021368,en_1307,CAUSES(SPEC),Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
637,Chronic inflammation,C0021376,en_1309,CAUSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,6
638,Chronic inflammation,C0021376,en_1309,CAUSES,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,Excitatory,3
639,Influenza,C0021400,en_1311,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,6
640,Influenza,C0021400,en_1311,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
641,Influenza,C0021400,en_1311,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
642,Influenza,C0021400,en_1311,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Excitatory,6
643,Influenza,C0021400,en_1311,CAUSES,Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Excitatory,3
644,Influenza,C0021400,en_1311,CAUSES,Viral respiratory infection,C0729531,en_4763,1,1,AFFECTS,Excitatory,3
645,Influenza,C0021400,en_1311,CAUSES,Infectious disease of lung,C0876973,en_5058,2,1,AFFECTS,Excitatory,3
646,Integrins,C0021701,en_1328,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
647,Integrins,C0021701,en_1328,CAUSES,[X]Injury of blood vessel(s) of unspecified body region,C0178324,en_2982,1,1,AFFECTS,Excitatory,3
648,Interleukin-1 beta,C0021753,en_1334,CAUSES,Neutrophil Infiltration,C0751982,en_4855,1,1,AFFECTS,Excitatory,3
649,Interleukin-1 beta,C0021753,en_1334,CAUSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,3
650,Interleukin-1 beta,C0021753,en_1334,CAUSES,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Excitatory,3
651,Interleukin-6,C0021760,en_1342,CAUSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
652,Interleukin-6,C0021760,en_1342,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
653,Interleukin-6,C0021760,en_1342,CAUSES,Lymphopenia,C0024312,en_1474,2,1,AFFECTS,Excitatory,3
654,Interleukin-6,C0021760,en_1342,CAUSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
655,Interleukin-6,C0021760,en_1342,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
656,Interleukin-6,C0021760,en_1342,CAUSES,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Excitatory,3
657,Interleukin-6,C0021760,en_1342,CAUSES,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Excitatory,3
658,Interleukin-6,C0021760,en_1342,CAUSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,3
659,Interleukin-6,C0021760,en_1342,CAUSES,Inflammatory Response,C1155266,en_5321,2,2,AFFECTS,Excitatory,6
660,Interleukin-6,C0021760,en_1342,CAUSES,Death (finding),C1306577,en_5521,4,2,AFFECTS,Excitatory,6
661,Interleukin-6,C0021760,en_1342,CAUSES(SPEC),Cytokine storm,C0919747,en_5119,4,2,AFFECTS,Excitatory,6
662,Ischemia,C0022116,en_1363,CAUSES,Cerebral Palsy,C0007789,en_605,1,1,AFFECTS,Excitatory,3
663,Ischemia,C0022116,en_1363,CAUSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
664,Ischemia,C0022116,en_1363,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
665,Ischemia,C0022116,en_1363,CAUSES,Organ failure,C0948600,en_5171,1,1,AFFECTS,Excitatory,3
666,Isopropanol,C0022237,en_1368,CAUSES,Eye Injuries,C0015408,en_954,1,1,AFFECTS,Excitatory,6
667,Isoproterenol,C0022245,en_1369,CAUSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,3
668,Isotretinoin,C0022265,en_1370,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,6,2,AFFECTS,Excitatory,6
669,Isotretinoin,C0022265,en_1370,CAUSES,Scab,C0205204,en_3127,3,1,AFFECTS,Excitatory,3
670,Isotretinoin,C0022265,en_1370,CAUSES,Nasal mucosa dry,C0231919,en_3267,3,1,AFFECTS,Excitatory,3
671,Isotretinoin,C0022265,en_1370,CAUSES,Death (finding),C1306577,en_5521,8,4,AFFECTS,Excitatory,12
672,Ivermectin,C0022322,en_1371,CAUSES,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,8
673,Ivermectin,C0022322,en_1371,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,8
674,"Kidney Failure, Acute",C0022660,en_1382,CAUSES,Chronic Kidney Diseases,C1561643,en_5967,1,1,AFFECTS,Excitatory,6
675,Peptidyl-Dipeptidase A,C0022709,en_1387,CAUSES,Diabetes,C0011847,en_797,2,1,AFFECTS,Excitatory,3
676,Peptidyl-Dipeptidase A,C0022709,en_1387,CAUSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
677,Peptidyl-Dipeptidase A,C0022709,en_1387,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
678,Peptidyl-Dipeptidase A,C0022709,en_1387,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
679,Klebsiella,C0022727,en_1388,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
680,Klebsiella,C0022727,en_1388,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
681,"Obstetric Labor, Premature",C0022876,en_1391,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
682,Lassa virus,C0023093,en_1400,CAUSES,"Hemorrhagic Fevers, Viral",C0019104,en_1164,1,1,AFFECTS,Excitatory,3
683,Leukotrienes,C0023545,en_1426,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
684,Ligation,C0023690,en_1434,CAUSES,"Fibrosis, Liver",C0239946,en_3377,1,1,AFFECTS,Excitatory,3
685,Lignin,C0023705,en_1436,CAUSES,Adaptation,C0392673,en_3925,1,1,AFFECTS,Excitatory,3
686,Lipase,C0023764,en_1438,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
687,Lipids,C0023779,en_1441,CAUSES,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Excitatory,6
688,Lipids,C0023779,en_1441,CAUSES,Diastasis,C0036679,en_2084,2,1,AFFECTS,Excitatory,3
689,Lipopolysaccharides,C0023810,en_1443,CAUSES,Inflammation,C0021368,en_1307,2,2,AFFECTS,Excitatory,6
690,Lipopolysaccharides,C0023810,en_1443,CAUSES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Excitatory,3
691,Lipopolysaccharides,C0023810,en_1443,CAUSES,Pneumonia,C0032285,en_1833,5,4,AFFECTS,Excitatory,12
692,Lipopolysaccharides,C0023810,en_1443,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,3,AFFECTS,Excitatory,9
693,Lipopolysaccharides,C0023810,en_1443,CAUSES,Septicemia,C0036690,en_2086,2,1,AFFECTS,Excitatory,3
694,Lipopolysaccharides,C0023810,en_1443,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
695,Lipopolysaccharides,C0023810,en_1443,CAUSES,Acute Lung Injury,C0242488,en_3416,3,3,AFFECTS,Excitatory,14
696,Lipopolysaccharides,C0023810,en_1443,CAUSES(SPEC),Acute Lung Injury,C0242488,en_3416,2,2,AFFECTS,Excitatory,6
697,Little's Disease,C0023882,en_1451,CAUSES,Acute failure,C0231176,en_3248,2,1,AFFECTS,Excitatory,3
698,Little's Disease,C0023882,en_1451,CAUSES,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Excitatory,3
699,Little's Disease,C0023882,en_1451,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
700,Liver Abscess,C0023885,en_1453,CAUSES,"Abdomen, Acute",C0000727,en_205,1,1,AFFECTS,Excitatory,3
701,Liver diseases,C0023895,en_1455,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
702,Lung diseases,C0024115,en_1462,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
703,Lung diseases,C0024115,en_1462,CAUSES,Dyspnea,C0013404,en_866,2,1,AFFECTS,Excitatory,3
704,Lung diseases,C0024115,en_1462,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
705,Lung diseases,C0024115,en_1462,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,6
706,Lung diseases,C0024115,en_1462,CAUSES,intensive care,C0085559,en_2678,2,1,AFFECTS,Excitatory,3
707,Lung diseases,C0024115,en_1462,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
708,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
709,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES,Coughing,C0010200,en_723,1,1,AFFECTS,Excitatory,3
710,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES,Cessation of life,C0011065,en_762,3,2,AFFECTS,Excitatory,6
711,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES,Fatigue,C0015672,en_966,1,1,AFFECTS,Excitatory,3
712,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
713,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES,follow-up,C1522577,en_5904,1,1,AFFECTS,Excitatory,7
714,Chronic Obstructive Airway Disease,C0024117,en_1463,CAUSES(SPEC),Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
715,Lung Neoplasms,C0024121,en_1465,CAUSES,Postobstructive pneumonia,C0747690,en_4824,1,1,AFFECTS,Excitatory,8
716,Lymphoma,C0024299,en_1471,CAUSES,Hypogammaglobulinemia,C0086438,en_2720,1,1,AFFECTS,Excitatory,3
717,Lymphopenia,C0024312,en_1474,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
718,Lymphopenia,C0024312,en_1474,CAUSES,Viremia,C0042749,en_2359,1,1,AFFECTS,Excitatory,3
719,Migration Inhibitory Factor,C0024429,en_1483,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
720,Malaria,C0024530,en_1493,CAUSES,Flu symptoms,C0948873,en_5174,1,1,AFFECTS,Excitatory,3
721,Masks,C0024861,en_1501,CAUSES,Extravasation,C0015376,en_949,3,3,AFFECTS,Excitatory,9
722,Masks,C0024861,en_1501,CAUSES,Heat Stroke,C0018843,en_1144,1,1,AFFECTS,Excitatory,3
723,Masks,C0024861,en_1501,CAUSES,skin disorder,C0037274,en_2115,2,1,AFFECTS,Excitatory,6
724,Masks,C0024861,en_1501,CAUSES,Hypoxia,C0242184,en_3396,2,1,AFFECTS,Excitatory,6
725,Masks,C0024861,en_1501,CAUSES,Acne,C0702166,en_4736,1,1,AFFECTS,Excitatory,6
726,mastocytosis,C0024899,en_1506,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
727,Medical Devices,C0025080,en_1517,CAUSES,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,Excitatory,3
728,Membrane Proteins,C0025252,en_1530,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
729,Metabolic Diseases,C0025517,en_1546,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
730,Metabolic Diseases,C0025517,en_1546,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
731,Methionine,C0025646,en_1555,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
732,Study models,C0026336,en_1575,CAUSES,Tissue damage,C0010957,en_756,1,1,AFFECTS,Excitatory,3
733,Study models,C0026336,en_1575,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
734,Study models,C0026336,en_1575,CAUSES,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,Excitatory,3
735,Study models,C0026336,en_1575,CAUSES,"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,1,1,AFFECTS,Excitatory,3
736,Study models,C0026336,en_1575,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
737,Study models,C0026336,en_1575,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,3
738,Study models,C0026336,en_1575,CAUSES,Suicide,C0038661,en_2178,1,1,AFFECTS,Excitatory,3
739,Study models,C0026336,en_1575,CAUSES,AOD use,C0237123,en_3341,1,1,AFFECTS,Excitatory,3
740,Study models,C0026336,en_1575,CAUSES,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,3
741,Study models,C0026336,en_1575,CAUSES,PULMONARY PROCESS,C0748169,en_4830,1,1,AFFECTS,Excitatory,3
742,Morphine,C0026549,en_1582,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
743,Physical activity,C0026606,en_1586,CAUSES,Stress,C0038435,en_2165,2,1,AFFECTS,Excitatory,3
744,Mouth Diseases,C0026636,en_1587,CAUSES,Deglutition Disorders,C0011168,en_772,1,1,AFFECTS,Excitatory,3
745,Mucous body substance,C0026727,en_1595,CAUSES,Airway Obstruction,C0001883,en_266,2,2,AFFECTS,Excitatory,9
746,Multiple Organ Failure,C0026766,en_1597,CAUSES,Cessation of life,C0011065,en_762,5,4,AFFECTS,Excitatory,21
747,Multiple Organ Failure,C0026766,en_1597,CAUSES,Septicemia,C0036690,en_2086,2,1,AFFECTS,Excitatory,3
748,Multiple Sclerosis,C0026769,en_1598,CAUSES,Disability NOS,C0231170,en_3247,5,3,AFFECTS,Excitatory,9
749,Myopathy,C0026848,en_1605,CAUSES,Fatigue,C0015672,en_966,1,1,AFFECTS,Excitatory,7
750,Musculoskeletal Diseases,C0026857,en_1607,CAUSES,Sensorimotor disorder,C0877401,en_5071,1,1,AFFECTS,Excitatory,3
751,Mutation,C0026882,en_1612,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
752,Mutation,C0026882,en_1612,CAUSES,Neuromuscular Diseases,C0027868,en_1668,1,1,AFFECTS,Excitatory,3
753,Mutation,C0026882,en_1612,CAUSES,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Excitatory,3
754,Mutation,C0026882,en_1612,CAUSES,Macular dystrophy,C0730292,en_4768,1,1,AFFECTS,Excitatory,3
755,Mutation,C0026882,en_1612,CAUSES,"Deficiency, immune",C0850497,en_4943,1,1,AFFECTS,Excitatory,3
756,Mutation,C0026882,en_1612,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
757,Mutation,C0026882,en_1612,CAUSES(SPEC),Primary immune deficiency disorder,C0398686,en_3951,1,1,AFFECTS,Excitatory,3
758,Mycobacterium avium,C0026913,en_1614,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
759,Mycobacterium avium,C0026913,en_1614,CAUSES,Mycobacterium Infections,C0026918,en_1615,1,1,AFFECTS,Excitatory,3
760,Mycobacterium avium,C0026913,en_1614,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,3
761,Mycobacterium leprae,C0026922,en_1617,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
762,Mycobacterium tuberculosis,C0026926,en_1618,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
763,Mycobacterium tuberculosis,C0026926,en_1618,CAUSES,Cessation of life,C0011065,en_762,4,3,AFFECTS,Excitatory,9
764,Mycobacterium tuberculosis,C0026926,en_1618,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
765,Mycobacterium tuberculosis,C0026926,en_1618,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,3
766,Myeloproliferative disease,C0027022,en_1622,CAUSES(SPEC),Leukocytosis,C0023518,en_1421,1,1,AFFECTS,Excitatory,3
767,Myocardial Infarction,C0027051,en_1625,CAUSES(SPEC),Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
768,Myocardial Infarction,C0027051,en_1625,CAUSES(SPEC),Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
769,Myocarditis,C0027059,en_1627,CAUSES,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Excitatory,3
770,Myocarditis,C0027059,en_1627,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,6
771,Myocarditis,C0027059,en_1627,CAUSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,6
772,Myocarditis,C0027059,en_1627,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
773,Myocarditis,C0027059,en_1627,CAUSES,Myocardial fibrosis,C0151654,en_2862,2,1,AFFECTS,Excitatory,3
774,Myocarditis,C0027059,en_1627,CAUSES,"[X]Acute myocarditis, unspecified",C0155686,en_2889,1,1,AFFECTS,Excitatory,3
775,Myocarditis,C0027059,en_1627,CAUSES,Cardiomyopathies,C0878544,en_5074,1,1,AFFECTS,Excitatory,3
776,Myocarditis,C0027059,en_1627,CAUSES(SPEC),"Death, Sudden, Cardiac",C0085298,en_2661,1,1,AFFECTS,Excitatory,3
777,Myopia,C0027092,en_1630,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,8
778,Nematoda,C0027581,en_1647,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
779,Neoplasm,C0027651,en_1651,CAUSES(SPEC),Infection,C3714514,en_6235,3,1,AFFECTS,Excitatory,3
780,Nephrotic Syndrome,C0027726,en_1654,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
781,Nerve Degeneration,C0027746,en_1657,CAUSES(SPEC),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
782,nervous system disorder,C0027765,en_1659,CAUSES,Organ failure,C0948600,en_5171,1,1,AFFECTS,Excitatory,3
783,nervous system disorder,C0027765,en_1659,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
784,Neurologic Manifestations,C0027854,en_1664,CAUSES,Central nervous system complication,C0161815,en_2897,1,1,AFFECTS,Excitatory,3
785,Acoustic Neuroma,C0027859,en_1665,CAUSES,Deafness,C0011053,en_761,1,1,AFFECTS,Excitatory,3
786,Neuromuscular Diseases,C0027868,en_1668,CAUSES,Asthenia,C0004093,en_416,2,1,AFFECTS,Excitatory,3
787,Neurotransmitters,C0027908,en_1674,CAUSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
788,Newcastle disease virus,C0027984,en_1678,CAUSES(SPEC),Newcastle Disease,C0027983,en_1677,1,1,AFFECTS,Excitatory,3
789,Nitric Oxide,C0028128,en_1682,CAUSES,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,Excitatory,3
790,Nitric Oxide,C0028128,en_1682,CAUSES,Increased methemoglobin,C1295713,en_5500,1,1,AFFECTS,Excitatory,3
791,Nitric Oxide,C0028128,en_1682,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
792,Nocardia,C0028240,en_1686,CAUSES,Brain Abscess,C0006105,en_509,1,1,AFFECTS,Excitatory,8
793,Obesity,C0028754,en_1699,CAUSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
794,Obesity,C0028754,en_1699,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
795,Obesity,C0028754,en_1699,CAUSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
796,Obesity,C0028754,en_1699,CAUSES,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Excitatory,3
797,Obesity,C0028754,en_1699,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
798,Obesity,C0028754,en_1699,CAUSES,Inflammation,C0021368,en_1307,4,2,AFFECTS,Excitatory,6
799,Obesity,C0028754,en_1699,CAUSES,Chronic inflammation,C0021376,en_1309,2,2,AFFECTS,Excitatory,6
800,Obesity,C0028754,en_1699,CAUSES,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Excitatory,3
801,Obstruction,C0028778,en_1702,CAUSES,Appendicitis,C0003615,en_387,2,1,AFFECTS,Excitatory,3
802,Obstruction,C0028778,en_1702,CAUSES,Cerebral Infarction,C0007785,en_603,1,1,AFFECTS,Excitatory,3
803,Obstruction,C0028778,en_1702,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
804,Obstruction,C0028778,en_1702,CAUSES,Myocardial Infarction,C0027051,en_1625,2,2,AFFECTS,Excitatory,6
805,Obstruction,C0028778,en_1702,CAUSES,Blood flow,C0232338,en_3276,2,1,AFFECTS,Excitatory,3
806,Obstruction,C0028778,en_1702,CAUSES(SPEC),Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,3
807,Oils,C0028908,en_1706,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
808,Onchocerca volvulus,C0029000,en_1708,CAUSES,Parasitic Diseases,C0030499,en_1748,1,1,AFFECTS,Excitatory,3
809,Onchocerca volvulus,C0029000,en_1708,CAUSES(SPEC),Onchocerciasis,C0029001,en_1709,1,1,AFFECTS,Excitatory,3
810,Opportunistic Infections,C0029118,en_1712,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
811,Organic Chemicals,C0029224,en_1716,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
812,Organism,C0029235,en_1717,CAUSES,Disease,C0012634,en_826,5,3,AFFECTS,Excitatory,14
813,Organism,C0029235,en_1717,CAUSES,"Pneumonia, Ventilator-Associated",C1701940,en_6025,1,1,AFFECTS,Excitatory,6
814,Orthomyxoviridae,C0029341,en_1720,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
815,Orthomyxoviridae,C0029341,en_1720,CAUSES,Infiltration,C0332448,en_3749,1,1,AFFECTS,Excitatory,6
816,Orthomyxoviridae,C0029341,en_1720,CAUSES,Community acquired pneumonia,C0694549,en_4692,3,1,AFFECTS,Excitatory,6
817,Orthomyxoviridae,C0029341,en_1720,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
818,Orthomyxoviridae,C0029341,en_1720,CAUSES,COVID-19,C5203670,en_6417,2,1,AFFECTS,Excitatory,6
819,Influenza A virus,C0029347,en_1721,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
820,Influenza A virus,C0029347,en_1721,CAUSES,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Excitatory,3
821,Influenza A virus,C0029347,en_1721,CAUSES(SPEC),Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Excitatory,3
822,Degenerative polyarthritis,C0029408,en_1723,CAUSES,Severe pain,C0278140,en_3598,1,1,AFFECTS,Excitatory,3
823,overdose,C4018909,en_6291,CAUSES,Heart Arrest,C0018790,en_1131,2,1,AFFECTS,Excitatory,3
824,overdose,C4018909,en_6291,CAUSES,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Excitatory,3
825,Oxygen,C0030054,en_1736,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
826,Oxygen,C0030054,en_1736,CAUSES,Airway pressure,C0428719,en_4015,1,1,AFFECTS,Excitatory,3
827,Oxygen,C0030054,en_1736,CAUSES,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Excitatory,3
828,Pancreatitis,C0030305,en_1745,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
829,Parasites,C0030498,en_1747,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
830,Parasites,C0030498,en_1747,CAUSES,Epilepsy,C0014544,en_917,1,1,AFFECTS,Excitatory,3
831,Parasites,C0030498,en_1747,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
832,Parasites,C0030498,en_1747,CAUSES,Leishmaniasis,C0023281,en_1410,1,1,AFFECTS,Excitatory,3
833,Parasites,C0030498,en_1747,CAUSES,Malaria,C0024530,en_1493,1,1,AFFECTS,Excitatory,3
834,Parasites,C0030498,en_1747,CAUSES,Chagas Disease,C0041234,en_2290,1,1,AFFECTS,Excitatory,3
835,Parasites,C0030498,en_1747,CAUSES,Tropical Disease,C1336827,en_5642,2,1,AFFECTS,Excitatory,3
836,Pelvic Pain,C0030794,en_1764,CAUSES,Infertility,C0021359,en_1305,1,1,AFFECTS,Excitatory,3
837,Endopeptidases,C0030946,en_1770,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
838,Endopeptidases,C0030946,en_1770,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
839,Endopeptidases,C0030946,en_1770,CAUSES,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,Excitatory,3
840,Peptides,C0030956,en_1771,CAUSES,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,Excitatory,3
841,Peptides,C0030956,en_1771,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
842,Periodontitis,C0031099,en_1775,CAUSES,loss; bone,C0599877,en_4480,1,1,AFFECTS,Excitatory,3
843,Phagocytosis,C0031308,en_1785,CAUSES,Apoptosis,C0162638,en_2922,2,1,AFFECTS,Excitatory,3
844,Phenformin,C0031404,en_1789,CAUSES,"Acidosis, Lactic",C0001125,en_223,1,1,AFFECTS,Excitatory,3
845,Phospholipids,C0031676,en_1797,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
846,Plasma,C0032105,en_1816,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
847,Plasminogen,C0032140,en_1822,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
848,Plasmodium falciparum,C0032150,en_1826,CAUSES,Malaria,C0024530,en_1493,1,1,AFFECTS,Excitatory,3
849,Pneumonia,C0032285,en_1833,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
850,Pneumonia,C0032285,en_1833,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
851,Pneumonia,C0032285,en_1833,CAUSES,Cessation of life,C0011065,en_762,23,14,AFFECTS,Excitatory,45
852,Pneumonia,C0032285,en_1833,CAUSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,3
853,Pneumonia,C0032285,en_1833,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
854,Pneumonia,C0032285,en_1833,CAUSES,Fibrosis,C0016059,en_994,4,2,AFFECTS,Excitatory,6
855,Pneumonia,C0032285,en_1833,CAUSES,Hospitalization,C0019993,en_1206,5,4,AFFECTS,Excitatory,12
856,Pneumonia,C0032285,en_1833,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
857,Pneumonia,C0032285,en_1833,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
858,Pneumonia,C0032285,en_1833,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Excitatory,3
859,Pneumonia,C0032285,en_1833,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,13,9,AFFECTS,Excitatory,33
860,Pneumonia,C0032285,en_1833,CAUSES,Septicemia,C0036690,en_2086,2,2,AFFECTS,Excitatory,6
861,Pneumonia,C0032285,en_1833,CAUSES,Septic Shock,C0036983,en_2101,7,1,AFFECTS,Excitatory,3
862,Pneumonia,C0032285,en_1833,CAUSES,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Excitatory,3
863,Pneumonia,C0032285,en_1833,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
864,Pneumonia,C0032285,en_1833,CAUSES,intensive care,C0085559,en_2678,1,1,AFFECTS,Excitatory,3
865,Pneumonia,C0032285,en_1833,CAUSES,Hospital admission,C0184666,en_3063,2,1,AFFECTS,Excitatory,3
866,Pneumonia,C0032285,en_1833,CAUSES,Acute respiratory failure,C0264490,en_3533,21,12,AFFECTS,Excitatory,51
867,Pneumonia,C0032285,en_1833,CAUSES,Congenital infectious disease,C0275544,en_3568,3,1,AFFECTS,Excitatory,3
868,Pneumonia,C0032285,en_1833,CAUSES,pulmonary complications,C0281169,en_3627,3,1,AFFECTS,Excitatory,3
869,Pneumonia,C0032285,en_1833,CAUSES,Hyaline membrane,C0333563,en_3768,1,1,AFFECTS,Excitatory,3
870,Pneumonia,C0032285,en_1833,CAUSES,Secondary bacterial pneumonia,C0339952,en_3811,5,1,AFFECTS,Excitatory,3
871,Pneumonia,C0032285,en_1833,CAUSES,Respiratory distress,C0476273,en_4149,3,2,AFFECTS,Excitatory,6
872,Pneumonia,C0032285,en_1833,CAUSES,Acute respiratory distress,C0748355,en_4831,2,2,AFFECTS,Excitatory,6
873,Pneumonia,C0032285,en_1833,CAUSES,"Communicable Diseases, Emerging",C0872315,en_5049,1,1,AFFECTS,Excitatory,6
874,Pneumonia,C0032285,en_1833,CAUSES,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Excitatory,3
875,Pneumonia,C0032285,en_1833,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,3
876,Pneumonia,C0032285,en_1833,CAUSES,Respiratory Failure,C1145670,en_5292,17,12,AFFECTS,Excitatory,50
877,Pneumonia,C0032285,en_1833,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,6
878,Pneumonia,C0032285,en_1833,CAUSES(SPEC),Nosocomial pneumonia,C0949083,en_5175,1,1,AFFECTS,Excitatory,3
879,"Pneumonia, Staphylococcal",C0032308,en_1836,CAUSES,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Excitatory,3
880,"Pneumonia, Viral",C0032310,en_1837,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
881,"Pneumonia, Viral",C0032310,en_1837,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Excitatory,3
882,"Pneumonia, Viral",C0032310,en_1837,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,2,AFFECTS,Excitatory,6
883,"Pneumonia, Viral",C0032310,en_1837,CAUSES,Respiratory failure without hypercapnia,C0340194,en_3812,1,1,AFFECTS,Excitatory,6
884,"Pneumonia, Viral",C0032310,en_1837,CAUSES,Respiratory Failure,C1145670,en_5292,11,6,AFFECTS,Excitatory,18
885,Poisoning,C0032343,en_1839,CAUSES,Dyspnea,C0013404,en_866,1,1,AFFECTS,Excitatory,6
886,Polycythemia Vera,C0032463,en_1846,CAUSES,Primary Myelofibrosis,C0001815,en_263,2,1,AFFECTS,Excitatory,3
887,Porphyrins,C0032712,en_1853,CAUSES,Lysis,C0024348,en_1476,2,1,AFFECTS,Excitatory,3
888,Porphyrins,C0032712,en_1853,CAUSES,Acquired porphyria,C0948592,en_5170,2,1,AFFECTS,Excitatory,3
889,Positive-Pressure Respiration,C0032740,en_1854,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
890,Postoperative Complications,C0032787,en_1858,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
891,Pressure- physical agent,C0033095,en_1882,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
892,Pressure- physical agent,C0033095,en_1882,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
893,Pressure- physical agent,C0033095,en_1882,CAUSES,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Excitatory,3
894,Procollagen-Proline Dioxygenase,C0033384,en_1897,CAUSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,3
895,Proteins,C0033684,en_1912,CAUSES,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Excitatory,6
896,Proteins,C0033684,en_1912,CAUSES,Cell Death,C0007587,en_587,2,2,AFFECTS,Excitatory,6
897,Proteins,C0033684,en_1912,CAUSES,Cerebrovascular accident,C0038454,en_2169,2,1,AFFECTS,Excitatory,3
898,Proteins,C0033684,en_1912,CAUSES,Injury,C0175677,en_2968,5,1,AFFECTS,Excitatory,3
899,Protons,C0033727,en_1915,CAUSES,Excitation,C0549255,en_4278,1,1,AFFECTS,Excitatory,3
900,Pseudomonas aeruginosa,C0033809,en_1917,CAUSES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Excitatory,3
901,Pseudomonas aeruginosa,C0033809,en_1917,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
902,Pseudomonas aeruginosa,C0033809,en_1917,CAUSES,Superinfection,C0038826,en_2184,1,1,AFFECTS,Excitatory,6
903,Pulmonary Edema,C0034063,en_1929,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
904,Pulmonary Embolism,C0034065,en_1930,CAUSES,Blood Coagulation Disorders,C0005779,en_485,2,1,AFFECTS,Excitatory,3
905,Pulmonary Embolism,C0034065,en_1930,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,6
906,Pulmonary Embolism,C0034065,en_1930,CAUSES,Acute right heart failure,C0264715,en_3537,1,1,AFFECTS,Excitatory,3
907,Pulmonary Embolism,C0034065,en_1930,CAUSES(SPEC),Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
908,Pulmonary Embolism,C0034065,en_1930,CAUSES(SPEC),Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
909,Pulmonary Embolism,C0034065,en_1930,CAUSES(SPEC),Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,3
910,Pulmonary Embolism,C0034065,en_1930,CAUSES(SPEC),Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,3
911,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
912,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Dyspnea,C0013404,en_866,1,1,AFFECTS,Excitatory,3
913,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
914,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
915,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
916,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Chronic respiratory failure,C0264492,en_3534,1,1,AFFECTS,Excitatory,3
917,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Postobstructive pneumonia,C0747690,en_4824,1,1,AFFECTS,Excitatory,8
918,Pulmonary Fibrosis,C0034069,en_1932,CAUSES,Abnormal breathing,C1260922,en_5414,1,1,AFFECTS,Excitatory,3
919,Pulmonary Surfactants,C0034085,en_1935,CAUSES,Respiratory Failure,C1145670,en_5292,3,2,AFFECTS,Excitatory,11
920,Pulmonary Valve Insufficiency,C0034088,en_1936,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
921,"Purpura, Thrombotic Thrombocytopenic",C0034155,en_1940,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
922,Quarantine,C0034386,en_1944,CAUSES,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,6
923,Electromagnetic Energy,C0034519,en_1952,CAUSES,Tissue damage,C0010957,en_756,1,1,AFFECTS,Excitatory,3
924,Electromagnetic Energy,C0034519,en_1952,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
925,Radiation Injuries,C0034530,en_1953,CAUSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
926,Radiation therapy,C0034618,en_1956,CAUSES,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,Excitatory,3
927,Radiation therapy,C0034618,en_1956,CAUSES,Mucositis,C0333355,en_3762,1,1,AFFECTS,Excitatory,3
928,Reading,C0034754,en_1960,CAUSES,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Excitatory,3
929,"Receptors, Antigen, B-Cell",C0034789,en_1964,CAUSES,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,Excitatory,3
930,T-Cell Receptor,C0034790,en_1965,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
931,Respiration Disorders,C0035204,en_2005,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
932,Respiration Disorders,C0035204,en_2005,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,6
933,Respiration Disorders,C0035204,en_2005,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
934,Respiration Disorders,C0035204,en_2005,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
935,Respiration Disorders,C0035204,en_2005,CAUSES,Disability NOS,C0231170,en_3247,2,1,AFFECTS,Excitatory,3
936,Respiration Disorders,C0035204,en_2005,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,3
937,Respiration Disorders,C0035204,en_2005,CAUSES(SPEC),Fibromyalgia,C0016053,en_993,1,1,AFFECTS,Excitatory,3
938,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Care of intensive care unit patient,C0010337,en_732,2,1,AFFECTS,Excitatory,3
939,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Cessation of life,C0011065,en_762,33,23,AFFECTS,Excitatory,73
940,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
941,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Edema,C0013604,en_877,2,2,AFFECTS,Excitatory,6
942,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
943,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Hospitalization,C0019993,en_1206,2,2,AFFECTS,Excitatory,6
944,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
945,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Inflammation,C0021368,en_1307,2,2,AFFECTS,Excitatory,6
946,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
947,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Excitatory,6
948,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Excitatory,3
949,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Respiratory Tract Infections,C0035243,en_2017,3,2,AFFECTS,Excitatory,6
950,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,intensive care,C0085559,en_2678,2,2,AFFECTS,Excitatory,6
951,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Impaired gas exchange,C0150034,en_2814,1,1,AFFECTS,Excitatory,3
952,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,Excitatory,6
953,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,3
954,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
955,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
956,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Endothelial dysfunction,C0856169,en_4968,3,1,AFFECTS,Excitatory,3
957,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Vascular inflammations,C0947751,en_5156,1,1,AFFECTS,Excitatory,3
958,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Organ failure,C0948600,en_5171,6,4,AFFECTS,Excitatory,12
959,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Respiratory Failure,C1145670,en_5292,9,7,AFFECTS,Excitatory,21
960,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Excitatory,3
961,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
962,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,CAUSES,postintensive care syndrome,C5391440,en_6438,1,1,AFFECTS,Excitatory,7
963,Respiratory Insufficiency,C0035229,en_2012,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
964,Respiratory syncytial virus,C0035236,en_2014,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
965,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Bacteremia,C0004610,en_439,1,1,AFFECTS,Excitatory,6
966,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
967,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
968,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Hospitalization,C0019993,en_1206,2,1,AFFECTS,Excitatory,8
969,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
970,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
971,Respiratory Tract Infections,C0035243,en_2017,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Excitatory,9
972,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Excitatory,3
973,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
974,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
975,Respiratory Tract Infections,C0035243,en_2017,CAUSES,Discomfort,C2364135,en_6112,1,1,AFFECTS,Excitatory,6
976,Rest,C0035253,en_2019,CAUSES,Crisis,C0231224,en_3253,2,1,AFFECTS,Excitatory,3
977,Retinal Diseases,C0035309,en_2021,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
978,Retinal Diseases,C0035309,en_2021,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,3
979,Retinal Vein Occlusion,C0035328,en_2022,CAUSES,Macular retinal edema,C0271051,en_3554,1,1,AFFECTS,Excitatory,3
980,Retroviridae,C0035366,en_2026,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
981,Retroviridae,C0035366,en_2026,CAUSES,Encephalitis,C0014038,en_896,1,1,AFFECTS,Excitatory,3
982,Rhinitis,C0035455,en_2030,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
983,Riboflavin,C0035527,en_2033,CAUSES,Inactivation,C0544461,en_4262,1,1,AFFECTS,Excitatory,3
984,Ribonucleosides,C0035546,en_2035,CAUSES,Mitochondrial DNA mutation,C0948444,en_5167,1,1,AFFECTS,Excitatory,3
985,Rickets,C0035579,en_2037,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Excitatory,3
986,RNA,C0035668,en_2040,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
987,RNA,C0035668,en_2040,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
988,RNA Viruses,C0035691,en_2044,CAUSES,Common Cold,C0009443,en_684,2,1,AFFECTS,Excitatory,3
989,RNA Viruses,C0035691,en_2044,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
990,RNA Viruses,C0035691,en_2044,CAUSES,Disease,C0012634,en_826,4,3,AFFECTS,Excitatory,9
991,RNA Viruses,C0035691,en_2044,CAUSES,Respiration Disorders,C0035204,en_2005,2,2,AFFECTS,Excitatory,6
992,RNA Viruses,C0035691,en_2044,CAUSES,"Infections, Upper Respiratory",C0041912,en_2315,6,3,AFFECTS,Excitatory,9
993,RNA Viruses,C0035691,en_2044,CAUSES,innate immune response,C1155265,en_5320,1,1,AFFECTS,Excitatory,3
994,RNA Viruses,C0035691,en_2044,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
995,"RNA, Messenger",C0035696,en_2046,CAUSES,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Excitatory,6
996,Rotavirus,C0035870,en_2049,CAUSES,Gastroenteritis,C0017160,en_1037,1,1,AFFECTS,Excitatory,3
997,Rotavirus,C0035870,en_2049,CAUSES,Poliomyelitis,C0032371,en_1841,1,1,AFFECTS,Excitatory,3
998,Rotavirus,C0035870,en_2049,CAUSES,Neonatal calf diarrhea,C0276467,en_3578,1,1,AFFECTS,Excitatory,8
999,Rubella virus,C0035924,en_2051,CAUSES,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,2,1,AFFECTS,Excitatory,3
1000,saliva,C0036087,en_2057,CAUSES,Common Cold,C0009443,en_684,1,1,AFFECTS,Excitatory,7
1001,saliva,C0036087,en_2057,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,7
1002,Salivary Gland Diseases,C0036093,en_2058,CAUSES,Xerostomia,C0043352,en_2405,1,1,AFFECTS,Excitatory,3
1003,Salmonella,C0036111,en_2062,CAUSES,Gastrointestinal Diseases,C0017178,en_1039,1,1,AFFECTS,Excitatory,3
1004,Sedatives,C0036557,en_2075,CAUSES(SPEC),"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,2,AFFECTS,Excitatory,6
1005,Sendai virus,C0036638,en_2082,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
1006,Diastasis,C0036679,en_2084,CAUSES,Breast Feeding,C0006147,en_512,1,1,AFFECTS,Excitatory,6
1007,Septicemia,C0036690,en_2086,CAUSES,Blood Coagulation Disorders,C0005779,en_485,17,10,AFFECTS,Excitatory,34
1008,Septicemia,C0036690,en_2086,CAUSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,3
1009,Septicemia,C0036690,en_2086,CAUSES,Cessation of life,C0011065,en_762,17,11,AFFECTS,Excitatory,36
1010,Septicemia,C0036690,en_2086,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
1011,Septicemia,C0036690,en_2086,CAUSES,Disseminated Intravascular Coagulation,C0012739,en_829,1,1,AFFECTS,Excitatory,3
1012,Septicemia,C0036690,en_2086,CAUSES,"Kidney Tubular Necrosis, Acute",C0022672,en_1385,1,1,AFFECTS,Excitatory,3
1013,Septicemia,C0036690,en_2086,CAUSES,Myopathy,C0026848,en_1605,3,1,AFFECTS,Excitatory,3
1014,Septicemia,C0036690,en_2086,CAUSES,Pregnancy,C0032961,en_1872,1,1,AFFECTS,Excitatory,3
1015,Septicemia,C0036690,en_2086,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1016,Septicemia,C0036690,en_2086,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
1017,Septicemia,C0036690,en_2086,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
1018,Septicemia,C0036690,en_2086,CAUSES,Patient identification,C1269815,en_5448,2,1,AFFECTS,Excitatory,3
1019,Septicemia,C0036690,en_2086,CAUSES,follow-up,C1522577,en_5904,1,1,AFFECTS,Excitatory,7
1020,Serine,C0036720,en_2087,CAUSES,Pain,C0030193,en_1741,2,1,AFFECTS,Excitatory,3
1021,Serotonin,C0036751,en_2090,CAUSES,Depressive disorder,C0011581,en_788,2,1,AFFECTS,Excitatory,3
1022,Shock,C0036974,en_2097,CAUSES,Acute Disease,C0001314,en_230,1,1,AFFECTS,Excitatory,6
1023,"Shock, Hemorrhagic",C0036982,en_2100,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1024,Septic Shock,C0036983,en_2101,CAUSES,Cessation of life,C0011065,en_762,5,3,AFFECTS,Excitatory,12
1025,Signal Pathways,C0037080,en_2104,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
1026,Signal Transduction,C0037083,en_2105,CAUSES,cell motility,C0007608,en_593,1,1,AFFECTS,Excitatory,3
1027,Signs and Symptoms,C0037088,en_2106,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
1028,"Signs and Symptoms, Respiratory",C0037090,en_2107,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
1029,"Signs and Symptoms, Respiratory",C0037090,en_2107,CAUSES,Diarrhea,C0011991,en_810,2,1,AFFECTS,Excitatory,3
1030,"Signs and Symptoms, Respiratory",C0037090,en_2107,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1031,"Signs and Symptoms, Respiratory",C0037090,en_2107,CAUSES,acute care,C0679878,en_4616,2,1,AFFECTS,Excitatory,3
1032,"Signs and Symptoms, Respiratory",C0037090,en_2107,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1033,Sleep Apnea Syndromes,C0037315,en_2120,CAUSES,Chronic heart failure,C0264716,en_3538,1,1,AFFECTS,Excitatory,3
1034,Soaps,C0037392,en_2125,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1035,Sodium Dodecyl Sulfate,C0037506,en_2131,CAUSES,Dermatitis,C0011603,en_790,1,1,AFFECTS,Excitatory,3
1036,Solutions,C0037633,en_2134,CAUSES,Asthma,C0004096,en_418,1,1,AFFECTS,Excitatory,3
1037,Solutions,C0037633,en_2134,CAUSES,Sexually Transmitted Diseases,C0036916,en_2095,1,1,AFFECTS,Excitatory,3
1038,Solutions,C0037633,en_2134,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1039,Stanolone,C0038148,en_2152,CAUSES,Adverse effects,C0879626,en_5081,2,1,AFFECTS,Excitatory,3
1040,Staphylococcus aureus,C0038172,en_2154,CAUSES,Community-Acquired Infections,C0206171,en_3151,1,1,AFFECTS,Excitatory,6
1041,Streptococcus pneumoniae,C0038410,en_2162,CAUSES,Community-Acquired Infections,C0206171,en_3151,1,1,AFFECTS,Excitatory,6
1042,Streptozocin,C0038432,en_2164,CAUSES,Diabetic,C0241863,en_3392,2,1,AFFECTS,Excitatory,3
1043,Cerebrovascular accident,C0038454,en_2169,CAUSES,Cessation of life,C0011065,en_762,12,8,AFFECTS,Excitatory,24
1044,Cerebrovascular accident,C0038454,en_2169,CAUSES,Epilepsy,C0014544,en_917,1,1,AFFECTS,Excitatory,7
1045,Cerebrovascular accident,C0038454,en_2169,CAUSES,Hospital admission,C0184666,en_3063,1,1,AFFECTS,Excitatory,6
1046,Cerebrovascular accident,C0038454,en_2169,CAUSES,Disability NOS,C0231170,en_3247,4,3,AFFECTS,Excitatory,9
1047,Cerebrovascular accident,C0038454,en_2169,CAUSES,Physical disability,C0520817,en_4192,1,1,AFFECTS,Excitatory,3
1048,Cerebrovascular accident,C0038454,en_2169,CAUSES,Sensorimotor disorder,C0877401,en_5071,1,1,AFFECTS,Excitatory,3
1049,Cerebrovascular accident,C0038454,en_2169,CAUSES(SPEC),Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
1050,Cerebrovascular accident,C0038454,en_2169,CAUSES(SPEC),Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,3
1051,Cerebrovascular accident,C0038454,en_2169,CAUSES(SPEC),Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,3
1052,Cerebrovascular accident,C0038454,en_2169,CAUSES(SPEC),Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,3
1053,Sulfides,C0038739,en_2180,CAUSES,Atrophic,C0333641,en_3770,1,1,AFFECTS,Excitatory,3
1054,Superinfection,C0038826,en_2184,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1055,Syncope,C0039070,en_2196,CAUSES,Procedure on heart,C1279986,en_5469,4,1,AFFECTS,Excitatory,6
1056,Syndrome,C0039082,en_2197,CAUSES,Cessation of life,C0011065,en_762,3,3,AFFECTS,Excitatory,9
1057,Syndrome,C0039082,en_2197,CAUSES,Multiple Organ Failure,C0026766,en_1597,4,3,AFFECTS,Excitatory,9
1058,Syndrome,C0039082,en_2197,CAUSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,6
1059,Syndrome,C0039082,en_2197,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
1060,Syndrome,C0039082,en_2197,CAUSES,Septicemia,C0036690,en_2086,4,1,AFFECTS,Excitatory,3
1061,Syndrome,C0039082,en_2197,CAUSES,Symptoms,C1457887,en_5784,3,2,AFFECTS,Excitatory,6
1062,Tachycardia,C0039231,en_2203,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
1063,Tamoxifen,C0039286,en_2205,CAUSES,Neutropenia,C0027947,en_1675,1,1,AFFECTS,Excitatory,3
1064,Tamoxifen,C0039286,en_2205,CAUSES,Death (finding),C1306577,en_5521,2,1,AFFECTS,Excitatory,3
1065,Tears body substance,C0039409,en_2210,CAUSES,Distal aortic dissection,C0340647,en_3820,1,1,AFFECTS,Excitatory,3
1066,Testosterone,C0039601,en_2216,CAUSES,Benign prostatic hypertrophy,C0005001,en_453,1,1,AFFECTS,Excitatory,3
1067,Testosterone,C0039601,en_2216,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1068,"Radiography, Thoracic",C0039985,en_2226,CAUSES,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Excitatory,6
1069,"Radiography, Thoracic",C0039985,en_2226,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
1070,Thrombin,C0040018,en_2228,CAUSES,Thrombosis,C0040053,en_2233,2,1,AFFECTS,Excitatory,3
1071,Thromboembolism,C0040038,en_2230,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,9
1072,Thrombosis,C0040053,en_2233,CAUSES,Cerebral Infarction,C0007785,en_603,1,1,AFFECTS,Excitatory,3
1073,Thrombosis,C0040053,en_2233,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
1074,Thrombosis,C0040053,en_2233,CAUSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,3
1075,Thrombosis,C0040053,en_2233,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
1076,Thrombosis,C0040053,en_2233,CAUSES,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,3
1077,Thrombosis,C0040053,en_2233,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,6
1078,Thrombosis,C0040053,en_2233,CAUSES,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,3
1079,Tobacco,C0040329,en_2243,CAUSES,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Excitatory,3
1080,tomography,C0040395,en_2245,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
1081,Antipsychotic Agents,C0040615,en_2262,CAUSES,Hyperprolactinemia,C0020514,en_1237,1,1,AFFECTS,Excitatory,3
1082,Anti-Anxiety Agents,C0040616,en_2263,CAUSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
1083,TRANSCRIPTION FACTOR,C0040648,en_2264,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
1084,TRANSCRIPTION FACTOR,C0040648,en_2264,CAUSES,Symptom aggravating factors,C0436331,en_4027,1,1,AFFECTS,Excitatory,3
1085,Transforming Growth Factor beta,C0040690,en_2272,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
1086,Tretinoin,C0040845,en_2280,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,2,1,AFFECTS,Excitatory,3
1087,Tretinoin,C0040845,en_2280,CAUSES,T-Cell Activation,C1155065,en_5315,1,1,AFFECTS,Excitatory,3
1088,Triage,C0040861,en_2281,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1089,Tuberculin Test,C0041290,en_2292,CAUSES,"Mycobacterium Infections, Atypical",C0026919,en_1616,2,1,AFFECTS,Excitatory,3
1090,Tuberculosis,C0041296,en_2293,CAUSES,Cessation of life,C0011065,en_762,5,4,AFFECTS,Excitatory,12
1091,Tuberculosis,C0041296,en_2293,CAUSES,Introduction procedure,C1293116,en_5496,3,2,AFFECTS,Excitatory,6
1092,Tumor Antigens,C0041361,en_2299,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1093,Tumor Necrosis Factors,C0041368,en_2300,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
1094,Tumor Necrosis Factors,C0041368,en_2300,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
1095,Tumor Necrosis Factors,C0041368,en_2300,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
1096,Upper gastrointestinal hemorrhage,C0041909,en_2314,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1097,"Infections, Upper Respiratory",C0041912,en_2315,CAUSES,Chilblains,C0008058,en_619,1,1,AFFECTS,Excitatory,6
1098,"Infections, Upper Respiratory",C0041912,en_2315,CAUSES,Coughing,C0010200,en_723,1,1,AFFECTS,Excitatory,3
1099,"Infections, Upper Respiratory",C0041912,en_2315,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,6
1100,Vaccination,C0042196,en_2326,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1101,Vaccination,C0042196,en_2326,CAUSES,Measles,C0025007,en_1512,1,1,AFFECTS,Excitatory,3
1102,Vaccination,C0042196,en_2326,CAUSES,Menstruation Disturbances,C0025345,en_1541,1,1,AFFECTS,Excitatory,3
1103,Vaccination,C0042196,en_2326,CAUSES,innate immune response,C1155265,en_5320,1,1,AFFECTS,Excitatory,3
1104,Vaccination,C0042196,en_2326,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1105,Vaccines,C0042210,en_2329,CAUSES,Antibody Formation,C0003261,en_352,8,6,AFFECTS,Excitatory,24
1106,Vaccines,C0042210,en_2329,CAUSES,Immunity,C0020964,en_1273,38,26,AFFECTS,Excitatory,83
1107,Vaccines,C0042210,en_2329,CAUSES,Thrombocytopenia,C0040034,en_2229,4,4,AFFECTS,Excitatory,18
1108,Vaccines,C0042210,en_2329,CAUSES,Autoimmune Thrombocytopenia,C0242584,en_3420,1,1,AFFECTS,Excitatory,7
1109,Vaccines,C0042210,en_2329,CAUSES,Immune,C0439662,en_4035,1,1,AFFECTS,Excitatory,8
1110,Vaccines,C0042210,en_2329,CAUSES,Responsive Disease,C5236984,en_6425,2,2,AFFECTS,Excitatory,13
1111,Vaccines,C0042210,en_2329,CAUSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
1112,Vaccines,C0042210,en_2329,CAUSES,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
1113,Vaccines,C0042210,en_2329,CAUSES,Inflammation,C0021368,en_1307,3,2,AFFECTS,Excitatory,6
1114,Vaccines,C0042210,en_2329,CAUSES,Narcolepsy,C0027404,en_1638,1,1,AFFECTS,Excitatory,3
1115,Vaccines,C0042210,en_2329,CAUSES,Pericarditis,C0031046,en_1772,6,1,AFFECTS,Excitatory,3
1116,Vaccines,C0042210,en_2329,CAUSES,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,Excitatory,3
1117,Vaccines,C0042210,en_2329,CAUSES,Syndrome,C0039082,en_2197,6,1,AFFECTS,Excitatory,3
1118,Vaccines,C0042210,en_2329,CAUSES,Injury,C0175677,en_2968,4,1,AFFECTS,Excitatory,3
1119,Vaccines,C0042210,en_2329,CAUSES,Malaise,C0231218,en_3251,2,1,AFFECTS,Excitatory,3
1120,Vaccines,C0042210,en_2329,CAUSES,Antibody-Dependent Enhancement,C0282632,en_3660,1,1,AFFECTS,Excitatory,3
1121,Vaccines,C0042210,en_2329,CAUSES,Adverse event,C0877248,en_5069,11,3,AFFECTS,Excitatory,9
1122,Vaccines,C0042210,en_2329,CAUSES,humoral immune response,C1155229,en_5318,2,2,AFFECTS,Excitatory,6
1123,Vaccines,C0042210,en_2329,CAUSES,Inflammatory disorder,C1290884,en_5483,4,1,AFFECTS,Excitatory,3
1124,Vaccines,C0042210,en_2329,CAUSES,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
1125,Vaccines,C0042210,en_2329,CAUSES,cell-mediated immune response,C1318468,en_5530,1,1,AFFECTS,Excitatory,3
1126,Vaccines,C0042210,en_2329,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
1127,Vaccines,C0042210,en_2329,CAUSES,Flare,C1517205,en_5867,1,1,AFFECTS,Excitatory,3
1128,Vaccines,C0042210,en_2329,CAUSES,Transgenic Model,C1519606,en_5888,1,1,AFFECTS,Excitatory,3
1129,Vaccines,C0042210,en_2329,CAUSES,Vaccinated,C1519885,en_5892,2,1,AFFECTS,Excitatory,3
1130,"Vaccines, Attenuated",C0042211,en_2330,CAUSES,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,7
1131,Vascular constriction (function),C0042396,en_2340,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1132,Vascular constriction (function),C0042396,en_2340,CAUSES,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Excitatory,3
1133,Ventilation-Perfusion Ratio,C0042495,en_2346,CAUSES,Hypoxemia,C0700292,en_4719,2,1,AFFECTS,Excitatory,3
1134,"Ventilators, Mechanical",C0042497,en_2348,CAUSES,Complication,C0009566,en_697,2,2,AFFECTS,Excitatory,6
1135,"Ventilators, Mechanical",C0042497,en_2348,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1136,Viral Proteins,C0042736,en_2357,CAUSES,Reproduction,C0035150,en_2001,3,3,AFFECTS,Excitatory,9
1137,Viral Proteins,C0042736,en_2357,CAUSES,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,Excitatory,3
1138,Viral Proteins,C0042736,en_2357,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1139,Viral Proteins,C0042736,en_2357,CAUSES,Antibody-Dependent Enhancement,C0282632,en_3660,2,1,AFFECTS,Excitatory,3
1140,Virus Diseases,C0042769,en_2362,CAUSES,Acclimatization,C0000934,en_212,1,1,AFFECTS,Excitatory,3
1141,Virus Diseases,C0042769,en_2362,CAUSES,Anosmia,C0003126,en_337,1,1,AFFECTS,Excitatory,3
1142,Virus Diseases,C0042769,en_2362,CAUSES,Autoimmunity,C0004368,en_430,1,1,AFFECTS,Excitatory,3
1143,Virus Diseases,C0042769,en_2362,CAUSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,3
1144,Virus Diseases,C0042769,en_2362,CAUSES,Bronchiolitis,C0006271,en_517,1,1,AFFECTS,Excitatory,3
1145,Virus Diseases,C0042769,en_2362,CAUSES,Communicable Diseases,C0009450,en_685,27,18,AFFECTS,Excitatory,54
1146,Virus Diseases,C0042769,en_2362,CAUSES,Complication,C0009566,en_697,6,5,AFFECTS,Excitatory,18
1147,Virus Diseases,C0042769,en_2362,CAUSES,Conjunctivitis,C0009763,en_704,2,1,AFFECTS,Excitatory,3
1148,Virus Diseases,C0042769,en_2362,CAUSES,Viral Conjunctivitis,C0009774,en_705,1,1,AFFECTS,Excitatory,3
1149,Virus Diseases,C0042769,en_2362,CAUSES,Coughing,C0010200,en_723,2,1,AFFECTS,Excitatory,3
1150,Virus Diseases,C0042769,en_2362,CAUSES,Critical Illness,C0010340,en_733,2,2,AFFECTS,Excitatory,10
1151,Virus Diseases,C0042769,en_2362,CAUSES,Cessation of life,C0011065,en_762,6,6,AFFECTS,Excitatory,18
1152,Virus Diseases,C0042769,en_2362,CAUSES,Disease,C0012634,en_826,152,108,AFFECTS,Excitatory,324
1153,Virus Diseases,C0042769,en_2362,CAUSES,Edema,C0013604,en_877,1,1,AFFECTS,Excitatory,3
1154,Virus Diseases,C0042769,en_2362,CAUSES,Fibrosis,C0016059,en_994,4,3,AFFECTS,Excitatory,9
1155,Virus Diseases,C0042769,en_2362,CAUSES,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Excitatory,3
1156,Virus Diseases,C0042769,en_2362,CAUSES,Hospitalization,C0019993,en_1206,2,2,AFFECTS,Excitatory,6
1157,Virus Diseases,C0042769,en_2362,CAUSES,Hypersensitivity,C0020517,en_1238,4,2,AFFECTS,Excitatory,6
1158,Virus Diseases,C0042769,en_2362,CAUSES,Infection,C3714514,en_6235,12,9,AFFECTS,Excitatory,27
1159,Virus Diseases,C0042769,en_2362,CAUSES,Inflammation,C0021368,en_1307,18,14,AFFECTS,Excitatory,46
1160,Virus Diseases,C0042769,en_2362,CAUSES,Chronic inflammation,C0021376,en_1309,2,2,AFFECTS,Excitatory,6
1161,Virus Diseases,C0042769,en_2362,CAUSES,Influenza,C0021400,en_1311,2,2,AFFECTS,Excitatory,6
1162,Virus Diseases,C0042769,en_2362,CAUSES,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Excitatory,3
1163,Virus Diseases,C0042769,en_2362,CAUSES,Little's Disease,C0023882,en_1451,1,1,AFFECTS,Excitatory,3
1164,Virus Diseases,C0042769,en_2362,CAUSES,"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,3,3,AFFECTS,Excitatory,9
1165,Virus Diseases,C0042769,en_2362,CAUSES,Lysis,C0024348,en_1476,2,1,AFFECTS,Excitatory,3
1166,Virus Diseases,C0042769,en_2362,CAUSES,Multiple Organ Failure,C0026766,en_1597,3,2,AFFECTS,Excitatory,6
1167,Virus Diseases,C0042769,en_2362,CAUSES,Myopathy,C0026848,en_1605,1,1,AFFECTS,Excitatory,3
1168,Virus Diseases,C0042769,en_2362,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
1169,Virus Diseases,C0042769,en_2362,CAUSES,Nephrotic Syndrome,C0027726,en_1654,1,1,AFFECTS,Excitatory,3
1170,Virus Diseases,C0042769,en_2362,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1171,Virus Diseases,C0042769,en_2362,CAUSES,Pneumonia,C0032285,en_1833,25,16,AFFECTS,Excitatory,48
1172,Virus Diseases,C0042769,en_2362,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
1173,Virus Diseases,C0042769,en_2362,CAUSES,Respiration Disorders,C0035204,en_2005,8,6,AFFECTS,Excitatory,18
1174,Virus Diseases,C0042769,en_2362,CAUSES,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,1,1,AFFECTS,Excitatory,3
1175,Virus Diseases,C0042769,en_2362,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,7,5,AFFECTS,Excitatory,15
1176,Virus Diseases,C0042769,en_2362,CAUSES,Respiratory Tract Diseases,C0035242,en_2016,2,1,AFFECTS,Excitatory,3
1177,Virus Diseases,C0042769,en_2362,CAUSES,Respiratory Tract Infections,C0035243,en_2017,13,8,AFFECTS,Excitatory,24
1178,Virus Diseases,C0042769,en_2362,CAUSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
1179,Virus Diseases,C0042769,en_2362,CAUSES,Shock,C0036974,en_2097,2,1,AFFECTS,Excitatory,3
1180,Virus Diseases,C0042769,en_2362,CAUSES,"Signs and Symptoms, Respiratory",C0037090,en_2107,6,4,AFFECTS,Excitatory,12
1181,Virus Diseases,C0042769,en_2362,CAUSES,Sneezing,C0037383,en_2124,2,1,AFFECTS,Excitatory,3
1182,Virus Diseases,C0042769,en_2362,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
1183,Virus Diseases,C0042769,en_2362,CAUSES,Syndrome,C0039082,en_2197,6,5,AFFECTS,Excitatory,15
1184,Virus Diseases,C0042769,en_2362,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
1185,Virus Diseases,C0042769,en_2362,CAUSES,"Infections, Upper Respiratory",C0041912,en_2315,1,1,AFFECTS,Excitatory,3
1186,Virus Diseases,C0042769,en_2362,CAUSES,Vasculitis,C0042384,en_2338,2,2,AFFECTS,Excitatory,6
1187,Virus Diseases,C0042769,en_2362,CAUSES,Wound Healing,C0043240,en_2400,1,1,AFFECTS,Excitatory,3
1188,Virus Diseases,C0042769,en_2362,CAUSES,Encephalopathies,C0085584,en_2680,1,1,AFFECTS,Excitatory,3
1189,Virus Diseases,C0042769,en_2362,CAUSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
1190,Virus Diseases,C0042769,en_2362,CAUSES,Lower respiratory tract infection,C0149725,en_2806,2,1,AFFECTS,Excitatory,3
1191,Virus Diseases,C0042769,en_2362,CAUSES,Advice,C0150600,en_2845,1,1,AFFECTS,Excitatory,3
1192,Virus Diseases,C0042769,en_2362,CAUSES,"Complications of pregnancy, childbirth and the puerperium",C0178292,en_2981,1,1,AFFECTS,Excitatory,3
1193,Virus Diseases,C0042769,en_2362,CAUSES,Coronavirus Infections,C0206750,en_3176,5,3,AFFECTS,Excitatory,9
1194,Virus Diseases,C0042769,en_2362,CAUSES,Screening procedure,C0220908,en_3208,1,1,AFFECTS,Excitatory,3
1195,Virus Diseases,C0042769,en_2362,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
1196,Virus Diseases,C0042769,en_2362,CAUSES,Nasal symptom,C0231918,en_3266,1,1,AFFECTS,Excitatory,3
1197,Virus Diseases,C0042769,en_2362,CAUSES,Psychological symptom,C0233397,en_3290,2,2,AFFECTS,Excitatory,6
1198,Virus Diseases,C0042769,en_2362,CAUSES,Emission,C0233929,en_3301,1,1,AFFECTS,Excitatory,3
1199,Virus Diseases,C0042769,en_2362,CAUSES,Recovery,C0237820,en_3354,2,1,AFFECTS,Excitatory,3
1200,Virus Diseases,C0042769,en_2362,CAUSES,Hypoxia,C0242184,en_3396,4,2,AFFECTS,Excitatory,6
1201,Virus Diseases,C0042769,en_2362,CAUSES,Acute respiratory disease,C0264219,en_3527,8,4,AFFECTS,Excitatory,12
1202,Virus Diseases,C0042769,en_2362,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
1203,Virus Diseases,C0042769,en_2362,CAUSES,Viral myocarditis,C0276138,en_3573,1,1,AFFECTS,Excitatory,3
1204,Virus Diseases,C0042769,en_2362,CAUSES,Immune response,C0301872,en_3696,14,10,AFFECTS,Excitatory,30
1205,Virus Diseases,C0042769,en_2362,CAUSES,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Excitatory,3
1206,Virus Diseases,C0042769,en_2362,CAUSES,Influenza-like symptoms,C0392171,en_3915,1,1,AFFECTS,Excitatory,3
1207,Virus Diseases,C0042769,en_2362,CAUSES,Neuropathic pain,C0423716,en_3989,1,1,AFFECTS,Excitatory,3
1208,Virus Diseases,C0042769,en_2362,CAUSES,Acute respiratory distress,C0748355,en_4831,1,1,AFFECTS,Excitatory,3
1209,Virus Diseases,C0042769,en_2362,CAUSES,Endothelial dysfunction,C0856169,en_4968,2,2,AFFECTS,Excitatory,6
1210,Virus Diseases,C0042769,en_2362,CAUSES,Unwell,C0857256,en_4972,2,1,AFFECTS,Excitatory,3
1211,Virus Diseases,C0042769,en_2362,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
1212,Virus Diseases,C0042769,en_2362,CAUSES,Cytokine storm,C0919747,en_5119,5,4,AFFECTS,Excitatory,12
1213,Virus Diseases,C0042769,en_2362,CAUSES,Respiratory Failure,C1145670,en_5292,7,4,AFFECTS,Excitatory,12
1214,Virus Diseases,C0042769,en_2362,CAUSES,innate immune response,C1155265,en_5320,1,1,AFFECTS,Excitatory,3
1215,Virus Diseases,C0042769,en_2362,CAUSES,Inflammatory Response,C1155266,en_5321,11,7,AFFECTS,Excitatory,21
1216,Virus Diseases,C0042769,en_2362,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,22,12,AFFECTS,Excitatory,36
1217,Virus Diseases,C0042769,en_2362,CAUSES,Abnormal breathing,C1260922,en_5414,2,1,AFFECTS,Excitatory,3
1218,Virus Diseases,C0042769,en_2362,CAUSES,imbalance,C1397014,en_5692,2,1,AFFECTS,Excitatory,3
1219,Virus Diseases,C0042769,en_2362,CAUSES,Symptoms,C1457887,en_5784,15,10,AFFECTS,Excitatory,30
1220,Virus Diseases,C0042769,en_2362,CAUSES,Paraosmia,C1510410,en_5793,2,1,AFFECTS,Excitatory,3
1221,Virus Diseases,C0042769,en_2362,CAUSES(SPEC),Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
1222,Virus Diseases,C0042769,en_2362,CAUSES(SPEC),Encephalopathies,C0085584,en_2680,1,1,AFFECTS,Excitatory,3
1223,Virus Diseases,C0042769,en_2362,CAUSES(SPEC),Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1224,Virus,C0042776,en_2364,CAUSES,Common Cold,C0009443,en_684,5,5,AFFECTS,Excitatory,15
1225,Virus,C0042776,en_2364,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
1226,Virus,C0042776,en_2364,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1227,Virus,C0042776,en_2364,CAUSES,Disease,C0012634,en_826,15,14,AFFECTS,Excitatory,48
1228,Virus,C0042776,en_2364,CAUSES,Dysautonomia,C0013363,en_863,1,1,AFFECTS,Excitatory,6
1229,Virus,C0042776,en_2364,CAUSES,"Hemorrhagic Fevers, Viral",C0019104,en_1164,1,1,AFFECTS,Excitatory,3
1230,Virus,C0042776,en_2364,CAUSES,Infection,C3714514,en_6235,5,4,AFFECTS,Excitatory,12
1231,Virus,C0042776,en_2364,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
1232,Virus,C0042776,en_2364,CAUSES,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Excitatory,6
1233,Virus,C0042776,en_2364,CAUSES,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Excitatory,6
1234,Virus,C0042776,en_2364,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1235,Virus,C0042776,en_2364,CAUSES,Respiratory Tract Infections,C0035243,en_2017,6,4,AFFECTS,Excitatory,12
1236,Virus,C0042776,en_2364,CAUSES,Syndrome,C0039082,en_2197,2,1,AFFECTS,Excitatory,3
1237,Virus,C0042776,en_2364,CAUSES,Virus Diseases,C0042769,en_2362,4,3,AFFECTS,Excitatory,9
1238,Virus,C0042776,en_2364,CAUSES,Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Excitatory,3
1239,Virus,C0042776,en_2364,CAUSES,"[X]Acute myocarditis, unspecified",C0155686,en_2889,1,1,AFFECTS,Excitatory,3
1240,Virus,C0042776,en_2364,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
1241,Virus,C0042776,en_2364,CAUSES,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,Excitatory,6
1242,Virus,C0042776,en_2364,CAUSES,Disorder of upper respiratory system,C0264221,en_3529,2,1,AFFECTS,Excitatory,3
1243,Virus,C0042776,en_2364,CAUSES,Anthropozoonosis,C0275535,en_3567,1,1,AFFECTS,Excitatory,3
1244,Virus,C0042776,en_2364,CAUSES,Infectious canine tracheobronchitis,C0276170,en_3575,1,1,AFFECTS,Excitatory,3
1245,Virus,C0042776,en_2364,CAUSES,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Excitatory,3
1246,Virus,C0042776,en_2364,CAUSES,Malignant disease,C0442867,en_4059,1,1,AFFECTS,Excitatory,3
1247,Virus,C0042776,en_2364,CAUSES,Reception,C0544683,en_4264,1,1,AFFECTS,Excitatory,3
1248,Virus,C0042776,en_2364,CAUSES,cell injury,C0599732,en_4467,1,1,AFFECTS,Excitatory,3
1249,Virus,C0042776,en_2364,CAUSES,AIRWAY DISEASE,C0699949,en_4711,2,1,AFFECTS,Excitatory,3
1250,Virus,C0042776,en_2364,CAUSES,Zoonotic infection NOS,C0854537,en_4961,1,1,AFFECTS,Excitatory,3
1251,Virus,C0042776,en_2364,CAUSES,"Communicable Diseases, Emerging",C0872315,en_5049,1,1,AFFECTS,Excitatory,8
1252,Virus,C0042776,en_2364,CAUSES,Infectious disease of lung,C0876973,en_5058,2,1,AFFECTS,Excitatory,3
1253,Virus,C0042776,en_2364,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1254,Virus,C0042776,en_2364,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
1255,Virus,C0042776,en_2364,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,7,7,AFFECTS,Excitatory,21
1256,Virus,C0042776,en_2364,CAUSES,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,Excitatory,3
1257,Virus,C0042776,en_2364,CAUSES,COVID-19,C5203670,en_6417,13,13,AFFECTS,Excitatory,88
1258,Virus,C0042776,en_2364,CAUSES(SPEC),Common Cold,C0009443,en_684,2,1,AFFECTS,Excitatory,3
1259,Vitamin D,C0042866,en_2371,CAUSES,Disease,C0012634,en_826,4,2,AFFECTS,Excitatory,6
1260,Vomiting,C0042963,en_2381,CAUSES,Anorexia,C0003123,en_336,1,1,AFFECTS,Excitatory,3
1261,Water Pollution,C0043056,en_2385,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1262,Wounds and Injuries,C0043251,en_2401,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1263,Zinc,C0043481,en_2409,CAUSES,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,3
1264,Zoonoses,C0043528,en_2410,CAUSES,Atypical pneumonia,C1412002,en_5696,1,1,AFFECTS,Excitatory,3
1265,Zoonoses,C0043528,en_2410,CAUSES(SPEC),Nephrotic Syndrome,C0027726,en_1654,1,1,AFFECTS,Excitatory,3
1266,2-toluenesulfonamide,C0046582,en_2418,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1267,anthrax toxin,C0051962,en_2431,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,3
1268,"enterotoxin B, staphylococcal",C0059386,en_2480,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1269,Fibrin fragment D,C0060323,en_2484,CAUSES,Blood Coagulation Disorders,C0005779,en_485,2,2,AFFECTS,Excitatory,15
1270,GTPase-Activating Proteins,C0061928,en_2499,CAUSES,Pathological accumulation of air in tissues,C0013990,en_891,1,1,AFFECTS,Excitatory,3
1271,GTPase-Activating Proteins,C0061928,en_2499,CAUSES,Equilibrium,C0014653,en_923,1,1,AFFECTS,Excitatory,3
1272,GTPase-Activating Proteins,C0061928,en_2499,CAUSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
1273,Interferon Regulatory Factor 1,C0063700,en_2508,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1274,Lactic acid,C0064582,en_2513,CAUSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
1275,cytokine,C0079189,en_2593,CAUSES,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Excitatory,3
1276,cytokine,C0079189,en_2593,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
1277,cytokine,C0079189,en_2593,CAUSES,Tissue damage,C0010957,en_756,4,2,AFFECTS,Excitatory,6
1278,cytokine,C0079189,en_2593,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1279,cytokine,C0079189,en_2593,CAUSES,Inflammation,C0021368,en_1307,6,5,AFFECTS,Excitatory,15
1280,cytokine,C0079189,en_2593,CAUSES,"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,1,1,AFFECTS,Excitatory,3
1281,cytokine,C0079189,en_2593,CAUSES,Multiple Organ Failure,C0026766,en_1597,3,2,AFFECTS,Excitatory,6
1282,cytokine,C0079189,en_2593,CAUSES,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Excitatory,6
1283,cytokine,C0079189,en_2593,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,2,AFFECTS,Excitatory,6
1284,cytokine,C0079189,en_2593,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,7
1285,cytokine,C0079189,en_2593,CAUSES,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,Excitatory,3
1286,cytokine,C0079189,en_2593,CAUSES,biological adaptation to stress,C0149784,en_2810,1,1,AFFECTS,Excitatory,3
1287,cytokine,C0079189,en_2593,CAUSES,Respiratory complication,C0161818,en_2899,3,2,AFFECTS,Excitatory,6
1288,cytokine,C0079189,en_2593,CAUSES,Injury,C0175677,en_2968,3,2,AFFECTS,Excitatory,6
1289,cytokine,C0079189,en_2593,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
1290,cytokine,C0079189,en_2593,CAUSES,Respiratory distress,C0476273,en_4149,4,2,AFFECTS,Excitatory,6
1291,cytokine,C0079189,en_2593,CAUSES,Severe inflammation,C0522569,en_4215,1,1,AFFECTS,Excitatory,3
1292,cytokine,C0079189,en_2593,CAUSES,Immunoregulation,C0678889,en_4580,2,2,AFFECTS,Excitatory,6
1293,cytokine,C0079189,en_2593,CAUSES,ALLERGIC SYMPTOM,C0740903,en_4785,1,1,AFFECTS,Excitatory,3
1294,cytokine,C0079189,en_2593,CAUSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,3
1295,cytokine,C0079189,en_2593,CAUSES,Cytokine storm,C0919747,en_5119,4,2,AFFECTS,Excitatory,6
1296,cytokine,C0079189,en_2593,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1297,cytokine,C0079189,en_2593,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
1298,cytokine,C0079189,en_2593,CAUSES,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Excitatory,6
1299,cytokine,C0079189,en_2593,CAUSES(SPEC),Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Excitatory,3
1300,cytokine,C0079189,en_2593,CAUSES(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1301,Deforestation,C0079201,en_2594,CAUSES,Zoonoses,C0043528,en_2410,1,1,AFFECTS,Excitatory,3
1302,TP53 gene,C0079419,en_2602,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
1303,TP53 gene,C0079419,en_2602,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
1304,Protein p53,C0080055,en_2618,CAUSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
1305,Walking,C0080331,en_2629,CAUSES,Weight Gain,C0043094,en_2388,1,1,AFFECTS,Excitatory,6
1306,Interleukin-10,C0085295,en_2659,CAUSES,Interstitial fibrosis,C0240035,en_3381,2,1,AFFECTS,Excitatory,3
1307,Interleukin-10,C0085295,en_2659,CAUSES,Severe inflammation,C0522569,en_4215,1,1,AFFECTS,Excitatory,3
1308,Oxidants,C0085403,en_2667,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
1309,Burkholderia cepacia,C0085469,en_2671,CAUSES,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Excitatory,3
1310,Burkholderia cepacia,C0085469,en_2671,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,3
1311,Encephalopathies,C0085584,en_2680,CAUSES,comatose,C0009421,en_682,1,1,AFFECTS,Excitatory,6
1312,Encephalopathies,C0085584,en_2680,CAUSES(SPEC),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1313,catheter device,C0085590,en_2681,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
1314,Ventricular arrhythmia,C0085612,en_2682,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,6
1315,Acute appendicitis NOS,C0085693,en_2687,CAUSES,"Abdomen, Acute",C0000727,en_205,1,1,AFFECTS,Excitatory,3
1316,Acute appendicitis NOS,C0085693,en_2687,CAUSES,Acute abdominal pain,C0740577,en_4779,1,1,AFFECTS,Excitatory,3
1317,Polyglandular Type I Autoimmune Syndrome,C0085859,en_2695,CAUSES,"Candidiasis, Chronic Mucocutaneous",C0006845,en_547,1,1,AFFECTS,Excitatory,3
1318,Diagnostic tests,C0086143,en_2703,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1319,Diagnostic tests,C0086143,en_2703,CAUSES,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,6
1320,Dissociation,C0086168,en_2707,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1321,Dynorphin (1-17),C0086191,en_2708,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1322,Hypokinesia,C0086439,en_2721,CAUSES,Disuse syndrome,C0184554,en_3053,1,1,AFFECTS,Excitatory,3
1323,Lung Capacities,C0086571,en_2727,CAUSES,poor health,C0683321,en_4658,1,1,AFFECTS,Excitatory,3
1324,Benign Neoplasm,C0086692,en_2732,CAUSES,Deafness,C0011053,en_761,1,1,AFFECTS,Excitatory,3
1325,Thrombus,C0087086,en_2743,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
1326,Thrombus,C0087086,en_2743,CAUSES,Obstruction,C0028778,en_1702,1,1,AFFECTS,Excitatory,3
1327,Thrombus,C0087086,en_2743,CAUSES,Intracranial Hemorrhages,C0151699,en_2864,1,1,AFFECTS,Excitatory,3
1328,Thrombus,C0087086,en_2743,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
1329,Thrombus,C0087086,en_2743,CAUSES,Organ failure,C0948600,en_5171,1,1,AFFECTS,Excitatory,3
1330,Therapeutic procedure,C0087111,en_2744,CAUSES,Disease,C0012634,en_826,4,3,AFFECTS,Excitatory,9
1331,Therapeutic procedure,C0087111,en_2744,CAUSES,Glomerulonephritis,C0017658,en_1065,2,1,AFFECTS,Excitatory,3
1332,Therapeutic procedure,C0087111,en_2744,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1333,Therapeutic procedure,C0087111,en_2744,CAUSES,"Lupus Erythematosus, Systemic",C0024141,en_1466,2,1,AFFECTS,Excitatory,3
1334,Therapeutic procedure,C0087111,en_2744,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
1335,Therapeutic procedure,C0087111,en_2744,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1336,Therapeutic procedure,C0087111,en_2744,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
1337,Therapeutic procedure,C0087111,en_2744,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
1338,Brain-Derived Neurotrophic Factor,C0107103,en_2754,CAUSES,Bioenergetics,C0005486,en_464,1,1,AFFECTS,Excitatory,3
1339,Brain-Derived Neurotrophic Factor,C0107103,en_2754,CAUSES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
1340,Enzyme Deficiency,C0149676,en_2803,CAUSES,Hereditary stomatocytosis,C1262483,en_5424,1,1,AFFECTS,Excitatory,3
1341,Lower respiratory tract infection,C0149725,en_2806,CAUSES,Cessation of life,C0011065,en_762,22,2,AFFECTS,Excitatory,6
1342,Steroid therapy,C0149783,en_2809,CAUSES,Adrenal gland hypofunction,C0001623,en_248,1,1,AFFECTS,Excitatory,3
1343,Deep Vein Thrombosis,C0149871,en_2812,CAUSES,Blood Coagulation Disorders,C0005779,en_485,2,1,AFFECTS,Excitatory,3
1344,Deep Vein Thrombosis,C0149871,en_2812,CAUSES(SPEC),Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
1345,Deep Vein Thrombosis,C0149871,en_2812,CAUSES(SPEC),Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,3
1346,Deep Vein Thrombosis,C0149871,en_2812,CAUSES(SPEC),Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
1347,Deep Vein Thrombosis,C0149871,en_2812,CAUSES(SPEC),Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Excitatory,3
1348,Impaired gas exchange,C0150034,en_2814,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1349,Chronic pain,C0150055,en_2816,CAUSES,Pain,C0030193,en_1741,2,2,AFFECTS,Excitatory,6
1350,Chronic pain,C0150055,en_2816,CAUSES,Peripheral Neuropathy,C0031117,en_1776,1,1,AFFECTS,Excitatory,3
1351,Calming,C0150157,en_2822,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1352,Chronic infectious disease,C0151317,en_2857,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1353,Chronic infectious disease,C0151317,en_2857,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
1354,Chronic infectious disease,C0151317,en_2857,CAUSES,Chronic liver disease NOS,C0341439,en_3823,1,1,AFFECTS,Excitatory,3
1355,Bacterial resistance,C0151521,en_2859,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,6
1356,Premature Birth,C0151526,en_2860,CAUSES,Pregnancy,C0032961,en_1872,1,1,AFFECTS,Excitatory,3
1357,Myocardial Ischemia,C0151744,en_2865,CAUSES,Cardiopulmonary Arrest,C0600228,en_4500,1,1,AFFECTS,Excitatory,6
1358,Biliary Colic,C0151824,en_2869,CAUSES,"Abdomen, Acute",C0000727,en_205,1,1,AFFECTS,Excitatory,3
1359,Thrombosis of cerebral veins,C0151945,en_2874,CAUSES,Cerebral Infarction,C0007785,en_603,1,1,AFFECTS,Excitatory,3
1360,Thrombosis of cerebral veins,C0151945,en_2874,CAUSES,Cerebral phlebitis,C0850824,en_4946,1,1,AFFECTS,Excitatory,3
1361,Congenital heart disease,C0152021,en_2877,CAUSES,Pulmonary arterial hypertension,C1619734,en_6012,1,1,AFFECTS,Excitatory,3
1362,Urinary hesitation,C0152032,en_2878,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1363,Urinary hesitation,C0152032,en_2878,CAUSES,Measles,C0025007,en_1512,1,1,AFFECTS,Excitatory,3
1364,Urinary hesitation,C0152032,en_2878,CAUSES,Pertussis,C0043167,en_2395,1,1,AFFECTS,Excitatory,3
1365,Urinary hesitation,C0152032,en_2878,CAUSES(SPEC),Measles,C0025007,en_1512,1,1,AFFECTS,Excitatory,3
1366,Urinary hesitation,C0152032,en_2878,CAUSES(SPEC),Pertussis,C0043167,en_2395,1,1,AFFECTS,Excitatory,3
1367,"[X]Acute myocarditis, unspecified",C0155686,en_2889,CAUSES,Acute heart failure,C0264714,en_3536,1,1,AFFECTS,Excitatory,8
1368,Disease of capillaries,C0155765,en_2890,CAUSES,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Excitatory,3
1369,Gastrointestinal tract vascular insufficiency,C0156149,en_2892,CAUSES,"Abdomen, Acute",C0000727,en_205,1,1,AFFECTS,Excitatory,3
1370,"Severe birth asphyxia, APGAR 0-3",C0158931,en_2894,CAUSES,Term pregnancy,C0232991,en_3289,1,1,AFFECTS,Excitatory,6
1371,Central nervous system complication,C0161815,en_2897,CAUSES(SPEC),Autoimmunity,C0004368,en_430,1,1,AFFECTS,Excitatory,3
1372,Respiratory complication,C0161818,en_2899,CAUSES,Cessation of life,C0011065,en_762,4,3,AFFECTS,Excitatory,9
1373,DNA Sequence,C0162326,en_2904,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1374,DNA Sequence,C0162326,en_2904,CAUSES,"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,1,1,AFFECTS,Excitatory,3
1375,RNA Sequence,C0162327,en_2905,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1376,Malnutrition,C0162429,en_2910,CAUSES,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Excitatory,3
1377,Malnutrition,C0162429,en_2910,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1378,Malnutrition,C0162429,en_2910,CAUSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
1379,Apoptosis,C0162638,en_2922,CAUSES,Down-Regulation,C0013081,en_844,1,1,AFFECTS,Excitatory,3
1380,"Receptor-CD3 Complex, Antigen, T-Cell",C0162681,en_2926,CAUSES,Autoimmunity,C0004368,en_430,1,1,AFFECTS,Excitatory,3
1381,Pain Threshold,C0162703,en_2927,CAUSES,Increased effect,C0595938,en_4372,1,1,AFFECTS,Excitatory,3
1382,HIV Protease Inhibitors,C0162714,en_2929,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1383,Reactive Oxygen Species,C0162772,en_2932,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1384,Reactive Oxygen Species,C0162772,en_2932,CAUSES,Inactivation,C0544461,en_4262,1,1,AFFECTS,Excitatory,3
1385,"Dermatitis, Irritant",C0162823,en_2934,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,6
1386,"Dermatitis, Irritant",C0162823,en_2934,CAUSES,Chronic hand eczema,C1276092,en_5464,1,1,AFFECTS,Excitatory,6
1387,"Aneurysm, Ruptured",C0162869,en_2939,CAUSES,Acute hemorrhage,C0333276,en_3760,1,1,AFFECTS,Excitatory,6
1388,Substance P Receptor,C0164209,en_2944,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1389,CD40 Ligand,C0167627,en_2954,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1390,Injury,C0175677,en_2968,CAUSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
1391,Injury,C0175677,en_2968,CAUSES,Disease,C0012634,en_826,8,4,AFFECTS,Excitatory,12
1392,Injury,C0175677,en_2968,CAUSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
1393,Injury,C0175677,en_2968,CAUSES,Multiple Organ Failure,C0026766,en_1597,3,2,AFFECTS,Excitatory,6
1394,Injury,C0175677,en_2968,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
1395,Injury,C0175677,en_2968,CAUSES,"Purpura, Thrombotic Thrombocytopenic",C0034155,en_1940,2,1,AFFECTS,Excitatory,3
1396,Injury,C0175677,en_2968,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1397,Injury,C0175677,en_2968,CAUSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
1398,Injury,C0175677,en_2968,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
1399,Injury,C0175677,en_2968,CAUSES,Hypoxia,C0242184,en_3396,2,1,AFFECTS,Excitatory,3
1400,Injury,C0175677,en_2968,CAUSES,Erectile dysfunction,C0242350,en_3407,1,1,AFFECTS,Excitatory,3
1401,Injury,C0175677,en_2968,CAUSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
1402,Injury,C0175677,en_2968,CAUSES,Impaired oxygen delivery,C0342968,en_3829,1,1,AFFECTS,Excitatory,3
1403,Injury,C0175677,en_2968,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,3
1404,Injury,C0175677,en_2968,CAUSES,Organ failure,C0948600,en_5171,2,1,AFFECTS,Excitatory,3
1405,Injury,C0175677,en_2968,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,3
1406,Injury,C0175677,en_2968,CAUSES,Inflammatory Response,C1155266,en_5321,3,2,AFFECTS,Excitatory,6
1407,Injury,C0175677,en_2968,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1408,Injury,C0175677,en_2968,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
1409,Injury,C0175677,en_2968,CAUSES,Idiopathic pneumonia syndrome,C1504431,en_5788,1,1,AFFECTS,Excitatory,3
1410,Blood specimen,C0178913,en_2993,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
1411,Adapters,C0178959,en_2994,CAUSES,Leak NOS,C1608322,en_6001,2,1,AFFECTS,Excitatory,3
1412,Airway device,C0178987,en_2996,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
1413,Airway device,C0178987,en_2996,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1414,"Cannulae, Nasal",C0179574,en_3003,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1415,Detectors,C0180392,en_3008,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
1416,"Lights, Ultraviolet",C0181651,en_3025,CAUSES,Disintegration,C1265875,en_5433,1,1,AFFECTS,Excitatory,3
1417,Surgical face mask,C0181758,en_3028,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,6
1418,Reservoirs,C0182967,en_3037,CAUSES,Urinary tract infection,C0042029,en_2320,1,1,AFFECTS,Excitatory,3
1419,"Support, device",C0183683,en_3046,CAUSES,comatose,C0009421,en_682,1,1,AFFECTS,Excitatory,6
1420,Traps,C0184047,en_3048,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1421,Traps,C0184047,en_3048,CAUSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
1422,Traps,C0184047,en_3048,CAUSES,Injury,C0175677,en_2968,2,2,AFFECTS,Excitatory,6
1423,Traps,C0184047,en_3048,CAUSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,3
1424,Traps,C0184047,en_3048,CAUSES,Chronic graft-versus-host disease,C0867389,en_4996,1,1,AFFECTS,Excitatory,3
1425,Reparative closure,C0185003,en_3066,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
1426,Reparative closure,C0185003,en_3066,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,3
1427,Muscle biopsy,C0185283,en_3073,CAUSES,Malaise,C0231218,en_3251,2,1,AFFECTS,Excitatory,3
1428,Prophylactic treatment,C0199176,en_3090,CAUSES,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Excitatory,3
1429,Prophylactic treatment,C0199176,en_3090,CAUSES,Disease,C0012634,en_826,3,2,AFFECTS,Excitatory,6
1430,Prophylactic treatment,C0199176,en_3090,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
1431,Mechanical ventilation,C0199470,en_3095,CAUSES,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,Excitatory,3
1432,Mechanical ventilation,C0199470,en_3095,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
1433,Mechanical ventilation,C0199470,en_3095,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,5,3,AFFECTS,Excitatory,9
1434,Mechanical ventilation,C0199470,en_3095,CAUSES,Atrophic,C0333641,en_3770,1,1,AFFECTS,Excitatory,3
1435,Mechanical ventilation,C0199470,en_3095,CAUSES,Respiratory Failure,C1145670,en_5292,4,2,AFFECTS,Excitatory,6
1436,Chest CT,C0202823,en_3107,CAUSES,Hypocapnia,C0085383,en_2664,1,1,AFFECTS,Excitatory,3
1437,Structural analysis,C0204514,en_3116,CAUSES,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,2,1,AFFECTS,Excitatory,3
1438,Isolation procedure,C0204727,en_3120,CAUSES,Inflammatory Bowel Diseases,C0021390,en_1310,2,1,AFFECTS,Excitatory,3
1439,Isolation procedure,C0204727,en_3120,CAUSES,disease transmission,C0242781,en_3438,1,1,AFFECTS,Excitatory,7
1440,Isolation procedure,C0204727,en_3120,CAUSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,12
1441,"Infections, Hospital",C0205721,en_3133,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1442,"Pneumonitis, Interstitial",C0206061,en_3141,CAUSES,Acute hypoxemic respiratory failure,C4039867,en_6301,1,1,AFFECTS,Excitatory,6
1443,Malaria Vaccines,C0206255,en_3156,CAUSES,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,3
1444,Genus: Coronavirus,C0206419,en_3158,CAUSES,Central Nervous System Infections,C0007684,en_598,1,1,AFFECTS,Excitatory,3
1445,Genus: Coronavirus,C0206419,en_3158,CAUSES,Common Cold,C0009443,en_684,10,8,AFFECTS,Excitatory,24
1446,Genus: Coronavirus,C0206419,en_3158,CAUSES,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Excitatory,3
1447,Genus: Coronavirus,C0206419,en_3158,CAUSES,Disease,C0012634,en_826,21,19,AFFECTS,Excitatory,57
1448,Genus: Coronavirus,C0206419,en_3158,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1449,Genus: Coronavirus,C0206419,en_3158,CAUSES,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,Excitatory,3
1450,Genus: Coronavirus,C0206419,en_3158,CAUSES,Pneumonia,C0032285,en_1833,4,3,AFFECTS,Excitatory,9
1451,Genus: Coronavirus,C0206419,en_3158,CAUSES,Respiration Disorders,C0035204,en_2005,3,3,AFFECTS,Excitatory,9
1452,Genus: Coronavirus,C0206419,en_3158,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,6,5,AFFECTS,Excitatory,15
1453,Genus: Coronavirus,C0206419,en_3158,CAUSES,Respiratory Tract Infections,C0035243,en_2017,8,4,AFFECTS,Excitatory,12
1454,Genus: Coronavirus,C0206419,en_3158,CAUSES,Syndrome,C0039082,en_2197,9,5,AFFECTS,Excitatory,15
1455,Genus: Coronavirus,C0206419,en_3158,CAUSES,Virus Diseases,C0042769,en_2362,4,4,AFFECTS,Excitatory,12
1456,Genus: Coronavirus,C0206419,en_3158,CAUSES,Iron Overload,C0282193,en_3639,1,1,AFFECTS,Excitatory,3
1457,Genus: Coronavirus,C0206419,en_3158,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,3
1458,Genus: Coronavirus,C0206419,en_3158,CAUSES,Cytokine storm,C0919747,en_5119,2,2,AFFECTS,Excitatory,6
1459,Genus: Coronavirus,C0206419,en_3158,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,2,AFFECTS,Excitatory,6
1460,Genus: Coronavirus,C0206419,en_3158,CAUSES(SPEC),Common Cold,C0009443,en_684,2,1,AFFECTS,Excitatory,3
1461,Genus: Coronavirus,C0206419,en_3158,CAUSES(SPEC),Disease,C0012634,en_826,4,2,AFFECTS,Excitatory,6
1462,Genus: Coronavirus,C0206419,en_3158,CAUSES(SPEC),Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Excitatory,3
1463,Genus: Coronavirus,C0206419,en_3158,CAUSES(SPEC),Disorder of upper respiratory system,C0264221,en_3529,2,1,AFFECTS,Excitatory,3
1464,Genus: Coronavirus,C0206419,en_3158,CAUSES(SPEC),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1465,Human coronavirus,C0206422,en_3159,CAUSES,Common Cold,C0009443,en_684,1,1,AFFECTS,Excitatory,3
1466,Human coronavirus,C0206422,en_3159,CAUSES,Disease,C0012634,en_826,4,4,AFFECTS,Excitatory,12
1467,Human coronavirus,C0206422,en_3159,CAUSES,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Excitatory,6
1468,Human coronavirus,C0206422,en_3159,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,3
1469,Human coronavirus,C0206422,en_3159,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
1470,Human coronavirus,C0206422,en_3159,CAUSES,"Infections, Upper Respiratory",C0041912,en_2315,1,1,AFFECTS,Excitatory,3
1471,Human coronavirus,C0206422,en_3159,CAUSES,Acute respiratory disease,C0264219,en_3527,1,1,AFFECTS,Excitatory,3
1472,Human coronavirus,C0206422,en_3159,CAUSES(SPEC),Respiration Disorders,C0035204,en_2005,2,2,AFFECTS,Excitatory,6
1473,Human respiratory syncytial virus,C0206545,en_3166,CAUSES,Acute lower respiratory tract infection,C0238990,en_3372,2,1,AFFECTS,Excitatory,3
1474,Coronavirus Infections,C0206750,en_3176,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,8
1475,Coronavirus Infections,C0206750,en_3176,CAUSES,Disease,C0012634,en_826,6,6,AFFECTS,Excitatory,30
1476,Coronavirus Infections,C0206750,en_3176,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
1477,Coronavirus Infections,C0206750,en_3176,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1478,Coronavirus Infections,C0206750,en_3176,CAUSES,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,Excitatory,3
1479,Coronavirus Infections,C0206750,en_3176,CAUSES,Physical Examination,C0031809,en_1804,1,1,AFFECTS,Excitatory,6
1480,Coronavirus Infections,C0206750,en_3176,CAUSES,Pneumonia,C0032285,en_1833,4,4,AFFECTS,Excitatory,18
1481,Coronavirus Infections,C0206750,en_3176,CAUSES,"Cardiomyopathies, Primary",C0033141,en_1885,1,1,AFFECTS,Excitatory,3
1482,Coronavirus Infections,C0206750,en_3176,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
1483,Coronavirus Infections,C0206750,en_3176,CAUSES,Respiration Disorders,C0035204,en_2005,3,2,AFFECTS,Excitatory,10
1484,Coronavirus Infections,C0206750,en_3176,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,6
1485,Coronavirus Infections,C0206750,en_3176,CAUSES,intensive care,C0085559,en_2678,3,2,AFFECTS,Excitatory,6
1486,Coronavirus Infections,C0206750,en_3176,CAUSES,Hospital admission,C0184666,en_3063,1,1,AFFECTS,Excitatory,3
1487,Coronavirus Infections,C0206750,en_3176,CAUSES,EXERCISE INTOLERANCE,C0241885,en_3393,2,1,AFFECTS,Excitatory,3
1488,Coronavirus Infections,C0206750,en_3176,CAUSES,"Myocarditis, chronic",C0865681,en_4995,1,1,AFFECTS,Excitatory,3
1489,Coronavirus Infections,C0206750,en_3176,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1490,Coronavirus Infections,C0206750,en_3176,CAUSES,Patient identification,C1269815,en_5448,1,1,AFFECTS,Excitatory,3
1491,Coronavirus Infections,C0206750,en_3176,CAUSES,Symptoms,C1457887,en_5784,10,7,AFFECTS,Excitatory,21
1492,Coronavirus Infections,C0206750,en_3176,CAUSES,COVID-19,C5203670,en_6417,7,7,AFFECTS,Excitatory,45
1493,Chemokine (C-C Motif) Ligand 4,C0209338,en_3183,CAUSES,"Injury to liver, NOS",C0160390,en_2896,1,1,AFFECTS,Excitatory,3
1494,Chemokine (C-C Motif) Ligand 4,C0209338,en_3183,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
1495,Chemokine (C-C Motif) Ligand 4,C0209338,en_3183,CAUSES,cell injury,C0599732,en_4467,1,1,AFFECTS,Excitatory,3
1496,Chemokine (C-C Motif) Ligand 4,C0209338,en_3183,CAUSES,"Steatohepatitis, non-alcoholic",C0878674,en_5075,1,1,AFFECTS,Excitatory,3
1497,"RTN1 protein, human",C0217373,en_3194,CAUSES,Vesicle,C0333262,en_3759,1,1,AFFECTS,Excitatory,3
1498,Chemicals,C0220806,en_3200,CAUSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
1499,Chemicals,C0220806,en_3200,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1500,Chemicals,C0220806,en_3200,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1501,Chemicals,C0220806,en_3200,CAUSES,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,Excitatory,3
1502,Chemicals,C0220806,en_3200,CAUSES,Hepatotoxicity,C0235378,en_3326,1,1,AFFECTS,Excitatory,3
1503,Hepatitis C virus,C0220847,en_3204,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
1504,Hepatitis C virus,C0220847,en_3204,CAUSES,Primary carcinoma of the liver cells,C0019204,en_1178,1,1,AFFECTS,Excitatory,3
1505,Hepatitis C virus,C0220847,en_3204,CAUSES,Liver diseases,C0023895,en_1455,1,1,AFFECTS,Excitatory,3
1506,Hepatitis C virus,C0220847,en_3204,CAUSES,Dyslipidemias,C0242339,en_3406,1,1,AFFECTS,Excitatory,3
1507,Liddle's syndrome,C0221043,en_3211,CAUSES,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Excitatory,3
1508,Mycobacterium marinum,C0221084,en_3214,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1509,Breath,C0225386,en_3238,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
1510,Breath,C0225386,en_3238,CAUSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,3
1511,Serum,C0229671,en_3244,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
1512,Decompensation,C0231187,en_3250,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1513,Malaise,C0231218,en_3251,CAUSES,Sleep,C0037313,en_2119,1,1,AFFECTS,Excitatory,3
1514,Malaise,C0231218,en_3251,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1515,Crisis,C0231224,en_3253,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,3
1516,Fluctuation,C0231239,en_3254,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1517,Myalgia,C0231528,en_3262,CAUSES,Cessation of life,C0011065,en_762,4,2,AFFECTS,Excitatory,6
1518,Myalgia,C0231528,en_3262,CAUSES,Chronic Fatigue Syndrome,C0015674,en_967,4,2,AFFECTS,Excitatory,6
1519,Alveolar ventilation function,C0231940,en_3269,CAUSES,Hypocapnia,C0085383,en_2664,1,1,AFFECTS,Excitatory,6
1520,Decrease in appetite,C0232462,en_3279,CAUSES,Xerostomia,C0043352,en_2405,1,1,AFFECTS,Excitatory,3
1521,Decrease in appetite,C0232462,en_3279,CAUSES,Catabolic state,C0853892,en_4958,1,1,AFFECTS,Excitatory,3
1522,Abnormal behavior,C0233514,en_3296,CAUSES,Metabolic syndrome,C0948265,en_5164,1,1,AFFECTS,Excitatory,3
1523,Pulmonary vasculitis,C0234962,en_3315,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1524,NEUROLOGIC COMPLICATION,C0235029,en_3317,CAUSES,Anaphylaxis,C0002792,en_313,1,1,AFFECTS,Excitatory,6
1525,Neurologic Symptoms,C0235031,en_3318,CAUSES,Consultation,C0009818,en_708,1,1,AFFECTS,Excitatory,3
1526,Neurologic Symptoms,C0235031,en_3318,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1527,Retinal damage,C0235272,en_3324,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1528,Right ventricular failure,C2939447,en_6155,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
1529,Zinc deficiency,C0235950,en_3334,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
1530,Cigarette smoke,C0239059,en_3373,CAUSES,Pathological accumulation of air in tissues,C0013990,en_891,3,1,AFFECTS,Excitatory,3
1531,Cigarette smoke,C0239059,en_3373,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
1532,Maternal infection,C0239997,en_3379,CAUSES,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Excitatory,3
1533,OPIOID TOLERANCE,C0240601,en_3385,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
1534,Hypoxia,C0242184,en_3396,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1535,Hypoxia,C0242184,en_3396,CAUSES,Ischemia,C0022116,en_1363,1,1,AFFECTS,Excitatory,3
1536,Hypoxia,C0242184,en_3396,CAUSES,Metabolism,C0025519,en_1547,1,1,AFFECTS,Excitatory,3
1537,Hypoxia,C0242184,en_3396,CAUSES,Histiocytosis haematophagic,C0876991,en_5059,6,2,AFFECTS,Excitatory,6
1538,Erectile dysfunction,C0242350,en_3407,CAUSES(SPEC),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
1539,Age related macular degeneration,C0242383,en_3409,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,3
1540,Opioids,C0242402,en_3412,CAUSES,Hyperalgesia,C0020429,en_1228,1,1,AFFECTS,Excitatory,3
1541,Opioids,C0242402,en_3412,CAUSES,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Excitatory,3
1542,Opioids,C0242402,en_3412,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1543,Opioids,C0242402,en_3412,CAUSES,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
1544,Sore Throat,C0242429,en_3414,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
1545,Acute Lung Injury,C0242488,en_3416,CAUSES,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,Excitatory,3
1546,Acute Lung Injury,C0242488,en_3416,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1547,Acute Lung Injury,C0242488,en_3416,CAUSES,Hypoxia,C0242184,en_3396,4,2,AFFECTS,Excitatory,6
1548,Acute Lung Injury,C0242488,en_3416,CAUSES,Organ failure,C0948600,en_5171,1,1,AFFECTS,Excitatory,3
1549,Acute Lung Injury,C0242488,en_3416,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1550,Drug usage,C0242510,en_3417,CAUSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
1551,Oxidative Stress,C0242606,en_3422,CAUSES,Cardiovascular Diseases,C0007222,en_569,6,3,AFFECTS,Excitatory,9
1552,Oxidative Stress,C0242606,en_3422,CAUSES,Diabetes,C0011847,en_797,2,1,AFFECTS,Excitatory,3
1553,Disease Progression,C0242656,en_3429,CAUSES,Appendicitis,C0003615,en_387,2,1,AFFECTS,Excitatory,3
1554,Disease Progression,C0242656,en_3429,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
1555,Disease Progression,C0242656,en_3429,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1556,Disease Progression,C0242656,en_3429,CAUSES,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Excitatory,3
1557,Disease Progression,C0242656,en_3429,CAUSES(SPEC),Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
1558,Muscle Fatigue,C0242979,en_3448,CAUSES,Sedentary,C0205254,en_3128,1,1,AFFECTS,Excitatory,3
1559,"Encephalitis, Viral",C0243010,en_3449,CAUSES(SPEC),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1560,Inflammation Mediators,C0243042,en_3453,CAUSES,END ORGAN DAMAGE,C0743496,en_4803,1,1,AFFECTS,Excitatory,3
1561,inhibitors,C0243077,en_3457,CAUSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
1562,inhibitors,C0243077,en_3457,CAUSES,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Excitatory,6
1563,uptake,C0243144,en_3467,CAUSES,agglutination,C0001801,en_260,4,1,AFFECTS,Excitatory,3
1564,agonists,C0243192,en_3469,CAUSES,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,Excitatory,3
1565,telmisartan,C0248719,en_3481,CAUSES,Down-Regulation,C0013081,en_844,1,1,AFFECTS,Excitatory,3
1566,ETS Variant Gene 6 Protein,C0254343,en_3490,CAUSES,Death (finding),C1306577,en_5521,2,1,AFFECTS,Excitatory,3
1567,zoledronic acid,C0257685,en_3497,CAUSES,Bone necrosis,C0029445,en_1725,1,1,AFFECTS,Excitatory,3
1568,Telogen effluvium,C0263518,en_3523,CAUSES,Non-scarring alopecia,C0406457,en_3965,2,1,AFFECTS,Excitatory,3
1569,Acute respiratory disease,C0264219,en_3527,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1570,Acute respiratory disease,C0264219,en_3527,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
1571,Acute respiratory failure,C0264490,en_3533,CAUSES,Cessation of life,C0011065,en_762,3,2,AFFECTS,Excitatory,6
1572,Acute respiratory failure,C0264490,en_3533,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1573,Acute respiratory failure,C0264490,en_3533,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1574,Acute heart failure,C0264714,en_3536,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1575,Acute heart failure,C0264714,en_3536,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,6
1576,Acute heart failure,C0264714,en_3536,CAUSES,Generalized ischemic myocardial dysfunction,C0349782,en_3846,1,1,AFFECTS,Excitatory,3
1577,Systemic vasculitis,C0264939,en_3540,CAUSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
1578,Cerebral Vasospasm,C0265110,en_3541,CAUSES,Cerebral Ischemia,C0917798,en_5107,2,1,AFFECTS,Excitatory,3
1579,Acute gastroenteritis,C0267446,en_3544,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1580,Recurrent appendicitis,C0267615,en_3545,CAUSES,Obstruction,C0028778,en_1702,1,1,AFFECTS,Excitatory,3
1581,Recurrent appendicitis,C0267615,en_3545,CAUSES,Vasculitis,C0042384,en_2338,1,1,AFFECTS,Excitatory,3
1582,Recurrent appendicitis,C0267615,en_3545,CAUSES(SPEC),Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
1583,Proteinosis,C0268422,en_3547,CAUSES,Postobstructive pneumonia,C0747690,en_4824,1,1,AFFECTS,Excitatory,8
1584,Brain Injuries,C0270611,en_3552,CAUSES,Motor disease or syndrome,C0221163,en_3218,1,1,AFFECTS,Excitatory,3
1585,Brain Injuries,C0270611,en_3552,CAUSES,Neurologic Symptoms,C0235031,en_3318,2,1,AFFECTS,Excitatory,3
1586,Brain Injuries,C0270611,en_3552,CAUSES,Cerebral dysfunction syndrome,C0262405,en_3515,1,1,AFFECTS,Excitatory,3
1587,Gray platelet syndrome,C0272302,en_3559,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,6
1588,Antithrombin III Deficiency,C0272375,en_3560,CAUSES,Thromboembolic event,C0857496,en_4977,1,1,AFFECTS,Excitatory,3
1589,Lung Injury,C0273115,en_3561,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
1590,Acute infectious disease,C0275518,en_3563,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
1591,Acute infectious disease,C0275518,en_3563,CAUSES,Kidney Failure,C0035078,en_1994,1,1,AFFECTS,Excitatory,3
1592,Mixed infectious disease,C0275524,en_3566,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,7
1593,Functional disorder,C0277785,en_3588,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1594,Social stigmata,C0277787,en_3590,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1595,Social stigmata,C0277787,en_3590,CAUSES,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Excitatory,3
1596,tumor necrosis factor therapy,C0279936,en_3618,CAUSES,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Excitatory,3
1597,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,CAUSES,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
1598,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,CAUSES,Hypertensive disease,C0020538,en_1239,2,1,AFFECTS,Excitatory,3
1599,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,CAUSES,Cardiac Hypertrophy,C1383860,en_5688,1,1,AFFECTS,Excitatory,3
1600,bone marrow suppression,C0280962,en_3625,CAUSES,Xerostomia,C0043352,en_2405,1,1,AFFECTS,Excitatory,3
1601,pulmonary complications,C0281169,en_3627,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1602,pulmonary complications,C0281169,en_3627,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1603,pulmonary complications,C0281169,en_3627,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1604,Iron Overload,C0282193,en_3639,CAUSES,Thalassemia,C0039730,en_2220,1,1,AFFECTS,Excitatory,3
1605,chemokine,C0282554,en_3651,CAUSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
1606,chemokine,C0282554,en_3651,CAUSES,Infiltration,C0332448,en_3749,2,1,AFFECTS,Excitatory,3
1607,chemokine,C0282554,en_3651,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1608,chemokine,C0282554,en_3651,CAUSES,Cytokine release syndrome,C0948245,en_5163,2,1,AFFECTS,Excitatory,3
1609,Antibody-Dependent Enhancement,C0282632,en_3660,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1610,"Antibodies, Blocking",C0282682,en_3665,CAUSES,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,3
1611,"Hemorrhagic Fever, Ebola",C0282687,en_3666,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
1612,Bone Morphogenetic Protein Receptors,C0289417,en_3675,CAUSES,Pulmonary arterial hypertension,C1619734,en_6012,1,1,AFFECTS,Excitatory,3
1613,Ritonavir,C0292818,en_3680,CAUSES(SPEC),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1614,pirfenidone,C0298067,en_3681,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
1615,bone morphogenetic protein receptor type II,C0299048,en_3683,CAUSES(SPEC),Pulmonary arterial hypertension,C1619734,en_6012,1,1,AFFECTS,Excitatory,3
1616,Cytokine Inducible SH2-Containing Protein,C0299250,en_3685,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Excitatory,3
1617,ran-binding protein 2,C0299456,en_3686,CAUSES,Acute encephalopathy,C1306587,en_5522,1,1,AFFECTS,Excitatory,3
1618,Therapeutic vaccine,C0301521,en_3690,CAUSES(SPEC),Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
1619,Strand breaks,C0301647,en_3692,CAUSES,"Metabolic Process, Cellular",C1524026,en_5914,1,1,AFFECTS,Excitatory,3
1620,Leucocytic infiltrate,C0302158,en_3703,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1621,Cell Therapy,C0302189,en_3706,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1622,Iron,C0302583,en_3708,CAUSES,Acquired porphyria,C0948592,en_5170,2,1,AFFECTS,Excitatory,3
1623,Angiogenesis,C0302600,en_3709,CAUSES,Surgical fistula,C1442858,en_5735,1,1,AFFECTS,Excitatory,3
1624,Vitamin supplementation,C0302837,en_3713,CAUSES,Decreasing,C0442797,en_4056,1,1,AFFECTS,Excitatory,8
1625,phenylpyruvate tautomerase,C0312359,en_3731,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1626,Complement component,C0312743,en_3735,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1627,Infectious agent,C0314732,en_3741,CAUSES,Arthritis,C0003864,en_400,1,1,AFFECTS,Excitatory,6
1628,Human rhinovirus,C0318467,en_3742,CAUSES,Common Cold,C0009443,en_684,1,1,AFFECTS,Excitatory,3
1629,"Paramyxovirus, NOS",C0318798,en_3744,CAUSES,Encephalitis,C0014038,en_896,1,1,AFFECTS,Excitatory,3
1630,"Paramyxovirus, NOS",C0318798,en_3744,CAUSES,Newcastle Disease,C0027983,en_1677,1,1,AFFECTS,Excitatory,3
1631,"Paramyxovirus, NOS",C0318798,en_3744,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
1632,Madurella mycetomatis,C0320105,en_3745,CAUSES,Maduromycosis,C0024449,en_1486,1,1,AFFECTS,Excitatory,3
1633,Infiltration,C0332448,en_3749,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1634,Plaque (lesion),C0332461,en_3750,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,8
1635,Crushing injury (morphology),C0332679,en_3754,CAUSES,Atelectasis,C0004144,en_420,1,1,AFFECTS,Excitatory,3
1636,Putrefaction,C0333532,en_3767,CAUSES,Smell Perception,C0037361,en_2122,1,1,AFFECTS,Excitatory,3
1637,Fibrin deposition,C0333565,en_3769,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1638,Blast,C0337026,en_3790,CAUSES,Traumatic Brain Injury,C0876926,en_5057,1,1,AFFECTS,Excitatory,3
1639,Acute respiratory infection NOS,C0339901,en_3809,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
1640,Endometriosis of uterus,C0341858,en_3826,CAUSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
1641,Capillary Leak Syndrome,C0343084,en_3831,CAUSES,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Excitatory,3
1642,Neoplasm of acoustic nerve,C0346330,en_3838,CAUSES,Deafness,C0011053,en_761,1,1,AFFECTS,Excitatory,3
1643,Specimen,C0370003,en_3868,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1644,Anti-platelet antibody,C0370058,en_3870,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,7
1645,Anti-platelet antibody,C0370058,en_3870,CAUSES,Thrombocytopenia,C0040034,en_2229,1,1,AFFECTS,Excitatory,7
1646,Porcine Reproductive and Respiratory Syndrome,C0376538,en_3880,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1647,"Vaccines, DNA",C0376613,en_3887,CAUSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
1648,vacuolar H+-ATPase,C0379099,en_3896,CAUSES,acidification,C1522821,en_5907,1,1,AFFECTS,Excitatory,3
1649,caveolin 1,C0379710,en_3898,CAUSES,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Excitatory,3
1650,cyclooxygenase 1,C0389003,en_3906,CAUSES,"Injury to liver, NOS",C0160390,en_2896,1,1,AFFECTS,Excitatory,3
1651,cyclooxygenase 1,C0389003,en_3906,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
1652,"ADAMTS13 protein, human|ADAMTS13",C0389918|11093,en_3908,CAUSES,Thrombotic Microangiopathies,C2717961,en_6123,1,1,AFFECTS,Excitatory,6
1653,H-Cadherin,C0390690,en_3911,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
1654,Intra-alveolar hemorrhage,C0392459,en_3921,CAUSES,Community acquired pneumonia,C0694549,en_4692,1,1,AFFECTS,Excitatory,6
1655,"Abortion, Induced",C0392535,en_3922,CAUSES,Complication,C0009566,en_697,3,1,AFFECTS,Excitatory,3
1656,Exhaustion,C0392674,en_3926,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
1657,Exhaustion,C0392674,en_3926,CAUSES,Secondary infection,C0442886,en_4061,3,2,AFFECTS,Excitatory,6
1658,rituximab,C0393022,en_3930,CAUSES,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Excitatory,6
1659,Venous cannula insertion,C0398266,en_3943,CAUSES,Thromboembolism,C0040038,en_2230,1,1,AFFECTS,Excitatory,6
1660,Central venous cannula insertion,C0398275,en_3944,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1661,Acute cardiac pulmonary edema,C0398350,en_3946,CAUSES,Community acquired pneumonia,C0694549,en_4692,1,1,AFFECTS,Excitatory,6
1662,Hypercapnic respiratory failure,C0398353,en_3947,CAUSES,"Acidosis, Respiratory",C0001127,en_224,1,1,AFFECTS,Excitatory,7
1663,Hypercapnic respiratory failure,C0398353,en_3947,CAUSES(SPEC),Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1664,Thrombophilia,C0398623,en_3949,CAUSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,6
1665,Thrombophilia,C0398623,en_3949,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,6
1666,Thrombophilia,C0398623,en_3949,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
1667,Thrombophilia,C0398623,en_3949,CAUSES,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,6
1668,Thrombophilia,C0398623,en_3949,CAUSES,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Excitatory,3
1669,Thrombophilia,C0398623,en_3949,CAUSES,Pulmonary Thromboembolisms,C0524702,en_4217,1,1,AFFECTS,Excitatory,6
1670,Thrombophilia,C0398623,en_3949,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1671,Cyclooxygenase deficiency,C0398634,en_3950,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
1672,Exploration with a probe,C0419358,en_3981,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,8
1673,Hyperactive behavior,C0424295,en_3992,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
1674,Prolonged periods,C0425945,en_4005,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1675,Gastrointestinal symptoms NOS,C0426576,en_4007,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
1676,Stiffness,C0427008,en_4008,CAUSES,Blood flow,C0232338,en_3276,1,1,AFFECTS,Excitatory,3
1677,Immune,C0439662,en_4035,CAUSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,7
1678,Substance,C0439861,en_4040,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
1679,Coagulation procedure,C0441509,en_4046,CAUSES,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Excitatory,3
1680,6/36,C0442755,en_4055,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
1681,Secondary infection,C0442886,en_4061,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
1682,Secondary infection,C0442886,en_4061,CAUSES,Cessation of life,C0011065,en_762,2,2,AFFECTS,Excitatory,9
1683,Secondary infection,C0442886,en_4061,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
1684,Autoimmune,C0443146,en_4064,CAUSES,"Pneumonitis, Interstitial",C0206061,en_3141,2,1,AFFECTS,Excitatory,3
1685,Nasopharyngeal swab,C0444192,en_4071,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
1686,Microorganism,C0445623,en_4075,CAUSES,Communicable Diseases,C0009450,en_685,4,4,AFFECTS,Excitatory,12
1687,Microorganism,C0445623,en_4075,CAUSES,Infection,C3714514,en_6235,2,2,AFFECTS,Excitatory,6
1688,Microorganism,C0445623,en_4075,CAUSES,Legionellosis,C0023240,en_1407,1,1,AFFECTS,Excitatory,3
1689,Microorganism,C0445623,en_4075,CAUSES(SPEC),Malaria,C0024530,en_1493,1,1,AFFECTS,Excitatory,3
1690,Pathogenic organism,C0450254,en_4083,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,6
1691,Pathogenic organism,C0450254,en_4083,CAUSES,Septicemia,C0036690,en_2086,2,2,AFFECTS,Excitatory,14
1692,Pathogenic organism,C0450254,en_4083,CAUSES,Acute respiratory disease,C0264219,en_3527,1,1,AFFECTS,Excitatory,7
1693,Pathogenic organism,C0450254,en_4083,CAUSES,Community acquired pneumonia,C0694549,en_4692,1,1,AFFECTS,Excitatory,6
1694,Agent,C0450442,en_4084,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1695,Agent,C0450442,en_4084,CAUSES,Disease,C0012634,en_826,5,3,AFFECTS,Excitatory,9
1696,Agent,C0450442,en_4084,CAUSES,Lung diseases,C0024115,en_1462,3,1,AFFECTS,Excitatory,6
1697,Agent,C0450442,en_4084,CAUSES,Chronic Obstructive Airway Disease,C0024117,en_1463,2,1,AFFECTS,Excitatory,6
1698,Agent,C0450442,en_4084,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
1699,Agent,C0450442,en_4084,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
1700,Agent,C0450442,en_4084,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
1701,Agent,C0450442,en_4084,CAUSES,Chronic lung disease,C0746102,en_4815,1,1,AFFECTS,Excitatory,6
1702,Agent,C0450442,en_4084,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
1703,Agent,C0450442,en_4084,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1704,Agent,C0450442,en_4084,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1705,Urolithiasis,C0451641,en_4086,CAUSES,Severe pain,C0278140,en_3598,1,1,AFFECTS,Excitatory,3
1706,Drink,C0452428,en_4095,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1707,Neuromuscular stimulation,C0454448,en_4104,CAUSES,Contraction,C1140999,en_5281,2,1,AFFECTS,Excitatory,3
1708,Sepsis of the newborn,C0456103,en_4115,CAUSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
1709,Contents,C0456205,en_4116,CAUSES,Abuse,C1328247,en_5567,1,1,AFFECTS,Excitatory,3
1710,Blind Vision,C0456909,en_4120,CAUSES,Medical observation,C0948564,en_5169,2,1,AFFECTS,Excitatory,3
1711,Specific antigen,C0456981,en_4121,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1712,Neutralizing antibody,C0475463,en_4145,CAUSES,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Excitatory,7
1713,Respiratory distress,C0476273,en_4149,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
1714,"Medical care, unspecified",C0496675,en_4163,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,3
1715,Materials,C0520510,en_4189,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1716,Indwelling urinary catheter,C0521197,en_4198,CAUSES,Latex allergy,C0577628,en_4337,1,1,AFFECTS,Excitatory,3
1717,Acute chest pain,C0522051,en_4208,CAUSES,Breast Feeding,C0006147,en_512,1,1,AFFECTS,Excitatory,3
1718,Paralysed,C0522224,en_4211,CAUSES,MOTILITY DISORDER NOS,C0679316,en_4595,1,1,AFFECTS,Excitatory,3
1719,RyR1,C0524965,en_4225,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
1720,Probiotics,C0525033,en_4227,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
1721,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
1722,Caspase-1,C0534519,en_4239,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1723,Sequela of disorder,C0543419,en_4257,CAUSES,Autoimmunity,C0004368,en_430,1,1,AFFECTS,Excitatory,3
1724,Complication of disease,C0544688,en_4265,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1725,Alveolitis,C0549493,en_4284,CAUSES,Postobstructive pneumonia,C0747690,en_4824,1,1,AFFECTS,Excitatory,8
1726,Cardiovascular injury,C0560570,en_4321,CAUSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
1727,Molecule,C0567416,en_4333,CAUSES,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Excitatory,3
1728,Molecule,C0567416,en_4333,CAUSES,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Excitatory,3
1729,Molecule,C0567416,en_4333,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1730,Molecule,C0567416,en_4333,CAUSES,Ischemia,C0022116,en_1363,1,1,AFFECTS,Excitatory,3
1731,Molecule,C0567416,en_4333,CAUSES,Lymphoma,C0024299,en_1471,1,1,AFFECTS,Excitatory,3
1732,Molecule,C0567416,en_4333,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
1733,Molecule,C0567416,en_4333,CAUSES,Blood Clot,C0302148,en_3702,1,1,AFFECTS,Excitatory,3
1734,Molecule,C0567416,en_4333,CAUSES,"Deficiency, immune",C0850497,en_4943,1,1,AFFECTS,Excitatory,3
1735,Molecule,C0567416,en_4333,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
1736,Infusion procedures,C0574032,en_4335,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1737,Chronic anemia,C0581384,en_4347,CAUSES,Thalassemia,C0039730,en_2220,1,1,AFFECTS,Excitatory,3
1738,Structural protein,C0582263,en_4352,CAUSES,Cell Death,C0007587,en_587,3,3,AFFECTS,Excitatory,9
1739,Structural protein,C0582263,en_4352,CAUSES,viral assembly,C1160681,en_5360,1,1,AFFECTS,Excitatory,3
1740,dimer,C0596448,en_4388,CAUSES,Blood Coagulation Disorders,C0005779,en_485,2,1,AFFECTS,Excitatory,3
1741,dimer,C0596448,en_4388,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
1742,immunosenescence,C0596761,en_4395,CAUSES,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,Excitatory,3
1743,Membrane Transport Proteins,C0596902,en_4401,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
1744,particle,C0597177,en_4414,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1745,receptor,C0597357,en_4422,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
1746,receptor,C0597357,en_4422,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1747,receptor,C0597357,en_4422,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1748,receptor,C0597357,en_4422,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1749,receptor,C0597357,en_4422,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1750,respiratory virus,C0597404,en_4426,CAUSES,Acute-Phase Reaction,C0001349,en_233,1,1,AFFECTS,Excitatory,3
1751,respiratory virus,C0597404,en_4426,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1752,respiratory virus,C0597404,en_4426,CAUSES,Disease,C0012634,en_826,4,3,AFFECTS,Excitatory,9
1753,respiratory virus,C0597404,en_4426,CAUSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
1754,respiratory virus,C0597404,en_4426,CAUSES,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Excitatory,6
1755,respiratory virus,C0597404,en_4426,CAUSES,"Infections, Upper Respiratory",C0041912,en_2315,2,2,AFFECTS,Excitatory,11
1756,respiratory virus,C0597404,en_4426,CAUSES,Chronic sinusitis NOS,C0149516,en_2800,1,1,AFFECTS,Excitatory,3
1757,respiratory virus,C0597404,en_4426,CAUSES,Lower respiratory tract infection,C0149725,en_2806,2,1,AFFECTS,Excitatory,3
1758,respiratory virus,C0597404,en_4426,CAUSES,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Excitatory,3
1759,stressor,C0597530,en_4430,CAUSES,Degenerative abnormality,C0011164,en_770,1,1,AFFECTS,Excitatory,3
1760,secondary immune deficiency,C0597745,en_4437,CAUSES,Immune response,C0301872,en_3696,2,1,AFFECTS,Excitatory,3
1761,intestinal bacteria,C0599752,en_4469,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1762,intestinal bacteria,C0599752,en_4469,CAUSES,Hepatic Encephalopathy,C0019151,en_1170,1,1,AFFECTS,Excitatory,3
1763,intestinal bacteria,C0599752,en_4469,CAUSES,Diarrheal disorder,C1290807,en_5481,1,1,AFFECTS,Excitatory,3
1764,genetic element,C0599770,en_4472,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1765,Pollutant,C0599786,en_4474,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1766,microbial,C0599840,en_4476,CAUSES,Disease,C0012634,en_826,4,3,AFFECTS,Excitatory,9
1767,attenuation,C0599946,en_4490,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1768,attenuation,C0599946,en_4490,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
1769,Cardiopulmonary Arrest,C0600228,en_4500,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,6
1770,"NOS3 protein, human",C0669365,en_4534,CAUSES,Brain Injuries,C0270611,en_3552,1,1,AFFECTS,Excitatory,3
1771,"NOS3 protein, human",C0669365,en_4534,CAUSES,Endothelial dysfunction,C0856169,en_4968,2,1,AFFECTS,Excitatory,3
1772,peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase,C0671368,en_4539,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1773,Sterility,C0678108,en_4552,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1774,Rare Diseases,C0678236,en_4556,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1775,Rare Diseases,C0678236,en_4556,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1776,Rare Diseases,C0678236,en_4556,CAUSES,Seizures,C0036572,en_2076,1,1,AFFECTS,Excitatory,3
1777,wave,C0678544,en_4560,CAUSES,Traumatic Brain Injury,C0876926,en_5057,1,1,AFFECTS,Excitatory,3
1778,enteral administration,C0678814,en_4573,CAUSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
1779,organic disorders,C0683324,en_4660,CAUSES,Fatigue,C0015672,en_966,1,1,AFFECTS,Excitatory,3
1780,Internal-External Locus of Control Scale,C0683454,en_4662,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
1781,Bacterial septicemia,C0684256,en_4678,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
1782,In Vitro Diagnostics,C0687640,en_4687,CAUSES,Communicable Diseases,C0009450,en_685,4,1,AFFECTS,Excitatory,3
1783,Community acquired pneumonia,C0694549,en_4692,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,7
1784,Metric,C0699680,en_4702,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1785,Metric,C0699680,en_4702,CAUSES,Discrepancy,C1290905,en_5486,2,2,AFFECTS,Excitatory,6
1786,flavor perception,C0699771,en_4704,CAUSES,Body Weight decreased,C0043096,en_2389,1,1,AFFECTS,Excitatory,3
1787,AIRWAY DISEASE,C0699949,en_4711,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
1788,Hypoxemia,C0700292,en_4719,CAUSES,Hypoxia,C0242184,en_3396,2,1,AFFECTS,Excitatory,3
1789,a & d,C0718133,en_4739,CAUSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,7
1790,Advance,C0725066,en_4752,CAUSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
1791,Solid organ transplant,C0730400,en_4770,CAUSES,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Excitatory,3
1792,human leukocyte interferon,C0733470,en_4772,CAUSES,Autophagy,C0004391,en_432,1,1,AFFECTS,Excitatory,3
1793,human leukocyte interferon,C0733470,en_4772,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1794,Middle Cerebral Artery Occlusion,C0740391,en_4777,CAUSES,MOTOR DEFICIT,C0746626,en_4816,1,1,AFFECTS,Excitatory,3
1795,Bedridden,C0741453,en_4787,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
1796,Acute chest syndrome,C0742343,en_4795,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
1797,HEMOPATHIES,C0744795,en_4808,CAUSES,Hypogammaglobulinemia,C0086438,en_2720,1,1,AFFECTS,Excitatory,3
1798,HYPERTENSION MEDICATION,C0745123,en_4811,CAUSES,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Excitatory,3
1799,IRON TOXICITY,C0745409,en_4814,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1800,myocardium; injury,C0746730,en_4817,CAUSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,3
1801,myocardium; injury,C0746730,en_4817,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
1802,myocardium; injury,C0746730,en_4817,CAUSES,Cardiomyopathies,C0878544,en_5074,1,1,AFFECTS,Excitatory,3
1803,myocardium; injury,C0746730,en_4817,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,3
1804,OBSTRUCTIVE DISEASE,C0746982,en_4822,CAUSES,Myocardial Ischemia,C0151744,en_2865,1,1,AFFECTS,Excitatory,3
1805,Parasitic infection,C0747256,en_4823,CAUSES,Tropical Disease,C1336827,en_5642,1,1,AFFECTS,Excitatory,3
1806,PULMONARY INVOLVEMENT,C0748159,en_4828,CAUSES,Complication,C0009566,en_697,3,1,AFFECTS,Excitatory,3
1807,PULMONARY INVOLVEMENT,C0748159,en_4828,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1808,PULMONARY INVOLVEMENT,C0748159,en_4828,CAUSES,sequels,C0243089,en_3462,2,1,AFFECTS,Excitatory,3
1809,PULMONARY INVOLVEMENT,C0748159,en_4828,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1810,Acute respiratory distress,C0748355,en_4831,CAUSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
1811,Acute respiratory distress,C0748355,en_4831,CAUSES,Cessation of life,C0011065,en_762,4,2,AFFECTS,Excitatory,6
1812,Acute respiratory distress,C0748355,en_4831,CAUSES,Respiratory Failure,C1145670,en_5292,3,2,AFFECTS,Excitatory,9
1813,WORK UP,C0750430,en_4841,CAUSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
1814,Hendra Virus,C0751672,en_4852,CAUSES(SPEC),Encephalitis,C0014038,en_896,1,1,AFFECTS,Excitatory,3
1815,Hendra Virus,C0751672,en_4852,CAUSES(SPEC),Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
1816,Nipah Virus,C0751673,en_4853,CAUSES,Encephalitis,C0014038,en_896,1,1,AFFECTS,Excitatory,3
1817,Nipah Virus,C0751673,en_4853,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
1818,Nipah Virus,C0751673,en_4853,CAUSES(SPEC),Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Excitatory,3
1819,4-ethoxymethylene-2-phenyl-2-oxazoline-5-one,C0768581,en_4868,CAUSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,3
1820,"Scales, Clinical",C0810506,en_4893,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
1821,TNF gene,C0812246,en_4896,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1822,TNF gene,C0812246,en_4896,CAUSES,Lymphopenia,C0024312,en_1474,2,1,AFFECTS,Excitatory,3
1823,TNF gene,C0812246,en_4896,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
1824,TNF gene,C0812246,en_4896,CAUSES,Cytokine storm,C0919747,en_5119,3,2,AFFECTS,Excitatory,6
1825,MAS1 gene,C0812372,en_4899,CAUSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
1826,MAS1 gene,C0812372,en_4899,CAUSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
1827,ELK3 gene,C0812375,en_4900,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1828,ELK3 gene,C0812375,en_4900,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1829,toxic proteins,C0815048,en_4919,CAUSES(SPEC),Cerebrovascular accident,C0038454,en_2169,2,1,AFFECTS,Excitatory,3
1830,"Problem, hormone",C0850832,en_4947,CAUSES,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Excitatory,3
1831,"Problem, hormone",C0850832,en_4947,CAUSES,Obesity,C0028754,en_1699,2,1,AFFECTS,Excitatory,3
1832,"Problem, hormone",C0850832,en_4947,CAUSES,Osteoporosis,C0029456,en_1726,2,1,AFFECTS,Excitatory,3
1833,Sleep Disorders,C0851578,en_4954,CAUSES,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,Excitatory,3
1834,Sleep Disorders,C0851578,en_4954,CAUSES,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Excitatory,3
1835,Pulmonary vascular disorders,C0854416,en_4960,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,6
1836,Endothelial dysfunction,C0856169,en_4968,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1837,Endothelial dysfunction,C0856169,en_4968,CAUSES,Extravasation,C0015376,en_949,2,1,AFFECTS,Excitatory,3
1838,Endothelial dysfunction,C0856169,en_4968,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
1839,Endothelial dysfunction,C0856169,en_4968,CAUSES,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Excitatory,3
1840,Endothelial dysfunction,C0856169,en_4968,CAUSES,Fatigue - symptom,C0439053,en_4033,1,1,AFFECTS,Excitatory,3
1841,Endothelial dysfunction,C0856169,en_4968,CAUSES,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Excitatory,3
1842,Endothelial dysfunction,C0856169,en_4968,CAUSES,Organ failure,C0948600,en_5171,2,1,AFFECTS,Excitatory,3
1843,Endothelial dysfunction,C0856169,en_4968,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
1844,Hypertensive,C0857121,en_4969,CAUSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
1845,Induction,C0857127,en_4970,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
1846,Thromboembolic event,C0857496,en_4977,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1847,General discomfort,C0858924,en_4985,CAUSES,Hospital admission,C0184666,en_3063,1,1,AFFECTS,Excitatory,6
1848,Distal bile duct stricture,C0860019,en_4988,CAUSES,"Jaundice, Obstructive",C0022354,en_1373,1,1,AFFECTS,Excitatory,3
1849,Deterioration,C0868945,en_4997,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1850,Deterioration,C0868945,en_4997,CAUSES,"Pancreatitis, Acute Necrotizing",C0267941,en_3546,1,1,AFFECTS,Excitatory,3
1851,Deterioration,C0868945,en_4997,CAUSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,14
1852,Prenatal Exposure,C0871124,en_5018,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
1853,Protein-Protein Interaction,C0872079,en_5036,CAUSES,Mitochondrion in division,C0230871,en_3246,1,1,AFFECTS,Excitatory,3
1854,functional disability,C0872173,en_5040,CAUSES,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Excitatory,3
1855,"Communicable Diseases, Emerging",C0872315,en_5049,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
1856,Infectious disease of lung,C0876973,en_5058,CAUSES,Cessation of life,C0011065,en_762,13,2,AFFECTS,Excitatory,6
1857,Infectious disease of lung,C0876973,en_5058,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,5,3,AFFECTS,Excitatory,9
1858,Infectious disease of lung,C0876973,en_5058,CAUSES,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Excitatory,3
1859,Infectious disease of lung,C0876973,en_5058,CAUSES,Intervention regimes,C1273869,en_5458,1,1,AFFECTS,Excitatory,3
1860,Cardiomyopathies,C0878544,en_5074,CAUSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,3
1861,Cardiomyopathies,C0878544,en_5074,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
1862,"Vaccines, Subunit",C0887892,en_5089,CAUSES,Antibody-Dependent Enhancement,C0282632,en_3660,1,1,AFFECTS,Excitatory,3
1863,"Vaccines, Subunit",C0887892,en_5089,CAUSES,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,Excitatory,3
1864,alpha-Defensins,C0887943,en_5093,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1865,TANK-binding kinase 1,C0911531,en_5099,CAUSES,Amyotrophic Lateral Sclerosis,C0002736,en_310,1,1,AFFECTS,Excitatory,3
1866,TANK-binding kinase 1,C0911531,en_5099,CAUSES,Frontotemporal dementia,C0338451,en_3803,1,1,AFFECTS,Excitatory,3
1867,Cerebral Ischemia,C0917798,en_5107,CAUSES,Cerebral Infarction,C0007785,en_603,1,1,AFFECTS,Excitatory,3
1868,Cerebral Ischemia,C0917798,en_5107,CAUSES,Necrosis,C0027540,en_1645,1,1,AFFECTS,Excitatory,3
1869,SMAD3 gene,C0919432,en_5112,CAUSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
1870,ATM gene,C0919524,en_5114,CAUSES,Obstruction,C0028778,en_1702,1,1,AFFECTS,Excitatory,3
1871,ATM gene,C0919524,en_5114,CAUSES,Increased blood vessel permeability,C0232374,en_3278,1,1,AFFECTS,Excitatory,3
1872,Genomic Instability,C0919532,en_5115,CAUSES,Premature aging syndrome,C0231341,en_3258,1,1,AFFECTS,Excitatory,3
1873,Cytokine storm,C0919747,en_5119,CAUSES,Blood Coagulation Disorders,C0005779,en_485,4,1,AFFECTS,Excitatory,3
1874,Cytokine storm,C0919747,en_5119,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,8
1875,Cytokine storm,C0919747,en_5119,CAUSES,Cessation of life,C0011065,en_762,9,6,AFFECTS,Excitatory,18
1876,Cytokine storm,C0919747,en_5119,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1877,Cytokine storm,C0919747,en_5119,CAUSES,Edema,C0013604,en_877,2,2,AFFECTS,Excitatory,6
1878,Cytokine storm,C0919747,en_5119,CAUSES,Extravasation,C0015376,en_949,2,2,AFFECTS,Excitatory,6
1879,Cytokine storm,C0919747,en_5119,CAUSES,Inflammation,C0021368,en_1307,6,5,AFFECTS,Excitatory,19
1880,Cytokine storm,C0919747,en_5119,CAUSES,Multiple Organ Failure,C0026766,en_1597,11,8,AFFECTS,Excitatory,28
1881,Cytokine storm,C0919747,en_5119,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,17,12,AFFECTS,Excitatory,36
1882,Cytokine storm,C0919747,en_5119,CAUSES,Virus Diseases,C0042769,en_2362,5,2,AFFECTS,Excitatory,6
1883,Cytokine storm,C0919747,en_5119,CAUSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
1884,Cytokine storm,C0919747,en_5119,CAUSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,3
1885,Cytokine storm,C0919747,en_5119,CAUSES,Immune response,C0301872,en_3696,5,3,AFFECTS,Excitatory,9
1886,Cytokine storm,C0919747,en_5119,CAUSES,Capillary Leak Syndrome,C0343084,en_3831,1,1,AFFECTS,Excitatory,3
1887,Cytokine storm,C0919747,en_5119,CAUSES,Exhaustion,C0392674,en_3926,1,1,AFFECTS,Excitatory,3
1888,Cytokine storm,C0919747,en_5119,CAUSES,Immunoregulation,C0678889,en_4580,2,1,AFFECTS,Excitatory,3
1889,Cytokine storm,C0919747,en_5119,CAUSES,END ORGAN DAMAGE,C0743496,en_4803,1,1,AFFECTS,Excitatory,3
1890,Cytokine storm,C0919747,en_5119,CAUSES,Respiratory Failure,C1145670,en_5292,2,2,AFFECTS,Excitatory,6
1891,Cytokine storm,C0919747,en_5119,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1892,Cytokine storm,C0919747,en_5119,CAUSES,Intervention regimes,C1273869,en_5458,28,2,AFFECTS,Excitatory,6
1893,Cancer Treatment,C0920425,en_5124,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1894,imatinib,C0935989,en_5138,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
1895,"Complication, infection",C0940933,en_5148,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
1896,"Stenosis, unspecified",C0947637,en_5154,CAUSES,Cerebral Infarction,C0007785,en_603,1,1,AFFECTS,Excitatory,3
1897,Vascular inflammations,C0947751,en_5156,CAUSES,Movement,C0026649,en_1588,2,1,AFFECTS,Excitatory,3
1898,Acute coronary syndrome,C0948089,en_5159,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
1899,Cytokine release syndrome,C0948245,en_5163,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1900,Metabolic syndrome,C0948265,en_5164,CAUSES,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,Excitatory,3
1901,Haemodynamic instability,C0948268,en_5165,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
1902,Haemodynamic instability,C0948268,en_5165,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
1903,Organ failure,C0948600,en_5171,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
1904,Organ failure,C0948600,en_5171,CAUSES,Histiocytosis haematophagic,C0876991,en_5059,6,2,AFFECTS,Excitatory,6
1905,Pulmonary failure,C0948755,en_5173,CAUSES,Cessation of life,C0011065,en_762,3,3,AFFECTS,Excitatory,9
1906,Pulmonary failure,C0948755,en_5173,CAUSES,Diaphragmatic paresis,C0521532,en_4203,1,1,AFFECTS,Excitatory,3
1907,Pulmonary failure,C0948755,en_5173,CAUSES,Unwell,C0857256,en_4972,2,1,AFFECTS,Excitatory,3
1908,Human coronavirus 229E,C0949880,en_5189,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,6
1909,"Coronavirus OC43, Human",C0949881,en_5190,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,6
1910,angiotensin converting enzyme 2,C0960880,en_5195,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,7
1911,angiotensin converting enzyme 2,C0960880,en_5195,CAUSES,imbalance,C1397014,en_5692,1,1,AFFECTS,Excitatory,8
1912,Reactive Nitrogen Species,C0969698,en_5209,CAUSES,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,Excitatory,3
1913,Boards,C0972401,en_5213,CAUSES,Wounds and Injuries,C0043251,en_2401,2,1,AFFECTS,Excitatory,3
1914,Spodoptera litura,C1027681,en_5223,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1915,Progressive multiple sclerosis,C1095979,en_5228,CAUSES,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,3
1916,Vascular occlusion,C1096458,en_5235,CAUSES,Cerebrovascular accident,C0038454,en_2169,2,2,AFFECTS,Excitatory,12
1917,Vascular occlusion,C1096458,en_5235,CAUSES,"Stroke, Acute",C0751956,en_4854,1,1,AFFECTS,Excitatory,6
1918,Virulence Factors,C1136170,en_5263,CAUSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
1919,"Pacemakers, Gastric",C1139843,en_5275,CAUSES,Abnormal gastric electrical activity,C0232595,en_3282,1,1,AFFECTS,Excitatory,3
1920,Contraction,C1140999,en_5281,CAUSES,Movement,C0026649,en_1588,3,2,AFFECTS,Excitatory,6
1921,Brugada syndrome,C1142166,en_5284,CAUSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,3
1922,Neutralising antibodies,C1142254,en_5285,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1923,Bilateral pneumonia,C1142578,en_5287,CAUSES,Organ failure,C0948600,en_5171,1,1,AFFECTS,Excitatory,3
1924,Respiratory Failure,C1145670,en_5292,CAUSES,Coughing,C0010200,en_723,2,1,AFFECTS,Excitatory,3
1925,Respiratory Failure,C1145670,en_5292,CAUSES,Cessation of life,C0011065,en_762,12,10,AFFECTS,Excitatory,36
1926,Respiratory Failure,C1145670,en_5292,CAUSES,Disease,C0012634,en_826,3,2,AFFECTS,Excitatory,6
1927,Respiratory Failure,C1145670,en_5292,CAUSES,Fatigue,C0015672,en_966,1,1,AFFECTS,Excitatory,3
1928,Respiratory Failure,C1145670,en_5292,CAUSES,Hospitalization,C0019993,en_1206,4,3,AFFECTS,Excitatory,9
1929,Respiratory Failure,C1145670,en_5292,CAUSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
1930,Respiratory Failure,C1145670,en_5292,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,3,1,AFFECTS,Excitatory,3
1931,Respiratory Failure,C1145670,en_5292,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,2,AFFECTS,Excitatory,6
1932,Respiratory Failure,C1145670,en_5292,CAUSES,Hypokinesia,C0086439,en_2721,1,1,AFFECTS,Excitatory,3
1933,Respiratory Failure,C1145670,en_5292,CAUSES,Hyaline membrane,C0333563,en_3768,1,1,AFFECTS,Excitatory,3
1934,Respiratory Failure,C1145670,en_5292,CAUSES,Respiratory distress,C0476273,en_4149,2,1,AFFECTS,Excitatory,3
1935,B-Cell Activation,C1155003,en_5311,CAUSES,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,3
1936,innate immune response,C1155265,en_5320,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1937,Inflammatory Response,C1155266,en_5321,CAUSES,Blood Coagulation Disorders,C0005779,en_485,8,8,AFFECTS,Excitatory,24
1938,Inflammatory Response,C1155266,en_5321,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1939,Inflammatory Response,C1155266,en_5321,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
1940,Inflammatory Response,C1155266,en_5321,CAUSES,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,2,1,AFFECTS,Excitatory,3
1941,Inflammatory Response,C1155266,en_5321,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,5,4,AFFECTS,Excitatory,12
1942,Inflammatory Response,C1155266,en_5321,CAUSES,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Excitatory,3
1943,Inflammatory Response,C1155266,en_5321,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1944,Inflammatory Response,C1155266,en_5321,CAUSES,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Excitatory,3
1945,Inflammatory Response,C1155266,en_5321,CAUSES(SPEC),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
1946,opsonization,C1159762,en_5344,CAUSES(SPEC),Apoptosis,C0162638,en_2922,2,1,AFFECTS,Excitatory,3
1947,Infection precautions,C1160949,en_5363,CAUSES,Punctate inner choroidopathy,C0730321,en_4769,1,1,AFFECTS,Excitatory,3
1948,Pulmonary arterial pressure,C1168098,en_5371,CAUSES,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Excitatory,3
1949,kinase inhibitor,C1171350,en_5378,CAUSES,Antiinflammatory Effect,C1516019,en_5851,2,1,AFFECTS,Excitatory,3
1950,"VEGF protein, human",C1171892,en_5379,CAUSES,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Excitatory,3
1951,"VEGF protein, human",C1171892,en_5379,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1952,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Cessation of life,C0011065,en_762,6,3,AFFECTS,Excitatory,12
1953,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Disease,C0012634,en_826,9,6,AFFECTS,Excitatory,18
1954,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1955,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Pneumonia,C0032285,en_1833,4,3,AFFECTS,Excitatory,9
1956,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
1957,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Syndrome,C0039082,en_2197,4,3,AFFECTS,Excitatory,9
1958,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
1959,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
1960,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
1961,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES,Storm Syndrome,C1861452,en_6056,1,1,AFFECTS,Excitatory,6
1962,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES(SPEC),Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
1963,Severe Acute Respiratory Syndrome,C1175175,en_5383,CAUSES(SPEC),Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
1964,SARS coronavirus,C1175743,en_5384,CAUSES,Communicable Diseases,C0009450,en_685,5,3,AFFECTS,Excitatory,13
1965,SARS coronavirus,C1175743,en_5384,CAUSES,Disease,C0012634,en_826,17,13,AFFECTS,Excitatory,42
1966,SARS coronavirus,C1175743,en_5384,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1967,SARS coronavirus,C1175743,en_5384,CAUSES,Pneumonia,C0032285,en_1833,4,3,AFFECTS,Excitatory,9
1968,SARS coronavirus,C1175743,en_5384,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,3
1969,SARS coronavirus,C1175743,en_5384,CAUSES,Syndrome,C0039082,en_2197,3,2,AFFECTS,Excitatory,9
1970,SARS coronavirus,C1175743,en_5384,CAUSES,Virus Diseases,C0042769,en_2362,4,3,AFFECTS,Excitatory,9
1971,SARS coronavirus,C1175743,en_5384,CAUSES,Acute respiratory disease,C0264219,en_3527,4,2,AFFECTS,Excitatory,6
1972,SARS coronavirus,C1175743,en_5384,CAUSES,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Excitatory,3
1973,SARS coronavirus,C1175743,en_5384,CAUSES,Acute respiratory infection NOS,C0339901,en_3809,2,1,AFFECTS,Excitatory,3
1974,SARS coronavirus,C1175743,en_5384,CAUSES,Inactivation,C0544461,en_4262,1,1,AFFECTS,Excitatory,3
1975,SARS coronavirus,C1175743,en_5384,CAUSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
1976,SARS coronavirus,C1175743,en_5384,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
1977,SARS coronavirus,C1175743,en_5384,CAUSES,Severe infection,C5139167,en_6407,1,1,AFFECTS,Excitatory,6
1978,SARS coronavirus,C1175743,en_5384,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
1979,Etiologic Agent,C1254373,en_5397,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
1980,Henipavirus,C1258015,en_5405,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1981,Abnormal breathing,C1260922,en_5414,CAUSES,Cessation of life,C0011065,en_762,2,1,AFFECTS,Excitatory,3
1982,Abnormal breathing,C1260922,en_5414,CAUSES,Hospitalization,C0019993,en_1206,2,1,AFFECTS,Excitatory,3
1983,Lymphocytic infiltration,C1262091,en_5420,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1984,Nontuberculous Mycobacteria,C1265234,en_5430,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
1985,Aspergillus species,C1265395,en_5431,CAUSES,Fungemia,C0085082,en_2640,2,1,AFFECTS,Excitatory,3
1986,Persistent inflammation,C1265824,en_5432,CAUSES,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,Excitatory,3
1987,Exploration procedure,C1280903,en_5471,CAUSES,Endemic Flea-Borne Typhus,C0041472,en_2303,1,1,AFFECTS,Excitatory,3
1988,Inflammatory disorder,C1290884,en_5483,CAUSES,Edema,C0013604,en_877,1,1,AFFECTS,Excitatory,3
1989,Inflammatory disorder,C1290884,en_5483,CAUSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
1990,Inflammatory disorder,C1290884,en_5483,CAUSES(SPEC),Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
1991,Procoagulant,C1292267,en_5493,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
1992,Death (finding),C1306577,en_5521,CAUSES,Shock,C0036974,en_2097,2,1,AFFECTS,Excitatory,3
1993,Death (finding),C1306577,en_5521,CAUSES(SPEC),Lung infiltration,C0235896,en_3332,1,1,AFFECTS,Excitatory,3
1994,"FRAP1 protein, human",C1307407,en_5524,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
1995,"FRAP1 protein, human",C1307407,en_5524,CAUSES,amino acid transport,C0596078,en_4380,1,1,AFFECTS,Excitatory,3
1996,"TLR4 protein, human",C1321919,en_5543,CAUSES,Endocytosis,C0014139,en_897,1,1,AFFECTS,Excitatory,3
1997,"TLR4 protein, human",C1321919,en_5543,CAUSES,Immune response,C0301872,en_3696,3,2,AFFECTS,Excitatory,6
1998,Hand Sanitizer,C1330330,en_5578,CAUSES,Eye Injuries,C0015408,en_954,1,1,AFFECTS,Excitatory,6
1999,Forkhead Box Protein O4,C1333634,en_5595,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
2000,Homologous Gene,C1334043,en_5599,CAUSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,3
2001,Polymerase,C1335439,en_5615,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
2002,Polymerase,C1335439,en_5615,CAUSES,Asymptomatic,C0231221,en_3252,1,1,AFFECTS,Excitatory,3
2003,Protein Fragment,C1335533,en_5616,CAUSES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
2004,RARB gene,C1335591,en_5617,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
2005,TLR7 gene,C1336639,en_5634,CAUSES,Autoimmunity,C0004368,en_430,1,1,AFFECTS,Excitatory,3
2006,TLR7 gene,C1336639,en_5634,CAUSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
2007,TLR7 gene,C1336639,en_5634,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
2008,MERTK gene,C1364081,en_5650,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
2009,APP gene,C1364818,en_5652,CAUSES,Decreased stress,C0231299,en_3255,1,1,AFFECTS,Excitatory,3
2010,BCAR1 gene,C1366459,en_5654,CAUSES,Wound Healing,C0043240,en_2400,1,1,AFFECTS,Excitatory,3
2011,LAMP3 Gene,C1366486,en_5656,CAUSES,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
2012,ATP8A2 gene,C1366628,en_5666,CAUSES,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
2013,ATP8A2 gene,C1366628,en_5666,CAUSES,pore complex location biogenesis,C1326292,en_5554,1,1,AFFECTS,Excitatory,3
2014,CD14 gene,C1367477,en_5672,CAUSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
2015,imbalance,C1397014,en_5692,CAUSES,"[X]Acute myocarditis, unspecified",C0155686,en_2889,2,1,AFFECTS,Excitatory,3
2016,imbalance,C1397014,en_5692,CAUSES,Disease of capillaries,C0155765,en_2890,1,1,AFFECTS,Excitatory,3
2017,imbalance,C1397014,en_5692,CAUSES,Cardiomyopathies,C0878544,en_5074,1,1,AFFECTS,Excitatory,7
2018,B VARIANT NOS,C1440117,en_5731,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,8
2019,B VARIANT NOS,C1440117,en_5731,CAUSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
2020,B VARIANT NOS,C1440117,en_5731,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,8
2021,Resistant organism,C1444089,en_5741,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
2022,Resistant bacteria,C1444090,en_5742,CAUSES,Infection,C3714514,en_6235,2,2,AFFECTS,Excitatory,9
2023,Resistant bacteria,C1444090,en_5742,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
2024,Resistant bacteria,C1444090,en_5742,CAUSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
2025,Drug resistant Streptococcus pneumoniae,C1444105,en_5744,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
2026,Instability,C1444783,en_5750,CAUSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,3
2027,"TNF protein, human",C1448177,en_5755,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
2028,"TNF protein, human|TNF",C1448177|7124,en_5756,CAUSES,Severe inflammation,C0522569,en_4215,1,1,AFFECTS,Excitatory,6
2029,"MAPK14 protein, human",C1456380,en_5771,CAUSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
2030,Symptoms,C1457887,en_5784,CAUSES,Cessation of life,C0011065,en_762,5,4,AFFECTS,Excitatory,12
2031,Symptoms,C1457887,en_5784,CAUSES,Diagnosis,C0011900,en_806,1,1,AFFECTS,Excitatory,3
2032,Symptoms,C1457887,en_5784,CAUSES,Disease,C0012634,en_826,4,2,AFFECTS,Excitatory,6
2033,Symptoms,C1457887,en_5784,CAUSES,Hospitalization,C0019993,en_1206,3,3,AFFECTS,Excitatory,9
2034,Symptoms,C1457887,en_5784,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
2035,Symptoms,C1457887,en_5784,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,6
2036,Symptoms,C1457887,en_5784,CAUSES,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Excitatory,3
2037,Symptoms,C1457887,en_5784,CAUSES,Health Care,C0086388,en_2715,1,1,AFFECTS,Excitatory,3
2038,Symptoms,C1457887,en_5784,CAUSES,Hospital care,C0259945,en_3505,1,1,AFFECTS,Excitatory,3
2039,Symptoms,C1457887,en_5784,CAUSES,Respiratory distress,C0476273,en_4149,2,1,AFFECTS,Excitatory,3
2040,Symptoms,C1457887,en_5784,CAUSES,Respiratory Failure,C1145670,en_5292,8,4,AFFECTS,Excitatory,12
2041,Symptoms,C1457887,en_5784,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
2042,Detection,C1511790,en_5814,CAUSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
2043,Detection,C1511790,en_5814,CAUSES,Localized desquamation,C0520893,en_4195,1,1,AFFECTS,Excitatory,3
2044,Supplementation,C1515075,en_5844,CAUSES,Measles,C0025007,en_1512,1,1,AFFECTS,Excitatory,3
2045,Supplementation,C1515075,en_5844,CAUSES,Rubella,C0035920,en_2050,1,1,AFFECTS,Excitatory,3
2046,Flare,C1517205,en_5867,CAUSES,Organ failure,C0948600,en_5171,4,1,AFFECTS,Excitatory,3
2047,Ligand Binding,C1517880,en_5869,CAUSES,Endocytosis,C0014139,en_897,1,1,AFFECTS,Excitatory,3
2048,Neurotropism,C1518304,en_5873,CAUSES,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,Excitatory,3
2049,Splice-Site Mutation,C1519478,en_5886,CAUSES,Rare Diseases,C0678236,en_4556,1,1,AFFECTS,Excitatory,3
2050,Vaccine Adjuvant,C1519886,en_5893,CAUSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
2051,Amplification,C1521871,en_5897,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
2052,Process,C1522240,en_5901,CAUSES,Arteriosclerosis,C0003850,en_399,1,1,AFFECTS,Excitatory,3
2053,Process,C1522240,en_5901,CAUSES,"Cardiomyopathy, Dilated",C0007193,en_566,1,1,AFFECTS,Excitatory,3
2054,Process,C1522240,en_5901,CAUSES,Immune System Diseases,C0021053,en_1284,1,1,AFFECTS,Excitatory,3
2055,Process,C1522240,en_5901,CAUSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
2056,Process,C1522240,en_5901,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
2057,Process,C1522240,en_5901,CAUSES,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Excitatory,3
2058,Process,C1522240,en_5901,CAUSES,Respiratory Failure,C1145670,en_5292,3,2,AFFECTS,Excitatory,6
2059,Percutaneous coronary intervention,C1532338,en_5932,CAUSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,6
2060,Injection procedure,C1533685,en_5937,CAUSES,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,Excitatory,3
2061,Injection procedure,C1533685,en_5937,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
2062,Injection procedure,C1533685,en_5937,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
2063,Bronchoalveolar Lavage,C1535502,en_5940,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
2064,Multimorbidity,C1535889,en_5942,CAUSES,Hospitalization,C0019993,en_1206,1,1,AFFECTS,Excitatory,3
2065,STEMI,C1536220,en_5944,CAUSES,Complication,C0009566,en_697,3,1,AFFECTS,Excitatory,6
2066,Flu-like syndrome,C1558931,en_5965,CAUSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
2067,Flu-like syndrome,C1558931,en_5965,CAUSES,Hospitalization,C0019993,en_1206,2,1,AFFECTS,Excitatory,3
2068,Airborne transmission,C1562835,en_5972,CAUSES,Acute respiratory disease,C0264219,en_3527,1,1,AFFECTS,Excitatory,3
2069,Acute Kidney Insufficiency,C1565662,en_5984,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
2070,Oral Mucositis,C1568868,en_5989,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,3
2071,Leak NOS,C1608322,en_6001,CAUSES,Septicemia,C0036690,en_2086,2,1,AFFECTS,Excitatory,3
2072,tocilizumab,C1609165,en_6003,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,7
2073,"Interferon Alpha, Human",C1610033,en_6007,CAUSES,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,Excitatory,3
2074,Pandemics,C1615608,en_6010,CAUSES,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,2,AFFECTS,Excitatory,6
2075,Pandemics,C1615608,en_6010,CAUSES,Amyotrophic Lateral Sclerosis,C0002736,en_310,1,1,AFFECTS,Excitatory,3
2076,Pandemics,C1615608,en_6010,CAUSES,Appendicitis,C0003615,en_387,2,1,AFFECTS,Excitatory,3
2077,Pandemics,C1615608,en_6010,CAUSES,Communicable Diseases,C0009450,en_685,3,2,AFFECTS,Excitatory,6
2078,Pandemics,C1615608,en_6010,CAUSES,Cross Infection,C0010356,en_735,2,1,AFFECTS,Excitatory,3
2079,Pandemics,C1615608,en_6010,CAUSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
2080,Pandemics,C1615608,en_6010,CAUSES,Disease,C0012634,en_826,32,16,AFFECTS,Excitatory,54
2081,Pandemics,C1615608,en_6010,CAUSES,Hypertensive disease,C0020538,en_1239,3,2,AFFECTS,Excitatory,6
2082,Pandemics,C1615608,en_6010,CAUSES,Infection,C3714514,en_6235,9,7,AFFECTS,Excitatory,21
2083,Pandemics,C1615608,en_6010,CAUSES,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Excitatory,3
2084,Pandemics,C1615608,en_6010,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
2085,Pandemics,C1615608,en_6010,CAUSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
2086,Pandemics,C1615608,en_6010,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
2087,Pandemics,C1615608,en_6010,CAUSES,Endemic Flea-Borne Typhus,C0041472,en_2303,1,1,AFFECTS,Excitatory,3
2088,Pandemics,C1615608,en_6010,CAUSES,Virus Diseases,C0042769,en_2362,7,5,AFFECTS,Excitatory,15
2089,Pandemics,C1615608,en_6010,CAUSES,Chronic pain,C0150055,en_2816,2,1,AFFECTS,Excitatory,3
2090,Pandemics,C1615608,en_6010,CAUSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
2091,Pandemics,C1615608,en_6010,CAUSES,Coronavirus Infections,C0206750,en_3176,3,2,AFFECTS,Excitatory,6
2092,Pandemics,C1615608,en_6010,CAUSES,Endometriosis of uterus,C0341858,en_3826,1,1,AFFECTS,Excitatory,3
2093,Pandemics,C1615608,en_6010,CAUSES,"Risk factor, cardiovascular",C0850624,en_4944,2,2,AFFECTS,Excitatory,6
2094,Pandemics,C1615608,en_6010,CAUSES,Sleep Disorders,C0851578,en_4954,1,1,AFFECTS,Excitatory,3
2095,Pandemics,C1615608,en_6010,CAUSES,Infectious disease of lung,C0876973,en_5058,2,1,AFFECTS,Excitatory,3
2096,Pandemics,C1615608,en_6010,CAUSES,Physical deconditioning,C0948688,en_5172,1,1,AFFECTS,Excitatory,3
2097,Pandemics,C1615608,en_6010,CAUSES,Progressive multiple sclerosis,C1095979,en_5228,1,1,AFFECTS,Excitatory,3
2098,Pandemics,C1615608,en_6010,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
2099,Pandemics,C1615608,en_6010,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,4,2,AFFECTS,Excitatory,6
2100,Pandemics,C1615608,en_6010,CAUSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,12
2101,BARRIER,C1706912,en_6034,CAUSES,Behavioral tic,C0278076,en_3596,1,1,AFFECTS,Excitatory,8
2102,IMPACT gene,C1825598,en_6044,CAUSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,7
2103,Basis,C1874451,en_6060,CAUSES,Adverse reactions,C0559546,en_4315,1,1,AFFECTS,Excitatory,6
2104,Noninvasive Ventilation,C1997883,en_6080,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,7
2105,Influenza A,C2062441,en_6088,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
2106,Volatile Organic Compounds,C2350439,en_6105,CAUSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,8
2107,Hoods,C2720748,en_6130,CAUSES,hearing impairment,C1384666,en_5689,1,1,AFFECTS,Excitatory,6
2108,"CD69 protein, human|CD69",C2744535|969,en_6133,CAUSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
2109,"CD69 protein, human|CD69",C2744535|969,en_6133,CAUSES,Interrupted breathing,C0235744,en_3330,1,1,AFFECTS,Excitatory,8
2110,"CD69 protein, human|CD69",C2744535|969,en_6133,CAUSES,Possible,C0332149,en_3747,1,1,AFFECTS,Excitatory,6
2111,"CD69 protein, human|CD69",C2744535|969,en_6133,CAUSES,Readiness,C1318963,en_5534,1,1,AFFECTS,Excitatory,7
2112,Duration,C2926735,en_6146,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,7
2113,tofacitinib,C2930696,en_6147,CAUSES,American College of Cardiology/American Heart Association Lesion Complexity Score A,C3272281,en_6189,1,1,AFFECTS,Excitatory,8
2114,ruxolitinib,C2931926,en_6148,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,7
2115,Cerebral Hemorrhage,C2937358,en_6154,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,6
2116,Systemic inflammatory response,C3554550,en_6220,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,6
2117,Middle East Respiratory Syndrome Coronavirus,C3698360,en_6233,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,7
2118,Infection,C3714514,en_6235,CAUSES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Excitatory,8
2119,Cytochrome P-450 CYP3A4 Inhibitors,C3850053,en_6268,CAUSES,Sense of smell impaired,C2364082,en_6111,1,1,AFFECTS,Excitatory,7
2120,PSMA5 wt Allele,C3889400,en_6282,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,8
2121,Hyperinflammatory state,C4014463,en_6290,CAUSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,6
2122,Recurrent thromboembolism,C4025286,en_6296,CAUSES,Pulmonary thrombosis,C0151946,en_2875,1,1,AFFECTS,Excitatory,6
2123,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
2124,Multidrug-resistant bacteria,C4076168,en_6314,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,6
2125,Cell-Free DNA,C4289789,en_6334,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,7
2126,Interferon-alpha2b,C4307370,en_6337,CAUSES,Favorable Response,C4054987,en_6310,1,1,AFFECTS,Excitatory,6
2127,Nitrosative Stress,C4505047,en_6351,CAUSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
2128,Noncommunicable Diseases,C4505065,en_6352,CAUSES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,6
2129,remdesivir,C4726677,en_6388,CAUSES,Bradycardia,C0428977,en_4018,1,1,AFFECTS,Excitatory,6
2130,Severe disease,C4740692,en_6396,CAUSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
2131,Severe infection,C5139167,en_6407,CAUSES,Multiple disability,C0935560,en_5135,1,1,AFFECTS,Excitatory,6
2132,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,CAUSES,Spontaneous hemorrhage,C1321132,en_5538,1,1,AFFECTS,Excitatory,6
2133,COVID-19,C5203670,en_6417,CAUSES,Acclimatization,C0000934,en_212,1,1,AFFECTS,Excitatory,8
2134,COVID-19,C5203670,en_6417,CAUSES,Apnea,C0003578,en_385,1,1,AFFECTS,Excitatory,6
2135,COVID-19,C5203670,en_6417,CAUSES,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Excitatory,6
2136,COVID-19,C5203670,en_6417,CAUSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,6
2137,COVID-19,C5203670,en_6417,CAUSES,Coitus,C0009253,en_671,1,1,AFFECTS,Excitatory,6
2138,COVID-19,C5203670,en_6417,CAUSES,Complication,C0009566,en_697,2,2,AFFECTS,Excitatory,14
2139,COVID-19,C5203670,en_6417,CAUSES,Critical Illness,C0010340,en_733,2,2,AFFECTS,Excitatory,12
2140,COVID-19,C5203670,en_6417,CAUSES,Cessation of life,C0011065,en_762,22,20,AFFECTS,Excitatory,126.5
2141,COVID-19,C5203670,en_6417,CAUSES,Disease,C0012634,en_826,6,6,AFFECTS,Excitatory,38
2142,COVID-19,C5203670,en_6417,CAUSES,Fibromyalgia,C0016053,en_993,1,1,AFFECTS,Excitatory,8
2143,COVID-19,C5203670,en_6417,CAUSES,Guillain-Barre Syndrome,C0018378,en_1104,1,1,AFFECTS,Excitatory,6
2144,COVID-19,C5203670,en_6417,CAUSES,Hospitalization,C0019993,en_1206,24,18,AFFECTS,Excitatory,121
2145,COVID-19,C5203670,en_6417,CAUSES,"Kidney Failure, Acute",C0022660,en_1382,5,3,AFFECTS,Excitatory,18
2146,COVID-19,C5203670,en_6417,CAUSES,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,Excitatory,7
2147,COVID-19,C5203670,en_6417,CAUSES,Multiple Organ Failure,C0026766,en_1597,2,2,AFFECTS,Excitatory,14
2148,COVID-19,C5203670,en_6417,CAUSES,Pain,C0030193,en_1741,1,1,AFFECTS,Excitatory,6
2149,COVID-19,C5203670,en_6417,CAUSES,Patient Discharge,C0030685,en_1758,1,1,AFFECTS,Excitatory,7
2150,COVID-19,C5203670,en_6417,CAUSES,Pneumonia,C0032285,en_1833,20,10,AFFECTS,Excitatory,67
2151,COVID-19,C5203670,en_6417,CAUSES,Pulmonary Valve Insufficiency,C0034088,en_1936,1,1,AFFECTS,Excitatory,7
2152,COVID-19,C5203670,en_6417,CAUSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,7
2153,COVID-19,C5203670,en_6417,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,29,22,AFFECTS,Excitatory,144
2154,COVID-19,C5203670,en_6417,CAUSES,Shock,C0036974,en_2097,1,1,AFFECTS,Excitatory,7
2155,COVID-19,C5203670,en_6417,CAUSES,"Shock, Cardiogenic",C0036980,en_2098,1,1,AFFECTS,Excitatory,6
2156,COVID-19,C5203670,en_6417,CAUSES,Sleep,C0037313,en_2119,1,1,AFFECTS,Excitatory,6
2157,COVID-19,C5203670,en_6417,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,6
2158,COVID-19,C5203670,en_6417,CAUSES,Syndrome,C0039082,en_2197,2,2,AFFECTS,Excitatory,12
2159,COVID-19,C5203670,en_6417,CAUSES,Taste Disorders,C0039338,en_2208,1,1,AFFECTS,Excitatory,6
2160,COVID-19,C5203670,en_6417,CAUSES,"Endoscopy, Gastrointestinal",C0079278,en_2595,1,1,AFFECTS,Excitatory,6
2161,COVID-19,C5203670,en_6417,CAUSES,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Excitatory,6
2162,COVID-19,C5203670,en_6417,CAUSES,Hospital admission,C0184666,en_3063,9,8,AFFECTS,Excitatory,53
2163,COVID-19,C5203670,en_6417,CAUSES,Admit hospital emergency NOS,C0184673,en_3064,1,1,AFFECTS,Excitatory,6
2164,COVID-19,C5203670,en_6417,CAUSES,Psychological symptom,C0233397,en_3290,1,1,AFFECTS,Excitatory,7
2165,COVID-19,C5203670,en_6417,CAUSES,Hypoxia,C0242184,en_3396,2,2,AFFECTS,Excitatory,13
2166,COVID-19,C5203670,en_6417,CAUSES,Vertical Disease Transmission,C0242648,en_3427,1,1,AFFECTS,Excitatory,6
2167,COVID-19,C5203670,en_6417,CAUSES,sequelae aspects,C0243088,en_3461,1,1,AFFECTS,Excitatory,7
2168,COVID-19,C5203670,en_6417,CAUSES,Acute respiratory failure,C0264490,en_3533,9,7,AFFECTS,Excitatory,46
2169,COVID-19,C5203670,en_6417,CAUSES,Respiratory failure without hypercapnia,C0340194,en_3812,8,4,AFFECTS,Excitatory,28
2170,COVID-19,C5203670,en_6417,CAUSES,Supportive care,C0344211,en_3836,2,2,AFFECTS,Excitatory,13
2171,COVID-19,C5203670,en_6417,CAUSES,Thrombophilia,C0398623,en_3949,2,2,AFFECTS,Excitatory,14
2172,COVID-19,C5203670,en_6417,CAUSES,Perceived quality of life,C0518214,en_4178,1,1,AFFECTS,Excitatory,6
2173,COVID-19,C5203670,en_6417,CAUSES,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Excitatory,6
2174,COVID-19,C5203670,en_6417,CAUSES,"Visit, outpatient",C0545084,en_4269,1,1,AFFECTS,Excitatory,8
2175,COVID-19,C5203670,en_6417,CAUSES,Emergency visit,C0553618,en_4287,1,1,AFFECTS,Excitatory,8
2176,COVID-19,C5203670,en_6417,CAUSES,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Excitatory,6
2177,COVID-19,C5203670,en_6417,CAUSES,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,Excitatory,7
2178,COVID-19,C5203670,en_6417,CAUSES,Challenge,C0805586,en_4885,3,3,AFFECTS,Excitatory,21
2179,COVID-19,C5203670,en_6417,CAUSES,Anxiety symptoms,C0860603,en_4992,1,1,AFFECTS,Excitatory,6
2180,COVID-19,C5203670,en_6417,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,7
2181,COVID-19,C5203670,en_6417,CAUSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,6
2182,COVID-19,C5203670,en_6417,CAUSES,Cytokine release syndrome,C0948245,en_5163,2,2,AFFECTS,Excitatory,12
2183,COVID-19,C5203670,en_6417,CAUSES,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Excitatory,7
2184,COVID-19,C5203670,en_6417,CAUSES,Respiratory Failure,C1145670,en_5292,7,7,AFFECTS,Excitatory,47
2185,COVID-19,C5203670,en_6417,CAUSES,Childbirth,C1148523,en_5296,1,1,AFFECTS,Excitatory,8
2186,COVID-19,C5203670,en_6417,CAUSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,7
2187,COVID-19,C5203670,en_6417,CAUSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,5,5,AFFECTS,Excitatory,34
2188,COVID-19,C5203670,en_6417,CAUSES,Assessment procedure,C1261322,en_5417,1,1,AFFECTS,Excitatory,6
2189,COVID-19,C5203670,en_6417,CAUSES,Intervention regimes,C1273869,en_5458,2,2,AFFECTS,Excitatory,13
2190,COVID-19,C5203670,en_6417,CAUSES,Immune System Suppression,C1373218,en_5686,1,1,AFFECTS,Excitatory,7
2191,COVID-19,C5203670,en_6417,CAUSES,Symptoms,C1457887,en_5784,4,4,AFFECTS,Excitatory,26
2192,COVID-19,C5203670,en_6417,CAUSES,follow-up,C1522577,en_5904,1,1,AFFECTS,Excitatory,6
2193,COVID-19,C5203670,en_6417,CAUSES,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,Excitatory,7
2194,COVID-19,C5203670,en_6417,CAUSES,Mobile Health,C2718080,en_6126,1,1,AFFECTS,Excitatory,8
2195,COVID-19,C5203670,en_6417,CAUSES,Small Fiber Neuropathy,C3276706,en_6197,1,1,AFFECTS,Excitatory,6
2196,COVID-19,C5203670,en_6417,CAUSES,Dysbiosis,C3658208,en_6224,1,1,AFFECTS,Excitatory,6
2197,COVID-19,C5203670,en_6417,CAUSES,Infection,C3714514,en_6235,2,2,AFFECTS,Excitatory,15
2198,COVID-19,C5203670,en_6417,CAUSES,Acute hypoxemic respiratory failure,C4039867,en_6301,3,3,AFFECTS,Excitatory,20
2199,COVID-19,C5203670,en_6417,CAUSES,Prone positioning,C4551696,en_6366,1,1,AFFECTS,Excitatory,7
2200,COVID-19,C5203670,en_6417,CAUSES,Standard Treatment,C4684780,en_6371,1,1,AFFECTS,Excitatory,8
2201,COVID-19,C5203670,en_6417,CAUSES,Physical Distancing,C5392135,en_6443,2,2,AFFECTS,Excitatory,13
2202,COVID-19,C5203670,en_6417,CAUSES,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,2,2,AFFECTS,Excitatory,13
2203,2019 novel coronavirus,C5203676,en_6420,CAUSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,6
2204,2019 novel coronavirus,C5203676,en_6420,CAUSES,Disease,C0012634,en_826,13,13,AFFECTS,Excitatory,86
2205,2019 novel coronavirus,C5203676,en_6420,CAUSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
2206,2019 novel coronavirus,C5203676,en_6420,CAUSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,6
2207,2019 novel coronavirus,C5203676,en_6420,CAUSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,6
2208,2019 novel coronavirus,C5203676,en_6420,CAUSES,Pneumonia,C0032285,en_1833,18,13,AFFECTS,Excitatory,86
2209,2019 novel coronavirus,C5203676,en_6420,CAUSES,Respiration Disorders,C0035204,en_2005,2,2,AFFECTS,Excitatory,13
2210,2019 novel coronavirus,C5203676,en_6420,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,11,9,AFFECTS,Excitatory,58
2211,2019 novel coronavirus,C5203676,en_6420,CAUSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,6
2212,2019 novel coronavirus,C5203676,en_6420,CAUSES,Vasodilation,C0042401,en_2342,1,1,AFFECTS,Excitatory,6
2213,2019 novel coronavirus,C5203676,en_6420,CAUSES,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Excitatory,12
2214,2019 novel coronavirus,C5203676,en_6420,CAUSES,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,Excitatory,6
2215,2019 novel coronavirus,C5203676,en_6420,CAUSES,Acute respiratory failure,C0264490,en_3533,3,2,AFFECTS,Excitatory,12
2216,2019 novel coronavirus,C5203676,en_6420,CAUSES,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Excitatory,6
2217,2019 novel coronavirus,C5203676,en_6420,CAUSES,Systemic disease,C0442893,en_4062,1,1,AFFECTS,Excitatory,6
2218,2019 novel coronavirus,C5203676,en_6420,CAUSES,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Excitatory,6
2219,2019 novel coronavirus,C5203676,en_6420,CAUSES,Pathogenesis,C0699748,en_4703,1,1,AFFECTS,Excitatory,6
2220,2019 novel coronavirus,C5203676,en_6420,CAUSES,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Excitatory,6
2221,2019 novel coronavirus,C5203676,en_6420,CAUSES,"Communicable Diseases, Emerging",C0872315,en_5049,1,1,AFFECTS,Excitatory,6
2222,2019 novel coronavirus,C5203676,en_6420,CAUSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,8
2223,2019 novel coronavirus,C5203676,en_6420,CAUSES,Cytokine storm,C0919747,en_5119,2,2,AFFECTS,Excitatory,13
2224,2019 novel coronavirus,C5203676,en_6420,CAUSES,Vascular inflammations,C0947751,en_5156,1,1,AFFECTS,Excitatory,7
2225,2019 novel coronavirus,C5203676,en_6420,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,7
2226,2019 novel coronavirus,C5203676,en_6420,CAUSES,Inflammatory Response,C1155266,en_5321,2,2,AFFECTS,Excitatory,14
2227,2019 novel coronavirus,C5203676,en_6420,CAUSES,Invasive mycosis,C1262313,en_5421,1,1,AFFECTS,Excitatory,6
2228,2019 novel coronavirus,C5203676,en_6420,CAUSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,7
2229,2019 novel coronavirus,C5203676,en_6420,CAUSES,Severe acute respiratory infection,C3873497,en_6279,1,1,AFFECTS,Excitatory,7
2230,2019 novel coronavirus,C5203676,en_6420,CAUSES,COVID-19,C5203670,en_6417,50,50,AFFECTS,Excitatory,330.5
2231,2019 novel coronavirus,C5203676,en_6420,CAUSES,Multisystem inflammatory syndrome,C5539184,en_6468,1,1,AFFECTS,Excitatory,6
2232,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,CAUSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,7
2233,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,CAUSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,6
2234,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,CAUSES,Rheumatic Fever,C0035436,en_2029,2,1,AFFECTS,Excitatory,6
2235,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,CAUSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
2236,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,CAUSES,Standard of Care,C2936643,en_6153,1,1,AFFECTS,Excitatory,6
2237,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,CAUSES,Acute hypoxemic respiratory failure,C4039867,en_6301,1,1,AFFECTS,Excitatory,7
2238,ChAdOx1 nCoV-19,C5383287,en_6435,CAUSES,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Excitatory,8
2239,pediatric inflammatory multisystem syndrome,C5389369,en_6437,CAUSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
2240,glycyrrhizae radix et rhizoma,C5391843,en_6440,CAUSES,Liddle's syndrome,C0221043,en_3211,1,1,AFFECTS,Excitatory,7
2241,CoVac-1,C5439905,en_6467,CAUSES,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Excitatory,7
2242,ABCA1,C1412058,en_1,STIMULATES,Cholesterol,C0008377,en_640,1,1,AFFECTS,Excitatory,3
2243,ABCA1,C1412058,en_1,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
2244,ADORA2A,C1412246,en_3,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
2245,PARP1,C1538577,en_4,AUGMENTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
2246,AGTR1,C1439284,en_5,AUGMENTS,Vascular Permeability,C0162337,en_2906,1,1,AFFECTS,Excitatory,3
2247,AGTR1,C1439284,en_5,AUGMENTS,microvasculature,C0243079,en_3458,1,1,AFFECTS,Excitatory,3
2248,APLNR,C1412289,en_6,AUGMENTS,Cardiovascular Physiology,C0007227,en_570,1,1,AFFECTS,Excitatory,3
2249,APLNR,C1412289,en_6,INHIBITS,AGTR1,C1439284,en_5,1,1,AFFECTS,Inhibitory,3
2250,AIF1,C1412299,en_7,STIMULATES,Microglia,C0206116,en_3147,1,1,AFFECTS,Excitatory,3
2251,BACH1,C1412729,en_9,DISRUPTS,Structure of parenchyma of lung,C0819757,en_4926,1,1,AFFECTS,Inhibitory,3
2252,BACH1,C1412729,en_9,INHIBITS,Genes,C0017337,en_1052,1,1,AFFECTS,Inhibitory,3
2253,BSG,C1412828,en_10,AUGMENTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Excitatory,3
2254,BSG,C1412828,en_10,PRODUCES,"NOS3 protein, human",C0669365,en_4534,1,1,AFFECTS,Excitatory,3
2255,CAMP,C1413106,en_11,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
2256,CAMP,C1413106,en_11,AFFECTS,psychological distress,C0815107,en_4922,1,1,AFFECTS,General/Uncertain,3
2257,CD86,C0527903,en_14,STIMULATES,Naive T-Lymphocyte,C3641721,en_6221,1,1,AFFECTS,Excitatory,7
2258,CD86,C0527903,en_14,DISRUPTS,Cell Maturation,C1516349,en_5855,1,1,AFFECTS,Inhibitory,3
2259,CD38,C0075742,en_16,AUGMENTS,Senile Plaques,C0333463,en_3764,1,1,AFFECTS,Excitatory,3
2260,CD40LG,C1539082,en_17,STIMULATES,"immunoglobulin A, human",C2825347,en_6135,1,1,AFFECTS,Excitatory,7
2261,CD40LG,C1539082,en_17,AFFECTS,Clinical finding,C0586173,en_4357,1,1,AFFECTS,General/Uncertain,3
2262,CD40LG,C1539082,en_17,AUGMENTS,viral entry,C1160648,en_5358,2,1,AFFECTS,Excitatory,3
2263,CD68,C1413234,en_18,PREVENTS,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,Inhibitory,3
2264,CD69,C1413235,en_19,STIMULATES,SPATA2 wt Allele|PDCD1|RPL17|SNCA|SPATA2,C4723666|5133|6139|6622|9825,en_6386,1,1,AFFECTS,Excitatory,7
2265,CDK9,C1413290,en_21,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2266,CECR,C1413326,en_22,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
2267,DBT,C1413925,en_27,INHIBITS,Tumor Antigens,C0041361,en_2299,1,1,AFFECTS,Inhibitory,3
2268,ACE,C1413931,en_28,INHIBITS,SLC5A2,C1420201,en_79,1,1,AFFECTS,Inhibitory,3
2269,ACE,C1413931,en_28,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
2270,ACE,C1413931,en_28,PRODUCES,Angiotensin II,C0003009,en_328,2,1,AFFECTS,Excitatory,3
2271,ACE,C1413931,en_28,PRODUCES,Angiotensins,C0003018,en_332,1,1,AFFECTS,Excitatory,3
2272,ACE,C1413931,en_28,STIMULATES,Angiotensin II,C0003009,en_328,1,1,AFFECTS,Excitatory,3
2273,ACE,C1413931,en_28,STIMULATES,Angiotensins,C0003018,en_332,1,1,AFFECTS,Excitatory,3
2274,CFD,C1824729,en_29,DISRUPTS,Clonal Expansion,C1516670,en_5861,1,1,AFFECTS,Inhibitory,3
2275,ENO2,C1414404,en_33,PREDISPOSES,Neuropathy,C0442874,en_4060,1,1,AFFECTS,Excitatory,3
2276,EPO gene,C1366564,en_5664,AUGMENTS,High altitude (physical force),C0238617,en_3367,1,1,AFFECTS,Excitatory,6
2277,EPO gene,C1366564,en_5664,STIMULATES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,6
2278,EPRS,C1414437,en_34,AUGMENTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,Excitatory,3
2279,GALNT3,C1414953,en_37,AFFECTS,glycosylation,C0017982,en_1086,2,1,AFFECTS,General/Uncertain,3
2280,GATA3,C1414994,en_38,DISRUPTS,"Inflammation, allergic",C0021375,en_1308,1,1,AFFECTS,Inhibitory,3
2281,GATA3,C1414994,en_38,DISRUPTS,leukotriene biosynthesis,C1157321,en_5332,1,1,AFFECTS,Inhibitory,3
2282,GIF,C0917588,en_39,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
2283,GPC3,C1415195,en_40,AFFECTS,Hypotension,C0020649,en_1248,1,1,AFFECTS,General/Uncertain,3
2284,GTF2I,C1415347,en_42,DISRUPTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
2285,HIF1A,C1333897,en_44,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
2286,HSPA5,C1415761,en_45,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
2287,IFNA1,C1415900,en_46,AFFECTS,Infected,C0439663,en_4036,1,1,AFFECTS,General/Uncertain,6
2288,IFNA1,C1415900,en_46,AUGMENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
2289,IFNA1,C1415900,en_46,AUGMENTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Excitatory,3
2290,IGFBP7,C1415932,en_47,STIMULATES,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Excitatory,3
2291,IGHE,C1415975,en_48,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
2292,IL1RN,C1416402,en_51,STIMULATES,monocyte,C0026473,en_1580,1,1,AFFECTS,Excitatory,3
2293,IL15,C1334105,en_52,DISRUPTS,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Inhibitory,7
2294,IRF7,C1416475,en_53,STIMULATES,Interferon Type I,C0021743,en_1331,1,1,AFFECTS,Excitatory,3
2295,IRF7,C1416475,en_53,STIMULATES,TLR3 gene,C1336635,en_5632,1,1,AFFECTS,Excitatory,3
2296,KRT16,C1416724,en_56,PRODUCES,gamma-glutamyl carboxylase,C0061495,en_2495,1,1,AFFECTS,Excitatory,3
2297,LCN2,C1416806,en_57,STIMULATES,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Excitatory,3
2298,MPO,C1417245,en_58,STIMULATES,neutrophil,C0027950,en_1676,1,1,AFFECTS,Excitatory,7
2299,MPO,C1417245,en_58,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,7
2300,MSR1,C1417374,en_59,AFFECTS,Foam Cells,C0016390,en_1010,1,1,AFFECTS,General/Uncertain,3
2301,MUC5AC,C1417497,en_60,PRODUCES,Sputum,C0038056,en_2149,3,2,AFFECTS,Excitatory,6
2302,NGF,C1417719,en_63,AFFECTS,Nerve Regeneration,C0027756,en_1658,1,1,AFFECTS,General/Uncertain,3
2303,NHS,C1417725,en_64,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2304,NHS,C1417725,en_64,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
2305,NHS,C1417725,en_64,AUGMENTS,Stress,C0038435,en_2165,1,1,AFFECTS,Excitatory,3
2306,NHS,C1417725,en_64,AUGMENTS,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
2307,NINJ1 gene,C1417728,en_5710,AFFECTS,Senile Plaques,C0333463,en_3764,2,1,AFFECTS,General/Uncertain,3
2308,NVL,C1417897,en_65,AFFECTS,Endocytosis,C0014139,en_897,2,1,AFFECTS,General/Uncertain,3
2309,P2RX7,C1418215,en_66,STIMULATES,ADAM17,C1412186,en_84,1,1,AFFECTS,Excitatory,3
2310,P2RY11,C1418218,en_67,PREDISPOSES,Narcolepsy,C0027404,en_1638,1,1,AFFECTS,Excitatory,3
2311,PIK3C2A,C1418571,en_69,STIMULATES,Troponin T,C0077404,en_2580,1,1,AFFECTS,Excitatory,6
2312,CTSA,C1824812,en_70,PREDISPOSES,Urinary hesitation,C0152032,en_2878,3,2,AFFECTS,Excitatory,6
2313,MASP1,C1417036,en_71,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
2314,PTPN2,C1419100,en_72,PREDISPOSES,Inflammatory Bowel Diseases,C0021390,en_1310,2,1,AFFECTS,Excitatory,3
2315,PTPN2,C1419100,en_72,STIMULATES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
2316,RIT2,C1419388,en_73,AFFECTS,Acute respiratory infection NOS,C0339901,en_3809,2,1,AFFECTS,General/Uncertain,3
2317,RIT2,C1419388,en_73,DISRUPTS,Respiratory Tract Infections,C0035243,en_2017,4,2,AFFECTS,Inhibitory,6
2318,RIT2,C1419388,en_73,DISRUPTS,Acute infectious disease,C0275518,en_3563,2,1,AFFECTS,Inhibitory,3
2319,ROS1,C0812281,en_74,DISRUPTS,Respiration,C0035203,en_2004,1,1,AFFECTS,Inhibitory,3
2320,RP2,C1419608,en_75,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
2321,RPS6KA1,C1419742,en_76,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
2322,RPS6KA1,C1419742,en_76,STIMULATES,Hydrogen Peroxide,C0020281,en_1221,1,1,AFFECTS,Excitatory,3
2323,SDC2,C1419892,en_77,AUGMENTS,Stromal Cells,C0162597,en_2918,1,1,AFFECTS,Excitatory,3
2324,SNRPE,C1420292,en_80,PREDISPOSES,Assault,C0004063,en_415,1,1,AFFECTS,Excitatory,3
2325,SREBF1,C1420398,en_82,PRODUCES,Genes,C0017337,en_1052,1,1,AFFECTS,Excitatory,3
2326,SRY,C1420418,en_83,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
2327,ADAM17,C1412186,en_84,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
2328,ADAM17,C1412186,en_84,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
2329,ADAM17,C1412186,en_84,STIMULATES,TNF gene,C0812246,en_4896,2,1,AFFECTS,Excitatory,3
2330,TAZ,C2183634,en_85,AUGMENTS,chemical composition,C0243176,en_3468,1,1,AFFECTS,Excitatory,3
2331,TLR2,C1336634,en_86,STIMULATES,Genes,C0017337,en_1052,1,1,AFFECTS,Excitatory,3
2332,UCP1,C1421313,en_87,AFFECTS,Fever,C0015967,en_985,1,1,AFFECTS,General/Uncertain,3
2333,SCGB1A1,C1421318,en_88,AFFECTS,Thrombus,C0087086,en_2743,1,1,AFFECTS,General/Uncertain,3
2334,SCGB1A1,C1421318,en_88,DISRUPTS,Platelet aggregation,C0032176,en_1828,1,1,AFFECTS,Inhibitory,3
2335,VEGFA,C1823619,en_89,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
2336,VEGFA,C1823619,en_89,DISRUPTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,Inhibitory,3
2337,VEGFB,C1421446,en_90,AFFECTS,Well in self,C0424578,en_3996,1,1,AFFECTS,General/Uncertain,7
2338,TFEB,C1420699,en_91,AFFECTS,Biogenesis,C0005495,en_466,1,1,AFFECTS,General/Uncertain,3
2339,TFEB,C1420699,en_91,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
2340,ANP32A,C1421894,en_92,AFFECTS,viral genome replication,C1160701,en_5361,1,1,AFFECTS,General/Uncertain,3
2341,HIST1H4K,N/A,en_93,AFFECTS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,General/Uncertain,3
2342,OGT,C1417945,en_94,AFFECTS,insulin secretion,C1256369,en_5399,1,1,AFFECTS,General/Uncertain,3
2343,OGT,C1417945,en_94,PRODUCES,Insulin,C0021641,en_1324,1,1,AFFECTS,Excitatory,3
2344,OGT,C1417945,en_94,STIMULATES,Glycogen,C0017911,en_1081,1,1,AFFECTS,Excitatory,3
2345,OGT,C1417945,en_94,STIMULATES,Trehalose,C0040815,en_2279,1,1,AFFECTS,Excitatory,3
2346,VAMP4,C1421421,en_96,AFFECTS,Cytoplasmic Granules,C0010837,en_755,1,1,AFFECTS,General/Uncertain,3
2347,SUCLA2,C3811915,en_97,AFFECTS,Immune system,C0020962,en_1271,1,1,AFFECTS,General/Uncertain,3
2348,AIP,C1412302,en_98,INHIBITS,Interferon Regulatory Factor-7,C0666411,en_4531,2,1,AFFECTS,Inhibitory,3
2349,ADAMTS2,C1412208,en_100,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
2350,ISG15,C1825621,en_101,AFFECTS,Cell Death,C0007587,en_587,2,2,AFFECTS,General/Uncertain,6
2351,ISG15,C1825621,en_101,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
2352,ISG15,C1825621,en_101,PREDISPOSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
2353,DCAF1,C1823635,en_102,STIMULATES,PLK4,C1420470,en_111,1,1,AFFECTS,Excitatory,3
2354,PCLAF,C1537443,en_103,STIMULATES,Phospholipids,C0031676,en_1797,1,1,AFFECTS,Excitatory,3
2355,KEAP1,C1427969,en_104,DISRUPTS,Ubiquitination,C1519751,en_5891,1,1,AFFECTS,Inhibitory,3
2356,ABI1,C1335864,en_105,AFFECTS,nucleosome disassembly,C1156193,en_5328,1,1,AFFECTS,General/Uncertain,3
2357,TLR6,C1336638,en_106,STIMULATES,neutrophil,C0027950,en_1676,1,1,AFFECTS,Excitatory,7
2358,PROCR,C1418944,en_107,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
2359,SPINT2,C1420362,en_108,INHIBITS,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Inhibitory,3
2360,MGEA5,C1417143,en_110,STIMULATES,Glycogen,C0017911,en_1081,1,1,AFFECTS,Excitatory,3
2361,MGEA5,C1417143,en_110,STIMULATES,Trehalose,C0040815,en_2279,1,1,AFFECTS,Excitatory,3
2362,PLK4,C1420470,en_111,AFFECTS,Centrioles,C0007708,en_599,1,1,AFFECTS,General/Uncertain,3
2363,PLK4,C1420470,en_111,AUGMENTS,Centrioles,C0007708,en_599,1,1,AFFECTS,Excitatory,3
2364,TRAF3IP2,C1540046,en_112,AUGMENTS,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
2365,DIAPH2-AS1,C3470078,en_113,AUGMENTS,Hedgehog signaling complex location,C1523748,en_5912,1,1,AFFECTS,Excitatory,3
2366,DIAPH2-AS1,C3470078,en_113,DISRUPTS,Cells,C0007634,en_596,1,1,AFFECTS,Inhibitory,3
2367,DIAPH2-AS1,C3470078,en_113,DISRUPTS,Protein Biosynthesis,C0597295,en_4419,1,1,AFFECTS,Inhibitory,3
2368,DIAPH2-AS1,C3470078,en_113,DISRUPTS,Diamond-Blackfan anemia,C1260899,en_5413,1,1,AFFECTS,Inhibitory,3
2369,EHMT2,C1825038,en_114,AFFECTS,Gene Expression Regulation,C0017263,en_1045,1,1,AFFECTS,General/Uncertain,3
2370,PTP4A3,C1419090,en_115,DISRUPTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
2371,KLRK1,C1425775,en_119,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
2372,SIRT1,C1423062,en_121,INHIBITS,"PARP1,COL11A2",C1538577;C1413571,en_173,1,1,AFFECTS,Inhibitory,3
2373,SIRT1,C1423062,en_121,INHIBITS,tumor necrosis factor-alpha convertase,C0529196,en_4232,2,1,AFFECTS,Inhibitory,3
2374,SIRT1,C1423062,en_121,STIMULATES,ADAM17,C1412186,en_84,1,1,AFFECTS,Excitatory,3
2375,SIRT1,C1423062,en_121,STIMULATES,Membrane Fluidity,C0025245,en_1527,1,1,AFFECTS,Excitatory,3
2376,SIRT1,C1423062,en_121,STIMULATES,TIMP3 gene,C1336630,en_5631,1,1,AFFECTS,Excitatory,3
2377,POLDIP2,C1428254,en_122,DISRUPTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
2378,POLDIP2,C1428254,en_122,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2379,ERLEC1,C1540220,en_125,AFFECTS,Recovery,C0237820,en_3354,2,1,AFFECTS,General/Uncertain,3
2380,"ABL2,RERE",C0812381;C1419345,en_127,STIMULATES,Ornithine,C0029277,en_1719,1,1,AFFECTS,Excitatory,3
2381,SETD2,C1822686,en_128,STIMULATES,Proto-Oncogene Proteins c-myc,C0080065,en_2619,1,1,AFFECTS,Excitatory,3
2382,UHRF1,C1421348,en_129,AUGMENTS,Hypermethylation,C1512554,en_5821,2,1,AFFECTS,Excitatory,3
2383,PSAT1,C1426033,en_130,PRODUCES,sterol ester,C0597522,en_4429,1,1,AFFECTS,Excitatory,3
2384,FOXP3,C1416467,en_131,PREVENTS,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,Inhibitory,3
2385,SERPINA10,C1423896,en_132,DISRUPTS,Erythrocytes,C0014792,en_926,1,1,AFFECTS,Inhibitory,3
2386,TLR7 gene,C1336639,en_5634,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
2387,NELFCD,C1423842,en_133,AFFECTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
2388,NELFCD,C1423842,en_133,AUGMENTS,Upper Extremity,C1140618,en_5280,1,1,AFFECTS,Excitatory,3
2389,IL23A,C1423526,en_134,AFFECTS,Integumentary system,C0037267,en_2113,1,1,AFFECTS,General/Uncertain,3
2390,TREM2,C1425067,en_136,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
2391,TREM2,C1425067,en_136,AFFECTS(SPEC),Cell Survival,C0007620,en_595,1,1,AFFECTS,General/Uncertain,3
2392,SASH3,C1423878,en_137,AFFECTS,T-Cell Activation,C1155065,en_5315,1,1,AFFECTS,General/Uncertain,3
2393,DLL4,C1414072,en_138,INHIBITS,MAPK8 gene,C1367731,en_5677,1,1,AFFECTS,Inhibitory,3
2394,TET2,C1825692,en_139,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
2395,SARS2,C1425041,en_140,DISRUPTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,Inhibitory,3
2396,TRMT1,C1428492,en_141,AFFECTS,host,C1167395,en_5368,1,1,AFFECTS,General/Uncertain,3
2397,RALGAPA2,C1424084,en_142,INHIBITS,HCC,C1825268,en_169,1,1,AFFECTS,Inhibitory,3
2398,MAVS,C1864770,en_143,STIMULATES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
2399,STIM2,C1426088,en_144,AFFECTS,Inactivation,C0544461,en_4262,1,1,AFFECTS,General/Uncertain,3
2400,PRX,C1422198,en_145,DISRUPTS,Insecurity,C0233497,en_3295,1,1,AFFECTS,Inhibitory,3
2401,ACE2,C1422064,en_5723,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
2402,ACE2,C1422064,en_5723,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2403,ACE2,C1422064,en_5723,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
2404,ACE2,C1422064,en_5723,AFFECTS,Renin-Angiotensin System,C0035096,en_1996,3,2,AFFECTS,General/Uncertain,6
2405,ACE2,C1422064,en_5723,AFFECTS,Salivary Glands,C0036098,en_2059,1,1,AFFECTS,General/Uncertain,3
2406,ACE2,C1422064,en_5723,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
2407,ACE2,C1422064,en_5723,AFFECTS,Body tissue,C0040300,en_2242,1,1,AFFECTS,General/Uncertain,3
2408,ACE2,C1422064,en_5723,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
2409,ACE2,C1422064,en_5723,AFFECTS,Signal Transduction Pathways,C0086982,en_2741,4,2,AFFECTS,General/Uncertain,6
2410,ACE2,C1422064,en_5723,AFFECTS,Organ,C0178784,en_2991,1,1,AFFECTS,General/Uncertain,3
2411,ACE2,C1422064,en_5723,AFFECTS,Skeletal muscle structure,C0242692,en_3432,2,1,AFFECTS,General/Uncertain,3
2412,ACE2,C1422064,en_5723,AFFECTS,enzyme activity,C0243102,en_3464,1,1,AFFECTS,General/Uncertain,3
2413,ACE2,C1422064,en_5723,AFFECTS,viral entry,C1160648,en_5358,3,3,AFFECTS,General/Uncertain,9
2414,ACE2,C1422064,en_5723,AFFECTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,General/Uncertain,3
2415,ACE2,C1422064,en_5723,AUGMENTS,"Protein Processing, Post-Translational",C0033666,en_1910,1,1,AFFECTS,Excitatory,3
2416,ACE2,C1422064,en_5723,AUGMENTS,Virulence,C0042765,en_2361,1,1,AFFECTS,Excitatory,3
2417,ACE2,C1422064,en_5723,AUGMENTS,Vascular Permeability,C0162337,en_2906,1,1,AFFECTS,Excitatory,3
2418,ACE2,C1422064,en_5723,AUGMENTS,uptake,C0243144,en_3467,2,1,AFFECTS,Excitatory,3
2419,ACE2,C1422064,en_5723,AUGMENTS,Nasal Epithelium,C0599331,en_4462,2,1,AFFECTS,Excitatory,3
2420,ACE2,C1422064,en_5723,AUGMENTS,innovativeness,C0683243,en_4654,1,1,AFFECTS,Excitatory,3
2421,ACE2,C1422064,en_5723,AUGMENTS,viral entry,C1160648,en_5358,2,1,AFFECTS,Excitatory,3
2422,ACE2,C1422064,en_5723,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2423,ACE2,C1422064,en_5723,DISRUPTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,Inhibitory,3
2424,ACE2,C1422064,en_5723,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2425,ACE2,C1422064,en_5723,DISRUPTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
2426,ACE2,C1422064,en_5723,DISRUPTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Inhibitory,3
2427,ACE2,C1422064,en_5723,INHIBITS,Angiotensin II,C0003009,en_328,1,1,AFFECTS,Inhibitory,3
2428,ACE2,C1422064,en_5723,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,3,2,AFFECTS,Inhibitory,6
2429,ACE2,C1422064,en_5723,INHIBITS,Interferon Type I,C0021743,en_1331,1,1,AFFECTS,Inhibitory,3
2430,ACE2,C1422064,en_5723,INHIBITS,Angiotensin Receptor,C0034787,en_1963,4,3,AFFECTS,Inhibitory,9
2431,ACE2,C1422064,en_5723,INHIBITS,Interleukin 6 Receptor,C0063717,en_2510,2,2,AFFECTS,Inhibitory,6
2432,ACE2,C1422064,en_5723,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
2433,ACE2,C1422064,en_5723,PREVENTS,Tissue damage,C0010957,en_756,1,1,AFFECTS,Inhibitory,3
2434,ACE2,C1422064,en_5723,PREVENTS,Acute Lung Injury,C0242488,en_3416,2,2,AFFECTS,Inhibitory,6
2435,ACE2,C1422064,en_5723,PRODUCES,Angiotensins,C0003018,en_332,1,1,AFFECTS,Excitatory,3
2436,ACE2,C1422064,en_5723,STIMULATES,Angiotensin II,C0003009,en_328,2,2,AFFECTS,Excitatory,6
2437,ACE2,C1422064,en_5723,STIMULATES,receptor,C0597357,en_4422,1,1,AFFECTS,Excitatory,3
2438,ACE2,C1422064,en_5723,STIMULATES,Protein Structure,C1510464,en_5794,3,2,AFFECTS,Excitatory,6
2439,NOD2,C1826449,en_146,STIMULATES,monocyte,C0026473,en_1580,1,1,AFFECTS,Excitatory,3
2440,STRA6,C1539887,en_148,INHIBITS,Retinoids,C0035339,en_2025,2,1,AFFECTS,Inhibitory,3
2441,STRA6,C1539887,en_148,INHIBITS,Vitamin A,C0042839,en_2368,2,1,AFFECTS,Inhibitory,3
2442,ACD,C1538901,en_151,PRODUCES,"XRCC1 protein, human",C0250029,en_3484,1,1,AFFECTS,Excitatory,3
2443,TBL1XR1,C1539940,en_152,AFFECTS,Pulmonary Pathology,C0748168,en_4829,2,1,AFFECTS,General/Uncertain,3
2444,NT5C1A,C1425101,en_154,INHIBITS,Calcineurin,C0054450,en_2450,1,1,AFFECTS,Inhibitory,3
2445,CHRFAM7A,C1423729,en_155,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Excitatory,6
2446,MGME1,C1424082,en_156,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
2447,NLRP3,C1424250,en_157,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2448,NLRP3,C1424250,en_157,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
2449,NLRP3,C1424250,en_157,STIMULATES,CASP1,C1366479,en_12,1,1,AFFECTS,Excitatory,3
2450,NLRP3,C1424250,en_157,STIMULATES,"STS,PYCARD",C1420490;C1538756,en_179,2,1,AFFECTS,Excitatory,3
2451,WDFY2,C1426966,en_158,PRODUCES,FRAGMENTS,C0486805,en_4153,1,1,AFFECTS,Excitatory,3
2452,ARAP2,C1424639,en_159,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
2453,SCGB3A2,C1425493,en_160,AFFECTS,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
2454,SCGB3A2,C1425493,en_160,STIMULATES,Growth Inhibitors,C0018282,en_1099,1,1,AFFECTS,Excitatory,3
2455,TAAR1,C1539908,en_161,STIMULATES,Cells,C0007634,en_596,2,1,AFFECTS,Excitatory,3
2456,TAAR1,C1539908,en_161,STIMULATES,Interleukin-10,C0085295,en_2659,1,1,AFFECTS,Excitatory,3
2457,NCOA7,C1427302,en_162,AFFECTS,adenosinetriphosphatase activity,C1148926,en_5300,1,1,AFFECTS,General/Uncertain,3
2458,NCOA7,C1427302,en_162,AFFECTS,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,General/Uncertain,3
2459,ANKRD23,C1428378,en_163,AUGMENTS,Decision Making,C0011109,en_765,1,1,AFFECTS,Excitatory,3
2460,NEAT1,C2681866,en_164,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
2461,CCR2,C1413188,en_171,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2462,"PARP1,COL11A2",C1538577;C1413571,en_173,AFFECTS,Down-Regulation,C0013081,en_844,1,1,AFFECTS,General/Uncertain,3
2463,"CLCN2,GABRG2",C1413451;C1414920,en_174,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
2464,"CSF2,LAMC2",C1332791;C1416786,en_175,AFFECTS,Autoimmunity,C0004368,en_430,1,1,AFFECTS,General/Uncertain,3
2465,"EPHB2,MAPK1",C1333340;C1366882,en_176,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2466,"EPHB2,MAPK1",C1333340;C1366882,en_176,AFFECTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,General/Uncertain,3
2467,"EPHB2,MAPK1",C1333340;C1366882,en_176,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
2468,"EPHB2,MAPK1",C1333340;C1366882,en_176,INHIBITS,MAPK8 gene,C1367731,en_5677,1,1,AFFECTS,Inhibitory,3
2469,"EPHB2,MAPK1",C1333340;C1366882,en_176,STIMULATES,Proto-Oncogene Proteins c-akt,C0164786,en_2945,1,1,AFFECTS,Excitatory,3
2470,"GABPA,NFE2L2",C1414905;C1417701,en_177,AUGMENTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,Excitatory,3
2471,"HELLS,SLC11A1",C1415508;C1420088,en_178,AFFECTS,Transcriptional Repression,C0920533,en_5127,1,1,AFFECTS,General/Uncertain,3
2472,"S100A1,S100B",C1419781;C1419790,en_180,PREDISPOSES,Neuropathy,C0442874,en_4060,1,1,AFFECTS,Excitatory,3
2473,CD24,C1413212,en_181,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
2474,CD24,C1413212,en_181,DISRUPTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
2475,CD24,C1413212,en_181,PREDISPOSES,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Excitatory,3
2476,"MT1JP,NCAPG2",C1826313;C1826383,en_183,INHIBITS,Heme Oxygenase-1,C0538674,en_4245,1,1,AFFECTS,Inhibitory,3
2477,"OAZ1,CEP131",C1417921;C1538309,en_184,AUGMENTS,Lysis,C0024348,en_1476,1,1,AFFECTS,Excitatory,3
2478,"HLA-DRB1,RBM45",C1415576;C1837204,en_185,STIMULATES,"Antibodies, Anti-Idiotypic",C0003242,en_348,1,1,AFFECTS,Excitatory,3
2479,"IGFBP7,TAF8",C1415932;C1424885,en_186,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
2480,"PSEN1,TAS2R62P",C1418985;C1427049,en_187,DISRUPTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
2481,"CHPT1,DHDDS",C1425131;C1427027,en_188,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
2482,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,AUGMENTS,Cell Survival,C0007620,en_595,1,1,AFFECTS,Excitatory,3
2483,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,DISRUPTS,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Inhibitory,3
2484,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,DISRUPTS,phosphatase activity,C1151861,en_5305,1,1,AFFECTS,Inhibitory,3
2485,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,INHIBITS,Calcineurin,C0054450,en_2450,1,1,AFFECTS,Inhibitory,3
2486,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,INHIBITS,Peptidylprolyl Isomerase,C0136073,en_2784,1,1,AFFECTS,Inhibitory,3
2487,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,PRODUCES,Interleukin-2,C0021756,en_1337,1,1,AFFECTS,Excitatory,3
2488,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
2489,"ERCC8,CSH1,HSPA9",C1414440;C1413752;C1825549,en_189,PRODUCES(SPEC),Interleukin-2,C0021756,en_1337,1,1,AFFECTS,Excitatory,3
2490,"PRKAA1,PRKAA2,PRKAB1",C1418897;C1418898;C1418899,en_190,AFFECTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,General/Uncertain,3
2491,"CD79A,LOC102723407",C1413238,en_191,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
2492,"CD79A,LOC102723407",C1413238,en_191,AFFECTS,Integumentary system,C0037267,en_2113,1,1,AFFECTS,General/Uncertain,3
2493,"CD79A,LOC102723407",C1413238,en_191,AFFECTS,Clinical finding,C0586173,en_4357,1,1,AFFECTS,General/Uncertain,3
2494,"CD79A,LOC102723407",C1413238,en_191,PREVENTS,Senile Plaques,C0333463,en_3764,1,1,AFFECTS,Inhibitory,3
2495,"CD79A,LOC102723407",C1413238,en_191,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
2496,"CEL,SLC27A5,PARP9",C1413336;C1420167;C1538586,en_192,COMPLICATES,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
2497,"MSR1,SRA1,APBB3",C1417374;C1420394;C1427086,en_194,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
2498,"PLA2G15,ACSS2,ACCS",C1424787;C1825842;C1842089,en_195,AFFECTS,overdose,C4018909,en_6291,1,1,AFFECTS,General/Uncertain,3
2499,"PLA2G15,ACSS2,ACCS",C1424787;C1825842;C1842089,en_195,PREVENTS,AOD use,C0237123,en_3341,1,1,AFFECTS,Inhibitory,3
2500,"RCBTB1,EHMT1,GOLGA6A",C1425391;C1539338;C1422069,en_196,AFFECTS,Gene Expression Regulation,C0017263,en_1045,1,1,AFFECTS,General/Uncertain,3
2501,"ERVW-1,ERVK-20,ERVK-18,ERVK-32",C1422036;C3147215;C3147213;C4320280,en_197,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
2502,DPYD|DPYS,C1366555;C1414144,en_198,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,6
2503,AMBP|CPOX|PTPN6,C1412376;C1413681;C1335283,en_199,AUGMENTS,Injury due to exposure to external cause,C0274281,en_3562,1,1,AFFECTS,Excitatory,8
2504,AZU1|HDLBP|SLBP|STAM2|HEBP1,C1332127;C1415507;C1420085;C1420452;C1424798,en_200,PREDISPOSES,Single organ dysfunction,C0349410,en_3841,1,1,AFFECTS,Excitatory,7
2505,CA2|SLC25A20,C1413043;C1413076,en_172,AFFECTS,Negative Regulation of Coagulation,C2917212,en_6142,1,1,AFFECTS,General/Uncertain,6
2506,Eicosapentaenoic Acid,C0000545,en_203,STIMULATES,Fatty Acids,C0015684,en_969,1,1,AFFECTS,Excitatory,3
2507,Eicosapentaenoic Acid,C0000545,en_203,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2508,Eicosapentaenoic Acid,C0000545,en_203,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
2509,Oxyquinoline,C0000665,en_204,AUGMENTS,Signal Transduction Pathways,C0086982,en_2741,1,1,AFFECTS,Excitatory,3
2510,Termination of pregnancy,C0000811,en_208,TREATS,Infertility,C0021359,en_1305,1,1,AFFECTS,Inhibitory,3
2511,Termination of pregnancy,C0000811,en_208,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
2512,Termination of pregnancy,C0000811,en_208,TREATS,Spontaneous Incomplete abortion,C1533689,en_5938,11,1,AFFECTS,Inhibitory,3
2513,Acclimatization,C0000934,en_212,AFFECTS,Age,C0001779,en_257,1,1,AFFECTS,General/Uncertain,3
2514,Acclimatization,C0000934,en_212,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
2515,Acclimatization,C0000934,en_212,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
2516,Acclimatization,C0000934,en_212,AFFECTS,RNA Viruses,C0035691,en_2044,1,1,AFFECTS,General/Uncertain,3
2517,Acclimatization,C0000934,en_212,AFFECTS,student,C0038492,en_2171,1,1,AFFECTS,General/Uncertain,3
2518,Acclimatization,C0000934,en_212,AFFECTS,Ability,C0085732,en_2688,2,2,AFFECTS,General/Uncertain,6
2519,Acclimatization,C0000934,en_212,AFFECTS,Teacher,C0221457,en_3226,1,1,AFFECTS,General/Uncertain,3
2520,Acclimatization,C0000934,en_212,AFFECTS,uptake,C0243144,en_3467,1,1,AFFECTS,General/Uncertain,6
2521,Acclimatization,C0000934,en_212,AFFECTS,Contagion,C0598197,en_4444,1,1,AFFECTS,General/Uncertain,3
2522,Acclimatization,C0000934,en_212,AFFECTS,network,C0679670,en_4604,1,1,AFFECTS,General/Uncertain,3
2523,Acclimatization,C0000934,en_212,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
2524,Visual Accommodation,C0000936,en_213,AFFECTS,Anxiety,C0003467,en_380,1,1,AFFECTS,General/Uncertain,6
2525,Visual Accommodation,C0000936,en_213,AFFECTS,Abnormal behavior,C0233514,en_3296,1,1,AFFECTS,General/Uncertain,6
2526,Acetaminophen,C0000970,en_215,AFFECTS(SPEC),Chronic liver disease NOS,C0341439,en_3823,1,1,AFFECTS,General/Uncertain,3
2527,Acetaminophen,C0000970,en_215,INHIBITS,Fever,C0015967,en_985,2,1,AFFECTS,Inhibitory,3
2528,Acetaminophen,C0000970,en_215,TREATS,Fever,C0015967,en_985,3,2,AFFECTS,Inhibitory,6
2529,Acetaminophen,C0000970,en_215,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
2530,Acetaminophen,C0000970,en_215,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
2531,Acetaminophen,C0000970,en_215,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
2532,Acetate,C0000975,en_216,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,2,AFFECTS,Inhibitory,6
2533,Acetate,C0000975,en_216,TREATS,Sarcoidosis,C0036202,en_2064,4,2,AFFECTS,Inhibitory,6
2534,Acetylcholine,C0001041,en_217,AFFECTS,acute inflammatory response,C1817978,en_6041,1,1,AFFECTS,General/Uncertain,7
2535,Acetylcholinesterase,C0001044,en_218,INHIBITS,Acetylcholine,C0001041,en_217,2,1,AFFECTS,Inhibitory,3
2536,Acetylcysteine,C0001047,en_219,INHIBITS,cytokine,C0079189,en_2593,2,1,AFFECTS,Inhibitory,3
2537,Acetylcysteine,C0001047,en_219,INHIBITS,Interleukin-8,C0079633,en_2608,1,1,AFFECTS,Inhibitory,3
2538,Acetylcysteine,C0001047,en_219,INHIBITS,chemokine,C0282554,en_3651,2,1,AFFECTS,Inhibitory,3
2539,Acetylcysteine,C0001047,en_219,INHIBITS,angiotensin converting enzyme 2,C0960880,en_5195,1,1,AFFECTS,Inhibitory,8
2540,Acetylcysteine,C0001047,en_219,PREVENTS,Adverse drug effect,C0041755,en_2312,1,1,AFFECTS,Inhibitory,3
2541,Acetylcysteine,C0001047,en_219,STIMULATES,glutathione S-transferase activity,C1152039,en_5306,2,1,AFFECTS,Excitatory,3
2542,Acetylcysteine,C0001047,en_219,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
2543,Acetylcysteine,C0001047,en_219,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
2544,Acetylcysteine,C0001047,en_219,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
2545,Acetylcysteine,C0001047,en_219,TREATS,"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,1,1,AFFECTS,Inhibitory,3
2546,Acetylcysteine,C0001047,en_219,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,8
2547,Acetylcysteine,C0001047,en_219,TREATS,COVID-19,C5203670,en_6417,3,1,AFFECTS,Inhibitory,7
2548,Acetylcysteine,C0001047,en_219,TREATS,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,Inhibitory,8
2549,Acetylcysteine,C0001047,en_219,TREATS(INFER),Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
2550,Acetylcysteine,C0001047,en_219,TREATS(INFER),Septic Shock,C0036983,en_2101,2,1,AFFECTS,Inhibitory,3
2551,Achievement,C0001072,en_221,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
2552,"Acidosis, Respiratory",C0001127,en_224,AFFECTS,Mental state finding,C0278060,en_3594,1,1,AFFECTS,General/Uncertain,3
2553,Acinetobacter,C0001138,en_225,PRODUCES,Extended-spectrum beta lactamase,C0486433,en_4152,1,1,AFFECTS,Excitatory,3
2554,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
2555,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,3
2556,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
2557,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
2558,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Male population group,C0025266,en_1533,1,1,AFFECTS,General/Uncertain,3
2559,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Persons,C0027361,en_1635,2,2,AFFECTS,General/Uncertain,6
2560,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Sexually Transmitted Diseases,C0036916,en_2095,1,1,AFFECTS,General/Uncertain,3
2561,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
2562,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,Immune response,C0301872,en_3696,5,2,AFFECTS,General/Uncertain,6
2563,Acquired Immunodeficiency Syndrome,C0001175,en_226,AFFECTS,funding recipient,C0680847,en_4627,1,1,AFFECTS,General/Uncertain,3
2564,Acquired Immunodeficiency Syndrome,C0001175,en_226,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,3,2,AFFECTS,Excitatory,6
2565,Acquired Immunodeficiency Syndrome,C0001175,en_226,PREDISPOSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
2566,Acquired Immunodeficiency Syndrome,C0001175,en_226,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
2567,Acquired Immunodeficiency Syndrome,C0001175,en_226,PREDISPOSES,END ORGAN DAMAGE,C0743496,en_4803,1,1,AFFECTS,Excitatory,3
2568,Acquired Immunodeficiency Syndrome,C0001175,en_226,PRODUCES,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Excitatory,3
2569,Actins,C0001271,en_227,AFFECTS,hair,C0018494,en_1107,1,1,AFFECTS,General/Uncertain,3
2570,Actins,C0001271,en_227,AFFECTS,Membrane,C0596901,en_4400,1,1,AFFECTS,General/Uncertain,3
2571,Actins,C0001271,en_227,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
2572,Armed macrophage,C0001280,en_228,PRODUCES,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,Excitatory,3
2573,Armed macrophage,C0001280,en_228,PRODUCES,cytokine,C0079189,en_2593,2,2,AFFECTS,Excitatory,10
2574,Armed macrophage,C0001280,en_228,PRODUCES,chemokine,C0282554,en_3651,1,1,AFFECTS,Excitatory,7
2575,Activities of Daily Living,C0001288,en_229,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
2576,Activities of Daily Living,C0001288,en_229,TREATS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Inhibitory,3
2577,Acute-Phase Proteins,C0001347,en_232,AFFECTS,Drug Kinetics,C0031327,en_1787,1,1,AFFECTS,General/Uncertain,8
2578,Acute-Phase Proteins,C0001347,en_232,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,6
2579,Acute-Phase Proteins,C0001347,en_232,INHIBITS,C-reactive protein,C0006560,en_529,1,1,AFFECTS,Inhibitory,7
2580,Acute-Phase Proteins,C0001347,en_232,INHIBITS,Ferritin,C0015879,en_980,1,1,AFFECTS,Inhibitory,7
2581,Acute-Phase Proteins,C0001347,en_232,INHIBITS,Fibrin fragment D,C0060323,en_2484,1,1,AFFECTS,Inhibitory,7
2582,Acute-Phase Proteins,C0001347,en_232,PREDISPOSES,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,6
2583,Acute-Phase Proteins,C0001347,en_232,DISRUPTS,Neutrophil chemotaxis,C0312861,en_3738,1,1,AFFECTS,Inhibitory,3
2584,Acute-Phase Proteins,C0001347,en_232,DISRUPTS,Leukocyte Trafficking,C1326500,en_5557,1,1,AFFECTS,Inhibitory,3
2585,Acyclovir,C0001367,en_234,TREATS,"Herpesvirus 1, Human",C0206679,en_3174,2,1,AFFECTS,Inhibitory,3
2586,Adenosine,C0001443,en_236,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
2587,Adenosine,C0001443,en_236,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2588,Adenosine,C0001443,en_236,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
2589,Adenosine,C0001443,en_236,STIMULATES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
2590,ATP phosphohydrolase,C0001473,en_238,AFFECTS,ATP Hydrolysis,C1510699,en_5800,1,1,AFFECTS,General/Uncertain,3
2591,Adhesions,C0001511,en_240,AFFECTS,Cell physiology,C0007613,en_594,2,1,AFFECTS,General/Uncertain,3
2592,Adhesions,C0001511,en_240,DISRUPTS,Endothelial Cells,C0225336,en_3237,1,1,AFFECTS,Inhibitory,3
2593,Adipose tissue,C0001527,en_241,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
2594,Immunologic Adjuvants,C0001551,en_242,AUGMENTS,Antigen-Presenting Cells,C0003315,en_362,1,1,AFFECTS,Excitatory,3
2595,Immunologic Adjuvants,C0001551,en_242,AUGMENTS,Immunity,C0020964,en_1273,3,3,AFFECTS,Excitatory,14
2596,Immunologic Adjuvants,C0001551,en_242,AUGMENTS,Pneumocyte,C0225698,en_3239,1,1,AFFECTS,Excitatory,3
2597,Immunologic Adjuvants,C0001551,en_242,AUGMENTS,Entire vagus nerve,C1305910,en_5518,1,1,AFFECTS,Excitatory,3
2598,Immunologic Adjuvants,C0001551,en_242,STIMULATES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
2599,Immunologic Adjuvants,C0001551,en_242,STIMULATES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,3
2600,Immunologic Adjuvants,C0001551,en_242,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,8
2601,Immunologic Adjuvants,C0001551,en_242,TREATS,HIV Seropositivity,C0019699,en_1193,1,1,AFFECTS,Inhibitory,3
2602,Immunologic Adjuvants,C0001551,en_242,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,3
2603,Immunologic Adjuvants,C0001551,en_242,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,8
2604,Immunologic Adjuvants,C0001551,en_242,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
2605,Immunologic Adjuvants,C0001551,en_242,TREATS,Patients,C0030705,en_1762,10,6,AFFECTS,Inhibitory,18
2606,Immunologic Adjuvants,C0001551,en_242,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
2607,Immunologic Adjuvants,C0001551,en_242,TREATS,Gram-negative septicemia NOS,C0036685,en_2085,1,1,AFFECTS,Inhibitory,6
2608,Immunologic Adjuvants,C0001551,en_242,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
2609,Immunologic Adjuvants,C0001551,en_242,TREATS,Well adult,C0686750,en_4683,3,2,AFFECTS,Inhibitory,6
2610,Immunologic Adjuvants,C0001551,en_242,TREATS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,6
2611,Immunologic Adjuvants,C0001551,en_242,TREATS,Deep breathing,C1328799,en_5570,2,1,AFFECTS,Inhibitory,3
2612,Immunologic Adjuvants,C0001551,en_242,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
2613,Immunologic Adjuvants,C0001551,en_242,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,3
2614,Immunologic Adjuvants,C0001551,en_242,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
2615,Immunologic Adjuvants,C0001551,en_242,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
2616,Inhalation Drug Administration,C0001559,en_243,PREVENTS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
2617,Inhalation Drug Administration,C0001559,en_243,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
2618,Inhalation Drug Administration,C0001559,en_243,TREATS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
2619,"Administration, Intranasal",C0001560,en_244,PREVENTS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
2620,"Administration, Intranasal",C0001560,en_244,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
2621,"Administration, Intranasal",C0001560,en_244,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
2622,"Administration, Oral",C0001563,en_245,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
2623,"Administration, Oral",C0001563,en_245,PREVENTS,Extravasation,C0015376,en_949,1,1,AFFECTS,Inhibitory,3
2624,"Administration, Oral",C0001563,en_245,TREATS,Predisposition,C0220898,en_3206,1,1,AFFECTS,Inhibitory,6
2625,"Administration, Oral",C0001563,en_245,TREATS,Bacterial Abscess,C0549483,en_4283,1,1,AFFECTS,Inhibitory,8
2626,"Administration, Oral",C0001563,en_245,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
2627,"Administration, Oral",C0001563,en_245,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
2628,Adrenal Cortex Hormones,C0001617,en_247,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,8
2629,Adrenal Cortex Hormones,C0001617,en_247,AFFECTS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,General/Uncertain,6
2630,Adrenal Cortex Hormones,C0001617,en_247,AFFECTS,Storm NOS,C2905612,en_6141,1,1,AFFECTS,General/Uncertain,7
2631,Adrenal Cortex Hormones,C0001617,en_247,DISRUPTS,Cessation of life,C0011065,en_762,3,3,AFFECTS,Inhibitory,12
2632,Adrenal Cortex Hormones,C0001617,en_247,DISRUPTS,Immune Cell,C4330475,en_6345,1,1,AFFECTS,Inhibitory,8
2633,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,Oxygen,C0030054,en_1736,1,1,AFFECTS,Inhibitory,6
2634,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,7
2635,Adrenal Cortex Hormones,C0001617,en_247,PREDISPOSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,6
2636,Adrenal Cortex Hormones,C0001617,en_247,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,6
2637,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,8
2638,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Critical Illness,C0010340,en_733,3,2,AFFECTS,Inhibitory,14
2639,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Disease,C0012634,en_826,3,3,AFFECTS,Inhibitory,23
2640,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,6
2641,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Matched Groups,C0024908,en_1508,1,1,AFFECTS,Inhibitory,6
2642,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Pneumonia,C0032285,en_1833,9,6,AFFECTS,Inhibitory,34
2643,Adrenal Cortex Hormones,C0001617,en_247,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,3,AFFECTS,Inhibitory,13
2644,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Rheumatic Fever,C0035436,en_2029,1,1,AFFECTS,Inhibitory,6
2645,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Present,C0150312,en_2833,1,1,AFFECTS,Inhibitory,6
2646,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Hypoxia,C0242184,en_3396,2,2,AFFECTS,Inhibitory,13
2647,Adrenal Cortex Hormones,C0001617,en_247,TREATS,cohort,C0599755,en_4470,2,2,AFFECTS,Inhibitory,12
2648,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Hospitalized Patients,C0870668,en_5010,14,10,AFFECTS,Inhibitory,54
2649,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Radiologic finding,C1290916,en_5487,1,1,AFFECTS,Inhibitory,7
2650,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,9
2651,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Sequential Organ Failure Assessment Scores,C3494459,en_6204,1,1,AFFECTS,Inhibitory,6
2652,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Inflammatory lung disease,C4230430,en_6320,1,1,AFFECTS,Inhibitory,7
2653,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,6
2654,Adrenal Cortex Hormones,C0001617,en_247,TREATS,COVID-19,C5203670,en_6417,29,19,AFFECTS,Inhibitory,126
2655,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Responsive Disease,C5236984,en_6425,2,2,AFFECTS,Inhibitory,12
2656,Adrenal Cortex Hormones,C0001617,en_247,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
2657,Adrenal Cortex Hormones,C0001617,en_247,AFFECTS,Lung,C0024109,en_1460,4,2,AFFECTS,General/Uncertain,6
2658,Adrenal Cortex Hormones,C0001617,en_247,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2659,Adrenal Cortex Hormones,C0001617,en_247,DISRUPTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Inhibitory,3
2660,Adrenal Cortex Hormones,C0001617,en_247,DISRUPTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
2661,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
2662,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
2663,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,Interleukin 6 Receptor,C0063717,en_2510,1,1,AFFECTS,Inhibitory,3
2664,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,Interleukin Receptor,C0206553,en_3168,1,1,AFFECTS,Inhibitory,3
2665,Adrenal Cortex Hormones,C0001617,en_247,INHIBITS,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Inhibitory,3
2666,Adrenal Cortex Hormones,C0001617,en_247,PREVENTS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
2667,Adrenal Cortex Hormones,C0001617,en_247,PREVENTS(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2668,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
2669,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
2670,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
2671,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2672,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Patients,C0030705,en_1762,33,19,AFFECTS,Inhibitory,57
2673,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Woman,C0043210,en_2396,2,1,AFFECTS,Inhibitory,3
2674,Adrenal Cortex Hormones,C0001617,en_247,TREATS,"Lung Diseases, Interstitial",C0206062,en_3142,1,1,AFFECTS,Inhibitory,3
2675,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
2676,Adrenal Cortex Hormones,C0001617,en_247,TREATS,PULMONARY PROCESS,C0748169,en_4830,2,1,AFFECTS,Inhibitory,3
2677,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
2678,Adrenal Cortex Hormones,C0001617,en_247,TREATS,Allergic Reaction,C1527304,en_5919,1,1,AFFECTS,Inhibitory,3
2679,Adrenal Cortex Hormones,C0001617,en_247,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
2680,Adrenal Cortex Hormones,C0001617,en_247,TREATS(INFER),Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
2681,Adrenal Cortex Hormones,C0001617,en_247,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,7,4,AFFECTS,Inhibitory,12
2682,Congenital adrenal hyperplasia,C0001627,en_249,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
2683,Adrenergic beta-Antagonists,C0001645,en_250,PREVENTS,Agitation,C0085631,en_2683,2,1,AFFECTS,Inhibitory,3
2684,Adrenergic beta-Antagonists,C0001645,en_250,TREATS,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,Inhibitory,3
2685,Adrenergic beta-Antagonists,C0001645,en_250,TREATS,Tachycardia,C0039231,en_2203,1,1,AFFECTS,Inhibitory,3
2686,Adrenergic beta-Antagonists,C0001645,en_250,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,6
2687,Adrenergic beta-Antagonists,C0001645,en_250,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
2688,Adrenergic beta-Antagonists,C0001645,en_250,TREATS,[D]Cardiovascular system symptoms,C0476270,en_4148,2,1,AFFECTS,Inhibitory,3
2689,Adrenergic Agonists,C0001648,en_251,AUGMENTS,Brown Fat,C0006298,en_521,1,1,AFFECTS,Excitatory,3
2690,Adrenergic Agonists,C0001648,en_251,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
2691,Adrenergic Agonists,C0001648,en_251,TREATS(INFER),Asthma,C0004096,en_418,2,1,AFFECTS,Inhibitory,3
2692,"Exercise, Aerobic",C0001701,en_253,AFFECTS,Immune System Processes,C1817756,en_6040,1,1,AFFECTS,General/Uncertain,8
2693,"Exercise, Aerobic",C0001701,en_253,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
2694,"Exercise, Aerobic",C0001701,en_253,TREATS,Fibromyalgia,C0016053,en_993,2,1,AFFECTS,Inhibitory,8
2695,"Exercise, Aerobic",C0001701,en_253,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
2696,"Exercise, Aerobic",C0001701,en_253,TREATS,Woman,C0043210,en_2396,3,2,AFFECTS,Inhibitory,11
2697,"Exercise, Aerobic",C0001701,en_253,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
2698,"Exercise, Aerobic",C0001701,en_253,TREATS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,Inhibitory,8
2699,"Exercise, Aerobic",C0001701,en_253,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
2700,"Exercise, Aerobic",C0001701,en_253,TREATS(INFER),"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
2701,"Exercise, Aerobic",C0001701,en_253,TREATS(INFER),Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
2702,Aerosols,C0001712,en_254,AFFECTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,General/Uncertain,3
2703,Aerosols,C0001712,en_254,AFFECTS,"Immunity, Mucosal",C0282558,en_3653,1,1,AFFECTS,General/Uncertain,3
2704,Aerosols,C0001712,en_254,AFFECTS,INFECTIOUS PROCESS,C0745283,en_4812,1,1,AFFECTS,General/Uncertain,3
2705,beta-Aminoethylisothiuronium Dihydrobromide,C0001716,en_255,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
2706,beta-Aminoethylisothiuronium Dihydrobromide,C0001716,en_255,TREATS(INFER),"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
2707,Aftercare,C0001758,en_256,TREATS,Well in self,C0424578,en_3996,1,1,AFFECTS,Inhibitory,7
2708,Aftercare,C0001758,en_256,TREATS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Inhibitory,8
2709,Age,C0001779,en_257,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
2710,Age,C0001779,en_257,PREDISPOSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
2711,Age,C0001779,en_257,PREDISPOSES,Disease,C0012634,en_826,4,3,AFFECTS,Excitatory,9
2712,Age,C0001779,en_257,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
2713,Age,C0001779,en_257,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
2714,Aging,C0001811,en_262,AFFECTS,Cardiovascular Physiology,C0007227,en_570,1,1,AFFECTS,General/Uncertain,3
2715,Aging,C0001811,en_262,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
2716,Aging,C0001811,en_262,AFFECTS,Mental Depression,C0011570,en_787,1,1,AFFECTS,General/Uncertain,3
2717,Aging,C0001811,en_262,AFFECTS,Diptera,C0012578,en_822,1,1,AFFECTS,General/Uncertain,3
2718,Aging,C0001811,en_262,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,3
2719,Aging,C0001811,en_262,AFFECTS,Ability,C0085732,en_2688,2,2,AFFECTS,General/Uncertain,6
2720,Aging,C0001811,en_262,AFFECTS,Muscle function,C0231484,en_3260,1,1,AFFECTS,General/Uncertain,3
2721,Aging,C0001811,en_262,AFFECTS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
2722,Aging,C0001811,en_262,AFFECTS,DNA Methylation,C0376452,en_3877,1,1,AFFECTS,General/Uncertain,3
2723,Aging,C0001811,en_262,AFFECTS,immunosenescence,C0596761,en_4395,1,1,AFFECTS,General/Uncertain,3
2724,Aging,C0001811,en_262,AFFECTS,SARS coronavirus,C1175743,en_5384,1,1,AFFECTS,General/Uncertain,3
2725,Aging,C0001811,en_262,AFFECTS,Immunologic function,C1268930,en_5445,3,1,AFFECTS,General/Uncertain,3
2726,Airway Obstruction,C0001883,en_266,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
2727,Albumins,C0001924,en_267,AUGMENTS,Instability cardiovascular,C0549406,en_4281,2,2,AFFECTS,Excitatory,6
2728,Albumins,C0001924,en_267,PREDISPOSES,Ischemia,C0022116,en_1363,1,1,AFFECTS,Excitatory,3
2729,Albumins,C0001924,en_267,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
2730,Albuterol,C0001927,en_268,DISRUPTS,Respiration,C0035203,en_2004,1,1,AFFECTS,Inhibitory,7
2731,Alcohol consumption,C0001948,en_269,AFFECTS,Risk Behavior,C0086931,en_2738,1,1,AFFECTS,General/Uncertain,3
2732,Alcohol consumption,C0001948,en_269,AFFECTS,Eating habit,C1266864,en_5434,1,1,AFFECTS,General/Uncertain,3
2733,Alcohol consumption,C0001948,en_269,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
2734,alcohol use disorder,C0001956,en_270,AFFECTS,microbial,C0599840,en_4476,1,1,AFFECTS,General/Uncertain,3
2735,alcohol use disorder,C0001956,en_270,AFFECTS,brain function,C0678908,en_4584,1,1,AFFECTS,General/Uncertain,3
2736,alcohol use disorder,C0001956,en_270,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
2737,Ethanol,C0001962,en_271,AFFECTS,Brain,C0006104,en_508,1,1,AFFECTS,General/Uncertain,3
2738,Ethanol,C0001962,en_271,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
2739,Ethanol,C0001962,en_271,AFFECTS,Surface Tension,C0038887,en_2189,1,1,AFFECTS,General/Uncertain,3
2740,Ethanol,C0001962,en_271,AFFECTS,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
2741,Ethanol,C0001962,en_271,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
2742,Ethanol,C0001962,en_271,AFFECTS,Family illness,C0344339,en_3837,1,1,AFFECTS,General/Uncertain,3
2743,Ethanol,C0001962,en_271,AFFECTS,attenuation,C0599946,en_4490,1,1,AFFECTS,General/Uncertain,3
2744,Ethanol,C0001962,en_271,AFFECTS,brain development,C1160340,en_5353,1,1,AFFECTS,General/Uncertain,3
2745,Ethanol,C0001962,en_271,AUGMENTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,Excitatory,3
2746,Ethanol,C0001962,en_271,AUGMENTS,Intestines,C0021853,en_1350,2,1,AFFECTS,Excitatory,3
2747,Ethanol,C0001962,en_271,AUGMENTS,Unplanned pregnancy,C0041747,en_2311,1,1,AFFECTS,Excitatory,3
2748,Ethanol,C0001962,en_271,AUGMENTS,Violence,C0042693,en_2353,1,1,AFFECTS,Excitatory,3
2749,Ethanol,C0001962,en_271,DISRUPTS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,3
2750,Ethanol,C0001962,en_271,DISRUPTS,Intestines,C0021853,en_1350,1,1,AFFECTS,Inhibitory,3
2751,Ethanol,C0001962,en_271,DISRUPTS,Lung,C0024109,en_1460,1,1,AFFECTS,Inhibitory,3
2752,Ethanol,C0001962,en_271,DISRUPTS,Virus Replication,C0042774,en_2363,2,1,AFFECTS,Inhibitory,3
2753,Ethanol,C0001962,en_271,INHIBITS,Hyperactive behavior,C0424295,en_3992,2,1,AFFECTS,Inhibitory,3
2754,Ethanol,C0001962,en_271,INHIBITS,stressor,C0597530,en_4430,1,1,AFFECTS,Inhibitory,3
2755,Ethanol,C0001962,en_271,PREDISPOSES,Suicide,C0038661,en_2178,1,1,AFFECTS,Excitatory,3
2756,Ethanol,C0001962,en_271,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
2757,Ethanol,C0001962,en_271,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
2758,Ethanol,C0001962,en_271,TREATS,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
2759,Ethanol,C0001962,en_271,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
2760,Ethanol,C0001962,en_271,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
2761,Ethanol,C0001962,en_271,TREATS(INFER),Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
2762,Ethanol,C0001962,en_271,TREATS(INFER),Homelessness,C0237154,en_3342,1,1,AFFECTS,Inhibitory,3
2763,Aldosterone,C0002006,en_274,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6.5
2764,Aldosterone,C0002006,en_274,AFFECTS(SPEC),Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
2765,Aldosterone,C0002006,en_274,AFFECTS(SPEC),fluid transport,C1159569,en_5343,1,1,AFFECTS,General/Uncertain,3
2766,Aldosterone,C0002006,en_274,PREVENTS(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
2767,Aldosterone,C0002006,en_274,STIMULATES,"RNA, Messenger",C0035696,en_2046,1,1,AFFECTS,Excitatory,3
2768,Alkaline Phosphatase,C0002059,en_275,AFFECTS,Congestive heart failure,C0018802,en_1136,1,1,AFFECTS,General/Uncertain,3
2769,Alkaline Phosphatase,C0002059,en_275,AFFECTS,Pulmonary arterial hypertension,C1619734,en_6012,1,1,AFFECTS,General/Uncertain,3
2770,Alkaline Phosphatase,C0002059,en_275,PREDISPOSES,Fracture,C0016658,en_1016,1,1,AFFECTS,Excitatory,3
2771,Alkaloids,C0002062,en_276,INHIBITS,neuraminidases,C0682744,en_4648,1,1,AFFECTS,Inhibitory,3
2772,Alkaloids,C0002062,en_276,STIMULATES,Interferon Type I,C0021743,en_1331,2,1,AFFECTS,Excitatory,3
2773,Alkylating Agents,C0002073,en_277,DISRUPTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,Inhibitory,3
2774,Alkylating Agents,C0002073,en_277,TREATS,Severe asthma,C0581126,en_4345,2,1,AFFECTS,Inhibitory,3
2775,Alleles,C0002085,en_278,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
2776,Allergens,C0002092,en_279,AFFECTS,Dendritic Cells,C0011306,en_777,1,1,AFFECTS,General/Uncertain,3
2777,Allergens,C0002092,en_279,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
2778,Alloys,C0002154,en_281,AUGMENTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Excitatory,3
2779,Almitrine,C0002164,en_282,AFFECTS,Respiratory Mechanics,C0035230,en_2013,1,1,AFFECTS,General/Uncertain,3
2780,Almitrine,C0002164,en_282,AFFECTS,Alveolar ventilation function,C0231940,en_3269,6,4,AFFECTS,General/Uncertain,16
2781,Almitrine,C0002164,en_282,INHIBITS,Vascular constriction (function),C0042396,en_2340,1,1,AFFECTS,Inhibitory,7
2782,Almitrine,C0002164,en_282,INHIBITS,Surgical fistula,C1442858,en_5735,1,1,AFFECTS,Inhibitory,3
2783,Almitrine,C0002164,en_282,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
2784,Almitrine,C0002164,en_282,TREATS,Acute respiratory failure,C0264490,en_3533,3,2,AFFECTS,Inhibitory,10
2785,Almitrine,C0002164,en_282,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,7
2786,Almitrine,C0002164,en_282,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
2787,Almitrine,C0002164,en_282,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
2788,Interferon-alpha,C0002199,en_285,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
2789,Interferon-alpha,C0002199,en_285,TREATS,Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,6
2790,Interferon-alpha,C0002199,en_285,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
2791,Interferon-alpha,C0002199,en_285,TREATS,SARS coronavirus,C1175743,en_5384,1,1,AFFECTS,Inhibitory,8
2792,Interferon-alpha,C0002199,en_285,TREATS,Cancer Patient,C1516213,en_5852,2,1,AFFECTS,Inhibitory,3
2793,Interferon-alpha,C0002199,en_285,TREATS,Middle East Respiratory Syndrome Coronavirus,C3698360,en_6233,1,1,AFFECTS,Inhibitory,8
2794,Interferon-alpha,C0002199,en_285,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,15
2795,Interferon-alpha|IFNA1,C0002199|3439,en_286,STIMULATES,Peripheral blood mononuclear cell,C1321301,en_5541,1,1,AFFECTS,Excitatory,7
2796,Eflornithine,C0002260,en_287,INHIBITS,Polyamines,C0032433,en_1845,1,1,AFFECTS,Inhibitory,3
2797,Alprostadil,C0002335,en_288,TREATS,Maximum,C0806909,en_4887,1,1,AFFECTS,Inhibitory,3
2798,Alternative Splicing,C0002345,en_289,AFFECTS,glycosylation,C0017982,en_1086,1,1,AFFECTS,General/Uncertain,3
2799,Aluminum Hydroxide,C0002371,en_290,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
2800,Aluminum Hydroxide,C0002371,en_290,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,8
2801,Alzheimer's Disease,C0002395,en_291,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
2802,Alzheimer's Disease,C0002395,en_291,AFFECTS,Patients,C0030705,en_1762,2,2,AFFECTS,General/Uncertain,6
2803,Alzheimer's Disease,C0002395,en_291,AFFECTS,Pain Threshold,C0162703,en_2927,1,1,AFFECTS,General/Uncertain,3
2804,Alzheimer's Disease,C0002395,en_291,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
2805,Alzheimer's Disease,C0002395,en_291,AFFECTS,Streptococcal lymphadenitis of swine,C0275814,en_3571,1,1,AFFECTS,General/Uncertain,3
2806,Alzheimer's Disease,C0002395,en_291,AFFECTS,American,C0596070,en_4379,6,1,AFFECTS,General/Uncertain,3
2807,Alzheimer's Disease,C0002395,en_291,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
2808,Alzheimer's Disease,C0002395,en_291,PREDISPOSES,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Excitatory,3
2809,Amantadine,C0002403,en_292,DISRUPTS,Cessation of life,C0011065,en_762,2,1,AFFECTS,Inhibitory,3
2810,Amantadine,C0002403,en_292,PREVENTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,3
2811,Amantadine,C0002403,en_292,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
2812,Amantadine,C0002403,en_292,TREATS,Orthomyxoviridae,C0029341,en_1720,2,1,AFFECTS,Inhibitory,3
2813,Amantadine,C0002403,en_292,TREATS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
2814,Amantadine,C0002403,en_292,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
2815,Amantadine,C0002403,en_292,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
2816,Amantadine,C0002403,en_292,TREATS,Degenerative disorder,C1285162,en_5478,1,1,AFFECTS,Inhibitory,3
2817,Amantadine,C0002403,en_292,TREATS,2019 novel coronavirus,C5203676,en_6420,2,1,AFFECTS,Inhibitory,6
2818,Ambroxol,C0002421,en_293,TREATS,Prognosis good,C0278250,en_3599,1,1,AFFECTS,Inhibitory,6
2819,Ambroxol,C0002421,en_293,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
2820,Ambulances,C0002422,en_294,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
2821,ambulatory care services,C0002423,en_295,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
2822,ambulatory care services,C0002423,en_295,TREATS,Sick child,C0260101,en_3509,1,1,AFFECTS,Inhibitory,3
2823,ambulatory care services,C0002423,en_295,TREATS,Chronic nervous system disorder,C1290882,en_5482,1,1,AFFECTS,Inhibitory,6
2824,ambulatory care services,C0002423,en_295,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
2825,Amines,C0002508,en_298,STIMULATES,Nitrogen,C0028158,en_1684,1,1,AFFECTS,Excitatory,3
2826,Amines,C0002508,en_298,TREATS,Shock,C0036974,en_2097,2,1,AFFECTS,Inhibitory,8
2827,Amino Acids,C0002520,en_299,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,7
2828,Amino Acids,C0002520,en_299,AFFECTS,Antigenic Variation,C0003319,en_364,1,1,AFFECTS,General/Uncertain,3
2829,Amino Acids,C0002520,en_299,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
2830,Amino Acids,C0002520,en_299,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
2831,Amino Acids,C0002520,en_299,PREVENTS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
2832,Amino Acids,C0002520,en_299,PREVENTS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
2833,Amino Acids,C0002520,en_299,STIMULATES,Lysophosphatidylcholines,C0024360,en_1477,1,1,AFFECTS,Excitatory,3
2834,Amino Acids,C0002520,en_299,STIMULATES,"TLR4 protein, human",C1321919,en_5543,1,1,AFFECTS,Excitatory,3
2835,Amino Acids,C0002520,en_299,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
2836,Amino Acids,C0002520,en_299,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
2837,"Amino Acids, Branched-Chain",C0002521,en_300,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
2838,"Amino Acids, Branched-Chain",C0002521,en_300,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
2839,Aminoglycosides,C0002556,en_301,DISRUPTS,Ototoxicity,C0235280,en_3325,1,1,AFFECTS,Inhibitory,3
2840,Aminoglycosides,C0002556,en_301,DISRUPTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
2841,Aminolevulinic Acid,C0002563,en_302,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
2842,Amiodarone,C0002598,en_303,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
2843,Ammonium Chloride,C0002615,en_304,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
2844,Ammonium Chloride,C0002615,en_304,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
2845,Ammonium Chloride,C0002615,en_304,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
2846,Amphotericin B,C0002679,en_305,TREATS,Mycoses,C0026946,en_1620,1,1,AFFECTS,Inhibitory,3
2847,Amphotericin B,C0002679,en_305,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
2848,Amputation,C0002688,en_306,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
2849,Amyloid,C0002716,en_308,AFFECTS,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
2850,Pain management,C0002766,en_311,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
2851,Pain management,C0002766,en_311,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
2852,Pain management,C0002766,en_311,TREATS,Hip Fractures,C0019557,en_1185,2,1,AFFECTS,Inhibitory,3
2853,Pain management,C0002766,en_311,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
2854,Pain management,C0002766,en_311,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,6
2855,Analgesics,C0002771,en_312,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
2856,Analgesics,C0002771,en_312,PREVENTS,Pain,C0030193,en_1741,3,1,AFFECTS,Inhibitory,3
2857,Androgen Antagonists,C0002842,en_314,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
2858,Androgen Antagonists,C0002842,en_314,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
2859,Androgens,C0002844,en_315,AUGMENTS,Cells,C0007634,en_596,6,5,AFFECTS,Excitatory,15
2860,Androgens,C0002844,en_315,STIMULATES,Androgen Receptor,C0034786,en_1962,3,3,AFFECTS,Excitatory,9
2861,Androgens,C0002844,en_315,STIMULATES,epitheliasin,C0964578,en_5200,2,1,AFFECTS,Excitatory,3
2862,Androgens,C0002844,en_315,STIMULATES,TMPRSS2 gene,C1336641,en_5636,2,1,AFFECTS,Excitatory,3
2863,Androgens,C0002844,en_315,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
2864,Androgens,C0002844,en_315,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
2865,Androgens,C0002844,en_315,TREATS,Infection status,C0517627,en_4174,1,1,AFFECTS,Inhibitory,3
2866,Anemia,C0002871,en_316,AFFECTS,Renal function,C0232804,en_3285,1,1,AFFECTS,General/Uncertain,3
2867,Anemia,C0002871,en_316,AFFECTS,targeting,C0599894,en_4482,2,1,AFFECTS,General/Uncertain,3
2868,Anemia,C0002871,en_316,AFFECTS,Old age,C1999167,en_6084,1,1,AFFECTS,General/Uncertain,6
2869,Anemia,C0002871,en_316,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
2870,Anemia,C0002871,en_316,COMPLICATES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,6
2871,Anemia,C0002871,en_316,PREDISPOSES,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Excitatory,3
2872,Anemia,C0002871,en_316,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
2873,Sickle Cell Anemia,C0002895,en_317,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
2874,Sickle Cell Anemia,C0002895,en_317,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
2875,Sickle Cell Anemia,C0002895,en_317,AFFECTS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,General/Uncertain,3
2876,Sickle Cell Anemia,C0002895,en_317,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
2877,Sickle Cell Anemia,C0002895,en_317,AFFECTS,targeting,C0599894,en_4482,2,1,AFFECTS,General/Uncertain,3
2878,Sickle Cell Anemia,C0002895,en_317,AFFECTS(SPEC),Caregiver,C0085537,en_2674,2,1,AFFECTS,General/Uncertain,3
2879,Sickle Cell Anemia,C0002895,en_317,AFFECTS(SPEC),American,C0596070,en_4379,1,1,AFFECTS,General/Uncertain,3
2880,Anesthesia procedures,C0002903,en_318,TREATS,Age,C0001779,en_257,1,1,AFFECTS,Inhibitory,6
2881,Anesthesia procedures,C0002903,en_318,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
2882,Anesthesia procedures,C0002903,en_318,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
2883,Anesthesia procedures,C0002903,en_318,TREATS,Cesarean section (finding),C1384674,en_5690,1,1,AFFECTS,Inhibitory,3
2884,Anesthesia procedures,C0002903,en_318,TREATS,Increased risk,C4699158,en_6379,1,1,AFFECTS,Inhibitory,7
2885,"Anesthesia, Conduction",C0002911,en_319,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
2886,General Anesthesia,C0002915,en_320,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
2887,General Anesthesia,C0002915,en_320,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
2888,General Anesthesia,C0002915,en_320,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
2889,General Anesthesia,C0002915,en_320,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
2890,General Anesthesia,C0002915,en_320,TREATS,Cesarean section (finding),C1384674,en_5690,1,1,AFFECTS,Inhibitory,3
2891,Spinal Anesthesia,C0002928,en_321,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
2892,Spinal Anesthesia,C0002928,en_321,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
2893,Spinal Anesthesia,C0002928,en_321,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
2894,Spinal Anesthesia,C0002928,en_321,TREATS,Present,C0150312,en_2833,1,1,AFFECTS,Inhibitory,6
2895,Spinal Anesthesia,C0002928,en_321,TREATS,Sitting position,C0277814,en_3592,1,1,AFFECTS,Inhibitory,3
2896,Spinal Anesthesia,C0002928,en_321,TREATS,Anesthetist,C0473161,en_4133,3,2,AFFECTS,Inhibitory,9
2897,Spinal Anesthesia,C0002928,en_321,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
2898,Anesthetics,C0002932,en_322,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
2899,"Angioplasty, Balloon",C0002996,en_326,TREATS,Thromboembolic pulmonary hypertension,C0340546,en_3817,1,1,AFFECTS,Inhibitory,3
2900,Angiotensin I,C0003006,en_327,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
2901,Angiotensin I,C0003006,en_327,STIMULATES,AGTR1,C1439284,en_5,2,1,AFFECTS,Excitatory,3
2902,Angiotensin II,C0003009,en_328,AFFECTS,Permeability,C0031164,en_1779,1,1,AFFECTS,General/Uncertain,7
2903,Angiotensin II,C0003009,en_328,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12.5
2904,Angiotensin II,C0003009,en_328,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
2905,Angiotensin II,C0003009,en_328,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
2906,Angiotensin II,C0003009,en_328,AFFECTS,Renin-Angiotensin System,C0035096,en_1996,1,1,AFFECTS,General/Uncertain,3
2907,Angiotensin II,C0003009,en_328,AFFECTS,Vascular constriction (function),C0042396,en_2340,15,3,AFFECTS,General/Uncertain,9
2908,Angiotensin II,C0003009,en_328,AFFECTS,Receptor Activation,C1514758,en_5837,1,1,AFFECTS,General/Uncertain,3
2909,Angiotensin II,C0003009,en_328,AUGMENTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,Excitatory,3
2910,Angiotensin II,C0003009,en_328,AUGMENTS,Influenza,C0021400,en_1311,3,1,AFFECTS,Excitatory,3
2911,Angiotensin II,C0003009,en_328,AUGMENTS,Vasodilation,C0042401,en_2342,1,1,AFFECTS,Excitatory,3
2912,Angiotensin II,C0003009,en_328,AUGMENTS,Apoptosis,C0162638,en_2922,3,1,AFFECTS,Excitatory,3
2913,Angiotensin II,C0003009,en_328,AUGMENTS(SPEC),Blood Pressure,C0005823,en_492,2,1,AFFECTS,Excitatory,3
2914,Angiotensin II,C0003009,en_328,COMPLICATES,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
2915,Angiotensin II,C0003009,en_328,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
2916,Angiotensin II,C0003009,en_328,INHIBITS,Vascular Permeability,C0162337,en_2906,1,1,AFFECTS,Inhibitory,3
2917,Angiotensin II,C0003009,en_328,PREVENTS,neurogenic hypertension,C0597048,en_4410,1,1,AFFECTS,Inhibitory,3
2918,Angiotensin II,C0003009,en_328,STIMULATES,Calcium,C0006675,en_537,14,2,AFFECTS,Excitatory,6
2919,Angiotensin II,C0003009,en_328,STIMULATES,Epithelial Cells,C0014597,en_919,1,1,AFFECTS,Excitatory,3
2920,Angiotensin II,C0003009,en_328,STIMULATES,"Receptor, Angiotensin, Type 1a",C0383165,en_3901,1,1,AFFECTS,Excitatory,3
2921,Angiotensin II,C0003009,en_328,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
2922,Angiotensin II,C0003009,en_328,TREATS,Mus,C0026809,en_1600,2,1,AFFECTS,Inhibitory,3
2923,Angiotensin II,C0003009,en_328,TREATS,Patients,C0030705,en_1762,14,7,AFFECTS,Inhibitory,21
2924,Angiotensin II,C0003009,en_328,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
2925,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,AFFECTS,Coughing,C0010200,en_723,1,1,AFFECTS,General/Uncertain,3
2926,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,8
2927,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
2928,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,AFFECTS,Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,1,1,AFFECTS,General/Uncertain,6
2929,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,AFFECTS,COVID-19,C5203670,en_6417,3,3,AFFECTS,General/Uncertain,18
2930,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,AUGMENTS,cell invasion,C2699153,en_6118,1,1,AFFECTS,Excitatory,3
2931,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,DISRUPTS,Down-Regulation,C0013081,en_844,1,1,AFFECTS,Inhibitory,6
2932,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,DISRUPTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
2933,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,INHIBITS,Angiotensin Receptor,C0034787,en_1963,1,1,AFFECTS,Inhibitory,3
2934,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,INHIBITS(SPEC),"Receptor, Angiotensin II",C0003011,en_329,2,1,AFFECTS,Inhibitory,3
2935,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
2936,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
2937,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
2938,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,PREVENTS,Acute Pneumonia,C0740766,en_4782,1,1,AFFECTS,Inhibitory,3
2939,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,STIMULATES,ACE2,C1422064,en_5723,2,1,AFFECTS,Excitatory,3
2940,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,STIMULATES,Peptidyl-Dipeptidase A,C0022709,en_1387,1,1,AFFECTS,Excitatory,3
2941,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,STIMULATES,"PER2 protein, mammalian",C0669679,en_4536,1,1,AFFECTS,Excitatory,3
2942,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,STIMULATES,angiotensin converting enzyme 2,C0960880,en_5195,1,1,AFFECTS,Excitatory,6
2943,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
2944,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,Inhibitory,3
2945,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,9
2946,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Heart failure,C0018801,en_1135,3,2,AFFECTS,Inhibitory,6
2947,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Hypertensive disease,C0020538,en_1239,12,9,AFFECTS,Inhibitory,33
2948,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,6
2949,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Patients,C0030705,en_1762,25,11,AFFECTS,Inhibitory,33
2950,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
2951,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,6
2952,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
2953,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Smoker,C0337664,en_3793,1,1,AFFECTS,Inhibitory,3
2954,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Pre-existing condition,C0521987,en_4206,1,1,AFFECTS,Inhibitory,3
2955,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Hypertensive,C0857121,en_4969,2,1,AFFECTS,Inhibitory,3
2956,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,6
2957,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Hospitalized Patients,C0870668,en_5010,5,4,AFFECTS,Inhibitory,19
2958,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Acute coronary syndrome,C0948089,en_5159,2,1,AFFECTS,Inhibitory,3
2959,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,Discontinued,C1444662,en_5749,1,1,AFFECTS,Inhibitory,8
2960,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",C3888198,en_6281,1,1,AFFECTS,Inhibitory,6
2961,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,COVID-19,C5203670,en_6417,5,4,AFFECTS,Inhibitory,25
2962,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
2963,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
2964,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
2965,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,TREATS(SPEC),Hypertensive disease,C0020538,en_1239,2,2,AFFECTS,Inhibitory,6
2966,Angiotensins,C0003018,en_332,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
2967,Angiotensins,C0003018,en_332,AFFECTS,Vascular Permeability,C0162337,en_2906,1,1,AFFECTS,General/Uncertain,3
2968,Angiotensins,C0003018,en_332,PREVENTS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
2969,Angiotensins,C0003018,en_332,STIMULATES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,3
2970,Angiotensins,C0003018,en_332,STIMULATES,ATM gene,C0919524,en_5114,1,1,AFFECTS,Excitatory,3
2971,Angiotensins,C0003018,en_332,TREATS,Patients,C0030705,en_1762,7,2,AFFECTS,Inhibitory,6
2972,Angiotensins,C0003018,en_332,TREATS(INFER),Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
2973,Anthelmintics,C0003158,en_338,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
2974,Anthocyanins,C0003161,en_339,AUGMENTS,Lipolysis,C0023796,en_1442,1,1,AFFECTS,Excitatory,3
2975,Anti-Infective Agents,C0003204,en_340,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
2976,Anti-Infective Agents,C0003204,en_340,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
2977,Anti-Infective Agents,C0003204,en_340,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
2978,Anti-Infective Agents,C0003204,en_340,TREATS,Tropical Disease,C1336827,en_5642,1,1,AFFECTS,Inhibitory,3
2979,"Anti-Infective Agents, Local",C0003205,en_341,AFFECTS,exacerbation acute,C0743630,en_4804,1,1,AFFECTS,General/Uncertain,8
2980,Anti-Inflammatory Agents,C0003209,en_342,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,7
2981,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,"Receptor, Angiotensin II",C0003011,en_329,1,1,AFFECTS,Inhibitory,3
2982,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,Monoclonal Antibodies,C0003250,en_350,1,1,AFFECTS,Inhibitory,3
2983,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,Eicosanoids,C0013725,en_880,1,1,AFFECTS,Inhibitory,3
2984,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,Heparin,C0019134,en_1166,1,1,AFFECTS,Inhibitory,8
2985,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,Interleukin-6,C0021760,en_1342,3,2,AFFECTS,Inhibitory,6
2986,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,Prostaglandin-Endoperoxide Synthase,C0033551,en_1901,1,1,AFFECTS,Inhibitory,3
2987,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,RNA,C0035668,en_2040,1,1,AFFECTS,Inhibitory,3
2988,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,Sphingolipids,C0037900,en_2142,1,1,AFFECTS,Inhibitory,6
2989,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,influenza A virus nucleoprotein,C0063529,en_2506,1,1,AFFECTS,Inhibitory,3
2990,Anti-Inflammatory Agents,C0003209,en_342,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
2991,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,6
2992,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
2993,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
2994,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Fibromyalgia,C0016053,en_993,1,1,AFFECTS,Inhibitory,3
2995,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
2996,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Inhibitory,6
2997,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Inhibitory,7
2998,Anti-Inflammatory Agents,C0003209,en_342,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
2999,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
3000,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
3001,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Autoimmune Diseases,C0004364,en_428,2,1,AFFECTS,Inhibitory,3
3002,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,8
3003,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Coronary heart disease,C0010068,en_718,1,1,AFFECTS,Inhibitory,8
3004,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,9
3005,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Gout,C0018099,en_1091,1,1,AFFECTS,Inhibitory,8
3006,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3007,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Pericarditis,C0031046,en_1772,1,1,AFFECTS,Inhibitory,8
3008,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,7
3009,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Vital signs,C0518766,en_4182,1,1,AFFECTS,Inhibitory,3
3010,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
3011,Anti-Inflammatory Agents,C0003209,en_342,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
3012,Anti-Inflammatory Agents,C0003209,en_342,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
3013,Anti-Inflammatory Agents,C0003209,en_342,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
3014,Anti-Inflammatory Agents,C0003209,en_342,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
3015,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,AUGMENTS,Polyamine Catabolism,C1156778,en_5331,1,1,AFFECTS,Excitatory,3
3016,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,DISRUPTS,Symptoms,C1457887,en_5784,3,1,AFFECTS,Inhibitory,3
3017,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,1,1,AFFECTS,Inhibitory,3
3018,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,INHIBITS,Eicosanoids,C0013725,en_880,1,1,AFFECTS,Inhibitory,3
3019,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,INHIBITS,Angiotensin Receptor,C0034787,en_1963,1,1,AFFECTS,Inhibitory,3
3020,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,PREVENTS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Inhibitory,6
3021,"Anti-Inflammatory Agents, Non-Steroidal",C0003211,en_343,TREATS,Fever,C0015967,en_985,2,1,AFFECTS,Inhibitory,3
3022,Antibiotics,C0003232,en_344,AFFECTS,Infection,C3714514,en_6235,4,4,AFFECTS,General/Uncertain,18
3023,Antibiotics,C0003232,en_344,AFFECTS,Respiration,C0035203,en_2004,2,1,AFFECTS,General/Uncertain,3
3024,Antibiotics,C0003232,en_344,AFFECTS,Malaise,C0231218,en_3251,1,1,AFFECTS,General/Uncertain,6
3025,Antibiotics,C0003232,en_344,AFFECTS,Cardiac rhythm type,C0232187,en_3273,1,1,AFFECTS,General/Uncertain,3
3026,Antibiotics,C0003232,en_344,AFFECTS,Cellular Structures,C0243092,en_3463,1,1,AFFECTS,General/Uncertain,3
3027,Antibiotics,C0003232,en_344,AFFECTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,General/Uncertain,3
3028,Antibiotics,C0003232,en_344,DISRUPTS,RNA translation,C0678935,en_4585,1,1,AFFECTS,Inhibitory,3
3029,Antibiotics,C0003232,en_344,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
3030,Antibiotics,C0003232,en_344,INHIBITS,Matrix Metalloproteinases,C0623362,en_4521,1,1,AFFECTS,Inhibitory,3
3031,Antibiotics,C0003232,en_344,PREDISPOSES,diseases and injuries,C0178237,en_2978,1,1,AFFECTS,Excitatory,6
3032,Antibiotics,C0003232,en_344,PREDISPOSES,Clostridium difficile colitis,C0238106,en_3361,1,1,AFFECTS,Excitatory,6
3033,Antibiotics,C0003232,en_344,PREDISPOSES,Antibiotic-associated diarrhea,C0578159,en_4340,2,1,AFFECTS,Excitatory,3
3034,Antibiotics,C0003232,en_344,PREVENTS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
3035,Antibiotics,C0003232,en_344,PREVENTS,Surgical Wound Infection,C0038941,en_2192,2,1,AFFECTS,Inhibitory,8
3036,Antibiotics,C0003232,en_344,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
3037,Antibiotics,C0003232,en_344,PREVENTS,Mixed infectious disease,C0275524,en_3566,1,1,AFFECTS,Inhibitory,6
3038,Antibiotics,C0003232,en_344,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
3039,Antibiotics,C0003232,en_344,TREATS,Back Pain,C0004604,en_437,1,1,AFFECTS,Inhibitory,3
3040,Antibiotics,C0003232,en_344,TREATS,Bacterial Infections,C0004623,en_441,6,4,AFFECTS,Inhibitory,12
3041,Antibiotics,C0003232,en_344,TREATS,"Pneumonia, Bacterial",C0004626,en_442,2,2,AFFECTS,Inhibitory,6
3042,Antibiotics,C0003232,en_344,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
3043,Antibiotics,C0003232,en_344,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3044,Antibiotics,C0003232,en_344,TREATS,Hepatic Encephalopathy,C0019151,en_1170,1,1,AFFECTS,Inhibitory,3
3045,Antibiotics,C0003232,en_344,TREATS,Infection,C3714514,en_6235,3,3,AFFECTS,Inhibitory,9
3046,Antibiotics,C0003232,en_344,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
3047,Antibiotics,C0003232,en_344,TREATS,Low Back Pain,C0024031,en_1458,1,1,AFFECTS,Inhibitory,3
3048,Antibiotics,C0003232,en_344,TREATS,Mus,C0026809,en_1600,3,2,AFFECTS,Inhibitory,6
3049,Antibiotics,C0003232,en_344,TREATS,Mycobacterium Infections,C0026918,en_1615,1,1,AFFECTS,Inhibitory,3
3050,Antibiotics,C0003232,en_344,TREATS,Mycoses,C0026946,en_1620,1,1,AFFECTS,Inhibitory,3
3051,Antibiotics,C0003232,en_344,TREATS,Pancreatitis,C0030305,en_1745,1,1,AFFECTS,Inhibitory,3
3052,Antibiotics,C0003232,en_344,TREATS,Patients,C0030705,en_1762,15,11,AFFECTS,Inhibitory,33
3053,Antibiotics,C0003232,en_344,TREATS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,9
3054,Antibiotics,C0003232,en_344,TREATS,Respiratory Tract Infections,C0035243,en_2017,6,4,AFFECTS,Inhibitory,12
3055,Antibiotics,C0003232,en_344,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,6
3056,Antibiotics,C0003232,en_344,TREATS,Superinfection,C0038826,en_2184,2,2,AFFECTS,Inhibitory,6
3057,Antibiotics,C0003232,en_344,TREATS,Urinary tract infection,C0042029,en_2320,1,1,AFFECTS,Inhibitory,7
3058,Antibiotics,C0003232,en_344,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
3059,Antibiotics,C0003232,en_344,TREATS,Frail Elderly,C0079377,en_2598,1,1,AFFECTS,Inhibitory,7
3060,Antibiotics,C0003232,en_344,TREATS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,3
3061,Antibiotics,C0003232,en_344,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,6
3062,Antibiotics,C0003232,en_344,TREATS,COMBATIVE,C0241845,en_3391,2,1,AFFECTS,Inhibitory,3
3063,Antibiotics,C0003232,en_344,TREATS,Epidemic disease,C0277548,en_3584,1,1,AFFECTS,Inhibitory,7
3064,Antibiotics,C0003232,en_344,TREATS,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Inhibitory,3
3065,Antibiotics,C0003232,en_344,TREATS,Bacterial Abscess,C0549483,en_4283,1,1,AFFECTS,Inhibitory,8
3066,Antibiotics,C0003232,en_344,TREATS,Community acquired pneumonia,C0694549,en_4692,3,2,AFFECTS,Inhibitory,14
3067,Antibiotics,C0003232,en_344,TREATS,Febrile neutropenia,C0746883,en_4819,1,1,AFFECTS,Inhibitory,7
3068,Antibiotics,C0003232,en_344,TREATS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Inhibitory,3
3069,Antibiotics,C0003232,en_344,TREATS,Primary infection NOS,C0948192,en_5162,1,1,AFFECTS,Inhibitory,3
3070,Antibiotics,C0003232,en_344,TREATS,Nosocomial pneumonia,C0949083,en_5175,1,1,AFFECTS,Inhibitory,6
3071,Antibiotics,C0003232,en_344,TREATS,Invasive mycosis,C1262313,en_5421,1,1,AFFECTS,Inhibitory,3
3072,Antibiotics,C0003232,en_344,TREATS,Infection due to resistant organism,C1269831,en_5449,1,1,AFFECTS,Inhibitory,6
3073,Antibiotics,C0003232,en_344,TREATS,Postoperative endophthalmitis,C1282227,en_5473,1,1,AFFECTS,Inhibitory,3
3074,Antibiotics,C0003232,en_344,TREATS,Symptoms,C1457887,en_5784,3,3,AFFECTS,Inhibitory,12
3075,Antibiotics,C0003232,en_344,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,18
3076,Antibiotics,C0003232,en_344,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
3077,Antibiotics,C0003232,en_344,TREATS(INFER),Abscess of appendix,C0238002,en_3359,1,1,AFFECTS,Inhibitory,3
3078,Antibiotics,C0003232,en_344,TREATS(INFER),Bacterial respiratory infection,C0729518,en_4762,1,1,AFFECTS,Inhibitory,3
3079,Antibiotics,C0003232,en_344,TREATS(INFER),Persistent infection,C1264606,en_5429,1,1,AFFECTS,Inhibitory,3
3080,Antibiotics,C0003232,en_344,TREATS(SPEC),Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
3081,Anthracycline Antibiotics,C0003234,en_345,TREATS,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,Inhibitory,3
3082,Macrolide Antibiotics,C0003240,en_346,DISRUPTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,Inhibitory,3
3083,Macrolide Antibiotics,C0003240,en_346,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
3084,Macrolide Antibiotics,C0003240,en_346,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
3085,Macrolide Antibiotics,C0003240,en_346,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3086,Antibodies,C0003241,en_347,AFFECTS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
3087,Antibodies,C0003241,en_347,AFFECTS,Cells,C0007634,en_596,2,2,AFFECTS,General/Uncertain,6
3088,Antibodies,C0003241,en_347,AFFECTS,Disease,C0012634,en_826,7,4,AFFECTS,General/Uncertain,12
3089,Antibodies,C0003241,en_347,AFFECTS,Immunity,C0020964,en_1273,10,7,AFFECTS,General/Uncertain,21
3090,Antibodies,C0003241,en_347,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
3091,Antibodies,C0003241,en_347,AFFECTS,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
3092,Antibodies,C0003241,en_347,AFFECTS,Stress,C0038435,en_2165,2,1,AFFECTS,General/Uncertain,3
3093,Antibodies,C0003241,en_347,AFFECTS,Vasculitis,C0042384,en_2338,1,1,AFFECTS,General/Uncertain,3
3094,Antibodies,C0003241,en_347,AFFECTS,Virus Diseases,C0042769,en_2362,7,6,AFFECTS,General/Uncertain,18
3095,Antibodies,C0003241,en_347,AFFECTS,Vision,C0042789,en_2366,1,1,AFFECTS,General/Uncertain,3
3096,Antibodies,C0003241,en_347,AFFECTS,Antibody-Dependent Enhancement,C0282632,en_3660,3,3,AFFECTS,General/Uncertain,9
3097,Antibodies,C0003241,en_347,AFFECTS,Cell-Mediated Cytolysis,C0301896,en_3698,1,1,AFFECTS,General/Uncertain,3
3098,Antibodies,C0003241,en_347,AFFECTS,transcytosis,C0597601,en_4433,1,1,AFFECTS,General/Uncertain,3
3099,Antibodies,C0003241,en_347,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
3100,Antibodies,C0003241,en_347,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
3101,Antibodies,C0003241,en_347,AFFECTS,Inflammation Process,C1512753,en_5825,2,1,AFFECTS,General/Uncertain,3
3102,Antibodies,C0003241,en_347,AFFECTS(SPEC),Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
3103,Antibodies,C0003241,en_347,AUGMENTS,Blood coagulation,C0005778,en_484,1,1,AFFECTS,Excitatory,3
3104,Antibodies,C0003241,en_347,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
3105,Antibodies,C0003241,en_347,AUGMENTS,Virion,C0042760,en_2360,1,1,AFFECTS,Excitatory,3
3106,Antibodies,C0003241,en_347,AUGMENTS,Plasmodium vivax infection,C0858321,en_4981,1,1,AFFECTS,Excitatory,3
3107,Antibodies,C0003241,en_347,AUGMENTS,Internalization,C0871786,en_5031,1,1,AFFECTS,Excitatory,3
3108,Antibodies,C0003241,en_347,AUGMENTS,opsonization,C1159762,en_5344,1,1,AFFECTS,Excitatory,3
3109,Antibodies,C0003241,en_347,AUGMENTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Excitatory,3
3110,Antibodies,C0003241,en_347,AUGMENTS,Platelet function,C1254881,en_5398,1,1,AFFECTS,Excitatory,3
3111,Antibodies,C0003241,en_347,DISRUPTS,Cells,C0007634,en_596,1,1,AFFECTS,Inhibitory,3
3112,Antibodies,C0003241,en_347,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
3113,Antibodies,C0003241,en_347,DISRUPTS,Virus Diseases,C0042769,en_2362,3,2,AFFECTS,Inhibitory,6
3114,Antibodies,C0003241,en_347,DISRUPTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Inhibitory,3
3115,Antibodies,C0003241,en_347,DISRUPTS,Platelet function,C1254881,en_5398,1,1,AFFECTS,Inhibitory,3
3116,Antibodies,C0003241,en_347,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
3117,Antibodies,C0003241,en_347,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
3118,Antibodies,C0003241,en_347,INHIBITS,cytokine,C0079189,en_2593,2,1,AFFECTS,Inhibitory,3
3119,Antibodies,C0003241,en_347,INHIBITS,"S100A12 protein, human",C0389073,en_3907,1,1,AFFECTS,Inhibitory,3
3120,Antibodies,C0003241,en_347,INHIBITS,small molecule,C1328819,en_5573,1,1,AFFECTS,Inhibitory,3
3121,Antibodies,C0003241,en_347,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
3122,Antibodies,C0003241,en_347,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
3123,Antibodies,C0003241,en_347,PREVENTS,Disease,C0012634,en_826,3,2,AFFECTS,Inhibitory,6
3124,Antibodies,C0003241,en_347,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
3125,Antibodies,C0003241,en_347,PREVENTS,Virus Diseases,C0042769,en_2362,4,4,AFFECTS,Inhibitory,12
3126,Antibodies,C0003241,en_347,PREVENTS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
3127,Antibodies,C0003241,en_347,PREVENTS,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Inhibitory,3
3128,Antibodies,C0003241,en_347,PREVENTS,Infectious transmissions,C0947878,en_5157,2,2,AFFECTS,Inhibitory,6
3129,Antibodies,C0003241,en_347,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
3130,Antibodies,C0003241,en_347,PRODUCES,Peptides,C0030956,en_1771,1,1,AFFECTS,Excitatory,3
3131,Antibodies,C0003241,en_347,PRODUCES,Recombinant Proteins,C0034861,en_1981,1,1,AFFECTS,Excitatory,3
3132,Antibodies,C0003241,en_347,PRODUCES,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Excitatory,3
3133,Antibodies,C0003241,en_347,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
3134,Antibodies,C0003241,en_347,PRODUCES,Peptide/MHC Complex,C1335376,en_5614,1,1,AFFECTS,Excitatory,3
3135,Antibodies,C0003241,en_347,STIMULATES,Natural Killer Cells,C0022688,en_1386,1,1,AFFECTS,Excitatory,3
3136,Antibodies,C0003241,en_347,STIMULATES,"TLR4 protein, human",C1321919,en_5543,2,1,AFFECTS,Excitatory,3
3137,Antibodies,C0003241,en_347,TREATS(SPEC),Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
3138,Antibodies,C0003241,en_347,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,7
3139,Antibodies,C0003241,en_347,AFFECTS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,General/Uncertain,6
3140,Antibodies,C0003241,en_347,AUGMENTS,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,8
3141,Antibodies,C0003241,en_347,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3142,Antibodies,C0003241,en_347,STIMULATES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,6
3143,Antibodies,C0003241,en_347,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
3144,Antibodies,C0003241,en_347,TREATS,Blood donor,C0005795,en_489,1,1,AFFECTS,Inhibitory,6
3145,Antibodies,C0003241,en_347,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
3146,Antibodies,C0003241,en_347,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,6
3147,Antibodies,C0003241,en_347,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
3148,Antibodies,C0003241,en_347,TREATS,HIV,C0019682,en_1190,1,1,AFFECTS,Inhibitory,7
3149,Antibodies,C0003241,en_347,TREATS,"Personnel, Hospital",C0031228,en_1781,1,1,AFFECTS,Inhibitory,6
3150,Antibodies,C0003241,en_347,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,6
3151,Antibodies,C0003241,en_347,TREATS,False Positive,C0205557,en_3131,1,1,AFFECTS,Inhibitory,6
3152,Antibodies,C0003241,en_347,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
3153,Antibodies,C0003241,en_347,TREATS,Neonatal calf diarrhea,C0276467,en_3578,1,1,AFFECTS,Inhibitory,8
3154,Antibodies,C0003241,en_347,TREATS,cohort,C0599755,en_4470,3,3,AFFECTS,Inhibitory,19
3155,Antibodies,C0003241,en_347,TREATS,Young child,C0728836,en_4758,1,1,AFFECTS,Inhibitory,7
3156,Antibodies,C0003241,en_347,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,7
3157,Antibodies,C0003241,en_347,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
3158,Antibodies,C0003241,en_347,TREATS,Affected Area,C1879646,en_6061,1,1,AFFECTS,Inhibitory,8
3159,Antibodies,C0003241,en_347,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,7
3160,Antibodies,C0003241,en_347,TREATS,Moderate disease,C4740691,en_6395,1,1,AFFECTS,Inhibitory,7
3161,Antibodies,C0003241,en_347,TREATS,Epidermal cGVHD Score 2,C4761314,en_6403,1,1,AFFECTS,Inhibitory,7
3162,Antibodies,C0003241,en_347,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,29
3163,Antibodies,C0003241,en_347,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
3164,Antibodies,C0003241,en_347,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
3165,"Antibodies, Anti-Idiotypic",C0003242,en_348,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
3166,"Antibodies, Anti-Idiotypic",C0003242,en_348,DISRUPTS,Signal Transduction,C0037083,en_2105,2,2,AFFECTS,Inhibitory,6
3167,"Antibodies, Anti-Idiotypic",C0003242,en_348,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
3168,"Antibodies, Anti-Idiotypic",C0003242,en_348,STIMULATES,Pharmaceutical Preparations,C0013227,en_856,1,1,AFFECTS,Excitatory,3
3169,"Antibodies, Antinuclear",C0003243,en_349,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
3170,Monoclonal Antibodies,C0003250,en_350,AFFECTS,Menstruation,C0025344,en_1540,1,1,AFFECTS,General/Uncertain,3
3171,Monoclonal Antibodies,C0003250,en_350,AFFECTS,Myocardium,C0027061,en_1628,1,1,AFFECTS,General/Uncertain,3
3172,Monoclonal Antibodies,C0003250,en_350,DISRUPTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Inhibitory,3
3173,Monoclonal Antibodies,C0003250,en_350,DISRUPTS,Viral Load result,C0376705,en_3889,2,1,AFFECTS,Inhibitory,3
3174,Monoclonal Antibodies,C0003250,en_350,INHIBITS,CALCA|S100A12,C1367551;C1335796,en_201,2,1,AFFECTS,Inhibitory,6
3175,Monoclonal Antibodies,C0003250,en_350,INHIBITS,Fibrin,C0015982,en_987,1,1,AFFECTS,Inhibitory,3
3176,Monoclonal Antibodies,C0003250,en_350,INHIBITS,cytokine,C0079189,en_2593,2,1,AFFECTS,Inhibitory,3
3177,Monoclonal Antibodies,C0003250,en_350,INHIBITS,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Inhibitory,3
3178,Monoclonal Antibodies,C0003250,en_350,INHIBITS,small molecule,C1328819,en_5573,1,1,AFFECTS,Inhibitory,3
3179,Monoclonal Antibodies,C0003250,en_350,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
3180,Monoclonal Antibodies,C0003250,en_350,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
3181,Monoclonal Antibodies,C0003250,en_350,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3182,Monoclonal Antibodies,C0003250,en_350,TREATS(SPEC),Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
3183,"Antibodies, Viral",C0003253,en_351,AFFECTS,"Immunity, Humoral",C0020967,en_1275,1,1,AFFECTS,General/Uncertain,3
3184,"Antibodies, Viral",C0003253,en_351,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
3185,"Antibodies, Viral",C0003253,en_351,AUGMENTS,Virus Diseases,C0042769,en_2362,3,2,AFFECTS,Excitatory,6
3186,Antibody Formation,C0003261,en_352,AFFECTS,Viral respiratory infection,C0729531,en_4763,1,1,AFFECTS,General/Uncertain,6
3187,Antibody Formation,C0003261,en_352,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
3188,Antibody Formation,C0003261,en_352,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
3189,Antibody Formation,C0003261,en_352,AFFECTS,Age,C0001779,en_257,3,2,AFFECTS,General/Uncertain,6
3190,Antibody Formation,C0003261,en_352,AFFECTS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,General/Uncertain,3
3191,Antibody Formation,C0003261,en_352,AFFECTS,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
3192,Antibody Formation,C0003261,en_352,AFFECTS,Natural Killer Cells,C0022688,en_1386,1,1,AFFECTS,General/Uncertain,3
3193,Antibody Formation,C0003261,en_352,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
3194,Antibody Formation,C0003261,en_352,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
3195,Antibody Formation,C0003261,en_352,PRODUCES,"Antibodies, Viral",C0003253,en_351,1,1,AFFECTS,Excitatory,3
3196,Antibody Formation,C0003261,en_352,PRODUCES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,3
3197,Anticoagulants,C0003280,en_354,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
3198,Anticoagulants,C0003280,en_354,AFFECTS,Virus Replication,C0042774,en_2363,3,1,AFFECTS,General/Uncertain,3
3199,Anticoagulants,C0003280,en_354,DISRUPTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
3200,Anticoagulants,C0003280,en_354,INHIBITS,Blood coagulation,C0005778,en_484,1,1,AFFECTS,Inhibitory,3
3201,Anticoagulants,C0003280,en_354,INHIBITS,Proteins,C0033684,en_1912,1,1,AFFECTS,Inhibitory,3
3202,Anticoagulants,C0003280,en_354,INHIBITS,"Receptor, PAR-2",C0259628,en_3498,1,1,AFFECTS,Inhibitory,3
3203,Anticoagulants,C0003280,en_354,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
3204,Anticoagulants,C0003280,en_354,PREVENTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
3205,Anticoagulants,C0003280,en_354,PREVENTS,Blood Clot,C0302148,en_3702,3,1,AFFECTS,Inhibitory,3
3206,Anticoagulants,C0003280,en_354,TREATS,Atrial Fibrillation,C0004238,en_423,2,1,AFFECTS,Inhibitory,3
3207,Anticoagulants,C0003280,en_354,TREATS,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Inhibitory,3
3208,Anticoagulants,C0003280,en_354,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,7
3209,Anticoagulants,C0003280,en_354,TREATS,Cystic Fibrosis,C0010674,en_745,2,1,AFFECTS,Inhibitory,3
3210,Anticoagulants,C0003280,en_354,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,6
3211,Anticoagulants,C0003280,en_354,TREATS,Disease,C0012634,en_826,6,1,AFFECTS,Inhibitory,3
3212,Anticoagulants,C0003280,en_354,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
3213,Anticoagulants,C0003280,en_354,TREATS,Patients,C0030705,en_1762,9,6,AFFECTS,Inhibitory,18
3214,Anticoagulants,C0003280,en_354,TREATS,Pulmonary thrombosis,C0151946,en_2875,1,1,AFFECTS,Inhibitory,3
3215,Anticoagulants,C0003280,en_354,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,7
3216,Anticoagulants,C0003280,en_354,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,6
3217,Anticoagulants,C0003280,en_354,TREATS,Epidermal cGVHD Score 2,C4761314,en_6403,1,1,AFFECTS,Inhibitory,6
3218,Anticoagulants,C0003280,en_354,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,20
3219,Anticoagulants,C0003280,en_354,TREATS(SPEC),Myocardial Infarction,C0027051,en_1625,6,1,AFFECTS,Inhibitory,3
3220,Anticoagulants,C0003280,en_354,TREATS(SPEC),Cerebrovascular accident,C0038454,en_2169,6,1,AFFECTS,Inhibitory,3
3221,Anticoagulants,C0003280,en_354,TREATS(SPEC),Thrombus,C0087086,en_2743,6,1,AFFECTS,Inhibitory,3
3222,anticoagulation,C0003281,en_355,TREATS,Adult,C0001675,en_252,3,2,AFFECTS,Inhibitory,6
3223,anticoagulation,C0003281,en_355,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
3224,anticoagulation,C0003281,en_355,TREATS,Patients,C0030705,en_1762,18,12,AFFECTS,Inhibitory,36
3225,anticoagulation,C0003281,en_355,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
3226,anticoagulation,C0003281,en_355,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
3227,anticoagulation,C0003281,en_355,TREATS(INFER),Patient in hospital,C0701159,en_4731,3,2,AFFECTS,Inhibitory,6
3228,anticoagulation,C0003281,en_355,TREATS(INFER),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
3229,Antidepressive Agents,C0003289,en_356,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
3230,Antidepressive Agents,C0003289,en_356,AFFECTS,Treatment Resistant Depression,C0871546,en_5026,1,1,AFFECTS,General/Uncertain,3
3231,Antidepressive Agents,C0003289,en_356,PREVENTS,Respiratory complication,C0161818,en_2899,1,1,AFFECTS,Inhibitory,3
3232,Antidepressive Agents,C0003289,en_356,STIMULATES,Muscarinic Acetylcholine Receptor,C0034826,en_1976,1,1,AFFECTS,Excitatory,3
3233,Antidepressive Agents,C0003289,en_356,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
3234,Antidepressive Agents,C0003289,en_356,TREATS,"Stress Disorders, Traumatic",C0038441,en_2167,1,1,AFFECTS,Inhibitory,3
3235,Antidepressive Agents,C0003289,en_356,TREATS,Generalized Anxiety Disorder,C0270549,en_3551,1,1,AFFECTS,Inhibitory,8
3236,Antidepressive Agents,C0003289,en_356,TREATS,COGNITIVE DEFICIT,C0679466,en_4596,2,1,AFFECTS,Inhibitory,3
3237,Antidepressive Agents,C0003289,en_356,TREATS(SPEC),Depressive disorder,C0011581,en_788,2,1,AFFECTS,Inhibitory,3
3238,Antidepressive Agents,C0003289,en_356,TREATS(SPEC),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3239,Antidotes,C0003295,en_358,TREATS,Readiness,C1318963,en_5534,2,2,AFFECTS,Inhibitory,6
3240,Antifungal Agents,C0003308,en_360,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,6
3241,Antifungal Agents,C0003308,en_360,STIMULATES,Interferons,C0021747,en_1333,2,1,AFFECTS,Excitatory,3
3242,Antifungal Agents,C0003308,en_360,TREATS,Opportunistic Infections,C0029118,en_1712,1,1,AFFECTS,Inhibitory,3
3243,Antifungal Agents,C0003308,en_360,TREATS,Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,6
3244,Antifungal Agents,C0003308,en_360,TREATS,high-risk group,C0684030,en_4676,1,1,AFFECTS,Inhibitory,3
3245,Antigen-Antibody Complex,C0003313,en_361,AFFECTS,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
3246,Antigen-Presenting Cells,C0003315,en_362,PRODUCES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
3247,Epitopes,C0003316,en_363,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
3248,Epitopes,C0003316,en_363,PREDISPOSES,Complication of disease,C0544688,en_4265,1,1,AFFECTS,Excitatory,3
3249,Epitopes,C0003316,en_363,PREVENTS,Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
3250,Antigens,C0003320,en_365,AFFECTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,General/Uncertain,3
3251,Antigens,C0003320,en_365,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
3252,Antigens,C0003320,en_365,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
3253,Antigens,C0003320,en_365,AFFECTS,T-Lymphocyte,C0039194,en_2198,2,1,AFFECTS,General/Uncertain,3
3254,Antigens,C0003320,en_365,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
3255,Antigens,C0003320,en_365,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
3256,Antigens,C0003320,en_365,AFFECTS,Exhaustion,C0392674,en_3926,1,1,AFFECTS,General/Uncertain,3
3257,Antigens,C0003320,en_365,AUGMENTS,Immunity,C0020964,en_1273,3,3,AFFECTS,Excitatory,19
3258,Antigens,C0003320,en_365,DISRUPTS,acidification,C1522821,en_5907,2,1,AFFECTS,Inhibitory,3
3259,Antigens,C0003320,en_365,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3260,Antigens,C0003320,en_365,STIMULATES,TLR9,C1423633,en_135,1,1,AFFECTS,Excitatory,3
3261,Antigens,C0003320,en_365,STIMULATES,Triiodothyronine,C0041014,en_2283,2,1,AFFECTS,Excitatory,3
3262,Antigens,C0003320,en_365,STIMULATES,Interleukin-10,C0085295,en_2659,1,1,AFFECTS,Excitatory,3
3263,Antigens,C0003320,en_365,STIMULATES,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,1,1,AFFECTS,Excitatory,6
3264,"Antigens, Viral",C0003342,en_366,PREDISPOSES,Retinal Diseases,C0035309,en_2021,2,1,AFFECTS,Excitatory,3
3265,Antihistamines,C0003360,en_367,TREATS,Allergic Reaction,C1527304,en_5919,1,1,AFFECTS,Inhibitory,3
3266,Antihistamines,C0003360,en_367,TREATS(SPEC),Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Inhibitory,3
3267,Antihypertensive Agents,C0003364,en_368,AUGMENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
3268,Antihypertensive Agents,C0003364,en_368,AUGMENTS,density,C0178587,en_2987,1,1,AFFECTS,Excitatory,3
3269,Antihypertensive Agents,C0003364,en_368,DISRUPTS,Platelet aggregation,C0032176,en_1828,2,1,AFFECTS,Inhibitory,3
3270,Antihypertensive Agents,C0003364,en_368,INHIBITS,"Receptor, Angiotensin II",C0003011,en_329,1,1,AFFECTS,Inhibitory,3
3271,Antihypertensive Agents,C0003364,en_368,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,2,2,AFFECTS,Inhibitory,6
3272,Antihypertensive Agents,C0003364,en_368,INHIBITS,Angiotensin Receptor,C0034787,en_1963,1,1,AFFECTS,Inhibitory,3
3273,Antihypertensive Agents,C0003364,en_368,STIMULATES,ACE2,C1422064,en_5723,2,1,AFFECTS,Excitatory,3
3274,Antihypertensive Agents,C0003364,en_368,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,6
3275,Antihypertensive Agents,C0003364,en_368,TREATS,Discontinued,C1444662,en_5749,1,1,AFFECTS,Inhibitory,6
3276,Antihypertensive Agents,C0003364,en_368,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
3277,Antimalarials,C0003374,en_369,AFFECTS,Cardiac rhythm type,C0232187,en_3273,1,1,AFFECTS,General/Uncertain,3
3278,Antimalarials,C0003374,en_369,PREVENTS,Parasitic Diseases,C0030499,en_1748,1,1,AFFECTS,Inhibitory,3
3279,Antimalarials,C0003374,en_369,TREATS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,3
3280,Antimalarials,C0003374,en_369,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
3281,Antimalarials,C0003374,en_369,TREATS,HIV Infections,C0019693,en_1192,2,1,AFFECTS,Inhibitory,3
3282,Antimalarials,C0003374,en_369,TREATS,Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,3
3283,Antimalarials,C0003374,en_369,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3284,Antimalarials,C0003374,en_369,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,6
3285,Antimalarials,C0003374,en_369,TREATS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3286,Muscarinic Antagonists,C0003385,en_370,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,6
3287,Muscarinic Antagonists,C0003385,en_370,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
3288,Antineoplastic Agents,C0003392,en_371,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,7
3289,Antineoplastic Agents,C0003392,en_371,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
3290,Antineoplastic Agents,C0003392,en_371,INHIBITS,POLDIP2,C1428254,en_122,1,1,AFFECTS,Inhibitory,3
3291,Antineoplastic Agents,C0003392,en_371,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3292,Antineoplastic Agents,C0003392,en_371,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
3293,Antineoplastic Agents,C0003392,en_371,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,3
3294,Antineoplastic Agents,C0003392,en_371,TREATS(SPEC),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
3295,Antioxidants,C0003402,en_372,AFFECTS,Lipid Peroxidation,C0023775,en_1440,2,1,AFFECTS,General/Uncertain,3
3296,Antioxidants,C0003402,en_372,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,7
3297,Antioxidants,C0003402,en_372,AFFECTS,Neuropathic pain,C0423716,en_3989,1,1,AFFECTS,General/Uncertain,3
3298,Antioxidants,C0003402,en_372,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,8
3299,Antioxidants,C0003402,en_372,AFFECTS,cellular metabolism,C1523924,en_5913,1,1,AFFECTS,General/Uncertain,3
3300,Antioxidants,C0003402,en_372,DISRUPTS,Capillary Permeability,C0006906,en_551,1,1,AFFECTS,Inhibitory,3
3301,Antioxidants,C0003402,en_372,DISRUPTS,Lipid Peroxidation,C0023775,en_1440,1,1,AFFECTS,Inhibitory,3
3302,Antioxidants,C0003402,en_372,DISRUPTS,Platelet aggregation,C0032176,en_1828,1,1,AFFECTS,Inhibitory,3
3303,Antioxidants,C0003402,en_372,INHIBITS,ROS1,C0812281,en_74,1,1,AFFECTS,Inhibitory,3
3304,Antioxidants,C0003402,en_372,INHIBITS,Sphingolipids,C0037900,en_2142,1,1,AFFECTS,Inhibitory,6
3305,Antioxidants,C0003402,en_372,INHIBITS,TNF gene,C0812246,en_4896,1,1,AFFECTS,Inhibitory,3
3306,Antioxidants,C0003402,en_372,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
3307,Antioxidants,C0003402,en_372,PREVENTS,Pathological accumulation of air in tissues,C0013990,en_891,1,1,AFFECTS,Inhibitory,3
3308,Antioxidants,C0003402,en_372,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
3309,Antioxidants,C0003402,en_372,PREVENTS,Adverse reaction to antitussives,C0261908,en_3514,2,1,AFFECTS,Inhibitory,3
3310,Antioxidants,C0003402,en_372,STIMULATES,Interferons,C0021747,en_1333,2,1,AFFECTS,Excitatory,3
3311,Antioxidants,C0003402,en_372,STIMULATES,Lipopolysaccharides,C0023810,en_1443,1,1,AFFECTS,Excitatory,3
3312,Antioxidants,C0003402,en_372,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,3
3313,Antioxidants,C0003402,en_372,TREATS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
3314,Antioxidants,C0003402,en_372,TREATS,Orthomyxoviridae,C0029341,en_1720,2,1,AFFECTS,Inhibitory,3
3315,Antioxidants,C0003402,en_372,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
3316,Antioxidants,C0003402,en_372,TREATS,Septic Shock,C0036983,en_2101,2,1,AFFECTS,Inhibitory,3
3317,Antioxidants,C0003402,en_372,TREATS,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Inhibitory,3
3318,Antiparasitic Agents,C0003404,en_373,AFFECTS,Anosmia,C0003126,en_337,2,1,AFFECTS,General/Uncertain,3
3319,Antiparasitic Agents,C0003404,en_373,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
3320,Antiprotozoal Agents,C0003416,en_374,TREATS,Influenza,C0021400,en_1311,2,2,AFFECTS,Inhibitory,6
3321,Antiprotozoal Agents,C0003416,en_374,TREATS,Viral respiratory infection,C0729531,en_4763,2,2,AFFECTS,Inhibitory,6
3322,Antiprotozoal Agents,C0003416,en_374,TREATS(SPEC),Influenza,C0021400,en_1311,2,2,AFFECTS,Inhibitory,6
3323,Antipyretics,C0003419,en_375,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3324,Antipyretics,C0003419,en_375,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
3325,Antipyretics,C0003419,en_375,TREATS(INFER),Fever,C0015967,en_985,1,1,AFFECTS,Inhibitory,3
3326,Antithrombins,C0003440,en_376,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
3327,Antithrombins,C0003440,en_376,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3328,Antithrombins,C0003440,en_376,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3329,Antitoxins,C0003445,en_377,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
3330,Antitoxins,C0003445,en_377,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
3331,Antitussive Agents,C0003449,en_378,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
3332,Antiviral Agents,C0003451,en_379,AFFECTS,Cells,C0007634,en_596,2,1,AFFECTS,General/Uncertain,3
3333,Antiviral Agents,C0003451,en_379,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
3334,Antiviral Agents,C0003451,en_379,AFFECTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,General/Uncertain,3
3335,Antiviral Agents,C0003451,en_379,AFFECTS,Cardiac rhythm type,C0232187,en_3273,1,1,AFFECTS,General/Uncertain,3
3336,Antiviral Agents,C0003451,en_379,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
3337,Antiviral Agents,C0003451,en_379,AFFECTS,viral genome replication,C1160701,en_5361,1,1,AFFECTS,General/Uncertain,3
3338,Antiviral Agents,C0003451,en_379,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
3339,Antiviral Agents,C0003451,en_379,DISRUPTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
3340,Antiviral Agents,C0003451,en_379,DISRUPTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
3341,Antiviral Agents,C0003451,en_379,DISRUPTS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,7
3342,Antiviral Agents,C0003451,en_379,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
3343,Antiviral Agents,C0003451,en_379,DISRUPTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,7
3344,Antiviral Agents,C0003451,en_379,INHIBITS,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Inhibitory,3
3345,Antiviral Agents,C0003451,en_379,INHIBITS,Peptide Hydrolases,C0030940,en_1769,1,1,AFFECTS,Inhibitory,3
3346,Antiviral Agents,C0003451,en_379,INHIBITS,RNA-Directed RNA Polymerase,C0035685,en_2042,1,1,AFFECTS,Inhibitory,7
3347,Antiviral Agents,C0003451,en_379,INHIBITS,Polymerase,C1335439,en_5615,1,1,AFFECTS,Inhibitory,3
3348,Antiviral Agents,C0003451,en_379,INHIBITS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,7
3349,Antiviral Agents,C0003451,en_379,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
3350,Antiviral Agents,C0003451,en_379,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
3351,Antiviral Agents,C0003451,en_379,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
3352,Antiviral Agents,C0003451,en_379,TREATS,Animal Viruses,C0003060,en_334,1,1,AFFECTS,Inhibitory,3
3353,Antiviral Agents,C0003451,en_379,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
3354,Antiviral Agents,C0003451,en_379,TREATS,Disease,C0012634,en_826,8,7,AFFECTS,Inhibitory,24
3355,Antiviral Agents,C0003451,en_379,TREATS,Hepatitis C,C0019196,en_1177,2,2,AFFECTS,Inhibitory,6
3356,Antiviral Agents,C0003451,en_379,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
3357,Antiviral Agents,C0003451,en_379,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
3358,Antiviral Agents,C0003451,en_379,TREATS,Influenza,C0021400,en_1311,8,5,AFFECTS,Inhibitory,15
3359,Antiviral Agents,C0003451,en_379,TREATS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Inhibitory,6
3360,Antiviral Agents,C0003451,en_379,TREATS,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
3361,Antiviral Agents,C0003451,en_379,TREATS,Patients,C0030705,en_1762,12,8,AFFECTS,Inhibitory,24
3362,Antiviral Agents,C0003451,en_379,TREATS,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Inhibitory,3
3363,Antiviral Agents,C0003451,en_379,TREATS,RNA Viruses,C0035691,en_2044,1,1,AFFECTS,Inhibitory,3
3364,Antiviral Agents,C0003451,en_379,TREATS,Superinfection,C0038826,en_2184,1,1,AFFECTS,Inhibitory,3
3365,Antiviral Agents,C0003451,en_379,TREATS,Virus Diseases,C0042769,en_2362,5,4,AFFECTS,Inhibitory,12
3366,Antiviral Agents,C0003451,en_379,TREATS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
3367,Antiviral Agents,C0003451,en_379,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,7
3368,Antiviral Agents,C0003451,en_379,TREATS,Hepatitis C virus,C0220847,en_3204,1,1,AFFECTS,Inhibitory,3
3369,Antiviral Agents,C0003451,en_379,TREATS,Clinical Syndromes,C0221444,en_3225,1,1,AFFECTS,Inhibitory,7
3370,Antiviral Agents,C0003451,en_379,TREATS,Possible,C0332149,en_3747,1,1,AFFECTS,Inhibitory,7
3371,Antiviral Agents,C0003451,en_379,TREATS,Acute respiratory infection NOS,C0339901,en_3809,2,1,AFFECTS,Inhibitory,3
3372,Antiviral Agents,C0003451,en_379,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
3373,Antiviral Agents,C0003451,en_379,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
3374,Antiviral Agents,C0003451,en_379,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
3375,Antiviral Agents,C0003451,en_379,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
3376,Antiviral Agents,C0003451,en_379,TREATS,COVID-19,C5203670,en_6417,7,7,AFFECTS,Inhibitory,53
3377,Antiviral Agents,C0003451,en_379,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
3378,Antiviral Agents,C0003451,en_379,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
3379,Anxiety,C0003467,en_380,AFFECTS,Child,C0008059,en_620,2,2,AFFECTS,General/Uncertain,14
3380,Anxiety,C0003467,en_380,AFFECTS,Sex Behavior,C0036864,en_2093,1,1,AFFECTS,General/Uncertain,6
3381,Anxiety,C0003467,en_380,AFFECTS,wave,C0678544,en_4560,1,1,AFFECTS,General/Uncertain,6
3382,Anxiety,C0003467,en_380,AFFECTS,Psychosocial problem,C0740697,en_4781,1,1,AFFECTS,General/Uncertain,7
3383,Anxiety,C0003467,en_380,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
3384,Anxiety Disorders,C0003469,en_381,AFFECTS,Pregnancy,C0032961,en_1872,2,1,AFFECTS,General/Uncertain,3
3385,Anxiety Disorders,C0003469,en_381,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
3386,Anxiety Disorders,C0003469,en_381,AFFECTS,myelination,C0596991,en_4407,1,1,AFFECTS,General/Uncertain,3
3387,Aortic valve replacement NOS,C0003506,en_383,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
3388,Aortic valve replacement NOS,C0003506,en_383,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3389,Aortic valve replacement NOS,C0003506,en_383,TREATS(INFER),Aortic Valve Stenosis,C0003507,en_384,1,1,AFFECTS,Inhibitory,3
3390,Apnea,C0003578,en_385,PREDISPOSES,Coronary Arteriosclerosis,C0010054,en_717,1,1,AFFECTS,Excitatory,6
3391,Appendectomy,C0003611,en_386,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
3392,Appendectomy,C0003611,en_386,TREATS,Acute appendicitis NOS,C0085693,en_2687,5,2,AFFECTS,Inhibitory,6
3393,Appendectomy,C0003611,en_386,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,12
3394,Appendectomy,C0003611,en_386,TREATS,World,C2700280,en_6119,1,1,AFFECTS,Inhibitory,6
3395,Appendicitis,C0003615,en_387,AFFECTS,Complication,C0009566,en_697,2,1,AFFECTS,General/Uncertain,3
3396,Appendicitis,C0003615,en_387,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,6
3397,Desire for food,C0003618,en_388,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
3398,Aprotinin,C0003641,en_389,DISRUPTS,Fibrinolysis,C0016017,en_990,1,1,AFFECTS,Inhibitory,8
3399,Aprotinin,C0003641,en_389,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
3400,Aprotinin,C0003641,en_389,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3401,Aprotinin,C0003641,en_389,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3402,Arachidonate 5-Lipoxygenase|ALOX5,C0003693|240,en_390,PRODUCES,lipid mediator,C0599745,en_4468,1,1,AFFECTS,Excitatory,7
3403,Arachidonate 5-Lipoxygenase|ALOX5,C0003693|240,en_390,PRODUCES,ALOX12 gene|ALOX12,C1412356|239,en_5698,1,1,AFFECTS,Excitatory,7
3404,Arachidonate 5-Lipoxygenase|ALOX5,C0003693|240,en_390,PRODUCES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human|PTGS2",C1565860|5743,en_5985,1,1,AFFECTS,Excitatory,7
3405,ARGINASE,C0003762,en_393,INHIBITS,Arginine,C0003765,en_394,1,1,AFFECTS,Inhibitory,3
3406,ARGINASE,C0003762,en_393,INHIBITS,Citrulline,C0008864,en_650,1,1,AFFECTS,Inhibitory,3
3407,Arginine,C0003765,en_394,DISRUPTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Inhibitory,6
3408,Arginine,C0003765,en_394,DISRUPTS,Endothelial Cells,C0225336,en_3237,1,1,AFFECTS,Inhibitory,6
3409,Arginine,C0003765,en_394,INHIBITS,T-Cell Receptor,C0034790,en_1965,1,1,AFFECTS,Inhibitory,6
3410,Arginine,C0003765,en_394,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
3411,Arginine,C0003765,en_394,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
3412,Arginine,C0003765,en_394,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,7
3413,Arginine,C0003765,en_394,TREATS,COVID-19,C5203670,en_6417,3,1,AFFECTS,Inhibitory,7
3414,Arginine,C0003765,en_394,TREATS,pediatric inflammatory multisystem syndrome,C5389369,en_6437,1,1,AFFECTS,Inhibitory,7
3415,Arginine,C0003765,en_394,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
3416,Arginine,C0003765,en_394,DISRUPTS,Pulmonary Vascular Resistance,C0456261,en_4118,1,1,AFFECTS,Inhibitory,3
3417,Arginine,C0003765,en_394,PREDISPOSES,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Excitatory,3
3418,DOPA decarboxylase,C0003806,en_396,PRODUCES,Dopamine,C0013030,en_842,2,1,AFFECTS,Excitatory,3
3419,DOPA decarboxylase,C0003806,en_396,PRODUCES,Neurotransmitters,C0027908,en_1674,2,1,AFFECTS,Excitatory,3
3420,DOPA decarboxylase,C0003806,en_396,PRODUCES,Serotonin,C0036751,en_2090,2,1,AFFECTS,Excitatory,3
3421,DOPA decarboxylase,C0003806,en_396,PRODUCES(SPEC),Dopamine,C0013030,en_842,2,1,AFFECTS,Excitatory,3
3422,DOPA decarboxylase,C0003806,en_396,PRODUCES(SPEC),Serotonin,C0036751,en_2090,2,1,AFFECTS,Excitatory,3
3423,cardiac arrhythmia,C0003811,en_397,AFFECTS,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
3424,cardiac arrhythmia,C0003811,en_397,AFFECTS,Individual,C0237401,en_3343,2,2,AFFECTS,General/Uncertain,6
3425,Arteriosclerosis,C0003850,en_399,AFFECTS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,General/Uncertain,3
3426,Arthritis,C0003864,en_400,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
3427,Arthritis,C0003864,en_400,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
3428,Arthritis,C0003864,en_400,PRODUCES,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Excitatory,3
3429,"Arthritis, Psoriatic",C0003872,en_401,PREDISPOSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
3430,Rheumatoid Arthritis,C0003873,en_402,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
3431,Rheumatoid Arthritis,C0003873,en_402,DISRUPTS,Down-Regulation,C0013081,en_844,5,3,AFFECTS,Inhibitory,9
3432,Rheumatoid Arthritis,C0003873,en_402,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
3433,Rheumatoid Arthritis,C0003873,en_402,PREDISPOSES,Personal Satisfaction,C0031206,en_1780,2,1,AFFECTS,Excitatory,3
3434,Arthroplasty,C0003893,en_403,TREATS,state of health,C0683314,en_4656,1,1,AFFECTS,Inhibitory,6
3435,Ascorbic Acid,C0003968,en_405,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3436,Ascorbic Acid,C0003968,en_405,TREATS,Disease,C0012634,en_826,7,4,AFFECTS,Inhibitory,16
3437,Ascorbic Acid,C0003968,en_405,TREATS,Healthy Volunteers,C1708335,en_6036,1,1,AFFECTS,Inhibitory,7
3438,Ascorbic Acid,C0003968,en_405,AFFECTS,Common Cold,C0009443,en_684,2,1,AFFECTS,General/Uncertain,3
3439,Ascorbic Acid,C0003968,en_405,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
3440,Ascorbic Acid,C0003968,en_405,AFFECTS,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,General/Uncertain,3
3441,Ascorbic Acid,C0003968,en_405,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
3442,Ascorbic Acid,C0003968,en_405,AFFECTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
3443,Ascorbic Acid,C0003968,en_405,AUGMENTS,Lymphocyte Activation,C0024262,en_1468,2,1,AFFECTS,Excitatory,3
3444,Ascorbic Acid,C0003968,en_405,AUGMENTS,Lymphocyte,C0024264,en_1469,2,1,AFFECTS,Excitatory,3
3445,Ascorbic Acid,C0003968,en_405,AUGMENTS,Signal Transduction,C0037083,en_2105,2,1,AFFECTS,Excitatory,3
3446,Ascorbic Acid,C0003968,en_405,DISRUPTS,tumor growth,C0598934,en_4455,1,1,AFFECTS,Inhibitory,3
3447,Ascorbic Acid,C0003968,en_405,INHIBITS,ROS1,C0812281,en_74,1,1,AFFECTS,Inhibitory,3
3448,Ascorbic Acid,C0003968,en_405,INHIBITS,Superoxides,C0038836,en_2185,1,1,AFFECTS,Inhibitory,3
3449,Ascorbic Acid,C0003968,en_405,INHIBITS,Intercellular adhesion molecule 1,C0063695,en_2507,1,1,AFFECTS,Inhibitory,3
3450,Ascorbic Acid,C0003968,en_405,INHIBITS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,Inhibitory,3
3451,Ascorbic Acid,C0003968,en_405,PREVENTS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Inhibitory,3
3452,Ascorbic Acid,C0003968,en_405,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
3453,Ascorbic Acid,C0003968,en_405,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
3454,Ascorbic Acid,C0003968,en_405,TREATS,Patients,C0030705,en_1762,16,9,AFFECTS,Inhibitory,27
3455,Ascorbic Acid,C0003968,en_405,TREATS,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Inhibitory,3
3456,Ascorbic Acid,C0003968,en_405,TREATS,Respiration Disorders,C0035204,en_2005,2,1,AFFECTS,Inhibitory,3
3457,Ascorbic Acid,C0003968,en_405,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
3458,Ascorbic Acid,C0003968,en_405,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
3459,Ascorbic Acid,C0003968,en_405,TREATS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Inhibitory,3
3460,Ascorbic Acid,C0003968,en_405,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
3461,Ascorbic Acid,C0003968,en_405,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
3462,Ascorbic Acid,C0003968,en_405,TREATS,Hospitalized Patients,C0870668,en_5010,3,1,AFFECTS,Inhibitory,3
3463,Ascorbic Acid,C0003968,en_405,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
3464,Ascorbic Acid,C0003968,en_405,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
3465,Ascorbic Acid,C0003968,en_405,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
3466,Ascorbic Acid,C0003968,en_405,TREATS(INFER),Septicemia,C0036690,en_2086,3,2,AFFECTS,Inhibitory,6
3467,Ascorbic Acid,C0003968,en_405,TREATS(INFER),Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
3468,Ascorbic Acid,C0003968,en_405,TREATS(INFER),CANCER END STAGE,C0741884,en_4790,1,1,AFFECTS,Inhibitory,3
3469,Aspartate Transaminase,C0004002,en_408,PREDISPOSES,Liver damage,C0151763,en_2867,1,1,AFFECTS,Excitatory,6
3470,Aspartate Transaminase,C0004002,en_408,AUGMENTS,Fatty Liver,C0015695,en_973,1,1,AFFECTS,Excitatory,3
3471,Aspartate Transaminase,C0004002,en_408,INHIBITS,Albumins,C0001924,en_267,1,1,AFFECTS,Inhibitory,3
3472,Aspartate Transaminase,C0004002,en_408,INHIBITS,Hemoglobin,C0019046,en_1159,1,1,AFFECTS,Inhibitory,3
3473,Inspiration function,C0004048,en_413,PRODUCES,Body Fluids,C0005889,en_496,1,1,AFFECTS,Excitatory,7
3474,Inspiration function,C0004048,en_413,AFFECTS,Cerebrovascular Circulation,C0007818,en_606,1,1,AFFECTS,General/Uncertain,3
3475,Inspiration function,C0004048,en_413,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
3476,Inspiration function,C0004048,en_413,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
3477,Inspiration function,C0004048,en_413,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
3478,Aspirin,C0004057,en_414,AFFECTS,Hypertension induced by pregnancy,C0340274,en_3815,1,1,AFFECTS,General/Uncertain,3
3479,Aspirin,C0004057,en_414,AFFECTS,Platelet function,C1254881,en_5398,1,1,AFFECTS,General/Uncertain,3
3480,Aspirin,C0004057,en_414,DISRUPTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3481,Aspirin,C0004057,en_414,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
3482,Aspirin,C0004057,en_414,DISRUPTS,Virus Replication,C0042774,en_2363,3,1,AFFECTS,Inhibitory,3
3483,Aspirin,C0004057,en_414,INHIBITS,cyclooxygenase 1,C0389003,en_3906,1,1,AFFECTS,Inhibitory,3
3484,Aspirin,C0004057,en_414,PREDISPOSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
3485,Aspirin,C0004057,en_414,PREVENTS,Complication,C0009566,en_697,3,1,AFFECTS,Inhibitory,3
3486,Aspirin,C0004057,en_414,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3487,Aspirin,C0004057,en_414,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,6
3488,Aspirin,C0004057,en_414,PREVENTS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
3489,Aspirin,C0004057,en_414,PREVENTS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,6
3490,Aspirin,C0004057,en_414,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
3491,Aspirin,C0004057,en_414,PREVENTS,Thrombosis,C0040053,en_2233,3,1,AFFECTS,Inhibitory,3
3492,Aspirin,C0004057,en_414,TREATS,Inflammation,C0021368,en_1307,4,1,AFFECTS,Inhibitory,3
3493,Aspirin,C0004057,en_414,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
3494,Aspirin,C0004057,en_414,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
3495,Aspirin,C0004057,en_414,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
3496,Aspirin,C0004057,en_414,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
3497,Aspirin,C0004057,en_414,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
3498,Aspirin,C0004057,en_414,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,23
3499,Assault,C0004063,en_415,DISRUPTS,Virion,C0042760,en_2360,1,1,AFFECTS,Inhibitory,8
3500,Asthenia,C0004093,en_416,PREDISPOSES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Excitatory,3
3501,Asthenopia,C0004095,en_417,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,8
3502,Asthma,C0004096,en_418,AFFECTS,Adult,C0001675,en_252,2,2,AFFECTS,General/Uncertain,6
3503,Asthma,C0004096,en_418,AFFECTS,Child,C0008059,en_620,2,2,AFFECTS,General/Uncertain,6
3504,Asthma,C0004096,en_418,AFFECTS,African race,C0027567,en_1646,1,1,AFFECTS,General/Uncertain,3
3505,Asthma,C0004096,en_418,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
3506,Asthma,C0004096,en_418,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,6
3507,Asthma,C0004096,en_418,COMPLICATES,Coronavirus Infections,C0206750,en_3176,3,1,AFFECTS,General/Uncertain,3
3508,Asthma,C0004096,en_418,PREDISPOSES,Unipolar Depression,C0041696,en_2310,1,1,AFFECTS,Excitatory,6
3509,Asthma,C0004096,en_418,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
3510,Asthma,C0004096,en_418,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,7
3511,Astrocytes,C0004112,en_419,PRODUCES,Biotin,C0005575,en_473,1,1,AFFECTS,Excitatory,3
3512,Astrocytes,C0004112,en_419,PRODUCES,Glutamates,C0017789,en_1074,1,1,AFFECTS,Excitatory,3
3513,Atherosclerosis,C0004153,en_421,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
3514,Atherosclerosis,C0004153,en_421,AFFECTS,Candida,C0006836,en_546,1,1,AFFECTS,General/Uncertain,3
3515,Atherosclerosis,C0004153,en_421,AFFECTS,Genus staphylococcus,C0038170,en_2153,1,1,AFFECTS,General/Uncertain,3
3516,Atherosclerosis,C0004153,en_421,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
3517,Atherosclerosis,C0004153,en_421,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
3518,Atrial Fibrillation,C0004238,en_423,PREDISPOSES,Present,C0150312,en_2833,1,1,AFFECTS,Excitatory,6
3519,Atrial Fibrillation,C0004238,en_423,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
3520,Atrial Fibrillation,C0004238,en_423,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,8
3521,Atrial Fibrillation,C0004238,en_423,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
3522,Atrial Fibrillation,C0004238,en_423,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
3523,Atrial Fibrillation,C0004238,en_423,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
3524,Atrial Fibrillation,C0004238,en_423,AFFECTS(SPEC),Individual,C0237401,en_3343,2,2,AFFECTS,General/Uncertain,6
3525,Atrial Fibrillation,C0004238,en_423,PREDISPOSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
3526,Atrial Fibrillation,C0004238,en_423,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,2,2,AFFECTS,Excitatory,6
3527,Autistic Disorder,C0004352,en_425,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
3528,Autoantibodies,C0004358,en_426,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
3529,Autoantibodies,C0004358,en_426,AFFECTS,receptor activity,C1152633,en_5307,1,1,AFFECTS,General/Uncertain,3
3530,Autoantibodies,C0004358,en_426,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
3531,Autoantibodies,C0004358,en_426,PREDISPOSES,cell injury,C0599732,en_4467,1,1,AFFECTS,Excitatory,3
3532,Autoantibodies,C0004358,en_426,STIMULATES,Topoisomerase,C1336767,en_5640,1,1,AFFECTS,Excitatory,3
3533,Autoantibodies,C0004358,en_426,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3534,Autoantigens,C0004359,en_427,AFFECTS,Endothelium,C0014257,en_902,1,1,AFFECTS,General/Uncertain,3
3535,Autoantigens,C0004359,en_427,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
3536,Autoimmune Diseases,C0004364,en_428,AFFECTS,Cell Death,C0007587,en_587,1,1,AFFECTS,General/Uncertain,3
3537,Autoimmune Diseases,C0004364,en_428,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
3538,Autoimmune Diseases,C0004364,en_428,AFFECTS,Decreased renal function,C0232807,en_3287,1,1,AFFECTS,General/Uncertain,3
3539,Autoimmune Diseases,C0004364,en_428,AFFECTS,American,C0596070,en_4379,1,1,AFFECTS,General/Uncertain,3
3540,Autoimmune Diseases,C0004364,en_428,AUGMENTS,Disease,C0012634,en_826,4,1,AFFECTS,Excitatory,3
3541,Autoimmune Diseases,C0004364,en_428,PRODUCES,Autoantibodies,C0004358,en_426,1,1,AFFECTS,Excitatory,3
3542,Autoimmune Diseases,C0004364,en_428,PRODUCES,Hydrocortisone,C0020268,en_1219,1,1,AFFECTS,Excitatory,3
3543,Autoimmune Response,C0004366,en_429,PRODUCES,Autoantibodies,C0004358,en_426,1,1,AFFECTS,Excitatory,3
3544,Autoimmunity,C0004368,en_430,AFFECTS,Growth,C0018270,en_1098,2,1,AFFECTS,General/Uncertain,3
3545,Autoimmunity,C0004368,en_430,AFFECTS,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
3546,Autoimmunity,C0004368,en_430,PRODUCES,Autoantibodies,C0004358,en_426,1,1,AFFECTS,Excitatory,3
3547,Autoimmunity,C0004368,en_430,PRODUCES,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Excitatory,3
3548,Vehicle Emissions,C0004380,en_431,STIMULATES,Nitrogen,C0028158,en_1684,2,1,AFFECTS,Excitatory,3
3549,Autophagy,C0004391,en_432,AFFECTS,Bioenergetics,C0005486,en_464,1,1,AFFECTS,General/Uncertain,3
3550,Autophagy,C0004391,en_432,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
3551,Autophagy,C0004391,en_432,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
3552,Autophagy,C0004391,en_432,AFFECTS,Antiviral Response,C1155328,en_5322,2,1,AFFECTS,General/Uncertain,3
3553,B-Lymphocytes,C0004561,en_434,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
3554,B-Lymphocytes,C0004561,en_434,AFFECTS,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
3555,B-Lymphocytes,C0004561,en_434,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
3556,B-Lymphocytes,C0004561,en_434,PRODUCES,"CD79A,LOC102723407",C1413238,en_191,3,2,AFFECTS,Excitatory,6
3557,B-Lymphocytes,C0004561,en_434,PRODUCES,Antibodies,C0003241,en_347,5,4,AFFECTS,Excitatory,12
3558,B-Lymphocytes,C0004561,en_434,PRODUCES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
3559,B-Lymphocytes,C0004561,en_434,PRODUCES,Autoantibodies,C0004358,en_426,2,2,AFFECTS,Excitatory,6
3560,B-Lymphocytes,C0004561,en_434,PRODUCES,Immunoglobulin A|CD79A|LOC102723407,C0020835|973|102723407,en_1260,1,1,AFFECTS,Excitatory,7
3561,B-Lymphocytes,C0004561,en_434,PRODUCES,IgA1,C0020840,en_1262,1,1,AFFECTS,Excitatory,3
3562,B-Lymphocytes,C0004561,en_434,PRODUCES,Specific antibody,C0443640,en_4068,1,1,AFFECTS,Excitatory,3
3563,B-Lymphocytes,C0004561,en_434,PRODUCES,trypsin-like serine protease,C0758336,en_4862,1,1,AFFECTS,Excitatory,3
3564,B-Lymphocytes,C0004561,en_434,PRODUCES,TLR7 gene,C1336639,en_5634,1,1,AFFECTS,Excitatory,3
3565,B-Lymphocytes,C0004561,en_434,PRODUCES,CD40LG wt Allele|CD40LG,C1706005|959,en_6032,1,1,AFFECTS,Excitatory,7
3566,Bacillus subtilis,C0004595,en_435,PRODUCES,Recombinant Proteins,C0034861,en_1981,1,1,AFFECTS,Excitatory,3
3567,Bacitracin,C0004599,en_436,PREVENTS,Surgical Wound Infection,C0038941,en_2192,2,1,AFFECTS,Inhibitory,8
3568,Baclofen,C0004609,en_438,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
3569,Bacteria,C0004611,en_440,PRODUCES,Cord Factors,C0010004,en_716,1,1,AFFECTS,Excitatory,3
3570,Bacteria,C0004611,en_440,PRODUCES,"Fatty Acids, Volatile",C0015691,en_972,1,1,AFFECTS,Excitatory,3
3571,Bacterial Infections,C0004623,en_441,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
3572,Bacterial Infections,C0004623,en_441,COMPLICATES,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,6
3573,Bacterial Proteins,C0004627,en_443,PREVENTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
3574,Bacterial Proteins,C0004627,en_443,PRODUCES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
3575,Balneology,C0004710,en_445,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3576,BCG Vaccine,C0004886,en_448,AUGMENTS,Protection,C1545588,en_5951,2,1,AFFECTS,Excitatory,7
3577,BCG Vaccine,C0004886,en_448,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
3578,BCG Vaccine,C0004886,en_448,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
3579,BCG Vaccine,C0004886,en_448,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,Inhibitory,3
3580,BCG Vaccine,C0004886,en_448,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
3581,BCG Vaccine,C0004886,en_448,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
3582,BCG Vaccine,C0004886,en_448,TREATS,Malignant neoplasm of urinary bladder,C0005684,en_479,1,1,AFFECTS,Inhibitory,3
3583,BCG Vaccine,C0004886,en_448,TREATS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,Inhibitory,3
3584,BCG Vaccine,C0004886,en_448,TREATS,Mycobacterium tuberculosis,C0026926,en_1618,1,1,AFFECTS,Inhibitory,3
3585,BCG Vaccine,C0004886,en_448,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
3586,Bed rest,C0004910,en_449,AFFECTS,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,3
3587,Bed rest,C0004910,en_449,COMPLICATES,Myopathy,C0026848,en_1605,1,1,AFFECTS,General/Uncertain,3
3588,Bed rest,C0004910,en_449,PREVENTS,Thromboembolism,C0040038,en_2230,1,1,AFFECTS,Inhibitory,3
3589,Behavior,C0004927,en_450,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,3
3590,Behavior,C0004927,en_450,AFFECTS,Conception,C0009637,en_701,1,1,AFFECTS,General/Uncertain,3
3591,Behavior,C0004927,en_450,AFFECTS,Health behavior,C0018687,en_1116,1,1,AFFECTS,General/Uncertain,3
3592,Behavior,C0004927,en_450,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,3
3593,Behavior,C0004927,en_450,AFFECTS,Pregnancy,C0032961,en_1872,3,2,AFFECTS,General/Uncertain,6
3594,Behavior,C0004927,en_450,AFFECTS,Vision,C0042789,en_2366,1,1,AFFECTS,General/Uncertain,3
3595,Behavior,C0004927,en_450,AFFECTS,Family Violence,C0206072,en_3143,1,1,AFFECTS,General/Uncertain,3
3596,Behavior,C0004927,en_450,AFFECTS,Performance,C0597198,en_4416,2,2,AFFECTS,General/Uncertain,6
3597,Behavior,C0004927,en_450,AFFECTS,Childbirth,C1148523,en_5296,2,1,AFFECTS,General/Uncertain,3
3598,Behavior,C0004927,en_450,AFFECTS,Smoking Behavior,C1519383,en_5884,1,1,AFFECTS,General/Uncertain,3
3599,Behavior,C0004927,en_450,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
3600,Behavior Therapy,C0004933,en_451,AFFECTS,uptake,C0243144,en_3467,3,2,AFFECTS,General/Uncertain,11
3601,Behavior Therapy,C0004933,en_451,PREVENTS,Social fear,C0424166,en_3991,1,1,AFFECTS,Inhibitory,3
3602,Behavior Therapy,C0004933,en_451,TREATS,alcohol use disorder,C0001956,en_270,3,2,AFFECTS,Inhibitory,6
3603,Behavior Therapy,C0004933,en_451,TREATS,Borderline Personality Disorder,C0006012,en_504,1,1,AFFECTS,Inhibitory,3
3604,Behavior Therapy,C0004933,en_451,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
3605,Behavior Therapy,C0004933,en_451,TREATS,Depressive disorder,C0011581,en_788,2,2,AFFECTS,Inhibitory,6
3606,Behavior Therapy,C0004933,en_451,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3607,Behavior Therapy,C0004933,en_451,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,7
3608,Behavior Therapy,C0004933,en_451,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
3609,Behavior Therapy,C0004933,en_451,TREATS,"Phobia, Social",C0031572,en_1793,1,1,AFFECTS,Inhibitory,3
3610,Behavior Therapy,C0004933,en_451,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
3611,Behavior Therapy,C0004933,en_451,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
3612,Behavior Therapy,C0004933,en_451,TREATS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,3
3613,Behavior Therapy,C0004933,en_451,TREATS,Social fear,C0424166,en_3991,3,1,AFFECTS,Inhibitory,3
3614,Behavior Therapy,C0004933,en_451,TREATS,Toddler,C0682053,en_4633,2,2,AFFECTS,Inhibitory,6
3615,Behavior Therapy,C0004933,en_451,TREATS,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,3
3616,Behavior Therapy,C0004933,en_451,TREATS(INFER),Sleep Disorders,C0851578,en_4954,1,1,AFFECTS,Inhibitory,3
3617,Behavior Therapy,C0004933,en_451,TREATS(INFER),Autism spectrum disorder,C1510586,en_5799,2,2,AFFECTS,Inhibitory,6
3618,Behavior Therapy,C0004933,en_451,TREATS(SPEC),Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
3619,Mental disorders,C0004936,en_452,AFFECTS,Elderly,C0001792,en_258,2,1,AFFECTS,General/Uncertain,3
3620,Mental disorders,C0004936,en_452,AFFECTS,Child,C0008059,en_620,3,2,AFFECTS,General/Uncertain,6
3621,Mental disorders,C0004936,en_452,AFFECTS,Mothers,C0026591,en_1583,2,1,AFFECTS,General/Uncertain,3
3622,Mental disorders,C0004936,en_452,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
3623,Mental disorders,C0004936,en_452,AFFECTS,Outpatients,C0029921,en_1729,2,1,AFFECTS,General/Uncertain,3
3624,Mental disorders,C0004936,en_452,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
3625,Mental disorders,C0004936,en_452,AFFECTS,student,C0038492,en_2171,1,1,AFFECTS,General/Uncertain,3
3626,Mental disorders,C0004936,en_452,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,3
3627,Mental disorders,C0004936,en_452,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
3628,Mental disorders,C0004936,en_452,AFFECTS,Participant,C0679646,en_4602,2,1,AFFECTS,General/Uncertain,3
3629,Mental disorders,C0004936,en_452,AFFECTS,participation,C0679823,en_4613,2,1,AFFECTS,General/Uncertain,3
3630,Mental disorders,C0004936,en_452,AFFECTS,Staff,C0851286,en_4950,1,1,AFFECTS,General/Uncertain,3
3631,Benzalkonium Chloride,C0005026,en_454,STIMULATES,Carrier Proteins,C0007292,en_573,1,1,AFFECTS,Excitatory,3
3632,Benzodiazepines,C0005064,en_456,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3633,Benzodiazepines,C0005064,en_456,TREATS,"Stress Disorders, Traumatic",C0038441,en_2167,1,1,AFFECTS,Inhibitory,3
3634,Benzodiazepines,C0005064,en_456,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
3635,Benzodiazepines,C0005064,en_456,TREATS(SPEC),Generalized Anxiety Disorder,C0270549,en_3551,1,1,AFFECTS,Inhibitory,3
3636,Berberine,C0005117,en_457,AFFECTS,Intestines,C0021853,en_1350,2,1,AFFECTS,General/Uncertain,3
3637,Berberine,C0005117,en_457,INHIBITS,Alkaline Phosphatase,C0002059,en_275,2,1,AFFECTS,Inhibitory,3
3638,Berberine,C0005117,en_457,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
3639,beta-Endorphin,C0005210,en_459,AUGMENTS,wave,C0678544,en_4560,1,1,AFFECTS,Excitatory,3
3640,Betamethasone,C0005308,en_460,AUGMENTS,Anosmia,C0003126,en_337,1,1,AFFECTS,Excitatory,8
3641,Betamethasone,C0005308,en_460,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,8
3642,Bicarbonates,C0005367,en_461,DISRUPTS,Injury,C0175677,en_2968,3,1,AFFECTS,Inhibitory,3
3643,Bile Acids,C0005390,en_462,AFFECTS,Emulsification,C0221105,en_3217,1,1,AFFECTS,General/Uncertain,3
3644,Bilirubin,C0005437,en_463,AFFECTS,"Biological function, NOS",C0277784,en_3587,2,2,AFFECTS,General/Uncertain,6
3645,Bilirubin,C0005437,en_463,PREDISPOSES,Mediastinal Emphysema,C0025062,en_1514,1,1,AFFECTS,Excitatory,6
3646,Biofeedback,C0005491,en_465,AFFECTS,Eating,C0013470,en_870,2,1,AFFECTS,General/Uncertain,3
3647,Biofeedback,C0005491,en_465,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
3648,Biofeedback,C0005491,en_465,TREATS,Voice Disorders,C0042940,en_2378,1,1,AFFECTS,Inhibitory,3
3649,Biofeedback,C0005491,en_465,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
3650,Biological Factors,C0005515,en_467,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
3651,Biological Factors,C0005515,en_467,PREVENTS,Neonatal calf diarrhea,C0276467,en_3578,1,1,AFFECTS,Inhibitory,8
3652,Biological Markers,C0005516,en_468,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,8
3653,Biological Markers,C0005516,en_468,PREDISPOSES,COVID-19,C5203670,en_6417,3,3,AFFECTS,Excitatory,18
3654,Biological Products,C0005522,en_469,AFFECTS,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,General/Uncertain,3
3655,Biological Products,C0005522,en_469,AFFECTS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,General/Uncertain,3
3656,Biological Products,C0005522,en_469,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
3657,Biological Products,C0005522,en_469,INHIBITS,Cytochromes,C0010798,en_749,1,1,AFFECTS,Inhibitory,3
3658,Biological Products,C0005522,en_469,INHIBITS,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Inhibitory,3
3659,Biological Products,C0005522,en_469,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
3660,Biological Products,C0005522,en_469,INHIBITS(SPEC),Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
3661,Biological Products,C0005522,en_469,PREVENTS(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
3662,Biological Products,C0005522,en_469,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
3663,Biological Products,C0005522,en_469,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
3664,Biological Products,C0005522,en_469,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
3665,Biological Products,C0005522,en_469,TREATS,Malaria,C0024530,en_1493,2,1,AFFECTS,Inhibitory,3
3666,Biological Products,C0005522,en_469,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3667,Biological Products,C0005522,en_469,TREATS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,3
3668,Biological Products,C0005522,en_469,TREATS,Sterility,C0678108,en_4552,1,1,AFFECTS,Inhibitory,3
3669,Biological Response Modifiers,C0005525,en_470,TREATS,Solid tumor,C0280100,en_3619,2,1,AFFECTS,Inhibitory,7
3670,Biological Response Modifiers,C0005525,en_470,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
3671,Biological Response Modifiers,C0005525,en_470,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,15
3672,Biological Response Modifiers,C0005525,en_470,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
3673,Biological Response Modifiers,C0005525,en_470,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
3674,Biological Response Modifiers,C0005525,en_470,AFFECTS,"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,General/Uncertain,3
3675,Biological Response Modifiers,C0005525,en_470,AFFECTS,Stem cells,C0038250,en_2158,1,1,AFFECTS,General/Uncertain,3
3676,Biological Response Modifiers,C0005525,en_470,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
3677,Biological Response Modifiers,C0005525,en_470,AFFECTS,Vesicle,C0333262,en_3759,1,1,AFFECTS,General/Uncertain,3
3678,Biological Response Modifiers,C0005525,en_470,AFFECTS,Virus-like particles,C0333785,en_3772,1,1,AFFECTS,General/Uncertain,3
3679,Biological Response Modifiers,C0005525,en_470,AFFECTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
3680,Biological Response Modifiers,C0005525,en_470,AFFECTS(SPEC),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
3681,Biological Response Modifiers,C0005525,en_470,AFFECTS(SPEC),Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
3682,Biological Response Modifiers,C0005525,en_470,AUGMENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
3683,Biological Response Modifiers,C0005525,en_470,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
3684,Biological Response Modifiers,C0005525,en_470,AUGMENTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Excitatory,3
3685,Biological Response Modifiers,C0005525,en_470,DISRUPTS,Lung,C0024109,en_1460,1,1,AFFECTS,Inhibitory,3
3686,Biological Response Modifiers,C0005525,en_470,DISRUPTS,Immune response,C0301872,en_3696,2,1,AFFECTS,Inhibitory,3
3687,Biological Response Modifiers,C0005525,en_470,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
3688,Biological Response Modifiers,C0005525,en_470,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
3689,Biological Response Modifiers,C0005525,en_470,PREVENTS,Inflammation,C0021368,en_1307,3,2,AFFECTS,Inhibitory,6
3690,Biological Response Modifiers,C0005525,en_470,PREVENTS,Reperfusion Injury,C0035126,en_1999,2,1,AFFECTS,Inhibitory,3
3691,Biological Response Modifiers,C0005525,en_470,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
3692,Biological Response Modifiers,C0005525,en_470,PREVENTS,Thrombus,C0087086,en_2743,1,1,AFFECTS,Inhibitory,3
3693,Biological Response Modifiers,C0005525,en_470,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
3694,Biological Response Modifiers,C0005525,en_470,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
3695,Biological Response Modifiers,C0005525,en_470,TREATS,Couples,C0010222,en_725,1,1,AFFECTS,Inhibitory,3
3696,Biological Response Modifiers,C0005525,en_470,TREATS,Herpes zoster disease,C0019360,en_1182,2,1,AFFECTS,Inhibitory,3
3697,Biological Response Modifiers,C0005525,en_470,TREATS,Inflammation,C0021368,en_1307,4,2,AFFECTS,Inhibitory,6
3698,Biological Response Modifiers,C0005525,en_470,TREATS,Patients,C0030705,en_1762,24,16,AFFECTS,Inhibitory,48
3699,Biological Response Modifiers,C0005525,en_470,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
3700,Biological Response Modifiers,C0005525,en_470,TREATS,Rheumatism,C0035435,en_2028,3,2,AFFECTS,Inhibitory,6
3701,Biological Response Modifiers,C0005525,en_470,TREATS,Sarcoidosis,C0036202,en_2064,1,1,AFFECTS,Inhibitory,3
3702,Biological Response Modifiers,C0005525,en_470,TREATS,Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
3703,Biological Response Modifiers,C0005525,en_470,TREATS,Inspired fraction of oxygen,C0428167,en_4012,1,1,AFFECTS,Inhibitory,3
3704,Biological Response Modifiers,C0005525,en_470,TREATS,Autoimmune,C0443146,en_4064,1,1,AFFECTS,Inhibitory,3
3705,Biological Response Modifiers,C0005525,en_470,TREATS,Inflammatory perforation,C0544791,en_4267,1,1,AFFECTS,Inhibitory,3
3706,Biological Response Modifiers,C0005525,en_470,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
3707,Biological Response Modifiers,C0005525,en_470,TREATS,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Inhibitory,3
3708,Biological Response Modifiers,C0005525,en_470,TREATS,Immune reconstitution syndrome,C1096197,en_5234,1,1,AFFECTS,Inhibitory,3
3709,Biological Response Modifiers,C0005525,en_470,TREATS,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
3710,Biological Response Modifiers,C0005525,en_470,TREATS,Flare,C1517205,en_5867,1,1,AFFECTS,Inhibitory,3
3711,Biological Response Modifiers,C0005525,en_470,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
3712,Biological Response Modifiers,C0005525,en_470,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3713,Biological Response Modifiers,C0005525,en_470,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
3714,Biological Response Modifiers,C0005525,en_470,TREATS(INFER),Rheumatism,C0035435,en_2028,2,1,AFFECTS,Inhibitory,3
3715,Biological Response Modifiers,C0005525,en_470,TREATS(SPEC),Malaria,C0024530,en_1493,2,1,AFFECTS,Inhibitory,3
3716,Biological Response Modifiers,C0005525,en_470,TREATS(SPEC),Patients,C0030705,en_1762,6,3,AFFECTS,Inhibitory,9
3717,Biological Response Modifiers,C0005525,en_470,TREATS(SPEC),cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
3718,Biological Response Modifier Therapy,C0005527,en_471,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,6
3719,Biological Response Modifier Therapy,C0005527,en_471,TREATS,Inflammatory Bowel Diseases,C0021390,en_1310,2,2,AFFECTS,Inhibitory,9
3720,Biological Response Modifier Therapy,C0005527,en_471,TREATS,Chronic Childhood Arthritis,C0553662,en_4288,1,1,AFFECTS,Inhibitory,3
3721,Biological Response Modifier Therapy,C0005527,en_471,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,6
3722,Biological Response Modifier Therapy,C0005527,en_471,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
3723,"Biological Transport, Active",C0005529,en_472,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
3724,Birth,C0005615,en_476,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,3
3725,Birth,C0005615,en_476,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
3726,Birth,C0005615,en_476,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
3727,Birth,C0005615,en_476,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
3728,Birth,C0005615,en_476,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
3729,Birth,C0005615,en_476,AFFECTS,"Depression, Postpartum",C0221074,en_3212,2,1,AFFECTS,General/Uncertain,3
3730,Birth,C0005615,en_476,AFFECTS,2019 novel coronavirus,C5203676,en_6420,2,1,AFFECTS,General/Uncertain,6
3731,Bromhexine Hydrochloride,C0005647,en_477,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
3732,Malignant neoplasm of urinary bladder,C0005684,en_479,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
3733,Bleomycin,C0005740,en_481,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
3734,Bleomycin,C0005740,en_481,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
3735,Blood,C0005767,en_482,AFFECTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
3736,Blood,C0005767,en_482,PRODUCES,Antibodies,C0003241,en_347,2,2,AFFECTS,Excitatory,6
3737,Blood Circulation,C0005775,en_483,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,8
3738,Blood Circulation,C0005775,en_483,AFFECTS,Heart,C0018787,en_1130,2,2,AFFECTS,General/Uncertain,6
3739,Blood Circulation,C0005775,en_483,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
3740,Blood Circulation,C0005775,en_483,AFFECTS,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,General/Uncertain,6
3741,Blood Circulation,C0005775,en_483,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
3742,Blood coagulation,C0005778,en_484,AFFECTS,"Lung Diseases, Interstitial",C0206062,en_3142,2,1,AFFECTS,General/Uncertain,3
3743,Blood Coagulation Disorders,C0005779,en_485,AFFECTS,Immunity,C0020964,en_1273,2,2,AFFECTS,General/Uncertain,6
3744,Blood Coagulation Disorders,C0005779,en_485,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
3745,Blood Coagulation Disorders,C0005779,en_485,AFFECTS,Cerebrovascular accident,C0038454,en_2169,2,1,AFFECTS,General/Uncertain,3
3746,Blood Coagulation Disorders,C0005779,en_485,AFFECTS,network,C0679670,en_4604,7,7,AFFECTS,General/Uncertain,21
3747,Blood Coagulation Disorders,C0005779,en_485,AUGMENTS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
3748,Blood Coagulation Disorders,C0005779,en_485,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
3749,Blood Coagulation Disorders,C0005779,en_485,PREDISPOSES,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Excitatory,3
3750,Blood Coagulation Disorders,C0005779,en_485,PREDISPOSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
3751,Blood Coagulation Disorders,C0005779,en_485,PREDISPOSES,Acute respiratory distress,C0748355,en_4831,1,1,AFFECTS,Excitatory,3
3752,Blood Coagulation Factor,C0005789,en_486,AFFECTS,associated disease,C0243083,en_3459,1,1,AFFECTS,General/Uncertain,3
3753,Blood Coagulation Factor,C0005789,en_486,DISRUPTS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Inhibitory,3
3754,Blood Coagulation Factor,C0005789,en_486,PREVENTS,Thrombus,C0087086,en_2743,1,1,AFFECTS,Inhibitory,3
3755,Blood Component Removal,C0005791,en_487,AFFECTS,attenuation,C0599946,en_4490,2,1,AFFECTS,General/Uncertain,3
3756,Blood Component Removal,C0005791,en_487,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
3757,Blood Component Removal,C0005791,en_487,TREATS,Disease Progression,C0242656,en_3429,3,1,AFFECTS,Inhibitory,3
3758,Blood Donation,C0005794,en_488,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
3759,Blood Glucose,C0005802,en_490,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
3760,Blood Glucose,C0005802,en_490,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
3761,Blood Glucose,C0005802,en_490,AFFECTS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,General/Uncertain,6
3762,Blood Glucose,C0005802,en_490,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
3763,Blood Glucose,C0005802,en_490,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
3764,Blood Pressure,C0005823,en_492,AFFECTS,Digestion,C0012238,en_815,1,1,AFFECTS,General/Uncertain,3
3765,Blood Pressure,C0005823,en_492,AFFECTS,heart rate,C0018810,en_1138,2,2,AFFECTS,General/Uncertain,6
3766,Blood Pressure,C0005823,en_492,AFFECTS,Respiration,C0035203,en_2004,2,2,AFFECTS,General/Uncertain,6
3767,Blood Pressure,C0005823,en_492,AFFECTS,Baroreflex,C0206162,en_3150,1,1,AFFECTS,General/Uncertain,3
3768,Blood Pressure,C0005823,en_492,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,9
3769,Blood Pressure,C0005823,en_492,PRODUCES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,3
3770,"Blood Transfusion, Intrauterine",C0005843,en_493,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3771,Blood Vessels,C0005847,en_494,PRODUCES,Endothelin,C0079284,en_2596,2,1,AFFECTS,Excitatory,3
3772,Body Weight,C0005910,en_498,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
3773,Bone Diseases,C0005940,en_499,AFFECTS,American,C0596070,en_4379,1,1,AFFECTS,General/Uncertain,3
3774,Bone Marrow Transplantation,C0005961,en_502,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
3775,Bone Marrow Transplantation,C0005961,en_502,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3776,Bone Marrow Transplantation,C0005961,en_502,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,3
3777,Bone Marrow Transplantation,C0005961,en_502,TREATS(INFER),Schizophrenia,C0036341,en_2068,1,1,AFFECTS,Inhibitory,3
3778,Botulinum Toxins,C0006055,en_505,TREATS,Child,C0008059,en_620,2,2,AFFECTS,Inhibitory,6
3779,Botulinum Toxins,C0006055,en_505,TREATS,Adolescent,C0205653,en_3132,2,2,AFFECTS,Inhibitory,6
3780,Botulinum Toxins,C0006055,en_505,TREATS(INFER),Cerebral Palsy,C0007789,en_605,2,2,AFFECTS,Inhibitory,6
3781,Brachytherapy,C0006098,en_506,STIMULATES,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,Excitatory,3
3782,Brachytherapy,C0006098,en_506,TREATS,Malignant neoplasm of tongue,C0153349,en_2882,1,1,AFFECTS,Inhibitory,3
3783,Bradykinin,C0006100,en_507,AUGMENTS,smooth muscle contraction,C1155937,en_5325,1,1,AFFECTS,Excitatory,3
3784,Bradykinin,C0006100,en_507,INHIBITS,ACE2,C1422064,en_5723,2,2,AFFECTS,Inhibitory,6
3785,Bradykinin,C0006100,en_507,INHIBITS,angiotensin converting enzyme 2,C0960880,en_5195,1,1,AFFECTS,Inhibitory,7
3786,Bradykinin,C0006100,en_507,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
3787,Bradykinin,C0006100,en_507,PREVENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,7
3788,Bradykinin,C0006100,en_507,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
3789,Malignant neoplasm of breast,C0006142,en_511,AFFECTS,hair,C0018494,en_1107,1,1,AFFECTS,General/Uncertain,3
3790,Malignant neoplasm of breast,C0006142,en_511,AFFECTS,Menarche,C0025274,en_1534,1,1,AFFECTS,General/Uncertain,3
3791,Malignant neoplasm of breast,C0006142,en_511,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
3792,Malignant neoplasm of breast,C0006142,en_511,AFFECTS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,7
3793,Malignant neoplasm of breast,C0006142,en_511,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
3794,Breast Feeding,C0006147,en_512,AFFECTS,Birth,C0005615,en_476,1,1,AFFECTS,General/Uncertain,3
3795,Breast Feeding,C0006147,en_512,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
3796,Breast Feeding,C0006147,en_512,AFFECTS,Persons,C0027361,en_1635,2,2,AFFECTS,General/Uncertain,6
3797,Breast Feeding,C0006147,en_512,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
3798,Breast Feeding,C0006147,en_512,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,3
3799,Breast Feeding,C0006147,en_512,AFFECTS,Obstetric Patient,C0700061,en_4712,1,1,AFFECTS,General/Uncertain,3
3800,Breathing Exercises,C0006155,en_513,AFFECTS,Exertion,C0015264,en_941,2,1,AFFECTS,General/Uncertain,8
3801,Breathing Exercises,C0006155,en_513,TREATS,Deglutition Disorders,C0011168,en_772,1,1,AFFECTS,Inhibitory,7
3802,Breathing Exercises,C0006155,en_513,TREATS,Persons,C0027361,en_1635,3,2,AFFECTS,Inhibitory,6
3803,Breathing Exercises,C0006155,en_513,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
3804,Breathing Exercises,C0006155,en_513,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,7
3805,Breathing Exercises,C0006155,en_513,TREATS,Survivors,C0206194,en_3154,3,1,AFFECTS,Inhibitory,3
3806,Breathing Exercises,C0006155,en_513,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
3807,Breathing Exercises,C0006155,en_513,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
3808,Breathing Exercises,C0006155,en_513,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
3809,Breathing Exercises,C0006155,en_513,TREATS(INFER),"Problem, cardiovascular",C0850760,en_4945,1,1,AFFECTS,Inhibitory,3
3810,Breeding,C0006159,en_514,AFFECTS,Larva,C0023047,en_1399,1,1,AFFECTS,General/Uncertain,3
3811,Bromelains,C0006217,en_515,INHIBITS,cytokine,C0079189,en_2593,2,1,AFFECTS,Inhibitory,3
3812,Bromelains,C0006217,en_515,INHIBITS,Inflammation Mediators,C0243042,en_3453,1,1,AFFECTS,Inhibitory,3
3813,Bromelains,C0006217,en_515,INHIBITS,chemokine,C0282554,en_3651,2,1,AFFECTS,Inhibitory,3
3814,Bromelains,C0006217,en_515,STIMULATES,Natural Killer Cells,C0022688,en_1386,1,1,AFFECTS,Excitatory,3
3815,Bromhexine,C0006220,en_516,INHIBITS,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Inhibitory,3
3816,Bromhexine,C0006220,en_516,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3817,Bronchiolitis,C0006271,en_517,AFFECTS(SPEC),Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
3818,Bronchodilator Agents,C0006280,en_519,INHIBITS,Angiotensin Receptor,C0034787,en_1963,1,1,AFFECTS,Inhibitory,3
3819,Bronchodilator Agents,C0006280,en_519,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
3820,Bronchodilator Agents,C0006280,en_519,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
3821,Bronchoscopy,C0006290,en_520,AFFECTS,Leak NOS,C1608322,en_6001,2,1,AFFECTS,General/Uncertain,3
3822,Buffers,C0006353,en_523,INHIBITS,Ribonucleases,C0035542,en_2034,1,1,AFFECTS,Inhibitory,3
3823,Bupivacaine,C0006400,en_524,PREVENTS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,8
3824,Buprenorphine,C0006405,en_525,TREATS,Opioid Use Disorders,C0029103,en_1711,2,1,AFFECTS,Inhibitory,3
3825,Butyrates,C0006521,en_527,AUGMENTS,monocyte,C0026473,en_1580,1,1,AFFECTS,Excitatory,3
3826,C-reactive protein,C0006560,en_529,AFFECTS,Immune system,C0020962,en_1271,1,1,AFFECTS,General/Uncertain,3
3827,C-reactive protein,C0006560,en_529,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,6
3828,C-reactive protein,C0006560,en_529,AFFECTS,Skeletal muscle structure,C0242692,en_3432,1,1,AFFECTS,General/Uncertain,3
3829,C-reactive protein,C0006560,en_529,AUGMENTS,Plethora,C0232370,en_3277,2,1,AFFECTS,Excitatory,3
3830,C-reactive protein,C0006560,en_529,AUGMENTS,Severe disorder,C1836348,en_6048,1,1,AFFECTS,Excitatory,6
3831,C-reactive protein,C0006560,en_529,INHIBITS,Prealbumin,C0032923,en_1868,1,1,AFFECTS,Inhibitory,6
3832,C-reactive protein,C0006560,en_529,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
3833,C-reactive protein,C0006560,en_529,PREDISPOSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,6
3834,C-reactive protein,C0006560,en_529,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
3835,C-reactive protein,C0006560,en_529,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
3836,C-reactive protein,C0006560,en_529,STIMULATES,Lactate Dehydrogenase,C0022917,en_1395,1,1,AFFECTS,Excitatory,6
3837,C-reactive protein|CRP,C0006560|1401,en_530,AUGMENTS,Desire for food,C0003618,en_388,1,1,AFFECTS,Excitatory,7
3838,Cadherins,C0006631,en_532,AFFECTS,Permeability,C0031164,en_1779,1,1,AFFECTS,General/Uncertain,3
3839,Caffeine,C0006644,en_533,AUGMENTS,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Excitatory,3
3840,Caffeine,C0006644,en_533,STIMULATES,Myoglobin,C0027078,en_1629,1,1,AFFECTS,Excitatory,3
3841,Caffeine,C0006644,en_533,TREATS,Neonatal apneic attack,C0521647,en_4204,1,1,AFFECTS,Inhibitory,3
3842,Calcifediol,C0006657,en_534,INHIBITS,Lymphocyte antigen,C0023158,en_1402,1,1,AFFECTS,Inhibitory,8
3843,Calcifediol,C0006657,en_534,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
3844,Calcifediol,C0006657,en_534,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
3845,Calcifediol,C0006657,en_534,STIMULATES,Cholecalciferol,C0008318,en_634,1,1,AFFECTS,Excitatory,8
3846,Calcifediol,C0006657,en_534,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
3847,Calcifediol,C0006657,en_534,TREATS,COVID-19,C5203670,en_6417,5,3,AFFECTS,Inhibitory,21
3848,Calcitriol,C0006674,en_536,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
3849,Calcitriol,C0006674,en_536,TREATS,Immune System Suppression,C1373218,en_5686,1,1,AFFECTS,Inhibitory,6
3850,Calcitriol,C0006674,en_536,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
3851,Calcium,C0006675,en_537,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
3852,Calcium,C0006675,en_537,AFFECTS,Organ,C0178784,en_2991,1,1,AFFECTS,General/Uncertain,3
3853,Calcium,C0006675,en_537,AUGMENTS,Muscle Rigidity,C0026837,en_1602,1,1,AFFECTS,Excitatory,3
3854,Calcium,C0006675,en_537,INHIBITS,ATM gene,C0919524,en_5114,4,2,AFFECTS,Inhibitory,6
3855,Calcium,C0006675,en_537,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3856,Calcium Carbonate,C0006681,en_538,TREATS,Plethora,C0232370,en_3277,1,1,AFFECTS,Inhibitory,3
3857,Calcium Channel Blockers,C0006684,en_539,DISRUPTS,Blood Pressure,C0005823,en_492,2,1,AFFECTS,Inhibitory,3
3858,Calcium Channel Blockers,C0006684,en_539,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,6
3859,Calcium Channel Blockers,C0006684,en_539,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,6
3860,Calcium Channel,C0006685,en_540,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
3861,calcium phosphate,C0006711,en_541,AFFECTS,soft tissue,C0225317,en_3235,1,1,AFFECTS,General/Uncertain,3
3862,Calmodulin,C0006772,en_543,DISRUPTS,Fibroblasts,C0016030,en_992,1,1,AFFECTS,Inhibitory,3
3863,Calpain,C0006784,en_544,DISRUPTS,NODE,C0746922,en_4820,1,1,AFFECTS,Inhibitory,3
3864,Malignant Neoplasms,C0006826,en_545,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
3865,Malignant Neoplasms,C0006826,en_545,AFFECTS,Child,C0008059,en_620,6,5,AFFECTS,General/Uncertain,18
3866,Malignant Neoplasms,C0006826,en_545,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
3867,Malignant Neoplasms,C0006826,en_545,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
3868,Malignant Neoplasms,C0006826,en_545,AFFECTS,Immunity,C0020964,en_1273,3,2,AFFECTS,General/Uncertain,6
3869,Malignant Neoplasms,C0006826,en_545,AFFECTS,Natural immunosuppression,C0021080,en_1288,1,1,AFFECTS,General/Uncertain,3
3870,Malignant Neoplasms,C0006826,en_545,AFFECTS,Persons,C0027361,en_1635,8,5,AFFECTS,General/Uncertain,15
3871,Malignant Neoplasms,C0006826,en_545,AFFECTS,Patients,C0030705,en_1762,9,6,AFFECTS,General/Uncertain,18
3872,Malignant Neoplasms,C0006826,en_545,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
3873,Malignant Neoplasms,C0006826,en_545,AFFECTS,Voice,C0042939,en_2377,1,1,AFFECTS,General/Uncertain,3
3874,Malignant Neoplasms,C0006826,en_545,AFFECTS,Youth,C0087178,en_2748,1,1,AFFECTS,General/Uncertain,3
3875,Malignant Neoplasms,C0006826,en_545,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,General/Uncertain,6
3876,Malignant Neoplasms,C0006826,en_545,AFFECTS,Cancer Patient,C1516213,en_5852,2,2,AFFECTS,General/Uncertain,6
3877,Malignant Neoplasms,C0006826,en_545,AFFECTS,COVID-19,C5203670,en_6417,3,3,AFFECTS,General/Uncertain,19
3878,Malignant Neoplasms,C0006826,en_545,PRODUCES,Mucins,C0026682,en_1591,1,1,AFFECTS,Excitatory,3
3879,Malignant Neoplasms,C0006826,en_545,PRODUCES,TSLP gene,C1336681,en_5638,1,1,AFFECTS,Excitatory,3
3880,Cannabidiol,C0006863,en_548,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
3881,Cannabidiol,C0006863,en_548,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
3882,Cannabidiol,C0006863,en_548,TREATS,Epilepsy,C0014544,en_917,1,1,AFFECTS,Inhibitory,3
3883,Cannabidiol,C0006863,en_548,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
3884,Cannabidiol,C0006863,en_548,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
3885,Cannabidiol,C0006863,en_548,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
3886,Cannabidiol,C0006863,en_548,TREATS,"Stress Disorders, Traumatic",C0038441,en_2167,1,1,AFFECTS,Inhibitory,3
3887,Cannabidiol,C0006863,en_548,TREATS,Substance Use Disorders,C0038586,en_2176,1,1,AFFECTS,Inhibitory,8
3888,Cannabidiol,C0006863,en_548,TREATS,Mental health problem,C1446377,en_5753,1,1,AFFECTS,Inhibitory,8
3889,Canrenoate Potassium,C0006881,en_549,TREATS,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Inhibitory,3
3890,Capital Expenditures,C0006910,en_552,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
3891,Captopril,C0006938,en_553,AFFECTS,Lung,C0024109,en_1460,2,1,AFFECTS,General/Uncertain,3
3892,Captopril,C0006938,en_553,INHIBITS,Peptidyl-Dipeptidase A,C0022709,en_1387,1,1,AFFECTS,Inhibitory,3
3893,Captopril,C0006938,en_553,INHIBITS,Endopeptidases,C0030946,en_1770,2,1,AFFECTS,Inhibitory,3
3894,Captopril,C0006938,en_553,TREATS,Benign prostatic hypertrophy,C0005001,en_453,1,1,AFFECTS,Inhibitory,3
3895,Carbohydrates,C0007004,en_554,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
3896,Carbohydrates,C0007004,en_554,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
3897,Carbohydrates,C0007004,en_554,STIMULATES,Ketone Bodies,C0022631,en_1377,2,1,AFFECTS,Excitatory,3
3898,Carbon,C0007009,en_555,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
3899,Carbon,C0007009,en_555,DISRUPTS,Emission,C0233929,en_3301,1,1,AFFECTS,Inhibitory,3
3900,Carbon Dioxide,C0007012,en_556,AFFECTS,Climate,C0008946,en_656,2,2,AFFECTS,General/Uncertain,6
3901,Carbon Dioxide,C0007012,en_556,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
3902,Carbon Dioxide,C0007012,en_556,AFFECTS,Esthesia,C0036658,en_2083,1,1,AFFECTS,General/Uncertain,3
3903,Carbon Dioxide,C0007012,en_556,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
3904,Carbon Dioxide,C0007012,en_556,AUGMENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
3905,Carbon Dioxide,C0007012,en_556,AUGMENTS(SPEC),Dizziness,C0012833,en_833,2,1,AFFECTS,Excitatory,3
3906,Carbon Dioxide,C0007012,en_556,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
3907,Carbon Dioxide,C0007012,en_556,STIMULATES,Oils,C0028908,en_1706,1,1,AFFECTS,Excitatory,3
3908,Carbon Dioxide,C0007012,en_556,STIMULATES,PHLDA2 gene,C1335210,en_5613,1,1,AFFECTS,Excitatory,3
3909,Cardiopulmonary Resuscitation,C0007203,en_567,PREVENTS,Brain Injuries,C0270611,en_3552,1,1,AFFECTS,Inhibitory,3
3910,Cardiopulmonary Resuscitation,C0007203,en_567,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3911,Cardiopulmonary Resuscitation,C0007203,en_567,TREATS(INFER),Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
3912,Cardiovascular Agents,C0007220,en_568,AFFECTS,Present,C0150312,en_2833,1,1,AFFECTS,General/Uncertain,6
3913,Cardiovascular Agents,C0007220,en_568,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
3914,Cardiovascular Agents,C0007220,en_568,TREATS,Endothelial dysfunction,C0856169,en_4968,2,1,AFFECTS,Inhibitory,3
3915,Cardiovascular Diseases,C0007222,en_569,AFFECTS,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,General/Uncertain,3
3916,Cardiovascular Diseases,C0007222,en_569,AFFECTS,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,General/Uncertain,3
3917,Cardiovascular Diseases,C0007222,en_569,AFFECTS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,General/Uncertain,6
3918,Cardiovascular Diseases,C0007222,en_569,AFFECTS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,General/Uncertain,6
3919,Cardiovascular Diseases,C0007222,en_569,AFFECTS,Dyslipidemias,C0242339,en_3406,1,1,AFFECTS,General/Uncertain,6
3920,Cardiovascular Diseases,C0007222,en_569,AFFECTS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,General/Uncertain,3
3921,Cardiovascular Diseases,C0007222,en_569,AFFECTS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,General/Uncertain,6
3922,Cardiovascular Diseases,C0007222,en_569,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
3923,Cardiovascular Diseases,C0007222,en_569,DISRUPTS,Epithelial Cells,C0014597,en_919,2,1,AFFECTS,Inhibitory,3
3924,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Complication,C0009566,en_697,5,3,AFFECTS,Excitatory,9
3925,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
3926,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
3927,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
3928,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
3929,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,1,1,AFFECTS,Excitatory,6
3930,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,6
3931,Cardiovascular Diseases,C0007222,en_569,PREDISPOSES,Severe infection,C5139167,en_6407,1,1,AFFECTS,Excitatory,8
3932,Cardiovascular Physiology,C0007227,en_570,AFFECTS,Malignant neoplasm of prostate,C0376358,en_3874,1,1,AFFECTS,General/Uncertain,3
3933,Carotenoids,C0007271,en_571,AFFECTS(SPEC),Photosynthesis,C0031764,en_1803,1,1,AFFECTS,General/Uncertain,3
3934,Carotenoids,C0007271,en_571,PREVENTS,Vitamin A Deficiency,C0042842,en_2369,1,1,AFFECTS,Inhibitory,3
3935,Catechol O-Methyltransferase,C0007407,en_576,AFFECTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
3936,Catechol O-Methyltransferase,C0007407,en_576,AFFECTS,Cardiovascular Physiology,C0007227,en_570,1,1,AFFECTS,General/Uncertain,3
3937,Catecholamines,C0007412,en_577,AFFECTS,Ulcerative Colitis,C0009324,en_676,1,1,AFFECTS,General/Uncertain,3
3938,Catecholamines,C0007412,en_577,INHIBITS,"Estrogens, Catechol",C0007406,en_575,1,1,AFFECTS,Inhibitory,3
3939,Catecholamines,C0007412,en_577,INHIBITS,Epinephrine,C0014563,en_918,1,1,AFFECTS,Inhibitory,3
3940,Catecholamines,C0007412,en_577,INHIBITS,Norepinephrine,C0028351,en_1687,1,1,AFFECTS,Inhibitory,3
3941,Cathepsins,C0007428,en_578,AFFECTS(SPEC),Protein Turnover,C0597297,en_4420,3,1,AFFECTS,General/Uncertain,3
3942,Cathepsins,C0007428,en_578,AUGMENTS,Autoimmune Response,C0004366,en_429,1,1,AFFECTS,Excitatory,3
3943,Cathepsins,C0007428,en_578,DISRUPTS,NODE,C0746922,en_4820,1,1,AFFECTS,Inhibitory,3
3944,Cathepsins,C0007428,en_578,INHIBITS(SPEC),Cytochrome P450,C0010762,en_747,2,1,AFFECTS,Inhibitory,3
3945,Cell Adhesion Molecules,C0007578,en_583,PREVENTS,Infiltration,C0332448,en_3749,1,1,AFFECTS,Inhibitory,6
3946,Cell Adhesion Molecules,C0007578,en_583,AUGMENTS,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,Excitatory,3
3947,Cell Adhesion Molecules,C0007578,en_583,DISRUPTS,lymphocyte proliferation,C0596873,en_4397,1,1,AFFECTS,Inhibitory,3
3948,Cell Adhesion Molecules,C0007578,en_583,PREDISPOSES,Immune Tolerance,C0020963,en_1272,1,1,AFFECTS,Excitatory,3
3949,Cell Adhesion Molecules,C0007578,en_583,PREVENTS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Inhibitory,3
3950,Cell Adhesion Molecules,C0007578,en_583,PREVENTS,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Inhibitory,3
3951,Cell Aging,C0007581,en_584,AFFECTS,drug culture,C0680304,en_4621,1,1,AFFECTS,General/Uncertain,3
3952,Cell Communication,C0007582,en_585,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
3953,Cell Communication,C0007582,en_585,AFFECTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
3954,Cell Communication,C0007582,en_585,AFFECTS,nucleosome assembly,C1156189,en_5327,1,1,AFFECTS,General/Uncertain,3
3955,Cell Death,C0007587,en_587,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
3956,Cell Death,C0007587,en_587,AFFECTS,Tumorigenesis,C1326912,en_5561,1,1,AFFECTS,General/Uncertain,3
3957,Cell Death,C0007587,en_587,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
3958,Cell Growth,C0007595,en_590,AFFECTS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,3
3959,Cell Line,C0007600,en_591,PRODUCES,Antibodies,C0003241,en_347,2,2,AFFECTS,Excitatory,6
3960,Cell Line,C0007600,en_591,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
3961,Cell Line,C0007600,en_591,PRODUCES,Viral Genome,C0042720,en_2355,1,1,AFFECTS,Excitatory,3
3962,Cell membrane,C0007603,en_592,PRODUCES,"RNA, Viral",C0035736,en_2048,1,1,AFFECTS,Excitatory,3
3963,cell motility,C0007608,en_593,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
3964,Cell physiology,C0007613,en_594,AFFECTS,Uveitis,C0042164,en_2325,1,1,AFFECTS,General/Uncertain,3
3965,Cell Survival,C0007620,en_595,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
3966,Cells,C0007634,en_596,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
3967,Cells,C0007634,en_596,AFFECTS,Fertility,C0015895,en_981,2,1,AFFECTS,General/Uncertain,3
3968,Cells,C0007634,en_596,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
3969,Cells,C0007634,en_596,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
3970,Cells,C0007634,en_596,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
3971,Cells,C0007634,en_596,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
3972,Cells,C0007634,en_596,AFFECTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,General/Uncertain,3
3973,Cells,C0007634,en_596,AFFECTS,Recovery,C0237820,en_3354,2,1,AFFECTS,General/Uncertain,3
3974,Cells,C0007634,en_596,AFFECTS,Immune response,C0301872,en_3696,8,7,AFFECTS,General/Uncertain,21
3975,Cells,C0007634,en_596,PRODUCES,CD8A,C1413244,en_13,1,1,AFFECTS,Excitatory,3
3976,Cells,C0007634,en_596,PRODUCES,CD70,C1824671,en_20,1,1,AFFECTS,Excitatory,3
3977,Cells,C0007634,en_596,PRODUCES,DPP4,C1414141,en_32,1,1,AFFECTS,Excitatory,3
3978,Cells,C0007634,en_596,PRODUCES,GATA3,C1414994,en_38,1,1,AFFECTS,Excitatory,3
3979,Cells,C0007634,en_596,PRODUCES,IGHE,C1415975,en_48,1,1,AFFECTS,Excitatory,3
3980,Cells,C0007634,en_596,PRODUCES,JAG2,C1416526,en_54,1,1,AFFECTS,Excitatory,3
3981,Cells,C0007634,en_596,PRODUCES,FOXP3,C1416467,en_131,1,1,AFFECTS,Excitatory,3
3982,Cells,C0007634,en_596,PRODUCES,ACE2,C1422064,en_5723,5,4,AFFECTS,Excitatory,12
3983,Cells,C0007634,en_596,PRODUCES,Antibodies,C0003241,en_347,5,4,AFFECTS,Excitatory,12
3984,Cells,C0007634,en_596,PRODUCES,Antigens,C0003320,en_365,3,3,AFFECTS,Excitatory,9
3985,Cells,C0007634,en_596,PRODUCES,Autoantibodies,C0004358,en_426,1,1,AFFECTS,Excitatory,3
3986,Cells,C0007634,en_596,PRODUCES,Biological Products,C0005522,en_469,1,1,AFFECTS,Excitatory,3
3987,Cells,C0007634,en_596,PRODUCES,Calcium Channel,C0006685,en_540,1,1,AFFECTS,Excitatory,3
3988,Cells,C0007634,en_596,PRODUCES,DNA,C0012854,en_834,2,2,AFFECTS,Excitatory,6
3989,Cells,C0007634,en_596,PRODUCES,Enzymes,C0014442,en_912,1,1,AFFECTS,Excitatory,3
3990,Cells,C0007634,en_596,PRODUCES,Immunologic Factors,C0021054,en_1285,1,1,AFFECTS,Excitatory,3
3991,Cells,C0007634,en_596,PRODUCES,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Excitatory,3
3992,Cells,C0007634,en_596,PRODUCES,Peptidyl-Dipeptidase A,C0022709,en_1387,2,1,AFFECTS,Excitatory,3
3993,Cells,C0007634,en_596,PRODUCES,Mucous body substance,C0026727,en_1595,4,4,AFFECTS,Excitatory,12
3994,Cells,C0007634,en_596,PRODUCES,Nitric Oxide,C0028128,en_1682,2,2,AFFECTS,Excitatory,6
3995,Cells,C0007634,en_596,PRODUCES,Proteins,C0033684,en_1912,3,2,AFFECTS,Excitatory,6
3996,Cells,C0007634,en_596,PRODUCES,Pulmonary Surfactants,C0034085,en_1935,2,2,AFFECTS,Excitatory,6
3997,Cells,C0007634,en_596,PRODUCES,T-Cell Receptor,C0034790,en_1965,1,1,AFFECTS,Excitatory,3
3998,Cells,C0007634,en_596,PRODUCES,Recombinant Proteins,C0034861,en_1981,1,1,AFFECTS,Excitatory,3
3999,Cells,C0007634,en_596,PRODUCES,tat Protein,C0039341,en_2209,1,1,AFFECTS,Excitatory,3
4000,Cells,C0007634,en_596,PRODUCES,Tretinoin,C0040845,en_2280,1,1,AFFECTS,Excitatory,3
4001,Cells,C0007634,en_596,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
4002,Cells,C0007634,en_596,PRODUCES,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Excitatory,3
4003,Cells,C0007634,en_596,PRODUCES,Heparan Sulfate Proteoglycan,C0062503,en_2500,1,1,AFFECTS,Excitatory,3
4004,Cells,C0007634,en_596,PRODUCES,perforin,C0070410,en_2541,1,1,AFFECTS,Excitatory,3
4005,Cells,C0007634,en_596,PRODUCES,Prorenin,C0072249,en_2548,1,1,AFFECTS,Excitatory,3
4006,Cells,C0007634,en_596,PRODUCES,cytokine,C0079189,en_2593,12,9,AFFECTS,Excitatory,27
4007,Cells,C0007634,en_596,PRODUCES,"Receptors, Notch",C0083792,en_2634,1,1,AFFECTS,Excitatory,3
4008,Cells,C0007634,en_596,PRODUCES,Proto-Oncogene Proteins c-fos,C0085301,en_2662,1,1,AFFECTS,Excitatory,3
4009,Cells,C0007634,en_596,PRODUCES,ectonucleoside triphosphate diphosphohydrolase 1,C0108783,en_2759,1,1,AFFECTS,Excitatory,3
4010,Cells,C0007634,en_596,PRODUCES,Interleukin-12,C0123759,en_2770,1,1,AFFECTS,Excitatory,3
4011,Cells,C0007634,en_596,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,2,1,AFFECTS,Excitatory,3
4012,Cells,C0007634,en_596,PRODUCES,Blood specimen,C0178913,en_2993,1,1,AFFECTS,Excitatory,3
4013,Cells,C0007634,en_596,PRODUCES,chemokine,C0282554,en_3651,3,1,AFFECTS,Excitatory,3
4014,Cells,C0007634,en_596,PRODUCES,DELIVER,C0308779,en_3728,1,1,AFFECTS,Excitatory,3
4015,Cells,C0007634,en_596,PRODUCES,Interleukin-17,C0384648,en_3903,3,2,AFFECTS,Excitatory,6
4016,Cells,C0007634,en_596,PRODUCES,receptor,C0597357,en_4422,1,1,AFFECTS,Excitatory,3
4017,Cells,C0007634,en_596,PRODUCES,caspase-4,C0908330,en_5096,1,1,AFFECTS,Excitatory,3
4018,Cells,C0007634,en_596,PRODUCES,CD4 gene,C1332714,en_5583,1,1,AFFECTS,Excitatory,3
4019,Cells,C0007634,en_596,PRODUCES,CD8B1 gene,C1367471,en_5671,2,1,AFFECTS,Excitatory,3
4020,Cells,C0007634,en_596,PRODUCES,SDC1 gene,C1419891,en_5715,1,1,AFFECTS,Excitatory,3
4021,Cells,C0007634,en_596,PRODUCES(SPEC),Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
4022,Cells,C0007634,en_596,PRODUCES(SPEC),Interleukin-4,C0021758,en_1340,1,1,AFFECTS,Excitatory,3
4023,Central Nervous System Infections,C0007684,en_598,AFFECTS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,3
4024,Ceramides,C0007745,en_600,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
4025,Cereals,C0007757,en_601,AFFECTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,6
4026,Cerebral Infarction,C0007785,en_603,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
4027,Cerebrovascular Circulation,C0007818,en_606,AFFECTS,Odors,C0028884,en_1704,1,1,AFFECTS,General/Uncertain,3
4028,Cerebrovascular Disorders,C0007820,en_607,PREDISPOSES,Abnormal mental state,C0278061,en_3595,1,1,AFFECTS,Excitatory,6
4029,Cesarean section,C0007876,en_610,AFFECTS,Childbirth,C1148523,en_5296,2,1,AFFECTS,General/Uncertain,3
4030,Cesarean section,C0007876,en_610,PREDISPOSES,Premature Birth,C0151526,en_2860,2,1,AFFECTS,Excitatory,3
4031,Cesarean section,C0007876,en_610,PREDISPOSES,Vertical Disease Transmission,C0242648,en_3427,2,1,AFFECTS,Excitatory,7
4032,Cesarean section,C0007876,en_610,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4033,Cesarean section,C0007876,en_610,TREATS,Pregnant Women,C0033011,en_1876,2,2,AFFECTS,Inhibitory,9
4034,Cesarean section,C0007876,en_610,TREATS,Woman,C0043210,en_2396,4,2,AFFECTS,Inhibitory,10
4035,Cesarean section,C0007876,en_610,TREATS,"Infections, Hospital",C0205721,en_3133,3,1,AFFECTS,Inhibitory,7
4036,Cesarean section,C0007876,en_610,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
4037,Cetylpyridinium Chloride,C0007907,en_612,PREVENTS,SARS coronavirus,C1175743,en_5384,1,1,AFFECTS,Inhibitory,3
4038,Cetylpyridinium Chloride,C0007907,en_612,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
4039,Charts,C0007963,en_613,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
4040,Charts,C0007963,en_613,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,3
4041,Charts,C0007963,en_613,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4042,Chelating Agents,C0007974,en_614,STIMULATES,Iron,C0302583,en_3708,1,1,AFFECTS,Excitatory,3
4043,Chilblains,C0008058,en_619,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
4044,Child,C0008059,en_620,PRODUCES,Classification,C0008902,en_651,1,1,AFFECTS,Excitatory,3
4045,Child,C0008059,en_620,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
4046,Child Development Disorders,C0008073,en_622,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
4047,Child Health Services,C0008079,en_623,TREATS,Low Birth Weight Infant,C0021288,en_1298,1,1,AFFECTS,Inhibitory,3
4048,Chlorambucil,C0008163,en_628,DISRUPTS,Lysosomes,C0024369,en_1478,1,1,AFFECTS,Inhibitory,3
4049,Chlorambucil,C0008163,en_628,PREDISPOSES,Lymphoma,C0024299,en_1471,1,1,AFFECTS,Excitatory,3
4050,Chlorhexidine,C0008196,en_629,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
4051,Chlorhexidine,C0008196,en_629,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
4052,Chlorhexidine,C0008196,en_629,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
4053,Chlorhexidine,C0008196,en_629,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
4054,4-Chloromercuribenzenesulfonate,C0008249,en_630,DISRUPTS,Cell membrane,C0007603,en_592,1,1,AFFECTS,Inhibitory,3
4055,Chloroquine,C0008269,en_631,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
4056,Chloroquine,C0008269,en_631,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
4057,Chloroquine,C0008269,en_631,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
4058,Chloroquine,C0008269,en_631,AFFECTS,QTC INTERVAL,C0489625,en_4157,1,1,AFFECTS,General/Uncertain,6
4059,Chloroquine,C0008269,en_631,AFFECTS,Cardiovascular event,C1320716,en_5537,2,1,AFFECTS,General/Uncertain,6
4060,Chloroquine,C0008269,en_631,DISRUPTS,Cell division,C0007590,en_589,2,1,AFFECTS,Inhibitory,3
4061,Chloroquine,C0008269,en_631,DISRUPTS,terminal glycosylation,C1157476,en_5333,2,1,AFFECTS,Inhibitory,3
4062,Chloroquine,C0008269,en_631,DISRUPTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Inhibitory,3
4063,Chloroquine,C0008269,en_631,DISRUPTS,acidification,C1522821,en_5907,1,1,AFFECTS,Inhibitory,3
4064,Chloroquine,C0008269,en_631,PREVENTS,Disease,C0012634,en_826,5,3,AFFECTS,Inhibitory,9
4065,Chloroquine,C0008269,en_631,PREVENTS,Infection,C3714514,en_6235,3,1,AFFECTS,Inhibitory,3
4066,Chloroquine,C0008269,en_631,PREVENTS(SPEC),Parasitic Diseases,C0030499,en_1748,1,1,AFFECTS,Inhibitory,3
4067,Chloroquine,C0008269,en_631,STIMULATES,Anti-Infective Agents,C0003204,en_340,1,1,AFFECTS,Excitatory,3
4068,Chloroquine,C0008269,en_631,STIMULATES,Isotretinoin,C0022265,en_1370,2,1,AFFECTS,Excitatory,3
4069,Chloroquine,C0008269,en_631,STIMULATES,DUSP1 gene|DUSP1,C1333257|1843,en_5588,1,1,AFFECTS,Excitatory,6
4070,Chloroquine,C0008269,en_631,STIMULATES(SPEC),Hydroxychloroquine,C0020336,en_1226,1,1,AFFECTS,Excitatory,3
4071,Chloroquine,C0008269,en_631,TREATS,Amebiasis,C0002438,en_296,2,1,AFFECTS,Inhibitory,3
4072,Chloroquine,C0008269,en_631,TREATS,Autoimmune Diseases,C0004364,en_428,3,2,AFFECTS,Inhibitory,6
4073,Chloroquine,C0008269,en_631,TREATS,Chikungunya virus,C0008056,en_618,1,1,AFFECTS,Inhibitory,3
4074,Chloroquine,C0008269,en_631,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
4075,Chloroquine,C0008269,en_631,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
4076,Chloroquine,C0008269,en_631,TREATS,Health Personnel,C0018724,en_1121,3,1,AFFECTS,Inhibitory,3
4077,Chloroquine,C0008269,en_631,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
4078,Chloroquine,C0008269,en_631,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
4079,Chloroquine,C0008269,en_631,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,6
4080,Chloroquine,C0008269,en_631,TREATS,Malaria,C0024530,en_1493,5,3,AFFECTS,Inhibitory,9
4081,Chloroquine,C0008269,en_631,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
4082,Chloroquine,C0008269,en_631,TREATS,Patients,C0030705,en_1762,28,17,AFFECTS,Inhibitory,51
4083,Chloroquine,C0008269,en_631,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
4084,Chloroquine,C0008269,en_631,TREATS,Research Personnel,C0035173,en_2002,2,1,AFFECTS,Inhibitory,3
4085,Chloroquine,C0008269,en_631,TREATS,Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
4086,Chloroquine,C0008269,en_631,TREATS,Hepatitis C virus,C0220847,en_3204,3,1,AFFECTS,Inhibitory,3
4087,Chloroquine,C0008269,en_631,TREATS,Systemic infection,C0243026,en_3451,2,1,AFFECTS,Inhibitory,8
4088,Chloroquine,C0008269,en_631,TREATS,Lung finding,C0577914,en_4338,1,1,AFFECTS,Inhibitory,3
4089,Chloroquine,C0008269,en_631,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
4090,Chloroquine,C0008269,en_631,TREATS,hearing impairment,C1384666,en_5689,1,1,AFFECTS,Inhibitory,3
4091,Chloroquine,C0008269,en_631,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
4092,Chloroquine,C0008269,en_631,TREATS,COVID-19,C5203670,en_6417,7,6,AFFECTS,Inhibitory,42
4093,Chloroquine,C0008269,en_631,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
4094,Chloroquine,C0008269,en_631,TREATS(SPEC),Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,3
4095,Chloroquine,C0008269,en_631,TREATS(SPEC),"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
4096,Chloroquine,C0008269,en_631,TREATS(SPEC),Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
4097,Chlorpromazine,C0008286,en_632,AFFECTS,Lysosomes,C0024369,en_1478,1,1,AFFECTS,General/Uncertain,3
4098,Chlorpromazine,C0008286,en_632,DISRUPTS,Contagion,C0598197,en_4444,1,1,AFFECTS,Inhibitory,8
4099,Chlorpromazine,C0008286,en_632,INHIBITS,Dopamine D2 Receptor,C0058698,en_2474,1,1,AFFECTS,Inhibitory,3
4100,Chlorpromazine,C0008286,en_632,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
4101,Chlorpromazine,C0008286,en_632,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
4102,Chlorpromazine,C0008286,en_632,TREATS,Infection status,C0517627,en_4174,1,1,AFFECTS,Inhibitory,8
4103,Chlorpromazine,C0008286,en_632,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
4104,Chlorpromazine,C0008286,en_632,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,14
4105,Chlorpromazine,C0008286,en_632,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
4106,Cholecalciferol,C0008318,en_634,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,8
4107,Cholecalciferol,C0008318,en_634,TREATS,Vitamin D Deficiency,C0042870,en_2372,2,1,AFFECTS,Inhibitory,6
4108,Cholecalciferol,C0008318,en_634,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,22
4109,Cholecalciferol,C0008318,en_634,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
4110,Cholecalciferol,C0008318,en_634,STIMULATES,25-hydroxyvitamin D,C0535968,en_4242,2,1,AFFECTS,Excitatory,3
4111,Cholecalciferol,C0008318,en_634,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
4112,Cholecalciferol,C0008318,en_634,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
4113,Cholecalciferol,C0008318,en_634,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4114,Cholecalciferol,C0008318,en_634,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
4115,Cholecalciferol,C0008318,en_634,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
4116,Cholecalciferol,C0008318,en_634,TREATS(INFER),Vitamin D Deficiency,C0042870,en_2372,2,1,AFFECTS,Inhibitory,3
4117,Cholecystectomy,C0008320,en_635,TREATS,Cholecystitis,C0008325,en_636,1,1,AFFECTS,Inhibitory,3
4118,Cholecystectomy,C0008320,en_635,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4119,Cholecystectomy,C0008320,en_635,TREATS,Gallstone acute pancreatitis,C0554117,en_4293,2,1,AFFECTS,Inhibitory,3
4120,Cholecystectomy,C0008320,en_635,TREATS(INFER),Pancreatitis,C0030305,en_1745,2,1,AFFECTS,Inhibitory,3
4121,Cholecystostomy,C0008339,en_637,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4122,Cholecystostomy,C0008339,en_637,TREATS,"Cholecystitis, Acute",C0149520,en_2801,1,1,AFFECTS,Inhibitory,3
4123,Cholecystostomy,C0008339,en_637,TREATS(INFER),"Cholecystitis, Acute",C0149520,en_2801,1,1,AFFECTS,Inhibitory,3
4124,Cholesterol,C0008377,en_640,AFFECTS,uptake,C0243144,en_3467,1,1,AFFECTS,General/Uncertain,3
4125,Cholesterol,C0008377,en_640,AUGMENTS,Expectation,C0679138,en_4589,1,1,AFFECTS,Excitatory,3
4126,Cholesterol,C0008377,en_640,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Excitatory,3
4127,Cholesterol,C0008377,en_640,PREVENTS,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Inhibitory,3
4128,Cholesterol,C0008377,en_640,STIMULATES,Low Density Lipoprotein Receptor,C0034821,en_1975,1,1,AFFECTS,Excitatory,3
4129,Cholesterol,C0008377,en_640,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
4130,Chronic Disease,C0008679,en_643,AFFECTS,Elderly,C0001792,en_258,2,2,AFFECTS,General/Uncertain,6
4131,Chronic Disease,C0008679,en_643,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
4132,Chronic Disease,C0008679,en_643,AFFECTS,Persons,C0027361,en_1635,5,4,AFFECTS,General/Uncertain,12
4133,Chronic Disease,C0008679,en_643,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
4134,Chronic Disease,C0008679,en_643,AFFECTS,Voice,C0042939,en_2377,1,1,AFFECTS,General/Uncertain,3
4135,Chronic Disease,C0008679,en_643,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
4136,Chronic Disease,C0008679,en_643,AFFECTS,Non-smoker,C0337672,en_3795,1,1,AFFECTS,General/Uncertain,6
4137,Chronic Disease,C0008679,en_643,AFFECTS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,General/Uncertain,3
4138,Chronic Disease,C0008679,en_643,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
4139,Chronic Disease,C0008679,en_643,AFFECTS(SPEC),Native Americans,C0282204,en_3640,1,1,AFFECTS,General/Uncertain,3
4140,Chronic Disease,C0008679,en_643,DISRUPTS,cooperation,C0392337,en_3917,1,1,AFFECTS,Inhibitory,3
4141,Chronic Disease,C0008679,en_643,PREDISPOSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
4142,Chronic Disease,C0008679,en_643,PREDISPOSES,Decompensation,C0231187,en_3250,1,1,AFFECTS,Excitatory,3
4143,Ciliary Motility Disorders,C0008780,en_646,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
4144,Circadian Rhythms,C0008810,en_647,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
4145,Citrates,C0008857,en_649,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
4146,Citrulline,C0008864,en_650,DISRUPTS,Pulmonary Vascular Resistance,C0456261,en_4118,1,1,AFFECTS,Inhibitory,3
4147,Clathrin,C0008905,en_652,AFFECTS,Endocytosis,C0014139,en_897,4,3,AFFECTS,General/Uncertain,9
4148,Clathrin,C0008905,en_652,AUGMENTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,Excitatory,3
4149,Climate,C0008946,en_656,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
4150,Climate,C0008946,en_656,AFFECTS,Floods,C0016248,en_1001,1,1,AFFECTS,General/Uncertain,3
4151,Climate,C0008946,en_656,AFFECTS,Natural Disasters,C0027485,en_1643,1,1,AFFECTS,General/Uncertain,3
4152,Climate,C0008946,en_656,AFFECTS,Ecosystem,C0162358,en_2908,1,1,AFFECTS,General/Uncertain,3
4153,Climate,C0008946,en_656,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
4154,Clindamycin,C0008947,en_657,INHIBITS,Exotoxins,C0015309,en_945,1,1,AFFECTS,Inhibitory,3
4155,Clinic Activities,C0008949,en_658,TREATS,Target Population,C0039309,en_2207,1,1,AFFECTS,Inhibitory,3
4156,Clinic Visits,C0008952,en_659,PREVENTS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
4157,Clinic Visits,C0008952,en_659,PREVENTS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,3
4158,Clinic Visits,C0008952,en_659,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4159,Clinical Protocols,C0008971,en_660,PREDISPOSES,Vascular inflammations,C0947751,en_5156,1,1,AFFECTS,Excitatory,3
4160,Clinical Protocols,C0008971,en_660,TREATS,Infant,C0021270,en_1297,2,1,AFFECTS,Inhibitory,3
4161,Clinical Protocols,C0008971,en_660,TREATS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
4162,Clinical Protocols,C0008971,en_660,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
4163,Clinical Protocols,C0008971,en_660,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
4164,Clinical Protocols,C0008971,en_660,TREATS,Ethics Committees,C0085546,en_2675,1,1,AFFECTS,Inhibitory,3
4165,Clinical Protocols,C0008971,en_660,TREATS,Autoimmune,C0443146,en_4064,1,1,AFFECTS,Inhibitory,3
4166,Clinical Protocols,C0008971,en_660,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
4167,Clinical Protocols,C0008971,en_660,TREATS,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
4168,Clinical Protocols,C0008971,en_660,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
4169,Clinical Trials,C0008976,en_661,TREATS,Ethics Committees,C0085546,en_2675,1,1,AFFECTS,Inhibitory,3
4170,Clofazimine,C0008996,en_662,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4171,Clofazimine,C0008996,en_662,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
4172,Coagulants,C0009117,en_663,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
4173,Coagulants,C0009117,en_663,AUGMENTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
4174,Coagulants,C0009117,en_663,PREDISPOSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
4175,Cobalt,C0009148,en_664,AFFECTS,Color,C0009393,en_680,1,1,AFFECTS,General/Uncertain,3
4176,Cocaine,C0009170,en_665,AUGMENTS,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Excitatory,3
4177,Cocaine,C0009170,en_665,AUGMENTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
4178,Cocaine,C0009170,en_665,AUGMENTS(SPEC),Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
4179,Cocaine,C0009170,en_665,DISRUPTS,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Inhibitory,3
4180,Cocaine,C0009170,en_665,STIMULATES,monoamine,C0599682,en_4464,1,1,AFFECTS,Excitatory,3
4181,Cod Liver Oil,C0009213,en_667,PREVENTS,Infection,C3714514,en_6235,4,1,AFFECTS,Inhibitory,3
4182,Cod Liver Oil,C0009213,en_667,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,Inhibitory,3
4183,Cognition Disorders,C0009241,en_669,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
4184,Cognitive Therapy,C0009244,en_670,PREVENTS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
4185,Cognitive Therapy,C0009244,en_670,PREVENTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
4186,Cognitive Therapy,C0009244,en_670,PREVENTS,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Inhibitory,8
4187,Cognitive Therapy,C0009244,en_670,PREVENTS,Social fear,C0424166,en_3991,1,1,AFFECTS,Inhibitory,3
4188,Cognitive Therapy,C0009244,en_670,PREVENTS,psychological distress,C0815107,en_4922,1,1,AFFECTS,Inhibitory,7
4189,Cognitive Therapy,C0009244,en_670,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
4190,Cognitive Therapy,C0009244,en_670,TREATS,Anxiety,C0003467,en_380,2,1,AFFECTS,Inhibitory,8
4191,Cognitive Therapy,C0009244,en_670,TREATS,Anxiety Disorders,C0003469,en_381,2,1,AFFECTS,Inhibitory,3
4192,Cognitive Therapy,C0009244,en_670,TREATS,Depressive disorder,C0011581,en_788,6,4,AFFECTS,Inhibitory,17
4193,Cognitive Therapy,C0009244,en_670,TREATS,[D]Musculoskeletal pain,C0026858,en_1608,1,1,AFFECTS,Inhibitory,7
4194,Cognitive Therapy,C0009244,en_670,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4195,Cognitive Therapy,C0009244,en_670,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
4196,Cognitive Therapy,C0009244,en_670,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,8
4197,Cognitive Therapy,C0009244,en_670,TREATS,Psychologist,C0033908,en_1920,2,1,AFFECTS,Inhibitory,3
4198,Cognitive Therapy,C0009244,en_670,TREATS,Psychotic Disorders,C0033975,en_1924,1,1,AFFECTS,Inhibitory,3
4199,Cognitive Therapy,C0009244,en_670,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,Inhibitory,3
4200,Cognitive Therapy,C0009244,en_670,TREATS,Veterans,C0042610,en_2351,1,1,AFFECTS,Inhibitory,7
4201,Cognitive Therapy,C0009244,en_670,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
4202,Cognitive Therapy,C0009244,en_670,TREATS,Chronic pain,C0150055,en_2816,3,2,AFFECTS,Inhibitory,10
4203,Cognitive Therapy,C0009244,en_670,TREATS,"Depression, Postpartum",C0221074,en_3212,10,5,AFFECTS,Inhibitory,20
4204,Cognitive Therapy,C0009244,en_670,TREATS,Emotional disorder,C0233459,en_3291,1,1,AFFECTS,Inhibitory,3
4205,Cognitive Therapy,C0009244,en_670,TREATS,Worried,C0233481,en_3292,2,1,AFFECTS,Inhibitory,8
4206,Cognitive Therapy,C0009244,en_670,TREATS,Mental distress,C0235109,en_3321,2,1,AFFECTS,Inhibitory,3
4207,Cognitive Therapy,C0009244,en_670,TREATS,Sleep behavior finding,C0474396,en_4140,1,1,AFFECTS,Inhibitory,3
4208,Cognitive Therapy,C0009244,en_670,TREATS,Dementia,C0497327,en_4164,4,1,AFFECTS,Inhibitory,3
4209,Cognitive Therapy,C0009244,en_670,TREATS,Associated symptom,C0521989,en_4207,1,1,AFFECTS,Inhibitory,8
4210,Cognitive Therapy,C0009244,en_670,TREATS,Catastrophization,C0563150,en_4327,1,1,AFFECTS,Inhibitory,7
4211,Cognitive Therapy,C0009244,en_670,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
4212,Cognitive Therapy,C0009244,en_670,TREATS,Offspring,C0680063,en_4620,1,1,AFFECTS,Inhibitory,8
4213,Cognitive Therapy,C0009244,en_670,TREATS,Circadian Rhythm Disorders,C0813142,en_4904,1,1,AFFECTS,Inhibitory,3
4214,Cognitive Therapy,C0009244,en_670,TREATS,psychological distress,C0815107,en_4922,2,1,AFFECTS,Inhibitory,3
4215,Cognitive Therapy,C0009244,en_670,TREATS,Anxiety symptoms,C0860603,en_4992,1,1,AFFECTS,Inhibitory,3
4216,Cognitive Therapy,C0009244,en_670,TREATS,Prediction Errors,C0871118,en_5017,1,1,AFFECTS,Inhibitory,7
4217,Cognitive Therapy,C0009244,en_670,TREATS,Teams,C0871489,en_5024,2,2,AFFECTS,Inhibitory,6
4218,Cognitive Therapy,C0009244,en_670,TREATS,Sleeplessness,C0917801,en_5108,4,3,AFFECTS,Inhibitory,14
4219,Cognitive Therapy,C0009244,en_670,TREATS,Major Depressive Disorder,C1269683,en_5447,1,1,AFFECTS,Inhibitory,3
4220,Cognitive Therapy,C0009244,en_670,TREATS,Symptoms,C1457887,en_5784,5,5,AFFECTS,Inhibitory,20
4221,Cognitive Therapy,C0009244,en_670,TREATS(INFER),Anxiety Disorders,C0003469,en_381,1,1,AFFECTS,Inhibitory,3
4222,Cognitive Therapy,C0009244,en_670,TREATS(INFER),Eating Disorders,C0013473,en_871,4,2,AFFECTS,Inhibitory,6
4223,Coitus,C0009253,en_671,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,6
4224,Coitus,C0009253,en_671,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,6
4225,Coitus,C0009253,en_671,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
4226,Coitus,C0009253,en_671,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,6
4227,Colchicine,C0009262,en_672,AFFECTS,Complication,C0009566,en_697,3,2,AFFECTS,General/Uncertain,15
4228,Colchicine,C0009262,en_672,AFFECTS,Heart,C0018787,en_1130,1,1,AFFECTS,General/Uncertain,8
4229,Colchicine,C0009262,en_672,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
4230,Colchicine,C0009262,en_672,AFFECTS,anti-apoptosis,C1159816,en_5345,1,1,AFFECTS,General/Uncertain,3
4231,Colchicine,C0009262,en_672,AFFECTS,neutrophil degranulation,C1622271,en_6014,1,1,AFFECTS,General/Uncertain,7
4232,Colchicine,C0009262,en_672,DISRUPTS,Cessation of life,C0011065,en_762,3,2,AFFECTS,Inhibitory,10
4233,Colchicine,C0009262,en_672,DISRUPTS,Neutrophil chemotaxis,C0312861,en_3738,1,1,AFFECTS,Inhibitory,3
4234,Colchicine,C0009262,en_672,DISRUPTS,Microtubule Polymerization,C1156032,en_5326,4,2,AFFECTS,Inhibitory,6
4235,Colchicine,C0009262,en_672,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
4236,Colchicine,C0009262,en_672,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
4237,Colchicine,C0009262,en_672,INHIBITS,Interleukin 6 Receptor,C0063717,en_2510,1,1,AFFECTS,Inhibitory,3
4238,Colchicine,C0009262,en_672,INHIBITS,Serum Response Factor,C0074398,en_2568,1,1,AFFECTS,Inhibitory,3
4239,Colchicine,C0009262,en_672,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
4240,Colchicine,C0009262,en_672,INHIBITS,chemokine,C0282554,en_3651,1,1,AFFECTS,Inhibitory,3
4241,Colchicine,C0009262,en_672,INHIBITS,alpha-Defensins,C0887943,en_5093,1,1,AFFECTS,Inhibitory,7
4242,Colchicine,C0009262,en_672,PREVENTS,Gout,C0018099,en_1091,1,1,AFFECTS,Inhibitory,3
4243,Colchicine,C0009262,en_672,PREVENTS,Familial Mediterranean Fever,C0031069,en_1773,1,1,AFFECTS,Inhibitory,3
4244,Colchicine,C0009262,en_672,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
4245,Colchicine,C0009262,en_672,TREATS,Disease,C0012634,en_826,4,3,AFFECTS,Inhibitory,17
4246,Colchicine,C0009262,en_672,TREATS,Gout,C0018099,en_1091,1,1,AFFECTS,Inhibitory,3
4247,Colchicine,C0009262,en_672,TREATS,Patients,C0030705,en_1762,15,9,AFFECTS,Inhibitory,27
4248,Colchicine,C0009262,en_672,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,7
4249,Colchicine,C0009262,en_672,TREATS,Viral pericarditis NOS,C0276139,en_3574,1,1,AFFECTS,Inhibitory,3
4250,Colchicine,C0009262,en_672,TREATS,Hospitalized Patients,C0870668,en_5010,15,9,AFFECTS,Inhibitory,48
4251,Colchicine,C0009262,en_672,TREATS,Population Group,C1257890,en_5403,2,1,AFFECTS,Inhibitory,3
4252,Colchicine,C0009262,en_672,TREATS,Inflammatory disorder,C1290884,en_5483,2,2,AFFECTS,Inhibitory,6
4253,Colchicine,C0009262,en_672,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,6
4254,Colchicine,C0009262,en_672,TREATS,COVID-19,C5203670,en_6417,11,6,AFFECTS,Inhibitory,45
4255,Colchicine,C0009262,en_672,TREATS(INFER),Compromise,C0518613,en_4180,2,1,AFFECTS,Inhibitory,3
4256,Colistin,C0009316,en_674,PREVENTS,Adverse drug effect,C0041755,en_2312,1,1,AFFECTS,Inhibitory,3
4257,Ulcerative Colitis,C0009324,en_676,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
4258,Collagen,C0009325,en_677,DISRUPTS,macrophage,C0024432,en_1484,1,1,AFFECTS,Inhibitory,3
4259,Collagen,C0009325,en_677,PRODUCES,Gelatin,C0017237,en_1042,1,1,AFFECTS,Excitatory,3
4260,Collagen,C0009325,en_677,PRODUCES,Oxidants,C0085403,en_2667,1,1,AFFECTS,Excitatory,3
4261,Collagen,C0009325,en_677,STIMULATES,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
4262,Collagen,C0009325,en_677,STIMULATES,Fibroblasts,C0016030,en_992,2,2,AFFECTS,Excitatory,6
4263,Collagen,C0009325,en_677,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
4264,Collagen,C0009325,en_677,STIMULATES,Endothelial Cells,C0225336,en_3237,1,1,AFFECTS,Excitatory,3
4265,Collagen,C0009325,en_677,STIMULATES,"Tumor cells, malignant",C0334227,en_3774,1,1,AFFECTS,Excitatory,3
4266,Collagen,C0009325,en_677,STIMULATES,Pericytes,C0598800,en_4453,1,1,AFFECTS,Excitatory,3
4267,Collagen Diseases,C0009326,en_678,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
4268,colonoscopy,C0009378,en_679,AFFECTS,Patient referral,C0034927,en_1985,1,1,AFFECTS,General/Uncertain,3
4269,Color,C0009393,en_680,AFFECTS,attenuation,C0599946,en_4490,1,1,AFFECTS,General/Uncertain,3
4270,Combined Modality Therapy,C0009429,en_683,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
4271,Combined Modality Therapy,C0009429,en_683,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
4272,Combined Modality Therapy,C0009429,en_683,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
4273,Combined Modality Therapy,C0009429,en_683,TREATS,"Carcinoma, Non-Small-Cell Lung",C0007131,en_563,1,1,AFFECTS,Inhibitory,3
4274,Combined Modality Therapy,C0009429,en_683,TREATS,Chondrosarcoma,C0008479,en_641,1,1,AFFECTS,Inhibitory,3
4275,Combined Modality Therapy,C0009429,en_683,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
4276,Combined Modality Therapy,C0009429,en_683,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
4277,Combined Modality Therapy,C0009429,en_683,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,6
4278,Combined Modality Therapy,C0009429,en_683,TREATS,Patients,C0030705,en_1762,11,6,AFFECTS,Inhibitory,18
4279,Combined Modality Therapy,C0009429,en_683,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
4280,Combined Modality Therapy,C0009429,en_683,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,6
4281,Combined Modality Therapy,C0009429,en_683,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
4282,Combined Modality Therapy,C0009429,en_683,TREATS,Infection due to resistant organism,C1269831,en_5449,1,1,AFFECTS,Inhibitory,3
4283,Combined Modality Therapy,C0009429,en_683,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12
4284,Combined Modality Therapy,C0009429,en_683,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
4285,Combined Modality Therapy,C0009429,en_683,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
4286,Communicable Diseases,C0009450,en_685,AFFECTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
4287,Communicable Diseases,C0009450,en_685,AFFECTS,Blood Circulation,C0005775,en_483,1,1,AFFECTS,General/Uncertain,3
4288,Communicable Diseases,C0009450,en_685,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4289,Communicable Diseases,C0009450,en_685,AFFECTS,"Infant, Newborn",C0021289,en_1299,2,1,AFFECTS,General/Uncertain,3
4290,Communicable Diseases,C0009450,en_685,AFFECTS,Mothers,C0026591,en_1583,1,1,AFFECTS,General/Uncertain,3
4291,Communicable Diseases,C0009450,en_685,AFFECTS,Persons,C0027361,en_1635,3,3,AFFECTS,General/Uncertain,9
4292,Communicable Diseases,C0009450,en_685,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4293,Communicable Diseases,C0009450,en_685,AFFECTS,student,C0038492,en_2171,1,1,AFFECTS,General/Uncertain,3
4294,Communicable Diseases,C0009450,en_685,AFFECTS,Smarting pain,C0235048,en_3319,1,1,AFFECTS,General/Uncertain,3
4295,Communicable Diseases,C0009450,en_685,AFFECTS,Individual,C0237401,en_3343,5,2,AFFECTS,General/Uncertain,6
4296,Communicable Diseases,C0009450,en_685,AFFECTS,Very large,C0450093,en_4082,2,1,AFFECTS,General/Uncertain,3
4297,Communicable Diseases,C0009450,en_685,AFFECTS,poor health,C0683321,en_4658,1,1,AFFECTS,General/Uncertain,3
4298,Communicable Diseases,C0009450,en_685,AFFECTS,STEMI,C1536220,en_5944,1,1,AFFECTS,General/Uncertain,6
4299,Communicable Diseases,C0009450,en_685,AFFECTS(SPEC),African race,C0027567,en_1646,1,1,AFFECTS,General/Uncertain,3
4300,Communicable Diseases,C0009450,en_685,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
4301,Communicable Diseases,C0009450,en_685,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
4302,Communicable Diseases,C0009450,en_685,PREDISPOSES,Falls,C0085639,en_2684,1,1,AFFECTS,Excitatory,3
4303,Communicable Diseases,C0009450,en_685,PREDISPOSES,disease transmission,C0242781,en_3438,1,1,AFFECTS,Excitatory,3
4304,Community Health Education,C0009470,en_688,PREVENTS,MISUSE,C0549649,en_4285,1,1,AFFECTS,Inhibitory,3
4305,Comorbidity,C0009488,en_690,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
4306,Comorbidity,C0009488,en_690,PREDISPOSES,Senility,C0231337,en_3257,1,1,AFFECTS,Excitatory,6
4307,Comorbidity,C0009488,en_690,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,6
4308,Comorbidity,C0009488,en_690,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
4309,Comorbidity,C0009488,en_690,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
4310,Comorbidity,C0009488,en_690,PREDISPOSES,Immune System Suppression,C1373218,en_5686,1,1,AFFECTS,Excitatory,8
4311,Comorbidity,C0009488,en_690,PREDISPOSES,Worse,C1457868,en_5783,1,1,AFFECTS,Excitatory,6
4312,Comorbidity,C0009488,en_690,PREDISPOSES,Increased risk,C4699158,en_6379,1,1,AFFECTS,Excitatory,6
4313,Comorbidity,C0009488,en_690,PREDISPOSES,Severe disease,C4740692,en_6396,2,2,AFFECTS,Excitatory,12
4314,Comorbidity,C0009488,en_690,PREDISPOSES,COVID-19,C5203670,en_6417,3,3,AFFECTS,Excitatory,20
4315,Complement System Proteins,C0009498,en_691,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
4316,Complement System Proteins,C0009498,en_691,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,7
4317,Complement System Proteins,C0009498,en_691,AFFECTS,Pathogenesis,C0699748,en_4703,1,1,AFFECTS,General/Uncertain,6
4318,Complement System Proteins,C0009498,en_691,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
4319,Complement System Proteins,C0009498,en_691,AUGMENTS,Autocrine Systems,C0596138,en_4381,1,1,AFFECTS,Excitatory,3
4320,Complement System Proteins,C0009498,en_691,DISRUPTS,neutrophil,C0027950,en_1676,1,1,AFFECTS,Inhibitory,3
4321,Complement System Proteins,C0009498,en_691,PRODUCES,Thrombin,C0040018,en_2228,2,1,AFFECTS,Excitatory,3
4322,Complement System Proteins,C0009498,en_691,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
4323,Complement System Proteins,C0009498,en_691,STIMULATES,Vitamin D,C0042866,en_2371,1,1,AFFECTS,Excitatory,3
4324,Complement System Proteins,C0009498,en_691,STIMULATES,Hepatocyte,C0227525,en_3241,1,1,AFFECTS,Excitatory,3
4325,Complement component C1,C0009499,en_692,STIMULATES,Endothelial Cells,C0225336,en_3237,1,1,AFFECTS,Excitatory,3
4326,Complement 1 Inactivators,C0009500,en_693,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
4327,Complement Activation,C0009528,en_695,AFFECTS,ravulizumab,C4550350,en_6364,1,1,AFFECTS,General/Uncertain,7
4328,Complement inhibitor,C0009543,en_696,INHIBITS,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Inhibitory,3
4329,Complication,C0009566,en_697,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
4330,Complication,C0009566,en_697,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
4331,Complication,C0009566,en_697,AFFECTS,Birth,C0005615,en_476,1,1,AFFECTS,General/Uncertain,3
4332,Complication,C0009566,en_697,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4333,Complication,C0009566,en_697,AFFECTS,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,3
4334,Complication,C0009566,en_697,AFFECTS,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
4335,Complication,C0009566,en_697,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
4336,Complication,C0009566,en_697,AFFECTS,Male population group,C0025266,en_1533,1,1,AFFECTS,General/Uncertain,3
4337,Complication,C0009566,en_697,AFFECTS,Mothers,C0026591,en_1583,3,2,AFFECTS,General/Uncertain,6
4338,Complication,C0009566,en_697,AFFECTS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
4339,Complication,C0009566,en_697,AFFECTS,Patients,C0030705,en_1762,4,3,AFFECTS,General/Uncertain,9
4340,Complication,C0009566,en_697,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
4341,Complication,C0009566,en_697,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
4342,Complication,C0009566,en_697,AFFECTS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,General/Uncertain,3
4343,Complication,C0009566,en_697,AFFECTS,Individual,C0237401,en_3343,3,2,AFFECTS,General/Uncertain,6
4344,Complication,C0009566,en_697,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
4345,Complication,C0009566,en_697,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
4346,Complication,C0009566,en_697,COMPLICATES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,General/Uncertain,3
4347,Complication,C0009566,en_697,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,4,2,AFFECTS,Excitatory,6
4348,Complication,C0009566,en_697,PREDISPOSES,Disease,C0012634,en_826,3,3,AFFECTS,Excitatory,9
4349,Complication,C0009566,en_697,PREDISPOSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
4350,Complication,C0009566,en_697,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
4351,Comprehensive Health Care,C0009586,en_698,PREVENTS,Maternal Mortality,C0024923,en_1510,1,1,AFFECTS,Inhibitory,3
4352,Comprehensive Health Care,C0009586,en_698,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4353,Comprehensive Health Care,C0009586,en_698,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
4354,Comprehensive Health Care,C0009586,en_698,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
4355,Obsessive-Compulsive Personality,C0009595,en_699,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
4356,"Condoms, Male",C0009653,en_702,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
4357,"Condoms, Male",C0009653,en_702,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,8
4358,"Condoms, Male",C0009653,en_702,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,15
4359,"Condoms, Male",C0009653,en_702,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,2,1,AFFECTS,Inhibitory,8
4360,"Condoms, Male",C0009653,en_702,TREATS,COVID-19,C5203670,en_6417,5,3,AFFECTS,Inhibitory,23
4361,Confusion,C0009676,en_703,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4362,Constitutions,C0009807,en_707,AFFECTS,Control Groups,C0009932,en_711,1,1,AFFECTS,General/Uncertain,3
4363,Constitutions,C0009807,en_707,AFFECTS,Health care facility,C0018704,en_1119,1,1,AFFECTS,General/Uncertain,3
4364,Consultation,C0009818,en_708,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
4365,Consultation,C0009818,en_708,TREATS,Ageusia,C0001800,en_259,2,1,AFFECTS,Inhibitory,3
4366,Consultation,C0009818,en_708,TREATS,Anosmia,C0003126,en_337,2,1,AFFECTS,Inhibitory,3
4367,Consultation,C0009818,en_708,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
4368,Consultation,C0009818,en_708,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
4369,Consultation,C0009818,en_708,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,6
4370,Consultation,C0009818,en_708,TREATS,Low Back Pain,C0024031,en_1458,1,1,AFFECTS,Inhibitory,6
4371,Consultation,C0009818,en_708,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
4372,Consultation,C0009818,en_708,TREATS,Otitis Media with Effusion,C0029883,en_1728,1,1,AFFECTS,Inhibitory,6
4373,Consultation,C0009818,en_708,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,3
4374,Consultation,C0009818,en_708,TREATS,Vertigo,C0042571,en_2350,1,1,AFFECTS,Inhibitory,6
4375,Consultation,C0009818,en_708,TREATS,Ear discharge,C0155540,en_2887,1,1,AFFECTS,Inhibitory,6
4376,Consultation,C0009818,en_708,TREATS,Acute otitis media,C0271429,en_3555,1,1,AFFECTS,Inhibitory,6
4377,Consultation,C0009818,en_708,TREATS,Chief complaint (finding),C0277786,en_3589,1,1,AFFECTS,Inhibitory,6
4378,Consultation,C0009818,en_708,TREATS,CHEST SYMPTOM,C0742337,en_4794,1,1,AFFECTS,Inhibitory,3
4379,Consultation,C0009818,en_708,TREATS,Diabetic ulcer,C0743150,en_4799,1,1,AFFECTS,Inhibitory,3
4380,Consultation,C0009818,en_708,TREATS,Psychiatric inpatient,C0748064,en_4827,1,1,AFFECTS,Inhibitory,3
4381,Consultation,C0009818,en_708,TREATS,Teams,C0871489,en_5024,1,1,AFFECTS,Inhibitory,3
4382,Consultation,C0009818,en_708,TREATS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Inhibitory,3
4383,Consultation,C0009818,en_708,TREATS,Provider,C1138603,en_5273,2,1,AFFECTS,Inhibitory,3
4384,Consultation,C0009818,en_708,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
4385,Consultation,C0009818,en_708,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,Inhibitory,6
4386,Contraceptive Agents,C0009871,en_709,INHIBITS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,Inhibitory,3
4387,Contraceptive Agents,C0009871,en_709,PREDISPOSES,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Excitatory,3
4388,Contraceptive Agents,C0009871,en_709,TREATS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
4389,Contraceptive Agents,C0009871,en_709,TREATS,loss; bone,C0599877,en_4480,1,1,AFFECTS,Inhibitory,3
4390,"Contraceptives, Oral",C0009905,en_710,PREVENTS,HIV,C0019682,en_1190,1,1,AFFECTS,Inhibitory,8
4391,Copper,C0009968,en_715,AFFECTS,Oxidation-Reduction,C0030012,en_1733,1,1,AFFECTS,General/Uncertain,7
4392,Copper,C0009968,en_715,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
4393,Coronary Arteriosclerosis,C0010054,en_717,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,8
4394,Coronary Arteriosclerosis,C0010054,en_717,PREDISPOSES,"Death, Sudden, Cardiac",C0085298,en_2661,2,1,AFFECTS,Excitatory,3
4395,Coronary Arteriosclerosis,C0010054,en_717,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,6
4396,Coronary heart disease,C0010068,en_718,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
4397,Corticosterone,C0010124,en_720,TREATS,Whales,C0043136,en_2392,1,1,AFFECTS,Inhibitory,3
4398,Corticotropin-Releasing Hormone,C0010132,en_721,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
4399,Coughing,C0010200,en_723,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
4400,Counseling,C0010210,en_724,AFFECTS,activity level,C0683317,en_4657,2,1,AFFECTS,General/Uncertain,3
4401,Counseling,C0010210,en_724,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
4402,Counseling,C0010210,en_724,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4403,Counseling,C0010210,en_724,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4404,Counseling,C0010210,en_724,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
4405,Counseling,C0010210,en_724,TREATS,cohort,C0599755,en_4470,2,1,AFFECTS,Inhibitory,3
4406,Counseling,C0010210,en_724,TREATS,VICTIM,C0680681,en_4626,1,1,AFFECTS,Inhibitory,3
4407,Counseling,C0010210,en_724,TREATS,college student,C0682177,en_4638,1,1,AFFECTS,Inhibitory,8
4408,Counseling,C0010210,en_724,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
4409,Counseling,C0010210,en_724,TREATS(SPEC),Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
4410,Creatine Kinase MB Isoenzyme|PIK3C2A,C0010290|5286,en_729,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
4411,Creatinine,C0010294,en_730,AFFECTS,Parenchyma,C0933845,en_5134,1,1,AFFECTS,General/Uncertain,6
4412,Crisis Intervention,C0010332,en_731,TREATS,Curb,C0263940,en_3526,1,1,AFFECTS,Inhibitory,3
4413,Care of intensive care unit patient,C0010337,en_732,AFFECTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,General/Uncertain,3
4414,Care of intensive care unit patient,C0010337,en_732,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
4415,Care of intensive care unit patient,C0010337,en_732,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
4416,Care of intensive care unit patient,C0010337,en_732,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
4417,Critical Illness,C0010340,en_733,AFFECTS,Delirium,C0011206,en_774,1,1,AFFECTS,General/Uncertain,3
4418,Critical Illness,C0010340,en_733,AFFECTS,Ethnic group,C0015031,en_934,1,1,AFFECTS,General/Uncertain,6
4419,Critical Illness,C0010340,en_733,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
4420,Critical Illness,C0010340,en_733,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
4421,Critical Illness,C0010340,en_733,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
4422,Critical Illness,C0010340,en_733,AFFECTS,Mental state finding,C0278060,en_3594,1,1,AFFECTS,General/Uncertain,3
4423,Critical Illness,C0010340,en_733,PREDISPOSES,poor health,C0683321,en_4658,1,1,AFFECTS,Excitatory,3
4424,Cross Infection,C0010356,en_735,AFFECTS,Life Threatening,C2826244,en_6137,1,1,AFFECTS,General/Uncertain,6
4425,Cross Infection,C0010356,en_735,AFFECTS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,General/Uncertain,6
4426,Curcumin,C0010467,en_737,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,7
4427,Curcumin,C0010467,en_737,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4428,Curcumin,C0010467,en_737,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
4429,Curcumin,C0010467,en_737,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
4430,Cyclohexanones,C0010571,en_738,DISRUPTS,Deubiquitination,C1157996,en_5335,1,1,AFFECTS,Inhibitory,3
4431,Cyclophosphamide,C0010583,en_739,TREATS,malignant neoplasm of breast staging,C2216702,en_6091,1,1,AFFECTS,Inhibitory,7
4432,Cyclophosphamide,C0010583,en_739,AFFECTS,Graft acceptance,C0301944,en_3699,1,1,AFFECTS,General/Uncertain,3
4433,Cyclosporine,C0010592,en_740,INHIBITS,Peptidylprolyl Isomerase,C0136073,en_2784,4,1,AFFECTS,Inhibitory,3
4434,Cyclosporine,C0010592,en_740,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
4435,Cyclosporine,C0010592,en_740,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
4436,Cyclosporine,C0010592,en_740,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
4437,Cyclosporine,C0010592,en_740,TREATS,Historical Cohort,C2348984,en_6100,1,1,AFFECTS,Inhibitory,6
4438,Cyclosporine,C0010592,en_740,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
4439,Cyclosporine,C0010592,en_740,TREATS(INFER),Keratoconjunctivitis,C0022573,en_1375,2,1,AFFECTS,Inhibitory,3
4440,Cyproheptadine,C0010620,en_741,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
4441,Cyproheptadine,C0010620,en_741,TREATS(INFER),Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
4442,Cysteine,C0010654,en_742,AFFECTS,Arteriosclerosis,C0003850,en_399,1,1,AFFECTS,General/Uncertain,3
4443,caspase,C0010656,en_743,AFFECTS,Cell Death,C0007587,en_587,1,1,AFFECTS,General/Uncertain,3
4444,caspase,C0010656,en_743,AUGMENTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
4445,Cysteine Protease,C0010661,en_744,AFFECTS,Protein Turnover,C0597297,en_4420,3,1,AFFECTS,General/Uncertain,3
4446,Cystic Fibrosis,C0010674,en_745,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4447,Cystic Fibrosis,C0010674,en_745,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
4448,Cystic Fibrosis,C0010674,en_745,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4449,Cystic Fibrosis,C0010674,en_745,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,6
4450,Cystine,C0010682,en_746,AUGMENTS,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
4451,Cytochrome P450,C0010762,en_747,STIMULATES,Interferons,C0021747,en_1333,2,1,AFFECTS,Excitatory,3
4452,Cytochrome P450|CYP2B6,C0010762|1555,en_748,PRODUCES,lipid mediator,C0599745,en_4468,1,1,AFFECTS,Excitatory,7
4453,Cytochrome P450|CYP2B6,C0010762|1555,en_748,PRODUCES,ALOX12 gene|ALOX12,C1412356|239,en_5698,1,1,AFFECTS,Excitatory,7
4454,Cytochrome P450|CYP2B6,C0010762|1555,en_748,PRODUCES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human|PTGS2",C1565860|5743,en_5985,1,1,AFFECTS,Excitatory,7
4455,Cytochromes,C0010798,en_749,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
4456,Cytochromes,C0010798,en_749,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
4457,Cytochromes,C0010798,en_749,PREDISPOSES,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Excitatory,3
4458,Cytochromes|PPIG,C0010798|9360,en_750,AFFECTS,Acute inflammation,C0333361,en_3763,1,1,AFFECTS,General/Uncertain,7
4459,Cytomegalovirus Infections,C0010823,en_751,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,3
4460,Cytopenia,C0010828,en_754,AFFECTS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,General/Uncertain,3
4461,Dance Therapy,C0010962,en_757,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
4462,Dance Therapy,C0010962,en_757,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,8
4463,Dancing,C0010963,en_758,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4464,Dancing,C0010963,en_758,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4465,Dancing,C0010963,en_758,TREATS,Sitting position,C0277814,en_3592,2,1,AFFECTS,Inhibitory,3
4466,Dancing,C0010963,en_758,TREATS,Ability to walk,C0559964,en_4318,1,1,AFFECTS,Inhibitory,3
4467,Dancing,C0010963,en_758,TREATS(INFER),Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
4468,Dapsone,C0010980,en_759,AFFECTS,Complication,C0009566,en_697,2,1,AFFECTS,General/Uncertain,3
4469,Dapsone,C0010980,en_759,PREVENTS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
4470,Dapsone,C0010980,en_759,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
4471,Dapsone,C0010980,en_759,TREATS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
4472,Dapsone,C0010980,en_759,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4473,Dapsone,C0010980,en_759,TREATS,High Risk Populations,C0870646,en_5008,2,1,AFFECTS,Inhibitory,3
4474,Cessation of life,C0011065,en_762,AFFECTS,Age,C0001779,en_257,4,4,AFFECTS,General/Uncertain,24
4475,Cessation of life,C0011065,en_762,AFFECTS,Blood coagulation,C0005778,en_484,2,1,AFFECTS,General/Uncertain,3
4476,Cessation of life,C0011065,en_762,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4477,Cessation of life,C0011065,en_762,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
4478,Cessation of life,C0011065,en_762,AFFECTS,Ethnic group,C0015031,en_934,1,1,AFFECTS,General/Uncertain,6
4479,Cessation of life,C0011065,en_762,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
4480,Cessation of life,C0011065,en_762,AFFECTS,Nurses,C0028661,en_1694,1,1,AFFECTS,General/Uncertain,3
4481,Cessation of life,C0011065,en_762,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4482,Cessation of life,C0011065,en_762,AFFECTS,Males,C0086582,en_2729,1,1,AFFECTS,General/Uncertain,6
4483,Cessation of life,C0011065,en_762,AFFECTS,Ritual compulsion,C0233622,en_3298,1,1,AFFECTS,General/Uncertain,3
4484,Cessation of life,C0011065,en_762,AFFECTS,Chronic heart failure,C0264716,en_3538,1,1,AFFECTS,General/Uncertain,3
4485,Cessation of life,C0011065,en_762,AFFECTS,microbial,C0599840,en_4476,1,1,AFFECTS,General/Uncertain,3
4486,Cessation of life,C0011065,en_762,AFFECTS,Staff,C0851286,en_4950,1,1,AFFECTS,General/Uncertain,6
4487,Cessation of life,C0011065,en_762,AFFECTS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,General/Uncertain,7
4488,Cessation of life,C0011065,en_762,AFFECTS,cell fate,C1540661,en_5948,1,1,AFFECTS,General/Uncertain,3
4489,Cessation of life,C0011065,en_762,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
4490,Cessation of life,C0011065,en_762,PRODUCES,cytokine,C0079189,en_2593,3,2,AFFECTS,Excitatory,6
4491,Debridement,C0011079,en_764,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
4492,Decontamination,C0011121,en_766,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
4493,Decontamination,C0011121,en_766,PREVENTS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
4494,Decontamination,C0011121,en_766,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4495,Decontamination,C0011121,en_766,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4496,Decontamination,C0011121,en_766,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
4497,Decontamination,C0011121,en_766,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4498,Defense Mechanisms,C0011142,en_769,PREDISPOSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
4499,Degenerative abnormality,C0011164,en_770,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
4500,Degenerative abnormality,C0011164,en_770,PREDISPOSES,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,Excitatory,3
4501,Deglutition,C0011167,en_771,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4502,Deglutition Disorders,C0011168,en_772,AFFECTS,Deglutition,C0011167,en_771,1,1,AFFECTS,General/Uncertain,3
4503,Deglutition Disorders,C0011168,en_772,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
4504,Deglutition Disorders,C0011168,en_772,AFFECTS,Tongue swallowing,C0858978,en_4986,1,1,AFFECTS,General/Uncertain,3
4505,Deglutition Disorders,C0011168,en_772,PREDISPOSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,3
4506,Delirium,C0011206,en_774,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
4507,Delirium,C0011206,en_774,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4508,Delivery of Health Care,C0011211,en_775,TREATS,"Child, Hospitalized",C0008098,en_624,1,1,AFFECTS,Inhibitory,3
4509,Delivery of Health Care,C0011211,en_775,TREATS,Huntington Disease,C0020179,en_1214,1,1,AFFECTS,Inhibitory,6
4510,Delivery of Health Care,C0011211,en_775,TREATS,Persons,C0027361,en_1635,4,4,AFFECTS,Inhibitory,12
4511,Delivery of Health Care,C0011211,en_775,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
4512,Delivery of Health Care,C0011211,en_775,TREATS,Psoriasis,C0033860,en_1918,2,1,AFFECTS,Inhibitory,6
4513,Delivery of Health Care,C0011211,en_775,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
4514,Delivery of Health Care,C0011211,en_775,TREATS,Caregiver,C0085537,en_2674,1,1,AFFECTS,Inhibitory,3
4515,Delivery of Health Care,C0011211,en_775,TREATS,Native Americans,C0282204,en_3640,1,1,AFFECTS,Inhibitory,3
4516,Demyelinating Diseases,C0011303,en_776,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
4517,Dendritic Cells,C0011306,en_777,PRODUCES,Tretinoin,C0040845,en_2280,1,1,AFFECTS,Excitatory,3
4518,Dendritic Cells,C0011306,en_777,PRODUCES,Retinal dehydrogenase,C0073099,en_2559,2,2,AFFECTS,Excitatory,6
4519,Dendritic Cells,C0011306,en_777,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
4520,Dengue Fever,C0011311,en_778,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
4521,Dental Procedures,C0011331,en_780,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
4522,Dental Procedures,C0011331,en_780,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4523,Dental Procedures,C0011331,en_780,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
4524,Dental Procedures,C0011331,en_780,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
4525,Dental caries,C0011334,en_781,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4526,Dental caries,C0011334,en_781,AFFECTS,Adolescent,C0205653,en_3132,1,1,AFFECTS,General/Uncertain,3
4527,Dental caries,C0011334,en_781,AFFECTS,Lesion,C0221198,en_3221,2,1,AFFECTS,General/Uncertain,3
4528,Dentist,C0011441,en_783,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4529,"Denture, Overlay",C0011459,en_784,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4530,Deoxyribonuclease I,C0011519,en_785,AFFECTS,Coronet,C0222033,en_3233,1,1,AFFECTS,General/Uncertain,3
4531,Deoxyribonuclease I,C0011519,en_785,INHIBITS,ELK3 gene,C0812375,en_4900,1,1,AFFECTS,Inhibitory,3
4532,Amyloid deposition,C0011560,en_786,AFFECTS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
4533,Depressive disorder,C0011581,en_788,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,6
4534,Depressive disorder,C0011581,en_788,AFFECTS,Behavior,C0004927,en_450,2,1,AFFECTS,General/Uncertain,3
4535,Depressive disorder,C0011581,en_788,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
4536,Depressive disorder,C0011581,en_788,AFFECTS,Child Development,C0008071,en_621,2,1,AFFECTS,General/Uncertain,3
4537,Depressive disorder,C0011581,en_788,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
4538,Depressive disorder,C0011581,en_788,AFFECTS,Family,C0015576,en_961,2,2,AFFECTS,General/Uncertain,6
4539,Depressive disorder,C0011581,en_788,AFFECTS,Nurses,C0028661,en_1694,1,1,AFFECTS,General/Uncertain,6
4540,Depressive disorder,C0011581,en_788,AFFECTS,Patients,C0030705,en_1762,3,3,AFFECTS,General/Uncertain,9
4541,Depressive disorder,C0011581,en_788,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
4542,Depressive disorder,C0011581,en_788,AFFECTS,Pregnancy,C0032961,en_1872,2,1,AFFECTS,General/Uncertain,3
4543,Depressive disorder,C0011581,en_788,AFFECTS,Sex Behavior,C0036864,en_2093,1,1,AFFECTS,General/Uncertain,6
4544,Depressive disorder,C0011581,en_788,AFFECTS,Loss of capacity for enjoyment,C0178417,en_2983,1,1,AFFECTS,General/Uncertain,3
4545,Depressive disorder,C0011581,en_788,AFFECTS,Participant,C0679646,en_4602,1,1,AFFECTS,General/Uncertain,3
4546,Depressive disorder,C0011581,en_788,AFFECTS,Offspring,C0680063,en_4620,1,1,AFFECTS,General/Uncertain,3
4547,Depressive disorder,C0011581,en_788,AFFECTS,Sleep Disorders,C0851578,en_4954,1,1,AFFECTS,General/Uncertain,3
4548,Depressive disorder,C0011581,en_788,AFFECTS,Phasis,C1067936,en_5224,1,1,AFFECTS,General/Uncertain,6
4549,Depressive disorder,C0011581,en_788,AFFECTS,Negative thoughts,C1142075,en_5283,1,1,AFFECTS,General/Uncertain,3
4550,Depressive disorder,C0011581,en_788,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
4551,Dermabrasion,C0011593,en_789,TREATS,Burn injury,C0006434,en_526,2,1,AFFECTS,Inhibitory,3
4552,Dermatitis,C0011603,en_790,PRODUCES,Autoantibodies,C0004358,en_426,1,1,AFFECTS,Excitatory,3
4553,Designer Drugs,C0011684,en_792,AUGMENTS,Structure of terminal stria nuclei of preoptic region,C0228365,en_3242,1,1,AFFECTS,Excitatory,3
4554,Designer Drugs,C0011684,en_792,DISRUPTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Inhibitory,3
4555,Desmosine,C0011702,en_793,PREDISPOSES,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Excitatory,3
4556,Deoxycorticosterone,C0011710,en_794,AFFECTS,Hypothalamic structure,C0020663,en_1249,1,1,AFFECTS,General/Uncertain,3
4557,Detergents,C0011740,en_795,AFFECTS,Hand eczema,C0239816,en_3375,1,1,AFFECTS,General/Uncertain,3
4558,Dexamethasone,C0011777,en_796,AFFECTS,Adrenal Cortex,C0001613,en_246,1,1,AFFECTS,General/Uncertain,6
4559,Dexamethasone,C0011777,en_796,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,7
4560,Dexamethasone,C0011777,en_796,AFFECTS,Lethality,C5203340,en_6416,1,1,AFFECTS,General/Uncertain,8
4561,Dexamethasone,C0011777,en_796,DISRUPTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Inhibitory,6
4562,Dexamethasone,C0011777,en_796,PREVENTS,Brain Edema,C1527311,en_5920,1,1,AFFECTS,Inhibitory,7
4563,Dexamethasone,C0011777,en_796,TREATS,Adult,C0001675,en_252,3,2,AFFECTS,Inhibitory,10
4564,Dexamethasone,C0011777,en_796,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
4565,Dexamethasone,C0011777,en_796,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
4566,Dexamethasone,C0011777,en_796,TREATS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,11
4567,Dexamethasone,C0011777,en_796,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,6
4568,Dexamethasone,C0011777,en_796,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,6,3,AFFECTS,Inhibitory,23
4569,Dexamethasone,C0011777,en_796,TREATS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,6
4570,Dexamethasone,C0011777,en_796,TREATS,Hypoxia,C0242184,en_3396,4,2,AFFECTS,Inhibitory,14
4571,Dexamethasone,C0011777,en_796,TREATS,Possible,C0332149,en_3747,1,1,AFFECTS,Inhibitory,8
4572,Dexamethasone,C0011777,en_796,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,8
4573,Dexamethasone,C0011777,en_796,TREATS,Hospitalized Patients,C0870668,en_5010,9,6,AFFECTS,Inhibitory,26
4574,Dexamethasone,C0011777,en_796,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,7
4575,Dexamethasone,C0011777,en_796,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,8
4576,Dexamethasone,C0011777,en_796,TREATS,COVID-19,C5203670,en_6417,17,12,AFFECTS,Inhibitory,86
4577,Dexamethasone,C0011777,en_796,AUGMENTS,Muscle,C0026845,en_1603,1,1,AFFECTS,Excitatory,3
4578,Dexamethasone,C0011777,en_796,DISRUPTS,T-Cell Lymphoma,C0079772,en_2610,1,1,AFFECTS,Inhibitory,3
4579,Dexamethasone,C0011777,en_796,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
4580,Dexamethasone,C0011777,en_796,PREVENTS,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Inhibitory,3
4581,Dexamethasone,C0011777,en_796,STIMULATES,Histone Deacetylase,C0019643,en_1188,1,1,AFFECTS,Excitatory,3
4582,Dexamethasone,C0011777,en_796,TREATS,Arthritis,C0003864,en_400,1,1,AFFECTS,Inhibitory,3
4583,Dexamethasone,C0011777,en_796,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
4584,Dexamethasone,C0011777,en_796,TREATS,Patients,C0030705,en_1762,51,23,AFFECTS,Inhibitory,69
4585,Dexamethasone,C0011777,en_796,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
4586,Dexamethasone,C0011777,en_796,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
4587,Dexamethasone,C0011777,en_796,TREATS,network,C0679670,en_4604,2,1,AFFECTS,Inhibitory,3
4588,Dexamethasone,C0011777,en_796,TREATS,Thromboembolic event,C0857496,en_4977,1,1,AFFECTS,Inhibitory,3
4589,Dexamethasone,C0011777,en_796,TREATS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
4590,Dexamethasone,C0011777,en_796,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,4,3,AFFECTS,Inhibitory,9
4591,Dexamethasone,C0011777,en_796,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
4592,Dexamethasone,C0011777,en_796,TREATS(INFER),Pneumonia,C0032285,en_1833,5,2,AFFECTS,Inhibitory,6
4593,Dexamethasone,C0011777,en_796,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,6,4,AFFECTS,Inhibitory,12
4594,Dexamethasone,C0011777,en_796,TREATS(INFER),Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,3
4595,Dexamethasone,C0011777,en_796,TREATS(INFER),Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
4596,Dexamethasone,C0011777,en_796,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,5,1,AFFECTS,Inhibitory,3
4597,Dexamethasone,C0011777,en_796,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
4598,Dexamethasone,C0011777,en_796,TREATS(INFER),Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
4599,Dexamethasone,C0011777,en_796,TREATS(SPEC),Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
4600,Diabetes,C0011847,en_797,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
4601,Diabetes,C0011847,en_797,AFFECTS,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,General/Uncertain,3
4602,Diabetes,C0011847,en_797,AFFECTS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,General/Uncertain,6
4603,Diabetes,C0011847,en_797,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
4604,Diabetes,C0011847,en_797,AFFECTS,Persons,C0027361,en_1635,5,3,AFFECTS,General/Uncertain,9
4605,Diabetes,C0011847,en_797,AFFECTS,Obesity,C0028754,en_1699,2,1,AFFECTS,General/Uncertain,3
4606,Diabetes,C0011847,en_797,AFFECTS,African American,C0085756,en_2689,1,1,AFFECTS,General/Uncertain,6
4607,Diabetes,C0011847,en_797,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
4608,Diabetes,C0011847,en_797,AFFECTS,Vitality,C0424589,en_3997,1,1,AFFECTS,General/Uncertain,3
4609,Diabetes,C0011847,en_797,AFFECTS,44717,C0442749,en_4053,1,1,AFFECTS,General/Uncertain,3
4610,Diabetes,C0011847,en_797,AFFECTS,Participant,C0679646,en_4602,2,1,AFFECTS,General/Uncertain,3
4611,Diabetes,C0011847,en_797,COMPLICATES,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
4612,Diabetes,C0011847,en_797,COMPLICATES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
4613,Diabetes,C0011847,en_797,COMPLICATES,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,7
4614,Diabetes,C0011847,en_797,DISRUPTS,Epithelial Cells,C0014597,en_919,2,1,AFFECTS,Inhibitory,3
4615,Diabetes,C0011847,en_797,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,3,2,AFFECTS,Excitatory,6
4616,Diabetes,C0011847,en_797,PREDISPOSES,Complication,C0009566,en_697,6,6,AFFECTS,Excitatory,21
4617,Diabetes,C0011847,en_797,PREDISPOSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
4618,Diabetes,C0011847,en_797,PREDISPOSES,Disease,C0012634,en_826,4,4,AFFECTS,Excitatory,20
4619,Diabetes,C0011847,en_797,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
4620,Diabetes,C0011847,en_797,PREDISPOSES,Severe (severity modifier),C0205082,en_3125,2,2,AFFECTS,Excitatory,12
4621,Diabetes,C0011847,en_797,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,6
4622,Diabetes,C0011847,en_797,PREDISPOSES,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Excitatory,6
4623,Diabetes,C0011847,en_797,PREDISPOSES,Degenerative disorder,C1285162,en_5478,1,1,AFFECTS,Excitatory,6
4624,Diabetes,C0011847,en_797,PREDISPOSES,COVID-19,C5203670,en_6417,3,3,AFFECTS,Excitatory,18
4625,Diabetes Mellitus,C0011849,en_798,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
4626,Diabetes Mellitus,C0011849,en_798,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
4627,Diabetes Mellitus,C0011849,en_798,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
4628,Diabetes Mellitus,C0011849,en_798,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Excitatory,3
4629,Diabetes Mellitus,C0011849,en_798,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
4630,Diabetes Mellitus,C0011849,en_798,PREDISPOSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,3
4631,Diabetes Mellitus,C0011849,en_798,PREDISPOSES,Reinfection,C0205339,en_3129,1,1,AFFECTS,Excitatory,6
4632,Diabetes Mellitus,C0011849,en_798,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
4633,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
4634,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
4635,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4636,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,AFFECTS,Adolescent,C0205653,en_3132,1,1,AFFECTS,General/Uncertain,6
4637,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,AFFECTS,Young adult,C0238598,en_3365,1,1,AFFECTS,General/Uncertain,6
4638,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,DISRUPTS,Structure of beta Cell of islet,C0030281,en_1744,2,1,AFFECTS,Inhibitory,3
4639,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,AFFECTS,Hypertriglyceridemia,C0020557,en_1242,1,1,AFFECTS,General/Uncertain,3
4640,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,AFFECTS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,General/Uncertain,6
4641,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
4642,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,AFFECTS,Dyslipidemias,C0242339,en_3406,1,1,AFFECTS,General/Uncertain,6
4643,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,AFFECTS,American,C0596070,en_4379,1,1,AFFECTS,General/Uncertain,3
4644,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,AFFECTS,US minority racial or ethnic group,C0682123,en_4635,4,1,AFFECTS,General/Uncertain,3
4645,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,PREDISPOSES,Disease,C0012634,en_826,4,1,AFFECTS,Excitatory,3
4646,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
4647,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,PREDISPOSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,3
4648,Diabetic Ketoacidosis,C0011880,en_801,AFFECTS,Increased glucose level,C0017747,en_1073,1,1,AFFECTS,General/Uncertain,3
4649,Diagnosis,C0011900,en_806,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,6
4650,Diagnosis,C0011900,en_806,AFFECTS,Collagen Diseases,C0009326,en_678,1,1,AFFECTS,General/Uncertain,7
4651,Diagnosis,C0011900,en_806,AFFECTS,Risk Assessment,C0086930,en_2737,1,1,AFFECTS,General/Uncertain,6
4652,Diagnosis,C0011900,en_806,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
4653,Diagnosis,C0011900,en_806,TREATS,Skin Manifestations,C0037285,en_2117,1,1,AFFECTS,Inhibitory,6
4654,Diagnosis,C0011900,en_806,TREATS,Asymptomatic,C0231221,en_3252,2,1,AFFECTS,Inhibitory,6
4655,Diagnosis,C0011900,en_806,AFFECTS,Stress,C0038435,en_2165,2,1,AFFECTS,General/Uncertain,3
4656,Diagnosis,C0011900,en_806,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
4657,Diagnosis,C0011900,en_806,PREVENTS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
4658,Diagnosis,C0011900,en_806,TREATS,"Abortion, Missed",C0000814,en_209,1,1,AFFECTS,Inhibitory,3
4659,Diagnosis,C0011900,en_806,TREATS,Adrenal gland hypofunction,C0001623,en_248,1,1,AFFECTS,Inhibitory,3
4660,Diagnosis,C0011900,en_806,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
4661,Diagnosis,C0011900,en_806,TREATS,Child,C0008059,en_620,8,6,AFFECTS,Inhibitory,18
4662,Diagnosis,C0011900,en_806,TREATS,Communicable Diseases,C0009450,en_685,2,2,AFFECTS,Inhibitory,6
4663,Diagnosis,C0011900,en_806,TREATS,Complication,C0009566,en_697,2,2,AFFECTS,Inhibitory,6
4664,Diagnosis,C0011900,en_806,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
4665,Diagnosis,C0011900,en_806,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
4666,Diagnosis,C0011900,en_806,TREATS,Disease,C0012634,en_826,4,4,AFFECTS,Inhibitory,12
4667,Diagnosis,C0011900,en_806,TREATS,Faculty,C0015535,en_960,1,1,AFFECTS,Inhibitory,3
4668,Diagnosis,C0011900,en_806,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
4669,Diagnosis,C0011900,en_806,TREATS,Households,C0020052,en_1208,2,1,AFFECTS,Inhibitory,3
4670,Diagnosis,C0011900,en_806,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
4671,Diagnosis,C0011900,en_806,TREATS,mastocytosis,C0024899,en_1506,1,1,AFFECTS,Inhibitory,3
4672,Diagnosis,C0011900,en_806,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
4673,Diagnosis,C0011900,en_806,TREATS,Persons,C0027361,en_1635,4,4,AFFECTS,Inhibitory,12
4674,Diagnosis,C0011900,en_806,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
4675,Diagnosis,C0011900,en_806,TREATS,Outpatients,C0029921,en_1729,2,2,AFFECTS,Inhibitory,6
4676,Diagnosis,C0011900,en_806,TREATS,Patients,C0030705,en_1762,26,23,AFFECTS,Inhibitory,69
4677,Diagnosis,C0011900,en_806,TREATS,Porphyrias,C0032708,en_1852,1,1,AFFECTS,Inhibitory,3
4678,Diagnosis,C0011900,en_806,TREATS,Pregnant Women,C0033011,en_1876,2,1,AFFECTS,Inhibitory,3
4679,Diagnosis,C0011900,en_806,TREATS,Psoriasis,C0033860,en_1918,1,1,AFFECTS,Inhibitory,3
4680,Diagnosis,C0011900,en_806,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
4681,Diagnosis,C0011900,en_806,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
4682,Diagnosis,C0011900,en_806,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
4683,Diagnosis,C0011900,en_806,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
4684,Diagnosis,C0011900,en_806,TREATS,Teacher,C0221457,en_3226,1,1,AFFECTS,Inhibitory,3
4685,Diagnosis,C0011900,en_806,TREATS,Hypoxia,C0242184,en_3396,3,1,AFFECTS,Inhibitory,3
4686,Diagnosis,C0011900,en_806,TREATS,associated disease,C0243083,en_3459,1,1,AFFECTS,Inhibitory,3
4687,Diagnosis,C0011900,en_806,TREATS,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Inhibitory,3
4688,Diagnosis,C0011900,en_806,TREATS,Autoimmune,C0443146,en_4064,1,1,AFFECTS,Inhibitory,3
4689,Diagnosis,C0011900,en_806,TREATS,[V]Insurance medical,C0481840,en_4151,1,1,AFFECTS,Inhibitory,3
4690,Diagnosis,C0011900,en_806,TREATS,Physical function,C0516981,en_4169,1,1,AFFECTS,Inhibitory,3
4691,Diagnosis,C0011900,en_806,TREATS,Perceived quality of life,C0518214,en_4178,1,1,AFFECTS,Inhibitory,3
4692,Diagnosis,C0011900,en_806,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
4693,Diagnosis,C0011900,en_806,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
4694,Diagnosis,C0011900,en_806,TREATS,member,C0680022,en_4618,2,1,AFFECTS,Inhibitory,3
4695,Diagnosis,C0011900,en_806,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,6
4696,Diagnosis,C0011900,en_806,TREATS,Spondylarthropathies,C0949691,en_5185,1,1,AFFECTS,Inhibitory,3
4697,Diagnosis,C0011900,en_806,TREATS,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
4698,Diagnosis,C0011900,en_806,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
4699,Diagnosis,C0011900,en_806,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
4700,Diagnosis,C0011900,en_806,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
4701,Diagnosis,C0011900,en_806,TREATS(INFER),"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
4702,Diagnosis,C0011900,en_806,TREATS(INFER),Asymptomatic,C0231221,en_3252,1,1,AFFECTS,Inhibitory,3
4703,Diagnosis,C0011900,en_806,TREATS(INFER),"Sleep Apnea, Obstructive",C0520679,en_4191,1,1,AFFECTS,Inhibitory,3
4704,Diagnosis,C0011900,en_806,TREATS(INFER),Co-morbid conditions,C1275743,en_5462,2,1,AFFECTS,Inhibitory,3
4705,Diagnosis,C0011900,en_806,TREATS(INFER),Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,6
4706,Differential Diagnosis,C0011906,en_807,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
4707,Laboratory Diagnosis,C0011911,en_808,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
4708,Dialysis procedure,C0011946,en_809,AFFECTS,Chronic Kidney Diseases,C1561643,en_5967,1,1,AFFECTS,General/Uncertain,6
4709,Dialysis procedure,C0011946,en_809,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
4710,Dialysis procedure,C0011946,en_809,TREATS,"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,Inhibitory,6
4711,Dialysis procedure,C0011946,en_809,TREATS,Patients,C0030705,en_1762,9,7,AFFECTS,Inhibitory,21
4712,Dialysis procedure,C0011946,en_809,TREATS,Kidney Failure,C0035078,en_1994,1,1,AFFECTS,Inhibitory,3
4713,Dialysis procedure,C0011946,en_809,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
4714,Dialysis procedure,C0011946,en_809,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
4715,Dialysis procedure,C0011946,en_809,TREATS,Perceived quality of life,C0518214,en_4178,1,1,AFFECTS,Inhibitory,3
4716,Dialysis procedure,C0011946,en_809,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
4717,Dialysis procedure,C0011946,en_809,TREATS(INFER),Hypercapnic respiratory failure,C0398353,en_3947,1,1,AFFECTS,Inhibitory,3
4718,Dialysis procedure,C0011946,en_809,TREATS(INFER),Sarcopenia,C0872084,en_5037,1,1,AFFECTS,Inhibitory,3
4719,Diet,C0012155,en_811,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
4720,Diet,C0012155,en_811,AFFECTS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
4721,Diet,C0012155,en_811,AFFECTS,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,3
4722,Diet,C0012155,en_811,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
4723,Diet,C0012155,en_811,AFFECTS,Reproduction,C0035150,en_2001,1,1,AFFECTS,General/Uncertain,3
4724,Diet,C0012155,en_811,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
4725,Diet,C0012155,en_811,AFFECTS,brain function,C0678908,en_4584,1,1,AFFECTS,General/Uncertain,3
4726,Diet,C0012155,en_811,PREDISPOSES,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Excitatory,3
4727,Diet,C0012155,en_811,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
4728,Diet,C0012155,en_811,PREDISPOSES,Periodontal Diseases,C0031090,en_1774,2,1,AFFECTS,Excitatory,3
4729,Diet,C0012155,en_811,PREDISPOSES,Metabolic syndrome,C0948265,en_5164,1,1,AFFECTS,Excitatory,3
4730,Diet therapy,C0012159,en_812,TREATS,Skin callus,C0376154,en_3872,1,1,AFFECTS,Inhibitory,3
4731,Dietary Fiber,C0012173,en_813,AFFECTS,Defecation,C0011135,en_768,1,1,AFFECTS,General/Uncertain,3
4732,Diffusion,C0012222,en_814,AFFECTS,"Endometriosis, site unspecified",C0014175,en_898,1,1,AFFECTS,General/Uncertain,3
4733,Diffusion,C0012222,en_814,AFFECTS,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,6
4734,Digestion,C0012238,en_815,AFFECTS,Sleep,C0037313,en_2119,1,1,AFFECTS,General/Uncertain,3
4735,Digestion,C0012238,en_815,PRODUCES,Hyaluronidase,C0020197,en_1216,1,1,AFFECTS,Excitatory,3
4736,Pathological Dilatation,C0012359,en_816,AFFECTS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,3
4737,Diminazene,C0012447,en_817,INHIBITS,ACE,C1413931,en_28,1,1,AFFECTS,Inhibitory,3
4738,Dinoprostone,C0012472,en_818,AFFECTS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,General/Uncertain,3
4739,Dinoprostone,C0012472,en_818,AUGMENTS,Muscle satellite cell,C0599856,en_4478,1,1,AFFECTS,Excitatory,3
4740,Dinoprostone,C0012472,en_818,TREATS,mental dysfunction,C0679224,en_4591,1,1,AFFECTS,Inhibitory,3
4741,Dinoprostone,C0012472,en_818,TREATS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Inhibitory,3
4742,Dioxins,C0012503,en_819,AFFECTS,Blood,C0005767,en_482,1,1,AFFECTS,General/Uncertain,3
4743,Diphtheria,C0012546,en_820,AFFECTS,Adoptive immunity,C0678209,en_4554,1,1,AFFECTS,General/Uncertain,6.5
4744,Diphtheria-Tetanus-Pertussis Vaccine,C0012559,en_821,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
4745,Dipyridamole,C0012582,en_823,INHIBITS,Blood coagulation,C0005778,en_484,2,1,AFFECTS,Inhibitory,3
4746,Dipyridamole,C0012582,en_823,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
4747,Disease,C0012634,en_826,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,4,1,AFFECTS,General/Uncertain,3
4748,Disease,C0012634,en_826,AFFECTS,Adult,C0001675,en_252,2,1,AFFECTS,General/Uncertain,3
4749,Disease,C0012634,en_826,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
4750,Disease,C0012634,en_826,AFFECTS,Anxiety,C0003467,en_380,1,1,AFFECTS,General/Uncertain,8
4751,Disease,C0012634,en_826,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
4752,Disease,C0012634,en_826,AFFECTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
4753,Disease,C0012634,en_826,AFFECTS,Child,C0008059,en_620,3,3,AFFECTS,General/Uncertain,9
4754,Disease,C0012634,en_826,AFFECTS,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,General/Uncertain,3
4755,Disease,C0012634,en_826,AFFECTS,Deglutition,C0011167,en_771,1,1,AFFECTS,General/Uncertain,3
4756,Disease,C0012634,en_826,AFFECTS,Eating Disorders,C0013473,en_871,1,1,AFFECTS,General/Uncertain,3
4757,Disease,C0012634,en_826,AFFECTS,enteritis,C0014335,en_906,1,1,AFFECTS,General/Uncertain,3
4758,Disease,C0012634,en_826,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
4759,Disease,C0012634,en_826,AFFECTS,Ethnic group,C0015031,en_934,1,1,AFFECTS,General/Uncertain,3
4760,Disease,C0012634,en_826,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
4761,Disease,C0012634,en_826,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
4762,Disease,C0012634,en_826,AFFECTS,Fever,C0015967,en_985,1,1,AFFECTS,General/Uncertain,3
4763,Disease,C0012634,en_826,AFFECTS,Health Personnel,C0018724,en_1121,5,4,AFFECTS,General/Uncertain,18
4764,Disease,C0012634,en_826,AFFECTS,Health Services Accessibility,C0018748,en_1126,1,1,AFFECTS,General/Uncertain,6
4765,Disease,C0012634,en_826,AFFECTS,Hematopoiesis,C0018951,en_1152,1,1,AFFECTS,General/Uncertain,3
4766,Disease,C0012634,en_826,AFFECTS,Human,C0020114,en_1210,2,2,AFFECTS,General/Uncertain,6
4767,Disease,C0012634,en_826,AFFECTS,Immunity,C0020964,en_1273,2,1,AFFECTS,General/Uncertain,3
4768,Disease,C0012634,en_826,AFFECTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,General/Uncertain,3
4769,Disease,C0012634,en_826,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,6
4770,Disease,C0012634,en_826,AFFECTS,Migrants,C0026093,en_1568,1,1,AFFECTS,General/Uncertain,3
4771,Disease,C0012634,en_826,AFFECTS,Mothers,C0026591,en_1583,2,1,AFFECTS,General/Uncertain,3
4772,Disease,C0012634,en_826,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,3
4773,Disease,C0012634,en_826,AFFECTS,Persons,C0027361,en_1635,8,5,AFFECTS,General/Uncertain,15
4774,Disease,C0012634,en_826,AFFECTS,Human Age Group,C0027362,en_1636,2,1,AFFECTS,General/Uncertain,3
4775,Disease,C0012634,en_826,AFFECTS,PARITY,C0030563,en_1752,2,1,AFFECTS,General/Uncertain,3
4776,Disease,C0012634,en_826,AFFECTS,Patients,C0030705,en_1762,23,19,AFFECTS,General/Uncertain,57
4777,Disease,C0012634,en_826,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
4778,Disease,C0012634,en_826,AFFECTS,Physicians,C0031831,en_1805,1,1,AFFECTS,General/Uncertain,3
4779,Disease,C0012634,en_826,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
4780,Disease,C0012634,en_826,AFFECTS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,General/Uncertain,6
4781,Disease,C0012634,en_826,AFFECTS,Pregnancy,C0032961,en_1872,2,1,AFFECTS,General/Uncertain,3
4782,Disease,C0012634,en_826,AFFECTS,Pregnant Women,C0033011,en_1876,3,2,AFFECTS,General/Uncertain,10
4783,Disease,C0012634,en_826,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
4784,Disease,C0012634,en_826,AFFECTS,Stress,C0038435,en_2165,4,2,AFFECTS,General/Uncertain,6
4785,Disease,C0012634,en_826,AFFECTS,Encounter due to tobacco use,C0040335,en_2244,1,1,AFFECTS,General/Uncertain,3
4786,Disease,C0012634,en_826,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
4787,Disease,C0012634,en_826,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,6
4788,Disease,C0012634,en_826,AFFECTS,African American,C0085756,en_2689,2,2,AFFECTS,General/Uncertain,6
4789,Disease,C0012634,en_826,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,6
4790,Disease,C0012634,en_826,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,7
4791,Disease,C0012634,en_826,AFFECTS,Normal respiratory function,C0231795,en_3263,1,1,AFFECTS,General/Uncertain,3
4792,Disease,C0012634,en_826,AFFECTS,AOD use,C0237123,en_3341,1,1,AFFECTS,General/Uncertain,3
4793,Disease,C0012634,en_826,AFFECTS,Individual,C0237401,en_3343,16,14,AFFECTS,General/Uncertain,42
4794,Disease,C0012634,en_826,AFFECTS,Disease Progression,C0242656,en_3429,2,2,AFFECTS,General/Uncertain,6
4795,Disease,C0012634,en_826,AFFECTS,Human body,C0242821,en_3440,1,1,AFFECTS,General/Uncertain,3
4796,Disease,C0012634,en_826,AFFECTS,microvasculature,C0243079,en_3458,1,1,AFFECTS,General/Uncertain,3
4797,Disease,C0012634,en_826,AFFECTS,associated disease,C0243083,en_3459,2,1,AFFECTS,General/Uncertain,3
4798,Disease,C0012634,en_826,AFFECTS,uptake,C0243144,en_3467,1,1,AFFECTS,General/Uncertain,3
4799,Disease,C0012634,en_826,AFFECTS,Immune response,C0301872,en_3696,3,2,AFFECTS,General/Uncertain,6
4800,Disease,C0012634,en_826,AFFECTS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,General/Uncertain,3
4801,Disease,C0012634,en_826,AFFECTS,Well in self,C0424578,en_3996,1,1,AFFECTS,General/Uncertain,3
4802,Disease,C0012634,en_826,AFFECTS,European origin,C0425355,en_4002,1,1,AFFECTS,General/Uncertain,7
4803,Disease,C0012634,en_826,AFFECTS,Symptom aggravating factors,C0436331,en_4027,1,1,AFFECTS,General/Uncertain,3
4804,Disease,C0012634,en_826,AFFECTS,Very high,C0442804,en_4057,1,1,AFFECTS,General/Uncertain,3
4805,Disease,C0012634,en_826,AFFECTS,Perceived quality of life,C0518214,en_4178,1,1,AFFECTS,General/Uncertain,3
4806,Disease,C0012634,en_826,AFFECTS,American,C0596070,en_4379,2,2,AFFECTS,General/Uncertain,6
4807,Disease,C0012634,en_826,AFFECTS,stressor,C0597530,en_4430,1,1,AFFECTS,General/Uncertain,3
4808,Disease,C0012634,en_826,AFFECTS,intestinal bacteria,C0599752,en_4469,1,1,AFFECTS,General/Uncertain,3
4809,Disease,C0012634,en_826,AFFECTS,cohort,C0599755,en_4470,1,1,AFFECTS,General/Uncertain,3
4810,Disease,C0012634,en_826,AFFECTS,brain function,C0678908,en_4584,1,1,AFFECTS,General/Uncertain,3
4811,Disease,C0012634,en_826,AFFECTS,Disease Outcome,C0679250,en_4593,2,2,AFFECTS,General/Uncertain,6
4812,Disease,C0012634,en_826,AFFECTS,member,C0680022,en_4618,1,1,AFFECTS,General/Uncertain,3
4813,Disease,C0012634,en_826,AFFECTS,citizen,C0682134,en_4636,1,1,AFFECTS,General/Uncertain,3
4814,Disease,C0012634,en_826,AFFECTS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,General/Uncertain,3
4815,Disease,C0012634,en_826,AFFECTS,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,General/Uncertain,3
4816,Disease,C0012634,en_826,AFFECTS,Dyads,C0870454,en_5003,1,1,AFFECTS,General/Uncertain,3
4817,Disease,C0012634,en_826,AFFECTS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,General/Uncertain,3
4818,Disease,C0012634,en_826,AFFECTS,Cognition:status,C0945985,en_5150,1,1,AFFECTS,General/Uncertain,3
4819,Disease,C0012634,en_826,AFFECTS,Vascular inflammations,C0947751,en_5156,2,1,AFFECTS,General/Uncertain,3
4820,Disease,C0012634,en_826,AFFECTS,Infectious transmissions,C0947878,en_5157,2,1,AFFECTS,General/Uncertain,3
4821,Disease,C0012634,en_826,AFFECTS,Inflammatory Response,C1155266,en_5321,2,2,AFFECTS,General/Uncertain,6
4822,Disease,C0012634,en_826,AFFECTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,General/Uncertain,3
4823,Disease,C0012634,en_826,AFFECTS,PATIENT SYMPTOMS,C1317600,en_5529,2,1,AFFECTS,General/Uncertain,3
4824,Disease,C0012634,en_826,AFFECTS,glucose homeostasis,C1326961,en_5562,1,1,AFFECTS,General/Uncertain,3
4825,Disease,C0012634,en_826,AFFECTS,Chronic Stress,C1510527,en_5797,1,1,AFFECTS,General/Uncertain,3
4826,Disease,C0012634,en_826,AFFECTS,Cancer Patient,C1516213,en_5852,3,3,AFFECTS,General/Uncertain,17
4827,Disease,C0012634,en_826,AFFECTS,Older Population,C1518563,en_5875,1,1,AFFECTS,General/Uncertain,7
4828,Disease,C0012634,en_826,AFFECTS,user - individual,C1706077,en_6033,1,1,AFFECTS,General/Uncertain,6
4829,Disease,C0012634,en_826,AFFECTS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,General/Uncertain,6
4830,Disease,C0012634,en_826,AFFECTS,Cardiovascular Risk,C4324389,en_6343,1,1,AFFECTS,General/Uncertain,6
4831,Disease,C0012634,en_826,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
4832,Disease,C0012634,en_826,AFFECTS(SPEC),Elderly,C0001792,en_258,2,1,AFFECTS,General/Uncertain,3
4833,Disease,C0012634,en_826,AFFECTS(SPEC),Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,3
4834,Disease,C0012634,en_826,AFFECTS(SPEC),"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,General/Uncertain,3
4835,Disease,C0012634,en_826,AUGMENTS,Familial benign pemphigus,C0085106,en_2644,1,1,AFFECTS,Excitatory,3
4836,Disease,C0012634,en_826,AUGMENTS,DISEASES/DIAGNOSES,C0338067,en_3801,1,1,AFFECTS,Excitatory,3
4837,Disease,C0012634,en_826,COMPLICATES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,General/Uncertain,3
4838,Disease,C0012634,en_826,COMPLICATES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
4839,Disease,C0012634,en_826,DISRUPTS,Mediating,C0086597,en_2730,1,1,AFFECTS,Inhibitory,3
4840,Disease,C0012634,en_826,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
4841,Disease,C0012634,en_826,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
4842,Disease,C0012634,en_826,PREDISPOSES,Cholecystitis,C0008325,en_636,1,1,AFFECTS,Excitatory,3
4843,Disease,C0012634,en_826,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
4844,Disease,C0012634,en_826,PREDISPOSES,Communicable Diseases,C0009450,en_685,2,2,AFFECTS,Excitatory,6
4845,Disease,C0012634,en_826,PREDISPOSES,Complication,C0009566,en_697,3,3,AFFECTS,Excitatory,14
4846,Disease,C0012634,en_826,PREDISPOSES,Encephalitis,C0014038,en_896,1,1,AFFECTS,Excitatory,3
4847,Disease,C0012634,en_826,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
4848,Disease,C0012634,en_826,PREDISPOSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
4849,Disease,C0012634,en_826,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
4850,Disease,C0012634,en_826,PREDISPOSES,Pregnancy Complications,C0032962,en_1873,1,1,AFFECTS,Excitatory,6
4851,Disease,C0012634,en_826,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
4852,Disease,C0012634,en_826,PREDISPOSES,Stress,C0038435,en_2165,1,1,AFFECTS,Excitatory,3
4853,Disease,C0012634,en_826,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
4854,Disease,C0012634,en_826,PREDISPOSES,Thrombosis,C0040053,en_2233,4,2,AFFECTS,Excitatory,6
4855,Disease,C0012634,en_826,PREDISPOSES,Adverse drug effect,C0041755,en_2312,1,1,AFFECTS,Excitatory,8
4856,Disease,C0012634,en_826,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
4857,Disease,C0012634,en_826,PREDISPOSES,Cardiovascular event,C1320716,en_5537,2,1,AFFECTS,Excitatory,3
4858,Disease,C0012634,en_826,PREDISPOSES,Myocardial necrosis,C1442837,en_5734,1,1,AFFECTS,Excitatory,3
4859,Disease,C0012634,en_826,PREDISPOSES,Paranoia,C1456784,en_5782,2,1,AFFECTS,Excitatory,3
4860,Disease,C0012634,en_826,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
4861,Disease,C0012634,en_826,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
4862,Disease,C0012634,en_826,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
4863,Disease,C0012634,en_826,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
4864,Disease,C0012634,en_826,PRODUCES,cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
4865,Disinfection,C0012683,en_828,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
4866,Disinfection,C0012683,en_828,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
4867,Disinfection,C0012683,en_828,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
4868,Disinfection,C0012683,en_828,TREATS,"Skin Diseases, Infectious",C0037278,en_2116,2,1,AFFECTS,Inhibitory,3
4869,Disinfection,C0012683,en_828,TREATS,Inactivation,C0544461,en_4262,2,2,AFFECTS,Inhibitory,6
4870,Disseminated Intravascular Coagulation,C0012739,en_829,PREDISPOSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,3
4871,Disseminated Intravascular Coagulation,C0012739,en_829,PREDISPOSES,Prognosis bad,C0278252,en_3600,2,1,AFFECTS,Excitatory,3
4872,Disulfiram,C0012772,en_830,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
4873,Disulfiram,C0012772,en_830,DISRUPTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
4874,Disulfiram,C0012772,en_830,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
4875,Disulfiram,C0012772,en_830,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,6
4876,Disulfiram,C0012772,en_830,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
4877,Disulfiram,C0012772,en_830,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
4878,Disulfiram,C0012772,en_830,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
4879,Disulfiram,C0012772,en_830,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
4880,Diuretics,C0012798,en_831,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
4881,Diuretics,C0012798,en_831,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
4882,Thiazide Diuretics,C0012802,en_832,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,6
4883,Thiazide Diuretics,C0012802,en_832,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,6
4884,DNA,C0012854,en_834,AFFECTS,Fluorescence,C0016315,en_1005,1,1,AFFECTS,General/Uncertain,3
4885,DNA,C0012854,en_834,AFFECTS,Gene Expression Regulation,C0017263,en_1045,1,1,AFFECTS,General/Uncertain,3
4886,DNA,C0012854,en_834,AFFECTS,"Polymorphism, Genetic",C0032529,en_1849,1,1,AFFECTS,General/Uncertain,3
4887,DNA,C0012854,en_834,AFFECTS,Electromagnetic Energy,C0034519,en_1952,1,1,AFFECTS,General/Uncertain,3
4888,DNA,C0012854,en_834,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
4889,DNA,C0012854,en_834,AFFECTS,Viscosity,C0042784,en_2365,2,2,AFFECTS,General/Uncertain,10
4890,DNA,C0012854,en_834,AUGMENTS,Antigen-Presenting Cells,C0003315,en_362,1,1,AFFECTS,Excitatory,3
4891,DNA,C0012854,en_834,AUGMENTS,Immunity,C0020964,en_1273,2,1,AFFECTS,Excitatory,3
4892,DNA,C0012854,en_834,DISRUPTS,Nuclear Envelope,C0028584,en_1689,1,1,AFFECTS,Inhibitory,3
4893,DNA,C0012854,en_834,DISRUPTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,Inhibitory,7
4894,DNA,C0012854,en_834,INHIBITS,Genes,C0017337,en_1052,1,1,AFFECTS,Inhibitory,3
4895,DNA,C0012854,en_834,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
4896,DNA,C0012854,en_834,PREDISPOSES,Symptoms,C1457887,en_5784,2,1,AFFECTS,Excitatory,3
4897,DNA,C0012854,en_834,STIMULATES,Chromogranin A,C0055633,en_2458,1,1,AFFECTS,Excitatory,3
4898,DNA,C0012854,en_834,STIMULATES,Toll-like receptors,C0670896,en_4538,2,2,AFFECTS,Excitatory,6
4899,DNA Damage,C0012860,en_835,AFFECTS,Cosmic Radiation,C0010166,en_722,1,1,AFFECTS,General/Uncertain,3
4900,"DNA, Mitochondrial",C0012929,en_837,AUGMENTS,Blood,C0005767,en_482,1,1,AFFECTS,Excitatory,3
4901,"DNA, Mitochondrial",C0012929,en_837,STIMULATES,Toll-like receptor 9,C0963057,en_5199,4,1,AFFECTS,Excitatory,3
4902,Docosahexaenoic Acids,C0012968,en_838,STIMULATES,Fatty Acids,C0015684,en_969,1,1,AFFECTS,Excitatory,3
4903,Docosahexaenoic Acids,C0012968,en_838,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
4904,Docosahexaenoic Acids,C0012968,en_838,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
4905,Docosahexaenoic Acids,C0012968,en_838,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
4906,Donor person,C0013018,en_840,PRODUCES,Medical Devices,C0025080,en_1517,2,2,AFFECTS,Excitatory,6
4907,Dopa,C0013023,en_841,AFFECTS,Dystonia,C0013421,en_867,2,1,AFFECTS,General/Uncertain,3
4908,Down-Regulation,C0013081,en_844,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
4909,Down-Regulation,C0013081,en_844,PRODUCES,Interleukin-17,C0384648,en_3903,1,1,AFFECTS,Excitatory,3
4910,Doxorubicin,C0013089,en_845,PREVENTS,Gastritis,C0017152,en_1036,2,1,AFFECTS,Inhibitory,3
4911,Doxycycline,C0013090,en_846,DISRUPTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Inhibitory,3
4912,Doxycycline,C0013090,en_846,INHIBITS(SPEC),Matrix Metalloproteinases,C0623362,en_4521,1,1,AFFECTS,Inhibitory,3
4913,Doxycycline,C0013090,en_846,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
4914,Doxycycline,C0013090,en_846,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
4915,Doxycycline,C0013090,en_846,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
4916,Doxycycline,C0013090,en_846,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,8
4917,Sterile coverings,C0013119,en_847,PREVENTS,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,Inhibitory,8
4918,Drought,C0013140,en_849,AFFECTS,Water consumption,C0013123,en_848,1,1,AFFECTS,General/Uncertain,3
4919,Drug abuse,C0013146,en_851,AFFECTS,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,General/Uncertain,3
4920,Drug Combinations,C0013162,en_852,INHIBITS,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Inhibitory,6
4921,Drug Combinations,C0013162,en_852,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
4922,Drug Combinations,C0013162,en_852,PREVENTS,Respiratory complication,C0161818,en_2899,2,2,AFFECTS,Inhibitory,6
4923,Drug Combinations,C0013162,en_852,TREATS,Patients,C0030705,en_1762,30,8,AFFECTS,Inhibitory,24
4924,Drug Combinations,C0013162,en_852,TREATS,Professional guide,C0181090,en_3019,1,1,AFFECTS,Inhibitory,3
4925,Drug Combinations,C0013162,en_852,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
4926,Drug Combinations,C0013162,en_852,TREATS(INFER),Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
4927,Drug Packaging,C0013194,en_853,TREATS,Physical Therapist,C2362565,en_6110,1,1,AFFECTS,Inhibitory,8
4928,Drug resistance,C0013203,en_854,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
4929,Drug resistance,C0013203,en_854,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
4930,Drug resistance,C0013203,en_854,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
4931,Pharmacotherapy,C0013216,en_855,AFFECTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,3
4932,Pharmacotherapy,C0013216,en_855,AFFECTS,brain development,C1160340,en_5353,1,1,AFFECTS,General/Uncertain,3
4933,Pharmacotherapy,C0013216,en_855,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
4934,Pharmacotherapy,C0013216,en_855,PREDISPOSES,Infection,C3714514,en_6235,2,2,AFFECTS,Excitatory,6
4935,Pharmacotherapy,C0013216,en_855,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
4936,Pharmacotherapy,C0013216,en_855,PREVENTS,Edema,C0013604,en_877,1,1,AFFECTS,Inhibitory,3
4937,Pharmacotherapy,C0013216,en_855,PREVENTS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
4938,Pharmacotherapy,C0013216,en_855,PREVENTS,hypoglycemia,C0020615,en_1245,1,1,AFFECTS,Inhibitory,3
4939,Pharmacotherapy,C0013216,en_855,PREVENTS,Nerve Degeneration,C0027746,en_1657,1,1,AFFECTS,Inhibitory,3
4940,Pharmacotherapy,C0013216,en_855,PREVENTS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
4941,Pharmacotherapy,C0013216,en_855,STIMULATES,Digestion,C0012238,en_815,1,1,AFFECTS,Excitatory,3
4942,Pharmacotherapy,C0013216,en_855,TREATS,alcohol use disorder,C0001956,en_270,2,1,AFFECTS,Inhibitory,3
4943,Pharmacotherapy,C0013216,en_855,TREATS,Anorexia,C0003123,en_336,1,1,AFFECTS,Inhibitory,3
4944,Pharmacotherapy,C0013216,en_855,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,3
4945,Pharmacotherapy,C0013216,en_855,TREATS,Mental disorders,C0004936,en_452,2,1,AFFECTS,Inhibitory,3
4946,Pharmacotherapy,C0013216,en_855,TREATS,Malignant neoplasm of breast,C0006142,en_511,3,2,AFFECTS,Inhibitory,6
4947,Pharmacotherapy,C0013216,en_855,TREATS,Malignant Neoplasms,C0006826,en_545,15,7,AFFECTS,Inhibitory,31
4948,Pharmacotherapy,C0013216,en_855,TREATS,"Carcinoma, Non-Small-Cell Lung",C0007131,en_563,1,1,AFFECTS,Inhibitory,3
4949,Pharmacotherapy,C0013216,en_855,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
4950,Pharmacotherapy,C0013216,en_855,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
4951,Pharmacotherapy,C0013216,en_855,TREATS,Hematological Disease,C0018939,en_1150,1,1,AFFECTS,Inhibitory,3
4952,Pharmacotherapy,C0013216,en_855,TREATS,Mycoses,C0026946,en_1620,1,1,AFFECTS,Inhibitory,3
4953,Pharmacotherapy,C0013216,en_855,TREATS,overdose,C4018909,en_6291,1,1,AFFECTS,Inhibitory,3
4954,Pharmacotherapy,C0013216,en_855,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
4955,Pharmacotherapy,C0013216,en_855,TREATS,Patients,C0030705,en_1762,10,7,AFFECTS,Inhibitory,21
4956,Pharmacotherapy,C0013216,en_855,TREATS,Target Population,C0039309,en_2207,1,1,AFFECTS,Inhibitory,3
4957,Pharmacotherapy,C0013216,en_855,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,7
4958,Pharmacotherapy,C0013216,en_855,TREATS,Addictive Behavior,C0085281,en_2658,1,1,AFFECTS,Inhibitory,3
4959,Pharmacotherapy,C0013216,en_855,TREATS,Acute leukemia,C0085669,en_2685,1,1,AFFECTS,Inhibitory,3
4960,Pharmacotherapy,C0013216,en_855,TREATS,Benign Neoplasm,C0086692,en_2732,1,1,AFFECTS,Inhibitory,3
4961,Pharmacotherapy,C0013216,en_855,TREATS,Pulmonary circulation disease NOS,C0178272,en_2980,1,1,AFFECTS,Inhibitory,6
4962,Pharmacotherapy,C0013216,en_855,TREATS,Malaise,C0231218,en_3251,2,1,AFFECTS,Inhibitory,3
4963,Pharmacotherapy,C0013216,en_855,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
4964,Pharmacotherapy,C0013216,en_855,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
4965,Pharmacotherapy,C0013216,en_855,TREATS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Inhibitory,7
4966,Pharmacotherapy,C0013216,en_855,TREATS,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Inhibitory,6
4967,Pharmacotherapy,C0013216,en_855,TREATS,Solid tumor,C0280100,en_3619,3,2,AFFECTS,Inhibitory,10
4968,Pharmacotherapy,C0013216,en_855,TREATS,Former smoker,C0337671,en_3794,1,1,AFFECTS,Inhibitory,6
4969,Pharmacotherapy,C0013216,en_855,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,3
4970,Pharmacotherapy,C0013216,en_855,TREATS,Prolonged periods,C0425945,en_4005,1,1,AFFECTS,Inhibitory,6
4971,Pharmacotherapy,C0013216,en_855,TREATS,advanced disease,C0679246,en_4592,1,1,AFFECTS,Inhibitory,6
4972,Pharmacotherapy,C0013216,en_855,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
4973,Pharmacotherapy,C0013216,en_855,TREATS,Teams,C0871489,en_5024,1,1,AFFECTS,Inhibitory,3
4974,Pharmacotherapy,C0013216,en_855,TREATS,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,8
4975,Pharmacotherapy,C0013216,en_855,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
4976,Pharmacotherapy,C0013216,en_855,TREATS,Cancer Patient,C1516213,en_5852,5,4,AFFECTS,Inhibitory,12
4977,Pharmacotherapy,C0013216,en_855,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
4978,Pharmacotherapy,C0013216,en_855,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,3,1,AFFECTS,Inhibitory,3
4979,Pharmacotherapy,C0013216,en_855,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
4980,Pharmacotherapy,C0013216,en_855,TREATS(INFER),"Tuberculosis, Pulmonary",C0041327,en_2297,1,1,AFFECTS,Inhibitory,3
4981,Pharmacotherapy,C0013216,en_855,TREATS(INFER),Esophageal carcinoma,C0152018,en_2876,1,1,AFFECTS,Inhibitory,3
4982,Pharmacotherapy,C0013216,en_855,TREATS(SPEC),Malignant tumor of colon,C0007102,en_559,2,1,AFFECTS,Inhibitory,3
4983,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Inspiration function,C0004048,en_413,1,1,AFFECTS,General/Uncertain,3
4984,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Blood,C0005767,en_482,3,3,AFFECTS,General/Uncertain,9
4985,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Blood coagulation,C0005778,en_484,2,2,AFFECTS,General/Uncertain,6
4986,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
4987,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Cell Communication,C0007582,en_585,1,1,AFFECTS,General/Uncertain,3
4988,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
4989,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,General/Uncertain,3
4990,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
4991,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Drug resistance,C0013203,en_854,1,1,AFFECTS,General/Uncertain,3
4992,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,General/Uncertain,3
4993,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
4994,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
4995,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Permeability,C0031164,en_1779,1,1,AFFECTS,General/Uncertain,3
4996,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Drug Kinetics,C0031327,en_1787,1,1,AFFECTS,General/Uncertain,3
4997,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
4998,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
4999,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
5000,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
5001,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,General/Uncertain,3
5002,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Ototoxicity,C0235280,en_3325,1,1,AFFECTS,General/Uncertain,3
5003,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,General/Uncertain,3
5004,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
5005,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Medical History,C0262926,en_3519,2,1,AFFECTS,General/Uncertain,3
5006,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Immune response,C0301872,en_3696,5,3,AFFECTS,General/Uncertain,9
5007,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Chronic liver disease NOS,C0341439,en_3823,1,1,AFFECTS,General/Uncertain,3
5008,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Proteolysis,C0597304,en_4421,1,1,AFFECTS,General/Uncertain,3
5009,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Disease Outcome,C0679250,en_4593,2,1,AFFECTS,General/Uncertain,3
5010,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Adverse event,C0877248,en_5069,2,1,AFFECTS,General/Uncertain,3
5011,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
5012,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,host-pathogen interaction,C1154482,en_5309,1,1,AFFECTS,General/Uncertain,3
5013,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
5014,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,host,C1167395,en_5368,1,1,AFFECTS,General/Uncertain,3
5015,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Skin toxicity,C1167791,en_5370,1,1,AFFECTS,General/Uncertain,3
5016,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Renal Excretion,C1373187,en_5685,1,1,AFFECTS,General/Uncertain,3
5017,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
5018,Pharmaceutical Preparations,C0013227,en_856,AFFECTS,cellular metabolism,C1523924,en_5913,1,1,AFFECTS,General/Uncertain,3
5019,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Blood Pressure,C0005823,en_492,4,2,AFFECTS,Excitatory,6
5020,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
5021,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Lung,C0024109,en_1460,1,1,AFFECTS,Excitatory,3
5022,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Stem cells,C0038250,en_2158,1,1,AFFECTS,Excitatory,3
5023,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,Excitatory,3
5024,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Recovery,C0237820,en_3354,4,2,AFFECTS,Excitatory,6
5025,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
5026,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
5027,Pharmaceutical Preparations,C0013227,en_856,AUGMENTS,Ectopic Expression,C1512167,en_5816,1,1,AFFECTS,Excitatory,3
5028,Pharmaceutical Preparations,C0013227,en_856,COMPLICATES,Atrophic,C0333641,en_3770,1,1,AFFECTS,General/Uncertain,3
5029,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Cells,C0007634,en_596,1,1,AFFECTS,Inhibitory,3
5030,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Cicatrix,C0008767,en_645,1,1,AFFECTS,Inhibitory,3
5031,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Cessation of life,C0011065,en_762,3,3,AFFECTS,Inhibitory,9
5032,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,Inhibitory,3
5033,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Growth,C0018270,en_1098,2,2,AFFECTS,Inhibitory,6
5034,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Natural Killer Cells,C0022688,en_1386,1,1,AFFECTS,Inhibitory,3
5035,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,neutrophil,C0027950,en_1676,1,1,AFFECTS,Inhibitory,3
5036,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Inhibitory,3
5037,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,Inhibitory,3
5038,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Inhibitory,3
5039,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Virulence,C0042765,en_2361,1,1,AFFECTS,Inhibitory,3
5040,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Virus Diseases,C0042769,en_2362,12,8,AFFECTS,Inhibitory,24
5041,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,"Frameshifting, Ribosomal",C0282572,en_3654,2,2,AFFECTS,Inhibitory,6
5042,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Immune response,C0301872,en_3696,2,2,AFFECTS,Inhibitory,6
5043,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Contagion,C0598197,en_4444,1,1,AFFECTS,Inhibitory,3
5044,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Inhibitory,3
5045,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,GTPase activity,C1149036,en_5301,1,1,AFFECTS,Inhibitory,3
5046,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,Inhibitory,3
5047,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,Inhibitory,3
5048,Pharmaceutical Preparations,C0013227,en_856,DISRUPTS,pore complex location biogenesis,C1326292,en_5554,1,1,AFFECTS,Inhibitory,3
5049,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,ADAM10,C1412181,en_2,1,1,AFFECTS,Inhibitory,3
5050,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,CYP2B6,C1382176,en_25,1,1,AFFECTS,Inhibitory,3
5051,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,DPP4,C1414141,en_32,1,1,AFFECTS,Inhibitory,3
5052,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,GAK,C1414944,en_36,1,1,AFFECTS,Inhibitory,3
5053,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,SLC5A2,C1420201,en_79,1,1,AFFECTS,Inhibitory,3
5054,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,AAK1,C1426329,en_117,1,1,AFFECTS,Inhibitory,3
5055,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Acetyltransferase,C0001068,en_220,1,1,AFFECTS,Inhibitory,3
5056,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Angiotensin II,C0003009,en_328,1,1,AFFECTS,Inhibitory,3
5057,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,3,1,AFFECTS,Inhibitory,3
5058,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Calcium,C0006675,en_537,1,1,AFFECTS,Inhibitory,3
5059,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Interferons,C0021747,en_1333,1,1,AFFECTS,Inhibitory,3
5060,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
5061,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Interleukin-6,C0021760,en_1342,3,2,AFFECTS,Inhibitory,6
5062,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Neuraminidase,C0027803,en_1662,1,1,AFFECTS,Inhibitory,3
5063,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Endopeptidases,C0030946,en_1770,3,3,AFFECTS,Inhibitory,9
5064,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Phosphotransferases,C0031727,en_1801,1,1,AFFECTS,Inhibitory,3
5065,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Proteins,C0033684,en_1912,1,1,AFFECTS,Inhibitory,3
5066,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Angiotensin Receptor,C0034787,en_1963,4,2,AFFECTS,Inhibitory,6
5067,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,RNA-Directed DNA Polymerase,C0035379,en_2027,1,1,AFFECTS,Inhibitory,3
5068,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,RNA-Directed RNA Polymerase,C0035685,en_2042,2,2,AFFECTS,Inhibitory,6
5069,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Inhibitory,3
5070,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Vaccines,C0042210,en_2329,1,1,AFFECTS,Inhibitory,3
5071,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
5072,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Dynamin,C0058836,en_2475,1,1,AFFECTS,Inhibitory,3
5073,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Interleukin 6 Receptor,C0063717,en_2510,1,1,AFFECTS,Inhibitory,3
5074,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Leukocyte Elastase,C0064833,en_2515,2,1,AFFECTS,Inhibitory,3
5075,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
5076,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Janus kinase 1,C0169658,en_2958,2,1,AFFECTS,Inhibitory,3
5077,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,Janus kinase 2,C0169661,en_2959,2,1,AFFECTS,Inhibitory,3
5078,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,receptor,C0597357,en_4422,1,1,AFFECTS,Inhibitory,3
5079,Pharmaceutical Preparations,C0013227,en_856,INHIBITS,epitheliasin,C0964578,en_5200,3,2,AFFECTS,Inhibitory,6
5080,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Excitatory,3
5081,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
5082,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
5083,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
5084,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
5085,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Excitatory,3
5086,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,overdose,C4018909,en_6291,2,2,AFFECTS,Excitatory,6
5087,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Recovery of Function,C0599766,en_4471,2,1,AFFECTS,Excitatory,3
5088,Pharmaceutical Preparations,C0013227,en_856,PREDISPOSES,Flare,C1517205,en_5867,2,1,AFFECTS,Excitatory,3
5089,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
5090,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
5091,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
5092,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
5093,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Complication,C0009566,en_697,9,5,AFFECTS,Inhibitory,15
5094,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Tissue damage,C0010957,en_756,1,1,AFFECTS,Inhibitory,3
5095,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Diabetes,C0011847,en_797,2,1,AFFECTS,Inhibitory,3
5096,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Disease,C0012634,en_826,8,7,AFFECTS,Inhibitory,21
5097,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
5098,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Inflammation,C0021368,en_1307,8,7,AFFECTS,Inhibitory,21
5099,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
5100,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,overdose,C4018909,en_6291,3,3,AFFECTS,Inhibitory,9
5101,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Pain,C0030193,en_1741,2,1,AFFECTS,Inhibitory,3
5102,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Inhibitory,3
5103,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
5104,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
5105,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
5106,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
5107,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Virus,C0042776,en_2364,3,1,AFFECTS,Inhibitory,3
5108,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Respiratory complication,C0161818,en_2899,1,1,AFFECTS,Inhibitory,3
5109,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Injury,C0175677,en_2968,2,2,AFFECTS,Inhibitory,6
5110,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Blood Clot,C0302148,en_3702,1,1,AFFECTS,Inhibitory,3
5111,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Respiratory distress,C0476273,en_4149,3,2,AFFECTS,Inhibitory,6
5112,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
5113,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,cytotoxicity,C0596402,en_4385,1,1,AFFECTS,Inhibitory,3
5114,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Emotional distress,C0700361,en_4722,1,1,AFFECTS,Inhibitory,3
5115,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Acute respiratory distress,C0748355,en_4831,1,1,AFFECTS,Inhibitory,3
5116,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Inhibitory,3
5117,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Cytokine storm,C0919747,en_5119,3,2,AFFECTS,Inhibitory,6
5118,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
5119,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
5120,Pharmaceutical Preparations,C0013227,en_856,PREVENTS,Symptoms,C1457887,en_5784,5,4,AFFECTS,Inhibitory,12
5121,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,ACE2,C1422064,en_5723,6,1,AFFECTS,Excitatory,3
5122,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,PGP,C1418520,en_165,3,1,AFFECTS,Excitatory,3
5123,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
5124,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,Methemoglobin,C0025635,en_1553,1,1,AFFECTS,Excitatory,3
5125,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,Retinoids,C0035339,en_2025,1,1,AFFECTS,Excitatory,3
5126,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,Triglycerides,C0041004,en_2282,1,1,AFFECTS,Excitatory,3
5127,Pharmaceutical Preparations,C0013227,en_856,STIMULATES,GLP-1 receptor,C0378073,en_3893,1,1,AFFECTS,Excitatory,3
5128,Pharmaceutical Preparations,C0013227,en_856,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,19,6,AFFECTS,Inhibitory,18
5129,Pharmaceutical Preparations,C0013227,en_856,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
5130,Pharmaceutical Preparations,C0013227,en_856,TREATS,Elderly,C0001792,en_258,2,2,AFFECTS,Inhibitory,6
5131,Pharmaceutical Preparations,C0013227,en_856,TREATS,alcohol use disorder,C0001956,en_270,3,2,AFFECTS,Inhibitory,6
5132,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Alcoholic Intoxication, Chronic",C0001973,en_273,4,3,AFFECTS,Inhibitory,9
5133,Pharmaceutical Preparations,C0013227,en_856,TREATS,Allergic rhinitis NOS,C0002103,en_280,1,1,AFFECTS,Inhibitory,3
5134,Pharmaceutical Preparations,C0013227,en_856,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
5135,Pharmaceutical Preparations,C0013227,en_856,TREATS,Amyotrophic Lateral Sclerosis,C0002736,en_310,2,1,AFFECTS,Inhibitory,3
5136,Pharmaceutical Preparations,C0013227,en_856,TREATS,Aortic Diseases,C0003493,en_382,1,1,AFFECTS,Inhibitory,3
5137,Pharmaceutical Preparations,C0013227,en_856,TREATS,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Inhibitory,3
5138,Pharmaceutical Preparations,C0013227,en_856,TREATS,Arthritis,C0003864,en_400,3,2,AFFECTS,Inhibitory,6
5139,Pharmaceutical Preparations,C0013227,en_856,TREATS,Rheumatoid Arthritis,C0003873,en_402,13,9,AFFECTS,Inhibitory,27
5140,Pharmaceutical Preparations,C0013227,en_856,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,3
5141,Pharmaceutical Preparations,C0013227,en_856,TREATS,Autoimmune Diseases,C0004364,en_428,5,4,AFFECTS,Inhibitory,12
5142,Pharmaceutical Preparations,C0013227,en_856,TREATS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
5143,Pharmaceutical Preparations,C0013227,en_856,TREATS,Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,3
5144,Pharmaceutical Preparations,C0013227,en_856,TREATS,Bipolar Disorder,C0005586,en_474,1,1,AFFECTS,Inhibitory,3
5145,Pharmaceutical Preparations,C0013227,en_856,TREATS,Brain Diseases,C0006111,en_510,1,1,AFFECTS,Inhibitory,3
5146,Pharmaceutical Preparations,C0013227,en_856,TREATS,Brucellosis,C0006309,en_522,1,1,AFFECTS,Inhibitory,3
5147,Pharmaceutical Preparations,C0013227,en_856,TREATS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,6
5148,Pharmaceutical Preparations,C0013227,en_856,TREATS,Cardiovascular Diseases,C0007222,en_569,2,2,AFFECTS,Inhibitory,6
5149,Pharmaceutical Preparations,C0013227,en_856,TREATS,Child,C0008059,en_620,3,3,AFFECTS,Inhibitory,9
5150,Pharmaceutical Preparations,C0013227,en_856,TREATS,Chronic Disease,C0008679,en_643,3,2,AFFECTS,Inhibitory,6
5151,Pharmaceutical Preparations,C0013227,en_856,TREATS,Cicatrix,C0008767,en_645,1,1,AFFECTS,Inhibitory,3
5152,Pharmaceutical Preparations,C0013227,en_856,TREATS,Common Cold,C0009443,en_684,3,1,AFFECTS,Inhibitory,3
5153,Pharmaceutical Preparations,C0013227,en_856,TREATS,Communicable Diseases,C0009450,en_685,3,3,AFFECTS,Inhibitory,9
5154,Pharmaceutical Preparations,C0013227,en_856,TREATS,Complication,C0009566,en_697,5,3,AFFECTS,Inhibitory,9
5155,Pharmaceutical Preparations,C0013227,en_856,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
5156,Pharmaceutical Preparations,C0013227,en_856,TREATS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,3
5157,Pharmaceutical Preparations,C0013227,en_856,TREATS,Cystic Fibrosis,C0010674,en_745,3,2,AFFECTS,Inhibitory,6
5158,Pharmaceutical Preparations,C0013227,en_856,TREATS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,Inhibitory,3
5159,Pharmaceutical Preparations,C0013227,en_856,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
5160,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,2,AFFECTS,Inhibitory,6
5161,Pharmaceutical Preparations,C0013227,en_856,TREATS,Diarrhea,C0011991,en_810,2,1,AFFECTS,Inhibitory,3
5162,Pharmaceutical Preparations,C0013227,en_856,TREATS,Disease,C0012634,en_826,60,50,AFFECTS,Inhibitory,150
5163,Pharmaceutical Preparations,C0013227,en_856,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,3
5164,Pharmaceutical Preparations,C0013227,en_856,TREATS,Filarial Elephantiases,C0013884,en_886,1,1,AFFECTS,Inhibitory,3
5165,Pharmaceutical Preparations,C0013227,en_856,TREATS,Empyema,C0014009,en_893,1,1,AFFECTS,Inhibitory,3
5166,Pharmaceutical Preparations,C0013227,en_856,TREATS,Escherichia coli,C0014834,en_929,1,1,AFFECTS,Inhibitory,3
5167,Pharmaceutical Preparations,C0013227,en_856,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
5168,Pharmaceutical Preparations,C0013227,en_856,TREATS,Fever,C0015967,en_985,4,4,AFFECTS,Inhibitory,12
5169,Pharmaceutical Preparations,C0013227,en_856,TREATS,Headache,C0018681,en_1115,2,2,AFFECTS,Inhibitory,6
5170,Pharmaceutical Preparations,C0013227,en_856,TREATS,Health Personnel,C0018724,en_1121,5,3,AFFECTS,Inhibitory,9
5171,Pharmaceutical Preparations,C0013227,en_856,TREATS,Heart failure,C0018801,en_1135,2,1,AFFECTS,Inhibitory,3
5172,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Hepatitis, Alcoholic",C0019187,en_1176,1,1,AFFECTS,Inhibitory,3
5173,Pharmaceutical Preparations,C0013227,en_856,TREATS,Hepatitis C,C0019196,en_1177,2,2,AFFECTS,Inhibitory,6
5174,Pharmaceutical Preparations,C0013227,en_856,TREATS,HIV Infections,C0019693,en_1192,3,2,AFFECTS,Inhibitory,6
5175,Pharmaceutical Preparations,C0013227,en_856,TREATS,Human,C0020114,en_1210,17,16,AFFECTS,Inhibitory,48
5176,Pharmaceutical Preparations,C0013227,en_856,TREATS,Hypertensive disease,C0020538,en_1239,6,5,AFFECTS,Inhibitory,15
5177,Pharmaceutical Preparations,C0013227,en_856,TREATS,Immune System Diseases,C0021053,en_1284,1,1,AFFECTS,Inhibitory,3
5178,Pharmaceutical Preparations,C0013227,en_856,TREATS,Infection,C3714514,en_6235,4,4,AFFECTS,Inhibitory,12
5179,Pharmaceutical Preparations,C0013227,en_856,TREATS,Inflammation,C0021368,en_1307,3,2,AFFECTS,Inhibitory,6
5180,Pharmaceutical Preparations,C0013227,en_856,TREATS,Inflammatory Bowel Diseases,C0021390,en_1310,2,1,AFFECTS,Inhibitory,3
5181,Pharmaceutical Preparations,C0013227,en_856,TREATS,leukemia,C0023418,en_1416,2,1,AFFECTS,Inhibitory,3
5182,Pharmaceutical Preparations,C0013227,en_856,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
5183,Pharmaceutical Preparations,C0013227,en_856,TREATS,Malaria,C0024530,en_1493,5,4,AFFECTS,Inhibitory,12
5184,Pharmaceutical Preparations,C0013227,en_856,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
5185,Pharmaceutical Preparations,C0013227,en_856,TREATS,Monkeys,C0026447,en_1578,2,1,AFFECTS,Inhibitory,3
5186,Pharmaceutical Preparations,C0013227,en_856,TREATS,Multiple Myeloma,C0026764,en_1596,1,1,AFFECTS,Inhibitory,3
5187,Pharmaceutical Preparations,C0013227,en_856,TREATS,Multiple Sclerosis,C0026769,en_1598,5,4,AFFECTS,Inhibitory,12
5188,Pharmaceutical Preparations,C0013227,en_856,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
5189,Pharmaceutical Preparations,C0013227,en_856,TREATS,Persons,C0027361,en_1635,18,14,AFFECTS,Inhibitory,42
5190,Pharmaceutical Preparations,C0013227,en_856,TREATS,Bovine coronavirus,C0027610,en_1649,1,1,AFFECTS,Inhibitory,3
5191,Pharmaceutical Preparations,C0013227,en_856,TREATS,Neoplasm,C0027651,en_1651,2,2,AFFECTS,Inhibitory,6
5192,Pharmaceutical Preparations,C0013227,en_856,TREATS,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,Inhibitory,3
5193,Pharmaceutical Preparations,C0013227,en_856,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
5194,Pharmaceutical Preparations,C0013227,en_856,TREATS,Obsessive-Compulsive Disorder,C0028768,en_1701,6,3,AFFECTS,Inhibitory,9
5195,Pharmaceutical Preparations,C0013227,en_856,TREATS,Onchocerciasis,C0029001,en_1709,1,1,AFFECTS,Inhibitory,3
5196,Pharmaceutical Preparations,C0013227,en_856,TREATS,Opioid Use Disorders,C0029103,en_1711,12,8,AFFECTS,Inhibitory,24
5197,Pharmaceutical Preparations,C0013227,en_856,TREATS,Degenerative polyarthritis,C0029408,en_1723,1,1,AFFECTS,Inhibitory,3
5198,Pharmaceutical Preparations,C0013227,en_856,TREATS,Outpatients,C0029921,en_1729,3,2,AFFECTS,Inhibitory,6
5199,Pharmaceutical Preparations,C0013227,en_856,TREATS,Pain,C0030193,en_1741,4,4,AFFECTS,Inhibitory,12
5200,Pharmaceutical Preparations,C0013227,en_856,TREATS,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,Inhibitory,3
5201,Pharmaceutical Preparations,C0013227,en_856,TREATS,Patients,C0030705,en_1762,141,107,AFFECTS,Inhibitory,321
5202,Pharmaceutical Preparations,C0013227,en_856,TREATS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,6
5203,Pharmaceutical Preparations,C0013227,en_856,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
5204,Pharmaceutical Preparations,C0013227,en_856,TREATS,Pruritus,C0033774,en_1916,1,1,AFFECTS,Inhibitory,3
5205,Pharmaceutical Preparations,C0013227,en_856,TREATS,Pulmonary Fibrosis,C0034069,en_1932,3,2,AFFECTS,Inhibitory,6
5206,Pharmaceutical Preparations,C0013227,en_856,TREATS,Rattus norvegicus,C0034693,en_1958,3,2,AFFECTS,Inhibitory,6
5207,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Rats, Sprague-Dawley",C0034715,en_1959,1,1,AFFECTS,Inhibitory,3
5208,Pharmaceutical Preparations,C0013227,en_856,TREATS,Research Personnel,C0035173,en_2002,2,1,AFFECTS,Inhibitory,3
5209,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,9,6,AFFECTS,Inhibitory,18
5210,Pharmaceutical Preparations,C0013227,en_856,TREATS,Sarcoidosis,C0036202,en_2064,1,1,AFFECTS,Inhibitory,3
5211,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
5212,Pharmaceutical Preparations,C0013227,en_856,TREATS,Stress,C0038435,en_2165,3,2,AFFECTS,Inhibitory,6
5213,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Stress Disorders, Traumatic",C0038441,en_2167,1,1,AFFECTS,Inhibitory,3
5214,Pharmaceutical Preparations,C0013227,en_856,TREATS,Substance Use Disorders,C0038586,en_2176,2,1,AFFECTS,Inhibitory,3
5215,Pharmaceutical Preparations,C0013227,en_856,TREATS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
5216,Pharmaceutical Preparations,C0013227,en_856,TREATS,Infection by Trypanosoma gambiense,C0041232,en_2289,1,1,AFFECTS,Inhibitory,3
5217,Pharmaceutical Preparations,C0013227,en_856,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
5218,Pharmaceutical Preparations,C0013227,en_856,TREATS,Virus Diseases,C0042769,en_2362,20,14,AFFECTS,Inhibitory,42
5219,Pharmaceutical Preparations,C0013227,en_856,TREATS,Virus,C0042776,en_2364,3,3,AFFECTS,Inhibitory,9
5220,Pharmaceutical Preparations,C0013227,en_856,TREATS,Agitation,C0085631,en_2683,1,1,AFFECTS,Inhibitory,3
5221,Pharmaceutical Preparations,C0013227,en_856,TREATS,Hamman-Rich syndrome,C0085786,en_2691,1,1,AFFECTS,Inhibitory,3
5222,Pharmaceutical Preparations,C0013227,en_856,TREATS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
5223,Pharmaceutical Preparations,C0013227,en_856,TREATS,Intestinal tract infectious disease NOS,C0178238,en_2979,2,1,AFFECTS,Inhibitory,3
5224,Pharmaceutical Preparations,C0013227,en_856,TREATS,Genus: Coronavirus,C0206419,en_3158,2,2,AFFECTS,Inhibitory,6
5225,Pharmaceutical Preparations,C0013227,en_856,TREATS,Human coronavirus,C0206422,en_3159,2,1,AFFECTS,Inhibitory,3
5226,Pharmaceutical Preparations,C0013227,en_856,TREATS,Coronavirus Infections,C0206750,en_3176,6,3,AFFECTS,Inhibitory,9
5227,Pharmaceutical Preparations,C0013227,en_856,TREATS,NEUROLOGIC COMPLICATION,C0235029,en_3317,1,1,AFFECTS,Inhibitory,3
5228,Pharmaceutical Preparations,C0013227,en_856,TREATS,Individual,C0237401,en_3343,6,5,AFFECTS,Inhibitory,15
5229,Pharmaceutical Preparations,C0013227,en_856,TREATS,CANADIAN,C0238884,en_3371,1,1,AFFECTS,Inhibitory,3
5230,Pharmaceutical Preparations,C0013227,en_856,TREATS,narcotic use,C0240602,en_3386,1,1,AFFECTS,Inhibitory,3
5231,Pharmaceutical Preparations,C0013227,en_856,TREATS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
5232,Pharmaceutical Preparations,C0013227,en_856,TREATS,Generalized Anxiety Disorder,C0270549,en_3551,1,1,AFFECTS,Inhibitory,3
5233,Pharmaceutical Preparations,C0013227,en_856,TREATS,Diabetic complications,C0271672,en_3556,1,1,AFFECTS,Inhibitory,3
5234,Pharmaceutical Preparations,C0013227,en_856,TREATS,Infection by Strongylus,C0277227,en_3582,1,1,AFFECTS,Inhibitory,3
5235,Pharmaceutical Preparations,C0013227,en_856,TREATS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
5236,Pharmaceutical Preparations,C0013227,en_856,TREATS,Malignant neoplasm of prostate,C0376358,en_3874,1,1,AFFECTS,Inhibitory,3
5237,Pharmaceutical Preparations,C0013227,en_856,TREATS,Neuropathic pain,C0423716,en_3989,1,1,AFFECTS,Inhibitory,3
5238,Pharmaceutical Preparations,C0013227,en_856,TREATS,Short menstrual periods,C0425946,en_4006,2,1,AFFECTS,Inhibitory,3
5239,Pharmaceutical Preparations,C0013227,en_856,TREATS,Patient's condition improved,C0438108,en_4030,2,1,AFFECTS,Inhibitory,3
5240,Pharmaceutical Preparations,C0013227,en_856,TREATS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
5241,Pharmaceutical Preparations,C0013227,en_856,TREATS,Periodic syndrome,C0585274,en_4354,1,1,AFFECTS,Inhibitory,3
5242,Pharmaceutical Preparations,C0013227,en_856,TREATS,cohort,C0599755,en_4470,5,4,AFFECTS,Inhibitory,12
5243,Pharmaceutical Preparations,C0013227,en_856,TREATS,Does run,C0600140,en_4498,1,1,AFFECTS,Inhibitory,3
5244,Pharmaceutical Preparations,C0013227,en_856,TREATS,Participant,C0679646,en_4602,4,3,AFFECTS,Inhibitory,9
5245,Pharmaceutical Preparations,C0013227,en_856,TREATS,network,C0679670,en_4604,2,2,AFFECTS,Inhibitory,6
5246,Pharmaceutical Preparations,C0013227,en_856,TREATS,AIRWAY DISEASE,C0699949,en_4711,1,1,AFFECTS,Inhibitory,3
5247,Pharmaceutical Preparations,C0013227,en_856,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
5248,Pharmaceutical Preparations,C0013227,en_856,TREATS,Acne,C0702166,en_4736,4,2,AFFECTS,Inhibitory,6
5249,Pharmaceutical Preparations,C0013227,en_856,TREATS,Parasitic infection,C0747256,en_4823,1,1,AFFECTS,Inhibitory,3
5250,Pharmaceutical Preparations,C0013227,en_856,TREATS,UNDERLYING INFECTION,C0749769,en_4837,2,1,AFFECTS,Inhibitory,3
5251,Pharmaceutical Preparations,C0013227,en_856,TREATS,undergraduate student,C0814964,en_4917,1,1,AFFECTS,Inhibitory,3
5252,Pharmaceutical Preparations,C0013227,en_856,TREATS,Hospitalized Patients,C0870668,en_5010,6,5,AFFECTS,Inhibitory,15
5253,Pharmaceutical Preparations,C0013227,en_856,TREATS,Teams,C0871489,en_5024,1,1,AFFECTS,Inhibitory,3
5254,Pharmaceutical Preparations,C0013227,en_856,TREATS,Traumatic Brain Injury,C0876926,en_5057,1,1,AFFECTS,Inhibitory,3
5255,Pharmaceutical Preparations,C0013227,en_856,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
5256,Pharmaceutical Preparations,C0013227,en_856,TREATS,Cytokine storm,C0919747,en_5119,6,5,AFFECTS,Inhibitory,15
5257,Pharmaceutical Preparations,C0013227,en_856,TREATS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Inhibitory,3
5258,Pharmaceutical Preparations,C0013227,en_856,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
5259,Pharmaceutical Preparations,C0013227,en_856,TREATS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
5260,Pharmaceutical Preparations,C0013227,en_856,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
5261,Pharmaceutical Preparations,C0013227,en_856,TREATS,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
5262,Pharmaceutical Preparations,C0013227,en_856,TREATS,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,Inhibitory,3
5263,Pharmaceutical Preparations,C0013227,en_856,TREATS,Symptoms,C1457887,en_5784,12,9,AFFECTS,Inhibitory,27
5264,Pharmaceutical Preparations,C0013227,en_856,TREATS,Paraosmia,C1510410,en_5793,4,2,AFFECTS,Inhibitory,6
5265,Pharmaceutical Preparations,C0013227,en_856,TREATS,Principal Investigator,C1521895,en_5898,2,1,AFFECTS,Inhibitory,3
5266,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Ageusia,C0001800,en_259,2,1,AFFECTS,Inhibitory,3
5267,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Anosmia,C0003126,en_337,2,1,AFFECTS,Inhibitory,3
5268,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,6
5269,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
5270,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
5271,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Diabetes Mellitus,C0011849,en_798,2,1,AFFECTS,Inhibitory,3
5272,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Disease,C0012634,en_826,7,5,AFFECTS,Inhibitory,15
5273,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
5274,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Hypertensive disease,C0020538,en_1239,2,1,AFFECTS,Inhibitory,3
5275,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
5276,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),"Myeloid Leukemia, Chronic",C0023473,en_1419,1,1,AFFECTS,Inhibitory,3
5277,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
5278,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
5279,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Pneumonia,C0032285,en_1833,5,4,AFFECTS,Inhibitory,12
5280,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
5281,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Rheumatism,C0035435,en_2028,2,1,AFFECTS,Inhibitory,3
5282,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
5283,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
5284,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
5285,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Malaise,C0231218,en_3251,3,3,AFFECTS,Inhibitory,9
5286,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
5287,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,3
5288,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Inhibitory,3
5289,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
5290,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Hypertensive,C0857121,en_4969,1,1,AFFECTS,Inhibitory,3
5291,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Inflammatory disorder,C1290884,en_5483,2,2,AFFECTS,Inhibitory,6
5292,Pharmaceutical Preparations,C0013227,en_856,TREATS(INFER),Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
5293,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
5294,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),"Alcoholic Intoxication, Chronic",C0001973,en_273,1,1,AFFECTS,Inhibitory,3
5295,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
5296,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,3
5297,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
5298,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),Vasculitis,C0042384,en_2338,1,1,AFFECTS,Inhibitory,3
5299,Pharmaceutical Preparations,C0013227,en_856,TREATS(SPEC),Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,3
5300,"Drugs, Investigational",C0013230,en_857,STIMULATES,MAS1 gene,C0812372,en_4899,2,1,AFFECTS,Excitatory,3
5301,"Drugs, Investigational",C0013230,en_857,TREATS,Meniere's Disease,C0025281,en_1535,1,1,AFFECTS,Inhibitory,3
5302,"Drugs, Investigational",C0013230,en_857,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
5303,"Drugs, Investigational",C0013230,en_857,TREATS,Voluntary Workers,C0042960,en_2380,1,1,AFFECTS,Inhibitory,3
5304,"Drugs, Investigational",C0013230,en_857,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
5305,"Drugs, Investigational",C0013230,en_857,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
5306,"Drugs, Investigational",C0013230,en_857,TREATS,Lactobacillus rhamnosus GG,C1629836,en_6016,1,1,AFFECTS,Inhibitory,7
5307,"Drugs, Investigational",C0013230,en_857,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
5308,"Drugs, Investigational",C0013230,en_857,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
5309,"Drugs, Investigational",C0013230,en_857,TREATS(INFER),Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Inhibitory,3
5310,"Drugs, Non-Prescription",C0013231,en_858,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
5311,"Drugs, Orphan",C0013232,en_859,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5312,Early Mobilization,C0013459,en_868,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
5313,Earthquakes,C0013463,en_869,AFFECTS,psychological distress,C0815107,en_4922,1,1,AFFECTS,General/Uncertain,3
5314,Eating,C0013470,en_870,AFFECTS,Movement,C0026649,en_1588,2,1,AFFECTS,General/Uncertain,3
5315,Eating,C0013470,en_870,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5316,Eating Disorders,C0013473,en_871,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
5317,Eating Disorders,C0013473,en_871,AFFECTS,Caregiver,C0085537,en_2674,1,1,AFFECTS,General/Uncertain,3
5318,Eating Disorders,C0013473,en_871,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
5319,Ecdysterone,C0013495,en_873,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
5320,Ecdysterone,C0013495,en_873,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
5321,Echocardiography,C0013516,en_874,AFFECTS,Hemodynamics,C0019010,en_1156,1,1,AFFECTS,General/Uncertain,3
5322,Echocardiography,C0013516,en_874,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
5323,Echocardiography,C0013516,en_874,AFFECTS,Risk Assessment,C0086930,en_2737,1,1,AFFECTS,General/Uncertain,6
5324,Echocardiography,C0013516,en_874,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,3
5325,Echocardiography,C0013516,en_874,AFFECTS,Clinical Management,C1516615,en_5859,1,1,AFFECTS,General/Uncertain,6
5326,2D Echocardiography,C0013524,en_875,AFFECTS,Assessment procedure,C1261322,en_5417,1,1,AFFECTS,General/Uncertain,6
5327,Edema,C0013604,en_877,AFFECTS,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,3
5328,Edema,C0013604,en_877,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
5329,Edema,C0013604,en_877,AFFECTS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,General/Uncertain,3
5330,Edetic Acid,C0013618,en_878,TREATS,Diastasis,C0036679,en_2084,2,2,AFFECTS,Inhibitory,6
5331,Knowledge acquisition,C0013621,en_879,AFFECTS,Personal Satisfaction,C0031206,en_1780,4,3,AFFECTS,General/Uncertain,9
5332,Knowledge acquisition,C0013621,en_879,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
5333,Knowledge acquisition,C0013621,en_879,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
5334,Knowledge acquisition,C0013621,en_879,AFFECTS,Pre-existing condition,C0521987,en_4206,1,1,AFFECTS,General/Uncertain,3
5335,Knowledge acquisition,C0013621,en_879,AFFECTS,Does turn,C0541749,en_4253,1,1,AFFECTS,General/Uncertain,3
5336,Eicosanoids,C0013725,en_880,AFFECTS,attenuation,C0599946,en_4490,1,1,AFFECTS,General/Uncertain,3
5337,Elastin,C0013765,en_881,DISRUPTS,Arteries,C0003842,en_398,2,1,AFFECTS,Inhibitory,3
5338,Elastin,C0013765,en_881,DISRUPTS,Lung,C0024109,en_1460,2,1,AFFECTS,Inhibitory,3
5339,Elastin,C0013765,en_881,INHIBITS,Desmosine,C0011702,en_793,3,1,AFFECTS,Inhibitory,3
5340,Elastin,C0013765,en_881,INHIBITS,Vitamin K,C0042878,en_2374,2,1,AFFECTS,Inhibitory,3
5341,Electrocardiogram,C0013798,en_882,AFFECTS,Blood Pressure,C0005823,en_492,3,3,AFFECTS,General/Uncertain,9
5342,Electrocardiogram,C0013798,en_882,AFFECTS,Cessation of life,C0011065,en_762,4,2,AFFECTS,General/Uncertain,9
5343,Electrocardiogram,C0013798,en_882,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
5344,Electrocardiogram,C0013798,en_882,AFFECTS,Respiration,C0035203,en_2004,3,1,AFFECTS,General/Uncertain,3
5345,Electroconvulsive Therapy,C0013806,en_883,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5346,Electroconvulsive Therapy,C0013806,en_883,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
5347,Electroconvulsive Therapy,C0013806,en_883,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
5348,Electroconvulsive Therapy,C0013806,en_883,TREATS,Gender,C0079399,en_2601,1,1,AFFECTS,Inhibitory,3
5349,Electroconvulsive Therapy,C0013806,en_883,TREATS(INFER),Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Inhibitory,3
5350,Elements,C0013879,en_885,AFFECTS,Natural Disasters,C0027485,en_1643,2,1,AFFECTS,General/Uncertain,3
5351,Elements,C0013879,en_885,AFFECTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,General/Uncertain,3
5352,Elements,C0013879,en_885,AUGMENTS,Hemostatic function,C0019116,en_1165,1,1,AFFECTS,Excitatory,3
5353,Elements,C0013879,en_885,AUGMENTS,Inflammation,C0021368,en_1307,2,2,AFFECTS,Excitatory,6
5354,Elements,C0013879,en_885,AUGMENTS,Learning,C0023185,en_1404,2,2,AFFECTS,Excitatory,6
5355,Elements,C0013879,en_885,STIMULATES,Factor Xa,C0015520,en_958,2,2,AFFECTS,Excitatory,6
5356,Elements,C0013879,en_885,STIMULATES,Fibrinogen,C0016006,en_988,2,2,AFFECTS,Excitatory,6
5357,Elements,C0013879,en_885,STIMULATES,Thrombin,C0040018,en_2228,2,2,AFFECTS,Excitatory,6
5358,Embryo Transfer,C0013938,en_888,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5359,Embryo Transfer,C0013938,en_888,TREATS,Encounter due to In vitro fertilization,C0733942,en_4773,1,1,AFFECTS,Inhibitory,3
5360,Emergency medical service,C0013961,en_889,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,6
5361,Emergency medical service,C0013961,en_889,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
5362,Emergency medical service,C0013961,en_889,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
5363,Emergency medical service,C0013961,en_889,TREATS,Outpatients,C0029921,en_1729,4,2,AFFECTS,Inhibitory,6
5364,Emergency medical service,C0013961,en_889,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5365,Emergency medical service,C0013961,en_889,TREATS,Cardiopulmonary Arrest,C0600228,en_4500,1,1,AFFECTS,Inhibitory,6
5366,Emergency medical service,C0013961,en_889,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,6
5367,Emergency treatment,C0013969,en_890,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5368,Emergency treatment,C0013969,en_890,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
5369,Emergency treatment,C0013969,en_890,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
5370,Emergency treatment,C0013969,en_890,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5371,Emergency treatment,C0013969,en_890,TREATS,Domestic abuse,C0413318,en_3973,1,1,AFFECTS,Inhibitory,3
5372,Emergency treatment,C0013969,en_890,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
5373,Pathological accumulation of air in tissues,C0013990,en_891,AFFECTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,General/Uncertain,3
5374,Employee Assistance Programs (Health Care),C0013995,en_892,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
5375,"Empyema, Pleural",C0014013,en_894,COMPLICATES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
5376,Emulsions,C0014020,en_895,AFFECTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
5377,Emulsions,C0014020,en_895,TREATS,Hemangiosarcoma,C0018923,en_1149,1,1,AFFECTS,Inhibitory,3
5378,Encephalitis,C0014038,en_896,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
5379,Endocytosis,C0014139,en_897,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
5380,Endocytosis,C0014139,en_897,AFFECTS,Vimentin,C0042666,en_2352,1,1,AFFECTS,General/Uncertain,3
5381,Endocytosis,C0014139,en_897,AFFECTS,uptake,C0243144,en_3467,1,1,AFFECTS,General/Uncertain,3
5382,Endocytosis,C0014139,en_897,AFFECTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
5383,"Endometriosis, site unspecified",C0014175,en_898,AFFECTS,Natural Disasters,C0027485,en_1643,1,1,AFFECTS,General/Uncertain,3
5384,Endorphins,C0014242,en_900,AUGMENTS,Chemotaxis,C0008018,en_615,1,1,AFFECTS,Excitatory,3
5385,Endoscopes,C0014243,en_901,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
5386,Endothelium,C0014257,en_902,AFFECTS,Pathological Dilatation,C0012359,en_816,1,1,AFFECTS,General/Uncertain,6
5387,Endothelium,C0014257,en_902,PRODUCES,Peptidyl-Dipeptidase A,C0022709,en_1387,1,1,AFFECTS,Excitatory,3
5388,Endothelium,C0014257,en_902,PRODUCES,Nitric Oxide,C0028128,en_1682,2,1,AFFECTS,Excitatory,3
5389,Endothelium,C0014257,en_902,PRODUCES,"PER2 protein, mammalian",C0669679,en_4536,1,1,AFFECTS,Excitatory,3
5390,Endotoxins,C0014264,en_903,INHIBITS,mitogen-activated protein kinase p38,C1120843,en_5249,1,1,AFFECTS,Inhibitory,3
5391,Endotoxins,C0014264,en_903,STIMULATES,Heparitin Sulfate,C0019143,en_1168,2,1,AFFECTS,Excitatory,3
5392,Endotoxins,C0014264,en_903,STIMULATES,TLR4 gene,C1336636,en_5633,1,1,AFFECTS,Excitatory,3
5393,Enteral Nutrition,C0014327,en_905,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,6
5394,Enteral Nutrition,C0014327,en_905,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5395,Enteral Nutrition,C0014327,en_905,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,6
5396,Enteral Nutrition,C0014327,en_905,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
5397,Enteral Nutrition,C0014327,en_905,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
5398,Enterobacteriaceae,C0014346,en_908,PRODUCES,carbapenemase,C0246081,en_3478,2,2,AFFECTS,Excitatory,6
5399,Enterobacteriaceae,C0014346,en_908,PRODUCES,Extended-spectrum beta lactamase,C0486433,en_4152,1,1,AFFECTS,Excitatory,3
5400,Enterovirus Infections,C0014378,en_909,AFFECTS,Myelitis,C0026975,en_1621,1,1,AFFECTS,General/Uncertain,3
5401,Enzymes,C0014442,en_912,PRODUCES,Prostaglandins,C0033554,en_1902,1,1,AFFECTS,Excitatory,6
5402,Enzymes,C0014442,en_912,AFFECTS,Cardiovascular Physiology,C0007227,en_570,3,1,AFFECTS,General/Uncertain,3
5403,Enzymes,C0014442,en_912,AFFECTS,Cell Growth,C0007595,en_590,1,1,AFFECTS,General/Uncertain,3
5404,Enzymes,C0014442,en_912,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
5405,Enzymes,C0014442,en_912,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
5406,Enzymes,C0014442,en_912,AFFECTS,Signal Transduction Pathways,C0086982,en_2741,1,1,AFFECTS,General/Uncertain,3
5407,Enzymes,C0014442,en_912,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
5408,Enzymes,C0014442,en_912,AFFECTS,Cap formation,C0302167,en_3704,1,1,AFFECTS,General/Uncertain,3
5409,Enzymes,C0014442,en_912,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
5410,Enzymes,C0014442,en_912,AFFECTS,transfer reaction,C0678610,en_4565,2,2,AFFECTS,General/Uncertain,6
5411,Enzymes,C0014442,en_912,AFFECTS,nucleocytoplasmic transport,C0872070,en_5034,1,1,AFFECTS,General/Uncertain,3
5412,Enzymes,C0014442,en_912,AFFECTS,tryptophan catabolism,C1156673,en_5330,2,1,AFFECTS,General/Uncertain,3
5413,Enzymes,C0014442,en_912,AFFECTS,Cell Death Process,C1516340,en_5854,1,1,AFFECTS,General/Uncertain,3
5414,Enzymes,C0014442,en_912,AUGMENTS,Virus Replication,C0042774,en_2363,2,1,AFFECTS,Excitatory,3
5415,Enzymes,C0014442,en_912,AUGMENTS,receptor expression,C0597360,en_4424,1,1,AFFECTS,Excitatory,3
5416,Enzymes,C0014442,en_912,DISRUPTS,Hypertensive disease,C0020538,en_1239,3,1,AFFECTS,Inhibitory,3
5417,Enzymes,C0014442,en_912,INHIBITS,CYP26A1,C1413863,en_26,1,1,AFFECTS,Inhibitory,3
5418,Enzymes,C0014442,en_912,INHIBITS,Angiotensin II,C0003009,en_328,4,3,AFFECTS,Inhibitory,9
5419,Enzymes,C0014442,en_912,INHIBITS,Bradykinin,C0006100,en_507,2,2,AFFECTS,Inhibitory,6
5420,Enzymes,C0014442,en_912,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
5421,Enzymes,C0014442,en_912,PREVENTS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
5422,Enzymes,C0014442,en_912,STIMULATES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
5423,Enzymes,C0014442,en_912,TREATS,Bacteria,C0004611,en_440,1,1,AFFECTS,Inhibitory,3
5424,Enzymes,C0014442,en_912,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
5425,Enzymes,C0014442,en_912,TREATS,Acute failure,C0231176,en_3248,3,1,AFFECTS,Inhibitory,3
5426,Eosinophilia,C0014457,en_913,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
5427,Epidermis,C0014520,en_916,PRODUCES,Aldosterone,C0002006,en_274,1,1,AFFECTS,Excitatory,3
5428,Epilepsy,C0014544,en_917,AFFECTS,Convulsions,C0009951,en_714,2,1,AFFECTS,General/Uncertain,3
5429,Epilepsy,C0014544,en_917,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
5430,Epinephrine,C0014563,en_918,TREATS,Allergic Reaction,C1527304,en_5919,1,1,AFFECTS,Inhibitory,3
5431,Epithelial Cells,C0014597,en_919,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
5432,Epithelial Cells,C0014597,en_919,PRODUCES,ACE2,C1422064,en_5723,3,2,AFFECTS,Excitatory,6
5433,Epithelial Cells,C0014597,en_919,PRODUCES,"CD79A,LOC102723407",C1413238,en_191,1,1,AFFECTS,Excitatory,3
5434,Epithelial Cells,C0014597,en_919,PRODUCES,Organic Chemicals,C0029224,en_1716,2,2,AFFECTS,Excitatory,6
5435,Epithelial Cells,C0014597,en_919,PRODUCES,Peptide Hydrolases,C0030940,en_1769,1,1,AFFECTS,Excitatory,3
5436,Epithelial Cells,C0014597,en_919,PRODUCES,Pulmonary Surfactants,C0034085,en_1935,1,1,AFFECTS,Excitatory,3
5437,Epithelial Cells,C0014597,en_919,PRODUCES,Androgen Receptor,C0034786,en_1962,1,1,AFFECTS,Excitatory,3
5438,Epithelial Cells,C0014597,en_919,PRODUCES,Fc Receptor,C0034805,en_1970,1,1,AFFECTS,Excitatory,3
5439,Epithelium,C0014609,en_920,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
5440,Epithelium,C0014609,en_920,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
5441,Epoxide hydrolase,C0014628,en_921,AFFECTS,Cardiovascular Physiology,C0007227,en_570,1,1,AFFECTS,General/Uncertain,3
5442,Epoxide hydrolase,C0014628,en_921,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
5443,Epoxide hydrolase,C0014628,en_921,PREDISPOSES,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Excitatory,3
5444,Equilibrium,C0014653,en_923,AFFECTS,Body Weight,C0005910,en_498,2,1,AFFECTS,General/Uncertain,3
5445,Equilibrium,C0014653,en_923,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
5446,Equilibrium,C0014653,en_923,AFFECTS,Hemodynamics,C0019010,en_1156,1,1,AFFECTS,General/Uncertain,3
5447,Equilibrium,C0014653,en_923,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,8
5448,Equilibrium,C0014653,en_923,AFFECTS,Posture,C0032818,en_1862,1,1,AFFECTS,General/Uncertain,3
5449,Equilibrium,C0014653,en_923,AFFECTS,warming,C0687712,en_4690,1,1,AFFECTS,General/Uncertain,3
5450,Equilibrium,C0014653,en_923,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
5451,Vitamin D2,C0014695,en_924,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,8
5452,Vitamin D2,C0014695,en_924,AFFECTS,muscle metabolism,C0596984,en_4406,1,1,AFFECTS,General/Uncertain,8
5453,Vitamin D2,C0014695,en_924,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,6
5454,Vitamin D2,C0014695,en_924,AUGMENTS,Finding of body mass index,C0578022,en_4339,1,1,AFFECTS,Excitatory,8
5455,Vitamin D2,C0014695,en_924,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,7
5456,Vitamin D2,C0014695,en_924,TREATS,Inflammatory Bowel Diseases,C0021390,en_1310,1,1,AFFECTS,Inhibitory,6
5457,Vitamin D2,C0014695,en_924,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,7
5458,Vitamin D2,C0014695,en_924,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,27
5459,Vitamin D2,C0014695,en_924,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
5460,Ergosterol,C0014705,en_925,STIMULATES,Tretinoin,C0040845,en_2280,1,1,AFFECTS,Excitatory,3
5461,Erythropoietin,C0014822,en_928,AFFECTS,Erythropoiesis,C0014819,en_927,1,1,AFFECTS,General/Uncertain,3
5462,Escherichia coli,C0014834,en_929,PRODUCES,IMPACT gene,C1825598,en_6044,1,1,AFFECTS,Excitatory,6
5463,Esters,C0014898,en_931,AUGMENTS,conjugation,C1160466,en_5355,1,1,AFFECTS,Excitatory,3
5464,Esters,C0014898,en_931,PREDISPOSES,Schizophrenia,C0036341,en_2068,1,1,AFFECTS,Excitatory,3
5465,Estradiol,C0014912,en_932,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
5466,Estradiol,C0014912,en_932,PREVENTS,Symptoms,C1457887,en_5784,4,2,AFFECTS,Inhibitory,6
5467,Estradiol,C0014912,en_932,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5468,Estrogens,C0014939,en_933,AUGMENTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,Excitatory,3
5469,Estrogens,C0014939,en_933,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
5470,Estrogens,C0014939,en_933,STIMULATES,Dopamine,C0013030,en_842,1,1,AFFECTS,Excitatory,3
5471,Estrogens,C0014939,en_933,TREATS,"Osteoporosis, Postmenopausal",C0029458,en_1727,1,1,AFFECTS,Inhibitory,3
5472,Estrogens,C0014939,en_933,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
5473,Estrogens,C0014939,en_933,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
5474,Ethylene,C0015075,en_935,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
5475,Etoposide,C0015133,en_936,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
5476,Etoposide,C0015133,en_936,TREATS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
5477,Evolution,C0015219,en_937,AFFECTS,FAAH,C1414512,en_35,1,1,AFFECTS,General/Uncertain,3
5478,Evolution,C0015219,en_937,AFFECTS,UTP20,C1823612,en_126,1,1,AFFECTS,General/Uncertain,3
5479,Evolution,C0015219,en_937,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
5480,Evolution,C0015219,en_937,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
5481,Evolution,C0015219,en_937,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
5482,Evolution,C0015219,en_937,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
5483,Evolution,C0015219,en_937,AFFECTS,Predisposition,C0220898,en_3206,1,1,AFFECTS,General/Uncertain,3
5484,Evolution,C0015219,en_937,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
5485,Evolution,C0015219,en_937,AFFECTS,microbial,C0599840,en_4476,1,1,AFFECTS,General/Uncertain,3
5486,Exanthema,C0015230,en_938,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5487,removal technique,C0015252,en_939,TREATS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,12
5488,removal technique,C0015252,en_939,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
5489,removal technique,C0015252,en_939,TREATS,Skin Abnormalities,C0037268,en_2114,1,1,AFFECTS,Inhibitory,8
5490,removal technique,C0015252,en_939,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
5491,removal technique,C0015252,en_939,TREATS,Diverticular Diseases,C4317009,en_6340,1,1,AFFECTS,Inhibitory,6
5492,Exercise,C0015259,en_940,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
5493,Exercise,C0015259,en_940,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
5494,Exercise,C0015259,en_940,PREVENTS,Chronic Disease,C0008679,en_643,2,2,AFFECTS,Inhibitory,6
5495,Exercise,C0015259,en_940,PREVENTS,Dyspnea,C0013404,en_866,2,2,AFFECTS,Inhibitory,6
5496,Exercise,C0015259,en_940,PREVENTS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,6
5497,Exercise,C0015259,en_940,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
5498,Exercise,C0015259,en_940,PREVENTS,Sedentary,C0205254,en_3128,1,1,AFFECTS,Inhibitory,3
5499,Exercise,C0015259,en_940,PREVENTS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,3
5500,Exercise,C0015259,en_940,PREVENTS,Oxygen uptake,C0429627,en_4020,4,2,AFFECTS,Inhibitory,6
5501,Exercise,C0015259,en_940,PREVENTS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,6
5502,Exercise,C0015259,en_940,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
5503,Exercise,C0015259,en_940,PREVENTS,Weakness,C3714552,en_6236,1,1,AFFECTS,Inhibitory,8
5504,Exercise,C0015259,en_940,STIMULATES,Upper limb training,C0556501,en_4300,1,1,AFFECTS,Excitatory,3
5505,Exercise,C0015259,en_940,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,6
5506,Exercise,C0015259,en_940,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
5507,Exercise,C0015259,en_940,TREATS,Rheumatoid Arthritis,C0003873,en_402,3,1,AFFECTS,Inhibitory,6
5508,Exercise,C0015259,en_940,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
5509,Exercise,C0015259,en_940,TREATS,Chronic Disease,C0008679,en_643,3,3,AFFECTS,Inhibitory,16
5510,Exercise,C0015259,en_940,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
5511,Exercise,C0015259,en_940,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
5512,Exercise,C0015259,en_940,TREATS,Coronary Arteriosclerosis,C0010054,en_717,2,1,AFFECTS,Inhibitory,7
5513,Exercise,C0015259,en_940,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
5514,Exercise,C0015259,en_940,TREATS,Fatigue,C0015672,en_966,2,1,AFFECTS,Inhibitory,3
5515,Exercise,C0015259,en_940,TREATS,Human,C0020114,en_1210,4,2,AFFECTS,Inhibitory,6
5516,Exercise,C0015259,en_940,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
5517,Exercise,C0015259,en_940,TREATS,Myositis,C0027121,en_1631,1,1,AFFECTS,Inhibitory,3
5518,Exercise,C0015259,en_940,TREATS,Persons,C0027361,en_1635,6,5,AFFECTS,Inhibitory,15
5519,Exercise,C0015259,en_940,TREATS,Degenerative polyarthritis,C0029408,en_1723,1,1,AFFECTS,Inhibitory,3
5520,Exercise,C0015259,en_940,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,6
5521,Exercise,C0015259,en_940,TREATS,Pain,C0030193,en_1741,2,1,AFFECTS,Inhibitory,3
5522,Exercise,C0015259,en_940,TREATS,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
5523,Exercise,C0015259,en_940,TREATS,Patients,C0030705,en_1762,16,12,AFFECTS,Inhibitory,36
5524,Exercise,C0015259,en_940,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
5525,Exercise,C0015259,en_940,TREATS,Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
5526,Exercise,C0015259,en_940,TREATS,Woman,C0043210,en_2396,4,3,AFFECTS,Inhibitory,20
5527,Exercise,C0015259,en_940,TREATS,Frail Older Adults,C0079379,en_2599,1,1,AFFECTS,Inhibitory,8
5528,Exercise,C0015259,en_940,TREATS,Polish population,C0220896,en_3205,1,1,AFFECTS,Inhibitory,7
5529,Exercise,C0015259,en_940,TREATS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Inhibitory,8
5530,Exercise,C0015259,en_940,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,6
5531,Exercise,C0015259,en_940,TREATS,Individual,C0237401,en_3343,5,3,AFFECTS,Inhibitory,9
5532,Exercise,C0015259,en_940,TREATS,Young adult,C0238598,en_3365,1,1,AFFECTS,Inhibitory,3
5533,Exercise,C0015259,en_940,TREATS,athlete,C0238703,en_3368,2,1,AFFECTS,Inhibitory,3
5534,Exercise,C0015259,en_940,TREATS,Form of muscle,C0240417,en_3384,1,1,AFFECTS,Inhibitory,3
5535,Exercise,C0015259,en_940,TREATS,"Multiple Sclerosis, Chronic Progressive",C0393665,en_3934,1,1,AFFECTS,Inhibitory,8
5536,Exercise,C0015259,en_940,TREATS,"Osteoarthritis, Knee",C0409959,en_3966,1,1,AFFECTS,Inhibitory,8
5537,Exercise,C0015259,en_940,TREATS,Bed-ridden,C0425251,en_4001,1,1,AFFECTS,Inhibitory,3
5538,Exercise,C0015259,en_940,TREATS,Endurance,C0518031,en_4176,1,1,AFFECTS,Inhibitory,3
5539,Exercise,C0015259,en_940,TREATS,Household composition,C0595998,en_4374,1,1,AFFECTS,Inhibitory,8
5540,Exercise,C0015259,en_940,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
5541,Exercise,C0015259,en_940,TREATS,physical symptom,C0679309,en_4594,1,1,AFFECTS,Inhibitory,3
5542,Exercise,C0015259,en_940,TREATS,CARDIAC PATIENT,C0741926,en_4792,1,1,AFFECTS,Inhibitory,7
5543,Exercise,C0015259,en_940,TREATS,"Problem, weight",C0848241,en_4932,1,1,AFFECTS,Inhibitory,3
5544,Exercise,C0015259,en_940,TREATS,Denture wearer,C0877122,en_5064,1,1,AFFECTS,Inhibitory,3
5545,Exercise,C0015259,en_940,TREATS,Postural orthostatic tachycardia syndrome,C1299624,en_5506,2,1,AFFECTS,Inhibitory,3
5546,Exercise,C0015259,en_940,TREATS,Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
5547,Exercise,C0015259,en_940,TREATS,Sedentary lifestyle,C1532253,en_5930,1,1,AFFECTS,Inhibitory,6
5548,Exercise,C0015259,en_940,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,21
5549,Exercise,C0015259,en_940,TREATS(INFER),Atrial Fibrillation,C0004238,en_423,2,1,AFFECTS,Inhibitory,3
5550,Exercise,C0015259,en_940,TREATS(INFER),Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
5551,Exercise,C0015259,en_940,TREATS(INFER),Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,3
5552,Exercise,C0015259,en_940,TREATS(INFER),Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
5553,Exercise,C0015259,en_940,TREATS(INFER),Reduced mobility,C0700572,en_4726,2,2,AFFECTS,Inhibitory,6
5554,Exocrine Glands,C0015282,en_942,PRODUCES,Transferrin,C0040679,en_2269,1,1,AFFECTS,Excitatory,3
5555,Exocytosis,C0015283,en_943,AFFECTS,tissue homeostasis,C1523351,en_5911,1,1,AFFECTS,General/Uncertain,3
5556,Exonuclease,C0015296,en_944,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
5557,Expectorants,C0015314,en_946,TREATS,Induration,C0332534,en_3752,1,1,AFFECTS,Inhibitory,3
5558,Extracellular Matrix,C0015350,en_947,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
5559,Extracorporeal Membrane Oxygenation,C0015357,en_948,AFFECTS,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,3
5560,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,"Acidosis, Respiratory",C0001127,en_224,1,1,AFFECTS,Inhibitory,6
5561,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Inhibitory,6
5562,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,3
5563,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Patients,C0030705,en_1762,20,13,AFFECTS,Inhibitory,39
5564,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
5565,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,7,4,AFFECTS,Inhibitory,15
5566,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,"Shock, Cardiogenic",C0036980,en_2098,1,1,AFFECTS,Inhibitory,3
5567,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
5568,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Thromboembolism,C0040038,en_2230,2,1,AFFECTS,Inhibitory,6
5569,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Arterial thrombosis,C0151942,en_2873,3,2,AFFECTS,Inhibitory,16
5570,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Inhibitory,3
5571,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Refractory shock,C0349412,en_3842,1,1,AFFECTS,Inhibitory,3
5572,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Hypoxemia,C0700292,en_4719,3,3,AFFECTS,Inhibitory,15
5573,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Clinicians,C0871685,en_5028,1,1,AFFECTS,Inhibitory,6
5574,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,6,3,AFFECTS,Inhibitory,15
5575,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
5576,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,Author,C3812881,en_6243,1,1,AFFECTS,Inhibitory,6
5577,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS,COVID-19,C5203670,en_6417,8,6,AFFECTS,Inhibitory,36
5578,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
5579,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,5,3,AFFECTS,Inhibitory,9
5580,Extracorporeal Membrane Oxygenation,C0015357,en_948,TREATS(INFER),Respiratory Failure,C1145670,en_5292,2,2,AFFECTS,Inhibitory,6
5581,Extravasation,C0015376,en_949,AFFECTS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,6
5582,Eye,C0015392,en_951,PRODUCES,Vaccines,C0042210,en_2329,2,1,AFFECTS,Excitatory,3
5583,Factor Xa,C0015520,en_958,STIMULATES,"Receptor, PAR-1",C0668084,en_4533,1,1,AFFECTS,Excitatory,3
5584,Factor XIIIa,C0015533,en_959,AFFECTS(SPEC),Blood Vessels,C0005847,en_494,1,1,AFFECTS,General/Uncertain,3
5585,Family,C0015576,en_961,PRODUCES,Study models,C0026336,en_1575,2,2,AFFECTS,Excitatory,6
5586,Famotidine,C0015620,en_962,INHIBITS,Chymase,C0055673,en_2459,2,1,AFFECTS,Inhibitory,3
5587,Famotidine,C0015620,en_962,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
5588,Famotidine,C0015620,en_962,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
5589,Famotidine,C0015620,en_962,TREATS,Patients,C0030705,en_1762,6,3,AFFECTS,Inhibitory,9
5590,Famotidine,C0015620,en_962,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,11
5591,Famotidine,C0015620,en_962,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
5592,Famotidine,C0015620,en_962,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
5593,Famotidine,C0015620,en_962,TREATS,Treatment Group,C5205742,en_6422,1,1,AFFECTS,Inhibitory,8
5594,"Fat Emulsions, Intravenous",C0015667,en_964,AFFECTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
5595,Fatty-acid synthase,C0015683,en_968,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
5596,Fatty-acid synthase,C0015683,en_968,PRODUCES,small molecule,C1328819,en_5573,1,1,AFFECTS,Excitatory,3
5597,Fatty Acids,C0015684,en_969,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
5598,"Fatty Acids, Nonesterified",C0015688,en_970,STIMULATES,Lysophosphatidylcholines,C0024360,en_1477,1,1,AFFECTS,Excitatory,3
5599,"Fatty Acids, Nonesterified",C0015688,en_970,STIMULATES,"TLR4 protein, human",C1321919,en_5543,1,1,AFFECTS,Excitatory,3
5600,"Fatty Acids, Omega-3",C0015689,en_971,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
5601,"Fatty Acids, Omega-3",C0015689,en_971,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
5602,"Fatty Acids, Omega-3",C0015689,en_971,DISRUPTS,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Inhibitory,3
5603,"Fatty Acids, Omega-3",C0015689,en_971,DISRUPTS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
5604,"Fatty Acids, Omega-3",C0015689,en_971,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5605,Feeding behaviors,C0015745,en_975,AFFECTS,Behavior,C0004927,en_450,1,1,AFFECTS,General/Uncertain,3
5606,Feeding behaviors,C0015745,en_975,AFFECTS,student,C0038492,en_2171,1,1,AFFECTS,General/Uncertain,6
5607,Fellowships,C0015770,en_976,AFFECTS,No incoordination,C0427184,en_4009,1,1,AFFECTS,General/Uncertain,3
5608,Fellowships,C0015770,en_976,AFFECTS,stressor,C0597530,en_4430,1,1,AFFECTS,General/Uncertain,3
5609,Fentanyl,C0015846,en_978,DISRUPTS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,3
5610,Ferritin,C0015879,en_980,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
5611,Ferritin,C0015879,en_980,STIMULATES,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Excitatory,6
5612,Ferritin,C0015879,en_980,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,7
5613,Ferritin,C0015879,en_980,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
5614,Ferritin,C0015879,en_980,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,6
5615,Ferritin,C0015879,en_980,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
5616,Ferritin,C0015879,en_980,AUGMENTS,Plethora,C0232370,en_3277,2,1,AFFECTS,Excitatory,3
5617,Ferritin,C0015879,en_980,STIMULATES,Creatine Kinase,C0010287,en_728,2,2,AFFECTS,Excitatory,6
5618,Ferritin,C0015879,en_980,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5619,Fetal Growth Retardation,C0015934,en_984,PREDISPOSES,Spontaneous abortion,C0000786,en_206,1,1,AFFECTS,Excitatory,3
5620,Fever,C0015967,en_985,PREDISPOSES,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Excitatory,12
5621,Fever,C0015967,en_985,PREDISPOSES,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Excitatory,6
5622,Interferon-beta,C0015980,en_986,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
5623,Interferon-beta,C0015980,en_986,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
5624,Interferon-beta,C0015980,en_986,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
5625,Fibrin,C0015982,en_987,DISRUPTS,Respiratory Insufficiency,C0035229,en_2012,1,1,AFFECTS,Inhibitory,3
5626,Fibrin,C0015982,en_987,PREDISPOSES,Thrombosis,C0040053,en_2233,2,1,AFFECTS,Excitatory,3
5627,Fibrin,C0015982,en_987,PREDISPOSES,Right ventricular failure,C2939447,en_6155,2,1,AFFECTS,Excitatory,3
5628,Fibrin,C0015982,en_987,PREDISPOSES,Abnormal breathing,C1260922,en_5414,2,1,AFFECTS,Excitatory,3
5629,Fibrin,C0015982,en_987,PRODUCES,FRAGMENTS,C0486805,en_4153,1,1,AFFECTS,Excitatory,3
5630,Fibrin,C0015982,en_987,STIMULATES,Plasminogen,C0032140,en_1822,1,1,AFFECTS,Excitatory,3
5631,Fibrinogen,C0016006,en_988,AFFECTS,Thrombus,C0087086,en_2743,1,1,AFFECTS,General/Uncertain,7
5632,Fibrinogen,C0016006,en_988,TREATS,Cytopenia,C0010828,en_754,1,1,AFFECTS,Inhibitory,7
5633,Fibrinogen,C0016006,en_988,INHIBITS,Albumins,C0001924,en_267,2,1,AFFECTS,Inhibitory,3
5634,Fibrinogen,C0016006,en_988,STIMULATES,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,Excitatory,3
5635,Plasmin,C0016016,en_989,INHIBITS,Fibrinogen,C0016006,en_988,1,1,AFFECTS,Inhibitory,3
5636,Plasmin,C0016016,en_989,INHIBITS,fibrinmonomer,C0060327,en_2485,1,1,AFFECTS,Inhibitory,3
5637,Fibrinolytic Agents,C0016018,en_991,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5638,Fibrinolytic Agents,C0016018,en_991,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
5639,Fibroblasts,C0016030,en_992,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
5640,Fibrosis,C0016059,en_994,AFFECTS,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,3
5641,Fibrosis,C0016059,en_994,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5642,Fibrosis,C0016059,en_994,AFFECTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
5643,Fibrosis,C0016059,en_994,AFFECTS,Caregiver,C0085537,en_2674,1,1,AFFECTS,General/Uncertain,3
5644,Fibrosis,C0016059,en_994,AFFECTS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
5645,Fibrosis,C0016059,en_994,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
5646,First Aid,C0016143,en_996,PREVENTS,psychological distress,C0815107,en_4922,1,1,AFFECTS,Inhibitory,3
5647,First Aid,C0016143,en_996,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
5648,First Aid,C0016143,en_996,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
5649,First Aid,C0016143,en_996,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5650,Fish Oils,C0016157,en_997,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5651,Fish Oils,C0016157,en_997,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
5652,Flagellin,C0016194,en_999,AUGMENTS,Sensitization,C1325847,en_5551,1,1,AFFECTS,Excitatory,3
5653,Floods,C0016248,en_1001,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
5654,Fluconazole,C0016277,en_1002,INHIBITS,Cytochrome P450,C0010762,en_747,1,1,AFFECTS,Inhibitory,3
5655,Flucytosine,C0016278,en_1003,TREATS,Invasive mycosis,C1262313,en_5421,1,1,AFFECTS,Inhibitory,3
5656,Fluorides,C0016327,en_1006,STIMULATES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,8
5657,Fluoxetine,C0016365,en_1007,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
5658,Fluoxetine,C0016365,en_1007,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
5659,Fluoxetine,C0016365,en_1007,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5660,Fluoxetine,C0016365,en_1007,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Inhibitory,3
5661,Flutamide,C0016384,en_1009,INHIBITS,Stanolone,C0038148,en_2152,1,1,AFFECTS,Inhibitory,3
5662,Food,C0016452,en_1011,AFFECTS,Immunity,C0020964,en_1273,3,2,AFFECTS,General/Uncertain,6
5663,Food,C0016452,en_1011,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
5664,Food,C0016452,en_1011,AFFECTS,Drug Kinetics,C0031327,en_1787,1,1,AFFECTS,General/Uncertain,3
5665,Food,C0016452,en_1011,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
5666,Food,C0016452,en_1011,PREDISPOSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
5667,Food Additives,C0016453,en_1012,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
5668,Influenza in Birds,C0016627,en_1015,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
5669,Influenza in Birds,C0016627,en_1015,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
5670,"Fractures, Open",C0016662,en_1017,DISRUPTS,viral transmission,C1160716,en_5362,2,1,AFFECTS,Inhibitory,3
5671,Fruit,C0016767,en_1020,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
5672,Fruit,C0016767,en_1020,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
5673,Fumarate Hydratase,C0016799,en_1021,STIMULATES,Fumarates,C0016801,en_1022,1,1,AFFECTS,Excitatory,3
5674,Fumarates,C0016801,en_1022,INHIBITS,Procollagen-Proline Dioxygenase,C0033384,en_1897,1,1,AFFECTS,Inhibitory,3
5675,Fumarates,C0016801,en_1022,PREDISPOSES,"Neoplastic Syndromes, Hereditary",C0027672,en_1652,1,1,AFFECTS,Excitatory,3
5676,Furosemide,C0016860,en_1024,TREATS,Hypokalemia,C0020621,en_1247,2,1,AFFECTS,Inhibitory,6
5677,Furosemide,C0016860,en_1024,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5678,Furosemide,C0016860,en_1024,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
5679,Furosemide,C0016860,en_1024,TREATS,Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,1,1,AFFECTS,Inhibitory,6
5680,Furosemide,C0016860,en_1024,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
5681,Gadolinium,C0016911,en_1027,AFFECTS,myocardium; injury,C0746730,en_4817,2,1,AFFECTS,General/Uncertain,3
5682,Gadolinium,C0016911,en_1027,TREATS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
5683,Galactosidase,C0016955,en_1029,STIMULATES,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,3
5684,Gamete Intrafallopian Transfer,C0016999,en_1031,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
5685,Gamma globulin,C0017007,en_1032,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
5686,Gases,C0017110,en_1034,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
5687,Gases,C0017110,en_1034,PREVENTS,Dysbarism,C0004760,en_446,1,1,AFFECTS,Inhibitory,3
5688,Gases,C0017110,en_1034,TREATS,Onychomycosis,C0040261,en_2240,1,1,AFFECTS,Inhibitory,3
5689,Gastrectomy,C0017118,en_1035,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
5690,Gastrectomy,C0017118,en_1035,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
5691,Gastrectomy,C0017118,en_1035,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,3,1,AFFECTS,Inhibitory,3
5692,Gastroesophageal reflux disease,C0017168,en_1038,AFFECTS,Permeability,C0031164,en_1779,1,1,AFFECTS,General/Uncertain,3
5693,Gastrointestinal tract structure,C0017189,en_1041,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
5694,Gene Expression Regulation,C0017263,en_1045,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
5695,Gene Rearrangement,C0017287,en_1047,AFFECTS,member,C0680022,en_4618,2,2,AFFECTS,General/Uncertain,6
5696,gene therapy,C0017296,en_1048,TREATS,Hereditary Diseases,C0019247,en_1180,1,1,AFFECTS,Inhibitory,3
5697,gene therapy,C0017296,en_1048,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
5698,gene therapy,C0017296,en_1048,TREATS,Diamond-Blackfan anemia,C1260899,en_5413,1,1,AFFECTS,Inhibitory,3
5699,gene therapy,C0017296,en_1048,TREATS(SPEC),Erectile dysfunction,C0242350,en_3407,1,1,AFFECTS,Inhibitory,3
5700,patient care,C0017313,en_1050,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
5701,patient care,C0017313,en_1050,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
5702,patient care,C0017313,en_1050,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
5703,patient care,C0017313,en_1050,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
5704,patient care,C0017313,en_1050,TREATS,Outpatients,C0029921,en_1729,2,2,AFFECTS,Inhibitory,12
5705,patient care,C0017313,en_1050,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5706,patient care,C0017313,en_1050,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,3
5707,patient care,C0017313,en_1050,TREATS,CANADIAN,C0238884,en_3371,1,1,AFFECTS,Inhibitory,3
5708,patient care,C0017313,en_1050,TREATS,Cancer Patient,C1516213,en_5852,2,1,AFFECTS,Inhibitory,3
5709,patient care,C0017313,en_1050,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
5710,General Practitioners,C0017319,en_1051,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
5711,General Practitioners,C0017319,en_1051,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
5712,Genes,C0017337,en_1052,AFFECTS,Cell Cycle,C0007586,en_586,1,1,AFFECTS,General/Uncertain,6
5713,Genes,C0017337,en_1052,AFFECTS,Metabolism,C0025519,en_1547,2,2,AFFECTS,General/Uncertain,9
5714,Genes,C0017337,en_1052,STIMULATES,Curcumin,C0010467,en_737,1,1,AFFECTS,Excitatory,8
5715,Genes,C0017337,en_1052,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
5716,Genes,C0017337,en_1052,AFFECTS,DNA Repair,C0012899,en_836,1,1,AFFECTS,General/Uncertain,3
5717,Genes,C0017337,en_1052,AFFECTS,Drug resistance,C0013203,en_854,1,1,AFFECTS,General/Uncertain,3
5718,Genes,C0017337,en_1052,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
5719,Genes,C0017337,en_1052,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
5720,Genes,C0017337,en_1052,AFFECTS,Starvation,C0038187,en_2155,1,1,AFFECTS,General/Uncertain,3
5721,Genes,C0017337,en_1052,AFFECTS,Stress,C0038435,en_2165,2,1,AFFECTS,General/Uncertain,3
5722,Genes,C0017337,en_1052,AFFECTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,General/Uncertain,3
5723,Genes,C0017337,en_1052,AFFECTS,Ion Transport,C0162585,en_2916,1,1,AFFECTS,General/Uncertain,3
5724,Genes,C0017337,en_1052,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
5725,Genes,C0017337,en_1052,AFFECTS,Congenital diaphragmatic hernia,C0235833,en_3331,1,1,AFFECTS,General/Uncertain,3
5726,Genes,C0017337,en_1052,AFFECTS,Microgravity,C0242535,en_3418,2,1,AFFECTS,General/Uncertain,3
5727,Genes,C0017337,en_1052,AFFECTS,"Biological function, NOS",C0277784,en_3587,1,1,AFFECTS,General/Uncertain,3
5728,Genes,C0017337,en_1052,AFFECTS,Immune response,C0301872,en_3696,7,5,AFFECTS,General/Uncertain,15
5729,Genes,C0017337,en_1052,AFFECTS,Cell-Matrix Junction,C0887869,en_5088,1,1,AFFECTS,General/Uncertain,3
5730,Genes,C0017337,en_1052,AFFECTS,host-pathogen interaction,C1154482,en_5309,1,1,AFFECTS,General/Uncertain,3
5731,Genes,C0017337,en_1052,COMPLICATES,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
5732,Genes,C0017337,en_1052,COMPLICATES,"Steatohepatitis, non-alcoholic",C0878674,en_5075,1,1,AFFECTS,General/Uncertain,3
5733,Genes,C0017337,en_1052,DISRUPTS,Labor (Childbirth),C0022864,en_1390,1,1,AFFECTS,Inhibitory,3
5734,Genes,C0017337,en_1052,DISRUPTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Inhibitory,3
5735,Genes,C0017337,en_1052,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
5736,Genes,C0017337,en_1052,PREDISPOSES,Mood Disorders,C0525045,en_4229,1,1,AFFECTS,Excitatory,3
5737,Genes,C0017337,en_1052,PREDISPOSES,Tauopathies,C0949664,en_5182,1,1,AFFECTS,Excitatory,3
5738,Genes,C0017337,en_1052,PRODUCES,KRT16,C1416724,en_56,1,1,AFFECTS,Excitatory,3
5739,"Genes, Viral",C0017376,en_1054,DISRUPTS,Immune response,C0301872,en_3696,2,2,AFFECTS,Inhibitory,6
5740,"Genes, Viral",C0017376,en_1054,PRODUCES,Viral Proteins,C0042736,en_2357,4,2,AFFECTS,Excitatory,6
5741,Genetic Counseling,C0017382,en_1055,AFFECTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
5742,genetic aspects,C0017399,en_1057,AFFECTS,Infant,C0021270,en_1297,1,1,AFFECTS,General/Uncertain,3
5743,genetic aspects,C0017399,en_1057,AFFECTS,Mothers,C0026591,en_1583,1,1,AFFECTS,General/Uncertain,3
5744,genetic aspects,C0017399,en_1057,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
5745,genetic aspects,C0017399,en_1057,PRODUCES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
5746,Genome,C0017428,en_1059,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
5747,Genome,C0017428,en_1059,PRODUCES,KRT16,C1416724,en_56,1,1,AFFECTS,Excitatory,3
5748,Genome,C0017428,en_1059,PRODUCES,FURIN gene,C0919550,en_5116,1,1,AFFECTS,Excitatory,3
5749,Glial Fibrillary Acidic Protein,C0017626,en_1061,PREDISPOSES,Chemically-Induced Menopause,C4727713,en_6389,1,1,AFFECTS,Excitatory,6
5750,Glial Fibrillary Acidic Protein,C0017626,en_1061,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
5751,Globin,C0017645,en_1064,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
5752,Globin,C0017645,en_1064,STIMULATES,Oxygen,C0030054,en_1736,1,1,AFFECTS,Excitatory,3
5753,IGA Glomerulonephritis,C0017661,en_1066,AFFECTS(SPEC),Decreased renal function,C0232807,en_3287,1,1,AFFECTS,General/Uncertain,3
5754,Glucans,C0017696,en_1067,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
5755,Glucans,C0017696,en_1067,DISRUPTS,Phagocytosis,C0031308,en_1785,1,1,AFFECTS,Inhibitory,3
5756,Glucans,C0017696,en_1067,DISRUPTS,cytokine secretion,C1327414,en_5565,1,1,AFFECTS,Inhibitory,3
5757,Glucans,C0017696,en_1067,STIMULATES,dectin 1,C0916194,en_5102,1,1,AFFECTS,Excitatory,3
5758,Glucans,C0017696,en_1067,STIMULATES,toll-like receptor 4,C1411976,en_5695,1,1,AFFECTS,Excitatory,3
5759,Glucocorticoids,C0017710,en_1068,AFFECTS,Lung Injury,C0273115,en_3561,1,1,AFFECTS,General/Uncertain,8
5760,Glucocorticoids,C0017710,en_1068,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,6
5761,Glucocorticoids,C0017710,en_1068,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,15
5762,Glucocorticoids,C0017710,en_1068,TREATS,Pneumonia,C0032285,en_1833,5,3,AFFECTS,Inhibitory,12
5763,Glucocorticoids,C0017710,en_1068,TREATS,Epidemic disease,C0277548,en_3584,1,1,AFFECTS,Inhibitory,7
5764,Glucocorticoids,C0017710,en_1068,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,12
5765,Glucocorticoids,C0017710,en_1068,TREATS,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,8
5766,Glucocorticoids,C0017710,en_1068,TREATS,COVID-19,C5203670,en_6417,7,4,AFFECTS,Inhibitory,25.5
5767,Glucocorticoids,C0017710,en_1068,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,2,2,AFFECTS,Inhibitory,14
5768,Glucocorticoids,C0017710,en_1068,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
5769,Glucocorticoids,C0017710,en_1068,AFFECTS,Injury,C0175677,en_2968,2,1,AFFECTS,General/Uncertain,3
5770,Glucocorticoids,C0017710,en_1068,AFFECTS,Tumorigenesis,C1326912,en_5561,1,1,AFFECTS,General/Uncertain,3
5771,Glucocorticoids,C0017710,en_1068,AFFECTS,Tumor Immunity,C1519680,en_5889,1,1,AFFECTS,General/Uncertain,3
5772,Glucocorticoids,C0017710,en_1068,AUGMENTS,Antiinflammatory Effect,C1516019,en_5851,2,1,AFFECTS,Excitatory,3
5773,Glucocorticoids,C0017710,en_1068,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
5774,Glucocorticoids,C0017710,en_1068,TREATS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,3
5775,Glucocorticoids,C0017710,en_1068,TREATS,Lung diseases,C0024115,en_1462,8,2,AFFECTS,Inhibitory,6
5776,Glucocorticoids,C0017710,en_1068,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
5777,Glucocorticoids,C0017710,en_1068,TREATS,Whales,C0043136,en_2392,1,1,AFFECTS,Inhibitory,3
5778,Glucocorticoids,C0017710,en_1068,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
5779,Synthetic glucocorticoid,C0017711,en_1069,TREATS,Inflammatory Bowel Diseases,C0021390,en_1310,2,1,AFFECTS,Inhibitory,3
5780,Glucokinase,C0017713,en_1070,INHIBITS,Blood Glucose,C0005802,en_490,1,1,AFFECTS,Inhibitory,3
5781,Glucose,C0017725,en_1072,AFFECTS,"Ventricular Function, Left",C0080310,en_2627,2,1,AFFECTS,General/Uncertain,3
5782,Glucose,C0017725,en_1072,AUGMENTS,insulin secretion,C1256369,en_5399,1,1,AFFECTS,Excitatory,3
5783,Glucose,C0017725,en_1072,INHIBITS,Carbon Dioxide,C0007012,en_556,1,1,AFFECTS,Inhibitory,3
5784,Glucose,C0017725,en_1072,INHIBITS,Pharmaceutical Preparations,C0013227,en_856,2,2,AFFECTS,Inhibitory,6
5785,Glucose,C0017725,en_1072,INHIBITS,ATM gene,C0919524,en_5114,4,2,AFFECTS,Inhibitory,6
5786,Glucose,C0017725,en_1072,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
5787,Glucose,C0017725,en_1072,STIMULATES,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Excitatory,3
5788,Glucose,C0017725,en_1072,TREATS,Patients,C0030705,en_1762,6,5,AFFECTS,Inhibitory,15
5789,Glucose,C0017725,en_1072,TREATS(INFER),Diabetes Mellitus,C0011849,en_798,3,3,AFFECTS,Inhibitory,9
5790,Glucose,C0017725,en_1072,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Inhibitory,3
5791,Glucose,C0017725,en_1072,TREATS(INFER),Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
5792,Glutamates,C0017789,en_1074,AFFECTS,Contusions,C0009938,en_712,1,1,AFFECTS,General/Uncertain,3
5793,Glutamates,C0017789,en_1074,STIMULATES,Formalin,C0949307,en_5178,1,1,AFFECTS,Excitatory,3
5794,Glutamine,C0017797,en_1075,TREATS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Inhibitory,7
5795,Glutathione,C0017817,en_1076,AUGMENTS,Protoplasm,C0175996,en_2976,2,1,AFFECTS,Excitatory,3
5796,Nitroglycerin,C0017887,en_1079,STIMULATES,Methemoglobin,C0025635,en_1553,1,1,AFFECTS,Excitatory,3
5797,Glycine,C0017890,en_1080,DISRUPTS,Platelet aggregation,C0032176,en_1828,1,1,AFFECTS,Inhibitory,3
5798,Glycine,C0017890,en_1080,INHIBITS,"Hemoglobin, Glycosylated",C0017853,en_1078,1,1,AFFECTS,Inhibitory,3
5799,Glycine,C0017890,en_1080,INHIBITS,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Inhibitory,3
5800,Glycine,C0017890,en_1080,STIMULATES,Glycine Receptors,C0061605,en_2496,1,1,AFFECTS,Excitatory,3
5801,Glycine,C0017890,en_1080,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5802,Phosphorylases,C0017916,en_1082,STIMULATES,Biochemical Reaction,C1511131,en_5807,1,1,AFFECTS,Excitatory,3
5803,Glycolipids,C0017950,en_1083,AFFECTS,glycolipid metabolism,C1158409,en_5338,1,1,AFFECTS,General/Uncertain,3
5804,Glycoproteins,C0017968,en_1085,PREDISPOSES,Lung Injury,C0273115,en_3561,1,1,AFFECTS,Excitatory,6
5805,Glycoproteins,C0017968,en_1085,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
5806,Glycoproteins,C0017968,en_1085,AFFECTS,virion attachment,C1160649,en_5359,2,1,AFFECTS,General/Uncertain,3
5807,Glycoproteins,C0017968,en_1085,DISRUPTS,viral entry,C1160648,en_5358,2,1,AFFECTS,Inhibitory,3
5808,Glycoproteins,C0017968,en_1085,INHIBITS,cytokine,C0079189,en_2593,2,1,AFFECTS,Inhibitory,3
5809,Glycoproteins,C0017968,en_1085,INHIBITS,chemokine,C0282554,en_3651,2,1,AFFECTS,Inhibitory,3
5810,Glycoproteins,C0017968,en_1085,STIMULATES,Neutralizing antibody,C0475463,en_4145,2,1,AFFECTS,Excitatory,3
5811,glycosylation,C0017982,en_1086,AFFECTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,3
5812,glycosylation,C0017982,en_1086,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
5813,glycosylation,C0017982,en_1086,AFFECTS,Tropism,C0242732,en_3436,1,1,AFFECTS,General/Uncertain,3
5814,glycosylation,C0017982,en_1086,AFFECTS,Animal Development,C0870137,en_5000,1,1,AFFECTS,General/Uncertain,3
5815,glycosylation,C0017982,en_1086,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
5816,Glycyrrhetinic Acid,C0017986,en_1087,INHIBITS,11-beta-Hydroxysteroid Dehydrogenase Type 2,C0608861,en_4518,1,1,AFFECTS,Inhibitory,3
5817,Gold,C0018026,en_1088,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
5818,Gold,C0018026,en_1088,TREATS,Compliance,C3714738,en_6237,2,1,AFFECTS,Inhibitory,6
5819,Gonorrhea,C0018081,en_1090,AUGMENTS,Bacterial Vaginosis,C0085166,en_2648,1,1,AFFECTS,Excitatory,3
5820,Graft-vs-Host Disease,C0018133,en_1092,AUGMENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
5821,granulosa cell,C0018207,en_1096,PRODUCES,Glycoproteins,C0017968,en_1085,1,1,AFFECTS,Excitatory,3
5822,Growth,C0018270,en_1098,AFFECTS,Acclimatization,C0000934,en_212,1,1,AFFECTS,General/Uncertain,3
5823,Growth,C0018270,en_1098,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
5824,Growth,C0018270,en_1098,AFFECTS,Movement,C0026649,en_1588,2,1,AFFECTS,General/Uncertain,3
5825,Growth,C0018270,en_1098,AFFECTS,Pathologic Neovascularization,C0027686,en_1653,1,1,AFFECTS,General/Uncertain,3
5826,Growth,C0018270,en_1098,AFFECTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,3
5827,Growth,C0018270,en_1098,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,3
5828,Growth,C0018270,en_1098,AFFECTS,"Farmer, unspecified",C0221460,en_3227,1,1,AFFECTS,General/Uncertain,3
5829,Growth,C0018270,en_1098,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
5830,Growth,C0018270,en_1098,AFFECTS,Microorganism,C0445623,en_4075,1,1,AFFECTS,General/Uncertain,3
5831,Growth,C0018270,en_1098,AFFECTS,Pathogenicity,C1136169,en_5262,1,1,AFFECTS,General/Uncertain,3
5832,Growth,C0018270,en_1098,PRODUCES,Milk,C0026131,en_1570,1,1,AFFECTS,Excitatory,3
5833,Growth Factor,C0018284,en_1100,AFFECTS,iron metabolism,C0596803,en_4396,1,1,AFFECTS,General/Uncertain,6
5834,Growth Factor,C0018284,en_1100,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
5835,Growth Factor,C0018284,en_1100,AUGMENTS,type 2 immune response,C3159116,en_6176,1,1,AFFECTS,Excitatory,7
5836,Growth Factor,C0018284,en_1100,AFFECTS,Hematopoiesis,C0018951,en_1152,2,2,AFFECTS,General/Uncertain,6
5837,Growth Factor,C0018284,en_1100,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
5838,Growth Factor,C0018284,en_1100,AFFECTS,pleiotropism,C0597257,en_4418,2,1,AFFECTS,General/Uncertain,3
5839,Growth Factor,C0018284,en_1100,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
5840,Growth Factor,C0018284,en_1100,AFFECTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,General/Uncertain,3
5841,Growth Factor,C0018284,en_1100,AUGMENTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,Excitatory,3
5842,Growth Factor,C0018284,en_1100,AUGMENTS,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,Excitatory,3
5843,Guanosine Diphosphate,C0018340,en_1102,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
5844,Guanosine Triphosphate,C0018353,en_1103,INHIBITS,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Inhibitory,3
5845,Gum Arabic,C0018389,en_1105,DISRUPTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
5846,Habits,C0018464,en_1106,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
5847,Habits,C0018464,en_1106,PREDISPOSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
5848,Haloperidol,C0018546,en_1109,INHIBITS,sigma-1 receptor,C0539266,en_4247,1,1,AFFECTS,Inhibitory,7
5849,Haloperidol,C0018546,en_1109,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,7
5850,Haloperidol,C0018546,en_1109,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
5851,Hamartoma,C0018552,en_1110,AFFECTS,Hair follicle structure,C0221971,en_3232,1,1,AFFECTS,General/Uncertain,3
5852,Handwashing,C0018581,en_1112,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
5853,Handwashing,C0018581,en_1112,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
5854,Hazardous Chemicals,C0018624,en_1113,PREDISPOSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
5855,Hazardous Substances,C0018626,en_1114,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
5856,Headache,C0018681,en_1115,AFFECTS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
5857,Health behavior,C0018687,en_1116,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
5858,Health behavior,C0018687,en_1116,AFFECTS,Childbirth,C1148523,en_5296,1,1,AFFECTS,General/Uncertain,3
5859,Health education,C0018701,en_1118,PREVENTS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
5860,Health education,C0018701,en_1118,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
5861,Health education,C0018701,en_1118,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
5862,Health education,C0018701,en_1118,TREATS,student,C0038492,en_2171,1,1,AFFECTS,Inhibitory,3
5863,Health education,C0018701,en_1118,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
5864,Health education,C0018701,en_1118,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
5865,Health care facility,C0018704,en_1119,PRODUCES,Research Infrastructure,C1514880,en_5840,1,1,AFFECTS,Excitatory,3
5866,Medicare,C0018717,en_1120,AFFECTS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,General/Uncertain,3
5867,Health Personnel,C0018724,en_1121,TREATS,Patients,C0030705,en_1762,27,22,AFFECTS,Inhibitory,66
5868,Health Personnel,C0018724,en_1121,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
5869,Health Planning,C0018727,en_1122,TREATS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,3
5870,Health Policy,C0018735,en_1123,AFFECTS,Child,C0008059,en_620,2,1,AFFECTS,General/Uncertain,3
5871,Health Policy,C0018735,en_1123,AFFECTS,Health Care Systems,C0018696,en_1117,1,1,AFFECTS,General/Uncertain,3
5872,Health Policy,C0018735,en_1123,AFFECTS,Societies,C0037455,en_2128,1,1,AFFECTS,General/Uncertain,3
5873,Health Policy,C0018735,en_1123,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
5874,Health Policy,C0018735,en_1123,AFFECTS,health organization,C0920545,en_5128,1,1,AFFECTS,General/Uncertain,3
5875,Health Promotion,C0018738,en_1124,TREATS,Disease,C0012634,en_826,4,1,AFFECTS,Inhibitory,3
5876,Health Promotion,C0018738,en_1124,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
5877,Health Promotion,C0018738,en_1124,TREATS,Fit and well,C0424576,en_3995,1,1,AFFECTS,Inhibitory,3
5878,Health Services,C0018747,en_1125,AFFECTS,Well in self,C0424578,en_3996,2,1,AFFECTS,General/Uncertain,3
5879,Health Services,C0018747,en_1125,PREVENTS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,8
5880,Health Services,C0018747,en_1125,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
5881,Health Services,C0018747,en_1125,TREATS,Child,C0008059,en_620,2,2,AFFECTS,Inhibitory,6
5882,Health Services,C0018747,en_1125,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
5883,Health Services,C0018747,en_1125,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
5884,Health Services,C0018747,en_1125,TREATS,Family,C0015576,en_961,2,2,AFFECTS,Inhibitory,6
5885,Health Services,C0018747,en_1125,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
5886,Health Services,C0018747,en_1125,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
5887,Health Services,C0018747,en_1125,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
5888,Health Services,C0018747,en_1125,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
5889,Health Services,C0018747,en_1125,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
5890,Health Services,C0018747,en_1125,TREATS,Viral hepatitis,C0042721,en_2356,1,1,AFFECTS,Inhibitory,3
5891,Health Services,C0018747,en_1125,TREATS,"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,1,1,AFFECTS,Inhibitory,7
5892,Health Services,C0018747,en_1125,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
5893,Health Services,C0018747,en_1125,TREATS,Individual,C0237401,en_3343,3,3,AFFECTS,Inhibitory,9
5894,Health Services,C0018747,en_1125,TREATS,Symptom mild,C0436343,en_4028,1,1,AFFECTS,Inhibitory,6
5895,Health Services,C0018747,en_1125,TREATS,Does run,C0600140,en_4498,1,1,AFFECTS,Inhibitory,3
5896,Health Services,C0018747,en_1125,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,3
5897,Health Services,C0018747,en_1125,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
5898,Health Services,C0018747,en_1125,TREATS(INFER),Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
5899,Hearing,C0018767,en_1127,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
5900,Hearing,C0018767,en_1127,AFFECTS,ion homeostasis,C1326962,en_5563,1,1,AFFECTS,General/Uncertain,3
5901,Hearing Aids,C0018768,en_1128,TREATS,hearing impairment,C1384666,en_5689,1,1,AFFECTS,Inhibitory,3
5902,Sensorineural Hearing Loss,C0018784,en_1129,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5903,Heart Arrest,C0018790,en_1131,AFFECTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
5904,Heart Diseases,C0018799,en_1134,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5905,Heart failure,C0018801,en_1135,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
5906,Heart failure,C0018801,en_1135,AFFECTS,"Ventricular Dysfunction, Left",C0242698,en_3433,1,1,AFFECTS,General/Uncertain,3
5907,Heart failure,C0018801,en_1135,PREDISPOSES,Ejection fraction,C0489482,en_4155,1,1,AFFECTS,Excitatory,3
5908,Heart failure,C0018801,en_1135,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,6
5909,Heart failure,C0018801,en_1135,PREDISPOSES,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Excitatory,3
5910,Congestive heart failure,C0018802,en_1136,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
5911,"Heart Septal Defects, Atrial",C0018817,en_1139,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
5912,Cardiac Surgery procedures,C0018821,en_1140,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
5913,Cardiac Surgery procedures,C0018821,en_1140,TREATS,Asymptomatic,C0231221,en_3252,3,1,AFFECTS,Inhibitory,6
5914,Cardiac Surgery procedures,C0018821,en_1140,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,Inhibitory,6
5915,Cardiac Surgery procedures,C0018821,en_1140,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
5916,Heart Transplantation,C0018823,en_1141,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
5917,Heat shock proteins,C0018850,en_1145,AFFECTS,Hypertrophy,C0020564,en_1243,1,1,AFFECTS,General/Uncertain,3
5918,Heat shock proteins,C0018850,en_1145,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
5919,Helminthiasis,C0018889,en_1146,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
5920,Helper-Inducer T-Lymphocyte,C0018894,en_1147,PRODUCES,Interleukin-13,C0214743,en_3188,1,1,AFFECTS,Excitatory,3
5921,Helper-Inducer T-Lymphocyte,C0018894,en_1147,PRODUCES,CD4 gene,C1332714,en_5583,1,1,AFFECTS,Excitatory,3
5922,Helper-Inducer T-Lymphocyte,C0018894,en_1147,PRODUCES,CD8B1 gene,C1367471,en_5671,1,1,AFFECTS,Excitatory,3
5923,Hematoma,C0018944,en_1151,COMPLICATES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
5924,Hematopoietic stem cells,C0018956,en_1153,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
5925,Hemodialysis,C0019004,en_1155,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
5926,Hemodialysis,C0019004,en_1155,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,6
5927,Hemodialysis,C0019004,en_1155,TREATS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,8
5928,Hemodialysis,C0019004,en_1155,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
5929,Hemodialysis,C0019004,en_1155,TREATS,Patients,C0030705,en_1762,9,7,AFFECTS,Inhibitory,21
5930,Hemodialysis,C0019004,en_1155,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
5931,Hemodialysis,C0019004,en_1155,TREATS,End stage renal failure,C1261469,en_5418,2,2,AFFECTS,Inhibitory,6
5932,Hemodialysis,C0019004,en_1155,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
5933,Hemodialysis,C0019004,en_1155,TREATS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5934,Hemodynamics,C0019010,en_1156,AFFECTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,General/Uncertain,3
5935,Glycosylated hemoglobin A,C0019018,en_1157,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
5936,Glycosylated hemoglobin A,C0019018,en_1157,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
5937,Hemoglobin,C0019046,en_1159,AFFECTS,Oxygen content,C0391841,en_3913,1,1,AFFECTS,General/Uncertain,3
5938,Hemoglobin,C0019046,en_1159,DISRUPTS,heme metabolism,C1158226,en_5336,3,1,AFFECTS,Inhibitory,3
5939,Hemoperfusion,C0019063,en_1160,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
5940,Hemoperfusion,C0019063,en_1160,TREATS,"Shock, Endotoxic",C0036981,en_2099,1,1,AFFECTS,Inhibitory,6
5941,Hemoperfusion,C0019063,en_1160,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
5942,Hemoperfusion,C0019063,en_1160,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
5943,Hemoperfusion,C0019063,en_1160,TREATS(INFER),Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
5944,Hemorrhagic Disorders,C0019087,en_1162,AFFECTS,secondary group,C0680398,en_4623,1,1,AFFECTS,General/Uncertain,3
5945,Hemostatic function,C0019116,en_1165,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
5946,Heparin,C0019134,en_1166,AUGMENTS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Excitatory,7
5947,Heparin,C0019134,en_1166,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
5948,Heparin,C0019134,en_1166,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,8
5949,Heparin,C0019134,en_1166,TREATS,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Inhibitory,6
5950,Heparin,C0019134,en_1166,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,8
5951,Heparin,C0019134,en_1166,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,7
5952,Heparin,C0019134,en_1166,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,10
5953,Heparin,C0019134,en_1166,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,7
5954,Heparin,C0019134,en_1166,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,23
5955,Heparin,C0019134,en_1166,AFFECTS,Neurologic Symptoms,C0235031,en_3318,2,1,AFFECTS,General/Uncertain,3
5956,Heparin,C0019134,en_1166,AFFECTS,Immunoregulation,C0678889,en_4580,2,2,AFFECTS,General/Uncertain,6
5957,Heparin,C0019134,en_1166,DISRUPTS,Blood Platelets,C0005821,en_491,1,1,AFFECTS,Inhibitory,3
5958,Heparin,C0019134,en_1166,DISRUPTS,Lung,C0024109,en_1460,3,1,AFFECTS,Inhibitory,3
5959,Heparin,C0019134,en_1166,DISRUPTS,Blood Clot,C0302148,en_3702,1,1,AFFECTS,Inhibitory,3
5960,Heparin,C0019134,en_1166,INHIBITS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Inhibitory,3
5961,Heparin,C0019134,en_1166,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
5962,Heparin,C0019134,en_1166,PREVENTS,Thromboembolism,C0040038,en_2230,14,1,AFFECTS,Inhibitory,3
5963,Heparin,C0019134,en_1166,PREVENTS,Virus Shedding,C0162633,en_2921,2,1,AFFECTS,Inhibitory,3
5964,Heparin,C0019134,en_1166,PREVENTS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
5965,Heparin,C0019134,en_1166,PREVENTS,Fibrin deposition,C0333565,en_3769,3,1,AFFECTS,Inhibitory,3
5966,Heparin,C0019134,en_1166,STIMULATES,Factor V,C0015498,en_957,1,1,AFFECTS,Excitatory,3
5967,Heparin,C0019134,en_1166,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
5968,Heparin,C0019134,en_1166,TREATS,Human,C0020114,en_1210,2,1,AFFECTS,Inhibitory,3
5969,Heparin,C0019134,en_1166,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
5970,Heparin,C0019134,en_1166,TREATS,Patients,C0030705,en_1762,11,7,AFFECTS,Inhibitory,21
5971,Heparin,C0019134,en_1166,TREATS,Acute Lung Injury,C0242488,en_3416,2,2,AFFECTS,Inhibitory,6
5972,Heparin,C0019134,en_1166,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
5973,Heparin,C0019134,en_1166,TREATS(INFER),Pneumonia,C0032285,en_1833,5,3,AFFECTS,Inhibitory,9
5974,Heparin,C0019134,en_1166,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
5975,"Heparin, Low-Molecular-Weight",C0019139,en_1167,INHIBITS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,7
5976,"Heparin, Low-Molecular-Weight",C0019139,en_1167,PREVENTS,Complication,C0009566,en_697,4,3,AFFECTS,Inhibitory,14
5977,"Heparin, Low-Molecular-Weight",C0019139,en_1167,PREVENTS,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,Inhibitory,6
5978,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Inhibitory,7
5979,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,6
5980,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
5981,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Hospitalized Patients,C0870668,en_5010,11,8,AFFECTS,Inhibitory,45
5982,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,7
5983,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,COVID-19,C5203670,en_6417,7,6,AFFECTS,Inhibitory,41
5984,"Heparin, Low-Molecular-Weight",C0019139,en_1167,INHIBITS,Thrombin,C0040018,en_2228,1,1,AFFECTS,Inhibitory,3
5985,"Heparin, Low-Molecular-Weight",C0019139,en_1167,INHIBITS,Factor IIa,C0060008,en_2482,1,1,AFFECTS,Inhibitory,3
5986,"Heparin, Low-Molecular-Weight",C0019139,en_1167,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
5987,"Heparin, Low-Molecular-Weight",C0019139,en_1167,PREVENTS,Thromboembolic event,C0857496,en_4977,2,1,AFFECTS,Inhibitory,3
5988,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Inhibitory,3
5989,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Patients,C0030705,en_1762,18,12,AFFECTS,Inhibitory,36
5990,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
5991,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
5992,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS,Medical Patients,C0870869,en_5013,1,1,AFFECTS,Inhibitory,3
5993,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS(INFER),Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Inhibitory,3
5994,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
5995,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
5996,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
5997,"Heparin, Low-Molecular-Weight",C0019139,en_1167,TREATS(SPEC),Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
5998,Heparitin Sulfate,C0019143,en_1168,AFFECTS,Protein Binding,C0033618,en_1907,1,1,AFFECTS,General/Uncertain,3
5999,Hepatectomy,C0019144,en_1169,TREATS,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,Inhibitory,3
6000,Hepatitis B e Antigens,C0019167,en_1173,PREDISPOSES,Hepatitis B,C0019163,en_1172,1,1,AFFECTS,Excitatory,3
6001,Hereditary Diseases,C0019247,en_1180,AFFECTS,Ethnic group,C0015031,en_934,1,1,AFFECTS,General/Uncertain,7
6002,Hesperidin,C0019392,en_1183,AFFECTS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,General/Uncertain,3
6003,Hesperidin,C0019392,en_1183,AFFECTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
6004,Hesperidin,C0019392,en_1183,AUGMENTS,Hemorrhage,C0019080,en_1161,2,1,AFFECTS,Excitatory,3
6005,Hesperidin,C0019392,en_1183,DISRUPTS,Exocytosis,C0015283,en_943,1,1,AFFECTS,Inhibitory,3
6006,Hesperidin,C0019392,en_1183,DISRUPTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,Inhibitory,3
6007,Hesperidin,C0019392,en_1183,DISRUPTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
6008,Hesperidin,C0019392,en_1183,STIMULATES,Mitogen-Activated Protein Kinases,C0752312,en_4859,1,1,AFFECTS,Excitatory,3
6009,Histamine,C0019588,en_1186,AFFECTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,General/Uncertain,6
6010,Histamine,C0019588,en_1186,AUGMENTS,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,8
6011,Histamine Antagonists,C0019590,en_1187,TREATS,Household composition,C0595998,en_4374,1,1,AFFECTS,Inhibitory,6
6012,Histamine Antagonists,C0019590,en_1187,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
6013,Histones,C0019652,en_1189,DISRUPTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,Inhibitory,3
6014,HIV Infections,C0019693,en_1192,AFFECTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,3
6015,HIV Infections,C0019693,en_1192,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
6016,HIV Infections,C0019693,en_1192,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
6017,HIV Infections,C0019693,en_1192,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
6018,HIV Infections,C0019693,en_1192,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
6019,HIV Infections,C0019693,en_1192,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,6
6020,HIV Infections,C0019693,en_1192,PREDISPOSES,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Excitatory,3
6021,HLA Antigens,C0019721,en_1195,STIMULATES,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
6022,Home Care Services,C0019855,en_1197,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
6023,Home Childbirth,C0019857,en_1198,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
6024,Home Childbirth,C0019857,en_1198,TREATS,Does run,C0600140,en_4498,1,1,AFFECTS,Inhibitory,3
6025,Home Nursing,C0019860,en_1199,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
6026,Home Nursing,C0019860,en_1199,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
6027,Home Nursing,C0019860,en_1199,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
6028,Homeopathy,C0019867,en_1200,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6029,Homeopathy,C0019867,en_1200,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
6030,Homeostasis,C0019868,en_1201,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
6031,Homeostasis,C0019868,en_1201,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
6032,homocysteine,C0019878,en_1203,DISRUPTS,Endothelial Cells,C0225336,en_3237,1,1,AFFECTS,Inhibitory,3
6033,Hormones,C0019932,en_1204,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
6034,Hormones,C0019932,en_1204,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
6035,Hormones,C0019932,en_1204,AFFECTS,fluid transport,C1159569,en_5343,1,1,AFFECTS,General/Uncertain,3
6036,Hormones,C0019932,en_1204,DISRUPTS,Organ,C0178784,en_2991,1,1,AFFECTS,Inhibitory,3
6037,Hormones,C0019932,en_1204,INHIBITS,NLRP3,C1424250,en_157,1,1,AFFECTS,Inhibitory,3
6038,Hormones,C0019932,en_1204,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
6039,Hormones,C0019932,en_1204,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
6040,Hormones,C0019932,en_1204,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
6041,Hormones,C0019932,en_1204,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
6042,Hospital Administrators,C0019949,en_1205,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
6043,Hospitalization,C0019993,en_1206,AFFECTS,Comorbidity,C0009488,en_690,2,2,AFFECTS,General/Uncertain,12
6044,Hospitalization,C0019993,en_1206,AFFECTS,Stress,C0038435,en_2165,2,1,AFFECTS,General/Uncertain,3
6045,Hospitalization,C0019993,en_1206,AFFECTS,CORTICOSTEROID USE,C0239126,en_3374,1,1,AFFECTS,General/Uncertain,6
6046,Hospitalization,C0019993,en_1206,AFFECTS,Frailty,C0424594,en_3998,1,1,AFFECTS,General/Uncertain,3
6047,Hospitalization,C0019993,en_1206,AFFECTS,Finding of body mass index,C0578022,en_4339,1,1,AFFECTS,General/Uncertain,6
6048,Hospitalization,C0019993,en_1206,AFFECTS,Impaired health,C0684336,en_4680,1,1,AFFECTS,General/Uncertain,3
6049,Hospitalization,C0019993,en_1206,AFFECTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,General/Uncertain,3
6050,Hospitalization,C0019993,en_1206,AFFECTS,Abnormality,C1704258,en_6026,1,1,AFFECTS,General/Uncertain,6
6051,Hospitalization,C0019993,en_1206,PREVENTS,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Inhibitory,3
6052,Hospitalization,C0019993,en_1206,PREVENTS,Complication,C0009566,en_697,3,2,AFFECTS,Inhibitory,6
6053,Hospitalization,C0019993,en_1206,PREVENTS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,8
6054,Hospitalization,C0019993,en_1206,PREVENTS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
6055,Hospitalization,C0019993,en_1206,PREVENTS,Secondary infection,C0442886,en_4061,2,2,AFFECTS,Inhibitory,11
6056,Hospitalization,C0019993,en_1206,PREVENTS,Thromboembolic event,C0857496,en_4977,1,1,AFFECTS,Inhibitory,3
6057,Hospitalization,C0019993,en_1206,TREATS,Acute Disease,C0001314,en_230,1,1,AFFECTS,Inhibitory,6
6058,Hospitalization,C0019993,en_1206,TREATS,Adult,C0001675,en_252,4,4,AFFECTS,Inhibitory,15
6059,Hospitalization,C0019993,en_1206,TREATS,Elderly,C0001792,en_258,3,2,AFFECTS,Inhibitory,6
6060,Hospitalization,C0019993,en_1206,TREATS,Unstable angina,C0002965,en_323,2,1,AFFECTS,Inhibitory,3
6061,Hospitalization,C0019993,en_1206,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
6062,Hospitalization,C0019993,en_1206,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,3
6063,Hospitalization,C0019993,en_1206,TREATS,Transient Ischemic Attack,C0007787,en_604,2,2,AFFECTS,Inhibitory,9
6064,Hospitalization,C0019993,en_1206,TREATS,Child,C0008059,en_620,8,5,AFFECTS,Inhibitory,18
6065,Hospitalization,C0019993,en_1206,TREATS,Complication,C0009566,en_697,4,4,AFFECTS,Inhibitory,16
6066,Hospitalization,C0019993,en_1206,TREATS,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,6
6067,Hospitalization,C0019993,en_1206,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,6
6068,Hospitalization,C0019993,en_1206,TREATS,Disease,C0012634,en_826,10,8,AFFECTS,Inhibitory,35
6069,Hospitalization,C0019993,en_1206,TREATS,Dyspnea,C0013404,en_866,2,2,AFFECTS,Inhibitory,14
6070,Hospitalization,C0019993,en_1206,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
6071,Hospitalization,C0019993,en_1206,TREATS,Fever,C0015967,en_985,1,1,AFFECTS,Inhibitory,6
6072,Hospitalization,C0019993,en_1206,TREATS,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Inhibitory,6
6073,Hospitalization,C0019993,en_1206,TREATS,Heart failure,C0018801,en_1135,6,6,AFFECTS,Inhibitory,30
6074,Hospitalization,C0019993,en_1206,TREATS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
6075,Hospitalization,C0019993,en_1206,TREATS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
6076,Hospitalization,C0019993,en_1206,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,8
6077,Hospitalization,C0019993,en_1206,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
6078,Hospitalization,C0019993,en_1206,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,3
6079,Hospitalization,C0019993,en_1206,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
6080,Hospitalization,C0019993,en_1206,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
6081,Hospitalization,C0019993,en_1206,TREATS,Myocardial Infarction,C0027051,en_1625,3,2,AFFECTS,Inhibitory,9
6082,Hospitalization,C0019993,en_1206,TREATS,Persons,C0027361,en_1635,7,3,AFFECTS,Inhibitory,9
6083,Hospitalization,C0019993,en_1206,TREATS,Human Age Group,C0027362,en_1636,2,1,AFFECTS,Inhibitory,3
6084,Hospitalization,C0019993,en_1206,TREATS,Outpatients,C0029921,en_1729,3,2,AFFECTS,Inhibitory,6
6085,Hospitalization,C0019993,en_1206,TREATS,Patients,C0030705,en_1762,40,29,AFFECTS,Inhibitory,87
6086,Hospitalization,C0019993,en_1206,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
6087,Hospitalization,C0019993,en_1206,TREATS,Pneumonia,C0032285,en_1833,8,4,AFFECTS,Inhibitory,20
6088,Hospitalization,C0019993,en_1206,TREATS,Pulmonary Embolism,C0034065,en_1930,2,1,AFFECTS,Inhibitory,6
6089,Hospitalization,C0019993,en_1206,TREATS,Respiration Disorders,C0035204,en_2005,5,4,AFFECTS,Inhibitory,19
6090,Hospitalization,C0019993,en_1206,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
6091,Hospitalization,C0019993,en_1206,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,8
6092,Hospitalization,C0019993,en_1206,TREATS,Rheumatism,C0035435,en_2028,1,1,AFFECTS,Inhibitory,6
6093,Hospitalization,C0019993,en_1206,TREATS,Septicemia,C0036690,en_2086,2,2,AFFECTS,Inhibitory,9
6094,Hospitalization,C0019993,en_1206,TREATS,Cerebrovascular accident,C0038454,en_2169,4,3,AFFECTS,Inhibitory,18
6095,Hospitalization,C0019993,en_1206,TREATS,Syncope,C0039070,en_2196,1,1,AFFECTS,Inhibitory,6
6096,Hospitalization,C0019993,en_1206,TREATS,Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
6097,Hospitalization,C0019993,en_1206,TREATS,Veterans,C0042610,en_2351,2,2,AFFECTS,Inhibitory,13
6098,Hospitalization,C0019993,en_1206,TREATS,Acute myocardial infarction,C0155626,en_2888,3,2,AFFECTS,Inhibitory,12
6099,Hospitalization,C0019993,en_1206,TREATS,Cardiac complication,C0161816,en_2898,1,1,AFFECTS,Inhibitory,6
6100,Hospitalization,C0019993,en_1206,TREATS,Adolescent,C0205653,en_3132,2,2,AFFECTS,Inhibitory,6
6101,Hospitalization,C0019993,en_1206,TREATS,"Lung Diseases, Interstitial",C0206062,en_3142,1,1,AFFECTS,Inhibitory,6
6102,Hospitalization,C0019993,en_1206,TREATS,Survivors,C0206194,en_3154,2,2,AFFECTS,Inhibitory,9
6103,Hospitalization,C0019993,en_1206,TREATS,Individual,C0237401,en_3343,3,2,AFFECTS,Inhibitory,6
6104,Hospitalization,C0019993,en_1206,TREATS,Disease Progression,C0242656,en_3429,2,2,AFFECTS,Inhibitory,6
6105,Hospitalization,C0019993,en_1206,TREATS,Sick child,C0260101,en_3509,1,1,AFFECTS,Inhibitory,3
6106,Hospitalization,C0019993,en_1206,TREATS,Acute respiratory disease,C0264219,en_3527,1,1,AFFECTS,Inhibitory,3
6107,Hospitalization,C0019993,en_1206,TREATS,Mixed infectious disease,C0275524,en_3566,1,1,AFFECTS,Inhibitory,6
6108,Hospitalization,C0019993,en_1206,TREATS,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Inhibitory,6
6109,Hospitalization,C0019993,en_1206,TREATS,Dissection of aorta,C0340643,en_3819,2,1,AFFECTS,Inhibitory,6
6110,Hospitalization,C0019993,en_1206,TREATS,Family illness,C0344339,en_3837,1,1,AFFECTS,Inhibitory,6
6111,Hospitalization,C0019993,en_1206,TREATS,Asthma attack NOS,C0347950,en_3839,1,1,AFFECTS,Inhibitory,3
6112,Hospitalization,C0019993,en_1206,TREATS,"Obstruction, adynamic ileus",C0544759,en_4266,1,1,AFFECTS,Inhibitory,6
6113,Hospitalization,C0019993,en_1206,TREATS,Brain hemorrhage,C0553692,en_4289,1,1,AFFECTS,Inhibitory,3
6114,Hospitalization,C0019993,en_1206,TREATS,cohort,C0599755,en_4470,2,2,AFFECTS,Inhibitory,12
6115,Hospitalization,C0019993,en_1206,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
6116,Hospitalization,C0019993,en_1206,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,6
6117,Hospitalization,C0019993,en_1206,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,6
6118,Hospitalization,C0019993,en_1206,TREATS,high-risk group,C0684030,en_4676,2,1,AFFECTS,Inhibitory,3
6119,Hospitalization,C0019993,en_1206,TREATS,Does transfer,C0728827,en_4757,1,1,AFFECTS,Inhibitory,6
6120,Hospitalization,C0019993,en_1206,TREATS,Acute Pneumonia,C0740766,en_4782,1,1,AFFECTS,Inhibitory,3
6121,Hospitalization,C0019993,en_1206,TREATS,Acute chest syndrome,C0742343,en_4795,1,1,AFFECTS,Inhibitory,6
6122,Hospitalization,C0019993,en_1206,TREATS,Diabetic ulcer,C0743150,en_4799,1,1,AFFECTS,Inhibitory,3
6123,Hospitalization,C0019993,en_1206,TREATS,OBSTRUCTIVE DISEASE,C0746982,en_4822,1,1,AFFECTS,Inhibitory,6
6124,Hospitalization,C0019993,en_1206,TREATS,"Stroke, Acute",C0751956,en_4854,1,1,AFFECTS,Inhibitory,6
6125,Hospitalization,C0019993,en_1206,TREATS,Maximum,C0806909,en_4887,2,1,AFFECTS,Inhibitory,3
6126,Hospitalization,C0019993,en_1206,TREATS,Staff,C0851286,en_4950,2,2,AFFECTS,Inhibitory,6
6127,Hospitalization,C0019993,en_1206,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
6128,Hospitalization,C0019993,en_1206,TREATS,Frail,C0871754,en_5030,1,1,AFFECTS,Inhibitory,6
6129,Hospitalization,C0019993,en_1206,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
6130,Hospitalization,C0019993,en_1206,TREATS,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,Inhibitory,3
6131,Hospitalization,C0019993,en_1206,TREATS,Acute coronary syndrome,C0948089,en_5159,2,2,AFFECTS,Inhibitory,12
6132,Hospitalization,C0019993,en_1206,TREATS,Cardiovascular event,C1320716,en_5537,1,1,AFFECTS,Inhibitory,6
6133,Hospitalization,C0019993,en_1206,TREATS,Mental health problem,C1446377,en_5753,1,1,AFFECTS,Inhibitory,3
6134,Hospitalization,C0019993,en_1206,TREATS,Symptoms,C1457887,en_5784,7,5,AFFECTS,Inhibitory,25
6135,Hospitalization,C0019993,en_1206,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
6136,Hospitalization,C0019993,en_1206,TREATS,user - individual,C1706077,en_6033,1,1,AFFECTS,Inhibitory,6
6137,Hospitalization,C0019993,en_1206,TREATS,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",C1849718,en_6051,1,1,AFFECTS,Inhibitory,6
6138,Hospitalization,C0019993,en_1206,TREATS,Rippling muscle disease,C1853698,en_6052,1,1,AFFECTS,Inhibitory,6
6139,Hospitalization,C0019993,en_1206,TREATS,Age Cohort,C2348001,en_6097,1,1,AFFECTS,Inhibitory,7
6140,Hospitalization,C0019993,en_1206,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,6
6141,Hospitalization,C0019993,en_1206,TREATS,Acute illness,C4061114,en_6312,1,1,AFFECTS,Inhibitory,6
6142,Hospitalization,C0019993,en_1206,TREATS,Exacerbation,C4086268,en_6319,1,1,AFFECTS,Inhibitory,6
6143,Hospitalization,C0019993,en_1206,TREATS,Primary Ciliary Dyskinesia,C4551720,en_6367,1,1,AFFECTS,Inhibitory,6
6144,Hospitalization,C0019993,en_1206,TREATS,Symptomatic & Ambulatory,C4697850,en_6374,1,1,AFFECTS,Inhibitory,7
6145,Hospitalization,C0019993,en_1206,TREATS,COVID-19,C5203670,en_6417,46,38,AFFECTS,Inhibitory,242.5
6146,Hospitalization,C0019993,en_1206,TREATS,Suspected COVID-19,C5203671,en_6418,1,1,AFFECTS,Inhibitory,8
6147,Hospitalization,C0019993,en_1206,TREATS,Treatment Group,C5205742,en_6422,1,1,AFFECTS,Inhibitory,6
6148,Hospitalization,C0019993,en_1206,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
6149,Hospitalization,C0019993,en_1206,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6150,Hospitalization,C0019993,en_1206,TREATS(INFER),Laboratory Infection,C0022882,en_1393,1,1,AFFECTS,Inhibitory,3
6151,Hospitalization,C0019993,en_1206,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
6152,Hospitalization,C0019993,en_1206,TREATS(INFER),Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
6153,Hospitalization,C0019993,en_1206,TREATS(INFER),Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
6154,Hospitalization,C0019993,en_1206,TREATS(INFER),Neurobehavioral Manifestations,C0525041,en_4228,1,1,AFFECTS,Inhibitory,3
6155,Hospitalization,C0019993,en_1206,TREATS(INFER),End stage renal failure,C1261469,en_5418,3,2,AFFECTS,Inhibitory,6
6156,"PTH protein, human",C0020063,en_1209,STIMULATES,Enzymes,C0014442,en_912,1,1,AFFECTS,Excitatory,3
6157,"PTH protein, human",C0020063,en_1209,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
6158,Humic Acids,C0020166,en_1212,AFFECTS,Volatilization,C0042945,en_2379,1,1,AFFECTS,General/Uncertain,3
6159,Hurricanes,C0020183,en_1215,AFFECTS,wave,C0678544,en_4560,1,1,AFFECTS,General/Uncertain,3
6160,Hydrocortisone,C0020268,en_1219,INHIBITS,treatment failure,C0162643,en_2923,1,1,AFFECTS,Inhibitory,8
6161,Hydrocortisone,C0020268,en_1219,STIMULATES,GJA1 gene|GJA1,C1415068|2697,en_5704,1,1,AFFECTS,Excitatory,8
6162,Hydrocortisone,C0020268,en_1219,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
6163,Hydrocortisone,C0020268,en_1219,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
6164,Hydrocortisone,C0020268,en_1219,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
6165,Hydrocortisone,C0020268,en_1219,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
6166,Hydrocortisone,C0020268,en_1219,TREATS,Hypoxia,C0242184,en_3396,3,2,AFFECTS,Inhibitory,16
6167,Hydrocortisone,C0020268,en_1219,TREATS,COVID-19,C5203670,en_6417,5,4,AFFECTS,Inhibitory,28
6168,Hydrocortisone,C0020268,en_1219,AFFECTS,brain function,C0678908,en_4584,1,1,AFFECTS,General/Uncertain,3
6169,Hydrocortisone,C0020268,en_1219,INHIBITS,Estrogens,C0014939,en_933,1,1,AFFECTS,Inhibitory,3
6170,Hydrocortisone,C0020268,en_1219,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
6171,Hydrocortisone,C0020268,en_1219,TREATS,father,C0015671,en_965,1,1,AFFECTS,Inhibitory,3
6172,Hydrocortisone,C0020268,en_1219,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
6173,Hydrocortisone,C0020268,en_1219,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6174,Hydrocortisone,C0020268,en_1219,TREATS,Whales,C0043136,en_2392,1,1,AFFECTS,Inhibitory,3
6175,Hydrocortisone,C0020268,en_1219,TREATS,Caregiver,C0085537,en_2674,1,1,AFFECTS,Inhibitory,3
6176,Hydrocortisone,C0020268,en_1219,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
6177,Hydrocortisone,C0020268,en_1219,TREATS(INFER),Neurodevelopmental disorder,C1535926,en_5943,1,1,AFFECTS,Inhibitory,3
6178,Hydrogen,C0020275,en_1220,AFFECTS,anti-apoptosis,C1159816,en_5345,1,1,AFFECTS,General/Uncertain,3
6179,Hydrogen,C0020275,en_1220,DISRUPTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,Inhibitory,3
6180,Hydrogen,C0020275,en_1220,DISRUPTS,Emission,C0233929,en_3301,1,1,AFFECTS,Inhibitory,3
6181,Hydrogen Peroxide,C0020281,en_1221,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
6182,Hydrogen Peroxide,C0020281,en_1221,STIMULATES,RPS6KA1,C1419742,en_76,1,1,AFFECTS,Excitatory,3
6183,Hydrogen Peroxide,C0020281,en_1221,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
6184,Hydrogen Peroxide,C0020281,en_1221,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
6185,Hydrogen Peroxide,C0020281,en_1221,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
6186,Hydrogen Peroxide,C0020281,en_1221,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
6187,Hydrogen Sulfide,C0020282,en_1222,PREVENTS,Atrophic,C0333641,en_3770,1,1,AFFECTS,Inhibitory,3
6188,Hydrotherapy,C0020311,en_1224,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
6189,Hydrotherapy,C0020311,en_1224,PREDISPOSES,Infectious transmissions,C0947878,en_5157,1,1,AFFECTS,Excitatory,3
6190,Hydrotherapy,C0020311,en_1224,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
6191,Hydrotherapy,C0020311,en_1224,STIMULATES,Blood Pressure,C0005823,en_492,1,1,AFFECTS,Excitatory,3
6192,Hydrotherapy,C0020311,en_1224,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
6193,Hydrotherapy,C0020311,en_1224,TREATS,Flushing,C0016382,en_1008,1,1,AFFECTS,Inhibitory,3
6194,Hydrotherapy,C0020311,en_1224,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
6195,Hydrotherapy,C0020311,en_1224,TREATS,Nairobi Sheep Disease,C0027345,en_1633,1,1,AFFECTS,Inhibitory,3
6196,Hydrotherapy,C0020311,en_1224,TREATS,Microbial Biofilms,C0081786,en_2630,1,1,AFFECTS,Inhibitory,3
6197,Hydrotherapy,C0020311,en_1224,TREATS,Rural Communities,C0086944,en_2739,2,1,AFFECTS,Inhibitory,3
6198,Hydrotherapy,C0020311,en_1224,TREATS,Individual,C0237401,en_3343,3,2,AFFECTS,Inhibitory,6
6199,Hydrotherapy,C0020311,en_1224,TREATS,Skin callus,C0376154,en_3872,1,1,AFFECTS,Inhibitory,3
6200,Hydrotherapy,C0020311,en_1224,TREATS,Bury,C1390944,en_5691,1,1,AFFECTS,Inhibitory,3
6201,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,7
6202,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
6203,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Adverse drug effect,C0041755,en_2312,2,1,AFFECTS,General/Uncertain,6
6204,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Virus Shedding,C0162633,en_2921,2,2,AFFECTS,General/Uncertain,10
6205,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
6206,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,8
6207,Hydroxychloroquine,C0020336,en_1226,AFFECTS,QTc,C0860814,en_4993,1,1,AFFECTS,General/Uncertain,3
6208,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,General/Uncertain,6
6209,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Cardiovascular event,C1320716,en_5537,2,1,AFFECTS,General/Uncertain,6
6210,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Treatment duration:Time:Pt:^Patient:Qn,C3259042,en_6186,1,1,AFFECTS,General/Uncertain,6
6211,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Ventricular Repolarization,C3537202,en_6210,1,1,AFFECTS,General/Uncertain,8
6212,Hydroxychloroquine,C0020336,en_1226,AFFECTS,Acute respiratory tract infection,C4759838,en_6402,1,1,AFFECTS,General/Uncertain,7
6213,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Cell division,C0007590,en_589,2,1,AFFECTS,Inhibitory,3
6214,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Inhibitory,3
6215,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Endocytosis,C0014139,en_897,2,1,AFFECTS,Inhibitory,3
6216,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
6217,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Virus Replication,C0042774,en_2363,3,2,AFFECTS,Inhibitory,10
6218,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,7
6219,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,Immunoregulation,C0678889,en_4580,2,1,AFFECTS,Inhibitory,3
6220,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,viral entry,C1160648,en_5358,3,2,AFFECTS,Inhibitory,6
6221,Hydroxychloroquine,C0020336,en_1226,DISRUPTS,viral transmission,C1160716,en_5362,1,1,AFFECTS,Inhibitory,8
6222,Hydroxychloroquine,C0020336,en_1226,INHIBITS,Antiviral Agents,C0003451,en_379,1,1,AFFECTS,Inhibitory,3
6223,Hydroxychloroquine,C0020336,en_1226,INHIBITS,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,1,1,AFFECTS,Inhibitory,6
6224,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Excitatory,3
6225,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
6226,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,Convulsions,C0009951,en_714,1,1,AFFECTS,Excitatory,3
6227,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
6228,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,Ventricular arrhythmia,C0085612,en_2682,1,1,AFFECTS,Excitatory,3
6229,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
6230,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,adverse drug interaction,C0678798,en_4569,1,1,AFFECTS,Excitatory,8
6231,Hydroxychloroquine,C0020336,en_1226,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,8
6232,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Disease,C0012634,en_826,15,8,AFFECTS,Inhibitory,24
6233,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Infection,C3714514,en_6235,4,3,AFFECTS,Inhibitory,14
6234,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Malaria,C0024530,en_1493,2,1,AFFECTS,Inhibitory,3
6235,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
6236,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Virus Shedding,C0162633,en_2921,3,2,AFFECTS,Inhibitory,11
6237,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
6238,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Acute Lung Injury,C0242488,en_3416,2,1,AFFECTS,Inhibitory,3
6239,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
6240,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Secondary infection,C0442886,en_4061,3,2,AFFECTS,Inhibitory,6
6241,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,4,2,AFFECTS,Inhibitory,10
6242,Hydroxychloroquine,C0020336,en_1226,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
6243,Hydroxychloroquine,C0020336,en_1226,PREVENTS,COVID-19,C5203670,en_6417,9,8,AFFECTS,Inhibitory,61
6244,Hydroxychloroquine,C0020336,en_1226,PREVENTS,2019 novel coronavirus,C5203676,en_6420,2,2,AFFECTS,Inhibitory,15
6245,Hydroxychloroquine,C0020336,en_1226,PREVENTS(SPEC),"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
6246,Hydroxychloroquine,C0020336,en_1226,STIMULATES,Anti-Infective Agents,C0003204,en_340,1,1,AFFECTS,Excitatory,3
6247,Hydroxychloroquine,C0020336,en_1226,STIMULATES(SPEC),Chloroquine,C0008269,en_631,1,1,AFFECTS,Excitatory,3
6248,Hydroxychloroquine,C0020336,en_1226,TREATS,Adult,C0001675,en_252,14,9,AFFECTS,Inhibitory,51
6249,Hydroxychloroquine,C0020336,en_1226,TREATS,Rheumatoid Arthritis,C0003873,en_402,9,5,AFFECTS,Inhibitory,18
6250,Hydroxychloroquine,C0020336,en_1226,TREATS,Autoimmune Diseases,C0004364,en_428,9,3,AFFECTS,Inhibitory,12
6251,Hydroxychloroquine,C0020336,en_1226,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,7
6252,Hydroxychloroquine,C0020336,en_1226,TREATS,Comorbidity,C0009488,en_690,1,1,AFFECTS,Inhibitory,6
6253,Hydroxychloroquine,C0020336,en_1226,TREATS,Critical Illness,C0010340,en_733,3,2,AFFECTS,Inhibitory,14
6254,Hydroxychloroquine,C0020336,en_1226,TREATS,Disease,C0012634,en_826,12,9,AFFECTS,Inhibitory,38
6255,Hydroxychloroquine,C0020336,en_1226,TREATS,Health Personnel,C0018724,en_1121,13,9,AFFECTS,Inhibitory,35
6256,Hydroxychloroquine,C0020336,en_1226,TREATS,Human,C0020114,en_1210,2,2,AFFECTS,Inhibitory,6
6257,Hydroxychloroquine,C0020336,en_1226,TREATS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
6258,Hydroxychloroquine,C0020336,en_1226,TREATS,inpatient,C0021562,en_1321,4,3,AFFECTS,Inhibitory,17
6259,Hydroxychloroquine,C0020336,en_1226,TREATS,"Lupus Erythematosus, Systemic",C0024141,en_1466,5,3,AFFECTS,Inhibitory,9
6260,Hydroxychloroquine,C0020336,en_1226,TREATS,Malaria,C0024530,en_1493,6,3,AFFECTS,Inhibitory,9
6261,Hydroxychloroquine,C0020336,en_1226,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
6262,Hydroxychloroquine,C0020336,en_1226,TREATS,Outpatients,C0029921,en_1729,15,10,AFFECTS,Inhibitory,53
6263,Hydroxychloroquine,C0020336,en_1226,TREATS,Patients,C0030705,en_1762,78,45,AFFECTS,Inhibitory,135
6264,Hydroxychloroquine,C0020336,en_1226,TREATS,Pneumonia,C0032285,en_1833,5,4,AFFECTS,Inhibitory,18
6265,Hydroxychloroquine,C0020336,en_1226,TREATS,Porphyrias,C0032708,en_1852,2,1,AFFECTS,Inhibitory,3
6266,Hydroxychloroquine,C0020336,en_1226,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,7
6267,Hydroxychloroquine,C0020336,en_1226,TREATS,Q Fever,C0034362,en_1943,1,1,AFFECTS,Inhibitory,3
6268,Hydroxychloroquine,C0020336,en_1226,TREATS,Respiration Disorders,C0035204,en_2005,2,1,AFFECTS,Inhibitory,3
6269,Hydroxychloroquine,C0020336,en_1226,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,8
6270,Hydroxychloroquine,C0020336,en_1226,TREATS,Rheumatism,C0035435,en_2028,2,2,AFFECTS,Inhibitory,6
6271,Hydroxychloroquine,C0020336,en_1226,TREATS,risk factors,C0035648,en_2039,1,1,AFFECTS,Inhibitory,6
6272,Hydroxychloroquine,C0020336,en_1226,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
6273,Hydroxychloroquine,C0020336,en_1226,TREATS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,7
6274,Hydroxychloroquine,C0020336,en_1226,TREATS,Voluntary Workers,C0042960,en_2380,1,1,AFFECTS,Inhibitory,3
6275,Hydroxychloroquine,C0020336,en_1226,TREATS,Homo sapiens,C0086418,en_2718,1,1,AFFECTS,Inhibitory,8
6276,Hydroxychloroquine,C0020336,en_1226,TREATS,Porphyria Cutanea Tarda,C0162566,en_2913,1,1,AFFECTS,Inhibitory,3
6277,Hydroxychloroquine,C0020336,en_1226,TREATS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,7
6278,Hydroxychloroquine,C0020336,en_1226,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,8
6279,Hydroxychloroquine,C0020336,en_1226,TREATS,Individual,C0237401,en_3343,8,4,AFFECTS,Inhibitory,12
6280,Hydroxychloroquine,C0020336,en_1226,TREATS,Clinical infection,C0275521,en_3564,2,1,AFFECTS,Inhibitory,3
6281,Hydroxychloroquine,C0020336,en_1226,TREATS,Possible,C0332149,en_3747,1,1,AFFECTS,Inhibitory,8
6282,Hydroxychloroquine,C0020336,en_1226,TREATS,Italians,C0337810,en_3799,2,1,AFFECTS,Inhibitory,3
6283,Hydroxychloroquine,C0020336,en_1226,TREATS,Cerebellar decompression injury,C0344191,en_3835,1,1,AFFECTS,Inhibitory,3
6284,Hydroxychloroquine,C0020336,en_1226,TREATS,Lupus Erythematosus,C0409974,en_3967,1,1,AFFECTS,Inhibitory,3
6285,Hydroxychloroquine,C0020336,en_1226,TREATS,Infected,C0439663,en_4036,1,1,AFFECTS,Inhibitory,6
6286,Hydroxychloroquine,C0020336,en_1226,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
6287,Hydroxychloroquine,C0020336,en_1226,TREATS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
6288,Hydroxychloroquine,C0020336,en_1226,TREATS,Participant,C0679646,en_4602,6,3,AFFECTS,Inhibitory,9
6289,Hydroxychloroquine,C0020336,en_1226,TREATS,Study Subject,C0681850,en_4632,1,1,AFFECTS,Inhibitory,7
6290,Hydroxychloroquine,C0020336,en_1226,TREATS,line worker,C0682215,en_4639,1,1,AFFECTS,Inhibitory,3
6291,Hydroxychloroquine,C0020336,en_1226,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,6
6292,Hydroxychloroquine,C0020336,en_1226,TREATS,General Population,C0683971,en_4674,2,1,AFFECTS,Inhibitory,3
6293,Hydroxychloroquine,C0020336,en_1226,TREATS,Drug Interactions,C0687133,en_4685,1,1,AFFECTS,Inhibitory,7
6294,Hydroxychloroquine,C0020336,en_1226,TREATS,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Inhibitory,8
6295,Hydroxychloroquine,C0020336,en_1226,TREATS,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,Inhibitory,3
6296,Hydroxychloroquine,C0020336,en_1226,TREATS,High Risk Populations,C0870646,en_5008,2,1,AFFECTS,Inhibitory,3
6297,Hydroxychloroquine,C0020336,en_1226,TREATS,Hospitalized Patients,C0870668,en_5010,30,25,AFFECTS,Inhibitory,134
6298,Hydroxychloroquine,C0020336,en_1226,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,7
6299,Hydroxychloroquine,C0020336,en_1226,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,3,2,AFFECTS,Inhibitory,9
6300,Hydroxychloroquine,C0020336,en_1226,TREATS,hearing impairment,C1384666,en_5689,1,1,AFFECTS,Inhibitory,3
6301,Hydroxychloroquine,C0020336,en_1226,TREATS,Symptoms,C1457887,en_5784,4,2,AFFECTS,Inhibitory,6
6302,Hydroxychloroquine,C0020336,en_1226,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
6303,Hydroxychloroquine,C0020336,en_1226,TREATS,Recurrent pregnancy loss,C2921106,en_6144,2,1,AFFECTS,Inhibitory,7
6304,Hydroxychloroquine,C0020336,en_1226,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,2,2,AFFECTS,Inhibitory,15
6305,Hydroxychloroquine,C0020336,en_1226,TREATS,"Systemic lupus erythematosus, childhood onset",C3280743,en_6199,1,1,AFFECTS,Inhibitory,7
6306,Hydroxychloroquine,C0020336,en_1226,TREATS,QTcF Prolongation,C3828431,en_6251,1,1,AFFECTS,Inhibitory,8
6307,Hydroxychloroquine,C0020336,en_1226,TREATS,Epidermal cGVHD Score 2,C4761314,en_6403,1,1,AFFECTS,Inhibitory,8
6308,Hydroxychloroquine,C0020336,en_1226,TREATS,COVID-19,C5203670,en_6417,80,54,AFFECTS,Inhibitory,378
6309,Hydroxychloroquine,C0020336,en_1226,TREATS,2019 novel coronavirus,C5203676,en_6420,3,3,AFFECTS,Inhibitory,20
6310,Hydroxychloroquine,C0020336,en_1226,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
6311,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Critical Illness,C0010340,en_733,6,2,AFFECTS,Inhibitory,6
6312,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6313,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
6314,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Respiration Disorders,C0035204,en_2005,3,1,AFFECTS,Inhibitory,3
6315,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
6316,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Lower respiratory tract infection,C0149725,en_2806,2,1,AFFECTS,Inhibitory,3
6317,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,5,1,AFFECTS,Inhibitory,3
6318,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Asymptomatic,C0231221,en_3252,2,1,AFFECTS,Inhibitory,3
6319,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
6320,Hydroxychloroquine,C0020336,en_1226,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
6321,Hydroxychloroquine,C0020336,en_1226,TREATS(SPEC),Autoimmune Diseases,C0004364,en_428,2,2,AFFECTS,Inhibitory,6
6322,Hydroxychloroquine,C0020336,en_1226,TREATS(SPEC),Immune System Diseases,C0021053,en_1284,1,1,AFFECTS,Inhibitory,3
6323,Hydroxychloroquine,C0020336,en_1226,TREATS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6324,Hydroxychloroquine,C0020336,en_1226,TREATS(SPEC),"Dermatitis, Phototoxic",C0162830,en_2935,1,1,AFFECTS,Inhibitory,3
6325,Hydroxyprostaglandin Dehydrogenases,C0020390,en_1227,INHIBITS,Dinoprostone,C0012472,en_818,1,1,AFFECTS,Inhibitory,3
6326,Hyperbaric Oxygenation,C0020431,en_1229,AFFECTS,virus pathogenesis,C0920672,en_5130,1,1,AFFECTS,General/Uncertain,3
6327,Hyperbaric Oxygenation,C0020431,en_1229,TREATS,Patients,C0030705,en_1762,7,5,AFFECTS,Inhibitory,15
6328,Hyperbaric Oxygenation,C0020431,en_1229,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,3
6329,Hyperbaric Oxygenation,C0020431,en_1229,TREATS,Peripheral Vascular Diseases,C0085096,en_2641,1,1,AFFECTS,Inhibitory,3
6330,Hyperbaric Oxygenation,C0020431,en_1229,TREATS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,7
6331,Hyperbaric Oxygenation,C0020431,en_1229,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
6332,hypercholesterolemia,C0020443,en_1231,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
6333,Hyperglycemia,C0020456,en_1232,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
6334,Hyperglycemia,C0020456,en_1232,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
6335,Hyperglycemia,C0020456,en_1232,PREDISPOSES,COVID-19,C5203670,en_6417,2,1,AFFECTS,Excitatory,6
6336,Hyperlipidemia,C0020473,en_1233,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,6
6337,Hyperlipidemia,C0020473,en_1233,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
6338,Hypersensitivity,C0020517,en_1238,AFFECTS,Candida,C0006836,en_546,1,1,AFFECTS,General/Uncertain,3
6339,Hypersensitivity,C0020517,en_1238,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
6340,Hypersensitivity,C0020517,en_1238,AFFECTS,Genus staphylococcus,C0038170,en_2153,1,1,AFFECTS,General/Uncertain,3
6341,Hypersensitivity,C0020517,en_1238,AFFECTS,Teacher,C0221457,en_3226,1,1,AFFECTS,General/Uncertain,3
6342,Hypersensitivity,C0020517,en_1238,AFFECTS,Contagion,C0598197,en_4444,1,1,AFFECTS,General/Uncertain,6
6343,Hypersensitivity,C0020517,en_1238,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
6344,Hypersensitivity,C0020517,en_1238,PREDISPOSES,Pneumothorax,C0032326,en_1838,1,1,AFFECTS,Excitatory,6
6345,Hypersensitivity,C0020517,en_1238,PRODUCES,gamma-interferon|IFNA1,C3539881|3439,en_6213,1,1,AFFECTS,Excitatory,7
6346,Hypertensive disease,C0020538,en_1239,AFFECTS,Adult,C0001675,en_252,1,1,AFFECTS,General/Uncertain,3
6347,Hypertensive disease,C0020538,en_1239,AFFECTS,Blood Pressure,C0005823,en_492,6,4,AFFECTS,General/Uncertain,15
6348,Hypertensive disease,C0020538,en_1239,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
6349,Hypertensive disease,C0020538,en_1239,AFFECTS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,General/Uncertain,6
6350,Hypertensive disease,C0020538,en_1239,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,6
6351,Hypertensive disease,C0020538,en_1239,AFFECTS,Dyslipidemias,C0242339,en_3406,1,1,AFFECTS,General/Uncertain,6
6352,Hypertensive disease,C0020538,en_1239,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
6353,Hypertensive disease,C0020538,en_1239,COMPLICATES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
6354,Hypertensive disease,C0020538,en_1239,DISRUPTS,Epithelial Cells,C0014597,en_919,2,1,AFFECTS,Inhibitory,3
6355,Hypertensive disease,C0020538,en_1239,DISRUPTS,Mediating,C0086597,en_2730,1,1,AFFECTS,Inhibitory,3
6356,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
6357,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,3,2,AFFECTS,Excitatory,6
6358,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Complication,C0009566,en_697,3,3,AFFECTS,Excitatory,9
6359,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Coronary heart disease,C0010068,en_718,2,1,AFFECTS,Excitatory,3
6360,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
6361,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Delirium,C0011206,en_774,2,1,AFFECTS,Excitatory,3
6362,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Diabetes,C0011847,en_797,2,1,AFFECTS,Excitatory,3
6363,Hypertensive disease,C0020538,en_1239,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
6364,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,Excitatory,6
6365,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Negative,C0205160,en_3126,1,1,AFFECTS,Excitatory,6
6366,Hypertensive disease,C0020538,en_1239,PREDISPOSES,NEUROLOGIC COMPLICATION,C0235029,en_3317,1,1,AFFECTS,Excitatory,3
6367,Hypertensive disease,C0020538,en_1239,PREDISPOSES,arterial stiffness,C0599949,en_4491,1,1,AFFECTS,Excitatory,6
6368,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Acute-On-Chronic Liver Failure,C3850141,en_6271,1,1,AFFECTS,Excitatory,6
6369,Hypertensive disease,C0020538,en_1239,PREDISPOSES,Severe infection,C5139167,en_6407,1,1,AFFECTS,Excitatory,6
6370,Hypertensive disease,C0020538,en_1239,PREDISPOSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,12
6371,"Hypertension, Pulmonary",C0020542,en_1240,AFFECTS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,General/Uncertain,3
6372,Induced Hyperthermia,C0020548,en_1241,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
6373,Induced Hyperthermia,C0020548,en_1241,TREATS,Parasitic infection,C0747256,en_4823,1,1,AFFECTS,Inhibitory,3
6374,Induced Hyperthermia,C0020548,en_1241,TREATS,malignant neoplasm of breast staging,C2216702,en_6091,1,1,AFFECTS,Inhibitory,7
6375,Hypertriglyceridemia,C0020557,en_1242,PREDISPOSES,Cardiovascular arteriosclerosis unspecified,C0003972,en_407,1,1,AFFECTS,Excitatory,3
6376,Hypertrophy,C0020564,en_1243,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
6377,Hypochlorous Acid,C0020600,en_1244,DISRUPTS,Virion,C0042760,en_2360,1,1,AFFECTS,Inhibitory,3
6378,hypoglycemia,C0020615,en_1245,DISRUPTS,cooperation,C0392337,en_3917,1,1,AFFECTS,Inhibitory,7
6379,Hypoglycemic Agents,C0020616,en_1246,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6380,Hypotension,C0020649,en_1248,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
6381,Hypoxanthine,C0020684,en_1252,PREDISPOSES,Myocardial Ischemia,C0151744,en_2865,1,1,AFFECTS,Excitatory,3
6382,Hysterectomy,C0020699,en_1253,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
6383,Hysterectomy,C0020699,en_1253,TREATS,Cervical carcinoma stage IA,C0278587,en_3603,1,1,AFFECTS,Inhibitory,6
6384,Hysteria,C0020701,en_1254,AFFECTS,Mass Hysteria,C0870849,en_5012,1,1,AFFECTS,General/Uncertain,3
6385,Ibuprofen,C0020740,en_1255,PREDISPOSES,"Injury to liver, NOS",C0160390,en_2896,3,1,AFFECTS,Excitatory,3
6386,Ibuprofen,C0020740,en_1255,PREVENTS,Fibrosis,C0016059,en_994,2,1,AFFECTS,Inhibitory,3
6387,Ibuprofen,C0020740,en_1255,STIMULATES,ACE2,C1422064,en_5723,2,1,AFFECTS,Excitatory,3
6388,Ibuprofen,C0020740,en_1255,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
6389,Ibuprofen,C0020740,en_1255,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
6390,Ibuprofen,C0020740,en_1255,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
6391,Ice,C0020746,en_1256,AUGMENTS,Evolution,C0015219,en_937,1,1,AFFECTS,Excitatory,3
6392,Ifosfamide,C0020823,en_1258,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
6393,"Immunoglobulin A, Secretory",C0020838,en_1261,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
6394,Immunoglobulin D,C0020843,en_1263,PRODUCES,CD40LG,C1539082,en_17,1,1,AFFECTS,Excitatory,3
6395,Immunoglobulin G,C0020852,en_1264,TREATS,2019 novel coronavirus,C5203676,en_6420,2,2,AFFECTS,Inhibitory,13
6396,IgG4,C0020860,en_1267,STIMULATES,IgG1,C0020855,en_1265,1,1,AFFECTS,Excitatory,3
6397,IgG4,C0020860,en_1267,STIMULATES,IgG3,C0020859,en_1266,1,1,AFFECTS,Excitatory,3
6398,Immobilization,C0020944,en_1269,AFFECTS,Respiration,C0035203,en_2004,2,2,AFFECTS,General/Uncertain,6
6399,Immobilization,C0020944,en_1269,AFFECTS,Survivors,C0206194,en_3154,2,1,AFFECTS,General/Uncertain,3
6400,Immune Sera,C0020960,en_1270,PREVENTS,Plasmodium vivax infection,C0858321,en_4981,1,1,AFFECTS,Inhibitory,3
6401,Immune Sera,C0020960,en_1270,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
6402,Immune Sera,C0020960,en_1270,TREATS,Oryctolagus cuniculus,C0034493,en_1947,1,1,AFFECTS,Inhibitory,3
6403,Immune Tolerance,C0020963,en_1272,PRODUCES,Enhancing Antibodies,C0282681,en_3664,1,1,AFFECTS,Excitatory,3
6404,Immunity,C0020964,en_1273,AFFECTS,Virus Diseases,C0042769,en_2362,3,3,AFFECTS,General/Uncertain,13
6405,Immunity,C0020964,en_1273,AFFECTS,Reinfection,C0205339,en_3129,1,1,AFFECTS,General/Uncertain,6
6406,Immunity,C0020964,en_1273,AFFECTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,General/Uncertain,8
6407,Immunity,C0020964,en_1273,AFFECTS,Severe SARS-CoV-2 infection,C5421637,en_6461,1,1,AFFECTS,General/Uncertain,7
6408,Immunity,C0020964,en_1273,AFFECTS,Adult,C0001675,en_252,2,1,AFFECTS,General/Uncertain,3
6409,Immunity,C0020964,en_1273,AFFECTS,Age,C0001779,en_257,1,1,AFFECTS,General/Uncertain,3
6410,Immunity,C0020964,en_1273,AFFECTS,Elderly,C0001792,en_258,2,1,AFFECTS,General/Uncertain,3
6411,Immunity,C0020964,en_1273,AFFECTS,Disease,C0012634,en_826,4,3,AFFECTS,General/Uncertain,9
6412,Immunity,C0020964,en_1273,AFFECTS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,General/Uncertain,3
6413,Immunity,C0020964,en_1273,AFFECTS,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,General/Uncertain,3
6414,Immunity,C0020964,en_1273,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
6415,Immunity,C0020964,en_1273,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
6416,Immunity,C0020964,en_1273,AFFECTS,Virus,C0042776,en_2364,1,1,AFFECTS,General/Uncertain,3
6417,Immunity,C0020964,en_1273,AFFECTS,Bacillus Calmette-Guerin,C0085957,en_2698,1,1,AFFECTS,General/Uncertain,3
6418,Immunity,C0020964,en_1273,AFFECTS,Individual,C0237401,en_3343,2,2,AFFECTS,General/Uncertain,6
6419,Immunity,C0020964,en_1273,AFFECTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,General/Uncertain,3
6420,Immunity,C0020964,en_1273,AFFECTS,Childhood asthma,C0264408,en_3532,1,1,AFFECTS,General/Uncertain,3
6421,Immunity,C0020964,en_1273,AFFECTS,Nasal infection,C0555970,en_4297,1,1,AFFECTS,General/Uncertain,3
6422,Immunity,C0020964,en_1273,AFFECTS,immunosenescence,C0596761,en_4395,1,1,AFFECTS,General/Uncertain,3
6423,Immunity,C0020964,en_1273,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
6424,Immunity,C0020964,en_1273,AFFECTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
6425,Immunity,C0020964,en_1273,PRODUCES,Immunoglobulins,C0021027,en_1282,1,1,AFFECTS,Excitatory,3
6426,Immunity,C0020964,en_1273,PRODUCES,Vaccines,C0042210,en_2329,2,2,AFFECTS,Excitatory,6
6427,Immunity,C0020964,en_1273,PRODUCES,chemokine,C0282554,en_3651,1,1,AFFECTS,Excitatory,3
6428,Immunity,C0020964,en_1273,PRODUCES,Interleukin-17,C0384648,en_3903,1,1,AFFECTS,Excitatory,3
6429,"Immunity, Natural",C0020969,en_1276,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
6430,Immunization,C0020971,en_1277,PREDISPOSES,Flare,C1517205,en_5867,1,1,AFFECTS,Excitatory,6
6431,Immunization,C0020971,en_1277,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6432,Immunization,C0020971,en_1277,PREVENTS,Antibody-Dependent Enhancement,C0282632,en_3660,2,2,AFFECTS,Inhibitory,6
6433,Immunization,C0020971,en_1277,STIMULATES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
6434,Immunization,C0020971,en_1277,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
6435,Immunization,C0020971,en_1277,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
6436,Immunization,C0020971,en_1277,TREATS,Alpacas,C0002186,en_284,1,1,AFFECTS,Inhibitory,3
6437,Immunization,C0020971,en_1277,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
6438,Immunization,C0020971,en_1277,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6439,Immunization,C0020971,en_1277,TREATS,Ferrets,C0015859,en_979,1,1,AFFECTS,Inhibitory,3
6440,Immunization,C0020971,en_1277,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
6441,Immunization,C0020971,en_1277,TREATS,Macaca,C0024398,en_1479,1,1,AFFECTS,Inhibitory,3
6442,Immunization,C0020971,en_1277,TREATS,Mus,C0026809,en_1600,2,2,AFFECTS,Inhibitory,6
6443,Immunization,C0020971,en_1277,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
6444,Immunization,C0020971,en_1277,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
6445,Immunization,C0020971,en_1277,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
6446,Immunization,C0020971,en_1277,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
6447,Immunization,C0020971,en_1277,TREATS,Females,C0086287,en_2713,1,1,AFFECTS,Inhibitory,6
6448,Immunization,C0020971,en_1277,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
6449,Immunization,C0020971,en_1277,TREATS,Recipient,C1709854,en_6037,2,1,AFFECTS,Inhibitory,6
6450,Immunization,C0020971,en_1277,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
6451,Immunization Schedule,C0020972,en_1278,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
6452,Immunization Schedule,C0020972,en_1278,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
6453,passive immunization procedure,C0020974,en_1279,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
6454,passive immunization procedure,C0020974,en_1279,PREVENTS,Neonatal calf diarrhea,C0276467,en_3578,1,1,AFFECTS,Inhibitory,8
6455,passive immunization procedure,C0020974,en_1279,STIMULATES,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,Excitatory,3
6456,passive immunization procedure,C0020974,en_1279,TREATS,"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,Inhibitory,6
6457,passive immunization procedure,C0020974,en_1279,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
6458,passive immunization procedure,C0020974,en_1279,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
6459,passive immunization procedure,C0020974,en_1279,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
6460,passive immunization procedure,C0020974,en_1279,TREATS,Symptoms,C1457887,en_5784,4,3,AFFECTS,Inhibitory,13
6461,"Immunization, Secondary",C0020975,en_1280,PREVENTS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,7
6462,"Immunization, Secondary",C0020975,en_1280,STIMULATES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
6463,"Immunization, Secondary",C0020975,en_1280,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6464,"Immunization, Secondary",C0020975,en_1280,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
6465,"Immunization, Secondary",C0020975,en_1280,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
6466,"Immunization, Secondary",C0020975,en_1280,TREATS(INFER),Chronic liver disease NOS,C0341439,en_3823,2,1,AFFECTS,Inhibitory,3
6467,Immunoglobulin Isotypes,C0021017,en_1281,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
6468,Immunoglobulin Isotypes,C0021017,en_1281,AFFECTS,cross immunity,C0178575,en_2986,1,1,AFFECTS,General/Uncertain,3
6469,Immunoglobulin Isotypes,C0021017,en_1281,AFFECTS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,General/Uncertain,3
6470,Immunoglobulin Isotypes,C0021017,en_1281,PRODUCES,"CD79A,LOC102723407",C1413238,en_191,1,1,AFFECTS,Excitatory,3
6471,Immunoglobulins,C0021027,en_1282,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,8
6472,Immunoglobulins,C0021027,en_1282,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,7
6473,Immunoglobulins,C0021027,en_1282,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
6474,Immunoglobulins,C0021027,en_1282,INHIBITS,Interleukin 6 Receptor,C0063717,en_2510,1,1,AFFECTS,Inhibitory,3
6475,Immunoglobulins,C0021027,en_1282,PRODUCES,Somatotropin,C0037663,en_2136,1,1,AFFECTS,Excitatory,3
6476,Immunoglobulins,C0021027,en_1282,TREATS,Chiroptera,C0008139,en_625,1,1,AFFECTS,Inhibitory,3
6477,Immunoglobulins,C0021027,en_1282,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6478,Immunoglobulins,C0021027,en_1282,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
6479,Immunoglobulins,C0021027,en_1282,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
6480,Immunoglobulins,C0021027,en_1282,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
6481,Immunoglobulins,C0021027,en_1282,TREATS,member,C0680022,en_4618,1,1,AFFECTS,Inhibitory,3
6482,Immunoglobulins,C0021027,en_1282,TREATS,Acute Pneumonia,C0740766,en_4782,1,1,AFFECTS,Inhibitory,3
6483,Immune System Diseases,C0021053,en_1284,PREDISPOSES,Secondary infection,C0442886,en_4061,2,1,AFFECTS,Excitatory,3
6484,Immunologic Factors,C0021054,en_1285,AFFECTS,host-pathogen interaction,C1154482,en_5309,2,1,AFFECTS,General/Uncertain,3
6485,Immunologic Factors,C0021054,en_1285,AUGMENTS,Blood coagulation,C0005778,en_484,2,1,AFFECTS,Excitatory,3
6486,Therapeutic immunosuppression,C0021079,en_1287,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
6487,Therapeutic immunosuppression,C0021079,en_1287,AFFECTS,"Recipient, Transplant",C0376387,en_3875,2,1,AFFECTS,General/Uncertain,3
6488,Therapeutic immunosuppression,C0021079,en_1287,PREDISPOSES,Aspergillosis,C0004030,en_409,1,1,AFFECTS,Excitatory,6
6489,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Arthritis,C0003864,en_400,1,1,AFFECTS,Inhibitory,3
6490,Therapeutic immunosuppression,C0021079,en_1287,TREATS,"Arthritis, Psoriatic",C0003872,en_401,1,1,AFFECTS,Inhibitory,3
6491,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
6492,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
6493,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Crohn's disease,C0010346,en_734,1,1,AFFECTS,Inhibitory,3
6494,Therapeutic immunosuppression,C0021079,en_1287,TREATS,"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
6495,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Patients,C0030705,en_1762,6,5,AFFECTS,Inhibitory,15
6496,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Pemphigus,C0030807,en_1765,1,1,AFFECTS,Inhibitory,3
6497,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
6498,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Psoriasis,C0033860,en_1918,1,1,AFFECTS,Inhibitory,6
6499,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Ankylosing spondylitis,C0038013,en_2147,1,1,AFFECTS,Inhibitory,3
6500,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Pustular psoriasis,C0152081,en_2880,1,1,AFFECTS,Inhibitory,3
6501,Therapeutic immunosuppression,C0021079,en_1287,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
6502,Therapeutic immunosuppression,C0021079,en_1287,TREATS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Inhibitory,3
6503,Therapeutic immunosuppression,C0021079,en_1287,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
6504,Therapeutic immunosuppression,C0021079,en_1287,TREATS(INFER),Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
6505,Immunosuppressive Agents,C0021081,en_1289,TREATS,"Abortion, Habitual",C0000809,en_207,1,1,AFFECTS,Inhibitory,7
6506,Immunosuppressive Agents,C0021081,en_1289,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
6507,Immunosuppressive Agents,C0021081,en_1289,TREATS,Psoriasis,C0033860,en_1918,1,1,AFFECTS,Inhibitory,7
6508,Immunosuppressive Agents,C0021081,en_1289,TREATS,Undifferentiated connective tissue disease,C0409999,en_3968,1,1,AFFECTS,Inhibitory,7
6509,Immunosuppressive Agents,C0021081,en_1289,AFFECTS(SPEC),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
6510,Immunosuppressive Agents,C0021081,en_1289,INHIBITS,cytokine,C0079189,en_2593,2,1,AFFECTS,Inhibitory,3
6511,Immunosuppressive Agents,C0021081,en_1289,PREVENTS,organ rejection,C0815080,en_4921,1,1,AFFECTS,Inhibitory,3
6512,Immunosuppressive Agents,C0021081,en_1289,PREVENTS(SPEC),Tissue damage,C0010957,en_756,1,1,AFFECTS,Inhibitory,3
6513,Immunosuppressive Agents,C0021081,en_1289,PREVENTS(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
6514,Immunosuppressive Agents,C0021081,en_1289,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
6515,Immunosuppressive Agents,C0021081,en_1289,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
6516,Immunosuppressive Agents,C0021081,en_1289,TREATS,Patients,C0030705,en_1762,8,5,AFFECTS,Inhibitory,15
6517,Immunosuppressive Agents,C0021081,en_1289,TREATS,Autoimmune,C0443146,en_4064,2,1,AFFECTS,Inhibitory,3
6518,Immunosuppressive Agents,C0021081,en_1289,TREATS,Inflammatory disorder,C1290884,en_5483,2,1,AFFECTS,Inhibitory,3
6519,Immunosuppressive Agents,C0021081,en_1289,TREATS,Rodent Model,C1519106,en_5880,1,1,AFFECTS,Inhibitory,3
6520,Immunotherapy,C0021083,en_1290,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
6521,Immunotherapy,C0021083,en_1290,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
6522,Immunotherapy,C0021083,en_1290,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
6523,Immunotherapy,C0021083,en_1290,AFFECTS(SPEC),Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,3
6524,Immunotherapy,C0021083,en_1290,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
6525,Immunotherapy,C0021083,en_1290,TREATS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,3
6526,Immunotherapy,C0021083,en_1290,TREATS,Malignant Neoplasms,C0006826,en_545,7,3,AFFECTS,Inhibitory,9
6527,Immunotherapy,C0021083,en_1290,TREATS,Communicable Diseases,C0009450,en_685,2,2,AFFECTS,Inhibitory,6
6528,Immunotherapy,C0021083,en_1290,TREATS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
6529,Immunotherapy,C0021083,en_1290,TREATS,Lymphoma,C0024299,en_1471,2,1,AFFECTS,Inhibitory,3
6530,Immunotherapy,C0021083,en_1290,TREATS,Multiple Sclerosis,C0026769,en_1598,2,1,AFFECTS,Inhibitory,3
6531,Immunotherapy,C0021083,en_1290,TREATS,Patients,C0030705,en_1762,18,8,AFFECTS,Inhibitory,24
6532,Immunotherapy,C0021083,en_1290,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
6533,Immunotherapy,C0021083,en_1290,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
6534,Immunotherapy,C0021083,en_1290,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
6535,Immunotherapy,C0021083,en_1290,TREATS,Solid tumor,C0280100,en_3619,1,1,AFFECTS,Inhibitory,3
6536,Immunotherapy,C0021083,en_1290,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
6537,Immunotherapy,C0021083,en_1290,TREATS,Advanced cancer,C0877373,en_5070,1,1,AFFECTS,Inhibitory,3
6538,Immunotherapy,C0021083,en_1290,TREATS,Cancer Patient,C1516213,en_5852,2,1,AFFECTS,Inhibitory,3
6539,Immunotherapy,C0021083,en_1290,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
6540,Immunotherapy,C0021083,en_1290,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6541,Immunotherapy,C0021083,en_1290,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
6542,Immunotherapy,C0021083,en_1290,TREATS(SPEC),Lymphoma,C0024299,en_1471,2,1,AFFECTS,Inhibitory,3
6543,Immunotherapy,C0021083,en_1290,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
6544,Implants,C0021102,en_1291,TREATS,Young adult,C0238598,en_3365,1,1,AFFECTS,Inhibitory,3
6545,Implantation procedure,C0021107,en_1292,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
6546,Implantation procedure,C0021107,en_1292,PREDISPOSES,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Excitatory,3
6547,Implantation procedure,C0021107,en_1292,TREATS,Dysbarism,C0004760,en_446,1,1,AFFECTS,Inhibitory,3
6548,Independent Living,C0021189,en_1293,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
6549,Independent Living,C0021189,en_1293,TREATS(INFER),Disability NOS,C0231170,en_3247,1,1,AFFECTS,Inhibitory,3
6550,Indicators,C0021212,en_1294,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
6551,Indicators,C0021212,en_1294,AFFECTS,Breast Feeding,C0006147,en_512,2,1,AFFECTS,General/Uncertain,3
6552,Indicators,C0021212,en_1294,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
6553,Indicators,C0021212,en_1294,AFFECTS,Kidney Diseases,C0022658,en_1381,3,1,AFFECTS,General/Uncertain,3
6554,Indicators,C0021212,en_1294,AFFECTS,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,3
6555,Indicators,C0021212,en_1294,AFFECTS,"Stress, Psychological",C0038443,en_2168,1,1,AFFECTS,General/Uncertain,3
6556,Indicators,C0021212,en_1294,AFFECTS,Zoonoses,C0043528,en_2410,1,1,AFFECTS,General/Uncertain,3
6557,Indicators,C0021212,en_1294,AFFECTS,Dementia,C0497327,en_4164,1,1,AFFECTS,General/Uncertain,3
6558,Indicators,C0021212,en_1294,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
6559,indole,C0021236,en_1295,DISRUPTS,Cell-Matrix Junction,C0887869,en_5088,2,1,AFFECTS,Inhibitory,3
6560,Indomethacin,C0021246,en_1296,INHIBITS,cyclooxygenase 1,C0389003,en_3906,1,1,AFFECTS,Inhibitory,3
6561,Indomethacin,C0021246,en_1296,INHIBITS,receptor,C0597357,en_4422,1,1,AFFECTS,Inhibitory,3
6562,Indomethacin,C0021246,en_1296,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6563,Indomethacin,C0021246,en_1296,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
6564,Indomethacin,C0021246,en_1296,TREATS(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
6565,Infection,C3714514,en_6235,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
6566,Infection,C3714514,en_6235,AFFECTS,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,9
6567,Infection,C3714514,en_6235,AFFECTS,Eating,C0013470,en_870,1,1,AFFECTS,General/Uncertain,3
6568,Infection,C3714514,en_6235,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
6569,Infection,C3714514,en_6235,AFFECTS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,General/Uncertain,3
6570,Infection,C3714514,en_6235,AFFECTS,Persons,C0027361,en_1635,3,2,AFFECTS,General/Uncertain,6
6571,Infection,C3714514,en_6235,AFFECTS,African race,C0027567,en_1646,1,1,AFFECTS,General/Uncertain,3
6572,Infection,C3714514,en_6235,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
6573,Infection,C3714514,en_6235,AFFECTS,physiological aspects,C0031843,en_1806,2,1,AFFECTS,General/Uncertain,3
6574,Infection,C3714514,en_6235,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
6575,Infection,C3714514,en_6235,AFFECTS,Sleep,C0037313,en_2119,1,1,AFFECTS,General/Uncertain,3
6576,Infection,C3714514,en_6235,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
6577,Infection,C3714514,en_6235,AFFECTS,biological adaptation to stress,C0149784,en_2810,1,1,AFFECTS,General/Uncertain,3
6578,Infection,C3714514,en_6235,AFFECTS,"Infections, Hospital",C0205721,en_3133,2,1,AFFECTS,General/Uncertain,3
6579,Infection,C3714514,en_6235,AFFECTS,Individual,C0237401,en_3343,2,2,AFFECTS,General/Uncertain,6
6580,Infection,C3714514,en_6235,AFFECTS,Immune response,C0301872,en_3696,2,2,AFFECTS,General/Uncertain,6
6581,Infection,C3714514,en_6235,AFFECTS,Staff,C0851286,en_4950,1,1,AFFECTS,General/Uncertain,3
6582,Infection,C3714514,en_6235,AFFECTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,General/Uncertain,3
6583,Infection,C3714514,en_6235,AFFECTS,Chronic Stress,C1510527,en_5797,2,1,AFFECTS,General/Uncertain,3
6584,Infection,C3714514,en_6235,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
6585,Infection,C3714514,en_6235,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
6586,Infection,C3714514,en_6235,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
6587,Infection,C3714514,en_6235,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
6588,Infection,C3714514,en_6235,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
6589,Infection,C3714514,en_6235,PREDISPOSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
6590,Infection,C3714514,en_6235,PREDISPOSES,Dementia,C0497327,en_4164,1,1,AFFECTS,Excitatory,3
6591,Infection,C3714514,en_6235,PREDISPOSES,Mood Disorders,C0525045,en_4229,1,1,AFFECTS,Excitatory,3
6592,Infection,C3714514,en_6235,PREDISPOSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
6593,Infection,C3714514,en_6235,PRODUCES,Antibodies,C0003241,en_347,2,1,AFFECTS,Excitatory,3
6594,Infertility,C0021359,en_1305,AFFECTS,Obstetrician,C0334897,en_3778,1,1,AFFECTS,General/Uncertain,3
6595,"Infertility, Male",C0021364,en_1306,DISRUPTS,sperm cell,C0037868,en_2141,1,1,AFFECTS,Inhibitory,3
6596,Inflammation,C0021368,en_1307,AFFECTS,Immunity,C0020964,en_1273,2,2,AFFECTS,General/Uncertain,6
6597,Inflammation,C0021368,en_1307,AFFECTS,Infection,C3714514,en_6235,4,2,AFFECTS,General/Uncertain,6
6598,Inflammation,C0021368,en_1307,AFFECTS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,General/Uncertain,6
6599,Inflammation,C0021368,en_1307,AFFECTS,Nerve Degeneration,C0027746,en_1657,1,1,AFFECTS,General/Uncertain,3
6600,Inflammation,C0021368,en_1307,AFFECTS,Patients,C0030705,en_1762,4,3,AFFECTS,General/Uncertain,9
6601,Inflammation,C0021368,en_1307,AFFECTS,Drug Kinetics,C0031327,en_1787,1,1,AFFECTS,General/Uncertain,3
6602,Inflammation,C0021368,en_1307,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
6603,Inflammation,C0021368,en_1307,AFFECTS,Natural regeneration,C0034963,en_1988,1,1,AFFECTS,General/Uncertain,3
6604,Inflammation,C0021368,en_1307,AFFECTS,Respiration,C0035203,en_2004,2,1,AFFECTS,General/Uncertain,3
6605,Inflammation,C0021368,en_1307,AFFECTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
6606,Inflammation,C0021368,en_1307,AFFECTS,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,General/Uncertain,3
6607,Inflammation,C0021368,en_1307,AFFECTS,biological adaptation to stress,C0149784,en_2810,1,1,AFFECTS,General/Uncertain,3
6608,Inflammation,C0021368,en_1307,AFFECTS,Blood flow,C0232338,en_3276,1,1,AFFECTS,General/Uncertain,3
6609,Inflammation,C0021368,en_1307,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
6610,Inflammation,C0021368,en_1307,AFFECTS,arterial stiffness,C0599949,en_4491,1,1,AFFECTS,General/Uncertain,3
6611,Inflammation,C0021368,en_1307,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
6612,Inflammation,C0021368,en_1307,AFFECTS,Congestion,C0700148,en_4714,1,1,AFFECTS,General/Uncertain,3
6613,Inflammation,C0021368,en_1307,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
6614,Inflammation,C0021368,en_1307,AFFECTS,Immunologic function,C1268930,en_5445,2,1,AFFECTS,General/Uncertain,3
6615,Inflammation,C0021368,en_1307,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
6616,Inflammation,C0021368,en_1307,COMPLICATES,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
6617,Inflammation,C0021368,en_1307,COMPLICATES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
6618,Inflammation,C0021368,en_1307,PREDISPOSES,Ageusia,C0001800,en_259,1,1,AFFECTS,Excitatory,3
6619,Inflammation,C0021368,en_1307,PREDISPOSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
6620,Inflammation,C0021368,en_1307,PREDISPOSES,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Excitatory,3
6621,Inflammation,C0021368,en_1307,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
6622,Inflammation,C0021368,en_1307,PREDISPOSES,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Excitatory,7
6623,Inflammation,C0021368,en_1307,PREDISPOSES,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,Excitatory,3
6624,Inflammation,C0021368,en_1307,PREDISPOSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,12
6625,Inflammation,C0021368,en_1307,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
6626,Inflammation,C0021368,en_1307,PRODUCES,Argipressin,C0003779,en_395,1,1,AFFECTS,Excitatory,3
6627,Inflammation,C0021368,en_1307,PRODUCES,cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
6628,Inflammation,C0021368,en_1307,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
6629,Chronic inflammation,C0021376,en_1309,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
6630,Chronic inflammation,C0021376,en_1309,PRODUCES,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Excitatory,3
6631,Inflammatory Bowel Diseases,C0021390,en_1310,AFFECTS,Spanish Person,C3161473,en_6177,1,1,AFFECTS,General/Uncertain,6
6632,Inflammatory Bowel Diseases,C0021390,en_1310,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
6633,Influenza,C0021400,en_1311,AFFECTS,Blood Circulation,C0005775,en_483,1,1,AFFECTS,General/Uncertain,3
6634,Influenza,C0021400,en_1311,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
6635,Influenza,C0021400,en_1311,AFFECTS,Fertility,C0015895,en_981,1,1,AFFECTS,General/Uncertain,3
6636,Influenza,C0021400,en_1311,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
6637,Influenza,C0021400,en_1311,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
6638,Influenza,C0021400,en_1311,AFFECTS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,3
6639,Influenza,C0021400,en_1311,AFFECTS,"Tuberculosis, Pulmonary",C0041327,en_2297,1,1,AFFECTS,General/Uncertain,3
6640,Influenza,C0021400,en_1311,AFFECTS,Individual,C0237401,en_3343,2,1,AFFECTS,General/Uncertain,3
6641,Influenza,C0021400,en_1311,AFFECTS,modern society,C0680319,en_4622,1,1,AFFECTS,General/Uncertain,3
6642,Influenza,C0021400,en_1311,AFFECTS(SPEC),Blood Circulation,C0005775,en_483,1,1,AFFECTS,General/Uncertain,3
6643,Influenza,C0021400,en_1311,PREDISPOSES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Excitatory,3
6644,Influenza,C0021400,en_1311,PREDISPOSES,Acute myocardial infarction,C0155626,en_2888,1,1,AFFECTS,Excitatory,3
6645,Influenza,C0021400,en_1311,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,3
6646,Influenza,C0021400,en_1311,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
6647,Influenza virus vaccine,C0021403,en_1312,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
6648,Influenza virus vaccine,C0021403,en_1312,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
6649,Influenza virus vaccine,C0021403,en_1312,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,2,1,AFFECTS,Inhibitory,3
6650,Influenza virus vaccine,C0021403,en_1312,INHIBITS,Angiotensin Receptor,C0034787,en_1963,2,1,AFFECTS,Inhibitory,3
6651,Influenza virus vaccine,C0021403,en_1312,INHIBITS,Cardiovascular event,C1320716,en_5537,1,1,AFFECTS,Inhibitory,8
6652,Influenza virus vaccine,C0021403,en_1312,PREVENTS,Influenza,C0021400,en_1311,3,2,AFFECTS,Inhibitory,6
6653,Influenza virus vaccine,C0021403,en_1312,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
6654,Influenza virus vaccine,C0021403,en_1312,PREVENTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,8
6655,Influenza virus vaccine,C0021403,en_1312,PREVENTS(SPEC),Influenza,C0021400,en_1311,2,1,AFFECTS,Inhibitory,3
6656,Influenza virus vaccine,C0021403,en_1312,STIMULATES,"CD79A,LOC102723407",C1413238,en_191,1,1,AFFECTS,Excitatory,3
6657,Influenza virus vaccine,C0021403,en_1312,STIMULATES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
6658,Influenza virus vaccine,C0021403,en_1312,TREATS,Adult,C0001675,en_252,3,2,AFFECTS,Inhibitory,11
6659,Influenza virus vaccine,C0021403,en_1312,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
6660,Influenza virus vaccine,C0021403,en_1312,TREATS,Mus,C0026809,en_1600,3,3,AFFECTS,Inhibitory,9
6661,Influenza virus vaccine,C0021403,en_1312,TREATS,Persons,C0027361,en_1635,4,1,AFFECTS,Inhibitory,3
6662,Influenza virus vaccine,C0021403,en_1312,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
6663,Informed Consent,C0021430,en_1313,AFFECTS,Laboratory,C0022877,en_1392,2,2,AFFECTS,General/Uncertain,6
6664,Intravenous infusion procedures,C0021440,en_1315,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
6665,Intravenous infusion procedures,C0021440,en_1315,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
6666,Intravenous infusion procedures,C0021440,en_1315,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
6667,Inhalation Therapy,C0021459,en_1316,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
6668,Inhalation Therapy,C0021459,en_1316,TREATS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Inhibitory,6
6669,Inhalation Therapy,C0021459,en_1316,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
6670,Inhalation Therapy,C0021459,en_1316,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
6671,Inhaler,C0021461,en_1317,TREATS,Asthma,C0004096,en_418,2,2,AFFECTS,Inhibitory,6
6672,Inhaler,C0021461,en_1317,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
6673,Inhaler,C0021461,en_1317,TREATS,Mild asthma,C0581124,en_4343,1,1,AFFECTS,Inhibitory,3
6674,Inhaler,C0021461,en_1317,TREATS,Symptoms,C1457887,en_5784,3,1,AFFECTS,Inhibitory,3
6675,nerve supply,C0021516,en_1318,AFFECTS,Contraction,C1140999,en_5281,1,1,AFFECTS,General/Uncertain,3
6676,Inosine,C0021528,en_1319,PREDISPOSES,Myocardial Ischemia,C0151744,en_2865,1,1,AFFECTS,Excitatory,3
6677,Inositol Phosphates,C0021554,en_1320,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
6678,Artificial Insemination,C0021587,en_1322,TREATS,Couples,C0010222,en_725,1,1,AFFECTS,Inhibitory,3
6679,Institutionalization,C0021629,en_1323,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
6680,Insulin,C0021641,en_1324,AFFECTS,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,1,1,AFFECTS,General/Uncertain,3
6681,Insulin,C0021641,en_1324,AUGMENTS,Memory,C0025260,en_1532,1,1,AFFECTS,Excitatory,3
6682,Insulin,C0021641,en_1324,AUGMENTS,Olfactory Thresholds,C0597130,en_4412,1,1,AFFECTS,Excitatory,3
6683,Insulin,C0021641,en_1324,INHIBITS,dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
6684,Insulin,C0021641,en_1324,INHIBITS(SPEC),dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
6685,Insulin,C0021641,en_1324,TREATS,Anosmia,C0003126,en_337,2,1,AFFECTS,Inhibitory,3
6686,Insulin,C0021641,en_1324,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
6687,Insulin,C0021641,en_1324,TREATS,Diabetes,C0011847,en_797,3,2,AFFECTS,Inhibitory,6
6688,Insulin,C0021641,en_1324,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,6
6689,Insulin,C0021641,en_1324,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
6690,Insulin,C0021641,en_1324,TREATS(INFER),"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,3
6691,Insulin Resistance,C0021655,en_1325,AFFECTS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,General/Uncertain,3
6692,Insulin Resistance,C0021655,en_1325,AFFECTS,Caenorhabditis elegans,C0162610,en_2920,1,1,AFFECTS,General/Uncertain,3
6693,Health Insurance,C0021682,en_1326,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
6694,Integrins,C0021701,en_1328,AFFECTS,Extravasation,C0015376,en_949,1,1,AFFECTS,General/Uncertain,3
6695,Integrins,C0021701,en_1328,AFFECTS,Neutrophil Infiltration,C0751982,en_4855,1,1,AFFECTS,General/Uncertain,3
6696,Integrins,C0021701,en_1328,AUGMENTS,Chemotaxis,C0008018,en_615,1,1,AFFECTS,Excitatory,3
6697,Interferon Alfa-2b,C0021735,en_1329,AFFECTS,Immune system,C0020962,en_1271,2,1,AFFECTS,General/Uncertain,3
6698,Interferon Alfa-2b,C0021735,en_1329,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
6699,Recombinant Interferon-gamma,C0021740,en_1330,INHIBITS,Lipoxygenase,C0023837,en_1449,1,1,AFFECTS,Inhibitory,3
6700,Recombinant Interferon-gamma,C0021740,en_1330,STIMULATES,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
6701,Recombinant Interferon-gamma,C0021740,en_1330,STIMULATES,Phagocytes,C0031307,en_1784,1,1,AFFECTS,Excitatory,3
6702,Recombinant Interferon-gamma,C0021740,en_1330,STIMULATES,Proteins,C0033684,en_1912,2,2,AFFECTS,Excitatory,13
6703,Recombinant Interferon-gamma,C0021740,en_1330,STIMULATES,T-Lymphocyte,C0039194,en_2198,2,2,AFFECTS,Excitatory,6
6704,Recombinant Interferon-gamma,C0021740,en_1330,TREATS,Lymphoma,C0024299,en_1471,1,1,AFFECTS,Inhibitory,3
6705,Recombinant Interferon-gamma,C0021740,en_1330,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
6706,Recombinant Interferon-gamma,C0021740,en_1330,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
6707,Interferon Type I,C0021743,en_1331,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
6708,Interferon Type I,C0021743,en_1331,AFFECTS,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,General/Uncertain,3
6709,Interferon Type I,C0021743,en_1331,AUGMENTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,3
6710,Interferon Type I,C0021743,en_1331,AUGMENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,6
6711,Interferon Type I,C0021743,en_1331,DISRUPTS,glycosylation,C0017982,en_1086,2,1,AFFECTS,Inhibitory,3
6712,Interferon Type I,C0021743,en_1331,DISRUPTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,Inhibitory,3
6713,Interferon Type I,C0021743,en_1331,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
6714,Interferon Type II,C0021745,en_1332,AUGMENTS,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,8
6715,Interferons,C0021747,en_1333,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
6716,Interferons,C0021747,en_1333,AFFECTS,enzyme activity,C0243102,en_3464,1,1,AFFECTS,General/Uncertain,3
6717,Interferons,C0021747,en_1333,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
6718,Interferons,C0021747,en_1333,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
6719,Interferons,C0021747,en_1333,AUGMENTS,Gene Expression,C0017262,en_1044,3,3,AFFECTS,Excitatory,13
6720,Interferons,C0021747,en_1333,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
6721,Interferons,C0021747,en_1333,AUGMENTS,"Polymorphism, Genetic",C0032529,en_1849,1,1,AFFECTS,Excitatory,7
6722,Interferons,C0021747,en_1333,AUGMENTS,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
6723,Interferons,C0021747,en_1333,AUGMENTS,T-Cell Activation,C1155065,en_5315,1,1,AFFECTS,Excitatory,3
6724,Interferons,C0021747,en_1333,DISRUPTS,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,Inhibitory,3
6725,Interferons,C0021747,en_1333,DISRUPTS,"Translation, Genetic",C0040711,en_2274,2,1,AFFECTS,Inhibitory,3
6726,Interferons,C0021747,en_1333,DISRUPTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
6727,Interferons,C0021747,en_1333,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
6728,Interferons,C0021747,en_1333,STIMULATES,MX1,C1417510,en_61,1,1,AFFECTS,Excitatory,3
6729,Interferons,C0021747,en_1333,STIMULATES,Cells,C0007634,en_596,2,2,AFFECTS,Excitatory,6
6730,Interferons,C0021747,en_1333,STIMULATES,Genes,C0017337,en_1052,5,4,AFFECTS,Excitatory,12
6731,Interferons,C0021747,en_1333,STIMULATES,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Excitatory,3
6732,Interferons,C0021747,en_1333,STIMULATES,Proteins,C0033684,en_1912,2,2,AFFECTS,Excitatory,6
6733,Interferons,C0021747,en_1333,STIMULATES,cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
6734,Interferons,C0021747,en_1333,STIMULATES,Interleukin-12,C0123759,en_2770,1,1,AFFECTS,Excitatory,3
6735,Interferons,C0021747,en_1333,STIMULATES,"NOS3 protein, human",C0669365,en_4534,1,1,AFFECTS,Excitatory,3
6736,Interferons,C0021747,en_1333,STIMULATES,B3GNT3 gene|B3GNT3,C1422039|10331,en_5722,1,1,AFFECTS,Excitatory,7
6737,Interferons,C0021747,en_1333,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
6738,Interferons,C0021747,en_1333,TREATS,Chiroptera,C0008139,en_625,1,1,AFFECTS,Inhibitory,3
6739,Interferons,C0021747,en_1333,TREATS,Hepatitis B Virus,C0019169,en_1174,1,1,AFFECTS,Inhibitory,3
6740,Interferons,C0021747,en_1333,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
6741,Interferons,C0021747,en_1333,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
6742,Interferons,C0021747,en_1333,TREATS,Patients,C0030705,en_1762,6,4,AFFECTS,Inhibitory,12
6743,Interferons,C0021747,en_1333,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
6744,Interferons,C0021747,en_1333,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,3,3,AFFECTS,Inhibitory,9
6745,Interferons,C0021747,en_1333,TREATS(INFER),"Tuberculosis, Pulmonary",C0041327,en_2297,1,1,AFFECTS,Inhibitory,3
6746,Interferons,C0021747,en_1333,TREATS(INFER),Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
6747,Interleukin-1 beta,C0021753,en_1334,AFFECTS,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,General/Uncertain,3
6748,Interleukin-1 beta,C0021753,en_1334,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
6749,Interleukin-1 beta,C0021753,en_1334,AFFECTS,Physiologic Responses,C1546213,en_5952,1,1,AFFECTS,General/Uncertain,3
6750,Interleukin-1 beta,C0021753,en_1334,AFFECTS(SPEC),Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
6751,Interleukin-1 beta,C0021753,en_1334,AUGMENTS,Menstruation,C0025344,en_1540,1,1,AFFECTS,Excitatory,3
6752,Interleukin-1 beta,C0021753,en_1334,AUGMENTS,Nasal Polyps,C0027430,en_1640,1,1,AFFECTS,Excitatory,3
6753,Interleukin-1 beta,C0021753,en_1334,AUGMENTS,Protoplasm,C0175996,en_2976,2,2,AFFECTS,Excitatory,6
6754,Interleukin-1 beta,C0021753,en_1334,AUGMENTS,Inflammation Process,C1512753,en_5825,2,2,AFFECTS,Excitatory,6
6755,Interleukin-1 beta,C0021753,en_1334,DISRUPTS,Armed macrophage,C0001280,en_228,1,1,AFFECTS,Inhibitory,3
6756,Interleukin-1 beta,C0021753,en_1334,DISRUPTS,Extravasation,C0015376,en_949,2,1,AFFECTS,Inhibitory,3
6757,Interleukin-1 beta,C0021753,en_1334,DISRUPTS,Granuloma,C0018188,en_1094,1,1,AFFECTS,Inhibitory,3
6758,Interleukin-1 beta,C0021753,en_1334,DISRUPTS,Inferior Colliculus,C0021358,en_1304,1,1,AFFECTS,Inhibitory,3
6759,Interleukin-1 beta,C0021753,en_1334,INHIBITS,TNF gene,C0812246,en_4896,1,1,AFFECTS,Inhibitory,3
6760,Interleukin-1 beta,C0021753,en_1334,PREDISPOSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
6761,Interleukin-1 beta,C0021753,en_1334,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
6762,Interleukin-1 beta,C0021753,en_1334,PRODUCES,cytokine,C0079189,en_2593,3,2,AFFECTS,Excitatory,6
6763,Interleukin-1 beta,C0021753,en_1334,PRODUCES,Interleukin-18,C0383327,en_3902,1,1,AFFECTS,Excitatory,3
6764,Interleukin-1 beta,C0021753,en_1334,STIMULATES,Cells,C0007634,en_596,2,2,AFFECTS,Excitatory,6
6765,Interleukin-1 beta,C0021753,en_1334,STIMULATES,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,3
6766,Interleukin-1 beta,C0021753,en_1334,STIMULATES,macrophage,C0024432,en_1484,1,1,AFFECTS,Excitatory,3
6767,Interleukin-1 beta,C0021753,en_1334,STIMULATES,Opioid Receptor,C0034801,en_1967,1,1,AFFECTS,Excitatory,3
6768,Interleukin-1 beta,C0021753,en_1334,STIMULATES,Interleukin-17,C0384648,en_3903,1,1,AFFECTS,Excitatory,3
6769,Interleukin-1 beta,C0021753,en_1334,STIMULATES,Toll-Like Receptor 2,C0754728,en_4860,1,1,AFFECTS,Excitatory,3
6770,Interleukin-1 beta,C0021753,en_1334,STIMULATES(SPEC),C-reactive protein,C0006560,en_529,2,1,AFFECTS,Excitatory,3
6771,Interleukin-1 beta,C0021753,en_1334,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
6772,Interleukin-1 beta,C0021753,en_1334,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
6773,Interleukin-1 beta|IL1B,C0021753|3553,en_1335,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
6774,Interleukin-1,C0021755,en_1336,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,7
6775,Interleukin-2,C0021756,en_1337,PRODUCES,Interferon Type II,C0021745,en_1332,1,1,AFFECTS,Excitatory,3
6776,Interleukin-2,C0021756,en_1337,PRODUCES,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,1,1,AFFECTS,Excitatory,3
6777,Interleukin-2,C0021756,en_1337,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
6778,Interleukin-2,C0021756,en_1337,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
6779,Interleukin-2|IL2,C0021756|3558,en_1338,DISRUPTS,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Inhibitory,7
6780,Interleukin-3,C0021757,en_1339,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
6781,Interleukin-4,C0021758,en_1340,INHIBITS,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Inhibitory,3
6782,Interleukin-4,C0021758,en_1340,INHIBITS,Hydroxyl Radical,C0063146,en_2503,1,1,AFFECTS,Inhibitory,3
6783,Interleukin-5,C0021759,en_1341,INHIBITS,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Inhibitory,3
6784,Interleukin-5,C0021759,en_1341,INHIBITS,Hydroxyl Radical,C0063146,en_2503,1,1,AFFECTS,Inhibitory,3
6785,Interleukin-6,C0021760,en_1342,AFFECTS,Acute-Phase Reaction,C0001349,en_233,1,1,AFFECTS,General/Uncertain,6
6786,Interleukin-6,C0021760,en_1342,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
6787,Interleukin-6,C0021760,en_1342,AFFECTS,Immune system,C0020962,en_1271,3,2,AFFECTS,General/Uncertain,6
6788,Interleukin-6,C0021760,en_1342,AFFECTS,Permeability,C0031164,en_1779,1,1,AFFECTS,General/Uncertain,3
6789,Interleukin-6,C0021760,en_1342,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
6790,Interleukin-6,C0021760,en_1342,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,8
6791,Interleukin-6,C0021760,en_1342,AFFECTS,Reduction (chemical),C0301630,en_3691,1,1,AFFECTS,General/Uncertain,8
6792,Interleukin-6,C0021760,en_1342,AFFECTS,Immune,C0439662,en_4035,1,1,AFFECTS,General/Uncertain,7
6793,Interleukin-6,C0021760,en_1342,AFFECTS,Cytokine storm,C0919747,en_5119,2,2,AFFECTS,General/Uncertain,6
6794,Interleukin-6,C0021760,en_1342,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
6795,Interleukin-6,C0021760,en_1342,AFFECTS,Storm NOS,C2905612,en_6141,1,1,AFFECTS,General/Uncertain,7
6796,Interleukin-6,C0021760,en_1342,AFFECTS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,General/Uncertain,6
6797,Interleukin-6,C0021760,en_1342,AUGMENTS,Cardiac Output,C0007165,en_565,1,1,AFFECTS,Excitatory,3
6798,Interleukin-6,C0021760,en_1342,AUGMENTS,Menstruation,C0025344,en_1540,1,1,AFFECTS,Excitatory,3
6799,Interleukin-6,C0021760,en_1342,AUGMENTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,Excitatory,3
6800,Interleukin-6,C0021760,en_1342,AUGMENTS,Vascular Permeability,C0162337,en_2906,1,1,AFFECTS,Excitatory,3
6801,Interleukin-6,C0021760,en_1342,AUGMENTS,Protoplasm,C0175996,en_2976,2,2,AFFECTS,Excitatory,6
6802,Interleukin-6,C0021760,en_1342,AUGMENTS,Plethora,C0232370,en_3277,2,1,AFFECTS,Excitatory,3
6803,Interleukin-6,C0021760,en_1342,AUGMENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,6
6804,Interleukin-6,C0021760,en_1342,AUGMENTS,Inflammation Process,C1512753,en_5825,2,2,AFFECTS,Excitatory,6
6805,Interleukin-6,C0021760,en_1342,DISRUPTS,Armed macrophage,C0001280,en_228,1,1,AFFECTS,Inhibitory,3
6806,Interleukin-6,C0021760,en_1342,DISRUPTS,Autophagy,C0004391,en_432,2,2,AFFECTS,Inhibitory,6
6807,Interleukin-6,C0021760,en_1342,DISRUPTS,Blood,C0005767,en_482,1,1,AFFECTS,Inhibitory,3
6808,Interleukin-6,C0021760,en_1342,DISRUPTS,Cessation of life,C0011065,en_762,2,1,AFFECTS,Inhibitory,3
6809,Interleukin-6,C0021760,en_1342,DISRUPTS,Granuloma,C0018188,en_1094,1,1,AFFECTS,Inhibitory,3
6810,Interleukin-6,C0021760,en_1342,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,6
6811,Interleukin-6,C0021760,en_1342,DISRUPTS,neutrophil,C0027950,en_1676,1,1,AFFECTS,Inhibitory,3
6812,Interleukin-6,C0021760,en_1342,DISRUPTS,Phosphorylation,C0031715,en_1800,1,1,AFFECTS,Inhibitory,3
6813,Interleukin-6,C0021760,en_1342,DISRUPTS,Decompensation,C0231187,en_3250,1,1,AFFECTS,Inhibitory,3
6814,Interleukin-6,C0021760,en_1342,DISRUPTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
6815,Interleukin-6,C0021760,en_1342,DISRUPTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,Inhibitory,3
6816,Interleukin-6,C0021760,en_1342,DISRUPTS,Clinical Response,C4055223,en_6311,1,1,AFFECTS,Inhibitory,8
6817,Interleukin-6,C0021760,en_1342,INHIBITS,SIRT1,C1423062,en_121,1,1,AFFECTS,Inhibitory,3
6818,Interleukin-6,C0021760,en_1342,INHIBITS,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Inhibitory,3
6819,Interleukin-6,C0021760,en_1342,INHIBITS,Proteins,C0033684,en_1912,1,1,AFFECTS,Inhibitory,3
6820,Interleukin-6,C0021760,en_1342,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,6
6821,Interleukin-6,C0021760,en_1342,INHIBITS,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Inhibitory,3
6822,Interleukin-6,C0021760,en_1342,INHIBITS,TNF gene,C0812246,en_4896,4,3,AFFECTS,Inhibitory,9
6823,Interleukin-6,C0021760,en_1342,INHIBITS,ATM gene,C0919524,en_5114,13,2,AFFECTS,Inhibitory,6
6824,Interleukin-6,C0021760,en_1342,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
6825,Interleukin-6,C0021760,en_1342,PREDISPOSES,Heart Injuries,C0018805,en_1137,1,1,AFFECTS,Excitatory,6
6826,Interleukin-6,C0021760,en_1342,PREDISPOSES,Inflammation,C0021368,en_1307,2,2,AFFECTS,Excitatory,9
6827,Interleukin-6,C0021760,en_1342,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
6828,Interleukin-6,C0021760,en_1342,PREDISPOSES,Fatal Outcome,C0206277,en_3157,2,2,AFFECTS,Excitatory,6
6829,Interleukin-6,C0021760,en_1342,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Excitatory,3
6830,Interleukin-6,C0021760,en_1342,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,7
6831,Interleukin-6,C0021760,en_1342,PREDISPOSES,cell injury,C0599732,en_4467,1,1,AFFECTS,Excitatory,6
6832,Interleukin-6,C0021760,en_1342,PREDISPOSES,Right ventricular systolic dysfunction,C1562095,en_5969,1,1,AFFECTS,Excitatory,6
6833,Interleukin-6,C0021760,en_1342,PREDISPOSES,Right ventricular failure,C2939447,en_6155,1,1,AFFECTS,Excitatory,6
6834,Interleukin-6,C0021760,en_1342,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
6835,Interleukin-6,C0021760,en_1342,PREVENTS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Inhibitory,3
6836,Interleukin-6,C0021760,en_1342,PREVENTS,Pulmonary Edema,C0034063,en_1929,2,2,AFFECTS,Inhibitory,6
6837,Interleukin-6,C0021760,en_1342,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
6838,Interleukin-6,C0021760,en_1342,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
6839,Interleukin-6,C0021760,en_1342,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,2,AFFECTS,Inhibitory,6
6840,Interleukin-6,C0021760,en_1342,PRODUCES,Colchicine,C0009262,en_672,2,1,AFFECTS,Excitatory,3
6841,Interleukin-6,C0021760,en_1342,PRODUCES,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Excitatory,3
6842,Interleukin-6,C0021760,en_1342,PRODUCES,Mucous body substance,C0026727,en_1595,3,1,AFFECTS,Excitatory,3
6843,Interleukin-6,C0021760,en_1342,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
6844,Interleukin-6,C0021760,en_1342,PRODUCES,Interleukin-18,C0383327,en_3902,1,1,AFFECTS,Excitatory,3
6845,Interleukin-6,C0021760,en_1342,PRODUCES,TNF gene,C0812246,en_4896,4,3,AFFECTS,Excitatory,9
6846,Interleukin-6,C0021760,en_1342,PRODUCES,Complement factor,C1305959,en_5520,1,1,AFFECTS,Excitatory,3
6847,Interleukin-6,C0021760,en_1342,PRODUCES,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Excitatory,3
6848,Interleukin-6,C0021760,en_1342,STIMULATES,Cells,C0007634,en_596,2,2,AFFECTS,Excitatory,6
6849,Interleukin-6,C0021760,en_1342,STIMULATES,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Excitatory,3
6850,Interleukin-6,C0021760,en_1342,STIMULATES,Epithelial Cells,C0014597,en_919,1,1,AFFECTS,Excitatory,3
6851,Interleukin-6,C0021760,en_1342,STIMULATES,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Excitatory,3
6852,Interleukin-6,C0021760,en_1342,STIMULATES,Androgen Receptor,C0034786,en_1962,1,1,AFFECTS,Excitatory,3
6853,Interleukin-6,C0021760,en_1342,STIMULATES,T-Lymphocyte,C0039194,en_2198,3,1,AFFECTS,Excitatory,3
6854,Interleukin-6,C0021760,en_1342,STIMULATES,"T-Lymphocytes, Cytotoxic",C0039195,en_2199,1,1,AFFECTS,Excitatory,3
6855,Interleukin-6,C0021760,en_1342,STIMULATES,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Excitatory,3
6856,Interleukin-6,C0021760,en_1342,STIMULATES,Interleukin-15,C0254610,en_3491,1,1,AFFECTS,Excitatory,3
6857,Interleukin-6,C0021760,en_1342,STIMULATES,human leukocyte interferon,C0733470,en_4772,2,1,AFFECTS,Excitatory,3
6858,Interleukin-6,C0021760,en_1342,STIMULATES,TNF gene,C0812246,en_4896,1,1,AFFECTS,Excitatory,3
6859,Interleukin-6,C0021760,en_1342,STIMULATES,androgen receptor activity,C1148774,en_5298,1,1,AFFECTS,Excitatory,3
6860,Interleukin-7,C0021761,en_1343,STIMULATES,Interleukin-2,C0021756,en_1337,1,1,AFFECTS,Excitatory,3
6861,Interleukin-7,C0021761,en_1343,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
6862,Interleukin-7|IL7,C0021761|3574,en_1344,DISRUPTS,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Inhibitory,7
6863,Interleukins,C0021764,en_1345,AUGMENTS,Immune response,C0301872,en_3696,2,1,AFFECTS,Excitatory,3
6864,Interleukins,C0021764,en_1345,DISRUPTS,Expectation,C0679138,en_4589,1,1,AFFECTS,Inhibitory,3
6865,Interleukins,C0021764,en_1345,INHIBITS,"TNF protein, human",C1448177,en_5755,2,1,AFFECTS,Inhibitory,3
6866,Intermittent Positive-Pressure Ventilation,C0021778,en_1346,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
6867,Internship,C0021793,en_1347,AFFECTS,Readiness,C1318963,en_5534,1,1,AFFECTS,General/Uncertain,3
6868,Intestinal Diseases,C0021831,en_1348,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
6869,Intestinal Mucosa,C0021839,en_1349,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
6870,Intracranial Pressure,C0021880,en_1351,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,3
6871,Intubation,C0021925,en_1352,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
6872,Intubation,C0021925,en_1352,AFFECTS,pulmonary function,C0231921,en_3268,2,1,AFFECTS,General/Uncertain,3
6873,Intubation,C0021925,en_1352,AFFECTS,Alveolar ventilation function,C0231940,en_3269,4,2,AFFECTS,General/Uncertain,6
6874,Intubation,C0021925,en_1352,AFFECTS,viral transmission,C1160716,en_5362,4,1,AFFECTS,General/Uncertain,3
6875,Intubation,C0021925,en_1352,PREDISPOSES,Secondary infection,C0442886,en_4061,2,1,AFFECTS,Excitatory,3
6876,Intubation,C0021925,en_1352,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
6877,Intubation,C0021925,en_1352,PREVENTS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,3
6878,Intubation,C0021925,en_1352,PREVENTS,Organ failure,C0948600,en_5171,1,1,AFFECTS,Inhibitory,3
6879,Intubation,C0021925,en_1352,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6880,Intubation,C0021925,en_1352,TREATS,Patients,C0030705,en_1762,33,15,AFFECTS,Inhibitory,45
6881,Intubation,C0021925,en_1352,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,2,AFFECTS,Inhibitory,6
6882,Intubation,C0021925,en_1352,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
6883,Intubation,C0021925,en_1352,TREATS,"Pneumonitis, Interstitial",C0206061,en_3141,2,1,AFFECTS,Inhibitory,6
6884,Intubation,C0021925,en_1352,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,6
6885,Intubation,C0021925,en_1352,TREATS,Respiratory failure without hypercapnia,C0340194,en_3812,1,1,AFFECTS,Inhibitory,6
6886,Intubation,C0021925,en_1352,TREATS,Inspired fraction of oxygen,C0428167,en_4012,2,1,AFFECTS,Inhibitory,3
6887,Intubation,C0021925,en_1352,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,3
6888,Intubation,C0021925,en_1352,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
6889,Intubation,C0021925,en_1352,TREATS,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Inhibitory,3
6890,Intubation,C0021925,en_1352,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
6891,Intubation,C0021925,en_1352,TREATS,Intubated,C4698386,en_6376,1,1,AFFECTS,Inhibitory,6
6892,Intubation,C0021925,en_1352,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12
6893,Intubation,C0021925,en_1352,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
6894,Intubation,C0021925,en_1352,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,2,2,AFFECTS,Inhibitory,6
6895,Intubation,C0021925,en_1352,TREATS(INFER),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
6896,"Intubation, Intratracheal",C0021932,en_1353,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
6897,"Intubation, Intratracheal",C0021932,en_1353,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
6898,"Intubation, Intratracheal",C0021932,en_1353,COMPLICATES,"Acidosis, Respiratory",C0001127,en_224,1,1,AFFECTS,General/Uncertain,3
6899,"Intubation, Intratracheal",C0021932,en_1353,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
6900,"Intubation, Intratracheal",C0021932,en_1353,TREATS,Patients,C0030705,en_1762,4,4,AFFECTS,Inhibitory,12
6901,"Intubation, Intratracheal",C0021932,en_1353,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,6
6902,"Intubation, Intratracheal",C0021932,en_1353,TREATS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
6903,"Intubation, Intratracheal",C0021932,en_1353,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,14
6904,"Intubation, Intratracheal",C0021932,en_1353,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
6905,Iodides,C0021966,en_1354,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
6906,Iodides,C0021966,en_1354,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,6
6907,Ionophores,C0022022,en_1356,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
6908,Ionophores,C0022022,en_1356,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
6909,Ions,C0022023,en_1357,AFFECTS,"Radiation, Charged Particles",C1516444,en_5857,2,1,AFFECTS,General/Uncertain,3
6910,Ions,C0022023,en_1357,INHIBITS,"S100A1,S100B",C1419781;C1419790,en_180,1,1,AFFECTS,Inhibitory,3
6911,Ions,C0022023,en_1357,STIMULATES,Buffers,C0006353,en_523,1,1,AFFECTS,Excitatory,3
6912,Iron Chelating Agents,C0022086,en_1358,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
6913,Irrigation,C0022100,en_1359,AFFECTS,Sinusitis,C0037199,en_2112,1,1,AFFECTS,General/Uncertain,8
6914,Irrigation,C0022100,en_1359,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6915,Irrigation,C0022100,en_1359,PREVENTS,Virus Shedding,C0162633,en_2921,2,1,AFFECTS,Inhibitory,3
6916,Irrigation,C0022100,en_1359,PREVENTS,Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
6917,Irrigation,C0022100,en_1359,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
6918,Irrigation,C0022100,en_1359,TREATS,"Infections, Upper Respiratory",C0041912,en_2315,1,1,AFFECTS,Inhibitory,3
6919,Irrigation,C0022100,en_1359,TREATS,Chronic sinusitis NOS,C0149516,en_2800,1,1,AFFECTS,Inhibitory,8
6920,Irrigation,C0022100,en_1359,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
6921,Irrigation,C0022100,en_1359,TREATS,post operative (finding),C0241311,en_3389,1,1,AFFECTS,Inhibitory,8
6922,Irrigation,C0022100,en_1359,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
6923,Irrigation,C0022100,en_1359,TREATS(INFER),Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,3
6924,Irritants,C0022108,en_1362,PREDISPOSES,Respiratory morbidity,C1301752,en_5512,1,1,AFFECTS,Excitatory,7
6925,Ischemia,C0022116,en_1363,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
6926,Ischemia,C0022116,en_1363,DISRUPTS,Platelet aggregation,C0032176,en_1828,1,1,AFFECTS,Inhibitory,3
6927,Ischemia,C0022116,en_1363,PREDISPOSES,Liver Dysfunction,C0086565,en_2726,1,1,AFFECTS,Excitatory,3
6928,Isoflurane,C0022180,en_1364,TREATS,Patient's condition improved,C0438108,en_4030,2,1,AFFECTS,Inhibitory,3
6929,Isoleucine,C0022192,en_1365,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
6930,Isoleucine,C0022192,en_1365,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
6931,Isomerism,C0022203,en_1366,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
6932,isoniazid,C0022209,en_1367,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6933,Isoproterenol,C0022245,en_1369,TREATS,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Inhibitory,3
6934,Isotretinoin,C0022265,en_1370,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
6935,Isotretinoin,C0022265,en_1370,AUGMENTS,"T-Lymphocytes, Cytotoxic",C0039195,en_2199,1,1,AFFECTS,Excitatory,3
6936,Isotretinoin,C0022265,en_1370,AUGMENTS,"Immunity, Mucosal",C0282558,en_3653,2,1,AFFECTS,Excitatory,3
6937,Isotretinoin,C0022265,en_1370,AUGMENTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,Excitatory,3
6938,Isotretinoin,C0022265,en_1370,DISRUPTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
6939,Isotretinoin,C0022265,en_1370,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
6940,Isotretinoin,C0022265,en_1370,INHIBITS,Endopeptidases,C0030946,en_1770,4,2,AFFECTS,Inhibitory,6
6941,Isotretinoin,C0022265,en_1370,INHIBITS,Stanolone,C0038148,en_2152,4,3,AFFECTS,Inhibitory,9
6942,Isotretinoin,C0022265,en_1370,INHIBITS,CD14 Antigen,C0108768,en_2758,1,1,AFFECTS,Inhibitory,3
6943,Isotretinoin,C0022265,en_1370,INHIBITS,ATM gene,C0919524,en_5114,4,2,AFFECTS,Inhibitory,6
6944,Isotretinoin,C0022265,en_1370,INHIBITS,epitheliasin,C0964578,en_5200,3,2,AFFECTS,Inhibitory,6
6945,Isotretinoin,C0022265,en_1370,INHIBITS(SPEC),Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
6946,Isotretinoin,C0022265,en_1370,PREVENTS,Viremia,C0042749,en_2359,2,1,AFFECTS,Inhibitory,3
6947,Isotretinoin,C0022265,en_1370,STIMULATES,Genes,C0017337,en_1052,1,1,AFFECTS,Excitatory,3
6948,Isotretinoin,C0022265,en_1370,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
6949,Isotretinoin,C0022265,en_1370,TREATS,Patients,C0030705,en_1762,6,4,AFFECTS,Inhibitory,12
6950,Isotretinoin,C0022265,en_1370,TREATS,skin disorder,C0037274,en_2115,3,1,AFFECTS,Inhibitory,3
6951,Isotretinoin,C0022265,en_1370,TREATS(SPEC),Acne,C0702166,en_4736,4,2,AFFECTS,Inhibitory,6
6952,Ivermectin,C0022322,en_1371,AFFECTS,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
6953,Ivermectin,C0022322,en_1371,AFFECTS,Contagion,C0598197,en_4444,1,1,AFFECTS,General/Uncertain,3
6954,Ivermectin,C0022322,en_1371,AFFECTS,nucleocytoplasmic transport,C0872070,en_5034,2,1,AFFECTS,General/Uncertain,3
6955,Ivermectin,C0022322,en_1371,AFFECTS,anticoagulant activity,C1148561,en_5297,1,1,AFFECTS,General/Uncertain,3
6956,Ivermectin,C0022322,en_1371,AFFECTS(SPEC),Anosmia,C0003126,en_337,2,1,AFFECTS,General/Uncertain,3
6957,Ivermectin,C0022322,en_1371,AUGMENTS,Negative,C0205160,en_3126,1,1,AFFECTS,Excitatory,8
6958,Ivermectin,C0022322,en_1371,DISRUPTS,Virus Diseases,C0042769,en_2362,5,3,AFFECTS,Inhibitory,9
6959,Ivermectin,C0022322,en_1371,DISRUPTS,Nuclear Import,C0887839,en_5087,1,1,AFFECTS,Inhibitory,3
6960,Ivermectin,C0022322,en_1371,INHIBITS,Negative,C0205160,en_3126,1,1,AFFECTS,Inhibitory,8
6961,Ivermectin,C0022322,en_1371,INHIBITS,receptor,C0597357,en_4422,1,1,AFFECTS,Inhibitory,3
6962,Ivermectin,C0022322,en_1371,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,8
6963,Ivermectin,C0022322,en_1371,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
6964,Ivermectin,C0022322,en_1371,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
6965,Ivermectin,C0022322,en_1371,PREVENTS,Viremia,C0042749,en_2359,1,1,AFFECTS,Inhibitory,3
6966,Ivermectin,C0022322,en_1371,PREVENTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,3
6967,Ivermectin,C0022322,en_1371,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
6968,Ivermectin,C0022322,en_1371,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
6969,Ivermectin,C0022322,en_1371,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
6970,Ivermectin,C0022322,en_1371,TREATS,Disease,C0012634,en_826,9,6,AFFECTS,Inhibitory,23
6971,Ivermectin,C0022322,en_1371,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
6972,Ivermectin,C0022322,en_1371,TREATS,Households,C0020052,en_1208,3,1,AFFECTS,Inhibitory,3
6973,Ivermectin,C0022322,en_1371,TREATS,Human,C0020114,en_1210,9,6,AFFECTS,Inhibitory,18
6974,Ivermectin,C0022322,en_1371,TREATS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
6975,Ivermectin,C0022322,en_1371,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
6976,Ivermectin,C0022322,en_1371,TREATS,Onchocerciasis,C0029001,en_1709,4,3,AFFECTS,Inhibitory,9
6977,Ivermectin,C0022322,en_1371,TREATS,Outpatients,C0029921,en_1729,4,2,AFFECTS,Inhibitory,6
6978,Ivermectin,C0022322,en_1371,TREATS,Patients,C0030705,en_1762,32,19,AFFECTS,Inhibitory,57
6979,Ivermectin,C0022322,en_1371,TREATS,Present,C0150312,en_2833,1,1,AFFECTS,Inhibitory,7
6980,Ivermectin,C0022322,en_1371,TREATS,Infected,C0439663,en_4036,2,2,AFFECTS,Inhibitory,16
6981,Ivermectin,C0022322,en_1371,TREATS,cohort,C0599755,en_4470,3,1,AFFECTS,Inhibitory,3
6982,Ivermectin,C0022322,en_1371,TREATS,Parasitic infection,C0747256,en_4823,1,1,AFFECTS,Inhibitory,3
6983,Ivermectin,C0022322,en_1371,TREATS,Hospitalized Patients,C0870668,en_5010,5,4,AFFECTS,Inhibitory,25
6984,Ivermectin,C0022322,en_1371,TREATS,Symptoms,C1457887,en_5784,5,3,AFFECTS,Inhibitory,14
6985,Ivermectin,C0022322,en_1371,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score A,C3272281,en_6189,1,1,AFFECTS,Inhibitory,7
6986,Ivermectin,C0022322,en_1371,TREATS,Epidermal cGVHD Score 2,C4761314,en_6403,3,2,AFFECTS,Inhibitory,15
6987,Ivermectin,C0022322,en_1371,TREATS,COVID-19,C5203670,en_6417,16,10,AFFECTS,Inhibitory,76
6988,Ivermectin,C0022322,en_1371,TREATS(INFER),Disease,C0012634,en_826,5,3,AFFECTS,Inhibitory,9
6989,Ivermectin,C0022322,en_1371,TREATS(INFER),Asymptomatic,C0231221,en_3252,2,1,AFFECTS,Inhibitory,3
6990,Ivermectin,C0022322,en_1371,TREATS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6991,Kininogenase,C0022478,en_1374,AFFECTS,Angioneurotic Edema,C0002994,en_325,1,1,AFFECTS,General/Uncertain,3
6992,Kininogenase,C0022478,en_1374,AFFECTS,Extravasation,C0015376,en_949,1,1,AFFECTS,General/Uncertain,3
6993,Kininogenase,C0022478,en_1374,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
6994,Ketamine,C0022614,en_1376,INHIBITS,aspartic acid receptor,C0052536,en_2438,1,1,AFFECTS,Inhibitory,3
6995,Ketamine,C0022614,en_1376,PREVENTS,Depressive Symptoms,C0086132,en_2702,2,1,AFFECTS,Inhibitory,3
6996,Ketamine,C0022614,en_1376,STIMULATES,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C0047123,en_2419,1,1,AFFECTS,Excitatory,3
6997,Ketamine,C0022614,en_1376,STIMULATES,"Receptors, AMPA",C0072899,en_2554,1,1,AFFECTS,Excitatory,3
6998,Ketamine,C0022614,en_1376,TREATS,Bipolar Disorder,C0005586,en_474,1,1,AFFECTS,Inhibitory,3
6999,Ketamine,C0022614,en_1376,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
7000,Ketamine,C0022614,en_1376,TREATS,Treatment Resistant Depression,C0871546,en_5026,1,1,AFFECTS,Inhibitory,3
7001,Ketamine,C0022614,en_1376,TREATS,Major Depressive Disorder,C1269683,en_5447,1,1,AFFECTS,Inhibitory,3
7002,Ketone Bodies,C0022631,en_1377,AFFECTS,Partial Pressure,C0030604,en_1754,1,1,AFFECTS,General/Uncertain,3
7003,Ketone Bodies,C0022631,en_1377,AUGMENTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,Excitatory,3
7004,Ketotifen,C0022642,en_1379,PREVENTS(SPEC),Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
7005,Ketotifen,C0022642,en_1379,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7006,Ketotifen,C0022642,en_1379,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
7007,Ketotifen,C0022642,en_1379,TREATS(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
7008,Kidney,C0022646,en_1380,PRODUCES,Autoantibodies,C0004358,en_426,1,1,AFFECTS,Excitatory,3
7009,Kidney Diseases,C0022658,en_1381,AFFECTS,microvasculature,C0243079,en_3458,1,1,AFFECTS,General/Uncertain,3
7010,"Kidney Failure, Acute",C0022660,en_1382,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
7011,"Kidney Failure, Acute",C0022660,en_1382,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
7012,"Kidney Failure, Acute",C0022660,en_1382,COMPLICATES,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
7013,"Kidney Failure, Acute",C0022660,en_1382,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,6
7014,"Kidney Failure, Acute",C0022660,en_1382,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
7015,"Kidney Failure, Acute",C0022660,en_1382,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
7016,"Kidney Failure, Acute",C0022660,en_1382,PREDISPOSES,Chronic Kidney Diseases,C1561643,en_5967,1,1,AFFECTS,Excitatory,6
7017,"Kidney Failure, Chronic",C0022661,en_1383,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
7018,"Kidney Failure, Chronic",C0022661,en_1383,AFFECTS,Participant,C0679646,en_4602,2,1,AFFECTS,General/Uncertain,3
7019,"Kidney Failure, Chronic",C0022661,en_1383,COMPLICATES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
7020,"Kidney Failure, Chronic",C0022661,en_1383,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
7021,"Kidney Failure, Chronic",C0022661,en_1383,PREDISPOSES,D-dimer above reference range,C0742969,en_4798,1,1,AFFECTS,Excitatory,6
7022,Kidney Transplantation,C0022671,en_1384,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
7023,Kidney Transplantation,C0022671,en_1384,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
7024,Kidney Transplantation,C0022671,en_1384,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,6
7025,Kidney Transplantation,C0022671,en_1384,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,6
7026,Kidney Transplantation,C0022671,en_1384,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7027,Kidney Transplantation,C0022671,en_1384,TREATS,General Population,C0683971,en_4674,3,1,AFFECTS,Inhibitory,3
7028,Kidney Transplantation,C0022671,en_1384,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
7029,Natural Killer Cells,C0022688,en_1386,AFFECTS,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,General/Uncertain,3
7030,Natural Killer Cells,C0022688,en_1386,AFFECTS,Immune response,C0301872,en_3696,3,2,AFFECTS,General/Uncertain,6
7031,Natural Killer Cells,C0022688,en_1386,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
7032,Natural Killer Cells,C0022688,en_1386,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
7033,Natural Killer Cells,C0022688,en_1386,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,7
7034,Natural Killer Cells,C0022688,en_1386,PRODUCES,perforin,C0070410,en_2541,1,1,AFFECTS,Excitatory,3
7035,Natural Killer Cells,C0022688,en_1386,PRODUCES,Interleukin-15,C0254610,en_3491,1,1,AFFECTS,Excitatory,3
7036,Natural Killer Cells,C0022688,en_1386,PRODUCES,Neural Cell Adhesion Molecules,C0282587,en_3657,1,1,AFFECTS,Excitatory,3
7037,Natural Killer Cells,C0022688,en_1386,PRODUCES,MUC3 protein,C0291545,en_3677,1,1,AFFECTS,Excitatory,7
7038,Natural Killer Cells,C0022688,en_1386,PRODUCES,T cell antibody,C0312594,en_3733,1,1,AFFECTS,Excitatory,7
7039,Peptidyl-Dipeptidase A,C0022709,en_1387,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
7040,Peptidyl-Dipeptidase A,C0022709,en_1387,AFFECTS,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,1,1,AFFECTS,General/Uncertain,3
7041,Peptidyl-Dipeptidase A,C0022709,en_1387,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,General/Uncertain,3
7042,Peptidyl-Dipeptidase A,C0022709,en_1387,AUGMENTS,Hydrolysis,C0020291,en_1223,1,1,AFFECTS,Excitatory,3
7043,Peptidyl-Dipeptidase A,C0022709,en_1387,AUGMENTS,Vasodilation,C0042401,en_2342,1,1,AFFECTS,Excitatory,3
7044,Peptidyl-Dipeptidase A,C0022709,en_1387,DISRUPTS,Hydrolysis,C0020291,en_1223,1,1,AFFECTS,Inhibitory,3
7045,Peptidyl-Dipeptidase A,C0022709,en_1387,INHIBITS,small molecule,C1328819,en_5573,1,1,AFFECTS,Inhibitory,3
7046,Peptidyl-Dipeptidase A,C0022709,en_1387,STIMULATES,Antioxidants,C0003402,en_372,1,1,AFFECTS,Excitatory,3
7047,Kynurenine,C0022818,en_1389,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,6
7048,Kynurenine,C0022818,en_1389,PRODUCES,Tryptophan,C0041249,en_2291,1,1,AFFECTS,Excitatory,7
7049,Kynurenine,C0022818,en_1389,PRODUCES,Dioxygenases,C0599874,en_4479,1,1,AFFECTS,Excitatory,7
7050,Labor (Childbirth),C0022864,en_1390,AFFECTS,Birth,C0005615,en_476,2,1,AFFECTS,General/Uncertain,3
7051,Labor (Childbirth),C0022864,en_1390,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
7052,Labor (Childbirth),C0022864,en_1390,AFFECTS,Vibration - physical agent,C0459800,en_4125,1,1,AFFECTS,General/Uncertain,3
7053,Lactams,C0022914,en_1394,TREATS,Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,6
7054,Lactams,C0022914,en_1394,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
7055,Lactams,C0022914,en_1394,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
7056,Lactate Dehydrogenase,C0022917,en_1395,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,6
7057,Lactate Dehydrogenase,C0022917,en_1395,INHIBITS,Ferritin,C0015879,en_980,1,1,AFFECTS,Inhibitory,8
7058,Lactate Dehydrogenase,C0022917,en_1395,PREDISPOSES,Respiratory Failure,C1145670,en_5292,2,2,AFFECTS,Excitatory,12
7059,Lactate Dehydrogenase,C0022917,en_1395,PREDISPOSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,12
7060,Lactate Dehydrogenase,C0022917,en_1395,STIMULATES,Ferritin,C0015879,en_980,1,1,AFFECTS,Excitatory,6
7061,Lactate Dehydrogenase,C0022917,en_1395,STIMULATES,GOT1 gene|GOT1,C1415181|2805,en_5705,1,1,AFFECTS,Excitatory,6
7062,Lactate Dehydrogenase,C0022917,en_1395,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,6
7063,Lactates,C0022924,en_1396,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
7064,Lactoferrin,C0022942,en_1397,AFFECTS,viral entry,C1160648,en_5358,2,1,AFFECTS,General/Uncertain,3
7065,Lactoferrin,C0022942,en_1397,AUGMENTS,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,3
7066,Lactoferrin,C0022942,en_1397,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
7067,Lactoferrin,C0022942,en_1397,DISRUPTS,Virus Replication,C0042774,en_2363,7,2,AFFECTS,Inhibitory,6
7068,Lactoferrin,C0022942,en_1397,DISRUPTS,viral entry,C1160648,en_5358,5,2,AFFECTS,Inhibitory,6
7069,Lactoferrin,C0022942,en_1397,INHIBITS,Interleukin-6,C0021760,en_1342,4,2,AFFECTS,Inhibitory,6
7070,Lactoferrin,C0022942,en_1397,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
7071,Lactoferrin,C0022942,en_1397,PREVENTS,IRON TOXICITY,C0745409,en_4814,1,1,AFFECTS,Inhibitory,3
7072,Lactoferrin,C0022942,en_1397,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
7073,Language Therapy,C0023017,en_1398,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
7074,Rules of conduct,C0023150,en_1401,AFFECTS,Organization administrative structures,C0029246,en_1718,1,1,AFFECTS,General/Uncertain,3
7075,Rules of conduct,C0023150,en_1401,AFFECTS,Societies,C0037455,en_2128,1,1,AFFECTS,General/Uncertain,3
7076,Rules of conduct,C0023150,en_1401,AFFECTS,Agencies,C0237463,en_3346,1,1,AFFECTS,General/Uncertain,3
7077,Rules of conduct,C0023150,en_1401,AFFECTS,network,C0679670,en_4604,1,1,AFFECTS,General/Uncertain,3
7078,Rules of conduct,C0023150,en_1401,AFFECTS,Dependent,C0851827,en_4956,1,1,AFFECTS,General/Uncertain,3
7079,Lead,C0023175,en_1403,DISRUPTS,Distress,C0231303,en_3256,1,1,AFFECTS,Inhibitory,6
7080,Lectin,C0023206,en_1405,PREDISPOSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,3
7081,Lectin,C0023206,en_1405,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
7082,Statutes and Laws,C0023252,en_1408,AFFECTS,Health care facility,C0018704,en_1119,1,1,AFFECTS,General/Uncertain,3
7083,Fibroid Tumor,C0023267,en_1409,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7084,Leisure Activities,C0023292,en_1411,PREDISPOSES,Dementia,C0497327,en_4164,2,1,AFFECTS,Excitatory,3
7085,Leisure Activities,C0023292,en_1411,TREATS,Performance at work,C1286385,en_5480,1,1,AFFECTS,Inhibitory,3
7086,Leprosy,C0023343,en_1412,AFFECTS,Persons,C0027361,en_1635,4,1,AFFECTS,General/Uncertain,3
7087,Leucine,C0023401,en_1414,AUGMENTS,Form of muscle,C0240417,en_3384,1,1,AFFECTS,Excitatory,3
7088,Leucine,C0023401,en_1414,AUGMENTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,Excitatory,3
7089,Leucine,C0023401,en_1414,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
7090,Leucine,C0023401,en_1414,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
7091,Leukapheresis,C0023416,en_1415,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
7092,Leukocytes,C0023516,en_1420,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
7093,Leukopenia,C0023530,en_1423,PREDISPOSES,Mucormycosis,C0026718,en_1593,1,1,AFFECTS,Excitatory,6
7094,Leukopenia,C0023530,en_1423,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
7095,Leukotriene C4,C0023542,en_1424,AUGMENTS,Basophils,C0004827,en_447,1,1,AFFECTS,Excitatory,3
7096,Leukotriene D4,C0023544,en_1425,AUGMENTS,Basophils,C0004827,en_447,1,1,AFFECTS,Excitatory,3
7097,Leukotrienes,C0023545,en_1426,AUGMENTS,Basophils,C0004827,en_447,1,1,AFFECTS,Excitatory,3
7098,Leukotriene B4,C0023546,en_1427,AUGMENTS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Excitatory,3
7099,Leukotriene B4,C0023546,en_1427,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
7100,Levamisole,C0023556,en_1428,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
7101,Levamisole,C0023556,en_1428,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
7102,Structure of interstitial cell of Leydig,C0023602,en_1429,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
7103,Gonadorelin,C0023610,en_1430,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7104,Lidocaine,C0023660,en_1431,PREVENTS,Local anesthetic agent poisoning,C0473977,en_4135,1,1,AFFECTS,Inhibitory,7
7105,Lidocaine,C0023660,en_1431,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
7106,Life Style,C0023676,en_1432,AFFECTS(SPEC),Health behavior,C0018687,en_1116,1,1,AFFECTS,General/Uncertain,3
7107,Ligase,C0023689,en_1433,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
7108,Ligation,C0023690,en_1434,TREATS,"Hernia, Diaphragmatic",C0019284,en_1181,1,1,AFFECTS,Inhibitory,3
7109,Light,C0023693,en_1435,AFFECTS,Darkness,C0010986,en_760,2,2,AFFECTS,General/Uncertain,6
7110,Lignin,C0023705,en_1436,INHIBITS,Carboxycyclohexadienyl dehydratase,C0104208,en_2751,1,1,AFFECTS,Inhibitory,3
7111,Linoleic Acid,C0023749,en_1437,INHIBITS,Lipids,C0023779,en_1441,2,1,AFFECTS,Inhibitory,3
7112,Lipids,C0023779,en_1441,AFFECTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,General/Uncertain,3
7113,Lipids,C0023779,en_1441,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
7114,Lipids,C0023779,en_1441,AFFECTS,Variation (Genetics),C0042333,en_2335,1,1,AFFECTS,General/Uncertain,3
7115,Lipids,C0023779,en_1441,AFFECTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,General/Uncertain,6
7116,Lipids,C0023779,en_1441,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
7117,Lipids,C0023779,en_1441,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
7118,Lipids,C0023779,en_1441,AUGMENTS,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
7119,Lipids,C0023779,en_1441,DISRUPTS,Lipid Bilayers,C0023768,en_1439,1,1,AFFECTS,Inhibitory,3
7120,Lipids,C0023779,en_1441,STIMULATES,Cholesterol,C0008377,en_640,1,1,AFFECTS,Excitatory,3
7121,Lipids,C0023779,en_1441,STIMULATES,Phospholipase A2,C0031667,en_1796,1,1,AFFECTS,Excitatory,3
7122,Lipopolysaccharides,C0023810,en_1443,AFFECTS,Bone Marrow Cells,C0005955,en_501,1,1,AFFECTS,General/Uncertain,3
7123,Lipopolysaccharides,C0023810,en_1443,AUGMENTS,Brain,C0006104,en_508,2,1,AFFECTS,Excitatory,3
7124,Lipopolysaccharides,C0023810,en_1443,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
7125,Lipopolysaccharides,C0023810,en_1443,AUGMENTS,Sensitization,C1325847,en_5551,1,1,AFFECTS,Excitatory,3
7126,Lipopolysaccharides,C0023810,en_1443,STIMULATES,SLC25A10,C1420151,en_23,1,1,AFFECTS,Excitatory,3
7127,Lipopolysaccharides,C0023810,en_1443,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
7128,Lipopolysaccharides,C0023810,en_1443,STIMULATES,TNF gene,C0812246,en_4896,1,1,AFFECTS,Excitatory,3
7129,Lipopolysaccharides,C0023810,en_1443,STIMULATES,Transcription Factor 3,C1336780,en_5641,1,1,AFFECTS,Excitatory,3
7130,Lipopolysaccharides,C0023810,en_1443,INHIBITS,Bradykinin,C0006100,en_507,1,1,AFFECTS,Inhibitory,7
7131,Lipoproteins,C0023820,en_1444,AUGMENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
7132,High Density Lipoproteins,C0023821,en_1445,AUGMENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
7133,High Density Lipoproteins,C0023821,en_1445,INHIBITS,Lipopolysaccharides,C0023810,en_1443,1,1,AFFECTS,Inhibitory,3
7134,Low-Density Lipoproteins,C0023823,en_1446,INHIBITS,Lipopolysaccharides,C0023810,en_1443,1,1,AFFECTS,Inhibitory,3
7135,LDL Cholesterol Lipoproteins,C0023824,en_1447,AUGMENTS,Myocardial Contraction,C0027045,en_1623,2,1,AFFECTS,Excitatory,3
7136,Liposomes,C0023828,en_1448,PREVENTS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,8
7137,Lithium,C0023870,en_1450,DISRUPTS,Astrocytes,C0004112,en_419,1,1,AFFECTS,Inhibitory,3
7138,Lithium,C0023870,en_1450,DISRUPTS,Cell Aging,C0007581,en_584,1,1,AFFECTS,Inhibitory,3
7139,Lithium,C0023870,en_1450,TREATS,Bipolar Disorder,C0005586,en_474,1,1,AFFECTS,Inhibitory,3
7140,Lithium,C0023870,en_1450,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
7141,Lithium,C0023870,en_1450,TREATS,high-risk group,C0684030,en_4676,1,1,AFFECTS,Inhibitory,3
7142,Lithium,C0023870,en_1450,TREATS(INFER),Bipolar Disorder,C0005586,en_474,1,1,AFFECTS,Inhibitory,3
7143,Little's Disease,C0023882,en_1451,AFFECTS,Desire for food,C0003618,en_388,2,2,AFFECTS,General/Uncertain,6
7144,Little's Disease,C0023882,en_1451,AFFECTS,Child,C0008059,en_620,2,2,AFFECTS,General/Uncertain,6
7145,Little's Disease,C0023882,en_1451,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
7146,Little's Disease,C0023882,en_1451,AFFECTS,Persons,C0027361,en_1635,5,2,AFFECTS,General/Uncertain,6
7147,Little's Disease,C0023882,en_1451,AFFECTS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,General/Uncertain,3
7148,Little's Disease,C0023882,en_1451,AFFECTS,Patients,C0030705,en_1762,3,3,AFFECTS,General/Uncertain,9
7149,Little's Disease,C0023882,en_1451,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
7150,Little's Disease,C0023882,en_1451,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
7151,Little's Disease,C0023882,en_1451,AFFECTS,Violence,C0042693,en_2353,1,1,AFFECTS,General/Uncertain,3
7152,Little's Disease,C0023882,en_1451,AFFECTS,Family Caregivers,C0086279,en_2711,1,1,AFFECTS,General/Uncertain,3
7153,Little's Disease,C0023882,en_1451,AFFECTS,Excretory function,C0221102,en_3215,1,1,AFFECTS,General/Uncertain,3
7154,Little's Disease,C0023882,en_1451,AFFECTS,Endocochlear potential,C0234738,en_3313,1,1,AFFECTS,General/Uncertain,3
7155,Little's Disease,C0023882,en_1451,AFFECTS,AOD use,C0237123,en_3341,1,1,AFFECTS,General/Uncertain,3
7156,Little's Disease,C0023882,en_1451,AFFECTS,Thrombophilia,C0398623,en_3949,2,1,AFFECTS,General/Uncertain,3
7157,Little's Disease,C0023882,en_1451,AFFECTS,Microorganism,C0445623,en_4075,1,1,AFFECTS,General/Uncertain,3
7158,Little's Disease,C0023882,en_1451,AFFECTS,Support System,C0748877,en_4834,1,1,AFFECTS,General/Uncertain,3
7159,Little's Disease,C0023882,en_1451,PREDISPOSES,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Excitatory,3
7160,Little's Disease,C0023882,en_1451,PREDISPOSES,Dementia,C0497327,en_4164,1,1,AFFECTS,Excitatory,3
7161,Liver,C0023884,en_1452,PRODUCES,Blood Coagulation Factor,C0005789,en_486,2,1,AFFECTS,Excitatory,3
7162,Liver Cirrhosis,C0023890,en_1454,PREDISPOSES,Decompensation,C0231187,en_3250,1,1,AFFECTS,Excitatory,3
7163,Liver diseases,C0023895,en_1455,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
7164,Liver diseases,C0023895,en_1455,PREDISPOSES,Primary carcinoma of the liver cells,C0019204,en_1178,1,1,AFFECTS,Excitatory,3
7165,Loneliness,C0023974,en_1456,PREDISPOSES,Mental distress,C0235109,en_3321,1,1,AFFECTS,Excitatory,6
7166,long-term care,C0023977,en_1457,AFFECTS,Falls,C0085639,en_2684,1,1,AFFECTS,General/Uncertain,3
7167,long-term care,C0023977,en_1457,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
7168,long-term care,C0023977,en_1457,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
7169,long-term care,C0023977,en_1457,TREATS,Persons,C0027361,en_1635,3,2,AFFECTS,Inhibitory,6
7170,long-term care,C0023977,en_1457,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7171,long-term care,C0023977,en_1457,TREATS,Uveitis,C0042164,en_2325,1,1,AFFECTS,Inhibitory,3
7172,long-term care,C0023977,en_1457,TREATS,Crisis,C0231224,en_3253,2,1,AFFECTS,Inhibitory,3
7173,long-term care,C0023977,en_1457,TREATS,Physical function,C0516981,en_4169,1,1,AFFECTS,Inhibitory,3
7174,long-term care,C0023977,en_1457,TREATS(INFER),Chronic Insomnia,C0751249,en_4847,2,1,AFFECTS,Inhibitory,3
7175,long-term care,C0023977,en_1457,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
7176,Low Birth Weights,C0024032,en_1459,AFFECTS(SPEC),Mothers,C0026591,en_1583,2,1,AFFECTS,General/Uncertain,3
7177,Low Birth Weights,C0024032,en_1459,PREDISPOSES,Encounter due to child abuse,C0700147,en_4713,1,1,AFFECTS,Excitatory,3
7178,Lung,C0024109,en_1460,PRODUCES,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,3
7179,Lung,C0024109,en_1460,PRODUCES,Pulmonary Surfactants,C0034085,en_1935,1,1,AFFECTS,Excitatory,3
7180,Lung,C0024109,en_1460,PRODUCES,Interleukin-10,C0085295,en_2659,3,3,AFFECTS,Excitatory,9
7181,Lung,C0024109,en_1460,PRODUCES,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Excitatory,3
7182,Lung diseases,C0024115,en_1462,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
7183,Lung diseases,C0024115,en_1462,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
7184,Lung diseases,C0024115,en_1462,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
7185,Lung diseases,C0024115,en_1462,PREDISPOSES,Cicatrix,C0008767,en_645,1,1,AFFECTS,Excitatory,3
7186,Lung diseases,C0024115,en_1462,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
7187,Chronic Obstructive Airway Disease,C0024117,en_1463,AFFECTS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
7188,Chronic Obstructive Airway Disease,C0024117,en_1463,AFFECTS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
7189,Chronic Obstructive Airway Disease,C0024117,en_1463,AFFECTS,Exacerbation,C4086268,en_6319,1,1,AFFECTS,General/Uncertain,6
7190,Chronic Obstructive Airway Disease,C0024117,en_1463,AFFECTS(SPEC),Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
7191,Chronic Obstructive Airway Disease,C0024117,en_1463,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
7192,Chronic Obstructive Airway Disease,C0024117,en_1463,PREDISPOSES,Unipolar Depression,C0041696,en_2310,1,1,AFFECTS,Excitatory,6
7193,Chronic Obstructive Airway Disease,C0024117,en_1463,PREDISPOSES,D-dimer above reference range,C0742969,en_4798,1,1,AFFECTS,Excitatory,6
7194,Pulmonary function tests,C0024119,en_1464,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
7195,Pulmonary function tests,C0024119,en_1464,AFFECTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
7196,Pulmonary function tests,C0024119,en_1464,AFFECTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,General/Uncertain,6
7197,Pulmonary function tests,C0024119,en_1464,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
7198,"Lupus Erythematosus, Systemic",C0024141,en_1466,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7199,Lymphocyte,C0024264,en_1469,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
7200,Lymphocyte,C0024264,en_1469,PRODUCES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
7201,Lymphoma,C0024299,en_1471,AFFECTS,Oncogenic Viruses,C0029017,en_1710,1,1,AFFECTS,General/Uncertain,3
7202,Lymphoma,C0024299,en_1471,AFFECTS(SPEC),"Herpesvirus 4, Human",C0014644,en_922,1,1,AFFECTS,General/Uncertain,3
7203,Lymphoma,C0024299,en_1471,AFFECTS(SPEC),Human Papillomavirus,C0021344,en_1303,1,1,AFFECTS,General/Uncertain,3
7204,Lymphopenia,C0024312,en_1474,AFFECTS,Antibody Formation,C0003261,en_352,2,1,AFFECTS,General/Uncertain,3
7205,Lymphopenia,C0024312,en_1474,DISRUPTS,monocyte,C0026473,en_1580,2,1,AFFECTS,Inhibitory,6
7206,Lymphopenia,C0024312,en_1474,DISRUPTS,T-Lymphocyte,C0039194,en_2198,2,1,AFFECTS,Inhibitory,3
7207,Lymphopenia,C0024312,en_1474,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,9
7208,Lymphopenia,C0024312,en_1474,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
7209,Lymphopenia,C0024312,en_1474,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
7210,Tumor Necrosis Factor-Beta,C0024320,en_1475,DISRUPTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,Inhibitory,3
7211,Macrophage Activation,C0024426,en_1482,AFFECTS,Contraction,C1140999,en_5281,1,1,AFFECTS,General/Uncertain,3
7212,Migration Inhibitory Factor,C0024429,en_1483,AFFECTS,Injury,C0175677,en_2968,3,1,AFFECTS,General/Uncertain,3
7213,Migration Inhibitory Factor,C0024429,en_1483,AFFECTS(SPEC),Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,General/Uncertain,3
7214,Migration Inhibitory Factor,C0024429,en_1483,PREDISPOSES,Injury,C0175677,en_2968,2,1,AFFECTS,Excitatory,3
7215,Migration Inhibitory Factor,C0024429,en_1483,STIMULATES,CLEC4E,C1539096,en_123,2,1,AFFECTS,Excitatory,3
7216,Migration Inhibitory Factor,C0024429,en_1483,STIMULATES,"NOS2A protein, human",C0669372,en_4535,1,1,AFFECTS,Excitatory,3
7217,Migration Inhibitory Factor,C0024429,en_1483,STIMULATES,CCL2 gene,C1337092,en_5643,1,1,AFFECTS,Excitatory,3
7218,Migration Inhibitory Factor,C0024429,en_1483,STIMULATES,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Excitatory,3
7219,macrophage,C0024432,en_1484,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
7220,macrophage,C0024432,en_1484,AFFECTS,attenuation,C0599946,en_4490,1,1,AFFECTS,General/Uncertain,3
7221,macrophage,C0024432,en_1484,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
7222,macrophage,C0024432,en_1484,PRODUCES,"TNPO1,RPTOR,MAPKAP1",C1416706;C1846723;C1425758,en_193,1,1,AFFECTS,Excitatory,3
7223,macrophage,C0024432,en_1484,PRODUCES,Immunoglobulins,C0021027,en_1282,1,1,AFFECTS,Excitatory,3
7224,macrophage,C0024432,en_1484,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
7225,macrophage,C0024432,en_1484,PRODUCES,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Excitatory,3
7226,macrophage,C0024432,en_1484,PRODUCES,Interleukins,C0021764,en_1345,1,1,AFFECTS,Excitatory,3
7227,macrophage,C0024432,en_1484,PRODUCES,Migration Inhibitory Factor,C0024429,en_1483,2,1,AFFECTS,Excitatory,3
7228,macrophage,C0024432,en_1484,PRODUCES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,3
7229,macrophage,C0024432,en_1484,PRODUCES,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Excitatory,3
7230,macrophage,C0024432,en_1484,PRODUCES,Retinal dehydrogenase,C0073099,en_2559,2,2,AFFECTS,Excitatory,6
7231,macrophage,C0024432,en_1484,PRODUCES,Interleukin-10,C0085295,en_2659,5,3,AFFECTS,Excitatory,9
7232,macrophage,C0024432,en_1484,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,2,2,AFFECTS,Excitatory,6
7233,Macular degeneration,C0024437,en_1485,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,7
7234,Magnesium Deficiency,C0024473,en_1487,PREDISPOSES,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,Excitatory,6
7235,Magnesium Sulfate,C0024480,en_1488,AFFECTS,Status Asthmaticus,C0038218,en_2156,1,1,AFFECTS,General/Uncertain,7
7236,Magnesium Sulfate,C0024480,en_1488,AFFECTS,Saturated,C0522534,en_4213,1,1,AFFECTS,General/Uncertain,7
7237,Magnesium Sulfate,C0024480,en_1488,DISRUPTS,Pulmonary artery structure,C0034052,en_1927,1,1,AFFECTS,Inhibitory,7
7238,Magnesium Sulfate,C0024480,en_1488,TREATS,Lung Injury,C0273115,en_3561,1,1,AFFECTS,Inhibitory,7
7239,Magnesium Sulfate,C0024480,en_1488,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,7
7240,Magnesium Sulfate,C0024480,en_1488,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
7241,Magnetic Resonance Imaging,C0024485,en_1489,AFFECTS,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,9
7242,Magnetic Resonance Imaging,C0024485,en_1489,AFFECTS,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,3
7243,Magnetic Resonance Spectroscopy,C0024487,en_1490,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7244,Magnetoencephalography,C0024489,en_1491,AFFECTS(SPEC),Vision,C0042789,en_2366,1,1,AFFECTS,General/Uncertain,3
7245,Malaria,C0024530,en_1493,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7246,Malaria,C0024530,en_1493,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
7247,Malaria,C0024530,en_1493,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,7
7248,Malaria,C0024530,en_1493,AFFECTS,Causative_agents,C0449411,en_4077,9,1,AFFECTS,General/Uncertain,3
7249,Malaria,C0024530,en_1493,PREDISPOSES,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,Excitatory,3
7250,Male gender,C0024554,en_1494,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
7251,Malondialdehyde,C0024643,en_1496,TREATS,Reperfusion Injury,C0035126,en_1999,1,1,AFFECTS,Inhibitory,3
7252,Manganese,C0024706,en_1498,AFFECTS,myocardium; injury,C0746730,en_4817,2,1,AFFECTS,General/Uncertain,3
7253,Mannitol,C0024730,en_1499,INHIBITS,thymic stromal lymphopoietin,C0762640,en_4865,1,1,AFFECTS,Inhibitory,8
7254,Marihuana,C0024808,en_1500,AFFECTS,Brain,C0006104,en_508,1,1,AFFECTS,General/Uncertain,3
7255,Marihuana,C0024808,en_1500,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
7256,Marihuana,C0024808,en_1500,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
7257,Marihuana,C0024808,en_1500,AFFECTS,brain development,C1160340,en_5353,1,1,AFFECTS,General/Uncertain,3
7258,Marihuana,C0024808,en_1500,AFFECTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
7259,Marihuana,C0024808,en_1500,AUGMENTS,Unplanned pregnancy,C0041747,en_2311,1,1,AFFECTS,Excitatory,3
7260,Marihuana,C0024808,en_1500,INHIBITS,stressor,C0597530,en_4430,1,1,AFFECTS,Inhibitory,3
7261,Marihuana,C0024808,en_1500,PREVENTS,Pain,C0030193,en_1741,3,1,AFFECTS,Inhibitory,3
7262,Marihuana,C0024808,en_1500,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
7263,Marihuana,C0024808,en_1500,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7264,Masks,C0024861,en_1501,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
7265,Masks,C0024861,en_1501,PREVENTS,Virus Diseases,C0042769,en_2362,6,3,AFFECTS,Inhibitory,9
7266,Masks,C0024861,en_1501,PREVENTS,disease transmission,C0242781,en_3438,3,3,AFFECTS,Inhibitory,14
7267,Masks,C0024861,en_1501,PREVENTS,Air leakage,C0333257,en_3758,2,1,AFFECTS,Inhibitory,3
7268,Masks,C0024861,en_1501,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,8
7269,Masks,C0024861,en_1501,PREVENTS,Leak NOS,C1608322,en_6001,2,1,AFFECTS,Inhibitory,3
7270,Masks,C0024861,en_1501,PREVENTS,COVID-19,C5203670,en_6417,4,3,AFFECTS,Inhibitory,19
7271,Masks,C0024861,en_1501,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,8
7272,Masks,C0024861,en_1501,TREATS,Extravasation,C0015376,en_949,1,1,AFFECTS,Inhibitory,3
7273,Masks,C0024861,en_1501,TREATS,Health Personnel,C0018724,en_1121,4,4,AFFECTS,Inhibitory,15
7274,Masks,C0024861,en_1501,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
7275,Masks,C0024861,en_1501,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
7276,Masks,C0024861,en_1501,TREATS,Patients,C0030705,en_1762,7,4,AFFECTS,Inhibitory,12
7277,Masks,C0024861,en_1501,TREATS,"Personnel, Hospital",C0031228,en_1781,1,1,AFFECTS,Inhibitory,8
7278,Masks,C0024861,en_1501,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
7279,Masks,C0024861,en_1501,TREATS,Urban Population,C0041935,en_2316,1,1,AFFECTS,Inhibitory,3
7280,Masks,C0024861,en_1501,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
7281,Masks,C0024861,en_1501,TREATS,"Lung Diseases, Interstitial",C0206062,en_3142,1,1,AFFECTS,Inhibitory,8
7282,Masks,C0024861,en_1501,TREATS,Hearing normal,C0234725,en_3312,1,1,AFFECTS,Inhibitory,6
7283,Masks,C0024861,en_1501,TREATS,Individual,C0237401,en_3343,3,2,AFFECTS,Inhibitory,6
7284,Masks,C0024861,en_1501,TREATS,athlete,C0238703,en_3368,2,1,AFFECTS,Inhibitory,3
7285,Masks,C0024861,en_1501,TREATS,Infantile Neuroaxonal Dystrophy,C0270724,en_3553,1,1,AFFECTS,Inhibitory,6
7286,Masks,C0024861,en_1501,TREATS,Chief complaint (finding),C0277786,en_3589,1,1,AFFECTS,Inhibitory,6
7287,Masks,C0024861,en_1501,TREATS,Anesthesiologist,C0334910,en_3779,1,1,AFFECTS,Inhibitory,3
7288,Masks,C0024861,en_1501,TREATS,Encounter due to sterilization,C0362065,en_3865,1,1,AFFECTS,Inhibitory,3
7289,Masks,C0024861,en_1501,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
7290,Masks,C0024861,en_1501,TREATS,professional occupation status,C0679924,en_4617,1,1,AFFECTS,Inhibitory,6
7291,Masks,C0024861,en_1501,TREATS,General Population,C0683971,en_4674,2,2,AFFECTS,Inhibitory,9
7292,Masks,C0024861,en_1501,TREATS,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Inhibitory,6
7293,Masks,C0024861,en_1501,TREATS,Protection,C1545588,en_5951,2,2,AFFECTS,Inhibitory,14
7294,Masks,C0024861,en_1501,TREATS,Static sitting,C4270719,en_6324,1,1,AFFECTS,Inhibitory,6
7295,Masks,C0024861,en_1501,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
7296,Masks,C0024861,en_1501,TREATS(INFER),Hypoxemia,C0700292,en_4719,2,1,AFFECTS,Inhibitory,3
7297,Mass Screening,C0024870,en_1502,AFFECTS,Diagnosis,C0011900,en_806,2,1,AFFECTS,General/Uncertain,3
7298,Massage,C0024875,en_1503,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
7299,Massage,C0024875,en_1503,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7300,Mastectomy,C0024881,en_1505,TREATS,Woman,C0043210,en_2396,2,1,AFFECTS,Inhibitory,3
7301,Mastectomy,C0024881,en_1505,TREATS,Breast cancer invasive NOS,C0853879,en_4957,2,1,AFFECTS,Inhibitory,3
7302,Mastectomy,C0024881,en_1505,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,2,1,AFFECTS,Inhibitory,3
7303,Maternal Health Services,C0024922,en_1509,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
7304,Measles Vaccine,C0025010,en_1513,AUGMENTS,Immunity,C0020964,en_1273,2,1,AFFECTS,Excitatory,3
7305,Mediastinoscopy,C0025065,en_1515,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,3
7306,Mediastinoscopy,C0025065,en_1515,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
7307,Mediastinoscopy,C0025065,en_1515,AFFECTS,paracrine,C0597170,en_4413,2,1,AFFECTS,General/Uncertain,3
7308,Medicaid,C0025071,en_1516,AFFECTS,Hospitals,C0019994,en_1207,1,1,AFFECTS,General/Uncertain,3
7309,Medical Devices,C0025080,en_1517,TREATS,Deglutition Disorders,C0011168,en_772,3,1,AFFECTS,Inhibitory,3
7310,Medical Devices,C0025080,en_1517,TREATS,pathologic fistula,C0016169,en_998,1,1,AFFECTS,Inhibitory,3
7311,Medical Devices,C0025080,en_1517,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
7312,Medical Devices,C0025080,en_1517,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
7313,Medical Devices,C0025080,en_1517,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
7314,Medical Devices,C0025080,en_1517,TREATS,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,Inhibitory,7
7315,Medical Devices,C0025080,en_1517,TREATS(INFER),Headache,C0018681,en_1115,1,1,AFFECTS,Inhibitory,3
7316,Medical Devices,C0025080,en_1517,TREATS(INFER),Heart Arrest,C0018790,en_1131,1,1,AFFECTS,Inhibitory,3
7317,Medical Imaging,C0025086,en_1518,AFFECTS,Diagnosis,C0011900,en_806,1,1,AFFECTS,General/Uncertain,3
7318,Medical Imaging,C0025086,en_1518,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
7319,Medical Imaging,C0025086,en_1518,AFFECTS,Vision,C0042789,en_2366,1,1,AFFECTS,General/Uncertain,3
7320,Medical Imaging,C0025086,en_1518,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
7321,Medical Staff,C0025106,en_1519,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7322,Mefloquine,C0025153,en_1520,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
7323,Mefloquine,C0025153,en_1520,TREATS,Households,C0020052,en_1208,2,1,AFFECTS,Inhibitory,3
7324,Mefloquine,C0025153,en_1520,TREATS,Patients,C0030705,en_1762,5,1,AFFECTS,Inhibitory,3
7325,Mefloquine,C0025153,en_1520,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
7326,Melanins,C0025196,en_1521,INHIBITS,Vitamin D,C0042866,en_2371,1,1,AFFECTS,Inhibitory,3
7327,Melarsoprol,C0025217,en_1523,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7328,Melatonin,C0025219,en_1524,AFFECTS,Thrombosis,C0040053,en_2233,2,1,AFFECTS,General/Uncertain,8
7329,Melatonin,C0025219,en_1524,AFFECTS,Immune,C0439662,en_4035,1,1,AFFECTS,General/Uncertain,8
7330,Melatonin,C0025219,en_1524,PREVENTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,8
7331,Melatonin,C0025219,en_1524,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
7332,Melatonin,C0025219,en_1524,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
7333,Melatonin,C0025219,en_1524,TREATS,COVID-19,C5203670,en_6417,6,4,AFFECTS,Inhibitory,30
7334,Melatonin,C0025219,en_1524,AFFECTS,Circadian Rhythms,C0008810,en_647,3,2,AFFECTS,General/Uncertain,6
7335,Melatonin,C0025219,en_1524,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
7336,Melatonin,C0025219,en_1524,DISRUPTS,Receptor Interactions,C1372999,en_5683,1,1,AFFECTS,Inhibitory,3
7337,Melatonin,C0025219,en_1524,INHIBITS(SPEC),NLRP3,C1424250,en_157,1,1,AFFECTS,Inhibitory,3
7338,Melatonin,C0025219,en_1524,PREVENTS,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,Inhibitory,3
7339,Melatonin,C0025219,en_1524,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
7340,Melatonin,C0025219,en_1524,TREATS,Outpatients,C0029921,en_1729,4,2,AFFECTS,Inhibitory,6
7341,Melatonin,C0025219,en_1524,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
7342,Melphalan,C0025241,en_1525,STIMULATES,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Excitatory,3
7343,Melphalan,C0025241,en_1525,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7344,Melphalan,C0025241,en_1525,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
7345,Melphalan,C0025241,en_1525,TREATS(SPEC),Severe asthma,C0581126,en_4345,2,1,AFFECTS,Inhibitory,3
7346,Memantine,C0025242,en_1526,DISRUPTS,receptor activity,C1152633,en_5307,1,1,AFFECTS,Inhibitory,3
7347,Tissue membrane,C0025255,en_1531,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
7348,Aseptic Meningitis,C0025290,en_1537,AFFECTS,Paralysed,C0522224,en_4211,1,1,AFFECTS,General/Uncertain,3
7349,Menopause,C0025320,en_1538,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
7350,Menopause,C0025320,en_1538,AFFECTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
7351,Menstrual cycle,C0025329,en_1539,AFFECTS,Age,C0001779,en_257,1,1,AFFECTS,General/Uncertain,3
7352,Menstrual cycle,C0025329,en_1539,AFFECTS,Muscle strength,C0517349,en_4170,2,1,AFFECTS,General/Uncertain,3
7353,Menstruation,C0025344,en_1540,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
7354,Mental Health Services,C0025355,en_1543,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,7
7355,Mental Health Services,C0025355,en_1543,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,7
7356,Mental Health Services,C0025355,en_1543,TREATS,Family,C0015576,en_961,2,1,AFFECTS,Inhibitory,7
7357,Mental Health Services,C0025355,en_1543,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
7358,Mental Health Services,C0025355,en_1543,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
7359,Mental Health Services,C0025355,en_1543,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
7360,Mental Health Services,C0025355,en_1543,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
7361,Mercury,C0025424,en_1545,AUGMENTS,Emission,C0233929,en_3301,1,1,AFFECTS,Excitatory,3
7362,Metabolic Diseases,C0025517,en_1546,AFFECTS,Adult,C0001675,en_252,1,1,AFFECTS,General/Uncertain,3
7363,Metabolic Diseases,C0025517,en_1546,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
7364,Metabolic Diseases,C0025517,en_1546,AFFECTS,Offspring,C0680063,en_4620,1,1,AFFECTS,General/Uncertain,3
7365,Metals,C0025552,en_1548,AUGMENTS,Vitality,C0424589,en_3997,1,1,AFFECTS,Excitatory,3
7366,Metals,C0025552,en_1548,STIMULATES,Hydrogen Sulfide,C0020282,en_1222,1,1,AFFECTS,Excitatory,3
7367,Metformin,C0025598,en_1549,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
7368,Metformin,C0025598,en_1549,AFFECTS,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
7369,Metformin,C0025598,en_1549,AFFECTS,Muscle,C0026845,en_1603,1,1,AFFECTS,General/Uncertain,3
7370,Metformin,C0025598,en_1549,AFFECTS,Gut,C0699819,en_4705,1,1,AFFECTS,General/Uncertain,3
7371,Metformin,C0025598,en_1549,DISRUPTS,Protein Turnover,C0597297,en_4420,1,1,AFFECTS,Inhibitory,3
7372,Metformin,C0025598,en_1549,INHIBITS,SLC5A2,C1420201,en_79,1,1,AFFECTS,Inhibitory,3
7373,Metformin,C0025598,en_1549,INHIBITS,dipalmitoylphosphatidylserine,C0058353,en_2473,2,2,AFFECTS,Inhibitory,6
7374,Metformin,C0025598,en_1549,INHIBITS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Inhibitory,3
7375,Metformin,C0025598,en_1549,INHIBITS(SPEC),dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
7376,Metformin,C0025598,en_1549,PREDISPOSES,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Excitatory,3
7377,Metformin,C0025598,en_1549,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
7378,Metformin,C0025598,en_1549,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
7379,Metformin,C0025598,en_1549,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
7380,Metformin,C0025598,en_1549,TREATS,Weight Gain,C0043094,en_2388,1,1,AFFECTS,Inhibitory,3
7381,Metformin,C0025598,en_1549,TREATS,Youth,C0087178,en_2748,2,1,AFFECTS,Inhibitory,3
7382,Metformin,C0025598,en_1549,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,2,AFFECTS,Inhibitory,6
7383,Metformin,C0025598,en_1549,TREATS(INFER),Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,3
7384,Methadone,C0025605,en_1550,TREATS,Opioid Use Disorders,C0029103,en_1711,2,1,AFFECTS,Inhibitory,3
7385,Methamphetamine,C0025611,en_1551,AUGMENTS(SPEC),Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
7386,Mesylates,C0025619,en_1552,AFFECTS,"Pancreatitis, Chronic",C0149521,en_2802,1,1,AFFECTS,General/Uncertain,3
7387,Mesylates,C0025619,en_1552,AFFECTS,myocardium; injury,C0746730,en_4817,2,1,AFFECTS,General/Uncertain,3
7388,Mesylates,C0025619,en_1552,INHIBITS,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Inhibitory,3
7389,Mesylates,C0025619,en_1552,PREVENTS,Blood Coagulation Disorders,C0005779,en_485,2,1,AFFECTS,Inhibitory,3
7390,Mesylates,C0025619,en_1552,TREATS(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
7391,Methemoglobin,C0025635,en_1553,PRODUCES,Methylene blue,C0025746,en_1558,2,1,AFFECTS,Excitatory,3
7392,Methionine,C0025646,en_1555,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
7393,Methionine,C0025646,en_1555,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
7394,Methotrexate,C0025677,en_1556,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
7395,Methotrexate,C0025677,en_1556,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
7396,Methotrexate,C0025677,en_1556,TREATS,Chronic Childhood Arthritis,C0553662,en_4288,1,1,AFFECTS,Inhibitory,3
7397,Methotrexate,C0025677,en_1556,TREATS,cohort,C0599755,en_4470,9,1,AFFECTS,Inhibitory,3
7398,Methylation,C0025723,en_1557,AFFECTS,TMPRSS2 gene|TMPRSS2,C1336641|7113,en_5637,1,1,AFFECTS,General/Uncertain,8
7399,Methylation,C0025723,en_1557,AFFECTS,DNA Methylation,C0376452,en_3877,3,1,AFFECTS,General/Uncertain,3
7400,Methylene blue,C0025746,en_1558,DISRUPTS,Protein-Protein Interaction,C0872079,en_5036,1,1,AFFECTS,Inhibitory,3
7401,Methylene blue,C0025746,en_1558,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
7402,Methylene blue,C0025746,en_1558,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
7403,Methylene blue,C0025746,en_1558,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
7404,Methylene blue,C0025746,en_1558,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
7405,Methylprednisolone,C0025815,en_1559,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
7406,Methylprednisolone,C0025815,en_1559,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
7407,Methylprednisolone,C0025815,en_1559,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
7408,Methylprednisolone,C0025815,en_1559,TREATS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,11
7409,Methylprednisolone,C0025815,en_1559,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,11
7410,Methylprednisolone,C0025815,en_1559,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,7
7411,Methylprednisolone,C0025815,en_1559,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,6
7412,Methylprednisolone,C0025815,en_1559,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,22
7413,Methylprednisolone,C0025815,en_1559,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
7414,Methylprednisolone,C0025815,en_1559,TREATS,Patients,C0030705,en_1762,11,8,AFFECTS,Inhibitory,24
7415,Methylprednisolone,C0025815,en_1559,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
7416,Methylprednisolone,C0025815,en_1559,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
7417,Methylprednisolone,C0025815,en_1559,TREATS(INFER),Disease,C0012634,en_826,3,2,AFFECTS,Inhibitory,6
7418,Methylprednisolone,C0025815,en_1559,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
7419,Methylprednisolone,C0025815,en_1559,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
7420,Methylprednisolone,C0025815,en_1559,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,3,2,AFFECTS,Inhibitory,6
7421,Methyltransferase,C0025831,en_1560,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7422,Metoprolol,C0025859,en_1561,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,8
7423,Metoprolol,C0025859,en_1561,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,8
7424,Metoprolol,C0025859,en_1561,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,8
7425,Metoprolol,C0025859,en_1561,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,8
7426,Metoprolol,C0025859,en_1561,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
7427,Microcirculation,C0025962,en_1564,AFFECTS,Energy Metabolism,C0014272,en_904,1,1,AFFECTS,General/Uncertain,3
7428,Microcirculation,C0025962,en_1564,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
7429,Midazolam,C0026056,en_1565,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7430,Midazolam,C0026056,en_1565,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
7431,Midazolam,C0026056,en_1565,TREATS(INFER),Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
7432,Mifepristone,C0026088,en_1567,INHIBITS,Glucocorticoid Receptor,C0034809,en_1971,1,1,AFFECTS,Inhibitory,3
7433,Milieu Therapy,C0026118,en_1569,PREVENTS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
7434,Minerals,C0026162,en_1571,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
7435,Minocycline,C0026187,en_1572,DISRUPTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
7436,Minocycline,C0026187,en_1572,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
7437,Minocycline,C0026187,en_1572,INHIBITS,TNF gene,C0812246,en_4896,2,1,AFFECTS,Inhibitory,3
7438,Minocycline,C0026187,en_1572,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7439,Minocycline,C0026187,en_1572,TREATS(INFER),"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,2,1,AFFECTS,Inhibitory,3
7440,Mitochondria,C0026237,en_1574,AFFECTS,Autophagy,C0004391,en_432,1,1,AFFECTS,General/Uncertain,3
7441,Mitochondria,C0026237,en_1574,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,6
7442,Mitochondria,C0026237,en_1574,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
7443,"Monitoring, Immunologic",C0026428,en_1576,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
7444,"Monitoring, Immunologic",C0026428,en_1576,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
7445,"Monitoring, Immunologic",C0026428,en_1576,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
7446,"Monitoring, Physiologic",C0026429,en_1577,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7447,Monoamine Oxidase Inhibitors,C0026457,en_1579,TREATS,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,Inhibitory,3
7448,Monoamine Oxidase Inhibitors,C0026457,en_1579,TREATS(SPEC),Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
7449,Monoamine Oxidase Inhibitors,C0026457,en_1579,TREATS(SPEC),Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
7450,monocyte,C0026473,en_1580,PRODUCES,Recombinant Interferon-gamma,C0021740,en_1330,1,1,AFFECTS,Excitatory,3
7451,monocyte,C0026473,en_1580,PRODUCES,Interleukin-1 beta,C0021753,en_1334,3,1,AFFECTS,Excitatory,7
7452,monocyte,C0026473,en_1580,PRODUCES,Thromboplastin,C0040048,en_2232,2,2,AFFECTS,Excitatory,6
7453,monocyte,C0026473,en_1580,PRODUCES,cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
7454,monocyte,C0026473,en_1580,PRODUCES,Interleukin-8,C0079633,en_2608,2,1,AFFECTS,Excitatory,7
7455,monocyte,C0026473,en_1580,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
7456,monocyte,C0026473,en_1580,PRODUCES,"NOS2A protein, human",C0669372,en_4535,1,1,AFFECTS,Excitatory,3
7457,Morphine,C0026549,en_1582,TREATS,Dyspnea,C0013404,en_866,5,2,AFFECTS,Inhibitory,6
7458,Morphine,C0026549,en_1582,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7459,Morphine,C0026549,en_1582,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
7460,Morphine,C0026549,en_1582,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
7461,Morphine,C0026549,en_1582,TREATS,Polypnea,C1142291,en_5286,1,1,AFFECTS,Inhibitory,3
7462,Motion Sickness,C0026603,en_1585,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
7463,Physical activity,C0026606,en_1586,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
7464,Physical activity,C0026606,en_1586,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
7465,Physical activity,C0026606,en_1586,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,3
7466,Physical activity,C0026606,en_1586,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
7467,Physical activity,C0026606,en_1586,PREDISPOSES,Binge Eating,C0424419,en_3993,1,1,AFFECTS,Excitatory,3
7468,Physical activity,C0026606,en_1586,PREVENTS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
7469,Physical activity,C0026606,en_1586,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
7470,Physical activity,C0026606,en_1586,PREVENTS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
7471,Physical activity,C0026606,en_1586,PREVENTS,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Inhibitory,3
7472,Physical activity,C0026606,en_1586,PREVENTS,Feeling hopeless,C0150041,en_2815,2,1,AFFECTS,Inhibitory,3
7473,Physical activity,C0026606,en_1586,PREVENTS,Community-Acquired Infections,C0206171,en_3151,1,1,AFFECTS,Inhibitory,3
7474,Physical activity,C0026606,en_1586,PREVENTS,Sun Exposure,C1456711,en_5780,1,1,AFFECTS,Inhibitory,3
7475,Physical activity,C0026606,en_1586,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
7476,Physical activity,C0026606,en_1586,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
7477,Physical activity,C0026606,en_1586,TREATS,Child,C0008059,en_620,2,2,AFFECTS,Inhibitory,6
7478,Physical activity,C0026606,en_1586,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
7479,Physical activity,C0026606,en_1586,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
7480,Physical activity,C0026606,en_1586,TREATS,Disease,C0012634,en_826,4,2,AFFECTS,Inhibitory,6
7481,Physical activity,C0026606,en_1586,TREATS,Human,C0020114,en_1210,2,1,AFFECTS,Inhibitory,3
7482,Physical activity,C0026606,en_1586,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
7483,Physical activity,C0026606,en_1586,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
7484,Physical activity,C0026606,en_1586,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
7485,Physical activity,C0026606,en_1586,TREATS,Degenerative polyarthritis,C0029408,en_1723,1,1,AFFECTS,Inhibitory,3
7486,Physical activity,C0026606,en_1586,TREATS,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
7487,Physical activity,C0026606,en_1586,TREATS,Patients,C0030705,en_1762,10,5,AFFECTS,Inhibitory,15
7488,Physical activity,C0026606,en_1586,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
7489,Physical activity,C0026606,en_1586,TREATS,Woman,C0043210,en_2396,2,1,AFFECTS,Inhibitory,3
7490,Physical activity,C0026606,en_1586,TREATS,Sedentary,C0205254,en_3128,2,1,AFFECTS,Inhibitory,3
7491,Physical activity,C0026606,en_1586,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
7492,Physical activity,C0026606,en_1586,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
7493,Physical activity,C0026606,en_1586,TREATS,Individual,C0237401,en_3343,8,5,AFFECTS,Inhibitory,15
7494,Physical activity,C0026606,en_1586,TREATS,Behavior showing increased motor activity,C0474395,en_4139,1,1,AFFECTS,Inhibitory,3
7495,Physical activity,C0026606,en_1586,TREATS,Sleep behavior finding,C0474396,en_4140,2,1,AFFECTS,Inhibitory,3
7496,Physical activity,C0026606,en_1586,TREATS,Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,3
7497,Physical activity,C0026606,en_1586,TREATS,Participant,C0679646,en_4602,4,1,AFFECTS,Inhibitory,3
7498,Physical activity,C0026606,en_1586,TREATS,college student,C0682177,en_4638,1,1,AFFECTS,Inhibitory,3
7499,Physical activity,C0026606,en_1586,TREATS,"Risk factor, cardiovascular",C0850624,en_4944,1,1,AFFECTS,Inhibitory,3
7500,Physical activity,C0026606,en_1586,TREATS(INFER),Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
7501,Physical activity,C0026606,en_1586,TREATS(INFER),Down Syndrome,C0013080,en_843,1,1,AFFECTS,Inhibitory,3
7502,Physical activity,C0026606,en_1586,TREATS(INFER),Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
7503,Physical activity,C0026606,en_1586,TREATS(INFER),Myocardial Ischemia,C0151744,en_2865,9,1,AFFECTS,Inhibitory,3
7504,Physical activity,C0026606,en_1586,TREATS(INFER),Postural orthostatic tachycardia syndrome,C1299624,en_5506,1,1,AFFECTS,Inhibitory,3
7505,Movement,C0026649,en_1588,AFFECTS,Persons,C0027361,en_1635,5,4,AFFECTS,General/Uncertain,12
7506,Movement,C0026649,en_1588,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
7507,Movement,C0026649,en_1588,AFFECTS,Posture,C0032818,en_1862,1,1,AFFECTS,General/Uncertain,3
7508,Movement,C0026649,en_1588,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,3
7509,Movement,C0026649,en_1588,AFFECTS,Biotic communities,C0259851,en_3501,1,1,AFFECTS,General/Uncertain,3
7510,Movement,C0026649,en_1588,AFFECTS,German population,C0337805,en_3798,1,1,AFFECTS,General/Uncertain,3
7511,Movement,C0026649,en_1588,AFFECTS,Maker NOS,C0554244,en_4294,1,1,AFFECTS,General/Uncertain,3
7512,Movement Disorders,C0026650,en_1589,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7513,Moxibustion,C0026652,en_1590,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6.5
7514,Moxibustion,C0026652,en_1590,TREATS,Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,8
7515,Moxibustion,C0026652,en_1590,TREATS,Distress,C0231303,en_3256,1,1,AFFECTS,Inhibitory,6.5
7516,Moxibustion,C0026652,en_1590,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6.5
7517,Moxibustion,C0026652,en_1590,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6.5
7518,Mucins,C0026682,en_1591,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
7519,Mucins,C0026682,en_1591,DISRUPTS,Cell Survival,C0007620,en_595,1,1,AFFECTS,Inhibitory,3
7520,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
7521,Mucormycosis,C0026718,en_1593,PREDISPOSES,Possible,C0332149,en_3747,1,1,AFFECTS,Excitatory,6
7522,Multiple Myeloma,C0026764,en_1596,AFFECTS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7523,Multiple Myeloma,C0026764,en_1596,PRODUCES,Monoclonal immunoglobulin,C0443737,en_4069,1,1,AFFECTS,Excitatory,3
7524,Multiple Organ Failure,C0026766,en_1597,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7525,Multiple Organ Failure,C0026766,en_1597,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
7526,Multiple Sclerosis,C0026769,en_1598,AFFECTS,Persons,C0027361,en_1635,9,5,AFFECTS,General/Uncertain,15
7527,Multiple Sclerosis,C0026769,en_1598,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7528,Multiple Sclerosis,C0026769,en_1598,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
7529,Multiple Sclerosis,C0026769,en_1598,AFFECTS,PATIENT SYMPTOMS,C1317600,en_5529,3,3,AFFECTS,General/Uncertain,9
7530,Multiple Sclerosis,C0026769,en_1598,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
7531,Multiple Sclerosis,C0026769,en_1598,AFFECTS(SPEC),Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
7532,Multiple Sclerosis,C0026769,en_1598,PREDISPOSES,Multiple sclerosis relapse,C0856120,en_4967,2,1,AFFECTS,Excitatory,3
7533,Muramic Acid,C0026792,en_1599,STIMULATES,NOD2,C1826449,en_146,1,1,AFFECTS,Excitatory,3
7534,Muscle,C0026845,en_1603,PRODUCES,15-Hydroxyprostaglandin dehydrogenase (NAD+),C0044894,en_2415,1,1,AFFECTS,Excitatory,3
7535,Muscular Dystrophies,C0026850,en_1606,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7536,Music Therapy,C0026868,en_1609,TREATS,Health Personnel,C0018724,en_1121,3,1,AFFECTS,Inhibitory,3
7537,Music Therapy,C0026868,en_1609,TREATS,Patients,C0030705,en_1762,6,2,AFFECTS,Inhibitory,6
7538,Music Therapy,C0026868,en_1609,TREATS,Schizophrenia,C0036341,en_2068,1,1,AFFECTS,Inhibitory,3
7539,Music Therapy,C0026868,en_1609,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
7540,Music Therapy,C0026868,en_1609,TREATS,physical symptom,C0679309,en_4594,1,1,AFFECTS,Inhibitory,3
7541,Music Therapy,C0026868,en_1609,TREATS,Anxiety symptoms,C0860603,en_4992,1,1,AFFECTS,Inhibitory,3
7542,Music Therapy,C0026868,en_1609,TREATS,Teams,C0871489,en_5024,1,1,AFFECTS,Inhibitory,3
7543,Music Therapy,C0026868,en_1609,TREATS(INFER),Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
7544,Mutagens,C0026879,en_1611,INHIBITS,Cytochrome P450,C0010762,en_747,1,1,AFFECTS,Inhibitory,3
7545,Mutation,C0026882,en_1612,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
7546,Mutation,C0026882,en_1612,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7547,Mutation,C0026882,en_1612,AFFECTS,Ethnic group,C0015031,en_934,1,1,AFFECTS,General/Uncertain,3
7548,Mutation,C0026882,en_1612,AFFECTS,Exocytosis,C0015283,en_943,1,1,AFFECTS,General/Uncertain,3
7549,Mutation,C0026882,en_1612,AFFECTS,Genes,C0017337,en_1052,1,1,AFFECTS,General/Uncertain,3
7550,Mutation,C0026882,en_1612,AFFECTS,Bone necrosis,C0029445,en_1725,1,1,AFFECTS,General/Uncertain,3
7551,Mutation,C0026882,en_1612,AFFECTS,Peptides,C0030956,en_1771,1,1,AFFECTS,General/Uncertain,7
7552,Mutation,C0026882,en_1612,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
7553,Mutation,C0026882,en_1612,AFFECTS,Virulence,C0042765,en_2361,1,1,AFFECTS,General/Uncertain,3
7554,Mutation,C0026882,en_1612,AFFECTS,Virus Diseases,C0042769,en_2362,5,5,AFFECTS,General/Uncertain,15
7555,Mutation,C0026882,en_1612,AFFECTS,Ability,C0085732,en_2688,4,4,AFFECTS,General/Uncertain,12
7556,Mutation,C0026882,en_1612,AFFECTS,Tropism,C0242732,en_3436,1,1,AFFECTS,General/Uncertain,3
7557,Mutation,C0026882,en_1612,AFFECTS,DNA biosynthesis,C0598312,en_4446,3,1,AFFECTS,General/Uncertain,3
7558,Mutation,C0026882,en_1612,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
7559,Mycophenolic Acid,C0026933,en_1619,INHIBITS,GJA1 gene|GJA1,C1415068|2697,en_5704,1,1,AFFECTS,Inhibitory,6
7560,Mycoses,C0026946,en_1620,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
7561,Mycoses,C0026946,en_1620,PREDISPOSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,3
7562,Myelitis,C0026975,en_1621,AFFECTS,Paralysed,C0522224,en_4211,1,1,AFFECTS,General/Uncertain,3
7563,Myeloproliferative disease,C0027022,en_1622,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7564,Myocardial Depressant Factor,C0027047,en_1624,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
7565,Myocardial Infarction,C0027051,en_1625,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7566,Myocardial Infarction,C0027051,en_1625,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7567,Myocardial Infarction,C0027051,en_1625,PREDISPOSES,disease transmission,C0242781,en_3438,1,1,AFFECTS,Excitatory,6
7568,Myocardial Reperfusion,C0027054,en_1626,TREATS,Fever,C0015967,en_985,1,1,AFFECTS,Inhibitory,3
7569,Myocarditis,C0027059,en_1627,AFFECTS,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
7570,Myocarditis,C0027059,en_1627,COMPLICATES,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,General/Uncertain,6
7571,Myopia,C0027092,en_1630,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,8
7572,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,AFFECTS,Circadian Rhythms,C0008810,en_647,1,1,AFFECTS,General/Uncertain,3
7573,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,AUGMENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
7574,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,INHIBITS,SIRT1,C1423062,en_121,1,1,AFFECTS,Inhibitory,3
7575,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,PREDISPOSES,Nerve Degeneration,C0027746,en_1657,1,1,AFFECTS,Excitatory,3
7576,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,CD38,C0075742,en_16,1,1,AFFECTS,Excitatory,3
7577,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,SIRT1,C1423062,en_121,1,1,AFFECTS,Excitatory,3
7578,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,Enzymes,C0014442,en_912,2,2,AFFECTS,Excitatory,6
7579,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,Niacinamide,C0028027,en_1680,1,1,AFFECTS,Excitatory,3
7580,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,Proteins,C0033684,en_1912,1,1,AFFECTS,Excitatory,3
7581,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,nicotinamide-beta-riboside,C0068711,en_2532,2,2,AFFECTS,Excitatory,6
7582,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,STIMULATES,Glutamate,C0220839,en_3202,1,1,AFFECTS,Excitatory,3
7583,Naltrexone,C0027360,en_1634,DISRUPTS,Hyperplasia,C0020507,en_1236,1,1,AFFECTS,Inhibitory,3
7584,Naltrexone,C0027360,en_1634,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
7585,Naltrexone,C0027360,en_1634,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
7586,Naltrexone,C0027360,en_1634,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
7587,Naltrexone,C0027360,en_1634,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
7588,Naltrexone,C0027360,en_1634,TREATS,"Alcoholic Intoxication, Chronic",C0001973,en_273,1,1,AFFECTS,Inhibitory,3
7589,Naltrexone,C0027360,en_1634,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
7590,Naltrexone,C0027360,en_1634,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
7591,Naltrexone,C0027360,en_1634,TREATS,Fibromyalgia,C0016053,en_993,1,1,AFFECTS,Inhibitory,3
7592,Naltrexone,C0027360,en_1634,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
7593,Naltrexone,C0027360,en_1634,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
7594,Naltrexone,C0027360,en_1634,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
7595,Naltrexone,C0027360,en_1634,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
7596,Naltrexone,C0027360,en_1634,TREATS,Vitality,C0424589,en_3997,1,1,AFFECTS,Inhibitory,3
7597,Naltrexone,C0027360,en_1634,TREATS,syndrome; fatigue,C1406736,en_5694,1,1,AFFECTS,Inhibitory,3
7598,Naltrexone,C0027360,en_1634,TREATS(INFER),Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
7599,Naltrexone,C0027360,en_1634,TREATS(INFER),Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
7600,Naproxen,C0027396,en_1637,INHIBITS(SPEC),Prostaglandin-Endoperoxide Synthase,C0033551,en_1901,1,1,AFFECTS,Inhibitory,3
7601,Naproxen,C0027396,en_1637,INHIBITS(SPEC),influenza A virus nucleoprotein,C0063529,en_2506,1,1,AFFECTS,Inhibitory,3
7602,Naproxen,C0027396,en_1637,TREATS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,8
7603,Naproxen,C0027396,en_1637,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,8
7604,Naproxen,C0027396,en_1637,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
7605,Narcolepsy,C0027404,en_1638,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
7606,Narcotic Antagonists,C0027410,en_1639,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
7607,"Health Services, National",C0027462,en_1642,TREATS,Readiness,C1318963,en_5534,2,1,AFFECTS,Inhibitory,3
7608,Natural Disasters,C0027485,en_1643,AFFECTS,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,3
7609,Nebulizers,C0027524,en_1644,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
7610,Nebulizers,C0027524,en_1644,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
7611,Nebulizers,C0027524,en_1644,TREATS,Human body,C0242821,en_3440,1,1,AFFECTS,Inhibitory,3
7612,Nebulizers,C0027524,en_1644,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
7613,Necrosis,C0027540,en_1645,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
7614,Neomycin,C0027603,en_1648,PREVENTS,Surgical Wound Infection,C0038941,en_2192,1,1,AFFECTS,Inhibitory,8
7615,Neoplasm,C0027651,en_1651,AFFECTS,Organ,C0178784,en_2991,1,1,AFFECTS,General/Uncertain,3
7616,Neoplasm,C0027651,en_1651,AFFECTS,Upper gastrointestinal surgeon,C0586900,en_4359,1,1,AFFECTS,General/Uncertain,7
7617,Nerve,C0027740,en_1655,PRODUCES,Norepinephrine,C0028351,en_1687,1,1,AFFECTS,Excitatory,3
7618,Nerve Block,C0027741,en_1656,TREATS,Monkeys,C0026447,en_1578,1,1,AFFECTS,Inhibitory,3
7619,nervous system disorder,C0027765,en_1659,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
7620,Neuromuscular Agents,C0027865,en_1666,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7621,Neuromuscular Blocking Agents,C0027866,en_1667,AUGMENTS,Asthenia,C0004093,en_416,1,1,AFFECTS,Excitatory,3
7622,Neuromuscular Blocking Agents,C0027866,en_1667,TREATS,Patients,C0030705,en_1762,5,2,AFFECTS,Inhibitory,6
7623,Neuromuscular Blocking Agents,C0027866,en_1667,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,12
7624,Neuromuscular Blocking Agents,C0027866,en_1667,TREATS,Compliance,C3714738,en_6237,1,1,AFFECTS,Inhibitory,6
7625,Neuromuscular Blocking Agents,C0027866,en_1667,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
7626,Neuron-Specific Enolase,C0027875,en_1670,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
7627,Neuronal Plasticity,C0027880,en_1671,AFFECTS,Nervous System Development,C0598282,en_4445,1,1,AFFECTS,General/Uncertain,3
7628,Neurons,C0027882,en_1672,PRODUCES,Gonadorelin,C0023610,en_1430,2,1,AFFECTS,Excitatory,3
7629,Neurons,C0027882,en_1672,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
7630,Neurons,C0027882,en_1672,PRODUCES,hypocretin,C1113696,en_5247,4,1,AFFECTS,Excitatory,3
7631,Neuropeptides,C0027895,en_1673,PREDISPOSES,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Excitatory,3
7632,Neurotransmitters,C0027908,en_1674,AUGMENTS,wave,C0678544,en_4560,1,1,AFFECTS,Excitatory,3
7633,neutrophil,C0027950,en_1676,PRODUCES,"CD79A,LOC102723407",C1413238,en_191,1,1,AFFECTS,Excitatory,3
7634,neutrophil,C0027950,en_1676,PRODUCES,5'-NUCLEOTIDASE,C0000530,en_202,1,1,AFFECTS,Excitatory,3
7635,neutrophil,C0027950,en_1676,PRODUCES,Chromatin,C0008546,en_642,1,1,AFFECTS,Excitatory,3
7636,neutrophil,C0027950,en_1676,PRODUCES,Enzymes,C0014442,en_912,1,1,AFFECTS,Excitatory,3
7637,neutrophil,C0027950,en_1676,PRODUCES,Immunoglobulins,C0021027,en_1282,1,1,AFFECTS,Excitatory,3
7638,neutrophil,C0027950,en_1676,PRODUCES,Transferrin,C0040679,en_2269,1,1,AFFECTS,Excitatory,3
7639,neutrophil,C0027950,en_1676,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
7640,neutrophil,C0027950,en_1676,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
7641,neutrophil,C0027950,en_1676,PRODUCES,ELK3 gene,C0812375,en_4900,4,3,AFFECTS,Excitatory,9
7642,Niclosamide,C0028017,en_1679,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
7643,Niclosamide,C0028017,en_1679,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
7644,Niclosamide,C0028017,en_1679,TREATS,Intestinal tract infectious disease NOS,C0178238,en_2979,1,1,AFFECTS,Inhibitory,3
7645,Niclosamide,C0028017,en_1679,TREATS(SPEC),Intestinal tract infectious disease NOS,C0178238,en_2979,2,1,AFFECTS,Inhibitory,3
7646,Niclosamide,C0028017,en_1679,TREATS(SPEC),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
7647,Niacinamide,C0028027,en_1680,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
7648,Niacinamide,C0028027,en_1680,INHIBITS,SIRT1,C1423062,en_121,1,1,AFFECTS,Inhibitory,3
7649,Nicotine,C0028040,en_1681,AFFECTS,response,C0871261,en_5019,1,1,AFFECTS,General/Uncertain,3
7650,Nicotine,C0028040,en_1681,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
7651,Nicotine,C0028040,en_1681,TREATS,Cricetinae,C0018557,en_1111,1,1,AFFECTS,Inhibitory,3
7652,Nicotine,C0028040,en_1681,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
7653,Nitric Oxide,C0028128,en_1682,AFFECTS,Inspiration function,C0004048,en_413,1,1,AFFECTS,General/Uncertain,3
7654,Nitric Oxide,C0028128,en_1682,AFFECTS,Hemodynamics,C0019010,en_1156,1,1,AFFECTS,General/Uncertain,3
7655,Nitric Oxide,C0028128,en_1682,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
7656,Nitric Oxide,C0028128,en_1682,AFFECTS,Alveolar ventilation function,C0231940,en_3269,2,2,AFFECTS,General/Uncertain,9
7657,Nitric Oxide,C0028128,en_1682,AFFECTS,mental dysfunction,C0679224,en_4591,1,1,AFFECTS,General/Uncertain,3
7658,Nitric Oxide,C0028128,en_1682,AUGMENTS,Inspiration function,C0004048,en_413,1,1,AFFECTS,Excitatory,3
7659,Nitric Oxide,C0028128,en_1682,AUGMENTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
7660,Nitric Oxide,C0028128,en_1682,AUGMENTS,Vascular constriction (function),C0042396,en_2340,1,1,AFFECTS,Excitatory,3
7661,Nitric Oxide,C0028128,en_1682,DISRUPTS,Extravasation,C0015376,en_949,2,1,AFFECTS,Inhibitory,3
7662,Nitric Oxide,C0028128,en_1682,DISRUPTS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
7663,Nitric Oxide,C0028128,en_1682,INHIBITS,Pharmaceutical Preparations,C0013227,en_856,2,1,AFFECTS,Inhibitory,3
7664,Nitric Oxide,C0028128,en_1682,PREDISPOSES,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Excitatory,3
7665,Nitric Oxide,C0028128,en_1682,PREVENTS,Infection,C3714514,en_6235,2,2,AFFECTS,Inhibitory,6
7666,Nitric Oxide,C0028128,en_1682,STIMULATES,PPAR gamma,C0166417,en_2949,1,1,AFFECTS,Excitatory,3
7667,Nitric Oxide,C0028128,en_1682,STIMULATES,Hypoxia-Inducible Factor 1,C0215848,en_3190,1,1,AFFECTS,Excitatory,3
7668,Nitric Oxide,C0028128,en_1682,STIMULATES,Fibroblast Growth Factor 2,C0380603,en_3900,1,1,AFFECTS,Excitatory,3
7669,Nitric Oxide,C0028128,en_1682,STIMULATES,mitogen-activated protein kinase p38,C1120843,en_5249,1,1,AFFECTS,Excitatory,3
7670,Nitric Oxide,C0028128,en_1682,STIMULATES,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Excitatory,3
7671,Nitric Oxide,C0028128,en_1682,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
7672,Nitrites,C0028137,en_1683,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
7673,Nitrogen,C0028158,en_1684,AUGMENTS,Somatostatin-Secreting Cells,C0524984,en_4226,1,1,AFFECTS,Excitatory,3
7674,Nitrogen Oxides,C0028167,en_1685,DISRUPTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,Inhibitory,3
7675,Norepinephrine,C0028351,en_1687,AUGMENTS,Blood Pressure,C0005823,en_492,2,1,AFFECTS,Excitatory,3
7676,Norepinephrine,C0028351,en_1687,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7677,Nucleic Acids,C0028606,en_1690,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
7678,Nucleic Acids,C0028606,en_1690,STIMULATES,Prions,C0033164,en_1888,1,1,AFFECTS,Excitatory,3
7679,Nucleosomes,C0028623,en_1692,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
7680,Nurses,C0028661,en_1694,TREATS,Patients,C0030705,en_1762,6,5,AFFECTS,Inhibitory,15
7681,Nurses,C0028661,en_1694,TREATS,Cancer Patient,C1516213,en_5852,3,2,AFFECTS,Inhibitory,6
7682,Nurses,C0028661,en_1694,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7683,nursing therapy,C0028678,en_1695,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,3
7684,nursing therapy,C0028678,en_1695,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
7685,nursing therapy,C0028678,en_1695,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
7686,nursing therapy,C0028678,en_1695,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
7687,nursing therapy,C0028678,en_1695,TREATS,Phlebitis,C0031542,en_1792,1,1,AFFECTS,Inhibitory,3
7688,nursing therapy,C0028678,en_1695,TREATS,Chronic heart failure,C0264716,en_3538,2,1,AFFECTS,Inhibitory,3
7689,nursing therapy,C0028678,en_1695,TREATS,Harmonious caregiver-patient relationship,C0516944,en_4167,1,1,AFFECTS,Inhibitory,3
7690,nursing therapy,C0028678,en_1695,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
7691,Nursing Assessment,C0028680,en_1696,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
7692,Nursing Staff,C0028698,en_1697,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
7693,Obesity,C0028754,en_1699,AFFECTS,Adult,C0001675,en_252,1,1,AFFECTS,General/Uncertain,3
7694,Obesity,C0028754,en_1699,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
7695,Obesity,C0028754,en_1699,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
7696,Obesity,C0028754,en_1699,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
7697,Obesity,C0028754,en_1699,AFFECTS,Thermogenesis,C0018841,en_1143,1,1,AFFECTS,General/Uncertain,3
7698,Obesity,C0028754,en_1699,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
7699,Obesity,C0028754,en_1699,AFFECTS,Hypertriglyceridemia,C0020557,en_1242,1,1,AFFECTS,General/Uncertain,3
7700,Obesity,C0028754,en_1699,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
7701,Obesity,C0028754,en_1699,AFFECTS,African American,C0085756,en_2689,1,1,AFFECTS,General/Uncertain,6
7702,Obesity,C0028754,en_1699,AFFECTS,Hispanics,C0086409,en_2717,1,1,AFFECTS,General/Uncertain,3
7703,Obesity,C0028754,en_1699,AFFECTS,Caenorhabditis elegans,C0162610,en_2920,1,1,AFFECTS,General/Uncertain,3
7704,Obesity,C0028754,en_1699,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,6
7705,Obesity,C0028754,en_1699,AFFECTS,Adolescent,C0205653,en_3132,1,1,AFFECTS,General/Uncertain,3
7706,Obesity,C0028754,en_1699,AFFECTS,Abnormal behavior,C0233514,en_3296,1,1,AFFECTS,General/Uncertain,3
7707,Obesity,C0028754,en_1699,AFFECTS,Native Americans,C0282204,en_3640,1,1,AFFECTS,General/Uncertain,3
7708,Obesity,C0028754,en_1699,AFFECTS,Vitality,C0424589,en_3997,1,1,AFFECTS,General/Uncertain,3
7709,Obesity,C0028754,en_1699,AFFECTS,adipocyte differentiation,C1159884,en_5347,1,1,AFFECTS,General/Uncertain,3
7710,Obesity,C0028754,en_1699,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
7711,Obesity,C0028754,en_1699,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
7712,Obesity,C0028754,en_1699,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
7713,Obesity,C0028754,en_1699,PREDISPOSES,Coronary heart disease,C0010068,en_718,1,1,AFFECTS,Excitatory,3
7714,Obesity,C0028754,en_1699,PREDISPOSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
7715,Obesity,C0028754,en_1699,PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Excitatory,3
7716,Obesity,C0028754,en_1699,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
7717,Obesity,C0028754,en_1699,PREDISPOSES,Influenza,C0021400,en_1311,2,1,AFFECTS,Excitatory,3
7718,Obesity,C0028754,en_1699,PREDISPOSES,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Excitatory,9
7719,Obesity,C0028754,en_1699,PREDISPOSES,"Diabetes, Gestational",C0085207,en_2652,1,1,AFFECTS,Excitatory,3
7720,Obesity,C0028754,en_1699,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,3,2,AFFECTS,Excitatory,6
7721,Obesity,C0028754,en_1699,PREDISPOSES,Prognosis bad,C0278252,en_3600,2,2,AFFECTS,Excitatory,12
7722,Obesity,C0028754,en_1699,PREDISPOSES,Co-morbid conditions,C1275743,en_5462,1,1,AFFECTS,Excitatory,6
7723,Obesity,C0028754,en_1699,PREDISPOSES,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
7724,Obesity,C0028754,en_1699,PREDISPOSES,COVID-19,C5203670,en_6417,6,6,AFFECTS,Excitatory,36
7725,Obstruction,C0028778,en_1702,AFFECTS,Muscle function,C0231484,en_3260,1,1,AFFECTS,General/Uncertain,3
7726,Occupational Exposure,C0028798,en_1703,COMPLICATES,Eczema,C0013595,en_876,1,1,AFFECTS,General/Uncertain,3
7727,Office Visits,C0028900,en_1705,TREATS,Readiness,C1318963,en_5534,1,1,AFFECTS,Inhibitory,6
7728,"Oils, Volatile",C0028910,en_1707,AFFECTS,Gargling,C0232464,en_3280,2,1,AFFECTS,General/Uncertain,3
7729,Opioid Use Disorders,C0029103,en_1711,AFFECTS,Clients,C0008942,en_654,1,1,AFFECTS,General/Uncertain,3
7730,Opioid Use Disorders,C0029103,en_1711,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7731,Opioid Use Disorders,C0029103,en_1711,AFFECTS,Clinicians,C0871685,en_5028,1,1,AFFECTS,General/Uncertain,3
7732,Opportunistic mycosis,C0029119,en_1713,AFFECTS,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,General/Uncertain,6
7733,Opportunistic mycosis,C0029119,en_1713,AFFECTS,Diabetic,C0241863,en_3392,1,1,AFFECTS,General/Uncertain,6
7734,Organ Transplantation,C0029216,en_1714,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
7735,Organ Transplantation,C0029216,en_1714,TREATS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
7736,Organelles,C0029219,en_1715,AFFECTS,cellular metabolism,C1523924,en_5913,1,1,AFFECTS,General/Uncertain,3
7737,Organic Chemicals,C0029224,en_1716,AFFECTS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
7738,Osteoporosis,C0029456,en_1726,AFFECTS,Candida,C0006836,en_546,1,1,AFFECTS,General/Uncertain,3
7739,Osteoporosis,C0029456,en_1726,AFFECTS,Genus staphylococcus,C0038170,en_2153,1,1,AFFECTS,General/Uncertain,3
7740,Osteoporosis,C0029456,en_1726,AFFECTS(SPEC),American,C0596070,en_4379,1,1,AFFECTS,General/Uncertain,3
7741,Ovalbumin,C0029923,en_1730,PRODUCES,Interleukin-13,C0214743,en_3188,1,1,AFFECTS,Excitatory,3
7742,Ovalbumin,C0029923,en_1730,PRODUCES,Interleukin-17,C0384648,en_3903,1,1,AFFECTS,Excitatory,3
7743,Ovary,C0029939,en_1731,PRODUCES,Estrogens,C0014939,en_933,1,1,AFFECTS,Excitatory,3
7744,overdose,C4018909,en_6291,DISRUPTS,Respiration,C0035203,en_2004,1,1,AFFECTS,Inhibitory,3
7745,Oxaloacetates,C0029989,en_1732,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
7746,Oxides,C0030015,en_1735,AUGMENTS,Encounter due to sterilization,C0362065,en_3865,1,1,AFFECTS,Excitatory,3
7747,Oxygen,C0030054,en_1736,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
7748,Oxygen,C0030054,en_1736,AUGMENTS,Glycolysis,C0017952,en_1084,1,1,AFFECTS,Excitatory,6
7749,Oxygen,C0030054,en_1736,AUGMENTS,Partial Pressure,C0030604,en_1754,1,1,AFFECTS,Excitatory,6
7750,Oxygen,C0030054,en_1736,DISRUPTS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Inhibitory,6
7751,Oxygen,C0030054,en_1736,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,6
7752,Oxygen,C0030054,en_1736,PREDISPOSES,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Excitatory,6
7753,Oxygen,C0030054,en_1736,TREATS,Disease,C0012634,en_826,7,5,AFFECTS,Inhibitory,18
7754,Oxygen,C0030054,en_1736,TREATS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,8
7755,Oxygen,C0030054,en_1736,TREATS,Pneumonia,C0032285,en_1833,12,9,AFFECTS,Inhibitory,34
7756,Oxygen,C0030054,en_1736,TREATS,Keratosis pilaris atrophicans,C0263428,en_3522,1,1,AFFECTS,Inhibitory,7
7757,Oxygen,C0030054,en_1736,TREATS,"Recipient, Transplant",C0376387,en_3875,1,1,AFFECTS,Inhibitory,6
7758,Oxygen,C0030054,en_1736,TREATS,Respiratory distress,C0476273,en_4149,2,2,AFFECTS,Inhibitory,10
7759,Oxygen,C0030054,en_1736,TREATS,Hypoxemia,C0700292,en_4719,3,2,AFFECTS,Inhibitory,11
7760,Oxygen,C0030054,en_1736,TREATS,5-6 days,C4740618,en_6391,1,1,AFFECTS,Inhibitory,6
7761,Oxygen,C0030054,en_1736,TREATS,COVID-19,C5203670,en_6417,10,8,AFFECTS,Inhibitory,60
7762,Oxygen,C0030054,en_1736,AFFECTS,Pulmonary Circulation,C0034057,en_1928,2,1,AFFECTS,General/Uncertain,3
7763,Oxygen,C0030054,en_1736,AFFECTS,saturation,C0678572,en_4563,1,1,AFFECTS,General/Uncertain,3
7764,Oxygen,C0030054,en_1736,AFFECTS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,General/Uncertain,3
7765,Oxygen,C0030054,en_1736,AUGMENTS,Diffusion,C0012222,en_814,1,1,AFFECTS,Excitatory,3
7766,Oxygen,C0030054,en_1736,AUGMENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
7767,Oxygen,C0030054,en_1736,AUGMENTS,Blood flow,C0232338,en_3276,1,1,AFFECTS,Excitatory,3
7768,Oxygen,C0030054,en_1736,AUGMENTS,Persistence,C0546816,en_4274,1,1,AFFECTS,Excitatory,3
7769,Oxygen,C0030054,en_1736,AUGMENTS,saturation,C0678572,en_4563,1,1,AFFECTS,Excitatory,3
7770,Oxygen,C0030054,en_1736,DISRUPTS,Respiration,C0035203,en_2004,2,1,AFFECTS,Inhibitory,3
7771,Oxygen,C0030054,en_1736,DISRUPTS,Oxygen affinity,C0369765,en_3867,1,1,AFFECTS,Inhibitory,3
7772,Oxygen,C0030054,en_1736,PREDISPOSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,3
7773,Oxygen,C0030054,en_1736,PREDISPOSES,Inflammation,C0021368,en_1307,3,2,AFFECTS,Excitatory,6
7774,Oxygen,C0030054,en_1736,PREVENTS,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Inhibitory,3
7775,Oxygen,C0030054,en_1736,PREVENTS,Injury,C0175677,en_2968,3,2,AFFECTS,Inhibitory,6
7776,Oxygen,C0030054,en_1736,PREVENTS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
7777,Oxygen,C0030054,en_1736,PREVENTS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
7778,Oxygen,C0030054,en_1736,STIMULATES,Nitrate,C0699857,en_4706,1,1,AFFECTS,Excitatory,3
7779,Oxygen,C0030054,en_1736,TREATS,Adult,C0001675,en_252,3,2,AFFECTS,Inhibitory,6
7780,Oxygen,C0030054,en_1736,TREATS,Complication,C0009566,en_697,4,4,AFFECTS,Inhibitory,12
7781,Oxygen,C0030054,en_1736,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
7782,Oxygen,C0030054,en_1736,TREATS,Coronaviridae,C0010076,en_719,1,1,AFFECTS,Inhibitory,3
7783,Oxygen,C0030054,en_1736,TREATS,Coughing,C0010200,en_723,3,2,AFFECTS,Inhibitory,6
7784,Oxygen,C0030054,en_1736,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
7785,Oxygen,C0030054,en_1736,TREATS,Disseminated Intravascular Coagulation,C0012739,en_829,1,1,AFFECTS,Inhibitory,3
7786,Oxygen,C0030054,en_1736,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
7787,Oxygen,C0030054,en_1736,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
7788,Oxygen,C0030054,en_1736,TREATS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Inhibitory,3
7789,Oxygen,C0030054,en_1736,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
7790,Oxygen,C0030054,en_1736,TREATS,Patients,C0030705,en_1762,68,38,AFFECTS,Inhibitory,114
7791,Oxygen,C0030054,en_1736,TREATS,Research Personnel,C0035173,en_2002,2,2,AFFECTS,Inhibitory,6
7792,Oxygen,C0030054,en_1736,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,3,AFFECTS,Inhibitory,9
7793,Oxygen,C0030054,en_1736,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
7794,Oxygen,C0030054,en_1736,TREATS,Shock,C0036974,en_2097,2,2,AFFECTS,Inhibitory,6
7795,Oxygen,C0030054,en_1736,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
7796,Oxygen,C0030054,en_1736,TREATS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
7797,Oxygen,C0030054,en_1736,TREATS,Professional guide,C0181090,en_3019,3,1,AFFECTS,Inhibitory,3
7798,Oxygen,C0030054,en_1736,TREATS,Genus: Coronavirus,C0206419,en_3158,2,1,AFFECTS,Inhibitory,3
7799,Oxygen,C0030054,en_1736,TREATS,Lesion,C0221198,en_3221,1,1,AFFECTS,Inhibitory,3
7800,Oxygen,C0030054,en_1736,TREATS,Hypoxia,C0242184,en_3396,3,2,AFFECTS,Inhibitory,6
7801,Oxygen,C0030054,en_1736,TREATS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
7802,Oxygen,C0030054,en_1736,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
7803,Oxygen,C0030054,en_1736,TREATS,Inspired fraction of oxygen,C0428167,en_4012,2,2,AFFECTS,Inhibitory,6
7804,Oxygen,C0030054,en_1736,TREATS,Endurance,C0518031,en_4176,2,1,AFFECTS,Inhibitory,3
7805,Oxygen,C0030054,en_1736,TREATS,Vital signs,C0518766,en_4182,1,1,AFFECTS,Inhibitory,3
7806,Oxygen,C0030054,en_1736,TREATS,Neurobehavioral Manifestations,C0525041,en_4228,1,1,AFFECTS,Inhibitory,3
7807,Oxygen,C0030054,en_1736,TREATS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Inhibitory,3
7808,Oxygen,C0030054,en_1736,TREATS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
7809,Oxygen,C0030054,en_1736,TREATS,Perinatal death,C0701826,en_4733,1,1,AFFECTS,Inhibitory,3
7810,Oxygen,C0030054,en_1736,TREATS,Hospitalized Patients,C0870668,en_5010,6,4,AFFECTS,Inhibitory,12
7811,Oxygen,C0030054,en_1736,TREATS,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Inhibitory,3
7812,Oxygen,C0030054,en_1736,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
7813,Oxygen,C0030054,en_1736,TREATS,Respiratory Failure,C1145670,en_5292,8,5,AFFECTS,Inhibitory,15
7814,Oxygen,C0030054,en_1736,TREATS,Systemic arterial pressure,C1272641,en_5453,2,1,AFFECTS,Inhibitory,3
7815,Oxygen,C0030054,en_1736,TREATS,Transfer factor - respiratory measure,C1280474,en_5470,1,1,AFFECTS,Inhibitory,3
7816,Oxygen,C0030054,en_1736,TREATS,Symptoms,C1457887,en_5784,4,4,AFFECTS,Inhibitory,12
7817,Oxygen,C0030054,en_1736,TREATS,Acute Kidney Insufficiency,C1565662,en_5984,1,1,AFFECTS,Inhibitory,3
7818,Oxygen,C0030054,en_1736,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
7819,Oxygen,C0030054,en_1736,TREATS(INFER),Disease,C0012634,en_826,4,3,AFFECTS,Inhibitory,9
7820,Oxygen,C0030054,en_1736,TREATS(INFER),Pneumonia,C0032285,en_1833,5,3,AFFECTS,Inhibitory,9
7821,Oxygen,C0030054,en_1736,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
7822,Oxygen,C0030054,en_1736,TREATS(INFER),"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
7823,Oxygen,C0030054,en_1736,TREATS(INFER),Awake,C0234422,en_3308,2,1,AFFECTS,Inhibitory,3
7824,Oxygen,C0030054,en_1736,TREATS(INFER),Hypoxia,C0242184,en_3396,1,1,AFFECTS,Inhibitory,3
7825,Oxygen,C0030054,en_1736,TREATS(INFER),Respiratory Failure,C1145670,en_5292,7,3,AFFECTS,Inhibitory,9
7826,Oxygen,C0030054,en_1736,TREATS(SPEC),Coughing,C0010200,en_723,2,2,AFFECTS,Inhibitory,6
7827,Oxygen,C0030054,en_1736,TREATS(SPEC),Fetal Death,C0015927,en_982,1,1,AFFECTS,Inhibitory,3
7828,Oxymetholone,C0030072,en_1737,TREATS,Sitting position,C0277814,en_3592,1,1,AFFECTS,Inhibitory,3
7829,Oxytocin,C0030095,en_1738,PREVENTS,Withdrawal Symptoms,C0087169,en_2747,1,1,AFFECTS,Inhibitory,3
7830,Oxytocin,C0030095,en_1738,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
7831,Ozone,C0030106,en_1739,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
7832,Ozone,C0030106,en_1739,AFFECTS,Emission,C0233929,en_3301,2,2,AFFECTS,General/Uncertain,6
7833,Plasminogen Activator Inhibitor 1,C0030190,en_1740,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
7834,Plasminogen Activator Inhibitor 1,C0030190,en_1740,AUGMENTS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
7835,Plasminogen Activator Inhibitor 1,C0030190,en_1740,DISRUPTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
7836,Plasminogen Activator Inhibitor 1,C0030190,en_1740,STIMULATES,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Excitatory,3
7837,Palliative Care,C0030231,en_1743,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
7838,Palliative Care,C0030231,en_1743,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
7839,Palliative Care,C0030231,en_1743,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
7840,Palliative Care,C0030231,en_1743,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
7841,Palliative Care,C0030231,en_1743,TREATS,Persons,C0027361,en_1635,5,3,AFFECTS,Inhibitory,9
7842,Palliative Care,C0030231,en_1743,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
7843,Palliative Care,C0030231,en_1743,TREATS,Pain,C0030193,en_1741,2,2,AFFECTS,Inhibitory,6
7844,Palliative Care,C0030231,en_1743,TREATS,Patients,C0030705,en_1762,5,5,AFFECTS,Inhibitory,15
7845,Palliative Care,C0030231,en_1743,TREATS,Frail Older Adults,C0079379,en_2599,1,1,AFFECTS,Inhibitory,3
7846,Palliative Care,C0030231,en_1743,TREATS,Latinos,C0086528,en_2724,2,1,AFFECTS,Inhibitory,3
7847,Palliative Care,C0030231,en_1743,TREATS,Individual,C0237401,en_3343,2,2,AFFECTS,Inhibitory,6
7848,Palliative Care,C0030231,en_1743,TREATS(INFER),"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,Inhibitory,3
7849,Palliative Care,C0030231,en_1743,TREATS,Malignant Childhood Neoplasm,C0278704,en_3604,1,1,AFFECTS,Inhibitory,7
7850,Parasitic Diseases,C0030499,en_1748,AFFECTS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,General/Uncertain,3
7851,Parenteral Nutrition,C0030547,en_1749,AFFECTS,Hypertriglyceridemia,C0020557,en_1242,1,1,AFFECTS,General/Uncertain,6
7852,parent,C0030551,en_1750,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
7853,Parkinson Disease,C0030567,en_1753,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
7854,Parkinson Disease,C0030567,en_1753,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
7855,Parkinson Disease,C0030567,en_1753,AFFECTS,Falls,C0085639,en_2684,1,1,AFFECTS,General/Uncertain,6
7856,Parkinson Disease,C0030567,en_1753,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
7857,Pathologic Processes,C0030660,en_1755,AFFECTS,Cytomegalovirus,C0010825,en_752,2,1,AFFECTS,General/Uncertain,3
7858,Pathologic Processes,C0030660,en_1755,AFFECTS,Organism,C0029235,en_1717,1,1,AFFECTS,General/Uncertain,3
7859,Pathologic Processes,C0030660,en_1755,AFFECTS,Simplexvirus,C0206558,en_3169,2,1,AFFECTS,General/Uncertain,3
7860,Pathologic Processes,C0030660,en_1755,AFFECTS,Zika virus,C0318793,en_3743,2,1,AFFECTS,General/Uncertain,3
7861,Pathologic Processes,C0030660,en_1755,AFFECTS(SPEC),Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
7862,Pathologic Processes,C0030660,en_1755,PRODUCES,Cell Adhesion Molecules,C0007578,en_583,1,1,AFFECTS,Excitatory,3
7863,Pathologic Processes,C0030660,en_1755,PRODUCES,Growth Factor,C0018284,en_1100,1,1,AFFECTS,Excitatory,3
7864,Pathologic Processes,C0030660,en_1755,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
7865,Pathologic Processes,C0030660,en_1755,PRODUCES,chemokine,C0282554,en_3651,1,1,AFFECTS,Excitatory,3
7866,Patient Admission,C0030673,en_1756,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
7867,Patient Admission,C0030673,en_1756,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
7868,Patient Care Management,C0030677,en_1757,AFFECTS,Drug Exposure,C0743284,en_4801,1,1,AFFECTS,General/Uncertain,3
7869,Patient Discharge,C0030685,en_1758,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
7870,Patient Discharge,C0030685,en_1758,TREATS,Respiratory complication,C0161818,en_2899,1,1,AFFECTS,Inhibitory,8
7871,Patient Discharge,C0030685,en_1758,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
7872,Patient Isolation,C0030693,en_1759,PREVENTS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
7873,Patient Isolation,C0030693,en_1759,TREATS,Symptoms,C1457887,en_5784,3,1,AFFECTS,Inhibitory,3
7874,Patient Monitoring,C0030695,en_1760,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7875,Patient Monitoring,C0030695,en_1760,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
7876,Patient Monitoring,C0030695,en_1760,TREATS,COVID-19,C5203670,en_6417,5,4,AFFECTS,Inhibitory,24
7877,Patient Monitoring,C0030695,en_1760,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7878,Patient Readmission,C0030700,en_1761,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
7879,Patients,C0030705,en_1762,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
7880,Patients,C0030705,en_1762,PRODUCES,Ventilator - respiratory equipment,C0087153,en_2745,1,1,AFFECTS,Excitatory,3
7881,Patients,C0030705,en_1762,PRODUCES,Traps,C0184047,en_3048,2,1,AFFECTS,Excitatory,3
7882,Patients,C0030705,en_1762,PRODUCES,"Ventilators, Portable/Home Care",C0184285,en_3050,1,1,AFFECTS,Excitatory,3
7883,Patients,C0030705,en_1762,PRODUCES,Sponge rubber,C0461785,en_4130,1,1,AFFECTS,Excitatory,3
7884,Peer Review,C0030768,en_1763,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
7885,Peer Review,C0030768,en_1763,TREATS(SPEC),Frail Elderly,C0079377,en_2598,1,1,AFFECTS,Inhibitory,3
7886,Pentoxifylline,C0030899,en_1766,AFFECTS,Fibrinolysis,C0016017,en_990,1,1,AFFECTS,General/Uncertain,3
7887,Pentoxifylline,C0030899,en_1766,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
7888,Pentoxifylline,C0030899,en_1766,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
7889,Pentoxifylline,C0030899,en_1766,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7890,Pentoxifylline,C0030899,en_1766,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
7891,Pentoxifylline,C0030899,en_1766,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,16
7892,Pentoxifylline,C0030899,en_1766,TREATS(SPEC),"Hepatitis, Alcoholic",C0019187,en_1176,1,1,AFFECTS,Inhibitory,3
7893,Peptide Fragments,C0030935,en_1768,DISRUPTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
7894,Peptide Hydrolases,C0030940,en_1769,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
7895,Peptide Hydrolases,C0030940,en_1769,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
7896,Peptide Hydrolases,C0030940,en_1769,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
7897,Peptide Hydrolases,C0030940,en_1769,AUGMENTS,viral entry,C1160648,en_5358,2,2,AFFECTS,Excitatory,6
7898,Peptide Hydrolases,C0030940,en_1769,AUGMENTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,Excitatory,3
7899,Peptide Hydrolases,C0030940,en_1769,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
7900,Peptide Hydrolases,C0030940,en_1769,INHIBITS,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Inhibitory,3
7901,Peptide Hydrolases,C0030940,en_1769,PREVENTS,Acute Lung Injury,C0242488,en_3416,4,1,AFFECTS,Inhibitory,3
7902,Peptide Hydrolases,C0030940,en_1769,STIMULATES,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Excitatory,3
7903,Endopeptidases,C0030946,en_1770,AFFECTS,Proteolysis,C0597304,en_4421,1,1,AFFECTS,General/Uncertain,3
7904,Endopeptidases,C0030946,en_1770,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
7905,Endopeptidases,C0030946,en_1770,AUGMENTS,Tropism,C0242732,en_3436,1,1,AFFECTS,Excitatory,3
7906,Endopeptidases,C0030946,en_1770,INHIBITS,Antigens,C0003320,en_365,1,1,AFFECTS,Inhibitory,3
7907,Endopeptidases,C0030946,en_1770,INHIBITS,Cytochrome P450,C0010762,en_747,2,1,AFFECTS,Inhibitory,3
7908,Endopeptidases,C0030946,en_1770,INHIBITS,Carrier of disorder,C0560175,en_4319,1,1,AFFECTS,Inhibitory,3
7909,Endopeptidases,C0030946,en_1770,INHIBITS,HDAC2 gene,C1333892,en_5597,1,1,AFFECTS,Inhibitory,3
7910,Endopeptidases,C0030946,en_1770,PREDISPOSES,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Excitatory,6
7911,Endopeptidases,C0030946,en_1770,PRODUCES,Proteins,C0033684,en_1912,2,1,AFFECTS,Excitatory,3
7912,Endopeptidases,C0030946,en_1770,STIMULATES,MUC5AC,C1417497,en_60,1,1,AFFECTS,Excitatory,3
7913,Endopeptidases,C0030946,en_1770,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
7914,Endopeptidases,C0030946,en_1770,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7915,Endopeptidases,C0030946,en_1770,TREATS,Primates,C0033147,en_1887,1,1,AFFECTS,Inhibitory,3
7916,Endopeptidases,C0030946,en_1770,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
7917,Endopeptidases,C0030946,en_1770,TREATS,Individual,C0237401,en_3343,2,2,AFFECTS,Inhibitory,6
7918,Endopeptidases,C0030946,en_1770,TREATS(SPEC),Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
7919,Peptides,C0030956,en_1771,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
7920,Peptides,C0030956,en_1771,AUGMENTS,Attention,C0004268,en_424,1,1,AFFECTS,Excitatory,3
7921,Peptides,C0030956,en_1771,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
7922,Peptides,C0030956,en_1771,DISRUPTS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
7923,Peptides,C0030956,en_1771,DISRUPTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Inhibitory,3
7924,Peptides,C0030956,en_1771,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
7925,Peptides,C0030956,en_1771,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
7926,Peptides,C0030956,en_1771,PREDISPOSES,Hypertensive disease,C0020538,en_1239,2,2,AFFECTS,Excitatory,6
7927,Peptides,C0030956,en_1771,PRODUCES,Insulin,C0021641,en_1324,2,1,AFFECTS,Excitatory,3
7928,Peptides,C0030956,en_1771,PRODUCES,angiogenin,C0051844,en_2430,2,2,AFFECTS,Excitatory,6
7929,Peptides,C0030956,en_1771,STIMULATES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
7930,Peptides,C0030956,en_1771,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
7931,Peptides,C0030956,en_1771,TREATS,Study Subject,C0681850,en_4632,1,1,AFFECTS,Inhibitory,7
7932,Peptides,C0030956,en_1771,TREATS,OC43,C4698071,en_6375,1,1,AFFECTS,Inhibitory,7
7933,Peptides,C0030956,en_1771,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
7934,Pericarditis,C0031046,en_1772,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
7935,Periodontal Diseases,C0031090,en_1774,AFFECTS,Periodontitis,C0031099,en_1775,1,1,AFFECTS,General/Uncertain,3
7936,Periodontal Diseases,C0031090,en_1774,PREDISPOSES,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Excitatory,3
7937,Periodontitis,C0031099,en_1775,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
7938,Periodontitis,C0031099,en_1775,PREDISPOSES,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Excitatory,3
7939,Periodontitis,C0031099,en_1775,PREDISPOSES,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,Excitatory,3
7940,Periodontitis,C0031099,en_1775,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
7941,Periodontitis,C0031099,en_1775,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
7942,Periodontitis,C0031099,en_1775,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
7943,Periodontitis,C0031099,en_1775,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
7944,Peritoneal Dialysis,C0031139,en_1777,TREATS,"Kidney Failure, Acute",C0022660,en_1382,2,1,AFFECTS,Inhibitory,6
7945,Peritoneal Dialysis,C0031139,en_1777,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
7946,Peritoneal Dialysis,C0031139,en_1777,TREATS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,6
7947,Permeability,C0031164,en_1779,AFFECTS,CNS disorder,C0007682,en_597,1,1,AFFECTS,General/Uncertain,3
7948,Permeability,C0031164,en_1779,AFFECTS,Hereditary angioneurotic edema,C0019243,en_1179,1,1,AFFECTS,General/Uncertain,3
7949,Permeability,C0031164,en_1779,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
7950,Permeability,C0031164,en_1779,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,General/Uncertain,3
7951,Permeability,C0031164,en_1779,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
7952,Permeability,C0031164,en_1779,AFFECTS,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
7953,Permeability,C0031164,en_1779,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
7954,Personal Satisfaction,C0031206,en_1780,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
7955,Personal Satisfaction,C0031206,en_1780,PREDISPOSES,Emotional,C0849912,en_4937,3,1,AFFECTS,Excitatory,3
7956,"Personnel, Hospital",C0031228,en_1781,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
7957,Pertussis Vaccine,C0031237,en_1782,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
7958,Phagocytes,C0031307,en_1784,PRODUCES,cytokine,C0079189,en_2593,2,2,AFFECTS,Excitatory,6
7959,Drug Kinetics,C0031327,en_1787,PRODUCES,GMP,C0520462,en_4187,1,1,AFFECTS,Excitatory,3
7960,Phenelzine,C0031392,en_1788,AUGMENTS,T-Lymphocyte,C0039194,en_2198,2,1,AFFECTS,Excitatory,3
7961,Phenelzine,C0031392,en_1788,AUGMENTS,Myeloid Cells,C0887899,en_5091,2,1,AFFECTS,Excitatory,3
7962,Phenelzine,C0031392,en_1788,DISRUPTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Inhibitory,3
7963,Phenelzine,C0031392,en_1788,INHIBITS,KDM1A,C1428785,en_120,1,1,AFFECTS,Inhibitory,3
7964,Phenelzine,C0031392,en_1788,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7965,Phenelzine,C0031392,en_1788,TREATS,Major Depressive Disorder,C1269683,en_5447,1,1,AFFECTS,Inhibitory,3
7966,Phenelzine,C0031392,en_1788,TREATS(INFER),Breast cancer metastatic,C0278488,en_3602,1,1,AFFECTS,Inhibitory,3
7967,phenothiazine,C0031434,en_1790,TREATS,Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,3
7968,phenothiazine,C0031434,en_1790,TREATS,Schizophrenia,C0036341,en_2068,1,1,AFFECTS,Inhibitory,3
7969,phenothiazine,C0031434,en_1790,TREATS,Manic,C0338831,en_3805,1,1,AFFECTS,Inhibitory,3
7970,Phenylalanine,C0031453,en_1791,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,7
7971,Phenylalanine,C0031453,en_1791,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
7972,Phosphodiesterase Inhibitors,C0031638,en_1795,TREATS,Asthma,C0004096,en_418,2,1,AFFECTS,Inhibitory,3
7973,Phospholipids,C0031676,en_1797,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
7974,Phospholipids,C0031676,en_1797,DISRUPTS,Catalysis,C0007382,en_574,1,1,AFFECTS,Inhibitory,3
7975,Phospholipids,C0031676,en_1797,INHIBITS,Pulmonary Surfactants,C0034085,en_1935,3,2,AFFECTS,Inhibitory,6
7976,Phospholipids,C0031676,en_1797,PREDISPOSES,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Excitatory,8
7977,Phosphorus,C0031705,en_1799,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
7978,Phosphorylation,C0031715,en_1800,AFFECTS,NLGN4Y,C1423557,en_116,1,1,AFFECTS,General/Uncertain,3
7979,Phosphotransferases,C0031727,en_1801,AFFECTS,Endosomes,C0034850,en_1980,1,1,AFFECTS,General/Uncertain,3
7980,Phosphotransferases,C0031727,en_1801,AFFECTS,Signal Pathways,C0037080,en_2104,2,1,AFFECTS,General/Uncertain,3
7981,Phosphotransferases,C0031727,en_1801,AFFECTS,Protoplasm,C0175996,en_2976,1,1,AFFECTS,General/Uncertain,3
7982,Phosphotransferases,C0031727,en_1801,DISRUPTS,Virus Assembly,C0282629,en_3659,1,1,AFFECTS,Inhibitory,3
7983,Phosphotransferases,C0031727,en_1801,PRODUCES,inhibitors,C0243077,en_3457,1,1,AFFECTS,Excitatory,3
7984,Phosphotransferases,C0031727,en_1801,STIMULATES,TRANSCRIPTION FACTOR,C0040648,en_2264,2,1,AFFECTS,Excitatory,3
7985,Photochemotherapy,C0031740,en_1802,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
7986,Physical Examination,C0031809,en_1804,PREVENTS,"Acidosis, Lactic",C0001125,en_223,1,1,AFFECTS,Inhibitory,3
7987,Physical Examination,C0031809,en_1804,PREVENTS,Ketoacidosis,C0220982,en_3210,1,1,AFFECTS,Inhibitory,3
7988,Physical Examination,C0031809,en_1804,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
7989,Physical Examination,C0031809,en_1804,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
7990,Physical Examination,C0031809,en_1804,TREATS,Patients,C0030705,en_1762,7,6,AFFECTS,Inhibitory,18
7991,Physical Examination,C0031809,en_1804,TREATS,student,C0038492,en_2171,2,1,AFFECTS,Inhibitory,3
7992,Physical Examination,C0031809,en_1804,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
7993,Physical Examination,C0031809,en_1804,TREATS,athlete,C0238703,en_3368,1,1,AFFECTS,Inhibitory,6
7994,Physical Examination,C0031809,en_1804,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
7995,Physical Examination,C0031809,en_1804,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
7996,Physical Examination,C0031809,en_1804,TREATS,Healthy Volunteers,C1708335,en_6036,1,1,AFFECTS,Inhibitory,6
7997,Physical Examination,C0031809,en_1804,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
7998,Physical Examination,C0031809,en_1804,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
7999,Physical Examination,C0031809,en_1804,TREATS(INFER),Acute cardiac pulmonary edema,C0398350,en_3946,1,1,AFFECTS,Inhibitory,3
8000,Physicians,C0031831,en_1805,TREATS,Patients,C0030705,en_1762,19,14,AFFECTS,Inhibitory,42
8001,Physicians,C0031831,en_1805,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
8002,Physicians,C0031831,en_1805,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
8003,physiological aspects,C0031843,en_1806,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8004,physiological aspects,C0031843,en_1806,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
8005,physiological aspects,C0031843,en_1806,AFFECTS,glycosylation,C0017982,en_1086,1,1,AFFECTS,General/Uncertain,3
8006,physiological aspects,C0031843,en_1806,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
8007,physiological aspects,C0031843,en_1806,AFFECTS,Patients,C0030705,en_1762,6,3,AFFECTS,General/Uncertain,9
8008,physiological aspects,C0031843,en_1806,AFFECTS,"Ventricular Function, Left",C0080310,en_2627,1,1,AFFECTS,General/Uncertain,3
8009,physiological aspects,C0031843,en_1806,AFFECTS,Family member,C0086282,en_2712,1,1,AFFECTS,General/Uncertain,3
8010,physiological aspects,C0031843,en_1806,AFFECTS,Elderly person,C0392363,en_3920,1,1,AFFECTS,General/Uncertain,3
8011,physiological aspects,C0031843,en_1806,AFFECTS,Brain activity,C0443158,en_4065,1,1,AFFECTS,General/Uncertain,3
8012,physiological aspects,C0031843,en_1806,AFFECTS,Pedestrian,C0450063,en_4081,1,1,AFFECTS,General/Uncertain,3
8013,physiological aspects,C0031843,en_1806,AFFECTS,brain function,C0678908,en_4584,1,1,AFFECTS,General/Uncertain,3
8014,physiological aspects,C0031843,en_1806,AFFECTS,Staff,C0851286,en_4950,2,1,AFFECTS,General/Uncertain,3
8015,physiological aspects,C0031843,en_1806,AFFECTS,humoral immune response,C1155229,en_5318,1,1,AFFECTS,General/Uncertain,7
8016,physiological aspects,C0031843,en_1806,AFFECTS,Major Depressive Disorder,C1269683,en_5447,3,2,AFFECTS,General/Uncertain,6
8017,physiological aspects,C0031843,en_1806,PRODUCES,Fatty Acids,C0015684,en_969,1,1,AFFECTS,Excitatory,3
8018,physiological aspects,C0031843,en_1806,PRODUCES,Glucose,C0017725,en_1072,1,1,AFFECTS,Excitatory,3
8019,physiological aspects,C0031843,en_1806,PRODUCES,Phospholipids,C0031676,en_1797,1,1,AFFECTS,Excitatory,3
8020,physiological aspects,C0031843,en_1806,PRODUCES,MicroRNAs,C1101610,en_5240,1,1,AFFECTS,Excitatory,3
8021,Physiological Processes,C0031845,en_1807,AFFECTS,host-pathogen interaction,C1154482,en_5309,1,1,AFFECTS,General/Uncertain,3
8022,Phytosterols,C0031866,en_1808,AFFECTS,nodulation,C1160630,en_5356,1,1,AFFECTS,General/Uncertain,3
8023,Pigment,C0031916,en_1810,AFFECTS,Photosynthesis,C0031764,en_1803,1,1,AFFECTS,General/Uncertain,3
8024,Pineal gland,C0031939,en_1811,PRODUCES,Hormones,C0019932,en_1204,1,1,AFFECTS,Excitatory,3
8025,Pineal gland,C0031939,en_1811,PRODUCES(SPEC),Melatonin,C0025219,en_1524,1,1,AFFECTS,Excitatory,3
8026,Placebos,C0032042,en_1813,AFFECTS,Cell secretion,C1327616,en_5566,1,1,AFFECTS,General/Uncertain,8
8027,Placebos,C0032042,en_1813,PREDISPOSES,Disease,C0012634,en_826,4,3,AFFECTS,Excitatory,9
8028,Placebos,C0032042,en_1813,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,8
8029,Placebos,C0032042,en_1813,PREVENTS,Complication,C0009566,en_697,3,2,AFFECTS,Inhibitory,10
8030,Placebos,C0032042,en_1813,PREVENTS,Disease,C0012634,en_826,6,2,AFFECTS,Inhibitory,6
8031,Placebos,C0032042,en_1813,PREVENTS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
8032,Placebos,C0032042,en_1813,PREVENTS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,8
8033,Placebos,C0032042,en_1813,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
8034,Placebos,C0032042,en_1813,PREVENTS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,8
8035,Placebos,C0032042,en_1813,PREVENTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,8
8036,Placebos,C0032042,en_1813,PREVENTS,Disease Progression,C0242656,en_3429,5,3,AFFECTS,Inhibitory,9
8037,Placebos,C0032042,en_1813,PREVENTS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,8
8038,Placebos,C0032042,en_1813,PREVENTS,physical symptom,C0679309,en_4594,1,1,AFFECTS,Inhibitory,8
8039,Placebos,C0032042,en_1813,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,6,3,AFFECTS,Inhibitory,9
8040,Placebos,C0032042,en_1813,PREVENTS,Symptoms,C1457887,en_5784,4,3,AFFECTS,Inhibitory,9
8041,Placebos,C0032042,en_1813,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
8042,Placebos,C0032042,en_1813,TREATS,Adult,C0001675,en_252,29,14,AFFECTS,Inhibitory,57
8043,Placebos,C0032042,en_1813,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
8044,Placebos,C0032042,en_1813,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
8045,Placebos,C0032042,en_1813,TREATS,Control Groups,C0009932,en_711,7,5,AFFECTS,Inhibitory,15
8046,Placebos,C0032042,en_1813,TREATS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,8
8047,Placebos,C0032042,en_1813,TREATS,Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,7
8048,Placebos,C0032042,en_1813,TREATS,Diarrhea,C0011991,en_810,1,1,AFFECTS,Inhibitory,3
8049,Placebos,C0032042,en_1813,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
8050,Placebos,C0032042,en_1813,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,8
8051,Placebos,C0032042,en_1813,TREATS,Fatigue,C0015672,en_966,3,2,AFFECTS,Inhibitory,6
8052,Placebos,C0032042,en_1813,TREATS,Health Personnel,C0018724,en_1121,9,5,AFFECTS,Inhibitory,24
8053,Placebos,C0032042,en_1813,TREATS,Households,C0020052,en_1208,2,1,AFFECTS,Inhibitory,3
8054,Placebos,C0032042,en_1813,TREATS,Human,C0020114,en_1210,2,1,AFFECTS,Inhibitory,3
8055,Placebos,C0032042,en_1813,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,8
8056,Placebos,C0032042,en_1813,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
8057,Placebos,C0032042,en_1813,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
8058,Placebos,C0032042,en_1813,TREATS,Outpatients,C0029921,en_1729,9,7,AFFECTS,Inhibitory,30
8059,Placebos,C0032042,en_1813,TREATS,Patients,C0030705,en_1762,68,41,AFFECTS,Inhibitory,123
8060,Placebos,C0032042,en_1813,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
8061,Placebos,C0032042,en_1813,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
8062,Placebos,C0032042,en_1813,TREATS,Postpartum Women,C0032804,en_1860,1,1,AFFECTS,Inhibitory,8
8063,Placebos,C0032042,en_1813,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,8
8064,Placebos,C0032042,en_1813,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,2,AFFECTS,Inhibitory,6
8065,Placebos,C0032042,en_1813,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
8066,Placebos,C0032042,en_1813,TREATS,Tuberculosis,C0041296,en_2293,2,1,AFFECTS,Inhibitory,3
8067,Placebos,C0032042,en_1813,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
8068,Placebos,C0032042,en_1813,TREATS,Voluntary Workers,C0042960,en_2380,5,3,AFFECTS,Inhibitory,9
8069,Placebos,C0032042,en_1813,TREATS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,7
8070,Placebos,C0032042,en_1813,TREATS,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,Inhibitory,6
8071,Placebos,C0032042,en_1813,TREATS,Myalgia,C0231528,en_3262,1,1,AFFECTS,Inhibitory,3
8072,Placebos,C0032042,en_1813,TREATS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Inhibitory,3
8073,Placebos,C0032042,en_1813,TREATS,Vital signs,C0518766,en_4182,4,1,AFFECTS,Inhibitory,3
8074,Placebos,C0032042,en_1813,TREATS,Lung finding,C0577914,en_4338,1,1,AFFECTS,Inhibitory,3
8075,Placebos,C0032042,en_1813,TREATS,High risk of heart disease,C0581228,en_4346,1,1,AFFECTS,Inhibitory,8
8076,Placebos,C0032042,en_1813,TREATS,cohort,C0599755,en_4470,4,4,AFFECTS,Inhibitory,12
8077,Placebos,C0032042,en_1813,TREATS,Participant,C0679646,en_4602,33,19,AFFECTS,Inhibitory,57
8078,Placebos,C0032042,en_1813,TREATS,Study Subject,C0681850,en_4632,1,1,AFFECTS,Inhibitory,7
8079,Placebos,C0032042,en_1813,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,3
8080,Placebos,C0032042,en_1813,TREATS,Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
8081,Placebos,C0032042,en_1813,TREATS,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
8082,Placebos,C0032042,en_1813,TREATS,Staff,C0851286,en_4950,2,2,AFFECTS,Inhibitory,11
8083,Placebos,C0032042,en_1813,TREATS,Hospitalized Patients,C0870668,en_5010,23,15,AFFECTS,Inhibitory,59
8084,Placebos,C0032042,en_1813,TREATS,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Inhibitory,3
8085,Placebos,C0032042,en_1813,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
8086,Placebos,C0032042,en_1813,TREATS,Patient ventilated,C1299448,en_5503,2,1,AFFECTS,Inhibitory,8
8087,Placebos,C0032042,en_1813,TREATS,Symptoms,C1457887,en_5784,7,7,AFFECTS,Inhibitory,36
8088,Placebos,C0032042,en_1813,TREATS,Cancer Patient,C1516213,en_5852,2,1,AFFECTS,Inhibitory,3
8089,Placebos,C0032042,en_1813,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,3,2,AFFECTS,Inhibitory,14
8090,Placebos,C0032042,en_1813,TREATS,COVID-19,C5203670,en_6417,11,10,AFFECTS,Inhibitory,76
8091,Placebos,C0032042,en_1813,TREATS(INFER),Disease,C0012634,en_826,8,5,AFFECTS,Inhibitory,15
8092,Placebos,C0032042,en_1813,TREATS(INFER),Pancreatitis,C0030305,en_1745,1,1,AFFECTS,Inhibitory,3
8093,Placebos,C0032042,en_1813,TREATS(INFER),Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,6
8094,Placebos,C0032042,en_1813,TREATS(INFER),Respiratory complication,C0161818,en_2899,4,1,AFFECTS,Inhibitory,3
8095,Placebos,C0032042,en_1813,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
8096,Placebos,C0032042,en_1813,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
8097,Placebos,C0032042,en_1813,TREATS(INFER),Asymptomatic,C0231221,en_3252,1,1,AFFECTS,Inhibitory,3
8098,Placebos,C0032042,en_1813,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
8099,Placebos,C0032042,en_1813,TREATS(INFER),Hypertensive,C0857121,en_4969,1,1,AFFECTS,Inhibitory,3
8100,Placebos,C0032042,en_1813,TREATS(INFER),Diffuse Scleroderma,C1258104,en_5406,2,1,AFFECTS,Inhibitory,3
8101,Placebos,C0032042,en_1813,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
8102,Placebos,C0032042,en_1813,TREATS(SPEC),Diarrhea,C0011991,en_810,1,1,AFFECTS,Inhibitory,3
8103,Placebos,C0032042,en_1813,TREATS(SPEC),Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
8104,Placebos,C0032042,en_1813,TREATS(SPEC),Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,3
8105,Placebos,C0032042,en_1813,TREATS(SPEC),Myalgia,C0231528,en_3262,1,1,AFFECTS,Inhibitory,3
8106,Plague,C0032064,en_1814,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
8107,Plasma Cells,C0032112,en_1817,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
8108,Plasma Exchange,C0032113,en_1818,AFFECTS,physiological aspects,C0031843,en_1806,2,1,AFFECTS,General/Uncertain,3
8109,Plasma Exchange,C0032113,en_1818,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
8110,Plasma Exchange,C0032113,en_1818,STIMULATES,Blood flow,C0232338,en_3276,2,1,AFFECTS,Excitatory,3
8111,Plasma Exchange,C0032113,en_1818,TREATS,Blood Coagulation Disorders,C0005779,en_485,2,2,AFFECTS,Inhibitory,6
8112,Plasma Exchange,C0032113,en_1818,TREATS,Critical Illness,C0010340,en_733,2,2,AFFECTS,Inhibitory,13
8113,Plasma Exchange,C0032113,en_1818,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
8114,Plasma Exchange,C0032113,en_1818,TREATS,Inflammation,C0021368,en_1307,2,2,AFFECTS,Inhibitory,6
8115,Plasma Exchange,C0032113,en_1818,TREATS,"Kidney Failure, Acute",C0022660,en_1382,2,1,AFFECTS,Inhibitory,6
8116,Plasma Exchange,C0032113,en_1818,TREATS,Patients,C0030705,en_1762,23,12,AFFECTS,Inhibitory,36
8117,Plasma Exchange,C0032113,en_1818,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
8118,Plasma Exchange,C0032113,en_1818,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,6
8119,Plasma Exchange,C0032113,en_1818,TREATS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Inhibitory,3
8120,Plasma Exchange,C0032113,en_1818,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
8121,Plasma Exchange,C0032113,en_1818,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,21
8122,Plasma Exchange,C0032113,en_1818,TREATS,pediatric inflammatory multisystem syndrome,C5389369,en_6437,1,1,AFFECTS,Inhibitory,7
8123,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Critical Illness,C0010340,en_733,4,3,AFFECTS,Inhibitory,9
8124,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
8125,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Inhibitory,3
8126,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
8127,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
8128,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
8129,Plasma Exchange,C0032113,en_1818,TREATS(INFER),Hepatitis fulminant,C0302809,en_3710,2,1,AFFECTS,Inhibitory,3
8130,Plasma Exchange,C0032113,en_1818,TREATS(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
8131,Plasma Proteins,C0032120,en_1819,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
8132,Plasmapheresis,C0032134,en_1820,PREVENTS,Tissue damage,C0010957,en_756,1,1,AFFECTS,Inhibitory,3
8133,Plasmapheresis,C0032134,en_1820,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8134,Plasmids,C0032136,en_1821,AFFECTS,Virulence,C0042765,en_2361,1,1,AFFECTS,General/Uncertain,3
8135,Alteplase,C0032143,en_1823,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,8
8136,Alteplase,C0032143,en_1823,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
8137,Alteplase,C0032143,en_1823,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
8138,Alteplase,C0032143,en_1823,TREATS,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Inhibitory,6
8139,Alteplase,C0032143,en_1823,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,6
8140,Alteplase,C0032143,en_1823,TREATS,"Stroke, Acute",C0751956,en_4854,2,2,AFFECTS,Inhibitory,9
8141,Alteplase,C0032143,en_1823,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,8
8142,Alteplase,C0032143,en_1823,TREATS,COVID-19,C5203670,en_6417,5,2,AFFECTS,Inhibitory,12
8143,Alteplase,C0032143,en_1823,DISRUPTS,cell motility,C0007608,en_593,1,1,AFFECTS,Inhibitory,3
8144,Alteplase,C0032143,en_1823,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8145,Alteplase,C0032143,en_1823,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
8146,Alteplase,C0032143,en_1823,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
8147,Alteplase,C0032143,en_1823,TREATS,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,Inhibitory,3
8148,Plasminogen Activator,C0032144,en_1824,DISRUPTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Inhibitory,3
8149,Plasminogen Activator,C0032144,en_1824,TREATS,Inspired fraction of oxygen,C0428167,en_4012,1,1,AFFECTS,Inhibitory,3
8150,Platelet Activation,C0032173,en_1827,AFFECTS,Thrombosis,C0040053,en_2233,2,1,AFFECTS,General/Uncertain,3
8151,Platelet Activation,C0032173,en_1827,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,7
8152,Platelet Activation,C0032173,en_1827,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
8153,Platelet Activation,C0032173,en_1827,PRODUCES,Thrombin,C0040018,en_2228,1,1,AFFECTS,Excitatory,7
8154,Platelet Activation,C0032173,en_1827,PRODUCES,"SELP protein, human|SELP",C2742134|6403,en_6132,1,1,AFFECTS,Excitatory,7
8155,Platelet aggregation,C0032176,en_1828,AFFECTS,Virus Replication,C0042774,en_2363,3,1,AFFECTS,General/Uncertain,3
8156,Platelet-Derived Growth Factor,C0032200,en_1829,AUGMENTS,fibrogenesis,C0596570,en_4392,1,1,AFFECTS,Excitatory,3
8157,Play,C0032214,en_1830,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
8158,Play,C0032214,en_1830,TREATS,Pericarditis,C0031046,en_1772,1,1,AFFECTS,Inhibitory,3
8159,Play,C0032214,en_1830,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
8160,Play,C0032214,en_1830,TREATS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Inhibitory,3
8161,Play,C0032214,en_1830,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
8162,Play Therapy,C0032216,en_1831,TREATS,VICTIM,C0680681,en_4626,1,1,AFFECTS,Inhibitory,3
8163,Pneumonia,C0032285,en_1833,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8164,Pneumonia,C0032285,en_1833,AFFECTS,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
8165,Pneumonia,C0032285,en_1833,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
8166,Pneumonia,C0032285,en_1833,AFFECTS,Persons,C0027361,en_1635,5,4,AFFECTS,General/Uncertain,12
8167,Pneumonia,C0032285,en_1833,AFFECTS,Patients,C0030705,en_1762,6,5,AFFECTS,General/Uncertain,15
8168,Pneumonia,C0032285,en_1833,AFFECTS,Respiratory physiology,C0035245,en_2018,1,1,AFFECTS,General/Uncertain,6
8169,Pneumonia,C0032285,en_1833,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,6
8170,Pneumonia,C0032285,en_1833,AFFECTS,Respiratory complication,C0161818,en_2899,1,1,AFFECTS,General/Uncertain,8
8171,Pneumonia,C0032285,en_1833,AFFECTS,Hemorheology,C0206502,en_3162,1,1,AFFECTS,General/Uncertain,3
8172,Pneumonia,C0032285,en_1833,AFFECTS,Individual,C0237401,en_3343,11,1,AFFECTS,General/Uncertain,3
8173,Pneumonia,C0032285,en_1833,AFFECTS,Hospitalized Patients,C0870668,en_5010,3,1,AFFECTS,General/Uncertain,3
8174,Pneumonia,C0032285,en_1833,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
8175,Pneumonia,C0032285,en_1833,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8176,Pneumonia,C0032285,en_1833,COMPLICATES,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
8177,Pneumonia,C0032285,en_1833,DISRUPTS,Mediating,C0086597,en_2730,2,1,AFFECTS,Inhibitory,3
8178,Pneumonia,C0032285,en_1833,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
8179,Pneumonia,C0032285,en_1833,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,2,AFFECTS,Excitatory,9
8180,Pneumonia,C0032285,en_1833,PREDISPOSES,Thrombosis,C0040053,en_2233,4,2,AFFECTS,Excitatory,6
8181,Pneumonia,C0032285,en_1833,PREDISPOSES,Decompensation,C0231187,en_3250,3,1,AFFECTS,Excitatory,3
8182,Pneumonia,C0032285,en_1833,PREDISPOSES,Disease Progression,C0242656,en_3429,5,3,AFFECTS,Excitatory,9
8183,Pneumonia,C0032285,en_1833,PREDISPOSES,poor health,C0683321,en_4658,1,1,AFFECTS,Excitatory,3
8184,Pneumonia,C0032285,en_1833,PREDISPOSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
8185,Pneumonia,C0032285,en_1833,PREDISPOSES,Ventilatory support,C4748623,en_6401,2,1,AFFECTS,Excitatory,6
8186,Pneumonia,C0032285,en_1833,PRODUCES,Interleukin-2,C0021756,en_1337,1,1,AFFECTS,Excitatory,3
8187,Pneumonia,C0032285,en_1833,PRODUCES,Lactamase,C0086518,en_2723,2,1,AFFECTS,Excitatory,3
8188,Pneumonia,C0032285,en_1833,PRODUCES,carbapenemase,C0246081,en_3478,1,1,AFFECTS,Excitatory,3
8189,Aspiration Pneumonia,C0032290,en_1834,AFFECTS,Cleans drug injection equipment finding,C0542277,en_4254,1,1,AFFECTS,General/Uncertain,3
8190,"Pneumonia, Pneumococcal",C0032300,en_1835,AFFECTS,Respiration,C0035203,en_2004,2,1,AFFECTS,General/Uncertain,3
8191,"Pneumonia, Pneumococcal",C0032300,en_1835,AFFECTS,Inflammation Process,C1512753,en_5825,2,1,AFFECTS,General/Uncertain,3
8192,"Pneumonia, Pneumococcal",C0032300,en_1835,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8193,"Pneumonia, Viral",C0032310,en_1837,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
8194,"Pneumonia, Viral",C0032310,en_1837,AFFECTS(SPEC),monocyte activation,C1155075,en_5316,1,1,AFFECTS,General/Uncertain,3
8195,"Pneumonia, Viral",C0032310,en_1837,COMPLICATES,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,General/Uncertain,3
8196,Poisons,C0032346,en_1840,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
8197,Poisons,C0032346,en_1840,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
8198,Poliovirus Vaccines,C0032374,en_1842,AUGMENTS,Immune response,C0301872,en_3696,2,1,AFFECTS,Excitatory,3
8199,"Poliovirus Vaccine, Oral",C0032375,en_1843,PREVENTS,Poliomyelitis,C0032371,en_1841,2,1,AFFECTS,Inhibitory,3
8200,Poly(ADP-ribose) Polymerases,C0032405,en_1844,INHIBITS,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,1,1,AFFECTS,Inhibitory,3
8201,Polyamines,C0032433,en_1845,DISRUPTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
8202,Polyethylene Glycols,C0032483,en_1847,TREATS,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,Inhibitory,7
8203,Polyethylene Glycols,C0032483,en_1847,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
8204,Polymers,C0032521,en_1848,PREVENTS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
8205,Polymers,C0032521,en_1848,PREVENTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
8206,"Polymorphism, Genetic",C0032529,en_1849,AFFECTS,IgG3,C0020859,en_1266,1,1,AFFECTS,General/Uncertain,3
8207,"Polymorphism, Genetic",C0032529,en_1849,AFFECTS,Predisposition,C0220898,en_3206,1,1,AFFECTS,General/Uncertain,8
8208,"Polymorphism, Genetic",C0032529,en_1849,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
8209,Polysaccharides,C0032594,en_1850,STIMULATES,"Fatty Acids, Volatile",C0015691,en_972,1,1,AFFECTS,Excitatory,7
8210,Polysaccharides,C0032594,en_1850,AUGMENTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,Excitatory,3
8211,Polysaccharides,C0032594,en_1850,AUGMENTS,Signal Transduction Pathways,C0086982,en_2741,1,1,AFFECTS,Excitatory,3
8212,Polysaccharides,C0032594,en_1850,AUGMENTS,host,C1167395,en_5368,1,1,AFFECTS,Excitatory,3
8213,Polysaccharides,C0032594,en_1850,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8214,Polysaccharides,C0032594,en_1850,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
8215,Polysaccharides,C0032594,en_1850,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,3
8216,Polysorbate 80,C0032601,en_1851,DISRUPTS,biofilm formation,C1325881,en_5552,1,1,AFFECTS,Inhibitory,3
8217,Porphyrins,C0032712,en_1853,AUGMENTS,luminescence,C1450275,en_5763,2,1,AFFECTS,Excitatory,3
8218,Positive-Pressure Respiration,C0032740,en_1854,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
8219,Positive-Pressure Respiration,C0032740,en_1854,AFFECTS,Respiratory physiology,C0035245,en_2018,1,1,AFFECTS,General/Uncertain,8
8220,Positive-Pressure Respiration,C0032740,en_1854,AFFECTS,Work of Breathing,C0043229,en_2398,1,1,AFFECTS,General/Uncertain,3
8221,Positive-Pressure Respiration,C0032740,en_1854,TREATS,Atelectasis,C0004144,en_420,1,1,AFFECTS,Inhibitory,3
8222,Positive-Pressure Respiration,C0032740,en_1854,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
8223,Positive-Pressure Respiration,C0032740,en_1854,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
8224,Positive-Pressure Respiration,C0032740,en_1854,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
8225,Positive-Pressure Respiration,C0032740,en_1854,TREATS,Prolonged periods,C0425945,en_4005,1,1,AFFECTS,Inhibitory,3
8226,Positive-Pressure Respiration,C0032740,en_1854,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
8227,Positive Reinforcement,C0032741,en_1855,TREATS,Staff,C0851286,en_4950,2,1,AFFECTS,Inhibitory,3
8228,Positron-Emission Tomography,C0032743,en_1856,AFFECTS,patient care,C0017313,en_1050,2,1,AFFECTS,General/Uncertain,3
8229,Postnatal Care,C0032782,en_1857,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
8230,Postoperative Complications,C0032787,en_1858,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
8231,Postoperative shock NOS,C0032792,en_1859,COMPLICATES,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,General/Uncertain,3
8232,Postphlebitic Syndrome,C0032807,en_1861,COMPLICATES,Blood Clot,C0302148,en_3702,1,1,AFFECTS,General/Uncertain,3
8233,Povidone,C0032856,en_1863,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
8234,Povidone-Iodine,C0032857,en_1864,AFFECTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
8235,Povidone-Iodine,C0032857,en_1864,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
8236,Povidone-Iodine,C0032857,en_1864,PREVENTS,Virus Diseases,C0042769,en_2362,3,1,AFFECTS,Inhibitory,3
8237,Povidone-Iodine,C0032857,en_1864,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
8238,Povidone-Iodine,C0032857,en_1864,TREATS,inpatient,C0021562,en_1321,2,1,AFFECTS,Inhibitory,3
8239,Povidone-Iodine,C0032857,en_1864,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8240,Povidone-Iodine,C0032857,en_1864,TREATS,Participant,C0679646,en_4602,4,2,AFFECTS,Inhibitory,6
8241,Povidone-Iodine,C0032857,en_1864,TREATS,member,C0680022,en_4618,2,1,AFFECTS,Inhibitory,3
8242,Praziquantel,C0032911,en_1865,AFFECTS,Fibrosis,C0016059,en_994,1,1,AFFECTS,General/Uncertain,3
8243,Praziquantel,C0032911,en_1865,TREATS,Schistosomiasis,C0036323,en_2067,1,1,AFFECTS,Inhibitory,3
8244,Praziquantel,C0032911,en_1865,TREATS,School child,C0260267,en_3511,1,1,AFFECTS,Inhibitory,3
8245,Prazosin,C0032912,en_1866,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
8246,Prazosin,C0032912,en_1866,PREVENTS,Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
8247,Prazosin,C0032912,en_1866,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
8248,prednisolone,C0032950,en_1870,TREATS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Inhibitory,8
8249,prednisolone,C0032950,en_1870,TREATS,Inflammatory lung disease,C4230430,en_6320,1,1,AFFECTS,Inhibitory,6
8250,prednisolone,C0032950,en_1870,PREDISPOSES,Kidney problem,C0812426,en_4903,2,1,AFFECTS,Excitatory,3
8251,prednisolone,C0032950,en_1870,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
8252,prednisolone,C0032950,en_1870,TREATS,Pruritus,C0033774,en_1916,2,1,AFFECTS,Inhibitory,3
8253,prednisolone,C0032950,en_1870,TREATS,Disability NOS,C0231170,en_3247,2,1,AFFECTS,Inhibitory,3
8254,prednisolone,C0032950,en_1870,TREATS,Severe pain,C0278140,en_3598,2,1,AFFECTS,Inhibitory,3
8255,prednisolone,C0032950,en_1870,TREATS(INFER),Diffuse Scleroderma,C1258104,en_5406,2,1,AFFECTS,Inhibitory,3
8256,prednisolone,C0032950,en_1870,TREATS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8257,Prednisone,C0032952,en_1871,TREATS,Recurrent pregnancy loss,C2921106,en_6144,2,1,AFFECTS,Inhibitory,7
8258,Prednisone,C0032952,en_1871,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
8259,Prednisone,C0032952,en_1871,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8260,Pregnancy,C0032961,en_1872,AFFECTS,Spontaneous abortion,C0000786,en_206,2,1,AFFECTS,General/Uncertain,3
8261,Pregnancy,C0032961,en_1872,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
8262,Pregnancy,C0032961,en_1872,AFFECTS,Mental disorders,C0004936,en_452,2,1,AFFECTS,General/Uncertain,3
8263,Pregnancy,C0032961,en_1872,AFFECTS,Birth Weight,C0005612,en_475,1,1,AFFECTS,General/Uncertain,7
8264,Pregnancy,C0032961,en_1872,AFFECTS,Birth,C0005615,en_476,1,1,AFFECTS,General/Uncertain,3
8265,Pregnancy,C0032961,en_1872,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,3
8266,Pregnancy,C0032961,en_1872,AFFECTS,Child,C0008059,en_620,3,3,AFFECTS,General/Uncertain,9
8267,Pregnancy,C0032961,en_1872,AFFECTS,Child Development,C0008071,en_621,1,1,AFFECTS,General/Uncertain,3
8268,Pregnancy,C0032961,en_1872,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
8269,Pregnancy,C0032961,en_1872,AFFECTS,Fetal Death,C0015927,en_982,2,1,AFFECTS,General/Uncertain,3
8270,Pregnancy,C0032961,en_1872,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
8271,Pregnancy,C0032961,en_1872,AFFECTS,Infant,C0021270,en_1297,3,2,AFFECTS,General/Uncertain,6
8272,Pregnancy,C0032961,en_1872,AFFECTS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,General/Uncertain,3
8273,Pregnancy,C0032961,en_1872,AFFECTS,Male population group,C0025266,en_1533,1,1,AFFECTS,General/Uncertain,3
8274,Pregnancy,C0032961,en_1872,AFFECTS,Mothers,C0026591,en_1583,3,2,AFFECTS,General/Uncertain,6
8275,Pregnancy,C0032961,en_1872,AFFECTS,Pregnancy Complications,C0032962,en_1873,1,1,AFFECTS,General/Uncertain,3
8276,Pregnancy,C0032961,en_1872,AFFECTS,Woman,C0043210,en_2396,13,3,AFFECTS,General/Uncertain,9
8277,Pregnancy,C0032961,en_1872,AFFECTS,Ability,C0085732,en_2688,2,1,AFFECTS,General/Uncertain,3
8278,Pregnancy,C0032961,en_1872,AFFECTS,[V]Other behavioral problems,C0260657,en_3512,1,1,AFFECTS,General/Uncertain,3
8279,Pregnancy,C0032961,en_1872,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
8280,Pregnancy,C0032961,en_1872,AFFECTS,neurodevelopment,C0599855,en_4477,2,1,AFFECTS,General/Uncertain,3
8281,Pregnancy,C0032961,en_1872,AFFECTS,Offspring,C0680063,en_4620,2,2,AFFECTS,General/Uncertain,6
8282,Pregnancy,C0032961,en_1872,AFFECTS,Fetal complications,C0851390,en_4953,1,1,AFFECTS,General/Uncertain,3
8283,Pregnancy,C0032961,en_1872,AFFECTS(SPEC),Depressive disorder,C0011581,en_788,2,1,AFFECTS,General/Uncertain,3
8284,Pregnancy,C0032961,en_1872,AFFECTS(SPEC),Pre-Eclampsia,C0032914,en_1867,1,1,AFFECTS,General/Uncertain,3
8285,"Pregnancy, Ectopic",C0032987,en_1875,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8286,Prejudice,C0033023,en_1877,AFFECTS,Health-related behavior,C0237121,en_3340,1,1,AFFECTS,General/Uncertain,3
8287,Prenatal care,C0033052,en_1878,PREVENTS,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Inhibitory,3
8288,Prenatal care,C0033052,en_1878,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
8289,Prenatal care,C0033052,en_1878,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
8290,Prenatal care,C0033052,en_1878,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
8291,Prenatal Diagnosis,C0033053,en_1879,AFFECTS,Prenatal Testing,C1456692,en_5778,1,1,AFFECTS,General/Uncertain,3
8292,prescription procedure,C0033080,en_1880,PREVENTS,Migraine Disorders,C0149931,en_2813,2,1,AFFECTS,Inhibitory,3
8293,prescription procedure,C0033080,en_1880,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,6
8294,prescription procedure,C0033080,en_1880,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8295,"Prescriptions, Drug",C0033081,en_1881,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
8296,"Prescriptions, Drug",C0033081,en_1881,TREATS(INFER),Spinal Cord Injuries,C0037929,en_2143,1,1,AFFECTS,Inhibitory,3
8297,Primary Care Physicians,C0033131,en_1883,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
8298,Primary Health Care,C0033137,en_1884,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
8299,Primary Health Care,C0033137,en_1884,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
8300,Primary Health Care,C0033137,en_1884,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
8301,Primary Health Care,C0033137,en_1884,TREATS,Chronic Disease,C0008679,en_643,2,1,AFFECTS,Inhibitory,3
8302,Primary Health Care,C0033137,en_1884,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,6
8303,Primary Health Care,C0033137,en_1884,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
8304,Primary Health Care,C0033137,en_1884,TREATS,Persons,C0027361,en_1635,3,3,AFFECTS,Inhibitory,9
8305,Primary Health Care,C0033137,en_1884,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
8306,Primary Health Care,C0033137,en_1884,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,6
8307,Primary Health Care,C0033137,en_1884,TREATS,Tuberculosis,C0041296,en_2293,2,1,AFFECTS,Inhibitory,3
8308,Primary Health Care,C0033137,en_1884,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
8309,Primary Health Care,C0033137,en_1884,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
8310,Primary Health Care,C0033137,en_1884,TREATS,Pre-existing disease,C1112199,en_5242,1,1,AFFECTS,Inhibitory,3
8311,Primary Health Care,C0033137,en_1884,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8312,Primary Health Care,C0033137,en_1884,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
8313,Primary Prevention,C0033144,en_1886,TREATS,Health Personnel,C0018724,en_1121,2,2,AFFECTS,Inhibitory,6
8314,Primary Prevention,C0033144,en_1886,TREATS,Violence,C0042693,en_2353,1,1,AFFECTS,Inhibitory,3
8315,Prions,C0033164,en_1888,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
8316,Probenecid,C0033209,en_1889,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
8317,Fenofibrate,C0033228,en_1891,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
8318,Progesterone,C0033308,en_1893,AUGMENTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,3
8319,Progesterone,C0033308,en_1893,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
8320,Progesterone,C0033308,en_1893,TREATS,Male population group,C0025266,en_1533,2,1,AFFECTS,Inhibitory,3
8321,Progesterone,C0033308,en_1893,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
8322,Progesterone,C0033308,en_1893,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
8323,Forecast of outcome,C0033325,en_1894,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8324,Forecast of outcome,C0033325,en_1894,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8325,Program Development,C0033333,en_1895,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
8326,Program Development,C0033333,en_1895,TREATS,Teacher,C0221457,en_3226,1,1,AFFECTS,Inhibitory,3
8327,Prolactin,C0033371,en_1896,STIMULATES,STAT5A gene,C1335875,en_5626,1,1,AFFECTS,Excitatory,3
8328,Propolis,C0033488,en_1899,INHIBITS,IMPACT gene,C1825598,en_6044,1,1,AFFECTS,Inhibitory,8
8329,Propolis,C0033488,en_1899,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
8330,Propolis,C0033488,en_1899,TREATS,Persons,C0027361,en_1635,6,1,AFFECTS,Inhibitory,3
8331,Propolis,C0033488,en_1899,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8332,Propolis,C0033488,en_1899,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
8333,Propranolol,C0033497,en_1900,INHIBITS,Propofol,C0033487,en_1898,3,1,AFFECTS,Inhibitory,3
8334,Propranolol,C0033497,en_1900,INHIBITS,Sedatives,C0036557,en_2075,5,1,AFFECTS,Inhibitory,3
8335,Propranolol,C0033497,en_1900,PREVENTS,Agitation,C0085631,en_2683,1,1,AFFECTS,Inhibitory,3
8336,Propranolol,C0033497,en_1900,PREVENTS(SPEC),Agitation,C0085631,en_2683,2,1,AFFECTS,Inhibitory,3
8337,Propranolol,C0033497,en_1900,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
8338,Propranolol,C0033497,en_1900,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
8339,Propranolol,C0033497,en_1900,TREATS(INFER),Critical Illness,C0010340,en_733,3,1,AFFECTS,Inhibitory,3
8340,Epoprostenol,C0033567,en_1903,AFFECTS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,General/Uncertain,8
8341,Epoprostenol,C0033567,en_1903,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,8
8342,Epoprostenol,C0033567,en_1903,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,8
8343,Epoprostenol,C0033567,en_1903,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
8344,Epoprostenol,C0033567,en_1903,STIMULATES,Alteplase,C0032143,en_1823,1,1,AFFECTS,Excitatory,3
8345,Epoprostenol,C0033567,en_1903,STIMULATES,Plasminogen Inactivators,C0032145,en_1825,1,1,AFFECTS,Excitatory,3
8346,"Prostaglandins, Synthetic",C0033568,en_1904,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
8347,Protease Inhibitor,C0033607,en_1905,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
8348,Protease Inhibitor,C0033607,en_1905,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
8349,Protease Inhibitor,C0033607,en_1905,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8350,Protease Inhibitor,C0033607,en_1905,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
8351,Protease Inhibitor,C0033607,en_1905,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8352,Protease Inhibitor,C0033607,en_1905,TREATS,Hospitalized Patients,C0870668,en_5010,4,2,AFFECTS,Inhibitory,6
8353,Protective Agents,C0033613,en_1906,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,7
8354,Protective Agents,C0033613,en_1906,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
8355,Protein Binding,C0033618,en_1907,AFFECTS,Chromatin,C0008546,en_642,1,1,AFFECTS,General/Uncertain,3
8356,Protein C,C0033621,en_1908,AFFECTS,Vascular inflammations,C0947751,en_5156,1,1,AFFECTS,General/Uncertain,3
8357,PROTEIN KINASE,C0033640,en_1909,PREDISPOSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
8358,"Protein Processing, Post-Translational",C0033666,en_1910,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
8359,"Protein Processing, Post-Translational",C0033666,en_1910,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
8360,Transglutaminases,C0033679,en_1911,AFFECTS,Blood Vessels,C0005847,en_494,1,1,AFFECTS,General/Uncertain,3
8361,Proteins,C0033684,en_1912,AFFECTS,Immune system,C0020962,en_1271,1,1,AFFECTS,General/Uncertain,8
8362,Proteins,C0033684,en_1912,AFFECTS,"Chemotaxis, Leukocyte",C0008019,en_616,1,1,AFFECTS,General/Uncertain,3
8363,Proteins,C0033684,en_1912,AFFECTS,Endocytosis,C0014139,en_897,2,2,AFFECTS,General/Uncertain,6
8364,Proteins,C0033684,en_1912,AFFECTS,Gene Expression Regulation,C0017263,en_1045,1,1,AFFECTS,General/Uncertain,3
8365,Proteins,C0033684,en_1912,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
8366,Proteins,C0033684,en_1912,AFFECTS,Phosphorylation,C0031715,en_1800,1,1,AFFECTS,General/Uncertain,3
8367,Proteins,C0033684,en_1912,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
8368,Proteins,C0033684,en_1912,AFFECTS,Signal Transduction,C0037083,en_2105,2,2,AFFECTS,General/Uncertain,6
8369,Proteins,C0033684,en_1912,AFFECTS,Immune response,C0301872,en_3696,4,3,AFFECTS,General/Uncertain,9
8370,Proteins,C0033684,en_1912,AFFECTS,Entire body system,C0392912,en_3927,1,1,AFFECTS,General/Uncertain,3
8371,Proteins,C0033684,en_1912,AFFECTS,Inactivation,C0544461,en_4262,1,1,AFFECTS,General/Uncertain,3
8372,Proteins,C0033684,en_1912,AFFECTS,Proteolysis,C0597304,en_4421,1,1,AFFECTS,General/Uncertain,3
8373,Proteins,C0033684,en_1912,AFFECTS,Neurophysiology - biologic function,C0700630,en_4729,1,1,AFFECTS,General/Uncertain,3
8374,Proteins,C0033684,en_1912,AFFECTS,caspase activation,C1159825,en_5346,1,1,AFFECTS,General/Uncertain,3
8375,Proteins,C0033684,en_1912,AFFECTS,RNA Degradation,C1257756,en_5400,1,1,AFFECTS,General/Uncertain,3
8376,Proteins,C0033684,en_1912,AFFECTS,photoreceptor outer segment,C1325525,en_5549,1,1,AFFECTS,General/Uncertain,3
8377,Proteins,C0033684,en_1912,AFFECTS,Protein Import,C1326471,en_5556,1,1,AFFECTS,General/Uncertain,3
8378,Proteins,C0033684,en_1912,AFFECTS,RNA Synthesis,C1328948,en_5575,1,1,AFFECTS,General/Uncertain,3
8379,Proteins,C0033684,en_1912,AFFECTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,General/Uncertain,3
8380,Proteins,C0033684,en_1912,AFFECTS,Alveolus,C1515933,en_5850,1,1,AFFECTS,General/Uncertain,3
8381,Proteins,C0033684,en_1912,AUGMENTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Excitatory,3
8382,Proteins,C0033684,en_1912,DISRUPTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Inhibitory,3
8383,Proteins,C0033684,en_1912,DISRUPTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
8384,Proteins,C0033684,en_1912,DISRUPTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
8385,Proteins,C0033684,en_1912,DISRUPTS,biofilm formation,C1325881,en_5552,1,1,AFFECTS,Inhibitory,3
8386,Proteins,C0033684,en_1912,INHIBITS,Hemoglobin,C0019046,en_1159,1,1,AFFECTS,Inhibitory,3
8387,Proteins,C0033684,en_1912,INHIBITS,Poisons,C0032346,en_1840,1,1,AFFECTS,Inhibitory,3
8388,Proteins,C0033684,en_1912,INHIBITS,Pulmonary Surfactants,C0034085,en_1935,2,1,AFFECTS,Inhibitory,3
8389,Proteins,C0033684,en_1912,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
8390,Proteins,C0033684,en_1912,PREDISPOSES,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,Excitatory,3
8391,Proteins,C0033684,en_1912,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
8392,Proteins,C0033684,en_1912,PREVENTS,Chlamydia Infections,C0008149,en_627,1,1,AFFECTS,Inhibitory,3
8393,Proteins,C0033684,en_1912,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8394,Proteins,C0033684,en_1912,PRODUCES,"RNA, Messenger",C0035696,en_2046,1,1,AFFECTS,Excitatory,3
8395,Proteins,C0033684,en_1912,PRODUCES,saliva,C0036087,en_2057,2,1,AFFECTS,Excitatory,3
8396,Proteins,C0033684,en_1912,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
8397,Proteins,C0033684,en_1912,PRODUCES,paramylon,C0070074,en_2538,1,1,AFFECTS,Excitatory,3
8398,Proteins,C0033684,en_1912,PRODUCES,Genetic Materials,C0440471,en_4042,1,1,AFFECTS,Excitatory,3
8399,Proteins,C0033684,en_1912,PRODUCES,receptor,C0597357,en_4422,1,1,AFFECTS,Excitatory,3
8400,Proteins,C0033684,en_1912,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
8401,Proteins,C0033684,en_1912,STIMULATES,TNF gene,C0812246,en_4896,1,1,AFFECTS,Excitatory,3
8402,Proteins,C0033684,en_1912,STIMULATES,cellulose synthase,C1571687,en_5991,1,1,AFFECTS,Excitatory,3
8403,Protons,C0033727,en_1915,AUGMENTS,experience,C0596545,en_4391,1,1,AFFECTS,Excitatory,3
8404,Protons,C0033727,en_1915,DISRUPTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
8405,Protons,C0033727,en_1915,STIMULATES,Photosensitizing Agents,C0162713,en_2928,2,1,AFFECTS,Excitatory,3
8406,Pseudomonas aeruginosa,C0033809,en_1917,PRODUCES,Lactamase,C0086518,en_2723,2,1,AFFECTS,Excitatory,3
8407,Psychiatrist,C0033872,en_1919,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8408,Psychotherapy,C0033968,en_1921,PREVENTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
8409,Psychotherapy,C0033968,en_1921,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
8410,Psychotherapy,C0033968,en_1921,TREATS,Mental disorders,C0004936,en_452,2,1,AFFECTS,Inhibitory,3
8411,Psychotherapy,C0033968,en_1921,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
8412,Psychotherapy,C0033968,en_1921,TREATS,Obesity,C0028754,en_1699,2,1,AFFECTS,Inhibitory,3
8413,Psychotherapy,C0033968,en_1921,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
8414,Psychotherapy,C0033968,en_1921,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,3
8415,Psychotherapy,C0033968,en_1921,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,Inhibitory,3
8416,Psychotherapy,C0033968,en_1921,TREATS,Addictive Behavior,C0085281,en_2658,1,1,AFFECTS,Inhibitory,3
8417,Psychotherapy,C0033968,en_1921,TREATS,Social fear,C0424166,en_3991,1,1,AFFECTS,Inhibitory,3
8418,Psychotherapy,C0033968,en_1921,TREATS,Symptoms,C1457887,en_5784,3,1,AFFECTS,Inhibitory,3
8419,Group Psychotherapy,C0033971,en_1922,PREVENTS,Suicide,C0038661,en_2178,1,1,AFFECTS,Inhibitory,3
8420,Group Psychotherapy,C0033971,en_1922,PREVENTS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,3
8421,Group Psychotherapy,C0033971,en_1922,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
8422,"Psychotherapy, Multiple",C0033972,en_1923,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
8423,"Psychotherapy, Multiple",C0033972,en_1923,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8424,"Psychotherapy, Multiple",C0033972,en_1923,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
8425,"Psychotherapy, Multiple",C0033972,en_1923,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
8426,Psychotic Disorders,C0033975,en_1924,AFFECTS,Sleep Disorders,C0851578,en_4954,2,1,AFFECTS,General/Uncertain,3
8427,Psychotic Disorders,C0033975,en_1924,AFFECTS(SPEC),Sleeplessness,C0917801,en_5108,2,1,AFFECTS,General/Uncertain,3
8428,Psychotropic Drugs,C0033978,en_1925,AUGMENTS,Brain,C0006104,en_508,1,1,AFFECTS,Excitatory,3
8429,Psychotropic Drugs,C0033978,en_1925,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
8430,Psychotropic Drugs,C0033978,en_1925,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,8
8431,Psychotropic Drugs,C0033978,en_1925,TREATS,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,8
8432,Pulmonary Edema,C0034063,en_1929,DISRUPTS,exchange,C0678640,en_4566,1,1,AFFECTS,Inhibitory,3
8433,Pulmonary Edema,C0034063,en_1929,PRODUCES,Pulmonary Surfactants,C0034085,en_1935,1,1,AFFECTS,Excitatory,3
8434,Pulmonary Edema,C0034063,en_1929,AFFECTS,Diffusion,C0012222,en_814,1,1,AFFECTS,General/Uncertain,8
8435,Pulmonary Embolism,C0034065,en_1930,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
8436,Pulmonary Embolism,C0034065,en_1930,COMPLICATES,Right ventricular failure,C2939447,en_6155,1,1,AFFECTS,General/Uncertain,3
8437,Pulmonary Embolism,C0034065,en_1930,PREDISPOSES,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,3
8438,Pulmonary Fibrosis,C0034069,en_1932,AFFECTS,physiological aspects,C0031843,en_1806,2,1,AFFECTS,General/Uncertain,3
8439,Pulmonary Fibrosis,C0034069,en_1932,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
8440,Pulmonary Fibrosis,C0034069,en_1932,AFFECTS,Animal Model,C0599779,en_4473,1,1,AFFECTS,General/Uncertain,3
8441,Pulmonary Fibrosis,C0034069,en_1932,DISRUPTS,Cells,C0007634,en_596,2,1,AFFECTS,Inhibitory,3
8442,Pulmonary Fibrosis,C0034069,en_1932,DISRUPTS,Epithelial Cells,C0014597,en_919,2,1,AFFECTS,Inhibitory,3
8443,Pulmonary Surfactants,C0034085,en_1935,TREATS,neonatal Intubations,C2234351,en_6092,1,1,AFFECTS,Inhibitory,6
8444,Pulmonary Surfactants,C0034085,en_1935,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,15
8445,Pulmonary Surfactants,C0034085,en_1935,AFFECTS,Lung,C0024109,en_1460,2,1,AFFECTS,General/Uncertain,3
8446,Pulmonary Surfactants,C0034085,en_1935,INHIBITS,Enzymes,C0014442,en_912,1,1,AFFECTS,Inhibitory,3
8447,Pulmonary Surfactants,C0034085,en_1935,INHIBITS,Phosphatidyl glycerol,C0031614,en_1794,2,1,AFFECTS,Inhibitory,3
8448,Pulmonary Surfactants,C0034085,en_1935,INHIBITS,Alveolar ventilation function,C0231940,en_3269,2,1,AFFECTS,Inhibitory,3
8449,Pulmonary Surfactants,C0034085,en_1935,TREATS,"Infant, Newborn",C0021289,en_1299,2,1,AFFECTS,Inhibitory,3
8450,Pulmonary Surfactants,C0034085,en_1935,TREATS,"Infant, Premature",C0021294,en_1300,1,1,AFFECTS,Inhibitory,3
8451,Pulmonary Surfactants,C0034085,en_1935,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
8452,Pulmonary Surfactants,C0034085,en_1935,TREATS,Patients,C0030705,en_1762,11,5,AFFECTS,Inhibitory,15
8453,Pulmonary Surfactants,C0034085,en_1935,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
8454,Pulmonary Surfactants,C0034085,en_1935,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,2,AFFECTS,Inhibitory,6
8455,Pulse taking,C0034107,en_1938,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,6
8456,Pulse taking,C0034107,en_1938,TREATS,Storm Syndrome,C1861452,en_6056,1,1,AFFECTS,Inhibitory,6
8457,Puncture procedure,C0034117,en_1939,TREATS,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Inhibitory,3
8458,Puncture procedure,C0034117,en_1939,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8459,"Purpura, Thrombotic Thrombocytopenic",C0034155,en_1940,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
8460,Pyridostigmine,C0034261,en_1941,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8461,Pyridostigmine,C0034261,en_1941,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
8462,Pyridostigmine,C0034261,en_1941,TREATS(INFER),Struck,C0275626,en_3570,1,1,AFFECTS,Inhibitory,3
8463,Quarantine,C0034386,en_1944,AFFECTS,Evolution,C0015219,en_937,2,1,AFFECTS,General/Uncertain,3
8464,Quarantine,C0034386,en_1944,AFFECTS,Mentally Ill Persons,C0025360,en_1544,1,1,AFFECTS,General/Uncertain,3
8465,Quarantine,C0034386,en_1944,AFFECTS,Movement,C0026649,en_1588,2,2,AFFECTS,General/Uncertain,9
8466,Quarantine,C0034386,en_1944,AFFECTS,Migraine Disorders,C0149931,en_2813,2,1,AFFECTS,General/Uncertain,6
8467,Quarantine,C0034386,en_1944,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
8468,Quarantine,C0034386,en_1944,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8469,Quarantine,C0034386,en_1944,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8470,Quarantine,C0034386,en_1944,PREVENTS,Community Transmission,C5392207,en_6447,1,1,AFFECTS,Inhibitory,6
8471,Quarantine,C0034386,en_1944,TREATS,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,Inhibitory,6
8472,Quarantine,C0034386,en_1944,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
8473,Quarantine,C0034386,en_1944,TREATS,Patients,C0030705,en_1762,4,4,AFFECTS,Inhibitory,12
8474,Quarantine,C0034386,en_1944,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
8475,Quarantine,C0034386,en_1944,TREATS,Migraine Disorders,C0149931,en_2813,2,1,AFFECTS,Inhibitory,6
8476,Quarantine,C0034386,en_1944,TREATS,Individual,C0237401,en_3343,2,2,AFFECTS,Inhibitory,6
8477,Quarantine,C0034386,en_1944,TREATS,Influenza-like symptoms,C0392171,en_3915,1,1,AFFECTS,Inhibitory,6
8478,Quarantine,C0034386,en_1944,TREATS,44716,C0442748,en_4052,2,1,AFFECTS,Inhibitory,3
8479,Quarantine,C0034386,en_1944,TREATS,Does run,C0600140,en_4498,2,1,AFFECTS,Inhibitory,3
8480,Quarantine,C0034386,en_1944,TREATS,General Population,C0683971,en_4674,2,1,AFFECTS,Inhibitory,3
8481,Quarantine,C0034386,en_1944,TREATS,Confirmed case,C4698719,en_6378,1,1,AFFECTS,Inhibitory,6
8482,Quercetin,C0034392,en_1945,DISRUPTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
8483,Quercetin,C0034392,en_1945,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
8484,Quercetin,C0034392,en_1945,INHIBITS,DNA-Directed RNA Polymerase,C0035681,en_2041,2,1,AFFECTS,Inhibitory,3
8485,Quercetin,C0034392,en_1945,PREVENTS,Disease Progression,C0242656,en_3429,3,1,AFFECTS,Inhibitory,3
8486,Quercetin,C0034392,en_1945,PREVENTS,Symptoms,C1457887,en_5784,3,1,AFFECTS,Inhibitory,3
8487,Quercetin,C0034392,en_1945,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
8488,Quercetin,C0034392,en_1945,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
8489,Quercetin,C0034392,en_1945,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
8490,Quercetin,C0034392,en_1945,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8491,Quercetin,C0034392,en_1945,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
8492,Quinolones,C0034428,en_1946,AUGMENTS,Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,1,1,AFFECTS,Excitatory,6
8493,Quinolones,C0034428,en_1946,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
8494,Rabies,C0034494,en_1948,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
8495,Rabies Vaccines,C0034496,en_1949,TREATS,Chiroptera,C0008139,en_625,1,1,AFFECTS,Inhibitory,3
8496,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
8497,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,General/Uncertain,3
8498,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Sleep,C0037313,en_2119,1,1,AFFECTS,General/Uncertain,3
8499,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,3
8500,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
8501,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Immune response,C0301872,en_3696,6,1,AFFECTS,General/Uncertain,3
8502,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Endocrine function,C0678896,en_4581,6,1,AFFECTS,General/Uncertain,3
8503,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Immunologic function,C1268930,en_5445,2,1,AFFECTS,General/Uncertain,3
8504,Electromagnetic Energy,C0034519,en_1952,AFFECTS,branching morphogenesis,C1326595,en_5558,1,1,AFFECTS,General/Uncertain,3
8505,Electromagnetic Energy,C0034519,en_1952,AFFECTS,organ development,C1523020,en_5908,5,1,AFFECTS,General/Uncertain,3
8506,Electromagnetic Energy,C0034519,en_1952,AFFECTS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,General/Uncertain,3
8507,Ionizing radiation,C0034538,en_1954,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
8508,Radiation-Sensitizing Agents,C0034541,en_1955,STIMULATES,Salazopyrin,C0592088,en_4368,1,1,AFFECTS,Excitatory,3
8509,Radiation therapy,C0034618,en_1956,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
8510,Radiation therapy,C0034618,en_1956,AFFECTS,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,3
8511,Radiation therapy,C0034618,en_1956,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
8512,Radiation therapy,C0034618,en_1956,AFFECTS,Bury,C1390944,en_5691,1,1,AFFECTS,General/Uncertain,3
8513,Radiation therapy,C0034618,en_1956,PREDISPOSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,3
8514,Radiation therapy,C0034618,en_1956,PREVENTS,Inflammation,C0021368,en_1307,4,2,AFFECTS,Inhibitory,6
8515,Radiation therapy,C0034618,en_1956,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
8516,Radiation therapy,C0034618,en_1956,PREVENTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Inhibitory,3
8517,Radiation therapy,C0034618,en_1956,TREATS,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,3
8518,Radiation therapy,C0034618,en_1956,TREATS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,6
8519,Radiation therapy,C0034618,en_1956,TREATS,"Carcinoma, Non-Small-Cell Lung",C0007131,en_563,1,1,AFFECTS,Inhibitory,3
8520,Radiation therapy,C0034618,en_1956,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
8521,Radiation therapy,C0034618,en_1956,TREATS,Female,C0015780,en_977,1,1,AFFECTS,Inhibitory,3
8522,Radiation therapy,C0034618,en_1956,TREATS,Glioma,C0017638,en_1063,1,1,AFFECTS,Inhibitory,3
8523,Radiation therapy,C0034618,en_1956,TREATS,Mus,C0026809,en_1600,2,2,AFFECTS,Inhibitory,6
8524,Radiation therapy,C0034618,en_1956,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,3
8525,Radiation therapy,C0034618,en_1956,TREATS,Patients,C0030705,en_1762,23,11,AFFECTS,Inhibitory,33
8526,Radiation therapy,C0034618,en_1956,TREATS,Pneumonia,C0032285,en_1833,6,4,AFFECTS,Inhibitory,12
8527,Radiation therapy,C0034618,en_1956,TREATS,"Pneumonia, Viral",C0032310,en_1837,2,1,AFFECTS,Inhibitory,3
8528,Radiation therapy,C0034618,en_1956,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
8529,Radiation therapy,C0034618,en_1956,TREATS,Malignant neoplasm of tongue,C0153349,en_2882,1,1,AFFECTS,Inhibitory,3
8530,Radiation therapy,C0034618,en_1956,TREATS,"Pneumonitis, Interstitial",C0206061,en_3141,3,2,AFFECTS,Inhibitory,6
8531,Radiation therapy,C0034618,en_1956,TREATS,Malignant neoplasm of lung,C0242379,en_3408,3,2,AFFECTS,Inhibitory,6
8532,Radiation therapy,C0034618,en_1956,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
8533,Radiation therapy,C0034618,en_1956,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,2,2,AFFECTS,Inhibitory,6
8534,Radiation therapy,C0034618,en_1956,TREATS(INFER),Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
8535,Radiation therapy,C0034618,en_1956,TREATS(INFER),Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
8536,Radiation therapy,C0034618,en_1956,TREATS(INFER),Radiation Injuries,C0034530,en_1953,2,1,AFFECTS,Inhibitory,3
8537,Radiation therapy,C0034618,en_1956,TREATS(INFER),Asymptomatic,C0231221,en_3252,3,1,AFFECTS,Inhibitory,3
8538,Radiation therapy,C0034618,en_1956,TREATS(INFER),Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,3
8539,Radiation therapy,C0034618,en_1956,TREATS(INFER),Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,Inhibitory,3
8540,Rain,C0034640,en_1957,AFFECTS,Natural Disasters,C0027485,en_1643,1,1,AFFECTS,General/Uncertain,3
8541,Rain,C0034640,en_1957,AFFECTS,Disability NOS,C0231170,en_3247,2,1,AFFECTS,General/Uncertain,3
8542,Reading,C0034754,en_1960,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8543,Reading,C0034754,en_1960,TREATS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
8544,Recanalization,C0034771,en_1961,TREATS,Adenocarcinoma in situ,C0334276,en_3775,1,1,AFFECTS,Inhibitory,6
8545,Androgen Receptor,C0034786,en_1962,AFFECTS,sexual dimorphism,C0598095,en_4443,1,1,AFFECTS,General/Uncertain,3
8546,Androgen Receptor,C0034786,en_1962,STIMULATES,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Excitatory,3
8547,Angiotensin Receptor,C0034787,en_1963,AUGMENTS,cell invasion,C2699153,en_6118,1,1,AFFECTS,Excitatory,3
8548,Angiotensin Receptor,C0034787,en_1963,INHIBITS,Aldosterone,C0002006,en_274,1,1,AFFECTS,Inhibitory,3
8549,Angiotensin Receptor,C0034787,en_1963,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,1,1,AFFECTS,Inhibitory,3
8550,Angiotensin Receptor,C0034787,en_1963,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
8551,"Receptors, Cell Surface",C0034800,en_1966,AUGMENTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Excitatory,3
8552,Epidermal Growth Factor Receptor,C0034802,en_1968,INHIBITS,Pharmaceutical Preparations,C0013227,en_856,1,1,AFFECTS,Inhibitory,3
8553,Estrogen Receptors,C0034804,en_1969,STIMULATES,Androgens,C0002844,en_315,1,1,AFFECTS,Excitatory,3
8554,Estrogen Receptors,C0034804,en_1969,STIMULATES,Tamoxifen,C0039286,en_2205,1,1,AFFECTS,Excitatory,3
8555,Glucocorticoid Receptor,C0034809,en_1971,AUGMENTS,Epithelial Cells,C0014597,en_919,1,1,AFFECTS,Excitatory,3
8556,Glucocorticoid Receptor,C0034809,en_1971,DISRUPTS,Colitis,C0009319,en_675,1,1,AFFECTS,Inhibitory,3
8557,Glucocorticoid Receptor,C0034809,en_1971,PREDISPOSES,Carcinoma of the Large Intestine,C0009402,en_681,1,1,AFFECTS,Excitatory,3
8558,Glucocorticoid Receptor,C0034809,en_1971,STIMULATES,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Excitatory,3
8559,Interleukin 2 Receptor,C0034819,en_1974,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,6
8560,Muscarinic Acetylcholine Receptor,C0034826,en_1976,INHIBITS,"Antidepressive Agents, Tricyclic",C0003290,en_357,1,1,AFFECTS,Inhibitory,3
8561,serotonin receptor,C0034838,en_1977,STIMULATES,Muscarinic Acetylcholine Receptor,C0034826,en_1976,1,1,AFFECTS,Excitatory,3
8562,"Receptors, Virus",C0034848,en_1979,AUGMENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
8563,Endosomes,C0034850,en_1980,PRODUCES,Viral Genome,C0042720,en_2355,1,1,AFFECTS,Excitatory,3
8564,Recombinant Proteins,C0034861,en_1981,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
8565,Recombinant Proteins,C0034861,en_1981,AUGMENTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,Excitatory,3
8566,Recombinant Proteins,C0034861,en_1981,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
8567,Recombinant Proteins,C0034861,en_1981,PRODUCES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
8568,Recombinant Proteins,C0034861,en_1981,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
8569,"Vaccines, Recombinant",C0034862,en_1982,INHIBITS,Vaccines,C0042210,en_2329,8,3,AFFECTS,Inhibitory,9
8570,"Vaccines, Recombinant",C0034862,en_1982,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
8571,"Vaccines, Recombinant",C0034862,en_1982,PREVENTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
8572,"Vaccines, Recombinant",C0034862,en_1982,PRODUCES,Glycoproteins,C0017968,en_1085,1,1,AFFECTS,Excitatory,7
8573,"Vaccines, Recombinant",C0034862,en_1982,PRODUCES,Membrane Glycoproteins,C0025248,en_1529,2,1,AFFECTS,Excitatory,3
8574,"Vaccines, Recombinant",C0034862,en_1982,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
8575,"Vaccines, Recombinant",C0034862,en_1982,TREATS,Persons,C0027361,en_1635,6,1,AFFECTS,Inhibitory,3
8576,"Vaccines, Recombinant",C0034862,en_1982,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
8577,"Vaccines, Recombinant",C0034862,en_1982,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
8578,"Vaccines, Recombinant",C0034862,en_1982,TREATS,"Recipient, Transplant",C0376387,en_3875,1,1,AFFECTS,Inhibitory,3
8579,"Vaccines, Recombinant",C0034862,en_1982,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
8580,"Vaccines, Recombinant",C0034862,en_1982,TREATS,Well adult,C0686750,en_4683,7,5,AFFECTS,Inhibitory,20
8581,"Vaccines, Recombinant",C0034862,en_1982,TREATS(INFER),Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
8582,"Vaccines, Recombinant",C0034862,en_1982,TREATS(INFER),Prostate cancer metastatic,C0936223,en_5141,1,1,AFFECTS,Inhibitory,3
8583,"Recombination, Genetic",C0034865,en_1983,AFFECTS,"CD79A,LOC102723407",C1413238,en_191,1,1,AFFECTS,General/Uncertain,3
8584,"Recombination, Genetic",C0034865,en_1983,AFFECTS,Immunoglobulins,C0021027,en_1282,1,1,AFFECTS,General/Uncertain,3
8585,Recreation,C0034872,en_1984,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
8586,Recreation,C0034872,en_1984,TREATS,Family,C0015576,en_961,2,1,AFFECTS,Inhibitory,3
8587,Patient referral,C0034927,en_1985,PREVENTS,hearing impairment,C1384666,en_5689,1,1,AFFECTS,Inhibitory,3
8588,Patient referral,C0034927,en_1985,TREATS,Transient Ischemic Attack,C0007787,en_604,1,1,AFFECTS,Inhibitory,6
8589,Patient referral,C0034927,en_1985,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
8590,Patient referral,C0034927,en_1985,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
8591,Patient referral,C0034927,en_1985,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,6
8592,Patient referral,C0034927,en_1985,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
8593,Patient referral,C0034927,en_1985,TREATS,Chemical Exposure,C0678803,en_4570,1,1,AFFECTS,Inhibitory,3
8594,Patient referral,C0034927,en_1985,TREATS,Psychiatric inpatient,C0748064,en_4827,1,1,AFFECTS,Inhibitory,3
8595,Patient referral,C0034927,en_1985,TREATS,Provider,C1138603,en_5273,2,1,AFFECTS,Inhibitory,3
8596,Reflexology,C0034945,en_1986,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
8597,Rehabilitation therapy,C0034991,en_1989,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,3
8598,Rehabilitation therapy,C0034991,en_1989,AFFECTS,Physiological action,C0442687,en_4049,1,1,AFFECTS,General/Uncertain,8
8599,Rehabilitation therapy,C0034991,en_1989,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
8600,Rehabilitation therapy,C0034991,en_1989,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
8601,Rehabilitation therapy,C0034991,en_1989,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
8602,Rehabilitation therapy,C0034991,en_1989,TREATS,Persons,C0027361,en_1635,4,3,AFFECTS,Inhibitory,9
8603,Rehabilitation therapy,C0034991,en_1989,TREATS,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
8604,Rehabilitation therapy,C0034991,en_1989,TREATS,Patients,C0030705,en_1762,16,12,AFFECTS,Inhibitory,36
8605,Rehabilitation therapy,C0034991,en_1989,TREATS,Pinnipedia,C0031944,en_1812,1,1,AFFECTS,Inhibitory,3
8606,Rehabilitation therapy,C0034991,en_1989,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
8607,Rehabilitation therapy,C0034991,en_1989,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,7
8608,Rehabilitation therapy,C0034991,en_1989,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
8609,Rehabilitation therapy,C0034991,en_1989,TREATS,Survivors,C0206194,en_3154,6,3,AFFECTS,Inhibitory,13
8610,Rehabilitation therapy,C0034991,en_1989,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,7
8611,Rehabilitation therapy,C0034991,en_1989,TREATS,Peripheral Arterial Diseases,C1704436,en_6030,1,1,AFFECTS,Inhibitory,6
8612,Rehabilitation therapy,C0034991,en_1989,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,13
8613,Rehabilitation therapy,C0034991,en_1989,TREATS(INFER),Chronic Disease,C0008679,en_643,2,2,AFFECTS,Inhibitory,6
8614,Rehabilitation therapy,C0034991,en_1989,TREATS(INFER),Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
8615,Rehabilitation therapy,C0034991,en_1989,TREATS(INFER),Malignant Childhood Neoplasm,C0278704,en_3604,1,1,AFFECTS,Inhibitory,3
8616,Rehabilitation therapy,C0034991,en_1989,TREATS(INFER),Sequela of disorder,C0543419,en_4257,4,3,AFFECTS,Inhibitory,9
8617,Rehydration,C0034997,en_1990,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8618,Rehydration,C0034997,en_1990,TREATS(INFER),Diarrhea,C0011991,en_810,1,1,AFFECTS,Inhibitory,3
8619,Relapsing Fever,C0035021,en_1991,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
8620,Relaxation,C0035028,en_1992,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
8621,Relaxation,C0035028,en_1992,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
8622,Relaxation Techniques,C0035029,en_1993,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8623,Kidney Failure,C0035078,en_1994,PRODUCES,Epithelium,C0014609,en_920,2,1,AFFECTS,Excitatory,3
8624,Renin,C0035094,en_1995,AUGMENTS,Fibrosis,C0016059,en_994,1,1,AFFECTS,Excitatory,3
8625,Renin,C0035094,en_1995,AUGMENTS,Internalization,C0871786,en_5031,1,1,AFFECTS,Excitatory,3
8626,Renin,C0035094,en_1995,INHIBITS,Sodium,C0037473,en_2129,1,1,AFFECTS,Inhibitory,3
8627,Renin,C0035094,en_1995,STIMULATES,Angiotensinogen,C0003017,en_331,1,1,AFFECTS,Excitatory,3
8628,Renin,C0035094,en_1995,STIMULATES,Blood Platelets,C0005821,en_491,3,1,AFFECTS,Excitatory,3
8629,Renin-Angiotensin System,C0035096,en_1996,AFFECTS,Blood Pressure,C0005823,en_492,2,2,AFFECTS,General/Uncertain,6
8630,Renin-Angiotensin System,C0035096,en_1996,AFFECTS,Electrolyte Balance,C0013831,en_884,3,2,AFFECTS,General/Uncertain,6
8631,Renin-Angiotensin System,C0035096,en_1996,AFFECTS,Fluid Balance,C0016284,en_1004,1,1,AFFECTS,General/Uncertain,3
8632,Renin-Angiotensin System,C0035096,en_1996,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
8633,Renin-Angiotensin System,C0035096,en_1996,AFFECTS,Blood flow,C0232338,en_3276,2,1,AFFECTS,General/Uncertain,3
8634,Repeat Surgery,C0035110,en_1997,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8635,Reperfusion Therapy,C0035124,en_1998,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8636,Reperfusion Therapy,C0035124,en_1998,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,6
8637,Reperfusion Therapy,C0035124,en_1998,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,6
8638,Reperfusion Therapy,C0035124,en_1998,TREATS,"Stroke, Acute",C0751956,en_4854,1,1,AFFECTS,Inhibitory,6
8639,Reperfusion Therapy,C0035124,en_1998,TREATS,STEMI,C1536220,en_5944,1,1,AFFECTS,Inhibitory,6
8640,Reperfusion Therapy,C0035124,en_1998,TREATS(INFER),Ischemic stroke,C0948008,en_5158,2,1,AFFECTS,Inhibitory,3
8641,Surgical Replantation,C0035139,en_2000,AFFECTS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
8642,Surgical Replantation,C0035139,en_2000,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
8643,Surgical Replantation,C0035139,en_2000,AFFECTS,Signal Pathways,C0037080,en_2104,2,1,AFFECTS,General/Uncertain,3
8644,Surgical Replantation,C0035139,en_2000,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8645,Surgical Replantation,C0035139,en_2000,TREATS,Human body,C0242821,en_3440,1,1,AFFECTS,Inhibitory,3
8646,Surgical Replantation,C0035139,en_2000,TREATS(INFER),Aortic Valve Stenosis,C0003507,en_384,1,1,AFFECTS,Inhibitory,3
8647,Reproduction,C0035150,en_2001,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
8648,Reproduction,C0035150,en_2001,AFFECTS,Ecosystem,C0162358,en_2908,1,1,AFFECTS,General/Uncertain,3
8649,Research Personnel,C0035173,en_2002,PRODUCES,Study models,C0026336,en_1575,4,3,AFFECTS,Excitatory,9
8650,Research Personnel,C0035173,en_2002,PRODUCES,Detectors,C0180392,en_3008,2,2,AFFECTS,Excitatory,6
8651,Research Personnel,C0035173,en_2002,PRODUCES,Advance,C0725066,en_4752,1,1,AFFECTS,Excitatory,3
8652,Research Personnel,C0035173,en_2002,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
8653,Research Personnel,C0035173,en_2002,TREATS,Patients,C0030705,en_1762,141,96,AFFECTS,Inhibitory,288
8654,Research Personnel,C0035173,en_2002,TREATS,Survivors,C0206194,en_3154,4,3,AFFECTS,Inhibitory,9
8655,Research Personnel,C0035173,en_2002,TREATS,"Recipient, Transplant",C0376387,en_3875,4,2,AFFECTS,Inhibitory,6
8656,Research Personnel,C0035173,en_2002,TREATS,Hospitalized Patients,C0870668,en_5010,6,3,AFFECTS,Inhibitory,9
8657,Research Personnel,C0035173,en_2002,TREATS,Surgical Patients,C0871463,en_5023,2,2,AFFECTS,Inhibitory,6
8658,Research Personnel,C0035173,en_2002,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
8659,"Resins, Plant",C0035191,en_2003,INHIBITS,Vitality,C0424589,en_3997,1,1,AFFECTS,Inhibitory,3
8660,"Resins, Plant",C0035191,en_2003,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8661,"Resins, Plant",C0035191,en_2003,TREATS(INFER),Hypertensive,C0857121,en_4969,1,1,AFFECTS,Inhibitory,3
8662,Respiration,C0035203,en_2004,AFFECTS,Ethnic group,C0015031,en_934,2,1,AFFECTS,General/Uncertain,6
8663,Respiration,C0035203,en_2004,AFFECTS,Heart,C0018787,en_1130,1,1,AFFECTS,General/Uncertain,3
8664,Respiration,C0035203,en_2004,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
8665,Respiration,C0035203,en_2004,AFFECTS,Lung,C0024109,en_1460,2,1,AFFECTS,General/Uncertain,3
8666,Respiration,C0035203,en_2004,AFFECTS,Motion,C0026597,en_1584,2,2,AFFECTS,General/Uncertain,6
8667,Respiration,C0035203,en_2004,AFFECTS,Patients,C0030705,en_1762,2,2,AFFECTS,General/Uncertain,6
8668,Respiration,C0035203,en_2004,AFFECTS,Sick Building Syndrome,C0037050,en_2102,1,1,AFFECTS,General/Uncertain,3
8669,Respiration,C0035203,en_2004,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,3
8670,Respiration,C0035203,en_2004,AFFECTS,Alveolar ventilation function,C0231940,en_3269,4,3,AFFECTS,General/Uncertain,9
8671,Respiration,C0035203,en_2004,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
8672,Respiration,C0035203,en_2004,AFFECTS,Secondary infection,C0442886,en_4061,2,1,AFFECTS,General/Uncertain,3
8673,Respiration,C0035203,en_2004,AFFECTS,Flow,C0806140,en_4886,2,1,AFFECTS,General/Uncertain,3
8674,Respiration,C0035203,en_2004,AFFECTS,Coaches,C0876909,en_5056,1,1,AFFECTS,General/Uncertain,3
8675,Respiration,C0035203,en_2004,AFFECTS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,3
8676,Respiration,C0035203,en_2004,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8677,Respiration Disorders,C0035204,en_2005,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
8678,Respiration Disorders,C0035204,en_2005,AFFECTS,General body state finding,C0424575,en_3994,2,1,AFFECTS,General/Uncertain,3
8679,Respiration Disorders,C0035204,en_2005,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
8680,"Respiration, Artificial",C0035205,en_2006,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8681,"Respiration, Artificial",C0035205,en_2006,TREATS,Family suidae,C0039005,en_2193,1,1,AFFECTS,Inhibitory,3
8682,"Respiration, Artificial",C0035205,en_2006,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
8683,"Respirators, Air-Purifying",C0035208,en_2007,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
8684,"Respirators, Air-Purifying",C0035208,en_2007,TREATS,network,C0679670,en_4604,2,1,AFFECTS,Inhibitory,3
8685,Pulmonary Ventilation,C0035213,en_2008,PRODUCES,Carbon Dioxide,C0007012,en_556,1,1,AFFECTS,Excitatory,3
8686,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,AFFECTS,Persons,C0027361,en_1635,2,2,AFFECTS,General/Uncertain,6
8687,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,PREDISPOSES,Thromboembolism,C0040038,en_2230,1,1,AFFECTS,Excitatory,3
8688,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Blood coagulation,C0005778,en_484,1,1,AFFECTS,General/Uncertain,3
8689,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Extravasation,C0015376,en_949,1,1,AFFECTS,General/Uncertain,3
8690,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Fibrinolysis,C0016017,en_990,1,1,AFFECTS,General/Uncertain,3
8691,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Inflammation,C0021368,en_1307,4,2,AFFECTS,General/Uncertain,6
8692,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Lung Compliance,C0024112,en_1461,1,1,AFFECTS,General/Uncertain,3
8693,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Patients,C0030705,en_1762,6,5,AFFECTS,General/Uncertain,15
8694,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Respiration,C0035203,en_2004,2,2,AFFECTS,General/Uncertain,6
8695,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Alveolar ventilation function,C0231940,en_3269,6,4,AFFECTS,General/Uncertain,12
8696,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Increased blood vessel permeability,C0232374,en_3278,11,1,AFFECTS,General/Uncertain,3
8697,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
8698,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Infiltration,C0332448,en_3749,1,1,AFFECTS,General/Uncertain,8
8699,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Hyperactive behavior,C0424295,en_3992,2,1,AFFECTS,General/Uncertain,3
8700,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Immune,C0439662,en_4035,1,1,AFFECTS,General/Uncertain,7
8701,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,member,C0680022,en_4618,1,1,AFFECTS,General/Uncertain,3
8702,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Hypoxemia,C0700292,en_4719,3,2,AFFECTS,General/Uncertain,6
8703,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,General/Uncertain,3
8704,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Inflammatory Response,C1155266,en_5321,2,2,AFFECTS,General/Uncertain,6
8705,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
8706,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,AUGMENTS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
8707,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,7
8708,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8709,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,General/Uncertain,3
8710,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,7
8711,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
8712,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
8713,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
8714,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,COMPLICATES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,3
8715,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,DISRUPTS,Epithelial Cells,C0014597,en_919,2,1,AFFECTS,Inhibitory,3
8716,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,DISRUPTS,exchange,C0678640,en_4566,5,2,AFFECTS,Inhibitory,6
8717,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,PREDISPOSES,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Excitatory,3
8718,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,PREDISPOSES,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,Excitatory,3
8719,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
8720,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
8721,Respiratory Therapy,C0035239,en_2015,AFFECTS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,3
8722,Respiratory Therapy,C0035239,en_2015,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
8723,Respiratory Therapy,C0035239,en_2015,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
8724,Respiratory Therapy,C0035239,en_2015,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
8725,Respiratory Therapy,C0035239,en_2015,TREATS,Pulmonary failure,C0948755,en_5173,1,1,AFFECTS,Inhibitory,3
8726,Respiratory Therapy,C0035239,en_2015,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
8727,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
8728,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,Male population group,C0025266,en_1533,2,1,AFFECTS,General/Uncertain,3
8729,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,"Lung Diseases, Interstitial",C0206062,en_3142,1,1,AFFECTS,General/Uncertain,3
8730,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
8731,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,General/Uncertain,3
8732,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,Severe disease,C4740692,en_6396,1,1,AFFECTS,General/Uncertain,6
8733,Respiratory Tract Infections,C0035243,en_2017,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
8734,Respiratory Tract Infections,C0035243,en_2017,AFFECTS(SPEC),Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
8735,Rest,C0035253,en_2019,PREVENTS,"Obstetric Labor, Premature",C0022876,en_1391,1,1,AFFECTS,Inhibitory,3
8736,Rest,C0035253,en_2019,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
8737,Rest,C0035253,en_2019,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
8738,Rest,C0035253,en_2019,TREATS,Young adult,C0238598,en_3365,2,1,AFFECTS,Inhibitory,3
8739,Rest,C0035253,en_2019,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
8740,Resuscitation,C0035273,en_2020,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
8741,Resuscitation,C0035273,en_2020,TREATS,Heart Arrest,C0018790,en_1131,1,1,AFFECTS,Inhibitory,3
8742,Resuscitation,C0035273,en_2020,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8743,Resuscitation,C0035273,en_2020,TREATS,Out-of-Hospital Cardiac Arrest,C2936490,en_6152,1,1,AFFECTS,Inhibitory,6
8744,Resuscitation,C0035273,en_2020,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
8745,Retinaldehyde,C0035331,en_2023,INHIBITS,Thrombin,C0040018,en_2228,2,2,AFFECTS,Inhibitory,6
8746,Retinoids,C0035339,en_2025,AFFECTS,Neuronal Plasticity,C0027880,en_1671,2,1,AFFECTS,General/Uncertain,3
8747,Retinoids,C0035339,en_2025,AFFECTS,Neural Development,C0814002,en_4907,2,1,AFFECTS,General/Uncertain,3
8748,Retinoids,C0035339,en_2025,AUGMENTS,Regulatory T-Lymphocytes,C0039198,en_2200,1,1,AFFECTS,Excitatory,3
8749,Retinoids,C0035339,en_2025,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
8750,Retinoids,C0035339,en_2025,STIMULATES,Genes,C0017337,en_1052,1,1,AFFECTS,Excitatory,3
8751,Retinoids,C0035339,en_2025,STIMULATES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
8752,Retinoids,C0035339,en_2025,TREATS,Pathological accumulation of air in tissues,C0013990,en_891,1,1,AFFECTS,Inhibitory,3
8753,RNA-Directed DNA Polymerase,C0035379,en_2027,AUGMENTS,Signal Detection,C0237566,en_3349,1,1,AFFECTS,Excitatory,3
8754,Rheumatic Fever,C0035436,en_2029,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8755,Rheumatic Fever,C0035436,en_2029,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,6
8756,Rhodopsin,C0035499,en_2031,DISRUPTS,Phagocytosis,C0031308,en_1785,1,1,AFFECTS,Inhibitory,3
8757,Ribavirin,C0035525,en_2032,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
8758,Ribavirin,C0035525,en_2032,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
8759,Ribavirin,C0035525,en_2032,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
8760,Ribavirin,C0035525,en_2032,TREATS,Patients,C0030705,en_1762,6,3,AFFECTS,Inhibitory,9
8761,Ribavirin,C0035525,en_2032,TREATS,Respiratory syncytial virus,C0035236,en_2014,1,1,AFFECTS,Inhibitory,3
8762,Ribavirin,C0035525,en_2032,TREATS,Hepatitis C virus,C0220847,en_3204,1,1,AFFECTS,Inhibitory,3
8763,Ribavirin,C0035525,en_2032,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
8764,Ribavirin,C0035525,en_2032,TREATS,Normal patient,C0848894,en_4933,1,1,AFFECTS,Inhibitory,6
8765,Ribavirin,C0035525,en_2032,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
8766,Ribavirin,C0035525,en_2032,TREATS,Middle East Respiratory Syndrome,C3694279,en_6232,1,1,AFFECTS,Inhibitory,6
8767,Ribavirin,C0035525,en_2032,TREATS,Moderate disease,C4740691,en_6395,1,1,AFFECTS,Inhibitory,8
8768,Ribavirin,C0035525,en_2032,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
8769,Riboflavin,C0035527,en_2033,AFFECTS,Arteriosclerosis,C0003850,en_399,2,1,AFFECTS,General/Uncertain,3
8770,Riboflavin,C0035527,en_2033,AUGMENTS,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
8771,Riboflavin,C0035527,en_2033,COMPLICATES,Arteriosclerosis,C0003850,en_399,1,1,AFFECTS,General/Uncertain,3
8772,Riboflavin,C0035527,en_2033,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
8773,Ribosomes,C0035553,en_2036,AFFECTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,General/Uncertain,3
8774,Rickets,C0035579,en_2037,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
8775,Rifampin,C0035608,en_2038,PREVENTS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
8776,Rifampin,C0035608,en_2038,TREATS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
8777,risk factors,C0035648,en_2039,PREDISPOSES,Prognosis bad,C0278252,en_3600,2,2,AFFECTS,Excitatory,14
8778,risk factors,C0035648,en_2039,PREDISPOSES,Mental health.status,C1829822,en_6045,1,1,AFFECTS,Excitatory,6
8779,risk factors,C0035648,en_2039,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
8780,RNA,C0035668,en_2040,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
8781,RNA,C0035668,en_2040,AFFECTS,Diffusion,C0012222,en_814,1,1,AFFECTS,General/Uncertain,3
8782,RNA,C0035668,en_2040,AFFECTS,Gene Expression Regulation,C0017263,en_1045,1,1,AFFECTS,General/Uncertain,3
8783,RNA,C0035668,en_2040,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
8784,RNA,C0035668,en_2040,AFFECTS,Transcription Termination,C0597600,en_4432,1,1,AFFECTS,General/Uncertain,3
8785,RNA,C0035668,en_2040,AFFECTS,Viral life cycle,C1160638,en_5357,1,1,AFFECTS,General/Uncertain,3
8786,RNA,C0035668,en_2040,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
8787,RNA,C0035668,en_2040,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
8788,RNA,C0035668,en_2040,AUGMENTS,genetic aspects,C0017399,en_1057,2,1,AFFECTS,Excitatory,3
8789,RNA,C0035668,en_2040,AUGMENTS,Viremia,C0042749,en_2359,1,1,AFFECTS,Excitatory,3
8790,RNA,C0035668,en_2040,AUGMENTS,Escape,C0870509,en_5004,1,1,AFFECTS,Excitatory,3
8791,RNA,C0035668,en_2040,DISRUPTS,Crossbreeding,C0020202,en_1217,1,1,AFFECTS,Inhibitory,3
8792,RNA,C0035668,en_2040,DISRUPTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Inhibitory,3
8793,RNA,C0035668,en_2040,INHIBITS,small molecule,C1328819,en_5573,1,1,AFFECTS,Inhibitory,3
8794,RNA,C0035668,en_2040,STIMULATES,Toll-like receptors,C0670896,en_4538,2,2,AFFECTS,Excitatory,6
8795,RNA,C0035668,en_2040,STIMULATES,"TLR7 protein, human",C0971207,en_5210,1,1,AFFECTS,Excitatory,3
8796,DNA-Directed RNA Polymerase,C0035681,en_2041,AUGMENTS,Abscess,C0000833,en_210,1,1,AFFECTS,Excitatory,3
8797,DNA-Directed RNA Polymerase,C0035681,en_2041,PRODUCES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
8798,RNA-Directed RNA Polymerase,C0035685,en_2042,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
8799,RNA-Directed RNA Polymerase,C0035685,en_2042,INHIBITS,DNA-Directed RNA Polymerase,C0035681,en_2041,1,1,AFFECTS,Inhibitory,3
8800,"RNA, Double-Stranded",C0035693,en_2045,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
8801,"RNA, Double-Stranded",C0035693,en_2045,AUGMENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Excitatory,3
8802,"RNA, Double-Stranded",C0035693,en_2045,AUGMENTS,Immune response,C0301872,en_3696,2,2,AFFECTS,Excitatory,6
8803,"RNA, Double-Stranded",C0035693,en_2045,STIMULATES,PROTEIN KINASE,C0033640,en_1909,3,2,AFFECTS,Excitatory,6
8804,"RNA, Messenger",C0035696,en_2046,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8805,"RNA, Messenger",C0035696,en_2046,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
8806,"RNA, Messenger",C0035696,en_2046,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
8807,"RNA, Messenger",C0035696,en_2046,AFFECTS,Virus-like particles,C0333785,en_3772,1,1,AFFECTS,General/Uncertain,3
8808,"RNA, Messenger",C0035696,en_2046,AFFECTS,Protein Biosynthesis,C0597295,en_4419,1,1,AFFECTS,General/Uncertain,3
8809,"RNA, Messenger",C0035696,en_2046,AUGMENTS,Abscess,C0000833,en_210,1,1,AFFECTS,Excitatory,3
8810,"RNA, Messenger",C0035696,en_2046,AUGMENTS,Antigen-Presenting Cells,C0003315,en_362,1,1,AFFECTS,Excitatory,3
8811,"RNA, Messenger",C0035696,en_2046,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
8812,"RNA, Messenger",C0035696,en_2046,DISRUPTS,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,Inhibitory,6
8813,"RNA, Messenger",C0035696,en_2046,INHIBITS,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Inhibitory,3
8814,"RNA, Messenger",C0035696,en_2046,PREVENTS,Chlamydia Infections,C0008149,en_627,1,1,AFFECTS,Inhibitory,3
8815,"RNA, Messenger",C0035696,en_2046,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8816,"RNA, Messenger",C0035696,en_2046,STIMULATES,PPAR gamma,C0166417,en_2949,1,1,AFFECTS,Excitatory,3
8817,"RNA, Messenger",C0035696,en_2046,STIMULATES,"immunoglobulin A, human",C2825347,en_6135,1,1,AFFECTS,Excitatory,6
8818,Transfer RNA,C0035711,en_2047,AUGMENTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,Excitatory,3
8819,"RNA, Viral",C0035736,en_2048,AFFECTS,Disease,C0012634,en_826,4,1,AFFECTS,General/Uncertain,3
8820,"RNA, Viral",C0035736,en_2048,AFFECTS,Virus Shedding,C0162633,en_2921,2,1,AFFECTS,General/Uncertain,3
8821,"RNA, Viral",C0035736,en_2048,AUGMENTS,hope,C0392347,en_3919,1,1,AFFECTS,Excitatory,3
8822,"RNA, Viral",C0035736,en_2048,AUGMENTS,specific immunity,C0683201,en_4653,1,1,AFFECTS,Excitatory,7
8823,Running,C0035953,en_2052,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
8824,S-Adenosylhomocysteine|ACSM3,C0036001|6296,en_2053,PREDISPOSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,6
8825,S-Adenosylmethionine,C0036002,en_2054,STIMULATES,Methyltransferase,C0025831,en_1560,1,1,AFFECTS,Excitatory,3
8826,S-Adenosylmethionine,C0036002,en_2054,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
8827,Salicylic Acid,C0036079,en_2055,TREATS,Cestode Infections,C0007894,en_611,1,1,AFFECTS,Inhibitory,3
8828,Salicylic Acid,C0036079,en_2055,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
8829,Saline,C0036082,en_2056,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
8830,Saline,C0036082,en_2056,PREVENTS,"Infections, Upper Respiratory",C0041912,en_2315,1,1,AFFECTS,Inhibitory,3
8831,Saline,C0036082,en_2056,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
8832,Saline,C0036082,en_2056,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
8833,Saline,C0036082,en_2056,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
8834,Saline,C0036082,en_2056,TREATS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
8835,Saline,C0036082,en_2056,TREATS(INFER),Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
8836,Saline,C0036082,en_2056,TREATS(INFER),Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
8837,Salivary Glands,C0036098,en_2059,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
8838,Minor salivary gland structure,C0036099,en_2060,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
8839,Salts,C0036140,en_2063,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
8840,Sarcoidosis,C0036202,en_2064,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
8841,Sarcomeres,C0036225,en_2065,PRODUCES,Steroids,C0038317,en_2161,1,1,AFFECTS,Excitatory,3
8842,Schizophrenia,C0036341,en_2068,AFFECTS,Synaptic Transmission,C0027793,en_1661,1,1,AFFECTS,General/Uncertain,3
8843,Schizophrenia,C0036341,en_2068,AFFECTS,Neural Development,C0814002,en_4907,1,1,AFFECTS,General/Uncertain,3
8844,Schizophrenia,C0036341,en_2068,AFFECTS(SPEC),Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
8845,Scleral Buckling,C0036411,en_2070,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
8846,Sclerosis,C0036429,en_2072,AFFECTS,Rheumatism,C0035435,en_2028,1,1,AFFECTS,General/Uncertain,3
8847,"Scoliosis, unspecified",C0036439,en_2073,AFFECTS,Candida,C0006836,en_546,1,1,AFFECTS,General/Uncertain,3
8848,"Scoliosis, unspecified",C0036439,en_2073,AFFECTS,Genus staphylococcus,C0038170,en_2153,1,1,AFFECTS,General/Uncertain,3
8849,Sedatives,C0036557,en_2075,AUGMENTS(SPEC),Recovery,C0237820,en_3354,3,1,AFFECTS,Excitatory,3
8850,Sedatives,C0036557,en_2075,INHIBITS,Pharmaceutical Preparations,C0013227,en_856,1,1,AFFECTS,Inhibitory,3
8851,Sedatives,C0036557,en_2075,PREVENTS,overdose,C4018909,en_6291,1,1,AFFECTS,Inhibitory,3
8852,Sedatives,C0036557,en_2075,PREVENTS(SPEC),Pain,C0030193,en_1741,2,1,AFFECTS,Inhibitory,3
8853,Sedatives,C0036557,en_2075,TREATS,Control Groups,C0009932,en_711,4,1,AFFECTS,Inhibitory,3
8854,Sedatives,C0036557,en_2075,TREATS,Patients,C0030705,en_1762,15,1,AFFECTS,Inhibitory,3
8855,Sedatives,C0036557,en_2075,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,11,1,AFFECTS,Inhibitory,3
8856,Sedatives,C0036557,en_2075,TREATS(SPEC),Agitation,C0085631,en_2683,1,1,AFFECTS,Inhibitory,3
8857,Sedatives,C0036557,en_2075,TREATS(SPEC),Patient's condition improved,C0438108,en_4030,2,1,AFFECTS,Inhibitory,3
8858,Seizures,C0036572,en_2076,PREDISPOSES,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Excitatory,3
8859,Seizures,C0036572,en_2076,PREDISPOSES,Epilepsy,C0014544,en_917,1,1,AFFECTS,Excitatory,6
8860,Selenium,C0036581,en_2077,PREVENTS,autoimmune thyroid disease,C0178468,en_2984,1,1,AFFECTS,Inhibitory,3
8861,Selenium,C0036581,en_2077,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8862,Selenium,C0036581,en_2077,INHIBITS,C-reactive protein|CRP,C0006560|1401,en_530,1,1,AFFECTS,Inhibitory,6
8863,Selenium,C0036581,en_2077,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8864,Self Care,C0036592,en_2078,PREVENTS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,8
8865,Self Care,C0036592,en_2078,PREVENTS,Immobile,C0231441,en_3259,1,1,AFFECTS,Inhibitory,3
8866,Self Care,C0036592,en_2078,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
8867,Self Care,C0036592,en_2078,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
8868,Self Care,C0036592,en_2078,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
8869,Self Care,C0036592,en_2078,TREATS,Heart failure,C0018801,en_1135,2,1,AFFECTS,Inhibitory,3
8870,Self Care,C0036592,en_2078,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
8871,Self Care,C0036592,en_2078,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
8872,Self Care,C0036592,en_2078,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
8873,Self Care,C0036592,en_2078,TREATS,Dry skin,C0151908,en_2871,1,1,AFFECTS,Inhibitory,3
8874,Self Care,C0036592,en_2078,TREATS,Population at Risk,C0242444,en_3415,2,1,AFFECTS,Inhibitory,3
8875,Self Care,C0036592,en_2078,TREATS,Frailty,C0424594,en_3998,1,1,AFFECTS,Inhibitory,3
8876,Self Care,C0036592,en_2078,TREATS,Cold symptoms,C0863093,en_4994,1,1,AFFECTS,Inhibitory,3
8877,Self Care,C0036592,en_2078,TREATS,Cancer Survivor,C1516231,en_5853,1,1,AFFECTS,Inhibitory,3
8878,Self Care,C0036592,en_2078,TREATS,Chemoradiation,C1559154,en_5966,1,1,AFFECTS,Inhibitory,3
8879,Self Care,C0036592,en_2078,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
8880,Self Care,C0036592,en_2078,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Inhibitory,3
8881,Self Care,C0036592,en_2078,TREATS(INFER),Disability NOS,C0231170,en_3247,1,1,AFFECTS,Inhibitory,3
8882,Self-Help Devices,C0036605,en_2080,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
8883,Seminoma,C0036631,en_2081,AFFECTS,Male population group,C0025266,en_1533,1,1,AFFECTS,General/Uncertain,3
8884,Esthesia,C0036658,en_2083,AFFECTS,Posture,C0032818,en_1862,1,1,AFFECTS,General/Uncertain,3
8885,Diastasis,C0036679,en_2084,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,6
8886,Diastasis,C0036679,en_2084,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
8887,Diastasis,C0036679,en_2084,AFFECTS,parent,C0030551,en_1750,1,1,AFFECTS,General/Uncertain,3
8888,Diastasis,C0036679,en_2084,AFFECTS,Individual,C0237401,en_3343,2,1,AFFECTS,General/Uncertain,3
8889,Septicemia,C0036690,en_2086,AFFECTS,Patients,C0030705,en_1762,2,2,AFFECTS,General/Uncertain,6
8890,Septicemia,C0036690,en_2086,AFFECTS,Veterans,C0042610,en_2351,1,1,AFFECTS,General/Uncertain,3
8891,Septicemia,C0036690,en_2086,AFFECTS,Caregiver,C0085537,en_2674,1,1,AFFECTS,General/Uncertain,3
8892,Septicemia,C0036690,en_2086,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
8893,Septicemia,C0036690,en_2086,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
8894,Septicemia,C0036690,en_2086,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8895,Septicemia,C0036690,en_2086,COMPLICATES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,3
8896,Septicemia,C0036690,en_2086,PREDISPOSES,Myopathy,C0026848,en_1605,1,1,AFFECTS,Excitatory,3
8897,Septicemia,C0036690,en_2086,PREDISPOSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
8898,Serine,C0036720,en_2087,AFFECTS,receptor activity,C1152633,en_5307,1,1,AFFECTS,General/Uncertain,3
8899,Serine,C0036720,en_2087,STIMULATES,Astrocytes,C0004112,en_419,1,1,AFFECTS,Excitatory,3
8900,Serine,C0036720,en_2087,STIMULATES,Formalin,C0949307,en_5178,2,1,AFFECTS,Excitatory,3
8901,Serine Proteinase Inhibitors,C0036733,en_2088,TREATS,Peptic Esophagitis,C0014869,en_930,1,1,AFFECTS,Inhibitory,7
8902,Serine Proteinase Inhibitors,C0036733,en_2088,TREATS,"Pancreatitis, Chronic",C0149521,en_2802,1,1,AFFECTS,Inhibitory,7
8903,Serine Proteinase Inhibitors,C0036733,en_2088,INHIBITS,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Inhibitory,3
8904,Serine Proteinase Inhibitors,C0036733,en_2088,INHIBITS,Kininogenase,C0022478,en_1374,1,1,AFFECTS,Inhibitory,3
8905,Serine Proteinase Inhibitors,C0036733,en_2088,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8906,Serine Proteinase Inhibitors,C0036733,en_2088,TREATS,Postoperative esophagitis,C0267058,en_3543,1,1,AFFECTS,Inhibitory,3
8907,Serine Proteinase Inhibitors,C0036733,en_2088,TREATS(INFER),"Pancreatitis, Chronic",C0149521,en_2802,1,1,AFFECTS,Inhibitory,3
8908,Serine Protease,C0036734,en_2089,AUGMENTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,Excitatory,3
8909,Serotonin,C0036751,en_2090,AFFECTS,secretion of saliva,C0036104,en_2061,1,1,AFFECTS,General/Uncertain,3
8910,Serotonin,C0036751,en_2090,AUGMENTS,wave,C0678544,en_4560,1,1,AFFECTS,Excitatory,3
8911,Serratia marcescens,C0036766,en_2091,PRODUCES,Lactamase,C0086518,en_2723,2,1,AFFECTS,Excitatory,3
8912,Structure of sertoli cell,C0036770,en_2092,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
8913,Sex Behavior,C0036864,en_2093,AFFECTS,self-management skills,C0814064,en_4908,1,1,AFFECTS,General/Uncertain,3
8914,Gonadal Steroid Hormones,C0036884,en_2094,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
8915,Gonadal Steroid Hormones,C0036884,en_2094,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
8916,Gonadal Steroid Hormones,C0036884,en_2094,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
8917,Gonadal Steroid Hormones,C0036884,en_2094,AFFECTS,microorganism interaction,C0596935,en_4404,1,1,AFFECTS,General/Uncertain,3
8918,Gonadal Steroid Hormones,C0036884,en_2094,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
8919,Gonadal Steroid Hormones,C0036884,en_2094,AFFECTS,Immunologic function,C1268930,en_5445,2,1,AFFECTS,General/Uncertain,3
8920,Gonadal Steroid Hormones,C0036884,en_2094,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
8921,Gonadal Steroid Hormones,C0036884,en_2094,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
8922,Shock,C0036974,en_2097,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
8923,Shock,C0036974,en_2097,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
8924,Shock,C0036974,en_2097,AFFECTS,cold temperature,C0009264,en_673,2,2,AFFECTS,General/Uncertain,6
8925,Shock,C0036974,en_2097,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
8926,Shock,C0036974,en_2097,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
8927,Shock,C0036974,en_2097,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
8928,Shock,C0036974,en_2097,COMPLICATES,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,General/Uncertain,6
8929,Shock,C0036974,en_2097,COMPLICATES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,General/Uncertain,8
8930,"Shock, Cardiogenic",C0036980,en_2098,AFFECTS,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
8931,Septic Shock,C0036983,en_2101,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
8932,Septic Shock,C0036983,en_2101,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8933,Septic Shock,C0036983,en_2101,COMPLICATES,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8934,Septic Shock,C0036983,en_2101,PRODUCES,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Excitatory,3
8935,Signal Pathways,C0037080,en_2104,AFFECTS,Degenerative abnormality,C0011164,en_770,1,1,AFFECTS,General/Uncertain,3
8936,Signal Pathways,C0037080,en_2104,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
8937,Signal Pathways,C0037080,en_2104,AFFECTS,Protein C,C0033621,en_1908,1,1,AFFECTS,General/Uncertain,3
8938,Signal Pathways,C0037080,en_2104,AFFECTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,General/Uncertain,3
8939,Signal Pathways,C0037080,en_2104,AFFECTS,biological adaptation to stress,C0149784,en_2810,1,1,AFFECTS,General/Uncertain,3
8940,Signal Pathways,C0037080,en_2104,AFFECTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,General/Uncertain,3
8941,Signal Pathways,C0037080,en_2104,AFFECTS,tissue homeostasis,C1523351,en_5911,1,1,AFFECTS,General/Uncertain,3
8942,Signal Pathways,C0037080,en_2104,AUGMENTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,Excitatory,3
8943,Signal Transduction,C0037083,en_2105,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
8944,Signal Transduction,C0037083,en_2105,AFFECTS,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,General/Uncertain,3
8945,Silicon Dioxide,C0037098,en_2108,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8946,Silicon,C0037107,en_2109,AFFECTS,Color,C0009393,en_680,1,1,AFFECTS,General/Uncertain,3
8947,Silymarin,C0037135,en_2110,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
8948,Silymarin,C0037135,en_2110,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
8949,skin disorder,C0037274,en_2115,AFFECTS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,General/Uncertain,3
8950,skin disorder,C0037274,en_2115,AFFECTS,Emotional,C0849912,en_4937,2,1,AFFECTS,General/Uncertain,3
8951,Sleep,C0037313,en_2119,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
8952,Sleep,C0037313,en_2119,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
8953,Sleep,C0037313,en_2119,AFFECTS,Obstetrician,C0334897,en_3778,1,1,AFFECTS,General/Uncertain,3
8954,Sleep,C0037313,en_2119,AFFECTS,network,C0679670,en_4604,1,1,AFFECTS,General/Uncertain,3
8955,Sleep,C0037313,en_2119,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
8956,Sleep disturbances,C0037317,en_2121,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
8957,Smell Perception,C0037361,en_2122,AFFECTS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,General/Uncertain,3
8958,Smell Perception,C0037361,en_2122,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,7
8959,Smell Perception,C0037361,en_2122,AFFECTS,Malnutrition,C0162429,en_2910,2,1,AFFECTS,General/Uncertain,3
8960,Smoke,C0037366,en_2123,DISRUPTS,Pathological accumulation of air in tissues,C0013990,en_891,1,1,AFFECTS,Inhibitory,3
8961,Soaps,C0037392,en_2125,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
8962,Social Interaction,C0037420,en_2126,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
8963,Socialization,C0037447,en_2127,AFFECTS,physical health,C0516977,en_4168,1,1,AFFECTS,General/Uncertain,3
8964,Sodium,C0037473,en_2129,AUGMENTS,Muscle Rigidity,C0026837,en_1602,1,1,AFFECTS,Excitatory,3
8965,Sodium,C0037473,en_2129,STIMULATES,Membrane Transport Proteins,C0596902,en_4401,4,2,AFFECTS,Excitatory,6
8966,Sodium Chloride,C0037494,en_2130,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
8967,Sodium Chloride,C0037494,en_2130,TREATS,Inactivation,C0544461,en_4262,1,1,AFFECTS,Inhibitory,3
8968,Heparin sodium,C0037513,en_2132,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
8969,Sodium Valproate,C0037567,en_2133,DISRUPTS,Cancer of Head and Neck,C0278996,en_3606,1,1,AFFECTS,Inhibitory,7
8970,Solvents,C0037638,en_2135,AFFECTS,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,3
8971,Solvents,C0037638,en_2135,AFFECTS,Viscosity,C0042784,en_2365,1,1,AFFECTS,General/Uncertain,3
8972,Somatotropin,C0037663,en_2136,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
8973,Sound - physical agent,C0037709,en_2137,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
8974,Species Specificity,C0037783,en_2138,AFFECTS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,General/Uncertain,3
8975,Spermatogonia,C0037866,en_2140,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
8976,Sphingolipids,C0037900,en_2142,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
8977,Sphingolipids,C0037900,en_2142,INHIBITS,NAD-Dependent Protein Deacetylases,C1136243,en_5264,1,1,AFFECTS,Inhibitory,3
8978,Spironolactone,C0037982,en_2144,PREVENTS,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Inhibitory,3
8979,Spironolactone,C0037982,en_2144,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
8980,Spironolactone,C0037982,en_2144,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
8981,Spleen,C0037993,en_2145,PRODUCES,Growth Hormone Receptor,C0034839,en_1978,2,1,AFFECTS,Excitatory,3
8982,Spleen,C0037993,en_2145,PRODUCES,Somatotropin,C0037663,en_2136,2,1,AFFECTS,Excitatory,3
8983,Splenectomy,C0037995,en_2146,TREATS,Anemia,C0002871,en_316,1,1,AFFECTS,Inhibitory,3
8984,Sports,C0038039,en_2148,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
8985,Squalene,C0038071,en_2150,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,7
8986,Stannous Fluoride,C0038143,en_2151,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
8987,Stanolone,C0038148,en_2152,INHIBITS,Pulmonary Surfactants,C0034085,en_1935,1,1,AFFECTS,Inhibitory,3
8988,Stanolone,C0038148,en_2152,STIMULATES,epitheliasin,C0964578,en_5200,8,3,AFFECTS,Excitatory,9
8989,Stanolone,C0038148,en_2152,STIMULATES,TMPRSS2 gene,C1336641,en_5636,3,2,AFFECTS,Excitatory,6
8990,Stanolone,C0038148,en_2152,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
8991,Stanolone,C0038148,en_2152,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
8992,Stanolone,C0038148,en_2152,TREATS(SPEC),Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
8993,Stanolone,C0038148,en_2152,TREATS(SPEC),Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
8994,Steel,C0038239,en_2157,DISRUPTS,Dependence,C0439857,en_4039,1,1,AFFECTS,Inhibitory,3
8995,Stem cells,C0038250,en_2158,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
8996,Stents,C0038257,en_2159,TREATS,STEMI,C1536220,en_5944,1,1,AFFECTS,Inhibitory,6
8997,Stereotypic Movement Disorder,C0038273,en_2160,AFFECTS,Performance,C0597198,en_4416,1,1,AFFECTS,General/Uncertain,3
8998,Steroids,C0038317,en_2161,DISRUPTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Inhibitory,7
8999,Steroids,C0038317,en_2161,INHIBITS,DUSP1 gene|DUSP1,C1333257|1843,en_5588,1,1,AFFECTS,Inhibitory,6
9000,Steroids,C0038317,en_2161,TREATS,Comorbidity,C0009488,en_690,1,1,AFFECTS,Inhibitory,6
9001,Steroids,C0038317,en_2161,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
9002,Steroids,C0038317,en_2161,TREATS,UNRESPONSIVENESS,C0241526,en_3390,1,1,AFFECTS,Inhibitory,7
9003,Steroids,C0038317,en_2161,TREATS,"Platelets, CTCAE",C1963076,en_6071,1,1,AFFECTS,Inhibitory,6
9004,Steroids,C0038317,en_2161,TREATS,Storm NOS,C2905612,en_6141,1,1,AFFECTS,Inhibitory,6
9005,Steroids,C0038317,en_2161,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,28
9006,Steroids,C0038317,en_2161,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
9007,Steroids,C0038317,en_2161,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
9008,Steroids,C0038317,en_2161,AFFECTS,Encephalitis,C0014038,en_896,1,1,AFFECTS,General/Uncertain,3
9009,Steroids,C0038317,en_2161,AFFECTS,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
9010,Steroids,C0038317,en_2161,AFFECTS,Acute encephalopathy,C1306587,en_5522,1,1,AFFECTS,General/Uncertain,3
9011,Steroids,C0038317,en_2161,AUGMENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Excitatory,3
9012,Steroids,C0038317,en_2161,DISRUPTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Inhibitory,3
9013,Steroids,C0038317,en_2161,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
9014,Steroids,C0038317,en_2161,PREVENTS,Inflammation,C0021368,en_1307,3,2,AFFECTS,Inhibitory,6
9015,Steroids,C0038317,en_2161,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
9016,Steroids,C0038317,en_2161,PREVENTS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Inhibitory,3
9017,Steroids,C0038317,en_2161,STIMULATES,Blood Glucose,C0005802,en_490,2,1,AFFECTS,Excitatory,3
9018,Steroids,C0038317,en_2161,TREATS,Fibrosis,C0016059,en_994,1,1,AFFECTS,Inhibitory,3
9019,Steroids,C0038317,en_2161,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
9020,Steroids,C0038317,en_2161,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
9021,Steroids,C0038317,en_2161,TREATS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
9022,Streptokinase,C0038418,en_2163,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
9023,Streptokinase,C0038418,en_2163,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
9024,Stress,C0038435,en_2165,COMPLICATES,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
9025,Stress,C0038435,en_2165,PREDISPOSES,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Excitatory,3
9026,Stress,C0038435,en_2165,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,2,2,AFFECTS,Excitatory,6
9027,Stress,C0038435,en_2165,PREDISPOSES,Mental disorders,C0004936,en_452,1,1,AFFECTS,Excitatory,3
9028,Stress,C0038435,en_2165,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,5,1,AFFECTS,Excitatory,3
9029,Stress,C0038435,en_2165,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,3
9030,Stress,C0038435,en_2165,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
9031,Stress,C0038435,en_2165,PREDISPOSES,Obesity,C0028754,en_1699,5,1,AFFECTS,Excitatory,3
9032,Stress,C0038435,en_2165,PREDISPOSES,Periodontal Diseases,C0031090,en_1774,1,1,AFFECTS,Excitatory,3
9033,Stress,C0038435,en_2165,PREDISPOSES,Weight Gain,C0043094,en_2388,1,1,AFFECTS,Excitatory,6
9034,Stress,C0038435,en_2165,PREDISPOSES,Autonomic nervous system function,C0234593,en_3310,1,1,AFFECTS,Excitatory,6
9035,Stress,C0038435,en_2165,PREDISPOSES,Vascular calcification,C0342649,en_3827,1,1,AFFECTS,Excitatory,3
9036,Stress,C0038435,en_2165,PREDISPOSES,Autoimmune,C0443146,en_4064,1,1,AFFECTS,Excitatory,3
9037,Stress,C0038435,en_2165,PREDISPOSES,Behavior showing increased motor activity,C0474395,en_4139,2,1,AFFECTS,Excitatory,3
9038,Stress,C0038435,en_2165,PREDISPOSES,Physical and emotional exhaustion state,C0476644,en_4150,10,4,AFFECTS,Excitatory,12
9039,Stress,C0038435,en_2165,PREDISPOSES,Symptom persistence,C0518691,en_4181,1,1,AFFECTS,Excitatory,3
9040,Stress,C0038435,en_2165,PREDISPOSES,Mood Disorders,C0525045,en_4229,1,1,AFFECTS,Excitatory,3
9041,Stress,C0038435,en_2165,PREDISPOSES,MISUSE,C0549649,en_4285,5,2,AFFECTS,Excitatory,6
9042,Stress,C0038435,en_2165,PREDISPOSES,Severe depression,C0588008,en_4364,2,2,AFFECTS,Excitatory,9
9043,Stress,C0038435,en_2165,PREDISPOSES,Emotional problems,C0677660,en_4546,1,1,AFFECTS,Excitatory,3
9044,Stress,C0038435,en_2165,PREDISPOSES,psychological distress,C0815107,en_4922,1,1,AFFECTS,Excitatory,3
9045,Stress,C0038435,en_2165,PREDISPOSES,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Excitatory,6
9046,"Stress Disorders, Post-Traumatic",C0038436,en_2166,COMPLICATES,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,General/Uncertain,3
9047,"Stress, Psychological",C0038443,en_2168,AFFECTS,Equilibrium,C0014653,en_923,2,1,AFFECTS,General/Uncertain,3
9048,"Stress, Psychological",C0038443,en_2168,AFFECTS,responsibility,C0678341,en_4557,1,1,AFFECTS,General/Uncertain,3
9049,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
9050,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Defecation,C0011135,en_768,2,1,AFFECTS,General/Uncertain,3
9051,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Disadvantaged,C0012613,en_824,1,1,AFFECTS,General/Uncertain,3
9052,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Minority Groups,C0026192,en_1573,1,1,AFFECTS,General/Uncertain,3
9053,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Persons,C0027361,en_1635,2,2,AFFECTS,General/Uncertain,6
9054,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
9055,Cerebrovascular accident,C0038454,en_2169,AFFECTS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,General/Uncertain,3
9056,Cerebrovascular accident,C0038454,en_2169,AFFECTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
9057,Cerebrovascular accident,C0038454,en_2169,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
9058,Cerebrovascular accident,C0038454,en_2169,PREDISPOSES,Coronary Arteriosclerosis,C0010054,en_717,1,1,AFFECTS,Excitatory,3
9059,Cerebrovascular accident,C0038454,en_2169,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
9060,Cerebrovascular accident,C0038454,en_2169,PREDISPOSES,Adverse event,C0877248,en_5069,2,1,AFFECTS,Excitatory,3
9061,Cerebrovascular accident,C0038454,en_2169,PREDISPOSES,Vascular occlusion,C1096458,en_5235,1,1,AFFECTS,Excitatory,6
9062,student,C0038492,en_2171,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
9063,Subarachnoid Hemorrhage,C0038525,en_2174,AFFECTS,Vascular constriction (function),C0042396,en_2340,1,1,AFFECTS,General/Uncertain,3
9064,Subarachnoid Hemorrhage,C0038525,en_2174,PREDISPOSES,Cerebral Ischemia,C0917798,en_5107,1,1,AFFECTS,Excitatory,3
9065,Suction drainage,C0038638,en_2177,TREATS,Flow,C0806140,en_4886,1,1,AFFECTS,Inhibitory,3
9066,"Sulfates, Inorganic",C0038720,en_2179,STIMULATES,Nitrogen,C0028158,en_1684,1,1,AFFECTS,Excitatory,3
9067,Sulfides,C0038739,en_2180,PREVENTS,Atrophic,C0333641,en_3770,1,1,AFFECTS,Inhibitory,3
9068,Sulfonylurea Compounds,C0038766,en_2181,INHIBITS,dipalmitoylphosphatidylserine,C0058353,en_2473,2,2,AFFECTS,Inhibitory,6
9069,Sulfonylurea Compounds,C0038766,en_2181,INHIBITS(SPEC),dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
9070,Sulfonylurea Compounds,C0038766,en_2181,PREVENTS,hypoglycemia,C0020615,en_1245,1,1,AFFECTS,Inhibitory,3
9071,Sulindac,C0038792,en_2182,AUGMENTS(SPEC),Polyamine Catabolism,C1156778,en_5331,1,1,AFFECTS,Excitatory,3
9072,Sulindac,C0038792,en_2182,INHIBITS,Polyamines,C0032433,en_1845,1,1,AFFECTS,Inhibitory,3
9073,Sunlight,C0038817,en_2183,AFFECTS,plant growth/development,C0597252,en_4417,1,1,AFFECTS,General/Uncertain,3
9074,Superinfection,C0038826,en_2184,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
9075,Superoxides,C0038836,en_2185,INHIBITS,G-Actin,C0016890,en_1025,1,1,AFFECTS,Inhibitory,3
9076,Superoxide Dismutase,C0038838,en_2186,INHIBITS,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Inhibitory,3
9077,Superoxide Dismutase,C0038838,en_2186,INHIBITS,Interleukin-4,C0021758,en_1340,2,1,AFFECTS,Inhibitory,3
9078,Superoxide Dismutase,C0038838,en_2186,STIMULATES,Antioxidants,C0003402,en_372,1,1,AFFECTS,Excitatory,3
9079,Supervision,C0038842,en_2187,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
9080,Supervision,C0038842,en_2187,TREATS,Relapsing Fever,C0035021,en_1991,1,1,AFFECTS,Inhibitory,3
9081,Supervision,C0038842,en_2187,TREATS(INFER),Neck Pain,C0007859,en_609,2,1,AFFECTS,Inhibitory,3
9082,Ophthalmologic Surgical Procedures,C0038901,en_2190,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9083,Gynecologic Surgical Procedures,C0038902,en_2191,TREATS,"Pain, Postoperative",C0030201,en_1742,1,1,AFFECTS,Inhibitory,8
9084,Gynecologic Surgical Procedures,C0038902,en_2191,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
9085,Symbiosis,C0039029,en_2194,AFFECTS,Microgravity,C0242535,en_3418,1,1,AFFECTS,General/Uncertain,3
9086,Sympatholytics,C0039051,en_2195,TREATS,Agitation,C0085631,en_2683,2,1,AFFECTS,Inhibitory,3
9087,Syndrome,C0039082,en_2197,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
9088,Syndrome,C0039082,en_2197,AFFECTS,Blood Circulation,C0005775,en_483,1,1,AFFECTS,General/Uncertain,3
9089,Syndrome,C0039082,en_2197,AFFECTS,Hemodynamics,C0019010,en_1156,2,1,AFFECTS,General/Uncertain,3
9090,Syndrome,C0039082,en_2197,AFFECTS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
9091,Syndrome,C0039082,en_2197,AFFECTS,Persons,C0027361,en_1635,3,2,AFFECTS,General/Uncertain,6
9092,Syndrome,C0039082,en_2197,AFFECTS,Patients,C0030705,en_1762,4,3,AFFECTS,General/Uncertain,9
9093,Syndrome,C0039082,en_2197,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
9094,Syndrome,C0039082,en_2197,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
9095,Syndrome,C0039082,en_2197,AFFECTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
9096,Syndrome,C0039082,en_2197,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
9097,Syndrome,C0039082,en_2197,AFFECTS,CANADIAN,C0238884,en_3371,2,2,AFFECTS,General/Uncertain,6
9098,Syndrome,C0039082,en_2197,AFFECTS,Frailty,C0424594,en_3998,1,1,AFFECTS,General/Uncertain,3
9099,Syndrome,C0039082,en_2197,AFFECTS,Intellectual functioning disability,C0453879,en_4099,1,1,AFFECTS,General/Uncertain,3
9100,Syndrome,C0039082,en_2197,AFFECTS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,General/Uncertain,3
9101,Syndrome,C0039082,en_2197,AFFECTS,THERAPEUTIC RESULTS,C0808233,en_4890,1,1,AFFECTS,General/Uncertain,7
9102,Syndrome,C0039082,en_2197,AFFECTS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,General/Uncertain,3
9103,Syndrome,C0039082,en_2197,AFFECTS,Platelet function,C1254881,en_5398,1,1,AFFECTS,General/Uncertain,3
9104,Syndrome,C0039082,en_2197,AFFECTS,Mental health problem,C1446377,en_5753,1,1,AFFECTS,General/Uncertain,8
9105,Syndrome,C0039082,en_2197,AFFECTS,Autism spectrum disorder,C1510586,en_5799,1,1,AFFECTS,General/Uncertain,3
9106,Syndrome,C0039082,en_2197,COMPLICATES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
9107,Syndrome,C0039082,en_2197,COMPLICATES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,6
9108,Syndrome,C0039082,en_2197,DISRUPTS,Life Style,C0023676,en_1432,1,1,AFFECTS,Inhibitory,3
9109,Syndrome,C0039082,en_2197,DISRUPTS,Normal cell,C1268443,en_5437,1,1,AFFECTS,Inhibitory,3
9110,Syndrome,C0039082,en_2197,PREDISPOSES,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Excitatory,3
9111,Syndrome,C0039082,en_2197,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
9112,Syndrome,C0039082,en_2197,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
9113,Syndrome,C0039082,en_2197,PREDISPOSES,Disability NOS,C0231170,en_3247,2,1,AFFECTS,Excitatory,3
9114,T-Lymphocyte,C0039194,en_2198,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,8
9115,T-Lymphocyte,C0039194,en_2198,AFFECTS,Homeostasis,C0019868,en_1201,2,2,AFFECTS,General/Uncertain,6
9116,T-Lymphocyte,C0039194,en_2198,AFFECTS,Immune response,C0301872,en_3696,4,4,AFFECTS,General/Uncertain,12
9117,T-Lymphocyte,C0039194,en_2198,PRODUCES,GATA3,C1414994,en_38,1,1,AFFECTS,Excitatory,3
9118,T-Lymphocyte,C0039194,en_2198,PRODUCES,FOXP3,C1416467,en_131,1,1,AFFECTS,Excitatory,3
9119,T-Lymphocyte,C0039194,en_2198,PRODUCES,CD24,C1413212,en_181,1,1,AFFECTS,Excitatory,3
9120,T-Lymphocyte,C0039194,en_2198,PRODUCES,5'-NUCLEOTIDASE,C0000530,en_202,1,1,AFFECTS,Excitatory,3
9121,T-Lymphocyte,C0039194,en_2198,PRODUCES,Recombinant Interferon-gamma,C0021740,en_1330,5,4,AFFECTS,Excitatory,12
9122,T-Lymphocyte,C0039194,en_2198,PRODUCES,Interleukin-2,C0021756,en_1337,2,2,AFFECTS,Excitatory,6
9123,T-Lymphocyte,C0039194,en_2198,PRODUCES,T-Cell Receptor,C0034790,en_1965,1,1,AFFECTS,Excitatory,6
9124,T-Lymphocyte,C0039194,en_2198,PRODUCES,"Receptors, Immunologic",C0034817,en_1973,1,1,AFFECTS,Excitatory,3
9125,T-Lymphocyte,C0039194,en_2198,PRODUCES,granzyme B,C0061878,en_2498,1,1,AFFECTS,Excitatory,3
9126,T-Lymphocyte,C0039194,en_2198,PRODUCES,perforin,C0070410,en_2541,1,1,AFFECTS,Excitatory,3
9127,T-Lymphocyte,C0039194,en_2198,PRODUCES,cytokine,C0079189,en_2593,2,2,AFFECTS,Excitatory,9
9128,T-Lymphocyte,C0039194,en_2198,PRODUCES,Lysosomal-Associated Membrane Protein 1,C0125271,en_2772,1,1,AFFECTS,Excitatory,3
9129,T-Lymphocyte,C0039194,en_2198,PRODUCES,granulysin,C0169007,en_2957,1,1,AFFECTS,Excitatory,3
9130,T-Lymphocyte,C0039194,en_2198,PRODUCES,Interleukin-17,C0384648,en_3903,3,3,AFFECTS,Excitatory,9
9131,T-Lymphocyte,C0039194,en_2198,PRODUCES,receptor,C0597357,en_4422,1,1,AFFECTS,Excitatory,3
9132,T-Lymphocyte,C0039194,en_2198,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
9133,T-Lymphocyte,C0039194,en_2198,PRODUCES,TNF gene,C0812246,en_4896,2,2,AFFECTS,Excitatory,6
9134,T-Lymphocyte,C0039194,en_2198,PRODUCES,interleukin-22,C0961814,en_5197,1,1,AFFECTS,Excitatory,3
9135,T-Lymphocyte,C0039194,en_2198,PRODUCES,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Excitatory,3
9136,Regulatory T-Lymphocytes,C0039198,en_2200,AFFECTS,Immune response,C0301872,en_3696,2,2,AFFECTS,General/Uncertain,6
9137,CD4 Positive T Lymphocytes,C0039215,en_2201,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,6
9138,CD4 Positive T Lymphocytes,C0039215,en_2201,PRODUCES,Interleukin-17,C0384648,en_3903,1,1,AFFECTS,Excitatory,3
9139,Tablets,C0039225,en_2202,AFFECTS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,General/Uncertain,3
9140,Tablets,C0039225,en_2202,AFFECTS,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,General/Uncertain,3
9141,Tablets,C0039225,en_2202,AFFECTS,pulmonary function,C0231921,en_3268,2,1,AFFECTS,General/Uncertain,3
9142,Tachycardia,C0039231,en_2203,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
9143,Tamoxifen,C0039286,en_2205,AFFECTS,cathepsin D activity,C1150114,en_5304,3,1,AFFECTS,General/Uncertain,3
9144,Tamoxifen,C0039286,en_2205,DISRUPTS,Lysosomes,C0024369,en_1478,1,1,AFFECTS,Inhibitory,3
9145,Tamoxifen,C0039286,en_2205,DISRUPTS,Endosomes,C0034850,en_1980,1,1,AFFECTS,Inhibitory,3
9146,Tamoxifen,C0039286,en_2205,DISRUPTS,acidification,C1522821,en_5907,3,1,AFFECTS,Inhibitory,3
9147,Tamoxifen,C0039286,en_2205,INHIBITS,receptor,C0597357,en_4422,2,1,AFFECTS,Inhibitory,3
9148,Tamoxifen,C0039286,en_2205,PREVENTS,Pulmonary Fibrosis,C0034069,en_1932,3,1,AFFECTS,Inhibitory,3
9149,Tamoxifen,C0039286,en_2205,TREATS,Neoplasm,C0027651,en_1651,2,1,AFFECTS,Inhibitory,3
9150,Tamoxifen,C0039286,en_2205,TREATS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
9151,Tannic Acid,C0039294,en_2206,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
9152,tat Protein,C0039341,en_2209,PREDISPOSES,B-Cell Lymphomas,C0079731,en_2609,1,1,AFFECTS,Excitatory,3
9153,Tellurium,C0039462,en_2211,AFFECTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
9154,Tellurium,C0039462,en_2211,AFFECTS,Weather,C0043085,en_2387,1,1,AFFECTS,General/Uncertain,3
9155,Tellurium,C0039462,en_2211,AFFECTS,Wasting,C0235394,en_3327,1,1,AFFECTS,General/Uncertain,3
9156,Tellurium,C0039462,en_2211,AFFECTS,organ development,C1523020,en_5908,1,1,AFFECTS,General/Uncertain,3
9157,Genetic Template,C0039480,en_2212,PRODUCES,"RNA, Messenger",C0035696,en_2046,1,1,AFFECTS,Excitatory,3
9158,terminal patient care,C0039548,en_2214,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,6
9159,terminal patient care,C0039548,en_2214,TREATS,Foreigners,C0079375,en_2597,1,1,AFFECTS,Inhibitory,3
9160,terminal patient care,C0039548,en_2214,TREATS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
9161,Testosterone,C0039601,en_2216,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
9162,Tetanus,C0039614,en_2217,AFFECTS,Adoptive immunity,C0678209,en_4554,1,1,AFFECTS,General/Uncertain,6.5
9163,Tetracycline,C0039644,en_2218,DISRUPTS,Collagenolysis,C0333471,en_3766,1,1,AFFECTS,Inhibitory,3
9164,Tetracyclines,C0039651,en_2219,TREATS,"Skin Diseases, Infectious",C0037278,en_2116,1,1,AFFECTS,Inhibitory,6
9165,Thalassemia,C0039730,en_2220,AFFECTS,targeting,C0599894,en_4482,2,1,AFFECTS,General/Uncertain,3
9166,Thalidomide,C0039736,en_2221,DISRUPTS,T-Cell Lymphoma,C0079772,en_2610,1,1,AFFECTS,Inhibitory,3
9167,Thalidomide,C0039736,en_2221,INHIBITS,"RNA, Messenger",C0035696,en_2046,1,1,AFFECTS,Inhibitory,3
9168,Thalidomide,C0039736,en_2221,TREATS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
9169,therapeutic use,C0039795,en_2222,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
9170,therapeutic use,C0039795,en_2222,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
9171,thermography,C0039810,en_2223,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,3
9172,Thiamine,C0039840,en_2224,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9173,Thimerosal,C0039867,en_2225,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
9174,Thimerosal,C0039867,en_2225,TREATS(INFER),Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
9175,"Radiography, Thoracic",C0039985,en_2226,AFFECTS(SPEC),Diagnosis,C0011900,en_806,1,1,AFFECTS,General/Uncertain,3
9176,"Radiography, Thoracic",C0039985,en_2226,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9177,Thoracotomy,C0039991,en_2227,TREATS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,8
9178,Thrombin,C0040018,en_2228,INHIBITS,Thrombomodulin,C0145779,en_2793,1,1,AFFECTS,Inhibitory,6
9179,Thrombin,C0040018,en_2228,INHIBITS,"SLC6A2 protein, human|SLC6A2",C1456447|6530,en_5773,1,1,AFFECTS,Inhibitory,7
9180,Thrombin,C0040018,en_2228,STIMULATES,"SELP protein, human|SELP",C2742134|6403,en_6132,1,1,AFFECTS,Excitatory,7
9181,Thrombin,C0040018,en_2228,TREATS,COVID-19,C5203670,en_6417,4,1,AFFECTS,Inhibitory,6
9182,Thrombin,C0040018,en_2228,AUGMENTS,Platelet Activation,C0032173,en_1827,2,1,AFFECTS,Excitatory,3
9183,Thrombin,C0040018,en_2228,PREDISPOSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
9184,Thrombin,C0040018,en_2228,PREVENTS,Arteriosclerosis,C0003850,en_399,1,1,AFFECTS,Inhibitory,3
9185,Thrombin,C0040018,en_2228,STIMULATES,"ACACA,BMS1",C1412104;C1428109,en_166,1,1,AFFECTS,Excitatory,3
9186,Thrombin,C0040018,en_2228,STIMULATES,Blood Platelets,C0005821,en_491,1,1,AFFECTS,Excitatory,3
9187,Thrombin,C0040018,en_2228,STIMULATES,Fibrin,C0015982,en_987,1,1,AFFECTS,Excitatory,3
9188,Thrombin,C0040018,en_2228,STIMULATES,Protein C,C0033621,en_1908,1,1,AFFECTS,Excitatory,3
9189,Thrombin,C0040018,en_2228,STIMULATES,PROTEIN KINASE,C0033640,en_1909,1,1,AFFECTS,Excitatory,3
9190,Thrombin,C0040018,en_2228,STIMULATES,Carboxypeptidase U,C0255161,en_3492,1,1,AFFECTS,Excitatory,3
9191,Thrombin,C0040018,en_2228,STIMULATES,"Receptor, PAR-1",C0668084,en_4533,1,1,AFFECTS,Excitatory,3
9192,Thrombocytopenia,C0040034,en_2229,PREDISPOSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,6
9193,Thrombocytopenia,C0040034,en_2229,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
9194,Thromboembolism,C0040038,en_2230,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
9195,Thromboembolism,C0040038,en_2230,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
9196,Thrombolytic Therapy,C0040044,en_2231,AFFECTS,associated disease,C0243083,en_3459,1,1,AFFECTS,General/Uncertain,3
9197,Thrombolytic Therapy,C0040044,en_2231,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
9198,Thrombolytic Therapy,C0040044,en_2231,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
9199,Thromboplastin,C0040048,en_2232,AUGMENTS,Pleural effusion disorder,C0032227,en_1832,1,1,AFFECTS,Excitatory,3
9200,Thromboplastin,C0040048,en_2232,STIMULATES,Glycoproteins,C0017968,en_1085,1,1,AFFECTS,Excitatory,3
9201,Thrombosis,C0040053,en_2233,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
9202,Thrombosis,C0040053,en_2233,AFFECTS,Impaired gas exchange,C0150034,en_2814,1,1,AFFECTS,General/Uncertain,3
9203,Thrombosis,C0040053,en_2233,AFFECTS,Respiratory Failure,C1145670,en_5292,3,1,AFFECTS,General/Uncertain,3
9204,Thrombosis,C0040053,en_2233,PREDISPOSES,Kidney Failure,C0035078,en_1994,1,1,AFFECTS,Excitatory,3
9205,Thrombosis,C0040053,en_2233,PREDISPOSES,Respiratory Failure,C1145670,en_5292,3,2,AFFECTS,Excitatory,6
9206,Thrombosis,C0040053,en_2233,PREDISPOSES,Venous Thromboembolism,C1861172,en_6055,1,1,AFFECTS,Excitatory,6
9207,Thymosin,C0040106,en_2234,AFFECTS,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,General/Uncertain,3
9208,Thymus Extracts,C0040112,en_2235,DISRUPTS,CD8-Positive T-Lymphocytes,C0242629,en_3424,1,1,AFFECTS,Inhibitory,3
9209,Thyroid Gland,C0040132,en_2236,PRODUCES,Thyroxine,C0040165,en_2239,1,1,AFFECTS,Excitatory,3
9210,Thyroidectomy,C0040145,en_2238,TREATS,Malignant neoplasm of thyroid,C0007115,en_562,1,1,AFFECTS,Inhibitory,3
9211,Body tissue,C0040300,en_2242,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
9212,Body tissue,C0040300,en_2242,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
9213,Body tissue,C0040300,en_2242,PRODUCES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
9214,Body tissue,C0040300,en_2242,PRODUCES,oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine,C1175112,en_5382,1,1,AFFECTS,Excitatory,3
9215,tomography,C0040395,en_2245,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
9216,tomography,C0040395,en_2245,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
9217,tomography,C0040395,en_2245,AFFECTS,Lung volume,C0231953,en_3270,1,1,AFFECTS,General/Uncertain,3
9218,tomography,C0040395,en_2245,AFFECTS(SPEC),Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
9219,tomography,C0040395,en_2245,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9220,X-Ray Computed Tomography,C0040405,en_2246,AFFECTS,Hospital admission,C0184666,en_3063,1,1,AFFECTS,General/Uncertain,3
9221,X-Ray Computed Tomography,C0040405,en_2246,AFFECTS,Pre-anesthetic assessment,C0474221,en_4137,2,1,AFFECTS,General/Uncertain,3
9222,X-Ray Computed Tomography,C0040405,en_2246,AFFECTS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,General/Uncertain,3
9223,Tonsillectomy,C0040423,en_2247,AFFECTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
9224,Tonsillectomy,C0040423,en_2247,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
9225,Tonsillectomy,C0040423,en_2247,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
9226,Tonsillectomy,C0040423,en_2247,TREATS,Deformity,C0302142,en_3701,1,1,AFFECTS,Inhibitory,3
9227,Tonsillectomy,C0040423,en_2247,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
9228,Toothbrushing,C0040461,en_2249,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
9229,"Hip Replacement, Total",C0040508,en_2251,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
9230,"Hip Replacement, Total",C0040508,en_2251,TREATS(INFER),Registered,C1578536,en_5994,2,1,AFFECTS,Inhibitory,3
9231,Toxin,C0040549,en_2252,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
9232,Toxoids,C0040555,en_2253,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,6.5
9233,Trace Elements,C0040577,en_2254,AFFECTS,"Biological function, NOS",C0277784,en_3587,1,1,AFFECTS,General/Uncertain,3
9234,Tracheostomy procedure,C0040590,en_2256,AFFECTS,Cross Infection,C0010356,en_735,1,1,AFFECTS,General/Uncertain,6
9235,Tracheostomy procedure,C0040590,en_2256,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
9236,Tracheostomy procedure,C0040590,en_2256,AFFECTS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,3
9237,Tracheostomy procedure,C0040590,en_2256,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
9238,Tracheostomy procedure,C0040590,en_2256,TREATS,Patients,C0030705,en_1762,9,4,AFFECTS,Inhibitory,12
9239,Tracheostomy procedure,C0040590,en_2256,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
9240,Tracheostomy procedure,C0040590,en_2256,TREATS,risk factors,C0035648,en_2039,1,1,AFFECTS,Inhibitory,6
9241,Tracheostomy procedure,C0040590,en_2256,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,6
9242,Tracheostomy procedure,C0040590,en_2256,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,6
9243,Tracheostomy procedure,C0040590,en_2256,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
9244,Tracheostomy procedure,C0040590,en_2256,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,6
9245,Tracheostomy procedure,C0040590,en_2256,TREATS,Intubated,C4698386,en_6376,1,1,AFFECTS,Inhibitory,6
9246,Tracheostomy procedure,C0040590,en_2256,TREATS,COVID-19,C5203670,en_6417,18,8,AFFECTS,Inhibitory,48
9247,Tracheostomy procedure,C0040590,en_2256,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
9248,Tracheostomy procedure,C0040590,en_2256,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
9249,Tracheotomy procedure,C0040591,en_2257,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
9250,Tracheotomy procedure,C0040591,en_2257,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
9251,Tracheotomy procedure,C0040591,en_2257,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9252,Traction,C0040597,en_2258,STIMULATES,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,3
9253,Traction,C0040597,en_2258,TREATS,SPHERE,C0946401,en_5152,1,1,AFFECTS,Inhibitory,3
9254,Training Programs,C0040607,en_2259,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
9255,Training Programs,C0040607,en_2259,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,7
9256,Tramadol,C0040610,en_2260,AFFECTS,Blood,C0005767,en_482,1,1,AFFECTS,General/Uncertain,3
9257,Tramadol,C0040610,en_2260,AUGMENTS,Bactericidal activity,C0544570,en_4263,1,1,AFFECTS,Excitatory,3
9258,Tramadol,C0040610,en_2260,INHIBITS,Norepinephrine,C0028351,en_1687,1,1,AFFECTS,Inhibitory,3
9259,Tramadol,C0040610,en_2260,INHIBITS,Serotonin,C0036751,en_2090,1,1,AFFECTS,Inhibitory,3
9260,Tramadol,C0040610,en_2260,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
9261,Tramadol,C0040610,en_2260,STIMULATES,Antioxidants,C0003402,en_372,1,1,AFFECTS,Excitatory,3
9262,Tramadol,C0040610,en_2260,STIMULATES,GLUTATHIONE PEROXIDASE,C0017822,en_1077,1,1,AFFECTS,Excitatory,3
9263,Tramadol,C0040610,en_2260,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
9264,Tranexamic Acid,C0040613,en_2261,TREATS,Hemorrhage,C0019080,en_1161,2,2,AFFECTS,Inhibitory,6
9265,Tranexamic Acid,C0040613,en_2261,TREATS,Hip Fractures,C0019557,en_1185,1,1,AFFECTS,Inhibitory,7
9266,Tranexamic Acid,C0040613,en_2261,TREATS,inpatient,C0021562,en_1321,2,1,AFFECTS,Inhibitory,3
9267,Tranexamic Acid,C0040613,en_2261,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
9268,Antipsychotic Agents,C0040615,en_2262,DISRUPTS,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Inhibitory,3
9269,Antipsychotic Agents,C0040615,en_2262,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
9270,Anti-Anxiety Agents,C0040616,en_2263,AFFECTS,Psychotic Disorders,C0033975,en_1924,1,1,AFFECTS,General/Uncertain,3
9271,Anti-Anxiety Agents,C0040616,en_2263,DISRUPTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,Inhibitory,3
9272,Anti-Anxiety Agents,C0040616,en_2263,INHIBITS,Ion Channel,C0022009,en_1355,1,1,AFFECTS,Inhibitory,3
9273,Anti-Anxiety Agents,C0040616,en_2263,INHIBITS,Viral Load result,C0376705,en_3889,1,1,AFFECTS,Inhibitory,3
9274,Anti-Anxiety Agents,C0040616,en_2263,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9275,Anti-Anxiety Agents,C0040616,en_2263,TREATS,Cystic Fibrosis,C0010674,en_745,2,1,AFFECTS,Inhibitory,3
9276,Anti-Anxiety Agents,C0040616,en_2263,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
9277,Anti-Anxiety Agents,C0040616,en_2263,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
9278,Anti-Anxiety Agents,C0040616,en_2263,TREATS(SPEC),Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
9279,TRANSCRIPTION FACTOR,C0040648,en_2264,AFFECTS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
9280,TRANSCRIPTION FACTOR,C0040648,en_2264,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
9281,TRANSCRIPTION FACTOR,C0040648,en_2264,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
9282,TRANSCRIPTION FACTOR,C0040648,en_2264,AFFECTS,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,General/Uncertain,3
9283,TRANSCRIPTION FACTOR,C0040648,en_2264,AFFECTS,Pluripotent Stem Cells,C0872076,en_5035,1,1,AFFECTS,General/Uncertain,3
9284,TRANSCRIPTION FACTOR,C0040648,en_2264,STIMULATES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
9285,"Transcription, Genetic",C0040649,en_2265,AFFECTS,ACE2,C1422064,en_5723,2,2,AFFECTS,General/Uncertain,6
9286,"Transcription, Genetic",C0040649,en_2265,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
9287,"Transcription, Genetic",C0040649,en_2265,AFFECTS,Chromatin,C0008546,en_642,1,1,AFFECTS,General/Uncertain,3
9288,"Transcription, Genetic",C0040649,en_2265,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
9289,"Transcription, Genetic",C0040649,en_2265,AFFECTS,Polypeptides,C1305923,en_5519,2,1,AFFECTS,General/Uncertain,3
9290,Transcutaneous Electric Nerve Stimulation,C0040654,en_2266,TREATS,Fibromyalgia,C0016053,en_993,2,1,AFFECTS,Inhibitory,3
9291,Transcutaneous Electric Nerve Stimulation,C0040654,en_2266,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
9292,Transducers,C0040661,en_2267,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
9293,Transfection,C0040669,en_2268,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
9294,Transfection,C0040669,en_2268,PRODUCES,Proteins,C0033684,en_1912,1,1,AFFECTS,Excitatory,3
9295,Transferrin,C0040679,en_2269,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
9296,Transferrin,C0040679,en_2269,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
9297,cell transformation,C0040682,en_2270,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
9298,Transforming Growth Factor beta,C0040690,en_2272,PRODUCES,CXCL13 gene,C1366572,en_5665,1,1,AFFECTS,Excitatory,3
9299,Transforming Growth Factors,C0040691,en_2273,DISRUPTS,Adhesions,C0001511,en_240,1,1,AFFECTS,Inhibitory,3
9300,"Translation, Genetic",C0040711,en_2274,AFFECTS,Biogenesis,C0005495,en_466,1,1,AFFECTS,General/Uncertain,3
9301,"Translation, Genetic",C0040711,en_2274,AFFECTS,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,General/Uncertain,3
9302,"Translation, Genetic",C0040711,en_2274,PREDISPOSES,Dementia,C0497327,en_4164,1,1,AFFECTS,Excitatory,3
9303,Transplantation,C0040732,en_2275,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
9304,Transplantation,C0040732,en_2275,PREVENTS,muscle injury,C0410256,en_3969,1,1,AFFECTS,Inhibitory,3
9305,Transplantation,C0040732,en_2275,PREVENTS,organ rejection,C0815080,en_4921,2,1,AFFECTS,Inhibitory,3
9306,Transplantation,C0040732,en_2275,TREATS,"Bladder, Neurogenic",C0005697,en_480,1,1,AFFECTS,Inhibitory,3
9307,Transplantation,C0040732,en_2275,TREATS,Child,C0008059,en_620,3,1,AFFECTS,Inhibitory,3
9308,Transplantation,C0040732,en_2275,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9309,Transplantation,C0040732,en_2275,TREATS,"Hepatitis, Alcoholic",C0019187,en_1176,1,1,AFFECTS,Inhibitory,6
9310,Transplantation,C0040732,en_2275,TREATS,Mycoses,C0026946,en_1620,1,1,AFFECTS,Inhibitory,3
9311,Transplantation,C0040732,en_2275,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
9312,Transplantation,C0040732,en_2275,TREATS,"Obesity, Morbid",C0028756,en_1700,1,1,AFFECTS,Inhibitory,3
9313,Transplantation,C0040732,en_2275,TREATS,Patients,C0030705,en_1762,22,12,AFFECTS,Inhibitory,36
9314,Transplantation,C0040732,en_2275,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
9315,Transplantation,C0040732,en_2275,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
9316,Transplantation,C0040732,en_2275,TREATS,Systemic Scleroderma,C0036421,en_2071,1,1,AFFECTS,Inhibitory,3
9317,Transplantation,C0040732,en_2275,TREATS,Intraoperative hemorrhage,C0475026,en_4143,1,1,AFFECTS,Inhibitory,3
9318,Transplantation,C0040732,en_2275,TREATS,UNDERLYING INFECTION,C0749769,en_4837,1,1,AFFECTS,Inhibitory,3
9319,Transplantation,C0040732,en_2275,TREATS,Primary infection NOS,C0948192,en_5162,1,1,AFFECTS,Inhibitory,3
9320,Transplantation,C0040732,en_2275,TREATS(INFER),Critical Illness,C0010340,en_733,3,1,AFFECTS,Inhibitory,3
9321,Transplantation,C0040732,en_2275,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
9322,Transplantation,C0040732,en_2275,TREATS(INFER),Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,Inhibitory,3
9323,Transplantation,C0040732,en_2275,TREATS(INFER),Antibiotic-associated diarrhea,C0578159,en_4340,3,1,AFFECTS,Inhibitory,3
9324,"Transplantation, Autologous",C0040736,en_2276,TREATS,Lower limb ischemia,C0340565,en_3818,1,1,AFFECTS,Inhibitory,3
9325,travel,C0040802,en_2277,PREVENTS,Congestion,C0700148,en_4714,1,1,AFFECTS,Inhibitory,3
9326,travel,C0040802,en_2277,TREATS,Couples,C0010222,en_725,1,1,AFFECTS,Inhibitory,3
9327,travel,C0040802,en_2277,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9328,travel,C0040802,en_2277,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
9329,travel,C0040802,en_2277,TREATS,Mycobacterium Infections,C0026918,en_1615,2,1,AFFECTS,Inhibitory,3
9330,travel,C0040802,en_2277,TREATS,Persons,C0027361,en_1635,3,3,AFFECTS,Inhibitory,9
9331,travel,C0040802,en_2277,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9332,travel,C0040802,en_2277,TREATS,High risk environment,C0557722,en_4310,2,1,AFFECTS,Inhibitory,3
9333,travel,C0040802,en_2277,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
9334,travel,C0040802,en_2277,TREATS,Imaging problem,C0740845,en_4783,1,1,AFFECTS,Inhibitory,3
9335,travel,C0040802,en_2277,TREATS,undergraduate student,C0814964,en_4917,1,1,AFFECTS,Inhibitory,3
9336,Treatment Protocols,C0040808,en_2278,AFFECTS,Cancer of Rectum,C0007113,en_560,1,1,AFFECTS,General/Uncertain,6
9337,Treatment Protocols,C0040808,en_2278,AFFECTS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,General/Uncertain,3
9338,Treatment Protocols,C0040808,en_2278,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
9339,Treatment Protocols,C0040808,en_2278,AFFECTS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,General/Uncertain,3
9340,Treatment Protocols,C0040808,en_2278,PREVENTS,Disease,C0012634,en_826,3,2,AFFECTS,Inhibitory,6
9341,Treatment Protocols,C0040808,en_2278,PREVENTS,Pulmonary Fibrosis,C0034069,en_1932,3,1,AFFECTS,Inhibitory,3
9342,Treatment Protocols,C0040808,en_2278,PREVENTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
9343,Treatment Protocols,C0040808,en_2278,STIMULATES,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
9344,Treatment Protocols,C0040808,en_2278,TREATS,Adult,C0001675,en_252,6,3,AFFECTS,Inhibitory,9
9345,Treatment Protocols,C0040808,en_2278,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
9346,Treatment Protocols,C0040808,en_2278,TREATS,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,3
9347,Treatment Protocols,C0040808,en_2278,TREATS,Chronic Disease,C0008679,en_643,2,1,AFFECTS,Inhibitory,3
9348,Treatment Protocols,C0040808,en_2278,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
9349,Treatment Protocols,C0040808,en_2278,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
9350,Treatment Protocols,C0040808,en_2278,TREATS,"Granulomatous Disease, Chronic",C0018203,en_1095,1,1,AFFECTS,Inhibitory,3
9351,Treatment Protocols,C0040808,en_2278,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
9352,Treatment Protocols,C0040808,en_2278,TREATS,"Lymphoma, Non-Hodgkin's",C0024305,en_1473,1,1,AFFECTS,Inhibitory,7
9353,Treatment Protocols,C0040808,en_2278,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
9354,Treatment Protocols,C0040808,en_2278,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
9355,Treatment Protocols,C0040808,en_2278,TREATS,Opioid Use Disorders,C0029103,en_1711,2,1,AFFECTS,Inhibitory,3
9356,Treatment Protocols,C0040808,en_2278,TREATS,Patients,C0030705,en_1762,46,29,AFFECTS,Inhibitory,87
9357,Treatment Protocols,C0040808,en_2278,TREATS,Pneumonia,C0032285,en_1833,3,3,AFFECTS,Inhibitory,9
9358,Treatment Protocols,C0040808,en_2278,TREATS,Viremia,C0042749,en_2359,1,1,AFFECTS,Inhibitory,3
9359,Treatment Protocols,C0040808,en_2278,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
9360,Treatment Protocols,C0040808,en_2278,TREATS,Severe Combined Immunodeficiency,C0085110,en_2645,1,1,AFFECTS,Inhibitory,3
9361,Treatment Protocols,C0040808,en_2278,TREATS,"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,1,1,AFFECTS,Inhibitory,3
9362,Treatment Protocols,C0040808,en_2278,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
9363,Treatment Protocols,C0040808,en_2278,TREATS,Lesion,C0221198,en_3221,1,1,AFFECTS,Inhibitory,3
9364,Treatment Protocols,C0040808,en_2278,TREATS,Individual,C0237401,en_3343,9,6,AFFECTS,Inhibitory,18
9365,Treatment Protocols,C0040808,en_2278,TREATS,Drugs Sensitivity,C0237865,en_3355,1,1,AFFECTS,Inhibitory,3
9366,Treatment Protocols,C0040808,en_2278,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
9367,Treatment Protocols,C0040808,en_2278,TREATS,secondary group,C0680398,en_4623,1,1,AFFECTS,Inhibitory,3
9368,Treatment Protocols,C0040808,en_2278,TREATS,Well adult,C0686750,en_4683,3,2,AFFECTS,Inhibitory,6
9369,Treatment Protocols,C0040808,en_2278,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,6
9370,Treatment Protocols,C0040808,en_2278,TREATS,Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
9371,Treatment Protocols,C0040808,en_2278,TREATS,Recipient,C1709854,en_6037,1,1,AFFECTS,Inhibitory,6
9372,Treatment Protocols,C0040808,en_2278,TREATS,Exacerbation,C4086268,en_6319,1,1,AFFECTS,Inhibitory,6
9373,Treatment Protocols,C0040808,en_2278,TREATS,Severe disease,C4740692,en_6396,1,1,AFFECTS,Inhibitory,8
9374,Treatment Protocols,C0040808,en_2278,TREATS,Epidermal cGVHD Score 2,C4761314,en_6403,1,1,AFFECTS,Inhibitory,7
9375,Treatment Protocols,C0040808,en_2278,TREATS,COVID-19,C5203670,en_6417,9,8,AFFECTS,Inhibitory,60
9376,Treatment Protocols,C0040808,en_2278,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9377,Treatment Protocols,C0040808,en_2278,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
9378,Treatment Protocols,C0040808,en_2278,TREATS(INFER),Organized pneumonia,C0264383,en_3531,4,1,AFFECTS,Inhibitory,3
9379,Treatment Protocols,C0040808,en_2278,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
9380,Treatment Protocols,C0040808,en_2278,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9381,Tretinoin,C0040845,en_2280,AFFECTS,Anosmia,C0003126,en_337,2,1,AFFECTS,General/Uncertain,3
9382,Tretinoin,C0040845,en_2280,AFFECTS,Gene Expression,C0017262,en_1044,3,1,AFFECTS,General/Uncertain,3
9383,Tretinoin,C0040845,en_2280,AFFECTS,Hyperplasia,C0020507,en_1236,2,2,AFFECTS,General/Uncertain,6
9384,Tretinoin,C0040845,en_2280,AFFECTS,Hypothalamic structure,C0020663,en_1249,2,1,AFFECTS,General/Uncertain,3
9385,Tretinoin,C0040845,en_2280,AFFECTS,Malaria,C0024530,en_1493,1,1,AFFECTS,General/Uncertain,3
9386,Tretinoin,C0040845,en_2280,AFFECTS,Neurons,C0027882,en_1672,2,1,AFFECTS,General/Uncertain,3
9387,Tretinoin,C0040845,en_2280,AFFECTS,cell injury,C0599732,en_4467,1,1,AFFECTS,General/Uncertain,3
9388,Tretinoin,C0040845,en_2280,AFFECTS,Entire hippocampus,C1284077,en_5476,2,1,AFFECTS,General/Uncertain,3
9389,Tretinoin,C0040845,en_2280,AUGMENTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,3
9390,Tretinoin,C0040845,en_2280,AUGMENTS,Dendritic Cells,C0011306,en_777,1,1,AFFECTS,Excitatory,3
9391,Tretinoin,C0040845,en_2280,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
9392,Tretinoin,C0040845,en_2280,AUGMENTS,Antibody-Dependent Enhancement,C0282632,en_3660,2,1,AFFECTS,Excitatory,3
9393,Tretinoin,C0040845,en_2280,AUGMENTS,viral entry,C1160648,en_5358,2,1,AFFECTS,Excitatory,3
9394,Tretinoin,C0040845,en_2280,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
9395,Tretinoin,C0040845,en_2280,DISRUPTS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
9396,Tretinoin,C0040845,en_2280,DISRUPTS,Apoptosis,C0162638,en_2922,2,2,AFFECTS,Inhibitory,6
9397,Tretinoin,C0040845,en_2280,DISRUPTS,cell injury,C0599732,en_4467,1,1,AFFECTS,Inhibitory,3
9398,Tretinoin,C0040845,en_2280,INHIBITS,Peptide Hydrolases,C0030940,en_1769,1,1,AFFECTS,Inhibitory,3
9399,Tretinoin,C0040845,en_2280,INHIBITS,Superoxides,C0038836,en_2185,1,1,AFFECTS,Inhibitory,3
9400,Tretinoin,C0040845,en_2280,INHIBITS,Thrombin,C0040018,en_2228,2,2,AFFECTS,Inhibitory,6
9401,Tretinoin,C0040845,en_2280,INHIBITS,receptor,C0597357,en_4422,2,1,AFFECTS,Inhibitory,3
9402,Tretinoin,C0040845,en_2280,STIMULATES,FOXP3,C1416467,en_131,1,1,AFFECTS,Excitatory,3
9403,Tretinoin,C0040845,en_2280,STIMULATES,Gonadorelin,C0023610,en_1430,2,1,AFFECTS,Excitatory,3
9404,Tretinoin,C0040845,en_2280,STIMULATES,TRANSCRIPTION FACTOR,C0040648,en_2264,2,1,AFFECTS,Excitatory,3
9405,Tretinoin,C0040845,en_2280,STIMULATES,G-Protein-Coupled Receptors,C0682972,en_4649,2,1,AFFECTS,Excitatory,3
9406,Tretinoin,C0040845,en_2280,STIMULATES,STAT1 gene,C1335872,en_5625,2,1,AFFECTS,Excitatory,3
9407,Tretinoin,C0040845,en_2280,STIMULATES,IRF1 gene,C1366516,en_5659,2,1,AFFECTS,Excitatory,3
9408,Tretinoin,C0040845,en_2280,STIMULATES,CD8B1 gene,C1367471,en_5671,1,1,AFFECTS,Excitatory,3
9409,Tretinoin,C0040845,en_2280,STIMULATES,RBP1 gene,C1419317,en_5713,1,1,AFFECTS,Excitatory,3
9410,Tretinoin,C0040845,en_2280,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
9411,Tretinoin,C0040845,en_2280,TREATS,Anosmia,C0003126,en_337,2,1,AFFECTS,Inhibitory,3
9412,Tretinoin,C0040845,en_2280,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9413,Tretinoin,C0040845,en_2280,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
9414,Tretinoin,C0040845,en_2280,TREATS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
9415,Tretinoin,C0040845,en_2280,TREATS,Principal Investigator,C1521895,en_5898,1,1,AFFECTS,Inhibitory,3
9416,Triage,C0040861,en_2281,PREDISPOSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,3
9417,Triage,C0040861,en_2281,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
9418,Triage,C0040861,en_2281,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
9419,Triage,C0040861,en_2281,TREATS,Patients,C0030705,en_1762,12,9,AFFECTS,Inhibitory,27
9420,Triage,C0040861,en_2281,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
9421,Triage,C0040861,en_2281,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
9422,Triage,C0040861,en_2281,TREATS,COVID-19,C5203670,en_6417,4,3,AFFECTS,Inhibitory,19
9423,Triage,C0040861,en_2281,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
9424,Triglycerides,C0041004,en_2282,AUGMENTS,Skin hydration,C0517390,en_4171,1,1,AFFECTS,Excitatory,3
9425,Triglycerides,C0041004,en_2282,AUGMENTS,Expectation,C0679138,en_4589,1,1,AFFECTS,Excitatory,3
9426,Triglycerides,C0041004,en_2282,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
9427,Triiodothyronine,C0041014,en_2283,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,6
9428,Triiodothyronine,C0041014,en_2283,TREATS,Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,7
9429,Trimetazidine,C0041037,en_2284,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
9430,Trimethoprim,C0041041,en_2285,PREVENTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
9431,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
9432,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,INHIBITS,fMet-Leu-Phe receptor,C0118022,en_2767,1,1,AFFECTS,Inhibitory,3
9433,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,PREVENTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
9434,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9435,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,TREATS,Patients,C0030705,en_1762,13,2,AFFECTS,Inhibitory,6
9436,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,TREATS(INFER),Disease,C0012634,en_826,4,1,AFFECTS,Inhibitory,3
9437,Trimethoprim-Sulfamethoxazole Combination,C0041044,en_2286,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
9438,Troponin,C0041199,en_2287,AFFECTS,Myocardium,C0027061,en_1628,1,1,AFFECTS,General/Uncertain,7
9439,Troponin,C0041199,en_2287,AUGMENTS,ST segment,C0429029,en_4019,1,1,AFFECTS,Excitatory,6
9440,Troponin,C0041199,en_2287,PREDISPOSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,6
9441,Troponin,C0041199,en_2287,STIMULATES,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Excitatory,6
9442,Troponin,C0041199,en_2287,STIMULATES,Brain natriuretic peptide|NPPB,C0054015|4879,en_2446,1,1,AFFECTS,Excitatory,7
9443,Troponin,C0041199,en_2287,DISRUPTS,Ejection fraction,C0489482,en_4155,1,1,AFFECTS,Inhibitory,3
9444,Troponin,C0041199,en_2287,PREDISPOSES,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
9445,Tuberculosis,C0041296,en_2293,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
9446,Tuberculosis,C0041296,en_2293,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
9447,Tuberculosis,C0041296,en_2293,AFFECTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,General/Uncertain,3
9448,Tuberculosis,C0041296,en_2293,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
9449,Tuberculosis,C0041296,en_2293,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
9450,Tuberculosis Vaccines,C0041305,en_2294,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
9451,Tuberculosis Vaccines,C0041305,en_2294,TREATS,immunodeficient mouse model,C0599920,en_4486,1,1,AFFECTS,Inhibitory,3
9452,"Tuberculosis, Bovine",C0041307,en_2295,AFFECTS,Wasting,C0235394,en_3327,2,1,AFFECTS,General/Uncertain,3
9453,Tubulin,C0041348,en_2298,DISRUPTS,Cell physiology,C0007613,en_594,2,2,AFFECTS,Inhibitory,6
9454,Tumor Necrosis Factors,C0041368,en_2300,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
9455,Tumor Necrosis Factors,C0041368,en_2300,AFFECTS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
9456,Tumor Necrosis Factors,C0041368,en_2300,COMPLICATES,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
9457,Tumor Necrosis Factors,C0041368,en_2300,DISRUPTS,anti-inflammatory response,C1154987,en_5310,1,1,AFFECTS,Inhibitory,3
9458,Tumor Necrosis Factors,C0041368,en_2300,PREDISPOSES,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Excitatory,3
9459,Tumor Necrosis Factors,C0041368,en_2300,PRODUCES,Mucous body substance,C0026727,en_1595,3,1,AFFECTS,Excitatory,3
9460,Tumor Necrosis Factors,C0041368,en_2300,STIMULATES,Acute-Phase Proteins,C0001347,en_232,2,2,AFFECTS,Excitatory,6
9461,Tumor Necrosis Factors,C0041368,en_2300,STIMULATES,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
9462,Tumor Necrosis Factors,C0041368,en_2300,STIMULATES,cytokine,C0079189,en_2593,2,2,AFFECTS,Excitatory,6
9463,Collagen Type I,C0041455,en_2301,DISRUPTS,Bone Resorption,C0005974,en_503,1,1,AFFECTS,Inhibitory,3
9464,Collagen Type I,C0041455,en_2301,DISRUPTS,Tissue fiber,C1304649,en_5514,1,1,AFFECTS,Inhibitory,3
9465,Collagen Type I,C0041455,en_2301,INHIBITS,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Inhibitory,3
9466,"Vaccines, Typhoid",C0041469,en_2302,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
9467,Endemic Flea-Borne Typhus,C0041472,en_2303,PREDISPOSES,disease transmission,C0242781,en_3438,1,1,AFFECTS,Excitatory,3
9468,Tyrosine,C0041485,en_2304,AFFECTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,General/Uncertain,3
9469,Ultrasonography,C0041618,en_2305,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
9470,Ultrasonography,C0041618,en_2305,AFFECTS,Physical Examination,C0031809,en_1804,2,2,AFFECTS,General/Uncertain,6
9471,Ultrasonography,C0041618,en_2305,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
9472,Ultrasonography,C0041618,en_2305,AFFECTS,Evaluation,C0220825,en_3201,1,1,AFFECTS,General/Uncertain,6
9473,Ultrasonography,C0041618,en_2305,AFFECTS,Alveolar ventilation function,C0231940,en_3269,2,1,AFFECTS,General/Uncertain,3
9474,Ultrasonography,C0041618,en_2305,AFFECTS,Endometriosis of uterus,C0341858,en_3826,1,1,AFFECTS,General/Uncertain,3
9475,Ultrasonography,C0041618,en_2305,AFFECTS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,General/Uncertain,6
9476,Ultrasonography,C0041618,en_2305,AFFECTS,Assessment procedure,C1261322,en_5417,1,1,AFFECTS,General/Uncertain,6
9477,Ultrasonography,C0041618,en_2305,AFFECTS,Clinical Management,C1516615,en_5859,2,1,AFFECTS,General/Uncertain,3
9478,Ultrasonography,C0041618,en_2305,AFFECTS,Longterm Follow-up,C1517942,en_5871,1,1,AFFECTS,General/Uncertain,6
9479,Ultrasonic Therapy,C0041620,en_2306,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9480,Ultraviolet Rays,C0041625,en_2307,AFFECTS,melanoma,C0025202,en_1522,1,1,AFFECTS,General/Uncertain,3
9481,Unemployment,C0041674,en_2309,PREDISPOSES,Homelessness,C0237154,en_3342,1,1,AFFECTS,Excitatory,3
9482,Unemployment,C0041674,en_2309,PREDISPOSES,poor health,C0683321,en_4658,1,1,AFFECTS,Excitatory,3
9483,Up-Regulation (Physiology),C0041904,en_2313,AFFECTS,Autophagy,C0004391,en_432,1,1,AFFECTS,General/Uncertain,3
9484,Up-Regulation (Physiology),C0041904,en_2313,AFFECTS,Biogenesis,C0005495,en_466,1,1,AFFECTS,General/Uncertain,3
9485,Up-Regulation (Physiology),C0041904,en_2313,AFFECTS,macrophage,C0024432,en_1484,1,1,AFFECTS,General/Uncertain,3
9486,Up-Regulation (Physiology),C0041904,en_2313,AFFECTS,Menstruation,C0025344,en_1540,1,1,AFFECTS,General/Uncertain,3
9487,Up-Regulation (Physiology),C0041904,en_2313,AFFECTS,TNF gene,C0812246,en_4896,1,1,AFFECTS,General/Uncertain,3
9488,Up-Regulation (Physiology),C0041904,en_2313,AFFECTS,"TLR4 protein, human",C1321919,en_5543,1,1,AFFECTS,General/Uncertain,3
9489,Up-Regulation (Physiology),C0041904,en_2313,PRODUCES,Interferon Type I,C0021743,en_1331,3,1,AFFECTS,Excitatory,3
9490,"Infections, Upper Respiratory",C0041912,en_2315,AFFECTS,Death (finding),C1306577,en_5521,3,3,AFFECTS,General/Uncertain,9
9491,Uric Acid,C0041980,en_2317,DISRUPTS,Intestines,C0021853,en_1350,2,1,AFFECTS,Inhibitory,3
9492,Uridine,C0041984,en_2318,INHIBITS,exhaust,C0178629,en_2988,1,1,AFFECTS,Inhibitory,3
9493,Urinary tract infection,C0042029,en_2320,AFFECTS(SPEC),Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
9494,Urination,C0042034,en_2322,AFFECTS,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,General/Uncertain,6
9495,Urokinase,C0042071,en_2323,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
9496,Uveitis,C0042164,en_2325,AFFECTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,6
9497,Uveitis,C0042164,en_2325,PRODUCES,T-Cell Receptor,C0034790,en_1965,1,1,AFFECTS,Excitatory,3
9498,Vaccination,C0042196,en_2326,AFFECTS,Antibody Formation,C0003261,en_352,2,1,AFFECTS,General/Uncertain,3
9499,Vaccination,C0042196,en_2326,AFFECTS,Blood Pressure,C0005823,en_492,2,1,AFFECTS,General/Uncertain,3
9500,Vaccination,C0042196,en_2326,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
9501,Vaccination,C0042196,en_2326,AFFECTS,Immunity,C0020964,en_1273,3,2,AFFECTS,General/Uncertain,6
9502,Vaccination,C0042196,en_2326,AFFECTS,"Immunity, Humoral",C0020967,en_1275,1,1,AFFECTS,General/Uncertain,7
9503,Vaccination,C0042196,en_2326,AFFECTS,Menstrual cycle,C0025329,en_1539,1,1,AFFECTS,General/Uncertain,3
9504,Vaccination,C0042196,en_2326,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
9505,Vaccination,C0042196,en_2326,AFFECTS,Virus Diseases,C0042769,en_2362,3,3,AFFECTS,General/Uncertain,9
9506,Vaccination,C0042196,en_2326,AFFECTS,uptake,C0243144,en_3467,4,3,AFFECTS,General/Uncertain,9
9507,Vaccination,C0042196,en_2326,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
9508,Vaccination,C0042196,en_2326,AFFECTS,Immunologic function,C1268930,en_5445,2,1,AFFECTS,General/Uncertain,3
9509,Vaccination,C0042196,en_2326,AFFECTS,Neurological morbidity,C1301721,en_5509,1,1,AFFECTS,General/Uncertain,6
9510,Vaccination,C0042196,en_2326,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
9511,Vaccination,C0042196,en_2326,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
9512,Vaccination,C0042196,en_2326,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
9513,Vaccination,C0042196,en_2326,PREDISPOSES,Influenza,C0021400,en_1311,1,1,AFFECTS,Excitatory,3
9514,Vaccination,C0042196,en_2326,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
9515,Vaccination,C0042196,en_2326,PREVENTS,Communicable Diseases,C0009450,en_685,2,2,AFFECTS,Inhibitory,6
9516,Vaccination,C0042196,en_2326,PREVENTS,Complication,C0009566,en_697,5,3,AFFECTS,Inhibitory,9
9517,Vaccination,C0042196,en_2326,PREVENTS,Disease,C0012634,en_826,9,6,AFFECTS,Inhibitory,23
9518,Vaccination,C0042196,en_2326,PREVENTS,Epilepsy,C0014544,en_917,1,1,AFFECTS,Inhibitory,3
9519,Vaccination,C0042196,en_2326,PREVENTS,Infection,C3714514,en_6235,7,5,AFFECTS,Inhibitory,19
9520,Vaccination,C0042196,en_2326,PREVENTS,Orthomyxoviridae,C0029341,en_1720,1,1,AFFECTS,Inhibitory,3
9521,Vaccination,C0042196,en_2326,PREVENTS,Respiration Disorders,C0035204,en_2005,4,2,AFFECTS,Inhibitory,6
9522,Vaccination,C0042196,en_2326,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
9523,Vaccination,C0042196,en_2326,PREVENTS,Septicemia,C0036690,en_2086,2,1,AFFECTS,Inhibitory,3
9524,Vaccination,C0042196,en_2326,PREVENTS,Tuberculosis,C0041296,en_2293,2,2,AFFECTS,Inhibitory,6
9525,Vaccination,C0042196,en_2326,PREVENTS,Virus Diseases,C0042769,en_2362,5,4,AFFECTS,Inhibitory,12
9526,Vaccination,C0042196,en_2326,PREVENTS,Vertical Disease Transmission,C0242648,en_3427,1,1,AFFECTS,Inhibitory,3
9527,Vaccination,C0042196,en_2326,PREVENTS,Acute upper respiratory infection,C0264222,en_3530,4,2,AFFECTS,Inhibitory,6
9528,Vaccination,C0042196,en_2326,PREVENTS,Acute infectious disease,C0275518,en_3563,1,1,AFFECTS,Inhibitory,3
9529,Vaccination,C0042196,en_2326,PREVENTS,Severe diarrhea,C1443924,en_5740,1,1,AFFECTS,Inhibitory,8
9530,Vaccination,C0042196,en_2326,PREVENTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,13
9531,Vaccination,C0042196,en_2326,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
9532,Vaccination,C0042196,en_2326,STIMULATES,Immune response,C0301872,en_3696,6,5,AFFECTS,Excitatory,15
9533,Vaccination,C0042196,en_2326,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
9534,Vaccination,C0042196,en_2326,TREATS,Adult,C0001675,en_252,3,2,AFFECTS,Inhibitory,6
9535,Vaccination,C0042196,en_2326,TREATS,Elderly,C0001792,en_258,4,3,AFFECTS,Inhibitory,12
9536,Vaccination,C0042196,en_2326,TREATS,Amyloidosis,C0002726,en_309,1,1,AFFECTS,Inhibitory,7
9537,Vaccination,C0042196,en_2326,TREATS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
9538,Vaccination,C0042196,en_2326,TREATS,Child,C0008059,en_620,9,7,AFFECTS,Inhibitory,25
9539,Vaccination,C0042196,en_2326,TREATS,Collagen Diseases,C0009326,en_678,1,1,AFFECTS,Inhibitory,6
9540,Vaccination,C0042196,en_2326,TREATS,Communicable Diseases,C0009450,en_685,3,2,AFFECTS,Inhibitory,6
9541,Vaccination,C0042196,en_2326,TREATS,Complication,C0009566,en_697,5,3,AFFECTS,Inhibitory,9
9542,Vaccination,C0042196,en_2326,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
9543,Vaccination,C0042196,en_2326,TREATS,Coronaviridae,C0010076,en_719,1,1,AFFECTS,Inhibitory,6
9544,Vaccination,C0042196,en_2326,TREATS,Cystic Fibrosis,C0010674,en_745,2,2,AFFECTS,Inhibitory,6
9545,Vaccination,C0042196,en_2326,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9546,Vaccination,C0042196,en_2326,TREATS,Ethnic group,C0015031,en_934,1,1,AFFECTS,Inhibitory,3
9547,Vaccination,C0042196,en_2326,TREATS,Female,C0015780,en_977,1,1,AFFECTS,Inhibitory,3
9548,Vaccination,C0042196,en_2326,TREATS,Health Personnel,C0018724,en_1121,12,8,AFFECTS,Inhibitory,27
9549,Vaccination,C0042196,en_2326,TREATS,Hepatitis B,C0019163,en_1172,1,1,AFFECTS,Inhibitory,3
9550,Vaccination,C0042196,en_2326,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
9551,Vaccination,C0042196,en_2326,TREATS,Human,C0020114,en_1210,2,2,AFFECTS,Inhibitory,6
9552,Vaccination,C0042196,en_2326,TREATS,Human Volunteers,C0020155,en_1211,1,1,AFFECTS,Inhibitory,3
9553,Vaccination,C0042196,en_2326,TREATS,"Infant, Newborn",C0021289,en_1299,2,1,AFFECTS,Inhibitory,3
9554,Vaccination,C0042196,en_2326,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
9555,Vaccination,C0042196,en_2326,TREATS,Influenza,C0021400,en_1311,6,1,AFFECTS,Inhibitory,3
9556,Vaccination,C0042196,en_2326,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,3
9557,Vaccination,C0042196,en_2326,TREATS,Chronic Lymphocytic Leukemia,C0023434,en_1417,1,1,AFFECTS,Inhibitory,7
9558,Vaccination,C0042196,en_2326,TREATS,Macaca mulatta,C0024400,en_1480,1,1,AFFECTS,Inhibitory,3
9559,Vaccination,C0042196,en_2326,TREATS,Measles,C0025007,en_1512,1,1,AFFECTS,Inhibitory,3
9560,Vaccination,C0042196,en_2326,TREATS,Multiple Sclerosis,C0026769,en_1598,2,2,AFFECTS,Inhibitory,6
9561,Vaccination,C0042196,en_2326,TREATS,Musculoskeletal Diseases,C0026857,en_1607,1,1,AFFECTS,Inhibitory,6
9562,Vaccination,C0042196,en_2326,TREATS,Persons,C0027361,en_1635,17,12,AFFECTS,Inhibitory,36
9563,Vaccination,C0042196,en_2326,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,6
9564,Vaccination,C0042196,en_2326,TREATS,African race,C0027567,en_1646,1,1,AFFECTS,Inhibitory,3
9565,Vaccination,C0042196,en_2326,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,7
9566,Vaccination,C0042196,en_2326,TREATS,Patients,C0030705,en_1762,80,33,AFFECTS,Inhibitory,99
9567,Vaccination,C0042196,en_2326,TREATS,Poliomyelitis,C0032371,en_1841,1,1,AFFECTS,Inhibitory,3
9568,Vaccination,C0042196,en_2326,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
9569,Vaccination,C0042196,en_2326,TREATS,Racial group,C0034510,en_1951,1,1,AFFECTS,Inhibitory,3
9570,Vaccination,C0042196,en_2326,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,3
9571,Vaccination,C0042196,en_2326,TREATS,Rheumatism,C0035435,en_2028,1,1,AFFECTS,Inhibitory,6
9572,Vaccination,C0042196,en_2326,TREATS,Sarcoidosis,C0036202,en_2064,1,1,AFFECTS,Inhibitory,3
9573,Vaccination,C0042196,en_2326,TREATS,student,C0038492,en_2171,1,1,AFFECTS,Inhibitory,3
9574,Vaccination,C0042196,en_2326,TREATS,Family suidae,C0039005,en_2193,1,1,AFFECTS,Inhibitory,3
9575,Vaccination,C0042196,en_2326,TREATS,Unemployment,C0041674,en_2309,4,1,AFFECTS,Inhibitory,3
9576,Vaccination,C0042196,en_2326,TREATS,Veterans,C0042610,en_2351,2,1,AFFECTS,Inhibitory,3
9577,Vaccination,C0042196,en_2326,TREATS,Virus Diseases,C0042769,en_2362,4,3,AFFECTS,Inhibitory,9
9578,Vaccination,C0042196,en_2326,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
9579,Vaccination,C0042196,en_2326,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
9580,Vaccination,C0042196,en_2326,TREATS,Immunocompromised Host,C0085393,en_2665,8,5,AFFECTS,Inhibitory,15
9581,Vaccination,C0042196,en_2326,TREATS,African American,C0085756,en_2689,3,2,AFFECTS,Inhibitory,6
9582,Vaccination,C0042196,en_2326,TREATS,Hispanics,C0086409,en_2717,1,1,AFFECTS,Inhibitory,3
9583,Vaccination,C0042196,en_2326,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
9584,Vaccination,C0042196,en_2326,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
9585,Vaccination,C0042196,en_2326,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,3
9586,Vaccination,C0042196,en_2326,TREATS,Adolescent,C0205653,en_3132,3,2,AFFECTS,Inhibitory,6
9587,Vaccination,C0042196,en_2326,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
9588,Vaccination,C0042196,en_2326,TREATS,Individual,C0237401,en_3343,22,12,AFFECTS,Inhibitory,36
9589,Vaccination,C0042196,en_2326,TREATS,Nonhuman Primates,C0237798,en_3353,1,1,AFFECTS,Inhibitory,3
9590,Vaccination,C0042196,en_2326,TREATS,Young adult,C0238598,en_3365,2,1,AFFECTS,Inhibitory,3
9591,Vaccination,C0042196,en_2326,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
9592,Vaccination,C0042196,en_2326,TREATS,Medical History,C0262926,en_3519,2,1,AFFECTS,Inhibitory,3
9593,Vaccination,C0042196,en_2326,TREATS,Prognosis bad,C0278252,en_3600,2,1,AFFECTS,Inhibitory,3
9594,Vaccination,C0042196,en_2326,TREATS,"Recipient, Transplant",C0376387,en_3875,5,3,AFFECTS,Inhibitory,12
9595,Vaccination,C0042196,en_2326,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,7
9596,Vaccination,C0042196,en_2326,TREATS,Severe asthma,C0581126,en_4345,1,1,AFFECTS,Inhibitory,3
9597,Vaccination,C0042196,en_2326,TREATS,cohort,C0599755,en_4470,8,6,AFFECTS,Inhibitory,21
9598,Vaccination,C0042196,en_2326,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
9599,Vaccination,C0042196,en_2326,TREATS,member,C0680022,en_4618,1,1,AFFECTS,Inhibitory,3
9600,Vaccination,C0042196,en_2326,TREATS,public housing resident,C0682285,en_4641,2,1,AFFECTS,Inhibitory,3
9601,Vaccination,C0042196,en_2326,TREATS,General Population,C0683971,en_4674,4,3,AFFECTS,Inhibitory,9
9602,Vaccination,C0042196,en_2326,TREATS,Well adult,C0686750,en_4683,6,4,AFFECTS,Inhibitory,20
9603,Vaccination,C0042196,en_2326,TREATS,Genitourinary Cancer,C0751569,en_4851,1,1,AFFECTS,Inhibitory,7
9604,Vaccination,C0042196,en_2326,TREATS,High Risk Populations,C0870646,en_5008,1,1,AFFECTS,Inhibitory,3
9605,Vaccination,C0042196,en_2326,TREATS,Pulmonary failure,C0948755,en_5173,5,3,AFFECTS,Inhibitory,9
9606,Vaccination,C0042196,en_2326,TREATS,Crosstalk,C1504598,en_5789,3,1,AFFECTS,Inhibitory,3
9607,Vaccination,C0042196,en_2326,TREATS,Cancer Patient,C1516213,en_5852,6,4,AFFECTS,Inhibitory,12
9608,Vaccination,C0042196,en_2326,TREATS,Old age,C1999167,en_6084,1,1,AFFECTS,Inhibitory,6
9609,Vaccination,C0042196,en_2326,TREATS,Food Insecurity,C3494174,en_6203,1,1,AFFECTS,Inhibitory,7
9610,Vaccination,C0042196,en_2326,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,19
9611,Vaccination,C0042196,en_2326,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
9612,Vaccination,C0042196,en_2326,TREATS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,7
9613,Vaccination,C0042196,en_2326,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,4,2,AFFECTS,Inhibitory,6
9614,Vaccination,C0042196,en_2326,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
9615,Vaccination,C0042196,en_2326,TREATS(INFER),Down Syndrome,C0013080,en_843,2,1,AFFECTS,Inhibitory,3
9616,Vaccination,C0042196,en_2326,TREATS(INFER),Immunologic Deficiency Syndromes,C0021051,en_1283,2,1,AFFECTS,Inhibitory,3
9617,Vaccination,C0042196,en_2326,TREATS(INFER),Inflammatory Bowel Diseases,C0021390,en_1310,1,1,AFFECTS,Inhibitory,3
9618,Vaccination,C0042196,en_2326,TREATS(INFER),Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
9619,Vaccination,C0042196,en_2326,TREATS(INFER),"Kidney Failure, Chronic",C0022661,en_1383,4,2,AFFECTS,Inhibitory,6
9620,Vaccination,C0042196,en_2326,TREATS(INFER),Liver diseases,C0023895,en_1455,3,1,AFFECTS,Inhibitory,3
9621,Vaccination,C0042196,en_2326,TREATS(INFER),"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
9622,Vaccination,C0042196,en_2326,TREATS(INFER),Multiple Sclerosis,C0026769,en_1598,2,1,AFFECTS,Inhibitory,3
9623,Vaccination,C0042196,en_2326,TREATS(INFER),Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
9624,Vaccination,C0042196,en_2326,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
9625,Vaccination,C0042196,en_2326,TREATS(INFER),Rheumatism,C0035435,en_2028,3,2,AFFECTS,Inhibitory,6
9626,Vaccination,C0042196,en_2326,TREATS(INFER),Sarcoidosis,C0036202,en_2064,9,1,AFFECTS,Inhibitory,3
9627,Vaccination,C0042196,en_2326,TREATS(INFER),Acute leukemia,C0085669,en_2685,1,1,AFFECTS,Inhibitory,3
9628,Vaccination,C0042196,en_2326,TREATS(INFER),Normal renal function,C0232805,en_3286,2,1,AFFECTS,Inhibitory,3
9629,Vaccination,C0042196,en_2326,TREATS(INFER),Homelessness,C0237154,en_3342,2,1,AFFECTS,Inhibitory,3
9630,Vaccination,C0042196,en_2326,TREATS(INFER),Chronic liver disease NOS,C0341439,en_3823,2,1,AFFECTS,Inhibitory,3
9631,Vaccination,C0042196,en_2326,TREATS(INFER),Hematologic Neoplasms,C0376545,en_3883,2,1,AFFECTS,Inhibitory,3
9632,Vaccination,C0042196,en_2326,TREATS(INFER),Autoimmune,C0443146,en_4064,1,1,AFFECTS,Inhibitory,3
9633,Vaccination,C0042196,en_2326,TREATS(INFER),Severe asthma,C0581126,en_4345,1,1,AFFECTS,Inhibitory,3
9634,Vaccination,C0042196,en_2326,TREATS(INFER),Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
9635,Vaccination,C0042196,en_2326,TREATS(INFER),Frail,C0871754,en_5030,1,1,AFFECTS,Inhibitory,3
9636,Vaccination,C0042196,en_2326,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
9637,Vaccination,C0042196,en_2326,TREATS(INFER),Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
9638,Vaccination,C0042196,en_2326,TREATS(SPEC),Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
9639,Influenza vaccination,C0042200,en_2327,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
9640,Influenza vaccination,C0042200,en_2327,AFFECTS,Platelet Activation,C0032173,en_1827,1,1,AFFECTS,General/Uncertain,3
9641,Influenza vaccination,C0042200,en_2327,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,3
9642,Influenza vaccination,C0042200,en_2327,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,8
9643,Influenza vaccination,C0042200,en_2327,PREDISPOSES,COVID-19,C5203670,en_6417,2,1,AFFECTS,Excitatory,6
9644,Influenza vaccination,C0042200,en_2327,PREVENTS,Influenza,C0021400,en_1311,2,1,AFFECTS,Inhibitory,3
9645,Influenza vaccination,C0042200,en_2327,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
9646,Influenza vaccination,C0042200,en_2327,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
9647,Influenza vaccination,C0042200,en_2327,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
9648,Influenza vaccination,C0042200,en_2327,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
9649,Influenza vaccination,C0042200,en_2327,TREATS,High risk of heart disease,C0581228,en_4346,1,1,AFFECTS,Inhibitory,8
9650,Influenza vaccination,C0042200,en_2327,TREATS,Does hit,C0596020,en_4378,1,1,AFFECTS,Inhibitory,3
9651,Influenza vaccination,C0042200,en_2327,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
9652,Influenza vaccination,C0042200,en_2327,TREATS,target group,C0680888,en_4628,1,1,AFFECTS,Inhibitory,3
9653,Vaccine Therapy,C0042209,en_2328,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
9654,Vaccines,C0042210,en_2329,AFFECTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,6
9655,Vaccines,C0042210,en_2329,AFFECTS,Immunity,C0020964,en_1273,3,3,AFFECTS,General/Uncertain,12
9656,Vaccines,C0042210,en_2329,AFFECTS,Curb,C0263940,en_3526,1,1,AFFECTS,General/Uncertain,8
9657,Vaccines,C0042210,en_2329,AFFECTS,Protection,C1545588,en_5951,1,1,AFFECTS,General/Uncertain,7
9658,Vaccines,C0042210,en_2329,AFFECTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,14
9659,Vaccines,C0042210,en_2329,AUGMENTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,7
9660,Vaccines,C0042210,en_2329,AUGMENTS,Immunity,C0020964,en_1273,8,8,AFFECTS,Excitatory,42
9661,Vaccines,C0042210,en_2329,AUGMENTS,T-Lymphocyte,C0039194,en_2198,2,2,AFFECTS,Excitatory,9
9662,Vaccines,C0042210,en_2329,AUGMENTS,Immune response,C0301872,en_3696,22,19,AFFECTS,Excitatory,61
9663,Vaccines,C0042210,en_2329,AUGMENTS,specific immunity,C0683201,en_4653,1,1,AFFECTS,Excitatory,6
9664,Vaccines,C0042210,en_2329,AUGMENTS,Antiviral Response,C1155328,en_5322,2,2,AFFECTS,Excitatory,11
9665,Vaccines,C0042210,en_2329,PREVENTS,Disease,C0012634,en_826,29,21,AFFECTS,Inhibitory,73
9666,Vaccines,C0042210,en_2329,PREVENTS,Virus,C0042776,en_2364,3,3,AFFECTS,Inhibitory,18
9667,Vaccines,C0042210,en_2329,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,5,3,AFFECTS,Inhibitory,14
9668,Vaccines,C0042210,en_2329,PREVENTS,COVID-19,C5203670,en_6417,14,13,AFFECTS,Inhibitory,92
9669,Vaccines,C0042210,en_2329,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
9670,Vaccines,C0042210,en_2329,PRODUCES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,6.5
9671,Vaccines,C0042210,en_2329,STIMULATES,"Antibodies, Anti-Idiotypic",C0003242,en_348,1,1,AFFECTS,Excitatory,6
9672,Vaccines,C0042210,en_2329,STIMULATES,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,6
9673,Vaccines,C0042210,en_2329,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,7
9674,Vaccines,C0042210,en_2329,STIMULATES,Specific antigen,C0456981,en_4121,1,1,AFFECTS,Excitatory,8
9675,Vaccines,C0042210,en_2329,STIMULATES,Neutralizing antibody,C0475463,en_4145,11,7,AFFECTS,Excitatory,30
9676,Vaccines,C0042210,en_2329,TREATS,Adult,C0001675,en_252,40,25,AFFECTS,Inhibitory,90
9677,Vaccines,C0042210,en_2329,TREATS,Elderly,C0001792,en_258,16,11,AFFECTS,Inhibitory,41
9678,Vaccines,C0042210,en_2329,TREATS,Autoimmune Diseases,C0004364,en_428,2,2,AFFECTS,Inhibitory,13
9679,Vaccines,C0042210,en_2329,TREATS,Malignant Neoplasms,C0006826,en_545,4,3,AFFECTS,Inhibitory,15
9680,Vaccines,C0042210,en_2329,TREATS,Child,C0008059,en_620,22,13,AFFECTS,Inhibitory,48
9681,Vaccines,C0042210,en_2329,TREATS,Comorbidity,C0009488,en_690,1,1,AFFECTS,Inhibitory,8
9682,Vaccines,C0042210,en_2329,TREATS,Coronaviridae,C0010076,en_719,1,1,AFFECTS,Inhibitory,6
9683,Vaccines,C0042210,en_2329,TREATS,Health Personnel,C0018724,en_1121,9,6,AFFECTS,Inhibitory,21
9684,Vaccines,C0042210,en_2329,TREATS,HIV,C0019682,en_1190,2,2,AFFECTS,Inhibitory,15
9685,Vaccines,C0042210,en_2329,TREATS,Waldenstrom Macroglobulinemia,C0024419,en_1481,1,1,AFFECTS,Inhibitory,7
9686,Vaccines,C0042210,en_2329,TREATS,Human Age Group,C0027362,en_1636,4,3,AFFECTS,Inhibitory,14
9687,Vaccines,C0042210,en_2329,TREATS,Virus Diseases,C0042769,en_2362,19,18,AFFECTS,Inhibitory,58
9688,Vaccines,C0042210,en_2329,TREATS,Homo sapiens,C0086418,en_2718,3,3,AFFECTS,Inhibitory,22
9689,Vaccines,C0042210,en_2329,TREATS,Negative,C0205160,en_3126,1,1,AFFECTS,Inhibitory,8
9690,Vaccines,C0042210,en_2329,TREATS,Adolescent,C0205653,en_3132,7,4,AFFECTS,Inhibitory,22
9691,Vaccines,C0042210,en_2329,TREATS,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,Inhibitory,11
9692,Vaccines,C0042210,en_2329,TREATS,Solid tumor,C0280100,en_3619,3,2,AFFECTS,Inhibitory,10
9693,Vaccines,C0042210,en_2329,TREATS,"Recipient, Transplant",C0376387,en_3875,7,5,AFFECTS,Inhibitory,20
9694,Vaccines,C0042210,en_2329,TREATS,Hematologic Neoplasms,C0376545,en_3883,3,2,AFFECTS,Inhibitory,10
9695,Vaccines,C0042210,en_2329,TREATS,Genitourinary Cancer,C0751569,en_4851,1,1,AFFECTS,Inhibitory,7
9696,Vaccines,C0042210,en_2329,TREATS,Subgroup A Nepoviruses,C1079230,en_5225,1,1,AFFECTS,Inhibitory,6
9697,Vaccines,C0042210,en_2329,TREATS,Cancer Patient,C1516213,en_5852,7,5,AFFECTS,Inhibitory,19
9698,Vaccines,C0042210,en_2329,TREATS,Workers,C1527116,en_5916,1,1,AFFECTS,Inhibitory,6
9699,Vaccines,C0042210,en_2329,TREATS,Recipient,C1709854,en_6037,1,1,AFFECTS,Inhibitory,8
9700,Vaccines,C0042210,en_2329,TREATS,COVID-19,C5203670,en_6417,9,9,AFFECTS,Inhibitory,64
9701,Vaccines,C0042210,en_2329,TREATS,2019 novel coronavirus,C5203676,en_6420,4,4,AFFECTS,Inhibitory,28
9702,Vaccines,C0042210,en_2329,AFFECTS,Antigen-Presenting Cells,C0003315,en_362,2,1,AFFECTS,General/Uncertain,3
9703,Vaccines,C0042210,en_2329,AFFECTS,Blood Pressure,C0005823,en_492,4,2,AFFECTS,General/Uncertain,6
9704,Vaccines,C0042210,en_2329,AFFECTS,Disease,C0012634,en_826,4,3,AFFECTS,General/Uncertain,9
9705,Vaccines,C0042210,en_2329,AFFECTS,Evolution,C0015219,en_937,2,1,AFFECTS,General/Uncertain,3
9706,Vaccines,C0042210,en_2329,AFFECTS,Menstrual cycle,C0025329,en_1539,2,1,AFFECTS,General/Uncertain,3
9707,Vaccines,C0042210,en_2329,AFFECTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,General/Uncertain,3
9708,Vaccines,C0042210,en_2329,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
9709,Vaccines,C0042210,en_2329,AFFECTS,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,General/Uncertain,3
9710,Vaccines,C0042210,en_2329,AFFECTS,Sore to touch,C0234233,en_3307,1,1,AFFECTS,General/Uncertain,3
9711,Vaccines,C0042210,en_2329,AFFECTS,uptake,C0243144,en_3467,2,2,AFFECTS,General/Uncertain,6
9712,Vaccines,C0042210,en_2329,AFFECTS,"Biological function, NOS",C0277784,en_3587,1,1,AFFECTS,General/Uncertain,3
9713,Vaccines,C0042210,en_2329,AFFECTS,Immune response,C0301872,en_3696,9,6,AFFECTS,General/Uncertain,18
9714,Vaccines,C0042210,en_2329,AFFECTS,"Passive immunity, function",C0678210,en_4555,1,1,AFFECTS,General/Uncertain,3
9715,Vaccines,C0042210,en_2329,AFFECTS,Maximum,C0806909,en_4887,1,1,AFFECTS,General/Uncertain,3
9716,Vaccines,C0042210,en_2329,AFFECTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,3
9717,Vaccines,C0042210,en_2329,AFFECTS,"Immunity, Herd",C1135927,en_5260,4,2,AFFECTS,General/Uncertain,6
9718,Vaccines,C0042210,en_2329,AFFECTS,Readiness,C1318963,en_5534,1,1,AFFECTS,General/Uncertain,3
9719,Vaccines,C0042210,en_2329,AUGMENTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,3
9720,Vaccines,C0042210,en_2329,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
9721,Vaccines,C0042210,en_2329,AUGMENTS,"Immunity, Humoral",C0020967,en_1275,3,2,AFFECTS,Excitatory,6
9722,Vaccines,C0042210,en_2329,AUGMENTS,Immunologic Memory,C0021055,en_1286,1,1,AFFECTS,Excitatory,3
9723,Vaccines,C0042210,en_2329,AUGMENTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Excitatory,3
9724,Vaccines,C0042210,en_2329,AUGMENTS,Lung nodule,C0034079,en_1934,1,1,AFFECTS,Excitatory,3
9725,Vaccines,C0042210,en_2329,AUGMENTS,Urinary hesitation,C0152032,en_2878,2,1,AFFECTS,Excitatory,3
9726,Vaccines,C0042210,en_2329,AUGMENTS,uptake,C0243144,en_3467,4,3,AFFECTS,Excitatory,9
9727,Vaccines,C0042210,en_2329,AUGMENTS,"Immune Response, Mucosal",C0282557,en_3652,1,1,AFFECTS,Excitatory,3
9728,Vaccines,C0042210,en_2329,AUGMENTS,Skin callus,C0376154,en_3872,1,1,AFFECTS,Excitatory,3
9729,Vaccines,C0042210,en_2329,AUGMENTS,Willing,C0600109,en_4497,2,1,AFFECTS,Excitatory,3
9730,Vaccines,C0042210,en_2329,AUGMENTS,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,Excitatory,3
9731,Vaccines,C0042210,en_2329,COMPLICATES,Disease,C0012634,en_826,4,1,AFFECTS,General/Uncertain,3
9732,Vaccines,C0042210,en_2329,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
9733,Vaccines,C0042210,en_2329,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
9734,Vaccines,C0042210,en_2329,INHIBITS,Antibodies,C0003241,en_347,2,1,AFFECTS,Inhibitory,3
9735,Vaccines,C0042210,en_2329,INHIBITS,vaccin protein,C0077967,en_2584,11,1,AFFECTS,Inhibitory,3
9736,Vaccines,C0042210,en_2329,INHIBITS,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,Inhibitory,3
9737,Vaccines,C0042210,en_2329,INHIBITS,small molecule,C1328819,en_5573,1,1,AFFECTS,Inhibitory,3
9738,Vaccines,C0042210,en_2329,PREDISPOSES,Disease,C0012634,en_826,3,2,AFFECTS,Excitatory,6
9739,Vaccines,C0042210,en_2329,PREDISPOSES,Lymphedema,C0024236,en_1467,2,1,AFFECTS,Excitatory,3
9740,Vaccines,C0042210,en_2329,PREDISPOSES,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,Excitatory,3
9741,Vaccines,C0042210,en_2329,PREVENTS,Chlamydia Infections,C0008149,en_627,1,1,AFFECTS,Inhibitory,3
9742,Vaccines,C0042210,en_2329,PREVENTS,Communicable Diseases,C0009450,en_685,4,3,AFFECTS,Inhibitory,9
9743,Vaccines,C0042210,en_2329,PREVENTS,Complication,C0009566,en_697,6,3,AFFECTS,Inhibitory,9
9744,Vaccines,C0042210,en_2329,PREVENTS,Ebola virus,C0013480,en_872,1,1,AFFECTS,Inhibitory,3
9745,Vaccines,C0042210,en_2329,PREVENTS,Flavivirus,C0016215,en_1000,1,1,AFFECTS,Inhibitory,3
9746,Vaccines,C0042210,en_2329,PREVENTS,Hepatitis B,C0019163,en_1172,1,1,AFFECTS,Inhibitory,3
9747,Vaccines,C0042210,en_2329,PREVENTS,Infection,C3714514,en_6235,14,8,AFFECTS,Inhibitory,24
9748,Vaccines,C0042210,en_2329,PREVENTS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
9749,Vaccines,C0042210,en_2329,PREVENTS,Laboratory Infection,C0022882,en_1393,6,3,AFFECTS,Inhibitory,9
9750,Vaccines,C0042210,en_2329,PREVENTS,Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,3
9751,Vaccines,C0042210,en_2329,PREVENTS,Meningitis,C0025289,en_1536,1,1,AFFECTS,Inhibitory,3
9752,Vaccines,C0042210,en_2329,PREVENTS,Myelitis,C0026975,en_1621,1,1,AFFECTS,Inhibitory,3
9753,Vaccines,C0042210,en_2329,PREVENTS,Orthomyxoviridae,C0029341,en_1720,1,1,AFFECTS,Inhibitory,3
9754,Vaccines,C0042210,en_2329,PREVENTS,Pneumonia,C0032285,en_1833,4,2,AFFECTS,Inhibitory,6
9755,Vaccines,C0042210,en_2329,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
9756,Vaccines,C0042210,en_2329,PREVENTS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
9757,Vaccines,C0042210,en_2329,PREVENTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
9758,Vaccines,C0042210,en_2329,PREVENTS,Virus Diseases,C0042769,en_2362,8,5,AFFECTS,Inhibitory,15
9759,Vaccines,C0042210,en_2329,PREVENTS,Urinary hesitation,C0152032,en_2878,2,1,AFFECTS,Inhibitory,3
9760,Vaccines,C0042210,en_2329,PREVENTS,"[X]Acute miliary tuberculosis, unspecified",C0152915,en_2881,10,1,AFFECTS,Inhibitory,3
9761,Vaccines,C0042210,en_2329,PREVENTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
9762,Vaccines,C0042210,en_2329,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
9763,Vaccines,C0042210,en_2329,PREVENTS,disease transmission,C0242781,en_3438,2,2,AFFECTS,Inhibitory,6
9764,Vaccines,C0042210,en_2329,PREVENTS,"Hemorrhagic Fever, Ebola",C0282687,en_3666,1,1,AFFECTS,Inhibitory,3
9765,Vaccines,C0042210,en_2329,PREVENTS,Symptoms,C1457887,en_5784,3,3,AFFECTS,Inhibitory,9
9766,Vaccines,C0042210,en_2329,STIMULATES,"CD79A,LOC102723407",C1413238,en_191,2,1,AFFECTS,Excitatory,3
9767,Vaccines,C0042210,en_2329,STIMULATES,Antibodies,C0003241,en_347,15,14,AFFECTS,Excitatory,42
9768,Vaccines,C0042210,en_2329,STIMULATES,Antiviral Agents,C0003451,en_379,2,1,AFFECTS,Excitatory,3
9769,Vaccines,C0042210,en_2329,STIMULATES,Immunoglobulin A,C0020835,en_1259,1,1,AFFECTS,Excitatory,3
9770,Vaccines,C0042210,en_2329,STIMULATES,Interleukin-15,C0254610,en_3491,1,1,AFFECTS,Excitatory,3
9771,Vaccines,C0042210,en_2329,STIMULATES,Specific antibody,C0443640,en_4068,4,1,AFFECTS,Excitatory,3
9772,Vaccines,C0042210,en_2329,STIMULATES,CD8B1 gene,C1367471,en_5671,1,1,AFFECTS,Excitatory,3
9773,Vaccines,C0042210,en_2329,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
9774,Vaccines,C0042210,en_2329,TREATS,Felis catus,C0007450,en_579,3,1,AFFECTS,Inhibitory,3
9775,Vaccines,C0042210,en_2329,TREATS,Caucasoid Race,C0007457,en_581,1,1,AFFECTS,Inhibitory,3
9776,Vaccines,C0042210,en_2329,TREATS,Communicable Diseases,C0009450,en_685,5,4,AFFECTS,Inhibitory,12
9777,Vaccines,C0042210,en_2329,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
9778,Vaccines,C0042210,en_2329,TREATS,Disease,C0012634,en_826,34,25,AFFECTS,Inhibitory,75
9779,Vaccines,C0042210,en_2329,TREATS,Ebola virus,C0013480,en_872,1,1,AFFECTS,Inhibitory,3
9780,Vaccines,C0042210,en_2329,TREATS,Cricetinae,C0018557,en_1111,2,2,AFFECTS,Inhibitory,6
9781,Vaccines,C0042210,en_2329,TREATS,Human,C0020114,en_1210,13,10,AFFECTS,Inhibitory,30
9782,Vaccines,C0042210,en_2329,TREATS,Infant,C0021270,en_1297,3,2,AFFECTS,Inhibitory,6
9783,Vaccines,C0042210,en_2329,TREATS,"Infant, Newborn",C0021289,en_1299,2,1,AFFECTS,Inhibitory,3
9784,Vaccines,C0042210,en_2329,TREATS,Infection,C3714514,en_6235,5,5,AFFECTS,Inhibitory,15
9785,Vaccines,C0042210,en_2329,TREATS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,3
9786,Vaccines,C0042210,en_2329,TREATS,Liver diseases,C0023895,en_1455,2,1,AFFECTS,Inhibitory,3
9787,Vaccines,C0042210,en_2329,TREATS,Macaca,C0024398,en_1479,1,1,AFFECTS,Inhibitory,3
9788,Vaccines,C0042210,en_2329,TREATS,Malaria,C0024530,en_1493,2,2,AFFECTS,Inhibitory,6
9789,Vaccines,C0042210,en_2329,TREATS,Mammals,C0024660,en_1497,1,1,AFFECTS,Inhibitory,3
9790,Vaccines,C0042210,en_2329,TREATS,Meningitis,C0025289,en_1536,1,1,AFFECTS,Inhibitory,3
9791,Vaccines,C0042210,en_2329,TREATS,Migrants,C0026093,en_1568,1,1,AFFECTS,Inhibitory,3
9792,Vaccines,C0042210,en_2329,TREATS,Monkeys,C0026447,en_1578,2,1,AFFECTS,Inhibitory,3
9793,Vaccines,C0042210,en_2329,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
9794,Vaccines,C0042210,en_2329,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
9795,Vaccines,C0042210,en_2329,TREATS,Mus,C0026809,en_1600,4,4,AFFECTS,Inhibitory,12
9796,Vaccines,C0042210,en_2329,TREATS,Myocarditis,C0027059,en_1627,2,1,AFFECTS,Inhibitory,3
9797,Vaccines,C0042210,en_2329,TREATS,Persons,C0027361,en_1635,26,16,AFFECTS,Inhibitory,48
9798,Vaccines,C0042210,en_2329,TREATS,Patients,C0030705,en_1762,100,56,AFFECTS,Inhibitory,168
9799,Vaccines,C0042210,en_2329,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
9800,Vaccines,C0042210,en_2329,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
9801,Vaccines,C0042210,en_2329,TREATS,Primates,C0033147,en_1887,1,1,AFFECTS,Inhibitory,3
9802,Vaccines,C0042210,en_2329,TREATS,Voluntary Workers,C0042960,en_2380,21,11,AFFECTS,Inhibitory,33
9803,Vaccines,C0042210,en_2329,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
9804,Vaccines,C0042210,en_2329,TREATS,Yellow Fever,C0043395,en_2407,1,1,AFFECTS,Inhibitory,3
9805,Vaccines,C0042210,en_2329,TREATS,Immunocompromised Host,C0085393,en_2665,14,11,AFFECTS,Inhibitory,33
9806,Vaccines,C0042210,en_2329,TREATS,African American,C0085756,en_2689,1,1,AFFECTS,Inhibitory,3
9807,Vaccines,C0042210,en_2329,TREATS,Hispanics,C0086409,en_2717,1,1,AFFECTS,Inhibitory,3
9808,Vaccines,C0042210,en_2329,TREATS,Youth,C0087178,en_2748,2,2,AFFECTS,Inhibitory,6
9809,Vaccines,C0042210,en_2329,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,3
9810,Vaccines,C0042210,en_2329,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
9811,Vaccines,C0042210,en_2329,TREATS,Human coronavirus,C0206422,en_3159,3,2,AFFECTS,Inhibitory,6
9812,Vaccines,C0042210,en_2329,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
9813,Vaccines,C0042210,en_2329,TREATS,Individual,C0237401,en_3343,14,5,AFFECTS,Inhibitory,15
9814,Vaccines,C0042210,en_2329,TREATS,Nonhuman Primates,C0237798,en_3353,2,2,AFFECTS,Inhibitory,6
9815,Vaccines,C0042210,en_2329,TREATS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,3
9816,Vaccines,C0042210,en_2329,TREATS,Acute infectious disease,C0275518,en_3563,1,1,AFFECTS,Inhibitory,3
9817,Vaccines,C0042210,en_2329,TREATS,Smoker,C0337664,en_3793,1,1,AFFECTS,Inhibitory,3
9818,Vaccines,C0042210,en_2329,TREATS,Hematopoietic Neoplasms,C0376544,en_3882,2,1,AFFECTS,Inhibitory,3
9819,Vaccines,C0042210,en_2329,TREATS,cohort,C0599755,en_4470,14,10,AFFECTS,Inhibitory,30
9820,Vaccines,C0042210,en_2329,TREATS,Participant,C0679646,en_4602,22,14,AFFECTS,Inhibitory,42
9821,Vaccines,C0042210,en_2329,TREATS,member,C0680022,en_4618,2,1,AFFECTS,Inhibitory,3
9822,Vaccines,C0042210,en_2329,TREATS,General Population,C0683971,en_4674,9,7,AFFECTS,Inhibitory,21
9823,Vaccines,C0042210,en_2329,TREATS,Well adolescent,C0686747,en_4682,2,1,AFFECTS,Inhibitory,3
9824,Vaccines,C0042210,en_2329,TREATS,Well adult,C0686750,en_4683,55,28,AFFECTS,Inhibitory,84
9825,Vaccines,C0042210,en_2329,TREATS,Nipah Virus,C0751673,en_4853,1,1,AFFECTS,Inhibitory,3
9826,Vaccines,C0042210,en_2329,TREATS,Geriatric Patients,C0870602,en_5007,2,1,AFFECTS,Inhibitory,3
9827,Vaccines,C0042210,en_2329,TREATS,High Risk Populations,C0870646,en_5008,2,2,AFFECTS,Inhibitory,6
9828,Vaccines,C0042210,en_2329,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
9829,Vaccines,C0042210,en_2329,TREATS,Frail,C0871754,en_5030,2,1,AFFECTS,Inhibitory,3
9830,Vaccines,C0042210,en_2329,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
9831,Vaccines,C0042210,en_2329,TREATS,Vulnerable Populations,C0949366,en_5180,2,2,AFFECTS,Inhibitory,6
9832,Vaccines,C0042210,en_2329,TREATS,Co-morbid conditions,C1275743,en_5462,2,1,AFFECTS,Inhibitory,3
9833,Vaccines,C0042210,en_2329,TREATS,Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
9834,Vaccines,C0042210,en_2329,TREATS,Transgenic Model,C1519606,en_5888,1,1,AFFECTS,Inhibitory,3
9835,Vaccines,C0042210,en_2329,TREATS,Teens,C1521910,en_5899,1,1,AFFECTS,Inhibitory,3
9836,Vaccines,C0042210,en_2329,TREATS(INFER),Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
9837,Vaccines,C0042210,en_2329,TREATS(INFER),Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
9838,Vaccines,C0042210,en_2329,TREATS(INFER),Autoimmune Diseases,C0004364,en_428,3,3,AFFECTS,Inhibitory,9
9839,Vaccines,C0042210,en_2329,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,8,4,AFFECTS,Inhibitory,12
9840,Vaccines,C0042210,en_2329,TREATS(INFER),Critical Illness,C0010340,en_733,2,2,AFFECTS,Inhibitory,6
9841,Vaccines,C0042210,en_2329,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
9842,Vaccines,C0042210,en_2329,TREATS(INFER),Down Syndrome,C0013080,en_843,2,1,AFFECTS,Inhibitory,3
9843,Vaccines,C0042210,en_2329,TREATS(INFER),HIV Infections,C0019693,en_1192,2,1,AFFECTS,Inhibitory,3
9844,Vaccines,C0042210,en_2329,TREATS(INFER),Immunologic Deficiency Syndromes,C0021051,en_1283,2,1,AFFECTS,Inhibitory,3
9845,Vaccines,C0042210,en_2329,TREATS(INFER),Inflammatory Bowel Diseases,C0021390,en_1310,2,1,AFFECTS,Inhibitory,3
9846,Vaccines,C0042210,en_2329,TREATS(INFER),Kidney Diseases,C0022658,en_1381,4,1,AFFECTS,Inhibitory,3
9847,Vaccines,C0042210,en_2329,TREATS(INFER),Chronic Lymphocytic Leukemia,C0023434,en_1417,2,1,AFFECTS,Inhibitory,3
9848,Vaccines,C0042210,en_2329,TREATS(INFER),Liver diseases,C0023895,en_1455,4,1,AFFECTS,Inhibitory,3
9849,Vaccines,C0042210,en_2329,TREATS(INFER),Multiple Sclerosis,C0026769,en_1598,3,2,AFFECTS,Inhibitory,6
9850,Vaccines,C0042210,en_2329,TREATS(INFER),Orthomyxoviridae,C0029341,en_1720,2,1,AFFECTS,Inhibitory,3
9851,Vaccines,C0042210,en_2329,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
9852,Vaccines,C0042210,en_2329,TREATS(INFER),Rheumatism,C0035435,en_2028,4,2,AFFECTS,Inhibitory,6
9853,Vaccines,C0042210,en_2329,TREATS(INFER),Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
9854,Vaccines,C0042210,en_2329,TREATS(INFER),Acute leukemia,C0085669,en_2685,1,1,AFFECTS,Inhibitory,3
9855,Vaccines,C0042210,en_2329,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
9856,Vaccines,C0042210,en_2329,TREATS(INFER),Chronic liver disease NOS,C0341439,en_3823,2,1,AFFECTS,Inhibitory,3
9857,Vaccines,C0042210,en_2329,TREATS(INFER),Hematopoietic Neoplasms,C0376544,en_3882,2,1,AFFECTS,Inhibitory,3
9858,Vaccines,C0042210,en_2329,TREATS(INFER),Hematologic Neoplasms,C0376545,en_3883,2,1,AFFECTS,Inhibitory,3
9859,Vaccines,C0042210,en_2329,TREATS(INFER),Malignant disease,C0442867,en_4059,2,1,AFFECTS,Inhibitory,3
9860,Vaccines,C0042210,en_2329,TREATS(INFER),Overweight,C0497406,en_4165,2,1,AFFECTS,Inhibitory,3
9861,Vaccines,C0042210,en_2329,TREATS(INFER),Physical disability,C0520817,en_4192,1,1,AFFECTS,Inhibitory,3
9862,Vaccines,C0042210,en_2329,TREATS(INFER),Well adult,C0686750,en_4683,4,2,AFFECTS,Inhibitory,6
9863,Vaccines,C0042210,en_2329,TREATS(INFER),"Problem, weight",C0848241,en_4932,1,1,AFFECTS,Inhibitory,3
9864,Vaccines,C0042210,en_2329,TREATS(INFER),Small Lymphocytic Lymphoma,C0855095,en_4964,2,1,AFFECTS,Inhibitory,3
9865,Vaccines,C0042210,en_2329,TREATS(INFER),autoimmune rheumatologic disease,C1328842,en_5574,2,2,AFFECTS,Inhibitory,6
9866,Vaccines,C0042210,en_2329,TREATS(SPEC),Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
9867,Vaccines,C0042210,en_2329,TREATS(SPEC),Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,3
9868,Vaccines,C0042210,en_2329,TREATS(SPEC),Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
9869,"Vaccines, Attenuated",C0042211,en_2330,AUGMENTS,Leukocytes,C0023516,en_1420,2,1,AFFECTS,Excitatory,3
9870,"Vaccines, Attenuated",C0042211,en_2330,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
9871,"Vaccines, Attenuated",C0042211,en_2330,PREVENTS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
9872,"Vaccines, Attenuated",C0042211,en_2330,PREVENTS,Tuberculosis,C0041296,en_2293,3,2,AFFECTS,Inhibitory,6
9873,"Vaccines, Attenuated",C0042211,en_2330,STIMULATES,"Vaccines, Inactivated",C0042212,en_2331,1,1,AFFECTS,Excitatory,7
9874,"Vaccines, Attenuated",C0042211,en_2330,TREATS,Possible,C0332149,en_3747,1,1,AFFECTS,Inhibitory,6
9875,"Vaccines, Attenuated",C0042211,en_2330,TREATS,Castrated male cattle for beef production,C3687530,en_6230,1,1,AFFECTS,Inhibitory,8
9876,"Vaccines, Inactivated",C0042212,en_2331,AFFECTS,Fertility,C0015895,en_981,1,1,AFFECTS,General/Uncertain,3
9877,"Vaccines, Inactivated",C0042212,en_2331,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
9878,"Vaccines, Inactivated",C0042212,en_2331,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
9879,"Vaccines, Inactivated",C0042212,en_2331,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
9880,"Vaccines, Inactivated",C0042212,en_2331,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
9881,"Vaccines, Inactivated",C0042212,en_2331,INHIBITS,Antibodies,C0003241,en_347,2,1,AFFECTS,Inhibitory,3
9882,"Vaccines, Inactivated",C0042212,en_2331,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9883,"Vaccines, Inactivated",C0042212,en_2331,STIMULATES,Isotretinoin,C0022265,en_1370,2,1,AFFECTS,Excitatory,3
9884,"Vaccines, Inactivated",C0042212,en_2331,STIMULATES,Tretinoin,C0040845,en_2280,2,1,AFFECTS,Excitatory,3
9885,"Vaccines, Inactivated",C0042212,en_2331,TREATS,Adult,C0001675,en_252,10,6,AFFECTS,Inhibitory,18
9886,"Vaccines, Inactivated",C0042212,en_2331,TREATS,Health Personnel,C0018724,en_1121,2,2,AFFECTS,Inhibitory,14
9887,"Vaccines, Inactivated",C0042212,en_2331,TREATS,Persons,C0027361,en_1635,4,2,AFFECTS,Inhibitory,6
9888,"Vaccines, Inactivated",C0042212,en_2331,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9889,"Vaccines, Inactivated",C0042212,en_2331,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
9890,"Vaccines, Inactivated",C0042212,en_2331,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
9891,"Vaccines, Inactivated",C0042212,en_2331,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
9892,"Vaccines, Inactivated",C0042212,en_2331,TREATS(INFER),"Tuberculosis, Pulmonary",C0041327,en_2297,1,1,AFFECTS,Inhibitory,3
9893,"Vaccines, Inactivated",C0042212,en_2331,TREATS(INFER),Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
9894,"Vaccines, Inactivated",C0042212,en_2331,TREATS(INFER),Pre-existing disease,C1112199,en_5242,4,2,AFFECTS,Inhibitory,6
9895,"Vaccines, Inactivated",C0042212,en_2331,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9896,Vaginal Rings,C0042260,en_2332,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
9897,Vaginal Rings,C0042260,en_2332,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
9898,Vaginal Rings,C0042260,en_2332,TREATS,Adolescent,C0205653,en_3132,2,2,AFFECTS,Inhibitory,6
9899,Valine,C0042285,en_2333,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
9900,Valine,C0042285,en_2333,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
9901,Vancomycin,C0042313,en_2334,PREVENTS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Inhibitory,6
9902,Variation (Genetics),C0042333,en_2335,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
9903,Variation (Genetics),C0042333,en_2335,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
9904,Variation (Genetics),C0042333,en_2335,AFFECTS,NATURAL KILLER CELL FUNCTION,C1317556,en_5528,1,1,AFFECTS,General/Uncertain,3
9905,Vascular Diseases,C0042373,en_2336,AFFECTS,South Asian,C1519427,en_5885,1,1,AFFECTS,General/Uncertain,3
9906,Vascular Diseases,C0042373,en_2336,PREDISPOSES,Compromise,C0518613,en_4180,1,1,AFFECTS,Excitatory,3
9907,Vascular Diseases,C0042373,en_2336,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,7
9908,Vascular Surgical Procedures,C0042381,en_2337,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
9909,Vasoactive Intestinal Peptide,C0042395,en_2339,AFFECTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,General/Uncertain,3
9910,Vasoactive Intestinal Peptide,C0042395,en_2339,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
9911,Vasoactive Intestinal Peptide,C0042395,en_2339,INHIBITS,cytokine,C0079189,en_2593,4,2,AFFECTS,Inhibitory,6
9912,Vasoactive Intestinal Peptide,C0042395,en_2339,INHIBITS,"TNF protein, human",C1448177,en_5755,2,1,AFFECTS,Inhibitory,3
9913,Vasoactive Intestinal Peptide,C0042395,en_2339,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
9914,Vasoactive Intestinal Peptide,C0042395,en_2339,STIMULATES,Pulmonary Surfactants,C0034085,en_1935,1,1,AFFECTS,Excitatory,3
9915,Vasoactive Intestinal Peptide,C0042395,en_2339,TREATS,"Hypertension, Pulmonary",C0020542,en_1240,4,2,AFFECTS,Inhibitory,6
9916,Vasoactive Intestinal Peptide,C0042395,en_2339,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
9917,Vasoactive Intestinal Peptide,C0042395,en_2339,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,8,4,AFFECTS,Inhibitory,12
9918,Vascular constriction (function),C0042396,en_2340,AFFECTS,Hypoxia,C0242184,en_3396,2,1,AFFECTS,General/Uncertain,3
9919,Vascular constriction (function),C0042396,en_2340,AFFECTS,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,General/Uncertain,3
9920,Vasoconstrictor Agents,C0042397,en_2341,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9921,Vasoconstrictor Agents,C0042397,en_2341,PREVENTS,Organ failure,C0948600,en_5171,1,1,AFFECTS,Inhibitory,3
9922,Vasoconstrictor Agents,C0042397,en_2341,TREATS,cardiac arrhythmia,C0003811,en_397,2,1,AFFECTS,Inhibitory,6
9923,Vasoconstrictor Agents,C0042397,en_2341,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
9924,Vasoconstrictor Agents,C0042397,en_2341,TREATS,Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
9925,Vasoconstrictor Agents,C0042397,en_2341,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
9926,Vasoconstrictor Agents,C0042397,en_2341,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
9927,Vasoconstrictor Agents,C0042397,en_2341,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
9928,Vasoconstrictor Agents,C0042397,en_2341,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9929,Vasoconstrictor Agents,C0042397,en_2341,TREATS(INFER),Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
9930,Vasoconstrictor Agents,C0042397,en_2341,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
9931,Vasodilator Agents,C0042402,en_2343,INHIBITS,ESAM gene,C1424976,en_5726,1,1,AFFECTS,Inhibitory,3
9932,Vegetables,C0042440,en_2344,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
9933,Vegetables,C0042440,en_2344,AFFECTS,Labor (Childbirth),C0022864,en_1390,1,1,AFFECTS,General/Uncertain,3
9934,Vegetables,C0042440,en_2344,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
9935,Venous Thrombosis,C0042487,en_2345,AFFECTS,Thrombus,C0087086,en_2743,2,1,AFFECTS,General/Uncertain,3
9936,Venous Thrombosis,C0042487,en_2345,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
9937,Ventilator Weaning,C0042496,en_2347,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9938,"Ventilators, Mechanical",C0042497,en_2348,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9939,"Ventilators, Mechanical",C0042497,en_2348,PREVENTS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,Inhibitory,3
9940,"Ventilators, Mechanical",C0042497,en_2348,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
9941,"Ventilators, Mechanical",C0042497,en_2348,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
9942,"Ventilators, Mechanical",C0042497,en_2348,TREATS,Patients,C0030705,en_1762,6,5,AFFECTS,Inhibitory,15
9943,"Ventilators, Mechanical",C0042497,en_2348,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Inhibitory,3
9944,Verapamil,C0042523,en_2349,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
9945,Vimentin,C0042666,en_2352,AFFECTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
9946,Vimentin,C0042666,en_2352,AFFECTS,uptake,C0243144,en_3467,3,1,AFFECTS,General/Uncertain,3
9947,Violence,C0042693,en_2353,AFFECTS,American Indians,C0002460,en_297,1,1,AFFECTS,General/Uncertain,3
9948,Violence,C0042693,en_2353,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
9949,Violence,C0042693,en_2353,AFFECTS,Voice,C0042939,en_2377,1,1,AFFECTS,General/Uncertain,3
9950,Violence,C0042693,en_2353,AFFECTS,Woman,C0043210,en_2396,2,2,AFFECTS,General/Uncertain,6
9951,Violence,C0042693,en_2353,AFFECTS,Youth,C0087178,en_2748,1,1,AFFECTS,General/Uncertain,3
9952,Violence,C0042693,en_2353,AFFECTS,AOD use,C0237123,en_3341,2,1,AFFECTS,General/Uncertain,3
9953,Violence,C0042693,en_2353,AFFECTS,General Population,C0683971,en_4674,1,1,AFFECTS,General/Uncertain,3
9954,Viral Envelope Proteins,C0042711,en_2354,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
9955,Viral Proteins,C0042736,en_2357,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
9956,Viral Proteins,C0042736,en_2357,AFFECTS,enzyme binding,C1149286,en_5303,1,1,AFFECTS,General/Uncertain,3
9957,Viral Proteins,C0042736,en_2357,AFFECTS,Viral life cycle,C1160638,en_5357,1,1,AFFECTS,General/Uncertain,3
9958,Viral Proteins,C0042736,en_2357,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
9959,Viral Proteins,C0042736,en_2357,DISRUPTS,Cells,C0007634,en_596,1,1,AFFECTS,Inhibitory,3
9960,Viral Proteins,C0042736,en_2357,DISRUPTS,enzyme activity,C0243102,en_3464,1,1,AFFECTS,Inhibitory,3
9961,Viral Proteins,C0042736,en_2357,INHIBITS,Peptidyl-Dipeptidase A,C0022709,en_1387,1,1,AFFECTS,Inhibitory,3
9962,Viral Proteins,C0042736,en_2357,INHIBITS,Peptides,C0030956,en_1771,1,1,AFFECTS,Inhibitory,3
9963,Viral Proteins,C0042736,en_2357,PRODUCES,IL1B,C1334112,en_49,1,1,AFFECTS,Excitatory,3
9964,Viral Proteins,C0042736,en_2357,PRODUCES,Antibodies,C0003241,en_347,2,1,AFFECTS,Excitatory,3
9965,Viral Proteins,C0042736,en_2357,PRODUCES,Serum,C0229671,en_3244,1,1,AFFECTS,Excitatory,3
9966,Viral Proteins,C0042736,en_2357,PRODUCES,Plasmid Cloning Vector,C1514152,en_5831,1,1,AFFECTS,Excitatory,3
9967,Viral Proteins,C0042736,en_2357,STIMULATES,Epithelial Cells,C0014597,en_919,1,1,AFFECTS,Excitatory,3
9968,Viral Proteins,C0042736,en_2357,STIMULATES,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Excitatory,3
9969,Viral Proteins,C0042736,en_2357,STIMULATES,"Complement Pathway, Mannose-Binding Lectin",C1138407,en_5270,1,1,AFFECTS,Excitatory,3
9970,Viral Proteins,C0042736,en_2357,STIMULATES,Ubiquitination,C1519751,en_5891,1,1,AFFECTS,Excitatory,3
9971,Viral Vaccines,C0042742,en_2358,PREDISPOSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,6
9972,Viremia,C0042749,en_2359,AFFECTS,Mothers,C0026591,en_1583,2,1,AFFECTS,General/Uncertain,3
9973,Viremia,C0042749,en_2359,AUGMENTS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
9974,Viremia,C0042749,en_2359,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
9975,Viremia,C0042749,en_2359,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,3
9976,Viremia,C0042749,en_2359,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
9977,Virulence,C0042765,en_2361,AFFECTS,Mutation,C0026882,en_1612,3,2,AFFECTS,General/Uncertain,6
9978,Virulence,C0042765,en_2361,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
9979,Virus Diseases,C0042769,en_2362,AFFECTS,Elderly,C0001792,en_258,2,2,AFFECTS,General/Uncertain,6
9980,Virus Diseases,C0042769,en_2362,AFFECTS,Animals,C0003062,en_335,2,2,AFFECTS,General/Uncertain,6
9981,Virus Diseases,C0042769,en_2362,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
9982,Virus Diseases,C0042769,en_2362,AFFECTS,Mental disorders,C0004936,en_452,2,2,AFFECTS,General/Uncertain,6
9983,Virus Diseases,C0042769,en_2362,AFFECTS,Blood Circulation,C0005775,en_483,2,1,AFFECTS,General/Uncertain,3
9984,Virus Diseases,C0042769,en_2362,AFFECTS,Blood Coagulation Disorders,C0005779,en_485,2,1,AFFECTS,General/Uncertain,3
9985,Virus Diseases,C0042769,en_2362,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
9986,Virus Diseases,C0042769,en_2362,AFFECTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
9987,Virus Diseases,C0042769,en_2362,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
9988,Virus Diseases,C0042769,en_2362,AFFECTS,Child,C0008059,en_620,2,1,AFFECTS,General/Uncertain,3
9989,Virus Diseases,C0042769,en_2362,AFFECTS,Coronaviridae,C0010076,en_719,1,1,AFFECTS,General/Uncertain,3
9990,Virus Diseases,C0042769,en_2362,AFFECTS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,2,2,AFFECTS,General/Uncertain,6
9991,Virus Diseases,C0042769,en_2362,AFFECTS,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
9992,Virus Diseases,C0042769,en_2362,AFFECTS,Down-Regulation,C0013081,en_844,1,1,AFFECTS,General/Uncertain,3
9993,Virus Diseases,C0042769,en_2362,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
9994,Virus Diseases,C0042769,en_2362,AFFECTS,Fertility,C0015895,en_981,2,1,AFFECTS,General/Uncertain,3
9995,Virus Diseases,C0042769,en_2362,AFFECTS,Human,C0020114,en_1210,5,4,AFFECTS,General/Uncertain,12
9996,Virus Diseases,C0042769,en_2362,AFFECTS,Immunity,C0020964,en_1273,3,3,AFFECTS,General/Uncertain,9
9997,Virus Diseases,C0042769,en_2362,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
9998,Virus Diseases,C0042769,en_2362,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
9999,Virus Diseases,C0042769,en_2362,AFFECTS,Persons,C0027361,en_1635,13,12,AFFECTS,General/Uncertain,36
10000,Virus Diseases,C0042769,en_2362,AFFECTS,Nerve Degeneration,C0027746,en_1657,2,2,AFFECTS,General/Uncertain,6
10001,Virus Diseases,C0042769,en_2362,AFFECTS,Nervous System Physiology,C0027767,en_1660,1,1,AFFECTS,General/Uncertain,3
10002,Virus Diseases,C0042769,en_2362,AFFECTS,Odors,C0028884,en_1704,1,1,AFFECTS,General/Uncertain,3
10003,Virus Diseases,C0042769,en_2362,AFFECTS,parent,C0030551,en_1750,1,1,AFFECTS,General/Uncertain,3
10004,Virus Diseases,C0042769,en_2362,AFFECTS,Patients,C0030705,en_1762,15,10,AFFECTS,General/Uncertain,30
10005,Virus Diseases,C0042769,en_2362,AFFECTS,Personal Satisfaction,C0031206,en_1780,2,2,AFFECTS,General/Uncertain,6
10006,Virus Diseases,C0042769,en_2362,AFFECTS,Pregnancy,C0032961,en_1872,17,4,AFFECTS,General/Uncertain,12
10007,Virus Diseases,C0042769,en_2362,AFFECTS,Pregnant Women,C0033011,en_1876,5,3,AFFECTS,General/Uncertain,13
10008,Virus Diseases,C0042769,en_2362,AFFECTS,Reproduction,C0035150,en_2001,2,2,AFFECTS,General/Uncertain,6
10009,Virus Diseases,C0042769,en_2362,AFFECTS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,General/Uncertain,3
10010,Virus Diseases,C0042769,en_2362,AFFECTS,Respiration,C0035203,en_2004,2,2,AFFECTS,General/Uncertain,6
10011,Virus Diseases,C0042769,en_2362,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,3
10012,Virus Diseases,C0042769,en_2362,AFFECTS,Encephalopathies,C0085584,en_2680,1,1,AFFECTS,General/Uncertain,3
10013,Virus Diseases,C0042769,en_2362,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,6
10014,Virus Diseases,C0042769,en_2362,AFFECTS,Adolescent,C0205653,en_3132,1,1,AFFECTS,General/Uncertain,3
10015,Virus Diseases,C0042769,en_2362,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,General/Uncertain,6
10016,Virus Diseases,C0042769,en_2362,AFFECTS,Nervous system problem,C0221571,en_3229,1,1,AFFECTS,General/Uncertain,3
10017,Virus Diseases,C0042769,en_2362,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
10018,Virus Diseases,C0042769,en_2362,AFFECTS,Renal function,C0232804,en_3285,1,1,AFFECTS,General/Uncertain,3
10019,Virus Diseases,C0042769,en_2362,AFFECTS,Individual,C0237401,en_3343,2,2,AFFECTS,General/Uncertain,6
10020,Virus Diseases,C0042769,en_2362,AFFECTS,Human Circadian Rhythms,C0237509,en_3347,1,1,AFFECTS,General/Uncertain,3
10021,Virus Diseases,C0042769,en_2362,AFFECTS,"Encephalitis, Viral",C0243010,en_3449,1,1,AFFECTS,General/Uncertain,3
10022,Virus Diseases,C0042769,en_2362,AFFECTS,Immune response,C0301872,en_3696,2,2,AFFECTS,General/Uncertain,6
10023,Virus Diseases,C0042769,en_2362,AFFECTS,Actor,C0335083,en_3783,1,1,AFFECTS,General/Uncertain,3
10024,Virus Diseases,C0042769,en_2362,AFFECTS,Reception,C0544683,en_4264,1,1,AFFECTS,General/Uncertain,3
10025,Virus Diseases,C0042769,en_2362,AFFECTS,Adverse reactions,C0559546,en_4315,2,1,AFFECTS,General/Uncertain,3
10026,Virus Diseases,C0042769,en_2362,AFFECTS,saturation,C0678572,en_4563,1,1,AFFECTS,General/Uncertain,3
10027,Virus Diseases,C0042769,en_2362,AFFECTS,network,C0679670,en_4604,1,1,AFFECTS,General/Uncertain,3
10028,Virus Diseases,C0042769,en_2362,AFFECTS,citizen,C0682134,en_4636,2,2,AFFECTS,General/Uncertain,6
10029,Virus Diseases,C0042769,en_2362,AFFECTS,Prediction Errors,C0871118,en_5017,1,1,AFFECTS,General/Uncertain,3
10030,Virus Diseases,C0042769,en_2362,AFFECTS,Clinicians,C0871685,en_5028,1,1,AFFECTS,General/Uncertain,3
10031,Virus Diseases,C0042769,en_2362,AFFECTS,Underserved Population,C0872319,en_5050,2,1,AFFECTS,General/Uncertain,3
10032,Virus Diseases,C0042769,en_2362,AFFECTS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,General/Uncertain,3
10033,Virus Diseases,C0042769,en_2362,AFFECTS,monocyte activation,C1155075,en_5316,1,1,AFFECTS,General/Uncertain,3
10034,Virus Diseases,C0042769,en_2362,AFFECTS,Inflammatory Response,C1155266,en_5321,8,4,AFFECTS,General/Uncertain,12
10035,Virus Diseases,C0042769,en_2362,AFFECTS,Antiviral Response,C1155328,en_5322,2,1,AFFECTS,General/Uncertain,3
10036,Virus Diseases,C0042769,en_2362,AFFECTS,SARS coronavirus,C1175743,en_5384,1,1,AFFECTS,General/Uncertain,3
10037,Virus Diseases,C0042769,en_2362,AFFECTS,Platelet function,C1254881,en_5398,1,1,AFFECTS,General/Uncertain,3
10038,Virus Diseases,C0042769,en_2362,AFFECTS,Principal Investigator,C1521895,en_5898,1,1,AFFECTS,General/Uncertain,3
10039,Virus Diseases,C0042769,en_2362,AFFECTS,cellular metabolism,C1523924,en_5913,1,1,AFFECTS,General/Uncertain,3
10040,Virus Diseases,C0042769,en_2362,AUGMENTS,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,Excitatory,3
10041,Virus Diseases,C0042769,en_2362,AUGMENTS,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Excitatory,3
10042,Virus Diseases,C0042769,en_2362,AUGMENTS,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,1,1,AFFECTS,Excitatory,3
10043,Virus Diseases,C0042769,en_2362,AUGMENTS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
10044,Virus Diseases,C0042769,en_2362,COMPLICATES,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
10045,Virus Diseases,C0042769,en_2362,COMPLICATES,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
10046,Virus Diseases,C0042769,en_2362,DISRUPTS,Cells,C0007634,en_596,7,5,AFFECTS,Inhibitory,15
10047,Virus Diseases,C0042769,en_2362,DISRUPTS,Epithelial Cells,C0014597,en_919,1,1,AFFECTS,Inhibitory,3
10048,Virus Diseases,C0042769,en_2362,DISRUPTS,Lymphocyte,C0024264,en_1469,4,1,AFFECTS,Inhibitory,3
10049,Virus Diseases,C0042769,en_2362,DISRUPTS,viral transmission,C1160716,en_5362,2,2,AFFECTS,Inhibitory,6
10050,Virus Diseases,C0042769,en_2362,DISRUPTS,Mammalian Cell,C1512977,en_5827,1,1,AFFECTS,Inhibitory,3
10051,Virus Diseases,C0042769,en_2362,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
10052,Virus Diseases,C0042769,en_2362,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
10053,Virus Diseases,C0042769,en_2362,PREDISPOSES,"Pneumonia, Viral",C0032310,en_1837,4,2,AFFECTS,Excitatory,6
10054,Virus Diseases,C0042769,en_2362,PREDISPOSES,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Excitatory,3
10055,Virus Diseases,C0042769,en_2362,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
10056,Virus Diseases,C0042769,en_2362,PREDISPOSES,psychological distress,C0815107,en_4922,1,1,AFFECTS,Excitatory,3
10057,Virus Diseases,C0042769,en_2362,PREDISPOSES,Multiple sclerosis relapse,C0856120,en_4967,4,1,AFFECTS,Excitatory,3
10058,Virus Diseases,C0042769,en_2362,PRODUCES,Antibodies,C0003241,en_347,3,2,AFFECTS,Excitatory,6
10059,Virus Diseases,C0042769,en_2362,PRODUCES,Membrane Proteins,C0025252,en_1530,1,1,AFFECTS,Excitatory,3
10060,Virus Diseases,C0042769,en_2362,PRODUCES,Proteins,C0033684,en_1912,2,1,AFFECTS,Excitatory,3
10061,Virus Diseases,C0042769,en_2362,PRODUCES,saliva,C0036087,en_2057,3,2,AFFECTS,Excitatory,6
10062,Virus Diseases,C0042769,en_2362,PRODUCES,Vaccines,C0042210,en_2329,2,2,AFFECTS,Excitatory,6
10063,Vision,C0042789,en_2366,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
10064,Vision,C0042789,en_2366,AFFECTS,Ecosystem,C0162358,en_2908,1,1,AFFECTS,General/Uncertain,3
10065,Vision,C0042789,en_2366,AFFECTS,warming,C0687712,en_4690,1,1,AFFECTS,General/Uncertain,3
10066,Visiting Nurses,C0042799,en_2367,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10067,Vitamin A,C0042839,en_2368,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
10068,Vitamin A,C0042839,en_2368,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
10069,Vitamin A,C0042839,en_2368,AFFECTS,Lung Development,C1160389,en_5354,1,1,AFFECTS,General/Uncertain,3
10070,Vitamin A,C0042839,en_2368,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
10071,Vitamin A,C0042839,en_2368,INHIBITS,Thrombin,C0040018,en_2228,2,2,AFFECTS,Inhibitory,6
10072,Vitamin A,C0042839,en_2368,INHIBITS,TNF gene,C0812246,en_4896,2,1,AFFECTS,Inhibitory,3
10073,Vitamin A,C0042839,en_2368,STIMULATES,AROMATICS,C0772162,en_4874,2,1,AFFECTS,Excitatory,3
10074,Vitamin A,C0042839,en_2368,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
10075,Vitamin B 12,C0042845,en_2370,AFFECTS,Prognostic Factor,C1514474,en_5834,1,1,AFFECTS,General/Uncertain,6
10076,Vitamin B 12,C0042845,en_2370,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,7
10077,Vitamin B 12,C0042845,en_2370,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
10078,Vitamin B 12,C0042845,en_2370,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
10079,Vitamin D,C0042866,en_2371,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
10080,Vitamin D,C0042866,en_2371,AFFECTS,Immunity,C0020964,en_1273,4,3,AFFECTS,General/Uncertain,9
10081,Vitamin D,C0042866,en_2371,AFFECTS,Ultraviolet Rays,C0041625,en_2307,1,1,AFFECTS,General/Uncertain,3
10082,Vitamin D,C0042866,en_2371,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
10083,Vitamin D,C0042866,en_2371,AFFECTS,pleiotropism,C0597257,en_4418,1,1,AFFECTS,General/Uncertain,3
10084,Vitamin D,C0042866,en_2371,AFFECTS,Inflammatory Response,C1155266,en_5321,2,2,AFFECTS,General/Uncertain,6
10085,Vitamin D,C0042866,en_2371,AFFECTS,Immunologic function,C1268930,en_5445,2,1,AFFECTS,General/Uncertain,3
10086,Vitamin D,C0042866,en_2371,AUGMENTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,Excitatory,3
10087,Vitamin D,C0042866,en_2371,AUGMENTS,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,Excitatory,3
10088,Vitamin D,C0042866,en_2371,DISRUPTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Inhibitory,3
10089,Vitamin D,C0042866,en_2371,DISRUPTS,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Inhibitory,3
10090,Vitamin D,C0042866,en_2371,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
10091,Vitamin D,C0042866,en_2371,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
10092,Vitamin D,C0042866,en_2371,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
10093,Vitamin D,C0042866,en_2371,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
10094,Vitamin D,C0042866,en_2371,PREDISPOSES,Rickets,C0035579,en_2037,1,1,AFFECTS,Excitatory,3
10095,Vitamin D,C0042866,en_2371,PREDISPOSES,Vitamin D Deficiency,C0042870,en_2372,2,2,AFFECTS,Excitatory,6
10096,Vitamin D,C0042866,en_2371,PREDISPOSES,Viral upper respiratory tract infection,C0339916,en_3810,1,1,AFFECTS,Excitatory,3
10097,Vitamin D,C0042866,en_2371,PREVENTS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
10098,Vitamin D,C0042866,en_2371,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
10099,Vitamin D,C0042866,en_2371,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
10100,Vitamin D,C0042866,en_2371,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
10101,Vitamin D,C0042866,en_2371,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
10102,Vitamin D,C0042866,en_2371,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
10103,Vitamin D,C0042866,en_2371,PREVENTS,Virus Diseases,C0042769,en_2362,5,3,AFFECTS,Inhibitory,9
10104,Vitamin D,C0042866,en_2371,PREVENTS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
10105,Vitamin D,C0042866,en_2371,PREVENTS,Acute respiratory infection NOS,C0339901,en_3809,2,1,AFFECTS,Inhibitory,3
10106,Vitamin D,C0042866,en_2371,PREVENTS,Viral respiratory infection,C0729531,en_4763,3,2,AFFECTS,Inhibitory,6
10107,Vitamin D,C0042866,en_2371,TREATS,Adult,C0001675,en_252,6,2,AFFECTS,Inhibitory,6
10108,Vitamin D,C0042866,en_2371,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
10109,Vitamin D,C0042866,en_2371,TREATS,Ethnic group,C0015031,en_934,2,1,AFFECTS,Inhibitory,3
10110,Vitamin D,C0042866,en_2371,TREATS,Households,C0020052,en_1208,2,1,AFFECTS,Inhibitory,3
10111,Vitamin D,C0042866,en_2371,TREATS,Human,C0020114,en_1210,2,1,AFFECTS,Inhibitory,3
10112,Vitamin D,C0042866,en_2371,TREATS,Male population group,C0025266,en_1533,3,1,AFFECTS,Inhibitory,3
10113,Vitamin D,C0042866,en_2371,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
10114,Vitamin D,C0042866,en_2371,TREATS,Patients,C0030705,en_1762,31,10,AFFECTS,Inhibitory,30
10115,Vitamin D,C0042866,en_2371,TREATS,Woman,C0043210,en_2396,4,2,AFFECTS,Inhibitory,6
10116,Vitamin D,C0042866,en_2371,TREATS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
10117,Vitamin D,C0042866,en_2371,TREATS,Asymptomatic,C0231221,en_3252,1,1,AFFECTS,Inhibitory,3
10118,Vitamin D,C0042866,en_2371,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
10119,Vitamin D,C0042866,en_2371,TREATS,Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
10120,Vitamin D,C0042866,en_2371,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
10121,Vitamin D,C0042866,en_2371,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
10122,Vitamin D,C0042866,en_2371,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
10123,Vitamin D,C0042866,en_2371,TREATS(INFER),Obesity,C0028754,en_1699,2,1,AFFECTS,Inhibitory,3
10124,Vitamin D,C0042866,en_2371,TREATS(INFER),Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
10125,Vitamin D,C0042866,en_2371,TREATS(INFER),"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,2,1,AFFECTS,Inhibitory,3
10126,Vitamin D,C0042866,en_2371,TREATS(INFER),Overweight,C0497406,en_4165,2,1,AFFECTS,Inhibitory,3
10127,Vitamin D Deficiency,C0042870,en_2372,AFFECTS,Individual,C0237401,en_3343,3,1,AFFECTS,General/Uncertain,3
10128,Vitamin D Deficiency,C0042870,en_2372,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,6
10129,Vitamin D Deficiency,C0042870,en_2372,AFFECTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
10130,Vitamin D Deficiency,C0042870,en_2372,PREDISPOSES,Inflammation,C0021368,en_1307,3,1,AFFECTS,Excitatory,3
10131,Vitamin D Deficiency,C0042870,en_2372,PREDISPOSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
10132,Vitamin D Deficiency,C0042870,en_2372,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
10133,Vitamin D Deficiency,C0042870,en_2372,PREDISPOSES,Prognosis bad,C0278252,en_3600,2,1,AFFECTS,Excitatory,6
10134,Vitamin E,C0042874,en_2373,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
10135,Vitamin K,C0042878,en_2374,STIMULATES,Proteins,C0033684,en_1912,5,1,AFFECTS,Excitatory,3
10136,Vitamin K,C0042878,en_2374,STIMULATES,Prothrombin,C0033706,en_1914,2,1,AFFECTS,Excitatory,3
10137,Vitamin K,C0042878,en_2374,STIMULATES,matrix Gla protein,C0065752,en_2521,2,1,AFFECTS,Excitatory,3
10138,Vitamins,C0042890,en_2375,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
10139,Vitamins,C0042890,en_2375,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
10140,Vitamins,C0042890,en_2375,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,3
10141,Vitamins,C0042890,en_2375,TREATS,Patients,C0030705,en_1762,9,4,AFFECTS,Inhibitory,12
10142,Vitamins,C0042890,en_2375,TREATS,Harmonious caregiver-patient relationship,C0516944,en_4167,1,1,AFFECTS,Inhibitory,3
10143,Vitamins,C0042890,en_2375,TREATS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,8
10144,Vitrectomy,C0042903,en_2376,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
10145,Vitrectomy,C0042903,en_2376,TREATS,Postoperative endophthalmitis,C1282227,en_5473,1,1,AFFECTS,Inhibitory,3
10146,Voice,C0042939,en_2377,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
10147,Voice,C0042939,en_2377,AFFECTS,Earthquakes,C0013463,en_869,1,1,AFFECTS,General/Uncertain,3
10148,Voice,C0042939,en_2377,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
10149,Voice,C0042939,en_2377,AFFECTS,parent,C0030551,en_1750,1,1,AFFECTS,General/Uncertain,3
10150,Voice,C0042939,en_2377,AFFECTS,Stereotypic Movement Disorder,C0038273,en_2160,1,1,AFFECTS,General/Uncertain,3
10151,Voice,C0042939,en_2377,AFFECTS,Coaches,C0876909,en_5056,1,1,AFFECTS,General/Uncertain,3
10152,Voluntary Workers,C0042960,en_2380,PRODUCES,Masks,C0024861,en_1501,1,1,AFFECTS,Excitatory,3
10153,von Willebrand Factor,C0042971,en_2382,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10154,Warfarin,C0043031,en_2383,AFFECTS,anticoagulant activity,C1148561,en_5297,1,1,AFFECTS,General/Uncertain,3
10155,Warfarin,C0043031,en_2383,TREATS,Atrial Fibrillation,C0004238,en_423,3,1,AFFECTS,Inhibitory,6
10156,Warfarin,C0043031,en_2383,TREATS,Bioprosthetic,C4697772,en_6373,2,1,AFFECTS,Inhibitory,6
10157,Water,C0043047,en_2384,PREVENTS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,7
10158,Water,C0043047,en_2384,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
10159,Water,C0043047,en_2384,PREVENTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,7
10160,Water,C0043047,en_2384,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
10161,Weaning,C0043084,en_2386,AFFECTS,Cessation of life,C0011065,en_762,2,1,AFFECTS,General/Uncertain,3
10162,Weather,C0043085,en_2387,AFFECTS,Humidity,C0020167,en_1213,1,1,AFFECTS,General/Uncertain,3
10163,Body Weight decreased,C0043096,en_2389,PREDISPOSES,Weight Gain,C0043094,en_2388,1,1,AFFECTS,Excitatory,3
10164,WELL BABY VISIT,C0043108,en_2390,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
10165,Wellness Programs,C0043113,en_2391,TREATS,Refugees,C0034961,en_1987,2,1,AFFECTS,Inhibitory,3
10166,Wellness Programs,C0043113,en_2391,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,3
10167,Wellness Programs,C0043113,en_2391,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
10168,Whole-Body Irradiation,C0043162,en_2394,TREATS,Recurrent Head and Neck Cancer,C1335703,en_5619,1,1,AFFECTS,Inhibitory,7
10169,Work of Breathing,C0043229,en_2398,AFFECTS,Muscle function,C0231484,en_3260,1,1,AFFECTS,General/Uncertain,3
10170,World Health Organization,C0043237,en_2399,PRODUCES,Classification,C0008902,en_651,1,1,AFFECTS,Excitatory,3
10171,Wound Healing,C0043240,en_2400,AFFECTS,Age,C0001779,en_257,1,1,AFFECTS,General/Uncertain,3
10172,Wound Healing,C0043240,en_2400,AFFECTS,DNA Repair,C0012899,en_836,1,1,AFFECTS,General/Uncertain,3
10173,Wound Healing,C0043240,en_2400,AFFECTS,Immunity,C0020964,en_1273,3,2,AFFECTS,General/Uncertain,10
10174,Wound Healing,C0043240,en_2400,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
10175,Diagnostic radiologic examination,C0043299,en_2402,AFFECTS,follow-up,C1522577,en_5904,1,1,AFFECTS,General/Uncertain,6
10176,xanthine,C0043314,en_2403,TREATS(SPEC),"Hepatitis, Alcoholic",C0019187,en_1176,1,1,AFFECTS,Inhibitory,3
10177,Xanthine Oxidase,C0043317,en_2404,STIMULATES,TRANSCRIPTION FACTOR,C0040648,en_2264,1,1,AFFECTS,Excitatory,3
10178,Xylitol,C0043369,en_2406,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10179,Yutopar,C0043440,en_2408,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
10180,Yutopar,C0043440,en_2408,TREATS,DISEASES/DIAGNOSES,C0338067,en_3801,1,1,AFFECTS,Inhibitory,3
10181,Zinc,C0043481,en_2409,AFFECTS,Common Cold,C0009443,en_684,1,1,AFFECTS,General/Uncertain,3
10182,Zinc,C0043481,en_2409,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
10183,Zinc,C0043481,en_2409,AFFECTS,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,General/Uncertain,3
10184,Zinc,C0043481,en_2409,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
10185,Zinc,C0043481,en_2409,AUGMENTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Excitatory,3
10186,Zinc,C0043481,en_2409,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10187,Zinc,C0043481,en_2409,DISRUPTS,NODE,C0746922,en_4820,1,1,AFFECTS,Inhibitory,3
10188,Zinc,C0043481,en_2409,INHIBITS,RNA-Directed RNA Polymerase,C0035685,en_2042,1,1,AFFECTS,Inhibitory,3
10189,Zinc,C0043481,en_2409,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
10190,Zinc,C0043481,en_2409,TREATS,Patients,C0030705,en_1762,6,4,AFFECTS,Inhibitory,12
10191,Zinc,C0043481,en_2409,TREATS,Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,7
10192,Zinc,C0043481,en_2409,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
10193,Zinc,C0043481,en_2409,TREATS,High Risk Populations,C0870646,en_5008,4,2,AFFECTS,Inhibitory,6
10194,Zinc,C0043481,en_2409,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
10195,Zinc,C0043481,en_2409,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,6
10196,Zinc,C0043481,en_2409,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
10197,Zinc,C0043481,en_2409,TREATS,Sense of smell impaired,C2364082,en_6111,1,1,AFFECTS,Inhibitory,8
10198,Zinc,C0043481,en_2409,TREATS,Moderate severity,C4740652,en_6393,1,1,AFFECTS,Inhibitory,7
10199,Zinc,C0043481,en_2409,TREATS,COVID-19,C5203670,en_6417,8,5,AFFECTS,Inhibitory,37
10200,Zoonoses,C0043528,en_2410,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
10201,1-(1-(2-thienyl)cyclohexyl)piperidine,C0044091,en_2411,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
10202,1-(1-(2-thienyl)cyclohexyl)piperidine,C0044091,en_2411,INHIBITS,zoledronic acid,C0257685,en_3497,1,1,AFFECTS,Inhibitory,3
10203,1-(1-phenylcyclohexyl)pyrrolidine,C0044103,en_2412,AFFECTS,neutrophil,C0027950,en_1676,1,1,AFFECTS,General/Uncertain,3
10204,1-(1-phenylcyclohexyl)pyrrolidine,C0044103,en_2412,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10205,1-(1-phenylcyclohexyl)pyrrolidine,C0044103,en_2412,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
10206,1-(1-phenylcyclohexyl)pyrrolidine,C0044103,en_2412,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
10207,1-(1-phenylcyclohexyl)pyrrolidine,C0044103,en_2412,TREATS(INFER),Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
10208,"1-phenyl-3,3-dimethyltriazene",C0044588,en_2413,AFFECTS,Oxidation-Reduction,C0030012,en_1733,1,1,AFFECTS,General/Uncertain,3
10209,1-piperidinocyclohexanecarbonitrile,C0044609,en_2414,DISRUPTS,targeting,C0599894,en_4482,1,1,AFFECTS,Inhibitory,3
10210,15-Hydroxyprostaglandin dehydrogenase (NAD+),C0044894,en_2415,INHIBITS(SPEC),Dinoprostone,C0012472,en_818,1,1,AFFECTS,Inhibitory,3
10211,15-Hydroxyprostaglandin dehydrogenase (NAD+),C0044894,en_2415,STIMULATES,Dinoprostone,C0012472,en_818,1,1,AFFECTS,Excitatory,3
10212,"2,6-dinitrotoluene",C0045622,en_2416,AUGMENTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,Excitatory,3
10213,2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole,C0045724,en_2417,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
10214,2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole,C0045724,en_2417,STIMULATES,DMD,C1414083,en_31,1,1,AFFECTS,Excitatory,3
10215,2-toluenesulfonamide,C0046582,en_2418,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
10216,2-toluenesulfonamide,C0046582,en_2418,TREATS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Inhibitory,3
10217,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C0047123,en_2419,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
10218,4-aminoquinoline,C0048060,en_2420,TREATS,Rheumatism,C0035435,en_2028,1,1,AFFECTS,Inhibitory,3
10219,4-aminoquinoline,C0048060,en_2420,TREATS(SPEC),Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
10220,4-aminoquinoline,C0048060,en_2420,TREATS(SPEC),"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
10221,5-aza-2'-deoxycytidine,C0049065,en_2421,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
10222,5-aza-2'-deoxycytidine,C0049065,en_2421,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
10223,5-aza-2'-deoxycytidine,C0049065,en_2421,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
10224,5-aza-2'-deoxycytidine,C0049065,en_2421,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
10225,Acitretin,C0050559,en_2423,TREATS,Older Population,C1518563,en_5875,4,1,AFFECTS,Inhibitory,3
10226,lansoprazole,C0050940,en_2424,AFFECTS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,General/Uncertain,3
10227,lansoprazole,C0050940,en_2424,AFFECTS,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
10228,lansoprazole,C0050940,en_2424,TREATS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,3
10229,alpha-cyclodextrin,C0051348,en_2426,INHIBITS,Sphingolipids,C0037900,en_2142,1,1,AFFECTS,Inhibitory,6
10230,Amlodipine,C0051696,en_2427,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10231,Amlodipine,C0051696,en_2427,TREATS,Essential Hypertension,C0085580,en_2679,1,1,AFFECTS,Inhibitory,8
10232,Amlodipine,C0051696,en_2427,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
10233,Amphiregulin,C0051755,en_2428,AFFECTS,Wound Healing,C0043240,en_2400,2,2,AFFECTS,General/Uncertain,6
10234,Amphiregulin,C0051755,en_2428,AUGMENTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Excitatory,3
10235,Amphiregulin,C0051755,en_2428,AUGMENTS,Wound Healing,C0043240,en_2400,2,2,AFFECTS,Excitatory,6
10236,amsonic acid,C0051767,en_2429,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
10237,angiogenin,C0051844,en_2430,AFFECTS,Bone Marrow,C0005953,en_500,1,1,AFFECTS,General/Uncertain,3
10238,angiogenin,C0051844,en_2430,AFFECTS,Renin-Angiotensin System,C0035096,en_1996,1,1,AFFECTS,General/Uncertain,3
10239,angiogenin,C0051844,en_2430,AFFECTS,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,1,1,AFFECTS,General/Uncertain,3
10240,angiogenin,C0051844,en_2430,AFFECTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
10241,antileukoprotease,C0052059,en_2432,DISRUPTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Inhibitory,3
10242,apolipoprotein E-3,C0052199,en_2433,AFFECTS,Electromagnetic Energy,C0034519,en_1952,1,1,AFFECTS,General/Uncertain,3
10243,apolipoprotein E-4,C0052201,en_2434,AFFECTS,Vascular Permeability,C0162337,en_2906,1,1,AFFECTS,General/Uncertain,3
10244,apolipoprotein E-4,C0052201,en_2434,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
10245,apolipoprotein E-4,C0052201,en_2434,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
10246,artemisinine,C0052430,en_2435,TREATS,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
10247,artesunate,C0052432,en_2436,TREATS,Malaria,C0024530,en_1493,2,1,AFFECTS,Inhibitory,3
10248,artesunate,C0052432,en_2436,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
10249,Aryl Hydrocarbon Receptor,C0052441,en_2437,DISRUPTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,Inhibitory,3
10250,Aryl Hydrocarbon Receptor,C0052441,en_2437,INHIBITS,Interferon Regulatory Factor-7,C0666411,en_4531,2,1,AFFECTS,Inhibitory,3
10251,Azithromycin,C0052796,en_2439,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,8
10252,Azithromycin,C0052796,en_2439,AFFECTS,Cardiotoxicity,C0876994,en_5060,1,1,AFFECTS,General/Uncertain,6
10253,Azithromycin,C0052796,en_2439,AFFECTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,6
10254,Azithromycin,C0052796,en_2439,AFFECTS,Ventricular Repolarization,C3537202,en_6210,3,2,AFFECTS,General/Uncertain,9
10255,Azithromycin,C0052796,en_2439,AUGMENTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,Excitatory,3
10256,Azithromycin,C0052796,en_2439,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
10257,Azithromycin,C0052796,en_2439,PREDISPOSES,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Excitatory,3
10258,Azithromycin,C0052796,en_2439,PREVENTS,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Inhibitory,7
10259,Azithromycin,C0052796,en_2439,PREVENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
10260,Azithromycin,C0052796,en_2439,STIMULATES,Hydroxychloroquine,C0020336,en_1226,1,1,AFFECTS,Excitatory,7
10261,Azithromycin,C0052796,en_2439,STIMULATES,Duration,C2926735,en_6146,1,1,AFFECTS,Excitatory,6
10262,Azithromycin,C0052796,en_2439,TREATS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,8
10263,Azithromycin,C0052796,en_2439,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,9
10264,Azithromycin,C0052796,en_2439,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,8
10265,Azithromycin,C0052796,en_2439,TREATS,Escherichia coli,C0014834,en_929,1,1,AFFECTS,Inhibitory,8
10266,Azithromycin,C0052796,en_2439,TREATS,Fever,C0015967,en_985,2,1,AFFECTS,Inhibitory,8
10267,Azithromycin,C0052796,en_2439,TREATS,Outpatients,C0029921,en_1729,2,2,AFFECTS,Inhibitory,14
10268,Azithromycin,C0052796,en_2439,TREATS,Patients,C0030705,en_1762,32,19,AFFECTS,Inhibitory,57
10269,Azithromycin,C0052796,en_2439,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
10270,Azithromycin,C0052796,en_2439,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,8
10271,Azithromycin,C0052796,en_2439,TREATS,Vesicle,C0333262,en_3759,1,1,AFFECTS,Inhibitory,3
10272,Azithromycin,C0052796,en_2439,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
10273,Azithromycin,C0052796,en_2439,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,6
10274,Azithromycin,C0052796,en_2439,TREATS,Chronic lung disease,C0746102,en_4815,1,1,AFFECTS,Inhibitory,8
10275,Azithromycin,C0052796,en_2439,TREATS,Hospitalized Patients,C0870668,en_5010,12,9,AFFECTS,Inhibitory,49
10276,Azithromycin,C0052796,en_2439,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,6
10277,Azithromycin,C0052796,en_2439,TREATS,Symptoms,C1457887,en_5784,4,3,AFFECTS,Inhibitory,14
10278,Azithromycin,C0052796,en_2439,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
10279,Azithromycin,C0052796,en_2439,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,7
10280,Azithromycin,C0052796,en_2439,TREATS,COVID-19,C5203670,en_6417,30,20,AFFECTS,Inhibitory,136
10281,Azithromycin,C0052796,en_2439,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
10282,Azithromycin,C0052796,en_2439,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
10283,Azithromycin,C0052796,en_2439,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
10284,Azithromycin,C0052796,en_2439,TREATS(INFER),Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
10285,Azithromycin,C0052796,en_2439,TREATS(INFER),pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
10286,Azithromycin,C0052796,en_2439,TREATS(SPEC),Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
10287,bismuth oxychloride,C0053787,en_2441,INHIBITS,RNA,C0035668,en_2040,2,1,AFFECTS,Inhibitory,3
10288,bismuth subsalicylate,C0053792,en_2442,DISRUPTS,Growth,C0018270,en_1098,2,1,AFFECTS,Inhibitory,3
10289,bismuth subsalicylate,C0053792,en_2442,INHIBITS,RNA,C0035668,en_2040,2,1,AFFECTS,Inhibitory,3
10290,bismuth subsalicylate,C0053792,en_2442,TREATS,Diarrhea,C0011991,en_810,1,1,AFFECTS,Inhibitory,3
10291,Bone Morphogenetic Proteins,C0053932,en_2443,AFFECTS,epithelial to mesenchymal transition,C1523298,en_5910,1,1,AFFECTS,General/Uncertain,3
10292,boswellic acid,C0053959,en_2444,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
10293,boswellic acid,C0053959,en_2444,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
10294,boswellic acid,C0053959,en_2444,INHIBITS,Interleukins,C0021764,en_1345,1,1,AFFECTS,Inhibitory,3
10295,boswellic acid,C0053959,en_2444,INHIBITS,Tumor Necrosis Factors,C0041368,en_2300,1,1,AFFECTS,Inhibitory,3
10296,boswellic acid,C0053959,en_2444,INHIBITS,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Inhibitory,3
10297,boswellic acid,C0053959,en_2444,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
10298,Brain natriuretic peptide,C0054015,en_2445,INHIBITS,Blood oxygen pressure,C1291013,en_5490,1,1,AFFECTS,Inhibitory,6
10299,Brain natriuretic peptide,C0054015,en_2445,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,6
10300,Brain natriuretic peptide,C0054015,en_2445,STIMULATES,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Excitatory,6
10301,Brain natriuretic peptide,C0054015,en_2445,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10302,Brain natriuretic peptide,C0054015,en_2445,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
10303,Brain natriuretic peptide,C0054015,en_2445,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10304,brassinolide,C0054029,en_2447,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
10305,Amoxicillin-Potassium Clavulanate Combination,C0054066,en_2448,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
10306,Amoxicillin-Potassium Clavulanate Combination,C0054066,en_2448,TREATS,Acute bacterial sinusitis,C0275556,en_3569,1,1,AFFECTS,Inhibitory,8
10307,Budesonide,C0054201,en_2449,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
10308,Budesonide,C0054201,en_2449,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,8
10309,Budesonide,C0054201,en_2449,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,16
10310,Budesonide,C0054201,en_2449,TREATS,Sense of smell impaired,C2364082,en_6111,2,1,AFFECTS,Inhibitory,3
10311,Calcineurin,C0054450,en_2450,INHIBITS,Interleukin-2,C0021756,en_1337,1,1,AFFECTS,Inhibitory,3
10312,Calcineurin,C0054450,en_2450,INHIBITS,Interleukin 2 Receptor,C0034819,en_1974,1,1,AFFECTS,Inhibitory,3
10313,Calcineurin,C0054450,en_2450,INHIBITS,Cyclophilins,C0917877,en_5109,1,1,AFFECTS,Inhibitory,3
10314,Cathepsin G,C0054868,en_2451,AUGMENTS,Neutrophil production,C0312833,en_3736,1,1,AFFECTS,Excitatory,3
10315,Cathepsin L,C0054871,en_2452,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
10316,Cathepsin L,C0054871,en_2452,AFFECTS,Proteolysis,C0597304,en_4421,1,1,AFFECTS,General/Uncertain,3
10317,Cathepsin L,C0054871,en_2452,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
10318,cercosporin,C0055102,en_2453,AUGMENTS,cytotoxicity,C0596402,en_4385,1,1,AFFECTS,Excitatory,3
10319,Cetirizine,C0055147,en_2454,TREATS,Household composition,C0595998,en_4374,1,1,AFFECTS,Inhibitory,6
10320,chlorhexidine gluconate,C0055361,en_2455,PREVENTS,SARS coronavirus,C1175743,en_5384,1,1,AFFECTS,Inhibitory,3
10321,chlorine dioxide,C0055370,en_2456,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
10322,chlorine dioxide,C0055370,en_2456,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
10323,chloroquine diphosphate,C0055447,en_2457,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
10324,chloroquine diphosphate,C0055447,en_2457,TREATS,Collagen Diseases,C0009326,en_678,1,1,AFFECTS,Inhibitory,7
10325,chloroquine diphosphate,C0055447,en_2457,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
10326,chloroquine diphosphate,C0055447,en_2457,TREATS,Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,7
10327,chloroquine diphosphate,C0055447,en_2457,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
10328,chloroquine diphosphate,C0055447,en_2457,TREATS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
10329,chloroquine diphosphate,C0055447,en_2457,TREATS,Lupus Erythematosus,C0409974,en_3967,2,1,AFFECTS,Inhibitory,3
10330,chloroquine diphosphate,C0055447,en_2457,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
10331,chloroquine diphosphate,C0055447,en_2457,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
10332,chloroquine diphosphate,C0055447,en_2457,TREATS(INFER),Virus Diseases,C0042769,en_2362,3,1,AFFECTS,Inhibitory,3
10333,chloroquine diphosphate,C0055447,en_2457,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
10334,chloroquine diphosphate,C0055447,en_2457,TREATS(SPEC),Malaria,C0024530,en_1493,2,1,AFFECTS,Inhibitory,3
10335,Clarithromycin,C0055856,en_2460,TREATS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,7
10336,Clarithromycin,C0055856,en_2460,TREATS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,8
10337,Clarithromycin,C0055856,en_2460,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,8
10338,Clarithromycin,C0055856,en_2460,TREATS,Fever,C0015967,en_985,2,1,AFFECTS,Inhibitory,8
10339,Clarithromycin,C0055856,en_2460,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10340,Clarithromycin,C0055856,en_2460,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
10341,Clarithromycin,C0055856,en_2460,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
10342,complement C5a-inhibitors,C0056197,en_2461,INHIBITS,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Inhibitory,3
10343,"Receptors, Corticotropin-Releasing Hormone",C0056373,en_2462,AUGMENTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Excitatory,3
10344,"Cre recombinase, Enterobacteria phage P1",C0056467,en_2463,INHIBITS,peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase,C0671368,en_4539,1,1,AFFECTS,Inhibitory,3
10345,CXC chemokine IP-10,C0056978,en_2464,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
10346,CXC chemokine IP-10,C0056978,en_2464,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10347,defibrotide,C0057257,en_2465,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
10348,defibrotide,C0057257,en_2465,STIMULATES,Anticoagulants,C0003280,en_354,1,1,AFFECTS,Excitatory,3
10349,defibrotide,C0057257,en_2465,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
10350,defibrotide,C0057257,en_2465,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
10351,defibrotide,C0057257,en_2465,TREATS,Pulmonary Veno-Occlusive Disease,C0034091,en_1937,1,1,AFFECTS,Inhibitory,3
10352,defibrotide,C0057257,en_2465,TREATS,VENTILATOR DEPENDENT,C0750173,en_4840,1,1,AFFECTS,Inhibitory,3
10353,dexchlorpheniramine,C0057606,en_2466,TREATS,Household composition,C0595998,en_4374,1,1,AFFECTS,Inhibitory,6
10354,diacetylrhein,C0057678,en_2467,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
10355,diacetylrhein,C0057678,en_2467,INHIBITS,Interleukin-6,C0021760,en_1342,2,2,AFFECTS,Inhibitory,6
10356,diacetylrhein,C0057678,en_2467,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
10357,diacetylrhein,C0057678,en_2467,TREATS,Degenerative polyarthritis,C0029408,en_1723,2,2,AFFECTS,Inhibitory,6
10358,diacetylrhein,C0057678,en_2467,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
10359,diacetylrhein,C0057678,en_2467,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
10360,diacetylrhein,C0057678,en_2467,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
10361,diacetylrhein,C0057678,en_2467,TREATS,Inflammatory Response,C1155266,en_5321,4,3,AFFECTS,Inhibitory,9
10362,diacetylrhein,C0057678,en_2467,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
10363,Diamond,C0057717,en_2468,AUGMENTS,Electric field,C0337037,en_3791,1,1,AFFECTS,Excitatory,3
10364,iproplatin,C0057856,en_2469,AFFECTS,response,C0871261,en_5019,2,2,AFFECTS,General/Uncertain,6
10365,dihydroxyacetone sulfate,C0058129,en_2471,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
10366,dimethyl fumarate,C0058218,en_2472,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,7
10367,Dynamin,C0058836,en_2475,AFFECTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,General/Uncertain,3
10368,Dynamin,C0058836,en_2475,AUGMENTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,Excitatory,3
10369,Dynamin,C0058836,en_2475,AUGMENTS,Membrane Fusion,C0025246,en_1528,1,1,AFFECTS,Excitatory,3
10370,ebselen,C0058903,en_2476,STIMULATES,GPX1,C1415275,en_41,1,1,AFFECTS,Excitatory,3
10371,ebselen,C0058903,en_2476,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10372,eicosapentaenoic acid ethyl ester,C0058978,en_2477,PREVENTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Inhibitory,7
10373,eicosapentaenoic acid ethyl ester,C0058978,en_2477,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,7
10374,eicosapentaenoic acid ethyl ester,C0058978,en_2477,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,2,1,AFFECTS,Inhibitory,7
10375,annexin A5,C0059249,en_2478,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
10376,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,PREVENTS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
10377,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,TREATS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
10378,epigallocatechin gallate,C0059438,en_2481,AFFECTS(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
10379,epigallocatechin gallate,C0059438,en_2481,AUGMENTS(SPEC),T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
10380,fexinidazole,C0060304,en_2483,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
10381,fexinidazole,C0060304,en_2483,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
10382,fexinidazole,C0060304,en_2483,TREATS,African Trypanosomiasis,C0041228,en_2288,3,2,AFFECTS,Inhibitory,6
10383,fexinidazole,C0060304,en_2483,TREATS(INFER),African Trypanosomiasis,C0041228,en_2288,2,1,AFFECTS,Inhibitory,3
10384,Fibrin fragment D,C0060323,en_2484,AFFECTS,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,General/Uncertain,6
10385,Fibrin fragment D,C0060323,en_2484,AUGMENTS,Worse,C1457868,en_5783,1,1,AFFECTS,Excitatory,6
10386,Fibrin fragment D,C0060323,en_2484,DISRUPTS,Thrombus,C0087086,en_2743,1,1,AFFECTS,Inhibitory,6
10387,Fibrin fragment D,C0060323,en_2484,INHIBITS,Complement 3,C0009506,en_694,1,1,AFFECTS,Inhibitory,6
10388,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,6
10389,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,Disseminated Intravascular Coagulation,C0012739,en_829,1,1,AFFECTS,Excitatory,7
10390,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
10391,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,Pulmonary Embolism,C0034065,en_1930,2,2,AFFECTS,Excitatory,12
10392,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,Pulmonary thrombosis,C0151946,en_2875,1,1,AFFECTS,Excitatory,6
10393,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,6
10394,Fibrin fragment D,C0060323,en_2484,PREDISPOSES,Venous Thromboembolism,C1861172,en_6055,1,1,AFFECTS,Excitatory,6
10395,Fibrin fragment D,C0060323,en_2484,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
10396,Fibrin fragment D,C0060323,en_2484,STIMULATES,N(4)-oleylcytosine arabinoside,C0642228,en_4523,1,1,AFFECTS,Excitatory,6
10397,Fibrin fragment D,C0060323,en_2484,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
10398,Fibrin fragment D,C0060323,en_2484,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,6
10399,Fibrin fragment D,C0060323,en_2484,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
10400,Fibrin fragment D,C0060323,en_2484,STIMULATES,Thrombin,C0040018,en_2228,2,1,AFFECTS,Excitatory,3
10401,fisetin,C0060397,en_2486,AUGMENTS,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
10402,fisetin,C0060397,en_2486,DISRUPTS,Cessation of life,C0011065,en_762,2,1,AFFECTS,Inhibitory,3
10403,fisetin,C0060397,en_2486,INHIBITS,"TXN protein, human",C1504637,en_5790,1,1,AFFECTS,Inhibitory,3
10404,fisetin,C0060397,en_2486,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
10405,fisetin,C0060397,en_2486,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
10406,fisetin,C0060397,en_2486,TREATS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
10407,fisetin,C0060397,en_2486,TREATS(SPEC),Complication,C0009566,en_697,4,2,AFFECTS,Inhibitory,6
10408,Fludarabine phosphate,C0060483,en_2487,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10409,formoterol,C0060657,en_2488,PREVENTS,Asthma attack NOS,C0347950,en_3839,1,1,AFFECTS,Inhibitory,3
10410,formoterol,C0060657,en_2488,TREATS,Mild asthma,C0581124,en_4343,1,1,AFFECTS,Inhibitory,3
10411,formoterol,C0060657,en_2488,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
10412,FOY 305,C0060700,en_2489,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10413,Fumaric acid,C0060825,en_2490,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10414,Gastrin releasing peptide,C0061132,en_2491,DISRUPTS,Calcinosis,C0006663,en_535,1,1,AFFECTS,Inhibitory,3
10415,Glucagon-Like Peptide 1,C0061355,en_2492,AFFECTS,insulin secretion,C1256369,en_5399,2,1,AFFECTS,General/Uncertain,3
10416,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,PREVENTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Inhibitory,3
10417,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
10418,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,TREATS,Thrombus,C0087086,en_2743,1,1,AFFECTS,Inhibitory,3
10419,Glutamic Acid,C0061472,en_2494,STIMULATES,Formalin,C0949307,en_5178,1,1,AFFECTS,Excitatory,3
10420,Glycocalyx,C0061622,en_2497,PRODUCES,Polysaccharides,C0032594,en_1850,2,1,AFFECTS,Excitatory,3
10421,granzyme B,C0061878,en_2498,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
10422,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
10423,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Cicatrix,C0008767,en_645,1,1,AFFECTS,General/Uncertain,3
10424,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
10425,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
10426,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
10427,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
10428,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
10429,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
10430,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
10431,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,Gaseousness,C0859980,en_4987,1,1,AFFECTS,General/Uncertain,3
10432,GTPase-Activating Proteins,C0061928,en_2499,AFFECTS,viral transmission,C1160716,en_5362,1,1,AFFECTS,General/Uncertain,3
10433,GTPase-Activating Proteins,C0061928,en_2499,AUGMENTS,Decision Making,C0011109,en_765,1,1,AFFECTS,Excitatory,3
10434,GTPase-Activating Proteins,C0061928,en_2499,AUGMENTS,Learning,C0023185,en_1404,2,2,AFFECTS,Excitatory,6
10435,GTPase-Activating Proteins,C0061928,en_2499,AUGMENTS,Animal tissue,C0229982,en_3245,1,1,AFFECTS,Excitatory,3
10436,GTPase-Activating Proteins,C0061928,en_2499,AUGMENTS,Homelessness,C0237154,en_3342,1,1,AFFECTS,Excitatory,3
10437,GTPase-Activating Proteins,C0061928,en_2499,AUGMENTS,Self-confidence,C0237529,en_3348,1,1,AFFECTS,Excitatory,3
10438,GTPase-Activating Proteins,C0061928,en_2499,AUGMENTS,experience,C0596545,en_4391,1,1,AFFECTS,Excitatory,3
10439,GTPase-Activating Proteins,C0061928,en_2499,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10440,GTPase-Activating Proteins,C0061928,en_2499,PRODUCES,"RNA, Viral",C0035736,en_2048,1,1,AFFECTS,Excitatory,3
10441,GTPase-Activating Proteins,C0061928,en_2499,STIMULATES,Microglia,C0206116,en_3147,1,1,AFFECTS,Excitatory,3
10442,Heparan Sulfate Proteoglycan,C0062503,en_2500,AFFECTS,Virion,C0042760,en_2360,2,1,AFFECTS,General/Uncertain,3
10443,Heparan Sulfate Proteoglycan,C0062503,en_2500,AUGMENTS,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
10444,Heparan Sulfate Proteoglycan,C0062503,en_2500,AUGMENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
10445,Heparan Sulfate Proteoglycan,C0062503,en_2500,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10446,Hepatitis B Vaccines,C0062527,en_2501,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
10447,leflunomide,C0063041,en_2502,AUGMENTS,Liver function,C0232741,en_3284,1,1,AFFECTS,Excitatory,3
10448,leflunomide,C0063041,en_2502,INHIBITS,Pyrimidine,C0034284,en_1942,1,1,AFFECTS,Inhibitory,3
10449,leflunomide,C0063041,en_2502,INHIBITS,RNA,C0035668,en_2040,2,1,AFFECTS,Inhibitory,3
10450,leflunomide,C0063041,en_2502,INHIBITS,Dihydroorotate dehydrogenase,C0058099,en_2470,2,1,AFFECTS,Inhibitory,3
10451,leflunomide,C0063041,en_2502,INHIBITS,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Inhibitory,3
10452,leflunomide,C0063041,en_2502,TREATS,Rheumatoid Arthritis,C0003873,en_402,2,1,AFFECTS,Inhibitory,3
10453,leflunomide,C0063041,en_2502,TREATS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,8
10454,leflunomide,C0063041,en_2502,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
10455,leflunomide,C0063041,en_2502,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
10456,leflunomide,C0063041,en_2502,TREATS,Unmarried person,C0037179,en_2111,2,1,AFFECTS,Inhibitory,3
10457,leflunomide,C0063041,en_2502,TREATS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
10458,leflunomide,C0063041,en_2502,TREATS,Favorable Clinical Outcome,C1333602,en_5594,1,1,AFFECTS,Inhibitory,3
10459,leflunomide,C0063041,en_2502,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
10460,leflunomide,C0063041,en_2502,TREATS(SPEC),Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
10461,Hydroxyl Radical,C0063146,en_2503,AFFECTS,Protoplasm,C0175996,en_2976,1,1,AFFECTS,General/Uncertain,3
10462,hypromellose,C0063242,en_2504,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10463,ifenprodil,C0063340,en_2505,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
10464,Intercellular adhesion molecule 1,C0063695,en_2507,STIMULATES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
10465,Interleukin 6 Receptor,C0063717,en_2510,INHIBITS,tocilizumab,C1609165,en_6003,1,1,AFFECTS,Inhibitory,7
10466,Interleukin 6 Receptor,C0063717,en_2510,STIMULATES,CD163,C1413204,en_99,1,1,AFFECTS,Excitatory,6
10467,Interleukin 6 Receptor,C0063717,en_2510,DISRUPTS,mast cell,C0024880,en_1504,1,1,AFFECTS,Inhibitory,3
10468,Interleukin 6 Receptor,C0063717,en_2510,DISRUPTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,Inhibitory,3
10469,Interleukin 6 Receptor,C0063717,en_2510,INHIBITS,ACE2,C1422064,en_5723,2,2,AFFECTS,Inhibitory,6
10470,isoquercitrin,C0064071,en_2511,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
10471,Itraconazole,C0064113,en_2512,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
10472,Itraconazole,C0064113,en_2512,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
10473,latrunculin B,C0064678,en_2514,DISRUPTS,actin cytoskeleton,C1166758,en_5367,1,1,AFFECTS,Inhibitory,3
10474,Leukocyte Elastase,C0064833,en_2515,AFFECTS,Phagocytosis,C0031308,en_1785,1,1,AFFECTS,General/Uncertain,3
10475,Leukocyte Elastase,C0064833,en_2515,AFFECTS,elastase activity,C1323717,en_5547,1,1,AFFECTS,General/Uncertain,3
10476,Leukocyte Elastase,C0064833,en_2515,AFFECTS,Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,General/Uncertain,3
10477,Leukocyte Elastase,C0064833,en_2515,AUGMENTS,Neutrophil production,C0312833,en_3736,1,1,AFFECTS,Excitatory,3
10478,Leukocyte Elastase,C0064833,en_2515,DISRUPTS,Tissue neutrophil,C0229611,en_3243,1,1,AFFECTS,Inhibitory,3
10479,Leukocyte Elastase,C0064833,en_2515,INHIBITS,ELK3 gene,C0812375,en_4900,1,1,AFFECTS,Inhibitory,3
10480,Leukocyte Elastase,C0064833,en_2515,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
10481,Leukocyte Elastase,C0064833,en_2515,PRODUCES,Proteins,C0033684,en_1912,1,1,AFFECTS,Excitatory,3
10482,Listerine,C0065081,en_2516,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10483,Loratadine,C0065180,en_2517,TREATS,Household composition,C0595998,en_4374,1,1,AFFECTS,Inhibitory,6
10484,Luteolin,C0065264,en_2518,TREATS,cohort,C0599755,en_4470,2,1,AFFECTS,Inhibitory,3
10485,zaprinast,C0065432,en_2519,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
10486,Mannose-Binding Lectins,C0065693,en_2520,AUGMENTS,anterograde transport,C0598952,en_4458,1,1,AFFECTS,Excitatory,3
10487,"nucleoprotein, Measles virus",C0065827,en_2522,STIMULATES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,8
10488,mitomycin C-dextran,C0066610,en_2524,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10489,mometasone furoate,C0066700,en_2525,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,8
10490,monoferrous acid citrate,C0066752,en_2526,AUGMENTS,heme metabolism,C1158226,en_5336,1,1,AFFECTS,Excitatory,3
10491,monoferrous acid citrate,C0066752,en_2526,STIMULATES,Heme,C0018966,en_1154,1,1,AFFECTS,Excitatory,3
10492,Proteinase 3,C0067033,en_2527,AUGMENTS,Neutrophil production,C0312833,en_3736,1,1,AFFECTS,Excitatory,3
10493,Glutamate Carboxypeptidase II,C0067685,en_2528,INHIBITS,Glutamates,C0017789,en_1074,1,1,AFFECTS,Inhibitory,3
10494,NADPH Oxidase,C0068355,en_2529,PRODUCES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,3
10495,NADPH Oxidase,C0068355,en_2529,PRODUCES,Peroxynitrite,C0136157,en_2785,1,1,AFFECTS,Excitatory,3
10496,nalmefene,C0068377,en_2530,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
10497,nalmefene,C0068377,en_2530,TREATS(SPEC),alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
10498,Nicorandil,C0068700,en_2531,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
10499,Nicorandil,C0068700,en_2531,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
10500,nicotinamide-beta-riboside,C0068711,en_2532,AFFECTS,Oxidation-Reduction,C0030012,en_1733,1,1,AFFECTS,General/Uncertain,3
10501,nicotinamide-beta-riboside,C0068711,en_2532,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
10502,nitazoxanide,C0068788,en_2533,DISRUPTS,glycosylation,C0017982,en_1086,1,1,AFFECTS,Inhibitory,3
10503,nitazoxanide,C0068788,en_2533,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10504,nitazoxanide,C0068788,en_2533,DISRUPTS,Protoplasm,C0175996,en_2976,1,1,AFFECTS,Inhibitory,3
10505,nitazoxanide,C0068788,en_2533,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
10506,nitazoxanide,C0068788,en_2533,TREATS,Diarrhea,C0011991,en_810,2,1,AFFECTS,Inhibitory,3
10507,nitazoxanide,C0068788,en_2533,TREATS,Disease,C0012634,en_826,3,2,AFFECTS,Inhibitory,6
10508,nitazoxanide,C0068788,en_2533,TREATS,Influenza,C0021400,en_1311,2,2,AFFECTS,Inhibitory,6
10509,nitazoxanide,C0068788,en_2533,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
10510,nitazoxanide,C0068788,en_2533,TREATS,Patients,C0030705,en_1762,9,3,AFFECTS,Inhibitory,9
10511,nitazoxanide,C0068788,en_2533,TREATS,risk factors,C0035648,en_2039,1,1,AFFECTS,Inhibitory,7
10512,nitazoxanide,C0068788,en_2533,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
10513,nitazoxanide,C0068788,en_2533,TREATS,Hospitalized Patients,C0870668,en_5010,8,3,AFFECTS,Inhibitory,9
10514,nitazoxanide,C0068788,en_2533,TREATS,Healthy Volunteers,C1708335,en_6036,1,1,AFFECTS,Inhibitory,7
10515,nitazoxanide,C0068788,en_2533,TREATS,Mild disease,C4740690,en_6394,1,1,AFFECTS,Inhibitory,8
10516,nitazoxanide,C0068788,en_2533,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
10517,nitazoxanide,C0068788,en_2533,TREATS(INFER),HIV Infections,C0019693,en_1192,2,1,AFFECTS,Inhibitory,3
10518,nitazoxanide,C0068788,en_2533,TREATS(INFER),Influenza,C0021400,en_1311,2,1,AFFECTS,Inhibitory,3
10519,nitazoxanide,C0068788,en_2533,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
10520,nitazoxanide,C0068788,en_2533,TREATS(SPEC),Influenza,C0021400,en_1311,2,2,AFFECTS,Inhibitory,6
10521,nitazoxanide,C0068788,en_2533,TREATS(SPEC),Viral respiratory infection,C0729531,en_4763,2,2,AFFECTS,Inhibitory,6
10522,Org 10172,C0069610,en_2534,TREATS,"Stroke, Acute",C0751956,en_4854,1,1,AFFECTS,Inhibitory,6
10523,ovomacroglobulin,C0069696,en_2535,INHIBITS,Papain,C0030346,en_1746,1,1,AFFECTS,Inhibitory,3
10524,oxysterol binding protein,C0069838,en_2536,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
10525,oxysterol binding protein,C0069838,en_2536,INHIBITS,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Inhibitory,3
10526,palmidrol,C0069964,en_2537,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
10527,palmidrol,C0069964,en_2537,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
10528,palmidrol,C0069964,en_2537,TREATS,cohort,C0599755,en_4470,2,1,AFFECTS,Inhibitory,3
10529,Paroxetine,C0070122,en_2539,AUGMENTS,Cerebral Aneurysm,C0917996,en_5111,2,1,AFFECTS,Excitatory,3
10530,Paroxetine,C0070122,en_2539,TREATS,Depressive disorder,C0011581,en_788,2,2,AFFECTS,Inhibitory,6
10531,Paroxetine,C0070122,en_2539,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10532,clopidogrel,C0070166,en_2540,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10533,clopidogrel,C0070166,en_2540,TREATS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Inhibitory,3
10534,phenylmethylpyrazolone,C0070694,en_2542,TREATS,Amyotrophic Lateral Sclerosis,C0002736,en_310,2,1,AFFECTS,Inhibitory,3
10535,phenylmethylpyrazolone,C0070694,en_2542,TREATS(SPEC),Amyotrophic Lateral Sclerosis,C0002736,en_310,2,1,AFFECTS,Inhibitory,3
10536,pioglitazone,C0071097,en_2543,INHIBITS,Glucose,C0017725,en_1072,2,1,AFFECTS,Inhibitory,3
10537,pioglitazone,C0071097,en_2543,PREVENTS,Chronic inflammation,C0021376,en_1309,2,1,AFFECTS,Inhibitory,3
10538,pioglitazone,C0071097,en_2543,STIMULATES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
10539,pioglitazone,C0071097,en_2543,STIMULATES,Anti-Inflammatory Agents,C0003209,en_342,2,1,AFFECTS,Excitatory,3
10540,pioglitazone,C0071097,en_2543,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Inhibitory,3
10541,pioglitazone,C0071097,en_2543,TREATS,Patients,C0030705,en_1762,5,2,AFFECTS,Inhibitory,6
10542,pioglitazone,C0071097,en_2543,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
10543,pioglitazone,C0071097,en_2543,TREATS,RNA Viruses,C0035691,en_2044,2,1,AFFECTS,Inhibitory,3
10544,pioglitazone,C0071097,en_2543,TREATS(INFER),Fatty Liver,C0015695,en_973,1,1,AFFECTS,Inhibitory,3
10545,piperaquine,C0071105,en_2544,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
10546,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
10547,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,AFFECTS,Kidney,C0022646,en_1380,2,1,AFFECTS,General/Uncertain,3
10548,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,AUGMENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
10549,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,PREDISPOSES,Complication,C0009566,en_697,3,1,AFFECTS,Excitatory,3
10550,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,PREDISPOSES,Abnormal renal function,C0151746,en_2866,1,1,AFFECTS,Excitatory,3
10551,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
10552,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,PREDISPOSES,Neoplasm progression,C0178874,en_2992,2,1,AFFECTS,Excitatory,3
10553,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,STIMULATES,Guanosine Triphosphate Phosphohydrolases,C0018296,en_1101,1,1,AFFECTS,Excitatory,3
10554,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,STIMULATES,Integrins,C0021701,en_1328,1,1,AFFECTS,Excitatory,3
10555,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,STIMULATES,Kininogenase,C0022478,en_1374,1,1,AFFECTS,Excitatory,3
10556,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,STIMULATES,Urokinase,C0042071,en_2323,4,1,AFFECTS,Excitatory,3
10557,polyphenols,C0071649,en_2546,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
10558,polyphenols,C0071649,en_2546,DISRUPTS,Inflammation,C0021368,en_1307,3,1,AFFECTS,Inhibitory,3
10559,procalcitonin,C0072027,en_2547,INHIBITS,Oxygen,C0030054,en_1736,1,1,AFFECTS,Inhibitory,6
10560,procalcitonin,C0072027,en_2547,INHIBITS,Duration,C2926735,en_6146,2,1,AFFECTS,Inhibitory,8
10561,procalcitonin,C0072027,en_2547,PREDISPOSES,Disseminated Intravascular Coagulation,C0012739,en_829,1,1,AFFECTS,Excitatory,6
10562,procalcitonin,C0072027,en_2547,PREDISPOSES,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,Excitatory,6
10563,procalcitonin,C0072027,en_2547,INHIBITS,Antibiotics,C0003232,en_344,3,2,AFFECTS,Inhibitory,6
10564,procalcitonin,C0072027,en_2547,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
10565,Prorenin,C0072249,en_2548,AUGMENTS,Escape,C0870509,en_5004,1,1,AFFECTS,Excitatory,3
10566,Prorenin,C0072249,en_2548,PREDISPOSES,Diabetic complications,C0271672,en_3556,2,1,AFFECTS,Excitatory,3
10567,Protein S,C0072393,en_2550,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
10568,Protein-Serine-Threonine Kinases,C0072402,en_2551,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
10569,protoporphyrin IX,C0072497,en_2552,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
10570,pyronaridine,C0072768,en_2553,AFFECTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,General/Uncertain,3
10571,Ramipril,C0072973,en_2555,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,7
10572,RANTES,C0072978,en_2556,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10573,Sirolimus (substance),C0072980,en_2557,INHIBITS,"FRAP1 protein, human",C1307407,en_5524,1,1,AFFECTS,Inhibitory,3
10574,Sirolimus (substance),C0072980,en_2557,PREVENTS(SPEC),organ rejection,C0815080,en_4921,1,1,AFFECTS,Inhibitory,3
10575,resveratrol,C0073096,en_2558,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
10576,ribosomal protein S19,C0073320,en_2560,INHIBITS,Creatinine,C0010294,en_730,1,1,AFFECTS,Inhibitory,3
10577,ribosomal protein S19,C0073320,en_2560,INHIBITS,Migration Inhibitory Factor,C0024429,en_1483,1,1,AFFECTS,Inhibitory,3
10578,ribosomal protein S19,C0073320,en_2560,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
10579,rifaximin,C0073374,en_2561,AFFECTS,host,C1167395,en_5368,1,1,AFFECTS,General/Uncertain,3
10580,rifaximin,C0073374,en_2561,TREATS(SPEC),Hepatic Encephalopathy,C0019151,en_1170,1,1,AFFECTS,Inhibitory,3
10581,Riluzole,C0073379,en_2562,TREATS,Amyotrophic Lateral Sclerosis,C0002736,en_310,2,1,AFFECTS,Inhibitory,3
10582,Riluzole,C0073379,en_2562,TREATS(SPEC),Amyotrophic Lateral Sclerosis,C0002736,en_310,2,1,AFFECTS,Inhibitory,3
10583,Risperidone,C0073393,en_2563,DISRUPTS,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Inhibitory,3
10584,Risperidone,C0073393,en_2563,DISRUPTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
10585,Risperidone,C0073393,en_2563,INHIBITS,Fever,C0015967,en_985,3,1,AFFECTS,Inhibitory,3
10586,RNA primers,C0073429,en_2564,AFFECTS,Replication Initiation,C1155650,en_5324,1,1,AFFECTS,General/Uncertain,3
10587,"RNA, circular",C0073432,en_2565,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10588,bucillamine,C0073917,en_2566,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10589,Salazopyrine,C0073966,en_2567,INHIBITS,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Inhibitory,3
10590,sevoflurane,C0074414,en_2569,AFFECTS,Alveolar ventilation function,C0231940,en_3269,2,1,AFFECTS,General/Uncertain,3
10591,sevoflurane,C0074414,en_2569,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,3
10592,sevoflurane,C0074414,en_2569,AUGMENTS,Vascular constriction (function),C0042396,en_2340,1,1,AFFECTS,Excitatory,3
10593,sevoflurane,C0074414,en_2569,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
10594,sevoflurane,C0074414,en_2569,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,2,AFFECTS,Inhibitory,6
10595,Simvastatin,C0074554,en_2570,AUGMENTS,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,Excitatory,3
10596,Simvastatin,C0074554,en_2570,DISRUPTS,uptake,C0243144,en_3467,2,1,AFFECTS,Inhibitory,3
10597,Simvastatin,C0074554,en_2570,DISRUPTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Inhibitory,3
10598,Simvastatin,C0074554,en_2570,DISRUPTS,Antiinflammatory Effect,C1516019,en_5851,1,1,AFFECTS,Inhibitory,3
10599,Simvastatin,C0074554,en_2570,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
10600,Singlet Oxygen,C0074565,en_2571,AUGMENTS,Phosphorescence,C0031694,en_1798,1,1,AFFECTS,Excitatory,3
10601,sodium thiosulfate,C0074774,en_2572,INHIBITS,Pharmaceutical Preparations,C0013227,en_856,1,1,AFFECTS,Inhibitory,3
10602,sodium thiosulfate,C0074774,en_2572,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
10603,Insulin-Like Growth-Factor-Binding Proteins,C0074825,en_2573,PREVENTS,Diabetic Nephropathy,C0011881,en_802,1,1,AFFECTS,Inhibitory,3
10604,Soy Proteins,C0074926,en_2574,DISRUPTS,Dependence,C0439857,en_4039,1,1,AFFECTS,Inhibitory,3
10605,tetrandrine,C0076316,en_2575,PREVENTS,Pulmonary Fibrosis,C0034069,en_1932,3,1,AFFECTS,Inhibitory,3
10606,tetraphenylporphine,C0076327,en_2576,PREVENTS,HIV Infections,C0019693,en_1192,3,1,AFFECTS,Inhibitory,3
10607,titanium dioxide,C0076733,en_2577,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
10608,Tolerogen,C0076797,en_2578,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
10609,Tolerogen,C0076797,en_2578,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
10610,triethylamine,C0077096,en_2579,INHIBITS,acetonitrile,C0050456,en_2422,1,1,AFFECTS,Inhibitory,3
10611,Troponin T,C0077404,en_2580,PREDISPOSES,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,Excitatory,6
10612,Troponin T,C0077404,en_2580,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,7
10613,Troponin T,C0077404,en_2580,AFFECTS,Heart,C0018787,en_1130,1,1,AFFECTS,General/Uncertain,3
10614,Tumor Necrosis Factor Receptor,C0077503,en_2581,AFFECTS,Organ,C0178784,en_2991,1,1,AFFECTS,General/Uncertain,6
10615,Tumor Necrosis Factor Receptor|TNF,C0077503|7124,en_2582,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
10616,ubiquitin-protein ligase,C0077678,en_2583,AFFECTS,Ubiquitination,C1519751,en_5891,2,2,AFFECTS,General/Uncertain,6
10617,ubiquitin-protein ligase,C0077678,en_2583,STIMULATES,TRANSCRIPTION FACTOR,C0040648,en_2264,1,1,AFFECTS,Excitatory,3
10618,Vascular Cell Adhesion Molecule-1,C0078056,en_2585,STIMULATES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
10619,Vascular Cell Adhesion Molecule-1,C0078056,en_2585,STIMULATES,"NOS3 protein, human",C0669365,en_4534,1,1,AFFECTS,Excitatory,3
10620,Vasopressin Receptor,C0078077,en_2586,AFFECTS,Endolymphatic Hydrops,C0206586,en_3170,1,1,AFFECTS,General/Uncertain,3
10621,VBM protocol,C0078140,en_2587,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
10622,daunorubicin/prednisone/vincristine protocol,C0078144,en_2588,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10623,Zinc Sulfate,C0078794,en_2589,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
10624,Zinc Sulfate,C0078794,en_2589,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10625,"Atrial Function, Left",C0078995,en_2590,AFFECTS,Cardiac dilatation NOS,C0264732,en_3539,1,1,AFFECTS,General/Uncertain,3
10626,Contact Tracing,C0079161,en_2592,PREVENTS,Infectious transmissions,C0947878,en_5157,1,1,AFFECTS,Inhibitory,3
10627,Contact Tracing,C0079161,en_2592,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
10628,Contact Tracing,C0079161,en_2592,TREATS,Health Personnel,C0018724,en_1121,2,2,AFFECTS,Inhibitory,6
10629,Contact Tracing,C0079161,en_2592,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
10630,Contact Tracing,C0079161,en_2592,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
10631,Contact Tracing,C0079161,en_2592,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,3
10632,cytokine,C0079189,en_2593,AFFECTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
10633,cytokine,C0079189,en_2593,AFFECTS,Blood,C0005767,en_482,1,1,AFFECTS,General/Uncertain,3
10634,cytokine,C0079189,en_2593,AFFECTS,Brain,C0006104,en_508,1,1,AFFECTS,General/Uncertain,3
10635,cytokine,C0079189,en_2593,AFFECTS,Cell Communication,C0007582,en_585,1,1,AFFECTS,General/Uncertain,3
10636,cytokine,C0079189,en_2593,AFFECTS,Cell Growth,C0007595,en_590,1,1,AFFECTS,General/Uncertain,3
10637,cytokine,C0079189,en_2593,AFFECTS,Complication,C0009566,en_697,2,1,AFFECTS,General/Uncertain,3
10638,cytokine,C0079189,en_2593,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
10639,cytokine,C0079189,en_2593,AFFECTS,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,9
10640,cytokine,C0079189,en_2593,AFFECTS,Male Genital Organs,C0017422,en_1058,1,1,AFFECTS,General/Uncertain,3
10641,cytokine,C0079189,en_2593,AFFECTS,Hematopoiesis,C0018951,en_1152,1,1,AFFECTS,General/Uncertain,3
10642,cytokine,C0079189,en_2593,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
10643,cytokine,C0079189,en_2593,AFFECTS,Immunity,C0020964,en_1273,6,3,AFFECTS,General/Uncertain,9
10644,cytokine,C0079189,en_2593,AFFECTS,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,General/Uncertain,3
10645,cytokine,C0079189,en_2593,AFFECTS,Inflammation,C0021368,en_1307,10,4,AFFECTS,General/Uncertain,12
10646,cytokine,C0079189,en_2593,AFFECTS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,General/Uncertain,3
10647,cytokine,C0079189,en_2593,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
10648,cytokine,C0079189,en_2593,AFFECTS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
10649,cytokine,C0079189,en_2593,AFFECTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,General/Uncertain,3
10650,cytokine,C0079189,en_2593,AFFECTS,"Polymorphism, Genetic",C0032529,en_1849,1,1,AFFECTS,General/Uncertain,3
10651,cytokine,C0079189,en_2593,AFFECTS,Respiration,C0035203,en_2004,2,2,AFFECTS,General/Uncertain,6
10652,cytokine,C0079189,en_2593,AFFECTS,Spermatogenesis,C0037864,en_2139,1,1,AFFECTS,General/Uncertain,3
10653,cytokine,C0079189,en_2593,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
10654,cytokine,C0079189,en_2593,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
10655,cytokine,C0079189,en_2593,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
10656,cytokine,C0079189,en_2593,AFFECTS,Injury,C0175677,en_2968,2,1,AFFECTS,General/Uncertain,3
10657,cytokine,C0079189,en_2593,AFFECTS,Organ,C0178784,en_2991,3,2,AFFECTS,General/Uncertain,6
10658,cytokine,C0079189,en_2593,AFFECTS,Acute Lung Injury,C0242488,en_3416,2,1,AFFECTS,General/Uncertain,3
10659,cytokine,C0079189,en_2593,AFFECTS,Immune response,C0301872,en_3696,3,3,AFFECTS,General/Uncertain,9
10660,cytokine,C0079189,en_2593,AFFECTS,Acute inflammation,C0333361,en_3763,1,1,AFFECTS,General/Uncertain,3
10661,cytokine,C0079189,en_2593,AFFECTS,Hyperactive behavior,C0424295,en_3992,1,1,AFFECTS,General/Uncertain,3
10662,cytokine,C0079189,en_2593,AFFECTS,iron metabolism,C0596803,en_4396,1,1,AFFECTS,General/Uncertain,6
10663,cytokine,C0079189,en_2593,AFFECTS,testicular function,C0678881,en_4579,1,1,AFFECTS,General/Uncertain,3
10664,cytokine,C0079189,en_2593,AFFECTS,Immunoregulation,C0678889,en_4580,2,1,AFFECTS,General/Uncertain,3
10665,cytokine,C0079189,en_2593,AFFECTS,Structure of parenchyma of lung,C0819757,en_4926,1,1,AFFECTS,General/Uncertain,3
10666,cytokine,C0079189,en_2593,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
10667,cytokine,C0079189,en_2593,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
10668,cytokine,C0079189,en_2593,AFFECTS,Alveolar,C1440080,en_5730,1,1,AFFECTS,General/Uncertain,3
10669,cytokine,C0079189,en_2593,AFFECTS,Inflammation Process,C1512753,en_5825,2,2,AFFECTS,General/Uncertain,6
10670,cytokine,C0079189,en_2593,AUGMENTS,Exocytosis,C0015283,en_943,1,1,AFFECTS,Excitatory,3
10671,cytokine,C0079189,en_2593,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
10672,cytokine,C0079189,en_2593,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
10673,cytokine,C0079189,en_2593,AUGMENTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,Excitatory,3
10674,cytokine,C0079189,en_2593,AUGMENTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Excitatory,3
10675,cytokine,C0079189,en_2593,AUGMENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
10676,cytokine,C0079189,en_2593,AUGMENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,3
10677,cytokine,C0079189,en_2593,AUGMENTS,Inflammation Process,C1512753,en_5825,2,2,AFFECTS,Excitatory,6
10678,cytokine,C0079189,en_2593,AUGMENTS,type 2 immune response,C3159116,en_6176,1,1,AFFECTS,Excitatory,7
10679,cytokine,C0079189,en_2593,DISRUPTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Inhibitory,3
10680,cytokine,C0079189,en_2593,DISRUPTS,Blood,C0005767,en_482,2,2,AFFECTS,Inhibitory,6
10681,cytokine,C0079189,en_2593,DISRUPTS,Inflammation,C0021368,en_1307,4,2,AFFECTS,Inhibitory,6
10682,cytokine,C0079189,en_2593,DISRUPTS,Lymphocyte,C0024264,en_1469,1,1,AFFECTS,Inhibitory,3
10683,cytokine,C0079189,en_2593,DISRUPTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Inhibitory,3
10684,cytokine,C0079189,en_2593,DISRUPTS,Structure of parenchyma of lung,C0819757,en_4926,1,1,AFFECTS,Inhibitory,3
10685,cytokine,C0079189,en_2593,INHIBITS,TNFSF13B,C1420816,en_109,1,1,AFFECTS,Inhibitory,3
10686,cytokine,C0079189,en_2593,INHIBITS,Genes,C0017337,en_1052,1,1,AFFECTS,Inhibitory,3
10687,cytokine,C0079189,en_2593,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
10688,cytokine,C0079189,en_2593,INHIBITS,Interleukin-6,C0021760,en_1342,4,3,AFFECTS,Inhibitory,9
10689,cytokine,C0079189,en_2593,INHIBITS,Interleukins,C0021764,en_1345,1,1,AFFECTS,Inhibitory,3
10690,cytokine,C0079189,en_2593,INHIBITS,Protein C,C0033621,en_1908,1,1,AFFECTS,Inhibitory,3
10691,cytokine,C0079189,en_2593,INHIBITS,metalloenzyme,C0596918,en_4402,2,1,AFFECTS,Inhibitory,3
10692,cytokine,C0079189,en_2593,INHIBITS,ANP32B gene,C1332090,en_5581,1,1,AFFECTS,Inhibitory,3
10693,cytokine,C0079189,en_2593,PREDISPOSES,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,Excitatory,3
10694,cytokine,C0079189,en_2593,PREDISPOSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
10695,cytokine,C0079189,en_2593,PREDISPOSES,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Excitatory,3
10696,cytokine,C0079189,en_2593,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
10697,cytokine,C0079189,en_2593,PREDISPOSES,Disease Progression,C0242656,en_3429,3,2,AFFECTS,Excitatory,6
10698,cytokine,C0079189,en_2593,PREDISPOSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
10699,cytokine,C0079189,en_2593,PREDISPOSES,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,3
10700,cytokine,C0079189,en_2593,PREDISPOSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
10701,cytokine,C0079189,en_2593,PREDISPOSES,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,Excitatory,3
10702,cytokine,C0079189,en_2593,PREDISPOSES,Macrophage activation syndrome,C1096155,en_5233,2,1,AFFECTS,Excitatory,3
10703,cytokine,C0079189,en_2593,PREDISPOSES,imbalance,C1397014,en_5692,1,1,AFFECTS,Excitatory,3
10704,cytokine,C0079189,en_2593,PREVENTS,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,Inhibitory,3
10705,cytokine,C0079189,en_2593,PREVENTS,organic disorders,C0683324,en_4660,1,1,AFFECTS,Inhibitory,3
10706,cytokine,C0079189,en_2593,PREVENTS,Cytokine storm,C0919747,en_5119,3,1,AFFECTS,Inhibitory,3
10707,cytokine,C0079189,en_2593,PREVENTS,Storm NOS,C2905612,en_6141,1,1,AFFECTS,Inhibitory,7
10708,cytokine,C0079189,en_2593,PRODUCES,Antigen-Antibody Complex,C0003313,en_361,1,1,AFFECTS,Excitatory,3
10709,cytokine,C0079189,en_2593,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
10710,cytokine,C0079189,en_2593,PRODUCES,Signaling Molecule,C1519315,en_5883,1,1,AFFECTS,Excitatory,3
10711,cytokine,C0079189,en_2593,STIMULATES,Acute-Phase Proteins,C0001347,en_232,1,1,AFFECTS,Excitatory,3
10712,cytokine,C0079189,en_2593,STIMULATES,C-reactive protein,C0006560,en_529,2,1,AFFECTS,Excitatory,3
10713,cytokine,C0079189,en_2593,STIMULATES,Cells,C0007634,en_596,3,2,AFFECTS,Excitatory,6
10714,cytokine,C0079189,en_2593,STIMULATES,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,3
10715,cytokine,C0079189,en_2593,STIMULATES,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,Excitatory,3
10716,cytokine,C0079189,en_2593,STIMULATES,NF-kappa B,C0079904,en_2615,2,2,AFFECTS,Excitatory,11
10717,cytokine,C0079189,en_2593,STIMULATES,"Toxins, Chimeric",C0085998,en_2700,1,1,AFFECTS,Excitatory,3
10718,cytokine,C0079189,en_2593,STIMULATES,activin A,C0100748,en_2749,1,1,AFFECTS,Excitatory,8
10719,cytokine,C0079189,en_2593,STIMULATES,Microglia,C0206116,en_3147,1,1,AFFECTS,Excitatory,3
10720,cytokine,C0079189,en_2593,STIMULATES,Matrix Metalloproteinases,C0623362,en_4521,1,1,AFFECTS,Excitatory,3
10721,cytokine,C0079189,en_2593,STIMULATES,"NOS3 protein, human",C0669365,en_4534,1,1,AFFECTS,Excitatory,3
10722,cytokine,C0079189,en_2593,STIMULATES,CD14+ cell,C0947286,en_5153,1,1,AFFECTS,Excitatory,3
10723,"Endoscopy, Gastrointestinal",C0079278,en_2595,TREATS,Lesion,C0221198,en_3221,1,1,AFFECTS,Inhibitory,3
10724,"Endoscopy, Gastrointestinal",C0079278,en_2595,TREATS(SPEC),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
10725,Endothelin,C0079284,en_2596,AFFECTS,Blood flow,C0232338,en_3276,2,1,AFFECTS,General/Uncertain,3
10726,TP53 gene,C0079419,en_2602,AFFECTS,Neoplasm progression,C0178874,en_2992,1,1,AFFECTS,General/Uncertain,3
10727,TP53 gene,C0079419,en_2602,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
10728,Tumor Suppressor Genes,C0079427,en_2603,PREVENTS,Lymphoma,C0024299,en_1471,1,1,AFFECTS,Inhibitory,3
10729,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,AFFECTS(SPEC),Hematopoiesis,C0018951,en_1152,1,1,AFFECTS,General/Uncertain,3
10730,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,AUGMENTS,Immunity,C0020964,en_1273,2,1,AFFECTS,Excitatory,3
10731,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,AUGMENTS,Wound Healing,C0043240,en_2400,2,1,AFFECTS,Excitatory,3
10732,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,AUGMENTS,"Macrophages, Alveolar",C0085236,en_2654,1,1,AFFECTS,Excitatory,3
10733,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,PREVENTS,Bacteremia,C0004610,en_439,1,1,AFFECTS,Inhibitory,3
10734,Granulocyte-Macrophage Colony-Stimulating Factor|CSF2|LAMC2,C0079460|1437|3918,en_2605,STIMULATES,Myeloid Cells,C0887899,en_5091,1,1,AFFECTS,Excitatory,6
10735,Iloprost,C0079594,en_2606,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
10736,Iloprost,C0079594,en_2606,TREATS(INFER),Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
10737,"Immunotherapy, Adoptive",C0079613,en_2607,PREVENTS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,7
10738,"Immunotherapy, Adoptive",C0079613,en_2607,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
10739,Interleukin-8,C0079633,en_2608,AUGMENTS,Menstruation,C0025344,en_1540,1,1,AFFECTS,Excitatory,3
10740,Interleukin-8,C0079633,en_2608,DISRUPTS,Autophagy,C0004391,en_432,1,1,AFFECTS,Inhibitory,3
10741,Interleukin-8,C0079633,en_2608,INHIBITS,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Inhibitory,3
10742,Interleukin-8,C0079633,en_2608,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,6
10743,Interleukin-8,C0079633,en_2608,INHIBITS,Xuebijing,C2933944,en_6149,1,1,AFFECTS,Inhibitory,7
10744,Interleukin-8,C0079633,en_2608,STIMULATES,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
10745,Macrophage Colony-Stimulating Factor,C0079784,en_2611,INHIBITS,Macrophage Colony-Stimulating Factor Receptor,C0080092,en_2621,1,1,AFFECTS,Inhibitory,3
10746,N-Methylaspartate,C0079883,en_2614,STIMULATES,caspase-3,C0291573,en_3678,2,1,AFFECTS,Excitatory,3
10747,N-Methylaspartate,C0079883,en_2614,STIMULATES,caspase activation,C1159825,en_5346,3,3,AFFECTS,Excitatory,9
10748,NF-kappa B,C0079904,en_2615,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
10749,NF-kappa B,C0079904,en_2615,COMPLICATES,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
10750,NF-kappa B,C0079904,en_2615,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
10751,"Oligonucleotides, Antisense",C0079925,en_2616,INHIBITS,Kininogenase,C0022478,en_1374,2,1,AFFECTS,Inhibitory,3
10752,National origin,C0079946,en_2617,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
10753,Reading Frames,C0080089,en_2620,AUGMENTS,Negative attitude,C1262620,en_5425,1,1,AFFECTS,Excitatory,8
10754,Reading Frames,C0080089,en_2620,PREDISPOSES,Adverse effects,C0879626,en_5081,1,1,AFFECTS,Excitatory,7
10755,N-Methyl-D-Aspartate Receptors,C0080093,en_2622,STIMULATES,casein kinase II,C0108555,en_2757,1,1,AFFECTS,Excitatory,3
10756,"Ventricular Function, Left",C0080310,en_2627,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
10757,Walking,C0080331,en_2629,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,2,2,AFFECTS,Excitatory,6
10758,Walking,C0080331,en_2629,PREVENTS,Chronic Disease,C0008679,en_643,2,1,AFFECTS,Inhibitory,3
10759,Walking,C0080331,en_2629,TREATS,Child,C0008059,en_620,4,3,AFFECTS,Inhibitory,9
10760,Walking,C0080331,en_2629,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
10761,Walking,C0080331,en_2629,TREATS,Adolescent,C0205653,en_3132,2,1,AFFECTS,Inhibitory,3
10762,Walking,C0080331,en_2629,TREATS,Middle Aged,C0205847,en_3136,2,1,AFFECTS,Inhibitory,6
10763,Walking,C0080331,en_2629,TREATS(INFER),Cerebral Palsy,C0007789,en_605,6,4,AFFECTS,Inhibitory,12
10764,Walking,C0080331,en_2629,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
10765,Dipeptidyl-Peptidase IV,C0081937,en_2631,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
10766,centhaquine,C0081963,en_2632,TREATS,Hypovolemic Shock,C0020683,en_1251,1,1,AFFECTS,Inhibitory,8
10767,centhaquine,C0081963,en_2632,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10768,centhaquine,C0081963,en_2632,TREATS,Oryctolagus cuniculus,C0034493,en_1947,2,1,AFFECTS,Inhibitory,3
10769,centhaquine,C0081963,en_2632,TREATS,Rattus norvegicus,C0034693,en_1958,2,1,AFFECTS,Inhibitory,3
10770,centhaquine,C0081963,en_2632,TREATS,Family suidae,C0039005,en_2193,2,1,AFFECTS,Inhibitory,3
10771,meloxicam,C0083381,en_2633,INHIBITS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,8
10772,phosducin,C0084024,en_2635,AUGMENTS,Moral Development,C0026527,en_1581,1,1,AFFECTS,Excitatory,3
10773,RNA Helicase,C0084378,en_2636,AFFECTS,Protein Biosynthesis,C0597295,en_4419,11,1,AFFECTS,General/Uncertain,3
10774,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,6
10775,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,PREDISPOSES,Acute Lung Injury,C0242488,en_3416,2,2,AFFECTS,Excitatory,9
10776,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
10777,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,STIMULATES,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Excitatory,3
10778,Mammaplasty,C0085076,en_2638,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
10779,Mammaplasty,C0085076,en_2638,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10780,Mammaplasty,C0085076,en_2638,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,3
10781,Chinese Hamster Ovary Cell,C0085080,en_2639,PRODUCES,TPO gene,C1364508,en_5651,1,1,AFFECTS,Excitatory,3
10782,Drug Delivery Systems,C0085104,en_2643,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,6
10783,Tacrolimus,C0085149,en_2646,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
10784,Generic Drugs,C0085155,en_2647,PREVENTS,Extravasation,C0015376,en_949,1,1,AFFECTS,Inhibitory,3
10785,Generic Drugs,C0085155,en_2647,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
10786,Generic Drugs,C0085155,en_2647,TREATS,Dyslipidemias,C0242339,en_3406,1,1,AFFECTS,Inhibitory,3
10787,Generic Drugs,C0085155,en_2647,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
10788,Misoprostol,C0085174,en_2649,TREATS,Spontaneous Incomplete abortion,C1533689,en_5938,1,1,AFFECTS,Inhibitory,3
10789,RNA-Binding Proteins,C0085177,en_2650,AFFECTS,Acclimatization,C0000934,en_212,1,1,AFFECTS,General/Uncertain,3
10790,Esophagectomy,C0085198,en_2651,TREATS,Malignant neoplasm of stomach,C0024623,en_1495,1,1,AFFECTS,Inhibitory,3
10791,"Diabetes, Gestational",C0085207,en_2652,PREDISPOSES,Fetal dystocia,C0269816,en_3548,1,1,AFFECTS,Excitatory,3
10792,Fluvoxamine,C0085228,en_2653,AFFECTS,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
10793,Fluvoxamine,C0085228,en_2653,INHIBITS,Pharmaceutical Preparations,C0013227,en_856,1,1,AFFECTS,Inhibitory,3
10794,Fluvoxamine,C0085228,en_2653,PREVENTS,Complication,C0009566,en_697,4,2,AFFECTS,Inhibitory,6
10795,Fluvoxamine,C0085228,en_2653,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
10796,Fluvoxamine,C0085228,en_2653,PREVENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
10797,Fluvoxamine,C0085228,en_2653,STIMULATES,sigma-1 receptor,C0539266,en_4247,2,1,AFFECTS,Excitatory,3
10798,Fluvoxamine,C0085228,en_2653,STIMULATES(SPEC),sigma-1 receptor,C0539266,en_4247,1,1,AFFECTS,Excitatory,3
10799,Fluvoxamine,C0085228,en_2653,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
10800,Fluvoxamine,C0085228,en_2653,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
10801,Fluvoxamine,C0085228,en_2653,TREATS(SPEC),Obsessive-Compulsive Disorder,C0028768,en_1701,6,3,AFFECTS,Inhibitory,9
10802,"Macrophages, Alveolar",C0085236,en_2654,PRODUCES,Tretinoin,C0040845,en_2280,1,1,AFFECTS,Excitatory,3
10803,Mupirocin,C0085259,en_2655,AFFECTS,Sinusitis,C0037199,en_2112,1,1,AFFECTS,General/Uncertain,8
10804,Mupirocin,C0085259,en_2655,TREATS,Chronic sinusitis NOS,C0149516,en_2800,1,1,AFFECTS,Inhibitory,8
10805,Antiphospholipid Syndrome,C0085278,en_2657,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
10806,Antiphospholipid Syndrome,C0085278,en_2657,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
10807,Addictive Behavior,C0085281,en_2658,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
10808,Addictive Behavior,C0085281,en_2658,AFFECTS,citizen,C0682134,en_4636,1,1,AFFECTS,General/Uncertain,3
10809,Interleukin-10,C0085295,en_2659,AUGMENTS,Menstruation,C0025344,en_1540,1,1,AFFECTS,Excitatory,3
10810,Interleukin-10,C0085295,en_2659,AUGMENTS,"Recombination, Genetic",C0034865,en_1983,1,1,AFFECTS,Excitatory,3
10811,Interleukin-10,C0085295,en_2659,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
10812,Interleukin-10,C0085295,en_2659,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
10813,Interleukin-10,C0085295,en_2659,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,6
10814,Interleukin-10,C0085295,en_2659,INHIBITS,TNF gene,C0812246,en_4896,2,1,AFFECTS,Inhibitory,3
10815,Interleukin-10,C0085295,en_2659,PRODUCES,"CD79A,LOC102723407",C1413238,en_191,2,1,AFFECTS,Excitatory,3
10816,Interleukin-10,C0085295,en_2659,PRODUCES,Mucous body substance,C0026727,en_1595,3,1,AFFECTS,Excitatory,3
10817,Interleukin-10,C0085295,en_2659,STIMULATES,Cells,C0007634,en_596,2,2,AFFECTS,Excitatory,6
10818,Interleukin-10,C0085295,en_2659,STIMULATES,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,6
10819,Interleukin-10,C0085295,en_2659,STIMULATES,Oxidative Phosphorylation,C0030013,en_1734,1,1,AFFECTS,Excitatory,3
10820,Interleukin-10,C0085295,en_2659,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
10821,Interleukin-10,C0085295,en_2659,STIMULATES,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,1,1,AFFECTS,Excitatory,7
10822,Interleukin-10,C0085295,en_2659,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10823,"Immunoglobulins, Intravenous",C0085297,en_2660,AFFECTS,Cell physiology,C0007613,en_594,2,1,AFFECTS,General/Uncertain,3
10824,"Immunoglobulins, Intravenous",C0085297,en_2660,AFFECTS,Immunity,C0020964,en_1273,2,1,AFFECTS,General/Uncertain,3
10825,"Immunoglobulins, Intravenous",C0085297,en_2660,AFFECTS,"Immunity, Humoral",C0020967,en_1275,1,1,AFFECTS,General/Uncertain,3
10826,"Immunoglobulins, Intravenous",C0085297,en_2660,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,7
10827,"Immunoglobulins, Intravenous",C0085297,en_2660,AFFECTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,General/Uncertain,3
10828,"Immunoglobulins, Intravenous",C0085297,en_2660,AFFECTS,Early disease stage,C4699609,en_6382,1,1,AFFECTS,General/Uncertain,8
10829,"Immunoglobulins, Intravenous",C0085297,en_2660,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
10830,"Immunoglobulins, Intravenous",C0085297,en_2660,PREVENTS,Respiratory complication,C0161818,en_2899,2,1,AFFECTS,Inhibitory,3
10831,"Immunoglobulins, Intravenous",C0085297,en_2660,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
10832,"Immunoglobulins, Intravenous",C0085297,en_2660,PREVENTS,Lung Injury,C0273115,en_3561,1,1,AFFECTS,Inhibitory,8
10833,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Autoimmune Diseases,C0004364,en_428,2,1,AFFECTS,Inhibitory,3
10834,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10835,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Comorbidity,C0009488,en_690,1,1,AFFECTS,Inhibitory,7
10836,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Disease,C0012634,en_826,3,2,AFFECTS,Inhibitory,10
10837,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Patients,C0030705,en_1762,8,4,AFFECTS,Inhibitory,12
10838,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Pneumonia,C0032285,en_1833,4,2,AFFECTS,Inhibitory,6
10839,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Thromboembolism,C0040038,en_2230,1,1,AFFECTS,Inhibitory,3
10840,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
10841,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Normal patient,C0848894,en_4933,1,1,AFFECTS,Inhibitory,6
10842,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,Severe infection,C5139167,en_6407,3,2,AFFECTS,Inhibitory,16
10843,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,13
10844,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
10845,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS,COVID-19-Associated Acute Respiratory Distress Syndrome,C5419164,en_6458,1,1,AFFECTS,Inhibitory,8
10846,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS(INFER),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,Inhibitory,3
10847,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS(INFER),Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
10848,"Immunoglobulins, Intravenous",C0085297,en_2660,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
10849,"Death, Sudden, Cardiac",C0085298,en_2661,AFFECTS,Ventricular arrhythmia,C0085612,en_2682,1,1,AFFECTS,General/Uncertain,3
10850,tau Proteins,C0085401,en_2666,PREDISPOSES,Neuropathy,C0442874,en_4060,1,1,AFFECTS,Excitatory,3
10851,Salvage Therapy,C0085405,en_2668,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
10852,Salvage Therapy,C0085405,en_2668,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10853,Salvage Therapy,C0085405,en_2668,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
10854,Ribonuclease H,C0085431,en_2669,PRODUCES,"DNA, Complementary",C0006556,en_528,1,1,AFFECTS,Excitatory,3
10855,AIDS Vaccines,C0085432,en_2670,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
10856,Enterobacter cloacae,C0085484,en_2672,PRODUCES,Lactamase,C0086518,en_2723,2,1,AFFECTS,Excitatory,3
10857,"Chemotherapy, Adjuvant",C0085533,en_2673,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
10858,Caregiver,C0085537,en_2674,TREATS,Patients,C0030705,en_1762,6,5,AFFECTS,Inhibitory,15
10859,Hospice Care,C0085555,en_2676,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
10860,Hospice Care,C0085555,en_2676,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
10861,Infectious disease prevention / control,C0085557,en_2677,AFFECTS,Cleans drug injection equipment finding,C0542277,en_4254,1,1,AFFECTS,General/Uncertain,3
10862,Infectious disease prevention / control,C0085557,en_2677,PREVENTS,"Infections, Hospital",C0205721,en_3133,3,2,AFFECTS,Inhibitory,6
10863,Infectious disease prevention / control,C0085557,en_2677,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
10864,Infectious disease prevention / control,C0085557,en_2677,TREATS,Appendicitis,C0003615,en_387,1,1,AFFECTS,Inhibitory,6
10865,Infectious disease prevention / control,C0085557,en_2677,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
10866,Infectious disease prevention / control,C0085557,en_2677,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
10867,Infectious disease prevention / control,C0085557,en_2677,TREATS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,3
10868,Infectious disease prevention / control,C0085557,en_2677,TREATS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
10869,Infectious disease prevention / control,C0085557,en_2677,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
10870,Infectious disease prevention / control,C0085557,en_2677,TREATS,Dyads,C0870454,en_5003,1,1,AFFECTS,Inhibitory,6
10871,intensive care,C0085559,en_2678,PREVENTS,Disease Progression,C0242656,en_3429,2,2,AFFECTS,Inhibitory,6
10872,intensive care,C0085559,en_2678,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,6
10873,intensive care,C0085559,en_2678,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,6
10874,intensive care,C0085559,en_2678,TREATS,Disease,C0012634,en_826,3,2,AFFECTS,Inhibitory,6
10875,intensive care,C0085559,en_2678,TREATS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,Inhibitory,6
10876,intensive care,C0085559,en_2678,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
10877,intensive care,C0085559,en_2678,TREATS,Persons,C0027361,en_1635,3,2,AFFECTS,Inhibitory,6
10878,intensive care,C0085559,en_2678,TREATS,Patients,C0030705,en_1762,27,19,AFFECTS,Inhibitory,57
10879,intensive care,C0085559,en_2678,TREATS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,6
10880,intensive care,C0085559,en_2678,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,8,5,AFFECTS,Inhibitory,15
10881,intensive care,C0085559,en_2678,TREATS,Virus Diseases,C0042769,en_2362,7,4,AFFECTS,Inhibitory,12
10882,intensive care,C0085559,en_2678,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
10883,intensive care,C0085559,en_2678,TREATS,Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,6
10884,intensive care,C0085559,en_2678,TREATS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
10885,intensive care,C0085559,en_2678,TREATS,concomitant disease,C0243087,en_3460,1,1,AFFECTS,Inhibitory,3
10886,intensive care,C0085559,en_2678,TREATS,Acute respiratory failure,C0264490,en_3533,5,2,AFFECTS,Inhibitory,6
10887,intensive care,C0085559,en_2678,TREATS,Test Result,C0456984,en_4122,1,1,AFFECTS,Inhibitory,3
10888,intensive care,C0085559,en_2678,TREATS,Respiratory distress,C0476273,en_4149,2,2,AFFECTS,Inhibitory,6
10889,intensive care,C0085559,en_2678,TREATS,"Medical care, unspecified",C0496675,en_4163,2,1,AFFECTS,Inhibitory,3
10890,intensive care,C0085559,en_2678,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
10891,intensive care,C0085559,en_2678,TREATS,Respiratory Failure,C1145670,en_5292,4,3,AFFECTS,Inhibitory,13
10892,intensive care,C0085559,en_2678,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
10893,intensive care,C0085559,en_2678,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10894,intensive care,C0085559,en_2678,TREATS(INFER),Chronically Ill,C0008715,en_644,1,1,AFFECTS,Inhibitory,3
10895,intensive care,C0085559,en_2678,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
10896,intensive care,C0085559,en_2678,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
10897,intensive care,C0085559,en_2678,TREATS(INFER),Malaise,C0231218,en_3251,3,2,AFFECTS,Inhibitory,6
10898,catheter device,C0085590,en_2681,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10899,Falls,C0085639,en_2684,PREDISPOSES,Dementia,C0497327,en_4164,1,1,AFFECTS,Excitatory,3
10900,Acute appendicitis NOS,C0085693,en_2687,PREDISPOSES,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Excitatory,3
10901,Ability,C0085732,en_2688,PREDISPOSES,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Excitatory,6
10902,Ability,C0085732,en_2688,PREDISPOSES,Cross Infection,C0010356,en_735,1,1,AFFECTS,Excitatory,6
10903,Ability,C0085732,en_2688,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
10904,Alcohol abuse,C0085762,en_2690,AFFECTS,General Population,C0683971,en_4674,1,1,AFFECTS,General/Uncertain,3
10905,Hamman-Rich syndrome,C0085786,en_2691,PREDISPOSES,Pulmonary Fibrosis,C0034069,en_1932,1,1,AFFECTS,Excitatory,3
10906,Antibody-Secreting Cells,C0085820,en_2693,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
10907,Antiplatelet Agents,C0085826,en_2694,PREVENTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
10908,Antiplatelet Agents,C0085826,en_2694,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
10909,Antiplatelet Agents,C0085826,en_2694,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10910,Basic life support,C0085873,en_2696,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10911,Basic life support,C0085873,en_2696,TREATS,Cardiopulmonary Arrest,C0600228,en_4500,1,1,AFFECTS,Inhibitory,3
10912,FOS gene,C0085940,en_2697,INHIBITS,haemoferritin,C0166450,en_2951,1,1,AFFECTS,Inhibitory,3
10913,Bacillus Calmette-Guerin,C0085957,en_2698,PRODUCES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
10914,Bacillus Calmette-Guerin,C0085957,en_2698,PRODUCES,Fusion Protein,C0162768,en_2931,2,2,AFFECTS,Excitatory,6
10915,Bacillus Calmette-Guerin,C0085957,en_2698,PRODUCES,CD4 gene,C1332714,en_5583,1,1,AFFECTS,Excitatory,3
10916,Bacillus Calmette-Guerin,C0085957,en_2698,PRODUCES,Protein Fragment,C1335533,en_5616,1,1,AFFECTS,Excitatory,3
10917,Bacillus Calmette-Guerin,C0085957,en_2698,PRODUCES,CD8B1 gene,C1367471,en_5671,1,1,AFFECTS,Excitatory,3
10918,Cromolyn,C0086073,en_2701,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
10919,Cromolyn,C0086073,en_2701,TREATS,PATIENT SYMPTOMS,C1317600,en_5529,2,1,AFFECTS,Inhibitory,3
10920,Cromolyn,C0086073,en_2701,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
10921,Depressive Symptoms,C0086132,en_2702,PREDISPOSES,Coronary heart disease,C0010068,en_718,1,1,AFFECTS,Excitatory,3
10922,Depressive Symptoms,C0086132,en_2702,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
10923,Diagnostic tests,C0086143,en_2703,AFFECTS,Diagnosis,C0011900,en_806,2,2,AFFECTS,General/Uncertain,6
10924,Dialyzable Leukocyte Extract,C0086145,en_2704,STIMULATES,cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
10925,Dietary Habits,C0086152,en_2705,AFFECTS,Choice Behavior,C0008300,en_633,1,1,AFFECTS,General/Uncertain,6
10926,Dietary Modification,C0086153,en_2706,TREATS,Body Weight,C0005910,en_498,1,1,AFFECTS,Inhibitory,8
10927,Dietary Modification,C0086153,en_2706,TREATS,Non-alcoholic fatty liver,C0400966,en_3955,1,1,AFFECTS,Inhibitory,8
10928,Dietary Modification,C0086153,en_2706,TREATS,Workers,C1527116,en_5916,2,2,AFFECTS,Inhibitory,15
10929,Dietary Modification,C0086153,en_2706,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,8
10930,Dietary Modification,C0086153,en_2706,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
10931,Dynorphin (1-17),C0086191,en_2708,AFFECTS,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
10932,Emotional Stress,C0086209,en_2709,AFFECTS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,General/Uncertain,3
10933,Enhancer,C0086222,en_2710,AUGMENTS,Mammary gland,C0929301,en_5133,1,1,AFFECTS,Excitatory,3
10934,GTP-Binding Proteins,C0086376,en_2714,AFFECTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
10935,Health Care,C0086388,en_2715,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
10936,Health Care,C0086388,en_2715,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
10937,Health Care,C0086388,en_2715,AFFECTS,Unemployment,C0041674,en_2309,1,1,AFFECTS,General/Uncertain,3
10938,Health Care,C0086388,en_2715,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
10939,Health Care,C0086388,en_2715,TREATS,Elderly,C0001792,en_258,2,2,AFFECTS,Inhibitory,6
10940,Health Care,C0086388,en_2715,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10941,Health Care,C0086388,en_2715,TREATS,Chronic Disease,C0008679,en_643,4,4,AFFECTS,Inhibitory,12
10942,Health Care,C0086388,en_2715,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
10943,Health Care,C0086388,en_2715,TREATS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
10944,Health Care,C0086388,en_2715,TREATS,Migrants,C0026093,en_1568,1,1,AFFECTS,Inhibitory,3
10945,Health Care,C0086388,en_2715,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
10946,Health Care,C0086388,en_2715,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
10947,Health Care,C0086388,en_2715,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
10948,Health Care,C0086388,en_2715,TREATS,Patients,C0030705,en_1762,15,10,AFFECTS,Inhibitory,30
10949,Health Care,C0086388,en_2715,TREATS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,Inhibitory,3
10950,Health Care,C0086388,en_2715,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
10951,Health Care,C0086388,en_2715,TREATS,Refugees,C0034961,en_1987,1,1,AFFECTS,Inhibitory,3
10952,Health Care,C0086388,en_2715,TREATS,Woman,C0043210,en_2396,3,2,AFFECTS,Inhibitory,6
10953,Health Care,C0086388,en_2715,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
10954,Health Care,C0086388,en_2715,TREATS,Does squat,C0241236,en_3388,1,1,AFFECTS,Inhibitory,3
10955,Health Care,C0086388,en_2715,TREATS,Bedwetting,C0270327,en_3550,1,1,AFFECTS,Inhibitory,3
10956,Health Care,C0086388,en_2715,TREATS,Does turn,C0541749,en_4253,1,1,AFFECTS,Inhibitory,3
10957,Health Care,C0086388,en_2715,TREATS,VICTIM,C0680681,en_4626,1,1,AFFECTS,Inhibitory,3
10958,Health Care,C0086388,en_2715,TREATS,Perpetrators,C0871061,en_5016,1,1,AFFECTS,Inhibitory,3
10959,Health Care,C0086388,en_2715,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,3
10960,Health Care,C0086388,en_2715,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
10961,Health Care,C0086388,en_2715,TREATS(INFER),Chronic Disease,C0008679,en_643,4,2,AFFECTS,Inhibitory,6
10962,Health Care,C0086388,en_2715,TREATS(INFER),Diabetic,C0241863,en_3392,2,1,AFFECTS,Inhibitory,3
10963,Health Care,C0086388,en_2715,TREATS(INFER),Chronic heart failure,C0264716,en_3538,1,1,AFFECTS,Inhibitory,3
10964,Medical Care Team,C0086390,en_2716,PREVENTS,Perceived discomfort,C0517478,en_4172,2,1,AFFECTS,Inhibitory,3
10965,Medical Care Team,C0086390,en_2716,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
10966,Medical Care Team,C0086390,en_2716,TREATS,Constipation,C0009806,en_706,1,1,AFFECTS,Inhibitory,3
10967,Medical Care Team,C0086390,en_2716,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10968,"Arthroplasty, Replacement, Knee",C0086511,en_2722,TREATS,Degenerative polyarthritis,C0029408,en_1723,2,1,AFFECTS,Inhibitory,3
10969,Lawyers,C0086530,en_2725,PRODUCES,Holders,C0181196,en_3022,1,1,AFFECTS,Excitatory,3
10970,Lymphoid Cells,C0086574,en_2728,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
10971,Males,C0086582,en_2729,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
10972,Natural Selection,C0086685,en_2731,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
10973,Natural Selection,C0086685,en_2731,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
10974,"Health Services, Outpatient",C0086751,en_2733,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
10975,"Health Services, Outpatient",C0086751,en_2733,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
10976,Promoter (Genetics),C0086860,en_2734,DISRUPTS,Cell Death,C0007587,en_587,1,1,AFFECTS,Inhibitory,3
10977,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,AFFECTS,Electrolyte Balance,C0013831,en_884,1,1,AFFECTS,General/Uncertain,3
10978,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,AFFECTS,blood pressure regulation,C0678863,en_4576,1,1,AFFECTS,General/Uncertain,3
10979,Risk Assessment,C0086930,en_2737,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
10980,Risk Assessment,C0086930,en_2737,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
10981,Risk Assessment,C0086930,en_2737,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
10982,Risk Assessment,C0086930,en_2737,TREATS,Deep Vein Thrombosis,C0149871,en_2812,3,1,AFFECTS,Inhibitory,6
10983,Risk Assessment,C0086930,en_2737,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
10984,Risk Assessment,C0086930,en_2737,TREATS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
10985,Risk Assessment,C0086930,en_2737,TREATS,Offspring,C0680063,en_4620,1,1,AFFECTS,Inhibitory,3
10986,Risk Assessment,C0086930,en_2737,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
10987,Self-Management,C0086969,en_2740,PREVENTS,Mastodynia,C0024902,en_1507,1,1,AFFECTS,Inhibitory,3
10988,Self-Management,C0086969,en_2740,PREVENTS,Pain intensity,C1320357,en_5535,1,1,AFFECTS,Inhibitory,3
10989,Self-Management,C0086969,en_2740,PREVENTS,Oral Mucositis,C1568868,en_5989,1,1,AFFECTS,Inhibitory,3
10990,Self-Management,C0086969,en_2740,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,6
10991,Self-Management,C0086969,en_2740,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
10992,Self-Management,C0086969,en_2740,TREATS,General Adaptation Syndrome,C0017301,en_1049,1,1,AFFECTS,Inhibitory,3
10993,Self-Management,C0086969,en_2740,TREATS,Male population group,C0025266,en_1533,2,1,AFFECTS,Inhibitory,3
10994,Self-Management,C0086969,en_2740,TREATS,African race,C0027567,en_1646,1,1,AFFECTS,Inhibitory,3
10995,Self-Management,C0086969,en_2740,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
10996,Self-Management,C0086969,en_2740,TREATS,Stress,C0038435,en_2165,6,2,AFFECTS,Inhibitory,6
10997,Self-Management,C0086969,en_2740,TREATS,Latinos,C0086528,en_2724,1,1,AFFECTS,Inhibitory,3
10998,Self-Management,C0086969,en_2740,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
10999,Self-Management,C0086969,en_2740,TREATS(INFER),Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,Inhibitory,3
11000,Signal Transduction Pathways,C0086982,en_2741,AFFECTS,ROS1,C0812281,en_74,1,1,AFFECTS,General/Uncertain,3
11001,Signal Transduction Pathways,C0086982,en_2741,AFFECTS,macrophage,C0024432,en_1484,1,1,AFFECTS,General/Uncertain,3
11002,Signal Transduction Pathways,C0086982,en_2741,AFFECTS,Retinitis,C0035333,en_2024,2,1,AFFECTS,General/Uncertain,3
11003,Signal Transduction Pathways,C0086982,en_2741,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
11004,Thrombus,C0087086,en_2743,AFFECTS,Oxidation-Reduction,C0030012,en_1733,1,1,AFFECTS,General/Uncertain,3
11005,Thrombus,C0087086,en_2743,AUGMENTS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
11006,Therapeutic procedure,C0087111,en_2744,AFFECTS,Alopecia Areata,C0002171,en_283,2,1,AFFECTS,General/Uncertain,3
11007,Therapeutic procedure,C0087111,en_2744,AFFECTS,Antibody Formation,C0003261,en_352,3,1,AFFECTS,General/Uncertain,3
11008,Therapeutic procedure,C0087111,en_2744,AFFECTS,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,General/Uncertain,3
11009,Therapeutic procedure,C0087111,en_2744,AFFECTS,Complication,C0009566,en_697,3,1,AFFECTS,General/Uncertain,3
11010,Therapeutic procedure,C0087111,en_2744,AFFECTS,Cessation of life,C0011065,en_762,2,2,AFFECTS,General/Uncertain,6
11011,Therapeutic procedure,C0087111,en_2744,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
11012,Therapeutic procedure,C0087111,en_2744,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
11013,Therapeutic procedure,C0087111,en_2744,AFFECTS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,3
11014,Therapeutic procedure,C0087111,en_2744,AFFECTS,Patients,C0030705,en_1762,7,6,AFFECTS,General/Uncertain,18
11015,Therapeutic procedure,C0087111,en_2744,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
11016,Therapeutic procedure,C0087111,en_2744,AFFECTS,Virus Diseases,C0042769,en_2362,5,4,AFFECTS,General/Uncertain,12
11017,Therapeutic procedure,C0087111,en_2744,AFFECTS,"Depression, Postpartum",C0221074,en_3212,3,3,AFFECTS,General/Uncertain,9
11018,Therapeutic procedure,C0087111,en_2744,AFFECTS,pulmonary function,C0231921,en_3268,2,1,AFFECTS,General/Uncertain,3
11019,Therapeutic procedure,C0087111,en_2744,AFFECTS,Immune response,C0301872,en_3696,5,3,AFFECTS,General/Uncertain,9
11020,Therapeutic procedure,C0087111,en_2744,AFFECTS,Neutrophil Infiltration,C0751982,en_4855,1,1,AFFECTS,General/Uncertain,3
11021,Therapeutic procedure,C0087111,en_2744,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
11022,Therapeutic procedure,C0087111,en_2744,AFFECTS,host-pathogen interaction,C1154482,en_5309,1,1,AFFECTS,General/Uncertain,3
11023,Therapeutic procedure,C0087111,en_2744,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
11024,Therapeutic procedure,C0087111,en_2744,PREDISPOSES,Infection,C3714514,en_6235,3,3,AFFECTS,Excitatory,9
11025,Therapeutic procedure,C0087111,en_2744,PREDISPOSES,Pain,C0030193,en_1741,2,1,AFFECTS,Excitatory,3
11026,Therapeutic procedure,C0087111,en_2744,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
11027,Therapeutic procedure,C0087111,en_2744,PREDISPOSES,Vertical Disease Transmission,C0242648,en_3427,1,1,AFFECTS,Excitatory,3
11028,Therapeutic procedure,C0087111,en_2744,PREDISPOSES,HEART PROBLEM,C0795691,en_4879,1,1,AFFECTS,Excitatory,3
11029,Therapeutic procedure,C0087111,en_2744,PREVENTS,Complication,C0009566,en_697,4,4,AFFECTS,Inhibitory,12
11030,Therapeutic procedure,C0087111,en_2744,PREVENTS,Disease,C0012634,en_826,5,4,AFFECTS,Inhibitory,12
11031,Therapeutic procedure,C0087111,en_2744,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
11032,Therapeutic procedure,C0087111,en_2744,PREVENTS,Inflammation,C0021368,en_1307,8,7,AFFECTS,Inhibitory,21
11033,Therapeutic procedure,C0087111,en_2744,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11034,Therapeutic procedure,C0087111,en_2744,PREVENTS,Virus Diseases,C0042769,en_2362,4,3,AFFECTS,Inhibitory,9
11035,Therapeutic procedure,C0087111,en_2744,PREVENTS,Virus Shedding,C0162633,en_2921,6,3,AFFECTS,Inhibitory,9
11036,Therapeutic procedure,C0087111,en_2744,PREVENTS,Diabetic complications,C0271672,en_3556,1,1,AFFECTS,Inhibitory,3
11037,Therapeutic procedure,C0087111,en_2744,PREVENTS,Epidemic disease,C0277548,en_3584,1,1,AFFECTS,Inhibitory,3
11038,Therapeutic procedure,C0087111,en_2744,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
11039,Therapeutic procedure,C0087111,en_2744,PREVENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
11040,Therapeutic procedure,C0087111,en_2744,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
11041,Therapeutic procedure,C0087111,en_2744,STIMULATES,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,3
11042,Therapeutic procedure,C0087111,en_2744,TREATS,Adult,C0001675,en_252,4,2,AFFECTS,Inhibitory,6
11043,Therapeutic procedure,C0087111,en_2744,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
11044,Therapeutic procedure,C0087111,en_2744,TREATS,Anosmia,C0003126,en_337,2,1,AFFECTS,Inhibitory,3
11045,Therapeutic procedure,C0087111,en_2744,TREATS,Mental disorders,C0004936,en_452,2,1,AFFECTS,Inhibitory,3
11046,Therapeutic procedure,C0087111,en_2744,TREATS,Malignant Neoplasms,C0006826,en_545,5,5,AFFECTS,Inhibitory,15
11047,Therapeutic procedure,C0087111,en_2744,TREATS,Malignant tumor of colon,C0007102,en_559,2,1,AFFECTS,Inhibitory,3
11048,Therapeutic procedure,C0087111,en_2744,TREATS,Child,C0008059,en_620,7,5,AFFECTS,Inhibitory,15
11049,Therapeutic procedure,C0087111,en_2744,TREATS,Chiroptera,C0008139,en_625,1,1,AFFECTS,Inhibitory,3
11050,Therapeutic procedure,C0087111,en_2744,TREATS,Chronic Disease,C0008679,en_643,2,1,AFFECTS,Inhibitory,3
11051,Therapeutic procedure,C0087111,en_2744,TREATS,Complication,C0009566,en_697,2,2,AFFECTS,Inhibitory,6
11052,Therapeutic procedure,C0087111,en_2744,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
11053,Therapeutic procedure,C0087111,en_2744,TREATS,Cystic Fibrosis,C0010674,en_745,2,1,AFFECTS,Inhibitory,3
11054,Therapeutic procedure,C0087111,en_2744,TREATS,Dengue Fever,C0011311,en_778,1,1,AFFECTS,Inhibitory,3
11055,Therapeutic procedure,C0087111,en_2744,TREATS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,Inhibitory,3
11056,Therapeutic procedure,C0087111,en_2744,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
11057,Therapeutic procedure,C0087111,en_2744,TREATS,Disease,C0012634,en_826,40,31,AFFECTS,Inhibitory,93
11058,Therapeutic procedure,C0087111,en_2744,TREATS,Ebola virus,C0013480,en_872,1,1,AFFECTS,Inhibitory,3
11059,Therapeutic procedure,C0087111,en_2744,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
11060,Therapeutic procedure,C0087111,en_2744,TREATS,Fibrosis,C0016059,en_994,1,1,AFFECTS,Inhibitory,3
11061,Therapeutic procedure,C0087111,en_2744,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
11062,Therapeutic procedure,C0087111,en_2744,TREATS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
11063,Therapeutic procedure,C0087111,en_2744,TREATS,Human,C0020114,en_1210,2,2,AFFECTS,Inhibitory,6
11064,Therapeutic procedure,C0087111,en_2744,TREATS,"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,3,3,AFFECTS,Inhibitory,9
11065,Therapeutic procedure,C0087111,en_2744,TREATS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
11066,Therapeutic procedure,C0087111,en_2744,TREATS,Infection,C3714514,en_6235,4,4,AFFECTS,Inhibitory,12
11067,Therapeutic procedure,C0087111,en_2744,TREATS,Leg Ulcer,C0023223,en_1406,1,1,AFFECTS,Inhibitory,3
11068,Therapeutic procedure,C0087111,en_2744,TREATS,Lymphoma,C0024299,en_1471,2,1,AFFECTS,Inhibitory,3
11069,Therapeutic procedure,C0087111,en_2744,TREATS,Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,3
11070,Therapeutic procedure,C0087111,en_2744,TREATS,Malignant neoplasm of stomach,C0024623,en_1495,1,1,AFFECTS,Inhibitory,3
11071,Therapeutic procedure,C0087111,en_2744,TREATS,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,Inhibitory,3
11072,Therapeutic procedure,C0087111,en_2744,TREATS,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,Inhibitory,3
11073,Therapeutic procedure,C0087111,en_2744,TREATS,Multiple Sclerosis,C0026769,en_1598,8,4,AFFECTS,Inhibitory,12
11074,Therapeutic procedure,C0087111,en_2744,TREATS,Persons,C0027361,en_1635,8,8,AFFECTS,Inhibitory,24
11075,Therapeutic procedure,C0087111,en_2744,TREATS,Neoplasm,C0027651,en_1651,2,2,AFFECTS,Inhibitory,6
11076,Therapeutic procedure,C0087111,en_2744,TREATS,Neuromyelitis Optica,C0027873,en_1669,2,1,AFFECTS,Inhibitory,3
11077,Therapeutic procedure,C0087111,en_2744,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
11078,Therapeutic procedure,C0087111,en_2744,TREATS,Orthomyxoviridae,C0029341,en_1720,1,1,AFFECTS,Inhibitory,3
11079,Therapeutic procedure,C0087111,en_2744,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,3
11080,Therapeutic procedure,C0087111,en_2744,TREATS,Pain,C0030193,en_1741,8,3,AFFECTS,Inhibitory,9
11081,Therapeutic procedure,C0087111,en_2744,TREATS,Parasitic Diseases,C0030499,en_1748,1,1,AFFECTS,Inhibitory,3
11082,Therapeutic procedure,C0087111,en_2744,TREATS,Patients,C0030705,en_1762,89,60,AFFECTS,Inhibitory,180
11083,Therapeutic procedure,C0087111,en_2744,TREATS,Pneumonia,C0032285,en_1833,5,3,AFFECTS,Inhibitory,9
11084,Therapeutic procedure,C0087111,en_2744,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
11085,Therapeutic procedure,C0087111,en_2744,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,14,8,AFFECTS,Inhibitory,24
11086,Therapeutic procedure,C0087111,en_2744,TREATS,RNA Virus Infections,C0035690,en_2043,1,1,AFFECTS,Inhibitory,3
11087,Therapeutic procedure,C0087111,en_2744,TREATS,Seizures,C0036572,en_2076,1,1,AFFECTS,Inhibitory,3
11088,Therapeutic procedure,C0087111,en_2744,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
11089,Therapeutic procedure,C0087111,en_2744,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
11090,Therapeutic procedure,C0087111,en_2744,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Inhibitory,3
11091,Therapeutic procedure,C0087111,en_2744,TREATS,Substance Use Disorders,C0038586,en_2176,1,1,AFFECTS,Inhibitory,3
11092,Therapeutic procedure,C0087111,en_2744,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
11093,Therapeutic procedure,C0087111,en_2744,TREATS,Tachycardia,C0039231,en_2203,2,1,AFFECTS,Inhibitory,3
11094,Therapeutic procedure,C0087111,en_2744,TREATS,"Tachycardia, Sinus",C0039239,en_2204,2,1,AFFECTS,Inhibitory,3
11095,Therapeutic procedure,C0087111,en_2744,TREATS,Unemployment,C0041674,en_2309,4,1,AFFECTS,Inhibitory,3
11096,Therapeutic procedure,C0087111,en_2744,TREATS,Uterine Fibroids,C0042133,en_2324,2,1,AFFECTS,Inhibitory,3
11097,Therapeutic procedure,C0087111,en_2744,TREATS,Viral hepatitis,C0042721,en_2356,5,1,AFFECTS,Inhibitory,3
11098,Therapeutic procedure,C0087111,en_2744,TREATS,Virus Diseases,C0042769,en_2362,4,3,AFFECTS,Inhibitory,9
11099,Therapeutic procedure,C0087111,en_2744,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
11100,Therapeutic procedure,C0087111,en_2744,TREATS,Chronic infectious disease,C0151317,en_2857,1,1,AFFECTS,Inhibitory,3
11101,Therapeutic procedure,C0087111,en_2744,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
11102,Therapeutic procedure,C0087111,en_2744,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,3
11103,Therapeutic procedure,C0087111,en_2744,TREATS,Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
11104,Therapeutic procedure,C0087111,en_2744,TREATS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
11105,Therapeutic procedure,C0087111,en_2744,TREATS,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Inhibitory,3
11106,Therapeutic procedure,C0087111,en_2744,TREATS,Sense of smell impaired,C2364082,en_6111,2,1,AFFECTS,Inhibitory,3
11107,Therapeutic procedure,C0087111,en_2744,TREATS,Individual,C0237401,en_3343,7,7,AFFECTS,Inhibitory,21
11108,Therapeutic procedure,C0087111,en_2744,TREATS,Erectile dysfunction,C0242350,en_3407,1,1,AFFECTS,Inhibitory,3
11109,Therapeutic procedure,C0087111,en_2744,TREATS,Disease Progression,C0242656,en_3429,3,3,AFFECTS,Inhibitory,9
11110,Therapeutic procedure,C0087111,en_2744,TREATS,Generalized Anxiety Disorder,C0270549,en_3551,1,1,AFFECTS,Inhibitory,3
11111,Therapeutic procedure,C0087111,en_2744,TREATS,"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,1,1,AFFECTS,Inhibitory,3
11112,Therapeutic procedure,C0087111,en_2744,TREATS,Chronic liver disease NOS,C0341439,en_3823,5,1,AFFECTS,Inhibitory,3
11113,Therapeutic procedure,C0087111,en_2744,TREATS,commune,C0598781,en_4451,1,1,AFFECTS,Inhibitory,3
11114,Therapeutic procedure,C0087111,en_2744,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
11115,Therapeutic procedure,C0087111,en_2744,TREATS,high-risk group,C0684030,en_4676,2,1,AFFECTS,Inhibitory,3
11116,Therapeutic procedure,C0087111,en_2744,TREATS,Hypoxemia,C0700292,en_4719,2,1,AFFECTS,Inhibitory,3
11117,Therapeutic procedure,C0087111,en_2744,TREATS,Patient in hospital,C0701159,en_4731,4,2,AFFECTS,Inhibitory,6
11118,Therapeutic procedure,C0087111,en_2744,TREATS,Old tuberculosis,C0857427,en_4976,1,1,AFFECTS,Inhibitory,3
11119,Therapeutic procedure,C0087111,en_2744,TREATS,Hospitalized Patients,C0870668,en_5010,6,5,AFFECTS,Inhibitory,15
11120,Therapeutic procedure,C0087111,en_2744,TREATS,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,Inhibitory,3
11121,Therapeutic procedure,C0087111,en_2744,TREATS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
11122,Therapeutic procedure,C0087111,en_2744,TREATS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
11123,Therapeutic procedure,C0087111,en_2744,TREATS,Co-morbid conditions,C1275743,en_5462,2,1,AFFECTS,Inhibitory,3
11124,Therapeutic procedure,C0087111,en_2744,TREATS,PATIENT SYMPTOMS,C1317600,en_5529,1,1,AFFECTS,Inhibitory,3
11125,Therapeutic procedure,C0087111,en_2744,TREATS,Tropical Disease,C1336827,en_5642,2,1,AFFECTS,Inhibitory,3
11126,Therapeutic procedure,C0087111,en_2744,TREATS,Neurologic Diseases,C1456669,en_5777,1,1,AFFECTS,Inhibitory,3
11127,Therapeutic procedure,C0087111,en_2744,TREATS,Symptoms,C1457887,en_5784,8,7,AFFECTS,Inhibitory,21
11128,Therapeutic procedure,C0087111,en_2744,TREATS,Autism spectrum disorder,C1510586,en_5799,1,1,AFFECTS,Inhibitory,3
11129,Therapeutic procedure,C0087111,en_2744,TREATS,Cancer Patient,C1516213,en_5852,3,2,AFFECTS,Inhibitory,6
11130,Therapeutic procedure,C0087111,en_2744,TREATS,Sjogren's Syndrome,C1527336,en_5921,1,1,AFFECTS,Inhibitory,3
11131,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Cerebral Palsy,C0007789,en_605,1,1,AFFECTS,Inhibitory,3
11132,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
11133,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Cystic Fibrosis,C0010674,en_745,2,1,AFFECTS,Inhibitory,3
11134,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Disease,C0012634,en_826,16,5,AFFECTS,Inhibitory,15
11135,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
11136,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Inflammatory Bowel Diseases,C0021390,en_1310,1,1,AFFECTS,Inhibitory,3
11137,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Multiple Sclerosis,C0026769,en_1598,2,2,AFFECTS,Inhibitory,6
11138,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,2,AFFECTS,Inhibitory,6
11139,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Uterine Fibroids,C0042133,en_2324,1,1,AFFECTS,Inhibitory,3
11140,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Diabetic,C0241863,en_3392,2,1,AFFECTS,Inhibitory,3
11141,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,2,1,AFFECTS,Inhibitory,3
11142,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Infectious disorder of bronchus,C0340238,en_3813,1,1,AFFECTS,Inhibitory,3
11143,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Feeling suicidal,C0424000,en_3990,1,1,AFFECTS,Inhibitory,3
11144,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
11145,Therapeutic procedure,C0087111,en_2744,TREATS(INFER),Treatment Resistant Depression,C0871546,en_5026,1,1,AFFECTS,Inhibitory,3
11146,Therapeutic procedure,C0087111,en_2744,TREATS(SPEC),Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
11147,Therapeutic procedure,C0087111,en_2744,TREATS(SPEC),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
11148,Ventilator - respiratory equipment,C0087153,en_2745,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11149,Ventilator - respiratory equipment,C0087153,en_2745,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
11150,Ventilator - respiratory equipment,C0087153,en_2745,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
11151,Ventilator - respiratory equipment,C0087153,en_2745,TREATS,Hypoxia,C0242184,en_3396,2,1,AFFECTS,Inhibitory,3
11152,Levocarnitine,C0087163,en_2746,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11153,Levocarnitine,C0087163,en_2746,TREATS,Research Personnel,C0035173,en_2002,3,1,AFFECTS,Inhibitory,3
11154,Levocarnitine,C0087163,en_2746,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
11155,Youth,C0087178,en_2748,PRODUCES,Study models,C0026336,en_1575,2,1,AFFECTS,Excitatory,3
11156,Neuropilin-1,C0100804,en_2750,STIMULATES,Sodium,C0037473,en_2129,1,1,AFFECTS,Excitatory,3
11157,BANS,C0105185,en_2752,INHIBITS,Traffic,C3840880,en_6254,1,1,AFFECTS,Inhibitory,6
11158,3-Hydroxybutyrate,C0106006,en_2753,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
11159,3-Hydroxybutyrate,C0106006,en_2753,INHIBITS,Interleukin-18,C0383327,en_3902,1,1,AFFECTS,Inhibitory,3
11160,Brain-Derived Neurotrophic Factor,C0107103,en_2754,AFFECTS,Heart,C0018787,en_1130,1,1,AFFECTS,General/Uncertain,3
11161,Vitamin D3 Receptor,C0108082,en_2755,AFFECTS(SPEC),Vitamin D Deficiency,C0042870,en_2372,1,1,AFFECTS,General/Uncertain,3
11162,Vitamin D3 Receptor,C0108082,en_2755,DISRUPTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
11163,Vitamin D3 Receptor,C0108082,en_2755,INHIBITS,Vitamin D,C0042866,en_2371,1,1,AFFECTS,Inhibitory,3
11164,Vitamin D3 Receptor,C0108082,en_2755,STIMULATES,Protein Biosynthesis,C0597295,en_4419,2,1,AFFECTS,Excitatory,3
11165,camostate-mesilate,C0108225,en_2756,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,7
11166,camostate-mesilate,C0108225,en_2756,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,7
11167,camostate-mesilate,C0108225,en_2756,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,7
11168,Cytotoxic T-Lymphocyte-Associated Protein 4,C0111208,en_2760,STIMULATES,"T-Lymphocytes, Cytotoxic",C0039195,en_2199,1,1,AFFECTS,Excitatory,3
11169,Curosurf,C0111318,en_2761,TREATS(SPEC),Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
11170,Dexmedetomidine,C0113293,en_2762,AUGMENTS,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
11171,Dexmedetomidine,C0113293,en_2762,PREVENTS,Atrial Fibrillation,C0004238,en_423,2,1,AFFECTS,Inhibitory,3
11172,Dexmedetomidine,C0113293,en_2762,PREVENTS,Encephalitis,C0014038,en_896,2,1,AFFECTS,Inhibitory,3
11173,Dexmedetomidine,C0113293,en_2762,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
11174,Dexmedetomidine,C0113293,en_2762,TREATS,Delirium,C0011206,en_774,1,1,AFFECTS,Inhibitory,3
11175,Dexmedetomidine,C0113293,en_2762,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
11176,E-Selectin,C0115305,en_2763,STIMULATES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
11177,Ecstasy - drug,C0115471,en_2764,DISRUPTS,Toxic symptom,C0858786,en_4984,1,1,AFFECTS,Inhibitory,3
11178,Ecstasy - drug,C0115471,en_2764,STIMULATES,monoamine,C0599682,en_4464,1,1,AFFECTS,Excitatory,3
11179,esmolol,C0116569,en_2765,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,7
11180,esmolol,C0116569,en_2765,TREATS,Tachycardia,C0039231,en_2203,1,1,AFFECTS,Inhibitory,7
11181,Fluticasone propionate,C0117996,en_2766,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11182,Green Fluorescent Proteins,C0120285,en_2768,PRODUCES,PTH gene,C1419072,en_5712,1,1,AFFECTS,Excitatory,3
11183,ibudilast,C0123047,en_2769,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
11184,Interleukin-12,C0123759,en_2770,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
11185,Interleukin-12,C0123759,en_2770,STIMULATES,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Excitatory,3
11186,khat,C0124604,en_2771,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
11187,Leukotriene E4,C0125644,en_2773,AUGMENTS,Basophils,C0004827,en_447,1,1,AFFECTS,Excitatory,3
11188,Losartan,C0126174,en_2774,INHIBITS,"Receptor, Angiotensin II",C0003011,en_329,1,1,AFFECTS,Inhibitory,3
11189,Losartan,C0126174,en_2774,TREATS,Adult,C0001675,en_252,3,1,AFFECTS,Inhibitory,3
11190,Losartan,C0126174,en_2774,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
11191,Losartan,C0126174,en_2774,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
11192,Losartan,C0126174,en_2774,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
11193,Losartan,C0126174,en_2774,TREATS,Essential Hypertension,C0085580,en_2679,1,1,AFFECTS,Inhibitory,8
11194,Losartan,C0126174,en_2774,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,6
11195,Losartan,C0126174,en_2774,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
11196,Losartan,C0126174,en_2774,TREATS,Cancer Patient,C1516213,en_5852,2,1,AFFECTS,Inhibitory,3
11197,Losartan,C0126174,en_2774,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11198,Losartan,C0126174,en_2774,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,Inhibitory,3
11199,magnesium citrate,C0126774,en_2775,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
11200,Interstitial Collagenase,C0127082,en_2776,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11201,Monocyte Chemoattractant Protein-1,C0128897,en_2777,AFFECTS,Necrosis,C0027540,en_1645,1,1,AFFECTS,General/Uncertain,3
11202,Monocyte Chemoattractant Protein-1|CCL2,C0128897|6347,en_2778,STIMULATES,Myeloid Cells,C0887899,en_5091,1,1,AFFECTS,Excitatory,6
11203,"N,N-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate methanesulfonate",C0129975,en_2779,TREATS,Peptic Esophagitis,C0014869,en_930,2,2,AFFECTS,Inhibitory,6
11204,"N,N-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate methanesulfonate",C0129975,en_2779,TREATS,"Pancreatitis, Chronic",C0149521,en_2802,2,2,AFFECTS,Inhibitory,6
11205,"N,N-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate methanesulfonate",C0129975,en_2779,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
11206,"N,N-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate methanesulfonate",C0129975,en_2779,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11207,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,INHIBITS,CD40LG,C1539082,en_17,1,1,AFFECTS,Inhibitory,3
11208,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,INHIBITS,Elastases,C0699918,en_4708,1,1,AFFECTS,Inhibitory,3
11209,P-Selectin,C0134835,en_2781,AFFECTS,Blood Platelets,C0005821,en_491,1,1,AFFECTS,General/Uncertain,3
11210,P-Selectin,C0134835,en_2781,AFFECTS,Leukocytes,C0023516,en_1420,1,1,AFFECTS,General/Uncertain,3
11211,"SYK protein, human",C0134982,en_2782,AFFECTS(SPEC),Signal Pathways,C0037080,en_2104,2,1,AFFECTS,General/Uncertain,3
11212,"PDCD1 protein, human|PDCD1",C0135710|5133,en_2783,INHIBITS,CD226 antigen,C0665737,en_4529,1,1,AFFECTS,Inhibitory,7
11213,Peptidylprolyl Isomerase,C0136073,en_2784,AFFECTS,protein folding,C0162847,en_2938,2,1,AFFECTS,General/Uncertain,3
11214,Peroxynitrite,C0136157,en_2785,AFFECTS,Protoplasm,C0175996,en_2976,1,1,AFFECTS,General/Uncertain,3
11215,"APEX1 protein, human",C0140145,en_2786,AUGMENTS,Pulmonary Vascular Resistance,C0456261,en_4118,2,1,AFFECTS,Excitatory,3
11216,Retinoid X Receptors,C0140283,en_2787,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
11217,RNase L,C0140694,en_2788,STIMULATES,TLR3 gene,C1336635,en_5632,1,1,AFFECTS,Excitatory,3
11218,Sodium Acetate,C0142785,en_2789,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
11219,Sodium Acetate,C0142785,en_2789,TREATS(INFER),Bronchiolitis,C0006271,en_517,1,1,AFFECTS,Inhibitory,3
11220,Sodium alginate,C0142791,en_2790,AUGMENTS,Viscosity,C0042784,en_2365,1,1,AFFECTS,Excitatory,3
11221,"auR protein, Staphylococcus aureus",C0143595,en_2791,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11222,Teicoplanin,C0145106,en_2792,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,7
11223,Teicoplanin,C0145106,en_2792,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
11224,Thrombomodulin,C0145779,en_2793,INHIBITS,Thrombin,C0040018,en_2228,1,1,AFFECTS,Inhibitory,3
11225,TimeLine,C0145943,en_2794,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
11226,TimeLine,C0145943,en_2794,TREATS,"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,Inhibitory,3
11227,TimeLine,C0145943,en_2794,TREATS,Delivery finding,C0559563,en_4316,1,1,AFFECTS,Inhibitory,3
11228,TimeLine,C0145943,en_2794,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
11229,"TIMP2 protein, human",C0145946,en_2795,STIMULATES,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Excitatory,3
11230,"TIMP2 protein, human",C0145946,en_2795,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11231,Tissue-Inhibitor of Metalloproteinase-1,C0145947,en_2796,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11232,Tissue Inhibitor of Metalloproteinases,C0145988,en_2797,INHIBITS,Matrix Metalloproteinases,C0623362,en_4521,1,1,AFFECTS,Inhibitory,3
11233,Tissue Inhibitor of Metalloproteinases,C0145988,en_2797,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11234,Tissue Inhibitor of Metalloproteinases,C0145988,en_2797,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11235,Tissue Inhibitor of Metalloproteinases,C0145988,en_2797,TREATS(INFER),"Tuberculosis, Lymph Node",C0041316,en_2296,1,1,AFFECTS,Inhibitory,3
11236,Topotecan,C0146224,en_2798,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
11237,Topotecan,C0146224,en_2798,TREATS(INFER),Hypoxia,C0242184,en_3396,1,1,AFFECTS,Inhibitory,3
11238,triphosphate,C0146894,en_2799,INHIBITS,DNA-Directed RNA Polymerase,C0035681,en_2041,5,5,AFFECTS,Inhibitory,15
11239,triphosphate,C0146894,en_2799,STIMULATES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
11240,Hepatitis B surface antigen positive,C0149709,en_2805,PREDISPOSES,Primary carcinoma of the liver cells,C0019204,en_1178,1,1,AFFECTS,Excitatory,3
11241,Steroid therapy,C0149783,en_2809,PREDISPOSES,Immune reconstitution syndrome,C1096197,en_5234,1,1,AFFECTS,Excitatory,3
11242,Steroid therapy,C0149783,en_2809,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
11243,Steroid therapy,C0149783,en_2809,TREATS,Anorexia,C0003123,en_336,1,1,AFFECTS,Inhibitory,3
11244,Steroid therapy,C0149783,en_2809,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
11245,Steroid therapy,C0149783,en_2809,TREATS,Encephalitis,C0014038,en_896,1,1,AFFECTS,Inhibitory,7
11246,Steroid therapy,C0149783,en_2809,TREATS,Patients,C0030705,en_1762,8,5,AFFECTS,Inhibitory,15
11247,Steroid therapy,C0149783,en_2809,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
11248,Steroid therapy,C0149783,en_2809,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
11249,Steroid therapy,C0149783,en_2809,TREATS,Tinnitus,C0040264,en_2241,2,1,AFFECTS,Inhibitory,6
11250,Steroid therapy,C0149783,en_2809,TREATS,Olfaction Disorders,C0553757,en_4291,1,1,AFFECTS,Inhibitory,8
11251,Steroid therapy,C0149783,en_2809,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,7
11252,Steroid therapy,C0149783,en_2809,TREATS,Pulmonary opacity,C4531104,en_6360,1,1,AFFECTS,Inhibitory,6
11253,Steroid therapy,C0149783,en_2809,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,14
11254,Steroid therapy,C0149783,en_2809,TREATS(INFER),Asthma,C0004096,en_418,2,1,AFFECTS,Inhibitory,3
11255,Steroid therapy,C0149783,en_2809,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
11256,Steroid therapy,C0149783,en_2809,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11257,biological adaptation to stress,C0149784,en_2810,AFFECTS,Antibiotic Resistance,C0085818,en_2692,1,1,AFFECTS,General/Uncertain,3
11258,biological adaptation to stress,C0149784,en_2810,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
11259,biological adaptation to stress,C0149784,en_2810,AFFECTS,Predisposition,C0220898,en_3206,1,1,AFFECTS,General/Uncertain,3
11260,VISUAL TRAINING,C0149811,en_2811,AFFECTS,motor ability,C0260026,en_3506,1,1,AFFECTS,General/Uncertain,3
11261,Migraine Disorders,C0149931,en_2813,AFFECTS(SPEC),Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
11262,Chronic pain,C0150055,en_2816,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
11263,Chronic pain,C0150055,en_2816,AFFECTS,AUSTRALIAN,C0238711,en_3369,2,1,AFFECTS,General/Uncertain,3
11264,Chronic pain,C0150055,en_2816,AFFECTS,CANADIAN,C0238884,en_3371,3,2,AFFECTS,General/Uncertain,6
11265,Activity care,C0150123,en_2817,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
11266,Airway management,C0150126,en_2818,TREATS,Patients,C0030705,en_1762,25,2,AFFECTS,Inhibitory,6
11267,Airway management,C0150126,en_2818,TREATS(INFER),Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
11268,Animal-assisted therapy,C0150133,en_2819,PREVENTS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,3
11269,Alleviating anxiety,C0150135,en_2820,AFFECTS,Weaning,C0043084,en_2386,3,1,AFFECTS,General/Uncertain,3
11270,Alleviating anxiety,C0150135,en_2820,TREATS,"Hypermobility, Joint",C0086437,en_2719,1,1,AFFECTS,Inhibitory,7
11271,Alleviating anxiety,C0150135,en_2820,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
11272,Alleviating anxiety,C0150135,en_2820,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11273,Bathing,C0150141,en_2821,PREVENTS,Asthenia,C0004093,en_416,1,1,AFFECTS,Inhibitory,3
11274,Bathing,C0150141,en_2821,PREVENTS,Edema,C0013604,en_877,1,1,AFFECTS,Inhibitory,3
11275,Cognitive restructuring,C0150173,en_2823,TREATS,Irritable Mood,C0022107,en_1361,2,1,AFFECTS,Inhibitory,3
11276,Cognitive restructuring,C0150173,en_2823,TREATS,"Women, Working",C0043215,en_2397,1,1,AFFECTS,Inhibitory,3
11277,Cognitive restructuring,C0150173,en_2823,TREATS,Mental problem,C0848067,en_4929,2,1,AFFECTS,Inhibitory,3
11278,Cognitive stimulation,C0150174,en_2824,TREATS(SPEC),Dementia,C0497327,en_4164,2,1,AFFECTS,Inhibitory,3
11279,Decision making encouragement,C0150185,en_2825,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
11280,Decision making encouragement,C0150185,en_2825,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11281,Decision making encouragement,C0150185,en_2825,TREATS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Inhibitory,3
11282,Decision making encouragement,C0150185,en_2825,TREATS(INFER),Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
11283,Decision making encouragement,C0150185,en_2825,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
11284,Fall prevention,C0150223,en_2826,TREATS,Elderly,C0001792,en_258,2,2,AFFECTS,Inhibitory,6
11285,Fall prevention,C0150223,en_2826,TREATS,Instability,C1444783,en_5750,1,1,AFFECTS,Inhibitory,3
11286,Family support,C0150232,en_2827,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
11287,Family support,C0150232,en_2827,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
11288,Family support,C0150232,en_2827,TREATS(INFER),Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,3
11289,Family support,C0150232,en_2827,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
11290,Fluid monitoring,C0150237,en_2828,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
11291,Infection protection,C0150259,en_2829,STIMULATES,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
11292,Intracranial pressure monitoring regime,C0150260,en_2830,TREATS,CNS disorder,C0007682,en_597,2,1,AFFECTS,Inhibitory,3
11293,Intracranial pressure monitoring regime,C0150260,en_2830,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11294,Medication Management,C0150270,en_2831,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
11295,Medication Management,C0150270,en_2831,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
11296,Medication Management,C0150270,en_2831,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11297,Medication Management,C0150270,en_2831,TREATS,narcotic use,C0240602,en_3386,1,1,AFFECTS,Inhibitory,3
11298,Medication Management,C0150270,en_2831,TREATS,School child,C0260267,en_3511,1,1,AFFECTS,Inhibitory,3
11299,Positioning - therapy,C0150305,en_2832,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
11300,Positioning - therapy,C0150305,en_2832,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,8
11301,Positioning - therapy,C0150305,en_2832,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11302,Present,C0150312,en_2833,PREDISPOSES,Comorbidity,C0009488,en_690,1,1,AFFECTS,Excitatory,6
11303,Present,C0150312,en_2833,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,7
11304,Present,C0150312,en_2833,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
11305,Present,C0150312,en_2833,PREDISPOSES,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,6
11306,Present,C0150312,en_2833,PREDISPOSES,Negative,C0205160,en_3126,1,1,AFFECTS,Excitatory,6
11307,Present,C0150312,en_2833,PREDISPOSES,Worse,C1457868,en_5783,1,1,AFFECTS,Excitatory,6
11308,Present,C0150312,en_2833,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
11309,Substance use therapy,C0150359,en_2834,TREATS,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
11310,Substance use therapy,C0150359,en_2834,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11311,Substance use therapy,C0150359,en_2834,TREATS(INFER),Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
11312,Support system enhancement,C0150365,en_2835,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
11313,Surveillance: safety,C0150370,en_2836,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
11314,Group education,C0150375,en_2837,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
11315,Values clarification,C0150401,en_2838,TREATS,athlete,C0238703,en_3368,1,1,AFFECTS,Inhibitory,3
11316,"Blood gases, arterial measurement",C0150411,en_2839,AFFECTS,Cerebrovascular Circulation,C0007818,en_606,1,1,AFFECTS,General/Uncertain,3
11317,addiction care,C0150444,en_2840,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
11318,addiction care,C0150444,en_2840,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11319,addiction care,C0150444,en_2840,TREATS,Drug Dependence,C1510472,en_5795,1,1,AFFECTS,Inhibitory,3
11320,Anticoagulant therapy,C0150457,en_2841,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
11321,Anticoagulant therapy,C0150457,en_2841,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
11322,Diabetic care,C0150544,en_2842,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11323,Educational Programs,C0150562,en_2843,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,3
11324,Educational Programs,C0150562,en_2843,AFFECTS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,General/Uncertain,3
11325,game,C0150593,en_2844,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11326,game,C0150593,en_2844,TREATS,Child,C0008059,en_620,4,1,AFFECTS,Inhibitory,3
11327,game,C0150593,en_2844,TREATS,student,C0038492,en_2171,1,1,AFFECTS,Inhibitory,3
11328,game,C0150593,en_2844,TREATS,Gegenhalten,C0231519,en_3261,1,1,AFFECTS,Inhibitory,3
11329,game,C0150593,en_2844,TREATS,high school student,C0682176,en_4637,1,1,AFFECTS,Inhibitory,3
11330,game,C0150593,en_2844,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
11331,game,C0150593,en_2844,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11332,Advice,C0150600,en_2845,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
11333,Advice,C0150600,en_2845,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
11334,Advice,C0150600,en_2845,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
11335,Advice,C0150600,en_2845,TREATS,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,6
11336,Advice,C0150600,en_2845,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
11337,Advice,C0150600,en_2845,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
11338,Advice,C0150600,en_2845,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
11339,Advice,C0150600,en_2845,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11340,Advice,C0150600,en_2845,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
11341,Advice,C0150600,en_2845,TREATS,Does turn,C0541749,en_4253,1,1,AFFECTS,Inhibitory,3
11342,Advice,C0150600,en_2845,TREATS,scholar,C0684017,en_4675,1,1,AFFECTS,Inhibitory,3
11343,Advice,C0150600,en_2845,TREATS,Clinicians,C0871685,en_5028,1,1,AFFECTS,Inhibitory,3
11344,Advice,C0150600,en_2845,TREATS,Carer,C1305660,en_5515,1,1,AFFECTS,Inhibitory,3
11345,Guided imagery,C0150627,en_2847,AFFECTS,Anxiety,C0003467,en_380,2,1,AFFECTS,General/Uncertain,8
11346,Guided imagery,C0150627,en_2847,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
11347,Guided imagery,C0150627,en_2847,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,8
11348,Preventing injury,C0150638,en_2848,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
11349,Preventing injury,C0150638,en_2848,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
11350,Interpreter,C0150646,en_2849,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11351,Life Review,C0150659,en_2850,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
11352,Life Review,C0150659,en_2850,TREATS(INFER),Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
11353,Safety precautions,C0150755,en_2851,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,6
11354,Safety precautions,C0150755,en_2851,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
11355,Sex Therapy,C0150764,en_2852,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11356,Shopping,C0150768,en_2853,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
11357,Shopping,C0150768,en_2853,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
11358,Shopping,C0150768,en_2853,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
11359,Skin Care,C0150773,en_2854,AFFECTS,Respiration,C0035203,en_2004,2,1,AFFECTS,General/Uncertain,6
11360,Stress management,C0150788,en_2856,PREVENTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
11361,Stress management,C0150788,en_2856,TREATS,Diabetes,C0011847,en_797,2,1,AFFECTS,Inhibitory,3
11362,Stress management,C0150788,en_2856,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
11363,Stress management,C0150788,en_2856,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
11364,Chronic infectious disease,C0151317,en_2857,PRODUCES,Interleukin-4,C0021758,en_1340,1,1,AFFECTS,Excitatory,3
11365,Chronic infectious disease,C0151317,en_2857,PRODUCES,Interleukin-10,C0085295,en_2659,1,1,AFFECTS,Excitatory,3
11366,Premature Birth,C0151526,en_2860,AFFECTS,Black race,C0005680,en_478,1,1,AFFECTS,General/Uncertain,6
11367,Premature Birth,C0151526,en_2860,AFFECTS,wave,C0678544,en_4560,1,1,AFFECTS,General/Uncertain,3
11368,Premature Birth,C0151526,en_2860,AFFECTS,Biologic Development,C0678723,en_4568,1,1,AFFECTS,General/Uncertain,7
11369,Increased fibrinogen,C0151646,en_2861,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
11370,Increased fibrinogen,C0151646,en_2861,PREDISPOSES,Hyperviscosity,C0221104,en_3216,2,1,AFFECTS,Excitatory,3
11371,Neutrophilia,C0151683,en_2863,PREDISPOSES,Hepatic inflammation,C3275700,en_6195,1,1,AFFECTS,Excitatory,6
11372,Intracranial Hemorrhages,C0151699,en_2864,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
11373,Myocardial Ischemia,C0151744,en_2865,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,7
11374,Liver damage,C0151763,en_2867,AFFECTS,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,General/Uncertain,3
11375,Urinary hesitation,C0152032,en_2878,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
11376,Therapeutic tactile stimulation,C0152054,en_2879,AFFECTS,Olfactory,C0439826,en_4038,1,1,AFFECTS,General/Uncertain,3
11377,Malignant neoplasm of testis,C0153594,en_2883,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
11378,Malignant neoplasm of thorax,C0153661,en_2884,AFFECTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,General/Uncertain,6
11379,Acute myocardial infarction,C0155626,en_2888,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
11380,Extrinsic asthma NOS,C0155877,en_2891,AFFECTS,"Inflammation, allergic",C0021375,en_1308,1,1,AFFECTS,General/Uncertain,3
11381,"Anaemia, postpartum",C0156847,en_2893,PREDISPOSES,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Excitatory,3
11382,abnormal glucose tolerance test,C0159069,en_2895,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
11383,Cardiac complication,C0161816,en_2898,AFFECTS,Fatal Outcome,C0206277,en_3157,1,1,AFFECTS,General/Uncertain,6
11384,Respiratory complication,C0161818,en_2899,AFFECTS,cardiac arrhythmia,C0003811,en_397,2,1,AFFECTS,General/Uncertain,3
11385,Total excision of stomach NOS,C0161899,en_2900,TREATS,Malignant neoplasm of stomach,C0024623,en_1495,1,1,AFFECTS,Inhibitory,3
11386,Cardiovascular monitoring,C0161959,en_2901,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
11387,Cardiovascular monitoring,C0161959,en_2901,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11388,DNA Sequence,C0162326,en_2904,AFFECTS,thermostability,C0597571,en_4431,1,1,AFFECTS,General/Uncertain,6
11389,DNA Sequence,C0162326,en_2904,AFFECTS,Protein-Protein Interaction,C0872079,en_5036,2,2,AFFECTS,General/Uncertain,6
11390,DNA Sequence,C0162326,en_2904,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
11391,DNA Sequence,C0162326,en_2904,STIMULATES,Peptides,C0030956,en_1771,1,1,AFFECTS,Excitatory,3
11392,Allergen Immunotherapy,C0162352,en_2907,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11393,Allergen Immunotherapy,C0162352,en_2907,TREATS(INFER),Allergic rhinitis NOS,C0002103,en_280,2,1,AFFECTS,Inhibitory,3
11394,Ecosystem,C0162358,en_2908,AFFECTS,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
11395,Ecosystem,C0162358,en_2908,AFFECTS,microorganism interaction,C0596935,en_4404,1,1,AFFECTS,General/Uncertain,3
11396,Malnutrition,C0162429,en_2910,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
11397,Malnutrition,C0162429,en_2910,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
11398,Malnutrition,C0162429,en_2910,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
11399,Malnutrition,C0162429,en_2910,AFFECTS,Frail,C0871754,en_5030,1,1,AFFECTS,General/Uncertain,3
11400,Malnutrition,C0162429,en_2910,AFFECTS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,General/Uncertain,3
11401,Malnutrition,C0162429,en_2910,PREDISPOSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
11402,Malnutrition,C0162429,en_2910,PREDISPOSES,loss; bone,C0599877,en_4480,1,1,AFFECTS,Excitatory,3
11403,Transcriptional Activation,C0162493,en_2911,PRODUCES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
11404,Boron Neutron Capture Therapy,C0162505,en_2912,TREATS,Hemangiosarcoma,C0018923,en_1149,1,1,AFFECTS,Inhibitory,3
11405,Angioplasty,C0162577,en_2914,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11406,Angioplasty,C0162577,en_2914,TREATS,Acute myocardial infarction,C0155626,en_2888,1,1,AFFECTS,Inhibitory,3
11407,Angioplasty,C0162577,en_2914,TREATS,STEMI,C1536220,en_5944,1,1,AFFECTS,Inhibitory,3
11408,Angioplasty,C0162577,en_2914,TREATS(INFER),STEMI,C1536220,en_5944,1,1,AFFECTS,Inhibitory,3
11409,Thrombectomy,C0162578,en_2915,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11410,Thrombectomy,C0162578,en_2915,TREATS,Organizing thrombus,C1318539,en_5532,1,1,AFFECTS,Inhibitory,3
11411,"Defibrillators, Implantable",C0162589,en_2917,TREATS,> 2 years,C3843647,en_6263,1,1,AFFECTS,Inhibitory,8
11412,Photoplethysmography,C0162599,en_2919,AFFECTS,microvasculature,C0243079,en_3458,1,1,AFFECTS,General/Uncertain,3
11413,Virus Shedding,C0162633,en_2921,AFFECTS,Scheuermann's Disease,C0036310,en_2066,1,1,AFFECTS,General/Uncertain,8
11414,Apoptosis,C0162638,en_2922,AFFECTS,Microgravity,C0242535,en_3418,1,1,AFFECTS,General/Uncertain,3
11415,Telemedicine,C0162648,en_2924,AFFECTS,Consideration,C0518609,en_4179,1,1,AFFECTS,General/Uncertain,6
11416,Telemedicine,C0162648,en_2924,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
11417,Telemedicine,C0162648,en_2924,TREATS,Celiac Disease,C0007570,en_582,1,1,AFFECTS,Inhibitory,3
11418,Telemedicine,C0162648,en_2924,TREATS,Chronic Disease,C0008679,en_643,2,2,AFFECTS,Inhibitory,9
11419,Telemedicine,C0162648,en_2924,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
11420,Telemedicine,C0162648,en_2924,TREATS,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,Inhibitory,6
11421,Telemedicine,C0162648,en_2924,TREATS,Persons,C0027361,en_1635,5,3,AFFECTS,Inhibitory,9
11422,Telemedicine,C0162648,en_2924,TREATS,Patients,C0030705,en_1762,8,7,AFFECTS,Inhibitory,21
11423,Telemedicine,C0162648,en_2924,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
11424,Telemedicine,C0162648,en_2924,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
11425,Telemedicine,C0162648,en_2924,TREATS,Chronic liver disease NOS,C0341439,en_3823,2,1,AFFECTS,Inhibitory,6
11426,Telemedicine,C0162648,en_2924,TREATS,Advanced chronic liver disease,C0860197,en_4989,1,1,AFFECTS,Inhibitory,3
11427,Telemedicine,C0162648,en_2924,TREATS,Surgical Patients,C0871463,en_5023,1,1,AFFECTS,Inhibitory,7
11428,Telemedicine,C0162648,en_2924,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
11429,Telemedicine,C0162648,en_2924,TREATS(INFER),Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,Inhibitory,3
11430,Telemedicine,C0162648,en_2924,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
11431,Telemedicine,C0162648,en_2924,TREATS(INFER),Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
11432,Telemedicine,C0162648,en_2924,TREATS(INFER),Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,3
11433,Telemedicine,C0162648,en_2924,TREATS(INFER),Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
11434,Telemedicine,C0162648,en_2924,TREATS(SPEC),Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
11435,Telemedicine,C0162648,en_2924,TREATS(SPEC),Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
11436,Orbit Evisceration,C0162661,en_2925,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
11437,Photosensitizing Agents,C0162713,en_2928,INHIBITS,acetonitrile,C0050456,en_2422,1,1,AFFECTS,Inhibitory,3
11438,Photosensitizing Agents,C0162713,en_2928,TREATS,Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,Inhibitory,3
11439,Photosensitizing Agents,C0162713,en_2928,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
11440,HIV Protease Inhibitors,C0162714,en_2929,TREATS,Hepatitis C,C0019196,en_1177,1,1,AFFECTS,Inhibitory,3
11441,HIV Protease Inhibitors,C0162714,en_2929,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11442,Serotonin Uptake Inhibitors,C0162758,en_2930,STIMULATES,sigma-1 receptor,C0539266,en_4247,1,1,AFFECTS,Excitatory,3
11443,Serotonin Uptake Inhibitors,C0162758,en_2930,TREATS,Major Depressive Disorder,C1269683,en_5447,1,1,AFFECTS,Inhibitory,3
11444,Reactive Oxygen Species,C0162772,en_2932,AFFECTS,Stem cells,C0038250,en_2158,1,1,AFFECTS,General/Uncertain,3
11445,Reactive Oxygen Species,C0162772,en_2932,AFFECTS,Surface Properties,C0038884,en_2188,1,1,AFFECTS,General/Uncertain,3
11446,Reactive Oxygen Species,C0162772,en_2932,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
11447,Reactive Oxygen Species,C0162772,en_2932,AUGMENTS,Light absorption,C0234682,en_3311,1,1,AFFECTS,Excitatory,3
11448,Reactive Oxygen Species,C0162772,en_2932,DISRUPTS,"Tumor cells, malignant",C0334227,en_3774,1,1,AFFECTS,Inhibitory,3
11449,Reactive Oxygen Species,C0162772,en_2932,PREDISPOSES,Acute Lung Injury,C0242488,en_3416,2,1,AFFECTS,Excitatory,3
11450,Reactive Oxygen Species,C0162772,en_2932,PREDISPOSES,Injury due to exposure to external cause,C0274281,en_3562,1,1,AFFECTS,Excitatory,3
11451,APC gene,C0162832,en_2936,INHIBITS,triphosphate,C0146894,en_2799,2,1,AFFECTS,Inhibitory,3
11452,APC gene,C0162832,en_2936,PRODUCES,triphosphate,C0146894,en_2799,1,1,AFFECTS,Excitatory,3
11453,Chitosan,C0162969,en_2940,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
11454,Chitosan,C0162969,en_2940,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
11455,Chitosan,C0162969,en_2940,STIMULATES,Dexamethasone,C0011777,en_796,1,1,AFFECTS,Excitatory,3
11456,A 7,C0163299,en_2941,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11457,milbemycin B,C0163557,en_2942,TREATS,Onchocerciasis,C0029001,en_1709,4,1,AFFECTS,Inhibitory,3
11458,Relate,C0163712,en_2943,AUGMENTS,activity level,C0683317,en_4657,1,1,AFFECTS,Excitatory,3
11459,Relate,C0163712,en_2943,PREVENTS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
11460,Relate,C0163712,en_2943,TREATS,Addictive Behavior,C0085281,en_2658,1,1,AFFECTS,Inhibitory,3
11461,Proto-Oncogene Proteins c-akt,C0164786,en_2945,DISRUPTS,anti-apoptosis,C1159816,en_5345,1,1,AFFECTS,Inhibitory,3
11462,Proto-Oncogene Proteins c-akt,C0164786,en_2945,INHIBITS,MAPK8 gene,C1367731,en_5677,1,1,AFFECTS,Inhibitory,3
11463,Proto-Oncogene Proteins c-akt,C0164786,en_2945,STIMULATES,protein kinase B gamma,C0673232,en_4541,1,1,AFFECTS,Excitatory,3
11464,Gelatinase B,C0165519,en_2946,AUGMENTS,fibrogenesis,C0596570,en_4392,1,1,AFFECTS,Excitatory,3
11465,Gelatinase B,C0165519,en_2946,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11466,Gelatinase B|MMP9,C0165519|4318,en_2947,STIMULATES,neutrophil,C0027950,en_1676,1,1,AFFECTS,Excitatory,7
11467,Matrilysin,C0166059,en_2948,AUGMENTS,fibrogenesis,C0596570,en_4392,1,1,AFFECTS,Excitatory,3
11468,Matrilysin,C0166059,en_2948,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11469,Peroxisome Proliferator-Activated Receptors,C0166418,en_2950,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
11470,Peroxisome Proliferator-Activated Receptors,C0166418,en_2950,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
11471,Peroxisome Proliferator-Activated Receptors,C0166418,en_2950,INHIBITS,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Inhibitory,3
11472,rac-PK beta,C0166559,en_2952,STIMULATES,protein kinase B gamma,C0673232,en_4541,1,1,AFFECTS,Excitatory,3
11473,bivalirudin,C0168273,en_2955,AFFECTS,Negative Regulation of Coagulation,C2917212,en_6142,1,1,AFFECTS,General/Uncertain,7
11474,bivalirudin,C0168273,en_2955,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
11475,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11476,Janus kinase 1,C0169658,en_2958,DISRUPTS,Endocytosis,C0014139,en_897,2,1,AFFECTS,Inhibitory,3
11477,Janus kinase 1,C0169658,en_2958,INHIBITS,Janus kinase 2,C0169661,en_2959,2,1,AFFECTS,Inhibitory,3
11478,Janus kinase 2,C0169661,en_2959,DISRUPTS,Endocytosis,C0014139,en_897,2,1,AFFECTS,Inhibitory,3
11479,Janus kinase 2,C0169661,en_2959,INHIBITS,Janus kinase 1,C0169658,en_2958,2,1,AFFECTS,Inhibitory,3
11480,harpin,C0169911,en_2960,AUGMENTS,Awareness,C0004448,en_433,1,1,AFFECTS,Excitatory,3
11481,harpin,C0169911,en_2960,AUGMENTS,Intention,C0162425,en_2909,1,1,AFFECTS,Excitatory,3
11482,Hepatitis A Vaccines,C0170300,en_2961,STIMULATES,trivalent influenza vaccine,C0770694,en_4871,1,1,AFFECTS,Excitatory,8
11483,Arsenal,C0172217,en_2962,TREATS,Bacteria,C0004611,en_440,1,1,AFFECTS,Inhibitory,3
11484,Arsenal,C0172217,en_2962,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
11485,Gelatinase A,C0172537,en_2963,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11486,Neutrophil Collagenase,C0172956,en_2964,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11487,Health evaluation,C0175637,en_2966,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
11488,Health evaluation,C0175637,en_2966,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
11489,Health evaluation,C0175637,en_2966,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
11490,Mats,C0175648,en_2967,PREVENTS,overdose,C4018909,en_6291,3,2,AFFECTS,Inhibitory,6
11491,Mats,C0175648,en_2967,TREATS,Persons,C0027361,en_1635,4,2,AFFECTS,Inhibitory,6
11492,Injury,C0175677,en_2968,DISRUPTS,Lung,C0024109,en_1460,1,1,AFFECTS,Inhibitory,3
11493,Injury,C0175677,en_2968,DISRUPTS,neutrophil,C0027950,en_1676,1,1,AFFECTS,Inhibitory,3
11494,Injury,C0175677,en_2968,DISRUPTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Inhibitory,3
11495,Injury,C0175677,en_2968,DISRUPTS,Blood flow,C0232338,en_3276,2,1,AFFECTS,Inhibitory,3
11496,Clip,C0175722,en_2970,TREATS,Protection,C1545588,en_5951,1,1,AFFECTS,Inhibitory,8
11497,Telephone consultation,C0175745,en_2971,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
11498,Telephone consultation,C0175745,en_2971,TREATS,pharmacist,C0031323,en_1786,2,1,AFFECTS,Inhibitory,3
11499,Telephone consultation,C0175745,en_2971,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
11500,Oral medication,C0175795,en_2972,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
11501,Oral medication,C0175795,en_2972,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
11502,Oral medication,C0175795,en_2972,TREATS,Malaria,C0024530,en_1493,2,1,AFFECTS,Inhibitory,3
11503,calcification,C0175895,en_2974,PREDISPOSES,Sciatica,C0036396,en_2069,2,1,AFFECTS,Excitatory,3
11504,Removal of tracheostomy tube,C0178148,en_2977,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
11505,Intestinal tract infectious disease NOS,C0178238,en_2979,PREDISPOSES,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,Excitatory,3
11506,cofactor,C0178555,en_2985,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
11507,free radical oxygen,C0178645,en_2989,STIMULATES,NADPH Oxidase,C0068355,en_2529,2,1,AFFECTS,Excitatory,3
11508,Nucleocapsid,C0178774,en_2990,STIMULATES,Recombinant Interferon-gamma,C0021740,en_1330,1,1,AFFECTS,Excitatory,3
11509,Organ,C0178784,en_2991,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
11510,Neoplasm progression,C0178874,en_2992,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
11511,Adapters,C0178959,en_2994,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11512,Aerosol Generators,C0178978,en_2995,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
11513,Airway device,C0178987,en_2996,PREVENTS,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,Inhibitory,3
11514,Airway device,C0178987,en_2996,TREATS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,12
11515,Airway device,C0178987,en_2996,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12
11516,Nocturnal bladder warning system,C0178997,en_2997,TREATS,Bedwetting,C0270327,en_3550,1,1,AFFECTS,Inhibitory,3
11517,Analyzer,C0179038,en_2998,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11518,Anesthesia machine,C0179064,en_2999,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11519,Applicator - device,C0179108,en_3000,TREATS,Plague,C0032064,en_1814,1,1,AFFECTS,Inhibitory,3
11520,Apron,C0179129,en_3001,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
11521,Bowls,C0179395,en_3002,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
11522,"Cannulae, Nasal",C0179574,en_3003,TREATS,Patients,C0030705,en_1762,9,6,AFFECTS,Inhibitory,18
11523,"Cannulae, Nasal",C0179574,en_3003,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
11524,"Cannulae, Nasal",C0179574,en_3003,TREATS,Acute respiratory failure,C0264490,en_3533,2,2,AFFECTS,Inhibitory,11
11525,"Cannulae, Nasal",C0179574,en_3003,TREATS,Respiratory failure without hypercapnia,C0340194,en_3812,2,1,AFFECTS,Inhibitory,6
11526,"Cannulae, Nasal",C0179574,en_3003,TREATS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,3
11527,"Cannulae, Nasal",C0179574,en_3003,TREATS,cohort,C0599755,en_4470,2,1,AFFECTS,Inhibitory,6
11528,"Cannulae, Nasal",C0179574,en_3003,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,8
11529,"Cannulae, Nasal",C0179574,en_3003,TREATS,Respiratory Failure,C1145670,en_5292,5,3,AFFECTS,Inhibitory,15
11530,"Cannulae, Nasal",C0179574,en_3003,TREATS,Acute hypoxemic respiratory failure,C4039867,en_6301,2,2,AFFECTS,Inhibitory,14
11531,"Cannulae, Nasal",C0179574,en_3003,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,6
11532,"Cannulae, Nasal",C0179574,en_3003,TREATS,COVID-19,C5203670,en_6417,12,6,AFFECTS,Inhibitory,38
11533,"Cannulae, Nasal",C0179574,en_3003,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
11534,"Cannulae, Nasal",C0179574,en_3003,TREATS(INFER),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
11535,Dialysis catheter,C0179747,en_3004,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11536,Ventricular assist device,C0179926,en_3005,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
11537,Cold pack,C0180006,en_3006,PREVENTS,Heat Stress Disorders,C0282507,en_3649,1,1,AFFECTS,Inhibitory,3
11538,Cushions,C0180249,en_3007,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
11539,Detectors,C0180392,en_3008,TREATS,Vitality,C0424589,en_3997,1,1,AFFECTS,Inhibitory,3
11540,Laryngoscopes,C0180453,en_3009,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11541,Dispensers,C0180463,en_3010,PREVENTS,Wounds and Injuries,C0043251,en_2401,1,1,AFFECTS,Inhibitory,3
11542,Dispensers,C0180463,en_3010,TREATS,Cleaners Occupation,C0402683,en_3961,1,1,AFFECTS,Inhibitory,3
11543,Surgical Helmet Systems,C0180797,en_3011,PREVENTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
11544,Explorers,C0180799,en_3012,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11545,Explorers,C0180799,en_3012,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,3
11546,Filters,C0180860,en_3013,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
11547,Filters,C0180860,en_3013,PREVENTS,Seizures,C0036572,en_2076,1,1,AFFECTS,Inhibitory,3
11548,Filters,C0180860,en_3013,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11549,Filters,C0180860,en_3013,TREATS,Secondary transmission,C0948191,en_5161,1,1,AFFECTS,Inhibitory,3
11550,Filters,C0180860,en_3013,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
11551,"Filters, Blood",C0180863,en_3014,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
11552,Filtration Systems,C0180877,en_3015,TREATS,Smarting pain,C0235048,en_3319,1,1,AFFECTS,Inhibitory,3
11553,Frame,C0180979,en_3016,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11554,Frame,C0180979,en_3016,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11555,Gauze,C0181024,en_3017,TREATS,Nail infection NOS,C0343026,en_3830,2,2,AFFECTS,Inhibitory,6
11556,Gown,C0181064,en_3018,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
11557,Gown,C0181064,en_3018,TREATS,Protection,C1545588,en_5951,1,1,AFFECTS,Inhibitory,6
11558,Hampers,C0181113,en_3020,TREATS,Financial problem,C0549106,en_4277,1,1,AFFECTS,Inhibitory,3
11559,Heating Units,C0181158,en_3021,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
11560,Hoods,C2720748,en_6130,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
11561,"Hoods, Oxygen",C0181208,en_3023,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11562,"Hoods, Oxygen",C0181208,en_3023,TREATS(INFER),Hypoxia,C0242184,en_3396,2,1,AFFECTS,Inhibitory,3
11563,Hoist device,C0181620,en_3024,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
11564,Hoist device,C0181620,en_3024,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
11565,Mailers,C0181711,en_3026,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11566,Radiology marker,C0181741,en_3027,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
11567,Surgical face mask,C0181758,en_3028,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11568,Surgical face mask,C0181758,en_3028,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
11569,Microscope,C0181839,en_3029,TREATS,Gegenhalten,C0231519,en_3261,1,1,AFFECTS,Inhibitory,3
11570,Microscope,C0181839,en_3029,TREATS,Normal sensation,C0576709,en_4336,1,1,AFFECTS,Inhibitory,3
11571,Biomedical Monitors,C0181904,en_3030,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
11572,Biomedical Monitors,C0181904,en_3030,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11573,Biomedical Monitors,C0181904,en_3030,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
11574,Biomedical Monitors,C0181904,en_3030,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
11575,Biomedical Monitors,C0181904,en_3030,TREATS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,Inhibitory,3
11576,Biomedical Monitors,C0181904,en_3030,TREATS,Carbon dioxide concentration,C0428653,en_4014,1,1,AFFECTS,Inhibitory,8
11577,"Oximeters, Pulse",C0182109,en_3031,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
11578,Oxygen Generators,C0182128,en_3032,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11579,Plug,C0182324,en_3033,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11580,Plug,C0182324,en_3033,TREATS,Individual,C0237401,en_3343,3,2,AFFECTS,Inhibitory,6
11581,Probes,C0182400,en_3034,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11582,Probes,C0182400,en_3034,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
11583,Probes,C0182400,en_3034,TREATS(INFER),nervous system disorder,C0027765,en_1659,4,1,AFFECTS,Inhibitory,3
11584,pump (device),C0182537,en_3035,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11585,Gamma Knife,C0182639,en_3036,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11586,Gamma Knife,C0182639,en_3036,TREATS,Metastatic malignant neoplasm to brain,C0220650,en_3198,1,1,AFFECTS,Inhibitory,3
11587,Gamma Knife,C0182639,en_3036,TREATS,Supervisor NOS,C0403172,en_3963,1,1,AFFECTS,Inhibitory,3
11588,Gamma Knife,C0182639,en_3036,TREATS(INFER),Glioblastoma,C0017636,en_1062,1,1,AFFECTS,Inhibitory,3
11589,Reservoirs,C0182967,en_3037,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
11590,Reservoirs,C0182967,en_3037,TREATS,Rabies,C0034494,en_1948,1,1,AFFECTS,Inhibitory,3
11591,Reservoirs,C0182967,en_3037,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
11592,Reservoirs,C0182967,en_3037,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11593,Resuscitator,C0182998,en_3038,TREATS,Endemic Flea-Borne Typhus,C0041472,en_2303,1,1,AFFECTS,Inhibitory,3
11594,Scanning Systems,C0183115,en_3039,TREATS,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,Inhibitory,3
11595,Scanning Systems,C0183115,en_3039,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
11596,Scanning Systems,C0183115,en_3039,TREATS,Does run,C0600140,en_4498,1,1,AFFECTS,Inhibitory,3
11597,Screens,C0183185,en_3040,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
11598,Screens,C0183185,en_3040,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
11599,Screens,C0183185,en_3040,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
11600,Sensors,C0183210,en_3041,PREVENTS,Wasting,C0235394,en_3327,1,1,AFFECTS,Inhibitory,3
11601,Sensors,C0183210,en_3041,TREATS,Cross Infection,C0010356,en_735,1,1,AFFECTS,Inhibitory,3
11602,Sensors,C0183210,en_3041,TREATS,Households,C0020052,en_1208,3,1,AFFECTS,Inhibitory,3
11603,Sensors,C0183210,en_3041,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
11604,Sensors,C0183210,en_3041,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,7
11605,Sensors,C0183210,en_3041,TREATS,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,Inhibitory,3
11606,Sensors,C0183210,en_3041,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
11607,Sensors,C0183210,en_3041,TREATS,Virus Diseases,C0042769,en_2362,5,3,AFFECTS,Inhibitory,9
11608,Sensors,C0183210,en_3041,TREATS,Illness (finding),C0221423,en_3224,1,1,AFFECTS,Inhibitory,7
11609,Sensors,C0183210,en_3041,TREATS,DISEASES/DIAGNOSES,C0338067,en_3801,1,1,AFFECTS,Inhibitory,3
11610,Sensors,C0183210,en_3041,TREATS,Readiness,C1318963,en_5534,1,1,AFFECTS,Inhibitory,3
11611,Shield,C0183251,en_3042,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
11612,Shield,C0183251,en_3042,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
11613,Shield,C0183251,en_3042,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
11614,Face Shields,C0183255,en_3043,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
11615,Face Shields,C0183255,en_3043,TREATS,Protection,C1545588,en_5951,1,1,AFFECTS,Inhibitory,6
11616,Simulators,C0183309,en_3044,TREATS,Short menstrual periods,C0425946,en_4006,1,1,AFFECTS,Inhibitory,8
11617,Stethoscopes,C0183559,en_3045,TREATS,inpatient,C0021562,en_1321,2,1,AFFECTS,Inhibitory,3
11618,Timer,C0183941,en_3047,TREATS,Judge,C0221191,en_3220,1,1,AFFECTS,Inhibitory,3
11619,Traps,C0184047,en_3048,PREVENTS,Respiratory distress,C0476273,en_4149,2,1,AFFECTS,Inhibitory,3
11620,Traps,C0184047,en_3048,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11621,Traps,C0184047,en_3048,TREATS,Patients,C0030705,en_1762,6,4,AFFECTS,Inhibitory,12
11622,Traps,C0184047,en_3048,TREATS,Vasculitis,C0042384,en_2338,1,1,AFFECTS,Inhibitory,3
11623,Traps,C0184047,en_3048,TREATS,Injury,C0175677,en_2968,2,2,AFFECTS,Inhibitory,6
11624,Traps,C0184047,en_3048,TREATS,Vitality,C0424589,en_3997,1,1,AFFECTS,Inhibitory,3
11625,Traps,C0184047,en_3048,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11626,Treadmill,C0184069,en_3049,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11627,Treadmill,C0184069,en_3049,TREATS(INFER),Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
11628,Vial device,C0184301,en_3051,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
11629,Bereavement support,C0184586,en_3055,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
11630,Medication Side Effects,C0184617,en_3056,TREATS,Gastroesophageal reflux disease,C0017168,en_1038,1,1,AFFECTS,Inhibitory,3
11631,Physical Health Care,C0184627,en_3057,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11632,Individual Safety,C0184641,en_3058,TREATS,family system,C0680024,en_4619,1,1,AFFECTS,Inhibitory,3
11633,Mental health care,C0184643,en_3059,TREATS,Older people,C3826770,en_6248,1,1,AFFECTS,Inhibitory,6
11634,Mental health care,C0184643,en_3059,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11635,Mental health care,C0184643,en_3059,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
11636,Mental health care,C0184643,en_3059,TREATS,Drug abuse,C0013146,en_851,1,1,AFFECTS,Inhibitory,3
11637,Mental health care,C0184643,en_3059,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
11638,Mental health care,C0184643,en_3059,TREATS,African race,C0027567,en_1646,2,2,AFFECTS,Inhibitory,6
11639,Mental health care,C0184643,en_3059,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
11640,Mental health care,C0184643,en_3059,TREATS,Public Health Nurses,C0034022,en_1926,1,1,AFFECTS,Inhibitory,3
11641,Mental health care,C0184643,en_3059,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
11642,Mental health care,C0184643,en_3059,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11643,Mental health care,C0184643,en_3059,TREATS,CANADIAN,C0238884,en_3371,1,1,AFFECTS,Inhibitory,3
11644,Mental health care,C0184643,en_3059,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11645,Mental health care,C0184643,en_3059,TREATS,Latinas,C0949335,en_5179,1,1,AFFECTS,Inhibitory,3
11646,Mental health care,C0184643,en_3059,TREATS,Provider,C1138603,en_5273,1,1,AFFECTS,Inhibitory,3
11647,Mental health care,C0184643,en_3059,TREATS,Teens,C1521910,en_5899,2,1,AFFECTS,Inhibitory,3
11648,Mental health care,C0184643,en_3059,TREATS(INFER),Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
11649,Mental health promotion,C0184645,en_3060,TREATS,"Students, Nursing",C0038496,en_2173,1,1,AFFECTS,Inhibitory,3
11650,Mental health treatment,C0184647,en_3061,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
11651,Mental health treatment,C0184647,en_3061,TREATS(INFER),Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,3
11652,Mental health treatment,C0184647,en_3061,TREATS(INFER),Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
11653,Procedures,C0184661,en_3062,PREVENTS,Social stigmata,C0277787,en_3590,2,1,AFFECTS,Inhibitory,3
11654,Procedures,C0184661,en_3062,TREATS,Child,C0008059,en_620,3,2,AFFECTS,Inhibitory,6
11655,Procedures,C0184661,en_3062,TREATS,Disease,C0012634,en_826,4,4,AFFECTS,Inhibitory,12
11656,Procedures,C0184661,en_3062,TREATS,Family,C0015576,en_961,2,1,AFFECTS,Inhibitory,3
11657,Procedures,C0184661,en_3062,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
11658,Procedures,C0184661,en_3062,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
11659,Procedures,C0184661,en_3062,TREATS,Patients,C0030705,en_1762,12,10,AFFECTS,Inhibitory,30
11660,Procedures,C0184661,en_3062,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
11661,Procedures,C0184661,en_3062,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11662,Procedures,C0184661,en_3062,TREATS,Seizures,C0036572,en_2076,1,1,AFFECTS,Inhibitory,3
11663,Procedures,C0184661,en_3062,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
11664,Procedures,C0184661,en_3062,TREATS,May-Hegglin anomaly,C0340978,en_3822,1,1,AFFECTS,Inhibitory,3
11665,Procedures,C0184661,en_3062,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11666,Procedures,C0184661,en_3062,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
11667,Procedures,C0184661,en_3062,TREATS,Staff,C0851286,en_4950,1,1,AFFECTS,Inhibitory,3
11668,Procedures,C0184661,en_3062,TREATS,Adverse effects,C0879626,en_5081,2,1,AFFECTS,Inhibitory,3
11669,Procedures,C0184661,en_3062,TREATS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
11670,Procedures,C0184661,en_3062,TREATS,Provider,C1138603,en_5273,1,1,AFFECTS,Inhibitory,3
11671,Procedures,C0184661,en_3062,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11672,Procedures,C0184661,en_3062,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
11673,Procedures,C0184661,en_3062,TREATS(INFER),Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,3
11674,Procedures,C0184661,en_3062,TREATS(SPEC),Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
11675,Procedures,C0184661,en_3062,AFFECTS,Blood Pressure,C0005823,en_492,2,1,AFFECTS,General/Uncertain,8
11676,Procedures,C0184661,en_3062,AFFECTS,Complication,C0009566,en_697,2,1,AFFECTS,General/Uncertain,6
11677,Procedures,C0184661,en_3062,AFFECTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,8
11678,Procedures,C0184661,en_3062,AFFECTS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,General/Uncertain,8
11679,Procedures,C0184661,en_3062,AFFECTS,COVID-19,C5203670,en_6417,4,4,AFFECTS,General/Uncertain,30
11680,Procedures,C0184661,en_3062,PREDISPOSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,8
11681,Procedures,C0184661,en_3062,PREVENTS,Anxiety,C0003467,en_380,2,2,AFFECTS,Inhibitory,16
11682,Procedures,C0184661,en_3062,PREVENTS,Asthenopia,C0004095,en_417,1,1,AFFECTS,Inhibitory,8
11683,Procedures,C0184661,en_3062,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
11684,Procedures,C0184661,en_3062,PREVENTS,Abnormal behavior,C0233514,en_3296,1,1,AFFECTS,Inhibitory,7
11685,Procedures,C0184661,en_3062,PREVENTS,Cancerophobia,C0233705,en_3299,1,1,AFFECTS,Inhibitory,8
11686,Procedures,C0184661,en_3062,PREVENTS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,7
11687,Procedures,C0184661,en_3062,PREVENTS,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,7
11688,Procedures,C0184661,en_3062,PREVENTS,Nosocomial pneumonia,C0949083,en_5175,1,1,AFFECTS,Inhibitory,8
11689,Procedures,C0184661,en_3062,PREVENTS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,23
11690,Procedures,C0184661,en_3062,TREATS,Anorexia,C0003123,en_336,1,1,AFFECTS,Inhibitory,6
11691,Procedures,C0184661,en_3062,TREATS,Anxiety,C0003467,en_380,3,2,AFFECTS,Inhibitory,16
11692,Procedures,C0184661,en_3062,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,7
11693,Procedures,C0184661,en_3062,TREATS,Depressive disorder,C0011581,en_788,3,2,AFFECTS,Inhibitory,16
11694,Procedures,C0184661,en_3062,TREATS,Medical Staff,C0025106,en_1519,1,1,AFFECTS,Inhibitory,7
11695,Procedures,C0184661,en_3062,TREATS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,6
11696,Procedures,C0184661,en_3062,TREATS,"Students, Medical",C0038495,en_2172,1,1,AFFECTS,Inhibitory,8
11697,Procedures,C0184661,en_3062,TREATS,Caregiver,C0085537,en_2674,1,1,AFFECTS,Inhibitory,8
11698,Procedures,C0184661,en_3062,TREATS,Cephalopelvic Disproportion,C0085988,en_2699,1,1,AFFECTS,Inhibitory,6
11699,Procedures,C0184661,en_3062,TREATS,Family member,C0086282,en_2712,1,1,AFFECTS,Inhibitory,8
11700,Procedures,C0184661,en_3062,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,8
11701,Procedures,C0184661,en_3062,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,8
11702,Procedures,C0184661,en_3062,TREATS,Distress,C0231303,en_3256,1,1,AFFECTS,Inhibitory,7
11703,Procedures,C0184661,en_3062,TREATS,Medication use,C0240320,en_3383,1,1,AFFECTS,Inhibitory,6
11704,Procedures,C0184661,en_3062,TREATS,Smoker,C0337664,en_3793,1,1,AFFECTS,Inhibitory,8
11705,Procedures,C0184661,en_3062,TREATS,Frailty,C0424594,en_3998,3,2,AFFECTS,Inhibitory,14
11706,Procedures,C0184661,en_3062,TREATS,Passenger,C0450048,en_4080,1,1,AFFECTS,Inhibitory,6
11707,Procedures,C0184661,en_3062,TREATS,Emotional problems,C0677660,en_4546,1,1,AFFECTS,Inhibitory,7
11708,Procedures,C0184661,en_3062,TREATS,parental mental health,C0814575,en_4916,1,1,AFFECTS,Inhibitory,8
11709,Procedures,C0184661,en_3062,TREATS,Clinicians,C0871685,en_5028,1,1,AFFECTS,Inhibitory,8
11710,Procedures,C0184661,en_3062,TREATS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,Inhibitory,6
11711,Procedures,C0184661,en_3062,TREATS,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,8
11712,Procedures,C0184661,en_3062,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,8
11713,Procedures,C0184661,en_3062,TREATS,Workers,C1527116,en_5916,1,1,AFFECTS,Inhibitory,8
11714,Procedures,C0184661,en_3062,TREATS,Functional capacity,C1998319,en_6082,1,1,AFFECTS,Inhibitory,7
11715,Procedures,C0184661,en_3062,TREATS,Intervention Group,C2986530,en_6170,3,3,AFFECTS,Inhibitory,23
11716,Procedures,C0184661,en_3062,TREATS,Sequential Organ Failure Assessment Scores,C3494459,en_6204,1,1,AFFECTS,Inhibitory,7
11717,Procedures,C0184661,en_3062,TREATS,Serious mental illness,C3841614,en_6258,1,1,AFFECTS,Inhibitory,8
11718,Procedures,C0184661,en_3062,TREATS,Autistic symptoms,C4314700,en_6339,1,1,AFFECTS,Inhibitory,8
11719,Procedures,C0184661,en_3062,TREATS,COVID-19,C5203670,en_6417,5,5,AFFECTS,Inhibitory,38
11720,Procedures,C0184661,en_3062,TREATS,Treatment Group,C5205742,en_6422,2,2,AFFECTS,Inhibitory,15
11721,Procedures,C0184661,en_3062,TREATS,Experimental Group,C5205743,en_6423,1,1,AFFECTS,Inhibitory,8
11722,Hospital admission,C0184666,en_3063,AFFECTS,Body Weight decreased,C0043096,en_2389,3,2,AFFECTS,General/Uncertain,6
11723,Hospital admission,C0184666,en_3063,PREVENTS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,6
11724,Hospital admission,C0184666,en_3063,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11725,Hospital admission,C0184666,en_3063,TREATS,Acute Disease,C0001314,en_230,2,1,AFFECTS,Inhibitory,6
11726,Hospital admission,C0184666,en_3063,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
11727,Hospital admission,C0184666,en_3063,TREATS,Carpal Tunnel Syndrome,C0007286,en_572,1,1,AFFECTS,Inhibitory,6
11728,Hospital admission,C0184666,en_3063,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
11729,Hospital admission,C0184666,en_3063,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,6
11730,Hospital admission,C0184666,en_3063,TREATS,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,Inhibitory,6
11731,Hospital admission,C0184666,en_3063,TREATS,Disease,C0012634,en_826,3,3,AFFECTS,Inhibitory,15
11732,Hospital admission,C0184666,en_3063,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
11733,Hospital admission,C0184666,en_3063,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
11734,Hospital admission,C0184666,en_3063,TREATS,inpatient,C0021562,en_1321,2,1,AFFECTS,Inhibitory,3
11735,Hospital admission,C0184666,en_3063,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
11736,Hospital admission,C0184666,en_3063,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
11737,Hospital admission,C0184666,en_3063,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
11738,Hospital admission,C0184666,en_3063,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
11739,Hospital admission,C0184666,en_3063,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
11740,Hospital admission,C0184666,en_3063,TREATS,Seizures,C0036572,en_2076,2,1,AFFECTS,Inhibitory,6
11741,Hospital admission,C0184666,en_3063,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
11742,Hospital admission,C0184666,en_3063,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
11743,Hospital admission,C0184666,en_3063,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,6
11744,Hospital admission,C0184666,en_3063,TREATS,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,Inhibitory,3
11745,Hospital admission,C0184666,en_3063,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,6
11746,Hospital admission,C0184666,en_3063,TREATS,Acute myocardial infarction,C0155626,en_2888,6,3,AFFECTS,Inhibitory,18
11747,Hospital admission,C0184666,en_3063,TREATS,Survivors,C0206194,en_3154,2,2,AFFECTS,Inhibitory,14
11748,Hospital admission,C0184666,en_3063,TREATS,Form of muscle,C0240417,en_3384,1,1,AFFECTS,Inhibitory,6
11749,Hospital admission,C0184666,en_3063,TREATS,Chronic disease of respiratory system,C0264220,en_3528,1,1,AFFECTS,Inhibitory,6
11750,Hospital admission,C0184666,en_3063,TREATS,[X]Unspecified osteoporosis with pathological fracture,C0521170,en_4197,1,1,AFFECTS,Inhibitory,6
11751,Hospital admission,C0184666,en_3063,TREATS,cohort,C0599755,en_4470,3,3,AFFECTS,Inhibitory,12
11752,Hospital admission,C0184666,en_3063,TREATS,General Population,C0683971,en_4674,3,1,AFFECTS,Inhibitory,3
11753,Hospital admission,C0184666,en_3063,TREATS,Acute coronary syndrome,C0948089,en_5159,5,2,AFFECTS,Inhibitory,12
11754,Hospital admission,C0184666,en_3063,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
11755,Hospital admission,C0184666,en_3063,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,6
11756,Hospital admission,C0184666,en_3063,TREATS,Symptoms,C1457887,en_5784,5,4,AFFECTS,Inhibitory,12
11757,Hospital admission,C0184666,en_3063,TREATS,STEMI,C1536220,en_5944,1,1,AFFECTS,Inhibitory,6
11758,Hospital admission,C0184666,en_3063,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,Inhibitory,6
11759,Hospital admission,C0184666,en_3063,TREATS,Non-ST Elevation Myocardial Infarction by ECG Finding,C3537184,en_6208,1,1,AFFECTS,Inhibitory,6
11760,Hospital admission,C0184666,en_3063,TREATS,At higher risk,C3843761,en_6264,1,1,AFFECTS,Inhibitory,7
11761,Hospital admission,C0184666,en_3063,TREATS,Hemorrhagic cerebrovascular disease,C4478521,en_6349,4,1,AFFECTS,Inhibitory,6
11762,Hospital admission,C0184666,en_3063,TREATS,COVID-19,C5203670,en_6417,21,21,AFFECTS,Inhibitory,131
11763,Hospital admission,C0184666,en_3063,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11764,Hospital admission,C0184666,en_3063,TREATS(SPEC),Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
11765,Admit hospital emergency NOS,C0184673,en_3064,PREVENTS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,6
11766,Admit hospital emergency NOS,C0184673,en_3064,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11767,Emergency operation,C0184893,en_3065,TREATS,"Abdomen, Acute",C0000727,en_205,1,1,AFFECTS,Inhibitory,6
11768,Emergency operation,C0184893,en_3065,TREATS,Hip Fractures,C0019557,en_1185,1,1,AFFECTS,Inhibitory,7
11769,Emergency operation,C0184893,en_3065,TREATS,Peritonitis,C0031154,en_1778,1,1,AFFECTS,Inhibitory,6
11770,Emergency operation,C0184893,en_3065,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
11771,Emergency operation,C0184893,en_3065,TREATS,Infected,C0439663,en_4036,1,1,AFFECTS,Inhibitory,6
11772,Emergency operation,C0184893,en_3065,TREATS,Secondary Peritonitis,C1449647,en_5760,1,1,AFFECTS,Inhibitory,6
11773,Reparative closure,C0185003,en_3066,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
11774,Reparative closure,C0185003,en_3066,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
11775,Reparative closure,C0185003,en_3066,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
11776,Reparative closure,C0185003,en_3066,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
11777,Reparative closure,C0185003,en_3066,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
11778,Reparative closure,C0185003,en_3066,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
11779,Reparative closure,C0185003,en_3066,TREATS,Addictive Behavior,C0085281,en_2658,1,1,AFFECTS,Inhibitory,3
11780,Reparative closure,C0185003,en_3066,TREATS,Emotional,C0849912,en_4937,1,1,AFFECTS,Inhibitory,3
11781,Imbrication,C0185027,en_3067,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11782,fragmentation procedure,C0185061,en_3068,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
11783,Therapeutic Mobilization,C0185112,en_3069,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
11784,Manual reduction,C0185114,en_3070,STIMULATES,Emission,C0233929,en_3301,1,1,AFFECTS,Excitatory,3
11785,Extraction,C0185115,en_3071,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
11786,Extraction,C0185115,en_3071,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
11787,Extraction,C0185115,en_3071,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
11788,Extraction,C0185115,en_3071,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
11789,Extraction,C0185115,en_3071,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
11790,Extraction,C0185115,en_3071,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
11791,Extraction,C0185115,en_3071,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,7
11792,Extraction,C0185115,en_3071,TREATS,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Inhibitory,6
11793,Extraction,C0185115,en_3071,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
11794,Extraction,C0185115,en_3071,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11795,Extraction,C0185115,en_3071,TREATS(INFER),hearing impairment,C1384666,en_5689,1,1,AFFECTS,Inhibitory,3
11796,Operation on joint,C0185132,en_3072,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
11797,Operation on joint,C0185132,en_3072,TREATS,Severe pain,C0278140,en_3598,1,1,AFFECTS,Inhibitory,3
11798,Orthognathic operation of mandible,C0185624,en_3074,TREATS,skin disorder,C0037274,en_2115,2,2,AFFECTS,Inhibitory,6
11799,Osteotomy of tibia,C0187826,en_3075,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11800,"Endotracheal intubation, emergency procedure",C0189377,en_3076,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
11801,Procedure on cardiovascular system,C0189573,en_3077,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,3
11802,Open heart surgery,C0189745,en_3078,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11803,Excision of left hemicolon NOS,C0192865,en_3079,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
11804,Excision of left hemicolon NOS,C0192865,en_3079,TREATS,Diverticular Diseases,C4317009,en_6340,1,1,AFFECTS,Inhibitory,6
11805,Excision of sigmoid colon NOS,C0192866,en_3080,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
11806,Excision of sigmoid colon NOS,C0192866,en_3080,TREATS,Diverticular Diseases,C4317009,en_6340,1,1,AFFECTS,Inhibitory,6
11807,Operation on pancreas,C0193594,en_3081,PREDISPOSES,Massive hemorrhage,C0333279,en_3761,1,1,AFFECTS,Excitatory,3
11808,Operation on pancreas,C0193594,en_3081,TREATS,Hemophiliacs,C0259931,en_3504,1,1,AFFECTS,Inhibitory,3
11809,Radical excision of lymph nodes,C0193854,en_3082,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11810,Radical excision of lymph nodes,C0193854,en_3082,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
11811,Autologous bone marrow transplant,C0194037,en_3083,AFFECTS,Blood flow,C0232338,en_3276,1,1,AFFECTS,General/Uncertain,3
11812,Radical prostatectomy,C0194810,en_3084,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11813,Posterior repair of vagina,C0195230,en_3085,AFFECTS,Obstruction,C0028778,en_1702,1,1,AFFECTS,General/Uncertain,8
11814,Cervicectomy,C0195331,en_3086,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
11815,Cervicectomy,C0195331,en_3086,TREATS,Cervical carcinoma stage IA,C0278587,en_3603,1,1,AFFECTS,Inhibitory,6
11816,Stellate ganglion block,C0196728,en_3087,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11817,Stellate ganglion block,C0196728,en_3087,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
11818,Medical service,C0199168,en_3088,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
11819,Medical service,C0199168,en_3088,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
11820,Medical procedure,C0199171,en_3089,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
11821,Medical procedure,C0199171,en_3089,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
11822,Medical procedure,C0199171,en_3089,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
11823,Medical procedure,C0199171,en_3089,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11824,Prophylactic treatment,C0199176,en_3090,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
11825,Prophylactic treatment,C0199176,en_3090,AFFECTS,Complication,C0009566,en_697,3,2,AFFECTS,General/Uncertain,6
11826,Prophylactic treatment,C0199176,en_3090,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
11827,Prophylactic treatment,C0199176,en_3090,AFFECTS,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
11828,Prophylactic treatment,C0199176,en_3090,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
11829,Prophylactic treatment,C0199176,en_3090,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
11830,Prophylactic treatment,C0199176,en_3090,AFFECTS,Migraine Disorders,C0149931,en_2813,1,1,AFFECTS,General/Uncertain,3
11831,Prophylactic treatment,C0199176,en_3090,AFFECTS,Dementia,C0497327,en_4164,1,1,AFFECTS,General/Uncertain,3
11832,Prophylactic treatment,C0199176,en_3090,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
11833,Prophylactic treatment,C0199176,en_3090,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
11834,Prophylactic treatment,C0199176,en_3090,PREVENTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,3
11835,Prophylactic treatment,C0199176,en_3090,PREVENTS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
11836,Prophylactic treatment,C0199176,en_3090,PREVENTS,Diastasis,C0036679,en_2084,1,1,AFFECTS,Inhibitory,3
11837,Prophylactic treatment,C0199176,en_3090,PREVENTS,Suicide,C0038661,en_2178,1,1,AFFECTS,Inhibitory,3
11838,Prophylactic treatment,C0199176,en_3090,PREVENTS,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,Inhibitory,7
11839,Prophylactic treatment,C0199176,en_3090,PREVENTS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
11840,Prophylactic treatment,C0199176,en_3090,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
11841,Prophylactic treatment,C0199176,en_3090,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11842,Prophylactic treatment,C0199176,en_3090,TREATS,Adult,C0001675,en_252,12,7,AFFECTS,Inhibitory,26
11843,Prophylactic treatment,C0199176,en_3090,TREATS,Mental disorders,C0004936,en_452,4,1,AFFECTS,Inhibitory,3
11844,Prophylactic treatment,C0199176,en_3090,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
11845,Prophylactic treatment,C0199176,en_3090,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,6
11846,Prophylactic treatment,C0199176,en_3090,TREATS,Complication,C0009566,en_697,2,2,AFFECTS,Inhibitory,11
11847,Prophylactic treatment,C0199176,en_3090,TREATS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,Inhibitory,3
11848,Prophylactic treatment,C0199176,en_3090,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,3,1,AFFECTS,Inhibitory,3
11849,Prophylactic treatment,C0199176,en_3090,TREATS,Disease,C0012634,en_826,7,6,AFFECTS,Inhibitory,22
11850,Prophylactic treatment,C0199176,en_3090,TREATS,Fever,C0015967,en_985,1,1,AFFECTS,Inhibitory,7
11851,Prophylactic treatment,C0199176,en_3090,TREATS,Health Personnel,C0018724,en_1121,15,8,AFFECTS,Inhibitory,29
11852,Prophylactic treatment,C0199176,en_3090,TREATS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
11853,Prophylactic treatment,C0199176,en_3090,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
11854,Prophylactic treatment,C0199176,en_3090,TREATS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
11855,Prophylactic treatment,C0199176,en_3090,TREATS,inpatient,C0021562,en_1321,2,1,AFFECTS,Inhibitory,3
11856,Prophylactic treatment,C0199176,en_3090,TREATS,Persons,C0027361,en_1635,3,3,AFFECTS,Inhibitory,9
11857,Prophylactic treatment,C0199176,en_3090,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
11858,Prophylactic treatment,C0199176,en_3090,TREATS,Patients,C0030705,en_1762,23,14,AFFECTS,Inhibitory,42
11859,Prophylactic treatment,C0199176,en_3090,TREATS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,10
11860,Prophylactic treatment,C0199176,en_3090,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
11861,Prophylactic treatment,C0199176,en_3090,TREATS,Schizophrenia,C0036341,en_2068,1,1,AFFECTS,Inhibitory,3
11862,Prophylactic treatment,C0199176,en_3090,TREATS,Tracheobronchitis NOS,C0040586,en_2255,1,1,AFFECTS,Inhibitory,6
11863,Prophylactic treatment,C0199176,en_3090,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
11864,Prophylactic treatment,C0199176,en_3090,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
11865,Prophylactic treatment,C0199176,en_3090,TREATS,Immunocompromised Host,C0085393,en_2665,2,1,AFFECTS,Inhibitory,3
11866,Prophylactic treatment,C0199176,en_3090,TREATS,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Inhibitory,3
11867,Prophylactic treatment,C0199176,en_3090,TREATS,Malnutrition,C0162429,en_2910,1,1,AFFECTS,Inhibitory,6
11868,Prophylactic treatment,C0199176,en_3090,TREATS,Adolescent,C0205653,en_3132,2,1,AFFECTS,Inhibitory,3
11869,Prophylactic treatment,C0199176,en_3090,TREATS,Individual,C0237401,en_3343,8,6,AFFECTS,Inhibitory,18
11870,Prophylactic treatment,C0199176,en_3090,TREATS,Methyl alcohol poisoning,C0392621,en_3924,2,1,AFFECTS,Inhibitory,3
11871,Prophylactic treatment,C0199176,en_3090,TREATS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
11872,Prophylactic treatment,C0199176,en_3090,TREATS,Participant,C0679646,en_4602,10,7,AFFECTS,Inhibitory,21
11873,Prophylactic treatment,C0199176,en_3090,TREATS,General Population,C0683971,en_4674,2,2,AFFECTS,Inhibitory,6
11874,Prophylactic treatment,C0199176,en_3090,TREATS,high-risk group,C0684030,en_4676,2,1,AFFECTS,Inhibitory,3
11875,Prophylactic treatment,C0199176,en_3090,TREATS,"Stroke, Acute",C0751956,en_4854,1,1,AFFECTS,Inhibitory,7
11876,Prophylactic treatment,C0199176,en_3090,TREATS,High Risk Populations,C0870646,en_5008,2,1,AFFECTS,Inhibitory,3
11877,Prophylactic treatment,C0199176,en_3090,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,6
11878,Prophylactic treatment,C0199176,en_3090,TREATS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
11879,Prophylactic treatment,C0199176,en_3090,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,3
11880,Prophylactic treatment,C0199176,en_3090,TREATS,Infectious disease of abdomen,C1112209,en_5243,1,1,AFFECTS,Inhibitory,8
11881,Prophylactic treatment,C0199176,en_3090,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,7
11882,Prophylactic treatment,C0199176,en_3090,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
11883,Prophylactic treatment,C0199176,en_3090,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
11884,Prophylactic treatment,C0199176,en_3090,TREATS,Latent tuberculosis,C1609538,en_6004,1,1,AFFECTS,Inhibitory,3
11885,Prophylactic treatment,C0199176,en_3090,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,30
11886,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
11887,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
11888,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
11889,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),abnormal glucose tolerance test,C0159069,en_2895,1,1,AFFECTS,Inhibitory,3
11890,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
11891,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Asymptomatic,C0231221,en_3252,3,2,AFFECTS,Inhibitory,6
11892,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Inhibitory,3
11893,Prophylactic treatment,C0199176,en_3090,TREATS(INFER),Atypical pneumonia,C1412002,en_5696,2,1,AFFECTS,Inhibitory,3
11894,Prophylactic treatment,C0199176,en_3090,TREATS(SPEC),Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
11895,Prophylactic treatment,C0199176,en_3090,TREATS(SPEC),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
11896,Prophylactic treatment,C0199176,en_3090,TREATS(SPEC),HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
11897,Prescription of prophylactic anticoagulant,C0199242,en_3091,PREDISPOSES,Thromboembolic event,C0857496,en_4977,1,1,AFFECTS,Excitatory,3
11898,Prescription of prophylactic anticoagulant,C0199242,en_3091,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
11899,Prescription of prophylactic anticoagulant,C0199242,en_3091,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
11900,Respiration monitoring,C0199438,en_3092,TREATS,Age,C0001779,en_257,1,1,AFFECTS,Inhibitory,3
11901,Continuous Positive Airway Pressure,C0199451,en_3093,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,8
11902,Continuous Positive Airway Pressure,C0199451,en_3093,PREVENTS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
11903,Continuous Positive Airway Pressure,C0199451,en_3093,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
11904,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,8
11905,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
11906,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Pneumonia,C0032285,en_1833,3,3,AFFECTS,Inhibitory,18
11907,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Sleep Apnea Syndromes,C0037315,en_2120,1,1,AFFECTS,Inhibitory,3
11908,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Respiratory failure without hypercapnia,C0340194,en_3812,1,1,AFFECTS,Inhibitory,6
11909,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,"Sleep Apnea, Obstructive",C0520679,en_4191,2,2,AFFECTS,Inhibitory,11
11910,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,6
11911,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Teams,C0871489,en_5024,2,1,AFFECTS,Inhibitory,3
11912,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,6
11913,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
11914,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
11915,Continuous Positive Airway Pressure,C0199451,en_3093,TREATS(INFER),[D]Respiratory abnormalities NOS,C0231796,en_3264,1,1,AFFECTS,Inhibitory,3
11916,Physiotherapy of chest,C0199467,en_3094,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
11917,Physiotherapy of chest,C0199467,en_3094,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
11918,Physiotherapy of chest,C0199467,en_3094,TREATS(INFER),Sequela of disorder,C0543419,en_4257,2,1,AFFECTS,Inhibitory,3
11919,Mechanical ventilation,C0199470,en_3095,AFFECTS,Cessation of life,C0011065,en_762,5,2,AFFECTS,General/Uncertain,6
11920,Mechanical ventilation,C0199470,en_3095,AFFECTS,Patients,C0030705,en_1762,5,4,AFFECTS,General/Uncertain,12
11921,Mechanical ventilation,C0199470,en_3095,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,8
11922,Mechanical ventilation,C0199470,en_3095,AFFECTS,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,3
11923,Mechanical ventilation,C0199470,en_3095,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,3
11924,Mechanical ventilation,C0199470,en_3095,AFFECTS,Alveolar ventilation function,C0231940,en_3269,6,4,AFFECTS,General/Uncertain,20
11925,Mechanical ventilation,C0199470,en_3095,AFFECTS,Neuropathy,C0442874,en_4060,2,1,AFFECTS,General/Uncertain,3
11926,Mechanical ventilation,C0199470,en_3095,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
11927,Mechanical ventilation,C0199470,en_3095,AFFECTS,Critical illness myopathy,C1135188,en_5255,2,1,AFFECTS,General/Uncertain,3
11928,Mechanical ventilation,C0199470,en_3095,PREDISPOSES,Complication,C0009566,en_697,4,2,AFFECTS,Excitatory,6
11929,Mechanical ventilation,C0199470,en_3095,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
11930,Mechanical ventilation,C0199470,en_3095,PREDISPOSES,Upper gastrointestinal hemorrhage,C0041909,en_2314,1,1,AFFECTS,Excitatory,6
11931,Mechanical ventilation,C0199470,en_3095,PREDISPOSES,Wasting,C0235394,en_3327,2,1,AFFECTS,Excitatory,3
11932,Mechanical ventilation,C0199470,en_3095,PREDISPOSES,Acute atrophy,C0333644,en_3771,2,1,AFFECTS,Excitatory,3
11933,Mechanical ventilation,C0199470,en_3095,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
11934,Mechanical ventilation,C0199470,en_3095,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
11935,Mechanical ventilation,C0199470,en_3095,PREVENTS,Ventilator-associated lung injury,C0340257,en_3814,2,1,AFFECTS,Inhibitory,3
11936,Mechanical ventilation,C0199470,en_3095,PREVENTS,Nosocomial pneumonia,C0949083,en_5175,1,1,AFFECTS,Inhibitory,3
11937,Mechanical ventilation,C0199470,en_3095,PREVENTS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
11938,Mechanical ventilation,C0199470,en_3095,STIMULATES,Weaning,C0043084,en_2386,2,1,AFFECTS,Excitatory,3
11939,Mechanical ventilation,C0199470,en_3095,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
11940,Mechanical ventilation,C0199470,en_3095,TREATS,Age,C0001779,en_257,1,1,AFFECTS,Inhibitory,7
11941,Mechanical ventilation,C0199470,en_3095,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
11942,Mechanical ventilation,C0199470,en_3095,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
11943,Mechanical ventilation,C0199470,en_3095,TREATS,Disease,C0012634,en_826,4,3,AFFECTS,Inhibitory,12
11944,Mechanical ventilation,C0199470,en_3095,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,7
11945,Mechanical ventilation,C0199470,en_3095,TREATS,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,Inhibitory,3
11946,Mechanical ventilation,C0199470,en_3095,TREATS,Persons,C0027361,en_1635,4,2,AFFECTS,Inhibitory,6
11947,Mechanical ventilation,C0199470,en_3095,TREATS,Obstruction,C0028778,en_1702,1,1,AFFECTS,Inhibitory,8
11948,Mechanical ventilation,C0199470,en_3095,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
11949,Mechanical ventilation,C0199470,en_3095,TREATS,Patients,C0030705,en_1762,70,47,AFFECTS,Inhibitory,141
11950,Mechanical ventilation,C0199470,en_3095,TREATS,Pneumonia,C0032285,en_1833,3,1,AFFECTS,Inhibitory,8
11951,Mechanical ventilation,C0199470,en_3095,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,16,12,AFFECTS,Inhibitory,39
11952,Mechanical ventilation,C0199470,en_3095,TREATS,Respiratory Insufficiency,C0035229,en_2012,1,1,AFFECTS,Inhibitory,3
11953,Mechanical ventilation,C0199470,en_3095,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
11954,Mechanical ventilation,C0199470,en_3095,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
11955,Mechanical ventilation,C0199470,en_3095,TREATS,Target Population,C0039309,en_2207,1,1,AFFECTS,Inhibitory,3
11956,Mechanical ventilation,C0199470,en_3095,TREATS,Males,C0086582,en_2729,1,1,AFFECTS,Inhibitory,6
11957,Mechanical ventilation,C0199470,en_3095,TREATS,Malnutrition,C0162429,en_2910,1,1,AFFECTS,Inhibitory,6
11958,Mechanical ventilation,C0199470,en_3095,TREATS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
11959,Mechanical ventilation,C0199470,en_3095,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,3
11960,Mechanical ventilation,C0199470,en_3095,TREATS,Inefficiency,C0231184,en_3249,1,1,AFFECTS,Inhibitory,6
11961,Mechanical ventilation,C0199470,en_3095,TREATS,Acute respiratory failure,C0264490,en_3533,5,3,AFFECTS,Inhibitory,13
11962,Mechanical ventilation,C0199470,en_3095,TREATS,Prolonged periods,C0425945,en_4005,1,1,AFFECTS,Inhibitory,3
11963,Mechanical ventilation,C0199470,en_3095,TREATS,Paralysed,C0522224,en_4211,1,1,AFFECTS,Inhibitory,3
11964,Mechanical ventilation,C0199470,en_3095,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
11965,Mechanical ventilation,C0199470,en_3095,TREATS,Participant,C0679646,en_4602,2,2,AFFECTS,Inhibitory,6
11966,Mechanical ventilation,C0199470,en_3095,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,6
11967,Mechanical ventilation,C0199470,en_3095,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
11968,Mechanical ventilation,C0199470,en_3095,TREATS,Hospitalized Patients,C0870668,en_5010,7,4,AFFECTS,Inhibitory,15
11969,Mechanical ventilation,C0199470,en_3095,TREATS,Medical Patients,C0870869,en_5013,1,1,AFFECTS,Inhibitory,6
11970,Mechanical ventilation,C0199470,en_3095,TREATS,Respiratory Failure,C1145670,en_5292,14,11,AFFECTS,Inhibitory,55
11971,Mechanical ventilation,C0199470,en_3095,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,3,3,AFFECTS,Inhibitory,9
11972,Mechanical ventilation,C0199470,en_3095,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,10
11973,Mechanical ventilation,C0199470,en_3095,TREATS,Severe disorder,C1836348,en_6048,1,1,AFFECTS,Inhibitory,6
11974,Mechanical ventilation,C0199470,en_3095,TREATS,Acute hypoxemic respiratory failure,C4039867,en_6301,2,1,AFFECTS,Inhibitory,8
11975,Mechanical ventilation,C0199470,en_3095,TREATS,COVID-19,C5203670,en_6417,14,13,AFFECTS,Inhibitory,87
11976,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Asthenia,C0004093,en_416,2,1,AFFECTS,Inhibitory,3
11977,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Critical Illness,C0010340,en_733,5,3,AFFECTS,Inhibitory,9
11978,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
11979,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,8,5,AFFECTS,Inhibitory,15
11980,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Respiratory Insufficiency,C0035229,en_2012,1,1,AFFECTS,Inhibitory,3
11981,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Respiratory complication,C0161818,en_2899,2,1,AFFECTS,Inhibitory,3
11982,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Patient in hospital,C0701159,en_4731,3,3,AFFECTS,Inhibitory,9
11983,Mechanical ventilation,C0199470,en_3095,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
11984,Administration of antibiotic,C0199779,en_3096,TREATS,Infectious disease of abdomen,C1112209,en_5243,1,1,AFFECTS,Inhibitory,8
11985,Administration of insulin,C0199782,en_3097,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
11986,Human vaccination,C0199798,en_3098,PREVENTS,Malignant neoplasm of cervix uteri,C0007847,en_608,1,1,AFFECTS,Inhibitory,3
11987,Human vaccination,C0199798,en_3098,TREATS,Macaca mulatta,C0024400,en_1480,1,1,AFFECTS,Inhibitory,8
11988,Human vaccination,C0199798,en_3098,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,8
11989,Vaccination against tuberculosis,C0199804,en_3099,AFFECTS,Immunity,C0020964,en_1273,2,2,AFFECTS,General/Uncertain,10
11990,Vaccination against tuberculosis,C0199804,en_3099,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
11991,Vaccination against tuberculosis,C0199804,en_3099,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
11992,Vaccination against tuberculosis,C0199804,en_3099,PREVENTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
11993,Vaccination against tuberculosis,C0199804,en_3099,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,8
11994,Vaccination against tuberculosis,C0199804,en_3099,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
11995,Vaccination against tuberculosis,C0199804,en_3099,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
11996,Vaccination against tuberculosis,C0199804,en_3099,TREATS,Health Personnel,C0018724,en_1121,2,2,AFFECTS,Inhibitory,10
11997,Vaccination against tuberculosis,C0199804,en_3099,TREATS,Old age,C1999167,en_6084,1,1,AFFECTS,Inhibitory,8
11998,Coronavirus vaccination,C0199848,en_3100,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
11999,Coronavirus vaccination,C0199848,en_3100,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12000,Coronavirus vaccination,C0199848,en_3100,TREATS,Solid tumor,C0280100,en_3619,1,1,AFFECTS,Inhibitory,6
12001,Coronavirus vaccination,C0199848,en_3100,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,8
12002,Coronavirus vaccination,C0199848,en_3100,TREATS,Cancer Patient,C1516213,en_5852,6,2,AFFECTS,Inhibitory,9
12003,Coronavirus vaccination,C0199848,en_3100,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,Inhibitory,3
12004,"Oncologic procedure, NOS",C0199939,en_3101,TREATS,Neoplasm Metastasis,C0027627,en_1650,1,1,AFFECTS,Inhibitory,6
12005,Cytokine therapy,C0199974,en_3102,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12006,Cytokine therapy,C0199974,en_3102,TREATS,Cytokine release syndrome,C0948245,en_5163,5,2,AFFECTS,Inhibitory,6
12007,Cytokine therapy,C0199974,en_3102,TREATS,Macrophage activation syndrome,C1096155,en_5233,4,1,AFFECTS,Inhibitory,3
12008,Cytokine therapy,C0199974,en_3102,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
12009,Ophthalmic examination and evaluation,C0200149,en_3103,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
12010,Ophthalmic examination and evaluation,C0200149,en_3103,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12011,Ophthalmic examination and evaluation,C0200149,en_3103,TREATS,Gastroenterologist,C0259901,en_3503,1,1,AFFECTS,Inhibitory,6
12012,Auditory rehabilitation,C0200323,en_3104,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
12013,Vestibular rehabilitation,C0200324,en_3105,TREATS,Postural dizziness,C0234987,en_3316,1,1,AFFECTS,Inhibitory,3
12014,Specimen collection,C0200345,en_3106,TREATS,Tailor,C0402883,en_3962,1,1,AFFECTS,Inhibitory,6
12015,Chest CT,C0202823,en_3107,AFFECTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,General/Uncertain,6
12016,Chest CT,C0202823,en_3107,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
12017,Interstitial brachytherapy,C0203580,en_3108,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
12018,hyperthermia treatment,C0203597,en_3109,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,7
12019,hyperthermia treatment,C0203597,en_3109,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6.5
12020,Radionuclide therapy,C0203608,en_3110,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12021,Radionuclide therapy,C0203608,en_3110,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12022,Radioisotope scan of lung,C0203683,en_3111,AFFECTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,General/Uncertain,6
12023,Assisting exercise,C0203989,en_3112,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,8
12024,Short wave diathermy,C0204027,en_3113,AFFECTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,7
12025,Short wave diathermy,C0204027,en_3113,TREATS,COVID-19,C5203670,en_6417,3,1,AFFECTS,Inhibitory,8
12026,Ultrashort wave diathermy,C0204028,en_3114,TREATS,Experimental Group,C5205743,en_6423,1,1,AFFECTS,Inhibitory,7
12027,Psychiatric follow-up,C0204511,en_3115,TREATS,Woman,C0043210,en_2396,3,1,AFFECTS,Inhibitory,3
12028,Individual psychotherapy,C0204525,en_3117,TREATS,Dementia,C0497327,en_4164,2,1,AFFECTS,Inhibitory,3
12029,Nursing procedure,C0204636,en_3118,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12030,Parenteral alimentation procedure,C0204706,en_3119,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
12031,Isolation procedure,C0204727,en_3120,AFFECTS,Conception,C0009637,en_701,1,1,AFFECTS,General/Uncertain,3
12032,Isolation procedure,C0204727,en_3120,AFFECTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,3
12033,Isolation procedure,C0204727,en_3120,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,6
12034,Isolation procedure,C0204727,en_3120,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12035,Isolation procedure,C0204727,en_3120,AFFECTS,Postoperative Complications,C0032787,en_1858,2,1,AFFECTS,General/Uncertain,7
12036,Isolation procedure,C0204727,en_3120,AFFECTS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,General/Uncertain,6
12037,Isolation procedure,C0204727,en_3120,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
12038,Isolation procedure,C0204727,en_3120,PREDISPOSES,Cross Infection,C0010356,en_735,1,1,AFFECTS,Excitatory,6
12039,Isolation procedure,C0204727,en_3120,PREDISPOSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
12040,Isolation procedure,C0204727,en_3120,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
12041,Isolation procedure,C0204727,en_3120,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
12042,Isolation procedure,C0204727,en_3120,PREDISPOSES,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Excitatory,3
12043,Isolation procedure,C0204727,en_3120,PREVENTS,Mental disorders,C0004936,en_452,3,2,AFFECTS,Inhibitory,6
12044,Isolation procedure,C0204727,en_3120,PREVENTS,Child Development Disorders,C0008073,en_622,1,1,AFFECTS,Inhibitory,3
12045,Isolation procedure,C0204727,en_3120,PREVENTS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
12046,Isolation procedure,C0204727,en_3120,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,6
12047,Isolation procedure,C0204727,en_3120,STIMULATES,Emission,C0233929,en_3301,1,1,AFFECTS,Excitatory,3
12048,Isolation procedure,C0204727,en_3120,TREATS,Age,C0001779,en_257,3,1,AFFECTS,Inhibitory,3
12049,Isolation procedure,C0204727,en_3120,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,8
12050,Isolation procedure,C0204727,en_3120,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
12051,Isolation procedure,C0204727,en_3120,TREATS,Body Weight,C0005910,en_498,2,1,AFFECTS,Inhibitory,3
12052,Isolation procedure,C0204727,en_3120,TREATS,Chest Pain,C0008031,en_617,2,1,AFFECTS,Inhibitory,3
12053,Isolation procedure,C0204727,en_3120,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
12054,Isolation procedure,C0204727,en_3120,TREATS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
12055,Isolation procedure,C0204727,en_3120,TREATS,Persons,C0027361,en_1635,5,4,AFFECTS,Inhibitory,12
12056,Isolation procedure,C0204727,en_3120,TREATS,parent,C0030551,en_1750,2,1,AFFECTS,Inhibitory,3
12057,Isolation procedure,C0204727,en_3120,TREATS,Patients,C0030705,en_1762,8,5,AFFECTS,Inhibitory,15
12058,Isolation procedure,C0204727,en_3120,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,3
12059,Isolation procedure,C0204727,en_3120,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
12060,Isolation procedure,C0204727,en_3120,TREATS,Survivors,C0206194,en_3154,3,1,AFFECTS,Inhibitory,3
12061,Isolation procedure,C0204727,en_3120,TREATS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,3
12062,Isolation procedure,C0204727,en_3120,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
12063,Isolation procedure,C0204727,en_3120,TREATS,Infected,C0439663,en_4036,1,1,AFFECTS,Inhibitory,7
12064,Isolation procedure,C0204727,en_3120,TREATS,"Medical care, unspecified",C0496675,en_4163,3,2,AFFECTS,Inhibitory,6
12065,Isolation procedure,C0204727,en_3120,TREATS,Does hit,C0596020,en_4378,1,1,AFFECTS,Inhibitory,3
12066,Isolation procedure,C0204727,en_3120,TREATS,Does run,C0600140,en_4498,1,1,AFFECTS,Inhibitory,3
12067,Isolation procedure,C0204727,en_3120,TREATS,General Population,C0683971,en_4674,2,1,AFFECTS,Inhibitory,3
12068,Isolation procedure,C0204727,en_3120,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
12069,Isolation procedure,C0204727,en_3120,TREATS,Mental problem,C0848067,en_4929,1,1,AFFECTS,Inhibitory,3
12070,Isolation procedure,C0204727,en_3120,TREATS,Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
12071,Isolation procedure,C0204727,en_3120,TREATS,Older Population,C1518563,en_5875,1,1,AFFECTS,Inhibitory,3
12072,Isolation procedure,C0204727,en_3120,TREATS,Artic Indian,C1551706,en_5957,1,1,AFFECTS,Inhibitory,3
12073,Isolation procedure,C0204727,en_3120,TREATS,Confirmed case,C4698719,en_6378,1,1,AFFECTS,Inhibitory,6
12074,Isolation procedure,C0204727,en_3120,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,25
12075,Isolation procedure,C0204727,en_3120,TREATS(INFER),Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,3
12076,Isolation procedure,C0204727,en_3120,TREATS(INFER),Cerebrovascular accident,C0038454,en_2169,3,1,AFFECTS,Inhibitory,3
12077,Suicide prevention,C0204732,en_3121,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
12078,Suicide prevention,C0204732,en_3121,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
12079,Suicide prevention,C0204732,en_3121,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
12080,Secluding patient,C0204742,en_3122,TREATS,Woman,C0043210,en_2396,2,1,AFFECTS,Inhibitory,3
12081,Diet education,C0204932,en_3123,TREATS,American,C0596070,en_4379,1,1,AFFECTS,Inhibitory,3
12082,Psychosocial procedure,C0204968,en_3124,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
12083,Severe (severity modifier),C0205082,en_3125,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
12084,Severe (severity modifier),C0205082,en_3125,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
12085,Severe (severity modifier),C0205082,en_3125,PREDISPOSES,COVID-19,C5203670,en_6417,3,2,AFFECTS,Excitatory,12
12086,Negative,C0205160,en_3126,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
12087,Sedentary,C0205254,en_3128,PREDISPOSES,Chronic Disease,C0008679,en_643,2,1,AFFECTS,Excitatory,3
12088,Sedentary,C0205254,en_3128,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
12089,Reinfection,C0205339,en_3129,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
12090,Thickened,C0205400,en_3130,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
12091,"Infections, Hospital",C0205721,en_3133,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
12092,"Infections, Hospital",C0205721,en_3133,AFFECTS,wave,C0678544,en_4560,1,1,AFFECTS,General/Uncertain,6
12093,"Opiates, Endogenous",C0205752,en_3134,AFFECTS,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
12094,Health Campaigns,C0205787,en_3135,AFFECTS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,General/Uncertain,3
12095,Health Campaigns,C0205787,en_3135,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
12096,Health Campaigns,C0205787,en_3135,PREVENTS,Social stigmata,C0277787,en_3590,1,1,AFFECTS,Inhibitory,3
12097,Sexism,C0205906,en_3138,AFFECTS,Racism,C0205905,en_3137,1,1,AFFECTS,General/Uncertain,3
12098,Prostaglandins I,C0205911,en_3139,AFFECTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,General/Uncertain,3
12099,"Surgical Procedures, Elective",C0206058,en_3140,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
12100,"Surgical Procedures, Elective",C0206058,en_3140,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12101,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,9
12102,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Child,C0008059,en_620,5,3,AFFECTS,Inhibitory,18
12103,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Carcinoma of the Large Intestine,C0009402,en_681,1,1,AFFECTS,Inhibitory,6
12104,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Degenerative polyarthritis,C0029408,en_1723,1,1,AFFECTS,Inhibitory,3
12105,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
12106,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Postoperative Complications,C0032787,en_1858,2,1,AFFECTS,Inhibitory,6
12107,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
12108,"Surgical Procedures, Elective",C0206058,en_3140,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12109,"Pneumonitis, Interstitial",C0206061,en_3141,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
12110,"Pneumonitis, Interstitial",C0206061,en_3141,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12111,"Pneumonitis, Interstitial",C0206061,en_3141,AFFECTS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,General/Uncertain,6
12112,"Pneumonitis, Interstitial",C0206061,en_3141,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
12113,Domestic Violence,C0206073,en_3144,AFFECTS,Child,C0008059,en_620,2,2,AFFECTS,General/Uncertain,6
12114,Domestic Violence,C0206073,en_3144,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,3
12115,Domestic Violence,C0206073,en_3144,AFFECTS,VICTIM,C0680681,en_4626,1,1,AFFECTS,General/Uncertain,3
12116,Renal Replacement Therapy,C0206074,en_3145,AFFECTS,Fluid Balance,C0016284,en_1004,2,1,AFFECTS,General/Uncertain,6
12117,Renal Replacement Therapy,C0206074,en_3145,AFFECTS,Graft loss,C0877042,en_5061,1,1,AFFECTS,General/Uncertain,6
12118,Renal Replacement Therapy,C0206074,en_3145,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
12119,Renal Replacement Therapy,C0206074,en_3145,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
12120,Renal Replacement Therapy,C0206074,en_3145,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
12121,Renal Replacement Therapy,C0206074,en_3145,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
12122,Renal Replacement Therapy,C0206074,en_3145,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,6
12123,Renal Replacement Therapy,C0206074,en_3145,TREATS,"Kidney Failure, Acute",C0022660,en_1382,2,2,AFFECTS,Inhibitory,12
12124,Renal Replacement Therapy,C0206074,en_3145,TREATS,Patients,C0030705,en_1762,9,4,AFFECTS,Inhibitory,12
12125,Renal Replacement Therapy,C0206074,en_3145,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12126,Renal Replacement Therapy,C0206074,en_3145,TREATS,Proteinuria,C0033687,en_1913,2,1,AFFECTS,Inhibitory,3
12127,Renal Replacement Therapy,C0206074,en_3145,TREATS,Single organ dysfunction,C0349410,en_3841,1,1,AFFECTS,Inhibitory,6
12128,Renal Replacement Therapy,C0206074,en_3145,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
12129,Renal Replacement Therapy,C0206074,en_3145,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12
12130,Renal Replacement Therapy,C0206074,en_3145,TREATS(INFER),Hypercapnia,C0020440,en_1230,1,1,AFFECTS,Inhibitory,3
12131,Renal Replacement Therapy,C0206074,en_3145,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
12132,Renal Replacement Therapy,C0206074,en_3145,TREATS(INFER),Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
12133,Renal Replacement Therapy,C0206074,en_3145,TREATS(INFER),Acute failure,C0231176,en_3248,1,1,AFFECTS,Inhibitory,3
12134,Renal Replacement Therapy,C0206074,en_3145,TREATS(INFER),End stage renal failure,C1261469,en_5418,2,1,AFFECTS,Inhibitory,3
12135,Immunization Programs,C0206082,en_3146,TREATS,citizen,C0682134,en_4636,1,1,AFFECTS,Inhibitory,6
12136,Microglia,C0206116,en_3147,PRODUCES,"TNF protein, human",C1448177,en_5755,2,2,AFFECTS,Excitatory,6
12137,Adipocytes,C0206131,en_3148,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
12138,Cell Transplantation,C0206153,en_3149,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
12139,Cell Transplantation,C0206153,en_3149,TREATS(INFER),Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
12140,Drug Utilization Review,C0206176,en_3153,TREATS,Acute failure,C0231176,en_3248,1,1,AFFECTS,Inhibitory,3
12141,"Vaccines, Combined",C0206253,en_3155,AUGMENTS,Immune response,C0301872,en_3696,2,1,AFFECTS,Excitatory,3
12142,Malaria Vaccines,C0206255,en_3156,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
12143,Malaria Vaccines,C0206255,en_3156,PREVENTS,Malaria,C0024530,en_1493,2,2,AFFECTS,Inhibitory,6
12144,Malaria Vaccines,C0206255,en_3156,TREATS,Malaria,C0024530,en_1493,1,1,AFFECTS,Inhibitory,3
12145,Enoxaparin,C0206460,en_3160,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
12146,Enoxaparin,C0206460,en_3160,TREATS,Medical contraindication,C1301624,en_5507,1,1,AFFECTS,Inhibitory,7
12147,Enoxaparin,C0206460,en_3160,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,13
12148,Enoxaparin,C0206460,en_3160,TREATS,Patients,C0030705,en_1762,14,4,AFFECTS,Inhibitory,12
12149,Enoxaparin,C0206460,en_3160,TREATS,Hospitalized Patients,C0870668,en_5010,3,1,AFFECTS,Inhibitory,3
12150,Enoxaparin,C0206460,en_3160,TREATS(INFER),Respiratory Failure,C1145670,en_5292,3,1,AFFECTS,Inhibitory,3
12151,"Antibodies, Bispecific",C0206492,en_3161,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
12152,"Antibodies, Bispecific",C0206492,en_3161,INHIBITS,Body Weight decreased,C0043096,en_2389,1,1,AFFECTS,Inhibitory,3
12153,"Antibodies, Bispecific",C0206492,en_3161,TREATS,Exanthema,C0015230,en_938,1,1,AFFECTS,Inhibitory,3
12154,"Receptors, Metabotropic Glutamate",C0206529,en_3165,PRODUCES,GABA-B Receptor,C0052887,en_2440,1,1,AFFECTS,Excitatory,3
12155,"Receptors, Cytokine",C0206552,en_3167,DISRUPTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Inhibitory,3
12156,"Receptors, Cytokine",C0206552,en_3167,INHIBITS,TNFSF13B,C1420816,en_109,1,1,AFFECTS,Inhibitory,3
12157,"Receptors, Cytokine",C0206552,en_3167,INHIBITS,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
12158,"Receptors, Cytokine",C0206552,en_3167,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
12159,"Receptors, Cytokine",C0206552,en_3167,INHIBITS,ANP32B gene,C1332090,en_5581,1,1,AFFECTS,Inhibitory,3
12160,"Receptors, Nuclear",C0206588,en_3171,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
12161,"Receptors, Nuclear",C0206588,en_3171,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
12162,Flavivirus Infections,C0206608,en_3172,PRODUCES,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Excitatory,3
12163,"Rhabdomyosarcoma, Alveolar",C0206655,en_3173,AFFECTS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,General/Uncertain,8
12164,Coronavirus Infections,C0206750,en_3176,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12165,Coronavirus Infections,C0206750,en_3176,AFFECTS,African American,C0085756,en_2689,1,1,AFFECTS,General/Uncertain,6
12166,Coronavirus Infections,C0206750,en_3176,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
12167,Coronavirus Infections,C0206750,en_3176,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,General/Uncertain,3
12168,Coronavirus Infections,C0206750,en_3176,AFFECTS,Old age,C1999167,en_6084,1,1,AFFECTS,General/Uncertain,8
12169,Coronavirus Infections,C0206750,en_3176,AFFECTS,World,C2700280,en_6119,1,1,AFFECTS,General/Uncertain,6
12170,Coronavirus Infections,C0206750,en_3176,AFFECTS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12171,Coronavirus Infections,C0206750,en_3176,DISRUPTS,viral transmission,C1160716,en_5362,1,1,AFFECTS,Inhibitory,6
12172,Coronavirus Infections,C0206750,en_3176,PREDISPOSES,Severe brain damage,C3279537,en_6198,1,1,AFFECTS,Excitatory,6
12173,zorubicin,C0206788,en_3177,STIMULATES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
12174,zorubicin,C0206788,en_3177,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
12175,zorubicin,C0206788,en_3177,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12176,5'-AMP-activated protein kinase,C0207262,en_3179,AFFECTS,Vitality,C0424589,en_3997,1,1,AFFECTS,General/Uncertain,3
12177,nafamostat,C0207683,en_3180,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
12178,nafamostat,C0207683,en_3180,TREATS,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Inhibitory,3
12179,nafamostat,C0207683,en_3180,TREATS(SPEC),Cystic Fibrosis,C0010674,en_745,2,1,AFFECTS,Inhibitory,3
12180,multicatalytic endopeptidase complex,C0208355,en_3181,INHIBITS,PLK4,C1420470,en_111,1,1,AFFECTS,Inhibitory,3
12181,multicatalytic endopeptidase complex,C0208355,en_3181,INHIBITS,cullin-3,C0909608,en_5097,1,1,AFFECTS,Inhibitory,3
12182,multicatalytic endopeptidase complex,C0208355,en_3181,STIMULATES,Phosphotransferases,C0031727,en_1801,1,1,AFFECTS,Excitatory,3
12183,Rocuronium,C0209337,en_3182,TREATS,Paralysed,C0522224,en_4211,1,1,AFFECTS,Inhibitory,3
12184,mycophenolate mofetil,C0209368,en_3184,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,6
12185,mycophenolate mofetil,C0209368,en_3184,TREATS,"Recipient, Transplant",C0376387,en_3875,1,1,AFFECTS,Inhibitory,6
12186,mycophenolate mofetil,C0209368,en_3184,TREATS,cohort,C0599755,en_4470,5,1,AFFECTS,Inhibitory,3
12187,QS 21,C0211668,en_3185,TREATS(SPEC),Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
12188,pigment epithelium-derived factor,C0213321,en_3186,AUGMENTS,Neurites,C0085103,en_2642,1,1,AFFECTS,Excitatory,3
12189,NF-Kappa B p65,C0214222,en_3187,AFFECTS,"Transcription, Genetic",C0040649,en_2265,1,1,AFFECTS,General/Uncertain,3
12190,NF-Kappa B p65,C0214222,en_3187,STIMULATES(SPEC),Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,3
12191,Interleukin-13,C0214743,en_3188,AFFECTS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
12192,Interleukin-13,C0214743,en_3188,INHIBITS,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Inhibitory,3
12193,Interleukin-13,C0214743,en_3188,INHIBITS,Hydroxyl Radical,C0063146,en_2503,1,1,AFFECTS,Inhibitory,3
12194,adrenomedullin,C0215825,en_3189,AFFECTS,Muscle,C0026845,en_1603,1,1,AFFECTS,General/Uncertain,3
12195,adrenomedullin,C0215825,en_3189,AFFECTS,Neonatal necrotizing enterocolitis,C1442826,en_5733,1,1,AFFECTS,General/Uncertain,3
12196,adrenomedullin,C0215825,en_3189,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12197,adrenomedullin,C0215825,en_3189,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
12198,adrenomedullin,C0215825,en_3189,TREATS,"Enterocolitis, Necrotizing",C0520459,en_4186,1,1,AFFECTS,Inhibitory,3
12199,Hypoxia-Inducible Factor 1,C0215848,en_3190,DISRUPTS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Inhibitory,3
12200,Hypoxia-Inducible Factor 1,C0215848,en_3190,STIMULATES,Gluconeogenesis,C0017715,en_1071,1,1,AFFECTS,Excitatory,3
12201,sargramostim,C0216231,en_3191,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,7
12202,tinzaparin,C0216278,en_3192,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,6
12203,tinzaparin,C0216278,en_3192,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12204,valsartan,C0216784,en_3193,AFFECTS,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,General/Uncertain,3
12205,valsartan,C0216784,en_3193,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
12206,valsartan,C0216784,en_3193,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
12207,valsartan,C0216784,en_3193,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,8
12208,valsartan,C0216784,en_3193,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
12209,valsartan,C0216784,en_3193,TREATS,Ejection Fraction Decreased,C0743400,en_4802,1,1,AFFECTS,Inhibitory,8
12210,valsartan,C0216784,en_3193,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
12211,heat-shock protein 70.1,C0217576,en_3195,AFFECTS,adenosinetriphosphatase activity,C1148926,en_5300,1,1,AFFECTS,General/Uncertain,3
12212,Agammaglobulinaemia tyrosine kinase,C0218158,en_3196,AFFECTS,Immune system,C0020962,en_1271,2,1,AFFECTS,General/Uncertain,3
12213,Agammaglobulinaemia tyrosine kinase,C0218158,en_3196,AFFECTS,Signal Transduction,C0037083,en_2105,2,1,AFFECTS,General/Uncertain,3
12214,Chemicals,C0220806,en_3200,AFFECTS,Motion,C0026597,en_1584,1,1,AFFECTS,General/Uncertain,3
12215,Chemicals,C0220806,en_3200,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
12216,Chemicals,C0220806,en_3200,AFFECTS,mammary gland development,C1326631,en_5559,1,1,AFFECTS,General/Uncertain,3
12217,Evaluation,C0220825,en_3201,PREVENTS,Sedated state,C0235195,en_3323,1,1,AFFECTS,Inhibitory,6
12218,Evaluation,C0220825,en_3201,PREVENTS,UPPER RESPIRATORY SYMPTOM,C0749874,en_4838,1,1,AFFECTS,Inhibitory,8
12219,Evaluation,C0220825,en_3201,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12220,Evaluation,C0220825,en_3201,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,6
12221,Evaluation,C0220825,en_3201,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,7
12222,Evaluation,C0220825,en_3201,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,6
12223,Evaluation,C0220825,en_3201,TREATS,Critical Illness,C0010340,en_733,2,2,AFFECTS,Inhibitory,12
12224,Evaluation,C0220825,en_3201,TREATS,Donor person,C0013018,en_840,1,1,AFFECTS,Inhibitory,7
12225,Evaluation,C0220825,en_3201,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,7
12226,Evaluation,C0220825,en_3201,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
12227,Evaluation,C0220825,en_3201,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,6
12228,Evaluation,C0220825,en_3201,TREATS,"Osteoarthritis, Knee",C0409959,en_3966,1,1,AFFECTS,Inhibitory,8
12229,Evaluation,C0220825,en_3201,TREATS,COVID-19,C5203670,en_6417,7,7,AFFECTS,Inhibitory,47
12230,Evaluation,C0220825,en_3201,TREATS,Treatment Group,C5205742,en_6422,2,2,AFFECTS,Inhibitory,16
12231,Evaluation,C0220825,en_3201,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
12232,Evaluation,C0220825,en_3201,TREATS,Psychosocial Functioning,C5392237,en_6448,1,1,AFFECTS,Inhibitory,7
12233,Evaluation,C0220825,en_3201,TREATS,Acute Ischemic Stroke,C5392833,en_6450,1,1,AFFECTS,Inhibitory,6
12234,grasp,C0220843,en_3203,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
12235,Predisposition,C0220898,en_3206,PREDISPOSES,Severe infection,C5139167,en_6407,1,1,AFFECTS,Excitatory,6
12236,regulatory,C0220905,en_3207,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12237,Screening procedure,C0220908,en_3208,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,6
12238,Screening procedure,C0220908,en_3208,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
12239,Screening procedure,C0220908,en_3208,PREVENTS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
12240,Screening procedure,C0220908,en_3208,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,3
12241,Screening procedure,C0220908,en_3208,TREATS,Child,C0008059,en_620,2,2,AFFECTS,Inhibitory,6
12242,Screening procedure,C0220908,en_3208,TREATS,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Inhibitory,3
12243,Screening procedure,C0220908,en_3208,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
12244,Screening procedure,C0220908,en_3208,TREATS,Diabetic Retinopathy,C0011884,en_804,1,1,AFFECTS,Inhibitory,3
12245,Screening procedure,C0220908,en_3208,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
12246,Screening procedure,C0220908,en_3208,TREATS,Down Syndrome,C0013080,en_843,1,1,AFFECTS,Inhibitory,3
12247,Screening procedure,C0220908,en_3208,TREATS,Edema,C0013604,en_877,1,1,AFFECTS,Inhibitory,3
12248,Screening procedure,C0220908,en_3208,TREATS,Family,C0015576,en_961,2,2,AFFECTS,Inhibitory,6
12249,Screening procedure,C0220908,en_3208,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
12250,Screening procedure,C0220908,en_3208,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
12251,Screening procedure,C0220908,en_3208,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
12252,Screening procedure,C0220908,en_3208,TREATS,Patients,C0030705,en_1762,20,14,AFFECTS,Inhibitory,42
12253,Screening procedure,C0220908,en_3208,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
12254,Screening procedure,C0220908,en_3208,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
12255,Screening procedure,C0220908,en_3208,TREATS,Stress,C0038435,en_2165,2,1,AFFECTS,Inhibitory,3
12256,Screening procedure,C0220908,en_3208,TREATS,Uveitis,C0042164,en_2325,1,1,AFFECTS,Inhibitory,3
12257,Screening procedure,C0220908,en_3208,TREATS,Woman,C0043210,en_2396,2,1,AFFECTS,Inhibitory,3
12258,Screening procedure,C0220908,en_3208,TREATS,Foreigners,C0079375,en_2597,1,1,AFFECTS,Inhibitory,3
12259,Screening procedure,C0220908,en_3208,TREATS,"Diabetes, Gestational",C0085207,en_2652,2,2,AFFECTS,Inhibitory,6
12260,Screening procedure,C0220908,en_3208,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
12261,Screening procedure,C0220908,en_3208,TREATS,Teacher,C0221457,en_3226,1,1,AFFECTS,Inhibitory,3
12262,Screening procedure,C0220908,en_3208,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,3
12263,Screening procedure,C0220908,en_3208,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
12264,Screening procedure,C0220908,en_3208,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
12265,Screening procedure,C0220908,en_3208,TREATS,Sick child,C0260101,en_3509,1,1,AFFECTS,Inhibitory,3
12266,Screening procedure,C0220908,en_3208,TREATS,Deep vein thrombosis of lower limb,C0340708,en_3821,1,1,AFFECTS,Inhibitory,3
12267,Screening procedure,C0220908,en_3208,TREATS,Household income,C0557163,en_4307,1,1,AFFECTS,Inhibitory,3
12268,Screening procedure,C0220908,en_3208,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
12269,Screening procedure,C0220908,en_3208,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
12270,Screening procedure,C0220908,en_3208,TREATS,General Population,C0683971,en_4674,3,2,AFFECTS,Inhibitory,6
12271,Screening procedure,C0220908,en_3208,TREATS,Clinicians,C0871685,en_5028,1,1,AFFECTS,Inhibitory,3
12272,Screening procedure,C0220908,en_3208,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
12273,Screening procedure,C0220908,en_3208,TREATS,Symptoms,C1457887,en_5784,9,6,AFFECTS,Inhibitory,18
12274,Screening procedure,C0220908,en_3208,TREATS,Cancer Patient,C1516213,en_5852,2,2,AFFECTS,Inhibitory,6
12275,Screening procedure,C0220908,en_3208,TREATS(INFER),"Abortion, Habitual",C0000809,en_207,2,1,AFFECTS,Inhibitory,3
12276,Screening procedure,C0220908,en_3208,TREATS(INFER),Deglutition Disorders,C0011168,en_772,2,1,AFFECTS,Inhibitory,3
12277,Screening procedure,C0220908,en_3208,TREATS(INFER),"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,2,2,AFFECTS,Inhibitory,6
12278,Screening procedure,C0220908,en_3208,TREATS(SPEC),Diabetic Retinopathy,C0011884,en_804,1,1,AFFECTS,Inhibitory,3
12279,Training,C0220931,en_3209,AFFECTS,Diabetes Mellitus,C0011849,en_798,11,1,AFFECTS,General/Uncertain,3
12280,Training,C0220931,en_3209,AFFECTS,Fatigue,C0015672,en_966,3,1,AFFECTS,General/Uncertain,3
12281,Training,C0220931,en_3209,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
12282,Training,C0220931,en_3209,AFFECTS,Stress,C0038435,en_2165,3,1,AFFECTS,General/Uncertain,3
12283,Training,C0220931,en_3209,AFFECTS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,General/Uncertain,3
12284,Training,C0220931,en_3209,AFFECTS,Ability,C0085732,en_2688,3,2,AFFECTS,General/Uncertain,6
12285,Training,C0220931,en_3209,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
12286,Training,C0220931,en_3209,AFFECTS,Clinical infection,C0275521,en_3564,1,1,AFFECTS,General/Uncertain,3
12287,Training,C0220931,en_3209,AFFECTS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,General/Uncertain,3
12288,Training,C0220931,en_3209,AFFECTS,Physical function,C0516981,en_4169,6,3,AFFECTS,General/Uncertain,9
12289,Training,C0220931,en_3209,AFFECTS,Recovery of Function,C0599766,en_4471,4,2,AFFECTS,General/Uncertain,6
12290,Training,C0220931,en_3209,AFFECTS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,General/Uncertain,3
12291,Training,C0220931,en_3209,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
12292,Training,C0220931,en_3209,AFFECTS,Outcomes of Therapy,C1518681,en_5877,1,1,AFFECTS,General/Uncertain,6
12293,Training,C0220931,en_3209,AFFECTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,14
12294,"Depression, Postpartum",C0221074,en_3212,AFFECTS,Black race,C0005680,en_478,1,1,AFFECTS,General/Uncertain,3
12295,"Depression, Postpartum",C0221074,en_3212,AFFECTS,gene polymorphism,C0678951,en_4586,1,1,AFFECTS,General/Uncertain,3
12296,"Depression, Postpartum",C0221074,en_3212,AFFECTS,Latinas,C0949335,en_5179,1,1,AFFECTS,General/Uncertain,3
12297,"Depression, Postpartum",C0221074,en_3212,AFFECTS,Childbirth,C1148523,en_5296,1,1,AFFECTS,General/Uncertain,3
12298,"Etiology, operative procedure, as cause of",C0221082,en_3213,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
12299,Author,C3812881,en_6243,TREATS,Patients,C0030705,en_1762,8,5,AFFECTS,Inhibitory,15
12300,Lesion,C0221198,en_3221,PREDISPOSES,Cerebral Hypoxia,C0007768,en_602,1,1,AFFECTS,Excitatory,3
12301,Lesion,C0221198,en_3221,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
12302,Lesion,C0221198,en_3221,PREDISPOSES,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,Excitatory,3
12303,Leptocyte,C0221284,en_3222,PRODUCES,Integral Membrane Proteins,C0021699,en_1327,1,1,AFFECTS,Excitatory,3
12304,Supportive psychotherapy,C0221295,en_3223,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
12305,Integumentary scale,C0222045,en_3234,PRODUCES,Cathepsins B,C0699919,en_4709,1,1,AFFECTS,Excitatory,3
12306,Integumentary scale,C0222045,en_3234,PRODUCES,FURIN gene,C0919550,en_5116,1,1,AFFECTS,Excitatory,3
12307,Fiber,C0225326,en_3236,AUGMENTS,Osmotic Pressure,C0029393,en_1722,2,1,AFFECTS,Excitatory,3
12308,Fiber,C0225326,en_3236,TREATS,Teacher,C0221457,en_3226,1,1,AFFECTS,Inhibitory,3
12309,Endothelial Cells,C0225336,en_3237,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
12310,Endothelial Cells,C0225336,en_3237,PRODUCES,Plasminogen Activator Inhibitor 1,C0030190,en_1740,1,1,AFFECTS,Excitatory,3
12311,Endothelial Cells,C0225336,en_3237,PRODUCES,receptor,C0597357,en_4422,1,1,AFFECTS,Excitatory,3
12312,Pneumocyte,C0225698,en_3239,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
12313,Pneumocyte,C0225698,en_3239,PRODUCES,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,Excitatory,3
12314,"Pneumocyte, type 2",C0225700,en_3240,PRODUCES,Pulmonary Surfactants,C0034085,en_1935,3,2,AFFECTS,Excitatory,6
12315,Hepatocyte,C0227525,en_3241,PRODUCES,IL6ST gene,C1325331,en_5548,1,1,AFFECTS,Excitatory,3
12316,Disability NOS,C0231170,en_3247,AFFECTS,Acclimatization,C0000934,en_212,1,1,AFFECTS,General/Uncertain,3
12317,Disability NOS,C0231170,en_3247,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
12318,Disability NOS,C0231170,en_3247,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
12319,Disability NOS,C0231170,en_3247,AFFECTS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,General/Uncertain,3
12320,Disability NOS,C0231170,en_3247,AFFECTS,Persons,C0027361,en_1635,4,3,AFFECTS,General/Uncertain,9
12321,Disability NOS,C0231170,en_3247,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12322,Disability NOS,C0231170,en_3247,AFFECTS,Euphoric,C0857304,en_4973,1,1,AFFECTS,General/Uncertain,3
12323,Acute failure,C0231176,en_3248,AFFECTS,Cardiovascular Physiology,C0007227,en_570,1,1,AFFECTS,General/Uncertain,3
12324,Decompensation,C0231187,en_3250,PREDISPOSES,Early respiratory failure,C3807376,en_6241,1,1,AFFECTS,Excitatory,6
12325,Malaise,C0231218,en_3251,PREDISPOSES,Graves' Disease,C0018213,en_1097,2,1,AFFECTS,Excitatory,3
12326,Asymptomatic,C0231221,en_3252,PREDISPOSES,"[X]Acute myocarditis, unspecified",C0155686,en_2889,1,1,AFFECTS,Excitatory,3
12327,Asymptomatic,C0231221,en_3252,PREDISPOSES,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,Excitatory,3
12328,Crisis,C0231224,en_3253,PREDISPOSES,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Excitatory,3
12329,Crisis,C0231224,en_3253,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,3
12330,Crisis,C0231224,en_3253,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
12331,Crisis,C0231224,en_3253,PREDISPOSES,Inflammation,C0021368,en_1307,3,1,AFFECTS,Excitatory,3
12332,Crisis,C0231224,en_3253,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,1,AFFECTS,Excitatory,3
12333,Crisis,C0231224,en_3253,PREDISPOSES,"Depression, Postpartum",C0221074,en_3212,2,1,AFFECTS,Excitatory,3
12334,Crisis,C0231224,en_3253,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
12335,Crisis,C0231224,en_3253,PREDISPOSES,Physical and emotional exhaustion state,C0476644,en_4150,1,1,AFFECTS,Excitatory,3
12336,Senility,C0231337,en_3257,PREDISPOSES,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Excitatory,12
12337,Senility,C0231337,en_3257,PREDISPOSES,Seroconversion,C4042908,en_6305,1,1,AFFECTS,Excitatory,6
12338,Senility,C0231337,en_3257,PREDISPOSES,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Excitatory,6
12339,pulmonary function,C0231921,en_3268,AFFECTS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,General/Uncertain,3
12340,Alveolar ventilation function,C0231940,en_3269,AFFECTS,Patients,C0030705,en_1762,3,3,AFFECTS,General/Uncertain,9
12341,Alveolar ventilation function,C0231940,en_3269,AFFECTS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,General/Uncertain,3
12342,Alveolar ventilation function,C0231940,en_3269,AFFECTS,Teams,C0871489,en_5024,1,1,AFFECTS,General/Uncertain,3
12343,Vascular function,C0232337,en_3275,PREDISPOSES,Hypertensive disease,C0020538,en_1239,2,1,AFFECTS,Excitatory,3
12344,Plethora,C0232370,en_3277,PREDISPOSES,Impaired health,C0684336,en_4680,1,1,AFFECTS,Excitatory,3
12345,Ingestion,C0232478,en_3281,AFFECTS,Child,C0008059,en_620,2,1,AFFECTS,General/Uncertain,3
12346,Ingestion,C0232478,en_3281,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
12347,Ingestion,C0232478,en_3281,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
12348,Rumination,C0232604,en_3283,AFFECTS,Child,C0008059,en_620,2,1,AFFECTS,General/Uncertain,3
12349,Rumination,C0232604,en_3283,AFFECTS,Contagion,C0598197,en_4444,1,1,AFFECTS,General/Uncertain,3
12350,Decreased renal function,C0232807,en_3287,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
12351,Worried,C0233481,en_3292,PREDISPOSES,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Excitatory,3
12352,Worried,C0233481,en_3292,PREDISPOSES,prevention outcome,C0683485,en_4665,1,1,AFFECTS,Excitatory,3
12353,Worried,C0233481,en_3292,PREDISPOSES,Worse,C1457868,en_5783,1,1,AFFECTS,Excitatory,7
12354,apprehension,C0233485,en_3293,PREDISPOSES,Antisocial behavior,C0233523,en_3297,1,1,AFFECTS,Excitatory,3
12355,Tension,C0233494,en_3294,AFFECTS,Refugees,C0034961,en_1987,1,1,AFFECTS,General/Uncertain,3
12356,Tension,C0233494,en_3294,AFFECTS,Caregiver,C0085537,en_2674,2,1,AFFECTS,General/Uncertain,3
12357,Tension,C0233494,en_3294,AFFECTS,participation,C0679823,en_4613,1,1,AFFECTS,General/Uncertain,3
12358,Abnormal behavior,C0233514,en_3296,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
12359,Ritual compulsion,C0233622,en_3298,AFFECTS,Muslim population group,C0026870,en_1610,1,1,AFFECTS,General/Uncertain,3
12360,Emission,C0233929,en_3301,AFFECTS,Climate,C0008946,en_656,2,1,AFFECTS,General/Uncertain,3
12361,Emission,C0233929,en_3301,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
12362,Emission,C0233929,en_3301,AFFECTS,Ecosystem,C0162358,en_2908,1,1,AFFECTS,General/Uncertain,3
12363,Emission,C0233929,en_3301,AFFECTS,Congestion,C0700148,en_4714,1,1,AFFECTS,General/Uncertain,3
12364,Summation,C0234108,en_3302,AFFECTS,Writer,C0341628,en_3824,1,1,AFFECTS,General/Uncertain,3
12365,Facilitation,C0234112,en_3303,AFFECTS,Neutrophil chemotaxis,C0312861,en_3738,1,1,AFFECTS,General/Uncertain,3
12366,Neuromuscular inhibition,C0234119,en_3304,AFFECTS,Shivering,C0036973,en_2096,2,1,AFFECTS,General/Uncertain,3
12367,Cold Sensation,C0234192,en_3306,AFFECTS,Heart failure,C0018801,en_1135,1,1,AFFECTS,General/Uncertain,3
12368,Speaking,C0234856,en_3314,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
12369,Speaking,C0234856,en_3314,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
12370,Speaking,C0234856,en_3314,TREATS,peer,C0679739,en_4608,1,1,AFFECTS,Inhibitory,3
12371,Speaking,C0234856,en_3314,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
12372,Respiratory Depression,C0235063,en_3320,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
12373,Wasting,C0235394,en_3327,AFFECTS,peer,C0679739,en_4608,1,1,AFFECTS,General/Uncertain,3
12374,Right ventricular failure,C2939447,en_6155,PREDISPOSES,Pulmonary artery pressure,C0428642,en_4013,1,1,AFFECTS,Excitatory,6
12375,Right ventricular failure,C2939447,en_6155,PREDISPOSES,Increased pulmonary vascular resistance,C1867423,en_6057,1,1,AFFECTS,Excitatory,6
12376,Lung infiltration,C0235896,en_3332,AFFECTS,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,General/Uncertain,3
12377,Muscle necrosis,C0235957,en_3335,AFFECTS,Thrombosis,C0040053,en_2233,2,1,AFFECTS,General/Uncertain,3
12378,AOD use,C0237123,en_3341,AFFECTS,Alcohol consumption,C0001948,en_269,1,1,AFFECTS,General/Uncertain,3
12379,AOD use,C0237123,en_3341,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
12380,AOD use,C0237123,en_3341,AFFECTS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,General/Uncertain,3
12381,AOD use,C0237123,en_3341,AFFECTS,Violence,C0042693,en_2353,1,1,AFFECTS,General/Uncertain,3
12382,AOD use,C0237123,en_3341,AFFECTS,Offspring,C0680063,en_4620,1,1,AFFECTS,General/Uncertain,3
12383,Individual,C0237401,en_3343,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
12384,Pediatrician,C0237433,en_3344,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12385,Pediatrician,C0237433,en_3344,TREATS,Sick child,C0260101,en_3509,1,1,AFFECTS,Inhibitory,3
12386,Psychiatric Hospital Admission,C0237457,en_3345,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
12387,Psychiatric Hospital Admission,C0237457,en_3345,TREATS(INFER),Mental health problem,C1446377,en_5753,1,1,AFFECTS,Inhibitory,3
12388,Pressors,C0237795,en_3352,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
12389,Pressors,C0237795,en_3352,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12390,Recovery,C0237820,en_3354,AFFECTS,Climate,C0008946,en_656,2,2,AFFECTS,General/Uncertain,6
12391,Recovery,C0237820,en_3354,AFFECTS,"Immunity, Natural",C0020969,en_1276,1,1,AFFECTS,General/Uncertain,3
12392,Recovery,C0237820,en_3354,AFFECTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,General/Uncertain,3
12393,Recovery,C0237820,en_3354,AFFECTS,student,C0038492,en_2171,1,1,AFFECTS,General/Uncertain,3
12394,Recovery,C0237820,en_3354,AFFECTS,Weather,C0043085,en_2387,2,2,AFFECTS,General/Uncertain,6
12395,Recovery,C0237820,en_3354,AFFECTS,Teacher,C0221457,en_3226,1,1,AFFECTS,General/Uncertain,3
12396,Recovery,C0237820,en_3354,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,3
12397,Recovery,C0237820,en_3354,AFFECTS,American,C0596070,en_4379,2,1,AFFECTS,General/Uncertain,3
12398,Recovery,C0237820,en_3354,AFFECTS,VICTIM,C0680681,en_4626,2,2,AFFECTS,General/Uncertain,6
12399,Recovery,C0237820,en_3354,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
12400,learning strategies,C0237896,en_3356,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
12401,health care utilization,C0237939,en_3357,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
12402,health care utilization,C0237939,en_3357,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
12403,health care utilization,C0237939,en_3357,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
12404,health care utilization,C0237939,en_3357,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
12405,health care utilization,C0237939,en_3357,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
12406,"Myositis, Inclusion Body",C0238190,en_3362,PREDISPOSES,Ischemic stroke,C0948008,en_5158,2,1,AFFECTS,Excitatory,6
12407,CANADIAN,C0238884,en_3371,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
12408,Cigarette smoke,C0239059,en_3373,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
12409,Cigarette smoke,C0239059,en_3373,PREDISPOSES,Pathological accumulation of air in tissues,C0013990,en_891,1,1,AFFECTS,Excitatory,3
12410,Hand eczema,C0239816,en_3375,AFFECTS,Staff,C0851286,en_4950,1,1,AFFECTS,General/Uncertain,6
12411,Hypoalbuminemia,C0239981,en_3378,PREDISPOSES,Epithelial Damage,C3272629,en_6191,1,1,AFFECTS,Excitatory,6
12412,Form of muscle,C0240417,en_3384,PREDISPOSES,medical complication,C0221791,en_3230,2,1,AFFECTS,Excitatory,3
12413,narcotic use,C0240602,en_3386,PREDISPOSES,Chronic pain,C0150055,en_2816,2,1,AFFECTS,Excitatory,3
12414,Hypoxia,C0242184,en_3396,AFFECTS,Diffusion,C0012222,en_814,2,1,AFFECTS,General/Uncertain,3
12415,Hypoxia,C0242184,en_3396,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
12416,Hypoxia,C0242184,en_3396,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12417,Hypoxia,C0242184,en_3396,AFFECTS,biological adaptation to stress,C0149784,en_2810,1,1,AFFECTS,General/Uncertain,3
12418,Hypoxia,C0242184,en_3396,AFFECTS,MOTOR DEFICIT,C0746626,en_4816,1,1,AFFECTS,General/Uncertain,3
12419,Hypoxia,C0242184,en_3396,AFFECTS,T-cell differentiation,C1155013,en_5313,1,1,AFFECTS,General/Uncertain,3
12420,Hypoxia,C0242184,en_3396,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
12421,Hypoxia,C0242184,en_3396,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
12422,Hypoxia,C0242184,en_3396,COMPLICATES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,General/Uncertain,3
12423,Hypoxia,C0242184,en_3396,PREDISPOSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,6
12424,Hypoxia,C0242184,en_3396,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
12425,Hypoxia,C0242184,en_3396,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
12426,Sugars,C0242209,en_3397,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
12427,Sugars,C0242209,en_3397,DISRUPTS,biofilm formation,C1325881,en_5552,1,1,AFFECTS,Inhibitory,3
12428,Sugars,C0242209,en_3397,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
12429,Sugars,C0242209,en_3397,PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Excitatory,3
12430,Sugars,C0242209,en_3397,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12431,Sugars,C0242209,en_3397,TREATS(INFER),"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,3
12432,Binding Protein,C0242210,en_3398,PREDISPOSES,Extravasation,C0015376,en_949,1,1,AFFECTS,Excitatory,3
12433,Educational workshop,C0242262,en_3399,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
12434,Educational workshop,C0242262,en_3399,AFFECTS,Personal Satisfaction,C0031206,en_1780,2,2,AFFECTS,General/Uncertain,6
12435,Educational workshop,C0242262,en_3399,AFFECTS,Does walk,C0600108,en_4496,1,1,AFFECTS,General/Uncertain,3
12436,Educational workshop,C0242262,en_3399,TREATS(SPEC),General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
12437,Employment Status,C0242271,en_3400,PREDISPOSES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Excitatory,3
12438,Epidermal Growth Factor,C0242275,en_3401,AUGMENTS,Cell division,C0007590,en_589,2,1,AFFECTS,Excitatory,3
12439,Dietary Supplements,C0242295,en_3402,AFFECTS,Recovery,C0237820,en_3354,2,1,AFFECTS,General/Uncertain,3
12440,Dietary Supplementation,C0242297,en_3403,AFFECTS,"Immunity, Mucosal",C0282558,en_3653,2,1,AFFECTS,General/Uncertain,3
12441,Dietary Supplementation,C0242297,en_3403,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
12442,Dietary Supplementation,C0242297,en_3403,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
12443,Dietary Supplementation,C0242297,en_3403,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
12444,Fostering,C0242298,en_3404,TREATS,audience,C0681273,en_4629,1,1,AFFECTS,Inhibitory,3
12445,Erectile dysfunction,C0242350,en_3407,AFFECTS,Male population group,C0025266,en_1533,1,1,AFFECTS,General/Uncertain,3
12446,Erectile dysfunction,C0242350,en_3407,AFFECTS(SPEC),microvasculature,C0243079,en_3458,1,1,AFFECTS,General/Uncertain,3
12447,Malignant neoplasm of lung,C0242379,en_3408,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
12448,Phytotherapy,C0242388,en_3410,PREVENTS,Common Cold,C0009443,en_684,1,1,AFFECTS,Inhibitory,8
12449,Phytotherapy,C0242388,en_3410,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
12450,Home Remedies,C0242390,en_3411,TREATS,Common Cold,C0009443,en_684,1,1,AFFECTS,Inhibitory,3
12451,Home Remedies,C0242390,en_3411,TREATS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
12452,Home Remedies,C0242390,en_3411,TREATS,Sinusitis,C0037199,en_2112,1,1,AFFECTS,Inhibitory,3
12453,Opioids,C0242402,en_3412,AFFECTS,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,General/Uncertain,3
12454,Opioids,C0242402,en_3412,AFFECTS,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
12455,Opioids,C0242402,en_3412,AFFECTS,Respiratory Depression,C0235063,en_3320,1,1,AFFECTS,General/Uncertain,3
12456,Opioids,C0242402,en_3412,AFFECTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,General/Uncertain,3
12457,Opioids,C0242402,en_3412,AUGMENTS,Acute onset pain,C0184567,en_3054,1,1,AFFECTS,Excitatory,3
12458,Opioids,C0242402,en_3412,AUGMENTS,uptake,C0243144,en_3467,2,1,AFFECTS,Excitatory,3
12459,Opioids,C0242402,en_3412,PREVENTS(SPEC),overdose,C4018909,en_6291,2,2,AFFECTS,Inhibitory,6
12460,Opioids,C0242402,en_3412,TREATS,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
12461,Opioids,C0242402,en_3412,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12462,Opioids,C0242402,en_3412,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
12463,Opioids,C0242402,en_3412,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
12464,Opioids,C0242402,en_3412,TREATS,Individual,C0237401,en_3343,2,2,AFFECTS,Inhibitory,6
12465,Oxidase,C0242417,en_3413,INHIBITS,Prostaglandins,C0033554,en_1902,1,1,AFFECTS,Inhibitory,3
12466,Drug usage,C0242510,en_3417,AFFECTS,Persons,C0027361,en_1635,2,2,AFFECTS,General/Uncertain,6
12467,Microgravity,C0242535,en_3418,AFFECTS,Cytomegalovirus Infections,C0010823,en_751,1,1,AFFECTS,General/Uncertain,3
12468,Microgravity,C0242535,en_3418,AFFECTS,Gene Expression,C0017262,en_1044,2,2,AFFECTS,General/Uncertain,6
12469,Microgravity,C0242535,en_3418,AFFECTS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
12470,Microgravity,C0242535,en_3418,AFFECTS,Signal Transduction,C0037083,en_2105,2,1,AFFECTS,General/Uncertain,3
12471,Microgravity,C0242535,en_3418,AFFECTS,Virulence,C0042765,en_2361,1,1,AFFECTS,General/Uncertain,3
12472,Microgravity,C0242535,en_3418,AFFECTS,Vision,C0042789,en_2366,1,1,AFFECTS,General/Uncertain,3
12473,Microgravity,C0242535,en_3418,AFFECTS,Bone remodeling,C0085268,en_2656,1,1,AFFECTS,General/Uncertain,3
12474,Microgravity,C0242535,en_3418,AFFECTS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,General/Uncertain,3
12475,Microgravity,C0242535,en_3418,AFFECTS,Gravity Perception,C0242675,en_3430,1,1,AFFECTS,General/Uncertain,3
12476,Microgravity,C0242535,en_3418,AFFECTS,"Biological function, NOS",C0277784,en_3587,1,1,AFFECTS,General/Uncertain,3
12477,Microgravity,C0242535,en_3418,AFFECTS,microorganism interaction,C0596935,en_4404,3,2,AFFECTS,General/Uncertain,6
12478,Microgravity,C0242535,en_3418,AFFECTS,biofilm formation,C1325881,en_5552,2,1,AFFECTS,General/Uncertain,3
12479,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
12480,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,7
12481,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,"Granulomatous Disease, Chronic",C0018203,en_1095,1,1,AFFECTS,Inhibitory,3
12482,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,Hematological Disease,C0018939,en_1150,1,1,AFFECTS,Inhibitory,3
12483,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12484,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,Perceived quality of life,C0518214,en_4178,1,1,AFFECTS,Inhibitory,7
12485,Hematopoietic Stem Cell Transplantation,C0242603,en_3421,TREATS,high-risk group,C0684030,en_4676,1,1,AFFECTS,Inhibitory,3
12486,Oxidative Stress,C0242606,en_3422,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
12487,Oxidative Stress,C0242606,en_3422,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
12488,Oxidative Stress,C0242606,en_3422,AFFECTS,Cardiomyopathies,C0878544,en_5074,1,1,AFFECTS,General/Uncertain,3
12489,Oxidative Stress,C0242606,en_3422,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
12490,"Codon, Terminator",C0242611,en_3423,DISRUPTS,translational elongation,C1157562,en_5334,1,1,AFFECTS,Inhibitory,3
12491,CD8-Positive T-Lymphocytes,C0242629,en_3424,PRODUCES,perforin,C0070410,en_2541,1,1,AFFECTS,Excitatory,3
12492,CD8-Positive T-Lymphocytes,C0242629,en_3424,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
12493,CD8-Positive T-Lymphocytes,C0242629,en_3424,PRODUCES,MUC3 protein,C0291545,en_3677,1,1,AFFECTS,Excitatory,7
12494,CD8-Positive T-Lymphocytes,C0242629,en_3424,PRODUCES,T cell antibody,C0312594,en_3733,1,1,AFFECTS,Excitatory,7
12495,CD8-Positive T-Lymphocytes,C0242629,en_3424,PRODUCES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,6
12496,Th1 Cells,C0242632,en_3425,PRODUCES,Interferon Type II,C0021745,en_1332,1,1,AFFECTS,Excitatory,3
12497,Th1 Cells,C0242632,en_3425,PRODUCES,Interleukin-2,C0021756,en_1337,1,1,AFFECTS,Excitatory,3
12498,Vertical Disease Transmission,C0242648,en_3427,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12499,"Disease Transmission, Horizontal",C0242649,en_3428,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,6
12500,Disease Progression,C0242656,en_3429,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12501,Disease Progression,C0242656,en_3429,AFFECTS,Pneumonia,C0032285,en_1833,7,6,AFFECTS,General/Uncertain,18
12502,Disease Progression,C0242656,en_3429,AFFECTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,General/Uncertain,3
12503,Disease Progression,C0242656,en_3429,AFFECTS,Microorganism,C0445623,en_4075,1,1,AFFECTS,General/Uncertain,8
12504,Disease Progression,C0242656,en_3429,AFFECTS,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,6,2,AFFECTS,General/Uncertain,6
12505,Disease Progression,C0242656,en_3429,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
12506,Early Intervention (Education),C0242687,en_3431,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
12507,Early Intervention (Education),C0242687,en_3431,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
12508,Early Intervention (Education),C0242687,en_3431,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12509,"Antirheumatic Drugs, Disease-Modifying",C0242708,en_3435,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
12510,"Antirheumatic Drugs, Disease-Modifying",C0242708,en_3435,TREATS,Arthritis,C0003864,en_400,1,1,AFFECTS,Inhibitory,6
12511,"Antirheumatic Drugs, Disease-Modifying",C0242708,en_3435,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,6
12512,"Antirheumatic Drugs, Disease-Modifying",C0242708,en_3435,TREATS,Rheumatism,C0035435,en_2028,2,2,AFFECTS,Inhibitory,12
12513,"Antirheumatic Drugs, Disease-Modifying",C0242708,en_3435,TREATS,Rheumatic Fever,C0035436,en_2029,1,1,AFFECTS,Inhibitory,6
12514,Tropism,C0242732,en_3436,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
12515,Nutritional Support,C0242739,en_3437,AFFECTS,Complication,C0009566,en_697,2,1,AFFECTS,General/Uncertain,3
12516,Nutritional Support,C0242739,en_3437,AFFECTS,Outpatients,C0029921,en_1729,2,1,AFFECTS,General/Uncertain,3
12517,Nutritional Support,C0242739,en_3437,PREVENTS,Complication,C0009566,en_697,6,1,AFFECTS,Inhibitory,3
12518,Nutritional Support,C0242739,en_3437,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,6
12519,Nutritional Support,C0242739,en_3437,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
12520,Nutritional Support,C0242739,en_3437,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
12521,Nutritional Support,C0242739,en_3437,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,6
12522,Nutritional Support,C0242739,en_3437,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
12523,Nutritional Support,C0242739,en_3437,TREATS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,Inhibitory,3
12524,Nutritional Support,C0242739,en_3437,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,6
12525,Nutritional Support,C0242739,en_3437,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12526,disease transmission,C0242781,en_3438,AFFECTS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,General/Uncertain,6
12527,disease transmission,C0242781,en_3438,PREDISPOSES,Communicable Diseases,C0009450,en_685,3,3,AFFECTS,Excitatory,9
12528,High-Risk Pregnancy,C0242786,en_3439,PREDISPOSES,Stillbirth,C0595939,en_4373,1,1,AFFECTS,Excitatory,3
12529,Anticholinergic Agents,C0242896,en_3441,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
12530,"Anesthetics, Inhalation",C0242903,en_3442,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12531,Neuroprotective Agents,C0242912,en_3443,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
12532,"Analgesics, Non-Narcotic",C0242937,en_3444,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
12533,Perinatal Care,C0242963,en_3445,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
12534,"Diet, Protein-Restricted",C0242972,en_3447,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
12535,"Diet, Protein-Restricted",C0242972,en_3447,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
12536,Patient-Centered Care,C0243024,en_3450,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
12537,Patient-Centered Care,C0243024,en_3450,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
12538,Patient-Centered Care,C0243024,en_3450,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
12539,Molecular Chaperones,C0243041,en_3452,AFFECTS,Crossbreeding,C0020202,en_1217,1,1,AFFECTS,General/Uncertain,3
12540,Molecular Chaperones,C0243041,en_3452,AFFECTS,adenosinetriphosphatase activity,C1148926,en_5300,1,1,AFFECTS,General/Uncertain,3
12541,Molecular Chaperones,C0243041,en_3452,AFFECTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,General/Uncertain,3
12542,Molecular Chaperones,C0243041,en_3452,AFFECTS,strand displacement,C1158517,en_5340,1,1,AFFECTS,General/Uncertain,3
12543,Inflammation Mediators,C0243042,en_3453,AFFECTS,Cell Line,C0007600,en_591,1,1,AFFECTS,General/Uncertain,3
12544,Inflammation Mediators,C0243042,en_3453,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
12545,Inflammation Mediators,C0243042,en_3453,AFFECTS,Sleep,C0037313,en_2119,1,1,AFFECTS,General/Uncertain,3
12546,Inflammation Mediators,C0243042,en_3453,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
12547,Inflammation Mediators,C0243042,en_3453,AUGMENTS,Organ,C0178784,en_2991,3,1,AFFECTS,Excitatory,3
12548,Inflammation Mediators,C0243042,en_3453,AUGMENTS,"Sleep, Slow-Wave",C0234451,en_3309,1,1,AFFECTS,Excitatory,3
12549,Inflammation Mediators,C0243042,en_3453,DISRUPTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
12550,Inflammation Mediators,C0243042,en_3453,STIMULATES,Thrombin,C0040018,en_2228,3,1,AFFECTS,Excitatory,3
12551,Inflammation Mediators,C0243042,en_3453,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
12552,Inflammation Mediators,C0243042,en_3453,TREATS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
12553,Inflammation Mediators,C0243042,en_3453,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12554,Viral Physiology,C0243052,en_3454,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
12555,Analog,C0243071,en_3455,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
12556,antagonists,C0243076,en_3456,TREATS,Cocaine Abuse,C0009171,en_666,1,1,AFFECTS,Inhibitory,3
12557,inhibitors,C0243077,en_3457,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
12558,inhibitors,C0243077,en_3457,AFFECTS,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,General/Uncertain,3
12559,inhibitors,C0243077,en_3457,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12560,inhibitors,C0243077,en_3457,AFFECTS,Crosstalk,C1504598,en_5789,1,1,AFFECTS,General/Uncertain,3
12561,inhibitors,C0243077,en_3457,AFFECTS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,General/Uncertain,3
12562,inhibitors,C0243077,en_3457,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
12563,inhibitors,C0243077,en_3457,INHIBITS(SPEC),Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
12564,inhibitors,C0243077,en_3457,INHIBITS(SPEC),RNA-Directed RNA Polymerase,C0035685,en_2042,2,2,AFFECTS,Inhibitory,6
12565,inhibitors,C0243077,en_3457,INHIBITS(SPEC),dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
12566,inhibitors,C0243077,en_3457,TREATS,Rheumatoid Arthritis,C0003873,en_402,2,1,AFFECTS,Inhibitory,3
12567,inhibitors,C0243077,en_3457,TREATS,Malignant Neoplasms,C0006826,en_545,3,2,AFFECTS,Inhibitory,6
12568,inhibitors,C0243077,en_3457,TREATS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
12569,inhibitors,C0243077,en_3457,TREATS,Disease,C0012634,en_826,4,3,AFFECTS,Inhibitory,9
12570,inhibitors,C0243077,en_3457,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,6
12571,inhibitors,C0243077,en_3457,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
12572,inhibitors,C0243077,en_3457,TREATS,Inflammation,C0021368,en_1307,4,2,AFFECTS,Inhibitory,6
12573,inhibitors,C0243077,en_3457,TREATS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
12574,inhibitors,C0243077,en_3457,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
12575,inhibitors,C0243077,en_3457,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12576,inhibitors,C0243077,en_3457,TREATS,"Pneumonia, Pneumococcal",C0032300,en_1835,2,1,AFFECTS,Inhibitory,3
12577,inhibitors,C0243077,en_3457,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
12578,inhibitors,C0243077,en_3457,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
12579,inhibitors,C0243077,en_3457,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
12580,inhibitors,C0243077,en_3457,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
12581,inhibitors,C0243077,en_3457,TREATS,Injury,C0175677,en_2968,2,2,AFFECTS,Inhibitory,6
12582,inhibitors,C0243077,en_3457,TREATS,Hyperoxia,C0242706,en_3434,1,1,AFFECTS,Inhibitory,3
12583,inhibitors,C0243077,en_3457,TREATS,Postoperative esophagitis,C0267058,en_3543,1,1,AFFECTS,Inhibitory,3
12584,inhibitors,C0243077,en_3457,TREATS,Cytokine release syndrome,C0948245,en_5163,2,1,AFFECTS,Inhibitory,3
12585,inhibitors,C0243077,en_3457,TREATS,Attention deficit hyperactivity disorder,C1263846,en_5428,1,1,AFFECTS,Inhibitory,3
12586,inhibitors,C0243077,en_3457,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
12587,inhibitors,C0243077,en_3457,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
12588,concomitant disease,C0243087,en_3460,COMPLICATES,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
12589,Cellular Structures,C0243092,en_3463,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
12590,enzyme activity,C0243102,en_3464,AFFECTS,cytokine,C0079189,en_2593,4,2,AFFECTS,General/Uncertain,6
12591,lawsuits,C0243118,en_3465,AFFECTS,company,C0683757,en_4672,1,1,AFFECTS,General/Uncertain,3
12592,uptake,C0243144,en_3467,AFFECTS,Community Workers,C0009484,en_689,2,2,AFFECTS,General/Uncertain,6
12593,uptake,C0243144,en_3467,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
12594,uptake,C0243144,en_3467,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
12595,uptake,C0243144,en_3467,AFFECTS,Malaria,C0024530,en_1493,1,1,AFFECTS,General/Uncertain,3
12596,uptake,C0243144,en_3467,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
12597,uptake,C0243144,en_3467,AFFECTS,Testis,C0039597,en_2215,1,1,AFFECTS,General/Uncertain,3
12598,uptake,C0243144,en_3467,AFFECTS,African American,C0085756,en_2689,2,1,AFFECTS,General/Uncertain,3
12599,uptake,C0243144,en_3467,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
12600,uptake,C0243144,en_3467,AFFECTS,AOD use,C0237123,en_3341,1,1,AFFECTS,General/Uncertain,3
12601,uptake,C0243144,en_3467,AFFECTS,respiratory virus,C0597404,en_4426,1,1,AFFECTS,General/Uncertain,3
12602,uptake,C0243144,en_3467,AFFECTS,virus entry,C1537068,en_5947,1,1,AFFECTS,General/Uncertain,3
12603,agonists,C0243192,en_3469,AFFECTS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
12604,agonists,C0243192,en_3469,AFFECTS,Cell Death,C0007587,en_587,1,1,AFFECTS,General/Uncertain,3
12605,agonists,C0243192,en_3469,AFFECTS,Microglia,C0206116,en_3147,1,1,AFFECTS,General/Uncertain,3
12606,agonists,C0243192,en_3469,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,3
12607,agonists,C0243192,en_3469,AUGMENTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,3
12608,agonists,C0243192,en_3469,AUGMENTS,Protoplasm,C0175996,en_2976,2,2,AFFECTS,Excitatory,6
12609,agonists,C0243192,en_3469,AUGMENTS,Adjuvanticity,C1510811,en_5803,1,1,AFFECTS,Excitatory,3
12610,agonists,C0243192,en_3469,DISRUPTS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
12611,agonists,C0243192,en_3469,INHIBITS,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Inhibitory,3
12612,agonists,C0243192,en_3469,PREDISPOSES,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
12613,agonists,C0243192,en_3469,PREVENTS,Inflammation,C0021368,en_1307,2,2,AFFECTS,Inhibitory,6
12614,agonists,C0243192,en_3469,PREVENTS,Asthma attack NOS,C0347950,en_3839,1,1,AFFECTS,Inhibitory,3
12615,agonists,C0243192,en_3469,STIMULATES,GLP-1 receptor,C0378073,en_3893,1,1,AFFECTS,Excitatory,3
12616,agonists,C0243192,en_3469,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
12617,agonists,C0243192,en_3469,TREATS,Hyperalgesia,C0020429,en_1228,1,1,AFFECTS,Inhibitory,3
12618,agonists,C0243192,en_3469,TREATS,Opioid Use Disorders,C0029103,en_1711,3,2,AFFECTS,Inhibitory,6
12619,agonists,C0243192,en_3469,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
12620,agonists,C0243192,en_3469,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
12621,agonists,C0243192,en_3469,TREATS,Pruritus,C0033774,en_1916,1,1,AFFECTS,Inhibitory,3
12622,agonists,C0243192,en_3469,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
12623,agonists,C0243192,en_3469,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
12624,agonists,C0243192,en_3469,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
12625,agonists,C0243192,en_3469,TREATS,Respiratory Depression,C0235063,en_3320,1,1,AFFECTS,Inhibitory,3
12626,agonists,C0243192,en_3469,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
12627,agonists,C0243192,en_3469,TREATS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
12628,agonists,C0243192,en_3469,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
12629,agonists,C0243192,en_3469,TREATS(INFER),Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
12630,Virustat,C0243244,en_3470,TREATS,Knock-out,C1522225,en_5900,1,1,AFFECTS,Inhibitory,3
12631,hydroxytyrosol,C0243264,en_3471,INHIBITS,Sphingolipids,C0037900,en_2142,1,1,AFFECTS,Inhibitory,6
12632,Formaldehyde dehydrogenase (glutathione),C0243628,en_3472,INHIBITS,Carbon Dioxide,C0007012,en_556,1,1,AFFECTS,Inhibitory,3
12633,Raloxifene,C0244404,en_3473,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12634,interferon beta-1b,C0244713,en_3474,TREATS,Adult,C0001675,en_252,2,2,AFFECTS,Inhibitory,15
12635,interferon beta-1b,C0244713,en_3474,TREATS,Multiple Sclerosis,C0026769,en_1598,2,2,AFFECTS,Inhibitory,6
12636,interferon beta-1b,C0244713,en_3474,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12637,interferon beta-1b,C0244713,en_3474,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
12638,interferon beta-1b,C0244713,en_3474,TREATS,Middle East Respiratory Syndrome,C3694279,en_6232,1,1,AFFECTS,Inhibitory,8
12639,anakinra,C0245109,en_3475,AFFECTS,targeting,C0599894,en_4482,1,1,AFFECTS,General/Uncertain,3
12640,anakinra,C0245109,en_3475,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
12641,anakinra,C0245109,en_3475,INHIBITS,Interleukin-1 beta,C0021753,en_1334,4,3,AFFECTS,Inhibitory,9
12642,anakinra,C0245109,en_3475,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,7
12643,anakinra,C0245109,en_3475,INHIBITS,"Receptors, Interleukin-1",C0063710,en_2509,1,1,AFFECTS,Inhibitory,3
12644,anakinra,C0245109,en_3475,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
12645,anakinra,C0245109,en_3475,INHIBITS,TNF gene,C0812246,en_4896,1,1,AFFECTS,Inhibitory,3
12646,anakinra,C0245109,en_3475,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,8
12647,anakinra,C0245109,en_3475,PREVENTS,Respiratory Failure,C1145670,en_5292,2,2,AFFECTS,Inhibitory,10
12648,anakinra,C0245109,en_3475,PREVENTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Inhibitory,3
12649,anakinra,C0245109,en_3475,STIMULATES,Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Excitatory,3
12650,anakinra,C0245109,en_3475,TREATS,Adult,C0001675,en_252,2,2,AFFECTS,Inhibitory,11
12651,anakinra,C0245109,en_3475,TREATS,Rheumatoid Arthritis,C0003873,en_402,2,1,AFFECTS,Inhibitory,3
12652,anakinra,C0245109,en_3475,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
12653,anakinra,C0245109,en_3475,TREATS,Escherichia coli,C0014834,en_929,1,1,AFFECTS,Inhibitory,3
12654,anakinra,C0245109,en_3475,TREATS,Patients,C0030705,en_1762,7,5,AFFECTS,Inhibitory,15
12655,anakinra,C0245109,en_3475,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,6
12656,anakinra,C0245109,en_3475,TREATS,Adult disease,C0277562,en_3585,1,1,AFFECTS,Inhibitory,3
12657,anakinra,C0245109,en_3475,TREATS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,3
12658,anakinra,C0245109,en_3475,TREATS,Rare Diseases,C0678236,en_4556,2,1,AFFECTS,Inhibitory,3
12659,anakinra,C0245109,en_3475,TREATS,Macrophage activation syndrome,C1096155,en_5233,2,2,AFFECTS,Inhibitory,6
12660,anakinra,C0245109,en_3475,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,6
12661,anakinra,C0245109,en_3475,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,6
12662,anakinra,C0245109,en_3475,TREATS,NOMID,C1611731,en_6009,1,1,AFFECTS,Inhibitory,3
12663,anakinra,C0245109,en_3475,TREATS,Severe disorder,C1836348,en_6048,1,1,AFFECTS,Inhibitory,6.5
12664,anakinra,C0245109,en_3475,TREATS,Hyperinflammatory state,C4014463,en_6290,1,1,AFFECTS,Inhibitory,6
12665,anakinra,C0245109,en_3475,TREATS,COVID-19,C5203670,en_6417,4,3,AFFECTS,Inhibitory,23
12666,anakinra,C0245109,en_3475,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,8
12667,anakinra,C0245109,en_3475,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12668,anakinra,C0245109,en_3475,TREATS(INFER),Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
12669,anakinra,C0245109,en_3475,TREATS(INFER),Lower respiratory tract infection,C0149725,en_2806,2,1,AFFECTS,Inhibitory,3
12670,anakinra,C0245109,en_3475,TREATS(INFER),Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
12671,anakinra,C0245109,en_3475,TREATS(INFER),Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Inhibitory,3
12672,Galectin 3,C0245382,en_3476,AFFECTS,Chronic fibrosis,C0334133,en_3773,1,1,AFFECTS,General/Uncertain,6
12673,Galectin 3,C0245382,en_3476,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,6
12674,Galectin 3,C0245382,en_3476,AFFECTS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,General/Uncertain,6
12675,Galectin 3,C0245382,en_3476,STIMULATES,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,3
12676,Galectin 3,C0245382,en_3476,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
12677,Galectin 3,C0245382,en_3476,STIMULATES(SPEC),Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,3
12678,CD95 Antigens|FAS,C0245662|355,en_3477,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,6
12679,icatibant,C0246269,en_3479,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
12680,icatibant,C0246269,en_3479,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
12681,tirofiban,C0247025,en_3480,TREATS,Research Personnel,C0035173,en_2002,2,1,AFFECTS,Inhibitory,3
12682,telmisartan,C0248719,en_3481,INHIBITS,Angiotensin I,C0003006,en_327,1,1,AFFECTS,Inhibitory,3
12683,telmisartan,C0248719,en_3481,INHIBITS,ATM gene,C0919524,en_5114,2,2,AFFECTS,Inhibitory,6
12684,telmisartan,C0248719,en_3481,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
12685,telmisartan,C0248719,en_3481,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
12686,telmisartan,C0248719,en_3481,TREATS(INFER),Hypertensive,C0857121,en_4969,1,1,AFFECTS,Inhibitory,3
12687,febuxostat,C0249529,en_3482,TREATS,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Inhibitory,8
12688,paricalcitol,C0249582,en_3483,TREATS,"Hyperparathyroidism, Secondary",C0020503,en_1235,1,1,AFFECTS,Inhibitory,6
12689,paricalcitol,C0249582,en_3483,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12690,CARE protocol,C0250336,en_3485,STIMULATES,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
12691,CARE protocol,C0250336,en_3485,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,6
12692,Pulmozyme,C0251564,en_3486,TREATS,Cystic Fibrosis,C0010674,en_745,2,2,AFFECTS,Inhibitory,6
12693,Pulmozyme,C0251564,en_3486,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12694,Pulmozyme,C0251564,en_3486,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12695,Janus kinase 3,C0253457,en_3487,PRODUCES,antagonists,C0243076,en_3456,1,1,AFFECTS,Excitatory,3
12696,Interferon beta-1a,C0254119,en_3488,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,8
12697,Interferon beta-1a,C0254119,en_3488,TREATS,Staff,C0851286,en_4950,1,1,AFFECTS,Inhibitory,8
12698,Interferon beta-1a,C0254119,en_3488,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,11
12699,Interferon beta-1a,C0254119,en_3488,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,8
12700,Interferon beta-1a,C0254119,en_3488,TREATS,COVID-19,C5203670,en_6417,7,6,AFFECTS,Inhibitory,46
12701,arbidol,C0254211,en_3489,AFFECTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,General/Uncertain,6
12702,arbidol,C0254211,en_3489,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,7
12703,arbidol,C0254211,en_3489,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12704,arbidol,C0254211,en_3489,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
12705,arbidol,C0254211,en_3489,TREATS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,6
12706,arbidol,C0254211,en_3489,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
12707,arbidol,C0254211,en_3489,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
12708,Interleukin-15,C0254610,en_3491,AUGMENTS,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,3
12709,Interleukin-15,C0254610,en_3491,STIMULATES,Natural Killer Cells,C0022688,en_1386,1,1,AFFECTS,Excitatory,3
12710,Interleukin-15,C0254610,en_3491,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
12711,collagenase 3,C0255672,en_3493,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
12712,"Receptors, Tumor Necrosis Factor, Type II|TNF",C0255813|7124,en_3494,INHIBITS,Tumor Necrosis Factor-Beta,C0024320,en_1475,1,1,AFFECTS,Inhibitory,8
12713,"Receptors, Tumor Necrosis Factor, Type II|TNF",C0255813|7124,en_3494,INHIBITS,"TNF protein, human|TNF",C1448177|7124,en_5756,1,1,AFFECTS,Inhibitory,8
12714,Mitogen-Activated Protein Kinase 14,C0257535,en_3495,STIMULATES,Neuroglia,C0027836,en_1663,1,1,AFFECTS,Excitatory,3
12715,Mitogen-Activated Protein Kinase 14,C0257535,en_3495,STIMULATES,Neurons,C0027882,en_1672,1,1,AFFECTS,Excitatory,3
12716,proadrenomedullin,C0257634,en_3496,PREDISPOSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,6
12717,proadrenomedullin,C0257634,en_3496,TREATS,Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,6
12718,proadrenomedullin,C0257634,en_3496,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
12719,proadrenomedullin,C0257634,en_3496,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12
12720,proadrenomedullin,C0257634,en_3496,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
12721,zoledronic acid,C0257685,en_3497,AFFECTS,Epithelial Cells,C0014597,en_919,1,1,AFFECTS,General/Uncertain,3
12722,Autonomic neuropathy,C0259749,en_3499,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
12723,"Diet, Carbohydrate-Restricted",C0259836,en_3500,TREATS,Patients,C0030705,en_1762,5,2,AFFECTS,Inhibitory,6
12724,"Diet, Carbohydrate-Restricted",C0259836,en_3500,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,5,2,AFFECTS,Inhibitory,6
12725,educator,C0259853,en_3502,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
12726,educator,C0259853,en_3502,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
12727,Hospital care,C0259945,en_3505,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
12728,Hospital care,C0259945,en_3505,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
12729,Hospital care,C0259945,en_3505,TREATS,Patients,C0030705,en_1762,8,5,AFFECTS,Inhibitory,15
12730,Hospital care,C0259945,en_3505,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
12731,Hospital care,C0259945,en_3505,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
12732,Hospital care,C0259945,en_3505,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12733,Hospital care,C0259945,en_3505,TREATS(INFER),Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
12734,Hospital care,C0259945,en_3505,TREATS(INFER),Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
12735,Nursing home care,C0260062,en_3507,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
12736,Steroid drugs,C0260264,en_3510,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
12737,[V]Other behavioral problems,C0260657,en_3512,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
12738,Cerebral dysfunction syndrome,C0262405,en_3515,AFFECTS,Motion,C0026597,en_1584,1,1,AFFECTS,General/Uncertain,3
12739,Pelvic floor exercises,C0262718,en_3516,PREVENTS,Urinary Incontinence,C0042024,en_2319,1,1,AFFECTS,Inhibitory,3
12740,Crisis Management,C0262762,en_3517,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
12741,Crisis Management,C0262762,en_3517,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12742,Crisis Management,C0262762,en_3517,TREATS,Crisis,C0231224,en_3253,2,2,AFFECTS,Inhibitory,6
12743,Crisis Management,C0262762,en_3517,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12744,Medical History,C0262926,en_3519,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,6
12745,Medical History,C0262926,en_3519,PREDISPOSES,Chronic fibrosis,C0334133,en_3773,1,1,AFFECTS,Excitatory,3
12746,Medical History,C0262926,en_3519,PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Excitatory,6
12747,Chronic disease of respiratory system,C0264220,en_3528,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
12748,Acute respiratory failure,C0264490,en_3533,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
12749,Acute respiratory failure,C0264490,en_3533,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12750,Acute respiratory failure,C0264490,en_3533,AFFECTS,Hypoxemia,C0700292,en_4719,2,1,AFFECTS,General/Uncertain,3
12751,Acute respiratory failure,C0264490,en_3533,COMPLICATES,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
12752,Pulmonary necrosis,C0264517,en_3535,AFFECTS,Animals,C0003062,en_335,1,1,AFFECTS,General/Uncertain,3
12753,Perinatal disorder,C0270075,en_3549,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
12754,Generalized Anxiety Disorder,C0270549,en_3551,AFFECTS,Adult,C0001675,en_252,1,1,AFFECTS,General/Uncertain,3
12755,Diabetic complications,C0271672,en_3556,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12756,Eosinopenia,C0272195,en_3557,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
12757,Immune thrombocytopenia,C0272286,en_3558,PREDISPOSES,Hemorrhage,C0019080,en_1161,2,1,AFFECTS,Excitatory,3
12758,Acute infectious disease,C0275518,en_3563,AUGMENTS,Thrombus,C0087086,en_2743,1,1,AFFECTS,Excitatory,3
12759,Acute infectious disease,C0275518,en_3563,PREDISPOSES,Muscle Weakness,C0151786,en_2868,2,1,AFFECTS,Excitatory,3
12760,Clinical infection,C0275521,en_3564,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
12761,Subclinical infection,C0275522,en_3565,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
12762,Mixed infectious disease,C0275524,en_3566,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
12763,Mixed infectious disease,C0275524,en_3566,PRODUCES,beta-Lactamase,C0597979,en_4439,1,1,AFFECTS,Excitatory,6
12764,Zika virus disease,C0276289,en_3576,PRODUCES,Recombinant Antibody,C1335676,en_5618,1,1,AFFECTS,Excitatory,3
12765,Equine influenza,C0276356,en_3577,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
12766,Equine influenza,C0276356,en_3577,AFFECTS,neighbor,C1553702,en_5962,1,1,AFFECTS,General/Uncertain,3
12767,Human immunodeficiency virus I infection,C0276500,en_3579,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
12768,Functional disease present,C0277543,en_3583,AFFECTS,Nitrosative Stress,C4505047,en_6351,1,1,AFFECTS,General/Uncertain,6
12769,Epidemic disease,C0277548,en_3584,AFFECTS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,General/Uncertain,3
12770,"Biological function, NOS",C0277784,en_3587,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
12771,"Biological function, NOS",C0277784,en_3587,AFFECTS,Organism,C0029235,en_1717,2,1,AFFECTS,General/Uncertain,3
12772,"Biological function, NOS",C0277784,en_3587,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12773,"Biological function, NOS",C0277784,en_3587,AFFECTS(SPEC),Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,General/Uncertain,3
12774,"Biological function, NOS",C0277784,en_3587,AFFECTS(SPEC),Nerve Degeneration,C0027746,en_1657,1,1,AFFECTS,General/Uncertain,3
12775,Functional disorder,C0277785,en_3588,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12776,Social stigmata,C0277787,en_3590,PREDISPOSES,Obesity,C0028754,en_1699,1,1,AFFECTS,Excitatory,3
12777,Mental state finding,C0278060,en_3594,PREDISPOSES,Nutrition Disorders,C0028709,en_1698,1,1,AFFECTS,Excitatory,3
12778,Mental state finding,C0278060,en_3594,PREDISPOSES,Memory observations,C0700327,en_4721,1,1,AFFECTS,Excitatory,3
12779,Sexual function,C0278092,en_3597,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
12780,Sexual function,C0278092,en_3597,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
12781,Prognosis good,C0278250,en_3599,PREDISPOSES,SEIZURE RECURRENT,C0748607,en_4833,1,1,AFFECTS,Excitatory,6
12782,Prognosis bad,C0278252,en_3600,PREDISPOSES,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,Excitatory,3
12783,Prescribed,C0278329,en_3601,TREATS,Tonsillitis,C0040425,en_2248,1,1,AFFECTS,Inhibitory,6
12784,Prescribed,C0278329,en_3601,TREATS,Urinary tract infection,C0042029,en_2320,2,1,AFFECTS,Inhibitory,7
12785,dietary intervention,C0278790,en_3605,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
12786,dietary intervention,C0278790,en_3605,PREVENTS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
12787,dietary intervention,C0278790,en_3605,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
12788,dietary intervention,C0278790,en_3605,TREATS,Hepatic pathology,C0857357,en_4975,1,1,AFFECTS,Inhibitory,3
12789,chemosensitization/potentiation,C0279023,en_3608,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
12790,Endocrine therapy,C0279025,en_3609,TREATS,Woman,C0043210,en_2396,2,1,AFFECTS,Inhibitory,3
12791,Endocrine therapy,C0279025,en_3609,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,2,1,AFFECTS,Inhibitory,3
12792,"Laser Therapy, Low-Level",C0279027,en_3610,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12793,"Laser Therapy, Low-Level",C0279027,en_3610,TREATS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
12794,"Laser Therapy, Low-Level",C0279027,en_3610,TREATS,Acute inflammation,C0333361,en_3763,2,1,AFFECTS,Inhibitory,3
12795,interferon therapy,C0279030,en_3611,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
12796,interferon therapy,C0279030,en_3611,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
12797,interferon therapy,C0279030,en_3611,TREATS,Middle East Respiratory Syndrome,C3694279,en_6232,1,1,AFFECTS,Inhibitory,6
12798,Replacement therapy,C0279033,en_3612,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
12799,Replacement therapy,C0279033,en_3612,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
12800,Replacement therapy,C0279033,en_3612,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12801,Replacement therapy,C0279033,en_3612,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
12802,Replacement therapy,C0279033,en_3612,TREATS,Age related macular degeneration,C0242383,en_3409,1,1,AFFECTS,Inhibitory,3
12803,Replacement therapy,C0279033,en_3612,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
12804,hyperbaric oxygen,C0279328,en_3613,AFFECTS,Pulmonary Gas Exchange,C0034071,en_1933,1,1,AFFECTS,General/Uncertain,3
12805,hyperbaric oxygen,C0279328,en_3613,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
12806,hyperbaric oxygen,C0279328,en_3613,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
12807,hyperbaric oxygen,C0279328,en_3613,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
12808,Antiandrogen therapy,C0279492,en_3614,TREATS,Malignant neoplasm of prostate,C0376358,en_3874,2,2,AFFECTS,Inhibitory,6
12809,Androgen therapy,C0279493,en_3615,TREATS,Malignant neoplasm of prostate,C0376358,en_3874,1,1,AFFECTS,Inhibitory,3
12810,Oestrogen therapy,C0279494,en_3616,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12811,Anti-Bacterial Agents,C0279516,en_3617,DISRUPTS,Ototoxicity,C0235280,en_3325,1,1,AFFECTS,Inhibitory,3
12812,Anti-Bacterial Agents,C0279516,en_3617,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
12813,Anti-Bacterial Agents,C0279516,en_3617,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,3
12814,tumor necrosis factor therapy,C0279936,en_3618,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12815,tumor necrosis factor therapy,C0279936,en_3618,TREATS(INFER),Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
12816,Antiviral Therapy,C0280274,en_3620,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,7
12817,Antiviral Therapy,C0280274,en_3620,AFFECTS,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
12818,Antiviral Therapy,C0280274,en_3620,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
12819,Antiviral Therapy,C0280274,en_3620,AFFECTS,cell injury,C0599732,en_4467,1,1,AFFECTS,General/Uncertain,3
12820,Antiviral Therapy,C0280274,en_3620,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
12821,Antiviral Therapy,C0280274,en_3620,PREVENTS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
12822,Antiviral Therapy,C0280274,en_3620,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
12823,Antiviral Therapy,C0280274,en_3620,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
12824,Antiviral Therapy,C0280274,en_3620,TREATS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
12825,Antiviral Therapy,C0280274,en_3620,TREATS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,8
12826,Antiviral Therapy,C0280274,en_3620,TREATS,Patients,C0030705,en_1762,13,8,AFFECTS,Inhibitory,24
12827,Antiviral Therapy,C0280274,en_3620,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12828,Antiviral Therapy,C0280274,en_3620,TREATS,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Inhibitory,3
12829,Antiviral Therapy,C0280274,en_3620,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
12830,Antiviral Therapy,C0280274,en_3620,TREATS,Injury,C0175677,en_2968,6,3,AFFECTS,Inhibitory,9
12831,Antiviral Therapy,C0280274,en_3620,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
12832,Antiviral Therapy,C0280274,en_3620,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,29
12833,brequinar,C0280509,en_3621,AFFECTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,General/Uncertain,3
12834,brequinar,C0280509,en_3621,INHIBITS,Dihydroorotate dehydrogenase,C0058099,en_2470,3,1,AFFECTS,Inhibitory,3
12835,brequinar,C0280509,en_3621,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12836,brequinar,C0280509,en_3621,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
12837,cytarabine/daunorubicin protocol,C0280573,en_3623,PREDISPOSES,Thrombophilia,C0398623,en_3949,2,1,AFFECTS,Excitatory,3
12838,metabolic abnormality assessment,C0280606,en_3624,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12839,educational intervention,C0281163,en_3626,AFFECTS,uptake,C0243144,en_3467,2,1,AFFECTS,General/Uncertain,3
12840,educational intervention,C0281163,en_3626,PREVENTS,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Inhibitory,3
12841,educational intervention,C0281163,en_3626,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12842,educational intervention,C0281163,en_3626,TREATS,student,C0038492,en_2171,1,1,AFFECTS,Inhibitory,3
12843,educational intervention,C0281163,en_3626,TREATS,Abnormal renal function,C0151746,en_2866,1,1,AFFECTS,Inhibitory,3
12844,educational intervention,C0281163,en_3626,TREATS(INFER),"Heart Septal Defects, Atrial",C0018817,en_1139,1,1,AFFECTS,Inhibitory,3
12845,educational intervention,C0281163,en_3626,TREATS(INFER),"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,Inhibitory,3
12846,antibody therapy,C0281176,en_3628,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
12847,antibody therapy,C0281176,en_3628,TREATS,Communicable Diseases,C0009450,en_685,3,3,AFFECTS,Inhibitory,9
12848,antibody therapy,C0281176,en_3628,TREATS,Disease,C0012634,en_826,6,5,AFFECTS,Inhibitory,15
12849,antibody therapy,C0281176,en_3628,TREATS,"Pneumonia, Pneumococcal",C0032300,en_1835,5,4,AFFECTS,Inhibitory,12
12850,antibody therapy,C0281176,en_3628,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
12851,Interleukin therapy,C0281177,en_3629,TREATS,Autoimmunity,C0004368,en_430,1,1,AFFECTS,Inhibitory,3
12852,Breast neoplasm screening,C0281182,en_3630,TREATS,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,3
12853,early detection of colorectal cancer,C0281185,en_3631,TREATS,Underserved Population,C0872319,en_5050,2,1,AFFECTS,Inhibitory,3
12854,early detection of cervical cancer,C0281187,en_3632,PREVENTS,Malignant neoplasm of cervix uteri,C0007847,en_608,1,1,AFFECTS,Inhibitory,3
12855,early detection of cervical cancer,C0281187,en_3632,TREATS,Malignant neoplasm of cervix uteri,C0007847,en_608,1,1,AFFECTS,Inhibitory,3
12856,early detection of cervical cancer,C0281187,en_3632,TREATS,Pregnant Women,C0033011,en_1876,2,1,AFFECTS,Inhibitory,3
12857,early detection of cervical cancer,C0281187,en_3632,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
12858,Lung neoplasm screening,C0281477,en_3633,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
12859,flavopiridol,C0281603,en_3634,INHIBITS,CDK9,C1413290,en_21,1,1,AFFECTS,Inhibitory,3
12860,flavopiridol,C0281603,en_3634,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12861,recombinant viral vaccine,C0281606,en_3635,INHIBITS,"Immunity, Mucosal",C0282558,en_3653,2,2,AFFECTS,Inhibitory,6
12862,recombinant viral vaccine,C0281606,en_3635,PREVENTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
12863,Steroid Use,C0281991,en_3636,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
12864,Qigong,C0282077,en_3637,TREATS,Chronic Fatigue Syndrome,C0015674,en_967,2,1,AFFECTS,Inhibitory,3
12865,beta-Lactams,C0282215,en_3641,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12866,Palliative Surgery,C0282282,en_3642,AFFECTS,Postoperative Complications,C0032787,en_1858,1,1,AFFECTS,General/Uncertain,3
12867,Levofloxacin,C0282386,en_3643,INHIBITS(SPEC),SLCO4C1,C1428158,en_168,1,1,AFFECTS,Inhibitory,3
12868,Leukocyte Adhesion Molecules,C0282400,en_3644,STIMULATES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
12869,Hormone replacement therapy,C0282402,en_3645,TREATS,Woman,C0043210,en_2396,2,2,AFFECTS,Inhibitory,6
12870,Hormone replacement therapy,C0282402,en_3645,TREATS,Menopausal symptom,C0236075,en_3338,1,1,AFFECTS,Inhibitory,3
12871,"Clinical Trials, Phase IV",C0282462,en_3646,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
12872,Maternal-Fetal Transmission,C0282474,en_3647,AFFECTS,"Complications of pregnancy, childbirth and the puerperium",C0178292,en_2981,1,1,AFFECTS,General/Uncertain,3
12873,"Surgical Procedures, Endoscopic",C0282493,en_3648,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
12874,Chemoprevention,C0282515,en_3650,PREVENTS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
12875,Chemoprevention,C0282515,en_3650,PREVENTS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
12876,Chemoprevention,C0282515,en_3650,TREATS,Rheumatoid Arthritis,C0003873,en_402,2,1,AFFECTS,Inhibitory,3
12877,Chemoprevention,C0282515,en_3650,TREATS,Health Personnel,C0018724,en_1121,3,3,AFFECTS,Inhibitory,17
12878,Chemoprevention,C0282515,en_3650,TREATS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
12879,Chemoprevention,C0282515,en_3650,TREATS,"Lupus Erythematosus, Systemic",C0024141,en_1466,2,1,AFFECTS,Inhibitory,3
12880,Chemoprevention,C0282515,en_3650,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12881,Chemoprevention,C0282515,en_3650,TREATS,Porphyrias,C0032708,en_1852,2,1,AFFECTS,Inhibitory,3
12882,Chemoprevention,C0282515,en_3650,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
12883,Chemoprevention,C0282515,en_3650,TREATS,Cerebellar decompression injury,C0344191,en_3835,1,1,AFFECTS,Inhibitory,3
12884,Chemoprevention,C0282515,en_3650,TREATS,Vulnerable Populations,C0949366,en_5180,2,1,AFFECTS,Inhibitory,3
12885,Chemoprevention,C0282515,en_3650,TREATS(INFER),Asymptomatic,C0231221,en_3252,1,1,AFFECTS,Inhibitory,3
12886,chemokine,C0282554,en_3651,AFFECTS,Immunity,C0020964,en_1273,3,2,AFFECTS,General/Uncertain,6
12887,chemokine,C0282554,en_3651,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
12888,chemokine,C0282554,en_3651,AFFECTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,General/Uncertain,3
12889,chemokine,C0282554,en_3651,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
12890,chemokine,C0282554,en_3651,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
12891,chemokine,C0282554,en_3651,AUGMENTS,Lung,C0024109,en_1460,1,1,AFFECTS,Excitatory,3
12892,chemokine,C0282554,en_3651,AUGMENTS,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,Excitatory,3
12893,chemokine,C0282554,en_3651,AUGMENTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,Excitatory,3
12894,chemokine,C0282554,en_3651,PREDISPOSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
12895,"Immunity, Mucosal",C0282558,en_3653,AFFECTS,Predisposition,C0220898,en_3206,2,1,AFFECTS,General/Uncertain,3
12896,"Frameshifting, Ribosomal",C0282572,en_3654,PRODUCES,Proteins,C0033684,en_1912,1,1,AFFECTS,Excitatory,3
12897,Micronutrients,C0282575,en_3655,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,7
12898,Micronutrients,C0282575,en_3655,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
12899,Micronutrients,C0282575,en_3655,PREVENTS,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,Inhibitory,3
12900,"Epitopes, T-Lymphocyte",C0282580,en_3656,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,7
12901,"Epitopes, T-Lymphocyte",C0282580,en_3656,STIMULATES,T-Cell Receptor,C0034790,en_1965,1,1,AFFECTS,Excitatory,3
12902,"Epitopes, T-Lymphocyte",C0282580,en_3656,STIMULATES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
12903,Acupressure,C0282614,en_3658,PREVENTS,Fatigue,C0015672,en_966,2,1,AFFECTS,Inhibitory,3
12904,Acupressure,C0282614,en_3658,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,7
12905,Acupressure,C0282614,en_3658,TREATS,Chronic Fatigue Syndrome,C0015674,en_967,2,1,AFFECTS,Inhibitory,3
12906,Acupressure,C0282614,en_3658,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,7
12907,Acupressure,C0282614,en_3658,TREATS,Adverse reactions,C0559546,en_4315,1,1,AFFECTS,Inhibitory,7
12908,Antibody-Dependent Enhancement,C0282632,en_3660,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
12909,Antibody-Dependent Enhancement,C0282632,en_3660,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
12910,Antibody-Dependent Enhancement,C0282632,en_3660,AFFECTS(SPEC),Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12911,Antibody-Dependent Enhancement,C0282632,en_3660,PRODUCES,Antibodies,C0003241,en_347,4,1,AFFECTS,Excitatory,3
12912,Antibiotic Prophylaxis,C0282638,en_3661,PREVENTS,Surgical Wound Infection,C0038941,en_2192,1,1,AFFECTS,Inhibitory,8
12913,Selectins,C0282651,en_3662,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Excitatory,3
12914,Point-of-Care Systems,C0282664,en_3663,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
12915,"Antibodies, Blocking",C0282682,en_3665,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
12916,"Antibodies, Blocking",C0282682,en_3665,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
12917,LDL-Receptor Related Protein 2,C0284555,en_3667,INHIBITS,SLC5A2,C1420201,en_79,1,1,AFFECTS,Inhibitory,3
12918,RAC-Alpha Serine/Threonine Kinase,C0285558,en_3668,STIMULATES,protein kinase B gamma,C0673232,en_4541,1,1,AFFECTS,Excitatory,3
12919,bicalutamide,C0285590,en_3669,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
12920,atorvastatin,C0286651,en_3670,STIMULATES,Angiotensin II,C0003009,en_328,1,1,AFFECTS,Excitatory,3
12921,atorvastatin,C0286651,en_3670,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
12922,atorvastatin,C0286651,en_3670,TREATS,Hospitalized Patients,C0870668,en_5010,3,1,AFFECTS,Inhibitory,3
12923,atorvastatin,C0286651,en_3670,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
12924,atorvastatin,C0286651,en_3670,TREATS(INFER),Neurologic Symptoms,C0235031,en_3318,2,1,AFFECTS,Inhibitory,3
12925,Saquinavir,C0286738,en_3671,INHIBITS,SLCO4C1,C1428158,en_168,1,1,AFFECTS,Inhibitory,3
12926,cefditoren,C0287573,en_3672,AFFECTS,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,General/Uncertain,3
12927,cefditoren,C0287573,en_3672,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12928,paired basic amino acid cleaving enzyme,C0287990,en_3673,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
12929,paired basic amino acid cleaving enzyme,C0287990,en_3673,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
12930,rosiglitazone,C0289313,en_3674,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
12931,"2,4-thiazolidinedione",C0289779,en_3676,INHIBITS,dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
12932,"2,4-thiazolidinedione",C0289779,en_3676,INHIBITS(SPEC),Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,2,1,AFFECTS,Inhibitory,3
12933,"2,4-thiazolidinedione",C0289779,en_3676,INHIBITS(SPEC),Angiotensin Receptor,C0034787,en_1963,2,1,AFFECTS,Inhibitory,3
12934,"2,4-thiazolidinedione",C0289779,en_3676,INHIBITS(SPEC),dipalmitoylphosphatidylserine,C0058353,en_2473,1,1,AFFECTS,Inhibitory,3
12935,kakkon-to,C0291753,en_3679,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,7
12936,Ritonavir,C0292818,en_3680,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
12937,Ritonavir,C0292818,en_3680,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
12938,Ritonavir,C0292818,en_3680,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
12939,Ritonavir,C0292818,en_3680,TREATS,Coronavirus Infections,C0206750,en_3176,3,2,AFFECTS,Inhibitory,6
12940,Ritonavir,C0292818,en_3680,TREATS,"Hepatitis C, Chronic",C0524910,en_4224,1,1,AFFECTS,Inhibitory,7
12941,Ritonavir,C0292818,en_3680,TREATS,Carrier of disorder,C0560175,en_4319,2,1,AFFECTS,Inhibitory,3
12942,Ritonavir,C0292818,en_3680,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
12943,Ritonavir,C0292818,en_3680,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
12944,pirfenidone,C0298067,en_3681,TREATS,Fibrosis,C0016059,en_994,2,1,AFFECTS,Inhibitory,3
12945,pirfenidone,C0298067,en_3681,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
12946,pirfenidone,C0298067,en_3681,TREATS,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,Inhibitory,3
12947,pirfenidone,C0298067,en_3681,TREATS,Hamman-Rich syndrome,C0085786,en_2691,4,2,AFFECTS,Inhibitory,6
12948,montelukast,C0298130,en_3682,INHIBITS,Interleukin-4,C0021758,en_1340,1,1,AFFECTS,Inhibitory,3
12949,montelukast,C0298130,en_3682,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
12950,montelukast,C0298130,en_3682,INHIBITS,Leukotriene Receptor,C0206517,en_3163,1,1,AFFECTS,Inhibitory,3
12951,montelukast,C0298130,en_3682,INHIBITS,smooth muscle contraction,C1155937,en_5325,1,1,AFFECTS,Inhibitory,3
12952,montelukast,C0298130,en_3682,STIMULATES,Recombinant Interferon-gamma,C0021740,en_1330,1,1,AFFECTS,Excitatory,3
12953,montelukast,C0298130,en_3682,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
12954,montelukast,C0298130,en_3682,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
12955,montelukast,C0298130,en_3682,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
12956,montelukast,C0298130,en_3682,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
12957,montelukast,C0298130,en_3682,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
12958,montelukast,C0298130,en_3682,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
12959,montelukast,C0298130,en_3682,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,6
12960,montelukast,C0298130,en_3682,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
12961,montelukast,C0298130,en_3682,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
12962,bone morphogenetic protein receptor type II,C0299048,en_3683,STIMULATES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
12963,bone morphogenetic protein receptor type II,C0299048,en_3683,STIMULATES,Proto-Oncogene Proteins c-akt,C0164786,en_2945,1,1,AFFECTS,Excitatory,3
12964,"Receptors, Serotonin, 5-HT4",C0299247,en_3684,STIMULATES,Acetylcholine,C0001041,en_217,1,1,AFFECTS,Excitatory,3
12965,Cytokine Inducible SH2-Containing Protein,C0299250,en_3685,PREVENTS,Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
12966,Interferon Regulatory Factor 4,C0299544,en_3687,DISRUPTS,Uveitis,C0042164,en_2325,1,1,AFFECTS,Inhibitory,3
12967,Leptin,C0299583,en_3688,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
12968,5-Trimethoxyamphetamine,C0301363,en_3689,AFFECTS,Renal function,C0232804,en_3285,1,1,AFFECTS,General/Uncertain,3
12969,Therapeutic vaccine,C0301521,en_3690,PREVENTS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
12970,Therapeutic vaccine,C0301521,en_3690,TREATS,Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,Inhibitory,3
12971,Reduction (chemical),C0301630,en_3691,AFFECTS,Substance Use Disorders,C0038586,en_2176,1,1,AFFECTS,General/Uncertain,8
12972,Hormone precursor,C0301817,en_3693,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
12973,Steroid hormone,C0301818,en_3694,AFFECTS,Blood,C0005767,en_482,1,1,AFFECTS,General/Uncertain,3
12974,Steroid hormone,C0301818,en_3694,AFFECTS,Immunity,C0020964,en_1273,2,1,AFFECTS,General/Uncertain,3
12975,Steroid hormone,C0301818,en_3694,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
12976,Hypothalamic inhibiting factor,C0301821,en_3695,INHIBITS,Procollagen-Proline Dioxygenase,C0033384,en_1897,1,1,AFFECTS,Inhibitory,3
12977,Immune response,C0301872,en_3696,AFFECTS,Age,C0001779,en_257,2,1,AFFECTS,General/Uncertain,3
12978,Immune response,C0301872,en_3696,AFFECTS,Animals,C0003062,en_335,1,1,AFFECTS,General/Uncertain,3
12979,Immune response,C0301872,en_3696,AFFECTS,Autophagy,C0004391,en_432,1,1,AFFECTS,General/Uncertain,3
12980,Immune response,C0301872,en_3696,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
12981,Immune response,C0301872,en_3696,AFFECTS,Cessation of life,C0011065,en_762,2,1,AFFECTS,General/Uncertain,3
12982,Immune response,C0301872,en_3696,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
12983,Immune response,C0301872,en_3696,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
12984,Immune response,C0301872,en_3696,AFFECTS,Inflammation,C0021368,en_1307,2,2,AFFECTS,General/Uncertain,6
12985,Immune response,C0301872,en_3696,AFFECTS,Malaria,C0024530,en_1493,1,1,AFFECTS,General/Uncertain,3
12986,Immune response,C0301872,en_3696,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
12987,Immune response,C0301872,en_3696,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,3,AFFECTS,General/Uncertain,9
12988,Immune response,C0301872,en_3696,AFFECTS,Ultraviolet Rays,C0041625,en_2307,1,1,AFFECTS,General/Uncertain,3
12989,Immune response,C0301872,en_3696,AFFECTS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,General/Uncertain,6
12990,Immune response,C0301872,en_3696,AFFECTS,Hospital specialist,C0087009,en_2742,1,1,AFFECTS,General/Uncertain,3
12991,Immune response,C0301872,en_3696,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
12992,Immune response,C0301872,en_3696,AFFECTS,Predisposition,C0220898,en_3206,2,2,AFFECTS,General/Uncertain,6
12993,Immune response,C0301872,en_3696,AFFECTS,Individual,C0237401,en_3343,2,1,AFFECTS,General/Uncertain,3
12994,Immune response,C0301872,en_3696,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
12995,Immune response,C0301872,en_3696,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
12996,Immune response,C0301872,en_3696,AFFECTS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,3
12997,Immune response,C0301872,en_3696,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
12998,Immune response,C0301872,en_3696,AFFECTS,South Asian,C1519427,en_5885,1,1,AFFECTS,General/Uncertain,3
12999,Immune response,C0301872,en_3696,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
13000,Immune response,C0301872,en_3696,PRODUCES,Specific antibody,C0443640,en_4068,2,2,AFFECTS,Excitatory,6
13001,Primary immune response,C0301875,en_3697,PRODUCES,Immunoglobulin M,C0020861,en_1268,2,1,AFFECTS,Excitatory,3
13002,Fragility,C0302113,en_3700,AFFECTS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,General/Uncertain,3
13003,Blood Clot,C0302148,en_3702,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
13004,Blood Clot,C0302148,en_3702,AFFECTS,Individual,C0237401,en_3343,2,1,AFFECTS,General/Uncertain,3
13005,"Visit, by telephone",C0302186,en_3705,AFFECTS,Loneliness,C0023974,en_1456,1,1,AFFECTS,General/Uncertain,8
13006,"Visit, by telephone",C0302186,en_3705,TREATS,Loneliness,C0023974,en_1456,1,1,AFFECTS,Inhibitory,8
13007,"Visit, by telephone",C0302186,en_3705,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
13008,"Visit, by telephone",C0302186,en_3705,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13009,Cell Therapy,C0302189,en_3706,PREVENTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
13010,Cell Therapy,C0302189,en_3706,PREVENTS,Fibrosis,C0016059,en_994,1,1,AFFECTS,Inhibitory,3
13011,Cell Therapy,C0302189,en_3706,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
13012,Cell Therapy,C0302189,en_3706,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
13013,Cell Therapy,C0302189,en_3706,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
13014,Cell Therapy,C0302189,en_3706,PREVENTS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
13015,Cell Therapy,C0302189,en_3706,TREATS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,3
13016,Cell Therapy,C0302189,en_3706,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
13017,Cell Therapy,C0302189,en_3706,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
13018,Cell Therapy,C0302189,en_3706,TREATS,Immune System Diseases,C0021053,en_1284,2,1,AFFECTS,Inhibitory,3
13019,Cell Therapy,C0302189,en_3706,TREATS,Lung diseases,C0024115,en_1462,2,2,AFFECTS,Inhibitory,6
13020,Cell Therapy,C0302189,en_3706,TREATS,Patients,C0030705,en_1762,8,3,AFFECTS,Inhibitory,9
13021,Cell Therapy,C0302189,en_3706,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
13022,Cell Therapy,C0302189,en_3706,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
13023,Cell Therapy,C0302189,en_3706,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
13024,Cell Therapy,C0302189,en_3706,TREATS(INFER),Hematopoietic Neoplasms,C0376544,en_3882,2,1,AFFECTS,Inhibitory,3
13025,Cochlear implant procedure,C0302559,en_3707,TREATS,Hearing Impaired Persons,C0525064,en_4230,1,1,AFFECTS,Inhibitory,3
13026,Iron,C0302583,en_3708,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
13027,Iron,C0302583,en_3708,AFFECTS,Fibrosis,C0016059,en_994,1,1,AFFECTS,General/Uncertain,3
13028,Iron,C0302583,en_3708,AFFECTS,Necrosis,C0027540,en_1645,1,1,AFFECTS,General/Uncertain,3
13029,Iron,C0302583,en_3708,AFFECTS,iron ion homeostasis,C1156273,en_5329,1,1,AFFECTS,General/Uncertain,3
13030,Iron,C0302583,en_3708,INHIBITS,Zinc,C0043481,en_2409,1,1,AFFECTS,Inhibitory,6
13031,Iron,C0302583,en_3708,INHIBITS,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Inhibitory,3
13032,Iron,C0302583,en_3708,INHIBITS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,6
13033,Iron,C0302583,en_3708,TREATS,Hip Fractures,C0019557,en_1185,1,1,AFFECTS,Inhibitory,7
13034,Iron,C0302583,en_3708,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
13035,Iron,C0302583,en_3708,TREATS,Iron deficiency anemia,C0162316,en_2903,2,1,AFFECTS,Inhibitory,3
13036,Iron,C0302583,en_3708,TREATS,Maximum oxygen uptake,C0429693,en_4022,3,1,AFFECTS,Inhibitory,3
13037,Iron,C0302583,en_3708,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
13038,Angiogenesis,C0302600,en_3709,AFFECTS,Physiological Processes,C0031845,en_1807,1,1,AFFECTS,General/Uncertain,3
13039,Couples Therapy,C0302822,en_3711,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Inhibitory,3
13040,Vitamin supplementation,C0302837,en_3713,AFFECTS,Vitamin D Deficiency,C0042870,en_2372,2,1,AFFECTS,General/Uncertain,3
13041,Vitamin supplementation,C0302837,en_3713,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,7
13042,Vitamin supplementation,C0302837,en_3713,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,8
13043,Vitamin supplementation,C0302837,en_3713,AFFECTS,Immune response,C0301872,en_3696,4,1,AFFECTS,General/Uncertain,3
13044,Vitamin supplementation,C0302837,en_3713,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
13045,Vitamin supplementation,C0302837,en_3713,DISRUPTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Inhibitory,8
13046,Vitamin supplementation,C0302837,en_3713,PREVENTS,Laboratory Infection,C0022882,en_1393,2,1,AFFECTS,Inhibitory,3
13047,Vitamin supplementation,C0302837,en_3713,PREVENTS,Osteoporosis,C0029456,en_1726,4,2,AFFECTS,Inhibitory,6
13048,Vitamin supplementation,C0302837,en_3713,PREVENTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
13049,Vitamin supplementation,C0302837,en_3713,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
13050,Vitamin supplementation,C0302837,en_3713,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,11
13051,Vitamin supplementation,C0302837,en_3713,TREATS,French Population,C0016702,en_1019,1,1,AFFECTS,Inhibitory,3
13052,Vitamin supplementation,C0302837,en_3713,TREATS,Health Personnel,C0018724,en_1121,3,2,AFFECTS,Inhibitory,6
13053,Vitamin supplementation,C0302837,en_3713,TREATS,Patients,C0030705,en_1762,7,5,AFFECTS,Inhibitory,15
13054,Vitamin supplementation,C0302837,en_3713,TREATS,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Inhibitory,3
13055,Vitamin supplementation,C0302837,en_3713,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
13056,Vitamin supplementation,C0302837,en_3713,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
13057,Vitamin supplementation,C0302837,en_3713,TREATS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,Inhibitory,3
13058,Vitamin supplementation,C0302837,en_3713,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,15
13059,Vitamin supplementation,C0302837,en_3713,TREATS(INFER),Critical Illness,C0010340,en_733,3,3,AFFECTS,Inhibitory,9
13060,Radicals (chemistry),C0302912,en_3714,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,3
13061,Radicals (chemistry),C0302912,en_3714,TREATS,"Stress, Psychological",C0038443,en_2168,1,1,AFFECTS,Inhibitory,6
13062,Molecular oxygen,C0302920,en_3715,AFFECTS,macrophage,C0024432,en_1484,1,1,AFFECTS,General/Uncertain,3
13063,Lead compound,C0303231,en_3716,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
13064,Thyme oil,C0304119,en_3717,AFFECTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
13065,Prescription drug,C0304227,en_3718,INHIBITS,Cardiovascular Risk,C4324389,en_6343,1,1,AFFECTS,Inhibitory,7
13066,Experimental drug,C0304229,en_3719,PREVENTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,3
13067,Experimental drug,C0304229,en_3719,TREATS,Alzheimer's Disease,C0002395,en_291,3,2,AFFECTS,Inhibitory,6
13068,Experimental drug,C0304229,en_3719,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
13069,Phenothiazine derivative,C0304370,en_3720,DISRUPTS,clathrin-dependent endocytosis,C3156642,en_6175,1,1,AFFECTS,Inhibitory,8
13070,Stimulant,C0304402,en_3721,AUGMENTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
13071,Stimulant,C0304402,en_3721,STIMULATES,Neurotransmitters,C0027908,en_1674,1,1,AFFECTS,Excitatory,3
13072,Stimulant,C0304402,en_3721,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
13073,Stimulant,C0304402,en_3721,TREATS(INFER),Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
13074,Psychostimulant,C0304403,en_3722,DISRUPTS,Capillary Permeability,C0006906,en_551,1,1,AFFECTS,Inhibitory,3
13075,Psychostimulant,C0304403,en_3722,DISRUPTS,Lipid Peroxidation,C0023775,en_1440,1,1,AFFECTS,Inhibitory,3
13076,Psychostimulant,C0304403,en_3722,DISRUPTS,Platelet aggregation,C0032176,en_1828,1,1,AFFECTS,Inhibitory,3
13077,Cytotoxic agent,C0304497,en_3723,TREATS,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,Inhibitory,3
13078,Cytotoxic agent,C0304497,en_3723,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13079,Aglycone,C0304518,en_3724,DISRUPTS,acidification,C1522821,en_5907,1,1,AFFECTS,Inhibitory,3
13080,Topical form corticosteroids,C0304604,en_3725,TREATS,"Dermatitis, Atopic",C0011615,en_791,1,1,AFFECTS,Inhibitory,8
13081,Topical form corticosteroids,C0304604,en_3725,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13082,Topical form corticosteroids,C0304604,en_3725,TREATS(INFER),Keratoconjunctivitis,C0022573,en_1375,2,1,AFFECTS,Inhibitory,3
13083,Polyvalent pneumococcal vaccine,C0305065,en_3726,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
13084,Listerine Antiseptic,C0306643,en_3727,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
13085,DELIVER,C0308779,en_3728,AFFECTS,Emotional,C0849912,en_4937,1,1,AFFECTS,General/Uncertain,3
13086,DELIVER,C0308779,en_3728,PREVENTS,Social stigmata,C0277787,en_3590,1,1,AFFECTS,Inhibitory,3
13087,DELIVER,C0308779,en_3728,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13088,FAVOR,C0309049,en_3729,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
13089,FAVOR,C0309049,en_3729,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13090,"[X]Zoonotic bacterial disease, unspecified",C0311376,en_3730,AFFECTS,Zoonoses,C0043528,en_2410,1,1,AFFECTS,General/Uncertain,3
13091,phenylpyruvate tautomerase,C0312359,en_3731,AFFECTS,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
13092,Polyclonal antibody,C0312586,en_3732,STIMULATES,"M Protein, multiple myeloma",C0700271,en_4717,1,1,AFFECTS,Excitatory,7
13093,Immunologic cell,C0312737,en_3734,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
13094,Immunologic cell,C0312737,en_3734,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
13095,Immunologic cell,C0312737,en_3734,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
13096,Complement component,C0312743,en_3735,STIMULATES,"Complement Pathway, Mannose-Binding Lectin",C1138407,en_5270,1,1,AFFECTS,Excitatory,3
13097,Human gene,C0314604,en_3739,PRODUCES,Genes,C0017337,en_1052,1,1,AFFECTS,Excitatory,3
13098,Matrix,C0331858,en_3746,PRODUCES,"Component, LOINC Axis 1",C1524073,en_5915,1,1,AFFECTS,Excitatory,3
13099,Infiltration,C0332448,en_3749,AFFECTS,Leucocytic infiltrate,C0302158,en_3703,1,1,AFFECTS,General/Uncertain,3
13100,Infiltration,C0332448,en_3749,PREDISPOSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
13101,Redness,C0332575,en_3753,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,3
13102,Congenital webbing,C0332875,en_3755,AFFECTS,General Practitioners,C0017319,en_1051,1,1,AFFECTS,General/Uncertain,6
13103,Recession,C0333047,en_3756,AFFECTS,citizen,C0682134,en_4636,1,1,AFFECTS,General/Uncertain,3
13104,Impaction,C0333124,en_3757,AFFECTS,Surgeon,C0582175,en_4350,1,1,AFFECTS,General/Uncertain,3
13105,Vesicle,C0333262,en_3759,AFFECTS,Cell Communication,C0007582,en_585,1,1,AFFECTS,General/Uncertain,3
13106,Senile Plaques,C0333463,en_3764,AFFECTS,Clinical Nurse Specialists,C0028654,en_1693,1,1,AFFECTS,General/Uncertain,3
13107,"Tumor cells, malignant",C0334227,en_3774,PRODUCES,Metabolites,C0870883,en_5015,1,1,AFFECTS,Excitatory,3
13108,Anesthesiologist,C0334910,en_3779,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13109,Physiotherapist,C0334948,en_3780,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
13110,Economist,C0334970,en_3781,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
13111,manager,C0335141,en_3784,PRODUCES,ordinances,C0243120,en_3466,1,1,AFFECTS,Excitatory,3
13112,Cooking,C0335326,en_3785,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
13113,Cooking,C0335326,en_3785,TREATS,Unemployment,C0041674,en_2309,1,1,AFFECTS,Inhibitory,3
13114,Endotracheal tube,C0336630,en_3787,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
13115,Alarm device,C0336648,en_3788,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
13116,Alarm device,C0336648,en_3788,TREATS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,8
13117,Hot water,C0337023,en_3789,AFFECTS,Heart Valves,C0018826,en_1142,1,1,AFFECTS,General/Uncertain,3
13118,Blast,C0337026,en_3790,AFFECTS,Violent,C0242151,en_3394,1,1,AFFECTS,General/Uncertain,3
13119,Rivers,C0337050,en_3792,AFFECTS,Floods,C0016248,en_1001,1,1,AFFECTS,General/Uncertain,3
13120,Social drinker,C0337676,en_3796,PREDISPOSES,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Excitatory,3
13121,Antibiotic therapy,C0338237,en_3802,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
13122,Antibiotic therapy,C0338237,en_3802,TREATS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
13123,Antibiotic therapy,C0338237,en_3802,TREATS,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,Inhibitory,3
13124,Antibiotic therapy,C0338237,en_3802,TREATS,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Inhibitory,3
13125,Impaired cognition,C0338656,en_3804,PREDISPOSES,Dementia,C0497327,en_4164,1,1,AFFECTS,Excitatory,3
13126,Mixed anxiety and depressive disorder,C0338908,en_3806,AFFECTS,Fibromyalgia,C0016053,en_993,1,1,AFFECTS,General/Uncertain,3
13127,Dissociated vertical deviation,C0339640,en_3807,AFFECTS,pharmacist,C0031323,en_1786,1,1,AFFECTS,General/Uncertain,3
13128,Dissociated vertical deviation,C0339640,en_3807,AFFECTS,Hospital pharmacist,C0402002,en_3957,1,1,AFFECTS,General/Uncertain,3
13129,Transjugular intrahepatic portosystemic shunt procedure,C0339897,en_3808,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
13130,Chronic liver disease NOS,C0341439,en_3823,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
13131,Chronic liver disease NOS,C0341439,en_3823,AFFECTS,cohort,C0599755,en_4470,1,1,AFFECTS,General/Uncertain,3
13132,Chronic liver disease NOS,C0341439,en_3823,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
13133,Renal impairment,C0341697,en_3825,AFFECTS,Drug Kinetics,C0031327,en_1787,1,1,AFFECTS,General/Uncertain,3
13134,Renal impairment,C0341697,en_3825,AFFECTS,Renal function,C0232804,en_3285,1,1,AFFECTS,General/Uncertain,3
13135,Organ dysfunction syndrome,C0342953,en_3828,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
13136,Eosinophilic cellulitis,C0343101,en_3832,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
13137,Interventional radiologic procedures,C0344093,en_3833,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
13138,Sedation procedure,C0344106,en_3834,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
13139,Sedation procedure,C0344106,en_3834,PREDISPOSES,Wasting,C0235394,en_3327,2,1,AFFECTS,Excitatory,3
13140,Sedation procedure,C0344106,en_3834,PREDISPOSES,Acute atrophy,C0333644,en_3771,2,1,AFFECTS,Excitatory,3
13141,Sedation procedure,C0344106,en_3834,PREVENTS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Inhibitory,3
13142,Sedation procedure,C0344106,en_3834,TREATS,Patients,C0030705,en_1762,9,4,AFFECTS,Inhibitory,12
13143,Sedation procedure,C0344106,en_3834,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,1,AFFECTS,Inhibitory,3
13144,Sedation procedure,C0344106,en_3834,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,3
13145,Sedation procedure,C0344106,en_3834,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,1,AFFECTS,Inhibitory,3
13146,Sedation procedure,C0344106,en_3834,TREATS(INFER),Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,3
13147,Supportive care,C0344211,en_3836,TREATS,Outpatients,C0029921,en_1729,8,4,AFFECTS,Inhibitory,16
13148,Supportive care,C0344211,en_3836,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
13149,Supportive care,C0344211,en_3836,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,5,4,AFFECTS,Inhibitory,16
13150,Supportive care,C0344211,en_3836,TREATS,High risk of,C0332167,en_3748,1,1,AFFECTS,Inhibitory,6
13151,Supportive care,C0344211,en_3836,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,6
13152,Supportive care,C0344211,en_3836,TREATS,Hospitalized Patients,C0870668,en_5010,5,3,AFFECTS,Inhibitory,13
13153,Supportive care,C0344211,en_3836,TREATS,imbalance,C1397014,en_5692,1,1,AFFECTS,Inhibitory,8
13154,Supportive care,C0344211,en_3836,TREATS,Storm Syndrome,C1861452,en_6056,1,1,AFFECTS,Inhibitory,8
13155,Supportive care,C0344211,en_3836,TREATS,Middle East Respiratory Syndrome,C3694279,en_6232,1,1,AFFECTS,Inhibitory,7
13156,Supportive care,C0344211,en_3836,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,6
13157,Supportive care,C0344211,en_3836,TREATS,COVID-19,C5203670,en_6417,7,6,AFFECTS,Inhibitory,41
13158,Supportive care,C0344211,en_3836,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,2,1,AFFECTS,Inhibitory,6
13159,Supportive care,C0344211,en_3836,PREVENTS,Virus Shedding,C0162633,en_2921,8,4,AFFECTS,Inhibitory,12
13160,Supportive care,C0344211,en_3836,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
13161,Supportive care,C0344211,en_3836,TREATS,Patients,C0030705,en_1762,19,11,AFFECTS,Inhibitory,33
13162,Supportive care,C0344211,en_3836,TREATS,Physicians,C0031831,en_1805,2,1,AFFECTS,Inhibitory,3
13163,Supportive care,C0344211,en_3836,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
13164,Supportive care,C0344211,en_3836,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
13165,Supportive care,C0344211,en_3836,TREATS,Symptoms,C1457887,en_5784,7,4,AFFECTS,Inhibitory,12
13166,Supportive care,C0344211,en_3836,TREATS(INFER),Critical Illness,C0010340,en_733,3,2,AFFECTS,Inhibitory,6
13167,Supportive care,C0344211,en_3836,TREATS(INFER),Disease,C0012634,en_826,6,3,AFFECTS,Inhibitory,9
13168,Supportive care,C0344211,en_3836,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
13169,Supportive care,C0344211,en_3836,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13170,Supportive care,C0344211,en_3836,TREATS(INFER),Hypoxia,C0242184,en_3396,2,1,AFFECTS,Inhibitory,3
13171,Supportive care,C0344211,en_3836,TREATS(SPEC),Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,Inhibitory,3
13172,Supportive care,C0344211,en_3836,TREATS(SPEC),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13173,Supportive care,C0344211,en_3836,TREATS(SPEC),Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
13174,Open approach,C0348025,en_3840,DISRUPTS,Wounds and Injuries,C0043251,en_2401,1,1,AFFECTS,Inhibitory,3
13175,Open approach,C0348025,en_3840,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
13176,Open approach,C0348025,en_3840,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13177,Aspiration-action,C0349707,en_3844,PREVENTS,Ventilator-associated lung injury,C0340257,en_3814,2,1,AFFECTS,Inhibitory,3
13178,Aspiration-action,C0349707,en_3844,TREATS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,6
13179,Aspiration-action,C0349707,en_3844,TREATS,Pneumonia,C0032285,en_1833,3,1,AFFECTS,Inhibitory,6
13180,Adsorbents,C0350056,en_3848,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
13181,Adsorbents,C0350056,en_3848,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13182,Cleansing preparations,C0353043,en_3849,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
13183,Subcutaneous heparin,C0353681,en_3850,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13184,Intravenous heparin,C0354566,en_3851,STIMULATES,Thromboplastin,C0040048,en_2232,2,1,AFFECTS,Excitatory,3
13185,Oral anticoagulants,C0354604,en_3852,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
13186,Oral anticoagulants,C0354604,en_3852,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,6
13187,Oral anticoagulants,C0354604,en_3852,TREATS,"[X]Disorder of vein, unspecified",C0235522,en_3329,1,1,AFFECTS,Inhibitory,3
13188,Anticholinergic bronchodilators,C0354764,en_3853,INHIBITS(SPEC),Angiotensin Receptor,C0034787,en_1963,1,1,AFFECTS,Inhibitory,3
13189,Intravenous nutrition,C0357168,en_3854,PREDISPOSES,diseases and injuries,C0178237,en_2978,1,1,AFFECTS,Excitatory,6
13190,Human immunoglobulin,C0358321,en_3855,INHIBITS,thymic stromal lymphopoietin,C0762640,en_4865,1,1,AFFECTS,Inhibitory,8
13191,Human immunoglobulin,C0358321,en_3855,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
13192,Human immunoglobulin,C0358321,en_3855,TREATS(INFER),Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
13193,Muscle relaxants,C0358430,en_3856,AFFECTS,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,General/Uncertain,3
13194,Muscle relaxants,C0358430,en_3856,AFFECTS,Muscle Weakness,C0151786,en_2868,1,1,AFFECTS,General/Uncertain,3
13195,Medical gases,C0358516,en_3857,DISRUPTS,Anatomical dead space,C0231974,en_3271,1,1,AFFECTS,Inhibitory,3
13196,Homeopathic medicine,C0358517,en_3858,TREATS,Fatigue,C0015672,en_966,2,1,AFFECTS,Inhibitory,3
13197,Homeopathic medicine,C0358517,en_3858,TREATS,Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
13198,Proton Pump Inhibitors,C0358591,en_3859,AUGMENTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Excitatory,3
13199,Albumin solution,C0359180,en_3860,AUGMENTS,Hemorrhage,C0019080,en_1161,2,2,AFFECTS,Excitatory,6
13200,Phenolics,C0359916,en_3861,AFFECTS,cell transformation,C0040682,en_2270,1,1,AFFECTS,General/Uncertain,3
13201,Topical form lidocaine,C0360097,en_3862,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
13202,Azole antifungal,C0360363,en_3863,INHIBITS(SPEC),CYP2B6,C1382176,en_25,1,1,AFFECTS,Inhibitory,3
13203,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,AFFECTS,Vasodilation,C0042401,en_2342,2,2,AFFECTS,General/Uncertain,6
13204,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,AFFECTS,pleiotropism,C0597257,en_4418,1,1,AFFECTS,General/Uncertain,3
13205,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,AFFECTS,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,General/Uncertain,3
13206,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,AFFECTS,COVID-19,C5203670,en_6417,4,3,AFFECTS,General/Uncertain,18
13207,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,AUGMENTS,BONE MASS,C0238806,en_3370,1,1,AFFECTS,Excitatory,3
13208,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,AUGMENTS,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,1,1,AFFECTS,Excitatory,3
13209,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,DISRUPTS,uptake,C0243144,en_3467,2,1,AFFECTS,Inhibitory,3
13210,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,DISRUPTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13211,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,INHIBITS,Cholesterol,C0008377,en_640,2,1,AFFECTS,Inhibitory,3
13212,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,8
13213,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
13214,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,PREVENTS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
13215,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,PREVENTS,"Complication, infection",C0940933,en_5148,1,1,AFFECTS,Inhibitory,7
13216,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,7
13217,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,6
13218,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,13
13219,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,Hyperlipidemia,C0020473,en_1233,1,1,AFFECTS,Inhibitory,3
13220,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
13221,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,Smoker,C0337664,en_3793,1,1,AFFECTS,Inhibitory,3
13222,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,Confirmation,C0750484,en_4843,1,1,AFFECTS,Inhibitory,6
13223,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,12
13224,Hydroxymethylglutaryl-CoA Reductase Inhibitors,C0360714,en_3864,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,12
13225,Blast Cell,C0368761,en_3866,PRODUCES,Interleukin-10,C0085295,en_2659,1,1,AFFECTS,Excitatory,3
13226,TCR-CD3,C0370049,en_3869,AFFECTS,T-Cell Activation,C1155065,en_5315,1,1,AFFECTS,General/Uncertain,3
13227,Laparoscopic appendectomy,C0372525,en_3871,TREATS,Acute appendicitis NOS,C0085693,en_2687,1,1,AFFECTS,Inhibitory,3
13228,Skin callus,C0376154,en_3872,AFFECTS,Persons,C0027361,en_1635,6,3,AFFECTS,General/Uncertain,9
13229,Skin callus,C0376154,en_3872,AFFECTS,Osteogenesis,C0029433,en_1724,1,1,AFFECTS,General/Uncertain,3
13230,Protein Glycosylation,C0376322,en_3873,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
13231,Protein Glycosylation,C0376322,en_3873,AFFECTS(SPEC),Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
13232,Protein Glycosylation,C0376322,en_3873,AFFECTS(SPEC),Bacterial Infections,C0004623,en_441,1,1,AFFECTS,General/Uncertain,3
13233,Protein Glycosylation,C0376322,en_3873,AFFECTS(SPEC),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
13234,Protein Glycosylation,C0376322,en_3873,AFFECTS(SPEC),Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,3
13235,Protein Glycosylation,C0376322,en_3873,AFFECTS(SPEC),Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,3
13236,Tai Ji,C0376403,en_3876,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,9
13237,Tai Ji,C0376403,en_3876,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,9
13238,DNA Methylation,C0376452,en_3877,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
13239,DNA Methylation,C0376452,en_3877,AFFECTS,TMPRSS2 gene|TMPRSS2,C1336641|7113,en_5637,1,1,AFFECTS,General/Uncertain,8
13240,Adoptive Transfer,C0376518,en_3878,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
13241,Adoptive Transfer,C0376518,en_3878,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
13242,Adoptive Transfer,C0376518,en_3878,TREATS,"Mice, Knockout",C0206745,en_3175,5,1,AFFECTS,Inhibitory,3
13243,Electrostatics,C0376534,en_3879,AFFECTS,Surface Properties,C0038884,en_2188,1,1,AFFECTS,General/Uncertain,3
13244,Recombinant Erythropoietin,C0376541,en_3881,PREVENTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,7
13245,Recombinant Erythropoietin,C0376541,en_3881,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,7
13246,Recombinant Growth Hormone,C0376560,en_3884,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
13247,Recombinant Growth Hormone,C0376560,en_3884,TREATS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Inhibitory,3
13248,Recombinant Granulocyte Colony Stimulating Factor|CSF2|LAMC2,C0376562|1437|3918,en_3885,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
13249,Integrase Inhibitors,C0376601,en_3886,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
13250,Integrase Inhibitors,C0376601,en_3886,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
13251,"Vaccines, DNA",C0376613,en_3887,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
13252,"Vaccines, DNA",C0376613,en_3887,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
13253,"Vaccines, DNA",C0376613,en_3887,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
13254,"Vaccines, DNA",C0376613,en_3887,DISRUPTS,"Tumor cells, malignant",C0334227,en_3774,1,1,AFFECTS,Inhibitory,3
13255,"Vaccines, DNA",C0376613,en_3887,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
13256,"Vaccines, DNA",C0376613,en_3887,STIMULATES,CD8B1 gene,C1367471,en_5671,1,1,AFFECTS,Excitatory,3
13257,"Vaccines, DNA",C0376613,en_3887,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13258,"Vaccines, DNA",C0376613,en_3887,TREATS,Voluntary Workers,C0042960,en_2380,6,3,AFFECTS,Inhibitory,9
13259,"Vaccines, DNA",C0376613,en_3887,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
13260,"Vaccines, DNA",C0376613,en_3887,TREATS(INFER),Malignant neoplasm of skin,C0007114,en_561,1,1,AFFECTS,Inhibitory,3
13261,Endotoxemia,C0376618,en_3888,COMPLICATES,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
13262,Viral Load result,C0376705,en_3889,PREDISPOSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
13263,Mechanics,C0376706,en_3890,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
13264,compound IP-10,C0377674,en_3892,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13265,zafirlukast,C0378466,en_3894,AFFECTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,General/Uncertain,3
13266,Vascular Endothelial Growth Factor Receptor-1,C0378516,en_3895,INHIBITS,PIGF,C1418563,en_68,1,1,AFFECTS,Inhibitory,3
13267,Becaplermin,C0379135,en_3897,AUGMENTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,Excitatory,6
13268,syntaxin 6,C0380202,en_3899,AFFECTS,Cytoplasmic Granules,C0010837,en_755,1,1,AFFECTS,General/Uncertain,3
13269,Fibroblast Growth Factor 2,C0380603,en_3900,PREVENTS,Bone necrosis,C0029445,en_1725,1,1,AFFECTS,Inhibitory,3
13270,Interleukin-18,C0383327,en_3902,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
13271,Interleukin-18,C0383327,en_3902,STIMULATES,Recombinant Interferon-gamma,C0021740,en_1330,1,1,AFFECTS,Excitatory,3
13272,Interleukin-17,C0384648,en_3903,AUGMENTS,"Neutrophil migration, function",C0312860,en_3737,1,1,AFFECTS,Excitatory,3
13273,Interleukin-17,C0384648,en_3903,INHIBITS,Interleukin-4,C0021758,en_1340,1,1,AFFECTS,Inhibitory,8
13274,Interleukin-17,C0384648,en_3903,INHIBITS,Janus kinase,C0597721,en_4436,1,1,AFFECTS,Inhibitory,8
13275,Interleukin-17,C0384648,en_3903,STIMULATES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
13276,Interleukin-17,C0384648,en_3903,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
13277,cyclooxygenase 2,C0387583,en_3904,DISRUPTS,Armed macrophage,C0001280,en_228,1,1,AFFECTS,Inhibitory,3
13278,Chemokine (C-C Motif) Receptor 5,C0387687,en_3905,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
13279,cyclooxygenase 1,C0389003,en_3906,AFFECTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
13280,cyclooxygenase 1,C0389003,en_3906,AFFECTS,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
13281,cyclooxygenase 1,C0389003,en_3906,PREVENTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,3
13282,cyclooxygenase 1,C0389003,en_3906,STIMULATES,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Excitatory,3
13283,"ADAMTS13 protein, human|ADAMTS13",C0389918|11093,en_3908,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
13284,"Angiotensin II Receptor, Type 2",C0390423,en_3909,AFFECTS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
13285,chicoric acid,C0391039,en_3912,AUGMENTS,macrophage,C0024432,en_1484,2,1,AFFECTS,Excitatory,3
13286,chicoric acid,C0391039,en_3912,AUGMENTS,Cell surface,C0699040,en_4699,1,1,AFFECTS,Excitatory,3
13287,Oxygen content,C0391841,en_3913,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
13288,Oxygen content,C0391841,en_3913,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
13289,Pain Disorder,C0391976,en_3914,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
13290,Genuineness,C0392344,en_3918,AFFECTS,Performance,C0597198,en_4416,1,1,AFFECTS,General/Uncertain,3
13291,Genuineness,C0392344,en_3918,PREDISPOSES,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Excitatory,3
13292,Adaptation,C0392673,en_3925,AFFECTS,Adolescent,C0205653,en_3132,1,1,AFFECTS,General/Uncertain,3
13293,Adaptation,C0392673,en_3925,AFFECTS,Staff,C0851286,en_4950,1,1,AFFECTS,General/Uncertain,3
13294,Chemotherapy-Oncologic Procedure,C0392920,en_3928,PREDISPOSES,Oral Mucositis,C1568868,en_5989,2,1,AFFECTS,Excitatory,3
13295,Chemotherapy-Oncologic Procedure,C0392920,en_3928,PREVENTS,Oral Mucositis,C1568868,en_5989,1,1,AFFECTS,Inhibitory,3
13296,Chemotherapy-Oncologic Procedure,C0392920,en_3928,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
13297,Chemotherapy-Oncologic Procedure,C0392920,en_3928,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13298,recombinant human thrombopoietin,C0392939,en_3929,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13299,rituximab,C0393022,en_3930,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
13300,rituximab,C0393022,en_3930,TREATS,Collagen Diseases,C0009326,en_678,3,2,AFFECTS,Inhibitory,12
13301,rituximab,C0393022,en_3930,TREATS,Multiple Sclerosis,C0026769,en_1598,7,2,AFFECTS,Inhibitory,6
13302,rituximab,C0393022,en_3930,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
13303,rituximab,C0393022,en_3930,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
13304,rituximab,C0393022,en_3930,TREATS,risk factors,C0035648,en_2039,1,1,AFFECTS,Inhibitory,6
13305,rituximab,C0393022,en_3930,TREATS,B-Cell Lymphomas,C0079731,en_2609,2,2,AFFECTS,Inhibitory,6
13306,rituximab,C0393022,en_3930,TREATS,Smoker,C0337664,en_3793,1,1,AFFECTS,Inhibitory,6
13307,rituximab,C0393022,en_3930,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,6
13308,rituximab,C0393022,en_3930,TREATS,<12 months,C4699604,en_6381,1,1,AFFECTS,Inhibitory,6
13309,rituximab,C0393022,en_3930,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13310,rituximab,C0393022,en_3930,TREATS(INFER),Immune thrombocytopenia,C0272286,en_3558,1,1,AFFECTS,Inhibitory,3
13311,rituximab,C0393022,en_3930,TREATS(INFER),Autoimmune,C0443146,en_4064,1,1,AFFECTS,Inhibitory,3
13312,voriconazole,C0393080,en_3931,PREVENTS,Toxic effect,C0600688,en_4513,2,1,AFFECTS,Inhibitory,3
13313,Brainstem encephalitis,C0393483,en_3932,AFFECTS,Paralysed,C0522224,en_4211,1,1,AFFECTS,General/Uncertain,3
13314,Deep Brain Stimulation,C0394162,en_3936,TREATS,Parkinson Disease,C0030567,en_1753,2,1,AFFECTS,Inhibitory,3
13315,Neurostimulation procedures of spinal cord tissue,C0394477,en_3937,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13316,Laser acupuncture,C0394654,en_3938,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,8
13317,Laser acupuncture,C0394654,en_3938,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,8
13318,Cupping,C0394663,en_3939,TREATS,Convalescence,C0009940,en_713,2,1,AFFECTS,Inhibitory,3
13319,Acupuncture procedure,C0394664,en_3940,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
13320,Acupuncture procedure,C0394664,en_3940,PREVENTS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,7
13321,Acupuncture procedure,C0394664,en_3940,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
13322,Acupuncture procedure,C0394664,en_3940,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
13323,Acupuncture procedure,C0394664,en_3940,TREATS,Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,Inhibitory,7
13324,Acupuncture procedure,C0394664,en_3940,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
13325,Acupuncture procedure,C0394664,en_3940,TREATS,Chronic pain,C0150055,en_2816,2,1,AFFECTS,Inhibitory,7
13326,Acupuncture procedure,C0394664,en_3940,TREATS,Muscular stiffness,C0221170,en_3219,1,1,AFFECTS,Inhibitory,3
13327,Acupuncture procedure,C0394664,en_3940,TREATS,Tension,C0233494,en_3294,1,1,AFFECTS,Inhibitory,3
13328,Orotracheal intubation,C0396621,en_3941,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
13329,Orotracheal intubation,C0396621,en_3941,TREATS,Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
13330,Nasotracheal intubation,C0396625,en_3942,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,8
13331,Nasotracheal intubation,C0396625,en_3942,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
13332,Extracorporeal carbon dioxide removal,C0398339,en_3945,TREATS,Acute hypoxemic respiratory failure,C4039867,en_6301,1,1,AFFECTS,Inhibitory,8
13333,Hypoplasminogenemia,C0398621,en_3948,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
13334,Thrombophilia,C0398623,en_3949,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
13335,Thrombophilia,C0398623,en_3949,PREDISPOSES,Complication,C0009566,en_697,2,2,AFFECTS,Excitatory,11
13336,Thrombophilia,C0398623,en_3949,PREDISPOSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
13337,Thrombophilia,C0398623,en_3949,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
13338,Thrombophilia,C0398623,en_3949,PREDISPOSES,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,Excitatory,3
13339,Interval appendectomy,C0399995,en_3952,PREVENTS,Recurrent appendicitis,C0267615,en_3545,1,1,AFFECTS,Inhibitory,3
13340,Emergency appendectomy,C0399997,en_3953,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13341,Emergency appendectomy,C0399997,en_3953,TREATS,Acute appendicitis NOS,C0085693,en_2687,1,1,AFFECTS,Inhibitory,3
13342,Bile duct drainage,C0400748,en_3954,TREATS,Distal bile duct stricture,C0860019,en_4988,1,1,AFFECTS,Inhibitory,3
13343,Transurethral resection of bladder neoplasm,C0401496,en_3956,TREATS,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,C4725841,en_6387,1,1,AFFECTS,Inhibitory,6
13344,Speech and language therapist,C0402015,en_3959,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13345,Scientist,C0402112,en_3960,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
13346,Expression of placenta NOS,C0404413,en_3964,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,6
13347,Intravenous sedation,C0412775,en_3971,AFFECTS,Brain activity,C0443158,en_4065,1,1,AFFECTS,General/Uncertain,3
13348,Intravenous sedation,C0412775,en_3971,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
13349,Intravenous sedation,C0412775,en_3971,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,1,AFFECTS,Inhibitory,3
13350,Inhalation sedation,C0412778,en_3972,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13351,Inhalation sedation,C0412778,en_3972,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13352,Medical therapy,C0418981,en_3974,TREATS,Sarcoidosis,C0036202,en_2064,1,1,AFFECTS,Inhibitory,3
13353,Airway Pressure Release Ventilation,C0419005,en_3975,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
13354,Airway Pressure Release Ventilation,C0419005,en_3975,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13355,Airway Pressure Release Ventilation,C0419005,en_3975,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13356,Controlled ventilation,C0419011,en_3976,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,1,AFFECTS,Inhibitory,7
13357,Liquid Ventilation,C0419019,en_3977,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
13358,Liquid Ventilation,C0419019,en_3977,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
13359,Advanced life support,C0419055,en_3978,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
13360,Teleradiotherapy procedure,C0419095,en_3979,TREATS,Rheumatoid Arthritis,C0003873,en_402,2,1,AFFECTS,Inhibitory,8
13361,Teleradiotherapy procedure,C0419095,en_3979,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,8
13362,Teleradiotherapy procedure,C0419095,en_3979,TREATS,"Depressive Disorder, Treatment-Resistant",C2063866,en_6089,1,1,AFFECTS,Inhibitory,7
13363,Social care,C0419189,en_3980,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
13364,Social care,C0419189,en_3980,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
13365,Social care,C0419189,en_3980,TREATS,Peptic Ulcer,C0030920,en_1767,1,1,AFFECTS,Inhibitory,3
13366,Single vaccination NOS,C0419687,en_3982,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
13367,Prophylactic drug therapy NOS,C0420172,en_3983,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,8
13368,Renal function monitoring,C0420204,en_3984,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13369,Intensive care monitoring,C0420205,en_3985,TREATS,Brain Diseases,C0006111,en_510,2,1,AFFECTS,Inhibitory,3
13370,Notifications NOS,C0422202,en_3986,TREATS,School child,C0260267,en_3511,1,1,AFFECTS,Inhibitory,3
13371,Notifications NOS,C0422202,en_3986,TREATS,Provider,C1138603,en_5273,1,1,AFFECTS,Inhibitory,3
13372,Follow-up consultation,C0422322,en_3987,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,8
13373,Frailty,C0424594,en_3998,PREDISPOSES,Fatal Outcome,C0206277,en_3157,1,1,AFFECTS,Excitatory,3
13374,Frailty,C0424594,en_3998,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
13375,Frailty,C0424594,en_3998,PREDISPOSES,Dementia,C0497327,en_4164,1,1,AFFECTS,Excitatory,3
13376,Bed-ridden,C0425251,en_4001,PREDISPOSES,Aspiration Pneumonia,C0032290,en_1834,1,1,AFFECTS,Excitatory,3
13377,Increased protein diet,C0425403,en_4003,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
13378,Increased protein diet,C0425403,en_4003,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
13379,Increased protein diet,C0425403,en_4003,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
13380,Dietary restriction NOS,C0425422,en_4004,TREATS,Reperfusion Injury,C0035126,en_1999,1,1,AFFECTS,Inhibitory,3
13381,Gastrointestinal symptoms NOS,C0426576,en_4007,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
13382,Stiffness,C0427008,en_4008,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
13383,Human cells,C0427861,en_4011,PREDISPOSES,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
13384,Systolic blood pressure,C0428880,en_4016,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
13385,Diastolic blood pressure,C0428883,en_4017,PREDISPOSES,Malignant neoplasm of prostate,C0376358,en_3874,1,1,AFFECTS,Excitatory,3
13386,Positive fluid balance,C0429651,en_4021,PREDISPOSES,Edema,C0013604,en_877,1,1,AFFECTS,Excitatory,3
13387,investigation,C0430007,en_4023,TREATS,Human,C0020114,en_1210,2,2,AFFECTS,Inhibitory,6
13388,investigation,C0430007,en_4023,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
13389,investigation,C0430007,en_4023,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
13390,investigation,C0430007,en_4023,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
13391,investigation,C0430007,en_4023,TREATS(INFER),Septic Shock,C0036983,en_2101,2,1,AFFECTS,Inhibitory,3
13392,diagnostic procedure,C0430022,en_4024,AFFECTS,Health Services,C0018747,en_1125,1,1,AFFECTS,General/Uncertain,3
13393,Proton therapy,C0436226,en_4025,TREATS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,3
13394,Radiochemotherapy NOS,C0436307,en_4026,TREATS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,3
13395,Symptom mild,C0436343,en_4028,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13396,Transcranial magnetic stimulation,C0436548,en_4029,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
13397,EKG finding,C0438154,en_4031,PREDISPOSES,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,Excitatory,6
13398,EKG finding,C0438154,en_4031,PREDISPOSES,"Death, Sudden",C0011071,en_763,1,1,AFFECTS,Excitatory,6
13399,EKG finding,C0438154,en_4031,PREDISPOSES,"Death, Sudden, Cardiac",C0085298,en_2661,1,1,AFFECTS,Excitatory,6
13400,EKG finding,C0438154,en_4031,PREDISPOSES,Increased risk,C4699158,en_6379,1,1,AFFECTS,Excitatory,6
13401,Living Alone,C0439044,en_4032,PREDISPOSES,High Level,C4321237,en_6341,1,1,AFFECTS,Excitatory,6
13402,Primary operation,C0439631,en_4034,TREATS,Cancer of Head and Neck,C0278996,en_3606,1,1,AFFECTS,Inhibitory,6
13403,Elevation procedure,C0439775,en_4037,AFFECTS,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
13404,Elevation procedure,C0439775,en_4037,PREDISPOSES,"Pneumonia, Bacterial",C0004626,en_442,2,1,AFFECTS,Excitatory,3
13405,Elevation procedure,C0439775,en_4037,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
13406,Elevation procedure,C0439775,en_4037,TREATS,Body Temperature,C0005903,en_497,1,1,AFFECTS,Inhibitory,3
13407,Elevation procedure,C0439775,en_4037,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
13408,Elevation procedure,C0439775,en_4037,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,6
13409,Elevation procedure,C0439775,en_4037,TREATS,Male population group,C0025266,en_1533,2,1,AFFECTS,Inhibitory,3
13410,Elevation procedure,C0439775,en_4037,TREATS,"Mice, Inbred C57BL",C0025921,en_1563,1,1,AFFECTS,Inhibitory,3
13411,Elevation procedure,C0439775,en_4037,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,6
13412,Elevation procedure,C0439775,en_4037,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
13413,Elevation procedure,C0439775,en_4037,TREATS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
13414,Elevation procedure,C0439775,en_4037,TREATS,Observation parameter,C0449381,en_4076,1,1,AFFECTS,Inhibitory,6
13415,Elevation procedure,C0439775,en_4037,TREATS,Core body temperature,C0456240,en_4117,1,1,AFFECTS,Inhibitory,3
13416,Elevation procedure,C0439775,en_4037,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
13417,Elevation procedure,C0439775,en_4037,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13418,Elevation procedure,C0439775,en_4037,TREATS(INFER),deceased,C1549464,en_5955,3,1,AFFECTS,Inhibitory,3
13419,Meters,C0441074,en_4043,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
13420,Meters,C0441074,en_4043,TREATS(INFER),Diabetic,C0241863,en_3392,1,1,AFFECTS,Inhibitory,3
13421,Electronic spirometer,C0441079,en_4044,TREATS,"Muscular Dystrophy, Duchenne",C0013264,en_860,1,1,AFFECTS,Inhibitory,6
13422,Electronic spirometer,C0441079,en_4044,TREATS,Boys,C0870221,en_5001,1,1,AFFECTS,Inhibitory,6
13423,Pack,C0441122,en_4045,PREVENTS,Heat Stress Disorders,C0282507,en_3649,1,1,AFFECTS,Inhibitory,3
13424,Coagulation procedure,C0441509,en_4046,AFFECTS,Anemia,C0002871,en_316,1,1,AFFECTS,General/Uncertain,6
13425,Coagulation procedure,C0441509,en_4046,AFFECTS,Fibrosis,C0016059,en_994,1,1,AFFECTS,General/Uncertain,3
13426,Coagulation procedure,C0441509,en_4046,AFFECTS,Homeostasis,C0019868,en_1201,3,2,AFFECTS,General/Uncertain,6
13427,Coagulation procedure,C0441509,en_4046,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
13428,Coagulation procedure,C0441509,en_4046,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
13429,Coagulation procedure,C0441509,en_4046,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
13430,Coagulation procedure,C0441509,en_4046,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
13431,Coagulation procedure,C0441509,en_4046,TREATS,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Inhibitory,3
13432,Coagulation procedure,C0441509,en_4046,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
13433,Coagulation procedure,C0441509,en_4046,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
13434,Coagulation procedure,C0441509,en_4046,TREATS,Patients,C0030705,en_1762,11,6,AFFECTS,Inhibitory,18
13435,Coagulation procedure,C0441509,en_4046,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
13436,Coagulation procedure,C0441509,en_4046,TREATS,COVID-19,C5203670,en_6417,4,4,AFFECTS,Inhibitory,25
13437,Coagulation procedure,C0441509,en_4046,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
13438,Demand (clinical),C0441516,en_4047,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13439,Washing,C0441648,en_4048,TREATS,Curb,C0263940,en_3526,3,2,AFFECTS,Inhibitory,6
13440,Washing,C0441648,en_4048,TREATS,Sitting position,C0277814,en_3592,1,1,AFFECTS,Inhibitory,3
13441,Very high,C0442804,en_4057,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
13442,Very high,C0442804,en_4057,PREDISPOSES,Rickets,C0035579,en_2037,2,1,AFFECTS,Excitatory,3
13443,Very high,C0442804,en_4057,PREDISPOSES,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,Excitatory,3
13444,Very high,C0442804,en_4057,PREDISPOSES,Autism spectrum disorder,C1510586,en_5799,1,1,AFFECTS,Excitatory,3
13445,Alternating current,C0442830,en_4058,AFFECTS,Brain activity,C0443158,en_4065,1,1,AFFECTS,General/Uncertain,3
13446,Neuropathy,C0442874,en_4060,AFFECTS,Oxidative Stress,C0242606,en_3422,2,1,AFFECTS,General/Uncertain,3
13447,Neuropathy,C0442874,en_4060,AFFECTS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,General/Uncertain,3
13448,Secondary infection,C0442886,en_4061,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
13449,Secondary infection,C0442886,en_4061,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
13450,Secondary infection,C0442886,en_4061,AFFECTS,Microbial Biofilms,C0081786,en_2630,1,1,AFFECTS,General/Uncertain,3
13451,Secondary infection,C0442886,en_4061,AFFECTS,Inspired fraction of oxygen,C0428167,en_4012,1,1,AFFECTS,General/Uncertain,3
13452,Secondary infection,C0442886,en_4061,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13453,Systemic disease,C0442893,en_4062,AFFECTS,oral function,C0678868,en_4578,1,1,AFFECTS,General/Uncertain,3
13454,Salvage procedure,C0442967,en_4063,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13455,Salvage procedure,C0442967,en_4063,TREATS(INFER),Bilateral pneumonia,C1142578,en_5287,1,1,AFFECTS,Inhibitory,3
13456,Apolipoprotein E isoform,C0443526,en_4066,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
13457,Bifunctional enzyme,C0443560,en_4067,DISRUPTS,lipid modification,C1158406,en_5337,1,1,AFFECTS,Inhibitory,3
13458,Specific antibody,C0443640,en_4068,AUGMENTS,Patient access,C3841939,en_6260,1,1,AFFECTS,Excitatory,7
13459,Specific antibody,C0443640,en_4068,INHIBITS,Vaccines,C0042210,en_2329,2,1,AFFECTS,Inhibitory,3
13460,Specific antibody,C0443640,en_4068,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
13461,Specific antibody,C0443640,en_4068,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
13462,Specific antibody,C0443640,en_4068,PREVENTS,Reinfection,C0205339,en_3129,1,1,AFFECTS,Inhibitory,7
13463,Specific antibody,C0443640,en_4068,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
13464,Specific antibody,C0443640,en_4068,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
13465,Specific antibody,C0443640,en_4068,PRODUCES,Monoclonal Antibodies,C0003250,en_350,1,1,AFFECTS,Excitatory,7
13466,Specific antibody,C0443640,en_4068,STIMULATES,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,3
13467,Vimentin antibody,C0443949,en_4070,AFFECTS,uptake,C0243144,en_3467,1,1,AFFECTS,General/Uncertain,3
13468,Neutral zone,C0445110,en_4072,AFFECTS,Energy Metabolism,C0014272,en_904,1,1,AFFECTS,General/Uncertain,3
13469,Normal saline,C0445115,en_4073,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
13470,Resorbable suture,C0445225,en_4074,TREATS,Wounds and Injuries,C0043251,en_2401,1,1,AFFECTS,Inhibitory,3
13471,Observation parameter,C0449381,en_4076,PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Excitatory,6
13472,Environmental stimuli,C0450025,en_4078,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
13473,Fog,C0450030,en_4079,AFFECTS,Recovery,C0237820,en_3354,3,2,AFFECTS,General/Uncertain,6
13474,Agent,C0450442,en_4084,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
13475,Agent,C0450442,en_4084,AFFECTS,Rheumatism,C0035435,en_2028,1,1,AFFECTS,General/Uncertain,3
13476,Agent,C0450442,en_4084,AFFECTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,6
13477,Agent,C0450442,en_4084,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
13478,Agent,C0450442,en_4084,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
13479,Agent,C0450442,en_4084,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
13480,Agent,C0450442,en_4084,TREATS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
13481,Agent,C0450442,en_4084,TREATS,Disease,C0012634,en_826,9,8,AFFECTS,Inhibitory,24
13482,Agent,C0450442,en_4084,TREATS,Hypovolemic Shock,C0020683,en_1251,4,1,AFFECTS,Inhibitory,3
13483,Agent,C0450442,en_4084,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
13484,Agent,C0450442,en_4084,TREATS,Multiple Sclerosis,C0026769,en_1598,2,1,AFFECTS,Inhibitory,3
13485,Agent,C0450442,en_4084,TREATS,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,Inhibitory,3
13486,Agent,C0450442,en_4084,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
13487,Agent,C0450442,en_4084,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
13488,Agent,C0450442,en_4084,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
13489,Agent,C0450442,en_4084,TREATS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,6
13490,Agent,C0450442,en_4084,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
13491,Agent,C0450442,en_4084,TREATS,Renal transplant rejection,C0238217,en_3364,1,1,AFFECTS,Inhibitory,3
13492,Agent,C0450442,en_4084,TREATS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
13493,Agent,C0450442,en_4084,TREATS,Autoimmune,C0443146,en_4064,1,1,AFFECTS,Inhibitory,3
13494,Agent,C0450442,en_4084,TREATS,Malignant neoplasm of kidney,C0740457,en_4778,1,1,AFFECTS,Inhibitory,3
13495,Agent,C0450442,en_4084,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,6
13496,Agent,C0450442,en_4084,TREATS,Pulmonary arterial hypertension,C1619734,en_6012,1,1,AFFECTS,Inhibitory,3
13497,Agent,C0450442,en_4084,TREATS,COVID-19,C5203670,en_6417,4,2,AFFECTS,Inhibitory,14
13498,Pain relief,C0451615,en_4085,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
13499,Pain relief,C0451615,en_4085,TREATS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,Inhibitory,3
13500,Pain relief,C0451615,en_4085,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
13501,Pain relief,C0451615,en_4085,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
13502,Physical therapy exercises,C0452240,en_4088,STIMULATES,Acclimatization,C0000934,en_212,2,1,AFFECTS,Excitatory,3
13503,Physical therapy exercises,C0452240,en_4088,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
13504,Physical therapy exercises,C0452240,en_4088,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,3
13505,Physical therapy exercises,C0452240,en_4088,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
13506,Physical therapy exercises,C0452240,en_4088,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
13507,Physical therapy exercises,C0452240,en_4088,TREATS,Individual,C0237401,en_3343,4,1,AFFECTS,Inhibitory,3
13508,Physical therapy exercises,C0452240,en_4088,TREATS,Maximum oxygen uptake,C0429693,en_4022,1,1,AFFECTS,Inhibitory,3
13509,Physical therapy exercises,C0452240,en_4088,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
13510,Physical therapy exercises,C0452240,en_4088,TREATS(INFER),Chronic Fatigue Syndrome,C0015674,en_967,1,1,AFFECTS,Inhibitory,3
13511,Physical therapy exercises,C0452240,en_4088,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13512,Muscular strength development exercise,C0452260,en_4089,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
13513,Muscular strength development exercise,C0452260,en_4089,TREATS,Chest expansion,C0231902,en_3265,1,1,AFFECTS,Inhibitory,3
13514,Very low energy diet,C0452268,en_4090,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13515,Protein diet,C0452269,en_4091,PREDISPOSES,Ketosis,C0022638,en_1378,1,1,AFFECTS,Excitatory,3
13516,Low nickel diet,C0452363,en_4092,TREATS,Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
13517,Balanced diet,C0452410,en_4093,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
13518,Diet good,C0452415,en_4094,PREVENTS,Chronic metabolic disorder,C1263722,en_5427,1,1,AFFECTS,Inhibitory,3
13519,Processed meat,C0452956,en_4096,PREDISPOSES,Carcinoma of the Large Intestine,C0009402,en_681,1,1,AFFECTS,Excitatory,3
13520,Aubergine,C0453111,en_4097,AFFECTS,furuncle,C0242301,en_3405,1,1,AFFECTS,General/Uncertain,3
13521,Fresh food,C0453829,en_4098,AFFECTS,microorganism interaction,C0596935,en_4404,1,1,AFFECTS,General/Uncertain,3
13522,Intellectual functioning disability,C0453879,en_4099,PREDISPOSES,Educated at mainstream school,C0557305,en_4308,1,1,AFFECTS,Excitatory,3
13523,Tobacco smoking behavior,C0453996,en_4100,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13524,Jacobson technique,C0454043,en_4101,AFFECTS,Anxiety,C0003467,en_380,2,1,AFFECTS,General/Uncertain,8
13525,Jacobson technique,C0454043,en_4101,PREVENTS,Anxiety,C0003467,en_380,2,2,AFFECTS,Inhibitory,16
13526,Jacobson technique,C0454043,en_4101,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
13527,Horticultural therapy,C0454057,en_4102,PREVENTS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
13528,Collimator,C0454169,en_4103,PREVENTS,Extravasation,C0015376,en_949,1,1,AFFECTS,Inhibitory,3
13529,Neuromuscular stimulation,C0454448,en_4104,AFFECTS,Muscular Atrophy,C0026846,en_1604,2,1,AFFECTS,General/Uncertain,3
13530,Neuromuscular stimulation,C0454448,en_4104,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13531,Neuromuscular stimulation,C0454448,en_4104,TREATS(INFER),Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,3
13532,Deep breathing exercises,C0454496,en_4105,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
13533,Deep breathing exercises,C0454496,en_4105,STIMULATES,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
13534,Deep breathing exercises,C0454496,en_4105,TREATS,Dyspnea,C0013404,en_866,3,1,AFFECTS,Inhibitory,3
13535,Deep breathing exercises,C0454496,en_4105,TREATS,Hypotension,C0020649,en_1248,2,1,AFFECTS,Inhibitory,3
13536,Deep breathing exercises,C0454496,en_4105,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
13537,Deep breathing exercises,C0454496,en_4105,TREATS,Pneumonia,C0032285,en_1833,6,1,AFFECTS,Inhibitory,3
13538,Sputum induction technique,C0454505,en_4106,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13539,Sputum induction technique,C0454505,en_4106,TREATS(INFER),Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,3
13540,Inspiratory muscle training,C0454511,en_4107,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
13541,Inspiratory muscle training,C0454511,en_4107,AFFECTS,Muscle function,C0231484,en_3260,1,1,AFFECTS,General/Uncertain,3
13542,Inspiratory muscle training,C0454511,en_4107,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,6.5
13543,Inspiratory muscle training,C0454511,en_4107,PREVENTS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,3
13544,Inspiratory muscle training,C0454511,en_4107,PREVENTS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,3
13545,Inspiratory muscle training,C0454511,en_4107,PREVENTS,Myalgia,C0231528,en_3262,1,1,AFFECTS,Inhibitory,3
13546,Inspiratory muscle training,C0454511,en_4107,TREATS,Deglutition Disorders,C0011168,en_772,1,1,AFFECTS,Inhibitory,7
13547,Inspiratory muscle training,C0454511,en_4107,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,3
13548,Inspiratory muscle training,C0454511,en_4107,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
13549,Inspiratory muscle training,C0454511,en_4107,TREATS,Patients,C0030705,en_1762,7,4,AFFECTS,Inhibitory,12
13550,Inspiratory muscle training,C0454511,en_4107,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,7
13551,Inspiratory muscle training,C0454511,en_4107,TREATS,Individual,C0237401,en_3343,4,2,AFFECTS,Inhibitory,6
13552,Inspiratory muscle training,C0454511,en_4107,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
13553,Inspiratory muscle training,C0454511,en_4107,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6.5
13554,Inspiratory muscle training,C0454511,en_4107,TREATS(INFER),Paroxysmal atrial fibrillation,C0235480,en_3328,3,1,AFFECTS,Inhibitory,3
13555,Inspiratory muscle training,C0454511,en_4107,TREATS(INFER),Abnormal breathing,C1260922,en_5414,1,1,AFFECTS,Inhibitory,3
13556,Positive pressure therapy,C0454517,en_4108,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
13557,Bowel preparation,C0455052,en_4109,TREATS,Surgical Wound Infection,C0038941,en_2192,1,1,AFFECTS,Inhibitory,8
13558,Intravenous therapy,C0455142,en_4110,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
13559,Intravenous therapy,C0455142,en_4110,TREATS,Headache Severe,C0239889,en_3376,2,1,AFFECTS,Inhibitory,3
13560,Intravenous therapy,C0455142,en_4110,TREATS,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,Inhibitory,6
13561,Intravenous therapy,C0455142,en_4110,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13562,Catheter procedure,C0455760,en_4111,TREATS,Congenital Heart Defects,C0018798,en_1133,1,1,AFFECTS,Inhibitory,6
13563,Transcranial electrical stimulation,C0455803,en_4112,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
13564,Waist circumference,C0455829,en_4113,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
13565,Fetal stress,C0456057,en_4114,AFFECTS,neurodevelopment,C0599855,en_4477,1,1,AFFECTS,General/Uncertain,3
13566,Blood product,C0456388,en_4119,PREDISPOSES,Vascular infections,C1328274,en_5568,1,1,AFFECTS,Excitatory,3
13567,Blood product,C0456388,en_4119,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13568,Blood product,C0456388,en_4119,TREATS,Special Population,C0597010,en_4408,1,1,AFFECTS,Inhibitory,3
13569,Specific antigen,C0456981,en_4121,AFFECTS,"T-Lymphocytes, Cytotoxic",C0039195,en_2199,1,1,AFFECTS,General/Uncertain,3
13570,Test Result,C0456984,en_4122,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
13571,Respiratory equipment,C0457169,en_4123,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
13572,Respiratory equipment,C0457169,en_4123,TREATS,Protection,C1545588,en_5951,1,1,AFFECTS,Inhibitory,6
13573,Renal disease diet,C0457987,en_4124,TREATS,Phosphorus intake,C0559872,en_4317,1,1,AFFECTS,Inhibitory,7
13574,Vibration - physical agent,C0459800,en_4125,AFFECTS,Esthesia,C0036658,en_2083,1,1,AFFECTS,General/Uncertain,3
13575,Vibration - physical agent,C0459800,en_4125,AFFECTS,Visual Thresholds,C0597665,en_4435,1,1,AFFECTS,General/Uncertain,3
13576,Conservative therapy,C0459914,en_4126,TREATS,Aortic Valve Stenosis,C0003507,en_384,1,1,AFFECTS,Inhibitory,3
13577,Conservative therapy,C0459914,en_4126,TREATS,Appendicitis,C0003615,en_387,1,1,AFFECTS,Inhibitory,6
13578,Conservative therapy,C0459914,en_4126,TREATS,Airway pressure,C0428719,en_4015,1,1,AFFECTS,Inhibitory,3
13579,Conservative therapy,C0459914,en_4126,TREATS,Anastomotic leak,C0919691,en_5118,1,1,AFFECTS,Inhibitory,6
13580,Throat spray,C0461724,en_4128,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
13581,Throat spray,C0461724,en_4128,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
13582,Nasal Spray,C0461725,en_4129,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
13583,Nasal Spray,C0461725,en_4129,TREATS,Common Cold,C0009443,en_684,1,1,AFFECTS,Inhibitory,7
13584,Exteriorization of trachea,C0472567,en_4131,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
13585,Exteriorization of trachea,C0472567,en_4131,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,6
13586,Exteriorization of trachea,C0472567,en_4131,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
13587,Hemopoietic stem cell transplant,C0472699,en_4132,TREATS,Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,Inhibitory,3
13588,Hemopoietic stem cell transplant,C0472699,en_4132,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13589,Hemopoietic stem cell transplant,C0472699,en_4132,TREATS,respiratory virus,C0597404,en_4426,2,1,AFFECTS,Inhibitory,6
13590,Hemopoietic stem cell transplant,C0472699,en_4132,TREATS(INFER),Severe Combined Immunodeficiency,C0085110,en_2645,1,1,AFFECTS,Inhibitory,3
13591,Pilot,C0473169,en_4134,TREATS,Patients,C0030705,en_1762,5,2,AFFECTS,Inhibitory,6
13592,Psychological counseling,C0474178,en_4136,PREVENTS,Anxiety symptoms,C0860603,en_4992,1,1,AFFECTS,Inhibitory,8
13593,Psychological counseling,C0474178,en_4136,TREATS,Distress,C0231303,en_3256,1,1,AFFECTS,Inhibitory,8
13594,Pre-anesthetic assessment,C0474221,en_4137,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13595,Hepatitis B vaccination,C0474232,en_4138,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,7
13596,Hepatitis B vaccination,C0474232,en_4138,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,7
13597,Flavoring,C0475332,en_4144,TREATS,Anorexia,C0003123,en_336,2,1,AFFECTS,Inhibitory,3
13598,Neutralizing antibody,C0475463,en_4145,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
13599,Neutralizing antibody,C0475463,en_4145,DISRUPTS,Receptor Binding,C0597358,en_4423,1,1,AFFECTS,Inhibitory,3
13600,Neutralizing antibody,C0475463,en_4145,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,8
13601,Neutralizing antibody,C0475463,en_4145,INHIBITS,"CXCL10 protein, human|CXCL10",C1308752|3627,en_5525,1,1,AFFECTS,Inhibitory,8
13602,Neutralizing antibody,C0475463,en_4145,PREDISPOSES,Infectious transmissions,C0947878,en_5157,1,1,AFFECTS,Excitatory,3
13603,Neutralizing antibody,C0475463,en_4145,STIMULATES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,7
13604,Neutralizing antibody,C0475463,en_4145,STIMULATES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
13605,Neutralizing antibody,C0475463,en_4145,STIMULATES,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,1,1,AFFECTS,Excitatory,6
13606,Home exercise program,C0475647,en_4146,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,7
13607,Home exercise program,C0475647,en_4146,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
13608,Respiratory distress,C0476273,en_4149,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
13609,Physical and emotional exhaustion state,C0476644,en_4150,PREDISPOSES,Stress,C0038435,en_2165,1,1,AFFECTS,Excitatory,6
13610,QT interval:Time:Point in time:Heart:Quantitative:EKG,C0488414,en_4154,PREDISPOSES,Torsades de Pointes,C0040479,en_2250,1,1,AFFECTS,Excitatory,6
13611,HOSPITAL CONSULTATIONS,C0489546,en_4156,TREATS,Diabetic ulcer,C0743150,en_4799,1,1,AFFECTS,Inhibitory,3
13612,Height,C0489786,en_4159,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13613,HEART STUDY,C0489835,en_4160,AFFECTS,"Risk factor, cardiovascular",C0850624,en_4944,1,1,AFFECTS,General/Uncertain,3
13614,"CONTROL, HEMOGLOBIN",C0491298,en_4161,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
13615,"HEART-VALVE, MECHANICAL",C0493527,en_4162,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13616,"Medical care, unspecified",C0496675,en_4163,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
13617,"Medical care, unspecified",C0496675,en_4163,PREDISPOSES,Complication,C0009566,en_697,2,1,AFFECTS,Excitatory,3
13618,"Medical care, unspecified",C0496675,en_4163,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
13619,"Medical care, unspecified",C0496675,en_4163,TREATS,Old age,C1999167,en_6084,1,1,AFFECTS,Inhibitory,7
13620,Dementia,C0497327,en_4164,AFFECTS,Elderly,C0001792,en_258,3,2,AFFECTS,General/Uncertain,6
13621,Dementia,C0497327,en_4164,AFFECTS,Persons,C0027361,en_1635,5,3,AFFECTS,General/Uncertain,9
13622,Dementia,C0497327,en_4164,AFFECTS,Patients,C0030705,en_1762,3,3,AFFECTS,General/Uncertain,9
13623,Dementia,C0497327,en_4164,AFFECTS,Caregiver,C0085537,en_2674,1,1,AFFECTS,General/Uncertain,3
13624,Dementia,C0497327,en_4164,AFFECTS,Individual,C0237401,en_3343,3,2,AFFECTS,General/Uncertain,6
13625,Dementia,C0497327,en_4164,AFFECTS,American,C0596070,en_4379,6,1,AFFECTS,General/Uncertain,3
13626,Dementia,C0497327,en_4164,AFFECTS,Dyads,C0870454,en_5003,1,1,AFFECTS,General/Uncertain,3
13627,Pulse oximetry monitoring,C0513686,en_4166,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13628,physical health,C0516977,en_4168,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
13629,Muscle strength,C0517349,en_4170,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
13630,Muscle strength,C0517349,en_4170,AFFECTS,Ability,C0085732,en_2688,1,1,AFFECTS,General/Uncertain,3
13631,Muscle strength,C0517349,en_4170,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
13632,Infection status,C0517627,en_4174,PREDISPOSES,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Excitatory,3
13633,Infection status,C0517627,en_4174,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
13634,Autonomic function,C0518003,en_4175,PREDISPOSES,Cardiac complication,C0161816,en_2898,1,1,AFFECTS,Excitatory,6
13635,Perceived quality of life,C0518214,en_4178,PREDISPOSES,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Excitatory,3
13636,Consideration,C0518609,en_4179,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13637,Vital signs,C0518766,en_4182,PREDISPOSES,Falls,C0085639,en_2684,1,1,AFFECTS,Excitatory,3
13638,Multiple interventional procedures,C0520251,en_4184,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
13639,Cannula device,C0520453,en_4185,TREATS,Snuffles,C1260880,en_5412,1,1,AFFECTS,Inhibitory,3
13640,GMP,C0520462,en_4187,AUGMENTS,Stromal Cells,C0162597,en_2918,1,1,AFFECTS,Excitatory,3
13641,Saponin,C0520481,en_4188,PREVENTS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
13642,Materials,C0520510,en_4189,AFFECTS,Membrane Fusion,C0025246,en_1528,1,1,AFFECTS,General/Uncertain,3
13643,cisplatin/cyclophosphamide/doxorubicin/etoposide chemotherapy protocol,C0520526,en_4190,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
13644,"Sleep Apnea, Obstructive",C0520679,en_4191,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,8
13645,"Sleep Apnea, Obstructive",C0520679,en_4191,PREDISPOSES,Fetal Growth Retardation,C0015934,en_984,1,1,AFFECTS,Excitatory,7
13646,"Sleep Apnea, Obstructive",C0520679,en_4191,PREDISPOSES,Cardiovascular morbidity,C1301700,en_5508,1,1,AFFECTS,Excitatory,3
13647,Physical disability,C0520817,en_4192,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
13648,Physical disability,C0520817,en_4192,AFFECTS,Individual,C0237401,en_3343,2,1,AFFECTS,General/Uncertain,3
13649,Diastolic dysfunction,C0520863,en_4194,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
13650,Anticoagulant effect,C0520996,en_4196,AFFECTS,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
13651,Closure by clamp,C0521213,en_4199,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,6
13652,Closure by clamp,C0521213,en_4199,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13653,Life support procedure,C0521300,en_4200,AFFECTS,Childbirth,C1148523,en_5296,1,1,AFFECTS,General/Uncertain,3
13654,Life support procedure,C0521300,en_4200,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
13655,Life support procedure,C0521300,en_4200,PREVENTS,Atrophic,C0333641,en_3770,1,1,AFFECTS,Inhibitory,3
13656,Life support procedure,C0521300,en_4200,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
13657,Life support procedure,C0521300,en_4200,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
13658,Life support procedure,C0521300,en_4200,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
13659,Life support procedure,C0521300,en_4200,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
13660,Life support procedure,C0521300,en_4200,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
13661,Life support procedure,C0521300,en_4200,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
13662,Life support procedure,C0521300,en_4200,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
13663,Life support procedure,C0521300,en_4200,TREATS(INFER),Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
13664,Life support procedure,C0521300,en_4200,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
13665,Lung consolidation,C0521530,en_4202,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
13666,Angiotensin II receptor antagonist,C0521942,en_4205,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,8
13667,Angiotensin II receptor antagonist,C0521942,en_4205,AFFECTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
13668,Angiotensin II receptor antagonist,C0521942,en_4205,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13669,Angiotensin II receptor antagonist,C0521942,en_4205,PREVENTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,7
13670,Angiotensin II receptor antagonist,C0521942,en_4205,STIMULATES,angiotensin converting enzyme 2,C0960880,en_5195,1,1,AFFECTS,Excitatory,6
13671,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,Hypertensive disease,C0020538,en_1239,2,2,AFFECTS,Inhibitory,12
13672,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,6
13673,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,6
13674,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,6
13675,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,Hospitalized Patients,C0870668,en_5010,3,3,AFFECTS,Inhibitory,19
13676,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,Discontinued,C1444662,en_5749,1,1,AFFECTS,Inhibitory,8
13677,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,COVID-19,C5203670,en_6417,8,6,AFFECTS,Inhibitory,37
13678,Angiotensin II receptor antagonist,C0521942,en_4205,TREATS,2019 novel coronavirus,C5203676,en_6420,3,2,AFFECTS,Inhibitory,14
13679,Pre-existing condition,C0521987,en_4206,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
13680,Cardiac troponin T,C0522086,en_4209,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13681,Long chain fatty acid,C0522095,en_4210,STIMULATES,Peroxisome Proliferator-Activated Receptors,C0166418,en_2950,1,1,AFFECTS,Excitatory,3
13682,Antigonadotropin,C0522260,en_4212,STIMULATES,Androgen Receptor,C0034786,en_1962,1,1,AFFECTS,Excitatory,3
13683,Severe inflammation,C0522569,en_4215,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
13684,Pervasive Development Disorders,C0524528,en_4216,AFFECTS,Health behavior,C0018687,en_1116,1,1,AFFECTS,General/Uncertain,6
13685,Gastrointestinal Surgical Procedure,C0524722,en_4218,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13686,Nucleocapsid Proteins,C0524816,en_4219,AFFECTS,Virion,C0042760,en_2360,1,1,AFFECTS,General/Uncertain,3
13687,Nucleocapsid Proteins,C0524816,en_4219,AFFECTS,Receptor Binding,C0597358,en_4423,2,1,AFFECTS,General/Uncertain,3
13688,Neurodegenerative Disorders,C0524851,en_4220,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,3
13689,Neurodegenerative Disorders,C0524851,en_4220,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
13690,Neurodegenerative Disorders,C0524851,en_4220,AFFECTS,Childbirth,C1148523,en_5296,1,1,AFFECTS,General/Uncertain,8
13691,Orthopedic Procedures,C0524852,en_4221,PREVENTS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,8
13692,Reconstructive Surgical Procedures,C0524865,en_4222,TREATS,Bacteria,C0004611,en_440,1,1,AFFECTS,Inhibitory,3
13693,Reconstructive Surgical Procedures,C0524865,en_4222,TREATS,Hematological Disease,C0018939,en_1150,1,1,AFFECTS,Inhibitory,3
13694,Reconstructive Surgical Procedures,C0524865,en_4222,TREATS,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,Inhibitory,3
13695,Reconstructive Surgical Procedures,C0524865,en_4222,TREATS,Obstruction,C0028778,en_1702,1,1,AFFECTS,Inhibitory,3
13696,Reconstructive Surgical Procedures,C0524865,en_4222,TREATS,Bladder dysfunction,C0232841,en_3288,1,1,AFFECTS,Inhibitory,3
13697,TRA@ gene cluster,C0524890,en_4223,STIMULATES,Growth Factor,C0018284,en_1100,1,1,AFFECTS,Excitatory,3
13698,RyR1,C0524965,en_4225,AFFECTS,Immune system,C0020962,en_1271,1,1,AFFECTS,General/Uncertain,3
13699,Probiotics,C0525033,en_4227,PRODUCES,Antibodies,C0003241,en_347,2,1,AFFECTS,Excitatory,3
13700,4'-N-benzoylstaurosporine,C0526371,en_4231,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13701,"Receptor, Angiotensin, Type 1",C0529330,en_4233,DISRUPTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,Inhibitory,3
13702,"Receptor, Angiotensin, Type 1",C0529330,en_4233,INHIBITS,AGTR1,C1439284,en_5,1,1,AFFECTS,Inhibitory,3
13703,"Receptor, Angiotensin, Type 1",C0529330,en_4233,PREDISPOSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
13704,sildenafil,C0529793,en_4234,AFFECTS,Alveolar ventilation function,C0231940,en_3269,2,1,AFFECTS,General/Uncertain,3
13705,TNF receptor-associated factor 6,C0530129,en_4235,DISRUPTS,Alveolar Cell,C1515931,en_5849,1,1,AFFECTS,Inhibitory,3
13706,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,AFFECTS,Immune system,C0020962,en_1271,3,1,AFFECTS,General/Uncertain,3
13707,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,AUGMENTS,macrophage,C0024432,en_1484,1,1,AFFECTS,Excitatory,3
13708,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,AUGMENTS,Alveolar,C1440080,en_5730,1,1,AFFECTS,Excitatory,3
13709,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,STIMULATES,VEGFA,C1823619,en_89,1,1,AFFECTS,Excitatory,3
13710,tissue inhibitor of metalloproteinase 4,C0532028,en_4237,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
13711,Angiopoietin-1,C0533670,en_4238,AFFECTS,Lung,C0024109,en_1460,1,1,AFFECTS,General/Uncertain,3
13712,Endostatins,C0534628,en_4240,INHIBITS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,Inhibitory,7
13713,"IFNA2 protein, human|IFNA2",C0535872|3440,en_4241,STIMULATES,ACE2 gene|ACE2,C1422064|59272,en_5724,1,1,AFFECTS,Excitatory,6
13714,xanthohumol,C0536128,en_4243,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
13715,TRPC3 ion channel,C0536252,en_4244,AFFECTS,"Fibrosis, Liver",C0239946,en_3377,1,1,AFFECTS,General/Uncertain,3
13716,Heme Oxygenase-1,C0538674,en_4245,PREDISPOSES,"Tuberculosis, active",C0151332,en_2858,1,1,AFFECTS,Excitatory,3
13717,celecoxib,C0538927,en_4246,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
13718,sigma-1 receptor,C0539266,en_4247,AFFECTS,cytokine production,C1327413,en_5564,1,1,AFFECTS,General/Uncertain,8
13719,"DNA, Catalytic",C0540193,en_4248,STIMULATES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
13720,Angiopoietin-2,C0540511,en_4249,AUGMENTS,Endothelium,C0014257,en_902,1,1,AFFECTS,Excitatory,6
13721,Angiopoietin-2,C0540511,en_4249,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13722,Drugs and Biologicals,C0541491,en_4250,TREATS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Inhibitory,6
13723,Chart evaluation by healthcare professional,C0541653,en_4251,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13724,Preventive Services - Orthodontics,C0541661,en_4252,TREATS,Youth,C0087178,en_2748,1,1,AFFECTS,Inhibitory,3
13725,Preventive Services - Orthodontics,C0541661,en_4252,TREATS,Frailty,C0424594,en_3998,1,1,AFFECTS,Inhibitory,3
13726,Behavioral change,C0542299,en_4255,AFFECTS,Behavior,C0004927,en_450,1,1,AFFECTS,General/Uncertain,3
13727,Behavioral change,C0542299,en_4255,AFFECTS,Health behavior,C0018687,en_1116,1,1,AFFECTS,General/Uncertain,3
13728,Direct current cardioversion,C0542380,en_4256,TREATS,Onset of illness,C0277793,en_3591,2,1,AFFECTS,Inhibitory,3
13729,Sequela of disorder,C0543419,en_4257,PREDISPOSES,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Excitatory,3
13730,Sequela of disorder,C0543419,en_4257,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
13731,Operative Surgical Procedures,C0543467,en_4258,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
13732,Operative Surgical Procedures,C0543467,en_4258,AFFECTS,Patients,C0030705,en_1762,3,2,AFFECTS,General/Uncertain,6
13733,Operative Surgical Procedures,C0543467,en_4258,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
13734,Operative Surgical Procedures,C0543467,en_4258,AFFECTS,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
13735,Operative Surgical Procedures,C0543467,en_4258,PREVENTS,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,Inhibitory,3
13736,Operative Surgical Procedures,C0543467,en_4258,STIMULATES,Growth,C0018270,en_1098,1,1,AFFECTS,Excitatory,6
13737,Operative Surgical Procedures,C0543467,en_4258,TREATS,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,6
13738,Operative Surgical Procedures,C0543467,en_4258,TREATS,Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,Inhibitory,3
13739,Operative Surgical Procedures,C0543467,en_4258,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
13740,Operative Surgical Procedures,C0543467,en_4258,TREATS,Community,C0009462,en_687,3,1,AFFECTS,Inhibitory,6
13741,Operative Surgical Procedures,C0543467,en_4258,TREATS,Endophthalmitis,C0014236,en_899,1,1,AFFECTS,Inhibitory,3
13742,Operative Surgical Procedures,C0543467,en_4258,TREATS,Hip Fractures,C0019557,en_1185,2,1,AFFECTS,Inhibitory,6
13743,Operative Surgical Procedures,C0543467,en_4258,TREATS,Infertility,C0021359,en_1305,1,1,AFFECTS,Inhibitory,3
13744,Operative Surgical Procedures,C0543467,en_4258,TREATS,Patients,C0030705,en_1762,31,16,AFFECTS,Inhibitory,48
13745,Operative Surgical Procedures,C0543467,en_4258,TREATS,Periodontitis,C0031099,en_1775,1,1,AFFECTS,Inhibitory,3
13746,Operative Surgical Procedures,C0543467,en_4258,TREATS,Sinusitis,C0037199,en_2112,1,1,AFFECTS,Inhibitory,3
13747,Operative Surgical Procedures,C0543467,en_4258,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
13748,Operative Surgical Procedures,C0543467,en_4258,TREATS,Missionaries,C0079844,en_2613,1,1,AFFECTS,Inhibitory,3
13749,Operative Surgical Procedures,C0543467,en_4258,TREATS,Sitting position,C0277814,en_3592,1,1,AFFECTS,Inhibitory,3
13750,Operative Surgical Procedures,C0543467,en_4258,TREATS,Vitality,C0424589,en_3997,1,1,AFFECTS,Inhibitory,3
13751,Operative Surgical Procedures,C0543467,en_4258,TREATS,Surgical Patients,C0871463,en_5023,2,1,AFFECTS,Inhibitory,3
13752,Operative Surgical Procedures,C0543467,en_4258,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,6
13753,Operative Surgical Procedures,C0543467,en_4258,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
13754,Operative Surgical Procedures,C0543467,en_4258,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,13
13755,Operative Surgical Procedures,C0543467,en_4258,TREATS(INFER),Acute appendicitis NOS,C0085693,en_2687,1,1,AFFECTS,Inhibitory,3
13756,Operative Surgical Procedures,C0543467,en_4258,TREATS(INFER),"Cholecystitis, Acute",C0149520,en_2801,1,1,AFFECTS,Inhibitory,3
13757,Hypercoagulability disease,C0543671,en_4260,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,6
13758,Human plasma,C0544357,en_4261,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,7
13759,Human plasma,C0544357,en_4261,TREATS,Disease,C0012634,en_826,4,3,AFFECTS,Inhibitory,9
13760,Human plasma,C0544357,en_4261,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13761,Human plasma,C0544357,en_4261,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,7
13762,Human plasma,C0544357,en_4261,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,7
13763,Human plasma,C0544357,en_4261,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,7
13764,Human plasma,C0544357,en_4261,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
13765,Inactivation,C0544461,en_4262,PRODUCES,Singlet Oxygen,C0074565,en_2571,1,1,AFFECTS,Excitatory,3
13766,Complication of disease,C0544688,en_4265,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
13767,Somatic mutation,C0544886,en_4268,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
13768,"Visit, outpatient",C0545084,en_4269,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,6
13769,"Visit, outpatient",C0545084,en_4269,TREATS,Epilepsy,C0014544,en_917,1,1,AFFECTS,Inhibitory,6
13770,"Visit, outpatient",C0545084,en_4269,TREATS,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,6
13771,"Visit, outpatient",C0545084,en_4269,TREATS,Migraine Disorders,C0149931,en_2813,1,1,AFFECTS,Inhibitory,6
13772,"Visit, hospital",C0545092,en_4270,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13773,Immunization procedure,C0545298,en_4271,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
13774,Immunization procedure,C0545298,en_4271,PREVENTS(SPEC),Hepatitis B,C0019163,en_1172,2,1,AFFECTS,Inhibitory,3
13775,Immunization procedure,C0545298,en_4271,PREVENTS(SPEC),Measles,C0025007,en_1512,2,1,AFFECTS,Inhibitory,3
13776,Immunization procedure,C0545298,en_4271,PREVENTS(SPEC),Rabies,C0034494,en_1948,2,1,AFFECTS,Inhibitory,3
13777,Immunization procedure,C0545298,en_4271,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,3
13778,B cell therapy,C0545321,en_4272,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13779,B cell therapy,C0545321,en_4272,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
13780,B cell therapy,C0545321,en_4272,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
13781,B cell therapy,C0545321,en_4272,TREATS(INFER),Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,Inhibitory,3
13782,T cell therapy,C0545322,en_4273,AFFECTS,"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,1,1,AFFECTS,General/Uncertain,3
13783,T cell therapy,C0545322,en_4273,AFFECTS,Graft acceptance,C0301944,en_3699,1,1,AFFECTS,General/Uncertain,3
13784,T cell therapy,C0545322,en_4273,AFFECTS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,3
13785,T cell therapy,C0545322,en_4273,TREATS,Malignant Neoplasms,C0006826,en_545,5,1,AFFECTS,Inhibitory,3
13786,T cell therapy,C0545322,en_4273,TREATS,Solid tumor,C0280100,en_3619,1,1,AFFECTS,Inhibitory,3
13787,T cell therapy,C0545322,en_4273,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,3
13788,T cell therapy,C0545322,en_4273,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
13789,protocols: surgery,C0548471,en_4275,TREATS,Dental Staff,C0011420,en_782,1,1,AFFECTS,Inhibitory,7
13790,Perforation (observation),C0549099,en_4276,PREDISPOSES,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Excitatory,3
13791,Hemoglobin increased,C0549448,en_4282,PREDISPOSES,Blood coagulation,C0005778,en_484,1,1,AFFECTS,Excitatory,6
13792,MISUSE,C0549649,en_4285,PREDISPOSES,Mental disorders,C0004936,en_452,1,1,AFFECTS,Excitatory,3
13793,MISUSE,C0549649,en_4285,PREDISPOSES,Delirium,C0011206,en_774,1,1,AFFECTS,Excitatory,3
13794,MISUSE,C0549649,en_4285,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
13795,MISUSE,C0549649,en_4285,PREDISPOSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
13796,MISUSE,C0549649,en_4285,PREDISPOSES,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Excitatory,3
13797,MISUSE,C0549649,en_4285,PREDISPOSES,Mental health problem,C1446377,en_5753,2,1,AFFECTS,Excitatory,3
13798,Renal Cell,C0553257,en_4286,PRODUCES,Adenovirus Vaccine,C1552907,en_5959,1,1,AFFECTS,Excitatory,3
13799,Emergency visit,C0553618,en_4287,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
13800,Emergency visit,C0553618,en_4287,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,6
13801,Chronic Childhood Arthritis,C0553662,en_4288,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
13802,Fluid Management,C0553741,en_4290,AFFECTS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
13803,Fluid Management,C0553741,en_4290,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13804,Removal of endotracheal tube,C0553891,en_4292,PREVENTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
13805,Removal of endotracheal tube,C0553891,en_4292,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
13806,Removal of endotracheal tube,C0553891,en_4292,TREATS,44730,C0442753,en_4054,1,1,AFFECTS,Inhibitory,3
13807,Maker NOS,C0554244,en_4294,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13808,Maker NOS,C0554244,en_4294,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
13809,Assisted breathing,C0554804,en_4295,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
13810,Assisted breathing,C0554804,en_4295,PREDISPOSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
13811,Assisted breathing,C0554804,en_4295,TREATS,Patients,C0030705,en_1762,8,5,AFFECTS,Inhibitory,15
13812,Assisted breathing,C0554804,en_4295,TREATS,"Stress, acute",C0848237,en_4931,1,1,AFFECTS,Inhibitory,3
13813,Assisted breathing,C0554804,en_4295,TREATS(INFER),Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
13814,Assisted breathing,C0554804,en_4295,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13815,Assisted breathing,C0554804,en_4295,TREATS(INFER),Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
13816,Human leukocyte antigen allele,C0555907,en_4296,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,6
13817,Repositioning,C0556030,en_4298,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
13818,Repositioning,C0556030,en_4298,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13819,Folic acid supplementation,C0556110,en_4299,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
13820,Attention training,C0556509,en_4301,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
13821,Meetings,C0556656,en_4302,TREATS,Persons,C0027361,en_1635,8,8,AFFECTS,Inhibitory,24
13822,Meetings,C0556656,en_4302,TREATS,Progeria,C0033300,en_1892,1,1,AFFECTS,Inhibitory,3
13823,Meetings,C0556656,en_4302,TREATS,Harmonious caregiver-patient relationship,C0516944,en_4167,1,1,AFFECTS,Inhibitory,3
13824,Meetings,C0556656,en_4302,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
13825,Meetings,C0556656,en_4302,TREATS,Teams,C0871489,en_5024,4,4,AFFECTS,Inhibitory,12
13826,Interferential therapy,C0556898,en_4303,TREATS,[V]Insurance medical,C0481840,en_4151,1,1,AFFECTS,Inhibitory,3
13827,Consulting with,C0557054,en_4305,TREATS,Family problems,C0424960,en_3999,1,1,AFFECTS,Inhibitory,3
13828,Reassuring,C0557055,en_4306,PREDISPOSES,Maternal-Fetal Transmission,C0282474,en_3647,1,1,AFFECTS,Excitatory,3
13829,Evaluating interventions,C0557980,en_4311,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
13830,Evaluating interventions,C0557980,en_4311,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13831,Evaluating interventions,C0557980,en_4311,TREATS,high-risk group,C0684030,en_4676,1,1,AFFECTS,Inhibitory,3
13832,Evaluating interventions,C0557980,en_4311,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
13833,Close supervision,C0557988,en_4312,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13834,Functional behavioral assessment,C0558024,en_4313,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
13835,Functional behavioral assessment,C0558024,en_4313,TREATS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
13836,preference,C0558295,en_4314,PREDISPOSES,hypoglycemia,C0020615,en_1245,1,1,AFFECTS,Excitatory,3
13837,Adverse reactions,C0559546,en_4315,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
13838,Moving,C0560560,en_4320,AFFECTS,Violent,C0242151,en_3394,1,1,AFFECTS,General/Uncertain,3
13839,Cardiovascular injury,C0560570,en_4321,AFFECTS(SPEC),Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,General/Uncertain,3
13840,Intrusive memories,C0561837,en_4322,PREDISPOSES,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,Excitatory,3
13841,Neuromuscular blockade monitoring,C0561865,en_4323,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13842,N-3 fatty acid supplementation,C0561929,en_4324,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
13843,Examination of heart,C0562319,en_4325,TREATS,CARDIAC SYMPTOM,C0741933,en_4793,1,1,AFFECTS,Inhibitory,6
13844,Laryngoscope blade,C0563576,en_4329,PREVENTS,Injury,C0175677,en_2968,2,1,AFFECTS,Inhibitory,3
13845,Ultraviolet B radiation,C0564461,en_4330,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
13846,Atom,C0567415,en_4332,AFFECTS,iron ion homeostasis,C1156273,en_5329,1,1,AFFECTS,General/Uncertain,3
13847,Atom,C0567415,en_4332,STIMULATES,Retinoids,C0035339,en_2025,1,1,AFFECTS,Excitatory,3
13848,Biologically active substance,C0574031,en_4334,DISRUPTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,Inhibitory,3
13849,Infusion procedures,C0574032,en_4335,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
13850,Infusion procedures,C0574032,en_4335,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
13851,Infusion procedures,C0574032,en_4335,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
13852,Infusion procedures,C0574032,en_4335,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,7
13853,Infusion procedures,C0574032,en_4335,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
13854,Infusion procedures,C0574032,en_4335,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
13855,Infusion procedures,C0574032,en_4335,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13856,Infusion procedures,C0574032,en_4335,TREATS,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,Inhibitory,3
13857,Infusion procedures,C0574032,en_4335,TREATS,cohort,C0599755,en_4470,3,2,AFFECTS,Inhibitory,6
13858,Infusion procedures,C0574032,en_4335,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,3
13859,Infusion procedures,C0574032,en_4335,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
13860,Infusion procedures,C0574032,en_4335,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,8
13861,Infusion procedures,C0574032,en_4335,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
13862,Infusion procedures,C0574032,en_4335,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
13863,Infusion procedures,C0574032,en_4335,TREATS,Experimental Group,C5205743,en_6423,1,1,AFFECTS,Inhibitory,7
13864,Infusion procedures,C0574032,en_4335,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
13865,Infusion procedures,C0574032,en_4335,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
13866,Infusion procedures,C0574032,en_4335,TREATS(INFER),"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
13867,Finding of body mass index,C0578022,en_4339,PREDISPOSES,Surgical Wound Infection,C0038941,en_2192,1,1,AFFECTS,Excitatory,8
13868,Finding of body mass index,C0578022,en_4339,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
13869,Carboxyhemoglobin level,C0580948,en_4342,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13870,Chronic anemia,C0581384,en_4347,AFFECTS,targeting,C0599894,en_4482,2,1,AFFECTS,General/Uncertain,3
13871,Functional modification,C0581601,en_4348,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
13872,Medical assessment,C0582103,en_4349,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
13873,Regular exercise,C0582191,en_4351,PREVENTS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
13874,Regular exercise,C0582191,en_4351,PREVENTS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
13875,Regular exercise,C0582191,en_4351,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
13876,Regular exercise,C0582191,en_4351,TREATS(INFER),Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
13877,Structural protein,C0582263,en_4352,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
13878,Structural protein,C0582263,en_4352,PRODUCES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
13879,Structural protein,C0582263,en_4352,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
13880,Percutaneous tracheostomy,C0584877,en_4353,PREVENTS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
13881,Percutaneous tracheostomy,C0584877,en_4353,TREATS,Patients,C0030705,en_1762,5,2,AFFECTS,Inhibitory,6
13882,Percutaneous tracheostomy,C0584877,en_4353,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
13883,Antihypertensive therapy,C0585941,en_4355,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13884,Lipid-lowering therapy,C0585943,en_4356,TREATS,Contraction,C1140999,en_5281,2,1,AFFECTS,Inhibitory,3
13885,Infectious disease specialist,C0586873,en_4358,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13886,Metabolic therapy,C0587059,en_4360,TREATS,Malignant neoplasm of stomach,C0024623,en_1495,1,1,AFFECTS,Inhibitory,3
13887,Methylprednisolone pulse therapy,C0587279,en_4362,TREATS,Child syndrome,C0265267,en_3542,1,1,AFFECTS,Inhibitory,6
13888,Physiotherapy service,C0587629,en_4363,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
13889,Physiotherapy service,C0587629,en_4363,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
13890,Self Monitoring,C0588436,en_4365,PREVENTS,Depressive Symptoms,C0086132,en_2702,2,1,AFFECTS,Inhibitory,3
13891,Self Monitoring,C0588436,en_4365,TREATS,Celiac Disease,C0007570,en_582,1,1,AFFECTS,Inhibitory,3
13892,Follow-up visit,C0589121,en_4366,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13893,Follow-up visit,C0589121,en_4366,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
13894,Desferal,C0591350,en_4367,PREVENTS(SPEC),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,1,AFFECTS,Inhibitory,3
13895,Salazopyrin,C0592088,en_4368,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
13896,Salazopyrin,C0592088,en_4368,TREATS(INFER),Glioblastoma,C0017636,en_1062,1,1,AFFECTS,Inhibitory,3
13897,Synacthen,C0592151,en_4369,TREATS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,6
13898,Leukotriene Antagonists,C0595726,en_4370,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
13899,Leukotriene Antagonists,C0595726,en_4370,DISRUPTS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Inhibitory,3
13900,Intraocular pressure disorder,C0595921,en_4371,AFFECTS,Contraction,C1140999,en_5281,1,1,AFFECTS,General/Uncertain,3
13901,Hydroxychloroquine Sulfate,C0596007,en_4375,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
13902,Hydroxychloroquine Sulfate,C0596007,en_4375,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
13903,Hydroxychloroquine Sulfate,C0596007,en_4375,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,7
13904,Hydroxychloroquine Sulfate,C0596007,en_4375,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
13905,Does stand,C0596013,en_4376,PREDISPOSES,Disease,C0012634,en_826,2,1,AFFECTS,Excitatory,3
13906,Chloride Ion,C0596019,en_4377,STIMULATES,Active Ingredients,C1372955,en_5682,2,1,AFFECTS,Excitatory,3
13907,Chloride Ion,C0596019,en_4377,STIMULATES(SPEC),Hypochlorous Acid,C0020600,en_1244,2,1,AFFECTS,Excitatory,3
13908,brain cell,C0596208,en_4382,PRODUCES,Neurotransmitters,C0027908,en_1674,1,1,AFFECTS,Excitatory,3
13909,Brain Metabolism,C0596215,en_4383,AFFECTS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,General/Uncertain,3
13910,Cell Proliferation,C0596290,en_4384,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
13911,diabetes education,C0596424,en_4386,AFFECTS,Self-care behavior,C0474417,en_4142,1,1,AFFECTS,General/Uncertain,3
13912,dietary aminoacid,C0596441,en_4387,AFFECTS,amino acid transport,C0596078,en_4380,2,1,AFFECTS,General/Uncertain,3
13913,dimer,C0596448,en_4388,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
13914,dimer,C0596448,en_4388,TREATS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
13915,dimer,C0596448,en_4388,TREATS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Inhibitory,3
13916,Early Diagnosis,C0596473,en_4389,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
13917,Early Diagnosis,C0596473,en_4389,AFFECTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
13918,Early Diagnosis,C0596473,en_4389,AFFECTS,Diagnosis,C0011900,en_806,1,1,AFFECTS,General/Uncertain,3
13919,Early Diagnosis,C0596473,en_4389,AFFECTS,melanoma,C0025202,en_1522,1,1,AFFECTS,General/Uncertain,3
13920,Early Diagnosis,C0596473,en_4389,AFFECTS,Primary Health Care,C0033137,en_1884,1,1,AFFECTS,General/Uncertain,3
13921,Early Diagnosis,C0596473,en_4389,AFFECTS,Virus Diseases,C0042769,en_2362,4,1,AFFECTS,General/Uncertain,3
13922,Early Diagnosis,C0596473,en_4389,AFFECTS,acute care,C0679878,en_4616,1,1,AFFECTS,General/Uncertain,6
13923,Flavonoids,C0596577,en_4393,AFFECTS,Cell membrane,C0007603,en_592,2,1,AFFECTS,General/Uncertain,3
13924,Flavonoids,C0596577,en_4393,DISRUPTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
13925,Hip surgery,C0596706,en_4394,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
13926,Hip surgery,C0596706,en_4394,TREATS,Patients,C0030705,en_1762,8,2,AFFECTS,Inhibitory,6
13927,Hip surgery,C0596706,en_4394,TREATS(INFER),Hip Fractures,C0019557,en_1185,1,1,AFFECTS,Inhibitory,3
13928,immunosenescence,C0596761,en_4395,AFFECTS,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
13929,immunosenescence,C0596761,en_4395,AFFECTS,Chronic infectious disease,C0151317,en_2857,1,1,AFFECTS,General/Uncertain,3
13930,immunosenescence,C0596761,en_4395,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
13931,Magnesium Ions,C0596876,en_4398,DISRUPTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,Inhibitory,3
13932,medical appointment,C0596893,en_4399,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
13933,medical appointment,C0596893,en_4399,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
13934,Membrane,C0596901,en_4400,PRODUCES,Petroleum,C0031264,en_1783,1,1,AFFECTS,Excitatory,3
13935,Membrane Transport Proteins,C0596902,en_4401,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
13936,metalloenzyme,C0596918,en_4402,AFFECTS,Hydrolysis,C0020291,en_1223,1,1,AFFECTS,General/Uncertain,3
13937,methyl group,C0596922,en_4403,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
13938,microorganism interaction,C0596935,en_4404,AFFECTS,life history,C0598779,en_4450,1,1,AFFECTS,General/Uncertain,3
13939,Muscle Cells,C0596981,en_4405,PRODUCES,Brain natriuretic peptide,C0054015,en_2445,1,1,AFFECTS,Excitatory,3
13940,myelination,C0596991,en_4407,AFFECTS,Psychotic Disorders,C0033975,en_1924,1,1,AFFECTS,General/Uncertain,3
13941,Neoplastic Cell,C0597032,en_4409,PRODUCES,Hemagglutinin,C0018909,en_1148,1,1,AFFECTS,Excitatory,3
13942,olfactory stimulus,C0597129,en_4411,AFFECTS,Cerebrovascular Circulation,C0007818,en_606,1,1,AFFECTS,General/Uncertain,3
13943,particle,C0597177,en_4414,AFFECTS,"Atmosphere, planetary",C0004178,en_422,1,1,AFFECTS,General/Uncertain,3
13944,particle,C0597177,en_4414,AFFECTS,Climate,C0008946,en_656,1,1,AFFECTS,General/Uncertain,3
13945,particle,C0597177,en_4414,AFFECTS,Gamma Rays,C0017011,en_1033,1,1,AFFECTS,General/Uncertain,3
13946,particle,C0597177,en_4414,AFFECTS,Precipitation,C0032931,en_1869,1,1,AFFECTS,General/Uncertain,3
13947,particle,C0597177,en_4414,AFFECTS,Prosody,C0233743,en_3300,1,1,AFFECTS,General/Uncertain,3
13948,particle,C0597177,en_4414,AFFECTS,Magnetism,C0563532,en_4328,1,1,AFFECTS,General/Uncertain,3
13949,particle,C0597177,en_4414,AFFECTS,evaporation,C0596539,en_4390,1,1,AFFECTS,General/Uncertain,3
13950,particle,C0597177,en_4414,AFFECTS,wave,C0678544,en_4560,1,1,AFFECTS,General/Uncertain,3
13951,particle,C0597177,en_4414,AFFECTS,cooling,C0678568,en_4562,1,1,AFFECTS,General/Uncertain,3
13952,particle,C0597177,en_4414,PREVENTS,Cardiovascular arteriosclerosis unspecified,C0003972,en_407,1,1,AFFECTS,Inhibitory,3
13953,particle,C0597177,en_4414,PREVENTS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
13954,particle,C0597177,en_4414,TREATS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,Inhibitory,3
13955,peptide hormone,C0597192,en_4415,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
13956,Performance,C0597198,en_4416,AFFECTS,Behavior,C0004927,en_450,2,2,AFFECTS,General/Uncertain,6
13957,Performance,C0597198,en_4416,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
13958,receptor,C0597357,en_4422,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
13959,receptor,C0597357,en_4422,AFFECTS,Cell Survival,C0007620,en_595,2,1,AFFECTS,General/Uncertain,3
13960,receptor,C0597357,en_4422,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
13961,receptor,C0597357,en_4422,AFFECTS,Vitamin D Deficiency,C0042870,en_2372,1,1,AFFECTS,General/Uncertain,3
13962,receptor,C0597357,en_4422,AFFECTS,host,C1167395,en_5368,1,1,AFFECTS,General/Uncertain,3
13963,receptor,C0597357,en_4422,DISRUPTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Inhibitory,3
13964,receptor,C0597357,en_4422,INHIBITS,"Antibodies, Anti-Idiotypic",C0003242,en_348,1,1,AFFECTS,Inhibitory,3
13965,receptor,C0597357,en_4422,INHIBITS,Heparan Sulfate Proteoglycan,C0062503,en_2500,2,1,AFFECTS,Inhibitory,3
13966,receptor,C0597357,en_4422,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
13967,receptor,C0597357,en_4422,PREDISPOSES,Injury,C0175677,en_2968,1,1,AFFECTS,Excitatory,3
13968,receptor,C0597357,en_4422,STIMULATES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
13969,receptor,C0597357,en_4422,STIMULATES,Signal Transduction Pathways,C0086982,en_2741,1,1,AFFECTS,Excitatory,3
13970,receptor,C0597357,en_4422,STIMULATES,SMAD3 gene,C0919432,en_5112,1,1,AFFECTS,Excitatory,3
13971,respiratory protein,C0597400,en_4425,DISRUPTS,Nuclear Import,C0887839,en_5087,1,1,AFFECTS,Inhibitory,3
13972,riboside,C0597413,en_4427,DISRUPTS,Nerve Degeneration,C0027746,en_1657,1,1,AFFECTS,Inhibitory,3
13973,riboside,C0597413,en_4427,DISRUPTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
13974,skeletal transplantation,C0597463,en_4428,TREATS,Bladder dysfunction,C0232841,en_3288,1,1,AFFECTS,Inhibitory,3
13975,stressor,C0597530,en_4430,PREDISPOSES,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Excitatory,3
13976,stressor,C0597530,en_4430,PREDISPOSES,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Excitatory,3
13977,stressor,C0597530,en_4430,PREDISPOSES,Emotional,C0849912,en_4937,1,1,AFFECTS,Excitatory,3
13978,stressor,C0597530,en_4430,PREDISPOSES,Mental health problem,C1446377,en_5753,1,1,AFFECTS,Excitatory,3
13979,vector vaccine,C0597641,en_4434,PREVENTS,Coronavirus Infections,C0206750,en_3176,4,3,AFFECTS,Inhibitory,9
13980,vector vaccine,C0597641,en_4434,TREATS,Adult,C0001675,en_252,11,6,AFFECTS,Inhibitory,18
13981,vector vaccine,C0597641,en_4434,TREATS,Adolescent,C0205653,en_3132,2,1,AFFECTS,Inhibitory,3
13982,vector vaccine,C0597641,en_4434,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
13983,Janus kinase,C0597721,en_4436,AFFECTS,Cytokine Activation,C1511613,en_5812,1,1,AFFECTS,General/Uncertain,7
13984,transcutaneous stimulation,C0597834,en_4438,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
13985,transcutaneous stimulation,C0597834,en_4438,TREATS,Female,C0015780,en_977,2,1,AFFECTS,Inhibitory,3
13986,transcutaneous stimulation,C0597834,en_4438,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
13987,transcutaneous stimulation,C0597834,en_4438,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
13988,Intercellular cell adhesion molecule,C0598077,en_4441,AUGMENTS,Myocardial tissue,C1267093,en_5435,1,1,AFFECTS,Excitatory,3
13989,stable cell line,C0598091,en_4442,PRODUCES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
13990,sexual dimorphism,C0598095,en_4443,PRODUCES,Pulmonary Surfactants,C0034085,en_1935,2,1,AFFECTS,Excitatory,3
13991,Contagion,C0598197,en_4444,AFFECTS,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,General/Uncertain,3
13992,Contagion,C0598197,en_4444,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
13993,Contagion,C0598197,en_4444,AFFECTS,Acute respiratory distress,C0748355,en_4831,2,1,AFFECTS,General/Uncertain,3
13994,Contagion,C0598197,en_4444,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
13995,fluorophore,C0598447,en_4447,AUGMENTS,"Translation, Genetic",C0040711,en_2274,1,1,AFFECTS,Excitatory,3
13996,long term hospitalization,C0598609,en_4449,PREVENTS,Disease Progression,C0242656,en_3429,2,2,AFFECTS,Inhibitory,6
13997,Lipid Metabolism,C0598783,en_4452,AFFECTS,Aging,C0001811,en_262,1,1,AFFECTS,General/Uncertain,3
13998,Musicians,C0598908,en_4454,PRODUCES,Scanning/Transmission Electron Microscopes,C0262879,en_3518,1,1,AFFECTS,Excitatory,3
13999,Biological Neural Networks,C0598941,en_4457,AFFECTS,Abnormal behavior,C0233514,en_3296,1,1,AFFECTS,General/Uncertain,3
14000,Aptamer,C0599013,en_4460,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
14001,protein activation,C0599177,en_4461,AFFECTS,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,General/Uncertain,3
14002,water channel,C0599635,en_4463,AFFECTS,Endolymphatic Hydrops,C0206586,en_3170,1,1,AFFECTS,General/Uncertain,3
14003,monoamine,C0599682,en_4464,AUGMENTS,Brain,C0006104,en_508,1,1,AFFECTS,Excitatory,3
14004,Anti-Retroviral Agents,C0599685,en_4465,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
14005,Anti-Retroviral Agents,C0599685,en_4465,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
14006,Anti-Retroviral Agents,C0599685,en_4465,TREATS,HIV,C0019682,en_1190,1,1,AFFECTS,Inhibitory,7
14007,Anti-Retroviral Agents,C0599685,en_4465,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
14008,Anti-Retroviral Agents,C0599685,en_4465,TREATS(INFER),Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
14009,antiviral nucleoside analog,C0599686,en_4466,TREATS,Respiratory syncytial virus,C0035236,en_2014,1,1,AFFECTS,Inhibitory,3
14010,antiviral nucleoside analog,C0599686,en_4466,TREATS,Hepatitis C virus,C0220847,en_3204,1,1,AFFECTS,Inhibitory,3
14011,cell injury,C0599732,en_4467,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14012,cell injury,C0599732,en_4467,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
14013,cell injury,C0599732,en_4467,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
14014,lipid mediator,C0599745,en_4468,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
14015,lipid mediator,C0599745,en_4468,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
14016,Pollutant,C0599786,en_4474,AFFECTS,Respiration,C0035203,en_2004,1,1,AFFECTS,General/Uncertain,3
14017,Pollutant,C0599786,en_4474,DISRUPTS,"Tumor cells, malignant",C0334227,en_3774,1,1,AFFECTS,Inhibitory,3
14018,ketogenesis,C0599816,en_4475,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
14019,neurodevelopment,C0599855,en_4477,AFFECTS,Offspring,C0680063,en_4620,1,1,AFFECTS,General/Uncertain,3
14020,Muscle satellite cell,C0599856,en_4478,PRODUCES,Prostaglandin E Receptor,C0072301,en_2549,1,1,AFFECTS,Excitatory,3
14021,disease characteristic,C0599878,en_4481,AFFECTS,Arthritis,C0003864,en_400,1,1,AFFECTS,General/Uncertain,3
14022,targeting,C0599894,en_4482,AFFECTS,student,C0038492,en_2171,1,1,AFFECTS,General/Uncertain,3
14023,targeting,C0599894,en_4482,AFFECTS,Viral Proteins,C0042736,en_2357,2,2,AFFECTS,General/Uncertain,6
14024,targeting,C0599894,en_4482,AFFECTS,uptake,C0243144,en_3467,2,1,AFFECTS,General/Uncertain,3
14025,targeting,C0599894,en_4482,AFFECTS,wave,C0678544,en_4560,1,1,AFFECTS,General/Uncertain,3
14026,targeting,C0599894,en_4482,AFFECTS,"Students, Public Health",C1136364,en_5267,1,1,AFFECTS,General/Uncertain,3
14027,protein transport,C0599895,en_4483,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
14028,intervention program,C0599917,en_4484,PREVENTS,Tendinitis,C0039503,en_2213,2,1,AFFECTS,Inhibitory,3
14029,intervention program,C0599917,en_4484,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
14030,intervention program,C0599917,en_4484,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
14031,intervention program,C0599917,en_4484,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
14032,intervention program,C0599917,en_4484,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
14033,intervention program,C0599917,en_4484,TREATS,Research Subject,C0080105,en_2624,1,1,AFFECTS,Inhibitory,3
14034,intervention program,C0599917,en_4484,TREATS,Well adolescent,C0686747,en_4682,1,1,AFFECTS,Inhibitory,8
14035,intervention program,C0599917,en_4484,TREATS,"Stress, acute",C0848237,en_4931,2,1,AFFECTS,Inhibitory,3
14036,intervention program,C0599917,en_4484,TREATS,Late pregnancy,C0878751,en_5077,1,1,AFFECTS,Inhibitory,3
14037,intervention program,C0599917,en_4484,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
14038,self diagnosis,C0599922,en_4487,PREDISPOSES,Depressive disorder,C0011581,en_788,11,1,AFFECTS,Excitatory,3
14039,"Vaccines, Peptide",C0599934,en_4488,TREATS,Adult,C0001675,en_252,4,2,AFFECTS,Inhibitory,6
14040,"Vaccines, Peptide",C0599934,en_4488,TREATS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,6
14041,"Vaccines, Peptide",C0599934,en_4488,TREATS,Renal Cell Carcinoma,C0007134,en_564,1,1,AFFECTS,Inhibitory,3
14042,"Vaccines, Peptide",C0599934,en_4488,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
14043,"Vaccines, Peptide",C0599934,en_4488,TREATS,Malignant neoplasm of kidney,C0740457,en_4778,1,1,AFFECTS,Inhibitory,3
14044,STF,C0599939,en_4489,AUGMENTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,3
14045,STF,C0599939,en_4489,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
14046,attenuation,C0599946,en_4490,AFFECTS,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
14047,attenuation,C0599946,en_4490,DISRUPTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,Inhibitory,3
14048,arterial stiffness,C0599949,en_4491,AFFECTS,Hemodynamics,C0019010,en_1156,2,1,AFFECTS,General/Uncertain,3
14049,TYK2,C0599969,en_4492,DISRUPTS,"Pneumonia, Bacterial",C0004626,en_442,1,1,AFFECTS,Inhibitory,3
14050,Emotional support,C0600015,en_4494,PREVENTS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,6
14051,Emotional support,C0600015,en_4494,TREATS,Health Personnel,C0018724,en_1121,3,3,AFFECTS,Inhibitory,15
14052,Emotional support,C0600015,en_4494,TREATS,Caregiver,C0085537,en_2674,3,3,AFFECTS,Inhibitory,15
14053,Emotional support,C0600015,en_4494,PREDISPOSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,3
14054,Emotional support,C0600015,en_4494,TREATS,Medical Staff,C0025106,en_1519,1,1,AFFECTS,Inhibitory,3
14055,Emotional support,C0600015,en_4494,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
14056,Emotional support,C0600015,en_4494,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14057,Emotional support,C0600015,en_4494,TREATS,Patients,C0030705,en_1762,7,5,AFFECTS,Inhibitory,15
14058,Emotional support,C0600015,en_4494,TREATS,Family Caregivers,C0086279,en_2711,1,1,AFFECTS,Inhibitory,3
14059,Emotional support,C0600015,en_4494,TREATS,VICTIM,C0680681,en_4626,1,1,AFFECTS,Inhibitory,3
14060,Emotional support,C0600015,en_4494,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
14061,Emotional support,C0600015,en_4494,TREATS,Staff,C0851286,en_4950,2,1,AFFECTS,Inhibitory,3
14062,Emotional support,C0600015,en_4494,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,3
14063,Feeding and dietary regimes,C0600072,en_4495,AFFECTS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
14064,Feeding and dietary regimes,C0600072,en_4495,AFFECTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,3
14065,Feeding and dietary regimes,C0600072,en_4495,AFFECTS,Erectile dysfunction,C0242350,en_3407,1,1,AFFECTS,General/Uncertain,3
14066,Feeding and dietary regimes,C0600072,en_4495,PREVENTS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,3
14067,Feeding and dietary regimes,C0600072,en_4495,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
14068,Feeding and dietary regimes,C0600072,en_4495,PREVENTS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
14069,Feeding and dietary regimes,C0600072,en_4495,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
14070,Feeding and dietary regimes,C0600072,en_4495,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,3
14071,Feeding and dietary regimes,C0600072,en_4495,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14072,"Immunotherapy, Passive",C0600249,en_4501,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14073,"Immunotherapy, Passive",C0600249,en_4501,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
14074,"Lung Diseases, Obstructive",C0600260,en_4502,PREDISPOSES,Impaired health,C0684336,en_4680,1,1,AFFECTS,Excitatory,3
14075,Hospital Readmissions,C0600290,en_4503,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
14076,Hospital Readmissions,C0600290,en_4503,TREATS(INFER),Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
14077,Biosensors,C0600364,en_4504,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
14078,Advance Care Planning,C0600371,en_4505,TREATS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,Inhibitory,3
14079,venipuncture,C0600406,en_4506,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14080,venipuncture,C0600406,en_4506,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
14081,Nucleic Acid Vaccines,C0600412,en_4507,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
14082,Human Endogenous Retroviruses,C0600465,en_4509,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14083,Educational Needs Assessment,C0600569,en_4510,TREATS,"Ethics Committees, Research",C0086911,en_2736,1,1,AFFECTS,Inhibitory,3
14084,Hospitalists,C0600620,en_4511,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
14085,Heavy Ions,C0600627,en_4512,AFFECTS,cell motility,C0007608,en_593,1,1,AFFECTS,General/Uncertain,3
14086,Toxic effect,C0600688,en_4513,COMPLICATES,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
14087,TB-2,C0606567,en_4514,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14088,serum P-component,C0607063,en_4515,DISRUPTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Inhibitory,3
14089,Galactose Binding Lectin,C0607430,en_4516,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,6
14090,P-2,C0608663,en_4517,PREDISPOSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,6
14091,RATE protocol,C0623041,en_4520,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,7
14092,Matrix Metalloproteinases,C0623362,en_4521,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
14093,Matrix Metalloproteinases,C0623362,en_4521,TREATS,cohort,C0599755,en_4470,2,1,AFFECTS,Inhibitory,3
14094,vinyltriethoxysilane,C0630906,en_4522,AFFECTS,Heart failure,C0018801,en_1135,1,1,AFFECTS,General/Uncertain,6
14095,3-bromoacetoxyandrostan-17-one,C0645690,en_4524,INHIBITS,Vitality,C0424589,en_3997,1,1,AFFECTS,Inhibitory,3
14096,3-methoxybutylcyanoacrylate,C0657206,en_4525,INHIBITS,Toxin,C0040549,en_2252,1,1,AFFECTS,Inhibitory,3
14097,pregabalin,C0657912,en_4526,TREATS,Neuropathic pain,C0423716,en_3989,1,1,AFFECTS,Inhibitory,3
14098,Secure,C0659450,en_4527,AFFECTS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,General/Uncertain,3
14099,linezolid,C0663241,en_4528,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14100,marenostrin,C0665818,en_4530,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
14101,infliximab,C0666743,en_4532,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
14102,infliximab,C0666743,en_4532,DISRUPTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
14103,infliximab,C0666743,en_4532,INHIBITS,TNF gene,C0812246,en_4896,1,1,AFFECTS,Inhibitory,3
14104,infliximab,C0666743,en_4532,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
14105,infliximab,C0666743,en_4532,TREATS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
14106,infliximab,C0666743,en_4532,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
14107,infliximab,C0666743,en_4532,TREATS,Hospitalized Patients,C0870668,en_5010,4,3,AFFECTS,Inhibitory,12
14108,infliximab,C0666743,en_4532,TREATS,Has difficulty doing (qualifier value),C1299586,en_5504,1,1,AFFECTS,Inhibitory,6
14109,infliximab,C0666743,en_4532,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14110,"NOS3 protein, human",C0669365,en_4534,AUGMENTS,Capillary Permeability,C0006906,en_551,1,1,AFFECTS,Excitatory,3
14111,"NOS3 protein, human",C0669365,en_4534,AUGMENTS,Lung,C0024109,en_1460,1,1,AFFECTS,Excitatory,3
14112,"NOS3 protein, human",C0669365,en_4534,AUGMENTS,cellular_component,C1166607,en_5365,1,1,AFFECTS,Excitatory,3
14113,"NOS3 protein, human",C0669365,en_4534,DISRUPTS,Blood - brain barrier anatomy,C0005854,en_495,1,1,AFFECTS,Inhibitory,3
14114,"NOS3 protein, human",C0669365,en_4534,DISRUPTS,Platelet aggregation,C0032176,en_1828,1,1,AFFECTS,Inhibitory,3
14115,"NOS3 protein, human",C0669365,en_4534,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
14116,"NOS3 protein, human",C0669365,en_4534,STIMULATES,Nitric Oxide,C0028128,en_1682,4,2,AFFECTS,Excitatory,6
14117,"NOS3 protein, human",C0669365,en_4534,STIMULATES,Vascular Endothelial Cells,C1257792,en_5402,1,1,AFFECTS,Excitatory,3
14118,"NOS3 protein, human",C0669365,en_4534,STIMULATES,"TNF protein, human",C1448177,en_5755,1,1,AFFECTS,Excitatory,3
14119,"NOS2A protein, human",C0669372,en_4535,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
14120,"PER2 protein, mammalian",C0669679,en_4536,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
14121,"PER2 protein, mammalian",C0669679,en_4536,AFFECTS,Protein-Protein Interaction,C0872079,en_5036,1,1,AFFECTS,General/Uncertain,3
14122,"PER2 protein, mammalian",C0669679,en_4536,AFFECTS,Antiviral Response,C1155328,en_5322,2,1,AFFECTS,General/Uncertain,3
14123,CXC chemokine receptor 3,C0670336,en_4537,PREVENTS,Pregnancy loss,C0687675,en_4689,1,1,AFFECTS,Inhibitory,3
14124,Toll-like receptors,C0670896,en_4538,AFFECTS,Body tissue,C0040300,en_2242,2,1,AFFECTS,General/Uncertain,3
14125,Toll-like receptors,C0670896,en_4538,INHIBITS,TNFSF13B,C1420816,en_109,1,1,AFFECTS,Inhibitory,3
14126,Toll-like receptors,C0670896,en_4538,INHIBITS,ANP32B gene,C1332090,en_5581,1,1,AFFECTS,Inhibitory,3
14127,pregnane X receptor,C0671771,en_4540,INHIBITS,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,Inhibitory,3
14128,lopinavir,C0674432,en_4542,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
14129,cysteinyl-leukotriene,C0675175,en_4543,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
14130,cysteinyl-leukotriene,C0675175,en_4543,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,3
14131,cysteinyl-leukotriene,C0675175,en_4543,INHIBITS,TNF gene,C0812246,en_4896,1,1,AFFECTS,Inhibitory,3
14132,cysteinyl-leukotriene,C0675175,en_4543,INHIBITS(SPEC),Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,Inhibitory,3
14133,cysteinyl-leukotriene,C0675175,en_4543,INHIBITS(SPEC),Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,3
14134,cysteinyl-leukotriene,C0675175,en_4543,INHIBITS(SPEC),Interleukin-8,C0079633,en_2608,1,1,AFFECTS,Inhibitory,3
14135,cysteinyl-leukotriene,C0675175,en_4543,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
14136,cysteinyl-leukotriene,C0675175,en_4543,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14137,cysteinyl-leukotriene,C0675175,en_4543,TREATS,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,Inhibitory,3
14138,17-(allylamino)-17-demethoxygeldanamycin,C0675974,en_4544,INHIBITS(SPEC),Hypothalamic inhibiting factor,C0301821,en_3695,1,1,AFFECTS,Inhibitory,3
14139,Immune status,C0677637,en_4545,PREDISPOSES,Critical Illness,C0010340,en_733,2,1,AFFECTS,Excitatory,3
14140,adjuvant therapy,C0677850,en_4547,AFFECTS,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
14141,adjuvant therapy,C0677850,en_4547,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
14142,adjuvant therapy,C0677850,en_4547,PREVENTS,Secondary infection,C0442886,en_4061,1,1,AFFECTS,Inhibitory,3
14143,adjuvant therapy,C0677850,en_4547,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,7
14144,adjuvant therapy,C0677850,en_4547,TREATS,Critical Illness,C0010340,en_733,4,3,AFFECTS,Inhibitory,21
14145,adjuvant therapy,C0677850,en_4547,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
14146,adjuvant therapy,C0677850,en_4547,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
14147,adjuvant therapy,C0677850,en_4547,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
14148,adjuvant therapy,C0677850,en_4547,TREATS,Patients,C0030705,en_1762,11,5,AFFECTS,Inhibitory,15
14149,adjuvant therapy,C0677850,en_4547,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
14150,adjuvant therapy,C0677850,en_4547,TREATS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,8
14151,adjuvant therapy,C0677850,en_4547,TREATS,Lower respiratory tract infection,C0149725,en_2806,1,1,AFFECTS,Inhibitory,7
14152,adjuvant therapy,C0677850,en_4547,TREATS,Primary Neoplasm,C0677930,en_4550,1,1,AFFECTS,Inhibitory,3
14153,adjuvant therapy,C0677850,en_4547,TREATS,Community acquired pneumonia,C0694549,en_4692,1,1,AFFECTS,Inhibitory,7
14154,adjuvant therapy,C0677850,en_4547,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,6
14155,adjuvant therapy,C0677850,en_4547,TREATS,ALLERGIC SYMPTOM,C0740903,en_4785,2,1,AFFECTS,Inhibitory,3
14156,adjuvant therapy,C0677850,en_4547,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
14157,adjuvant therapy,C0677850,en_4547,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,6
14158,adjuvant therapy,C0677850,en_4547,TREATS,COVID-19,C5203670,en_6417,7,6,AFFECTS,Inhibitory,46
14159,adjuvant therapy,C0677850,en_4547,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
14160,adjuvant therapy,C0677850,en_4547,TREATS(INFER),Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,6
14161,Maintenance therapy,C0677908,en_4549,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14162,Maintenance therapy,C0677908,en_4549,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,6
14163,Maintenance therapy,C0677908,en_4549,TREATS(INFER),"Lymphoma, Follicular",C0024301,en_1472,1,1,AFFECTS,Inhibitory,3
14164,Maintenance therapy,C0677908,en_4549,TREATS(INFER),"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C0334634,en_3777,1,1,AFFECTS,Inhibitory,3
14165,T-cell depletion,C0677960,en_4551,AFFECTS,"Tuberculosis, active",C0151332,en_2858,1,1,AFFECTS,General/Uncertain,3
14166,Sterility,C0678108,en_4552,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
14167,Clexane,C0678145,en_4553,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14168,Rare Diseases,C0678236,en_4556,AFFECTS,Child,C0008059,en_620,3,1,AFFECTS,General/Uncertain,3
14169,Rare Diseases,C0678236,en_4556,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
14170,Rare Diseases,C0678236,en_4556,AFFECTS,Patients,C0030705,en_1762,4,3,AFFECTS,General/Uncertain,9
14171,Rare Diseases,C0678236,en_4556,AFFECTS,Woman,C0043210,en_2396,1,1,AFFECTS,General/Uncertain,3
14172,Rare Diseases,C0678236,en_4556,AFFECTS,Adolescent,C0205653,en_3132,3,1,AFFECTS,General/Uncertain,3
14173,Rare Diseases,C0678236,en_4556,AFFECTS,Young adult,C0238598,en_3365,3,1,AFFECTS,General/Uncertain,3
14174,Rare Diseases,C0678236,en_4556,PRODUCES,Collagen,C0009325,en_677,3,1,AFFECTS,Excitatory,3
14175,responsibility,C0678341,en_4557,AFFECTS,Performance,C0597198,en_4416,1,1,AFFECTS,General/Uncertain,3
14176,mixed drink,C0678420,en_4558,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
14177,controlled substance,C0678485,en_4559,TREATS,Substance Use Disorders,C0038586,en_2176,2,1,AFFECTS,Inhibitory,3
14178,wave,C0678544,en_4560,AFFECTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,General/Uncertain,3
14179,wave,C0678544,en_4560,AFFECTS,uptake,C0243144,en_3467,1,1,AFFECTS,General/Uncertain,3
14180,fluid property,C0678547,en_4561,AFFECTS,Motion,C0026597,en_1584,1,1,AFFECTS,General/Uncertain,3
14181,saturation,C0678572,en_4563,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
14182,saturation,C0678572,en_4563,AFFECTS,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
14183,steady state,C0678587,en_4564,AFFECTS,Brain activity,C0443158,en_4065,1,1,AFFECTS,General/Uncertain,3
14184,Nutrients,C0678695,en_4567,AFFECTS,Cell Growth,C0007595,en_590,1,1,AFFECTS,General/Uncertain,3
14185,Nutrients,C0678695,en_4567,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
14186,Nutrients,C0678695,en_4567,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
14187,prenatal alcohol exposure,C0678807,en_4571,AFFECTS,Fetal Growth Retardation,C0015934,en_984,1,1,AFFECTS,General/Uncertain,3
14188,systemic administration,C0678812,en_4572,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14189,systemic administration,C0678812,en_4572,PREVENTS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,Inhibitory,3
14190,systemic administration,C0678812,en_4572,PREVENTS,Adverse drug effect,C0041755,en_2312,1,1,AFFECTS,Inhibitory,3
14191,systemic administration,C0678812,en_4572,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
14192,systemic administration,C0678812,en_4572,TREATS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,8
14193,systemic administration,C0678812,en_4572,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,7
14194,systemic administration,C0678812,en_4572,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14195,parenteral administration,C0678823,en_4574,TREATS,Vitamin D Deficiency,C0042870,en_2372,1,1,AFFECTS,Inhibitory,6
14196,parenteral administration,C0678823,en_4574,TREATS,Hospitalized Patients,C0870668,en_5010,4,2,AFFECTS,Inhibitory,6
14197,parenteral administration,C0678823,en_4574,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14198,parenteral administration,C0678823,en_4574,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
14199,skills,C0678856,en_4575,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
14200,skills,C0678856,en_4575,AFFECTS,Substance Use Disorders,C0038586,en_2176,1,1,AFFECTS,General/Uncertain,3
14201,skills,C0678856,en_4575,AFFECTS,AOD use,C0237123,en_3341,1,1,AFFECTS,General/Uncertain,3
14202,skills,C0678856,en_4575,AFFECTS,Eating habit,C1266864,en_5434,4,1,AFFECTS,General/Uncertain,3
14203,diaphragm function,C0678866,en_4577,AFFECTS,Weaning,C0043084,en_2386,2,1,AFFECTS,General/Uncertain,3
14204,diaphragm function,C0678866,en_4577,AFFECTS,pulmonary function,C0231921,en_3268,2,1,AFFECTS,General/Uncertain,3
14205,oral function,C0678868,en_4578,AFFECTS,Tooth Loss,C0080233,en_2626,1,1,AFFECTS,General/Uncertain,3
14206,Immunoregulation,C0678889,en_4580,AFFECTS,Septic Shock,C0036983,en_2101,1,1,AFFECTS,General/Uncertain,7
14207,Immunoregulation,C0678889,en_4580,AFFECTS,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,General/Uncertain,8
14208,Immunoregulation,C0678889,en_4580,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
14209,Neuronal Transmission,C0678903,en_4583,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
14210,Neuronal Transmission,C0678903,en_4583,AFFECTS,physiological aspects,C0031843,en_1806,2,1,AFFECTS,General/Uncertain,3
14211,brain function,C0678908,en_4584,AFFECTS,Tooth Loss,C0080233,en_2626,1,1,AFFECTS,General/Uncertain,3
14212,life skills,C0678999,en_4588,AFFECTS,skills,C0678856,en_4575,1,1,AFFECTS,General/Uncertain,3
14213,defensiveness,C0679190,en_4590,AFFECTS,Recovery,C0237820,en_3354,2,1,AFFECTS,General/Uncertain,3
14214,defensiveness,C0679190,en_4590,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
14215,defensiveness,C0679190,en_4590,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
14216,neuroimaging,C0679575,en_4597,AFFECTS,brain development,C1160340,en_5353,1,1,AFFECTS,General/Uncertain,3
14217,neuroimaging,C0679575,en_4597,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14218,treatment method,C0679607,en_4598,AFFECTS,Cell Aging,C0007581,en_584,1,1,AFFECTS,General/Uncertain,3
14219,treatment method,C0679607,en_4598,AFFECTS,Immune response,C0301872,en_3696,3,1,AFFECTS,General/Uncertain,3
14220,treatment method,C0679607,en_4598,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
14221,treatment method,C0679607,en_4598,TREATS,Hemangiosarcoma,C0018923,en_1149,1,1,AFFECTS,Inhibitory,3
14222,treatment method,C0679607,en_4598,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
14223,treatment method,C0679607,en_4598,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14224,treatment method,C0679607,en_4598,TREATS,Spinal Cord Injuries,C0037929,en_2143,1,1,AFFECTS,Inhibitory,3
14225,treatment method,C0679607,en_4598,TREATS,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Inhibitory,3
14226,treatment method,C0679607,en_4598,TREATS,Human body,C0242821,en_3440,1,1,AFFECTS,Inhibitory,3
14227,treatment method,C0679607,en_4598,TREATS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Inhibitory,3
14228,treatment method,C0679607,en_4598,TREATS,Spatial Neglect,C0871399,en_5022,1,1,AFFECTS,Inhibitory,3
14229,treatment method,C0679607,en_4598,TREATS,Degenerative disorder,C1285162,en_5478,1,1,AFFECTS,Inhibitory,3
14230,medical treatment method,C0679624,en_4599,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
14231,blood modification,C0679628,en_4600,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14232,major surgery,C0679637,en_4601,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
14233,major surgery,C0679637,en_4601,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
14234,Participant,C0679646,en_4602,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14235,directive therapy,C0679651,en_4603,TREATS,Chronic Lymphocytic Leukemia,C0023434,en_1417,1,1,AFFECTS,Inhibitory,7
14236,network,C0679670,en_4604,PRODUCES,Plates,C1139930,en_5277,1,1,AFFECTS,Excitatory,3
14237,protective factors,C0679688,en_4605,AFFECTS,Drug abuse,C0013146,en_851,1,1,AFFECTS,General/Uncertain,3
14238,protective factors,C0679688,en_4605,AFFECTS,"Stress, Psychological",C0038443,en_2168,1,1,AFFECTS,General/Uncertain,3
14239,protective factors,C0679688,en_4605,AFFECTS,Violence,C0042693,en_2353,1,1,AFFECTS,General/Uncertain,3
14240,prevention of disorder,C0679698,en_4606,PREVENTS,Cardiovascular morbidity,C1301700,en_5508,1,1,AFFECTS,Inhibitory,3
14241,prevention of disorder,C0679698,en_4606,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
14242,prevention of disorder,C0679698,en_4606,TREATS,Wounds and Injuries,C0043251,en_2401,1,1,AFFECTS,Inhibitory,3
14243,prevention of disorder,C0679698,en_4606,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
14244,prevention of disorder,C0679698,en_4606,TREATS,manager,C0335141,en_3784,1,1,AFFECTS,Inhibitory,3
14245,prevention of disorder,C0679698,en_4606,TREATS,Cancer Patient,C1516213,en_5852,2,2,AFFECTS,Inhibitory,14
14246,prevention service,C0679721,en_4607,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
14247,prevention service,C0679721,en_4607,TREATS(INFER),Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,Inhibitory,3
14248,Harm Reduction,C0679771,en_4609,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
14249,Harm Reduction,C0679771,en_4609,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
14250,Harm Reduction,C0679771,en_4609,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14251,guided intervention,C0679803,en_4610,PREVENTS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,8
14252,guided intervention,C0679803,en_4610,PREVENTS,Associated symptom,C0521989,en_4207,1,1,AFFECTS,Inhibitory,8
14253,guided intervention,C0679803,en_4610,PREVENTS,Mental problem,C0848067,en_4929,2,1,AFFECTS,Inhibitory,3
14254,guided intervention,C0679803,en_4610,TREATS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,3
14255,family intervention,C0679804,en_4611,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
14256,family intervention,C0679804,en_4611,TREATS,Smoker,C0337664,en_3793,2,2,AFFECTS,Inhibitory,6
14257,peer intervention,C0679805,en_4612,PREVENTS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
14258,peer intervention,C0679805,en_4612,PREVENTS,Asthenopia,C0004095,en_417,1,1,AFFECTS,Inhibitory,8
14259,peer intervention,C0679805,en_4612,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
14260,peer intervention,C0679805,en_4612,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
14261,participation,C0679823,en_4613,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
14262,participation,C0679823,en_4613,AFFECTS,skills,C0678856,en_4575,1,1,AFFECTS,General/Uncertain,3
14263,participation,C0679823,en_4613,AFFECTS,literacy skills,C0678998,en_4587,1,1,AFFECTS,General/Uncertain,3
14264,treatment program,C0679841,en_4614,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
14265,treatment program,C0679841,en_4614,TREATS,Headache,C0018681,en_1115,1,1,AFFECTS,Inhibitory,3
14266,treatment program,C0679841,en_4614,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14267,treatment program,C0679841,en_4614,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
14268,psychological care,C0679875,en_4615,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
14269,psychological care,C0679875,en_4615,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Inhibitory,3
14270,psychological care,C0679875,en_4615,TREATS(INFER),Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Inhibitory,3
14271,psychological care,C0679875,en_4615,TREATS(INFER),"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Inhibitory,3
14272,psychological care,C0679875,en_4615,TREATS(INFER),Chronic pain,C0150055,en_2816,1,1,AFFECTS,Inhibitory,3
14273,acute care,C0679878,en_4616,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
14274,acute care,C0679878,en_4616,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14275,acute care,C0679878,en_4616,TREATS(INFER),Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,3
14276,ABC monopoly system,C0680582,en_4625,AFFECTS,company,C0683757,en_4672,1,1,AFFECTS,General/Uncertain,3
14277,audience,C0681273,en_4629,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
14278,vitamin supplement,C0681579,en_4630,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
14279,Olympic Games,C0681662,en_4631,TREATS,Livestock farmer,C0335415,en_3786,1,1,AFFECTS,Inhibitory,3
14280,politician,C0682232,en_4640,PRODUCES,Study models,C0026336,en_1575,1,1,AFFECTS,Excitatory,3
14281,Human Cell Line,C0682523,en_4644,PRODUCES,ACE2,C1422064,en_5723,2,2,AFFECTS,Excitatory,6
14282,Human Cell Line,C0682523,en_4644,PRODUCES,epitheliasin,C0964578,en_5200,1,1,AFFECTS,Excitatory,3
14283,Memory B-Lymphocyte,C0682638,en_4647,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
14284,G-Protein-Coupled Receptors,C0682972,en_4649,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
14285,G-Protein-Coupled Receptors,C0682972,en_4649,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
14286,G-Protein-Coupled Receptors,C0682972,en_4649,AFFECTS,Neuroprotection,C0598958,en_4459,1,1,AFFECTS,General/Uncertain,3
14287,G-Protein-Coupled Receptors,C0682972,en_4649,AFFECTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,General/Uncertain,3
14288,G-Protein-Coupled Receptors,C0682972,en_4649,STIMULATES,Gonadotropins,C0018061,en_1089,1,1,AFFECTS,Excitatory,3
14289,G-Protein-Coupled Receptors,C0682972,en_4649,STIMULATES,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,Excitatory,3
14290,synthetic opioids,C0682986,en_4650,AUGMENTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Excitatory,3
14291,INTRAVENOUS DRUG,C0683092,en_4651,AFFECTS,Disease,C0012634,en_826,6,1,AFFECTS,General/Uncertain,3
14292,INTRAVENOUS DRUG,C0683092,en_4651,AFFECTS,uptake,C0243144,en_3467,2,1,AFFECTS,General/Uncertain,3
14293,INTRAVENOUS DRUG,C0683092,en_4651,AUGMENTS,Crisis,C0231224,en_3253,1,1,AFFECTS,Excitatory,3
14294,INTRAVENOUS DRUG,C0683092,en_4651,INHIBITS,Polymerase,C1335439,en_5615,2,2,AFFECTS,Inhibitory,6
14295,INTRAVENOUS DRUG,C0683092,en_4651,PREDISPOSES,Symptoms,C1457887,en_5784,2,2,AFFECTS,Excitatory,6
14296,INTRAVENOUS DRUG,C0683092,en_4651,PREVENTS,overdose,C4018909,en_6291,1,1,AFFECTS,Inhibitory,3
14297,INTRAVENOUS DRUG,C0683092,en_4651,TREATS,Addictive Behavior,C0085281,en_2658,1,1,AFFECTS,Inhibitory,3
14298,topical application,C0683174,en_4652,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
14299,topical application,C0683174,en_4652,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
14300,specific immunity,C0683201,en_4653,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
14301,Mental Suffering,C0683278,en_4655,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14302,poor health,C0683321,en_4658,PREDISPOSES,Alcohol problem,C0549393,en_4279,1,1,AFFECTS,Excitatory,3
14303,clinical aspects,C0683325,en_4661,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,6
14304,Internal-External Locus of Control Scale,C0683454,en_4662,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
14305,Internal-External Locus of Control Scale,C0683454,en_4662,AFFECTS,Intervention regimes,C1273869,en_5458,1,1,AFFECTS,General/Uncertain,3
14306,internal-external locus of control scale,C0683454,en_4662,AFFECTS,Patient Monitoring,C0030695,en_1760,1,1,AFFECTS,General/Uncertain,8
14307,invasive treatment,C0683468,en_4663,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
14308,invasive treatment,C0683468,en_4663,TREATS,Clinicians,C0871685,en_5028,1,1,AFFECTS,Inhibitory,3
14309,motivational interviewing,C0683474,en_4664,AFFECTS,uptake,C0243144,en_3467,2,1,AFFECTS,General/Uncertain,3
14310,motivational interviewing,C0683474,en_4664,PREVENTS,psychological distress,C0815107,en_4922,2,1,AFFECTS,Inhibitory,3
14311,motivational interviewing,C0683474,en_4664,TREATS,Sleep Disorders,C0851578,en_4954,1,1,AFFECTS,Inhibitory,3
14312,disease detection,C0683509,en_4666,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
14313,Identifying problems,C0683510,en_4667,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14314,Identifying problems,C0683510,en_4667,TREATS,modern society,C0680319,en_4622,1,1,AFFECTS,Inhibitory,3
14315,patient state,C0683521,en_4668,PREDISPOSES,Patient Deceased,C1555024,en_5963,1,1,AFFECTS,Excitatory,6
14316,personal experience,C0683573,en_4669,AFFECTS,Performance,C0597198,en_4416,1,1,AFFECTS,General/Uncertain,3
14317,free time,C0683585,en_4670,TREATS,Accountant,C0000937,en_214,1,1,AFFECTS,Inhibitory,3
14318,tourism,C0683587,en_4671,TREATS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,Inhibitory,3
14319,tourism,C0683587,en_4671,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
14320,tourism,C0683587,en_4671,TREATS,Norwegians,C0337812,en_3800,1,1,AFFECTS,Inhibitory,3
14321,Outreach,C0683805,en_4673,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
14322,Homeopathic therapy,C0684199,en_4677,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14323,underage drinking,C0684314,en_4679,AFFECTS,Alcohol consumption,C0001948,en_269,1,1,AFFECTS,General/Uncertain,3
14324,heavy drinking,C0687132,en_4684,AFFECTS,Alcohol consumption,C0001948,en_269,1,1,AFFECTS,General/Uncertain,3
14325,"Information Systems, Telemedicine",C0687593,en_4686,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14326,"Information Systems, Telemedicine",C0687593,en_4686,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
14327,In Vitro Diagnostics,C0687640,en_4687,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14328,Mullerian duct inhibiting substance,C0687670,en_4688,AFFECTS,Immune system,C0020962,en_1271,3,1,AFFECTS,General/Uncertain,3
14329,Mullerian duct inhibiting substance,C0687670,en_4688,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
14330,Mullerian duct inhibiting substance,C0687670,en_4688,TREATS,Adolescent,C0205653,en_3132,2,1,AFFECTS,Inhibitory,3
14331,warming,C0687712,en_4690,AFFECTS,Respiratory physiology,C0035245,en_2018,4,2,AFFECTS,General/Uncertain,6
14332,STK11 gene,C0694883,en_4693,DISRUPTS,uptake,C0243144,en_3467,1,1,AFFECTS,Inhibitory,3
14333,TSC2 gene,C0694895,en_4694,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
14334,VHL gene,C0694897,en_4695,INHIBITS,VEGFA,C1823619,en_89,1,1,AFFECTS,Inhibitory,3
14335,VHL gene,C0694897,en_4695,INHIBITS,Transforming Growth Factor alpha,C0040688,en_2271,1,1,AFFECTS,Inhibitory,3
14336,PHYSICAL PERFORMANCE,C0695470,en_4696,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
14337,PHYSICAL PERFORMANCE,C0695470,en_4696,TREATS,Individual,C0237401,en_3343,4,2,AFFECTS,Inhibitory,6
14338,PHYSICAL PERFORMANCE,C0695470,en_4696,TREATS,Form of muscle,C0240417,en_3384,1,1,AFFECTS,Inhibitory,3
14339,Myofascial release,C0695600,en_4697,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14340,Applicants,C0696628,en_4698,AFFECTS,Permeability,C0031164,en_1779,1,1,AFFECTS,General/Uncertain,3
14341,Applicants,C0696628,en_4698,AFFECTS,Sarcomeres,C0036225,en_2065,1,1,AFFECTS,General/Uncertain,3
14342,Applicants,C0696628,en_4698,AFFECTS,Encounter due to sterilization,C0362065,en_3865,1,1,AFFECTS,General/Uncertain,3
14343,Applicants,C0696628,en_4698,AUGMENTS,Blood pressure fluctuation,C0549405,en_4280,1,1,AFFECTS,Excitatory,3
14344,Applicants,C0696628,en_4698,AUGMENTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,Excitatory,3
14345,Applicants,C0696628,en_4698,DISRUPTS,Lung,C0024109,en_1460,1,1,AFFECTS,Inhibitory,3
14346,Applicants,C0696628,en_4698,INHIBITS,HMGB1 gene,C1333908,en_5598,1,1,AFFECTS,Inhibitory,3
14347,Applicants,C0696628,en_4698,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,2,AFFECTS,Inhibitory,6
14348,Applicants,C0696628,en_4698,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14349,Applicants,C0696628,en_4698,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14350,Applicants,C0696628,en_4698,TREATS,Social stigmata,C0277787,en_3590,1,1,AFFECTS,Inhibitory,3
14351,Applicants,C0696628,en_4698,TREATS,Vesicle,C0333262,en_3759,1,1,AFFECTS,Inhibitory,3
14352,Applicants,C0696628,en_4698,TREATS,manager,C0335141,en_3784,1,1,AFFECTS,Inhibitory,3
14353,Applicants,C0696628,en_4698,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
14354,Applicants,C0696628,en_4698,TREATS,Viral Pathogenesis,C1520005,en_5895,1,1,AFFECTS,Inhibitory,3
14355,Applicants,C0696628,en_4698,TREATS(INFER),"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Inhibitory,3
14356,Applicants,C0696628,en_4698,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
14357,Fluimucil,C0699251,en_4700,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
14358,Fluimucil,C0699251,en_4700,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14359,Neoral,C0699605,en_4701,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
14360,Metric,C0699680,en_4702,AFFECTS,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
14361,Metric,C0699680,en_4702,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14362,Metric,C0699680,en_4702,AFFECTS,Gait,C0016928,en_1028,1,1,AFFECTS,General/Uncertain,3
14363,Metric,C0699680,en_4702,AFFECTS,Disease Progression,C0242656,en_3429,2,2,AFFECTS,General/Uncertain,6
14364,Metric,C0699680,en_4702,AUGMENTS,Brain,C0006104,en_508,2,1,AFFECTS,Excitatory,3
14365,Metric,C0699680,en_4702,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14366,Metric,C0699680,en_4702,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,3,1,AFFECTS,Inhibitory,6
14367,Metric,C0699680,en_4702,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
14368,Metric,C0699680,en_4702,TREATS,Vasculitis,C0042384,en_2338,1,1,AFFECTS,Inhibitory,3
14369,Metric,C0699680,en_4702,TREATS,Reporter,C0335038,en_3782,2,2,AFFECTS,Inhibitory,6
14370,Metric,C0699680,en_4702,TREATS,Ventilator-associated lung injury,C0340257,en_3814,1,1,AFFECTS,Inhibitory,3
14371,Metric,C0699680,en_4702,TREATS,cohort,C0599755,en_4470,2,1,AFFECTS,Inhibitory,6
14372,Metric,C0699680,en_4702,TREATS,High income,C0948433,en_5166,1,1,AFFECTS,Inhibitory,3
14373,Metric,C0699680,en_4702,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14374,Gut,C0699819,en_4705,PRODUCES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
14375,Nitrate,C0699857,en_4706,AFFECTS,Blood flow,C0232338,en_3276,1,1,AFFECTS,General/Uncertain,3
14376,Nitrate,C0699857,en_4706,AFFECTS,saturation,C0678572,en_4563,1,1,AFFECTS,General/Uncertain,3
14377,Nitrate,C0699857,en_4706,AFFECTS,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,General/Uncertain,3
14378,Elastases,C0699918,en_4708,AUGMENTS,lymphocyte differentiation,C1159914,en_5348,1,1,AFFECTS,Excitatory,3
14379,Elastases,C0699918,en_4708,DISRUPTS,Very large,C0450093,en_4082,1,1,AFFECTS,Inhibitory,3
14380,Cathepsins B,C0699919,en_4709,PREDISPOSES,Suicide,C0038661,en_2178,2,1,AFFECTS,Excitatory,3
14381,Public health service,C0699943,en_4710,TREATS,Readiness,C1318963,en_5534,1,1,AFFECTS,Inhibitory,3
14382,AIRWAY DISEASE,C0699949,en_4711,AFFECTS,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,General/Uncertain,3
14383,Congestion,C0700148,en_4714,AFFECTS,Medical Staff,C0025106,en_1519,1,1,AFFECTS,General/Uncertain,3
14384,Congestion,C0700148,en_4714,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
14385,Dyssomnias,C0700201,en_4715,AFFECTS,Immune System Processes,C1817756,en_6040,1,1,AFFECTS,General/Uncertain,6
14386,Cigarette Smoking,C0700219,en_4716,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
14387,"M Protein, multiple myeloma",C0700271,en_4717,AFFECTS,Membrane,C0596901,en_4400,1,1,AFFECTS,General/Uncertain,3
14388,"M Protein, multiple myeloma",C0700271,en_4717,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,8
14389,"M Protein, multiple myeloma",C0700271,en_4717,AUGMENTS,Protoplasm,C0175996,en_2976,1,1,AFFECTS,Excitatory,7
14390,Reporting,C0700287,en_4718,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
14391,Reporting,C0700287,en_4718,TREATS,Blood donor,C0005795,en_489,1,1,AFFECTS,Inhibitory,3
14392,Reporting,C0700287,en_4718,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
14393,Reporting,C0700287,en_4718,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
14394,Reporting,C0700287,en_4718,TREATS,Health Personnel,C0018724,en_1121,3,2,AFFECTS,Inhibitory,6
14395,Reporting,C0700287,en_4718,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14396,Reporting,C0700287,en_4718,TREATS,Pregnant Women,C0033011,en_1876,2,1,AFFECTS,Inhibitory,3
14397,Reporting,C0700287,en_4718,TREATS,High risk environment,C0557722,en_4310,1,1,AFFECTS,Inhibitory,3
14398,Reporting,C0700287,en_4718,TREATS,Adverse event,C0877248,en_5069,2,1,AFFECTS,Inhibitory,3
14399,Reporting,C0700287,en_4718,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
14400,Reporting,C0700287,en_4718,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
14401,Hypoxemia,C0700292,en_4719,COMPLICATES,Malaria,C0024530,en_1493,1,1,AFFECTS,General/Uncertain,3
14402,Patient observation,C0700325,en_4720,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14403,Patient observation,C0700325,en_4720,TREATS(INFER),Lung infiltration,C0235896,en_3332,2,1,AFFECTS,Inhibitory,3
14404,Patient observation,C0700325,en_4720,TREATS(INFER),Hypoxemia,C0700292,en_4719,2,1,AFFECTS,Inhibitory,3
14405,Emotional distress,C0700361,en_4722,AFFECTS,student,C0038492,en_2171,2,1,AFFECTS,General/Uncertain,3
14406,Washing hands,C0700382,en_4723,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
14407,Cardiac rehabilitation,C0700431,en_4724,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,7
14408,6 alpha-Methylprednisolone Sodium Hemisuccinate,C0700546,en_4725,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14409,Reduced mobility,C0700572,en_4726,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
14410,Contraceptive methods,C0700589,en_4727,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14411,Leuprolide Acetate,C0700596,en_4728,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,8
14412,Leuprolide Acetate,C0700596,en_4728,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,8
14413,Botox,C0700702,en_4730,INHIBITS,Skin Wrinkling,C0037301,en_2118,1,1,AFFECTS,Inhibitory,3
14414,Botox,C0700702,en_4730,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14415,Patient in hospital,C0701159,en_4731,PREDISPOSES,Inflammation,C0021368,en_1307,2,1,AFFECTS,Excitatory,3
14416,Leukine,C0701500,en_4732,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
14417,Virazole,C0702029,en_4734,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,6
14418,EQUIPOISE,C0702057,en_4735,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,1,1,AFFECTS,Inhibitory,3
14419,EQUIPOISE,C0702057,en_4735,INHIBITS,Angiotensin Receptor,C0034787,en_1963,1,1,AFFECTS,Inhibitory,3
14420,EQUIPOISE,C0702057,en_4735,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14421,Touch sensation,C0702221,en_4737,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
14422,candesartan,C0717550,en_4738,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14423,Anti-Fungal,C0718566,en_4740,TREATS,Mycoses,C0026946,en_1620,2,1,AFFECTS,Inhibitory,3
14424,Anti-Fungal,C0718566,en_4740,TREATS,Pulmonary Aspergillosis,C2350529,en_6107,1,1,AFFECTS,Inhibitory,6
14425,Century,C0719214,en_4741,TREATS,Medical Condition,C4745084,en_6400,1,1,AFFECTS,Inhibitory,7
14426,Compete,C0719453,en_4742,PREDISPOSES,Tendon rupture NOS,C0151937,en_2872,1,1,AFFECTS,Excitatory,3
14427,Compete,C0719453,en_4742,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14428,Coreg,C0719509,en_4743,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
14429,Four-Way,C0720523,en_4744,TREATS,Metastatic malignant neoplasm to brain,C0220650,en_3198,1,1,AFFECTS,Inhibitory,3
14430,Iron Supplement,C0721124,en_4745,TREATS,Iron deficiency,C0240066,en_3382,1,1,AFFECTS,Inhibitory,3
14431,SFC,C0723176,en_4746,AUGMENTS,heme metabolism,C1158226,en_5336,1,1,AFFECTS,Excitatory,3
14432,Saline Spray,C0723198,en_4747,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14433,Tace,C0723595,en_4748,STIMULATES,TNF gene,C0812246,en_4896,1,1,AFFECTS,Excitatory,3
14434,Thrombogen,C0723739,en_4749,INHIBITS,P2RY12,C1425330,en_150,1,1,AFFECTS,Inhibitory,3
14435,Tricor,C0723893,en_4750,TREATS,"Kidney Failure, Chronic",C0022661,en_1383,2,2,AFFECTS,Inhibitory,6
14436,bacteriostats,C0724534,en_4751,TREATS,Dysentery,C0013369,en_864,2,1,AFFECTS,Inhibitory,3
14437,Advance,C0725066,en_4752,TREATS,Callithrix,C0006764,en_542,1,1,AFFECTS,Inhibitory,3
14438,Advance,C0725066,en_4752,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
14439,Advance,C0725066,en_4752,TREATS,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,Inhibitory,3
14440,Advance,C0725066,en_4752,TREATS,Obstruction,C0028778,en_1702,1,1,AFFECTS,Inhibitory,3
14441,Advance,C0725066,en_4752,TREATS,Visiting Nurses,C0042799,en_2367,1,1,AFFECTS,Inhibitory,3
14442,Advance,C0725066,en_4752,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,3
14443,Advance,C0725066,en_4752,TREATS,Harmonious caregiver-patient relationship,C0516944,en_4167,4,4,AFFECTS,Inhibitory,12
14444,Easy Test,C0725972,en_4753,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14445,Linear Test,C0726916,en_4754,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14446,Ultra,C0728475,en_4755,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,7
14447,Ultra,C0728475,en_4755,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
14448,Legal system,C0728724,en_4756,AFFECTS,Social group NOS,C0687744,en_4691,1,1,AFFECTS,General/Uncertain,3
14449,Electrocardiographic axis,C0728839,en_4759,PREDISPOSES,PULMONARY INVOLVEMENT,C0748159,en_4828,2,1,AFFECTS,Excitatory,3
14450,Excision,C0728940,en_4760,AFFECTS,Blood flow,C0232338,en_3276,1,1,AFFECTS,General/Uncertain,6
14451,Excision,C0728940,en_4760,AFFECTS,transpiration,C1326386,en_5555,1,1,AFFECTS,General/Uncertain,3
14452,Excision,C0728940,en_4760,TREATS,Atelectasis,C0004144,en_420,2,1,AFFECTS,Inhibitory,3
14453,Excision,C0728940,en_4760,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
14454,Excision,C0728940,en_4760,TREATS,Patients,C0030705,en_1762,5,4,AFFECTS,Inhibitory,12
14455,Excision,C0728940,en_4760,TREATS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
14456,Excision,C0728940,en_4760,TREATS(INFER),Hypercapnia,C0020440,en_1230,1,1,AFFECTS,Inhibitory,3
14457,Excision,C0728940,en_4760,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14458,Excision,C0728940,en_4760,TREATS(INFER),Septicemia,C0036690,en_2086,2,1,AFFECTS,Inhibitory,3
14459,Excision,C0728940,en_4760,TREATS(INFER),Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,3
14460,Care provision regimes,C0729338,en_4761,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
14461,Care provision regimes,C0729338,en_4761,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
14462,Care provision regimes,C0729338,en_4761,TREATS,Muscular Dystrophies,C0026850,en_1606,2,2,AFFECTS,Inhibitory,6
14463,Care provision regimes,C0729338,en_4761,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14464,Care provision regimes,C0729338,en_4761,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
14465,Care provision regimes,C0729338,en_4761,TREATS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
14466,Care provision regimes,C0729338,en_4761,TREATS,Provider,C1138603,en_5273,1,1,AFFECTS,Inhibitory,3
14467,Proton beam,C0729603,en_4764,AFFECTS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
14468,Maternal antibody,C0729663,en_4765,AFFECTS,Immune response,C0301872,en_3696,4,4,AFFECTS,General/Uncertain,12
14469,Panretinal photocoagulation,C0730064,en_4766,TREATS,Diabetic Retinopathy,C0011884,en_804,1,1,AFFECTS,Inhibitory,6
14470,Solid organ transplant,C0730400,en_4770,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14471,Solid organ transplant,C0730400,en_4770,TREATS,Septicemia,C0036690,en_2086,2,1,AFFECTS,Inhibitory,3
14472,Solid organ transplant,C0730400,en_4770,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
14473,Solid organ transplant,C0730400,en_4770,TREATS(INFER),Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
14474,Aggrenox,C0732282,en_4771,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
14475,human leukocyte interferon,C0733470,en_4772,AUGMENTS,Antibody Formation,C0003261,en_352,2,1,AFFECTS,Excitatory,3
14476,human leukocyte interferon,C0733470,en_4772,AUGMENTS,Autoimmunity,C0004368,en_430,1,1,AFFECTS,Excitatory,3
14477,human leukocyte interferon,C0733470,en_4772,AUGMENTS,"Immunity, Cellular",C0020966,en_1274,1,1,AFFECTS,Excitatory,3
14478,human leukocyte interferon,C0733470,en_4772,AUGMENTS,"Immunity, Humoral",C0020967,en_1275,1,1,AFFECTS,Excitatory,3
14479,human leukocyte interferon,C0733470,en_4772,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
14480,human leukocyte interferon,C0733470,en_4772,AUGMENTS,B-Cell Development,C1511002,en_5806,1,1,AFFECTS,Excitatory,3
14481,human leukocyte interferon,C0733470,en_4772,AUGMENTS(SPEC),Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Excitatory,3
14482,human leukocyte interferon,C0733470,en_4772,DISRUPTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
14483,human leukocyte interferon,C0733470,en_4772,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
14484,human leukocyte interferon,C0733470,en_4772,PREDISPOSES,Ageusia,C0001800,en_259,1,1,AFFECTS,Excitatory,3
14485,human leukocyte interferon,C0733470,en_4772,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
14486,human leukocyte interferon,C0733470,en_4772,PREVENTS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,6
14487,human leukocyte interferon,C0733470,en_4772,PRODUCES,IRF7,C1416475,en_53,3,2,AFFECTS,Excitatory,6
14488,human leukocyte interferon,C0733470,en_4772,PRODUCES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
14489,human leukocyte interferon,C0733470,en_4772,PRODUCES,Dinoprostone,C0012472,en_818,1,1,AFFECTS,Excitatory,3
14490,human leukocyte interferon,C0733470,en_4772,PRODUCES,Nucleoproteins,C0028612,en_1691,1,1,AFFECTS,Excitatory,3
14491,human leukocyte interferon,C0733470,en_4772,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
14492,human leukocyte interferon,C0733470,en_4772,STIMULATES,Cells,C0007634,en_596,1,1,AFFECTS,Excitatory,3
14493,human leukocyte interferon,C0733470,en_4772,STIMULATES,Genes,C0017337,en_1052,4,4,AFFECTS,Excitatory,12
14494,human leukocyte interferon,C0733470,en_4772,STIMULATES,Integral Membrane Proteins,C0021699,en_1327,1,1,AFFECTS,Excitatory,3
14495,human leukocyte interferon,C0733470,en_4772,STIMULATES,Monocyte Chemoattractant Protein-1,C0128897,en_2777,2,1,AFFECTS,Excitatory,3
14496,human leukocyte interferon,C0733470,en_4772,STIMULATES,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,Excitatory,3
14497,human leukocyte interferon,C0733470,en_4772,STIMULATES,"TLR4 protein, human",C1321919,en_5543,1,1,AFFECTS,Excitatory,3
14498,human leukocyte interferon,C0733470,en_4772,STIMULATES(SPEC),Cells,C0007634,en_596,2,2,AFFECTS,Excitatory,6
14499,human leukocyte interferon,C0733470,en_4772,STIMULATES(SPEC),Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Excitatory,3
14500,human leukocyte interferon,C0733470,en_4772,STIMULATES(SPEC),cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
14501,human leukocyte interferon,C0733470,en_4772,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
14502,human leukocyte interferon,C0733470,en_4772,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
14503,human leukocyte interferon,C0733470,en_4772,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
14504,human leukocyte interferon,C0733470,en_4772,TREATS,Viral hepatitis,C0042721,en_2356,2,1,AFFECTS,Inhibitory,3
14505,human leukocyte interferon,C0733470,en_4772,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
14506,human leukocyte interferon,C0733470,en_4772,TREATS,Young adult,C0238598,en_3365,1,1,AFFECTS,Inhibitory,3
14507,human leukocyte interferon,C0733470,en_4772,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
14508,medical supplies,C0740043,en_4774,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
14509,medical supplies,C0740043,en_4774,TREATS,Spinal Cord Injuries,C0037929,en_2143,1,1,AFFECTS,Inhibitory,6
14510,medical supplies,C0740043,en_4774,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,6
14511,Oxygen nasal cannula,C0740087,en_4775,TREATS,Spontaneous respiration,C0412771,en_3970,1,1,AFFECTS,Inhibitory,3
14512,Multisystem problem,C0740901,en_4784,AFFECTS,Research Personnel,C0035173,en_2002,2,1,AFFECTS,General/Uncertain,3
14513,atrial fibrillation new onset,C0741281,en_4786,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
14514,Bedridden,C0741453,en_4787,PREDISPOSES,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,Excitatory,3
14515,Bedridden,C0741453,en_4787,PREDISPOSES,skin disorder,C0037274,en_2115,1,1,AFFECTS,Excitatory,3
14516,BREAST TATTOO,C0741765,en_4788,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,3
14517,Bypass,C0741847,en_4789,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14518,CARDIAC EVENT,C0741923,en_4791,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
14519,CHEST TUBE PLACEMENT,C0742344,en_4796,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14520,Elevated C-reactive protein,C0742906,en_4797,PREDISPOSES,Critical Illness,C0010340,en_733,1,1,AFFECTS,Excitatory,6
14521,D-dimer above reference range,C0742969,en_4798,PREDISPOSES,Blood coagulation,C0005778,en_484,1,1,AFFECTS,Excitatory,6
14522,D-dimer above reference range,C0742969,en_4798,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,7
14523,D-dimer above reference range,C0742969,en_4798,PREDISPOSES,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,6
14524,dialysis chronic,C0743165,en_4800,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14525,Ferritin increased,C0743912,en_4805,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
14526,GLUCOCORTICOID THERAPY,C0744425,en_4807,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14527,HIP FRACTURE REPAIR,C0744924,en_4809,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14528,HORMONE REPLACEMENT,C0745034,en_4810,AFFECTS,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
14529,INFECTIOUS PROCESS,C0745283,en_4812,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
14530,INFECTIOUS PROCESS,C0745283,en_4812,AFFECTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
14531,INSULIN TREATMENT,C0745343,en_4813,TREATS,Diabetes,C0011847,en_797,2,1,AFFECTS,Inhibitory,3
14532,Chronic lung disease,C0746102,en_4815,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
14533,Chronic lung disease,C0746102,en_4815,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
14534,NAPROXEN TREATMENT,C0746751,en_4818,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
14535,OBSTRUCTIVE DISEASE,C0746982,en_4822,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
14536,Elective procedure,C0747973,en_4825,PREVENTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
14537,PSYCHIATRIC COUNSELING,C0748054,en_4826,TREATS,Medical Patients,C0870869,en_5013,1,1,AFFECTS,Inhibitory,3
14538,PULMONARY INVOLVEMENT,C0748159,en_4828,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
14539,PULMONARY INVOLVEMENT,C0748159,en_4828,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
14540,Pulmonary Pathology,C0748168,en_4829,AFFECTS,Infiltration,C0332448,en_3749,1,1,AFFECTS,General/Uncertain,3
14541,Pulmonary Pathology,C0748168,en_4829,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
14542,Acute respiratory distress,C0748355,en_4831,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
14543,RESPIRATORY ISOLATION,C0748359,en_4832,AFFECTS,Personal Satisfaction,C0031206,en_1780,1,1,AFFECTS,General/Uncertain,3
14544,TUBERCULOSIS TREATMENT,C0749724,en_4836,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
14545,VASCULAR ACCESS,C0750138,en_4839,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14546,Arthroscopic Surgical Procedures,C0750934,en_4844,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14547,Arthroscopic Surgical Procedures,C0750934,en_4844,TREATS(INFER),Rotator cuff syndrome,C0263912,en_3525,2,1,AFFECTS,Inhibitory,3
14548,Communication Disabilities,C0751049,en_4846,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
14549,Learning Disabilities,C0751265,en_4848,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
14550,Natural Remedies,C0751363,en_4849,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
14551,"Stroke, Acute",C0751956,en_4854,AFFECTS,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
14552,Neutrophil Infiltration,C0751982,en_4855,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
14553,Single Nucleotide Polymorphism,C0752046,en_4856,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
14554,Single Nucleotide Polymorphism,C0752046,en_4856,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
14555,Single Nucleotide Polymorphism,C0752046,en_4856,STIMULATES,GTF2I,C1415347,en_42,1,1,AFFECTS,Excitatory,3
14556,Single Nucleotide Polymorphism,C0752046,en_4856,STIMULATES,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Excitatory,3
14557,"Technology, Health Care",C0752189,en_4857,PREVENTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
14558,"Technology, Health Care",C0752189,en_4857,TREATS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
14559,"Technology, Health Care",C0752189,en_4857,TREATS,PATIENT SYMPTOMS,C1317600,en_5529,1,1,AFFECTS,Inhibitory,3
14560,"Acupuncture, Ear",C0752217,en_4858,PREVENTS,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Inhibitory,3
14561,"Acupuncture, Ear",C0752217,en_4858,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
14562,Mitogen-Activated Protein Kinases,C0752312,en_4859,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
14563,Mitogen-Activated Protein Kinases,C0752312,en_4859,STIMULATES,Proto-Oncogene Proteins c-myc,C0080065,en_2619,1,1,AFFECTS,Excitatory,3
14564,"TNFSF13 protein, human|TNFSF13",C0757844|8741,en_4861,AFFECTS,44715,C1630409,en_6017,1,1,AFFECTS,General/Uncertain,7
14565,"TNFSF13 protein, human|TNFSF13",C0757844|8741,en_4861,AFFECTS,Premature Birth rates,C1822488,en_6042,1,1,AFFECTS,General/Uncertain,6
14566,SC 560,C0759583,en_4863,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
14567,artemin,C0761955,en_4864,AFFECTS,Exhalation,C0442689,en_4051,1,1,AFFECTS,General/Uncertain,3
14568,Apoptosis Inducing Factor,C0763396,en_4866,AUGMENTS,Cell Death,C0007587,en_587,1,1,AFFECTS,Excitatory,3
14569,Apoptosis Inducing Factor,C0763396,en_4866,AUGMENTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Excitatory,3
14570,interleukin-18 binding protein,C0765701,en_4867,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
14571,qing-fei-tang,C0769578,en_4869,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
14572,qing-fei-tang,C0769578,en_4869,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
14573,MUCOLYTIC,C0770152,en_4870,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
14574,ANTISEPTIC SOLUTION,C0770751,en_4872,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
14575,ANTISEPTIC SOLUTION,C0770751,en_4872,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
14576,Poractant alfa,C0771648,en_4873,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14577,Poractant alfa,C0771648,en_4873,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
14578,Poractant alfa,C0771648,en_4873,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,1,AFFECTS,Inhibitory,3
14579,AROMATICS,C0772162,en_4874,AFFECTS,Smell Perception,C0037361,en_2122,1,1,AFFECTS,General/Uncertain,6
14580,COLLOIDAL SILVER,C0772313,en_4875,DISRUPTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14581,COLLOIDAL SILVER,C0772313,en_4875,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14582,HIV Test Kit,C0792850,en_4876,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,8
14583,RESPIRATORY VACCINE,C0795658,en_4877,TREATS,Primates,C0033147,en_1887,1,1,AFFECTS,Inhibitory,3
14584,RESPIRATORY VACCINE,C0795658,en_4877,TREATS(SPEC),Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
14585,"von Willebrand factor, human|VWF",C0795677|7450,en_4878,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
14586,"von Willebrand factor, human|VWF",C0795677|7450,en_4878,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14587,Hyperlactacidaemia,C0795692,en_4880,PREDISPOSES,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Excitatory,7
14588,bevacizumab,C0796392,en_4882,INHIBITS,VEGFA,C1823619,en_89,1,1,AFFECTS,Inhibitory,3
14589,bevacizumab,C0796392,en_4882,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,3
14590,bevacizumab,C0796392,en_4882,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14591,bevacizumab,C0796392,en_4882,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14592,bevacizumab,C0796392,en_4882,TREATS(INFER),Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,3
14593,bevacizumab,C0796392,en_4882,TREATS(SPEC),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
14594,bevacizumab,C0796392,en_4882,TREATS(SPEC),Diabetic macular edema,C0730285,en_4767,1,1,AFFECTS,Inhibitory,3
14595,geldanamycin analogue,C0796552,en_4883,INHIBITS,Hypothalamic inhibiting factor,C0301821,en_3695,1,1,AFFECTS,Inhibitory,3
14596,Challenge,C0805586,en_4885,AFFECTS,state of health,C0683314,en_4656,1,1,AFFECTS,General/Uncertain,6
14597,Challenge,C0805586,en_4885,TREATS,General Practitioners,C0017319,en_1051,1,1,AFFECTS,Inhibitory,7
14598,Challenge,C0805586,en_4885,TREATS,Diabetic Foot,C0206172,en_3152,1,1,AFFECTS,Inhibitory,8
14599,Challenge,C0805586,en_4885,TREATS,Austrians,C0337795,en_3797,1,1,AFFECTS,Inhibitory,7
14600,Challenge,C0805586,en_4885,TREATS,Emergency physician,C4699551,en_6380,1,1,AFFECTS,Inhibitory,6
14601,Challenge,C0805586,en_4885,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,13
14602,Flow,C0806140,en_4886,PREDISPOSES,Cholera,C0008354,en_639,1,1,AFFECTS,Excitatory,3
14603,Maximum,C0806909,en_4887,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
14604,RESPIRATORY MASK,C0807749,en_4888,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
14605,RESPIRATORY MASK,C0807749,en_4888,TREATS,line worker,C0682215,en_4639,1,1,AFFECTS,Inhibitory,3
14606,Therapeutic Intervention,C0808232,en_4889,PREVENTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,3,3,AFFECTS,Inhibitory,9
14607,Therapeutic Intervention,C0808232,en_4889,TREATS,Dyspnea,C0013404,en_866,1,1,AFFECTS,Inhibitory,3
14608,Therapeutic Intervention,C0808232,en_4889,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14609,Therapeutic Intervention,C0808232,en_4889,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
14610,Therapeutic Intervention,C0808232,en_4889,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14611,Therapeutic Intervention,C0808232,en_4889,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
14612,Therapeutic Intervention,C0808232,en_4889,TREATS,Tachyarrhythmia,C0080203,en_2625,2,1,AFFECTS,Inhibitory,3
14613,Therapeutic Intervention,C0808232,en_4889,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
14614,Therapeutic Intervention,C0808232,en_4889,TREATS,Acute infectious disease,C0275518,en_3563,1,1,AFFECTS,Inhibitory,3
14615,Therapeutic Intervention,C0808232,en_4889,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14616,Therapeutic Intervention,C0808232,en_4889,TREATS(INFER),Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
14617,OXYGEN DELIVERY SYSTEM,C0809836,en_4891,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14618,OXYGEN DELIVERY SYSTEM,C0809836,en_4891,TREATS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,Inhibitory,8
14619,OXYGEN DELIVERY SYSTEM,C0809836,en_4891,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
14620,OXYGEN DELIVERY SYSTEM,C0809836,en_4891,TREATS(INFER),Hypoxia,C0242184,en_3396,2,1,AFFECTS,Inhibitory,3
14621,Colorectal resection,C0810152,en_4892,TREATS,Ileus,C1258215,en_5407,1,1,AFFECTS,Inhibitory,3
14622,"Scales, Clinical",C0810506,en_4893,TREATS,Autoimmune encephalitis,C0393639,en_3933,1,1,AFFECTS,Inhibitory,3
14623,Pacemakers,C0810633,en_4894,TREATS,Catalonian,C1553362,en_5960,1,1,AFFECTS,Inhibitory,6
14624,RHOA gene,C0812234,en_4895,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
14625,TNF gene,C0812246,en_4896,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
14626,TNF gene,C0812246,en_4896,AUGMENTS,Nasal Polyps,C0027430,en_1640,1,1,AFFECTS,Excitatory,3
14627,TNF gene,C0812246,en_4896,DISRUPTS,Armed macrophage,C0001280,en_228,1,1,AFFECTS,Inhibitory,3
14628,TNF gene,C0812246,en_4896,DISRUPTS,Coughing,C0010200,en_723,4,2,AFFECTS,Inhibitory,6
14629,TNF gene,C0812246,en_4896,DISRUPTS,Dyspnea,C0013404,en_866,4,2,AFFECTS,Inhibitory,6
14630,TNF gene,C0812246,en_4896,DISRUPTS,Granuloma,C0018188,en_1094,1,1,AFFECTS,Inhibitory,3
14631,TNF gene,C0812246,en_4896,DISRUPTS,Inferior Colliculus,C0021358,en_1304,1,1,AFFECTS,Inhibitory,3
14632,TNF gene,C0812246,en_4896,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
14633,TNF gene,C0812246,en_4896,INHIBITS,Ferritin,C0015879,en_980,4,2,AFFECTS,Inhibitory,6
14634,TNF gene,C0812246,en_4896,INHIBITS,Interleukin-1 beta,C0021753,en_1334,2,1,AFFECTS,Inhibitory,3
14635,TNF gene,C0812246,en_4896,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
14636,TNF gene,C0812246,en_4896,INHIBITS,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Inhibitory,3
14637,TNF gene,C0812246,en_4896,INHIBITS,Hydroxyl Radical,C0063146,en_2503,1,1,AFFECTS,Inhibitory,3
14638,TNF gene,C0812246,en_4896,INHIBITS,Interleukin-10,C0085295,en_2659,2,1,AFFECTS,Inhibitory,3
14639,TNF gene,C0812246,en_4896,PREVENTS,Pulmonary Edema,C0034063,en_1929,2,2,AFFECTS,Inhibitory,6
14640,TNF gene,C0812246,en_4896,STIMULATES,SIRT1,C1423062,en_121,1,1,AFFECTS,Excitatory,3
14641,TNF gene,C0812246,en_4896,STIMULATES,"PER2 protein, mammalian",C0669679,en_4536,1,1,AFFECTS,Excitatory,3
14642,TNF gene,C0812246,en_4896,STIMULATES,human leukocyte interferon,C0733470,en_4772,2,1,AFFECTS,Excitatory,3
14643,RALA gene,C0812284,en_4897,AUGMENTS,Primary carcinoma of the liver cells,C0019204,en_1178,1,1,AFFECTS,Excitatory,3
14644,RALA gene,C0812284,en_4897,AUGMENTS,Tumor Initiation,C0598935,en_4456,1,1,AFFECTS,Excitatory,3
14645,RALA gene,C0812284,en_4897,DISRUPTS,Cells,C0007634,en_596,1,1,AFFECTS,Inhibitory,3
14646,RALA gene,C0812284,en_4897,DISRUPTS,Secondary malignant neoplasm of lung,C0153676,en_2885,1,1,AFFECTS,Inhibitory,3
14647,RALA gene,C0812284,en_4897,DISRUPTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,Inhibitory,3
14648,RALA gene,C0812284,en_4897,DISRUPTS,Tumorigenicity,C1519697,en_5890,1,1,AFFECTS,Inhibitory,3
14649,RALA gene,C0812284,en_4897,PREDISPOSES,Hepatocarcinogenesis,C1512409,en_5818,1,1,AFFECTS,Excitatory,3
14650,RALA gene,C0812284,en_4897,STIMULATES,HCCS,C1415491,en_43,4,1,AFFECTS,Excitatory,3
14651,FYN gene,C0812303,en_4898,AFFECTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,General/Uncertain,3
14652,MAS1 gene,C0812372,en_4899,AFFECTS,Renin-Angiotensin System,C0035096,en_1996,2,1,AFFECTS,General/Uncertain,3
14653,MAS1 gene,C0812372,en_4899,INHIBITS,ACE,C1413931,en_28,1,1,AFFECTS,Inhibitory,3
14654,ELK3 gene,C0812375,en_4900,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14655,ELK3 gene,C0812375,en_4900,AFFECTS,[X]Erosion of bone,C0587240,en_4361,1,1,AFFECTS,General/Uncertain,3
14656,ELK3 gene,C0812375,en_4900,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
14657,ELK3 gene,C0812375,en_4900,PREVENTS,Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
14658,ABL2 gene,C0812381,en_4901,INHIBITS,Phosphotransferases,C0031727,en_1801,1,1,AFFECTS,Inhibitory,3
14659,BCR gene,C0812385,en_4902,INHIBITS,Phosphotransferases,C0031727,en_1801,1,1,AFFECTS,Inhibitory,3
14660,BCR gene,C0812385,en_4902,STIMULATES,Antigens,C0003320,en_365,1,1,AFFECTS,Excitatory,3
14661,Hyaluronan,C0813622,en_4905,AFFECTS,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
14662,Hyaluronan,C0813622,en_4905,AFFECTS,Stratum granulosum,C0221923,en_3231,1,1,AFFECTS,General/Uncertain,3
14663,Hyaluronan,C0813622,en_4905,AUGMENTS,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
14664,Hyaluronan,C0813622,en_4905,DISRUPTS,Neural Development,C0814002,en_4907,1,1,AFFECTS,Inhibitory,3
14665,Hyaluronan,C0813622,en_4905,DISRUPTS,Entire dentate gyrus,C1281026,en_5472,1,1,AFFECTS,Inhibitory,3
14666,Hyaluronan,C0813622,en_4905,STIMULATES,Hyaluronidase,C0020197,en_1216,1,1,AFFECTS,Excitatory,3
14667,Hyaluronan,C0813622,en_4905,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
14668,Hyaluronan,C0813622,en_4905,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14669,Hyaluronan,C0813622,en_4905,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14670,Hyaluronan,C0813622,en_4905,TREATS,Injury,C0175677,en_2968,2,2,AFFECTS,Inhibitory,6
14671,Hyaluronan,C0813622,en_4905,TREATS,Tissue healing,C0518033,en_4177,1,1,AFFECTS,Inhibitory,3
14672,Environmental Tobacco Smoke,C0813971,en_4906,AFFECTS,brain function,C0678908,en_4584,1,1,AFFECTS,General/Uncertain,3
14673,universal prevention,C0814357,en_4910,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
14674,universal prevention,C0814357,en_4910,TREATS,physical health,C0516977,en_4168,2,1,AFFECTS,Inhibitory,3
14675,universal prevention,C0814357,en_4910,TREATS,Physical function,C0516981,en_4169,2,1,AFFECTS,Inhibitory,3
14676,universal prevention,C0814357,en_4910,TREATS,Emotional,C0849912,en_4937,2,1,AFFECTS,Inhibitory,3
14677,resistance education,C0814409,en_4911,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14678,resistance education,C0814409,en_4911,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
14679,early identification,C0814435,en_4912,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
14680,early identification,C0814435,en_4912,TREATS,Fasting,C0015663,en_963,1,1,AFFECTS,Inhibitory,6
14681,early identification,C0814435,en_4912,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14682,early identification,C0814435,en_4912,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14683,early identification,C0814435,en_4912,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
14684,treatment referral,C0814457,en_4913,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
14685,brief intervention,C0814459,en_4914,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
14686,brief intervention,C0814459,en_4914,PREVENTS,Loneliness,C0023974,en_1456,1,1,AFFECTS,Inhibitory,8
14687,brief intervention,C0814459,en_4914,PREVENTS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
14688,brief intervention,C0814459,en_4914,PREVENTS,Distress,C0231303,en_3256,1,1,AFFECTS,Inhibitory,7
14689,brief intervention,C0814459,en_4914,PREVENTS,Social stigmata,C0277787,en_3590,2,1,AFFECTS,Inhibitory,3
14690,brief intervention,C0814459,en_4914,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
14691,brief intervention,C0814459,en_4914,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14692,brief intervention,C0814459,en_4914,TREATS,parent,C0030551,en_1750,3,2,AFFECTS,Inhibitory,6
14693,brief intervention,C0814459,en_4914,TREATS,Veterans,C0042610,en_2351,1,1,AFFECTS,Inhibitory,7
14694,brief intervention,C0814459,en_4914,TREATS,Depressive Symptoms,C0086132,en_2702,2,1,AFFECTS,Inhibitory,3
14695,brief intervention,C0814459,en_4914,TREATS,Worried,C0233481,en_3292,1,1,AFFECTS,Inhibitory,3
14696,brief intervention,C0814459,en_4914,TREATS,college student,C0682177,en_4638,1,1,AFFECTS,Inhibitory,3
14697,brief intervention,C0814459,en_4914,TREATS,"Stress, acute",C0848237,en_4931,1,1,AFFECTS,Inhibitory,3
14698,brief intervention,C0814459,en_4914,TREATS(INFER),Mental health problem,C1446377,en_5753,1,1,AFFECTS,Inhibitory,3
14699,elective care,C0814500,en_4915,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14700,elective care,C0814500,en_4915,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
14701,Skin cell,C0814995,en_4918,AFFECTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,General/Uncertain,3
14702,toxic proteins,C0815048,en_4919,PREVENTS,Blood Clot,C0302148,en_3702,2,1,AFFECTS,Inhibitory,3
14703,isoflavonoids,C0815051,en_4920,PREVENTS(SPEC),Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
14704,psychological distress,C0815107,en_4922,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,3
14705,psychological distress,C0815107,en_4922,AFFECTS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,General/Uncertain,3
14706,psychological distress,C0815107,en_4922,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
14707,psychological distress,C0815107,en_4922,AFFECTS,neurodevelopment,C0599855,en_4477,2,1,AFFECTS,General/Uncertain,3
14708,psychological distress,C0815107,en_4922,AFFECTS,protective factors,C0679688,en_4605,1,1,AFFECTS,General/Uncertain,6
14709,perfectionism,C0815110,en_4923,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,3
14710,impulsivity,C0815111,en_4924,PREDISPOSES,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Excitatory,3
14711,patient characteristics,C0815172,en_4925,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
14712,Structure of parenchyma of lung,C0819757,en_4926,PRODUCES,Peptide Hydrolases,C0030940,en_1769,1,1,AFFECTS,Excitatory,3
14713,Structure of parenchyma of lung,C0819757,en_4926,PRODUCES,Reactive Oxygen Species,C0162772,en_2932,1,1,AFFECTS,Excitatory,3
14714,Psychosocial counseling,C0841579,en_4927,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,7
14715,Genetic assessment,C0846617,en_4928,TREATS,parent,C0030551,en_1750,1,1,AFFECTS,Inhibitory,3
14716,Genetic assessment,C0846617,en_4928,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14717,Mental problem,C0848067,en_4929,PREDISPOSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,3
14718,Mental problem,C0848067,en_4929,PREDISPOSES,Stress,C0038435,en_2165,1,1,AFFECTS,Excitatory,3
14719,"Morbidity, perinatal",C0848215,en_4930,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
14720,Removes,C0849355,en_4934,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14721,"Rehabilitation, physical",C0849487,en_4935,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
14722,"Rehabilitation, physical",C0849487,en_4935,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14723,"Rehabilitation, physical",C0849487,en_4935,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
14724,"Rehabilitation, physical",C0849487,en_4935,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14725,"Rehabilitation, physical",C0849487,en_4935,TREATS(INFER),nervous system disorder,C0027765,en_1659,1,1,AFFECTS,Inhibitory,3
14726,Generalized illness,C0849867,en_4936,AFFECTS,Birth,C0005615,en_476,2,1,AFFECTS,General/Uncertain,3
14727,Emotional,C0849912,en_4937,PREDISPOSES,Crisis,C0231224,en_3253,2,2,AFFECTS,Excitatory,6
14728,Pulmonary Function Test/Forced Expiratory Volume 1,C0849974,en_4938,AFFECTS,Lung consolidation,C0521530,en_4202,1,1,AFFECTS,General/Uncertain,3
14729,"Examination, postpartum",C0849975,en_4939,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
14730,"Information, health",C0850397,en_4942,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,6
14731,"Information, health",C0850397,en_4942,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14732,"Information, health",C0850397,en_4942,TREATS,Caregiver,C0085537,en_2674,1,1,AFFECTS,Inhibitory,3
14733,"Information, health",C0850397,en_4942,TREATS,target group,C0680888,en_4628,1,1,AFFECTS,Inhibitory,3
14734,"Risk factor, cardiovascular",C0850624,en_4944,AFFECTS,cohort,C0599755,en_4470,1,1,AFFECTS,General/Uncertain,3
14735,"Risk factor, cardiovascular",C0850624,en_4944,PREDISPOSES,Lower limb ischemia,C0340565,en_3818,1,1,AFFECTS,Excitatory,3
14736,Stop medication,C0850893,en_4948,PREDISPOSES,Flare,C1517205,en_5867,2,1,AFFECTS,Excitatory,3
14737,Medical exam,C0851027,en_4949,AFFECTS,Sleep Disorders,C0851578,en_4954,1,1,AFFECTS,General/Uncertain,3
14738,Staff,C0851286,en_4950,TREATS,Patients,C0030705,en_1762,4,3,AFFECTS,Inhibitory,9
14739,Breast surgery,C0851312,en_4951,TREATS,Malignant neoplasm of breast,C0006142,en_511,2,1,AFFECTS,Inhibitory,3
14740,Radiation,C0851346,en_4952,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,7
14741,Sleep Disorders,C0851578,en_4954,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
14742,Sleep Disorders,C0851578,en_4954,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
14743,Sleep Disorders,C0851578,en_4954,AFFECTS,metabolomics,C1328813,en_5571,1,1,AFFECTS,General/Uncertain,3
14744,Sleep Disorders,C0851578,en_4954,AFFECTS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,3
14745,Sleep Disorders,C0851578,en_4954,DISRUPTS,Neurons,C0027882,en_1672,1,1,AFFECTS,Inhibitory,3
14746,Sleep Disorders,C0851578,en_4954,PREDISPOSES,Mental disorders,C0004936,en_452,1,1,AFFECTS,Excitatory,3
14747,Nasal Therapies,C0851680,en_4955,TREATS,Acute respiratory failure,C0264490,en_3533,2,2,AFFECTS,Inhibitory,12
14748,Nasal Therapies,C0851680,en_4955,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
14749,Autologous bone marrow transplantation therapy,C0854630,en_4962,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14750,Autologous bone marrow transplantation therapy,C0854630,en_4962,TREATS(INFER),Lower limb ischemia,C0340565,en_3818,1,1,AFFECTS,Inhibitory,3
14751,Antioestrogen therapy,C0854638,en_4963,TREATS,Breast cancer invasive NOS,C0853879,en_4957,2,1,AFFECTS,Inhibitory,3
14752,Endothelial dysfunction,C0856169,en_4968,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
14753,Endothelial dysfunction,C0856169,en_4968,AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
14754,Endothelial dysfunction,C0856169,en_4968,AFFECTS,Neoplasm Metastasis,C0027627,en_1650,1,1,AFFECTS,General/Uncertain,6
14755,Endothelial dysfunction,C0856169,en_4968,AFFECTS,Anabolism,C0220781,en_3199,1,1,AFFECTS,General/Uncertain,7
14756,Endothelial dysfunction,C0856169,en_4968,AFFECTS,Respiratory process,C0442688,en_4050,3,2,AFFECTS,General/Uncertain,6
14757,Endothelial dysfunction,C0856169,en_4968,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
14758,Endothelial dysfunction,C0856169,en_4968,PREDISPOSES,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,Excitatory,3
14759,Induction,C0857127,en_4970,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14760,Induction,C0857127,en_4970,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
14761,Induction,C0857127,en_4970,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,6
14762,Induction,C0857127,en_4970,PREVENTS,Virus,C0042776,en_2364,1,1,AFFECTS,Inhibitory,3
14763,Induction,C0857127,en_4970,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,3
14764,Induction,C0857127,en_4970,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14765,Induction,C0857127,en_4970,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14766,Induction,C0857127,en_4970,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
14767,Routine vaccination,C0857208,en_4971,PREDISPOSES,Vaccine-Preventable Diseases,C5197682,en_6412,1,1,AFFECTS,Excitatory,6
14768,Anemic,C0857322,en_4974,PREDISPOSES,Infection,C3714514,en_6235,2,1,AFFECTS,Excitatory,3
14769,Booster,C0857515,en_4978,STIMULATES,Immune response,C0301872,en_3696,2,2,AFFECTS,Excitatory,6
14770,Booster,C0857515,en_4978,TREATS,Adult,C0001675,en_252,6,3,AFFECTS,Inhibitory,9
14771,Booster,C0857515,en_4978,TREATS,Age,C0001779,en_257,1,1,AFFECTS,Inhibitory,3
14772,Booster,C0857515,en_4978,TREATS,Elderly,C0001792,en_258,4,1,AFFECTS,Inhibitory,3
14773,Booster,C0857515,en_4978,TREATS,"Kidney Failure, Chronic",C0022661,en_1383,2,1,AFFECTS,Inhibitory,3
14774,Booster,C0857515,en_4978,TREATS,Persons,C0027361,en_1635,3,2,AFFECTS,Inhibitory,6
14775,Booster,C0857515,en_4978,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,3
14776,Booster,C0857515,en_4978,TREATS,Patients,C0030705,en_1762,6,4,AFFECTS,Inhibitory,12
14777,Booster,C0857515,en_4978,TREATS,Individual,C0237401,en_3343,14,8,AFFECTS,Inhibitory,24
14778,Booster,C0857515,en_4978,TREATS,"Recipient, Transplant",C0376387,en_3875,1,1,AFFECTS,Inhibitory,3
14779,Booster,C0857515,en_4978,TREATS,Participant,C0679646,en_4602,6,4,AFFECTS,Inhibitory,12
14780,Booster,C0857515,en_4978,TREATS,General Population,C0683971,en_4674,2,1,AFFECTS,Inhibitory,3
14781,Booster,C0857515,en_4978,TREATS,Well adult,C0686750,en_4683,5,3,AFFECTS,Inhibitory,9
14782,Booster,C0857515,en_4978,TREATS(INFER),Amyloidosis,C0002726,en_309,2,1,AFFECTS,Inhibitory,3
14783,Booster,C0857515,en_4978,TREATS(INFER),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
14784,Booster,C0857515,en_4978,TREATS(INFER),Multiple Myeloma,C0026764,en_1596,2,1,AFFECTS,Inhibitory,3
14785,Booster,C0857515,en_4978,TREATS(INFER),Hematopoietic Neoplasms,C0376544,en_3882,2,1,AFFECTS,Inhibitory,3
14786,Influenza A virus infection,C0858004,en_4979,COMPLICATES,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,General/Uncertain,3
14787,Plasmodium falciparum infection,C0858318,en_4980,AFFECTS(SPEC),Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
14788,Gambler,C0858352,en_4982,AFFECTS,Gambling,C0016995,en_1030,1,1,AFFECTS,General/Uncertain,3
14789,Interleukin-6 therapy,C0860390,en_4990,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14790,Interleukin-6 therapy,C0860390,en_4990,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
14791,Interleukin-6 therapy,C0860390,en_4990,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
14792,Interleukin-8 therapy,C0860392,en_4991,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
14793,Interleukin-8 therapy,C0860392,en_4991,TREATS(INFER),Respiration Disorders,C0035204,en_2005,2,1,AFFECTS,Inhibitory,3
14794,Digests,C0868946,en_4998,AFFECTS,Target Population,C0039309,en_2207,1,1,AFFECTS,General/Uncertain,3
14795,Institutional care,C0868975,en_4999,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
14796,Institutional care,C0868975,en_4999,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
14797,Institutional care,C0868975,en_4999,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
14798,Institutional care,C0868975,en_4999,TREATS(INFER),Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
14799,Institutional care,C0868975,en_4999,TREATS(INFER),Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,3
14800,Cognitive Rehabilitation,C0870303,en_5002,TREATS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
14801,Exposure Therapy,C0870527,en_5005,TREATS,Irritable Bowel Syndrome,C0022104,en_1360,1,1,AFFECTS,Inhibitory,3
14802,Exposure Therapy,C0870527,en_5005,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,4,2,AFFECTS,Inhibitory,6
14803,Eye Movement Desensitization Therapy,C0870535,en_5006,TREATS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,Inhibitory,3
14804,Eye Movement Desensitization Therapy,C0870535,en_5006,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,Inhibitory,3
14805,Eye Movement Desensitization Therapy,C0870535,en_5006,TREATS,Well in self,C0424578,en_3996,2,1,AFFECTS,Inhibitory,3
14806,Eye Movement Desensitization Therapy,C0870535,en_5006,TREATS,"Counseling, health",C0850252,en_4941,1,1,AFFECTS,Inhibitory,7
14807,Home Schooling,C0870657,en_5009,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
14808,Lifesaving,C0870810,en_5011,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
14809,Lifesaving,C0870810,en_5011,TREATS,Patients,C0030705,en_1762,4,4,AFFECTS,Inhibitory,12
14810,Lifesaving,C0870810,en_5011,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
14811,Lifesaving,C0870810,en_5011,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
14812,Lifesaving,C0870810,en_5011,TREATS,Social stigmata,C0277787,en_3590,1,1,AFFECTS,Inhibitory,3
14813,Lifesaving,C0870810,en_5011,TREATS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,6
14814,Lifesaving,C0870810,en_5011,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,6
14815,Lifesaving,C0870810,en_5011,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14816,Lifesaving,C0870810,en_5011,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
14817,Metabolic Rates,C0870882,en_5014,AFFECTS,Alveolar ventilation function,C0231940,en_3269,2,1,AFFECTS,General/Uncertain,3
14818,Metabolic Rates,C0870882,en_5014,PRODUCES,Carbon Dioxide,C0007012,en_556,1,1,AFFECTS,Excitatory,3
14819,Metabolites,C0870883,en_5015,AFFECTS,Metabolism,C0025519,en_1547,1,1,AFFECTS,General/Uncertain,3
14820,Metabolites,C0870883,en_5015,AFFECTS,Immunologic function,C1268930,en_5445,2,1,AFFECTS,General/Uncertain,3
14821,Metabolites,C0870883,en_5015,AUGMENTS,Glycolysis,C0017952,en_1084,1,1,AFFECTS,Excitatory,3
14822,Metabolites,C0870883,en_5015,INHIBITS,11-beta-Hydroxysteroid Dehydrogenase Type 2,C0608861,en_4518,1,1,AFFECTS,Inhibitory,3
14823,response,C0871261,en_5019,PREDISPOSES,Aggressive behavior,C0001807,en_261,1,1,AFFECTS,Excitatory,3
14824,response,C0871261,en_5019,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,3
14825,response,C0871261,en_5019,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,10
14826,response,C0871261,en_5019,PREDISPOSES,Encephalitis,C0014038,en_896,1,1,AFFECTS,Excitatory,3
14827,response,C0871261,en_5019,PREDISPOSES,Lung diseases,C0024115,en_1462,2,1,AFFECTS,Excitatory,3
14828,Screening Tests,C0871311,en_5020,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
14829,Screening Tests,C0871311,en_5020,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
14830,Sleep Treatment,C0871378,en_5021,TREATS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
14831,Teams,C0871489,en_5024,PRODUCES,Face Shields,C0183255,en_3043,1,1,AFFECTS,Excitatory,3
14832,Therapists,C0871525,en_5025,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
14833,Treatment Resistant Disorders,C0871547,en_5027,PRODUCES,glial cell-line derived neurotrophic factor,C0207072,en_3178,1,1,AFFECTS,Excitatory,3
14834,Clinicians,C0871685,en_5028,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
14835,Clinicians,C0871685,en_5028,TREATS,Patients,C0030705,en_1762,14,12,AFFECTS,Inhibitory,36
14836,Clinicians,C0871685,en_5028,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
14837,Daily Activities,C0871707,en_5029,PREVENTS,Stress,C0038435,en_2165,1,1,AFFECTS,Inhibitory,3
14838,Daily Activities,C0871707,en_5029,PREVENTS,Well in self,C0424578,en_3996,1,1,AFFECTS,Inhibitory,3
14839,Daily Activities,C0871707,en_5029,TREATS,inpatient,C0021562,en_1321,2,1,AFFECTS,Inhibitory,3
14840,Daily Activities,C0871707,en_5029,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14841,Daily Activities,C0871707,en_5029,TREATS,Chest expansion,C0231902,en_3265,2,1,AFFECTS,Inhibitory,3
14842,Frail,C0871754,en_5030,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
14843,Life Sustaining Treatment,C0871803,en_5032,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14844,Medical Diagnosis,C0871813,en_5033,AFFECTS,Asthma,C0004096,en_418,2,1,AFFECTS,General/Uncertain,3
14845,nucleocytoplasmic transport,C0872070,en_5034,AFFECTS,Molecular Chaperones,C0243041,en_3452,1,1,AFFECTS,General/Uncertain,3
14846,Protein-Protein Interaction,C0872079,en_5036,AFFECTS,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,General/Uncertain,3
14847,Sarcopenia,C0872084,en_5037,COMPLICATES,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
14848,Sarcopenia,C0872084,en_5037,PREDISPOSES,Falls,C0085639,en_2684,3,2,AFFECTS,Excitatory,6
14849,Sarcopenia,C0872084,en_5037,PREDISPOSES,Dependence,C0439857,en_4039,1,1,AFFECTS,Excitatory,3
14850,"Reproductive Technology, Assisted",C0872104,en_5038,TREATS,Couples,C0010222,en_725,1,1,AFFECTS,Inhibitory,3
14851,"Reproductive Technology, Assisted",C0872104,en_5038,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
14852,"Reproductive Technology, Assisted",C0872104,en_5038,TREATS,Infertility,C0021359,en_1305,1,1,AFFECTS,Inhibitory,3
14853,"Reproductive Technology, Assisted",C0872104,en_5038,TREATS,Pregnancy Outcome,C0032972,en_1874,1,1,AFFECTS,Inhibitory,6
14854,"Reproductive Technology, Assisted",C0872104,en_5038,TREATS,Woman,C0043210,en_2396,3,2,AFFECTS,Inhibitory,14
14855,"Reproductive Technology, Assisted",C0872104,en_5038,TREATS,<12 months,C4699604,en_6381,1,1,AFFECTS,Inhibitory,6
14856,case control,C0872128,en_5039,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14857,"Monitors, Personal, Glucose",C0872182,en_5041,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14858,multipotent cell,C0872223,en_5042,PRODUCES,MicroRNAs,C1101610,en_5240,1,1,AFFECTS,Excitatory,3
14859,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,3
14860,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
14861,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,TREATS,Obsessive-Compulsive Disorder,C0028768,en_1701,1,1,AFFECTS,Inhibitory,3
14862,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,TREATS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
14863,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,TREATS,Major Depressive Disorder,C1269683,en_5447,2,1,AFFECTS,Inhibitory,3
14864,stem cell therapy,C0872278,en_5044,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
14865,stem cell therapy,C0872278,en_5044,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14866,stem cell therapy,C0872278,en_5044,TREATS,Incurable diseases,C0175969,en_2975,2,1,AFFECTS,Inhibitory,3
14867,Resistance Training,C0872279,en_5045,TREATS,Recovery of Function,C0599766,en_4471,1,1,AFFECTS,Inhibitory,8
14868,telenursing,C0872283,en_5046,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14869,telenursing,C0872283,en_5046,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
14870,therapeutic protein,C0872285,en_5047,AFFECTS,Protein Binding,C0033618,en_1907,1,1,AFFECTS,General/Uncertain,3
14871,arthritis therapy,C0872310,en_5048,TREATS,Chronic Childhood Arthritis,C0553662,en_4288,1,1,AFFECTS,Inhibitory,3
14872,prenatal therapy,C0872361,en_5051,PREVENTS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,3
14873,prenatal therapy,C0872361,en_5051,TREATS,Fetal Growth Retardation,C0015934,en_984,1,1,AFFECTS,Inhibitory,7
14874,telecare,C0872369,en_5052,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
14875,Tenecteplase,C0872913,en_5053,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
14876,Tenecteplase,C0872913,en_5053,TREATS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
14877,Tenecteplase,C0872913,en_5053,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
14878,Oseltamivir,C0874161,en_5054,INHIBITS,Neuraminidase,C0027803,en_1662,1,1,AFFECTS,Inhibitory,3
14879,Oseltamivir,C0874161,en_5054,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
14880,Oseltamivir,C0874161,en_5054,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
14881,Oseltamivir,C0874161,en_5054,TREATS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,7
14882,Oseltamivir,C0874161,en_5054,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14883,Oseltamivir,C0874161,en_5054,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
14884,Oseltamivir,C0874161,en_5054,TREATS,Coronavirus Infections,C0206750,en_3176,2,2,AFFECTS,Inhibitory,16
14885,Oseltamivir,C0874161,en_5054,TREATS,Normal patient,C0848894,en_4933,1,1,AFFECTS,Inhibitory,6
14886,Tamiflu,C0876173,en_5055,TREATS(SPEC),Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
14887,Acute generalised exanthematous pustulosis,C0877055,en_5062,AFFECTS,Life Threatening,C2826244,en_6137,1,1,AFFECTS,General/Uncertain,6
14888,Antifungal prophylaxis,C0877136,en_5065,PREVENTS,"Aspergillosis, Allergic Bronchopulmonary",C0004031,en_410,1,1,AFFECTS,Inhibitory,6
14889,Antifungal prophylaxis,C0877136,en_5065,PREVENTS,"ASPERGILLOSIS, INVASIVE",C0238013,en_3360,2,1,AFFECTS,Inhibitory,3
14890,Implantable defibrillator insertion,C0877213,en_5067,TREATS,Catalonian,C1553362,en_5960,1,1,AFFECTS,Inhibitory,6
14891,Assisted delivery,C0877233,en_5068,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
14892,Assisted delivery,C0877233,en_5068,TREATS(INFER),Substance Use Disorders,C0038586,en_2176,1,1,AFFECTS,Inhibitory,3
14893,Adverse event,C0877248,en_5069,COMPLICATES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,8
14894,Cerebral Arteriosclerosis,C0877854,en_5072,AFFECTS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,General/Uncertain,3
14895,Engineer,C0878517,en_5073,PRODUCES,Masks,C0024861,en_1501,1,1,AFFECTS,Excitatory,3
14896,Cardiomyopathies,C0878544,en_5074,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
14897,SHORT syndrome,C0878684,en_5076,AFFECTS,Cicatrix,C0008767,en_645,1,1,AFFECTS,General/Uncertain,3
14898,"Blankets, Forced-Air",C0878874,en_5078,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14899,"Blankets, Forced-Air",C0878874,en_5078,TREATS(INFER),"hypothermia, natural",C0020672,en_1250,1,1,AFFECTS,Inhibitory,3
14900,Nasal Swabs,C0879240,en_5079,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
14901,Nasal Swabs,C0879240,en_5079,TREATS,Child,C0008059,en_620,5,3,AFFECTS,Inhibitory,12
14902,Nasal Swabs,C0879240,en_5079,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14903,Nasal Swabs,C0879240,en_5079,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
14904,Nasal Swabs,C0879240,en_5079,TREATS,Individual,C0237401,en_3343,3,2,AFFECTS,Inhibitory,6
14905,Nasal Swabs,C0879240,en_5079,TREATS,Persistent cough,C0562483,en_4326,1,1,AFFECTS,Inhibitory,6
14906,tositumomab,C0879399,en_5080,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14907,Adverse effects,C0879626,en_5081,AFFECTS,Human,C0020114,en_1210,1,1,AFFECTS,General/Uncertain,3
14908,Adverse effects,C0879626,en_5081,AFFECTS,Malignant neoplasm of testis,C0153594,en_2883,1,1,AFFECTS,General/Uncertain,3
14909,Adverse effects,C0879626,en_5081,AFFECTS,Teacher,C0221457,en_3226,1,1,AFFECTS,General/Uncertain,3
14910,MYCOPHENOLATE,C0883242,en_5082,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14911,Circulatory care,C0885924,en_5083,TREATS,Midwife,C0026083,en_1566,1,1,AFFECTS,Inhibitory,3
14912,Circulatory care,C0885924,en_5083,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
14913,Circulatory care,C0885924,en_5083,TREATS,Obstetrician,C0334897,en_3778,1,1,AFFECTS,Inhibitory,3
14914,wound care,C0886052,en_5084,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
14915,wound care,C0886052,en_5084,TREATS,Malleolar fracture,C1096630,en_5236,1,1,AFFECTS,Inhibitory,6
14916,Nursing interventions,C0886296,en_5085,TREATS,Family,C0015576,en_961,2,1,AFFECTS,Inhibitory,3
14917,Nursing interventions,C0886296,en_5085,TREATS,Households,C0020052,en_1208,2,1,AFFECTS,Inhibitory,3
14918,Nursing interventions,C0886296,en_5085,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14919,Nursing interventions,C0886296,en_5085,TREATS,Shock,C0036974,en_2097,1,1,AFFECTS,Inhibitory,3
14920,Nursing interventions,C0886296,en_5085,TREATS,Vital signs,C0518766,en_4182,1,1,AFFECTS,Inhibitory,3
14921,Nursing interventions,C0886296,en_5085,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
14922,Total Liquid Ventilation,C0887805,en_5086,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
14923,Total Liquid Ventilation,C0887805,en_5086,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
14924,"Vaccines, Subunit",C0887892,en_5089,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
14925,"Vaccines, Subunit",C0887892,en_5089,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
14926,"Vaccines, Subunit",C0887892,en_5089,TREATS(INFER),Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
14927,Respiratory Syncytial Virus Vaccines,C0887894,en_5090,TREATS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,Inhibitory,3
14928,Respiratory Syncytial Virus Vaccines,C0887894,en_5090,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
14929,"RNA, Untranslated",C0887909,en_5092,AFFECTS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
14930,alpha-Defensins,C0887943,en_5093,STIMULATES,Fibrin fragment D,C0060323,en_2484,1,1,AFFECTS,Excitatory,7
14931,alpha-Defensins,C0887943,en_5093,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
14932,tafenoquine,C0903411,en_5094,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
14933,tafenoquine,C0903411,en_5094,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
14934,ciclesonide,C0907850,en_5095,PREVENTS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,8
14935,ciclesonide,C0907850,en_5095,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
14936,ciclesonide,C0907850,en_5095,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
14937,ciclesonide,C0907850,en_5095,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
14938,ciclesonide,C0907850,en_5095,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14939,emtricitabine,C0909839,en_5098,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
14940,emtricitabine,C0909839,en_5098,TREATS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Inhibitory,3
14941,emtricitabine,C0909839,en_5098,TREATS(SPEC),Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
14942,emtricitabine,C0909839,en_5098,TREATS(SPEC),Hepatitis,C0019158,en_1171,2,1,AFFECTS,Inhibitory,3
14943,TANK-binding kinase 1,C0911531,en_5099,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
14944,BGP 15,C0912893,en_5100,PREVENTS,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,Inhibitory,3
14945,BGP 15,C0912893,en_5100,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
14946,BGP 15,C0912893,en_5100,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
14947,bemiparin,C0916062,en_5101,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
14948,bemiparin,C0916062,en_5101,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
14949,tropomyosin 3,C0916380,en_5103,AFFECTS,Skeletal muscle structure,C0242692,en_3432,1,1,AFFECTS,General/Uncertain,3
14950,alpha-Actinin,C0917705,en_5104,AFFECTS,Skeletal muscle structure,C0242692,en_3432,1,1,AFFECTS,General/Uncertain,3
14951,Cannulation,C0917707,en_5105,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
14952,Cerebral Ischemia,C0917798,en_5107,AFFECTS,MOTOR DEFICIT,C0746626,en_4816,1,1,AFFECTS,General/Uncertain,3
14953,Sleeplessness,C0917801,en_5108,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
14954,Cyclophilins,C0917877,en_5109,AFFECTS(SPEC),protein folding,C0162847,en_2938,2,1,AFFECTS,General/Uncertain,3
14955,Cyclophilins,C0917877,en_5109,INHIBITS,cyclophilin D,C0390425,en_3910,1,1,AFFECTS,Inhibitory,3
14956,Breast-Conserving Surgery,C0917927,en_5110,TREATS,Invasive Malignant Neoplasm,C0677898,en_4548,1,1,AFFECTS,Inhibitory,6
14957,MAF gene,C0919481,en_5113,AFFECTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
14958,ATM gene,C0919524,en_5114,DISRUPTS,Body tissue,C0040300,en_2242,1,1,AFFECTS,Inhibitory,3
14959,Oxygen supplementation,C0919655,en_5117,AFFECTS,Pre-Eclampsia,C0032914,en_1867,1,1,AFFECTS,General/Uncertain,6
14960,Oxygen supplementation,C0919655,en_5117,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
14961,Oxygen supplementation,C0919655,en_5117,TREATS,Pneumonia,C0032285,en_1833,3,1,AFFECTS,Inhibitory,3
14962,Oxygen supplementation,C0919655,en_5117,TREATS,Hyperactive behavior,C0424295,en_3992,3,1,AFFECTS,Inhibitory,3
14963,Cytokine storm,C0919747,en_5119,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
14964,Cytokine storm,C0919747,en_5119,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
14965,Cytokine storm,C0919747,en_5119,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
14966,Cytokine storm,C0919747,en_5119,AFFECTS,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,1,1,AFFECTS,General/Uncertain,3
14967,Cytokine storm,C0919747,en_5119,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
14968,Cytokine storm,C0919747,en_5119,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,7
14969,Cytokine storm,C0919747,en_5119,AFFECTS,Decompensation,C0231187,en_3250,1,1,AFFECTS,General/Uncertain,3
14970,Cytokine storm,C0919747,en_5119,AFFECTS,Severe inflammation,C0522569,en_4215,1,1,AFFECTS,General/Uncertain,3
14971,Cytokine storm,C0919747,en_5119,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
14972,Cytokine storm,C0919747,en_5119,AFFECTS,kidney development,C1171312,en_5377,2,1,AFFECTS,General/Uncertain,3
14973,Cytokine storm,C0919747,en_5119,COMPLICATES,Adult disease,C0277562,en_3585,1,1,AFFECTS,General/Uncertain,3
14974,Cytokine storm,C0919747,en_5119,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
14975,Cytokine storm,C0919747,en_5119,PREDISPOSES,Cytokine release syndrome,C0948245,en_5163,2,1,AFFECTS,Excitatory,3
14976,Cytokine storm,C0919747,en_5119,PREDISPOSES,Macrophage activation syndrome,C1096155,en_5233,2,1,AFFECTS,Excitatory,3
14977,Cytokine storm,C0919747,en_5119,PREDISPOSES,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Excitatory,3
14978,Cytokine storm,C0919747,en_5119,PRODUCES,cytokine,C0079189,en_2593,3,2,AFFECTS,Excitatory,6
14979,Cytokine storm,C0919747,en_5119,PRODUCES,Signaling Protein,C1335962,en_5629,1,1,AFFECTS,Excitatory,3
14980,helicase,C0920283,en_5120,AFFECTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,General/Uncertain,3
14981,Weight maintenance regimen,C0920298,en_5121,TREATS,Body Weight,C0005910,en_498,1,1,AFFECTS,Inhibitory,3
14982,Weight maintenance regimen,C0920298,en_5121,TREATS,Chronic heart failure,C0264716,en_3538,1,1,AFFECTS,Inhibitory,3
14983,Weight maintenance regimen,C0920298,en_5121,TREATS,secondary group,C0680398,en_4623,1,1,AFFECTS,Inhibitory,3
14984,Homeopathic Remedies,C0920324,en_5122,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
14985,Homeopathic Remedies,C0920324,en_5122,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
14986,"Carcinogenesis, Radiation",C0920372,en_5123,AFFECTS,"Biological function, NOS",C0277784,en_3587,1,1,AFFECTS,General/Uncertain,3
14987,Cancer Treatment,C0920425,en_5124,AFFECTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
14988,Cancer Treatment,C0920425,en_5124,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
14989,Cancer Treatment,C0920425,en_5124,TREATS,Ascites,C0003962,en_404,1,1,AFFECTS,Inhibitory,3
14990,Cancer Treatment,C0920425,en_5124,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
14991,Cancer Treatment,C0920425,en_5124,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
14992,Cancer Treatment,C0920425,en_5124,TREATS,Neoplasm,C0027651,en_1651,2,1,AFFECTS,Inhibitory,6
14993,Cancer Treatment,C0920425,en_5124,TREATS,Patients,C0030705,en_1762,4,2,AFFECTS,Inhibitory,6
14994,Cancer Treatment,C0920425,en_5124,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
14995,Cancer Treatment,C0920425,en_5124,TREATS,Discontinued,C1444662,en_5749,1,1,AFFECTS,Inhibitory,7
14996,Cancer Treatment,C0920425,en_5124,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,3
14997,Cancer Treatment,C0920425,en_5124,TREATS,<12 months,C4699604,en_6381,1,1,AFFECTS,Inhibitory,7
14998,Cancer Treatment,C0920425,en_5124,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
14999,Cancer Treatment,C0920425,en_5124,TREATS(SPEC),Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
15000,disorder control,C0920467,en_5125,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
15001,disorder control,C0920467,en_5125,PREVENTS,Disease,C0012634,en_826,3,3,AFFECTS,Inhibitory,12
15002,disorder control,C0920467,en_5125,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
15003,disorder control,C0920467,en_5125,TREATS,Human,C0020114,en_1210,2,2,AFFECTS,Inhibitory,6
15004,disorder control,C0920467,en_5125,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15005,disorder control,C0920467,en_5125,TREATS,Rural Communities,C0086944,en_2739,1,1,AFFECTS,Inhibitory,3
15006,drug mechanism,C0920474,en_5126,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
15007,nursing technique,C0920625,en_5129,TREATS,Phlebitis,C0031542,en_1792,1,1,AFFECTS,Inhibitory,3
15008,cancer care,C0920687,en_5131,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
15009,cancer care,C0920687,en_5131,AFFECTS,Localized Malignant Neoplasm,C0796563,en_4884,1,1,AFFECTS,General/Uncertain,3
15010,cancer care,C0920687,en_5131,TREATS,Child,C0008059,en_620,3,1,AFFECTS,Inhibitory,3
15011,cancer care,C0920687,en_5131,TREATS,Adolescent,C0205653,en_3132,3,1,AFFECTS,Inhibitory,3
15012,cancer care,C0920687,en_5131,TREATS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
15013,Treatment Guidelines,C0935576,en_5136,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
15014,Treatment Guidelines,C0935576,en_5136,PREVENTS,Allergic Reaction,C1527304,en_5919,2,1,AFFECTS,Inhibitory,3
15015,Treatment Guidelines,C0935576,en_5136,PREVENTS(SPEC),Anaphylaxis,C0002792,en_313,2,1,AFFECTS,Inhibitory,3
15016,Treatment Guidelines,C0935576,en_5136,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
15017,Treatment Guidelines,C0935576,en_5136,TREATS,Research Personnel,C0035173,en_2002,1,1,AFFECTS,Inhibitory,3
15018,Treatment Guidelines,C0935576,en_5136,TREATS,Infection by Trypanosoma gambiense,C0041232,en_2289,1,1,AFFECTS,Inhibitory,3
15019,Treatment Guidelines,C0935576,en_5136,TREATS,Hamman-Rich syndrome,C0085786,en_2691,1,1,AFFECTS,Inhibitory,3
15020,Treatment Guidelines,C0935576,en_5136,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
15021,Treatment Guidelines,C0935576,en_5136,TREATS,pediatric inflammatory multisystem syndrome,C5389369,en_6437,1,1,AFFECTS,Inhibitory,6
15022,Antidiabetics,C0935929,en_5137,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,2,1,AFFECTS,Inhibitory,3
15023,Antidiabetics,C0935929,en_5137,INHIBITS,Angiotensin Receptor,C0034787,en_1963,2,1,AFFECTS,Inhibitory,3
15024,imatinib,C0935989,en_5138,AFFECTS,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,General/Uncertain,3
15025,imatinib,C0935989,en_5138,AFFECTS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,General/Uncertain,3
15026,imatinib,C0935989,en_5138,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
15027,imatinib,C0935989,en_5138,INHIBITS,Phosphotransferases,C0031727,en_1801,1,1,AFFECTS,Inhibitory,3
15028,imatinib,C0935989,en_5138,PREDISPOSES,Inflammation,C0021368,en_1307,3,2,AFFECTS,Excitatory,6
15029,imatinib,C0935989,en_5138,PREVENTS,Edema,C0013604,en_877,1,1,AFFECTS,Inhibitory,3
15030,imatinib,C0935989,en_5138,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
15031,imatinib,C0935989,en_5138,PREVENTS,Leak NOS,C1608322,en_6001,4,2,AFFECTS,Inhibitory,6
15032,imatinib,C0935989,en_5138,TREATS,Adult,C0001675,en_252,8,4,AFFECTS,Inhibitory,16
15033,imatinib,C0935989,en_5138,TREATS,Patients,C0030705,en_1762,8,3,AFFECTS,Inhibitory,9
15034,imatinib,C0935989,en_5138,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
15035,imatinib,C0935989,en_5138,TREATS,Gastrointestinal Stromal Tumors,C0238198,en_3363,1,1,AFFECTS,Inhibitory,8
15036,imatinib,C0935989,en_5138,TREATS,Acute Lung Injury,C0242488,en_3416,2,1,AFFECTS,Inhibitory,3
15037,imatinib,C0935989,en_5138,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
15038,imatinib,C0935989,en_5138,TREATS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
15039,imatinib,C0935989,en_5138,TREATS,Patient in hospital,C0701159,en_4731,3,1,AFFECTS,Inhibitory,7
15040,imatinib,C0935989,en_5138,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,7
15041,imatinib,C0935989,en_5138,TREATS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,Inhibitory,3
15042,imatinib,C0935989,en_5138,TREATS,COVID-19,C5203670,en_6417,7,3,AFFECTS,Inhibitory,23
15043,imatinib,C0935989,en_5138,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
15044,imatinib,C0935989,en_5138,TREATS(INFER),Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
15045,Complementary therapies,C0936077,en_5139,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,3
15046,Complementary therapies,C0936077,en_5139,TREATS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
15047,Complementary therapies,C0936077,en_5139,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
15048,Complementary therapies,C0936077,en_5139,TREATS(INFER),Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
15049,posaconazole,C0936148,en_5140,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15050,posaconazole,C0936148,en_5140,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
15051,Computed Tomography Scanning Systems,C0936234,en_5142,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15052,Lopinavir+ritonavir,C0939237,en_5143,INHIBITS,RNA-Directed RNA Polymerase,C0035685,en_2042,1,1,AFFECTS,Inhibitory,3
15053,Lopinavir+ritonavir,C0939237,en_5143,PREVENTS,Disease Progression,C0242656,en_3429,3,1,AFFECTS,Inhibitory,3
15054,Lopinavir+ritonavir,C0939237,en_5143,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
15055,Lopinavir+ritonavir,C0939237,en_5143,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15056,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Adult,C0001675,en_252,3,2,AFFECTS,Inhibitory,11
15057,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Critical Illness,C0010340,en_733,3,2,AFFECTS,Inhibitory,14
15058,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
15059,Lopinavir+ritonavir,C0939237,en_5143,TREATS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Inhibitory,6
15060,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
15061,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
15062,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
15063,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Patients,C0030705,en_1762,10,8,AFFECTS,Inhibitory,24
15064,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,10
15065,Lopinavir+ritonavir,C0939237,en_5143,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
15066,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Malaise,C0231218,en_3251,2,1,AFFECTS,Inhibitory,7
15067,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Systemic infection,C0243026,en_3451,2,1,AFFECTS,Inhibitory,8
15068,Lopinavir+ritonavir,C0939237,en_5143,TREATS,reference group,C0680399,en_4624,1,1,AFFECTS,Inhibitory,3
15069,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,13
15070,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,7
15071,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Inhibitory,8
15072,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,8
15073,Lopinavir+ritonavir,C0939237,en_5143,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,8
15074,Lopinavir+ritonavir,C0939237,en_5143,TREATS,Middle East Respiratory Syndrome,C3694279,en_6232,1,1,AFFECTS,Inhibitory,8
15075,Lopinavir+ritonavir,C0939237,en_5143,TREATS,COVID-19,C5203670,en_6417,13,11,AFFECTS,Inhibitory,77
15076,Lopinavir+ritonavir,C0939237,en_5143,TREATS(INFER),Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
15077,Lopinavir+ritonavir,C0939237,en_5143,TREATS(INFER),Syndrome,C0039082,en_2197,2,1,AFFECTS,Inhibitory,3
15078,Lopinavir+ritonavir,C0939237,en_5143,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
15079,Campath,C0939276,en_5144,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15080,Campath,C0939276,en_5144,TREATS(INFER),"Granulomatous Disease, Chronic",C0018203,en_1095,1,1,AFFECTS,Inhibitory,3
15081,Imatinib mesylate,C0939537,en_5145,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15082,Imatinib mesylate,C0939537,en_5145,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
15083,Imatinib mesylate,C0939537,en_5145,TREATS(INFER),Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,3
15084,Honey preparation,C0939937,en_5146,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,6
15085,"Complication, hemorrhage",C0940931,en_5147,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,6
15086,Manometry catheter,C0941139,en_5149,TREATS,Well adult,C0686750,en_4683,1,1,AFFECTS,Inhibitory,3
15087,Manipulation procedure,C0947647,en_5155,AFFECTS,Alveolar ventilation function,C0231940,en_3269,2,1,AFFECTS,General/Uncertain,3
15088,Manipulation procedure,C0947647,en_5155,TREATS,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,Inhibitory,3
15089,Manipulation procedure,C0947647,en_5155,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
15090,Pancreas infection,C0948160,en_5160,AFFECTS,viral entry,C1160648,en_5358,1,1,AFFECTS,General/Uncertain,3
15091,Primary infection NOS,C0948192,en_5162,AFFECTS,Immunologic Memory,C0021055,en_1286,1,1,AFFECTS,General/Uncertain,3
15092,Cytokine release syndrome,C0948245,en_5163,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
15093,Metabolic syndrome,C0948265,en_5164,AFFECTS,Inflammation Process,C1512753,en_5825,1,1,AFFECTS,General/Uncertain,3
15094,Metabolic syndrome,C0948265,en_5164,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
15095,Haemodynamic instability,C0948268,en_5165,AFFECTS,biological adaptation to stress,C0149784,en_2810,1,1,AFFECTS,General/Uncertain,3
15096,Ultrasound examination,C0948501,en_5168,AFFECTS,Diagnosis,C0011900,en_806,2,1,AFFECTS,General/Uncertain,3
15097,Physical deconditioning,C0948688,en_5172,PREDISPOSES,Falls,C0085639,en_2684,2,1,AFFECTS,Excitatory,3
15098,Pulmonary failure,C0948755,en_5173,AFFECTS,Vasodilation,C0042401,en_2342,2,1,AFFECTS,General/Uncertain,3
15099,Alternative Therapies,C0949216,en_5176,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
15100,Alternative Therapies,C0949216,en_5176,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
15101,Alternative Therapies,C0949216,en_5176,TREATS,Complication,C0009566,en_697,2,1,AFFECTS,Inhibitory,3
15102,Alternative Therapies,C0949216,en_5176,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
15103,"Therapies, Investigational",C0949266,en_5177,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
15104,"Therapies, Investigational",C0949266,en_5177,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
15105,"Therapies, Investigational",C0949266,en_5177,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
15106,"Therapies, Investigational",C0949266,en_5177,TREATS,COVID-19,C5203670,en_6417,6,5,AFFECTS,Inhibitory,32
15107,Mitochondrial Proteins,C0949610,en_5181,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
15108,Tauopathies,C0949664,en_5182,AFFECTS,Neuropathy,C0442874,en_4060,1,1,AFFECTS,General/Uncertain,3
15109,Fluoroquinolones,C0949665,en_5183,PREDISPOSES,Tendon rupture NOS,C0151937,en_2872,1,1,AFFECTS,Excitatory,3
15110,Fluoroquinolones,C0949665,en_5183,TREATS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
15111,Spondylarthritis,C0949690,en_5184,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
15112,Osteopathic manipulation (procedure),C0949744,en_5186,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
15113,Physical therapy,C0949766,en_5187,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
15114,Physical therapy,C0949766,en_5187,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
15115,Physical therapy,C0949766,en_5187,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
15116,Physical therapy,C0949766,en_5187,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
15117,Physical therapy,C0949766,en_5187,AFFECTS,Survivors,C0206194,en_3154,2,1,AFFECTS,General/Uncertain,3
15118,Physical therapy,C0949766,en_5187,AFFECTS,Recovery,C0237820,en_3354,1,1,AFFECTS,General/Uncertain,3
15119,Physical therapy,C0949766,en_5187,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
15120,Physical therapy,C0949766,en_5187,TREATS,Mental disorders,C0004936,en_452,1,1,AFFECTS,Inhibitory,3
15121,Physical therapy,C0949766,en_5187,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
15122,Physical therapy,C0949766,en_5187,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
15123,Physical therapy,C0949766,en_5187,TREATS,Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
15124,Physical therapy,C0949766,en_5187,TREATS,Pain,C0030193,en_1741,2,1,AFFECTS,Inhibitory,3
15125,Physical therapy,C0949766,en_5187,TREATS,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
15126,Physical therapy,C0949766,en_5187,TREATS,Patients,C0030705,en_1762,12,8,AFFECTS,Inhibitory,24
15127,Physical therapy,C0949766,en_5187,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
15128,Physical therapy,C0949766,en_5187,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
15129,Physical therapy,C0949766,en_5187,TREATS,Chronic pain,C0150055,en_2816,2,1,AFFECTS,Inhibitory,3
15130,Physical therapy,C0949766,en_5187,TREATS,Respiratory complication,C0161818,en_2899,2,1,AFFECTS,Inhibitory,3
15131,Physical therapy,C0949766,en_5187,TREATS,Survivors,C0206194,en_3154,6,1,AFFECTS,Inhibitory,3
15132,Physical therapy,C0949766,en_5187,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
15133,Physical therapy,C0949766,en_5187,TREATS,Individual,C0237401,en_3343,7,3,AFFECTS,Inhibitory,9
15134,Physical therapy,C0949766,en_5187,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
15135,Physical therapy,C0949766,en_5187,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
15136,Physical therapy,C0949766,en_5187,TREATS,Teams,C0871489,en_5024,1,1,AFFECTS,Inhibitory,3
15137,Physical therapy,C0949766,en_5187,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
15138,Physical therapy,C0949766,en_5187,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
15139,Physical therapy,C0949766,en_5187,TREATS(INFER),Back Pain,C0004604,en_437,1,1,AFFECTS,Inhibitory,3
15140,Physical therapy,C0949766,en_5187,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,2,1,AFFECTS,Inhibitory,3
15141,Physical therapy,C0949766,en_5187,TREATS(INFER),Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,3
15142,Physical therapy,C0949766,en_5187,TREATS(INFER),Cerebrovascular accident,C0038454,en_2169,6,1,AFFECTS,Inhibitory,3
15143,Plant Preparations,C0949854,en_5188,AFFECTS,pleiotropism,C0597257,en_4418,1,1,AFFECTS,General/Uncertain,3
15144,Sentinel,C0950580,en_5191,STIMULATES,TP53 gene,C0079419,en_2602,1,1,AFFECTS,Excitatory,3
15145,Leukocyte L1 Antigen Complex,C0950624,en_5192,AFFECTS,Hematopoiesis,C0018951,en_1152,1,1,AFFECTS,General/Uncertain,3
15146,Leukocyte L1 Antigen Complex,C0950624,en_5192,AUGMENTS,Infected,C0439663,en_4036,1,1,AFFECTS,Excitatory,6
15147,Leukocyte L1 Antigen Complex,C0950624,en_5192,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,6
15148,Leukocyte L1 Antigen Complex,C0950624,en_5192,STIMULATES,monocyte,C0026473,en_1580,2,1,AFFECTS,Excitatory,3
15149,Leukocyte L1 Antigen Complex,C0950624,en_5192,STIMULATES,Immature Granulocyte,C1317395,en_5527,2,1,AFFECTS,Excitatory,3
15150,Neural Cell Adhesion Molecule L1,C0950625,en_5193,AUGMENTS,Viral Physiology,C0243052,en_3454,1,1,AFFECTS,Excitatory,3
15151,"alpha-aminobutyric acid, (S)-isomer",C0952472,en_5194,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,7
15152,angiotensin converting enzyme 2,C0960880,en_5195,AFFECTS,Adipose tissue,C0001527,en_241,1,1,AFFECTS,General/Uncertain,8
15153,angiotensin converting enzyme 2,C0960880,en_5195,AFFECTS,hypothalamus-pituitary axis,C0678897,en_4582,1,1,AFFECTS,General/Uncertain,6
15154,angiotensin converting enzyme 2,C0960880,en_5195,AFFECTS,Weight decreased,C1262477,en_5423,1,1,AFFECTS,General/Uncertain,8
15155,angiotensin converting enzyme 2,C0960880,en_5195,AFFECTS,virus entry,C1537068,en_5947,1,1,AFFECTS,General/Uncertain,6
15156,angiotensin converting enzyme 2,C0960880,en_5195,DISRUPTS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,6
15157,angiotensin converting enzyme 2,C0960880,en_5195,DISRUPTS,Resistance Process,C1514892,en_5842,1,1,AFFECTS,Inhibitory,8
15158,angiotensin converting enzyme 2,C0960880,en_5195,INHIBITS,Pulmonary Surfactants,C0034085,en_1935,1,1,AFFECTS,Inhibitory,8
15159,angiotensin converting enzyme 2,C0960880,en_5195,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,8
15160,angiotensin converting enzyme 2,C0960880,en_5195,STIMULATES,Up-Regulation (Physiology),C0041904,en_2313,1,1,AFFECTS,Excitatory,7
15161,angiotensin converting enzyme 2|ACE2,C0960880|59272,en_5196,AUGMENTS,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,7
15162,fibroblast growth factor 23,C0962301,en_5198,INHIBITS,Vitamin D,C0042866,en_2371,1,1,AFFECTS,Inhibitory,3
15163,epitheliasin,C0964578,en_5200,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
15164,epitheliasin,C0964578,en_5200,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
15165,epitheliasin,C0964578,en_5200,AUGMENTS,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
15166,epitheliasin,C0964578,en_5200,AUGMENTS,Nasal Epithelium,C0599331,en_4462,2,1,AFFECTS,Excitatory,3
15167,epitheliasin,C0964578,en_5200,AUGMENTS,Prostatic Tissue,C1514521,en_5835,3,2,AFFECTS,Excitatory,6
15168,epitheliasin,C0964578,en_5200,AUGMENTS(SPEC),Cytokinesis of the fertilized ovum,C1330957,en_5579,1,1,AFFECTS,Excitatory,3
15169,epitheliasin,C0964578,en_5200,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
15170,epitheliasin,C0964578,en_5200,DISRUPTS,Proteolysis,C0597304,en_4421,1,1,AFFECTS,Inhibitory,3
15171,epitheliasin,C0964578,en_5200,DISRUPTS,viral entry,C1160648,en_5358,1,1,AFFECTS,Inhibitory,3
15172,epitheliasin,C0964578,en_5200,INHIBITS,Peptide Hydrolases,C0030940,en_1769,1,1,AFFECTS,Inhibitory,3
15173,epitheliasin,C0964578,en_5200,INHIBITS,Stanolone,C0038148,en_2152,1,1,AFFECTS,Inhibitory,3
15174,epitheliasin,C0964578,en_5200,STIMULATES,Protease Inhibitor,C0033607,en_1905,1,1,AFFECTS,Excitatory,3
15175,epitheliasin,C0964578,en_5200,STIMULATES,Androgen Receptor,C0034786,en_1962,1,1,AFFECTS,Excitatory,3
15176,epitheliasin,C0964578,en_5200,STIMULATES,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Excitatory,3
15177,epitheliasin,C0964578,en_5200,STIMULATES,Protein S,C0072393,en_2550,1,1,AFFECTS,Excitatory,3
15178,epitheliasin,C0964578,en_5200,STIMULATES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
15179,EP4 receptor,C0964859,en_5201,STIMULATES,Muscle satellite cell,C0599856,en_4478,1,1,AFFECTS,Excitatory,3
15180,rosuvastatin,C0965129,en_5202,TREATS,Hypotension,C0020649,en_1248,1,1,AFFECTS,Inhibitory,8
15181,rosuvastatin,C0965129,en_5202,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15182,rosuvastatin,C0965129,en_5202,TREATS,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,3
15183,rosuvastatin,C0965129,en_5202,TREATS,Hospitalized Patients,C0870668,en_5010,3,2,AFFECTS,Inhibitory,11
15184,rosuvastatin,C0965129,en_5202,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15185,"CD274 protein, human|CD274",C0965245|29126,en_5203,STIMULATES,Conventional Dendritic Cell,C4085194,en_6318,1,1,AFFECTS,Excitatory,7
15186,5'-deoxyribose phosphate lyase,C0965505,en_5204,AFFECTS,RNA Binding,C1148846,en_5299,1,1,AFFECTS,General/Uncertain,3
15187,omalizumab,C0966225,en_5205,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15188,omalizumab,C0966225,en_5205,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
15189,omalizumab,C0966225,en_5205,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15190,omalizumab,C0966225,en_5205,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
15191,omalizumab,C0966225,en_5205,TREATS,Wheezing,C0043144,en_2393,1,1,AFFECTS,Inhibitory,3
15192,omalizumab,C0966225,en_5205,TREATS,Chronic urticaria,C0263338,en_3521,1,1,AFFECTS,Inhibitory,3
15193,omalizumab,C0966225,en_5205,TREATS,Moderate asthma,C0581125,en_4344,1,1,AFFECTS,Inhibitory,3
15194,omalizumab,C0966225,en_5205,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
15195,omalizumab,C0966225,en_5205,TREATS(INFER),Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
15196,omalizumab,C0966225,en_5205,TREATS(INFER),Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
15197,hepcidin,C0966897,en_5206,INHIBITS,Albumins,C0001924,en_267,2,1,AFFECTS,Inhibitory,3
15198,hepcidin,C0966897,en_5206,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15199,mepolizumab,C0969324,en_5207,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15200,mepolizumab,C0969324,en_5207,TREATS(INFER),Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
15201,Enhancement Technologies,C0969683,en_5208,STIMULATES,seed germination,C1160189,en_5352,1,1,AFFECTS,Excitatory,3
15202,"TLR7 protein, human",C0971207,en_5210,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
15203,"TLR7 protein, human|TLR7",C0971207|51284,en_5211,DISRUPTS,Drug Kinetics,C0031327,en_1787,1,1,AFFECTS,Inhibitory,8
15204,type I collagen alpha 1,C0972255,en_5212,INHIBITS,Genes,C0017337,en_1052,1,1,AFFECTS,Inhibitory,3
15205,Boards,C0972401,en_5213,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15206,Boards,C0972401,en_5213,TREATS,Target Population,C0039309,en_2207,1,1,AFFECTS,Inhibitory,3
15207,Boards,C0972401,en_5213,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
15208,Boards,C0972401,en_5213,TREATS,citizen,C0682134,en_4636,1,1,AFFECTS,Inhibitory,3
15209,ALCOHOL/BENZOIC ACID/EUCALYPTOL/METHYL SALICYLATE/THYMOL LIQUID,C0973919,en_5214,PREVENTS,Sexually Transmitted Diseases,C0036916,en_2095,1,1,AFFECTS,Inhibitory,8
15210,BABY SHAMPOO,C0974718,en_5215,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
15211,Aspirin 150 MG,C0983851,en_5216,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15212,Dapsone 100 MG,C0985298,en_5217,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
15213,Dexamethasone 6 MG,C0985347,en_5218,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
15214,Ritonavir 100 MG,C0992889,en_5219,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
15215,Spironolactone 50 MG,C0992989,en_5220,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
15216,Henbane preparation,C1095899,en_5226,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,8
15217,Henbane preparation,C1095899,en_5226,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15218,Saline gargle,C1095959,en_5227,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
15219,Saline gargle,C1095959,en_5227,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
15220,Saline gargle,C1095959,en_5227,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
15221,Saline gargle,C1095959,en_5227,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
15222,Saline gargle,C1095959,en_5227,TREATS(INFER),"Infections, Upper Respiratory",C0041912,en_2315,1,1,AFFECTS,Inhibitory,3
15223,Antiplatelet therapy,C1096021,en_5229,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
15224,Antiplatelet therapy,C1096021,en_5229,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15225,Antiplatelet therapy,C1096021,en_5229,TREATS,COVID-19,C5203670,en_6417,4,3,AFFECTS,Inhibitory,18
15226,Antiinflammatory therapy,C1096024,en_5230,PREVENTS,Complication,C0009566,en_697,2,2,AFFECTS,Inhibitory,6
15227,Antiinflammatory therapy,C1096024,en_5230,PREVENTS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
15228,Antiinflammatory therapy,C1096024,en_5230,PREVENTS,Acute arthritis,C0263678,en_3524,1,1,AFFECTS,Inhibitory,3
15229,Intractable epilepsy,C1096063,en_5231,PREDISPOSES,Fit frequency,C0149775,en_2807,1,1,AFFECTS,Excitatory,6
15230,Off label use,C1096117,en_5232,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15231,Macrophage activation syndrome,C1096155,en_5233,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
15232,Macrophage activation syndrome,C1096155,en_5233,COMPLICATES,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,General/Uncertain,6
15233,aviptadil,C1098515,en_5237,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
15234,aviptadil,C1098515,en_5237,TREATS,Primates,C0033147,en_1887,2,2,AFFECTS,Inhibitory,6
15235,aviptadil,C1098515,en_5237,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
15236,aviptadil,C1098515,en_5237,TREATS,Erectile dysfunction,C0242350,en_3407,2,2,AFFECTS,Inhibitory,6
15237,aviptadil,C1098515,en_5237,TREATS,Acute Lung Injury,C0242488,en_3416,2,1,AFFECTS,Inhibitory,3
15238,aviptadil,C1098515,en_5237,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
15239,aviptadil,C1098515,en_5237,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
15240,aviptadil,C1098515,en_5237,TREATS(SPEC),Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
15241,Escitalopram,C1099456,en_5238,STIMULATES,Cytochrome P-450 CYP3A4|CYP3A4,C3714798|1576,en_6238,1,1,AFFECTS,Excitatory,8
15242,MicroRNAs,C1101610,en_5240,AFFECTS,Biogenesis,C0005495,en_466,1,1,AFFECTS,General/Uncertain,3
15243,MicroRNAs,C1101610,en_5240,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
15244,MicroRNAs,C1101610,en_5240,AFFECTS,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
15245,MicroRNAs,C1101610,en_5240,AFFECTS,Intestines,C0021853,en_1350,1,1,AFFECTS,General/Uncertain,3
15246,MicroRNAs,C1101610,en_5240,AFFECTS,Protein Biosynthesis,C0597295,en_4419,1,1,AFFECTS,General/Uncertain,3
15247,MicroRNAs,C1101610,en_5240,AFFECTS,receptor expression,C0597360,en_4424,2,1,AFFECTS,General/Uncertain,3
15248,MicroRNAs,C1101610,en_5240,DISRUPTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
15249,MicroRNAs,C1101610,en_5240,DISRUPTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Inhibitory,3
15250,MicroRNAs,C1101610,en_5240,INHIBITS,HMGB1 gene,C1333908,en_5598,1,1,AFFECTS,Inhibitory,3
15251,itavastatin,C1101838,en_5241,AFFECTS,host,C1167395,en_5368,1,1,AFFECTS,General/Uncertain,3
15252,itavastatin,C1101838,en_5241,PREVENTS,Cardiovascular Diseases,C0007222,en_569,4,1,AFFECTS,Inhibitory,3
15253,itavastatin,C1101838,en_5241,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
15254,Hepatic infection,C1112211,en_5244,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,3
15255,patient safety,C1113679,en_5246,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
15256,patient safety,C1113679,en_5246,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
15257,patient safety,C1113679,en_5246,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
15258,hypocretin,C1113696,en_5247,AFFECTS,"Sleep, Slow-Wave",C0234451,en_3309,1,1,AFFECTS,General/Uncertain,3
15259,aliskiren,C1120110,en_5248,AFFECTS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
15260,aliskiren,C1120110,en_5248,AFFECTS,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
15261,mitogen-activated protein kinase p38,C1120843,en_5249,AUGMENTS,Cytopathic effect,C0333467,en_3765,1,1,AFFECTS,Excitatory,3
15262,adalimumab,C1122087,en_5250,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,8
15263,Hydroxychloroquine 200 MG,C1125266,en_5251,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
15264,Hydroxychloroquine 200 MG,C1125266,en_5251,TREATS(INFER),Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,Inhibitory,3
15265,Azithromycin 500 MG,C1126333,en_5252,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15266,Azithromycin 500 MG,C1126333,en_5252,TREATS(INFER),Superinfection,C0038826,en_2184,2,1,AFFECTS,Inhibitory,3
15267,Chinese herbs,C1134558,en_5253,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15268,beta-Glucans,C1134651,en_5254,AUGMENTS,Phagocytosis,C0031308,en_1785,1,1,AFFECTS,Excitatory,3
15269,Critical illness myopathy,C1135188,en_5255,AFFECTS,Recovery,C0237820,en_3354,2,1,AFFECTS,General/Uncertain,3
15270,Nitric oxide therapy,C1135474,en_5256,TREATS,Patients,C0030705,en_1762,5,3,AFFECTS,Inhibitory,9
15271,Nitric oxide therapy,C1135474,en_5256,TREATS(INFER),Disease,C0012634,en_826,4,2,AFFECTS,Inhibitory,6
15272,Adaptor Signaling Protein,C1135629,en_5257,DISRUPTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,Inhibitory,3
15273,recombinant human DNase,C1135662,en_5258,DISRUPTS,Respiration,C0035203,en_2004,1,1,AFFECTS,Inhibitory,7
15274,recombinant human DNase,C1135662,en_5258,INHIBITS,DNA,C0012854,en_834,3,2,AFFECTS,Inhibitory,10
15275,recombinant human DNase,C1135662,en_5258,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
15276,recombinant human DNase,C1135662,en_5258,AFFECTS(SPEC),pulmonary function,C0231921,en_3268,2,1,AFFECTS,General/Uncertain,3
15277,recombinant human DNase,C1135662,en_5258,INHIBITS,ELK3 gene,C0812375,en_4900,3,2,AFFECTS,Inhibitory,6
15278,recombinant human DNase,C1135662,en_5258,STIMULATES,ELK3 gene,C0812375,en_4900,1,1,AFFECTS,Excitatory,3
15279,recombinant human DNase,C1135662,en_5258,TREATS,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,3
15280,recombinant human DNase,C1135662,en_5258,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15281,recombinant human DNase,C1135662,en_5258,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
15282,recombinant human DNase,C1135662,en_5258,TREATS(INFER),Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,3
15283,recombinant human DNase,C1135662,en_5258,TREATS(SPEC),Cystic Fibrosis,C0010674,en_745,4,2,AFFECTS,Inhibitory,6
15284,Caloric Restriction,C1135809,en_5259,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
15285,Caloric Restriction,C1135809,en_5259,TREATS,Middle Aged,C0205847,en_3136,1,1,AFFECTS,Inhibitory,3
15286,Caloric Restriction,C1135809,en_5259,TREATS,Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,3
15287,Caloric Restriction,C1135809,en_5259,TREATS(INFER),Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,3
15288,"Immunity, Herd",C1135927,en_5260,AFFECTS,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
15289,"Immunity, Herd",C1135927,en_5260,AFFECTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
15290,Mass Vaccination,C1135929,en_5261,TREATS,Workers,C1527116,en_5916,1,1,AFFECTS,Inhibitory,6
15291,Virulence Factors,C1136170,en_5263,DISRUPTS,macrophage,C0024432,en_1484,1,1,AFFECTS,Inhibitory,3
15292,Microbicides,C1136254,en_5265,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
15293,Microbicides,C1136254,en_5265,AFFECTS,Dermatitis,C0011603,en_790,1,1,AFFECTS,General/Uncertain,3
15294,Microbicides,C1136254,en_5265,AFFECTS,Equilibrium,C0014653,en_923,1,1,AFFECTS,General/Uncertain,3
15295,Microbicides,C1136254,en_5265,AFFECTS,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,General/Uncertain,3
15296,Microbicides,C1136254,en_5265,AFFECTS,Cleans drug injection equipment finding,C0542277,en_4254,1,1,AFFECTS,General/Uncertain,3
15297,Microbicides,C1136254,en_5265,DISRUPTS,Growth,C0018270,en_1098,1,1,AFFECTS,Inhibitory,3
15298,Microbicides,C1136254,en_5265,PREVENTS,Thrombosis,C0040053,en_2233,2,1,AFFECTS,Inhibitory,3
15299,Microbicides,C1136254,en_5265,PREVENTS,Sexual transmission,C1519279,en_5882,1,1,AFFECTS,Inhibitory,3
15300,Microbicides,C1136254,en_5265,TREATS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,7
15301,Microbicides,C1136254,en_5265,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
15302,Microbicides,C1136254,en_5265,TREATS,Human,C0020114,en_1210,2,1,AFFECTS,Inhibitory,3
15303,Microbicides,C1136254,en_5265,TREATS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
15304,Microbicides,C1136254,en_5265,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
15305,Microbicides,C1136254,en_5265,TREATS,Physicians,C0031831,en_1805,2,1,AFFECTS,Inhibitory,3
15306,Microbicides,C1136254,en_5265,TREATS,Respiratory Tract Infections,C0035243,en_2017,2,2,AFFECTS,Inhibitory,6
15307,Microbicides,C1136254,en_5265,TREATS,Pyotraumatic dermatitis,C0263214,en_3520,1,1,AFFECTS,Inhibitory,3
15308,Microbicides,C1136254,en_5265,TREATS,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,Inhibitory,3
15309,Microbicides,C1136254,en_5265,TREATS,Epidermal cGVHD Score 2,C4761314,en_6403,1,1,AFFECTS,Inhibitory,6
15310,Microbicides,C1136254,en_5265,TREATS(SPEC),Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
15311,Protein Arrays,C1136346,en_5266,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15312,Risk Reduction,C1137094,en_5268,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
15313,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,INHIBITS,RNA-Directed RNA Polymerase,C0035685,en_2042,1,1,AFFECTS,Inhibitory,6
15314,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Adult,C0001675,en_252,4,3,AFFECTS,Inhibitory,23
15315,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
15316,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Influenza,C0021400,en_1311,2,2,AFFECTS,Inhibitory,14
15317,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
15318,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,6
15319,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Hospitalized Patients,C0870668,en_5010,3,3,AFFECTS,Inhibitory,19
15320,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Outcomes of Therapy,C1518681,en_5877,1,1,AFFECTS,Inhibitory,6
15321,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,Life-threatening infections,C1859430,en_6054,1,1,AFFECTS,Inhibitory,7
15322,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,Inhibitory,8
15323,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,COVID-19,C5203670,en_6417,17,12,AFFECTS,Inhibitory,85
15324,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,2019 novel coronavirus,C5203676,en_6420,2,2,AFFECTS,Inhibitory,16
15325,6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,TREATS,pediatric inflammatory multisystem syndrome,C5389369,en_6437,1,1,AFFECTS,Inhibitory,7
15326,"Diet, Mediterranean",C1138412,en_5271,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
15327,Voluntary Programs,C1138559,en_5272,TREATS,Congestive heart failure,C0018802,en_1136,1,1,AFFECTS,Inhibitory,3
15328,Voluntary Programs,C1138559,en_5272,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
15329,Provider,C1138603,en_5273,TREATS,Patients,C0030705,en_1762,10,8,AFFECTS,Inhibitory,24
15330,Provider,C1138603,en_5273,TREATS,Physicians,C0031831,en_1805,1,1,AFFECTS,Inhibitory,3
15331,Monitoring Systems,C1139730,en_5274,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
15332,Monitoring Systems,C1139730,en_5274,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
15333,Monitoring Systems,C1139730,en_5274,TREATS,Respiration Disorders,C0035204,en_2005,2,2,AFFECTS,Inhibitory,6
15334,Monitoring Systems,C1139730,en_5274,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,3
15335,Monitoring Systems,C1139730,en_5274,TREATS,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Inhibitory,3
15336,Monitoring Systems,C1139730,en_5274,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
15337,Tags,C1139855,en_5276,TREATS,Persons,C0027361,en_1635,2,1,AFFECTS,Inhibitory,3
15338,Plates,C1139930,en_5277,TREATS,Reader,C1514743,en_5836,1,1,AFFECTS,Inhibitory,3
15339,"Recorders, Electronic Storage, Data, Physical Activity",C1139952,en_5278,TREATS,Couples,C0010222,en_725,1,1,AFFECTS,Inhibitory,3
15340,Insulin pump,C1140609,en_5279,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15341,Insulin pump,C1140609,en_5279,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,3
15342,Insulin pump,C1140609,en_5279,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
15343,Insulin pump,C1140609,en_5279,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15344,Insulin pump,C1140609,en_5279,TREATS,Teacher,C0221457,en_3226,1,1,AFFECTS,Inhibitory,3
15345,Insulin pump,C1140609,en_5279,TREATS,School child,C0260267,en_3511,2,1,AFFECTS,Inhibitory,3
15346,Insulin pump,C1140609,en_5279,TREATS,School nurse,C0302833,en_3712,1,1,AFFECTS,Inhibitory,3
15347,Insulin pump,C1140609,en_5279,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
15348,Insulin pump,C1140609,en_5279,TREATS(INFER),"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,3
15349,Contraction,C1140999,en_5281,AFFECTS,Adverse effects,C0879626,en_5081,1,1,AFFECTS,General/Uncertain,3
15350,AM3,C1141624,en_5282,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
15351,Neutralising antibodies,C1142254,en_5285,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
15352,Neutralising antibodies,C1142254,en_5285,AFFECTS,Infection,C3714514,en_6235,2,2,AFFECTS,General/Uncertain,6
15353,Neutralising antibodies,C1142254,en_5285,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
15354,Neutralising antibodies,C1142254,en_5285,AFFECTS,Virus Diseases,C0042769,en_2362,3,3,AFFECTS,General/Uncertain,9
15355,Cytochrome P450 3A4,C1142644,en_5288,DISRUPTS,Insensitivity,C0237677,en_3351,1,1,AFFECTS,Inhibitory,3
15356,lenalidomide,C1144149,en_5289,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15357,Natriuretic Peptides,C1144709,en_5290,AFFECTS,Heart,C0018787,en_1130,2,1,AFFECTS,General/Uncertain,3
15358,Natriuretic Peptides,C1144709,en_5290,DISRUPTS,Renal function,C0232804,en_3285,1,1,AFFECTS,Inhibitory,3
15359,Natriuretic Peptides,C1144709,en_5290,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,8
15360,Multi-disciplinary team,C1144866,en_5291,TREATS,Offered,C1444648,en_5748,1,1,AFFECTS,Inhibitory,6
15361,Respiratory Failure,C1145670,en_5292,AFFECTS,Patients,C0030705,en_1762,4,2,AFFECTS,General/Uncertain,6
15362,Respiratory Failure,C1145670,en_5292,AFFECTS,Respiration,C0035203,en_2004,3,2,AFFECTS,General/Uncertain,6
15363,Respiratory Failure,C1145670,en_5292,AFFECTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
15364,Respiratory Failure,C1145670,en_5292,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
15365,Respiratory Failure,C1145670,en_5292,AFFECTS,Compromise,C0518613,en_4180,1,1,AFFECTS,General/Uncertain,3
15366,Respiratory Failure,C1145670,en_5292,COMPLICATES,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,General/Uncertain,8
15367,Respiratory Failure,C1145670,en_5292,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
15368,Atazanavir,C1145759,en_5293,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
15369,Atazanavir,C1145759,en_5293,INHIBITS,HIV-1 Protease,C0917721,en_5106,1,1,AFFECTS,Inhibitory,3
15370,Atazanavir,C1145759,en_5293,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
15371,Atazanavir,C1145759,en_5293,TREATS,Hepatitis C,C0019196,en_1177,1,1,AFFECTS,Inhibitory,3
15372,Treprostinil,C1145760,en_5294,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,8
15373,Treprostinil,C1145760,en_5294,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,8
15374,Treprostinil,C1145760,en_5294,TREATS,Acute hypoxemic respiratory failure,C4039867,en_6301,1,1,AFFECTS,Inhibitory,8
15375,Treprostinil,C1145760,en_5294,TREATS,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
15376,Childbirth,C1148523,en_5296,AFFECTS,Birth,C0005615,en_476,2,1,AFFECTS,General/Uncertain,3
15377,Childbirth,C1148523,en_5296,AFFECTS,Low Birth Weight Infant,C0021288,en_1298,1,1,AFFECTS,General/Uncertain,3
15378,Childbirth,C1148523,en_5296,AFFECTS,Male population group,C0025266,en_1533,1,1,AFFECTS,General/Uncertain,3
15379,Childbirth,C1148523,en_5296,AFFECTS,Pregnancy,C0032961,en_1872,1,1,AFFECTS,General/Uncertain,3
15380,Childbirth,C1148523,en_5296,AFFECTS,Woman,C0043210,en_2396,3,3,AFFECTS,General/Uncertain,9
15381,Childbirth,C1148523,en_5296,AFFECTS,Instructor,C0556993,en_4304,1,1,AFFECTS,General/Uncertain,7
15382,Childbirth,C1148523,en_5296,AFFECTS,Boys,C0870221,en_5001,1,1,AFFECTS,General/Uncertain,8
15383,ion channel activity,C1153415,en_5308,AFFECTS,Homeostasis,C0019868,en_1201,1,1,AFFECTS,General/Uncertain,3
15384,host-pathogen interaction,C1154482,en_5309,AFFECTS,Communicable Diseases,C0009450,en_685,2,2,AFFECTS,General/Uncertain,6
15385,host-pathogen interaction,C1154482,en_5309,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,3
15386,anti-inflammatory response,C1154987,en_5310,AFFECTS,Thrombin,C0040018,en_2228,2,1,AFFECTS,General/Uncertain,3
15387,anti-inflammatory response,C1154987,en_5310,AFFECTS,Predisposition,C0220898,en_3206,3,1,AFFECTS,General/Uncertain,3
15388,anti-inflammatory response,C1154987,en_5310,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
15389,B-cell differentiation,C1155004,en_5312,AFFECTS,Signal Transduction,C0037083,en_2105,1,1,AFFECTS,General/Uncertain,3
15390,T-Cell Activation,C1155065,en_5315,PRODUCES,cytokine,C0079189,en_2593,3,2,AFFECTS,Excitatory,6
15391,cytokine biosynthesis,C1155099,en_5317,AFFECTS,Genes,C0017337,en_1052,1,1,AFFECTS,General/Uncertain,3
15392,humoral immune response,C1155229,en_5318,PRODUCES,Antibodies,C0003241,en_347,3,2,AFFECTS,Excitatory,6
15393,humoral immune response,C1155229,en_5318,PRODUCES,Neutralizing antibody,C0475463,en_4145,1,1,AFFECTS,Excitatory,3
15394,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,AFFECTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,General/Uncertain,3
15395,innate immune response,C1155265,en_5320,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
15396,innate immune response,C1155265,en_5320,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
15397,Inflammatory Response,C1155266,en_5321,AFFECTS,Complication,C0009566,en_697,2,1,AFFECTS,General/Uncertain,3
15398,Inflammatory Response,C1155266,en_5321,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,7
15399,Inflammatory Response,C1155266,en_5321,AFFECTS,Exocytosis,C0015283,en_943,1,1,AFFECTS,General/Uncertain,3
15400,Inflammatory Response,C1155266,en_5321,AFFECTS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
15401,Inflammatory Response,C1155266,en_5321,AFFECTS,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,3
15402,Inflammatory Response,C1155266,en_5321,AFFECTS,Cerebrovascular accident,C0038454,en_2169,2,1,AFFECTS,General/Uncertain,3
15403,Inflammatory Response,C1155266,en_5321,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
15404,Inflammatory Response,C1155266,en_5321,AFFECTS,Hypoxia,C0242184,en_3396,1,1,AFFECTS,General/Uncertain,3
15405,Inflammatory Response,C1155266,en_5321,AFFECTS,Acute respiratory disease,C0264219,en_3527,1,1,AFFECTS,General/Uncertain,3
15406,Inflammatory Response,C1155266,en_5321,AFFECTS,Cell Proliferation,C0596290,en_4384,1,1,AFFECTS,General/Uncertain,3
15407,Inflammatory Response,C1155266,en_5321,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
15408,Inflammatory Response,C1155266,en_5321,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
15409,Inflammatory Response,C1155266,en_5321,PREDISPOSES,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Excitatory,3
15410,Inflammatory Response,C1155266,en_5321,PREDISPOSES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Excitatory,3
15411,Antiviral Response,C1155328,en_5322,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
15412,Antiviral Response,C1155328,en_5322,PRODUCES,cytokine,C0079189,en_2593,2,2,AFFECTS,Excitatory,6
15413,autophagic vacuole formation,C1155607,en_5323,AFFECTS,Autophagy,C0004391,en_432,1,1,AFFECTS,General/Uncertain,3
15414,iron ion homeostasis,C1156273,en_5329,AFFECTS,macrophage,C0024432,en_1484,1,1,AFFECTS,General/Uncertain,3
15415,iron ion homeostasis,C1156273,en_5329,AFFECTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
15416,sphingomyelin metabolism,C1158437,en_5339,AFFECTS,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,General/Uncertain,3
15417,negative regulation of transcription by glucose,C1158774,en_5341,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
15418,Protein Secretion,C1159339,en_5342,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
15419,adipocyte differentiation,C1159884,en_5347,AFFECTS,Body Weight,C0005910,en_498,1,1,AFFECTS,General/Uncertain,3
15420,platelet formation,C1159962,en_5351,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,7
15421,brain development,C1160340,en_5353,AFFECTS,Infant,C0021270,en_1297,1,1,AFFECTS,General/Uncertain,3
15422,brain development,C1160340,en_5353,AFFECTS,Toddler,C0682053,en_4633,1,1,AFFECTS,General/Uncertain,3
15423,viral entry,C1160648,en_5358,AFFECTS,blood pressure regulation,C0678863,en_4576,1,1,AFFECTS,General/Uncertain,3
15424,viral transmission,C1160716,en_5362,AFFECTS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,General/Uncertain,3
15425,viral transmission,C1160716,en_5362,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
15426,Infection precautions,C1160949,en_5363,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15427,Infection precautions,C1160949,en_5363,TREATS(INFER),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
15428,Dialysis care,C1161201,en_5364,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
15429,host,C1167395,en_5368,AFFECTS,Genetic Markers,C0017393,en_1056,2,1,AFFECTS,General/Uncertain,3
15430,host,C1167395,en_5368,AFFECTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,General/Uncertain,3
15431,host,C1167395,en_5368,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
15432,Therapeutic hypothermia,C1167780,en_5369,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
15433,Therapeutic hypothermia,C1167780,en_5369,TREATS,Heart Arrest,C0018790,en_1131,2,1,AFFECTS,Inhibitory,3
15434,Pulmonary arterial pressure,C1168098,en_5371,AFFECTS,"Ventricular Function, Right",C0080311,en_2628,1,1,AFFECTS,General/Uncertain,3
15435,Pulmonary arterial pressure,C1168098,en_5371,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
15436,Fertility care,C1171194,en_5373,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15437,Renal care,C1171215,en_5374,TREATS,Native Americans,C0282204,en_3640,1,1,AFFECTS,Inhibitory,3
15438,Sexual behavior analysis,C1171217,en_5375,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,6
15439,Delivery care,C1171257,en_5376,TREATS,Degenerative polyarthritis,C0029408,en_1723,1,1,AFFECTS,Inhibitory,8
15440,kinase inhibitor,C1171350,en_5378,AUGMENTS,Invasive pulmonary aspergillosis,C0276653,en_3581,1,1,AFFECTS,Excitatory,3
15441,kinase inhibitor,C1171350,en_5378,DISRUPTS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
15442,kinase inhibitor,C1171350,en_5378,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,3
15443,kinase inhibitor,C1171350,en_5378,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
15444,kinase inhibitor,C1171350,en_5378,TREATS,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
15445,kinase inhibitor,C1171350,en_5378,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
15446,kinase inhibitor,C1171350,en_5378,TREATS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
15447,"VEGF protein, human",C1171892,en_5379,AFFECTS,Capillarity,C0006903,en_550,2,1,AFFECTS,General/Uncertain,3
15448,"VEGF protein, human",C1171892,en_5379,AUGMENTS,Vascular Permeability,C0162337,en_2906,2,2,AFFECTS,Excitatory,6
15449,"VEGF protein, human",C1171892,en_5379,AUGMENTS,Angiogenesis,C0302600,en_3709,1,1,AFFECTS,Excitatory,3
15450,"VEGF protein, human",C1171892,en_5379,AUGMENTS,Entire respiratory epithelium,C1282653,en_5475,1,1,AFFECTS,Excitatory,3
15451,"VEGF protein, human",C1171892,en_5379,TREATS(SPEC),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
15452,Alvesco,C1174745,en_5380,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,3
15453,Basen,C1174791,en_5381,TREATS,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,Inhibitory,3
15454,oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine,C1175112,en_5382,AUGMENTS,Endocytosis,C0014139,en_897,1,1,AFFECTS,Excitatory,3
15455,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
15456,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Anemia,C0002871,en_316,1,1,AFFECTS,General/Uncertain,3
15457,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
15458,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Down Syndrome,C0013080,en_843,1,1,AFFECTS,General/Uncertain,3
15459,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Hemoglobinopathies,C0019045,en_1158,1,1,AFFECTS,General/Uncertain,3
15460,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Persons,C0027361,en_1635,2,1,AFFECTS,General/Uncertain,3
15461,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Sickle Cell Trait,C0037054,en_2103,1,1,AFFECTS,General/Uncertain,3
15462,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Thalassemia,C0039730,en_2220,1,1,AFFECTS,General/Uncertain,3
15463,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Caregiver,C0085537,en_2674,1,1,AFFECTS,General/Uncertain,3
15464,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
15465,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Onset of illness,C0277793,en_3591,1,1,AFFECTS,General/Uncertain,3
15466,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,US minority racial or ethnic group,C0682123,en_4635,4,1,AFFECTS,General/Uncertain,3
15467,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,Hypoxemia,C0700292,en_4719,2,1,AFFECTS,General/Uncertain,3
15468,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,SYSTEMIC INFLAMMATORY PROCESS,C0749224,en_4835,1,1,AFFECTS,General/Uncertain,3
15469,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS,erythrocyte homeostasis,C2247681,en_6094,1,1,AFFECTS,General/Uncertain,6
15470,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS(SPEC),Health Personnel,C0018724,en_1121,1,1,AFFECTS,General/Uncertain,3
15471,Severe Acute Respiratory Syndrome,C1175175,en_5383,AFFECTS(SPEC),Human Circadian Rhythms,C0237509,en_3347,1,1,AFFECTS,General/Uncertain,3
15472,Severe Acute Respiratory Syndrome,C1175175,en_5383,COMPLICATES,Bilateral pneumonia,C1142578,en_5287,3,1,AFFECTS,General/Uncertain,3
15473,Severe Acute Respiratory Syndrome,C1175175,en_5383,PREDISPOSES,Syndrome,C0039082,en_2197,1,1,AFFECTS,Excitatory,3
15474,Severe Acute Respiratory Syndrome,C1175175,en_5383,PREDISPOSES,Thromboembolism,C0040038,en_2230,2,1,AFFECTS,Excitatory,3
15475,Severe Acute Respiratory Syndrome,C1175175,en_5383,PREDISPOSES,Poor outcome,C3806166,en_6240,1,1,AFFECTS,Excitatory,6
15476,Severe Acute Respiratory Syndrome,C1175175,en_5383,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
15477,tadalafil,C1176316,en_5385,TREATS,Healthy Volunteers,C1708335,en_6036,1,1,AFFECTS,Inhibitory,8
15478,tadalafil,C1176316,en_5385,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15479,ambrisentan,C1176329,en_5386,AFFECTS,Lung,C0024109,en_1460,2,1,AFFECTS,General/Uncertain,3
15480,ambrisentan,C1176329,en_5386,AFFECTS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,General/Uncertain,3
15481,ambrisentan,C1176329,en_5386,STIMULATES,Oxygen,C0030054,en_1736,2,1,AFFECTS,Excitatory,3
15482,ambrisentan,C1176329,en_5386,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
15483,ambrisentan,C1176329,en_5386,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15484,ambrisentan,C1176329,en_5386,TREATS(INFER),"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,Inhibitory,3
15485,Wall of endosome,C1179907,en_5387,PRODUCES,Viral Genome,C0042720,en_2355,1,1,AFFECTS,Excitatory,3
15486,Nucleated cell,C1180059,en_5388,PRODUCES,Proteins,C0033684,en_1912,1,1,AFFECTS,Excitatory,3
15487,Protein complex,C1180347,en_5389,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
15488,Protein complex,C1180347,en_5389,AFFECTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,General/Uncertain,3
15489,Protein complex,C1180347,en_5389,INHIBITS,Superoxides,C0038836,en_2185,1,1,AFFECTS,Inhibitory,3
15490,Protein complex,C1180347,en_5389,STIMULATES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,3
15491,Dakin's solution,C1186762,en_5391,AFFECTS,Body tissue,C0040300,en_2242,2,1,AFFECTS,General/Uncertain,3
15492,instruction,C1186996,en_5392,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
15493,instruction,C1186996,en_5392,AFFECTS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
15494,Aspirin Enteric Coated Tablet,C1244973,en_5393,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15495,Povidone-Iodine Mouthwash,C1251768,en_5394,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15496,Pharmacologic Substance,C1254351,en_5395,INHIBITS,"FRAP1 protein, human",C1307407,en_5524,1,1,AFFECTS,Inhibitory,3
15497,Pharmacologic Substance,C1254351,en_5395,TREATS,Neonatal Jaundice,C0022353,en_1372,1,1,AFFECTS,Inhibitory,3
15498,Pharmacologic Substance,C1254351,en_5395,TREATS,INFECTIOUS PROCESS,C0745283,en_4812,1,1,AFFECTS,Inhibitory,3
15499,Physiologic Function,C1254359,en_5396,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
15500,Physiologic Function,C1254359,en_5396,AFFECTS,Recovery,C0237820,en_3354,2,1,AFFECTS,General/Uncertain,3
15501,Platelet function,C1254881,en_5398,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
15502,Angiogenic Proteins,C1257776,en_5401,AUGMENTS,Permeability,C0031164,en_1779,1,1,AFFECTS,Excitatory,3
15503,Angiogenic Proteins,C1257776,en_5401,PREDISPOSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,3
15504,Mesenchymal Stem Cells,C1257975,en_5404,AFFECTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,General/Uncertain,3
15505,Mesenchymal Stem Cells,C1257975,en_5404,PRODUCES,Growth Factor,C0018284,en_1100,1,1,AFFECTS,Excitatory,3
15506,Mesenchymal Stem Cells,C1257975,en_5404,PRODUCES,Major Histocompatibility Complex,C0024518,en_1492,1,1,AFFECTS,Excitatory,3
15507,Mesenchymal Stem Cells,C1257975,en_5404,PRODUCES,Biologically active substance,C0574031,en_4334,1,1,AFFECTS,Excitatory,3
15508,Mesenchymal Stem Cells,C1257975,en_5404,PRODUCES(SPEC),cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,3
15509,Bronchipret,C1259299,en_5408,AFFECTS,Recovery,C0237820,en_3354,3,1,AFFECTS,General/Uncertain,3
15510,Bronchipret,C1259299,en_5408,AFFECTS,Immune response,C0301872,en_3696,3,1,AFFECTS,General/Uncertain,3
15511,laquinimod,C1260208,en_5409,STIMULATES,Aryl Hydrocarbon Receptor,C0052441,en_2437,1,1,AFFECTS,Excitatory,3
15512,Pronto,C1260720,en_5411,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
15513,Pronto,C1260720,en_5411,TREATS,Teens,C1521910,en_5899,1,1,AFFECTS,Inhibitory,3
15514,Diamond-Blackfan anemia,C1260899,en_5413,AFFECTS(SPEC),targeting,C0599894,en_4482,2,1,AFFECTS,General/Uncertain,3
15515,Swab,C1261188,en_5415,TREATS,Adult,C0001675,en_252,2,2,AFFECTS,Inhibitory,6
15516,Swab,C1261188,en_5415,TREATS,Child,C0008059,en_620,3,2,AFFECTS,Inhibitory,6
15517,Swab,C1261188,en_5415,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
15518,Swab,C1261188,en_5415,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
15519,Swab,C1261188,en_5415,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15520,Swab,C1261188,en_5415,TREATS,Readiness,C1318963,en_5534,1,1,AFFECTS,Inhibitory,3
15521,Swab,C1261188,en_5415,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
15522,Swab,C1261188,en_5415,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
15523,Encounter due to HIV negative,C1261243,en_5416,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Excitatory,3
15524,Assessment procedure,C1261322,en_5417,AFFECTS,Possible,C0332149,en_3747,1,1,AFFECTS,General/Uncertain,6
15525,Assessment procedure,C1261322,en_5417,AFFECTS,Discontinued,C1444662,en_5749,1,1,AFFECTS,General/Uncertain,8
15526,Assessment procedure,C1261322,en_5417,PREVENTS,Reinfection,C0205339,en_3129,1,1,AFFECTS,Inhibitory,6
15527,Assessment procedure,C1261322,en_5417,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,6
15528,Assessment procedure,C1261322,en_5417,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,7
15529,Assessment procedure,C1261322,en_5417,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,7
15530,Assessment procedure,C1261322,en_5417,TREATS,Deglutition Disorders,C0011168,en_772,1,1,AFFECTS,Inhibitory,6
15531,Assessment procedure,C1261322,en_5417,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,6
15532,Assessment procedure,C1261322,en_5417,TREATS,Hoarseness,C0019825,en_1196,1,1,AFFECTS,Inhibitory,6
15533,Assessment procedure,C1261322,en_5417,TREATS,Patients,C0030705,en_1762,4,4,AFFECTS,Inhibitory,12
15534,Assessment procedure,C1261322,en_5417,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
15535,Assessment procedure,C1261322,en_5417,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
15536,Assessment procedure,C1261322,en_5417,TREATS,risk factors,C0035648,en_2039,1,1,AFFECTS,Inhibitory,6
15537,Assessment procedure,C1261322,en_5417,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,6
15538,Assessment procedure,C1261322,en_5417,TREATS,Participant,C0679646,en_4602,6,4,AFFECTS,Inhibitory,12
15539,Assessment procedure,C1261322,en_5417,TREATS,Acute ulcerative colitis,C1260710,en_5410,1,1,AFFECTS,Inhibitory,6
15540,Assessment procedure,C1261322,en_5417,TREATS,Weight decreased,C1262477,en_5423,1,1,AFFECTS,Inhibitory,6
15541,Assessment procedure,C1261322,en_5417,TREATS,Hematopoietic system finding,C1292123,en_5492,1,1,AFFECTS,Inhibitory,8
15542,Assessment procedure,C1261322,en_5417,TREATS,user - individual,C1706077,en_6033,1,1,AFFECTS,Inhibitory,8
15543,Assessment procedure,C1261322,en_5417,TREATS,Pseudoexfoliation,C4022815,en_6295,1,1,AFFECTS,Inhibitory,6
15544,Assessment procedure,C1261322,en_5417,TREATS,COVID-19,C5203670,en_6417,8,6,AFFECTS,Inhibitory,39
15545,Assessment procedure,C1261322,en_5417,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
15546,End stage renal failure,C1261469,en_5418,PREDISPOSES,Fungemia,C0085082,en_2640,1,1,AFFECTS,Excitatory,3
15547,Substance administration,C1262471,en_5422,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
15548,Weight decreased,C1262477,en_5423,PREDISPOSES,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Excitatory,8
15549,Weight decreased,C1262477,en_5423,PREDISPOSES,Weight Gain,C0043094,en_2388,1,1,AFFECTS,Excitatory,6
15550,Body position,C1262869,en_5426,PREDISPOSES,Musculoskeletal Diseases,C0026857,en_1607,1,1,AFFECTS,Excitatory,8
15551,Attention deficit hyperactivity disorder,C1263846,en_5428,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
15552,Disintegration,C1265875,en_5433,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
15553,CD19+ B Lymphocyte,C1267837,en_5436,PRODUCES,"Vascular Endothelial Growth Factor Receptor 2, human|KDR",C3849882|3791,en_6267,1,1,AFFECTS,Excitatory,7
15554,Echinocandin,C1268551,en_5438,TREATS,Invasive mycosis,C1262313,en_5421,1,1,AFFECTS,Inhibitory,3
15555,Protein-tyrosine kinase inhibitor,C1268567,en_5439,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
15556,Protein-tyrosine kinase inhibitor,C1268567,en_5439,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15557,Protein-tyrosine kinase inhibitor,C1268567,en_5439,TREATS,Interstitial fibrosis,C0240035,en_3381,1,1,AFFECTS,Inhibitory,3
15558,Protein-tyrosine kinase inhibitor,C1268567,en_5439,TREATS(INFER),Malignant neoplasm of thyroid,C0007115,en_562,1,1,AFFECTS,Inhibitory,3
15559,Prophylactic substance,C1268823,en_5440,TREATS,"Infections, Upper Respiratory",C0041912,en_2315,1,1,AFFECTS,Inhibitory,3
15560,Prophylactic substance,C1268823,en_5440,TREATS,Individual,C0237401,en_3343,2,1,AFFECTS,Inhibitory,3
15561,Lipase inhibitor,C1268854,en_5441,DISRUPTS,Cell Degranulation,C0007588,en_588,2,1,AFFECTS,Inhibitory,3
15562,Gonadotropin releasing hormone antagonist,C1268855,en_5442,TREATS,"Endometriosis, site unspecified",C0014175,en_898,1,1,AFFECTS,Inhibitory,8
15563,Gonadotropin releasing hormone antagonist,C1268855,en_5442,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,8
15564,Zinc supplement,C1268859,en_5443,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,3
15565,Purine analog,C1268902,en_5444,INHIBITS,RNA-Directed RNA Polymerase,C0035685,en_2042,1,1,AFFECTS,Inhibitory,3
15566,Immunologic function,C1268930,en_5445,AFFECTS,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
15567,Immunologic function,C1268930,en_5445,AFFECTS,Predisposition,C0220898,en_3206,1,1,AFFECTS,General/Uncertain,3
15568,Immunologic function,C1268930,en_5445,AFFECTS(SPEC),Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
15569,Eosinophilic major basic protein,C1269100,en_5446,AFFECTS,Nerve Regeneration,C0027756,en_1658,1,1,AFFECTS,General/Uncertain,3
15570,Major Depressive Disorder,C1269683,en_5447,AFFECTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,3
15571,Patient identification,C1269815,en_5448,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15572,Recombinant human granulocyte colony stimulating factor,C1271481,en_5451,DISRUPTS,Leukopenia,C0023530,en_1423,1,1,AFFECTS,Inhibitory,6
15573,Recombinant human granulocyte colony stimulating factor,C1271481,en_5451,TREATS,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,Inhibitory,8
15574,Recombinant human granulocyte colony stimulating factor,C1271481,en_5451,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15575,Test kit,C1272835,en_5454,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,3
15576,Test kit,C1272835,en_5454,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,3
15577,Test kit,C1272835,en_5454,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15578,Test kit,C1272835,en_5454,TREATS,Rural Communities,C0086944,en_2739,4,1,AFFECTS,Inhibitory,3
15579,Test kit,C1272835,en_5454,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,3
15580,Test kit,C1272835,en_5454,TREATS,Staff,C0851286,en_4950,2,1,AFFECTS,Inhibitory,3
15581,Test kit,C1272835,en_5454,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
15582,Test kit,C1272835,en_5454,TREATS(INFER),Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
15583,Stereotactic radiotherapy,C1273404,en_5455,TREATS,Malignant neoplasm of lung,C0242379,en_3408,2,1,AFFECTS,Inhibitory,3
15584,Stereotactic radiotherapy,C1273404,en_5455,TREATS(SPEC),"Carcinoma, Non-Small-Cell Lung",C0007131,en_563,1,1,AFFECTS,Inhibitory,3
15585,Chinese herbal medicine,C1273412,en_5456,TREATS,Coughing,C0010200,en_723,1,1,AFFECTS,Inhibitory,3
15586,Chinese herbal medicine,C1273412,en_5456,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15587,Chinese herbal medicine,C1273412,en_5456,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
15588,Chinese herbal medicine,C1273412,en_5456,TREATS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,8
15589,Chinese herbal medicine,C1273412,en_5456,TREATS,Genus: Coronavirus,C0206419,en_3158,1,1,AFFECTS,Inhibitory,3
15590,Chinese herbal medicine,C1273412,en_5456,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
15591,Chinese herbal medicine,C1273412,en_5456,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
15592,Diagnostic device,C1273532,en_5457,TREATS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,3
15593,Intervention regimes,C1273869,en_5458,AFFECTS,Personal Satisfaction,C0031206,en_1780,3,3,AFFECTS,General/Uncertain,14
15594,Intervention regimes,C1273869,en_5458,AFFECTS,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
15595,Intervention regimes,C1273869,en_5458,AFFECTS,Improved,C0184511,en_3052,1,1,AFFECTS,General/Uncertain,7
15596,Intervention regimes,C1273869,en_5458,AFFECTS,Vitality,C0424589,en_3997,1,1,AFFECTS,General/Uncertain,3
15597,Intervention regimes,C1273869,en_5458,AFFECTS,Physical function,C0516981,en_4169,1,1,AFFECTS,General/Uncertain,3
15598,Intervention regimes,C1273869,en_5458,AFFECTS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,General/Uncertain,3
15599,Intervention regimes,C1273869,en_5458,AFFECTS,Maximum,C0806909,en_4887,1,1,AFFECTS,General/Uncertain,3
15600,Intervention regimes,C1273869,en_5458,PREVENTS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
15601,Intervention regimes,C1273869,en_5458,PREVENTS,Cachexia,C0006625,en_531,1,1,AFFECTS,Inhibitory,3
15602,Intervention regimes,C1273869,en_5458,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
15603,Intervention regimes,C1273869,en_5458,PREVENTS,Complication,C0009566,en_697,5,4,AFFECTS,Inhibitory,12
15604,Intervention regimes,C1273869,en_5458,PREVENTS,Cross Infection,C0010356,en_735,2,1,AFFECTS,Inhibitory,3
15605,Intervention regimes,C1273869,en_5458,PREVENTS,Diabetes,C0011847,en_797,2,2,AFFECTS,Inhibitory,6
15606,Intervention regimes,C1273869,en_5458,PREVENTS,Disease,C0012634,en_826,7,5,AFFECTS,Inhibitory,15
15607,Intervention regimes,C1273869,en_5458,PREVENTS,HIV Infections,C0019693,en_1192,2,1,AFFECTS,Inhibitory,3
15608,Intervention regimes,C1273869,en_5458,PREVENTS,Infection,C3714514,en_6235,2,2,AFFECTS,Inhibitory,6
15609,Intervention regimes,C1273869,en_5458,PREVENTS,"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,Inhibitory,3
15610,Intervention regimes,C1273869,en_5458,PREVENTS,Loneliness,C0023974,en_1456,2,2,AFFECTS,Inhibitory,15
15611,Intervention regimes,C1273869,en_5458,PREVENTS,Maternal Mortality,C0024923,en_1510,1,1,AFFECTS,Inhibitory,3
15612,Intervention regimes,C1273869,en_5458,PREVENTS,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,Inhibitory,3
15613,Intervention regimes,C1273869,en_5458,PREVENTS,Obesity,C0028754,en_1699,5,3,AFFECTS,Inhibitory,9
15614,Intervention regimes,C1273869,en_5458,PREVENTS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
15615,Intervention regimes,C1273869,en_5458,PREVENTS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,6
15616,Intervention regimes,C1273869,en_5458,PREVENTS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,Inhibitory,3
15617,Intervention regimes,C1273869,en_5458,PREVENTS,Stress,C0038435,en_2165,13,12,AFFECTS,Inhibitory,41
15618,Intervention regimes,C1273869,en_5458,PREVENTS,Body Weight decreased,C0043096,en_2389,1,1,AFFECTS,Inhibitory,3
15619,Intervention regimes,C1273869,en_5458,PREVENTS,Falls,C0085639,en_2684,2,2,AFFECTS,Inhibitory,6
15620,Intervention regimes,C1273869,en_5458,PREVENTS,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Inhibitory,3
15621,Intervention regimes,C1273869,en_5458,PREVENTS,Urinary hesitation,C0152032,en_2878,6,3,AFFECTS,Inhibitory,12
15622,Intervention regimes,C1273869,en_5458,PREVENTS,Sedentary,C0205254,en_3128,1,1,AFFECTS,Inhibitory,3
15623,Intervention regimes,C1273869,en_5458,PREVENTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,8
15624,Intervention regimes,C1273869,en_5458,PREVENTS,Disability NOS,C0231170,en_3247,2,2,AFFECTS,Inhibitory,6
15625,Intervention regimes,C1273869,en_5458,PREVENTS,Cerebral atrophy,C0235946,en_3333,1,1,AFFECTS,Inhibitory,3
15626,Intervention regimes,C1273869,en_5458,PREVENTS,Homelessness,C0237154,en_3342,1,1,AFFECTS,Inhibitory,3
15627,Intervention regimes,C1273869,en_5458,PREVENTS,Disease Progression,C0242656,en_3429,2,1,AFFECTS,Inhibitory,3
15628,Intervention regimes,C1273869,en_5458,PREVENTS,disease transmission,C0242781,en_3438,3,3,AFFECTS,Inhibitory,9
15629,Intervention regimes,C1273869,en_5458,PREVENTS,Social stigmata,C0277787,en_3590,4,3,AFFECTS,Inhibitory,9
15630,Intervention regimes,C1273869,en_5458,PREVENTS,Impaired cognition,C0338656,en_3804,1,1,AFFECTS,Inhibitory,3
15631,Intervention regimes,C1273869,en_5458,PREVENTS,Frailty,C0424594,en_3998,1,1,AFFECTS,Inhibitory,3
15632,Intervention regimes,C1273869,en_5458,PREVENTS,Physical and emotional exhaustion state,C0476644,en_4150,3,3,AFFECTS,Inhibitory,14
15633,Intervention regimes,C1273869,en_5458,PREVENTS,"Medical care, unspecified",C0496675,en_4163,1,1,AFFECTS,Inhibitory,3
15634,Intervention regimes,C1273869,en_5458,PREVENTS,Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,3
15635,Intervention regimes,C1273869,en_5458,PREVENTS,Sequela of disorder,C0543419,en_4257,2,2,AFFECTS,Inhibitory,6
15636,Intervention regimes,C1273869,en_5458,PREVENTS,MISUSE,C0549649,en_4285,3,1,AFFECTS,Inhibitory,3
15637,Intervention regimes,C1273869,en_5458,PREVENTS,Intrusive memories,C0561837,en_4322,2,1,AFFECTS,Inhibitory,3
15638,Intervention regimes,C1273869,en_5458,PREVENTS,Emotional,C0849912,en_4937,1,1,AFFECTS,Inhibitory,3
15639,Intervention regimes,C1273869,en_5458,PREVENTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
15640,Intervention regimes,C1273869,en_5458,PREVENTS,Adverse effects,C0879626,en_5081,6,6,AFFECTS,Inhibitory,18
15641,Intervention regimes,C1273869,en_5458,PREVENTS,Nosocomial pneumonia,C0949083,en_5175,3,1,AFFECTS,Inhibitory,8
15642,Intervention regimes,C1273869,en_5458,PREVENTS,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,Inhibitory,3
15643,Intervention regimes,C1273869,en_5458,PREVENTS,Late effect of,C1368999,en_5678,1,1,AFFECTS,Inhibitory,3
15644,Intervention regimes,C1273869,en_5458,PREVENTS,Mental health problem,C1446377,en_5753,3,2,AFFECTS,Inhibitory,6
15645,Intervention regimes,C1273869,en_5458,PREVENTS,Symptoms,C1457887,en_5784,7,5,AFFECTS,Inhibitory,15
15646,Intervention regimes,C1273869,en_5458,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15647,Intervention regimes,C1273869,en_5458,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,3,3,AFFECTS,Inhibitory,9
15648,Intervention regimes,C1273869,en_5458,TREATS,Adult,C0001675,en_252,3,3,AFFECTS,Inhibitory,9
15649,Intervention regimes,C1273869,en_5458,TREATS,Elderly,C0001792,en_258,2,2,AFFECTS,Inhibitory,6
15650,Intervention regimes,C1273869,en_5458,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
15651,Intervention regimes,C1273869,en_5458,TREATS,Celiac Disease,C0007570,en_582,1,1,AFFECTS,Inhibitory,3
15652,Intervention regimes,C1273869,en_5458,TREATS,Child,C0008059,en_620,20,16,AFFECTS,Inhibitory,52
15653,Intervention regimes,C1273869,en_5458,TREATS,Clients,C0008942,en_654,2,2,AFFECTS,Inhibitory,6
15654,Intervention regimes,C1273869,en_5458,TREATS,Communicable Diseases,C0009450,en_685,3,2,AFFECTS,Inhibitory,6
15655,Intervention regimes,C1273869,en_5458,TREATS,Community,C0009462,en_687,3,3,AFFECTS,Inhibitory,21
15656,Intervention regimes,C1273869,en_5458,TREATS,Complication,C0009566,en_697,3,2,AFFECTS,Inhibitory,6
15657,Intervention regimes,C1273869,en_5458,TREATS,Control Groups,C0009932,en_711,3,3,AFFECTS,Inhibitory,9
15658,Intervention regimes,C1273869,en_5458,TREATS,Couples,C0010222,en_725,1,1,AFFECTS,Inhibitory,3
15659,Intervention regimes,C1273869,en_5458,TREATS,Cross Infection,C0010356,en_735,1,1,AFFECTS,Inhibitory,6
15660,Intervention regimes,C1273869,en_5458,TREATS,Disease,C0012634,en_826,16,14,AFFECTS,Inhibitory,51
15661,Intervention regimes,C1273869,en_5458,TREATS,Dutch Population,C0013331,en_862,1,1,AFFECTS,Inhibitory,3
15662,Intervention regimes,C1273869,en_5458,TREATS,Edema,C0013604,en_877,1,1,AFFECTS,Inhibitory,3
15663,Intervention regimes,C1273869,en_5458,TREATS,Family,C0015576,en_961,5,5,AFFECTS,Inhibitory,20
15664,Intervention regimes,C1273869,en_5458,TREATS,Chronic Fatigue Syndrome,C0015674,en_967,3,1,AFFECTS,Inhibitory,3
15665,Intervention regimes,C1273869,en_5458,TREATS,General Practitioners,C0017319,en_1051,1,1,AFFECTS,Inhibitory,3
15666,Intervention regimes,C1273869,en_5458,TREATS,Health Personnel,C0018724,en_1121,6,4,AFFECTS,Inhibitory,12
15667,Intervention regimes,C1273869,en_5458,TREATS,Households,C0020052,en_1208,8,6,AFFECTS,Inhibitory,18
15668,Intervention regimes,C1273869,en_5458,TREATS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,Inhibitory,3
15669,Intervention regimes,C1273869,en_5458,TREATS,Infection,C3714514,en_6235,4,3,AFFECTS,Inhibitory,9
15670,Intervention regimes,C1273869,en_5458,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
15671,Intervention regimes,C1273869,en_5458,TREATS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,8
15672,Intervention regimes,C1273869,en_5458,TREATS,inpatient,C0021562,en_1321,5,3,AFFECTS,Inhibitory,9
15673,Intervention regimes,C1273869,en_5458,TREATS,Irritable Mood,C0022107,en_1361,1,1,AFFECTS,Inhibitory,3
15674,Intervention regimes,C1273869,en_5458,TREATS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
15675,Intervention regimes,C1273869,en_5458,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
15676,Intervention regimes,C1273869,en_5458,TREATS,Maternal Mortality,C0024923,en_1510,1,1,AFFECTS,Inhibitory,3
15677,Intervention regimes,C1273869,en_5458,TREATS,Male population group,C0025266,en_1533,4,2,AFFECTS,Inhibitory,6
15678,Intervention regimes,C1273869,en_5458,TREATS,Mothers,C0026591,en_1583,2,1,AFFECTS,Inhibitory,3
15679,Intervention regimes,C1273869,en_5458,TREATS,Muscle Rigidity,C0026837,en_1602,2,1,AFFECTS,Inhibitory,3
15680,Intervention regimes,C1273869,en_5458,TREATS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
15681,Intervention regimes,C1273869,en_5458,TREATS,Persons,C0027361,en_1635,23,23,AFFECTS,Inhibitory,69
15682,Intervention regimes,C1273869,en_5458,TREATS,African race,C0027567,en_1646,1,1,AFFECTS,Inhibitory,3
15683,Intervention regimes,C1273869,en_5458,TREATS,Nurses,C0028661,en_1694,2,1,AFFECTS,Inhibitory,3
15684,Intervention regimes,C1273869,en_5458,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
15685,Intervention regimes,C1273869,en_5458,TREATS,Obstruction,C0028778,en_1702,1,1,AFFECTS,Inhibitory,8
15686,Intervention regimes,C1273869,en_5458,TREATS,Osteoporosis,C0029456,en_1726,1,1,AFFECTS,Inhibitory,3
15687,Intervention regimes,C1273869,en_5458,TREATS,Outpatients,C0029921,en_1729,4,2,AFFECTS,Inhibitory,6
15688,Intervention regimes,C1273869,en_5458,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
15689,Intervention regimes,C1273869,en_5458,TREATS,parent,C0030551,en_1750,7,7,AFFECTS,Inhibitory,21
15690,Intervention regimes,C1273869,en_5458,TREATS,Patients,C0030705,en_1762,88,65,AFFECTS,Inhibitory,195
15691,Intervention regimes,C1273869,en_5458,TREATS,Personal Satisfaction,C0031206,en_1780,2,2,AFFECTS,Inhibitory,6
15692,Intervention regimes,C1273869,en_5458,TREATS,"Personnel, Hospital",C0031228,en_1781,1,1,AFFECTS,Inhibitory,3
15693,Intervention regimes,C1273869,en_5458,TREATS,Phlebitis,C0031542,en_1792,1,1,AFFECTS,Inhibitory,3
15694,Intervention regimes,C1273869,en_5458,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
15695,Intervention regimes,C1273869,en_5458,TREATS,Psychologist,C0033908,en_1920,2,1,AFFECTS,Inhibitory,3
15696,Intervention regimes,C1273869,en_5458,TREATS,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,Inhibitory,3
15697,Intervention regimes,C1273869,en_5458,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,Inhibitory,6
15698,Intervention regimes,C1273869,en_5458,TREATS,Respiratory Tract Diseases,C0035242,en_2016,1,1,AFFECTS,Inhibitory,3
15699,Intervention regimes,C1273869,en_5458,TREATS,Stress,C0038435,en_2165,6,4,AFFECTS,Inhibitory,12
15700,Intervention regimes,C1273869,en_5458,TREATS,Strongyloidiasis,C0038463,en_2170,1,1,AFFECTS,Inhibitory,3
15701,Intervention regimes,C1273869,en_5458,TREATS,student,C0038492,en_2171,3,2,AFFECTS,Inhibitory,6
15702,Intervention regimes,C1273869,en_5458,TREATS,"Students, Medical",C0038495,en_2172,1,1,AFFECTS,Inhibitory,3
15703,Intervention regimes,C1273869,en_5458,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,3
15704,Intervention regimes,C1273869,en_5458,TREATS,Veterans,C0042610,en_2351,2,2,AFFECTS,Inhibitory,6
15705,Intervention regimes,C1273869,en_5458,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
15706,Intervention regimes,C1273869,en_5458,TREATS,Voluntary Workers,C0042960,en_2380,1,1,AFFECTS,Inhibitory,3
15707,Intervention regimes,C1273869,en_5458,TREATS,Woman,C0043210,en_2396,4,4,AFFECTS,Inhibitory,16
15708,Intervention regimes,C1273869,en_5458,TREATS,Frail Elderly,C0079377,en_2598,1,1,AFFECTS,Inhibitory,3
15709,Intervention regimes,C1273869,en_5458,TREATS,friend,C0079382,en_2600,1,1,AFFECTS,Inhibitory,8
15710,Intervention regimes,C1273869,en_5458,TREATS,Milk Hypersensitivity,C0079840,en_2612,1,1,AFFECTS,Inhibitory,3
15711,Intervention regimes,C1273869,en_5458,TREATS,Relative (related person),C0080103,en_2623,2,1,AFFECTS,Inhibitory,3
15712,Intervention regimes,C1273869,en_5458,TREATS,"Diabetes, Gestational",C0085207,en_2652,1,1,AFFECTS,Inhibitory,8
15713,Intervention regimes,C1273869,en_5458,TREATS,Caregiver,C0085537,en_2674,6,6,AFFECTS,Inhibitory,23
15714,Intervention regimes,C1273869,en_5458,TREATS,Falls,C0085639,en_2684,2,2,AFFECTS,Inhibitory,6
15715,Intervention regimes,C1273869,en_5458,TREATS,African American,C0085756,en_2689,2,1,AFFECTS,Inhibitory,3
15716,Intervention regimes,C1273869,en_5458,TREATS,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Inhibitory,3
15717,Intervention regimes,C1273869,en_5458,TREATS,Family member,C0086282,en_2712,1,1,AFFECTS,Inhibitory,3
15718,Intervention regimes,C1273869,en_5458,TREATS,Hispanics,C0086409,en_2717,2,1,AFFECTS,Inhibitory,3
15719,Intervention regimes,C1273869,en_5458,TREATS,Latinos,C0086528,en_2724,2,1,AFFECTS,Inhibitory,3
15720,Intervention regimes,C1273869,en_5458,TREATS,Youth,C0087178,en_2748,2,2,AFFECTS,Inhibitory,6
15721,Intervention regimes,C1273869,en_5458,TREATS,Adolescent,C0205653,en_3132,3,3,AFFECTS,Inhibitory,9
15722,Intervention regimes,C1273869,en_5458,TREATS,Survivors,C0206194,en_3154,10,6,AFFECTS,Inhibitory,26
15723,Intervention regimes,C1273869,en_5458,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
15724,Intervention regimes,C1273869,en_5458,TREATS,Psychological symptom,C0233397,en_3290,2,1,AFFECTS,Inhibitory,3
15725,Intervention regimes,C1273869,en_5458,TREATS,Individual,C0237401,en_3343,16,13,AFFECTS,Inhibitory,39
15726,Intervention regimes,C1273869,en_5458,TREATS,Young adult,C0238598,en_3365,3,2,AFFECTS,Inhibitory,6
15727,Intervention regimes,C1273869,en_5458,TREATS,"AFRICAN, EAST",C0238603,en_3366,1,1,AFFECTS,Inhibitory,3
15728,Intervention regimes,C1273869,en_5458,TREATS,CANADIAN,C0238884,en_3371,2,2,AFFECTS,Inhibitory,6
15729,Intervention regimes,C1273869,en_5458,TREATS,Form of muscle,C0240417,en_3384,1,1,AFFECTS,Inhibitory,3
15730,Intervention regimes,C1273869,en_5458,TREATS,Prostitute NOS,C0240816,en_3387,1,1,AFFECTS,Inhibitory,3
15731,Intervention regimes,C1273869,en_5458,TREATS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,3
15732,Intervention regimes,C1273869,en_5458,TREATS,Acute respiratory failure,C0264490,en_3533,2,2,AFFECTS,Inhibitory,6
15733,Intervention regimes,C1273869,en_5458,TREATS,Social stigmata,C0277787,en_3590,1,1,AFFECTS,Inhibitory,3
15734,Intervention regimes,C1273869,en_5458,TREATS,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,Inhibitory,3
15735,Intervention regimes,C1273869,en_5458,TREATS,Impaired cognition,C0338656,en_3804,2,2,AFFECTS,Inhibitory,6
15736,Intervention regimes,C1273869,en_5458,TREATS,Scientist,C0402112,en_3960,2,1,AFFECTS,Inhibitory,3
15737,Intervention regimes,C1273869,en_5458,TREATS,Well in self,C0424578,en_3996,3,2,AFFECTS,Inhibitory,6
15738,Intervention regimes,C1273869,en_5458,TREATS,Frailty,C0424594,en_3998,1,1,AFFECTS,Inhibitory,3
15739,Intervention regimes,C1273869,en_5458,TREATS,Behavior showing increased motor activity,C0474395,en_4139,1,1,AFFECTS,Inhibitory,3
15740,Intervention regimes,C1273869,en_5458,TREATS,Disruptive behavior,C0474416,en_4141,1,1,AFFECTS,Inhibitory,7
15741,Intervention regimes,C1273869,en_5458,TREATS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,3
15742,Intervention regimes,C1273869,en_5458,TREATS,Physical and emotional exhaustion state,C0476644,en_4150,1,1,AFFECTS,Inhibitory,3
15743,Intervention regimes,C1273869,en_5458,TREATS,Health promotion behavior,C0517496,en_4173,1,1,AFFECTS,Inhibitory,3
15744,Intervention regimes,C1273869,en_5458,TREATS,Perceived quality of life,C0518214,en_4178,1,1,AFFECTS,Inhibitory,3
15745,Intervention regimes,C1273869,en_5458,TREATS,Complication of disease,C0544688,en_4265,3,3,AFFECTS,Inhibitory,9
15746,Intervention regimes,C1273869,en_5458,TREATS,Employed,C0557351,en_4309,1,1,AFFECTS,Inhibitory,3
15747,Intervention regimes,C1273869,en_5458,TREATS,High risk environment,C0557722,en_4310,2,1,AFFECTS,Inhibitory,3
15748,Intervention regimes,C1273869,en_5458,TREATS,Does hit,C0596020,en_4378,1,1,AFFECTS,Inhibitory,3
15749,Intervention regimes,C1273869,en_5458,TREATS,Functional Status,C0598463,en_4448,1,1,AFFECTS,Inhibitory,3
15750,Intervention regimes,C1273869,en_5458,TREATS,cohort,C0599755,en_4470,4,3,AFFECTS,Inhibitory,9
15751,Intervention regimes,C1273869,en_5458,TREATS,Recovery of Function,C0599766,en_4471,1,1,AFFECTS,Inhibitory,3
15752,Intervention regimes,C1273869,en_5458,TREATS,Employee,C0599987,en_4493,1,1,AFFECTS,Inhibitory,3
15753,Intervention regimes,C1273869,en_5458,TREATS,Participant,C0679646,en_4602,3,2,AFFECTS,Inhibitory,6
15754,Intervention regimes,C1273869,en_5458,TREATS,network,C0679670,en_4604,2,2,AFFECTS,Inhibitory,6
15755,Intervention regimes,C1273869,en_5458,TREATS,target group,C0680888,en_4628,1,1,AFFECTS,Inhibitory,3
15756,Intervention regimes,C1273869,en_5458,TREATS,General Population,C0683971,en_4674,2,2,AFFECTS,Inhibitory,6
15757,Intervention regimes,C1273869,en_5458,TREATS,Patient in hospital,C0701159,en_4731,1,1,AFFECTS,Inhibitory,3
15758,Intervention regimes,C1273869,en_5458,TREATS,Punctate inner choroidopathy,C0730321,en_4769,1,1,AFFECTS,Inhibitory,7
15759,Intervention regimes,C1273869,en_5458,TREATS,Emotional,C0849912,en_4937,1,1,AFFECTS,Inhibitory,6
15760,Intervention regimes,C1273869,en_5458,TREATS,Distal bile duct stricture,C0860019,en_4988,2,1,AFFECTS,Inhibitory,3
15761,Intervention regimes,C1273869,en_5458,TREATS,Dyads,C0870454,en_5003,1,1,AFFECTS,Inhibitory,3
15762,Intervention regimes,C1273869,en_5458,TREATS,High Risk Populations,C0870646,en_5008,1,1,AFFECTS,Inhibitory,3
15763,Intervention regimes,C1273869,en_5458,TREATS,Hospitalized Patients,C0870668,en_5010,5,4,AFFECTS,Inhibitory,12
15764,Intervention regimes,C1273869,en_5458,TREATS,Teams,C0871489,en_5024,4,3,AFFECTS,Inhibitory,9
15765,Intervention regimes,C1273869,en_5458,TREATS,Sarcopenia,C0872084,en_5037,1,1,AFFECTS,Inhibitory,3
15766,Intervention regimes,C1273869,en_5458,TREATS,Adverse effects,C0879626,en_5081,3,2,AFFECTS,Inhibitory,6
15767,Intervention regimes,C1273869,en_5458,TREATS,Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,3
15768,Intervention regimes,C1273869,en_5458,TREATS,Cytokine storm,C0919747,en_5119,3,2,AFFECTS,Inhibitory,6
15769,Intervention regimes,C1273869,en_5458,TREATS,Vulnerable Populations,C0949366,en_5180,7,4,AFFECTS,Inhibitory,12
15770,Intervention regimes,C1273869,en_5458,TREATS,Tobacco user,C1112669,en_5245,1,1,AFFECTS,Inhibitory,3
15771,Intervention regimes,C1273869,en_5458,TREATS,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,Inhibitory,3
15772,Intervention regimes,C1273869,en_5458,TREATS,Instrumental activities of daily living,C1290928,en_5488,1,1,AFFECTS,Inhibitory,3
15773,Intervention regimes,C1273869,en_5458,TREATS,Carer,C1305660,en_5515,2,1,AFFECTS,Inhibitory,3
15774,Intervention regimes,C1273869,en_5458,TREATS,Readiness,C1318963,en_5534,1,1,AFFECTS,Inhibitory,7
15775,Intervention regimes,C1273869,en_5458,TREATS,Late effect of,C1368999,en_5678,1,1,AFFECTS,Inhibitory,3
15776,Intervention regimes,C1273869,en_5458,TREATS,Instability,C1444783,en_5750,1,1,AFFECTS,Inhibitory,3
15777,Intervention regimes,C1273869,en_5458,TREATS,Mental health problem,C1446377,en_5753,11,6,AFFECTS,Inhibitory,22
15778,Intervention regimes,C1273869,en_5458,TREATS,Symptoms,C1457887,en_5784,11,9,AFFECTS,Inhibitory,30
15779,Intervention regimes,C1273869,en_5458,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,8
15780,Intervention regimes,C1273869,en_5458,TREATS,Cancer Survivor,C1516231,en_5853,3,2,AFFECTS,Inhibitory,6
15781,Intervention regimes,C1273869,en_5458,TREATS,Vulnerable adult,C1562367,en_5971,1,1,AFFECTS,Inhibitory,3
15782,Intervention regimes,C1273869,en_5458,TREATS,Leak NOS,C1608322,en_6001,1,1,AFFECTS,Inhibitory,3
15783,Intervention regimes,C1273869,en_5458,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,6
15784,Intervention regimes,C1273869,en_5458,TREATS,Specific population,C4740649,en_6392,1,1,AFFECTS,Inhibitory,8
15785,Intervention regimes,C1273869,en_5458,TREATS,COVID-19,C5203670,en_6417,8,8,AFFECTS,Inhibitory,51
15786,Intervention regimes,C1273869,en_5458,TREATS(INFER),Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,Inhibitory,3
15787,Intervention regimes,C1273869,en_5458,TREATS(INFER),Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,Inhibitory,3
15788,Intervention regimes,C1273869,en_5458,TREATS(INFER),Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
15789,Intervention regimes,C1273869,en_5458,TREATS(INFER),Cleft Palate,C0008925,en_653,1,1,AFFECTS,Inhibitory,3
15790,Intervention regimes,C1273869,en_5458,TREATS(INFER),Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
15791,Intervention regimes,C1273869,en_5458,TREATS(INFER),Diabetic Neuropathies,C0011882,en_803,1,1,AFFECTS,Inhibitory,3
15792,Intervention regimes,C1273869,en_5458,TREATS(INFER),"Endometriosis, site unspecified",C0014175,en_898,1,1,AFFECTS,Inhibitory,3
15793,Intervention regimes,C1273869,en_5458,TREATS(INFER),Fatigue,C0015672,en_966,2,1,AFFECTS,Inhibitory,3
15794,Intervention regimes,C1273869,en_5458,TREATS(INFER),Inflammatory Bowel Diseases,C0021390,en_1310,1,1,AFFECTS,Inhibitory,3
15795,Intervention regimes,C1273869,en_5458,TREATS(INFER),Degenerative polyarthritis,C0029408,en_1723,2,1,AFFECTS,Inhibitory,3
15796,Intervention regimes,C1273869,en_5458,TREATS(INFER),Pancreatitis,C0030305,en_1745,7,1,AFFECTS,Inhibitory,3
15797,Intervention regimes,C1273869,en_5458,TREATS(INFER),Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
15798,Intervention regimes,C1273869,en_5458,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
15799,Intervention regimes,C1273869,en_5458,TREATS(INFER),Sleep disturbances,C0037317,en_2121,1,1,AFFECTS,Inhibitory,3
15800,Intervention regimes,C1273869,en_5458,TREATS(INFER),Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,3
15801,Intervention regimes,C1273869,en_5458,TREATS(INFER),Impaired cognition,C0338656,en_3804,2,2,AFFECTS,Inhibitory,6
15802,Intervention regimes,C1273869,en_5458,TREATS(INFER),Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,3
15803,Intervention regimes,C1273869,en_5458,TREATS(INFER),Mental health problem,C1446377,en_5753,1,1,AFFECTS,Inhibitory,3
15804,Intervention regimes,C1273869,en_5458,TREATS(SPEC),Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,Inhibitory,3
15805,Intervention regimes,C1273869,en_5458,TREATS(SPEC),Elderly,C0001792,en_258,3,3,AFFECTS,Inhibitory,9
15806,Intervention regimes,C1273869,en_5458,TREATS(SPEC),Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
15807,Management procedure,C1273870,en_5459,TREATS,Edema,C0013604,en_877,1,1,AFFECTS,Inhibitory,3
15808,Fusion inhibitor,C1275666,en_5460,DISRUPTS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
15809,Implantable venous access port,C1275732,en_5461,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,6
15810,Solution-Focused Brief Therapy,C1276047,en_5463,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,7
15811,Atrial fibrillation monitoring,C1276351,en_5465,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15812,Therapeutic regimen,C1276413,en_5466,AFFECTS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,General/Uncertain,6
15813,Therapeutic regimen,C1276413,en_5466,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
15814,Therapeutic regimen,C1276413,en_5466,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
15815,Therapeutic regimen,C1276413,en_5466,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
15816,Therapeutic regimen,C1276413,en_5466,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
15817,Stroke prevention,C1277289,en_5467,AFFECTS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,General/Uncertain,3
15818,Statin prophylaxis,C1278454,en_5468,AFFECTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,13
15819,Statin prophylaxis,C1278454,en_5468,TREATS,Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,7
15820,Statin prophylaxis,C1278454,en_5468,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
15821,Statin prophylaxis,C1278454,en_5468,TREATS,COVID-19,C5203670,en_6417,4,2,AFFECTS,Inhibitory,13
15822,Procedure on heart,C1279986,en_5469,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,7
15823,Exploration procedure,C1280903,en_5471,PREDISPOSES,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,Excitatory,3
15824,Exploration procedure,C1280903,en_5471,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
15825,Exploration procedure,C1280903,en_5471,PREDISPOSES,Heart failure,C0018801,en_1135,1,1,AFFECTS,Excitatory,3
15826,Exploration procedure,C1280903,en_5471,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15827,Exploration procedure,C1280903,en_5471,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
15828,Exploration procedure,C1280903,en_5471,TREATS,Infarction,C0021308,en_1301,1,1,AFFECTS,Inhibitory,3
15829,Exploration procedure,C1280903,en_5471,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,3
15830,Exploration procedure,C1280903,en_5471,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
15831,Exploration procedure,C1280903,en_5471,TREATS,Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
15832,Exploration procedure,C1280903,en_5471,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,3
15833,Exploration procedure,C1280903,en_5471,TREATS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
15834,Exploration procedure,C1280903,en_5471,TREATS,Cancer Patient,C1516213,en_5852,2,2,AFFECTS,Inhibitory,6
15835,Evacuation procedure,C1282573,en_5474,TREATS,Age,C0001779,en_257,1,1,AFFECTS,Inhibitory,3
15836,Evacuation procedure,C1282573,en_5474,TREATS,Spontaneous Incomplete abortion,C1533689,en_5938,1,1,AFFECTS,Inhibitory,3
15837,Entire respiratory epithelium,C1282653,en_5475,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
15838,Gland structure,C1285092,en_5477,PRODUCES,ACE2 gene|ACE2,C1422064|59272,en_5724,1,1,AFFECTS,Excitatory,6
15839,Dietary intake,C1286104,en_5479,AFFECTS,Growth,C0018270,en_1098,1,1,AFFECTS,General/Uncertain,3
15840,Dietary intake,C1286104,en_5479,AFFECTS,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,3
15841,Chronic nervous system disorder,C1290882,en_5482,AFFECTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
15842,Taking medication,C1290952,en_5489,TREATS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
15843,Taking medication,C1290952,en_5489,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,7
15844,Hematopoietic system finding,C1292123,en_5492,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
15845,Procoagulant,C1292267,en_5493,AFFECTS,Blood,C0005767,en_482,1,1,AFFECTS,General/Uncertain,3
15846,Procoagulant,C1292267,en_5493,PREDISPOSES,Thrombosis,C0040053,en_2233,1,1,AFFECTS,Excitatory,3
15847,Complex procedure,C1292781,en_5494,TREATS,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,Inhibitory,8
15848,Procedure on lung,C1292960,en_5495,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
15849,Introduction procedure,C1293116,en_5496,AFFECTS,Unemployment,C0041674,en_2309,1,1,AFFECTS,General/Uncertain,3
15850,Introduction procedure,C1293116,en_5496,PREVENTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Inhibitory,3
15851,Introduction procedure,C1293116,en_5496,TREATS,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Inhibitory,3
15852,Introduction procedure,C1293116,en_5496,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
15853,Introduction procedure,C1293116,en_5496,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15854,Introduction procedure,C1293116,en_5496,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
15855,Introduction procedure,C1293116,en_5496,TREATS,Functional disorder,C0277785,en_3588,1,1,AFFECTS,Inhibitory,3
15856,Stabilization,C1293130,en_5497,PREVENTS,Heart Arrest,C0018790,en_1131,2,1,AFFECTS,Inhibitory,3
15857,Stabilization,C1293130,en_5497,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,3
15858,Stabilization,C1293130,en_5497,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
15859,Heart implantation procedure,C1293382,en_5498,TREATS,Catalonian,C1553362,en_5960,2,1,AFFECTS,Inhibitory,6
15860,Heart implantation procedure,C1293382,en_5498,TREATS,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,Inhibitory,6
15861,Vagal stimulation,C1293903,en_5499,AFFECTS,Respiration,C0035203,en_2004,2,1,AFFECTS,General/Uncertain,3
15862,Vagal stimulation,C1293903,en_5499,AFFECTS,Bronchoconstriction,C0079043,en_2591,2,1,AFFECTS,General/Uncertain,3
15863,Vagal stimulation,C1293903,en_5499,AFFECTS,pulmonary function,C0231921,en_3268,2,1,AFFECTS,General/Uncertain,3
15864,Emergency procedure,C1298802,en_5501,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,7
15865,Emergency procedure,C1298802,en_5501,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15866,Emergency procedure,C1298802,en_5501,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
15867,Routine procedure,C1298805,en_5502,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
15868,Empirical antibiotic therapy,C1299622,en_5505,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
15869,Postural orthostatic tachycardia syndrome,C1299624,en_5506,AFFECTS,Patients,C0030705,en_1762,3,1,AFFECTS,General/Uncertain,3
15870,Percutaneous dilational tracheostomy,C1301722,en_5510,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
15871,Documented,C1301725,en_5511,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,3
15872,Problem solving therapy,C1303140,en_5513,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
15873,Problem solving therapy,C1303140,en_5513,TREATS,Teens,C1521910,en_5899,1,1,AFFECTS,Inhibitory,3
15874,Problem solving therapy,C1303140,en_5513,TREATS(INFER),Traumatic Brain Injury,C0876926,en_5057,1,1,AFFECTS,Inhibitory,3
15875,Tissue fiber,C1304649,en_5514,PRODUCES,Synthetic polymer,C0440257,en_4041,1,1,AFFECTS,Excitatory,3
15876,Carer,C1305660,en_5515,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15877,Body mass index,C1305855,en_5516,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,3
15878,Anesthesia type,C1305863,en_5517,TREATS,Obstetric Patient,C0700061,en_4712,2,1,AFFECTS,Inhibitory,3
15879,Death (finding),C1306577,en_5521,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
15880,Death (finding),C1306577,en_5521,PREDISPOSES,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Excitatory,3
15881,Death (finding),C1306577,en_5521,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
15882,Plain x-ray,C1306645,en_5523,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
15883,"FRAP1 protein, human",C1307407,en_5524,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,3
15884,"FRAP1 protein, human",C1307407,en_5524,AFFECTS,cytokine biosynthesis,C1155099,en_5317,1,1,AFFECTS,General/Uncertain,3
15885,"FRAP1 protein, human",C1307407,en_5524,DISRUPTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
15886,"FRAP1 protein, human",C1307407,en_5524,DISRUPTS,Cognitive function: planning,C0032074,en_1815,1,1,AFFECTS,Inhibitory,3
15887,"CXCL10 protein, human|CXCL10",C1308752|3627,en_5525,AFFECTS,Reduction (chemical),C0301630,en_3691,1,1,AFFECTS,General/Uncertain,8
15888,"SH2D3A protein, human",C1309025,en_5526,DISRUPTS,Signal Transduction,C0037083,en_2105,2,1,AFFECTS,Inhibitory,3
15889,Radioprotective drug,C1318473,en_5531,TREATS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
15890,Asthma management,C1318955,en_5533,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,3
15891,Newly diagnosed diabetes,C1320655,en_5536,PREDISPOSES,COVID-19,C5203670,en_6417,2,1,AFFECTS,Excitatory,6
15892,Cardiovascular event,C1320716,en_5537,PREDISPOSES,Embolism,C0013922,en_887,1,1,AFFECTS,Excitatory,3
15893,Cardiovascular event,C1320716,en_5537,PREDISPOSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,3
15894,Cardiovascular event,C1320716,en_5537,PREDISPOSES,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Excitatory,3
15895,Cardiovascular event,C1320716,en_5537,PREDISPOSES,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,Excitatory,3
15896,Cardiovascular event,C1320716,en_5537,PREDISPOSES,Fibrillation,C0232197,en_3274,1,1,AFFECTS,Excitatory,3
15897,Dialectical behavior therapy,C1321145,en_5539,AFFECTS,Anxiety,C0003467,en_380,2,1,AFFECTS,General/Uncertain,8
15898,Dialectical behavior therapy,C1321145,en_5539,AFFECTS,Depressive disorder,C0011581,en_788,2,1,AFFECTS,General/Uncertain,8
15899,Dialectical behavior therapy,C1321145,en_5539,TREATS,Anxiety,C0003467,en_380,1,1,AFFECTS,Inhibitory,8
15900,Dialectical behavior therapy,C1321145,en_5539,TREATS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,8
15901,Dialectical behavior therapy,C1321145,en_5539,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15902,Behavioral phenotype,C1321146,en_5540,AFFECTS,Self Stimulation,C0036602,en_2079,1,1,AFFECTS,General/Uncertain,3
15903,Behavioral phenotype,C1321146,en_5540,AFFECTS,Withdrawal,C0237955,en_3358,1,1,AFFECTS,General/Uncertain,3
15904,Peripheral blood mononuclear cell,C1321301,en_5541,PRODUCES,cytokine,C0079189,en_2593,2,1,AFFECTS,Excitatory,3
15905,Respiratory monitors,C1321577,en_5542,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15906,"TLR4 protein, human",C1321919,en_5543,AFFECTS,host,C1167395,en_5368,1,1,AFFECTS,General/Uncertain,3
15907,"TLR4 protein, human|TLR4",C1321919|7099,en_5544,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,8
15908,"TLR4 protein, human|TLR4",C1321919|7099,en_5544,AUGMENTS,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,7
15909,Samplers,C1322502,en_5545,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15910,Covered Stents,C1322797,en_5546,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15911,Covered Stents,C1322797,en_5546,TREATS(INFER),Distal bile duct stricture,C0860019,en_4988,1,1,AFFECTS,Inhibitory,3
15912,photoreceptor outer segment,C1325525,en_5549,PRODUCES,Hydroxybutyrates,C0020332,en_1225,1,1,AFFECTS,Excitatory,3
15913,apolipoprotein B mRNA editing enzyme complex location,C1325696,en_5550,AFFECTS,RNA Editing,C0162782,en_2933,1,1,AFFECTS,General/Uncertain,3
15914,Pigmentation physiologic function,C1326702,en_5560,AFFECTS,Hyperpigmentation,C0162834,en_2937,1,1,AFFECTS,General/Uncertain,3
15915,ion homeostasis,C1326962,en_5563,AFFECTS,Hearing problem,C0260662,en_3513,1,1,AFFECTS,General/Uncertain,3
15916,cytokine secretion,C1327414,en_5565,AFFECTS,Contraction,C1140999,en_5281,1,1,AFFECTS,General/Uncertain,3
15917,Abuse,C1328247,en_5567,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,3
15918,Health Management,C1328735,en_5569,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
15919,Health Management,C1328735,en_5569,TREATS,Caregiver,C0085537,en_2674,1,1,AFFECTS,Inhibitory,3
15920,Podocytes,C1328818,en_5572,PRODUCES,ZHX2,C1425569,en_118,1,1,AFFECTS,Excitatory,3
15921,Podocytes,C1328818,en_5572,PRODUCES,ACE2,C1422064,en_5723,1,1,AFFECTS,Excitatory,3
15922,small molecule,C1328819,en_5573,AFFECTS,Wound Healing,C0043240,en_2400,2,1,AFFECTS,General/Uncertain,3
15923,small molecule,C1328819,en_5573,AFFECTS,T-Cell Activation,C1155065,en_5315,1,1,AFFECTS,General/Uncertain,3
15924,small molecule,C1328819,en_5573,DISRUPTS,RNA translation,C0678935,en_4585,1,1,AFFECTS,Inhibitory,3
15925,small molecule,C1328819,en_5573,INHIBITS,Acetyltransferase,C0001068,en_220,1,1,AFFECTS,Inhibitory,3
15926,small molecule,C1328819,en_5573,INHIBITS,Amylases,C0002712,en_307,1,1,AFFECTS,Inhibitory,3
15927,small molecule,C1328819,en_5573,INHIBITS,Exonuclease,C0015296,en_944,1,1,AFFECTS,Inhibitory,3
15928,small molecule,C1328819,en_5573,INHIBITS,Nucleoproteins,C0028612,en_1691,1,1,AFFECTS,Inhibitory,3
15929,small molecule,C1328819,en_5573,INHIBITS,Plasminogen Activator Inhibitor 1,C0030190,en_1740,1,1,AFFECTS,Inhibitory,3
15930,small molecule,C1328819,en_5573,INHIBITS,Peptide Hydrolases,C0030940,en_1769,2,2,AFFECTS,Inhibitory,6
15931,small molecule,C1328819,en_5573,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
15932,small molecule,C1328819,en_5573,INHIBITS,Glutamate Carboxypeptidase II,C0067685,en_2528,1,1,AFFECTS,Inhibitory,3
15933,small molecule,C1328819,en_5573,INHIBITS,NADPH Oxidase,C0068355,en_2529,2,1,AFFECTS,Inhibitory,3
15934,small molecule,C1328819,en_5573,INHIBITS,Janus kinase 1,C0169658,en_2958,1,1,AFFECTS,Inhibitory,3
15935,small molecule,C1328819,en_5573,INHIBITS,TYK2,C0599969,en_4492,1,1,AFFECTS,Inhibitory,3
15936,small molecule,C1328819,en_5573,INHIBITS,Proprotein Convertases,C1100660,en_5239,1,1,AFFECTS,Inhibitory,3
15937,small molecule,C1328819,en_5573,PREVENTS,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,Inhibitory,3
15938,small molecule,C1328819,en_5573,STIMULATES,"MPL protein, human",C0218227,en_3197,1,1,AFFECTS,Excitatory,3
15939,small molecule,C1328819,en_5573,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
15940,Telehealth,C1328956,en_5577,PREVENTS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
15941,Telehealth,C1328956,en_5577,PREVENTS(SPEC),Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
15942,Telehealth,C1328956,en_5577,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
15943,Telehealth,C1328956,en_5577,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15944,Telehealth,C1328956,en_5577,TREATS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,Inhibitory,6
15945,Telehealth,C1328956,en_5577,TREATS,Persons,C0027361,en_1635,5,3,AFFECTS,Inhibitory,9
15946,Telehealth,C1328956,en_5577,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
15947,Telehealth,C1328956,en_5577,TREATS,"Sleep Apnea, Obstructive",C0520679,en_4191,1,1,AFFECTS,Inhibitory,3
15948,Telehealth,C1328956,en_5577,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
15949,Telehealth,C1328956,en_5577,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,3
15950,Telehealth,C1328956,en_5577,TREATS(INFER),Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,3
15951,Telehealth,C1328956,en_5577,TREATS(SPEC),Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
15952,Telehealth,C1328956,en_5577,TREATS(SPEC),Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
15953,Telehealth,C1328956,en_5577,TREATS(SPEC),Persons,C0027361,en_1635,2,2,AFFECTS,Inhibitory,6
15954,Telehealth,C1328956,en_5577,TREATS(SPEC),parent,C0030551,en_1750,2,2,AFFECTS,Inhibitory,6
15955,Telehealth,C1328956,en_5577,TREATS(SPEC),Sleeplessness,C0917801,en_5108,1,1,AFFECTS,Inhibitory,3
15956,Cytokinesis of the fertilized ovum,C1330957,en_5579,AFFECTS,Renal function,C0232804,en_3285,1,1,AFFECTS,General/Uncertain,3
15957,vaccine delivery,C1331096,en_5580,TREATS,Adult,C0001675,en_252,5,2,AFFECTS,Inhibitory,6
15958,vaccine delivery,C1331096,en_5580,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
15959,vaccine delivery,C1331096,en_5580,TREATS,Does hit,C0596020,en_4378,1,1,AFFECTS,Inhibitory,3
15960,ASK Gene,C1332118,en_5582,AUGMENTS,Awareness,C0004448,en_433,1,1,AFFECTS,Excitatory,3
15961,CD4 gene,C1332714,en_5583,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
15962,CD4 gene,C1332714,en_5583,AUGMENTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Excitatory,3
15963,CD4 gene,C1332714,en_5583,AUGMENTS,Antiinflammatory Effect,C1516019,en_5851,1,1,AFFECTS,Excitatory,3
15964,CD4 gene,C1332714,en_5583,DISRUPTS,Graft-vs-Host Disease,C0018133,en_1092,1,1,AFFECTS,Inhibitory,3
15965,CD4 gene,C1332714,en_5583,INHIBITS,Antibodies,C0003241,en_347,1,1,AFFECTS,Inhibitory,3
15966,CD4 gene,C1332714,en_5583,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
15967,CD4 gene,C1332714,en_5583,PREVENTS,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,Inhibitory,3
15968,CD4 gene,C1332714,en_5583,PRODUCES,Interferons,C0021747,en_1333,2,1,AFFECTS,Excitatory,3
15969,CD4 gene,C1332714,en_5583,STIMULATES,Antigens,C0003320,en_365,2,1,AFFECTS,Excitatory,3
15970,CD4 gene,C1332714,en_5583,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
15971,CXCR4 gene,C1332823,en_5584,AFFECTS,cell motility,C0007608,en_593,2,2,AFFECTS,General/Uncertain,6
15972,CYP2C9 gene,C1332829,en_5585,STIMULATES,Pharmaceutical Preparations,C0013227,en_856,1,1,AFFECTS,Excitatory,3
15973,CYP2C9 gene,C1332829,en_5585,STIMULATES,Cytochrome P450 3A4,C1142644,en_5288,1,1,AFFECTS,Excitatory,3
15974,CYP2C9 gene,C1332829,en_5585,STIMULATES,CYP2D6 gene,C1332830,en_5586,1,1,AFFECTS,Excitatory,3
15975,CYP2D6 gene,C1332830,en_5586,AFFECTS,Hyperprolactinemia,C0020514,en_1237,1,1,AFFECTS,General/Uncertain,3
15976,Candidate Disease Gene,C1332838,en_5587,AFFECTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,General/Uncertain,3
15977,DUSP3 gene,C1333258,en_5589,INHIBITS,small molecule,C1328819,en_5573,1,1,AFFECTS,Inhibitory,3
15978,Dual Specificity Phosphatase 3,C1333317,en_5590,AFFECTS,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
15979,ERCC3 gene,C1333357,en_5591,INHIBITS,multicatalytic endopeptidase complex,C0208355,en_3181,1,1,AFFECTS,Inhibitory,3
15980,FIBP gene,C1333548,en_5592,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
15981,FLT3 gene,C1333568,en_5593,AFFECTS,"Leukemia, Myelocytic, Acute",C0023467,en_1418,1,1,AFFECTS,General/Uncertain,3
15982,Functional RNA,C1333647,en_5596,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
15983,Homologous Gene,C1334043,en_5599,AFFECTS,Virulence,C0042765,en_2361,1,1,AFFECTS,General/Uncertain,3
15984,Homologous Gene,C1334043,en_5599,AFFECTS,protein activity,C1537044,en_5946,1,1,AFFECTS,General/Uncertain,3
15985,IL13 gene|IL13,C1334103|3596,en_5600,DISRUPTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
15986,ILK gene|ILK,C1334128|3611,en_5601,INHIBITS,Monoclonal Antibodies,C0003250,en_350,1,1,AFFECTS,Inhibitory,8
15987,IRF3 gene,C1334139,en_5602,AFFECTS,neutrophil,C0027950,en_1676,2,2,AFFECTS,General/Uncertain,6
15988,IRF3 gene,C1334139,en_5602,AFFECTS,MONOCYTES AND MACROPHAGES,C1148382,en_5295,2,2,AFFECTS,General/Uncertain,6
15989,IRF3 gene,C1334139,en_5602,PRODUCES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
15990,ITGB2 gene,C1334146,en_5603,AUGMENTS,Myocardial tissue,C1267093,en_5435,1,1,AFFECTS,Excitatory,3
15991,Ion Channel Protein,C1334283,en_5604,AFFECTS,Autoimmune Diseases,C0004364,en_428,2,2,AFFECTS,General/Uncertain,6
15992,Ion Channel Protein,C1334283,en_5604,AFFECTS(SPEC),Myasthenia Gravis,C0026896,en_1613,2,2,AFFECTS,General/Uncertain,6
15993,JTB gene,C1334294,en_5605,AFFECTS,Cell Death,C0007587,en_587,1,1,AFFECTS,General/Uncertain,3
15994,JTB gene,C1334294,en_5605,AUGMENTS,Cell Death,C0007587,en_587,2,1,AFFECTS,Excitatory,3
15995,JTB gene,C1334294,en_5605,PRODUCES,DNA,C0012854,en_834,1,1,AFFECTS,Excitatory,3
15996,KDR gene,C1334306,en_5606,STIMULATES,Receptor Signaling,C1514762,en_5838,1,1,AFFECTS,Excitatory,3
15997,LOX gene,C1334349,en_5607,PRODUCES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,3
15998,MADHIP gene,C1334471,en_5608,PREDISPOSES,Violence,C0042693,en_2353,1,1,AFFECTS,Excitatory,3
15999,NGFR gene,C1334879,en_5609,AFFECTS,Nerve Regeneration,C0027756,en_1658,1,1,AFFECTS,General/Uncertain,3
16000,"PTPN22 protein, human|PTPN22",C1335057|26191,en_5610,AFFECTS,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,General/Uncertain,8
16001,OSA,C1335091,en_5611,AFFECTS,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,1,1,AFFECTS,General/Uncertain,3
16002,OSA,C1335091,en_5611,STIMULATES,CD4 gene,C1332714,en_5583,1,1,AFFECTS,Excitatory,3
16003,PGF gene|PGF,C1335207|5228,en_5612,AUGMENTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,Excitatory,6
16004,PHLDA2 gene,C1335210,en_5613,AFFECTS,Hemodynamics,C0019010,en_1156,1,1,AFFECTS,General/Uncertain,3
16005,PHLDA2 gene,C1335210,en_5613,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
16006,PHLDA2 gene,C1335210,en_5613,PREDISPOSES,Complication,C0009566,en_697,1,1,AFFECTS,Excitatory,3
16007,Polymerase,C1335439,en_5615,PRODUCES,Adenosine Diphosphate Ribose,C0001461,en_237,1,1,AFFECTS,Excitatory,3
16008,Polymerase,C1335439,en_5615,PRODUCES,JTB gene,C1334294,en_5605,1,1,AFFECTS,Excitatory,3
16009,Refractory Hematologic Malignancy,C1335724,en_5620,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
16010,SCTR gene,C1335806,en_5621,AUGMENTS,uptake,C0243144,en_3467,1,1,AFFECTS,Excitatory,3
16011,SECTM1 gene,C1335807,en_5622,DISRUPTS,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Inhibitory,3
16012,SECTM1 gene,C1335807,en_5622,DISRUPTS,Lung,C0024109,en_1460,1,1,AFFECTS,Inhibitory,3
16013,SECTM1 gene,C1335807,en_5622,DISRUPTS,Respiratory tract infection viral,C0877203,en_5066,1,1,AFFECTS,Inhibitory,3
16014,SH2D3C gene,C1335818,en_5623,DISRUPTS,Signal Transduction,C0037083,en_2105,2,1,AFFECTS,Inhibitory,3
16015,SKIL gene,C1335828,en_5624,AFFECTS,Adhesions,C0001511,en_240,1,1,AFFECTS,General/Uncertain,3
16016,STIM1 gene,C1335879,en_5627,AFFECTS,Inactivation,C0544461,en_4262,1,1,AFFECTS,General/Uncertain,3
16017,SYK gene,C1335892,en_5628,AFFECTS,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
16018,SYK gene,C1335892,en_5628,AFFECTS,Platelet function,C1254881,en_5398,1,1,AFFECTS,General/Uncertain,3
16019,TEK gene,C1336602,en_5630,INHIBITS,Cell Adhesion Molecules,C0007578,en_583,1,1,AFFECTS,Inhibitory,3
16020,TLR3 gene,C1336635,en_5632,PREVENTS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,3
16021,TLR3 gene,C1336635,en_5632,STIMULATES,Genes,C0017337,en_1052,1,1,AFFECTS,Excitatory,3
16022,TLR7 gene,C1336639,en_5634,AFFECTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,3
16023,TLR8 gene,C1336640,en_5635,DISRUPTS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,Inhibitory,3
16024,TMPRSS2 gene|TMPRSS2,C1336641|7113,en_5637,STIMULATES,Enterocytes,C0682610,en_4646,1,1,AFFECTS,Excitatory,6
16025,TYRP1 gene,C1336694,en_5639,INHIBITS,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Inhibitory,3
16026,Topoisomerase,C1336767,en_5640,AFFECTS,"Translation, Genetic",C0040711,en_2274,11,1,AFFECTS,General/Uncertain,3
16027,Topoisomerase,C1336767,en_5640,STIMULATES,Ethidium Bromide,C0019873,en_1202,1,1,AFFECTS,Excitatory,3
16028,CCL2 gene,C1337092,en_5643,DISRUPTS,Armed macrophage,C0001280,en_228,1,1,AFFECTS,Inhibitory,3
16029,CCL2 gene,C1337092,en_5643,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
16030,RBBP1L1 Protein,C1337094,en_5644,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
16031,RBBP1L1 Protein,C1337094,en_5644,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
16032,POMC gene,C1337111,en_5645,AFFECTS,Brain Hypoxia,C1527348,en_5923,2,1,AFFECTS,General/Uncertain,3
16033,BAMBOO,C1337281,en_5646,PREVENTS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
16034,BAMBOO,C1337281,en_5646,PREVENTS,Overweight,C0497406,en_4165,1,1,AFFECTS,Inhibitory,3
16035,Nitrous oxide gas,C1342362,en_5647,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,3
16036,Herbal Drugs,C1360419,en_5648,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
16037,TNFRSF1A gene|TNFRSF1A,C1363984|7132,en_5649,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
16038,TNFRSF1A gene|TNFRSF1A,C1363984|7132,en_5649,PREDISPOSES,Endothelial dysfunction,C0856169,en_4968,1,1,AFFECTS,Excitatory,6
16039,MERTK gene,C1364081,en_5650,AFFECTS,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
16040,MERTK gene,C1364081,en_5650,AFFECTS,Neuraxis,C0927232,en_5132,1,1,AFFECTS,General/Uncertain,3
16041,MERTK gene,C1364081,en_5650,DISRUPTS,Death (finding),C1306577,en_5521,1,1,AFFECTS,Inhibitory,3
16042,APP gene,C1364818,en_5652,DISRUPTS,Gingivitis,C0017574,en_1060,2,1,AFFECTS,Inhibitory,6
16043,APP gene,C1364818,en_5652,AFFECTS,Muscle Contraction,C0026820,en_1601,1,1,AFFECTS,General/Uncertain,3
16044,APP gene,C1364818,en_5652,AFFECTS,Personal Satisfaction,C0031206,en_1780,2,1,AFFECTS,General/Uncertain,3
16045,APP gene,C1364818,en_5652,AFFECTS,grasp,C0220843,en_3203,1,1,AFFECTS,General/Uncertain,3
16046,APP gene,C1364818,en_5652,AFFECTS,uptake,C0243144,en_3467,2,1,AFFECTS,General/Uncertain,3
16047,APP gene,C1364818,en_5652,AFFECTS,Feeling suicidal,C0424000,en_3990,4,1,AFFECTS,General/Uncertain,3
16048,APP gene,C1364818,en_5652,AUGMENTS,Awareness,C0004448,en_433,1,1,AFFECTS,Excitatory,3
16049,APP gene,C1364818,en_5652,AUGMENTS,Cognition,C0009240,en_668,2,1,AFFECTS,Excitatory,3
16050,APP gene,C1364818,en_5652,AUGMENTS,Self-confidence,C0237529,en_3348,2,2,AFFECTS,Excitatory,6
16051,APP gene,C1364818,en_5652,AUGMENTS,experience,C0596545,en_4391,3,3,AFFECTS,Excitatory,9
16052,APP gene,C1364818,en_5652,DISRUPTS,Anxiety,C0003467,en_380,2,1,AFFECTS,Inhibitory,3
16053,Olive leaf extract,C1364955,en_5653,AFFECTS,Immune response,C0301872,en_3696,1,1,AFFECTS,General/Uncertain,3
16054,BCAR1 gene,C1366459,en_5654,DISRUPTS,Depressive disorder,C0011581,en_788,3,1,AFFECTS,Inhibitory,3
16055,BCAR1 gene,C1366459,en_5654,PRODUCES,CD33,C3491277,en_15,1,1,AFFECTS,Excitatory,3
16056,KITLG gene,C1366480,en_5655,AFFECTS,Vascular constriction (function),C0042396,en_2340,1,1,AFFECTS,General/Uncertain,3
16057,KLK3 gene,C1366489,en_5657,AFFECTS,Emotional,C0849912,en_4937,1,1,AFFECTS,General/Uncertain,3
16058,ADRBK1 gene,C1366490,en_5658,INHIBITS,RNA-Directed DNA Polymerase,C0035379,en_2027,3,1,AFFECTS,Inhibitory,3
16059,TIE gene,C1366528,en_5660,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
16060,TIE gene,C1366528,en_5660,AUGMENTS,experience (practice),C0237607,en_3350,1,1,AFFECTS,Excitatory,3
16061,RARA gene,C1366536,en_5661,INHIBITS,ATM gene,C0919524,en_5114,4,2,AFFECTS,Inhibitory,6
16062,TGFB1 gene,C1366557,en_5662,DISRUPTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Inhibitory,3
16063,CD80 gene,C1366561,en_5663,DISRUPTS,Cell Maturation,C1516349,en_5855,1,1,AFFECTS,Inhibitory,3
16064,EPO gene,C1366564,en_5664,PREVENTS,Thromboembolism,C0040038,en_2230,2,1,AFFECTS,Inhibitory,3
16065,ATP8A2 gene,C1366628,en_5666,AUGMENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,3
16066,ATP8A2 gene,C1366628,en_5666,INHIBITS,ecto-nucleotidase,C0377293,en_3891,1,1,AFFECTS,Inhibitory,3
16067,ATP8A2 gene,C1366628,en_5666,STIMULATES,Acyltransferase,C0001390,en_235,1,1,AFFECTS,Excitatory,3
16068,ATP8A2 gene,C1366628,en_5666,STIMULATES,Ligase,C0023689,en_1433,1,1,AFFECTS,Excitatory,3
16069,ATP8A2 gene,C1366628,en_5666,STIMULATES,RNA,C0035668,en_2040,1,1,AFFECTS,Excitatory,3
16070,CD36 gene,C1366645,en_5667,AFFECTS,Foam Cells,C0016390,en_1010,1,1,AFFECTS,General/Uncertain,3
16071,VIP gene,C1366646,en_5668,DISRUPTS,Emission,C0233929,en_3301,1,1,AFFECTS,Inhibitory,3
16072,TYMS gene,C1366824,en_5669,PREDISPOSES,Cytokine storm,C0919747,en_5119,2,1,AFFECTS,Excitatory,3
16073,Calmodulin 1,C1366910,en_5670,AFFECTS,Stress,C0038435,en_2165,2,2,AFFECTS,General/Uncertain,6
16074,Calmodulin 1,C1366910,en_5670,PREVENTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,3
16075,CD8B1 gene,C1367471,en_5671,AUGMENTS,Antiinflammatory Effect,C1516019,en_5851,1,1,AFFECTS,Excitatory,3
16076,CD8B1 gene,C1367471,en_5671,DISRUPTS,Graft-vs-Host Disease,C0018133,en_1092,1,1,AFFECTS,Inhibitory,3
16077,CD8B1 gene,C1367471,en_5671,INHIBITS,Antibodies,C0003241,en_347,1,1,AFFECTS,Inhibitory,3
16078,CD8B1 gene,C1367471,en_5671,PREVENTS,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,Inhibitory,3
16079,CD8B1 gene,C1367471,en_5671,PRODUCES,Interferons,C0021747,en_1333,2,1,AFFECTS,Excitatory,3
16080,CD8B1 gene,C1367471,en_5671,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
16081,CD8B1 gene,C1367471,en_5671,STIMULATES,"NOS3 protein, human",C0669365,en_4534,1,1,AFFECTS,Excitatory,3
16082,CD14 gene,C1367477,en_5672,AFFECTS,cell activation,C1326120,en_5553,2,1,AFFECTS,General/Uncertain,3
16083,CD14 gene,C1367477,en_5672,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
16084,CD14 gene,C1367477,en_5672,AUGMENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Excitatory,3
16085,CD14 gene,C1367477,en_5672,DISRUPTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
16086,CD14 gene,C1367477,en_5672,PREDISPOSES,Septicemia,C0036690,en_2086,1,1,AFFECTS,Excitatory,3
16087,PTGS2 gene,C1367485,en_5673,PRODUCES,Nitric Oxide,C0028128,en_1682,1,1,AFFECTS,Excitatory,3
16088,PTGS2 gene,C1367485,en_5673,PRODUCES,TNF gene,C0812246,en_4896,1,1,AFFECTS,Excitatory,3
16089,AR gene,C1367578,en_5674,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
16090,PLAT gene|PLAT,C1367601|5327,en_5675,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,8
16091,MAP3K14 gene,C1367673,en_5676,AUGMENTS,Lung,C0024109,en_1460,1,1,AFFECTS,Excitatory,3
16092,MAP3K14 gene,C1367673,en_5676,DISRUPTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,3
16093,MAP3K14 gene,C1367673,en_5676,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
16094,Late effect of,C1368999,en_5678,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
16095,Hydroxychloroquine 400 MG,C1370448,en_5679,TREATS,Critical Illness,C0010340,en_733,2,1,AFFECTS,Inhibitory,3
16096,Increased T Lymphocyte Production,C1372688,en_5680,AFFECTS,Hypertrophy of thymus,C1510517,en_5796,1,1,AFFECTS,General/Uncertain,6
16097,Physiological Effects,C1372798,en_5681,AFFECTS,Respiratory Mechanics,C0035230,en_2013,1,1,AFFECTS,General/Uncertain,3
16098,Active Ingredients,C1372955,en_5682,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
16099,Active Ingredients,C1372955,en_5682,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,3
16100,Active Ingredients,C1372955,en_5682,TREATS,network,C0679670,en_4604,1,1,AFFECTS,Inhibitory,3
16101,Nucleoside Reverse Transcriptase Inhibitors,C1373111,en_5684,INHIBITS,RNA,C0035668,en_2040,1,1,AFFECTS,Inhibitory,3
16102,Immune System Suppression,C1373218,en_5686,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
16103,Immune System Suppression,C1373218,en_5686,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16104,Preservative free ingredient,C1377705,en_5687,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
16105,Preservative free ingredient,C1377705,en_5687,TREATS,Participant,C0679646,en_4602,2,2,AFFECTS,Inhibitory,6
16106,Preservative free ingredient,C1377705,en_5687,TREATS(INFER),Well adult,C0686750,en_4683,2,2,AFFECTS,Inhibitory,6
16107,glomerulopathy,C1398810,en_5693,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
16108,ABL1 gene,C1412097,en_5697,INHIBITS,Phosphotransferases,C0031727,en_1801,1,1,AFFECTS,Inhibitory,3
16109,CD3D gene,C1413222,en_5699,STIMULATES,"Receptors, Nuclear",C0206588,en_3171,1,1,AFFECTS,Excitatory,3
16110,CEACAM6 gene|CEACAM6,C1413309|4680,en_5700,AFFECTS,risk factors,C0035648,en_2039,1,1,AFFECTS,General/Uncertain,6
16111,CH25H gene,C1413371,en_5701,PRODUCES,small molecule,C1328819,en_5573,1,1,AFFECTS,Excitatory,3
16112,CLOCK gene,C1413503,en_5702,AFFECTS,Circadian Rhythms,C0008810,en_647,1,1,AFFECTS,General/Uncertain,3
16113,CST3 gene|CST3,C1413772|1471,en_5703,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
16114,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Comorbidity,C0009488,en_690,1,1,AFFECTS,General/Uncertain,6
16115,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,6
16116,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Dysgeusia,C0013378,en_865,1,1,AFFECTS,General/Uncertain,6.5
16117,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Reduction (chemical),C0301630,en_3691,1,1,AFFECTS,General/Uncertain,8
16118,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Monocytopenia,C0427544,en_4010,1,1,AFFECTS,General/Uncertain,6
16119,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,General/Uncertain,6
16120,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Hyposmia/anosmia,C3554023,en_6219,1,1,AFFECTS,General/Uncertain,6.5
16121,GJA1 gene|GJA1,C1415068|2697,en_5704,AFFECTS,Additional day,C4534574,en_6362,1,1,AFFECTS,General/Uncertain,6
16122,GJA1 gene|GJA1,C1415068|2697,en_5704,AUGMENTS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Excitatory,6
16123,GJA1 gene|GJA1,C1415068|2697,en_5704,INHIBITS,ACE2 gene|ACE2,C1422064|59272,en_5724,1,1,AFFECTS,Inhibitory,8
16124,LAG3 gene|LAG3,C1416771|3902,en_5707,STIMULATES,TLR6,C1336638,en_106,1,1,AFFECTS,Excitatory,7
16125,LAG3 gene|LAG3,C1416771|3902,en_5707,STIMULATES,Gelatinase B|MMP9,C0165519|4318,en_2947,1,1,AFFECTS,Excitatory,7
16126,MS4A1 gene,C1417326,en_5708,TREATS(SPEC),Disease,C0012634,en_826,3,1,AFFECTS,Inhibitory,3
16127,MS4A1 gene,C1417326,en_5708,TREATS(SPEC),Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
16128,TRIM37 gene|TRIM37,C1417503|4591,en_5709,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
16129,SARS gene,C1419818,en_5714,DISRUPTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,Inhibitory,3
16130,SDC2 gene|SDC2,C1419892|6383,en_5716,AUGMENTS,Cone-Rod Dystrophy 2,C3489532,en_6200,1,1,AFFECTS,Excitatory,7
16131,SIGLEC1 gene|SIGLEC1,C1420266|6614,en_5717,STIMULATES,monocyte,C0026473,en_1580,1,1,AFFECTS,Excitatory,6
16132,SOD1 gene|SOD1,C1420306|6647,en_5718,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,7
16133,STN gene,C1420485,en_5719,PREVENTS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,Inhibitory,3
16134,STN gene,C1420485,en_5719,PREVENTS,Dementia,C0497327,en_4164,1,1,AFFECTS,Inhibitory,3
16135,TOP3B gene,C1420860,en_5720,STIMULATES,RNA replication,C1328949,en_5576,4,1,AFFECTS,Excitatory,3
16136,WASF1 gene|WASF1,C1421479|8936,en_5721,AFFECTS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,General/Uncertain,6
16137,WASF1 gene|WASF1,C1421479|8936,en_5721,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16138,ACE2 gene,C1422064,en_5723,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
16139,ACE2 gene|ACE2,C1422064|59272,en_5724,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
16140,ACE2 gene|ACE2,C1422064|59272,en_5724,AUGMENTS,Lung,C0024109,en_1460,1,1,AFFECTS,Excitatory,7
16141,ACE2 gene|ACE2,C1422064|59272,en_5724,AUGMENTS,Cell Invasion,C2699153,en_6118,1,1,AFFECTS,Excitatory,6
16142,ACE2 gene|ACE2,C1422064|59272,en_5724,STIMULATES,Enterocytes,C0682610,en_4646,1,1,AFFECTS,Excitatory,6
16143,NELFCD gene|NELFCD,C1423842|51497,en_5725,STIMULATES,Th2 Cells,C0242633,en_3426,1,1,AFFECTS,Excitatory,6
16144,IL27 gene,C1426048,en_5727,STIMULATES,Endothelial Cells,C0225336,en_3237,1,1,AFFECTS,Excitatory,3
16145,Rintatolimod,C1434913,en_5728,AFFECTS,Immune,C0439662,en_4035,1,1,AFFECTS,General/Uncertain,8
16146,Rintatolimod,C1434913,en_5728,STIMULATES,TLR3 gene,C1336635,en_5632,1,1,AFFECTS,Excitatory,8
16147,Rintatolimod,C1434913,en_5728,TREATS,Chronic Fatigue Syndrome,C0015674,en_967,1,1,AFFECTS,Inhibitory,8
16148,UIC94017,C1435444,en_5729,TREATS,2019 novel coronavirus,C5203676,en_6420,3,1,AFFECTS,Inhibitory,6
16149,B VARIANT NOS,C1440117,en_5731,AFFECTS,Blood,C0005767,en_482,1,1,AFFECTS,General/Uncertain,3
16150,B VARIANT NOS,C1440117,en_5731,AFFECTS,Cells,C0007634,en_596,1,1,AFFECTS,General/Uncertain,3
16151,B VARIANT NOS,C1440117,en_5731,INHIBITS,Vaccines,C0042210,en_2329,1,1,AFFECTS,Inhibitory,6
16152,DELETION,C1442161,en_5732,AFFECTS,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
16153,Proteasome inhibitor,C1443643,en_5736,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16154,Proteasome inhibitor,C1443643,en_5736,TREATS(INFER),"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,Inhibitory,3
16155,Epidermal growth factor receptor inhibitor,C1443775,en_5737,TREATS,Nerve Pain,C0751372,en_4850,4,1,AFFECTS,Inhibitory,3
16156,Post-exposure prophylaxis,C1443861,en_5738,PREVENTS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,7
16157,Post-exposure prophylaxis,C1443861,en_5738,PREVENTS,Disease,C0012634,en_826,3,1,AFFECTS,Inhibitory,3
16158,Post-exposure prophylaxis,C1443861,en_5738,PREVENTS,Acute respiratory infection NOS,C0339901,en_3809,1,1,AFFECTS,Inhibitory,3
16159,Post-exposure prophylaxis,C1443861,en_5738,PREVENTS,SARS coronavirus,C1175743,en_5384,1,1,AFFECTS,Inhibitory,8
16160,Post-exposure prophylaxis,C1443861,en_5738,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16161,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Adult,C0001675,en_252,6,3,AFFECTS,Inhibitory,9
16162,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Inhibitory,3
16163,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
16164,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Hepatitis B,C0019163,en_1172,7,1,AFFECTS,Inhibitory,3
16165,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
16166,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
16167,Post-exposure prophylaxis,C1443861,en_5738,TREATS,Persons,C0027361,en_1635,3,2,AFFECTS,Inhibitory,6
16168,Post-exposure prophylaxis,C1443861,en_5738,TREATS,STUDY DURATION,C0489652,en_4158,2,1,AFFECTS,Inhibitory,3
16169,Post-exposure prophylaxis,C1443861,en_5738,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
16170,Post-exposure prophylaxis,C1443861,en_5738,TREATS(INFER),Asymptomatic,C0231221,en_3252,2,1,AFFECTS,Inhibitory,3
16171,Respiratory secretion precautions,C1443870,en_5739,PREVENTS,Infection following immunization,C0452115,en_4087,1,1,AFFECTS,Inhibitory,6
16172,Respiratory secretion precautions,C1443870,en_5739,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
16173,ESBL,C1444096,en_5743,PRODUCES,carbapenemase,C0246081,en_3478,1,1,AFFECTS,Excitatory,3
16174,Pre-hospital care,C1444165,en_5745,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16175,Respiratory function management,C1444338,en_5746,TREATS,Patient ventilated,C1299448,en_5503,2,1,AFFECTS,Inhibitory,6
16176,Respiratory function management,C1444338,en_5746,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16177,Wanted,C1444647,en_5747,PREDISPOSES,Diabetes,C0011847,en_797,1,1,AFFECTS,Excitatory,3
16178,Instability,C1444783,en_5750,PREDISPOSES,poor health,C0683321,en_4658,1,1,AFFECTS,Excitatory,3
16179,Microbial agent,C1445706,en_5751,AUGMENTS,Wound Healing,C0043240,en_2400,1,1,AFFECTS,Excitatory,3
16180,Microbial agent,C1445706,en_5751,PREVENTS,Mycoses,C0026946,en_1620,1,1,AFFECTS,Inhibitory,3
16181,Protein antibody,C1445860,en_5752,AFFECTS,Protein-Protein Interaction,C0872079,en_5036,1,1,AFFECTS,General/Uncertain,3
16182,Protein antibody,C1445860,en_5752,AUGMENTS,Cutaneous muscle,C1184459,en_5390,1,1,AFFECTS,Excitatory,3
16183,Protein antibody,C1445860,en_5752,PREVENTS,Senile Plaques,C0333463,en_3764,1,1,AFFECTS,Inhibitory,3
16184,Protein antibody,C1445860,en_5752,STIMULATES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,3
16185,Scheduling (procedure),C1446911,en_5754,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,7
16186,Scheduling (procedure),C1446911,en_5754,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16187,"TNF protein, human",C1448177,en_5755,AUGMENTS,Blood Vessels,C0005847,en_494,2,2,AFFECTS,Excitatory,6
16188,"TNF protein, human",C1448177,en_5755,DISRUPTS,Extravasation,C0015376,en_949,2,1,AFFECTS,Inhibitory,3
16189,"TNF protein, human",C1448177,en_5755,DISRUPTS,Phosphorylation,C0031715,en_1800,1,1,AFFECTS,Inhibitory,3
16190,"TNF protein, human",C1448177,en_5755,PRODUCES,Colchicine,C0009262,en_672,2,1,AFFECTS,Excitatory,3
16191,"TNF protein, human",C1448177,en_5755,STIMULATES,NF-kappa B,C0079904,en_2615,1,1,AFFECTS,Excitatory,3
16192,"TNF protein, human",C1448177,en_5755,STIMULATES,Interleukin-15,C0254610,en_3491,1,1,AFFECTS,Excitatory,3
16193,"TNF protein, human|TNF",C1448177|7124,en_5756,INHIBITS,cytokine,C0079189,en_2593,1,1,AFFECTS,Inhibitory,6
16194,"SPRR2A protein, human|SPRR2A",C1449035|6700,en_5757,STIMULATES,phosphatidylethanolamine:Kdo2-lipid A phosphoethanolamine transferase activity,C2248756,en_6095,1,1,AFFECTS,Excitatory,6
16195,Ebola Vaccines,C1449556,en_5758,TREATS,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,Inhibitory,3
16196,Dermoscopy,C1449565,en_5759,AFFECTS,Physical Examination,C0031809,en_1804,1,1,AFFECTS,General/Uncertain,3
16197,Angiotensin II Type 1 Receptor Blockers,C1449680,en_5761,DISRUPTS,Down-Regulation,C0013081,en_844,1,1,AFFECTS,Inhibitory,6
16198,Angiotensin II Type 1 Receptor Blockers,C1449680,en_5761,TREATS,Heart failure,C0018801,en_1135,2,1,AFFECTS,Inhibitory,3
16199,Angiotensin II Type 1 Receptor Blockers,C1449680,en_5761,TREATS,Hypertensive disease,C0020538,en_1239,2,1,AFFECTS,Inhibitory,3
16200,Angiotensin II Type 1 Receptor Blockers,C1449680,en_5761,TREATS,Acute coronary syndrome,C0948089,en_5159,2,1,AFFECTS,Inhibitory,3
16201,"Blood Pressure Monitoring, Home",C1449681,en_5762,AFFECTS,Blood Pressure,C0005823,en_492,1,1,AFFECTS,General/Uncertain,3
16202,Bromhexin,C1450658,en_5764,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16203,Bromhexin,C1450658,en_5764,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
16204,"AraC protein, E coli",C1450935,en_5765,AFFECTS,protein oligomerization,C1523273,en_5909,2,2,AFFECTS,General/Uncertain,6
16205,MLN 4760,C1452025,en_5766,AUGMENTS,Blood Vessels,C0005847,en_494,1,1,AFFECTS,Excitatory,3
16206,"CABIN1 protein, human|CABIN1",C1453118|23523,en_5767,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
16207,degarelix,C1455035,en_5768,INHIBITS,Androgen Receptor,C0034786,en_1962,1,1,AFFECTS,Inhibitory,7
16208,degarelix,C1455035,en_5768,TREATS,Malignant neoplasm of prostate,C0376358,en_3874,1,1,AFFECTS,Inhibitory,7
16209,Psychosocial care,C1455743,en_5769,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16210,Psychosocial care,C1455743,en_5769,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,3
16211,Psychosocial care,C1455743,en_5769,TREATS,Staff,C0851286,en_4950,1,1,AFFECTS,Inhibitory,3
16212,Allogeneic hematopoietic stem cell transplant,C1456094,en_5770,TREATS,Chronic graft-versus-host disease,C0867389,en_4996,1,1,AFFECTS,Inhibitory,3
16213,"MAPK14 protein, human",C1456380,en_5771,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
16214,liraglutide,C1456408,en_5772,STIMULATES,GLP-1 receptor,C0378073,en_3893,1,1,AFFECTS,Excitatory,3
16215,liraglutide,C1456408,en_5772,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,3
16216,liraglutide,C1456408,en_5772,TREATS,Obesity,C0028754,en_1699,1,1,AFFECTS,Inhibitory,3
16217,Botanicals,C1456557,en_5774,AFFECTS,Energy Balance,C0597987,en_4440,1,1,AFFECTS,General/Uncertain,3
16218,Botanicals,C1456557,en_5774,PREVENTS,Mycoses,C0026946,en_1620,1,1,AFFECTS,Inhibitory,3
16219,Bariatric Surgery,C1456587,en_5775,PREDISPOSES,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,Excitatory,3
16220,Bariatric Surgery,C1456587,en_5775,TREATS,Diabetes,C0011847,en_797,1,1,AFFECTS,Inhibitory,6
16221,Bariatric Surgery,C1456587,en_5775,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,Inhibitory,6
16222,Bariatric Surgery,C1456587,en_5775,TREATS,Obesity,C0028754,en_1699,5,3,AFFECTS,Inhibitory,13
16223,Bariatric Surgery,C1456587,en_5775,TREATS,"Obesity, Morbid",C0028756,en_1700,1,1,AFFECTS,Inhibitory,6
16224,Bariatric Surgery,C1456587,en_5775,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,6
16225,Sexual Health,C1456614,en_5776,PREDISPOSES,Cross Infection,C0010356,en_735,1,1,AFFECTS,Excitatory,3
16226,Prenatal Testing,C1456692,en_5778,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
16227,Prenatal Testing,C1456692,en_5778,TREATS,Obstetrician,C0334897,en_3778,1,1,AFFECTS,Inhibitory,3
16228,Fitness,C1456706,en_5779,PREVENTS,Symptoms,C1457887,en_5784,3,2,AFFECTS,Inhibitory,6
16229,Fitness,C1456706,en_5779,STIMULATES,Isolation procedure,C0204727,en_3120,1,1,AFFECTS,Excitatory,3
16230,Fitness,C1456706,en_5779,TREATS,Patients,C0030705,en_1762,6,3,AFFECTS,Inhibitory,9
16231,Fitness,C1456706,en_5779,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,8
16232,Fitness,C1456706,en_5779,TREATS,Fourth Stage of Labor,C2985294,en_6165,1,1,AFFECTS,Inhibitory,8
16233,K11777,C1456738,en_5781,INHIBITS,Cathepsin L,C0054871,en_2452,1,1,AFFECTS,Inhibitory,3
16234,K11777,C1456738,en_5781,INHIBITS,cruzain,C0167118,en_2953,1,1,AFFECTS,Inhibitory,3
16235,Symptoms,C1457887,en_5784,PREDISPOSES,Anxiety,C0003467,en_380,2,2,AFFECTS,Excitatory,14
16236,Symptoms,C1457887,en_5784,PREDISPOSES,Bipolar Disorder,C0005586,en_474,1,1,AFFECTS,Excitatory,3
16237,Symptoms,C1457887,en_5784,PREDISPOSES,Disease,C0012634,en_826,2,2,AFFECTS,Excitatory,11
16238,Symptoms,C1457887,en_5784,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
16239,Symptoms,C1457887,en_5784,PREDISPOSES,"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Excitatory,3
16240,Symptoms,C1457887,en_5784,PREDISPOSES,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,Excitatory,3
16241,Symptoms,C1457887,en_5784,PREDISPOSES,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Excitatory,3
16242,Symptoms,C1457887,en_5784,PREDISPOSES,Clinical infection,C0275521,en_3564,1,1,AFFECTS,Excitatory,3
16243,Symptoms,C1457887,en_5784,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
16244,"Filters, Air, Particulate, High-Efficiency",C1458019,en_5785,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
16245,Stem cell transplant,C1504389,en_5787,TREATS,Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,Inhibitory,3
16246,Stem cell transplant,C1504389,en_5787,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,3
16247,"TXN protein, human",C1504637,en_5790,DISRUPTS,Defense Mechanisms,C0011142,en_769,1,1,AFFECTS,Inhibitory,3
16248,"TXN protein, human",C1504637,en_5790,STIMULATES,Viral Proteins,C0042736,en_2357,1,1,AFFECTS,Excitatory,3
16249,"IL1RN protein, human|IL1RN",C1504688|3557,en_5791,TREATS,Severe disease,C4740692,en_6396,1,1,AFFECTS,Inhibitory,6
16250,Aloe Polysaccharide,C1509940,en_5792,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
16251,Online Therapy,C1510559,en_5798,TREATS,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,Inhibitory,3
16252,Autism spectrum disorder,C1510586,en_5799,AFFECTS,Persons,C0027361,en_1635,1,1,AFFECTS,General/Uncertain,3
16253,Autism spectrum disorder,C1510586,en_5799,AFFECTS,Disability NOS,C0231170,en_3247,1,1,AFFECTS,General/Uncertain,3
16254,Adenovirus Vector,C1510800,en_5801,AUGMENTS,"Immunity, Mucosal",C0282558,en_3653,1,1,AFFECTS,Excitatory,3
16255,Adenovirus Vector,C1510800,en_5801,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
16256,Adjuvant Analgesic,C1510809,en_5802,TREATS,"Stroke, Acute",C0751956,en_4854,2,1,AFFECTS,Inhibitory,3
16257,Aging-Related Process,C1510835,en_5804,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
16258,Autologous Stem Cell Transplantation,C1510984,en_5805,TREATS,Patients,C0030705,en_1762,4,1,AFFECTS,Inhibitory,3
16259,Autologous Stem Cell Transplantation,C1510984,en_5805,TREATS,Hematologic Neoplasms,C0376545,en_3883,2,1,AFFECTS,Inhibitory,3
16260,Autologous Stem Cell Transplantation,C1510984,en_5805,TREATS,Malignant disease,C0442867,en_4059,2,1,AFFECTS,Inhibitory,3
16261,Bone Marrow Stem Cell,C1511246,en_5808,PRODUCES,PDCD1 gene,C1418401,en_5711,1,1,AFFECTS,Excitatory,3
16262,Breast Cancer Treatment,C1511300,en_5809,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
16263,Breast Cancer Treatment,C1511300,en_5809,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16264,Continuous Intravenous Infusion,C1511497,en_5810,AFFECTS,Patients,C0030705,en_1762,1,1,AFFECTS,General/Uncertain,3
16265,Core Facility,C1511521,en_5811,PRODUCES,Classification,C0008902,en_651,2,2,AFFECTS,Excitatory,6
16266,Dendritic Cell Vaccine,C1511767,en_5813,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,3
16267,Detection,C1511790,en_5814,AFFECTS,Breast Feeding,C0006147,en_512,1,1,AFFECTS,General/Uncertain,6
16268,Detection,C1511790,en_5814,AFFECTS,Hallucinations,C0018524,en_1108,1,1,AFFECTS,General/Uncertain,3
16269,Detection,C1511790,en_5814,AFFECTS,HIV Infections,C0019693,en_1192,1,1,AFFECTS,General/Uncertain,3
16270,Detection,C1511790,en_5814,AFFECTS,"Lymphoma, Non-Hodgkin's",C0024305,en_1473,1,1,AFFECTS,General/Uncertain,6
16271,Detection,C1511790,en_5814,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
16272,Detection,C1511790,en_5814,AFFECTS,Male reproductive function,C0278054,en_3593,3,1,AFFECTS,General/Uncertain,3
16273,Detection,C1511790,en_5814,AFFECTS,specific immunity,C0683201,en_4653,1,1,AFFECTS,General/Uncertain,3
16274,Detection,C1511790,en_5814,PREDISPOSES,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Excitatory,3
16275,Detection,C1511790,en_5814,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,3
16276,Detection,C1511790,en_5814,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
16277,Detection,C1511790,en_5814,PREDISPOSES,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Excitatory,3
16278,Detection,C1511790,en_5814,PREDISPOSES,Epstein-Barr Virus Infections,C0149678,en_2804,1,1,AFFECTS,Excitatory,7
16279,Detection,C1511790,en_5814,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
16280,Detection,C1511790,en_5814,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
16281,Detection,C1511790,en_5814,PREVENTS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,3
16282,Detection,C1511790,en_5814,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16283,Detection,C1511790,en_5814,TREATS,Felis catus,C0007450,en_579,1,1,AFFECTS,Inhibitory,3
16284,Detection,C1511790,en_5814,TREATS,Malignant neoplasm of cervix uteri,C0007847,en_608,1,1,AFFECTS,Inhibitory,3
16285,Detection,C1511790,en_5814,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
16286,Detection,C1511790,en_5814,TREATS,Chiroptera,C0008139,en_625,2,1,AFFECTS,Inhibitory,3
16287,Detection,C1511790,en_5814,TREATS,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,Inhibitory,3
16288,Detection,C1511790,en_5814,TREATS,Comorbidity,C0009488,en_690,1,1,AFFECTS,Inhibitory,7
16289,Detection,C1511790,en_5814,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
16290,Detection,C1511790,en_5814,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
16291,Detection,C1511790,en_5814,TREATS,Canis familiaris,C0012984,en_839,2,2,AFFECTS,Inhibitory,6
16292,Detection,C1511790,en_5814,TREATS,Donor person,C0013018,en_840,1,1,AFFECTS,Inhibitory,7
16293,Detection,C1511790,en_5814,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
16294,Detection,C1511790,en_5814,TREATS,Human,C0020114,en_1210,5,5,AFFECTS,Inhibitory,15
16295,Detection,C1511790,en_5814,TREATS,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,Inhibitory,7
16296,Detection,C1511790,en_5814,TREATS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,Inhibitory,3
16297,Detection,C1511790,en_5814,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,7
16298,Detection,C1511790,en_5814,TREATS,Mothers,C0026591,en_1583,3,2,AFFECTS,Inhibitory,6
16299,Detection,C1511790,en_5814,TREATS,Mus,C0026809,en_1600,3,3,AFFECTS,Inhibitory,9
16300,Detection,C1511790,en_5814,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
16301,Detection,C1511790,en_5814,TREATS,Outpatients,C0029921,en_1729,2,1,AFFECTS,Inhibitory,3
16302,Detection,C1511790,en_5814,TREATS,Patients,C0030705,en_1762,15,13,AFFECTS,Inhibitory,39
16303,Detection,C1511790,en_5814,TREATS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,3
16304,Detection,C1511790,en_5814,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
16305,Detection,C1511790,en_5814,TREATS,"Diabetes, Gestational",C0085207,en_2652,1,1,AFFECTS,Inhibitory,6
16306,Detection,C1511790,en_5814,TREATS,Hamman-Rich syndrome,C0085786,en_2691,2,1,AFFECTS,Inhibitory,3
16307,Detection,C1511790,en_5814,TREATS,Proliferative diabetic retinopathy,C0154830,en_2886,3,1,AFFECTS,Inhibitory,3
16308,Detection,C1511790,en_5814,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,3
16309,Detection,C1511790,en_5814,TREATS,Asymptomatic,C0231221,en_3252,2,2,AFFECTS,Inhibitory,10
16310,Detection,C1511790,en_5814,TREATS,Individual,C0237401,en_3343,2,2,AFFECTS,Inhibitory,6
16311,Detection,C1511790,en_5814,TREATS,Women's Groups,C0242543,en_3419,1,1,AFFECTS,Inhibitory,3
16312,Detection,C1511790,en_5814,TREATS,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,Inhibitory,6
16313,Detection,C1511790,en_5814,TREATS,Social stigmata,C0277787,en_3590,4,2,AFFECTS,Inhibitory,6
16314,Detection,C1511790,en_5814,TREATS,Carrier of disorder,C0560175,en_4319,1,1,AFFECTS,Inhibitory,3
16315,Detection,C1511790,en_5814,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
16316,Detection,C1511790,en_5814,TREATS,General Population,C0683971,en_4674,4,1,AFFECTS,Inhibitory,3
16317,Detection,C1511790,en_5814,TREATS,Pulmonary Pathology,C0748168,en_4829,1,1,AFFECTS,Inhibitory,3
16318,Detection,C1511790,en_5814,TREATS,blank,C0750479,en_4842,1,1,AFFECTS,Inhibitory,3
16319,Detection,C1511790,en_5814,TREATS,"Brain Injury, Ischemic",C0751015,en_4845,1,1,AFFECTS,Inhibitory,3
16320,Detection,C1511790,en_5814,TREATS,COVID-19,C5203670,en_6417,5,5,AFFECTS,Inhibitory,31
16321,Detection,C1511790,en_5814,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,7
16322,Detection,C1511790,en_5814,TREATS(INFER),Little's Disease,C0023882,en_1451,1,1,AFFECTS,Inhibitory,3
16323,Detection,C1511790,en_5814,TREATS(INFER),Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,3
16324,Detection,C1511790,en_5814,TREATS(INFER),Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
16325,Dihydroorotate Dehydrogenase Inhibitor,C1511961,en_5815,AFFECTS,Immune,C0439662,en_4035,1,1,AFFECTS,General/Uncertain,8
16326,Dihydroorotate Dehydrogenase Inhibitor,C1511961,en_5815,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
16327,Dihydroorotate Dehydrogenase Inhibitor,C1511961,en_5815,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
16328,Harvest,C1512335,en_5817,TREATS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
16329,High Resolution Computed Tomography,C1512457,en_5819,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16330,Human Papilloma Virus Vaccine,C1512511,en_5820,AFFECTS,Malignant neoplasm of cervix uteri,C0007847,en_608,2,1,AFFECTS,General/Uncertain,3
16331,Immunocompetent,C1512656,en_5822,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,7
16332,Implantable Pump,C1512682,en_5823,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,3
16333,Inferential Current Treatment,C1512721,en_5824,TREATS,Cattle,C0007452,en_580,1,1,AFFECTS,Inhibitory,3
16334,Inferential Current Treatment,C1512721,en_5824,TREATS,Nurses,C0028661,en_1694,1,1,AFFECTS,Inhibitory,3
16335,Inferential Current Treatment,C1512721,en_5824,TREATS,Public Health Nurses,C0034022,en_1926,1,1,AFFECTS,Inhibitory,3
16336,Inflammation Process,C1512753,en_5825,AFFECTS,Multiple Organ Failure,C0026766,en_1597,2,1,AFFECTS,General/Uncertain,3
16337,Inflammation Process,C1512753,en_5825,AFFECTS,Individual,C0237401,en_3343,1,1,AFFECTS,General/Uncertain,3
16338,"Radiotherapy, Intensity-Modulated",C1512814,en_5826,TREATS,Pancreatic carcinoma,C0235974,en_3336,1,1,AFFECTS,Inhibitory,3
16339,mind-body interventions,C1513305,en_5828,TREATS,Staff,C0851286,en_4950,1,1,AFFECTS,Inhibitory,3
16340,Moderate Exercise,C1513375,en_5829,PREVENTS,"Infections, Upper Respiratory",C0041912,en_2315,4,1,AFFECTS,Inhibitory,3
16341,Moderate Exercise,C1513375,en_5829,TREATS,Sedentary lifestyle,C1532253,en_5930,1,1,AFFECTS,Inhibitory,6
16342,Molecular Target,C1513403,en_5830,TREATS,Diabetes,C0011847,en_797,2,1,AFFECTS,Inhibitory,3
16343,Molecular Target,C1513403,en_5830,TREATS,Pain,C0030193,en_1741,1,1,AFFECTS,Inhibitory,3
16344,Population Intervention,C1514232,en_5832,TREATS,Chronic Kidney Diseases,C1561643,en_5967,1,1,AFFECTS,Inhibitory,6
16345,Preventive Intervention,C1514416,en_5833,PREVENTS,Social stigmata,C0277787,en_3590,1,1,AFFECTS,Inhibitory,3
16346,Preventive Intervention,C1514416,en_5833,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
16347,Preventive Intervention,C1514416,en_5833,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
16348,Preventive Intervention,C1514416,en_5833,TREATS,Mothers,C0026591,en_1583,1,1,AFFECTS,Inhibitory,3
16349,Receptor Activation,C1514758,en_5837,AFFECTS,Vasodilation,C0042401,en_2342,1,1,AFFECTS,General/Uncertain,3
16350,Registration,C1514821,en_5839,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
16351,Registration,C1514821,en_5839,TREATS,Infertility,C0021359,en_1305,1,1,AFFECTS,Inhibitory,3
16352,Registration,C1514821,en_5839,TREATS,Muscular Dystrophies,C0026850,en_1606,1,1,AFFECTS,Inhibitory,3
16353,Registration,C1514821,en_5839,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,3
16354,Registration,C1514821,en_5839,TREATS,student,C0038492,en_2171,1,1,AFFECTS,Inhibitory,3
16355,Research Training,C1514886,en_5841,AFFECTS,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
16356,Resistance Process,C1514892,en_5842,AFFECTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,6
16357,Retrieval,C1514918,en_5843,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
16358,Supplementation,C1515075,en_5844,AFFECTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,General/Uncertain,3
16359,Supplementation,C1515075,en_5844,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
16360,Supplementation,C1515075,en_5844,AFFECTS,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
16361,Supplementation,C1515075,en_5844,AFFECTS,monocyte activation,C1155075,en_5316,1,1,AFFECTS,General/Uncertain,3
16362,Supplementation,C1515075,en_5844,PREVENTS,Adhesions,C0001511,en_240,1,1,AFFECTS,Inhibitory,3
16363,Supplementation,C1515075,en_5844,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
16364,Supplementation,C1515075,en_5844,PREVENTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
16365,Supplementation,C1515075,en_5844,PREVENTS,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,Inhibitory,3
16366,Supplementation,C1515075,en_5844,PREVENTS,autoimmune thyroid disease,C0178468,en_2984,1,1,AFFECTS,Inhibitory,3
16367,Supplementation,C1515075,en_5844,PREVENTS,Oxidative Stress,C0242606,en_3422,2,1,AFFECTS,Inhibitory,3
16368,Supplementation,C1515075,en_5844,STIMULATES,Aging,C0001811,en_262,1,1,AFFECTS,Excitatory,3
16369,Supplementation,C1515075,en_5844,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,3
16370,Supplementation,C1515075,en_5844,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,3
16371,Supplementation,C1515075,en_5844,TREATS,Female,C0015780,en_977,1,1,AFFECTS,Inhibitory,3
16372,Supplementation,C1515075,en_5844,TREATS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,Inhibitory,3
16373,Supplementation,C1515075,en_5844,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,3
16374,Supplementation,C1515075,en_5844,TREATS,Infection,C3714514,en_6235,4,2,AFFECTS,Inhibitory,6
16375,Supplementation,C1515075,en_5844,TREATS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
16376,Supplementation,C1515075,en_5844,TREATS,Insulin Resistance,C0021655,en_1325,1,1,AFFECTS,Inhibitory,3
16377,Supplementation,C1515075,en_5844,TREATS,Male gender,C0024554,en_1494,1,1,AFFECTS,Inhibitory,3
16378,Supplementation,C1515075,en_5844,TREATS,Male population group,C0025266,en_1533,1,1,AFFECTS,Inhibitory,3
16379,Supplementation,C1515075,en_5844,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
16380,Supplementation,C1515075,en_5844,TREATS,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,Inhibitory,3
16381,Supplementation,C1515075,en_5844,TREATS,Patients,C0030705,en_1762,9,6,AFFECTS,Inhibitory,18
16382,Supplementation,C1515075,en_5844,TREATS,"Signs and Symptoms, Respiratory",C0037090,en_2107,2,1,AFFECTS,Inhibitory,3
16383,Supplementation,C1515075,en_5844,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
16384,Supplementation,C1515075,en_5844,TREATS,Voluntary Workers,C0042960,en_2380,1,1,AFFECTS,Inhibitory,3
16385,Supplementation,C1515075,en_5844,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
16386,Supplementation,C1515075,en_5844,TREATS,Individual,C0237401,en_3343,1,1,AFFECTS,Inhibitory,3
16387,Supplementation,C1515075,en_5844,TREATS,Disease Progression,C0242656,en_3429,3,2,AFFECTS,Inhibitory,6
16388,Supplementation,C1515075,en_5844,TREATS,Elderly person,C0392363,en_3920,1,1,AFFECTS,Inhibitory,3
16389,Supplementation,C1515075,en_5844,TREATS,Endothelial dysfunction,C0856169,en_4968,2,1,AFFECTS,Inhibitory,3
16390,Supplementation,C1515075,en_5844,TREATS(INFER),Coronary Arteriosclerosis,C0010054,en_717,1,1,AFFECTS,Inhibitory,3
16391,Supplementation,C1515075,en_5844,TREATS(INFER),HIV-1,C0019704,en_1194,1,1,AFFECTS,Inhibitory,3
16392,Supplementation,C1515075,en_5844,TREATS(INFER),Rickets,C0035579,en_2037,1,1,AFFECTS,Inhibitory,3
16393,Surgical Management,C1515089,en_5845,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16394,Surgical Management,C1515089,en_5845,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
16395,Surgical Management,C1515089,en_5845,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
16396,Systemic Therapy,C1515119,en_5846,PREVENTS,Symptoms,C1457887,en_5784,2,1,AFFECTS,Inhibitory,3
16397,Systemic Therapy,C1515119,en_5846,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,6
16398,Systemic Therapy,C1515119,en_5846,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,6
16399,Systemic Therapy,C1515119,en_5846,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
16400,Zadaxin,C1515426,en_5847,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
16401,mTOR Inhibitor,C1515672,en_5848,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16402,Alveolus,C1515933,en_5850,PRODUCES,Peptide Hydrolases,C0030940,en_1769,1,1,AFFECTS,Excitatory,3
16403,Antiinflammatory Effect,C1516019,en_5851,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,3
16404,Antiinflammatory Effect,C1516019,en_5851,AFFECTS,member,C0680022,en_4618,1,1,AFFECTS,General/Uncertain,3
16405,Antiinflammatory Effect,C1516019,en_5851,AFFECTS,Microbiota,C1000792,en_5221,2,1,AFFECTS,General/Uncertain,3
16406,Antiinflammatory Effect,C1516019,en_5851,PRODUCES,Thyroid Hormones,C0040135,en_2237,1,1,AFFECTS,Excitatory,3
16407,Cell Maturation,C1516349,en_5855,AFFECTS,Contraction,C1140999,en_5281,1,1,AFFECTS,General/Uncertain,3
16408,Cellular Infiltration,C1516369,en_5856,AFFECTS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,General/Uncertain,3
16409,Chemopreventive Agent,C1516463,en_5858,TREATS,pulmonary complications,C0281169,en_3627,2,1,AFFECTS,Inhibitory,3
16410,Chemopreventive Agent,C1516463,en_5858,TREATS,Oral Dysplasia,C4330858,en_6347,1,1,AFFECTS,Inhibitory,7
16411,Clinical Management,C1516615,en_5859,AFFECTS,Severe disease,C4740692,en_6396,1,1,AFFECTS,General/Uncertain,6
16412,Clinical Management,C1516615,en_5859,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
16413,Clinical Management,C1516615,en_5859,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
16414,Clinical Management,C1516615,en_5859,TREATS,Acute infectious disease,C0275518,en_3563,1,1,AFFECTS,Inhibitory,3
16415,Clinical Management,C1516615,en_5859,TREATS,Infected,C0439663,en_4036,1,1,AFFECTS,Inhibitory,6
16416,Clinical Treatment,C1516635,en_5860,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,3
16417,Clinical Treatment,C1516635,en_5860,TREATS,Persons,C0027361,en_1635,1,1,AFFECTS,Inhibitory,3
16418,Clinical Treatment,C1516635,en_5860,TREATS,Patients,C0030705,en_1762,3,3,AFFECTS,Inhibitory,9
16419,Clonal Expansion,C1516670,en_5861,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
16420,Community Practice,C1516735,en_5862,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16421,Enrollment,C1516879,en_5863,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
16422,Enrollment,C1516879,en_5863,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16423,Epigenetic Process,C1516924,en_5864,AFFECTS,ACE2,C1422064,en_5723,3,1,AFFECTS,General/Uncertain,3
16424,Epigenetic Process,C1516924,en_5864,AFFECTS,Ability,C0085732,en_2688,11,1,AFFECTS,General/Uncertain,3
16425,Epigenetic Process,C1516924,en_5864,AFFECTS,DNA Methylation,C0376452,en_3877,1,1,AFFECTS,General/Uncertain,3
16426,Epigenetic Process,C1516924,en_5864,AFFECTS,Immunologic function,C1268930,en_5445,11,1,AFFECTS,General/Uncertain,3
16427,External Beam Radiation Therapy,C1517033,en_5866,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16428,Glandular Cell,C1517548,en_5868,PRODUCES,Transferrin,C0040679,en_2269,3,2,AFFECTS,Excitatory,6
16429,Local Therapy,C1517925,en_5870,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16430,Local Therapy,C1517925,en_5870,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,3
16431,Local Therapy,C1517925,en_5870,TREATS,Sense of smell impaired,C2364082,en_6111,1,1,AFFECTS,Inhibitory,7
16432,Low Dose Radiation,C1518010,en_5872,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
16433,Low Dose Radiation,C1518010,en_5872,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,8
16434,Low Dose Radiation,C1518010,en_5872,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
16435,Low Dose Radiation,C1518010,en_5872,TREATS,Pneumonia,C0032285,en_1833,5,3,AFFECTS,Inhibitory,22
16436,Low Dose Radiation,C1518010,en_5872,TREATS,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,Inhibitory,7
16437,Low Dose Radiation,C1518010,en_5872,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,8
16438,Low Dose Radiation,C1518010,en_5872,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16439,Low Dose Radiation,C1518010,en_5872,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,2,2,AFFECTS,Inhibitory,15
16440,Nonsense-Mediated Decay,C1518412,en_5874,AFFECTS,Mutant Proteins,C1564139,en_5976,1,1,AFFECTS,General/Uncertain,3
16441,Opioid Rotation,C1518592,en_5876,TREATS,Opioid Use Disorders,C0029103,en_1711,2,2,AFFECTS,Inhibitory,6
16442,Peripheral Blood Lymphocyte,C1518997,en_5878,PRODUCES,Recombinant Interferon-gamma,C0021740,en_1330,2,1,AFFECTS,Excitatory,3
16443,Peripheral Blood Lymphocyte,C1518997,en_5878,PRODUCES,Caspase-1,C0534519,en_4239,2,1,AFFECTS,Excitatory,3
16444,Pharmacological Treatment,C1519033,en_5879,TREATS,Age,C0001779,en_257,2,1,AFFECTS,Inhibitory,3
16445,Pharmacological Treatment,C1519033,en_5879,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
16446,Pharmacological Treatment,C1519033,en_5879,TREATS,"Stress Disorders, Post-Traumatic",C0038436,en_2166,2,1,AFFECTS,Inhibitory,3
16447,Pharmacological Treatment,C1519033,en_5879,TREATS,Migraine Disorders,C0149931,en_2813,2,1,AFFECTS,Inhibitory,3
16448,Pharmacological Treatment,C1519033,en_5879,TREATS,virus pathogenesis,C0920672,en_5130,2,1,AFFECTS,Inhibitory,3
16449,Rodent Model,C1519106,en_5880,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
16450,Secretory Cell,C1519221,en_5881,PRODUCES,Insulin,C0021641,en_1324,1,1,AFFECTS,Excitatory,3
16451,Signaling Molecule,C1519315,en_5883,AFFECTS,Cell Growth,C0007595,en_590,1,1,AFFECTS,General/Uncertain,3
16452,Signaling Molecule,C1519315,en_5883,AFFECTS,Cell physiology,C0007613,en_594,1,1,AFFECTS,General/Uncertain,3
16453,Signaling Molecule,C1519315,en_5883,AFFECTS,Microgravity,C0242535,en_3418,1,1,AFFECTS,General/Uncertain,3
16454,Signaling Molecule,C1519315,en_5883,DISRUPTS,Cells,C0007634,en_596,1,1,AFFECTS,Inhibitory,3
16455,Transcript,C1519595,en_5887,AFFECTS,Gene type,C0314611,en_3740,1,1,AFFECTS,General/Uncertain,3
16456,Vaccine Antigen,C1519887,en_5894,TREATS,Raccoons,C0034500,en_1950,1,1,AFFECTS,Inhibitory,3
16457,Viral Vector,C1520007,en_5896,AUGMENTS,Mucous Membrane,C0026724,en_1594,1,1,AFFECTS,Excitatory,3
16458,Principal Investigator,C1521895,en_5898,PRODUCES,Reservoirs,C0182967,en_3037,1,1,AFFECTS,Excitatory,3
16459,Principal Investigator,C1521895,en_5898,PRODUCES,Sensors,C0183210,en_3041,1,1,AFFECTS,Excitatory,3
16460,Tracer,C1522485,en_5902,AFFECTS,Eye Movements,C0015413,en_955,1,1,AFFECTS,General/Uncertain,3
16461,Recombinant Interferon,C1522537,en_5903,TREATS,Middle East Respiratory Syndrome,C3694279,en_6232,1,1,AFFECTS,Inhibitory,6
16462,follow-up,C1522577,en_5904,AFFECTS,Physical function,C0516981,en_4169,1,1,AFFECTS,General/Uncertain,3
16463,follow-up,C1522577,en_5904,AFFECTS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,General/Uncertain,6
16464,follow-up,C1522577,en_5904,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
16465,follow-up,C1522577,en_5904,PREVENTS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
16466,follow-up,C1522577,en_5904,PREVENTS,Infection,C3714514,en_6235,2,1,AFFECTS,Inhibitory,3
16467,follow-up,C1522577,en_5904,PREVENTS,Decompensation,C0231187,en_3250,1,1,AFFECTS,Inhibitory,6
16468,follow-up,C1522577,en_5904,PREVENTS,Feeling suicidal,C0424000,en_3990,1,1,AFFECTS,Inhibitory,3
16469,follow-up,C1522577,en_5904,PREVENTS,Blind Vision,C0456909,en_4120,1,1,AFFECTS,Inhibitory,3
16470,follow-up,C1522577,en_5904,PREVENTS,Responsive Disease,C5236984,en_6425,2,1,AFFECTS,Inhibitory,7
16471,follow-up,C1522577,en_5904,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,3
16472,follow-up,C1522577,en_5904,TREATS,Child,C0008059,en_620,3,3,AFFECTS,Inhibitory,9
16473,follow-up,C1522577,en_5904,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,3
16474,follow-up,C1522577,en_5904,TREATS,Control Groups,C0009932,en_711,3,2,AFFECTS,Inhibitory,6
16475,follow-up,C1522577,en_5904,TREATS,Deglutition Disorders,C0011168,en_772,1,1,AFFECTS,Inhibitory,6
16476,follow-up,C1522577,en_5904,TREATS,Family,C0015576,en_961,1,1,AFFECTS,Inhibitory,3
16477,follow-up,C1522577,en_5904,TREATS,Graft-vs-Host Disease,C0018133,en_1092,1,1,AFFECTS,Inhibitory,3
16478,follow-up,C1522577,en_5904,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,7
16479,follow-up,C1522577,en_5904,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,3
16480,follow-up,C1522577,en_5904,TREATS,Infant,C0021270,en_1297,1,1,AFFECTS,Inhibitory,6
16481,follow-up,C1522577,en_5904,TREATS,"Lupus Erythematosus, Systemic",C0024141,en_1466,2,1,AFFECTS,Inhibitory,3
16482,follow-up,C1522577,en_5904,TREATS,Persons,C0027361,en_1635,5,3,AFFECTS,Inhibitory,9
16483,follow-up,C1522577,en_5904,TREATS,Outpatients,C0029921,en_1729,2,2,AFFECTS,Inhibitory,9
16484,follow-up,C1522577,en_5904,TREATS,Patients,C0030705,en_1762,29,23,AFFECTS,Inhibitory,69
16485,follow-up,C1522577,en_5904,TREATS,Pregnant Women,C0033011,en_1876,3,2,AFFECTS,Inhibitory,10
16486,follow-up,C1522577,en_5904,TREATS,Psychiatrist,C0033872,en_1919,1,1,AFFECTS,Inhibitory,3
16487,follow-up,C1522577,en_5904,TREATS,Tinnitus,C0040264,en_2241,1,1,AFFECTS,Inhibitory,6
16488,follow-up,C1522577,en_5904,TREATS,Voluntary Workers,C0042960,en_2380,2,1,AFFECTS,Inhibitory,3
16489,follow-up,C1522577,en_5904,TREATS,Falls,C0085639,en_2684,1,1,AFFECTS,Inhibitory,3
16490,follow-up,C1522577,en_5904,TREATS,Present,C0150312,en_2833,1,1,AFFECTS,Inhibitory,7
16491,follow-up,C1522577,en_5904,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,3
16492,follow-up,C1522577,en_5904,TREATS,Survivors,C0206194,en_3154,3,3,AFFECTS,Inhibitory,12
16493,follow-up,C1522577,en_5904,TREATS,Individual,C0237401,en_3343,2,2,AFFECTS,Inhibitory,6
16494,follow-up,C1522577,en_5904,TREATS,Young adult,C0238598,en_3365,1,1,AFFECTS,Inhibitory,3
16495,follow-up,C1522577,en_5904,TREATS,Form of muscle,C0240417,en_3384,1,1,AFFECTS,Inhibitory,8
16496,follow-up,C1522577,en_5904,TREATS,cohort,C0599755,en_4470,7,6,AFFECTS,Inhibitory,21
16497,follow-up,C1522577,en_5904,TREATS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,Inhibitory,3
16498,follow-up,C1522577,en_5904,TREATS,Participant,C0679646,en_4602,9,6,AFFECTS,Inhibitory,18
16499,follow-up,C1522577,en_5904,TREATS,General Population,C0683971,en_4674,1,1,AFFECTS,Inhibitory,3
16500,follow-up,C1522577,en_5904,TREATS,Diabetic ulcer,C0743150,en_4799,1,1,AFFECTS,Inhibitory,3
16501,follow-up,C1522577,en_5904,TREATS,Maximum,C0806909,en_4887,1,1,AFFECTS,Inhibitory,3
16502,follow-up,C1522577,en_5904,TREATS,Hospitalized Patients,C0870668,en_5010,4,3,AFFECTS,Inhibitory,12
16503,follow-up,C1522577,en_5904,TREATS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,3
16504,follow-up,C1522577,en_5904,TREATS,Symptoms,C1457887,en_5784,2,2,AFFECTS,Inhibitory,11
16505,follow-up,C1522577,en_5904,TREATS,COVID-19,C5203670,en_6417,5,4,AFFECTS,Inhibitory,26
16506,follow-up,C1522577,en_5904,TREATS,Treatment Group,C5205742,en_6422,1,1,AFFECTS,Inhibitory,8
16507,follow-up,C1522577,en_5904,TREATS(INFER),Myocardial Infarction,C0027051,en_1625,2,1,AFFECTS,Inhibitory,3
16508,follow-up,C1522577,en_5904,TREATS(INFER),Persistent infection,C1264606,en_5429,2,1,AFFECTS,Inhibitory,3
16509,follow-up,C1522577,en_5904,TREATS(INFER),Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
16510,follow-up,C1522577,en_5904,TREATS(SPEC),Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,3
16511,Clone,C1522642,en_5905,PRODUCES,Endopeptidases,C0030946,en_1770,1,1,AFFECTS,Excitatory,3
16512,Clone,C1522642,en_5905,PRODUCES,FRAGMENTS,C0486805,en_4153,1,1,AFFECTS,Excitatory,3
16513,Recombinant Interferon-alpha Inducible Protein 10,C1522712,en_5906,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16514,organ development,C1523020,en_5908,AFFECTS,Immunologic function,C1268930,en_5445,11,1,AFFECTS,General/Uncertain,3
16515,cellular metabolism,C1523924,en_5913,AFFECTS,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,General/Uncertain,3
16516,Therapeutic Effect,C1527144,en_5917,PREVENTS,Lesion,C0221198,en_3221,1,1,AFFECTS,Inhibitory,3
16517,Therapeutic Effect,C1527144,en_5917,PREVENTS,narcotic use,C0240602,en_3386,1,1,AFFECTS,Inhibitory,3
16518,Therapeutic Effect,C1527144,en_5917,PREVENTS,MISUSE,C0549649,en_4285,1,1,AFFECTS,Inhibitory,3
16519,Therapeutic Effect,C1527144,en_5917,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,3
16520,Therapeutic Effect,C1527144,en_5917,TREATS,Nasopharyngitis,C0027441,en_1641,2,1,AFFECTS,Inhibitory,3
16521,Therapeutic Effect,C1527144,en_5917,TREATS,Patients,C0030705,en_1762,7,6,AFFECTS,Inhibitory,18
16522,Therapeutic Effect,C1527144,en_5917,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,Inhibitory,3
16523,Therapeutic Effect,C1527144,en_5917,TREATS(INFER),Graft-vs-Host Disease,C0018133,en_1092,1,1,AFFECTS,Inhibitory,3
16524,Therapeutic Effect,C1527144,en_5917,TREATS(INFER),Pneumonia,C0032285,en_1833,2,2,AFFECTS,Inhibitory,6
16525,American College of Physicians,C1527272,en_5918,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16526,Allergic Reaction,C1527304,en_5919,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,3
16527,Dysphonia,C1527344,en_5922,DISRUPTS,Communication,C0009452,en_686,1,1,AFFECTS,Inhibitory,3
16528,"TIMP3 protein, human",C1527365,en_5924,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,3
16529,Immunomodulators,C1527392,en_5925,AFFECTS,"T-Lymphocytes, Cytotoxic",C0039195,en_2199,1,1,AFFECTS,General/Uncertain,3
16530,Immunomodulators,C1527392,en_5925,TREATS,Lung diseases,C0024115,en_1462,2,1,AFFECTS,Inhibitory,3
16531,"HRH2 protein, human",C1531432,en_5926,INHIBITS,Histamine Receptor,C0034813,en_1972,1,1,AFFECTS,Inhibitory,3
16532,Biological treatment,C1531518,en_5927,AFFECTS,Psoriasis,C0033860,en_1918,1,1,AFFECTS,General/Uncertain,6
16533,Chest imaging,C1531652,en_5928,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16534,Active monitoring,C1531698,en_5929,TREATS,World,C2700280,en_6119,1,1,AFFECTS,Inhibitory,8
16535,Active monitoring,C1531698,en_5929,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16536,Sedentary lifestyle,C1532253,en_5930,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,8
16537,Sedentary lifestyle,C1532253,en_5930,PREDISPOSES,Problem,C0033213,en_1890,1,1,AFFECTS,Excitatory,7
16538,Emergency percutaneous coronary intervention,C1532297,en_5931,TREATS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,Inhibitory,6
16539,Percutaneous coronary intervention,C1532338,en_5932,TREATS,"Fatty Streak, Arterial",C0015697,en_974,1,1,AFFECTS,Inhibitory,3
16540,Percutaneous coronary intervention,C1532338,en_5932,TREATS,Infarction,C0021308,en_1301,1,1,AFFECTS,Inhibitory,3
16541,Percutaneous coronary intervention,C1532338,en_5932,TREATS,Myocardial Infarction,C0027051,en_1625,2,2,AFFECTS,Inhibitory,12
16542,Percutaneous coronary intervention,C1532338,en_5932,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16543,Percutaneous coronary intervention,C1532338,en_5932,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
16544,Percutaneous coronary intervention,C1532338,en_5932,TREATS,Acute coronary syndrome,C0948089,en_5159,2,2,AFFECTS,Inhibitory,12
16545,Percutaneous coronary intervention,C1532338,en_5932,TREATS,STEMI,C1536220,en_5944,2,2,AFFECTS,Inhibitory,13
16546,Percutaneous coronary intervention,C1532338,en_5932,TREATS(INFER),Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,Inhibitory,3
16547,Percutaneous coronary intervention,C1532338,en_5932,TREATS(INFER),HIV Infections,C0019693,en_1192,2,1,AFFECTS,Inhibitory,3
16548,Obtaining consent,C1532670,en_5933,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
16549,Rotavirus vaccination,C1532786,en_5934,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,Inhibitory,3
16550,Waters' circuit,C1532950,en_5935,PREVENTS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
16551,Waters' circuit,C1532950,en_5935,PREVENTS(SPEC),Non-tuberculous mycobacterial pneumonia,C0349650,en_3843,1,1,AFFECTS,Inhibitory,3
16552,Waters' circuit,C1532950,en_5935,TREATS,Nairobi Sheep Disease,C0027345,en_1633,1,1,AFFECTS,Inhibitory,3
16553,Waters' circuit,C1532950,en_5935,TREATS,network,C0679670,en_4604,2,2,AFFECTS,Inhibitory,6
16554,N-terminal pro-B-type natriuretic peptide,C1533070,en_5936,TREATS,Patients,C0030705,en_1762,3,2,AFFECTS,Inhibitory,6
16555,Injection procedure,C1533685,en_5937,PREVENTS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,1,AFFECTS,Inhibitory,3
16556,Injection procedure,C1533685,en_5937,STIMULATES,Recovery,C0237820,en_3354,1,1,AFFECTS,Excitatory,3
16557,Injection procedure,C1533685,en_5937,TREATS,Body Temperature,C0005903,en_497,2,2,AFFECTS,Inhibitory,6
16558,Injection procedure,C1533685,en_5937,TREATS,Cricetinae,C0018557,en_1111,1,1,AFFECTS,Inhibitory,3
16559,Injection procedure,C1533685,en_5937,TREATS,House mice,C0025914,en_1562,1,1,AFFECTS,Inhibitory,3
16560,Injection procedure,C1533685,en_5937,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
16561,Injection procedure,C1533685,en_5937,TREATS,Patients,C0030705,en_1762,10,8,AFFECTS,Inhibitory,24
16562,Injection procedure,C1533685,en_5937,TREATS,Participant,C0679646,en_4602,1,1,AFFECTS,Inhibitory,3
16563,Injection procedure,C1533685,en_5937,TREATS,Diabetic macular edema,C0730285,en_4767,1,1,AFFECTS,Inhibitory,3
16564,Injection procedure,C1533685,en_5937,TREATS,GAIT FUNCTIONAL,C0744248,en_4806,2,2,AFFECTS,Inhibitory,6
16565,Injection procedure,C1533685,en_5937,TREATS,Flow,C0806140,en_4886,1,1,AFFECTS,Inhibitory,3
16566,Injection procedure,C1533685,en_5937,TREATS,Hospitalized Patients,C0870668,en_5010,3,1,AFFECTS,Inhibitory,3
16567,Injection procedure,C1533685,en_5937,TREATS(INFER),Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,3
16568,Injection procedure,C1533685,en_5937,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
16569,Injection procedure,C1533685,en_5937,TREATS(INFER),respiratory virus,C0597404,en_4426,1,1,AFFECTS,Inhibitory,3
16570,Injection procedure,C1533685,en_5937,TREATS(INFER),Encounter due to In vitro fertilization,C0733942,en_4773,1,1,AFFECTS,Inhibitory,3
16571,Quinolone Antibacterial Agents,C1533693,en_5939,INHIBITS,SLCO4C1,C1428158,en_168,1,1,AFFECTS,Inhibitory,3
16572,Bronchoalveolar Lavage,C1535502,en_5940,TREATS,Mus,C0026809,en_1600,1,1,AFFECTS,Inhibitory,3
16573,Bronchoalveolar Lavage,C1535502,en_5940,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
16574,Bronchoalveolar Lavage,C1535502,en_5940,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
16575,Bronchoalveolar Lavage,C1535502,en_5940,TREATS,Voluntary Workers,C0042960,en_2380,1,1,AFFECTS,Inhibitory,3
16576,Bronchoalveolar Lavage,C1535502,en_5940,TREATS(INFER),Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,3
16577,Bronchoalveolar Lavage,C1535502,en_5940,TREATS(SPEC),Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16578,Tracheal aspiration,C1535528,en_5941,AFFECTS,Possible,C0332149,en_3747,1,1,AFFECTS,General/Uncertain,7
16579,STEMI,C1536220,en_5944,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16580,diffusion tensor imaging,C1537007,en_5945,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
16581,eculizumab,C1541483,en_5949,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16582,eculizumab,C1541483,en_5949,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
16583,eculizumab,C1541483,en_5949,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,3
16584,eculizumab,C1541483,en_5949,TREATS,Acute Lung Injury,C0242488,en_3416,2,1,AFFECTS,Inhibitory,3
16585,eculizumab,C1541483,en_5949,TREATS,Participant,C0679646,en_4602,2,1,AFFECTS,Inhibitory,3
16586,eculizumab,C1541483,en_5949,TREATS(INFER),Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,3
16587,CYTOMEGALOVIRUS GENE,C1545478,en_5950,PREVENTS,tumor growth,C0598934,en_4455,2,1,AFFECTS,Inhibitory,3
16588,Health Safety,C1546216,en_5953,TREATS,Smarting pain,C0235048,en_3319,1,1,AFFECTS,Inhibitory,3
16589,Attending,C1547429,en_5954,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16590,Attending,C1547429,en_5954,TREATS,Provider,C1138603,en_5273,1,1,AFFECTS,Inhibitory,3
16591,ingredient,C1550600,en_5956,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
16592,Holistic,C1552235,en_5958,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16593,Adenovirus Vaccine,C1552907,en_5959,AUGMENTS,Immune response,C0301872,en_3696,1,1,AFFECTS,Excitatory,8
16594,Adenovirus Vaccine,C1552907,en_5959,TREATS,Well adult,C0686750,en_4683,2,1,AFFECTS,Inhibitory,3
16595,virtual patient encounter,C1553497,en_5961,AFFECTS,NONVERBAL,C0746940,en_4821,1,1,AFFECTS,General/Uncertain,8
16596,Internal medicine physicians,C1555750,en_5964,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16597,Chronic Kidney Diseases,C1561643,en_5967,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16598,Chronic Kidney Diseases,C1561643,en_5967,AUGMENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,7
16599,Chronic Kidney Diseases,C1561643,en_5967,PREDISPOSES,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,Excitatory,6
16600,Chronic Kidney Diseases,C1561643,en_5967,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
16601,Calcineurin inhibitor,C1562036,en_5968,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16602,Calcineurin inhibitor,C1562036,en_5968,TREATS,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,Inhibitory,6
16603,Calcineurin inhibitor,C1562036,en_5968,TREATS,"Recipient, Transplant",C0376387,en_3875,2,1,AFFECTS,Inhibitory,3
16604,Calcineurin inhibitor,C1562036,en_5968,TREATS(INFER),Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,3
16605,Anti-tumor necrosis factor alpha drug,C1562242,en_5970,TREATS,Patients,C0030705,en_1762,1,1,AFFECTS,Inhibitory,3
16606,Anti-tumor necrosis factor alpha drug,C1562242,en_5970,TREATS(INFER),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
16607,Roux-en-Y Gastric Bypass,C1563737,en_5973,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
16608,Roux-en-Y Gastric Bypass,C1563737,en_5973,TREATS(INFER),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,3,1,AFFECTS,Inhibitory,3
16609,Oncolytic Virotherapy,C1563738,en_5974,TREATS,sarcoma,C1261473,en_5419,1,1,AFFECTS,Inhibitory,3
16610,Treg Cells,C1563924,en_5975,PRODUCES,SLAMF1,C1420084,en_78,1,1,AFFECTS,Excitatory,3
16611,Treg Cells,C1563924,en_5975,PRODUCES,ectonucleoside triphosphate diphosphohydrolase 1,C0108783,en_2759,1,1,AFFECTS,Excitatory,3
16612,Mutant Proteins,C1564139,en_5976,DISRUPTS,Injury,C0175677,en_2968,1,1,AFFECTS,Inhibitory,3
16613,GATA Transcription Factors,C1564871,en_5977,AFFECTS,erythrocyte differentiation,C1159942,en_5349,2,1,AFFECTS,General/Uncertain,3
16614,Complement Inactivating Agents,C1564892,en_5978,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,7
16615,"Receptors, Pattern Recognition",C1564907,en_5979,STIMULATES,Interferons,C0021747,en_1333,1,1,AFFECTS,Excitatory,3
16616,Apoptosis Inhibiting Proteins,C1565114,en_5980,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
16617,ramelteon,C1565316,en_5981,STIMULATES,Melatonin Receptors,C0065911,en_2523,1,1,AFFECTS,Excitatory,3
16618,Actin-Related Protein 2-3 Complex,C1565319,en_5982,AUGMENTS,actin cortical patch,C1166660,en_5366,1,1,AFFECTS,Excitatory,3
16619,Renal Insufficiency,C1565489,en_5983,PREDISPOSES,Abnormal mental state,C0278061,en_3595,1,1,AFFECTS,Excitatory,6
16620,Renal Insufficiency,C1565489,en_5983,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
16621,Renal Insufficiency,C1565489,en_5983,PREDISPOSES,Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,1,1,AFFECTS,Excitatory,6
16622,Natural Products,C1566558,en_5986,INHIBITS,Enzymes,C0014442,en_912,1,1,AFFECTS,Inhibitory,3
16623,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,TREATS,Canis familiaris,C0012984,en_839,1,1,AFFECTS,Inhibitory,3
16624,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,TREATS,Human,C0020114,en_1210,1,1,AFFECTS,Inhibitory,3
16625,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,TREATS,House mice,C0025914,en_1562,1,1,AFFECTS,Inhibitory,3
16626,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,TREATS,Rattus norvegicus,C0034693,en_1958,1,1,AFFECTS,Inhibitory,3
16627,Endocrine Disruptors,C1568245,en_5988,AFFECTS,Body tissue,C0040300,en_2242,1,1,AFFECTS,General/Uncertain,3
16628,varenicline,C1569608,en_5990,TREATS,alcohol use disorder,C0001956,en_270,1,1,AFFECTS,Inhibitory,3
16629,SODIUM PYRUVATE,C1576824,en_5992,DISRUPTS,Coughing,C0010200,en_723,3,2,AFFECTS,Inhibitory,6
16630,SODIUM PYRUVATE,C1576824,en_5992,DISRUPTS,Nose,C0028429,en_1688,4,2,AFFECTS,Inhibitory,6
16631,SODIUM PYRUVATE,C1576824,en_5992,PREVENTS,Inflammation,C0021368,en_1307,2,1,AFFECTS,Inhibitory,3
16632,SODIUM PYRUVATE,C1576824,en_5992,STIMULATES,Nitric Oxide,C0028128,en_1682,4,2,AFFECTS,Excitatory,6
16633,SODIUM PYRUVATE,C1576824,en_5992,TREATS,Mus,C0026809,en_1600,4,2,AFFECTS,Inhibitory,6
16634,SODIUM PYRUVATE,C1576824,en_5992,TREATS,Patients,C0030705,en_1762,3,1,AFFECTS,Inhibitory,3
16635,SODIUM PYRUVATE,C1576824,en_5992,TREATS,Symptoms,C1457887,en_5784,4,2,AFFECTS,Inhibitory,6
16636,Human normal immunoglobulin,C1578092,en_5993,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16637,Human normal immunoglobulin,C1578092,en_5993,TREATS(INFER),Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,3
16638,Renin-angiotensin-aldosterone System Inhibitors,C1579267,en_5995,AFFECTS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
16639,Renin-angiotensin-aldosterone System Inhibitors,C1579267,en_5995,INHIBITS,"Receptor, Angiotensin II",C0003011,en_329,2,1,AFFECTS,Inhibitory,3
16640,Renin-angiotensin-aldosterone System Inhibitors,C1579267,en_5995,INHIBITS,Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,2,1,AFFECTS,Inhibitory,3
16641,Renin-angiotensin-aldosterone System Inhibitors,C1579267,en_5995,PREVENTS,Acute Pneumonia,C0740766,en_4782,1,1,AFFECTS,Inhibitory,3
16642,Renin-angiotensin-aldosterone System Inhibitors,C1579267,en_5995,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16643,Immunological Agents,C1579312,en_5996,TREATS,Genus: Coronavirus,C0206419,en_3158,2,1,AFFECTS,Inhibitory,3
16644,Pneumococcal Conjugate Vaccine,C1579319,en_5997,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
16645,Nucleoside Analogs,C1579410,en_5998,DISRUPTS,Interested,C0543488,en_4259,1,1,AFFECTS,Inhibitory,3
16646,Nucleoside Analogs,C1579410,en_5998,TREATS,Patients,C0030705,en_1762,2,2,AFFECTS,Inhibitory,6
16647,Complement C5 Convertases,C1579593,en_5999,PRODUCES,"C5,C5AR1",C1367710;C1824180,en_170,1,1,AFFECTS,Excitatory,3
16648,Protex,C1588494,en_6000,STIMULATES,DNA,C0012854,en_834,1,1,AFFECTS,Excitatory,3
16649,Leak NOS,C1608322,en_6001,AFFECTS,Patients,C0030705,en_1762,2,1,AFFECTS,General/Uncertain,3
16650,Leak NOS,C1608322,en_6001,AFFECTS,Emission,C0233929,en_3301,1,1,AFFECTS,General/Uncertain,3
16651,monoclonal antibody CNTO 1275,C1608841,en_6002,TREATS,Ulcerative Colitis,C0009324,en_676,1,1,AFFECTS,Inhibitory,6
16652,monoclonal antibody CNTO 1275,C1608841,en_6002,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
16653,tocilizumab,C1609165,en_6003,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
16654,tocilizumab,C1609165,en_6003,AFFECTS,Evolution,C0015219,en_937,2,1,AFFECTS,General/Uncertain,3
16655,tocilizumab,C1609165,en_6003,AFFECTS,Apoptosis,C0162638,en_2922,1,1,AFFECTS,General/Uncertain,3
16656,tocilizumab,C1609165,en_6003,AFFECTS,Immune response,C0301872,en_3696,2,1,AFFECTS,General/Uncertain,3
16657,tocilizumab,C1609165,en_6003,AFFECTS,Structure of parenchyma of lung,C0819757,en_4926,1,1,AFFECTS,General/Uncertain,3
16658,tocilizumab,C1609165,en_6003,AFFECTS,Storm NOS,C2905612,en_6141,1,1,AFFECTS,General/Uncertain,6
16659,tocilizumab,C1609165,en_6003,AFFECTS,Lethality,C5203340,en_6416,1,1,AFFECTS,General/Uncertain,7
16660,tocilizumab,C1609165,en_6003,AFFECTS,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,7
16661,tocilizumab,C1609165,en_6003,DISRUPTS,Cessation of life,C0011065,en_762,2,2,AFFECTS,Inhibitory,10
16662,tocilizumab,C1609165,en_6003,DISRUPTS,Ligand Binding,C1517880,en_5869,1,1,AFFECTS,Inhibitory,6
16663,tocilizumab,C1609165,en_6003,DISRUPTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16664,tocilizumab,C1609165,en_6003,INHIBITS,Acute-Phase Proteins,C0001347,en_232,1,1,AFFECTS,Inhibitory,6
16665,tocilizumab,C1609165,en_6003,INHIBITS,C-reactive protein,C0006560,en_529,2,2,AFFECTS,Inhibitory,12
16666,tocilizumab,C1609165,en_6003,INHIBITS,Immunity,C0020964,en_1273,1,1,AFFECTS,Inhibitory,6
16667,tocilizumab,C1609165,en_6003,INHIBITS,Interleukin-6,C0021760,en_1342,15,9,AFFECTS,Inhibitory,31
16668,tocilizumab,C1609165,en_6003,INHIBITS,Interleukin 6 Receptor,C0063717,en_2510,6,6,AFFECTS,Inhibitory,31
16669,tocilizumab,C1609165,en_6003,INHIBITS,receptor,C0597357,en_4422,1,1,AFFECTS,Inhibitory,7
16670,tocilizumab,C1609165,en_6003,INHIBITS,Complement factor,C1305959,en_5520,1,1,AFFECTS,Inhibitory,3
16671,tocilizumab,C1609165,en_6003,INHIBITS,Death (finding),C1306577,en_5521,2,1,AFFECTS,Inhibitory,3
16672,tocilizumab,C1609165,en_6003,INHIBITS,Inflammation Process,C1512753,en_5825,2,1,AFFECTS,Inhibitory,3
16673,tocilizumab,C1609165,en_6003,INHIBITS,Complete Response with Incomplete Platelet Recovery,C3890735,en_6283,1,1,AFFECTS,Inhibitory,6
16674,tocilizumab,C1609165,en_6003,INHIBITS,Lethality,C5203340,en_6416,1,1,AFFECTS,Inhibitory,7
16675,tocilizumab,C1609165,en_6003,INHIBITS(SPEC),Interleukin 6 Receptor,C0063717,en_2510,1,1,AFFECTS,Inhibitory,3
16676,tocilizumab,C1609165,en_6003,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,3
16677,tocilizumab,C1609165,en_6003,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,3
16678,tocilizumab,C1609165,en_6003,PREVENTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,Inhibitory,6
16679,tocilizumab,C1609165,en_6003,STIMULATES,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Excitatory,7
16680,tocilizumab,C1609165,en_6003,TREATS,Adult,C0001675,en_252,3,3,AFFECTS,Inhibitory,22
16681,tocilizumab,C1609165,en_6003,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
16682,tocilizumab,C1609165,en_6003,TREATS,Control Groups,C0009932,en_711,1,1,AFFECTS,Inhibitory,3
16683,tocilizumab,C1609165,en_6003,TREATS,Critical Illness,C0010340,en_733,2,2,AFFECTS,Inhibitory,12
16684,tocilizumab,C1609165,en_6003,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
16685,tocilizumab,C1609165,en_6003,TREATS,Fever,C0015967,en_985,3,2,AFFECTS,Inhibitory,9
16686,tocilizumab,C1609165,en_6003,TREATS,Inflammation,C0021368,en_1307,3,3,AFFECTS,Inhibitory,17
16687,tocilizumab,C1609165,en_6003,TREATS,Myocarditis,C0027059,en_1627,1,1,AFFECTS,Inhibitory,3
16688,tocilizumab,C1609165,en_6003,TREATS,Patients,C0030705,en_1762,49,25,AFFECTS,Inhibitory,75
16689,tocilizumab,C1609165,en_6003,TREATS,Pneumonia,C0032285,en_1833,20,15,AFFECTS,Inhibitory,91
16690,tocilizumab,C1609165,en_6003,TREATS,Syndrome,C0039082,en_2197,1,1,AFFECTS,Inhibitory,6
16691,tocilizumab,C1609165,en_6003,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,6
16692,tocilizumab,C1609165,en_6003,TREATS,Hypoxia,C0242184,en_3396,2,1,AFFECTS,Inhibitory,8
16693,tocilizumab,C1609165,en_6003,TREATS,Sepsis Syndrome,C0242966,en_3446,1,1,AFFECTS,Inhibitory,3
16694,tocilizumab,C1609165,en_6003,TREATS,Respiratory distress,C0476273,en_4149,2,2,AFFECTS,Inhibitory,6
16695,tocilizumab,C1609165,en_6003,TREATS,Mild inflammation,C0522567,en_4214,1,1,AFFECTS,Inhibitory,6
16696,tocilizumab,C1609165,en_6003,TREATS,Participant,C0679646,en_4602,4,2,AFFECTS,Inhibitory,6
16697,tocilizumab,C1609165,en_6003,TREATS,Hospitalized Patients,C0870668,en_5010,16,14,AFFECTS,Inhibitory,75
16698,tocilizumab,C1609165,en_6003,TREATS,Cytokine storm,C0919747,en_5119,5,4,AFFECTS,Inhibitory,20
16699,tocilizumab,C1609165,en_6003,TREATS,Cytokine release syndrome,C0948245,en_5163,14,8,AFFECTS,Inhibitory,33
16700,tocilizumab,C1609165,en_6003,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,3
16701,tocilizumab,C1609165,en_6003,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,6
16702,tocilizumab,C1609165,en_6003,TREATS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,6
16703,tocilizumab,C1609165,en_6003,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,6
16704,tocilizumab,C1609165,en_6003,TREATS,"Pulmonary involvement, severe",C1843376,en_6050,1,1,AFFECTS,Inhibitory,6
16705,tocilizumab,C1609165,en_6003,TREATS,Actual Adequate Hydration,C2364300,en_6113,1,1,AFFECTS,Inhibitory,6
16706,tocilizumab,C1609165,en_6003,TREATS,Storm NOS,C2905612,en_6141,1,1,AFFECTS,Inhibitory,6
16707,tocilizumab,C1609165,en_6003,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,6
16708,tocilizumab,C1609165,en_6003,TREATS,Hyperinflammatory state,C4014463,en_6290,1,1,AFFECTS,Inhibitory,6
16709,tocilizumab,C1609165,en_6003,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,5,4,AFFECTS,Inhibitory,27
16710,tocilizumab,C1609165,en_6003,TREATS,Intubated,C4698386,en_6376,1,1,AFFECTS,Inhibitory,6
16711,tocilizumab,C1609165,en_6003,TREATS,Severe infection,C5139167,en_6407,3,1,AFFECTS,Inhibitory,7
16712,tocilizumab,C1609165,en_6003,TREATS,COVID-19,C5203670,en_6417,44,29,AFFECTS,Inhibitory,193
16713,tocilizumab,C1609165,en_6003,TREATS,2019 novel coronavirus,C5203676,en_6420,2,2,AFFECTS,Inhibitory,12
16714,tocilizumab,C1609165,en_6003,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,4,2,AFFECTS,Inhibitory,14
16715,tocilizumab,C1609165,en_6003,TREATS(INFER),Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,Inhibitory,3
16716,tocilizumab,C1609165,en_6003,TREATS(INFER),Disease,C0012634,en_826,3,3,AFFECTS,Inhibitory,9
16717,tocilizumab,C1609165,en_6003,TREATS(INFER),Pneumonia,C0032285,en_1833,9,5,AFFECTS,Inhibitory,15
16718,tocilizumab,C1609165,en_6003,TREATS(INFER),Virus Diseases,C0042769,en_2362,4,1,AFFECTS,Inhibitory,3
16719,tocilizumab,C1609165,en_6003,TREATS(SPEC),Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,3
16720,tocilizumab,C1609165,en_6003,TREATS(SPEC),Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,3
16721,lucinactant,C1609686,en_6005,AUGMENTS,Respiration:status,C0946344,en_5151,1,1,AFFECTS,Excitatory,3
16722,monoclonal antibody CNTO 328,C1609931,en_6006,INHIBITS,Interleukin-8,C0079633,en_2608,1,1,AFFECTS,Inhibitory,6
16723,monoclonal antibody CNTO 328,C1609931,en_6006,INHIBITS,PTX3 protein,C0174234,en_2965,1,1,AFFECTS,Inhibitory,6
16724,Therapeutic agent (substance),C1611640,en_6008,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,3
16725,Therapeutic agent (substance),C1611640,en_6008,INHIBITS,ACE2,C1422064,en_5723,1,1,AFFECTS,Inhibitory,3
16726,Therapeutic agent (substance),C1611640,en_6008,INHIBITS,"Receptor, Angiotensin II",C0003011,en_329,1,1,AFFECTS,Inhibitory,3
16727,Therapeutic agent (substance),C1611640,en_6008,INHIBITS,Underweight,C0041667,en_2308,1,1,AFFECTS,Inhibitory,3
16728,Therapeutic agent (substance),C1611640,en_6008,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
16729,Therapeutic agent (substance),C1611640,en_6008,TREATS,Adult,C0001675,en_252,7,4,AFFECTS,Inhibitory,12
16730,Therapeutic agent (substance),C1611640,en_6008,TREATS,Disease,C0012634,en_826,5,3,AFFECTS,Inhibitory,9
16731,Therapeutic agent (substance),C1611640,en_6008,TREATS,Hereditary Diseases,C0019247,en_1180,1,1,AFFECTS,Inhibitory,3
16732,Therapeutic agent (substance),C1611640,en_6008,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,3
16733,Therapeutic agent (substance),C1611640,en_6008,TREATS,Kidney Diseases,C0022658,en_1381,2,2,AFFECTS,Inhibitory,6
16734,Therapeutic agent (substance),C1611640,en_6008,TREATS,Patients,C0030705,en_1762,2,1,AFFECTS,Inhibitory,3
16735,Therapeutic agent (substance),C1611640,en_6008,TREATS,Septicemia,C0036690,en_2086,1,1,AFFECTS,Inhibitory,3
16736,Therapeutic agent (substance),C1611640,en_6008,TREATS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,3
16737,Therapeutic agent (substance),C1611640,en_6008,TREATS,Respiratory complication,C0161818,en_2899,1,1,AFFECTS,Inhibitory,3
16738,Therapeutic agent (substance),C1611640,en_6008,TREATS,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,Inhibitory,3
16739,Therapeutic agent (substance),C1611640,en_6008,TREATS,Hepatitis C virus,C0220847,en_3204,1,1,AFFECTS,Inhibitory,3
16740,Therapeutic agent (substance),C1611640,en_6008,TREATS,Hospitalized Patients,C0870668,en_5010,5,3,AFFECTS,Inhibitory,9
16741,Therapeutic agent (substance),C1611640,en_6008,TREATS(INFER),Respiration Disorders,C0035204,en_2005,2,1,AFFECTS,Inhibitory,3
16742,Therapeutic agent (substance),C1611640,en_6008,TREATS(INFER),Patient in hospital,C0701159,en_4731,7,4,AFFECTS,Inhibitory,12
16743,NOMID,C1611731,en_6009,AFFECTS,physiological aspects,C0031843,en_1806,1,1,AFFECTS,General/Uncertain,3
16744,NOMID,C1611731,en_6009,AFFECTS,monocyte differentiation,C1159954,en_5350,1,1,AFFECTS,General/Uncertain,3
16745,Injection Caps,C1619687,en_6011,TREATS,Human body,C0242821,en_3440,1,1,AFFECTS,Inhibitory,3
16746,Immune reconstitution inflammatory syndrome,C1619738,en_6013,AFFECTS,Immunologic function,C1268930,en_5445,1,1,AFFECTS,General/Uncertain,3
16747,Immune reconstitution inflammatory syndrome,C1619738,en_6013,COMPLICATES,"Toxoplasmosis, Cerebral",C0085315,en_2663,1,1,AFFECTS,General/Uncertain,3
16748,Anti-Antibodies,C1624602,en_6015,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,7
16749,44715,C1630409,en_6017,PREDISPOSES,Severe disorder,C1836348,en_6048,1,1,AFFECTS,Excitatory,6
16750,Complicated appendicitis,C1632842,en_6018,AFFECTS,American,C0596070,en_4379,1,1,AFFECTS,General/Uncertain,6
16751,nebulization-mediated drug administration,C1659427,en_6019,TREATS,"Platelets, CTCAE",C1963076,en_6071,1,1,AFFECTS,Inhibitory,7
16752,nebulization-mediated drug administration,C1659427,en_6019,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,15
16753,Respiratory problem,C1659989,en_6020,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
16754,regadenoson,C1698215,en_6021,AUGMENTS,Vasodilation,C0042401,en_2342,1,1,AFFECTS,Excitatory,7
16755,fingolimod,C1699926,en_6022,INHIBITS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,6
16756,fingolimod,C1699926,en_6022,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,6
16757,"ITGAM protein, human|ITGAM",C1701032|3684,en_6023,INHIBITS,PTGDR2 gene|PTGDR2,C1415238|11251,en_5706,1,1,AFFECTS,Inhibitory,6
16758,cytoflavin,C1701400,en_6024,PREVENTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Inhibitory,7
16759,green tea extract,C1704263,en_6028,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16760,Clinical Services,C1704289,en_6029,TREATS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,6
16761,Active Method,C1704532,en_6031,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
16762,Active Method,C1704532,en_6031,TREATS,Acute leukemia,C0085669,en_2685,1,1,AFFECTS,Inhibitory,6
16763,Active Method,C1704532,en_6031,TREATS,Solid tumor,C0280100,en_3619,1,1,AFFECTS,Inhibitory,6
16764,Active Method,C1704532,en_6031,TREATS,[M]Solid carcinoma NOS,C0334296,en_3776,1,1,AFFECTS,Inhibitory,6
16765,Active Method,C1704532,en_6031,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
16766,Active Method,C1704532,en_6031,TREATS,<12 months,C4699604,en_6381,1,1,AFFECTS,Inhibitory,8
16767,BARRIER,C1706912,en_6034,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16768,BARRIER,C1706912,en_6034,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,7
16769,BARRIER,C1706912,en_6034,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,6
16770,BARRIER,C1706912,en_6034,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,6
16771,BARRIER,C1706912,en_6034,TREATS,Special mental health,C3841227,en_6256,1,1,AFFECTS,Inhibitory,7
16772,First line treatment,C1708063,en_6035,TREATS,Appendicitis,C0003615,en_387,1,1,AFFECTS,Inhibitory,6
16773,First line treatment,C1708063,en_6035,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
16774,First line treatment,C1708063,en_6035,TREATS,Historical Cohort,C2348984,en_6100,1,1,AFFECTS,Inhibitory,6
16775,Human mesenchymal stem cell,C1720336,en_6038,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,7
16776,Human mesenchymal stem cell,C1720336,en_6038,TREATS,COVID-19,C5203670,en_6417,4,2,AFFECTS,Inhibitory,16
16777,rivaroxaban,C1739768,en_6039,DISRUPTS,Arteries,C0003842,en_398,1,1,AFFECTS,Inhibitory,7
16778,rivaroxaban,C1739768,en_6039,DISRUPTS,major vein,C0682606,en_4645,1,1,AFFECTS,Inhibitory,7
16779,rivaroxaban,C1739768,en_6039,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,6
16780,rivaroxaban,C1739768,en_6039,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,7
16781,rivaroxaban,C1739768,en_6039,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16782,SKAP1 gene|SKAP1,C1822730|8631,en_6043,STIMULATES,TLR6,C1336638,en_106,1,1,AFFECTS,Excitatory,7
16783,SKAP1 gene|SKAP1,C1822730|8631,en_6043,STIMULATES,Gelatinase B|MMP9,C0165519|4318,en_2947,1,1,AFFECTS,Excitatory,7
16784,IMPACT gene,C1825598,en_6044,AFFECTS,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,8
16785,IMPACT gene,C1825598,en_6044,AFFECTS,Movement,C0026649,en_1588,1,1,AFFECTS,General/Uncertain,6
16786,IMPACT gene,C1825598,en_6044,AFFECTS,Myocardium,C0027061,en_1628,1,1,AFFECTS,General/Uncertain,7
16787,IMPACT gene,C1825598,en_6044,AFFECTS,Migraine Disorders,C0149931,en_2813,1,1,AFFECTS,General/Uncertain,6
16788,IMPACT gene,C1825598,en_6044,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,6
16789,IMPACT gene,C1825598,en_6044,AFFECTS,Negative,C0205160,en_3126,2,2,AFFECTS,General/Uncertain,13
16790,IMPACT gene,C1825598,en_6044,AFFECTS,Well in self,C0424578,en_3996,1,1,AFFECTS,General/Uncertain,8
16791,IMPACT gene,C1825598,en_6044,AFFECTS,Protection,C1545588,en_5951,1,1,AFFECTS,General/Uncertain,8
16792,IMPACT gene,C1825598,en_6044,AFFECTS,Underlying,C4722602,en_6385,1,1,AFFECTS,General/Uncertain,6
16793,IMPACT gene,C1825598,en_6044,AFFECTS,COVID-19,C5203670,en_6417,4,4,AFFECTS,General/Uncertain,24
16794,IMPACT gene,C1825598,en_6044,AUGMENTS,Acclimatization,C0000934,en_212,1,1,AFFECTS,Excitatory,6
16795,IMPACT gene,C1825598,en_6044,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,6
16796,IMPACT gene,C1825598,en_6044,AUGMENTS,Duration of gestation,C0460089,en_4127,1,1,AFFECTS,Excitatory,7
16797,IMPACT gene,C1825598,en_6044,AUGMENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,7
16798,IMPACT gene,C1825598,en_6044,AUGMENTS,Affected Area,C1879646,en_6061,1,1,AFFECTS,Excitatory,6
16799,IMPACT gene,C1825598,en_6044,DISRUPTS,Premature Birth,C0151526,en_2860,1,1,AFFECTS,Inhibitory,6
16800,IMPACT gene,C1825598,en_6044,DISRUPTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16801,IMPACT gene,C1825598,en_6044,INHIBITS,Enzyme Inhibitors,C0014432,en_911,1,1,AFFECTS,Inhibitory,6
16802,IMPACT gene,C1825598,en_6044,INHIBITS,Aldosterone Receptors,C0051133,en_2425,1,1,AFFECTS,Inhibitory,6
16803,IMPACT gene,C1825598,en_6044,PREDISPOSES,Spontaneous abortion,C0000786,en_206,1,1,AFFECTS,Excitatory,6
16804,IMPACT gene,C1825598,en_6044,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
16805,IMPACT gene,C1825598,en_6044,PREDISPOSES,Lethargy,C0023380,en_1413,1,1,AFFECTS,Excitatory,6
16806,IMPACT gene,C1825598,en_6044,PREDISPOSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,13
16807,IMPACT gene,C1825598,en_6044,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,6
16808,IMPACT gene,C1825598,en_6044,PREVENTS,Eating disorder symptom,C0855228,en_4965,1,1,AFFECTS,Inhibitory,8
16809,apixaban,C1831808,en_6046,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,6
16810,apixaban,C1831808,en_6046,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
16811,Lyso-Thermosensitive Liposome Doxorubicin,C1831903,en_6047,TREATS,malignant neoplasm of breast staging,C2216702,en_6091,1,1,AFFECTS,Inhibitory,7
16812,IRAK4 Deficiency,C1843256,en_6049,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16813,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",C1849718,en_6051,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
16814,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,AFFECTS,Child,C0008059,en_620,1,1,AFFECTS,General/Uncertain,6
16815,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,AFFECTS,Abnormal behavior,C0233514,en_3296,1,1,AFFECTS,General/Uncertain,6
16816,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
16817,Venous Thromboembolism,C1861172,en_6055,PREDISPOSES,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,Excitatory,6
16818,Cognitive Training Programs,C1868940,en_6058,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,8
16819,Cognitive Training Programs,C1868940,en_6058,TREATS,Mild cognitive disorder,C1270972,en_5450,1,1,AFFECTS,Inhibitory,8
16820,Invasive mechanical ventilation NOS,C1868981,en_6059,AFFECTS,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,6
16821,Invasive mechanical ventilation NOS,C1868981,en_6059,AFFECTS,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,6
16822,Invasive mechanical ventilation NOS,C1868981,en_6059,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,6
16823,Invasive mechanical ventilation NOS,C1868981,en_6059,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,6
16824,Invasive mechanical ventilation NOS,C1868981,en_6059,PREDISPOSES,"Pneumonia, Ventilator-Associated",C1701940,en_6025,1,1,AFFECTS,Excitatory,6
16825,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,7
16826,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Critical Illness,C0010340,en_733,2,2,AFFECTS,Inhibitory,12
16827,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
16828,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,6
16829,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,6
16830,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,3,AFFECTS,Inhibitory,21
16831,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Females,C0086287,en_2713,1,1,AFFECTS,Inhibitory,6
16832,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,6
16833,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Hospitalized Patients,C0870668,en_5010,2,2,AFFECTS,Inhibitory,13
16834,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,6
16835,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,High Level,C4321237,en_6341,2,2,AFFECTS,Inhibitory,12
16836,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,Severe infection,C5139167,en_6407,2,1,AFFECTS,Inhibitory,7
16837,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,COVID-19,C5203670,en_6417,9,6,AFFECTS,Inhibitory,38
16838,Invasive mechanical ventilation NOS,C1868981,en_6059,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
16839,Basis,C1874451,en_6060,TREATS,Asthma,C0004096,en_418,1,1,AFFECTS,Inhibitory,7
16840,Basis,C1874451,en_6060,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16841,Informational Intervention,C1881205,en_6062,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16842,ocrelizumab,C1882138,en_6063,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,6
16843,Therapeutic Nutritional Supplementation,C1883299,en_6064,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
16844,Therapeutic Nutritional Supplementation,C1883299,en_6064,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
16845,Yoga,C1883583,en_6065,TREATS,Health Personnel,C0018724,en_1121,2,2,AFFECTS,Inhibitory,14
16846,Yoga,C1883583,en_6065,TREATS,Decreased stress,C0231299,en_3255,1,1,AFFECTS,Inhibitory,8
16847,Adipokines,C1955907,en_6066,AFFECTS,iron metabolism,C0596803,en_4396,1,1,AFFECTS,General/Uncertain,6
16848,Deep Sedation,C1956064,en_6067,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,Inhibitory,6
16849,Biphasic Continuous Positive Airway Pressure,C1956423,en_6069,AFFECTS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,8
16850,Biphasic Continuous Positive Airway Pressure,C1956423,en_6069,TREATS,Intubated,C4698386,en_6376,1,1,AFFECTS,Inhibitory,7
16851,"Platelets, CTCAE",C1963076,en_6071,PREDISPOSES,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,Excitatory,6
16852,Antiretroviral therapy,C1963724,en_6072,TREATS,HIV,C0019682,en_1190,1,1,AFFECTS,Inhibitory,6
16853,Immunomodulation,C1963758,en_6073,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
16854,Immunomodulation,C1963758,en_6073,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,8
16855,Immunomodulation,C1963758,en_6073,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,8
16856,Immunomodulation,C1963758,en_6073,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16857,early/brief intervention/therapy (treatment),C1964029,en_6074,TREATS,Autistic Children,C0175842,en_2973,1,1,AFFECTS,Inhibitory,8
16858,early/brief intervention/therapy (treatment),C1964029,en_6074,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
16859,early/brief intervention/therapy (treatment),C1964029,en_6074,TREATS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,Inhibitory,6
16860,early/brief intervention/therapy (treatment),C1964029,en_6074,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,6
16861,early/brief intervention/therapy (treatment),C1964029,en_6074,TREATS,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,C4725841,en_6387,1,1,AFFECTS,Inhibitory,6
16862,early/brief intervention/therapy (treatment),C1964029,en_6074,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
16863,darunavir and ritonavir,C1976853,en_6075,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
16864,Nutritional risk index:Arbitrary Concentration:Point in time:^Patient:Quantitative,C1977904,en_6076,PREDISPOSES,Malnutrition,C0162429,en_2910,1,1,AFFECTS,Excitatory,6
16865,Psychiatric drugs,C1979799,en_6077,TREATS,Mixed anxiety and depressive disorder,C0338908,en_3806,1,1,AFFECTS,Inhibitory,6
16866,Psychiatric drugs,C1979799,en_6077,TREATS,Dyssomnias,C0700201,en_4715,1,1,AFFECTS,Inhibitory,6
16867,Extended interval dosing,C1979887,en_6078,TREATS,"Leukoencephalopathy, Progressive Multifocal",C0023524,en_1422,1,1,AFFECTS,Inhibitory,6
16868,Extended interval dosing,C1979887,en_6078,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,6
16869,Microglobulin,C1979927,en_6079,AFFECTS,Day 4,C3840892,en_6255,1,1,AFFECTS,General/Uncertain,6
16870,Noninvasive Ventilation,C1997883,en_6080,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
16871,Noninvasive Ventilation,C1997883,en_6080,TREATS,Disease,C0012634,en_826,5,1,AFFECTS,Inhibitory,6
16872,Noninvasive Ventilation,C1997883,en_6080,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,6
16873,Noninvasive Ventilation,C1997883,en_6080,TREATS,Hypoxemia,C0700292,en_4719,1,1,AFFECTS,Inhibitory,8
16874,Noninvasive Ventilation,C1997883,en_6080,TREATS,Preterm Infant,C4048294,en_6308,1,1,AFFECTS,Inhibitory,6
16875,Noninvasive Ventilation,C1997883,en_6080,TREATS,COVID-19,C5203670,en_6417,6,4,AFFECTS,Inhibitory,27
16876,Computerized cognitive behavioral therapy,C1998288,en_6081,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
16877,Meal (occasion for eating),C1998602,en_6083,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
16878,ferric carboxymaltose,C2001867,en_6085,TREATS,Iron deficiency,C0240066,en_3382,1,1,AFFECTS,Inhibitory,8
16879,ferric carboxymaltose,C2001867,en_6085,TREATS,Acute heart failure,C0264714,en_3536,1,1,AFFECTS,Inhibitory,8
16880,ferric carboxymaltose,C2001867,en_6085,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
16881,intravenous Saline,C2034490,en_6087,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
16882,urgent Operation,C2188405,en_6090,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16883,ciclesonide Metered Dose Inhaler,C2344604,en_6096,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16884,dabigatran,C2348066,en_6098,TREATS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Inhibitory,6
16885,Dose Regimen,C2348331,en_6099,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
16886,Dose Regimen,C2348331,en_6099,TREATS,Influenza,C0021400,en_1311,2,1,AFFECTS,Inhibitory,7
16887,Dose Regimen,C2348331,en_6099,TREATS,"Rhabdomyosarcoma, Alveolar",C0206655,en_3173,1,1,AFFECTS,Inhibitory,7
16888,Dose Regimen,C2348331,en_6099,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,7
16889,Non-invasive mechanical ventilation,C2349740,en_6101,PREDISPOSES,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Excitatory,7
16890,Myobacterium w (attenuated),C2349988,en_6102,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16891,Valved Holding Chambers,C2350030,en_6103,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
16892,Valved Holding Chambers,C2350030,en_6103,TREATS,Respiratory Hypersensitivity,C0035228,en_2011,1,1,AFFECTS,Inhibitory,8
16893,Nasal Lavage,C2350442,en_6106,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
16894,Nasal Lavage,C2350442,en_6106,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16895,dapagliflozin,C2353951,en_6108,DISRUPTS,Kidney,C0022646,en_1380,1,1,AFFECTS,Inhibitory,7
16896,dapagliflozin,C2353951,en_6108,PREVENTS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,7
16897,dapagliflozin,C2353951,en_6108,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,7
16898,dapagliflozin,C2353951,en_6108,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,15
16899,Additional assessment,C2359834,en_6109,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
16900,Discomfort,C2364135,en_6112,PREDISPOSES,Delirium,C0011206,en_774,1,1,AFFECTS,Excitatory,8
16901,Vaccine Administration,C2368628,en_6114,TREATS,Females,C0086287,en_2713,1,1,AFFECTS,Inhibitory,6
16902,macitentan,C2606556,en_6115,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
16903,Colon and Rectal Surgery (procedure),C2608114,en_6116,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,8
16904,perampanel,C2698764,en_6117,AFFECTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,8
16905,perampanel,C2698764,en_6117,TREATS,Amyotrophic Lateral Sclerosis,C0002736,en_310,1,1,AFFECTS,Inhibitory,8
16906,Steatohepatitis,C2711227,en_6120,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
16907,Revaccination,C2713304,en_6121,PREVENTS,Leprosy,C0023343,en_1412,1,1,AFFECTS,Inhibitory,8
16908,Revaccination,C2713304,en_6121,PREVENTS,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,Inhibitory,8
16909,Revaccination,C2713304,en_6121,TREATS,"Immunity, Natural",C0020969,en_1276,2,1,AFFECTS,Inhibitory,8
16910,fostamatinib,C2713632,en_6122,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,7
16911,fostamatinib,C2713632,en_6122,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,7
16912,fostamatinib,C2713632,en_6122,PREVENTS,Venous Thromboembolism,C1861172,en_6055,1,1,AFFECTS,Inhibitory,7
16913,fostamatinib,C2713632,en_6122,PREVENTS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
16914,fostamatinib,C2713632,en_6122,TREATS,Thrombocytopenia,C0040034,en_2229,1,1,AFFECTS,Inhibitory,7
16915,fostamatinib,C2713632,en_6122,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
16916,Compassionate Use,C2718016,en_6124,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
16917,Compassionate Use,C2718016,en_6124,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
16918,Climate Change,C2718051,en_6125,AFFECTS,Infrared Rays,C0021431,en_1314,1,1,AFFECTS,General/Uncertain,6
16919,Mobile Health,C2718080,en_6126,PREVENTS,Distress,C0231303,en_3256,1,1,AFFECTS,Inhibitory,8
16920,Mobile Health,C2718080,en_6126,TREATS,Engaged to be married,C0425152,en_4000,1,1,AFFECTS,Inhibitory,8
16921,canakinumab,C2718773,en_6127,TREATS,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Inhibitory,7
16922,canakinumab,C2718773,en_6127,TREATS,Day 7,C3842672,en_6261,1,1,AFFECTS,Inhibitory,7
16923,canakinumab,C2718773,en_6127,TREATS,High Level,C4321237,en_6341,1,1,AFFECTS,Inhibitory,7
16924,canakinumab,C2718773,en_6127,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,15
16925,canakinumab,C2718773,en_6127,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,4,2,AFFECTS,Inhibitory,13
16926,onabotulinumtoxinA,C2719767,en_6128,TREATS,user - individual,C1706077,en_6033,1,1,AFFECTS,Inhibitory,8
16927,Mental health assessment,C2720502,en_6129,TREATS,CANADIAN,C0238884,en_3371,1,1,AFFECTS,Inhibitory,8
16928,Low molecular weight heparin therapy,C2733531,en_6131,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
16929,Low molecular weight heparin therapy,C2733531,en_6131,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16930,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Anxiety,C0003467,en_380,1,1,AFFECTS,General/Uncertain,8
16931,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
16932,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Climacteric,C0008943,en_655,1,1,AFFECTS,General/Uncertain,6
16933,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,6
16934,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Immune system,C0020962,en_1271,1,1,AFFECTS,General/Uncertain,6
16935,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Myocardium,C0027061,en_1628,2,2,AFFECTS,General/Uncertain,12
16936,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,risk factors,C0035648,en_2039,1,1,AFFECTS,General/Uncertain,8
16937,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Seizures,C0036572,en_2076,1,1,AFFECTS,General/Uncertain,6
16938,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Vision,C0042789,en_2366,1,1,AFFECTS,General/Uncertain,6
16939,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,6
16940,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Possible,C0332149,en_3747,1,1,AFFECTS,General/Uncertain,6
16941,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,"Risk factor, cardiovascular",C0850624,en_4944,1,1,AFFECTS,General/Uncertain,6
16942,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,7
16943,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Childbirth,C1148523,en_5296,1,1,AFFECTS,General/Uncertain,6
16944,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,8
16945,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Biochemical Pathway,C1704259,en_6027,1,1,AFFECTS,General/Uncertain,6
16946,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,Dynamics,C3826426,en_6247,1,1,AFFECTS,General/Uncertain,7
16947,"CD69 protein, human|CD69",C2744535|969,en_6133,AFFECTS,COVID-19,C5203670,en_6417,7,7,AFFECTS,General/Uncertain,42
16948,"CD69 protein, human|CD69",C2744535|969,en_6133,AUGMENTS,mental health,C0025353,en_1542,1,1,AFFECTS,Excitatory,8
16949,"CD69 protein, human|CD69",C2744535|969,en_6133,AUGMENTS,"Dermatitis, Irritant",C0162823,en_2934,1,1,AFFECTS,Excitatory,6
16950,"CD69 protein, human|CD69",C2744535|969,en_6133,COMPLICATES,Adrenal gland hypofunction,C0001623,en_248,1,1,AFFECTS,General/Uncertain,6
16951,"CD69 protein, human|CD69",C2744535|969,en_6133,PREDISPOSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,6
16952,"CD69 protein, human|CD69",C2744535|969,en_6133,PREDISPOSES,"Polyneuropathy, Critical Illness",C0393851,en_3935,1,1,AFFECTS,Excitatory,6
16953,"CD69 protein, human|CD69",C2744535|969,en_6133,PREDISPOSES,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,Excitatory,6
16954,"CD69 protein, human|CD69",C2744535|969,en_6133,PREDISPOSES,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,Excitatory,6
16955,"CD69 protein, human|CD69",C2744535|969,en_6133,PREDISPOSES,Symptoms,C1457887,en_5784,1,1,AFFECTS,Excitatory,6
16956,"CD69 protein, human|CD69",C2744535|969,en_6133,PREDISPOSES,COVID-19,C5203670,en_6417,2,2,AFFECTS,Excitatory,12
16957,"CD69 protein, human|CD69",C2744535|969,en_6133,PREVENTS,Influenza,C0021400,en_1311,1,1,AFFECTS,Inhibitory,7
16958,"CD69 protein, human|CD69",C2744535|969,en_6133,PREVENTS,skin disorder,C0037274,en_2115,1,1,AFFECTS,Inhibitory,6
16959,"CD69 protein, human|CD69",C2744535|969,en_6133,PREVENTS,Ventilator-Induced Lung Injury,C2350350,en_6104,1,1,AFFECTS,Inhibitory,6
16960,"CD69 protein, human|CD69",C2744535|969,en_6133,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
16961,"CD69 protein, human|CD69",C2744535|969,en_6133,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
16962,Aversion,C2825146,en_6134,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16963,"immunoglobulin A, human",C2825347,en_6135,TREATS,Survivors,C0206194,en_3154,2,2,AFFECTS,Inhibitory,12
16964,"immunoglobulin A, human",C2825347,en_6135,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
16965,Adjunctive Orthodontic Procedure,C2825951,en_6136,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,8
16966,Adjunctive Orthodontic Procedure,C2825951,en_6136,TREATS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,Inhibitory,8
16967,Current Therapy,C2827774,en_6138,TREATS,Facial Dermatoses,C0015456,en_956,1,1,AFFECTS,Inhibitory,6
16968,Acute pulmonary embolism,C2882221,en_6139,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
16969,Negative Regulation of Coagulation,C2917212,en_6142,AFFECTS,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,General/Uncertain,6
16970,Negative Regulation of Coagulation,C2917212,en_6142,AFFECTS,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,General/Uncertain,6
16971,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,TREATS,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,Inhibitory,7
16972,"Discharge, body substance",C2926602,en_6145,PREDISPOSES,Anxiety,C0003467,en_380,1,1,AFFECTS,Excitatory,6
16973,"Discharge, body substance",C2926602,en_6145,PREDISPOSES,Paresis,C0030552,en_1751,1,1,AFFECTS,Excitatory,6
16974,"Discharge, body substance",C2926602,en_6145,PREDISPOSES,"Stress Disorders, Post-Traumatic",C0038436,en_2166,1,1,AFFECTS,Excitatory,6
16975,Duration,C2926735,en_6146,AFFECTS,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
16976,Duration,C2926735,en_6146,AFFECTS,Virus Shedding,C0162633,en_2921,2,2,AFFECTS,General/Uncertain,13
16977,Duration,C2926735,en_6146,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,6
16978,Duration,C2926735,en_6146,AFFECTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
16979,Duration,C2926735,en_6146,AFFECTS,Influenza A,C2062441,en_6088,1,1,AFFECTS,General/Uncertain,6
16980,Duration,C2926735,en_6146,AFFECTS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,General/Uncertain,6
16981,Duration,C2926735,en_6146,AFFECTS,Sign or Symptom,C3540840,en_6216,1,1,AFFECTS,General/Uncertain,7
16982,Duration,C2926735,en_6146,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
16983,Duration,C2926735,en_6146,AFFECTS,Severe Acute Respiratory Distress Syndrome,C5419624,en_6459,1,1,AFFECTS,General/Uncertain,7
16984,Duration,C2926735,en_6146,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
16985,Duration,C2926735,en_6146,PREVENTS,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,Inhibitory,6
16986,Duration,C2926735,en_6146,TREATS,Adult,C0001675,en_252,2,2,AFFECTS,Inhibitory,12
16987,Duration,C2926735,en_6146,TREATS,Anosmia,C0003126,en_337,1,1,AFFECTS,Inhibitory,8
16988,Duration,C2926735,en_6146,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
16989,Duration,C2926735,en_6146,TREATS,Fever,C0015967,en_985,1,1,AFFECTS,Inhibitory,6
16990,Duration,C2926735,en_6146,TREATS,Myasthenia Gravis,C0026896,en_1613,1,1,AFFECTS,Inhibitory,7
16991,Duration,C2926735,en_6146,TREATS,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,Inhibitory,6
16992,Duration,C2926735,en_6146,TREATS,Malnutrition,C0162429,en_2910,1,1,AFFECTS,Inhibitory,6
16993,Duration,C2926735,en_6146,TREATS,Survivors,C0206194,en_3154,2,1,AFFECTS,Inhibitory,6
16994,Duration,C2926735,en_6146,TREATS,Tuberculosis of intestines,C0275911,en_3572,1,1,AFFECTS,Inhibitory,7
16995,Duration,C2926735,en_6146,TREATS,Symptoms,C1457887,en_5784,5,5,AFFECTS,Inhibitory,37
16996,Duration,C2926735,en_6146,TREATS,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,Inhibitory,8
16997,Duration,C2926735,en_6146,TREATS,Sequential Organ Failure Assessment Scores,C3494459,en_6204,1,1,AFFECTS,Inhibitory,7
16998,Duration,C2926735,en_6146,TREATS,COVID-19,C5203670,en_6417,5,4,AFFECTS,Inhibitory,27
16999,tofacitinib,C2930696,en_6147,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,8
17000,tofacitinib,C2930696,en_6147,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
17001,tofacitinib,C2930696,en_6147,TREATS,Historical Cohort,C2348984,en_6100,1,1,AFFECTS,Inhibitory,6
17002,tofacitinib,C2930696,en_6147,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17003,ruxolitinib,C2931926,en_6148,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,7
17004,ruxolitinib,C2931926,en_6148,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,7
17005,ruxolitinib,C2931926,en_6148,PREVENTS,Venous Thromboembolism,C1861172,en_6055,1,1,AFFECTS,Inhibitory,7
17006,ruxolitinib,C2931926,en_6148,PREVENTS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
17007,ruxolitinib,C2931926,en_6148,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
17008,ruxolitinib,C2931926,en_6148,TREATS,Infected,C0439663,en_4036,1,1,AFFECTS,Inhibitory,7
17009,ruxolitinib,C2931926,en_6148,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,7
17010,ruxolitinib,C2931926,en_6148,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,15
17011,ruxolitinib,C2931926,en_6148,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
17012,ruxolitinib,C2931926,en_6148,TREATS,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,Inhibitory,7
17013,Xuebijing,C2933944,en_6149,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17014,"Vaccines, Virus-Like Particle",C2936379,en_6150,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17015,Drug Repositioning,C2936405,en_6151,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17016,Standard of Care,C2936643,en_6153,PREVENTS,Fatigue,C0015672,en_966,1,1,AFFECTS,Inhibitory,7
17017,Standard of Care,C2936643,en_6153,PREVENTS,Worse,C1457868,en_5783,1,1,AFFECTS,Inhibitory,8
17018,Standard of Care,C2936643,en_6153,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17019,Standard of Care,C2936643,en_6153,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
17020,Standard of Care,C2936643,en_6153,TREATS,Confirmation,C0750484,en_4843,1,1,AFFECTS,Inhibitory,7
17021,Standard of Care,C2936643,en_6153,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,8
17022,Standard of Care,C2936643,en_6153,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
17023,Standard of Care,C2936643,en_6153,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,8
17024,Standard of Care,C2936643,en_6153,TREATS,Severe disease,C4740692,en_6396,1,1,AFFECTS,Inhibitory,8
17025,Standard of Care,C2936643,en_6153,TREATS,COVID-19,C5203670,en_6417,6,5,AFFECTS,Inhibitory,37
17026,Standard of Care,C2936643,en_6153,TREATS,Suspected COVID-19,C5203671,en_6418,1,1,AFFECTS,Inhibitory,7
17027,Standard of Care,C2936643,en_6153,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
17028,Limb ischemia,C2945695,en_6156,AUGMENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
17029,Conventional Treatment,C2945704,en_6157,TREATS,Lymphedema,C0024236,en_1467,1,1,AFFECTS,Inhibitory,8
17030,Conventional Treatment,C2945704,en_6157,TREATS,PATIENT SYMPTOMS,C1317600,en_5529,1,1,AFFECTS,Inhibitory,7
17031,Conventional Treatment,C2945704,en_6157,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
17032,Conventional Treatment,C2945704,en_6157,TREATS,Severe infection,C5139167,en_6407,1,1,AFFECTS,Inhibitory,7
17033,Conventional Treatment,C2945704,en_6157,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17034,Overtime,C2961731,en_6158,TREATS,History and physical examination,C0150618,en_2846,1,1,AFFECTS,Inhibitory,6
17035,TAC,C2962221,en_6159,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
17036,danoprevir,C2973564,en_6160,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,7
17037,canagliflozin,C2974540,en_6161,PREVENTS,[D]Cardiovascular system symptoms,C0476270,en_4148,1,1,AFFECTS,Inhibitory,7
17038,canagliflozin,C2974540,en_6161,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,7
17039,canagliflozin,C2974540,en_6161,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
17040,sofosbuvir,C2976303,en_6162,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,8
17041,sofosbuvir,C2976303,en_6162,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
17042,sofosbuvir,C2976303,en_6162,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
17043,sofosbuvir,C2976303,en_6162,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
17044,"Antibodies, Monoclonal, Humanized",C2985546,en_6167,INHIBITS,Interleukin-6,C0021760,en_1342,1,1,AFFECTS,Inhibitory,7
17045,"Antibodies, Monoclonal, Humanized",C2985546,en_6167,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17046,Targeted Therapy,C2985566,en_6168,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,6
17047,Chemoimmunotherapy,C2986423,en_6169,TREATS,Solid tumor,C0280100,en_3619,1,1,AFFECTS,Inhibitory,7
17048,Primary Endpoint,C2986535,en_6171,AFFECTS,Heart failure,C0018801,en_1135,1,1,AFFECTS,General/Uncertain,6
17049,Tailored Intervention,C2986593,en_6172,TREATS,Survivors,C0206194,en_3154,1,1,AFFECTS,Inhibitory,7
17050,Agonist,C2987634,en_6173,PREVENTS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,8
17051,Prevail,C3152857,en_6174,AUGMENTS,Food Consumption,C2983605,en_6164,1,1,AFFECTS,Excitatory,7
17052,Transarterial embolization,C3163695,en_6178,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17053,Early Therapy,C3177188,en_6179,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17054,Early Therapy,C3177188,en_6179,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,7
17055,Early Therapy,C3177188,en_6179,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,15
17056,Concurrent Chemoradiotherapy,C3178775,en_6180,TREATS,N2c,C3833426,en_6252,1,1,AFFECTS,Inhibitory,7
17057,Concurrent Chemoradiotherapy,C3178775,en_6180,TREATS,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,C4725841,en_6387,1,1,AFFECTS,Inhibitory,6
17058,Transcriptome,C3178810,en_6181,STIMULATES,Angiogenesis Factor,C0002976,en_324,1,1,AFFECTS,Excitatory,6
17059,Transcriptome,C3178810,en_6181,STIMULATES,Complement System Proteins,C0009498,en_691,1,1,AFFECTS,Excitatory,6
17060,secukinumab,C3179547,en_6182,INHIBITS,ACE2 gene|ACE2,C1422064|59272,en_5724,1,1,AFFECTS,Inhibitory,8
17061,secukinumab,C3179547,en_6182,PREVENTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,Inhibitory,8
17062,secukinumab,C3179547,en_6182,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
17063,secukinumab,C3179547,en_6182,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17064,C1 esterase inhibitor (recombinant),C3195420,en_6183,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17065,C1 esterase inhibitor (recombinant),C3195420,en_6183,TREATS,Lung diseases,C0024115,en_1462,1,1,AFFECTS,Inhibitory,7
17066,C1 esterase inhibitor (recombinant),C3195420,en_6183,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17067,daclatasvir,C3252090,en_6184,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,8
17068,daclatasvir,C3252090,en_6184,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,8
17069,daclatasvir,C3252090,en_6184,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
17070,daclatasvir,C3252090,en_6184,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
17071,daclatasvir,C3252090,en_6184,TREATS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,8
17072,daclatasvir,C3252090,en_6184,TREATS,Moderate disease,C4740691,en_6395,1,1,AFFECTS,Inhibitory,8
17073,daclatasvir,C3252090,en_6184,TREATS,COVID-19,C5203670,en_6417,5,5,AFFECTS,Inhibitory,40
17074,dolutegravir,C3253985,en_6185,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,6
17075,dolutegravir,C3253985,en_6185,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,6
17076,dolutegravir,C3253985,en_6185,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
17077,Multiple Chronic Conditions,C3266262,en_6187,AUGMENTS,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
17078,Urgent Procedure,C3272275,en_6188,TREATS,Negative,C0205160,en_3126,1,1,AFFECTS,Inhibitory,6
17079,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,7
17080,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,PREDISPOSES,Nutritional status,C0392209,en_3916,1,1,AFFECTS,Excitatory,6
17081,Novaferon,C3273451,en_6192,DISRUPTS,Virus Replication,C0042774,en_2363,1,1,AFFECTS,Inhibitory,8
17082,Novaferon,C3273451,en_6192,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
17083,Novaferon,C3273451,en_6192,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
17084,Sodium-Glucose Transporter 2 Inhibitors,C3273807,en_6193,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,6
17085,Sodium-Glucose Transporter 2 Inhibitors,C3273807,en_6193,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17086,Cardiac Lead Procedure,C3275067,en_6194,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,7
17087,Air Travel,C3489667,en_6201,TREATS,World,C2700280,en_6119,1,1,AFFECTS,Inhibitory,6
17088,Air Travel,C3489667,en_6201,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17089,ixekizumab,C3489764,en_6202,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17090,Sequential Organ Failure Assessment Scores,C3494459,en_6204,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,Excitatory,6
17091,Sequential Organ Failure Assessment Scores,C3494459,en_6204,PREDISPOSES,Death in hospital,C0277608,en_3586,2,2,AFFECTS,Excitatory,12
17092,Hand Hygiene,C3494474,en_6205,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
17093,Mobility aid,C3495449,en_6206,TREATS,Does transfer,C0728827,en_4757,1,1,AFFECTS,Inhibitory,6
17094,enzalutamide,C3496793,en_6207,INHIBITS,Testosterone,C0039601,en_2216,1,1,AFFECTS,Inhibitory,7
17095,Tumor Necrosis Factor Inhibitors,C3537192,en_6209,PREVENTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,Inhibitory,6
17096,Tumor Necrosis Factor Inhibitors,C3537192,en_6209,TREATS,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,Inhibitory,6
17097,Hepatitis A Virus Cellular Receptor 2,C3537335,en_6211,STIMULATES,neutrophil,C0027950,en_1676,1,1,AFFECTS,Excitatory,7
17098,Hepatitis A Virus Cellular Receptor 2,C3537335,en_6211,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,7
17099,other medicated shampoos in ATC,C3539125,en_6212,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,8
17100,other medicated shampoos in ATC,C3539125,en_6212,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17101,gamma-interferon|IFNA1,C3539881|3439,en_6213,STIMULATES,Peripheral blood mononuclear cell,C1321301,en_5541,1,1,AFFECTS,Excitatory,7
17102,opium alkaloids and derivative combination cough suppressants,C3539957,en_6214,AUGMENTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,6
17103,opium alkaloids and derivative combination cough suppressants,C3539957,en_6214,TREATS,Infection,C3714514,en_6235,1,1,AFFECTS,Inhibitory,6
17104,TONICS,C3543842,en_6217,PREDISPOSES,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Excitatory,6
17105,Arterial thromboembolism,C3544094,en_6218,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17106,Continuous Renal Replacement Therapy,C3649547,en_6222,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
17107,Continuous Renal Replacement Therapy,C3649547,en_6222,TREATS,"Kidney Failure, Acute",C0022660,en_1382,3,2,AFFECTS,Inhibitory,12
17108,Continuous Renal Replacement Therapy,C3649547,en_6222,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,6
17109,Interleukin inhibitors,C3653320,en_6223,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,6
17110,Childbirth Classes,C3658257,en_6226,TREATS,Relative (related person),C0080103,en_2623,1,1,AFFECTS,Inhibitory,8
17111,Warburg Therapy,C3665674,en_6227,AFFECTS,Alveolar ventilation function,C0231940,en_3269,1,1,AFFECTS,General/Uncertain,8
17112,Warburg Therapy,C3665674,en_6227,PREDISPOSES,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,Excitatory,6
17113,Warburg Therapy,C3665674,en_6227,TREATS,Disease,C0012634,en_826,2,2,AFFECTS,Inhibitory,12
17114,Warburg Therapy,C3665674,en_6227,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
17115,Warburg Therapy,C3665674,en_6227,TREATS,Inefficiency,C0231184,en_3249,1,1,AFFECTS,Inhibitory,6
17116,Warburg Therapy,C3665674,en_6227,TREATS,Malaise,C0231218,en_3251,1,1,AFFECTS,Inhibitory,7
17117,Warburg Therapy,C3665674,en_6227,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,6
17118,Warburg Therapy,C3665674,en_6227,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17119,Therapy Modification,C3665894,en_6228,TREATS,Outpatients,C0029921,en_1729,1,1,AFFECTS,Inhibitory,6
17120,"S protein, severe acute respiratory syndrome coronavirus",C3711684,en_6234,AFFECTS,virus entry,C1537068,en_5947,1,1,AFFECTS,General/Uncertain,7
17121,Infection,C3714514,en_6235,AFFECTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,General/Uncertain,6
17122,Infection,C3714514,en_6235,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
17123,Infection,C3714514,en_6235,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17124,Infection,C3714514,en_6235,PRODUCES,neuronal,C0521390,en_4201,1,1,AFFECTS,Excitatory,6
17125,AKR1A1 wt Allele,C3715044,en_6239,AFFECTS,Day 5,C3842674,en_6262,1,1,AFFECTS,General/Uncertain,8
17126,AKR1A1 wt Allele,C3715044,en_6239,AUGMENTS,Endothelium,C0014257,en_902,1,1,AFFECTS,Excitatory,7
17127,Ventilator dependency,C3808499,en_6242,PREDISPOSES,Renal function,C0232804,en_3285,1,1,AFFECTS,Excitatory,7
17128,Author,C3812881,en_6243,TREATS,member,C0680022,en_4618,1,1,AFFECTS,Inhibitory,6
17129,TBX4 wt Allele|SMS|TBX4|SEPHS1|PDSS1,C3813609|6611|9496|22929|23590,en_6244,AFFECTS,Possible,C0332149,en_3747,1,1,AFFECTS,General/Uncertain,6
17130,Interleukin-6 Receptor Antagonist [EPC],C3819026,en_6245,TREATS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,Inhibitory,6
17131,Complement inhibition,C3825076,en_6246,INHIBITS,Thromboplastin,C0040048,en_2232,1,1,AFFECTS,Inhibitory,7
17132,Ground Glass Opacity,C3827002,en_6249,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
17133,Anti-CD6 Monoclonal Antibody|CD6,C3827262|923,en_6250,TREATS,Geriatric Patients,C0870602,en_5007,2,1,AFFECTS,Inhibitory,7
17134,Anti-CD6 Monoclonal Antibody|CD6,C3827262|923,en_6250,TREATS,Moderate disease,C4740691,en_6395,1,1,AFFECTS,Inhibitory,7
17135,75+ years,C3840862,en_6253,PREDISPOSES,Worse,C1457868,en_5783,1,1,AFFECTS,Excitatory,8
17136,Day 4,C3840892,en_6255,PREDISPOSES,Negative,C0205160,en_3126,1,1,AFFECTS,Excitatory,8
17137,Anaerobic exercise,C3841233,en_6257,TREATS,Healthy Volunteers,C1708335,en_6036,1,1,AFFECTS,Inhibitory,6
17138,In center hemodialysis,C3841812,en_6259,TREATS,"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,Inhibitory,6
17139,Continuous Cardiac Monitoring,C3845192,en_6265,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,8
17140,Neutrophil Extracellular Traps,C3850088,en_6269,AFFECTS,Catabolism,C0699900,en_4707,1,1,AFFECTS,General/Uncertain,7
17141,Pre-Exposure Prophylaxis,C3850098,en_6270,PREVENTS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,21
17142,Pre-Exposure Prophylaxis,C3850098,en_6270,TREATS,COVID-19,C5203670,en_6417,3,2,AFFECTS,Inhibitory,16
17143,Patient Activation,C3853034,en_6273,TREATS,Chronic Disease,C0008679,en_643,1,1,AFFECTS,Inhibitory,7
17144,Janus kinase inhibitor,C3854325,en_6274,TREATS,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,Inhibitory,8
17145,Janus kinase inhibitor,C3854325,en_6274,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17146,Janus kinase inhibitor,C3854325,en_6274,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
17147,Cardiovascular Examination,C3854344,en_6275,TREATS,Cardiomyopathies,C0878544,en_5074,1,1,AFFECTS,Inhibitory,6
17148,adjunctive treatment,C3858690,en_6276,TREATS,Complication,C0009566,en_697,1,1,AFFECTS,Inhibitory,6
17149,adjunctive treatment,C3858690,en_6276,TREATS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,Inhibitory,6
17150,adjunctive treatment,C3858690,en_6276,TREATS,Hypoxemia,C0700292,en_4719,2,1,AFFECTS,Inhibitory,6
17151,Interleukin-6 Antagonist,C3864917,en_6277,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,7
17152,cobicistat / darunavir,C3871454,en_6278,TREATS,Negative,C0205160,en_3126,1,1,AFFECTS,Inhibitory,6
17153,cobicistat / darunavir,C3871454,en_6278,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,6
17154,sarilumab,C3885145,en_6280,AFFECTS,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,6
17155,sarilumab,C3885145,en_6280,DISRUPTS,interleukin-6 receptor activity,C1149209,en_5302,1,1,AFFECTS,Inhibitory,6
17156,sarilumab,C3885145,en_6280,INHIBITS,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,Inhibitory,6
17157,sarilumab,C3885145,en_6280,TREATS,Adult,C0001675,en_252,2,1,AFFECTS,Inhibitory,7
17158,sarilumab,C3885145,en_6280,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
17159,sarilumab,C3885145,en_6280,TREATS,Pneumonia,C0032285,en_1833,3,2,AFFECTS,Inhibitory,13
17160,sarilumab,C3885145,en_6280,TREATS,Lung consolidation,C0521530,en_4202,1,1,AFFECTS,Inhibitory,6
17161,sarilumab,C3885145,en_6280,TREATS,Cytokine release syndrome,C0948245,en_5163,4,2,AFFECTS,Inhibitory,13
17162,sarilumab,C3885145,en_6280,TREATS,Intervention Group,C2986530,en_6170,1,1,AFFECTS,Inhibitory,7
17163,sarilumab,C3885145,en_6280,TREATS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,1,1,AFFECTS,Inhibitory,8
17164,sarilumab,C3885145,en_6280,TREATS,Severe infection,C5139167,en_6407,2,1,AFFECTS,Inhibitory,7
17165,sarilumab,C3885145,en_6280,TREATS,COVID-19,C5203670,en_6417,3,3,AFFECTS,Inhibitory,22
17166,Complete Response with Incomplete Platelet Recovery,C3890735,en_6283,PREDISPOSES,Very strong,C4698492,en_6377,1,1,AFFECTS,Excitatory,6
17167,Alarmins,C3891560,en_6284,AFFECTS,iron metabolism,C0596803,en_4396,1,1,AFFECTS,General/Uncertain,6
17168,lower tip-link density,C3896197,en_6285,PRODUCES,Doxorubicin,C0013089,en_845,1,1,AFFECTS,Excitatory,7
17169,Memory Intervention,C3898430,en_6286,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,7
17170,Internet-Based Intervention,C3898714,en_6287,PREVENTS,Occupational Stress,C0814090,en_4909,1,1,AFFECTS,Inhibitory,7
17171,Internet-Based Intervention,C3898714,en_6287,PREVENTS,Mental health problem,C1446377,en_5753,1,1,AFFECTS,Inhibitory,8
17172,Internet-Based Intervention,C3898714,en_6287,TREATS,Stress,C0038435,en_2165,2,2,AFFECTS,Inhibitory,16
17173,Internet-Based Intervention,C3898714,en_6287,TREATS,Difficulty sleeping,C0235162,en_3322,1,1,AFFECTS,Inhibitory,7
17174,Internet-Based Intervention,C3898714,en_6287,TREATS,Partner in relationship,C0682323,en_4643,1,1,AFFECTS,Inhibitory,8
17175,Internet-Based Intervention,C3898714,en_6287,TREATS,Cancer Survivor,C1516231,en_5853,2,1,AFFECTS,Inhibitory,8
17176,Cognitive Intervention,C3899527,en_6288,AFFECTS,Intrusive memories,C0561837,en_4322,1,1,AFFECTS,General/Uncertain,8
17177,Cognitive Intervention,C3899527,en_6288,PREVENTS,Intrusive memories,C0561837,en_4322,1,1,AFFECTS,Inhibitory,8
17178,Apoptosis Marker,C3900018,en_6289,AFFECTS,Immunoregulation,C0678889,en_4580,1,1,AFFECTS,General/Uncertain,7
17179,Transitional Care,C4019071,en_6292,TREATS,Caregiver,C0085537,en_2674,1,1,AFFECTS,Inhibitory,7
17180,Phosphate Binders,C4020599,en_6294,TREATS,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,Inhibitory,7
17181,Entresto,C4033616,en_6297,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,8
17182,sacubitril / valsartan,C4033631,en_6298,TREATS,Heart failure,C0018801,en_1135,1,1,AFFECTS,Inhibitory,8
17183,Blood Indices,C4033634,en_6299,PREDISPOSES,Possible,C0332149,en_3747,1,1,AFFECTS,Excitatory,6
17184,Contacts,C4036459,en_6300,TREATS,Social Networks,C0150775,en_2855,1,1,AFFECTS,Inhibitory,8
17185,Maintenance hemodialysis,C4040576,en_6302,TREATS,Comorbidity,C0009488,en_690,1,1,AFFECTS,Inhibitory,6
17186,Maintenance hemodialysis,C4040576,en_6302,TREATS,Responsive Disease,C5236984,en_6425,1,1,AFFECTS,Inhibitory,6
17187,Re-Irradiation,C4042794,en_6303,TREATS,Squamous cell carcinoma of head and neck,C1168401,en_5372,1,1,AFFECTS,Inhibitory,7
17188,Telerehabilitation,C4042802,en_6304,TREATS,Coronary Arteriosclerosis,C0010054,en_717,1,1,AFFECTS,Inhibitory,8
17189,Telerehabilitation,C4042802,en_6304,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
17190,Telerehabilitation,C4042802,en_6304,TREATS,Obesity,C0028754,en_1699,2,1,AFFECTS,Inhibitory,8
17191,Telerehabilitation,C4042802,en_6304,TREATS,Overweight,C0497406,en_4165,2,1,AFFECTS,Inhibitory,8
17192,Telerehabilitation,C4042802,en_6304,TREATS,patient state,C0683521,en_4668,1,1,AFFECTS,Inhibitory,6
17193,Telerehabilitation,C4042802,en_6304,TREATS,Functional capacity,C1998319,en_6082,1,1,AFFECTS,Inhibitory,6
17194,Telerehabilitation,C4042802,en_6304,TREATS,COVID-19,C5203670,en_6417,2,1,AFFECTS,Inhibitory,8
17195,Seroconversion,C4042908,en_6305,AFFECTS,Coitus,C0009253,en_671,1,1,AFFECTS,General/Uncertain,6
17196,Seroconversion,C4042908,en_6305,AFFECTS,Severe infection,C5139167,en_6407,1,1,AFFECTS,General/Uncertain,6
17197,baricitinib,C4044947,en_6306,AFFECTS,Respiration,C0035203,en_2004,2,1,AFFECTS,General/Uncertain,6
17198,baricitinib,C4044947,en_6306,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,6
17199,baricitinib,C4044947,en_6306,AFFECTS,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,General/Uncertain,6
17200,baricitinib,C4044947,en_6306,AFFECTS,virus entry,C1537068,en_5947,1,1,AFFECTS,General/Uncertain,6
17201,baricitinib,C4044947,en_6306,AUGMENTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Excitatory,7
17202,baricitinib,C4044947,en_6306,DISRUPTS,Cessation of life,C0011065,en_762,1,1,AFFECTS,Inhibitory,6
17203,baricitinib,C4044947,en_6306,INHIBITS,Platelet Activation,C0032173,en_1827,1,1,AFFECTS,Inhibitory,6
17204,baricitinib,C4044947,en_6306,PREVENTS,Pulmonary Valve Insufficiency,C0034088,en_1936,1,1,AFFECTS,Inhibitory,7
17205,baricitinib,C4044947,en_6306,TREATS,Adult,C0001675,en_252,4,2,AFFECTS,Inhibitory,14
17206,baricitinib,C4044947,en_6306,TREATS,Elderly,C0001792,en_258,2,1,AFFECTS,Inhibitory,6
17207,baricitinib,C4044947,en_6306,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,7
17208,baricitinib,C4044947,en_6306,TREATS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,8
17209,baricitinib,C4044947,en_6306,TREATS,COVID-19,C5203670,en_6417,6,2,AFFECTS,Inhibitory,14
17210,baricitinib,C4044947,en_6306,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,3,2,AFFECTS,Inhibitory,13
17211,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,AUGMENTS,Protection,C1545588,en_5951,1,1,AFFECTS,Excitatory,8
17212,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,DISRUPTS,CD8-Positive T-Lymphocytes,C0242629,en_3424,1,1,AFFECTS,Inhibitory,6
17213,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,PREDISPOSES,Exhaustion,C0392674,en_3926,1,1,AFFECTS,Excitatory,6
17214,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,PRODUCES,"C-C Chemokine Receptor Type 4, human|CCR4",C4284283|1233,en_6329,1,1,AFFECTS,Excitatory,7
17215,"T-Cell Surface Glycoprotein CD4, human|CD4",C4048280|920,en_6307,STIMULATES,CD8A wt Allele|CD8A,C3540595|925,en_6215,1,1,AFFECTS,Excitatory,7
17216,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,PREDISPOSES,Nutritional status,C0392209,en_3916,1,1,AFFECTS,Excitatory,6
17217,Social vulnerability,C4063051,en_6313,PREDISPOSES,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,Excitatory,6
17218,clazakizumab,C4077748,en_6315,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17219,venetoclax,C4079830,en_6316,TREATS,Chronic Lymphocytic Leukemia,C0023434,en_1417,1,1,AFFECTS,Inhibitory,8
17220,Antimicrobial Peptide,C4084937,en_6317,STIMULATES,neutrophil,C0027950,en_1676,1,1,AFFECTS,Excitatory,7
17221,Exacerbation,C4086268,en_6319,PREDISPOSES,Depressive disorder,C0011581,en_788,1,1,AFFECTS,Excitatory,6
17222,motor learning,C4236819,en_6321,AFFECTS,Elderly,C0001792,en_258,1,1,AFFECTS,General/Uncertain,8
17223,Chemo-radiotherapy,C4264454,en_6322,TREATS,Woman,C0043210,en_2396,1,1,AFFECTS,Inhibitory,6
17224,Chemo-radiotherapy,C4264454,en_6322,TREATS,Locally Advanced Cervical Carcinoma,C4744723,en_6398,1,1,AFFECTS,Inhibitory,6
17225,Vigorous physical activity,C4267713,en_6323,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,6
17226,Vigorous physical activity,C4267713,en_6323,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,6
17227,sofosbuvir / velpatasvir,C4271578,en_6325,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
17228,Myeloid-Derived Suppressor Cells,C4277543,en_6326,PRODUCES,CYBB,C1413844,en_24,1,1,AFFECTS,Excitatory,6
17229,Myeloid-Derived Suppressor Cells,C4277543,en_6326,PRODUCES,NOX1,C1456389,en_124,1,1,AFFECTS,Excitatory,6
17230,High-Intensity Interval Training,C4277545,en_6327,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,8
17231,High-Intensity Interval Training,C4277545,en_6327,AFFECTS,Cardiorespiratory Fitness,C2981722,en_6163,1,1,AFFECTS,General/Uncertain,7
17232,Vaccination Campaign,C4279933,en_6328,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17233,"C-C Chemokine Receptor Type 4, human|CCR4",C4284283|1233,en_6329,STIMULATES,CD8-Positive T-Lymphocytes,C0242629,en_3424,1,1,AFFECTS,Excitatory,7
17234,Behavioral and psychological symptoms of dementia,C4285807,en_6330,PREDISPOSES,psychological distress,C0815107,en_4922,1,1,AFFECTS,Excitatory,6
17235,Quadrivalent Inactivated Influenza Vaccine,C4287651,en_6331,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,6
17236,Droplet transmission,C4287874,en_6332,AFFECTS,Anxiety,C0003467,en_380,1,1,AFFECTS,General/Uncertain,8
17237,Cell-Free DNA,C4289789,en_6334,AFFECTS,Negative Regulation of Coagulation,C2917212,en_6142,1,1,AFFECTS,General/Uncertain,6
17238,Cell-Free DNA,C4289789,en_6334,PREVENTS,Toxic effect,C0600688,en_4513,1,1,AFFECTS,Inhibitory,7
17239,Sudden Unexpected Death in Epilepsy,C4304727,en_6335,PREDISPOSES,Epilepsy,C0014544,en_917,1,1,AFFECTS,Excitatory,6
17240,Interferon-alpha2b,C4307370,en_6337,INHIBITS,Duration,C2926735,en_6146,1,1,AFFECTS,Inhibitory,7
17241,Disseminated coagulopathy,C4314584,en_6338,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
17242,High Level,C4321237,en_6341,PREDISPOSES,Inflammation,C0021368,en_1307,1,1,AFFECTS,Excitatory,6
17243,High Level,C4321237,en_6341,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
17244,High Level,C4321237,en_6341,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,6
17245,High Level,C4321237,en_6341,PREDISPOSES,Overdose,C4018909,en_6291,1,1,AFFECTS,Excitatory,7
17246,High Level,C4321237,en_6341,PREDISPOSES,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Excitatory,6
17247,Low Level,C4321351,en_6342,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
17248,Opioid Use Disorder,C4324621,en_6344,AFFECTS,narcotic use,C0240602,en_3386,1,1,AFFECTS,General/Uncertain,8
17249,Opioid Use Disorder,C4324621,en_6344,AFFECTS,Vulnerable Populations,C0949366,en_5180,1,1,AFFECTS,General/Uncertain,6
17250,JAK1 Inhibitor,C4330505,en_6346,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17251,Readmission,C4489276,en_6350,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17252,Immunization Coverage,C4505149,en_6353,TREATS,Households,C0020052,en_1208,1,1,AFFECTS,Inhibitory,6
17253,ergoferon,C4508358,en_6354,AFFECTS,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,General/Uncertain,8
17254,ergoferon,C4508358,en_6354,AFFECTS,patient state,C0683521,en_4668,1,1,AFFECTS,General/Uncertain,8
17255,ravidasvir,C4508633,en_6355,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17256,Tocilizumab therapy,C4510396,en_6356,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
17257,Tradipitant,C4519147,en_6357,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
17258,Tradipitant,C4519147,en_6357,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17259,Telehealth service,C4520476,en_6358,TREATS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Inhibitory,6
17260,Annular Plane Systolic Excursion,C4528237,en_6359,PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,Excitatory,6
17261,Mechanical thrombectomy,C4534538,en_6361,TREATS,Vascular occlusion,C1096458,en_5235,2,2,AFFECTS,Inhibitory,12
17262,tezepelumab,C4550163,en_6363,INHIBITS,Eosinophilic inflammation,C3687252,en_6229,1,1,AFFECTS,Inhibitory,8
17263,Virus Host Interactions,C4551660,en_6365,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
17264,Prone positioning,C4551696,en_6366,AFFECTS,Intubated,C4698386,en_6376,1,1,AFFECTS,General/Uncertain,6
17265,Prone positioning,C4551696,en_6366,PREVENTS,treatment failure,C0162643,en_2923,1,1,AFFECTS,Inhibitory,8
17266,Prone positioning,C4551696,en_6366,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,5,3,AFFECTS,Inhibitory,21
17267,Prone positioning,C4551696,en_6366,TREATS,Respiratory failure without hypercapnia,C0340194,en_3812,2,1,AFFECTS,Inhibitory,8
17268,Prone positioning,C4551696,en_6366,TREATS,Spontaneous respiration,C0412771,en_3970,1,1,AFFECTS,Inhibitory,7
17269,Prone positioning,C4551696,en_6366,TREATS,Hypoxemia,C0700292,en_4719,3,3,AFFECTS,Inhibitory,20
17270,Prone positioning,C4551696,en_6366,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,6
17271,Prone positioning,C4551696,en_6366,TREATS,Patient ventilated,C1299448,en_5503,1,1,AFFECTS,Inhibitory,7
17272,Prone positioning,C4551696,en_6366,TREATS,Acute hypoxemic respiratory failure,C4039867,en_6301,1,1,AFFECTS,Inhibitory,8
17273,Prone positioning,C4551696,en_6366,TREATS,Intubated,C4698386,en_6376,1,1,AFFECTS,Inhibitory,7
17274,Prone positioning,C4551696,en_6366,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,13
17275,Anti-CD20 Monoclonal Antibody|MS4A1|KRT20,C4553138|931|54474,en_6368,TREATS,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,Inhibitory,6
17276,Anti-CD20 Monoclonal Antibody|MS4A1|KRT20,C4553138|931|54474,en_6368,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,6
17277,Anti-CD20 Monoclonal Antibody|MS4A1|KRT20,C4553138|931|54474,en_6368,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,6
17278,Retrieval - procedure,C4554488,en_6369,TREATS,Neoplasm,C0027651,en_1651,1,1,AFFECTS,Inhibitory,6
17279,Baseline Assessment,C4684571,en_6370,TREATS,Deglutition Disorders,C0011168,en_772,1,1,AFFECTS,Inhibitory,6
17280,Standard Treatment,C4684780,en_6371,TREATS,Bacterial Abscess,C0549483,en_4283,1,1,AFFECTS,Inhibitory,8
17281,Standard Treatment,C4684780,en_6371,TREATS,COVID-19,C5203670,en_6417,14,9,AFFECTS,Inhibitory,67
17282,Immune Checkpoint Inhibitor,C4684977,en_6372,TREATS,Pulmonary circulation disease NOS,C0178272,en_2980,1,1,AFFECTS,Inhibitory,6
17283,>65 years,C4699618,en_6383,COMPLICATES,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,General/Uncertain,6
17284,>65 years,C4699618,en_6383,PREDISPOSES,Fatal Outcome,C0206277,en_3157,1,1,AFFECTS,Excitatory,6
17285,>65 years,C4699618,en_6383,PREDISPOSES,Death in hospital,C0277608,en_3586,1,1,AFFECTS,Excitatory,6
17286,interferon type III,C4705734,en_6384,AFFECTS,Antiviral Response,C1155328,en_5322,1,1,AFFECTS,General/Uncertain,8
17287,remdesivir,C4726677,en_6388,DISRUPTS,Adverse event,C0877248,en_5069,1,1,AFFECTS,Inhibitory,8
17288,remdesivir,C4726677,en_6388,INHIBITS,DNA-Directed RNA Polymerase,C0035681,en_2041,1,1,AFFECTS,Inhibitory,8
17289,remdesivir,C4726677,en_6388,INHIBITS,GJA1 gene|GJA1,C1415068|2697,en_5704,1,1,AFFECTS,Inhibitory,7
17290,remdesivir,C4726677,en_6388,PREVENTS,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Inhibitory,6
17291,remdesivir,C4726677,en_6388,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17292,remdesivir,C4726677,en_6388,TREATS,Adult,C0001675,en_252,9,6,AFFECTS,Inhibitory,45
17293,remdesivir,C4726677,en_6388,TREATS,Child,C0008059,en_620,2,1,AFFECTS,Inhibitory,6
17294,remdesivir,C4726677,en_6388,TREATS,Critical Illness,C0010340,en_733,1,1,AFFECTS,Inhibitory,6
17295,remdesivir,C4726677,en_6388,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,6
17296,remdesivir,C4726677,en_6388,TREATS,inpatient,C0021562,en_1321,1,1,AFFECTS,Inhibitory,8
17297,remdesivir,C4726677,en_6388,TREATS,Pneumonia,C0032285,en_1833,2,1,AFFECTS,Inhibitory,6
17298,remdesivir,C4726677,en_6388,TREATS,Pregnant Women,C0033011,en_1876,1,1,AFFECTS,Inhibitory,6
17299,remdesivir,C4726677,en_6388,TREATS,Diabetic,C0241863,en_3392,3,1,AFFECTS,Inhibitory,6
17300,remdesivir,C4726677,en_6388,TREATS,cohort,C0599755,en_4470,1,1,AFFECTS,Inhibitory,6
17301,remdesivir,C4726677,en_6388,TREATS,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,Inhibitory,8
17302,remdesivir,C4726677,en_6388,TREATS,Hospitalized Patients,C0870668,en_5010,5,4,AFFECTS,Inhibitory,30
17303,remdesivir,C4726677,en_6388,TREATS,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Inhibitory,7
17304,remdesivir,C4726677,en_6388,TREATS,Elevated inflammatory markers,C3276087,en_6196,1,1,AFFECTS,Inhibitory,6
17305,remdesivir,C4726677,en_6388,TREATS,COVID-19,C5203670,en_6417,37,23,AFFECTS,Inhibitory,166
17306,remdesivir,C4726677,en_6388,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,3,2,AFFECTS,Inhibitory,16
17307,Ozone therapy,C4727847,en_6390,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,7
17308,Proactive Therapy,C4744673,en_6397,TREATS,Disease,C0012634,en_826,2,1,AFFECTS,Inhibitory,8
17309,Proactive Therapy,C4744673,en_6397,TREATS,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Inhibitory,8
17310,Proactive Therapy,C4744673,en_6397,TREATS,"Pneumonia, Viral",C0032310,en_1837,1,1,AFFECTS,Inhibitory,8
17311,Proactive Therapy,C4744673,en_6397,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
17312,Pharmacological Ascorbate,C4744839,en_6399,TREATS,Heart Injuries,C0018805,en_1137,2,1,AFFECTS,Inhibitory,6
17313,Pharmacological Ascorbate,C4744839,en_6399,TREATS,myocardium; injury,C0746730,en_4817,2,1,AFFECTS,Inhibitory,6
17314,Pharmacological Ascorbate,C4744839,en_6399,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,16
17315,Medical Condition,C4745084,en_6400,PREDISPOSES,COVID-19,C5203670,en_6417,1,1,AFFECTS,Excitatory,6
17316,Bemcentinib,C4763383,en_6404,PREVENTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,Inhibitory,7
17317,Single Agent Therapy,C4763675,en_6405,TREATS,Hypotension,C0020649,en_1248,1,1,AFFECTS,Inhibitory,8
17318,Single Agent Therapy,C4763675,en_6405,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
17319,Single Agent Therapy,C4763675,en_6405,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
17320,Cognitive Behavioral Therapy for Insomnia,C4763869,en_6406,PREVENTS,Symptoms,C1457887,en_5784,1,1,AFFECTS,Inhibitory,7
17321,Cognitive Behavioral Therapy for Insomnia,C4763869,en_6406,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,8
17322,Severe infection,C5139167,en_6407,PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Excitatory,6
17323,Severe infection,C5139167,en_6407,PREDISPOSES,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,Excitatory,7
17324,abrocitinib,C5139788,en_6408,TREATS,"Dermatitis, Atopic",C0011615,en_791,2,1,AFFECTS,Inhibitory,8
17325,Hydroxychloroquine therapy,C5190549,en_6409,TREATS,Hospitalized Patients,C0870668,en_5010,2,1,AFFECTS,Inhibitory,6
17326,Hydroxychloroquine therapy,C5190549,en_6409,TREATS,COVID-19,C5203670,en_6417,4,3,AFFECTS,Inhibitory,19
17327,Venoarterial extracorporeal membrane oxygenation,C5192097,en_6410,TREATS,Toxic Epidermal Necrolysis,C0014518,en_915,1,1,AFFECTS,Inhibitory,6
17328,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,Age,C0001779,en_257,1,1,AFFECTS,Inhibitory,6
17329,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
17330,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,Males,C0086582,en_2729,1,1,AFFECTS,Inhibitory,6
17331,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,infection induced,C0858744,en_4983,1,1,AFFECTS,Inhibitory,7
17332,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,Cerebral Hemorrhage,C2937358,en_6154,1,1,AFFECTS,Inhibitory,6
17333,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
17334,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
17335,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,TREATS,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,Inhibitory,7
17336,Prolonged Intermittent Renal Replacement Therapy,C5197699,en_6413,TREATS,"Kidney Failure, Acute",C0022660,en_1382,2,1,AFFECTS,Inhibitory,6
17337,Prolonged Intermittent Renal Replacement Therapy,C5197699,en_6413,TREATS,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,Inhibitory,6
17338,Prolonged Intermittent Renal Replacement Therapy,C5197699,en_6413,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,6
17339,Modified vaccinia ankara,C5202641,en_6414,PRODUCES,"Spike Glycoprotein, Coronavirus",C3658243,en_6225,1,1,AFFECTS,Excitatory,7
17340,Right and Left Lung Irradiation,C5202843,en_6415,TREATS,Matched Groups,C0024908,en_1508,1,1,AFFECTS,Inhibitory,8
17341,Right and Left Lung Irradiation,C5202843,en_6415,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17342,Right and Left Lung Irradiation,C5202843,en_6415,TREATS,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,Inhibitory,8
17343,COVID-19,C5203670,en_6417,AFFECTS,Anxiety,C0003467,en_380,2,2,AFFECTS,General/Uncertain,15
17344,COVID-19,C5203670,en_6417,AFFECTS,cardiac arrhythmia,C0003811,en_397,1,1,AFFECTS,General/Uncertain,6
17345,COVID-19,C5203670,en_6417,AFFECTS,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,6
17346,COVID-19,C5203670,en_6417,AFFECTS,Blood donor,C0005795,en_489,1,1,AFFECTS,General/Uncertain,7
17347,COVID-19,C5203670,en_6417,AFFECTS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,8
17348,COVID-19,C5203670,en_6417,AFFECTS,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
17349,COVID-19,C5203670,en_6417,AFFECTS,Transient Ischemic Attack,C0007787,en_604,1,1,AFFECTS,General/Uncertain,6
17350,COVID-19,C5203670,en_6417,AFFECTS,Child,C0008059,en_620,11,9,AFFECTS,General/Uncertain,55
17351,COVID-19,C5203670,en_6417,AFFECTS,Chronic Disease,C0008679,en_643,2,2,AFFECTS,General/Uncertain,12
17352,COVID-19,C5203670,en_6417,AFFECTS,Carcinoma of the Large Intestine,C0009402,en_681,1,1,AFFECTS,General/Uncertain,6
17353,COVID-19,C5203670,en_6417,AFFECTS,Community,C0009462,en_687,6,6,AFFECTS,General/Uncertain,41
17354,COVID-19,C5203670,en_6417,AFFECTS,Comorbidity,C0009488,en_690,1,1,AFFECTS,General/Uncertain,6
17355,COVID-19,C5203670,en_6417,AFFECTS,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
17356,COVID-19,C5203670,en_6417,AFFECTS,Conception,C0009637,en_701,1,1,AFFECTS,General/Uncertain,6
17357,COVID-19,C5203670,en_6417,AFFECTS,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
17358,COVID-19,C5203670,en_6417,AFFECTS,Eating Disorders,C0013473,en_871,1,1,AFFECTS,General/Uncertain,6
17359,COVID-19,C5203670,en_6417,AFFECTS,Ethnic group,C0015031,en_934,1,1,AFFECTS,General/Uncertain,7
17360,COVID-19,C5203670,en_6417,AFFECTS,Family,C0015576,en_961,1,1,AFFECTS,General/Uncertain,6
17361,COVID-19,C5203670,en_6417,AFFECTS,Fasting,C0015663,en_963,1,1,AFFECTS,General/Uncertain,8
17362,COVID-19,C5203670,en_6417,AFFECTS,Health Personnel,C0018724,en_1121,2,1,AFFECTS,General/Uncertain,6
17363,COVID-19,C5203670,en_6417,AFFECTS,Households,C0020052,en_1208,1,1,AFFECTS,General/Uncertain,6
17364,COVID-19,C5203670,en_6417,AFFECTS,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,General/Uncertain,6
17365,COVID-19,C5203670,en_6417,AFFECTS,Immunity,C0020964,en_1273,1,1,AFFECTS,General/Uncertain,8
17366,COVID-19,C5203670,en_6417,AFFECTS,"Infant, Newborn",C0021289,en_1299,1,1,AFFECTS,General/Uncertain,6
17367,COVID-19,C5203670,en_6417,AFFECTS,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,7
17368,COVID-19,C5203670,en_6417,AFFECTS,inpatient,C0021562,en_1321,2,1,AFFECTS,General/Uncertain,6
17369,COVID-19,C5203670,en_6417,AFFECTS,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,6
17370,COVID-19,C5203670,en_6417,AFFECTS,Minority Groups,C0026192,en_1573,1,1,AFFECTS,General/Uncertain,6
17371,COVID-19,C5203670,en_6417,AFFECTS,Myasthenia Gravis,C0026896,en_1613,1,1,AFFECTS,General/Uncertain,6
17372,COVID-19,C5203670,en_6417,AFFECTS,Necrosis,C0027540,en_1645,1,1,AFFECTS,General/Uncertain,6
17373,COVID-19,C5203670,en_6417,AFFECTS,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,6
17374,COVID-19,C5203670,en_6417,AFFECTS,Pregnancy Outcome,C0032972,en_1874,1,1,AFFECTS,General/Uncertain,6
17375,COVID-19,C5203670,en_6417,AFFECTS,Pregnant Women,C0033011,en_1876,4,3,AFFECTS,General/Uncertain,20
17376,COVID-19,C5203670,en_6417,AFFECTS,Racial group,C0034510,en_1951,1,1,AFFECTS,General/Uncertain,7
17377,COVID-19,C5203670,en_6417,AFFECTS,risk factors,C0035648,en_2039,1,1,AFFECTS,General/Uncertain,7
17378,COVID-19,C5203670,en_6417,AFFECTS,Stress,C0038435,en_2165,4,4,AFFECTS,General/Uncertain,25
17379,COVID-19,C5203670,en_6417,AFFECTS,Cerebrovascular accident,C0038454,en_2169,3,3,AFFECTS,General/Uncertain,18
17380,COVID-19,C5203670,en_6417,AFFECTS,"Students, Medical",C0038495,en_2172,1,1,AFFECTS,General/Uncertain,7
17381,COVID-19,C5203670,en_6417,AFFECTS,cell transformation,C0040682,en_2270,1,1,AFFECTS,General/Uncertain,8
17382,COVID-19,C5203670,en_6417,AFFECTS,Urinary Tract Physiology,C0042031,en_2321,1,1,AFFECTS,General/Uncertain,6
17383,COVID-19,C5203670,en_6417,AFFECTS,Variation (Genetics),C0042333,en_2335,2,1,AFFECTS,General/Uncertain,6
17384,COVID-19,C5203670,en_6417,AFFECTS,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,6
17385,COVID-19,C5203670,en_6417,AFFECTS,Social Networks,C0150775,en_2855,1,1,AFFECTS,General/Uncertain,6
17386,COVID-19,C5203670,en_6417,AFFECTS,Severe (severity modifier),C0205082,en_3125,1,1,AFFECTS,General/Uncertain,6
17387,COVID-19,C5203670,en_6417,AFFECTS,Negative,C0205160,en_3126,7,7,AFFECTS,General/Uncertain,45
17388,COVID-19,C5203670,en_6417,AFFECTS,Adolescent,C0205653,en_3132,4,3,AFFECTS,General/Uncertain,20
17389,COVID-19,C5203670,en_6417,AFFECTS,Survivors,C0206194,en_3154,1,1,AFFECTS,General/Uncertain,7
17390,COVID-19,C5203670,en_6417,AFFECTS,Crisis,C0231224,en_3253,1,1,AFFECTS,General/Uncertain,6
17391,COVID-19,C5203670,en_6417,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,8
17392,COVID-19,C5203670,en_6417,AFFECTS,Cardiac function,C0232164,en_3272,1,1,AFFECTS,General/Uncertain,6
17393,COVID-19,C5203670,en_6417,AFFECTS,Liver function,C0232741,en_3284,2,1,AFFECTS,General/Uncertain,6
17394,COVID-19,C5203670,en_6417,AFFECTS,Motor function,C0234130,en_3305,1,1,AFFECTS,General/Uncertain,6
17395,COVID-19,C5203670,en_6417,AFFECTS,uptake,C0243144,en_3467,2,2,AFFECTS,General/Uncertain,12
17396,COVID-19,C5203670,en_6417,AFFECTS,Otolaryngologist,C0260087,en_3508,3,1,AFFECTS,General/Uncertain,6
17397,COVID-19,C5203670,en_6417,AFFECTS,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,General/Uncertain,6
17398,COVID-19,C5203670,en_6417,AFFECTS,Death in hospital,C0277608,en_3586,1,1,AFFECTS,General/Uncertain,6
17399,COVID-19,C5203670,en_6417,AFFECTS,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,General/Uncertain,6
17400,COVID-19,C5203670,en_6417,AFFECTS,Respondents,C0282122,en_3638,1,1,AFFECTS,General/Uncertain,6
17401,COVID-19,C5203670,en_6417,AFFECTS,Possible,C0332149,en_3747,3,3,AFFECTS,General/Uncertain,22
17402,COVID-19,C5203670,en_6417,AFFECTS,Acute hemorrhage,C0333276,en_3760,1,1,AFFECTS,General/Uncertain,6
17403,COVID-19,C5203670,en_6417,AFFECTS,Graft infection,C0349725,en_3845,1,1,AFFECTS,General/Uncertain,6
17404,COVID-19,C5203670,en_6417,AFFECTS,Exacerbation of asthma,C0349790,en_3847,1,1,AFFECTS,General/Uncertain,6
17405,COVID-19,C5203670,en_6417,AFFECTS,"Recipient, Transplant",C0376387,en_3875,1,1,AFFECTS,General/Uncertain,6
17406,COVID-19,C5203670,en_6417,AFFECTS,Medical radiographer,C0402007,en_3958,1,1,AFFECTS,General/Uncertain,6
17407,COVID-19,C5203670,en_6417,AFFECTS,Neurological observations,C0422837,en_3988,1,1,AFFECTS,General/Uncertain,6
17408,COVID-19,C5203670,en_6417,AFFECTS,Frailty,C0424594,en_3998,1,1,AFFECTS,General/Uncertain,6
17409,COVID-19,C5203670,en_6417,AFFECTS,Physical and emotional exhaustion state,C0476644,en_4150,1,1,AFFECTS,General/Uncertain,6
17410,COVID-19,C5203670,en_6417,AFFECTS,"Sleep Apnea, Obstructive",C0520679,en_4191,2,1,AFFECTS,General/Uncertain,6
17411,COVID-19,C5203670,en_6417,AFFECTS,Sequela of disorder,C0543419,en_4257,1,1,AFFECTS,General/Uncertain,7
17412,COVID-19,C5203670,en_6417,AFFECTS,Level of anxiety,C0564474,en_4331,2,1,AFFECTS,General/Uncertain,6
17413,COVID-19,C5203670,en_6417,AFFECTS,Household composition,C0595998,en_4374,2,2,AFFECTS,General/Uncertain,13
17414,COVID-19,C5203670,en_6417,AFFECTS,Family health status,C0600220,en_4499,1,1,AFFECTS,General/Uncertain,6
17415,COVID-19,C5203670,en_6417,AFFECTS,Gravidity,C0600457,en_4508,2,2,AFFECTS,General/Uncertain,12
17416,COVID-19,C5203670,en_6417,AFFECTS,professional occupation status,C0679924,en_4617,1,1,AFFECTS,General/Uncertain,6
17417,COVID-19,C5203670,en_6417,AFFECTS,nursing home resident,C0682287,en_4642,2,2,AFFECTS,General/Uncertain,12
17418,COVID-19,C5203670,en_6417,AFFECTS,COPD exacerbation,C0740304,en_4776,1,1,AFFECTS,General/Uncertain,6
17419,COVID-19,C5203670,en_6417,AFFECTS,Nance-Horan syndrome,C0796085,en_4881,1,1,AFFECTS,General/Uncertain,6
17420,COVID-19,C5203670,en_6417,AFFECTS,psychological distress,C0815107,en_4922,2,1,AFFECTS,General/Uncertain,6
17421,COVID-19,C5203670,en_6417,AFFECTS,Staff,C0851286,en_4950,1,1,AFFECTS,General/Uncertain,6
17422,COVID-19,C5203670,en_6417,AFFECTS,Eating disorder symptom,C0855228,en_4965,1,1,AFFECTS,General/Uncertain,8
17423,COVID-19,C5203670,en_6417,AFFECTS,Geriatric Patients,C0870602,en_5007,1,1,AFFECTS,General/Uncertain,6
17424,COVID-19,C5203670,en_6417,AFFECTS,Hospitalized Patients,C0870668,en_5010,7,6,AFFECTS,General/Uncertain,41
17425,COVID-19,C5203670,en_6417,AFFECTS,Surgical Patients,C0871463,en_5023,1,1,AFFECTS,General/Uncertain,6
17426,COVID-19,C5203670,en_6417,AFFECTS,Underserved Population,C0872319,en_5050,1,1,AFFECTS,General/Uncertain,8
17427,COVID-19,C5203670,en_6417,AFFECTS,Ischemic stroke,C0948008,en_5158,1,1,AFFECTS,General/Uncertain,6
17428,COVID-19,C5203670,en_6417,AFFECTS,Acute coronary syndrome,C0948089,en_5159,1,1,AFFECTS,General/Uncertain,6
17429,COVID-19,C5203670,en_6417,AFFECTS,Vulnerable Populations,C0949366,en_5180,2,2,AFFECTS,General/Uncertain,12
17430,COVID-19,C5203670,en_6417,AFFECTS,Cafeteria,C1004632,en_5222,1,1,AFFECTS,General/Uncertain,7
17431,COVID-19,C5203670,en_6417,AFFECTS,Childbirth,C1148523,en_5296,7,6,AFFECTS,General/Uncertain,38
17432,COVID-19,C5203670,en_6417,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
17433,COVID-19,C5203670,en_6417,AFFECTS,Female sexual finding,C1291724,en_5491,2,1,AFFECTS,General/Uncertain,6
17434,COVID-19,C5203670,en_6417,AFFECTS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,General/Uncertain,6
17435,COVID-19,C5203670,en_6417,AFFECTS,Exogenous Factors,C1516998,en_5865,1,1,AFFECTS,General/Uncertain,6
17436,COVID-19,C5203670,en_6417,AFFECTS,Older Population,C1518563,en_5875,1,1,AFFECTS,General/Uncertain,6
17437,COVID-19,C5203670,en_6417,AFFECTS,STEMI,C1536220,en_5944,2,2,AFFECTS,General/Uncertain,12
17438,COVID-19,C5203670,en_6417,AFFECTS,Protection,C1545588,en_5951,1,1,AFFECTS,General/Uncertain,6
17439,COVID-19,C5203670,en_6417,AFFECTS,Respiratory problem,C1659989,en_6020,1,1,AFFECTS,General/Uncertain,8
17440,COVID-19,C5203670,en_6417,AFFECTS,Microbiome,C1956108,en_6068,1,1,AFFECTS,General/Uncertain,7
17441,COVID-19,C5203670,en_6417,AFFECTS,Functional capacity,C1998319,en_6082,1,1,AFFECTS,General/Uncertain,6
17442,COVID-19,C5203670,en_6417,AFFECTS,Old age,C1999167,en_6084,1,1,AFFECTS,General/Uncertain,7
17443,COVID-19,C5203670,en_6417,AFFECTS,Transplanted heart present,C2029943,en_6086,1,1,AFFECTS,General/Uncertain,6
17444,COVID-19,C5203670,en_6417,AFFECTS,thyroid function,C2242456,en_6093,2,2,AFFECTS,General/Uncertain,12
17445,COVID-19,C5203670,en_6417,AFFECTS,World,C2700280,en_6119,2,2,AFFECTS,General/Uncertain,12
17446,COVID-19,C5203670,en_6417,AFFECTS,Intestinal Microbiome,C2985398,en_6166,1,1,AFFECTS,General/Uncertain,7
17447,COVID-19,C5203670,en_6417,AFFECTS,American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,1,1,AFFECTS,General/Uncertain,6
17448,COVID-19,C5203670,en_6417,AFFECTS,Delayed Treatment,C3693346,en_6231,1,1,AFFECTS,General/Uncertain,6
17449,COVID-19,C5203670,en_6417,AFFECTS,Dynamics,C3826426,en_6247,1,1,AFFECTS,General/Uncertain,6
17450,COVID-19,C5203670,en_6417,AFFECTS,Major change,C3845593,en_6266,1,1,AFFECTS,General/Uncertain,6
17451,COVID-19,C5203670,en_6417,AFFECTS,Ovarian Reserve,C3850153,en_6272,1,1,AFFECTS,General/Uncertain,6
17452,COVID-19,C5203670,en_6417,AFFECTS,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",C3888198,en_6281,1,1,AFFECTS,General/Uncertain,8
17453,COVID-19,C5203670,en_6417,AFFECTS,Dietary behavior,C4019289,en_6293,1,1,AFFECTS,General/Uncertain,6
17454,COVID-19,C5203670,en_6417,AFFECTS,Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,3,3,AFFECTS,General/Uncertain,20
17455,COVID-19,C5203670,en_6417,AFFECTS,Exacerbation,C4086268,en_6319,1,1,AFFECTS,General/Uncertain,6
17456,COVID-19,C5203670,en_6417,AFFECTS,Increased risk,C4699158,en_6379,1,1,AFFECTS,General/Uncertain,6
17457,COVID-19,C5203670,en_6417,AFFECTS,Underlying,C4722602,en_6385,1,1,AFFECTS,General/Uncertain,7
17458,COVID-19,C5203670,en_6417,AFFECTS,Responsive Disease,C5236984,en_6425,2,2,AFFECTS,General/Uncertain,12
17459,COVID-19,C5203670,en_6417,AFFECTS,Community Transmission,C5392207,en_6447,1,1,AFFECTS,General/Uncertain,6
17460,COVID-19,C5203670,en_6417,AFFECTS,Acute Ischemic Stroke,C5392833,en_6450,1,1,AFFECTS,General/Uncertain,6
17461,COVID-19,C5203670,en_6417,AUGMENTS,Atrial Fibrillation,C0004238,en_423,1,1,AFFECTS,Excitatory,7
17462,COVID-19,C5203670,en_6417,AUGMENTS,Systemic infection,C0243026,en_3451,1,1,AFFECTS,Excitatory,6
17463,COVID-19,C5203670,en_6417,AUGMENTS,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,Excitatory,6
17464,COVID-19,C5203670,en_6417,COMPLICATES,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
17465,COVID-19,C5203670,en_6417,PREDISPOSES,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,Excitatory,6
17466,COVID-19,C5203670,en_6417,PREDISPOSES,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,Excitatory,6
17467,COVID-19,C5203670,en_6417,PREDISPOSES,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,Excitatory,6
17468,COVID-19,C5203670,en_6417,PREDISPOSES,Comorbidity,C0009488,en_690,1,1,AFFECTS,Excitatory,6
17469,COVID-19,C5203670,en_6417,PREDISPOSES,Critical Illness,C0010340,en_733,2,2,AFFECTS,Excitatory,12
17470,COVID-19,C5203670,en_6417,PREDISPOSES,Disease,C0012634,en_826,1,1,AFFECTS,Excitatory,6
17471,COVID-19,C5203670,en_6417,PREDISPOSES,Eye diseases,C0015397,en_952,1,1,AFFECTS,Excitatory,6.5
17472,COVID-19,C5203670,en_6417,PREDISPOSES,"Kidney Failure, Acute",C0022660,en_1382,4,4,AFFECTS,Excitatory,24
17473,COVID-19,C5203670,en_6417,PREDISPOSES,Pneumonia,C0032285,en_1833,1,1,AFFECTS,Excitatory,6
17474,COVID-19,C5203670,en_6417,PREDISPOSES,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,Excitatory,6
17475,COVID-19,C5203670,en_6417,PREDISPOSES,Violence,C0042693,en_2353,1,1,AFFECTS,Excitatory,6
17476,COVID-19,C5203670,en_6417,PREDISPOSES,Pulmonary thrombosis,C0151946,en_2875,1,1,AFFECTS,Excitatory,6
17477,COVID-19,C5203670,en_6417,PREDISPOSES,Domestic Violence,C0206073,en_3144,1,1,AFFECTS,Excitatory,6
17478,COVID-19,C5203670,en_6417,PREDISPOSES,Disease Progression,C0242656,en_3429,4,2,AFFECTS,Excitatory,12
17479,COVID-19,C5203670,en_6417,PREDISPOSES,disease transmission,C0242781,en_3438,1,1,AFFECTS,Excitatory,7
17480,COVID-19,C5203670,en_6417,PREDISPOSES,Death in hospital,C0277608,en_3586,2,2,AFFECTS,Excitatory,12
17481,COVID-19,C5203670,en_6417,PREDISPOSES,Possible,C0332149,en_3747,2,2,AFFECTS,Excitatory,12.5
17482,COVID-19,C5203670,en_6417,PREDISPOSES,Nutritional status,C0392209,en_3916,1,1,AFFECTS,Excitatory,6
17483,COVID-19,C5203670,en_6417,PREDISPOSES,Very high,C0442804,en_4057,1,1,AFFECTS,Excitatory,7
17484,COVID-19,C5203670,en_6417,PREDISPOSES,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,Excitatory,6
17485,COVID-19,C5203670,en_6417,PREDISPOSES,ethnic differences,C0682076,en_4634,1,1,AFFECTS,Excitatory,7
17486,COVID-19,C5203670,en_6417,PREDISPOSES,patient state,C0683521,en_4668,1,1,AFFECTS,Excitatory,7
17487,COVID-19,C5203670,en_6417,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,6
17488,COVID-19,C5203670,en_6417,PREDISPOSES,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,Excitatory,6
17489,COVID-19,C5203670,en_6417,PREDISPOSES,Severe disorder,C1836348,en_6048,1,1,AFFECTS,Excitatory,6
17490,COVID-19,C5203670,en_6417,PREDISPOSES,Venous Thromboembolism,C1861172,en_6055,3,3,AFFECTS,Excitatory,19
17491,COVID-19,C5203670,en_6417,PREDISPOSES,Infection,C3714514,en_6235,1,1,AFFECTS,Excitatory,6
17492,COVID-19,C5203670,en_6417,PREDISPOSES,Sudden Unexpected Death in Epilepsy,C4304727,en_6335,1,1,AFFECTS,Excitatory,6
17493,COVID-19,C5203670,en_6417,PREDISPOSES,Severe disease,C4740692,en_6396,1,1,AFFECTS,Excitatory,6
17494,COVID-19,C5203670,en_6417,PREDISPOSES,Acute Ischemic Stroke,C5392833,en_6450,1,1,AFFECTS,Excitatory,6
17495,COVID-19,C5203670,en_6417,PRODUCES,Vaccines,C0042210,en_2329,1,1,AFFECTS,Excitatory,8
17496,COVID-19,C5203670,en_6417,PRODUCES,cytokine,C0079189,en_2593,1,1,AFFECTS,Excitatory,6
17497,SARS-CoV-2 vaccination,C5203672,en_6419,PREVENTS,Postoperative infection NOS,C0392618,en_3923,1,1,AFFECTS,Inhibitory,6
17498,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,Homo sapiens,C0086418,en_2718,1,1,AFFECTS,Inhibitory,8
17499,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,"INFECTION, RECURRENT",C0239998,en_3380,1,1,AFFECTS,Inhibitory,6
17500,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,Autoimmune Thrombocytopenia,C0242584,en_3420,1,1,AFFECTS,Inhibitory,6
17501,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,Fragility,C0302113,en_3700,1,1,AFFECTS,Inhibitory,6
17502,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,Genitourinary Cancer,C0751569,en_4851,1,1,AFFECTS,Inhibitory,7
17503,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,Hematopoietic Cell Transplant Recipient,C4288965,en_6333,1,1,AFFECTS,Inhibitory,6
17504,SARS-CoV-2 vaccination,C5203672,en_6419,TREATS,Solid Organ Transplant Recipient,C4331301,en_6348,1,1,AFFECTS,Inhibitory,7
17505,Zilucoplan,C5203810,en_6421,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
17506,Zilucoplan,C5203810,en_6421,TREATS,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,Inhibitory,8
17507,Opioid Use Disorder Treatment,C5209216,en_6424,TREATS,Endurance,C0518031,en_4176,1,1,AFFECTS,Inhibitory,7
17508,Responsive Disease,C5236984,en_6425,PREDISPOSES,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,8
17509,Responsive Disease,C5236984,en_6425,PREDISPOSES,Disease Outcome,C0679250,en_4593,1,1,AFFECTS,Excitatory,7
17510,Symptomatic treatment,C5243901,en_6426,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
17511,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,AFFECTS,pulmonary function,C0231921,en_3268,1,1,AFFECTS,General/Uncertain,6
17512,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,AFFECTS,Negative Regulation of Coagulation,C2917212,en_6142,1,1,AFFECTS,General/Uncertain,6
17513,COVID-19 drug treatment,C5244048,en_6429,AFFECTS,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
17514,COVID-19 drug treatment,C5244048,en_6429,PREVENTS,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,Inhibitory,8
17515,COVID-19 drug treatment,C5244048,en_6429,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,8
17516,COVID-19 drug treatment,C5244048,en_6429,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17517,mRNA-1273,C5244457,en_6430,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17518,mRNA-1273,C5244457,en_6430,PREVENTS,Asymptomatic SARS-CoV-2,C5244047,en_6428,1,1,AFFECTS,Inhibitory,8
17519,mRNA-1273,C5244457,en_6430,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,8
17520,Ad5-nCoV,C5244458,en_6431,AUGMENTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,8
17521,Pillbox,C5381951,en_6432,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
17522,Feedback system,C5381984,en_6433,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,7
17523,Feedback system,C5381984,en_6433,TREATS,Adolescent,C0205653,en_3132,1,1,AFFECTS,Inhibitory,7
17524,AZD1222,C5383286,en_6434,AUGMENTS,"Immunity, Humoral",C0020967,en_1275,1,1,AFFECTS,Excitatory,8
17525,ChAdOx1 nCoV-19,C5383287,en_6435,AUGMENTS,Antibody Formation,C0003261,en_352,1,1,AFFECTS,Excitatory,7
17526,ChAdOx1 nCoV-19,C5383287,en_6435,COMPLICATES,Thrombosis of cerebral veins,C0151945,en_2874,1,1,AFFECTS,General/Uncertain,6
17527,ChAdOx1 nCoV-19,C5383287,en_6435,TREATS,Elderly,C0001792,en_258,1,1,AFFECTS,Inhibitory,8
17528,ChAdOx1 nCoV-19,C5383287,en_6435,TREATS,HIV,C0019682,en_1190,1,1,AFFECTS,Inhibitory,8
17529,ChAdOx1 nCoV-19,C5383287,en_6435,TREATS,Young adult,C0238598,en_3365,1,1,AFFECTS,Inhibitory,8
17530,COVID-19 Vaccines,C5387588,en_6436,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,7
17531,COVID-19 Vaccines,C5387588,en_6436,AUGMENTS,Hypercoagulability disease,C0543671,en_4260,1,1,AFFECTS,Excitatory,6
17532,COVID-19 Vaccines,C5387588,en_6436,PREVENTS,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,Inhibitory,8
17533,COVID-19 Vaccines,C5387588,en_6436,PREVENTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
17534,COVID-19 Vaccines,C5387588,en_6436,PREVENTS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,6
17535,COVID-19 Vaccines,C5387588,en_6436,PRODUCES,"spike protein, SARS-CoV-2",C5391442,en_6439,1,1,AFFECTS,Excitatory,8
17536,COVID-19 Vaccines,C5387588,en_6436,STIMULATES,Antibodies,C0003241,en_347,1,1,AFFECTS,Excitatory,7
17537,COVID-19 Vaccines,C5387588,en_6436,STIMULATES,gamma-interferon|IFNA1,C3539881|3439,en_6213,1,1,AFFECTS,Excitatory,7
17538,COVID-19 Vaccines,C5387588,en_6436,TREATS,Adult,C0001675,en_252,2,2,AFFECTS,Inhibitory,16
17539,COVID-19 Vaccines,C5387588,en_6436,TREATS,Malignant Neoplasms,C0006826,en_545,2,2,AFFECTS,Inhibitory,14
17540,COVID-19 Vaccines,C5387588,en_6436,TREATS,Child,C0008059,en_620,1,1,AFFECTS,Inhibitory,8
17541,COVID-19 Vaccines,C5387588,en_6436,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
17542,COVID-19 Vaccines,C5387588,en_6436,TREATS,"Myeloid Leukemia, Chronic",C0023473,en_1419,1,1,AFFECTS,Inhibitory,7
17543,COVID-19 Vaccines,C5387588,en_6436,TREATS,Multiple Myeloma,C0026764,en_1596,1,1,AFFECTS,Inhibitory,7
17544,COVID-19 Vaccines,C5387588,en_6436,TREATS,Human Age Group,C0027362,en_1636,1,1,AFFECTS,Inhibitory,8
17545,COVID-19 Vaccines,C5387588,en_6436,TREATS,Rheumatic Fever,C0035436,en_2029,1,1,AFFECTS,Inhibitory,6
17546,COVID-19 Vaccines,C5387588,en_6436,TREATS,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,Inhibitory,7
17547,COVID-19 Vaccines,C5387588,en_6436,TREATS,Adolescent,C0205653,en_3132,3,3,AFFECTS,Inhibitory,24
17548,COVID-19 Vaccines,C5387588,en_6436,TREATS,Solid tumor,C0280100,en_3619,1,1,AFFECTS,Inhibitory,7
17549,COVID-19 Vaccines,C5387588,en_6436,TREATS,"Recipient, Transplant",C0376387,en_3875,1,1,AFFECTS,Inhibitory,6
17550,COVID-19 Vaccines,C5387588,en_6436,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,7
17551,COVID-19 Vaccines,C5387588,en_6436,TREATS,Well child,C0686744,en_4681,1,1,AFFECTS,Inhibitory,8
17552,COVID-19 Vaccines,C5387588,en_6436,TREATS,Well adult,C0686750,en_4683,6,5,AFFECTS,Inhibitory,40
17553,COVID-19 Vaccines,C5387588,en_6436,TREATS,Autoimmune disease (systemic) NOS,C2895206,en_6140,1,1,AFFECTS,Inhibitory,6
17554,COVID-19 Vaccines,C5387588,en_6436,TREATS,2019 novel coronavirus,C5203676,en_6420,1,1,AFFECTS,Inhibitory,8
17555,glycyrrhizae radix et rhizoma,C5391843,en_6440,INHIBITS,11-beta-Hydroxysteroid Dehydrogenase Type 2|HSD11B2|RNU1-4,C0608861|3291|6060,en_4519,1,1,AFFECTS,Inhibitory,7
17556,Psychosocial Intervention,C5392103,en_6441,PREVENTS,SOMATIZATION,C0149779,en_2808,1,1,AFFECTS,Inhibitory,6
17557,Psychosocial Intervention,C5392103,en_6441,TREATS,Adult,C0001675,en_252,1,1,AFFECTS,Inhibitory,7
17558,Psychosocial Intervention,C5392103,en_6441,TREATS,Gravidity,C0600457,en_4508,1,1,AFFECTS,Inhibitory,7
17559,Psychosocial Intervention,C5392103,en_6441,TREATS,psychological distress,C0815107,en_4922,1,1,AFFECTS,Inhibitory,7
17560,Glycemic Control,C5392125,en_6442,AFFECTS,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,General/Uncertain,8
17561,Glycemic Control,C5392125,en_6442,AFFECTS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,General/Uncertain,8
17562,Glycemic Control,C5392125,en_6442,AFFECTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
17563,Glycemic Control,C5392125,en_6442,TREATS,Child,C0008059,en_620,6,4,AFFECTS,Inhibitory,24
17564,Glycemic Control,C5392125,en_6442,TREATS,Diabetes,C0011847,en_797,2,2,AFFECTS,Inhibitory,12
17565,Glycemic Control,C5392125,en_6442,TREATS,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,9,7,AFFECTS,Inhibitory,43
17566,Glycemic Control,C5392125,en_6442,TREATS,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,Inhibitory,6
17567,Glycemic Control,C5392125,en_6442,TREATS,Adolescent,C0205653,en_3132,4,3,AFFECTS,Inhibitory,18
17568,Physical Distancing,C5392135,en_6443,AFFECTS,Weight Gain,C0043094,en_2388,1,1,AFFECTS,General/Uncertain,8
17569,Physical Distancing,C5392135,en_6443,AFFECTS,Negative,C0205160,en_3126,1,1,AFFECTS,General/Uncertain,7
17570,Physical Distancing,C5392135,en_6443,PREVENTS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,8
17571,Physical Distancing,C5392135,en_6443,PREVENTS,disease transmission,C0242781,en_3438,1,1,AFFECTS,Inhibitory,6
17572,Physical Distancing,C5392135,en_6443,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17573,Physical Distancing,C5392135,en_6443,TREATS,Community,C0009462,en_687,1,1,AFFECTS,Inhibitory,6
17574,Physical Distancing,C5392135,en_6443,TREATS,Disease,C0012634,en_826,1,1,AFFECTS,Inhibitory,7
17575,Physical Distancing,C5392135,en_6443,TREATS,Crisis,C0231224,en_3253,1,1,AFFECTS,Inhibitory,6
17576,Physical Distancing,C5392135,en_6443,TREATS,Transformed migraine,C1960870,en_6070,1,1,AFFECTS,Inhibitory,6
17577,Physical Distancing,C5392135,en_6443,TREATS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,14
17578,N95 Respirators,C5392166,en_6444,TREATS,Health Personnel,C0018724,en_1121,1,1,AFFECTS,Inhibitory,6
17579,Risk Scores,C5392186,en_6445,PREDISPOSES,Adverse event,C0877248,en_5069,1,1,AFFECTS,Excitatory,7
17580,Tetravalent Vaccines,C5392198,en_6446,TREATS,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,Inhibitory,7
17581,qingfei paidu decoction,C5392475,en_6449,AFFECTS,Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,1,1,AFFECTS,General/Uncertain,6
17582,qingfei paidu decoction,C5392475,en_6449,TREATS,Hospitalized Patients,C0870668,en_5010,1,1,AFFECTS,Inhibitory,6
17583,Brief Treatment,C5392902,en_6451,TREATS,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,Inhibitory,8
17584,BNT162b2 SARS-CoV-2 Vaccine,C5398043,en_6453,AUGMENTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,6
17585,BNT162b2 SARS-CoV-2 Vaccine,C5398043,en_6453,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,6
17586,BNT162b2 SARS-CoV-2 Vaccine,C5398043,en_6453,TREATS,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,Inhibitory,7
17587,BNT162b2 SARS-CoV-2 Vaccine,C5398043,en_6453,TREATS,[M]Solid carcinoma NOS,C0334296,en_3776,1,1,AFFECTS,Inhibitory,6
17588,BNT162b2 SARS-CoV-2 Vaccine,C5398043,en_6453,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
17589,BNT162b2 SARS-CoV-2 Vaccine,C5398043,en_6453,TREATS,Kidney Transplant Recipient,C4304779,en_6336,1,1,AFFECTS,Inhibitory,7
17590,SARS-CoV-2 mRNA vaccine,C5416826,en_6454,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17591,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,TREATS,HIV,C0019682,en_1190,1,1,AFFECTS,Inhibitory,7
17592,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,AUGMENTS,Immunity,C0020964,en_1273,1,1,AFFECTS,Excitatory,8
17593,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,TREATS,Young adult,C0238598,en_3365,1,1,AFFECTS,Inhibitory,8
17594,BBV152,C5416846,en_6457,INHIBITS,COVID-19 Vaccines,C5387588,en_6436,2,2,AFFECTS,Inhibitory,15
17595,mRNA Vaccine,C5419859,en_6460,PREVENTS,COVID-19,C5203670,en_6417,2,2,AFFECTS,Inhibitory,12
17596,mRNA Vaccine,C5419859,en_6460,TREATS,Hematologic Neoplasms,C0376545,en_3883,1,1,AFFECTS,Inhibitory,7
17597,bamlanivimab,C5421805,en_6462,PREVENTS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17598,post-acute COVID-19 syndrome,C5433293,en_6463,AFFECTS,Physical function,C0516981,en_4169,1,1,AFFECTS,General/Uncertain,6
17599,mRNA-1273 vaccine,C5433459,en_6464,AUGMENTS,B-Lymphocytes,C0004561,en_434,1,1,AFFECTS,Excitatory,6
17600,mRNA-1273 vaccine,C5433459,en_6464,AUGMENTS,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,6
17601,sotrovimab,C5433947,en_6465,PREVENTS,Disease Progression,C0242656,en_3429,1,1,AFFECTS,Inhibitory,8
17602,sotrovimab,C5433947,en_6465,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,8
17603,RNA Vaccine,C5435313,en_6466,TREATS,[M]Solid carcinoma NOS,C0334296,en_3776,1,1,AFFECTS,Inhibitory,6
17604,RNA Vaccine,C5435313,en_6466,TREATS,Cancer Patient,C1516213,en_5852,1,1,AFFECTS,Inhibitory,6
17605,CoVac-1,C5439905,en_6467,STIMULATES,T-Lymphocyte,C0039194,en_2198,1,1,AFFECTS,Excitatory,7
17606,CoVac-1,C5439905,en_6467,TREATS,COVID-19,C5203670,en_6417,1,1,AFFECTS,Inhibitory,7
17607,PARP1,C1538577,en_4,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
17608,APLNR,C1412289,en_6,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
17609,APLNR,C1412289,en_6,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
17610,FAS,C1539477,en_6469,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,6
17611,CD33,C3491277,en_15,ASSOCIATED_WITH,"Leukemia, Myelocytic, Acute",C0023467,en_1418,1,1,AFFECTS,General/Uncertain,3
17612,CD38,C0075742,en_16,ASSOCIATED_WITH,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,General/Uncertain,3
17613,CD38,C0075742,en_16,ASSOCIATED_WITH,Thrombus,C0087086,en_2743,1,1,AFFECTS,General/Uncertain,3
17614,SLC25A10,C1420151,en_23,ASSOCIATED_WITH,Aortic Aneurysm,C0003486,en_6499,1,1,AFFECTS,General/Uncertain,3
17615,SLC25A10,C1420151,en_23,ASSOCIATED_WITH,Advanced cancer,C0877373,en_5070,1,1,AFFECTS,General/Uncertain,3
17616,CYP2J2,C1413880,en_6470,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
17617,CYP2J2,C1413880,en_6470,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
17618,ACE,C1413931,en_28,ASSOCIATED_WITH,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,3
17619,DMD,C1414083,en_31,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
17620,GBA,C1414998,en_6471,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
17621,GRIN2A,C1415299,en_6472,ASSOCIATED_WITH,Neurodevelopmental disorder,C1535926,en_5943,1,1,AFFECTS,General/Uncertain,3
17622,HSD11B1,C1415736,en_6473,ASSOCIATED_WITH,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,General/Uncertain,3
17623,HSD11B1,C1415736,en_6473,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
17624,IFNA1,C1415900,en_46,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17625,LTBP3,C1416929,en_6474,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
17626,NHS,C1417725,en_64,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
17627,NHS,C1417725,en_64,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
17628,MASP1,C1417036,en_71,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
17629,ROS1,C0812281,en_74,ASSOCIATED_WITH,Mitochondrial alteration,C0544926,en_6646,1,1,AFFECTS,General/Uncertain,3
17630,SCN10A,C1419853,en_6475,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
17631,SLC6A3,C1420213,en_6476,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
17632,SLC12A2,C1420091,en_6477,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
17633,ADAM17,C1412186,en_84,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
17634,ADAM17,C1412186,en_84,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17635,TYRO3,C1367457,en_6478,ASSOCIATED_WITH(INFER),Hip pain,C0019559,en_6526,1,1,AFFECTS,General/Uncertain,3
17636,VEGFA,C1823619,en_89,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
17637,VEGFA,C1823619,en_89,ASSOCIATED_WITH,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,General/Uncertain,3
17638,IKBKG,C1416380,en_6479,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
17639,TRAF3IP2,C1540046,en_112,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17640,DIAPH2-AS1,C3470078,en_113,ASSOCIATED_WITH,Refractory anemias,C0002893,en_6498,1,1,AFFECTS,General/Uncertain,3
17641,DIAPH2-AS1,C3470078,en_113,ASSOCIATED_WITH,Diamond-Blackfan anemia,C1260899,en_5413,2,1,AFFECTS,General/Uncertain,3
17642,IBTK,C1425132,en_6480,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17643,BPIFA1,C1423701,en_6481,ASSOCIATED_WITH,Cystic Fibrosis,C0010674,en_745,1,1,AFFECTS,General/Uncertain,3
17644,CMAS,C1425425,en_6483,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17645,RALGAPA2,C1424084,en_142,ASSOCIATED_WITH,Primary carcinoma of the liver cells,C0019204,en_1178,2,1,AFFECTS,General/Uncertain,3
17646,ACE2,C1422064,en_5723,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
17647,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
17648,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,3
17649,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Obesity,C0028754,en_1699,2,1,AFFECTS,General/Uncertain,3
17650,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
17651,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Pulmonary Edema,C0034063,en_1929,1,1,AFFECTS,General/Uncertain,3
17652,ACE2,C1422064,en_5723,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
17653,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,General/Uncertain,3
17654,ACE2,C1422064,en_5723,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
17655,PIEZO2,C1539429,en_6484,ASSOCIATED_WITH,Pruritus,C0033774,en_1916,1,1,AFFECTS,General/Uncertain,3
17656,STRA6,C1539887,en_148,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,2,1,AFFECTS,General/Uncertain,3
17657,STRA6,C1539887,en_148,ASSOCIATED_WITH,Vitamin A Deficiency,C0042842,en_2369,2,1,AFFECTS,General/Uncertain,3
17658,NDNF,C3472710,en_6485,ASSOCIATED_WITH,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
17659,PRSS27,C1423515,en_6486,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17660,NLRP3,C1424250,en_157,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,2,1,AFFECTS,General/Uncertain,3
17661,NLRP3,C1424250,en_157,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
17662,ARAP2,C1424639,en_159,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
17663,SCGB3A2,C1425493,en_160,ASSOCIATED_WITH(INFER),Adenocarcinoma,C0001418,en_6494,1,1,AFFECTS,General/Uncertain,3
17664,NCOA7,C1427302,en_162,ASSOCIATED_WITH,cytotoxicity,C0596402,en_4385,1,1,AFFECTS,General/Uncertain,3
17665,NEAT1,C2681866,en_164,ASSOCIATED_WITH,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,General/Uncertain,3
17666,"ACACA,BMS1",C1412104; C1428109,en_6487,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
17667,TMEM173,C4077403,en_6488,ASSOCIATED_WITH(INFER),"Lung Diseases, Interstitial",C0206062,en_3142,1,1,AFFECTS,General/Uncertain,3
17668,HCC,C1825268,en_169,ASSOCIATED_WITH,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,2,2,AFFECTS,General/Uncertain,6
17669,NCF1,C1417608,en_6489,ASSOCIATED_WITH,Macrophage activation syndrome,C1096155,en_5233,1,1,AFFECTS,General/Uncertain,3
17670,"CSF2,LAMC2",C1332791; C1416786,en_6490,ASSOCIATED_WITH(INFER),Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,3
17671,"CSF2,LAMC2",C1332791; C1416786,en_6490,ASSOCIATED_WITH(INFER),Neurologic Diseases,C1456669,en_5777,1,1,AFFECTS,General/Uncertain,3
17672,"GGT1,GGTLC5P,GGTLC3,GGT2,GGTLC4P",C1415053; C2681547; C2676726; C1415054; C2681546,en_6491,ASSOCIATED_WITH,Complication,C0009566,en_697,3,1,AFFECTS,General/Uncertain,3
17673,AGTR2|PGR-AS1,C1332036; C4320607,en_6492,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,7
17674,AZU1|HDLBP|SLBP|STAM2|HEBP1,C1332127;C1415507;C1420085;C1420452;C1424798,en_200,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17675,"Abdomen, Acute",C0000727,en_205,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
17676,Abdominal Pain,C0000737,en_6493,ASSOCIATED_WITH,Familial Mediterranean Fever,C0031069,en_1773,1,1,AFFECTS,General/Uncertain,3
17677,Acclimatization,C0000934,en_212,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17678,Acclimatization,C0000934,en_212,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17679,Acute-Phase Proteins,C0001347,en_232,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,6
17680,Acute-Phase Proteins,C0001347,en_232,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
17681,Acute-Phase Proteins,C0001347,en_232,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
17682,Immunologic Adjuvants,C0001551,en_242,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,8
17683,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Infection of amniotic sac and membranes,C0008495,en_6510,1,1,AFFECTS,General/Uncertain,7
17684,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,8
17685,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,8
17686,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
17687,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,2,AFFECTS,General/Uncertain,14
17688,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,6
17689,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Hypoxia,C0242184,en_3396,3,2,AFFECTS,General/Uncertain,14
17690,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Decreased metabolic requirement,C0520918,en_6643,1,1,AFFECTS,General/Uncertain,6
17691,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,5,5,AFFECTS,General/Uncertain,33
17692,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,General/Uncertain,7
17693,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
17694,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17695,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Irritable Bowel Syndrome,C0022104,en_1360,1,1,AFFECTS,General/Uncertain,3
17696,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,8,4,AFFECTS,General/Uncertain,12
17697,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Avascular necrosis,C0221247,en_6600,1,1,AFFECTS,General/Uncertain,3
17698,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Acute respiratory failure,C0264490,en_3533,4,1,AFFECTS,General/Uncertain,3
17699,Adrenal Cortex Hormones,C0001617,en_247,ASSOCIATED_WITH,Nosocomial pneumonia,C0949083,en_5175,2,1,AFFECTS,General/Uncertain,3
17700,Age,C0001779,en_257,ASSOCIATED_WITH,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,8
17701,Age,C0001779,en_257,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
17702,Age,C0001779,en_257,ASSOCIATED_WITH,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,9
17703,Age,C0001779,en_257,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,8
17704,Age,C0001779,en_257,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
17705,Age,C0001779,en_257,ASSOCIATED_WITH,Pulmonary Embolism,C0034065,en_1930,1,1,AFFECTS,General/Uncertain,3
17706,Age,C0001779,en_257,ASSOCIATED_WITH,Chronic disease of respiratory system,C0264220,en_3528,1,1,AFFECTS,General/Uncertain,8
17707,Age,C0001779,en_257,ASSOCIATED_WITH,Hyperuricemia,C0740394,en_6671,1,1,AFFECTS,General/Uncertain,3
17708,Age,C0001779,en_257,ASSOCIATED_WITH,Acute chest syndrome,C0742343,en_4795,1,1,AFFECTS,General/Uncertain,6
17709,Age,C0001779,en_257,ASSOCIATED_WITH,Chronic lung disease,C0746102,en_4815,1,1,AFFECTS,General/Uncertain,6
17710,Age,C0001779,en_257,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,6
17711,Age,C0001779,en_257,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,4,4,AFFECTS,General/Uncertain,24
17712,Aging,C0001811,en_262,ASSOCIATED_WITH,Asthenia,C0004093,en_416,1,1,AFFECTS,General/Uncertain,3
17713,Aging,C0001811,en_262,ASSOCIATED_WITH,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,9
17714,Aging,C0001811,en_262,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
17715,Aging,C0001811,en_262,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17716,Aging,C0001811,en_262,ASSOCIATED_WITH,Degenerative disorder,C1285162,en_5478,1,1,AFFECTS,General/Uncertain,3
17717,Aging,C0001811,en_262,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
17718,Air Pollutants,C0001869,en_6495,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17719,Albumins,C0001924,en_267,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,7
17720,Alleles,C0002085,en_278,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,8
17721,Alleles,C0002085,en_278,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17722,ALPHA-AMYLASE,C0002245,en_6496,ASSOCIATED_WITH,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,General/Uncertain,3
17723,ALPHA-AMYLASE,C0002245,en_6496,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
17724,Amino Acids,C0002520,en_299,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
17725,Amino Acids,C0002520,en_299,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17726,Amino Acids,C0002520,en_299,ASSOCIATED_WITH,Hepatitis B,C0019163,en_1172,1,1,AFFECTS,General/Uncertain,3
17727,Amino Acids,C0002520,en_299,ASSOCIATED_WITH,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,General/Uncertain,3
17728,Amyloid,C0002716,en_308,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
17729,Amyloid,C0002716,en_308,ASSOCIATED_WITH,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,General/Uncertain,3
17730,Angiotensin II,C0003009,en_328,ASSOCIATED_WITH,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,6
17731,Angiotensin II,C0003009,en_328,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
17732,Angiotensin II,C0003009,en_328,ASSOCIATED_WITH,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,General/Uncertain,3
17733,Angiotensin II,C0003009,en_328,ASSOCIATED_WITH,Shock,C0036974,en_2097,1,1,AFFECTS,General/Uncertain,3
17734,Angiotensin II,C0003009,en_328,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,3
17735,Angiotensins,C0003018,en_332,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,3
17736,Anosmia,C0003126,en_337,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17737,Anosmia,C0003126,en_337,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17738,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17739,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
17740,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
17741,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Psychotic Disorders,C0033975,en_1924,1,1,AFFECTS,General/Uncertain,3
17742,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
17743,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
17744,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Mood Disorders,C0525045,en_4229,1,1,AFFECTS,General/Uncertain,3
17745,Antibodies,C0003241,en_347,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17746,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Urticaria,C0042109,en_6560,1,1,AFFECTS,General/Uncertain,6
17747,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,7
17748,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Reinfection,C0205339,en_3129,1,1,AFFECTS,General/Uncertain,6
17749,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,7
17750,Antibodies,C0003241,en_347,ASSOCIATED_WITH,Autoimmune Thrombocytopenia,C0242584,en_3420,1,1,AFFECTS,General/Uncertain,7
17751,Antibodies,C0003241,en_347,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17752,"Antibodies, Anti-Idiotypic",C0003242,en_348,ASSOCIATED_WITH,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
17753,"Antibodies, Anti-Idiotypic",C0003242,en_348,ASSOCIATED_WITH,Encephalitis,C0014038,en_896,1,1,AFFECTS,General/Uncertain,3
17754,"Antibodies, Anti-Idiotypic",C0003242,en_348,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17755,"Antibodies, Anti-Idiotypic",C0003242,en_348,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17756,Monoclonal Antibodies,C0003250,en_350,ASSOCIATED_WITH,Mycoses,C0026946,en_1620,1,1,AFFECTS,General/Uncertain,3
17757,Monoclonal Antibodies,C0003250,en_350,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17758,Monoclonal Antibodies,C0003250,en_350,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
17759,Monoclonal Antibodies,C0003250,en_350,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
17760,"Antibodies, Viral",C0003253,en_351,ASSOCIATED_WITH,Encephalitis,C0014038,en_896,1,1,AFFECTS,General/Uncertain,3
17761,"Antibodies, Viral",C0003253,en_351,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17762,Antigen-Antibody Complex,C0003313,en_361,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17763,Epitopes,C0003316,en_363,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17764,Epitopes,C0003316,en_363,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
17765,Antigens,C0003320,en_365,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
17766,Antigens,C0003320,en_365,ASSOCIATED_WITH,Hypersensitivity,C0020517,en_1238,1,1,AFFECTS,General/Uncertain,3
17767,Antigens,C0003320,en_365,ASSOCIATED_WITH,Antibody-Dependent Enhancement,C0282632,en_3660,2,2,AFFECTS,General/Uncertain,6
17768,Antigens,C0003320,en_365,ASSOCIATED_WITH,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
17769,Apnea,C0003578,en_385,ASSOCIATED_WITH,TPO gene,C1364508,en_5651,1,1,AFFECTS,General/Uncertain,3
17770,Apolipoprotein E,C0003595,en_6500,ASSOCIATED_WITH,Delirium,C0011206,en_774,2,1,AFFECTS,General/Uncertain,3
17771,Apolipoprotein E,C0003595,en_6500,ASSOCIATED_WITH,Dementia,C0497327,en_4164,1,1,AFFECTS,General/Uncertain,3
17772,Arginine,C0003765,en_394,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17773,Arginine,C0003765,en_394,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
17774,Arginine,C0003765,en_394,ASSOCIATED_WITH,Septic Shock,C0036983,en_2101,1,1,AFFECTS,General/Uncertain,3
17775,Arthralgia,C0003862,en_6501,ASSOCIATED_WITH,Familial Mediterranean Fever,C0031069,en_1773,1,1,AFFECTS,General/Uncertain,3
17776,Rheumatoid Arthritis,C0003873,en_402,ASSOCIATED_WITH,"Protein Processing, Post-Translational",C0033666,en_1910,1,1,AFFECTS,General/Uncertain,3
17777,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
17778,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,6
17779,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,2,1,AFFECTS,General/Uncertain,7
17780,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17781,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
17782,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,3,2,AFFECTS,General/Uncertain,6
17783,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,2,1,AFFECTS,General/Uncertain,3
17784,Ascorbic Acid,C0003968,en_405,ASSOCIATED_WITH(SPEC),Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
17785,Inspiration function,C0004048,en_413,ASSOCIATED_WITH,Fatigue,C0015672,en_966,1,1,AFFECTS,General/Uncertain,8
17786,Asthenia,C0004093,en_416,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,2,1,AFFECTS,General/Uncertain,3
17787,Asthenia,C0004093,en_416,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17788,Asthenia,C0004093,en_416,ASSOCIATED_WITH,Myopathy,C0026848,en_1605,2,1,AFFECTS,General/Uncertain,3
17789,Asthenia,C0004093,en_416,ASSOCIATED_WITH,Neurodegenerative Disorders,C0524851,en_4220,2,1,AFFECTS,General/Uncertain,3
17790,Asthenia,C0004093,en_416,ASSOCIATED_WITH(SPEC),Amyotrophic Lateral Sclerosis,C0002736,en_310,2,1,AFFECTS,General/Uncertain,3
17791,Atrial Fibrillation,C0004238,en_423,ASSOCIATED_WITH,ANP32B gene,C1332090,en_5581,1,1,AFFECTS,General/Uncertain,3
17792,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,2,1,AFFECTS,General/Uncertain,3
17793,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Autoimmunity,C0004368,en_430,1,1,AFFECTS,General/Uncertain,3
17794,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Tissue damage,C0010957,en_756,1,1,AFFECTS,General/Uncertain,3
17795,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17796,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Dysautonomia,C0013363,en_863,1,1,AFFECTS,General/Uncertain,3
17797,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,7
17798,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
17799,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH,Polyglandular Type I Autoimmune Syndrome,C0085859,en_2695,1,1,AFFECTS,General/Uncertain,7
17800,Autoantibodies,C0004358,en_426,ASSOCIATED_WITH(INFER),Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
17801,Autoantigens,C0004359,en_427,ASSOCIATED_WITH,IGA Glomerulonephritis,C0017661,en_1066,1,1,AFFECTS,General/Uncertain,3
17802,Autoantigens,C0004359,en_427,ASSOCIATED_WITH,Antiphospholipid Syndrome,C0085278,en_2657,1,1,AFFECTS,General/Uncertain,3
17803,Autoantigens,C0004359,en_427,ASSOCIATED_WITH,Sjogren's Syndrome,C1527336,en_5921,1,1,AFFECTS,General/Uncertain,3
17804,Bacteria,C0004611,en_440,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
17805,Bacteria,C0004611,en_440,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
17806,BCG Vaccine,C0004886,en_448,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
17807,BCG Vaccine,C0004886,en_448,ASSOCIATED_WITH,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
17808,beta-1 Interferon,C0005148,en_6503,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
17809,Bile Acids,C0005390,en_462,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
17810,Bioenergetics,C0005486,en_464,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
17811,Biological Factors,C0005515,en_467,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17812,Biological Factors,C0005515,en_467,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
17813,Biological Factors,C0005515,en_467,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17814,Blood,C0005767,en_482,ASSOCIATED_WITH,Lesion,C0221198,en_3221,1,1,AFFECTS,General/Uncertain,6
17815,Blood Glucose,C0005802,en_490,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,2,AFFECTS,General/Uncertain,6
17816,Blood Glucose,C0005802,en_490,ASSOCIATED_WITH,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,General/Uncertain,3
17817,Blood Pressure,C0005823,en_492,ASSOCIATED_WITH,Diabetes,C0011847,en_797,2,2,AFFECTS,General/Uncertain,6
17818,Blood Pressure,C0005823,en_492,ASSOCIATED_WITH,Dizziness,C0012833,en_833,1,1,AFFECTS,General/Uncertain,3
17819,Blood Pressure,C0005823,en_492,ASSOCIATED_WITH,Sleep Apnea Syndromes,C0037315,en_2120,1,1,AFFECTS,General/Uncertain,3
17820,Blood Pressure,C0005823,en_492,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17821,Body Fluids,C0005889,en_496,ASSOCIATED_WITH,Infected,C0439663,en_4036,1,1,AFFECTS,General/Uncertain,8
17822,Body Fluids,C0005889,en_496,ASSOCIATED_WITH,Death (finding),C1306577,en_5521,2,1,AFFECTS,General/Uncertain,3
17823,Body Size,C0005901,en_6504,ASSOCIATED_WITH,Aortic calcification,C1096249,en_6695,1,1,AFFECTS,General/Uncertain,3
17824,Body Temperature,C0005903,en_497,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
17825,Body Temperature,C0005903,en_497,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17826,Body Weight,C0005910,en_498,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17827,Boron,C0006030,en_6505,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
17828,Bradykinin,C0006100,en_507,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,3
17829,Bradykinin,C0006100,en_507,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17830,Breast Feeding,C0006147,en_512,ASSOCIATED_WITH,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
17831,Breast Feeding,C0006147,en_512,ASSOCIATED_WITH,Punctate inner choroidopathy,C0730321,en_4769,1,1,AFFECTS,General/Uncertain,3
17832,Breast Feeding,C0006147,en_512,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17833,Breeding,C0006159,en_514,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17834,Buffers,C0006353,en_523,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
17835,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,Disease,C0012634,en_826,6,4,AFFECTS,General/Uncertain,12
17836,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
17837,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
17838,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,6
17839,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
17840,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,7
17841,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,General/Uncertain,6
17842,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17843,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17844,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH(INFER),Infiltration,C0332448,en_3749,1,1,AFFECTS,General/Uncertain,3
17845,C-reactive protein,C0006560,en_529,ASSOCIATED_WITH(SPEC),Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
17846,CA-15-3 Antigen,C0006611,en_6508,ASSOCIATED_WITH,Prostate cancer metastatic,C0936223,en_5141,1,1,AFFECTS,General/Uncertain,3
17847,Calcifediol,C0006657,en_534,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17848,Carbohydrates,C0007004,en_554,ASSOCIATED_WITH,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,General/Uncertain,3
17849,Carbohydrates,C0007004,en_554,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
17850,Cardiovascular Diseases,C0007222,en_569,ASSOCIATED_WITH,intestinal bacteria,C0599752,en_4469,1,1,AFFECTS,General/Uncertain,3
17851,Catechol O-Methyltransferase,C0007407,en_576,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,2,1,AFFECTS,General/Uncertain,3
17852,Cathepsins,C0007428,en_578,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,3,1,AFFECTS,General/Uncertain,3
17853,Cell Adhesion Molecules,C0007578,en_583,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
17854,Ceramides,C0007745,en_600,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17855,Chest Pain,C0008031,en_617,ASSOCIATED_WITH,Familial Mediterranean Fever,C0031069,en_1773,1,1,AFFECTS,General/Uncertain,3
17856,Citrulline,C0008864,en_650,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
17857,Citrulline,C0008864,en_650,ASSOCIATED_WITH,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,General/Uncertain,3
17858,Cocaine,C0009170,en_665,ASSOCIATED_WITH,overdose,C4018909,en_6291,1,1,AFFECTS,General/Uncertain,3
17859,Cocaine,C0009170,en_665,ASSOCIATED_WITH(SPEC),overdose,C4018909,en_6291,1,1,AFFECTS,General/Uncertain,3
17860,Coitus,C0009253,en_671,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,6
17861,Coitus,C0009253,en_671,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,6
17862,Coitus,C0009253,en_671,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17863,Complement System Proteins,C0009498,en_691,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
17864,Complement System Proteins,C0009498,en_691,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
17865,Complement System Proteins,C0009498,en_691,ASSOCIATED_WITH,Thrombophilia,C0398623,en_3949,1,1,AFFECTS,General/Uncertain,3
17866,Complement System Proteins,C0009498,en_691,ASSOCIATED_WITH(SPEC),Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
17867,Complement 1 Inactivators,C0009500,en_693,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17868,Complication,C0009566,en_697,ASSOCIATED_WITH,TMEM173,C4077403,en_6488,1,1,AFFECTS,General/Uncertain,3
17869,Complication,C0009566,en_697,ASSOCIATED_WITH,Abnormal Hemoglobins,C0019047,en_6523,1,1,AFFECTS,General/Uncertain,3
17870,Complication,C0009566,en_697,ASSOCIATED_WITH,Pancreatic Polypeptide,C0030298,en_6541,1,1,AFFECTS,General/Uncertain,3
17871,Complication,C0009566,en_697,ASSOCIATED_WITH,Troponin,C0041199,en_2287,1,1,AFFECTS,General/Uncertain,3
17872,Coughing,C0010200,en_723,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17873,Coughing,C0010200,en_723,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17874,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,3,3,AFFECTS,General/Uncertain,12
17875,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
17876,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
17877,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,3
17878,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Diabetes,C0011847,en_797,3,3,AFFECTS,General/Uncertain,12
17879,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Diabetes Mellitus,C0011849,en_798,2,2,AFFECTS,General/Uncertain,9
17880,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Disease,C0012634,en_826,5,4,AFFECTS,General/Uncertain,12
17881,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Disseminated Intravascular Coagulation,C0012739,en_829,1,1,AFFECTS,General/Uncertain,6
17882,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Dyspnea,C0013404,en_866,1,1,AFFECTS,General/Uncertain,6
17883,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Fatigue,C0015672,en_966,1,1,AFFECTS,General/Uncertain,6
17884,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Hyperglycemia,C0020456,en_1232,2,1,AFFECTS,General/Uncertain,3
17885,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,2,2,AFFECTS,General/Uncertain,10
17886,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Immunologic Deficiency Syndromes,C0021051,en_1283,1,1,AFFECTS,General/Uncertain,6
17887,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Infection,C3714514,en_6235,2,2,AFFECTS,General/Uncertain,6
17888,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,General/Uncertain,6
17889,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,6
17890,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
17891,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,General/Uncertain,6
17892,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Obesity,C0028754,en_1699,2,2,AFFECTS,General/Uncertain,9
17893,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Kidney Failure,C0035078,en_1994,1,1,AFFECTS,General/Uncertain,3
17894,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,4,4,AFFECTS,General/Uncertain,12
17895,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,3
17896,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,3,3,AFFECTS,General/Uncertain,9
17897,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,General/Uncertain,3
17898,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,8
17899,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17900,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,3,3,AFFECTS,General/Uncertain,9
17901,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Chronic heart failure,C0264716,en_3538,1,1,AFFECTS,General/Uncertain,6
17902,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Secondary infection,C0442886,en_4061,1,1,AFFECTS,General/Uncertain,3
17903,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Autosomal Recessive Juvenile Parkinson Disease,C0752099,en_6682,1,1,AFFECTS,General/Uncertain,3
17904,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Nance-Horan syndrome,C0796085,en_4881,1,1,AFFECTS,General/Uncertain,6
17905,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,2,2,AFFECTS,General/Uncertain,6
17906,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
17907,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
17908,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Pulmonary Aspergillosis,C2350529,en_6107,1,1,AFFECTS,General/Uncertain,6
17909,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,General/Uncertain,6
17910,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Noncommunicable Diseases,C4505065,en_6352,1,1,AFFECTS,General/Uncertain,6
17911,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,17,14,AFFECTS,General/Uncertain,91
17912,Cessation of life,C0011065,en_762,ASSOCIATED_WITH,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,7
17913,Deoxyribonuclease I,C0011519,en_785,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17914,Deoxycorticosterone,C0011710,en_794,ASSOCIATED_WITH,Narcolepsy,C0027404,en_1638,1,1,AFFECTS,General/Uncertain,3
17915,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,ASSOCIATED_WITH,Signal Transduction Pathways,C0086982,en_2741,1,1,AFFECTS,General/Uncertain,3
17916,Heroin,C0011892,en_805,ASSOCIATED_WITH,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,General/Uncertain,3
17917,Diarrhea,C0011991,en_810,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,6
17918,Diarrhea,C0011991,en_810,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17919,"Discharge, Body Substance",C2926602,en_6145,ASSOCIATED_WITH,Adverse reactions,C0559546,en_4315,2,1,AFFECTS,General/Uncertain,3
17920,"Discharge, Body Substance",C2926602,en_6145,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,3
17921,Disease,C0012634,en_826,ASSOCIATED_WITH,Nontuberculous Mycobacteria,C1265234,en_5430,1,1,AFFECTS,General/Uncertain,3
17922,DNA,C0012854,en_834,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17923,DNA,C0012854,en_834,ASSOCIATED_WITH,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,General/Uncertain,3
17924,DNA,C0012854,en_834,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
17925,DNA,C0012854,en_834,ASSOCIATED_WITH,Mucoid sputum,C0577978,en_6650,3,2,AFFECTS,General/Uncertain,10
17926,DNA,C0012854,en_834,ASSOCIATED_WITH,Pulmonary arterial hypertension,C1619734,en_6012,1,1,AFFECTS,General/Uncertain,3
17927,DNA,C0012854,en_834,ASSOCIATED_WITH(SPEC),Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
17928,"DNA, Mitochondrial",C0012929,en_837,ASSOCIATED_WITH,Toxic effect,C0600688,en_4513,1,1,AFFECTS,General/Uncertain,3
17929,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
17930,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,Disease,C0012634,en_826,5,4,AFFECTS,General/Uncertain,18
17931,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
17932,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,3
17933,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,"Lung Diseases, Interstitial",C0206062,en_3142,1,1,AFFECTS,General/Uncertain,3
17934,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,Severe infection,C5139167,en_6407,1,1,AFFECTS,General/Uncertain,6
17935,Dyspnea,C0013404,en_866,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,3,3,AFFECTS,General/Uncertain,18
17936,Dyspnea,C0013404,en_866,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17937,Dyspnea,C0013404,en_866,ASSOCIATED_WITH(SPEC),Heart failure,C0018801,en_1135,2,1,AFFECTS,General/Uncertain,3
17938,Dyspnea,C0013404,en_866,ASSOCIATED_WITH(SPEC),Chronic Obstructive Airway Disease,C0024117,en_1463,2,1,AFFECTS,General/Uncertain,3
17939,Eating,C0013470,en_870,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
17940,Eicosanoids,C0013725,en_880,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
17941,Endocrine system,C0014136,en_6511,ASSOCIATED_WITH,Decreasing,C0442797,en_4056,1,1,AFFECTS,General/Uncertain,8
17942,Endorphins,C0014242,en_900,ASSOCIATED_WITH,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
17943,Endotoxins,C0014264,en_903,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
17944,Endotoxins,C0014264,en_903,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
17945,Enzymes,C0014442,en_912,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,General/Uncertain,3
17946,Enzymes,C0014442,en_912,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
17947,Enzymes,C0014442,en_912,ASSOCIATED_WITH,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,General/Uncertain,3
17948,Enzymes,C0014442,en_912,ASSOCIATED_WITH,Nerve Degeneration,C0027746,en_1657,1,1,AFFECTS,General/Uncertain,3
17949,Enzymes,C0014442,en_912,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17950,Vitamin D2,C0014695,en_924,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,6,5,AFFECTS,General/Uncertain,33
17951,Estrogens,C0014939,en_933,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
17952,Estrogens,C0014939,en_933,ASSOCIATED_WITH(INFER),Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
17953,Exanthema,C0015230,en_938,ASSOCIATED_WITH,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,6
17954,Exanthema,C0015230,en_938,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
17955,Eye Manifestations,C0015411,en_6512,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17956,Factor VIII|COX8A,C0015506|1351,en_6513,ASSOCIATED_WITH,Acquired von Willebrand's disease,C0272362,en_6616,1,1,AFFECTS,General/Uncertain,6
17957,Factor VIII|COX8A,C0015506|1351,en_6513,ASSOCIATED_WITH,platelet dysfunction,C0679429,en_6667,1,1,AFFECTS,General/Uncertain,6
17958,Factor VIII|COX8A,C0015506|1351,en_6513,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17959,Factor VIII-Related Antigen,C0015513,en_6514,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
17960,Factor VIII-Related Antigen,C0015513,en_6514,ASSOCIATED_WITH,Vascular inflammations,C0947751,en_5156,1,1,AFFECTS,General/Uncertain,3
17961,Fatigue,C0015672,en_966,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
17962,Fatigue,C0015672,en_966,ASSOCIATED_WITH,Chronic Fatigue Syndrome,C0015674,en_967,1,1,AFFECTS,General/Uncertain,3
17963,Fatigue,C0015672,en_966,ASSOCIATED_WITH,Chronic Obstructive Airway Disease,C0024117,en_1463,2,1,AFFECTS,General/Uncertain,3
17964,Fatigue,C0015672,en_966,ASSOCIATED_WITH,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,7
17965,Fatigue,C0015672,en_966,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
17966,Fatigue,C0015672,en_966,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17967,Fatigue,C0015672,en_966,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
17968,Fatigue,C0015672,en_966,ASSOCIATED_WITH(SPEC),SYSTEMIC INFLAMMATORY PROCESS,C0749224,en_4835,1,1,AFFECTS,General/Uncertain,3
17969,Feces,C0015733,en_6515,ASSOCIATED_WITH,Asymptomatic,C0231221,en_3252,1,1,AFFECTS,General/Uncertain,3
17970,Ferritin,C0015879,en_980,ASSOCIATED_WITH,Lung Injury,C0273115,en_3561,1,1,AFFECTS,General/Uncertain,6
17971,Ferritin,C0015879,en_980,ASSOCIATED_WITH,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,General/Uncertain,7
17972,Fever,C0015967,en_985,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
17973,Fever,C0015967,en_985,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
17974,Fever,C0015967,en_985,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
17975,Fibrinogen,C0016006,en_988,ASSOCIATED_WITH,imbalance,C1397014,en_5692,1,1,AFFECTS,General/Uncertain,3
17976,Fumarate Hydratase,C0016799,en_1021,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
17977,gamma-Aminobutyric Acid,C0016904,en_1026,ASSOCIATED_WITH,Hunger,C0020175,en_6528,1,1,AFFECTS,General/Uncertain,3
17978,Genes,C0017337,en_1052,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,6
17979,Genes,C0017337,en_1052,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,6
17980,Genes,C0017337,en_1052,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17981,Genes,C0017337,en_1052,ASSOCIATED_WITH,Blood Coagulation Disorders,C0005779,en_485,2,1,AFFECTS,General/Uncertain,3
17982,Genes,C0017337,en_1052,ASSOCIATED_WITH,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,2,1,AFFECTS,General/Uncertain,3
17983,Genes,C0017337,en_1052,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
17984,Genes,C0017337,en_1052,ASSOCIATED_WITH,Fibrosis,C0016059,en_994,2,2,AFFECTS,General/Uncertain,6
17985,Genes,C0017337,en_1052,ASSOCIATED_WITH,Foreign Bodies,C0016542,en_6517,1,1,AFFECTS,General/Uncertain,3
17986,Genes,C0017337,en_1052,ASSOCIATED_WITH,"Depression, Postpartum",C0221074,en_3212,1,1,AFFECTS,General/Uncertain,3
17987,Genes,C0017337,en_1052,ASSOCIATED_WITH,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,General/Uncertain,3
17988,Genes,C0017337,en_1052,ASSOCIATED_WITH,Mood Disorders,C0525045,en_4229,1,1,AFFECTS,General/Uncertain,3
17989,Genome,C0017428,en_1059,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
17990,Genome,C0017428,en_1059,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
17991,"Genome, Human",C0017429,en_6519,ASSOCIATED_WITH,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,General/Uncertain,3
17992,"Genome, Human",C0017429,en_6519,ASSOCIATED_WITH,Hepatocarcinogenesis,C1512409,en_5818,1,1,AFFECTS,General/Uncertain,3
17993,Genotype,C0017431,en_6520,ASSOCIATED_WITH,Retinal Diseases,C0035309,en_2021,1,1,AFFECTS,General/Uncertain,3
17994,Glucocorticoids,C0017710,en_1068,ASSOCIATED_WITH,Community acquired pneumonia,C0694549,en_4692,1,1,AFFECTS,General/Uncertain,8
17995,Glucocorticoids,C0017710,en_1068,ASSOCIATED_WITH,Storm Syndrome,C1861452,en_6056,1,1,AFFECTS,General/Uncertain,6
17996,Glucocorticoids,C0017710,en_1068,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
17997,Glucocorticoids,C0017710,en_1068,ASSOCIATED_WITH,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,7
17998,Glucocorticoids,C0017710,en_1068,ASSOCIATED_WITH,Fragility,C0302113,en_3700,1,1,AFFECTS,General/Uncertain,3
17999,Glucosaminidases,C0017724,en_6521,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18000,Glucose,C0017725,en_1072,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,7
18001,Glycoproteins,C0017968,en_1085,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18002,Gold,C0018026,en_1088,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,3
18003,Growth,C0018270,en_1098,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
18004,Guanosine Triphosphate Phosphohydrolases,C0018296,en_1101,ASSOCIATED_WITH,Liver and Intrahepatic Biliary Tract Carcinoma,C0279000,en_3607,1,1,AFFECTS,General/Uncertain,3
18005,Haemophilus influenzae,C0018483,en_6522,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
18006,Haemophilus influenzae,C0018483,en_6522,ASSOCIATED_WITH,Primary Antibody Deficiencies,C5197804,en_6767,1,1,AFFECTS,General/Uncertain,6
18007,Hazardous Chemicals,C0018624,en_1113,ASSOCIATED_WITH,"Kidney Failure, Chronic",C0022661,en_1383,1,1,AFFECTS,General/Uncertain,3
18008,Headache,C0018681,en_1115,ASSOCIATED_WITH,Systemic disease,C0442893,en_4062,1,1,AFFECTS,General/Uncertain,6
18009,Headache,C0018681,en_1115,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,6
18010,Headache,C0018681,en_1115,ASSOCIATED_WITH,Bleeding tendency,C1458140,en_6735,2,1,AFFECTS,General/Uncertain,3
18011,Headache,C0018681,en_1115,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,4,4,AFFECTS,General/Uncertain,24
18012,Headache,C0018681,en_1115,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18013,Hemoglobin,C0019046,en_1159,ASSOCIATED_WITH,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,General/Uncertain,6
18014,Hemorrhage,C0019080,en_1161,ASSOCIATED_WITH,AKR1A1 wt Allele,C3715044,en_6239,1,1,AFFECTS,General/Uncertain,8
18015,Heparin,C0019134,en_1166,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
18016,Heparin,C0019134,en_1166,ASSOCIATED_WITH,Malaise,C0231218,en_3251,1,1,AFFECTS,General/Uncertain,3
18017,"Heparin, Low-Molecular-Weight",C0019139,en_1167,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
18018,Heparitin Sulfate,C0019143,en_1168,ASSOCIATED_WITH,Secondary amyloidosis,C0221014,en_6599,1,1,AFFECTS,General/Uncertain,3
18019,Hepatitis B Antibodies,C0019164,en_6525,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,7
18020,Hereditary Diseases,C0019247,en_1180,ASSOCIATED_WITH,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
18021,HLA Antigens,C0019721,en_1195,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18022,HLA Antigens,C0019721,en_1195,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
18023,HLA Antigens,C0019721,en_1195,ASSOCIATED_WITH,Autoimmune,C0443146,en_4064,1,1,AFFECTS,General/Uncertain,3
18024,HLA-B Antigens,C0019737,en_6527,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18025,Homeostasis,C0019868,en_1201,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18026,Homeostasis,C0019868,en_1201,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18027,Hormones,C0019932,en_1204,ASSOCIATED_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,General/Uncertain,6
18028,Hydrocortisone,C0020268,en_1219,ASSOCIATED_WITH,Neurodevelopmental disorder,C1535926,en_5943,1,1,AFFECTS,General/Uncertain,3
18029,Hypercapnia,C0020440,en_1230,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,General/Uncertain,3
18030,"hypothermia, natural",C0020672,en_1250,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18031,IgA1,C0020840,en_1262,ASSOCIATED_WITH,IGA Glomerulonephritis,C0017661,en_1066,1,1,AFFECTS,General/Uncertain,3
18032,IgG4,C0020860,en_1267,ASSOCIATED_WITH,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,3
18033,Immune system,C0020962,en_1271,ASSOCIATED_WITH,Personal Satisfaction,C0031206,en_1780,2,1,AFFECTS,General/Uncertain,3
18034,Immune system,C0020962,en_1271,ASSOCIATED_WITH,Lesion,C0221198,en_3221,1,1,AFFECTS,General/Uncertain,6
18035,Immune system,C0020962,en_1271,ASSOCIATED_WITH,Scaling,C0237849,en_6611,1,1,AFFECTS,General/Uncertain,3
18036,Immune system,C0020962,en_1271,ASSOCIATED_WITH,Symptom aggravating factors,C0436331,en_4027,2,1,AFFECTS,General/Uncertain,3
18037,Immune system,C0020962,en_1271,ASSOCIATED_WITH,Duration of gestation,C0460089,en_4127,1,1,AFFECTS,General/Uncertain,3
18038,Immune system,C0020962,en_1271,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,3
18039,Immunity,C0020964,en_1273,ASSOCIATED_WITH,Antibodies,C0003241,en_347,1,1,AFFECTS,General/Uncertain,7
18040,Immunity,C0020964,en_1273,ASSOCIATED_WITH,Interferon Type I,C0021743,en_1331,1,1,AFFECTS,General/Uncertain,3
18041,Immunity,C0020964,en_1273,ASSOCIATED_WITH,Vaccines,C0042210,en_2329,4,3,AFFECTS,General/Uncertain,9
18042,Immunity,C0020964,en_1273,ASSOCIATED_WITH,Measles-Mumps-Rubella Vaccine,C0065828,en_6568,2,1,AFFECTS,General/Uncertain,3
18043,Immunity,C0020964,en_1273,ASSOCIATED_WITH,human leukocyte interferon,C0733470,en_4772,1,1,AFFECTS,General/Uncertain,3
18044,Immunity,C0020964,en_1273,ASSOCIATED_WITH,Pharmacologic Substance,C1254351,en_5395,1,1,AFFECTS,General/Uncertain,3
18045,"Immunity, Cellular",C0020966,en_1274,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18046,"Immunity, Humoral",C0020967,en_1275,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
18047,"Immunity, Humoral",C0020967,en_1275,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,3
18048,"Immunity, Natural",C0020969,en_1276,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,7
18049,Immunoglobulins,C0021027,en_1282,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,8
18050,Immunologic Surveillance,C0021059,en_6530,ASSOCIATED_WITH,Adrenoleukodystrophy,C0162309,en_6586,1,1,AFFECTS,General/Uncertain,3
18051,Infection,C3714514,en_6235,ASSOCIATED_WITH,Brucella,C0006303,en_6507,1,1,AFFECTS,General/Uncertain,3
18052,"Infertility, Male",C0021364,en_1306,ASSOCIATED_WITH,DNA Fragmentation,C0376669,en_6631,1,1,AFFECTS,General/Uncertain,3
18053,Inflammation,C0021368,en_1307,ASSOCIATED_WITH,SLC25A10,C1420151,en_23,1,1,AFFECTS,General/Uncertain,3
18054,Inflammation,C0021368,en_1307,ASSOCIATED_WITH,C-reactive protein,C0006560,en_529,1,1,AFFECTS,General/Uncertain,3
18055,Inflammation,C0021368,en_1307,ASSOCIATED_WITH,cytokine,C0079189,en_2593,4,3,AFFECTS,General/Uncertain,9
18056,"Inflammation, allergic",C0021375,en_1308,ASSOCIATED_WITH,neurturin,C0531925,en_6644,1,1,AFFECTS,General/Uncertain,3
18057,Influenza virus vaccine,C0021403,en_1312,ASSOCIATED_WITH,Guillain-Barre Syndrome,C0018378,en_1104,1,1,AFFECTS,General/Uncertain,3
18058,Influenza virus vaccine,C0021403,en_1312,ASSOCIATED_WITH,Little's Disease,C0023882,en_1451,1,1,AFFECTS,General/Uncertain,3
18059,Influenza virus vaccine,C0021403,en_1312,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
18060,Interferon Type I,C0021743,en_1331,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
18061,Interferon Type I,C0021743,en_1331,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18062,Interferon Type I,C0021743,en_1331,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18063,Interferons,C0021747,en_1333,ASSOCIATED_WITH,Autoimmunity,C0004368,en_430,1,1,AFFECTS,General/Uncertain,3
18064,Interferons,C0021747,en_1333,ASSOCIATED_WITH,Viremia,C0042749,en_2359,1,1,AFFECTS,General/Uncertain,3
18065,Interferons,C0021747,en_1333,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18066,Interferons,C0021747,en_1333,ASSOCIATED_WITH,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,General/Uncertain,6
18067,Interferons,C0021747,en_1333,ASSOCIATED_WITH,"Rhabdomyosarcoma, Alveolar",C0206655,en_3173,1,1,AFFECTS,General/Uncertain,8
18068,Interferons,C0021747,en_1333,ASSOCIATED_WITH,innate immune response,C1155265,en_5320,2,2,AFFECTS,General/Uncertain,6
18069,Interferons,C0021747,en_1333,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18070,Interleukin-1 beta,C0021753,en_1334,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
18071,Interleukin-1 beta,C0021753,en_1334,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
18072,Interleukin-1 beta,C0021753,en_1334,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18073,Interleukin-1 beta,C0021753,en_1334,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18074,Interleukin-1 beta,C0021753,en_1334,ASSOCIATED_WITH(SPEC),Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18075,Interleukin-1 beta,C0021753,en_1334,ASSOCIATED_WITH,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,General/Uncertain,8
18076,Interleukin-1,C0021755,en_1336,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,15
18077,Interleukin-2,C0021756,en_1337,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,3
18078,Interleukin-2,C0021756,en_1337,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18079,Interleukin-2,C0021756,en_1337,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,7
18080,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
18081,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Disease,C0012634,en_826,3,2,AFFECTS,General/Uncertain,9
18082,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
18083,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,2,2,AFFECTS,General/Uncertain,15
18084,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18085,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18086,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18087,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
18088,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,General/Uncertain,8
18089,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,2,2,AFFECTS,General/Uncertain,9
18090,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,7
18091,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,3,2,AFFECTS,General/Uncertain,6
18092,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,6
18093,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
18094,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,8,8,AFFECTS,General/Uncertain,57
18095,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH(SPEC),Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18096,Interleukin-6,C0021760,en_1342,ASSOCIATED_WITH(SPEC),Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
18097,Interleukins,C0021764,en_1345,ASSOCIATED_WITH,Viremia,C0042749,en_2359,1,1,AFFECTS,General/Uncertain,3
18098,K-ras Oncogene,C0022457,en_6531,ASSOCIATED_WITH,Malignant neoplasm of lung,C0242379,en_3408,1,1,AFFECTS,General/Uncertain,3
18099,Kidney Diseases,C0022658,en_1381,ASSOCIATED_WITH,Phosphorylation,C0031715,en_1800,1,1,AFFECTS,General/Uncertain,3
18100,Labor (Childbirth),C0022864,en_1390,ASSOCIATED_WITH,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,General/Uncertain,3
18101,Lactate Dehydrogenase,C0022917,en_1395,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,13
18102,Lead,C0023175,en_1403,ASSOCIATED_WITH,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,3
18103,Leukotrienes,C0023545,en_1426,ASSOCIATED_WITH,"Signs and Symptoms, Respiratory",C0037090,en_2107,1,1,AFFECTS,General/Uncertain,3
18104,Lipids,C0023779,en_1441,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
18105,Lipids,C0023779,en_1441,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,2,2,AFFECTS,General/Uncertain,6
18106,Lipids,C0023779,en_1441,ASSOCIATED_WITH,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,General/Uncertain,3
18107,Lipids,C0023779,en_1441,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18108,Lipids,C0023779,en_1441,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
18109,Lipids,C0023779,en_1441,ASSOCIATED_WITH(SPEC),Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18110,Lung diseases,C0024115,en_1462,ASSOCIATED_WITH,Bacteria,C0004611,en_440,1,1,AFFECTS,General/Uncertain,7
18111,Tumor Necrosis Factor-Beta,C0024320,en_1475,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,8
18112,Migration Inhibitory Factor,C0024429,en_1483,ASSOCIATED_WITH,Reperfusion Injury,C0035126,en_1999,1,1,AFFECTS,General/Uncertain,3
18113,Migration Inhibitory Factor,C0024429,en_1483,ASSOCIATED_WITH,Injury,C0175677,en_2968,7,1,AFFECTS,General/Uncertain,3
18114,Magnesium,C0024467,en_6533,ASSOCIATED_WITH,Diabetes,C0011847,en_797,3,1,AFFECTS,General/Uncertain,3
18115,Magnesium,C0024467,en_6533,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18116,Magnesium,C0024467,en_6533,ASSOCIATED_WITH(SPEC),Carcinoma of unknown primary,C0220647,en_6597,1,1,AFFECTS,General/Uncertain,3
18117,Male gender,C0024554,en_1494,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18118,Male gender,C0024554,en_1494,ASSOCIATED_WITH,Metabolic Diseases,C0025517,en_1546,1,1,AFFECTS,General/Uncertain,3
18119,Melatonin,C0025219,en_1524,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,7
18120,Melatonin,C0025219,en_1524,ASSOCIATED_WITH,Decreased inflammatory response,C4022804,en_6762,1,1,AFFECTS,General/Uncertain,7
18121,Melatonin,C0025219,en_1524,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,14
18122,Menstruation,C0025344,en_1540,ASSOCIATED_WITH,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
18123,Menstruation,C0025344,en_1540,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
18124,Metabolism,C0025519,en_1547,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18125,Metals,C0025552,en_1548,ASSOCIATED_WITH,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,General/Uncertain,3
18126,Metals,C0025552,en_1548,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
18127,Metals,C0025552,en_1548,ASSOCIATED_WITH,Carcinoma of unknown primary,C0220647,en_6597,1,1,AFFECTS,General/Uncertain,3
18128,Methoxyhydroxyphenylglycol,C0025691,en_6534,ASSOCIATED_WITH,Neurodevelopmental disorder,C1535926,en_5943,1,1,AFFECTS,General/Uncertain,3
18129,Methylprednisolone,C0025815,en_1559,ASSOCIATED_WITH,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
18130,Methylprednisolone,C0025815,en_1559,ASSOCIATED_WITH,Storm Syndrome,C1861452,en_6056,1,1,AFFECTS,General/Uncertain,8
18131,Methylprednisolone,C0025815,en_1559,ASSOCIATED_WITH,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,6
18132,Methylprednisolone,C0025815,en_1559,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,2,1,AFFECTS,General/Uncertain,3
18133,"Milk, Human",C0026140,en_6535,ASSOCIATED_WITH,Lactation established in non-human animal,C3668831,en_6756,1,1,AFFECTS,General/Uncertain,6
18134,Movement,C0026649,en_1588,ASSOCIATED_WITH,Muscle hypotonia,C0026827,en_6536,1,1,AFFECTS,General/Uncertain,3
18135,Movement,C0026649,en_1588,ASSOCIATED_WITH,Signs and Symptoms,C0037088,en_2106,1,1,AFFECTS,General/Uncertain,3
18136,Mutation,C0026882,en_1612,ASSOCIATED_WITH,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
18137,Mycobacterium avium,C0026913,en_1614,ASSOCIATED_WITH,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,General/Uncertain,3
18138,Mycobacterium tuberculosis,C0026926,en_1618,ASSOCIATED_WITH,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,General/Uncertain,3
18139,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,ASSOCIATED_WITH,Atherosclerosis,C0004153,en_421,2,1,AFFECTS,General/Uncertain,3
18140,Nicotinamide adenine dinucleotide (NAD),C0027270,en_1632,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18141,Atrial Natriuretic Factor,C0027481,en_6537,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18142,Nervous system structure,C0027763,en_6538,ASSOCIATED_WITH,Neurologic Manifestations,C0027854,en_1664,1,1,AFFECTS,General/Uncertain,6
18143,Neuropeptides,C0027895,en_1673,ASSOCIATED_WITH,Migraine Disorders,C0149931,en_2813,1,1,AFFECTS,General/Uncertain,3
18144,Neuropeptides,C0027895,en_1673,ASSOCIATED_WITH,Chronic pain,C0150055,en_2816,1,1,AFFECTS,General/Uncertain,3
18145,Nitric Oxide,C0028128,en_1682,ASSOCIATED_WITH,Septic Shock,C0036983,en_2101,1,1,AFFECTS,General/Uncertain,3
18146,Nitric Oxide,C0028128,en_1682,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,3
18147,Nucleic Acids,C0028606,en_1690,ASSOCIATED_WITH,Encephalitis,C0014038,en_896,1,1,AFFECTS,General/Uncertain,3
18148,Nucleic Acids,C0028606,en_1690,ASSOCIATED_WITH(INFER),Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18149,Obesity,C0028754,en_1699,ASSOCIATED_WITH,Signal Transduction Pathways,C0086982,en_2741,1,1,AFFECTS,General/Uncertain,3
18150,Obesity,C0028754,en_1699,ASSOCIATED_WITH,Lipid Metabolism,C0598783,en_4452,1,1,AFFECTS,General/Uncertain,3
18151,Obesity,C0028754,en_1699,ASSOCIATED_WITH,Epigenetic Process,C1516924,en_5864,1,1,AFFECTS,General/Uncertain,3
18152,Organism,C0029235,en_1717,ASSOCIATED_WITH,Gastrointestinal Diseases,C0017178,en_1039,1,1,AFFECTS,General/Uncertain,6
18153,overdose,C4018909,en_6291,ASSOCIATED_WITH,Agent,C0450442,en_4084,1,1,AFFECTS,General/Uncertain,3
18154,Oxidoreductase,C0030016,en_6539,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
18155,Oxidoreductase,C0030016,en_6539,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,8
18156,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
18157,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
18158,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,General/Uncertain,6
18159,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,3,3,AFFECTS,General/Uncertain,21
18160,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,3
18161,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,Hyperoxia,C0242706,en_3434,1,1,AFFECTS,General/Uncertain,3
18162,Oxygen,C0030054,en_1736,ASSOCIATED_WITH,Acute respiratory failure,C0264490,en_3533,2,2,AFFECTS,General/Uncertain,6
18163,Oxygen,C0030054,en_1736,ASSOCIATED_WITH(INFER),Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,3
18164,Oxygen Consumption,C0030055,en_6540,ASSOCIATED_WITH,Dyspnea,C0013404,en_866,2,1,AFFECTS,General/Uncertain,3
18165,Oxytocin,C0030095,en_1738,ASSOCIATED_WITH,"Heart Septal Defects, Atrial",C0018817,en_1139,1,1,AFFECTS,General/Uncertain,3
18166,Oxytocin,C0030095,en_1738,ASSOCIATED_WITH,"Pain, Postoperative",C0030201,en_1742,1,1,AFFECTS,General/Uncertain,3
18167,Plasminogen Activator Inhibitor 1,C0030190,en_1740,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
18168,Pain,C0030193,en_1741,ASSOCIATED_WITH,Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,General/Uncertain,3
18169,Pain,C0030193,en_1741,ASSOCIATED_WITH,Toxic Epidermal Necrolysis,C0014518,en_915,1,1,AFFECTS,General/Uncertain,7
18170,Pain,C0030193,en_1741,ASSOCIATED_WITH,Fibromyalgia,C0016053,en_993,1,1,AFFECTS,General/Uncertain,3
18171,Pain,C0030193,en_1741,ASSOCIATED_WITH,RNA Virus Infections,C0035690,en_2043,1,1,AFFECTS,General/Uncertain,3
18172,Pain,C0030193,en_1741,ASSOCIATED_WITH,Caries,C0333519,en_6626,1,1,AFFECTS,General/Uncertain,3
18173,Peptides,C0030956,en_1771,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,2,2,AFFECTS,General/Uncertain,6
18174,Peptides,C0030956,en_1771,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18175,Peptides,C0030956,en_1771,ASSOCIATED_WITH,Cytopathic effect,C0333467,en_3765,1,1,AFFECTS,General/Uncertain,3
18176,Phenotype,C0031437,en_6544,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18177,Phenotype,C0031437,en_6544,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,6
18178,Phenotype,C0031437,en_6544,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
18179,Phenotype,C0031437,en_6544,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
18180,Phenotype,C0031437,en_6544,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18181,Phosphoric Monoester Hydrolases,C0031678,en_6546,ASSOCIATED_WITH,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,General/Uncertain,3
18182,Plasma,C0032105,en_1816,ASSOCIATED_WITH,Immunocompromised Host,C0085393,en_2665,1,1,AFFECTS,General/Uncertain,3
18183,Plasma,C0032105,en_1816,ASSOCIATED_WITH,Asymptomatic,C0231221,en_3252,2,1,AFFECTS,General/Uncertain,3
18184,Plasma,C0032105,en_1816,ASSOCIATED_WITH,Resting state,C0679218,en_6666,1,1,AFFECTS,General/Uncertain,3
18185,Plasma,C0032105,en_1816,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,3
18186,Plasma,C0032105,en_1816,ASSOCIATED_WITH,Radiologic finding,C1290916,en_5487,2,1,AFFECTS,General/Uncertain,3
18187,Plasma,C0032105,en_1816,ASSOCIATED_WITH,Progressive Disease,C1335499,en_6711,1,1,AFFECTS,General/Uncertain,3
18188,Platinum,C0032207,en_6547,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,3
18189,Polysaccharides,C0032594,en_1850,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
18190,Polyunsaturated Fatty Acids,C0032615,en_6549,ASSOCIATED_WITH,Acute Pneumonia,C0740766,en_4782,1,1,AFFECTS,General/Uncertain,3
18191,Prednisone,C0032952,en_1871,ASSOCIATED_WITH,Community acquired pneumonia,C0694549,en_4692,1,1,AFFECTS,General/Uncertain,8
18192,Pregnancy,C0032961,en_1872,ASSOCIATED_WITH,Obesity,C0028754,en_1699,2,1,AFFECTS,General/Uncertain,3
18193,Pregnancy,C0032961,en_1872,ASSOCIATED_WITH,Pre-Eclampsia,C0032914,en_1867,4,2,AFFECTS,General/Uncertain,6
18194,Pregnancy,C0032961,en_1872,ASSOCIATED_WITH,"Diabetes, Gestational",C0085207,en_2652,1,1,AFFECTS,General/Uncertain,3
18195,Pregnancy,C0032961,en_1872,ASSOCIATED_WITH,Acute viral disease,C1443953,en_6732,1,1,AFFECTS,General/Uncertain,3
18196,Pregnancy,C0032961,en_1872,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
18197,Pregnancy,C0032961,en_1872,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,3,3,AFFECTS,General/Uncertain,18
18198,Prions,C0033164,en_1888,ASSOCIATED_WITH,Prion Diseases,C0162534,en_6587,2,1,AFFECTS,General/Uncertain,3
18199,Prions,C0033164,en_1888,ASSOCIATED_WITH,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,General/Uncertain,3
18200,Pro-Opiomelanocortin,C0033195,en_6550,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
18201,Prostaglandins,C0033554,en_1902,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,3
18202,Epoprostenol,C0033567,en_1903,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,6
18203,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,8
18204,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,3,3,AFFECTS,General/Uncertain,9
18205,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Amyloidosis,C0002726,en_309,1,1,AFFECTS,General/Uncertain,3
18206,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18207,Proteins,C0033684,en_1912,ASSOCIATED_WITH,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,General/Uncertain,3
18208,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,2,2,AFFECTS,General/Uncertain,6
18209,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,General/Uncertain,3
18210,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,3,1,AFFECTS,General/Uncertain,3
18211,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,7,4,AFFECTS,General/Uncertain,12
18212,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Neurodegenerative Disorders,C0524851,en_4220,2,1,AFFECTS,General/Uncertain,3
18213,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Allergy to peanuts,C0559470,en_6647,1,1,AFFECTS,General/Uncertain,3
18214,Proteins,C0033684,en_1912,ASSOCIATED_WITH,Acute heart disease,C1290838,en_6703,1,1,AFFECTS,General/Uncertain,3
18215,Pulmonary Embolism,C0034065,en_1930,ASSOCIATED_WITH,Fibrin fragment D,C0060323,en_2484,1,1,AFFECTS,General/Uncertain,6
18216,Pulmonary Surfactants,C0034085,en_1935,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
18217,Quercetin,C0034392,en_1945,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,2,1,AFFECTS,General/Uncertain,3
18218,Quercetin,C0034392,en_1945,ASSOCIATED_WITH,Oxidative Stress,C0242606,en_3422,1,1,AFFECTS,General/Uncertain,3
18219,T-Cell Receptor,C0034790,en_1965,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,General/Uncertain,3
18220,T-Cell Receptor,C0034790,en_1965,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18221,T-Cell Receptor,C0034790,en_1965,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
18222,"Receptors, Cell Surface",C0034800,en_1966,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,6
18223,"Receptors, Cell Surface",C0034800,en_1966,ASSOCIATED_WITH,Hamman-Rich syndrome,C0085786,en_2691,2,1,AFFECTS,General/Uncertain,3
18224,Insulin Receptor,C0034818,en_6552,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18225,"Recombination, Genetic",C0034865,en_1983,ASSOCIATED_WITH,DNA biosynthesis,C0598312,en_4446,1,1,AFFECTS,General/Uncertain,3
18226,Respiration,C0035203,en_2004,ASSOCIATED_WITH,Creatinine,C0010294,en_730,1,1,AFFECTS,General/Uncertain,3
18227,Respiration,C0035203,en_2004,ASSOCIATED_WITH,Glucose,C0017725,en_1072,1,1,AFFECTS,General/Uncertain,6
18228,Respiration,C0035203,en_2004,ASSOCIATED_WITH,Oxygen,C0030054,en_1736,1,1,AFFECTS,General/Uncertain,3
18229,Respiration,C0035203,en_2004,ASSOCIATED_WITH,INTRAVENOUS DRUG,C0683092,en_4651,1,1,AFFECTS,General/Uncertain,3
18230,Respiratory Tract Infections,C0035243,en_2017,ASSOCIATED_WITH,Probiotics,C0525033,en_4227,1,1,AFFECTS,General/Uncertain,3
18231,RNA,C0035668,en_2040,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18232,RNA,C0035668,en_2040,ASSOCIATED_WITH,"Infections, Hospital",C0205721,en_3133,1,1,AFFECTS,General/Uncertain,3
18233,RNA,C0035668,en_2040,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
18234,RNA,C0035668,en_2040,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
18235,"RNA, Messenger",C0035696,en_2046,ASSOCIATED_WITH,"[X]Acute myocarditis, unspecified",C0155686,en_2889,2,1,AFFECTS,General/Uncertain,3
18236,"RNA, Messenger",C0035696,en_2046,ASSOCIATED_WITH,[D]Cardiovascular system symptoms,C0476270,en_4148,2,1,AFFECTS,General/Uncertain,3
18237,Transfer RNA,C0035711,en_2047,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18238,saliva,C0036087,en_2057,ASSOCIATED_WITH,Frailty,C0424594,en_3998,1,1,AFFECTS,General/Uncertain,3
18239,saliva,C0036087,en_2057,ASSOCIATED_WITH,Infected,C0439663,en_4036,1,1,AFFECTS,General/Uncertain,8
18240,saliva,C0036087,en_2057,ASSOCIATED_WITH,Discordance,C3639994,en_6755,1,1,AFFECTS,General/Uncertain,6
18241,Seizures,C0036572,en_2076,ASSOCIATED_WITH,Epilepsy,C0014544,en_917,2,2,AFFECTS,General/Uncertain,9
18242,Selenium,C0036581,en_2077,ASSOCIATED_WITH,Infection,C3714514,en_6235,2,1,AFFECTS,General/Uncertain,3
18243,Selenium,C0036581,en_2077,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,14
18244,Selenium,C0036581,en_2077,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,7
18245,Selenium,C0036581,en_2077,ASSOCIATED_WITH,Chronic heart disease,C1290386,en_6702,1,1,AFFECTS,General/Uncertain,6
18246,Serine,C0036720,en_2087,ASSOCIATED_WITH,Neuropathic pain,C0423716,en_3989,1,1,AFFECTS,General/Uncertain,3
18247,"Serum Albumin, Bovine",C0036774,en_6553,ASSOCIATED_WITH,Arthus Reaction,C0003907,en_6502,1,1,AFFECTS,General/Uncertain,3
18248,Sex Characteristics,C0036866,en_6554,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,13
18249,Sex Hormone-Binding Globulin,C0036883,en_6555,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18250,Gonadal Steroid Hormones,C0036884,en_2094,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18251,Shock,C0036974,en_2097,ASSOCIATED_WITH,SIAE,C1822723,en_6482,1,1,AFFECTS,General/Uncertain,3
18252,Signs and Symptoms,C0037088,en_2106,ASSOCIATED_WITH,Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,1,1,AFFECTS,General/Uncertain,6
18253,Signs and Symptoms,C0037088,en_2106,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
18254,"Signs and Symptoms, Respiratory",C0037090,en_2107,ASSOCIATED_WITH,Disease,C0012634,en_826,4,2,AFFECTS,General/Uncertain,6
18255,"Signs and Symptoms, Respiratory",C0037090,en_2107,ASSOCIATED_WITH,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,6
18256,"Signs and Symptoms, Respiratory",C0037090,en_2107,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,4,1,AFFECTS,General/Uncertain,3
18257,"Signs and Symptoms, Respiratory",C0037090,en_2107,ASSOCIATED_WITH,PULMONARY INVOLVEMENT,C0748159,en_4828,1,1,AFFECTS,General/Uncertain,6
18258,"Signs and Symptoms, Respiratory",C0037090,en_2107,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18259,Silver,C0037125,en_6556,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,3
18260,Integumentary system,C0037267,en_2113,ASSOCIATED_WITH,Stress,C0038435,en_2165,1,1,AFFECTS,General/Uncertain,3
18261,Integumentary system,C0037267,en_2113,ASSOCIATED_WITH,Core body temperature,C0456240,en_4117,1,1,AFFECTS,General/Uncertain,3
18262,Skin Manifestations,C0037285,en_2117,ASSOCIATED_WITH,mastocytosis,C0024899,en_1506,1,1,AFFECTS,General/Uncertain,3
18263,Skin Manifestations,C0037285,en_2117,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
18264,Sleep,C0037313,en_2119,ASSOCIATED_WITH,Epilepsy,C0014544,en_917,1,1,AFFECTS,General/Uncertain,3
18265,Sleep,C0037313,en_2119,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,3,2,AFFECTS,General/Uncertain,10
18266,Smell Perception,C0037361,en_2122,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18267,Sodium Chloride,C0037494,en_2130,ASSOCIATED_WITH,Inactivation,C0544461,en_4262,1,1,AFFECTS,General/Uncertain,3
18268,Sphingolipids,C0037900,en_2142,ASSOCIATED_WITH,Neurodegenerative Disorders,C0524851,en_4220,1,1,AFFECTS,General/Uncertain,3
18269,Steroids,C0038317,en_2161,ASSOCIATED_WITH,Mycoses,C0026946,en_1620,1,1,AFFECTS,General/Uncertain,3
18270,Steroids,C0038317,en_2161,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18271,Streptococcus pneumoniae,C0038410,en_2162,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
18272,Succinate Dehydrogenase,C0038615,en_6557,ASSOCIATED_WITH,Paraganglioma,C0030421,en_6542,1,1,AFFECTS,General/Uncertain,3
18273,Succinate Dehydrogenase,C0038615,en_6557,ASSOCIATED_WITH,Pheochromocytoma,C0031511,en_6545,1,1,AFFECTS,General/Uncertain,3
18274,Succinate Dehydrogenase,C0038615,en_6557,ASSOCIATED_WITH,Gastrointestinal Stromal Tumors,C0238198,en_3363,1,1,AFFECTS,General/Uncertain,3
18275,Syndrome,C0039082,en_2197,ASSOCIATED_WITH,Cytokine Signaling,C1511617,en_6738,1,1,AFFECTS,General/Uncertain,3
18276,Testosterone,C0039601,en_2216,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18277,Thalidomide,C0039736,en_2221,ASSOCIATED_WITH,Adverse effects,C0879626,en_5081,1,1,AFFECTS,General/Uncertain,3
18278,Thrombin,C0040018,en_2228,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18279,Thrombin,C0040018,en_2228,ASSOCIATED_WITH,Thromboembolic event,C0857496,en_4977,2,1,AFFECTS,General/Uncertain,3
18280,Thromboembolism,C0040038,en_2230,ASSOCIATED_WITH,LDLR gene,C1366529,en_6716,1,1,AFFECTS,General/Uncertain,3
18281,Thromboplastin,C0040048,en_2232,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
18282,Thrombosis,C0040053,en_2233,ASSOCIATED_WITH,Vimentin,C0042666,en_2352,1,1,AFFECTS,General/Uncertain,3
18283,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
18284,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,6
18285,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH,Hamman-Rich syndrome,C0085786,en_2691,1,1,AFFECTS,General/Uncertain,3
18286,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH,Hypoxia,C0242184,en_3396,1,1,AFFECTS,General/Uncertain,7
18287,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH,Bacterial septicemia,C0684256,en_4678,1,1,AFFECTS,General/Uncertain,6
18288,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18289,Thyroid Hormones,C0040135,en_2237,ASSOCIATED_WITH(INFER),Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18290,Thyrotropin,C0040160,en_6558,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18291,Thyroxine,C0040165,en_2239,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18292,Toxin,C0040549,en_2252,ASSOCIATED_WITH,Tuberculosis,C0041296,en_2293,1,1,AFFECTS,General/Uncertain,3
18293,Trace Elements,C0040577,en_2254,ASSOCIATED_WITH,Common Cold,C0009443,en_684,2,1,AFFECTS,General/Uncertain,3
18294,TRANSCRIPTION FACTOR,C0040648,en_2264,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18295,"Translation, Genetic",C0040711,en_2274,ASSOCIATED_WITH,Translational Regulation,C1519618,en_6740,1,1,AFFECTS,General/Uncertain,3
18296,Triglycerides,C0041004,en_2282,ASSOCIATED_WITH,Bacterial Infections,C0004623,en_441,1,1,AFFECTS,General/Uncertain,3
18297,Triiodothyronine,C0041014,en_2283,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
18298,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
18299,Troponin,C0041199,en_2287,ASSOCIATED_WITH,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,General/Uncertain,6
18300,Troponin,C0041199,en_2287,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,13
18301,Troponin,C0041199,en_2287,ASSOCIATED_WITH,cardiac arrhythmia,C0003811,en_397,2,2,AFFECTS,General/Uncertain,6
18302,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Disease,C0012634,en_826,3,1,AFFECTS,General/Uncertain,3
18303,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Myocarditis,C0027059,en_1627,2,2,AFFECTS,General/Uncertain,6
18304,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Pericarditis,C0031046,en_1772,2,2,AFFECTS,General/Uncertain,6
18305,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Septic Shock,C0036983,en_2101,2,2,AFFECTS,General/Uncertain,6
18306,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Acute heart failure,C0264714,en_3536,2,2,AFFECTS,General/Uncertain,6
18307,Troponin,C0041199,en_2287,ASSOCIATED_WITH,Acute coronary syndrome,C0948089,en_5159,2,2,AFFECTS,General/Uncertain,6
18308,Trypsin Inhibitors,C0041242,en_6559,ASSOCIATED_WITH,Injury,C0175677,en_2968,2,1,AFFECTS,General/Uncertain,3
18309,Tryptophan,C0041249,en_2291,ASSOCIATED_WITH,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,3
18310,Tryptophan,C0041249,en_2291,ASSOCIATED_WITH,Attention deficit hyperactivity disorder,C1263846,en_5428,1,1,AFFECTS,General/Uncertain,3
18311,Tumor Necrosis Factors,C0041368,en_2300,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,2,1,AFFECTS,General/Uncertain,3
18312,Tumor Necrosis Factors,C0041368,en_2300,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,2,1,AFFECTS,General/Uncertain,3
18313,Tumor Necrosis Factors,C0041368,en_2300,ASSOCIATED_WITH,Tumorigenesis,C1326912,en_5561,1,1,AFFECTS,General/Uncertain,3
18314,Adverse drug effect,C0041755,en_2312,ASSOCIATED_WITH,AKR1A1 wt Allele,C3715044,en_6239,1,1,AFFECTS,General/Uncertain,7
18315,"Infections, Upper Respiratory",C0041912,en_2315,ASSOCIATED_WITH(SPEC),Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
18316,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,HIV Infections,C0019693,en_1192,1,1,AFFECTS,General/Uncertain,7
18317,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,General/Uncertain,6
18318,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,7
18319,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,7,4,AFFECTS,General/Uncertain,12
18320,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Malignant neoplasm of breast,C0006142,en_511,1,1,AFFECTS,General/Uncertain,3
18321,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,2,1,AFFECTS,General/Uncertain,3
18322,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18323,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Infection,C3714514,en_6235,2,2,AFFECTS,General/Uncertain,6
18324,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,"Infertility, Male",C0021364,en_1306,1,1,AFFECTS,General/Uncertain,3
18325,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,3
18326,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,mastocytosis,C0024899,en_1506,2,1,AFFECTS,General/Uncertain,3
18327,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,3
18328,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
18329,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Pain,C0030193,en_1741,2,1,AFFECTS,General/Uncertain,3
18330,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Respiration Disorders,C0035204,en_2005,2,1,AFFECTS,General/Uncertain,3
18331,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,3
18332,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Sarcoidosis,C0036202,en_2064,1,1,AFFECTS,General/Uncertain,3
18333,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,6,4,AFFECTS,General/Uncertain,12
18334,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Urinary hesitation,C0152032,en_2878,1,1,AFFECTS,General/Uncertain,3
18335,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Antibody-Dependent Enhancement,C0282632,en_3660,1,1,AFFECTS,General/Uncertain,3
18336,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Acute respiratory infection NOS,C0339901,en_3809,2,1,AFFECTS,General/Uncertain,3
18337,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Overweight,C0497406,en_4165,1,1,AFFECTS,General/Uncertain,3
18338,Vaccines,C0042210,en_2329,ASSOCIATED_WITH,Thromboembolic event,C0857496,en_4977,1,1,AFFECTS,General/Uncertain,3
18339,Vancomycin,C0042313,en_2334,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18340,Vimentin,C0042666,en_2352,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
18341,Viral Proteins,C0042736,en_2357,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18342,Virus Diseases,C0042769,en_2362,ASSOCIATED_WITH,Evolution,C0015219,en_937,2,1,AFFECTS,General/Uncertain,3
18343,Virus Diseases,C0042769,en_2362,ASSOCIATED_WITH,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
18344,Virus Diseases,C0042769,en_2362,ASSOCIATED_WITH,Organism,C0029235,en_1717,4,3,AFFECTS,General/Uncertain,9
18345,Virus Diseases,C0042769,en_2362,ASSOCIATED_WITH,protein activation,C0599177,en_4461,1,1,AFFECTS,General/Uncertain,3
18346,Virus Diseases,C0042769,en_2362,ASSOCIATED_WITH,protein palmitoylation,C1157492,en_6697,1,1,AFFECTS,General/Uncertain,3
18347,Vision,C0042789,en_2366,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18348,Vision,C0042789,en_2366,ASSOCIATED_WITH,Diabetic Retinopathy,C0011884,en_804,1,1,AFFECTS,General/Uncertain,6
18349,Vision,C0042789,en_2366,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
18350,Vision,C0042789,en_2366,ASSOCIATED_WITH,Age related macular degeneration,C0242383,en_3409,1,1,AFFECTS,General/Uncertain,6
18351,Vision,C0042789,en_2366,ASSOCIATED_WITH,Disorder of macula of retina,C0730362,en_6670,1,1,AFFECTS,General/Uncertain,6
18352,Vitamin A,C0042839,en_2368,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
18353,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,Disease,C0012634,en_826,6,3,AFFECTS,General/Uncertain,9
18354,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18355,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,Rickets,C0035579,en_2037,2,1,AFFECTS,General/Uncertain,3
18356,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,"Infections, Upper Respiratory",C0041912,en_2315,2,1,AFFECTS,General/Uncertain,3
18357,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,3,2,AFFECTS,General/Uncertain,6
18358,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,4,3,AFFECTS,General/Uncertain,9
18359,Vitamin D,C0042866,en_2371,ASSOCIATED_WITH,Flail,C0231445,en_6603,1,1,AFFECTS,General/Uncertain,3
18360,Vitamin K,C0042878,en_2374,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18361,Voice,C0042939,en_2377,ASSOCIATED_WITH,Idiopathic Inflammatory Myopathies,C0751356,en_6675,1,1,AFFECTS,General/Uncertain,6
18362,von Willebrand Factor,C0042971,en_2382,ASSOCIATED_WITH,Acquired von Willebrand's disease,C0272362,en_6616,1,1,AFFECTS,General/Uncertain,6
18363,von Willebrand Factor,C0042971,en_2382,ASSOCIATED_WITH,platelet dysfunction,C0679429,en_6667,1,1,AFFECTS,General/Uncertain,6
18364,von Willebrand Factor,C0042971,en_2382,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18365,Weaning,C0043084,en_2386,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,2,1,AFFECTS,General/Uncertain,3
18366,Wound Healing,C0043240,en_2400,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18367,Wound Healing,C0043240,en_2400,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
18368,Wound Healing,C0043240,en_2400,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18369,Zinc,C0043481,en_2409,ASSOCIATED_WITH,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,3
18370,Zinc,C0043481,en_2409,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,1,1,AFFECTS,General/Uncertain,7
18371,Zinc,C0043481,en_2409,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18372,Zinc,C0043481,en_2409,ASSOCIATED_WITH(SPEC),Common Cold,C0009443,en_684,2,1,AFFECTS,General/Uncertain,3
18373,alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid,C0051318,en_6562,ASSOCIATED_WITH(SPEC),Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,General/Uncertain,3
18374,Amphiregulin,C0051755,en_2428,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,2,2,AFFECTS,General/Uncertain,6
18375,activin B,C0052851,en_6563,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18376,Brain natriuretic peptide,C0054015,en_2445,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18377,Budesonide,C0054201,en_2449,ASSOCIATED_WITH,Chronic sinusitis NOS,C0149516,en_2800,1,1,AFFECTS,General/Uncertain,3
18378,cationic antimicrobial protein CAP 37,C0054878,en_6564,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18379,CXC chemokine IP-10,C0056978,en_2464,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,1,1,AFFECTS,General/Uncertain,3
18380,Defensins,C0057256,en_6565,ASSOCIATED_WITH(SPEC),Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18381,Fatty Acid-Binding Proteins,C0060095,en_6566,ASSOCIATED_WITH,Metabolic syndrome,C0948265,en_5164,1,1,AFFECTS,General/Uncertain,3
18382,Fibrin fragment D,C0060323,en_2484,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
18383,Fibrin fragment D,C0060323,en_2484,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,6
18384,Fibrin fragment D,C0060323,en_2484,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18385,Fibrin fragment D,C0060323,en_2484,ASSOCIATED_WITH,Hypoperfusion,C0442856,en_6637,1,1,AFFECTS,General/Uncertain,6
18386,Fibrin fragment D,C0060323,en_2484,ASSOCIATED_WITH,Progressive Neoplastic Disease,C0677932,en_6664,1,1,AFFECTS,General/Uncertain,6
18387,Fibrin fragment D,C0060323,en_2484,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,6,5,AFFECTS,General/Uncertain,31
18388,formycin diphosphate,C0060663,en_6567,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
18389,Gastrin releasing peptide,C0061132,en_2491,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
18390,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
18391,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
18392,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Autistic Disorder,C0004352,en_425,1,1,AFFECTS,General/Uncertain,3
18393,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
18394,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18395,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,"Genital Diseases, Female",C0017411,en_6518,1,1,AFFECTS,General/Uncertain,3
18396,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
18397,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Traumatic Brain Injury,C0876926,en_5057,1,1,AFFECTS,General/Uncertain,3
18398,GTPase-Activating Proteins,C0061928,en_2499,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
18399,"nucleoprotein, Measles virus",C0065827,en_2522,ASSOCIATED_WITH,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,7
18400,Glutamate Carboxypeptidase II,C0067685,en_2528,ASSOCIATED_WITH,Toxic effect,C0600688,en_4513,1,1,AFFECTS,General/Uncertain,3
18401,ORALIT,C0069590,en_6569,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18402,Urokinase Plasminogen Activator Receptor,C0071216,en_2545,ASSOCIATED_WITH,Brain Injuries,C0270611,en_3552,1,1,AFFECTS,General/Uncertain,3
18403,procalcitonin,C0072027,en_2547,ASSOCIATED_WITH,Anemia,C0002871,en_316,1,1,AFFECTS,General/Uncertain,6
18404,procalcitonin,C0072027,en_2547,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
18405,procalcitonin,C0072027,en_2547,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,2,1,AFFECTS,General/Uncertain,3
18406,procalcitonin,C0072027,en_2547,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,3
18407,proenkephalin,C0072068,en_6570,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
18408,Prorenin,C0072249,en_2548,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
18409,Protein S,C0072393,en_2550,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,2,1,AFFECTS,General/Uncertain,3
18410,Protein-Serine-Threonine Kinases,C0072402,en_2551,ASSOCIATED_WITH,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
18411,RANTES,C0072978,en_2556,ASSOCIATED_WITH,Severe infection,C5139167,en_6407,1,1,AFFECTS,General/Uncertain,6
18412,Singlet Oxygen,C0074565,en_2571,ASSOCIATED_WITH,Injury due to exposure to external cause,C0274281,en_3562,1,1,AFFECTS,General/Uncertain,3
18413,Insulin-Like Growth-Factor-Binding Proteins,C0074825,en_2573,ASSOCIATED_WITH,Diabetic Nephropathy,C0011881,en_802,1,1,AFFECTS,General/Uncertain,3
18414,Troponin I,C0077401,en_6571,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18415,Tumor Necrosis Factor Receptor,C0077503,en_2581,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,6
18416,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18417,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
18418,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Disease,C0012634,en_826,8,8,AFFECTS,General/Uncertain,27
18419,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,5,4,AFFECTS,General/Uncertain,12
18420,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,General/Uncertain,3
18421,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Influenza,C0021400,en_1311,1,1,AFFECTS,General/Uncertain,6
18422,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Pathologic Processes,C0030660,en_1755,1,1,AFFECTS,General/Uncertain,3
18423,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Pulmonary Fibrosis,C0034069,en_1932,2,1,AFFECTS,General/Uncertain,3
18424,cytokine,C0079189,en_2593,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,8,6,AFFECTS,General/Uncertain,22
18425,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,2,2,AFFECTS,General/Uncertain,10
18426,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Septic Shock,C0036983,en_2101,1,1,AFFECTS,General/Uncertain,3
18427,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18428,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
18429,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18430,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,General/Uncertain,8
18431,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Single organ dysfunction,C0349410,en_3841,1,1,AFFECTS,General/Uncertain,6
18432,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Hypos,C0858246,en_6688,1,1,AFFECTS,General/Uncertain,3
18433,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,4,3,AFFECTS,General/Uncertain,9
18434,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,3
18435,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
18436,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,2,2,AFFECTS,General/Uncertain,6
18437,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Acute encephalopathy,C1306587,en_5522,1,1,AFFECTS,General/Uncertain,3
18438,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
18439,cytokine,C0079189,en_2593,ASSOCIATED_WITH,Severe infection,C5139167,en_6407,1,1,AFFECTS,General/Uncertain,6
18440,cytokine,C0079189,en_2593,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,8,8,AFFECTS,General/Uncertain,53
18441,Gender,C0079399,en_2601,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18442,Gender,C0079399,en_2601,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
18443,TP53 gene,C0079419,en_2602,ASSOCIATED_WITH,Carcinoma of the Large Intestine,C0009402,en_681,1,1,AFFECTS,General/Uncertain,3
18444,Granulocyte-Macrophage Colony-Stimulating Factor,C0079460,en_2604,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18445,Interleukin-8,C0079633,en_2608,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,3
18446,Interleukin-8,C0079633,en_2608,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18447,Interleukin-8,C0079633,en_2608,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18448,NF-kappa B,C0079904,en_2615,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18449,Valproate,C0080356,en_6573,ASSOCIATED_WITH,Delirium,C0011206,en_774,2,1,AFFECTS,General/Uncertain,3
18450,bone morphogenetic protein 7,C0083867,en_6574,ASSOCIATED_WITH,Wounds and Injuries,C0043251,en_2401,1,1,AFFECTS,General/Uncertain,3
18451,bone morphogenetic protein 7,C0083867,en_6574,ASSOCIATED_WITH,Chronic graft-versus-host disease,C0867389,en_4996,1,1,AFFECTS,General/Uncertain,3
18452,phosducin,C0084024,en_2635,ASSOCIATED_WITH,Zoonoses,C0043528,en_2410,1,1,AFFECTS,General/Uncertain,3
18453,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
18454,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,ASSOCIATED_WITH,Lung Injury,C0273115,en_3561,1,1,AFFECTS,General/Uncertain,6
18455,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18456,Pulmonary Surfactant-Associated Protein D,C0084692,en_2637,ASSOCIATED_WITH,Infectious disease of lung,C0876973,en_5058,2,1,AFFECTS,General/Uncertain,3
18457,Lupus Coagulation Inhibitor,C0085240,en_6575,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18458,Interleukin-10,C0085295,en_2659,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,3
18459,Interleukin-10,C0085295,en_2659,ASSOCIATED_WITH,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,General/Uncertain,8
18460,Interleukin-10|IL10,C0085295|3586,en_6576,ASSOCIATED_WITH,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
18461,"Immunoglobulins, Intravenous",C0085297,en_2660,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,8
18462,"Immunoglobulins, Intravenous",C0085297,en_2660,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18463,"Immunoglobulins, Intravenous",C0085297,en_2660,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
18464,"Immunoglobulins, Intravenous",C0085297,en_2660,ASSOCIATED_WITH,Child syndrome,C0265267,en_3542,1,1,AFFECTS,General/Uncertain,6
18465,"Immunoglobulins, Intravenous",C0085297,en_2660,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,15
18466,Enterococcus faecium,C0085495,en_6577,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18467,Chills,C0085593,en_6578,ASSOCIATED_WITH,Flu-like syndrome,C1558931,en_5965,1,1,AFFECTS,General/Uncertain,3
18468,Agitation,C0085631,en_2683,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,2,1,AFFECTS,General/Uncertain,3
18469,Ability,C0085732,en_2688,ASSOCIATED_WITH,Bronchiolitis,C0006271,en_517,1,1,AFFECTS,General/Uncertain,3
18470,Ability,C0085732,en_2688,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,6
18471,Ability,C0085732,en_2688,ASSOCIATED_WITH,Chronic Fatigue Syndrome,C0015674,en_967,2,1,AFFECTS,General/Uncertain,3
18472,Ability,C0085732,en_2688,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,2,1,AFFECTS,General/Uncertain,3
18473,Ability,C0085732,en_2688,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,3,2,AFFECTS,General/Uncertain,6
18474,Ability,C0085732,en_2688,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18475,Ability,C0085732,en_2688,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,2,2,AFFECTS,General/Uncertain,6
18476,Ability,C0085732,en_2688,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,2,1,AFFECTS,General/Uncertain,3
18477,Ability,C0085732,en_2688,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,4,4,AFFECTS,General/Uncertain,25
18478,Antibiotic Resistance,C0085818,en_2692,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,3
18479,Bacillus Calmette-Guerin,C0085957,en_2698,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,3
18480,Depressive Symptoms,C0086132,en_2702,ASSOCIATED_WITH,Disease,C0012634,en_826,2,2,AFFECTS,General/Uncertain,11
18481,Dialyzable Leukocyte Extract,C0086145,en_2704,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
18482,Dialyzable Leukocyte Extract,C0086145,en_2704,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,General/Uncertain,3
18483,Females,C0086287,en_2713,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
18484,Females,C0086287,en_2713,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,7
18485,Males,C0086582,en_2729,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,6
18486,Males,C0086582,en_2729,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18487,Renin-Angiotensin-Aldosterone System,C0086907,en_2735,ASSOCIATED_WITH,Present,C0150312,en_2833,1,1,AFFECTS,General/Uncertain,6
18488,Synapsin I,C0087044,en_6579,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,7
18489,activin A,C0100748,en_2749,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18490,Antineutrophil Cytoplasmic Antibodies,C0103647,en_6580,ASSOCIATED_WITH,Chilblains,C0008058,en_619,1,1,AFFECTS,General/Uncertain,6
18491,Connexin 43,C0110613,en_6581,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18492,Fragile X Mental Retardation Protein,C0118036,en_6582,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18493,P-Selectin,C0134835,en_2781,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
18494,P-Selectin,C0134835,en_2781,ASSOCIATED_WITH,Vascular inflammations,C0947751,en_5156,1,1,AFFECTS,General/Uncertain,3
18495,"APEX1 protein, human",C0140145,en_2786,ASSOCIATED_WITH,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,General/Uncertain,3
18496,Selenoprotein P,C0141947,en_6583,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,7
18497,Thrombomodulin,C0145779,en_2793,ASSOCIATED_WITH,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,General/Uncertain,7
18498,Tissue Inhibitor of Metalloproteinases,C0145988,en_2797,ASSOCIATED_WITH,"Tuberculosis, Lymph Node",C0041316,en_2296,1,1,AFFECTS,General/Uncertain,3
18499,Tissue Inhibitor of Metalloproteinases,C0145988,en_2797,ASSOCIATED_WITH,"Tuberculosis, Pulmonary",C0041327,en_2297,1,1,AFFECTS,General/Uncertain,3
18500,[D]Anasarca,C0151603,en_6584,ASSOCIATED_WITH,"TAL1 protein, human",C0378781,en_6632,1,1,AFFECTS,General/Uncertain,3
18501,Urinary hesitation,C0152032,en_2878,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,General/Uncertain,3
18502,DNA Sequence,C0162326,en_2904,ASSOCIATED_WITH,Primary sclerosing cholangitis,C0566602,en_6649,1,1,AFFECTS,General/Uncertain,3
18503,RNA Sequence,C0162327,en_2905,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18504,RNA Sequence,C0162327,en_2905,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18505,Reactive Oxygen Species,C0162772,en_2932,ASSOCIATED_WITH,Muscular Atrophy,C0026846,en_1604,1,1,AFFECTS,General/Uncertain,3
18506,diacylglycerol O-acyltransferase,C0163260,en_6589,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18507,Fibrin split products,C0163275,en_6590,ASSOCIATED_WITH,Thromboembolism,C0040038,en_2230,1,1,AFFECTS,General/Uncertain,3
18508,ectoine,C0164311,en_6591,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
18509,Proto-Oncogene Proteins c-akt,C0164786,en_2945,ASSOCIATED_WITH,Tick-Borne Infections,C0162699,en_6588,1,1,AFFECTS,General/Uncertain,3
18510,Synucleins,C0165073,en_6592,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,3
18511,Gelatinase B,C0165519,en_2946,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
18512,Gelatinase B|MMP9,C0165519|4318,en_2947,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,7
18513,Matrilysin|MMP7,C0166059|4316,en_6593,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,7
18514,harpin,C0169911,en_2960,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18515,Refined carbohydrate,C0175898,en_6594,ASSOCIATED_WITH,Hyperglycemia,C0020456,en_1232,1,1,AFFECTS,General/Uncertain,3
18516,Refined carbohydrate,C0175898,en_6594,ASSOCIATED_WITH,Hyperlipidemia,C0020473,en_1233,1,1,AFFECTS,General/Uncertain,3
18517,Refined carbohydrate,C0175898,en_6594,ASSOCIATED_WITH,Chronic inflammation,C0021376,en_1309,1,1,AFFECTS,General/Uncertain,3
18518,Folate,C0178638,en_6595,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18519,Blood specimen,C0178913,en_2993,ASSOCIATED_WITH,Immunocompromised Host,C0085393,en_2665,3,1,AFFECTS,General/Uncertain,3
18520,Blood specimen,C0178913,en_2993,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,3
18521,glial cell-line derived neurotrophic factor,C0207072,en_3178,ASSOCIATED_WITH,COGNITIVE DEFICIT,C0679466,en_4596,1,1,AFFECTS,General/Uncertain,3
18522,glial cell-line derived neurotrophic factor,C0207072,en_3178,ASSOCIATED_WITH,Treatment Resistant Disorders,C0871547,en_5027,1,1,AFFECTS,General/Uncertain,3
18523,adrenomedullin,C0215825,en_3189,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,2,1,AFFECTS,General/Uncertain,3
18524,adrenomedullin,C0215825,en_3189,ASSOCIATED_WITH,Septic Shock,C0036983,en_2101,1,1,AFFECTS,General/Uncertain,3
18525,secretoneurin,C0216115,en_6596,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
18526,Hydroxide Ion,C0220853,en_6598,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18527,Predisposition,C0220898,en_3206,ASSOCIATED_WITH,Disease,C0012634,en_826,3,2,AFFECTS,General/Uncertain,6
18528,Predisposition,C0220898,en_3206,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
18529,Predisposition,C0220898,en_3206,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
18530,Predisposition,C0220898,en_3206,ASSOCIATED_WITH,Neutropenia,C0027947,en_1675,1,1,AFFECTS,General/Uncertain,3
18531,Predisposition,C0220898,en_3206,ASSOCIATED_WITH,Chronic lung disease,C0746102,en_4815,1,1,AFFECTS,General/Uncertain,3
18532,Predisposition,C0220898,en_3206,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,3,2,AFFECTS,General/Uncertain,6
18533,Mycobacterium marinum,C0221084,en_3214,ASSOCIATED_WITH,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,General/Uncertain,3
18534,Serum,C0229671,en_3244,ASSOCIATED_WITH,Prognosis bad,C0278252,en_3600,1,1,AFFECTS,General/Uncertain,3
18535,Serum,C0229671,en_3244,ASSOCIATED_WITH,Increased risk,C4699158,en_6379,1,1,AFFECTS,General/Uncertain,6
18536,Multiple symptoms,C0231217,en_6602,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18537,Malaise,C0231218,en_3251,ASSOCIATED_WITH,"Hypertension, Pulmonary",C0020542,en_1240,1,1,AFFECTS,General/Uncertain,3
18538,Myalgia,C0231528,en_3262,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
18539,Myalgia,C0231528,en_3262,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18540,[D]Tachypnea,C0231835,en_6604,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
18541,[D]Tachypnea,C0231835,en_6604,ASSOCIATED_WITH,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,3
18542,Blood flow,C0232338,en_3276,ASSOCIATED_WITH,Sickle Cell Anemia,C0002895,en_317,1,1,AFFECTS,General/Uncertain,3
18543,Blood flow,C0232338,en_3276,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
18544,Halo sign,C0233205,en_6606,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
18545,Psychological symptom,C0233397,en_3290,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18546,Multiple somatic complaints,C0233756,en_6607,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,2,1,AFFECTS,General/Uncertain,3
18547,Motor dysfunction,C0234131,en_6608,ASSOCIATED_WITH,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,General/Uncertain,3
18548,Motor dysfunction,C0234131,en_6608,ASSOCIATED_WITH,REM Sleep Behavior Disorder,C0751772,en_6679,1,1,AFFECTS,General/Uncertain,3
18549,Rebound tenderness,C0234246,en_6609,ASSOCIATED_WITH,Recurrent appendicitis,C0267615,en_3545,1,1,AFFECTS,General/Uncertain,3
18550,Referred pain,C0234250,en_6610,ASSOCIATED_WITH,Heart Diseases,C0018799,en_1134,1,1,AFFECTS,General/Uncertain,3
18551,NEUROLOGIC COMPLICATION,C0235029,en_3317,ASSOCIATED_WITH,WASF1 gene|WASF1,C1421479|8936,en_5721,1,1,AFFECTS,General/Uncertain,6
18552,Neurologic Symptoms,C0235031,en_3318,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18553,Neurologic Symptoms,C0235031,en_3318,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
18554,Difficulty sleeping,C0235162,en_3322,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
18555,Recovery,C0237820,en_3354,ASSOCIATED_WITH,Anosmia,C0003126,en_337,1,1,AFFECTS,General/Uncertain,3
18556,Recovery,C0237820,en_3354,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
18557,Frontal headache,C0239886,en_6612,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18558,Hypoxia,C0242184,en_3396,ASSOCIATED_WITH,Endostatins,C0534628,en_4240,1,1,AFFECTS,General/Uncertain,7
18559,Binding Protein,C0242210,en_3398,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18560,Opioids,C0242402,en_3412,ASSOCIATED_WITH,overdose,C4018909,en_6291,1,1,AFFECTS,General/Uncertain,3
18561,P-Glycoprotein,C0242643,en_6614,ASSOCIATED_WITH,Epilepsy,C0014544,en_917,1,1,AFFECTS,General/Uncertain,3
18562,Disease Progression,C0242656,en_3429,ASSOCIATED_WITH,Nucleocapsid Proteins,C0524816,en_4219,1,1,AFFECTS,General/Uncertain,3
18563,uptake,C0243144,en_3467,ASSOCIATED_WITH,Vaccines,C0042210,en_2329,3,2,AFFECTS,General/Uncertain,6
18564,interferon beta-1b,C0244713,en_3474,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18565,anakinra,C0245109,en_3475,ASSOCIATED_WITH,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,General/Uncertain,3
18566,anakinra,C0245109,en_3475,ASSOCIATED_WITH,Gout,C0018099,en_1091,1,1,AFFECTS,General/Uncertain,3
18567,anakinra,C0245109,en_3475,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18568,anakinra,C0245109,en_3475,ASSOCIATED_WITH,skin disorder,C0037274,en_2115,1,1,AFFECTS,General/Uncertain,3
18569,anakinra,C0245109,en_3475,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18570,anakinra,C0245109,en_3475,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,General/Uncertain,3
18571,anakinra,C0245109,en_3475,ASSOCIATED_WITH,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,General/Uncertain,3
18572,anakinra,C0245109,en_3475,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18573,Galectin 3,C0245382,en_3476,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18574,icatibant,C0246269,en_3479,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18575,"XRCC1 protein, human",C0250029,en_3484,ASSOCIATED_WITH,Acquired disease,C0277564,en_6617,1,1,AFFECTS,General/Uncertain,3
18576,Pulmozyme,C0251564,en_3486,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18577,Interferon beta-1a,C0254119,en_3488,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18578,arbidol,C0254211,en_3489,ASSOCIATED_WITH,Virus Shedding,C0162633,en_2921,1,1,AFFECTS,General/Uncertain,6
18579,Interleukin-15,C0254610,en_3491,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,3
18580,Interleukin-15,C0254610,en_3491,ASSOCIATED_WITH,Fatal Outcome,C0206277,en_3157,1,1,AFFECTS,General/Uncertain,6
18581,Peripheral nerve injury NOS,C0262593,en_6615,ASSOCIATED_WITH,Oxidants,C0085403,en_2667,1,1,AFFECTS,General/Uncertain,3
18582,Social stigmata,C0277787,en_3590,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,1,AFFECTS,General/Uncertain,3
18583,Social stigmata,C0277787,en_3590,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18584,Severe pain,C0278140,en_3598,ASSOCIATED_WITH(SPEC),Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
18585,chemokine,C0282554,en_3651,ASSOCIATED_WITH,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,9
18586,chemokine,C0282554,en_3651,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18587,chemokine,C0282554,en_3651,ASSOCIATED_WITH,Viremia,C0042749,en_2359,1,1,AFFECTS,General/Uncertain,3
18588,chemokine,C0282554,en_3651,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
18589,chemokine,C0282554,en_3651,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,1,1,AFFECTS,General/Uncertain,3
18590,chemokine,C0282554,en_3651,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18591,"Antibodies, Blocking",C0282682,en_3665,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18592,Integration Host Factors,C0284965,en_6620,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
18593,alpha-Synuclein,C0285890,en_6621,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,2,1,AFFECTS,General/Uncertain,3
18594,Leptin,C0299583,en_3688,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,2,1,AFFECTS,General/Uncertain,3
18595,Leptin,C0299583,en_3688,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
18596,B cell antibody,C0301850,en_6622,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18597,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,2,2,AFFECTS,General/Uncertain,6
18598,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,2,1,AFFECTS,General/Uncertain,3
18599,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Disease,C0012634,en_826,5,3,AFFECTS,General/Uncertain,9
18600,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Infection,C3714514,en_6235,2,2,AFFECTS,General/Uncertain,6
18601,Immune response,C0301872,en_3696,ASSOCIATED_WITH,"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,2,2,AFFECTS,General/Uncertain,6
18602,Immune response,C0301872,en_3696,ASSOCIATED_WITH,"Mycobacterium Infections, Atypical",C0026919,en_1616,1,1,AFFECTS,General/Uncertain,3
18603,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
18604,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
18605,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,3
18606,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Sarcoidosis,C0036202,en_2064,1,1,AFFECTS,General/Uncertain,3
18607,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,3
18608,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
18609,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,5,5,AFFECTS,General/Uncertain,15
18610,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,2,1,AFFECTS,General/Uncertain,3
18611,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Acute infectious disease,C0275518,en_3563,1,1,AFFECTS,General/Uncertain,3
18612,Immune response,C0301872,en_3696,ASSOCIATED_WITH,"Hemorrhagic Fever, Ebola",C0282687,en_3666,1,1,AFFECTS,General/Uncertain,3
18613,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Chronic lung disease,C0746102,en_4815,1,1,AFFECTS,General/Uncertain,3
18614,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Infectious disease of lung,C0876973,en_5058,1,1,AFFECTS,General/Uncertain,3
18615,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
18616,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,2,1,AFFECTS,General/Uncertain,3
18617,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,3
18618,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,3,3,AFFECTS,General/Uncertain,9
18619,Immune response,C0301872,en_3696,ASSOCIATED_WITH,Renal Insufficiency,C1565489,en_5983,1,1,AFFECTS,General/Uncertain,3
18620,Iron,C0302583,en_3708,ASSOCIATED_WITH,Aplastic Anemia,C0002874,en_6497,1,1,AFFECTS,General/Uncertain,3
18621,Iron,C0302583,en_3708,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18622,Stimulant,C0304402,en_3721,ASSOCIATED_WITH,overdose,C4018909,en_6291,1,1,AFFECTS,General/Uncertain,3
18623,"Insulin, Long-Acting",C0304870,en_6623,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
18624,phenylpyruvate tautomerase,C0312359,en_3731,ASSOCIATED_WITH,Injury,C0175677,en_2968,7,1,AFFECTS,General/Uncertain,3
18625,Polyclonal antibody,C0312586,en_3732,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,3
18626,Polyclonal antibody,C0312586,en_3732,ASSOCIATED_WITH,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,8
18627,Genetic Predisposition to Disease,C0314657,en_6624,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18628,Infectious agent,C0314732,en_3741,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18629,Haemophilus parahaemolyticus,C0317570,en_6625,ASSOCIATED_WITH,Pharyngitis,C0031350,en_6543,1,1,AFFECTS,General/Uncertain,3
18630,Acute hemorrhage,C0333276,en_3760,ASSOCIATED_WITH,Hemoglobin,C0019046,en_1159,1,1,AFFECTS,General/Uncertain,7
18631,Involution,C0333953,en_6627,ASSOCIATED_WITH,Mitochondrial Diseases,C0751651,en_6678,1,1,AFFECTS,General/Uncertain,3
18632,Viral upper respiratory tract infection,C0339916,en_3810,ASSOCIATED_WITH,Probiotics,C0525033,en_4227,1,1,AFFECTS,General/Uncertain,8
18633,Single organ dysfunction,C0349410,en_3841,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18634,Single organ dysfunction,C0349410,en_3841,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,7
18635,Single organ dysfunction,C0349410,en_3841,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
18636,Opiates,C0376196,en_6628,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18637,Opiates,C0376196,en_6628,ASSOCIATED_WITH,Opioid Use Disorders,C0029103,en_1711,1,1,AFFECTS,General/Uncertain,3
18638,"Pregnanolone, (3alpha,5alpha)-isomer",C0376202,en_6629,ASSOCIATED_WITH,"Pain, Postoperative",C0030201,en_1742,1,1,AFFECTS,General/Uncertain,3
18639,"PLAUR protein, human|PLAUR",C0376277|5329,en_6630,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18640,"PLAUR protein, human|PLAUR",C0376277|5329,en_6630,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18641,DNA Methylation,C0376452,en_3877,ASSOCIATED_WITH,Gene Expression,C0017262,en_1044,1,1,AFFECTS,General/Uncertain,3
18642,"TAL1 protein, human",C0378781,en_6632,ASSOCIATED_WITH,Mental disorders,C0004936,en_452,1,1,AFFECTS,General/Uncertain,3
18643,"TAL1 protein, human",C0378781,en_6632,ASSOCIATED_WITH,Monoclonal gammopathy of uncertain significance,C0278494,en_6618,1,1,AFFECTS,General/Uncertain,3
18644,"TAL1 protein, human",C0378781,en_6632,ASSOCIATED_WITH(INFER),Leak NOS,C1608322,en_6001,1,1,AFFECTS,General/Uncertain,3
18645,Adiponectin,C0389071,en_6633,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18646,"ADAMTS13 protein, human|ADAMTS13",C0389918|11093,en_3908,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18647,"ADAMTS13 protein, human|ADAMTS13",C0389918|11093,en_3908,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18648,Influenza-like symptoms,C0392171,en_3915,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18649,Influenza-like symptoms,C0392171,en_3915,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18650,Nutritional status,C0392209,en_3916,ASSOCIATED_WITH,Decubitus ulcer,C0011127,en_767,1,1,AFFECTS,General/Uncertain,3
18651,Nutritional status,C0392209,en_3916,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,3
18652,Exhaustion,C0392674,en_3926,ASSOCIATED_WITH,Chronic inflammatory disorder,C1290886,en_5485,1,1,AFFECTS,General/Uncertain,3
18653,rituximab,C0393022,en_3930,ASSOCIATED_WITH,Immune thrombocytopenia,C0272286,en_3558,2,1,AFFECTS,General/Uncertain,3
18654,Gastrointestinal symptoms NOS,C0426576,en_4007,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,7
18655,Gastrointestinal symptoms NOS,C0426576,en_4007,ASSOCIATED_WITH,Inflammatory Bowel Diseases,C0021390,en_1310,1,1,AFFECTS,General/Uncertain,6
18656,Gastrointestinal symptoms NOS,C0426576,en_4007,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,13
18657,Motor symptoms,C0426980,en_6635,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,6
18658,Crystal - human material,C0427896,en_6636,ASSOCIATED_WITH,Does hit,C0596020,en_4378,1,1,AFFECTS,General/Uncertain,3
18659,Specific antibody,C0443640,en_4068,ASSOCIATED_WITH,Acquired Immunodeficiency Syndrome,C0001175,en_226,1,1,AFFECTS,General/Uncertain,3
18660,Specific antibody,C0443640,en_4068,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,3
18661,Liver enzyme,C0443764,en_6638,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,8
18662,Nasopharyngeal swab,C0444192,en_4071,ASSOCIATED_WITH,Patient in hospital,C0701159,en_4731,2,1,AFFECTS,General/Uncertain,3
18663,Nasopharyngeal swab,C0444192,en_4071,ASSOCIATED_WITH,Adverse event,C0877248,en_5069,1,1,AFFECTS,General/Uncertain,3
18664,Plasma specimen,C0444263,en_6639,ASSOCIATED_WITH,Asymptomatic,C0231221,en_3252,1,1,AFFECTS,General/Uncertain,3
18665,Respiratory sample,C0444279,en_6640,ASSOCIATED_WITH,Severe disease,C4740692,en_6396,1,1,AFFECTS,General/Uncertain,6
18666,Microorganism,C0445623,en_4075,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
18667,Fetal stress,C0456057,en_4114,ASSOCIATED_WITH,SLC6A4 gene|SLC6A4,C1420214|6532,en_6723,1,1,AFFECTS,General/Uncertain,7
18668,body system,C0460002,en_6641,ASSOCIATED_WITH,Frailty,C0424594,en_3998,1,1,AFFECTS,General/Uncertain,3
18669,Neutralizing antibody,C0475463,en_4145,ASSOCIATED_WITH,Respiratory distress,C0476273,en_4149,3,1,AFFECTS,General/Uncertain,3
18670,Respiratory distress,C0476273,en_4149,ASSOCIATED_WITH,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,6
18671,Respiratory distress,C0476273,en_4149,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
18672,FRAGMENTS,C0486805,en_4153,ASSOCIATED_WITH,Lesion,C0221198,en_3221,1,1,AFFECTS,General/Uncertain,3
18673,Vascular System,C0489903,en_6642,ASSOCIATED_WITH,Fever,C0015967,en_985,2,1,AFFECTS,General/Uncertain,3
18674,Associated symptom,C0521989,en_4207,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18675,Probiotics,C0525033,en_4227,ASSOCIATED_WITH,Diarrhea,C0011991,en_810,2,1,AFFECTS,General/Uncertain,3
18676,Probiotics,C0525033,en_4227,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18677,Probiotics,C0525033,en_4227,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,General/Uncertain,3
18678,Probiotics,C0525033,en_4227,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
18679,TNF receptor-associated factor 6,C0530129,en_4235,ASSOCIATED_WITH,Pathological accumulation of air in tissues,C0013990,en_891,3,1,AFFECTS,General/Uncertain,3
18680,TNF receptor-associated factor 6,C0530129,en_4235,ASSOCIATED_WITH,Respiration Disorders,C0035204,en_2005,1,1,AFFECTS,General/Uncertain,3
18681,TNF receptor-associated factor 6,C0530129,en_4235,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
18682,neurturin,C0531925,en_6644,ASSOCIATED_WITH,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
18683,Endostatins,C0534628,en_4240,ASSOCIATED_WITH,Acute respiratory failure,C0264490,en_3533,1,1,AFFECTS,General/Uncertain,7
18684,Endostatins,C0534628,en_4240,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18685,bone morphogenetic protein 6,C0537467,en_6645,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
18686,Angiopoietin-2,C0540511,en_4249,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18687,Angiopoietin-2,C0540511,en_4249,ASSOCIATED_WITH,Lung Injury,C0273115,en_3561,1,1,AFFECTS,General/Uncertain,6
18688,Angiopoietin-2,C0540511,en_4249,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18689,Sequela of disorder,C0543419,en_4257,ASSOCIATED_WITH,Mullerian duct inhibiting substance|AMH,C0687670|268,en_6668,1,1,AFFECTS,General/Uncertain,6
18690,preference,C0558295,en_4314,ASSOCIATED_WITH,Acute onset pain,C0184567,en_3054,1,1,AFFECTS,General/Uncertain,3
18691,Hand functions,C0562230,en_6648,ASSOCIATED_WITH,Cerebrovascular accident,C0038454,en_2169,1,1,AFFECTS,General/Uncertain,8
18692,Biologically active substance,C0574031,en_4334,ASSOCIATED_WITH,Organ failure,C0948600,en_5171,1,1,AFFECTS,General/Uncertain,3
18693,Structural protein,C0582263,en_4352,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18694,gene interaction,C0596610,en_6652,ASSOCIATED_WITH,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
18695,nuclease,C0597094,en_6653,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
18696,oral bacteria,C0597134,en_6654,ASSOCIATED_WITH,Oral candidiasis,C0006849,en_6509,1,1,AFFECTS,General/Uncertain,3
18697,receptor,C0597357,en_4422,ASSOCIATED_WITH,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,General/Uncertain,3
18698,receptor,C0597357,en_4422,ASSOCIATED_WITH,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
18699,receptor,C0597357,en_4422,ASSOCIATED_WITH,Neurologic Symptoms,C0235031,en_3318,1,1,AFFECTS,General/Uncertain,3
18700,Tumor Suppressor Proteins,C0597611,en_6655,ASSOCIATED_WITH,Acoustic Neuroma,C0027859,en_1665,1,1,AFFECTS,General/Uncertain,3
18701,Biological Neural Networks,C0598941,en_4457,ASSOCIATED_WITH,Motor dysfunction,C0234131,en_6608,1,1,AFFECTS,General/Uncertain,3
18702,E protein,C0599561,en_6656,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,5,1,AFFECTS,General/Uncertain,3
18703,water channel,C0599635,en_4463,ASSOCIATED_WITH,Endolymphatic Hydrops,C0206586,en_3170,1,1,AFFECTS,General/Uncertain,3
18704,Recovery of Function,C0599766,en_4471,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18705,genetic element,C0599770,en_4472,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18706,Pollutant,C0599786,en_4474,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
18707,human leukocyte antigen gene,C0599797,en_6657,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18708,microbial,C0599840,en_4476,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18709,trait,C0599883,en_6658,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
18710,trait,C0599883,en_6658,ASSOCIATED_WITH,Zoonoses,C0043528,en_2410,1,1,AFFECTS,General/Uncertain,3
18711,Endogenous Retroviruses,C0600466,en_6660,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18712,Endogenous Retroviruses,C0600466,en_6660,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18713,Endogenous Retroviruses,C0600466,en_6660,ASSOCIATED_WITH,nervous system disorder,C0027765,en_1659,1,1,AFFECTS,General/Uncertain,3
18714,serum P-component,C0607063,en_4515,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,3
18715,Matrix Metalloproteinases,C0623362,en_4521,ASSOCIATED_WITH,"Tuberculosis, Lymph Node",C0041316,en_2296,1,1,AFFECTS,General/Uncertain,3
18716,Matrix Metalloproteinases,C0623362,en_4521,ASSOCIATED_WITH,"Tuberculosis, Pulmonary",C0041327,en_2297,2,1,AFFECTS,General/Uncertain,3
18717,pregabalin,C0657912,en_4526,ASSOCIATED_WITH,Secondary malignant neoplasm of bone,C0153690,en_6585,1,1,AFFECTS,General/Uncertain,3
18718,infliximab,C0666743,en_4532,ASSOCIATED_WITH,Bipolar Disorder,C0005586,en_474,1,1,AFFECTS,General/Uncertain,3
18719,infliximab,C0666743,en_4532,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
18720,"NOS3 protein, human",C0669365,en_4534,ASSOCIATED_WITH,Vasculitis,C0042384,en_2338,1,1,AFFECTS,General/Uncertain,3
18721,pro-brain natriuretic peptide (1-76)|NPPB,C0669479|4879,en_6661,ASSOCIATED_WITH,Myocarditis,C0027059,en_1627,1,1,AFFECTS,General/Uncertain,6
18722,peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase,C0671368,en_4539,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
18723,protease-activated receptor 4,C0676301,en_6662,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
18724,basiliximab,C0676831,en_6663,ASSOCIATED_WITH(SPEC),Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
18725,Immunoregulation,C0678889,en_4580,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18726,Immunoregulation,C0678889,en_4580,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18727,Immunoregulation,C0678889,en_4580,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,14
18728,Immunoregulation,C0678889,en_4580,ASSOCIATED_WITH,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,1,1,AFFECTS,General/Uncertain,8
18729,mutant gene,C0678941,en_6665,ASSOCIATED_WITH,Appendicitis,C0003615,en_387,1,1,AFFECTS,General/Uncertain,6
18730,clinical aspects,C0683325,en_4661,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
18731,Mullerian duct inhibiting substance|AMH,C0687670|268,en_6668,ASSOCIATED_WITH,Fatigue,C0015672,en_966,1,1,AFFECTS,General/Uncertain,6
18732,TSC1 gene,C0694894,en_6669,ASSOCIATED_WITH(INFER),fibroma,C0016045,en_6516,1,1,AFFECTS,General/Uncertain,3
18733,Neoral,C0699605,en_4701,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,3
18734,Leukine,C0701500,en_4732,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,General/Uncertain,3
18735,Leukine,C0701500,en_4732,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,2,1,AFFECTS,General/Uncertain,3
18736,Thrombogen,C0723739,en_4749,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,2,1,AFFECTS,General/Uncertain,3
18737,human leukocyte interferon,C0733470,en_4772,ASSOCIATED_WITH,Ageusia,C0001800,en_259,1,1,AFFECTS,General/Uncertain,3
18738,human leukocyte interferon,C0733470,en_4772,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,3
18739,human leukocyte interferon,C0733470,en_4772,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18740,human leukocyte interferon,C0733470,en_4772,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18741,human leukocyte interferon,C0733470,en_4772,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18742,"Creutzfeldt-Jakob Disease, Familial",C0751254,en_6673,ASSOCIATED_WITH,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
18743,Macromolecular Complexes,C0751282,en_6674,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18744,"Gene Products, Protein",C0751455,en_6676,ASSOCIATED_WITH,Exhaustion,C0392674,en_3926,2,2,AFFECTS,General/Uncertain,6
18745,"Subarachnoid Hemorrhage, Aneurysmal",C0751530,en_6677,ASSOCIATED_WITH,ELAVL2 gene|ELAVL2,C1414372|1993,en_6719,1,1,AFFECTS,General/Uncertain,6
18746,Proteome,C0751973,en_6681,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18747,Single Nucleotide Polymorphism,C0752046,en_4856,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18748,Single Nucleotide Polymorphism,C0752046,en_4856,ASSOCIATED_WITH,Brugada syndrome,C1142166,en_5284,1,1,AFFECTS,General/Uncertain,3
18749,Single Nucleotide Polymorphism,C0752046,en_4856,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,3,3,AFFECTS,General/Uncertain,9
18750,"Neuro-Oncological Ventral Antigen 2, Human",C0753802,en_6683,ASSOCIATED_WITH,Depressive disorder,C0011581,en_788,1,1,AFFECTS,General/Uncertain,8
18751,artemin,C0761955,en_4864,ASSOCIATED_WITH,"Inflammation, allergic",C0021375,en_1308,1,1,AFFECTS,General/Uncertain,3
18752,trivalent influenza vaccine,C0770694,en_4871,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,8
18753,bevacizumab,C0796392,en_4882,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18754,peginterferon alfa-2b,C0796545,en_6684,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18755,Flow,C0806140,en_4886,ASSOCIATED_WITH,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,General/Uncertain,3
18756,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,General/Uncertain,3
18757,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,3
18758,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Inflammatory Bowel Diseases,C0021390,en_1310,1,1,AFFECTS,General/Uncertain,3
18759,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Viremia,C0042749,en_2359,1,1,AFFECTS,General/Uncertain,3
18760,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18761,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
18762,TNF gene,C0812246,en_4896,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18763,RALA gene,C0812284,en_4897,ASSOCIATED_WITH,Neoplasm,C0027651,en_1651,2,1,AFFECTS,General/Uncertain,3
18764,RALA gene,C0812284,en_4897,ASSOCIATED_WITH,Hepatocarcinogenesis,C1512409,en_5818,2,1,AFFECTS,General/Uncertain,3
18765,ELK3 gene,C0812375,en_4900,ASSOCIATED_WITH,Rheumatoid Arthritis,C0003873,en_402,1,1,AFFECTS,General/Uncertain,3
18766,ELK3 gene,C0812375,en_4900,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18767,ELK3 gene,C0812375,en_4900,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18768,ELK3 gene,C0812375,en_4900,ASSOCIATED_WITH,Congestion,C0700148,en_4714,2,1,AFFECTS,General/Uncertain,3
18769,ELK3 gene,C0812375,en_4900,ASSOCIATED_WITH,Thromboembolic event,C0857496,en_4977,1,1,AFFECTS,General/Uncertain,3
18770,Hyaluronan,C0813622,en_4905,ASSOCIATED_WITH,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,3
18771,Hyaluronan,C0813622,en_4905,ASSOCIATED_WITH,Injury,C0175677,en_2968,1,1,AFFECTS,General/Uncertain,3
18772,fibrinolytic system,C0814026,en_6685,ASSOCIATED_WITH,Underweight,C0041667,en_2308,1,1,AFFECTS,General/Uncertain,3
18773,patient characteristics,C0815172,en_4925,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,3,3,AFFECTS,General/Uncertain,9
18774,Local reaction,C0853813,en_6686,ASSOCIATED_WITH,Toxic Epidermal Necrolysis,C0014518,en_915,1,1,AFFECTS,General/Uncertain,7
18775,Persistent dry cough,C0857172,en_6687,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
18776,Unwell,C0857256,en_4972,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
18777,Unwell,C0857256,en_4972,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,3
18778,Metabolites,C0870883,en_5015,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,8
18779,Metabolites,C0870883,en_5015,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18780,Psychotic symptom,C0871189,en_6689,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18781,response,C0871261,en_5019,ASSOCIATED_WITH,Pain,C0030193,en_1741,1,1,AFFECTS,General/Uncertain,3
18782,response,C0871261,en_5019,ASSOCIATED_WITH,Seizures,C0036572,en_2076,1,1,AFFECTS,General/Uncertain,3
18783,response,C0871261,en_5019,ASSOCIATED_WITH,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,General/Uncertain,3
18784,response,C0871261,en_5019,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,3,2,AFFECTS,General/Uncertain,6
18785,response,C0871261,en_5019,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
18786,response,C0871261,en_5019,ASSOCIATED_WITH,Toxic Epidermal Necrolysis,C0014518,en_915,1,1,AFFECTS,General/Uncertain,7
18787,response,C0871261,en_5019,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,7
18788,response,C0871261,en_5019,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,14
18789,Infectious disease of lung,C0876973,en_5058,ASSOCIATED_WITH,microbial,C0599840,en_4476,1,1,AFFECTS,General/Uncertain,3
18790,Adverse event,C0877248,en_5069,ASSOCIATED_WITH,C-reactive protein,C0006560,en_529,1,1,AFFECTS,General/Uncertain,7
18791,Adverse event,C0877248,en_5069,ASSOCIATED_WITH,GJA1 gene|GJA1,C1415068|2697,en_5704,2,1,AFFECTS,General/Uncertain,6
18792,Adverse event,C0877248,en_5069,ASSOCIATED_WITH,tocilizumab,C1609165,en_6003,1,1,AFFECTS,General/Uncertain,6
18793,Adverse event,C0877248,en_5069,ASSOCIATED_WITH,COVID-19 Vaccines,C5387588,en_6436,1,1,AFFECTS,General/Uncertain,6
18794,Upper respiratory tract inflammation,C0877266,en_6691,ASSOCIATED_WITH,Olfaction Disorders,C0553757,en_4291,1,1,AFFECTS,General/Uncertain,3
18795,Cardiomyopathies,C0878544,en_5074,ASSOCIATED_WITH,Mutation,C0026882,en_1612,1,1,AFFECTS,General/Uncertain,3
18796,"WFDC2 protein, human",C0903042,en_6692,ASSOCIATED_WITH,Atrophic,C0333641,en_3770,1,1,AFFECTS,General/Uncertain,3
18797,Sleeplessness,C0917801,en_5108,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,3
18798,Sleeplessness,C0917801,en_5108,ASSOCIATED_WITH,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,General/Uncertain,3
18799,Genetic Drift,C0917892,en_6693,ASSOCIATED_WITH,Evolution,C0015219,en_937,1,1,AFFECTS,General/Uncertain,3
18800,Neuraxis,C0927232,en_5132,ASSOCIATED_WITH,Scaling,C0237849,en_6611,1,1,AFFECTS,General/Uncertain,3
18801,Organ failure,C0948600,en_5171,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18802,Organ failure,C0948600,en_5171,ASSOCIATED_WITH,Disease,C0012634,en_826,7,1,AFFECTS,General/Uncertain,3
18803,Organ failure,C0948600,en_5171,ASSOCIATED_WITH,"Pancreatitis, Acute Necrotizing",C0267941,en_3546,1,1,AFFECTS,General/Uncertain,3
18804,Organ failure,C0948600,en_5171,ASSOCIATED_WITH,Thrombophilia,C0398623,en_3949,2,1,AFFECTS,General/Uncertain,3
18805,Organ failure,C0948600,en_5171,ASSOCIATED_WITH,Cytokine storm,C0919747,en_5119,1,1,AFFECTS,General/Uncertain,3
18806,High weight,C0948775,en_6694,ASSOCIATED_WITH,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,3
18807,High weight,C0948775,en_6694,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,3
18808,High weight,C0948775,en_6694,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18809,Sentinel,C0950580,en_5191,ASSOCIATED_WITH,Acute Lung Injury,C0242488,en_3416,1,1,AFFECTS,General/Uncertain,3
18810,Leukocyte L1 Antigen Complex,C0950624,en_5192,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,12
18811,angiotensin converting enzyme 2,C0960880,en_5195,ASSOCIATED_WITH,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE",C3888198,en_6281,1,1,AFFECTS,General/Uncertain,6
18812,angiotensin converting enzyme 2,C0960880,en_5195,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18813,epitheliasin,C0964578,en_5200,ASSOCIATED_WITH,Prostatic Neoplasms,C0033578,en_6551,2,2,AFFECTS,General/Uncertain,6
18814,epitheliasin,C0964578,en_5200,ASSOCIATED_WITH,Malignant neoplasm of prostate,C0376358,en_3874,4,2,AFFECTS,General/Uncertain,6
18815,epitheliasin,C0964578,en_5200,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
18816,omalizumab,C0966225,en_5205,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18817,omalizumab,C0966225,en_5205,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18818,MicroRNAs,C1101610,en_5240,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,2,1,AFFECTS,General/Uncertain,3
18819,MicroRNAs,C1101610,en_5240,ASSOCIATED_WITH,Eye Infections,C0015403,en_953,1,1,AFFECTS,General/Uncertain,3
18820,MicroRNAs,C1101610,en_5240,ASSOCIATED_WITH,Lipodystrophy,C0023787,en_6532,1,1,AFFECTS,General/Uncertain,3
18821,MicroRNAs,C1101610,en_5240,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,2,1,AFFECTS,General/Uncertain,3
18822,MicroRNAs,C1101610,en_5240,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
18823,Hepatic infection,C1112211,en_5244,ASSOCIATED_WITH,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
18824,mitogen-activated protein kinase p38,C1120843,en_5249,ASSOCIATED_WITH,Atherosclerosis,C0004153,en_421,1,1,AFFECTS,General/Uncertain,3
18825,mitogen-activated protein kinase p38,C1120843,en_5249,ASSOCIATED_WITH,Myocardial Infarction,C0027051,en_1625,1,1,AFFECTS,General/Uncertain,3
18826,mitogen-activated protein kinase p38,C1120843,en_5249,ASSOCIATED_WITH,Myocardial Ischemia,C0151744,en_2865,1,1,AFFECTS,General/Uncertain,3
18827,mitogen-activated protein kinase p38,C1120843,en_5249,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18828,Skin,C1123023,en_6696,ASSOCIATED_WITH,Lesion,C0221198,en_3221,2,1,AFFECTS,General/Uncertain,6
18829,recombinant human DNase,C1135662,en_5258,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18830,Pathogenicity,C1136169,en_5262,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
18831,Pathogenicity,C1136169,en_5262,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18832,Pathogenicity,C1136169,en_5262,ASSOCIATED_WITH,"Heart Septal Defects, Atrial",C0018817,en_1139,1,1,AFFECTS,General/Uncertain,3
18833,Pathogenicity,C1136169,en_5262,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,5,3,AFFECTS,General/Uncertain,9
18834,Pathogenicity,C1136169,en_5262,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,2,1,AFFECTS,General/Uncertain,3
18835,Virulence Factors,C1136170,en_5263,ASSOCIATED_WITH,Infection,C3714514,en_6235,1,1,AFFECTS,General/Uncertain,3
18836,Natriuretic Peptides,C1144709,en_5290,ASSOCIATED_WITH,Kidney Diseases,C0022658,en_1381,1,1,AFFECTS,General/Uncertain,3
18837,Natriuretic Peptides,C1144709,en_5290,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
18838,Childbirth,C1148523,en_5296,ASSOCIATED_WITH,Nance-Horan syndrome,C0796085,en_4881,1,1,AFFECTS,General/Uncertain,6
18839,humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,ASSOCIATED_WITH,Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18840,Inflammatory Response,C1155266,en_5321,ASSOCIATED_WITH,Interleukin-6,C0021760,en_1342,2,1,AFFECTS,General/Uncertain,3
18841,Inflammatory Response,C1155266,en_5321,ASSOCIATED_WITH,cytokine,C0079189,en_2593,3,3,AFFECTS,General/Uncertain,9
18842,Inflammatory Response,C1155266,en_5321,ASSOCIATED_WITH,chemokine,C0282554,en_3651,1,1,AFFECTS,General/Uncertain,3
18843,Inflammatory Response,C1155266,en_5321,ASSOCIATED_WITH,cyclooxygenase 2,C0387583,en_3904,1,1,AFFECTS,General/Uncertain,3
18844,Inflammatory Response,C1155266,en_5321,ASSOCIATED_WITH(SPEC),Interleukin-1 beta,C0021753,en_1334,1,1,AFFECTS,General/Uncertain,3
18845,Inflammatory Response,C1155266,en_5321,ASSOCIATED_WITH(SPEC),chemokine,C0282554,en_3651,1,1,AFFECTS,General/Uncertain,3
18846,Antiviral Response,C1155328,en_5322,ASSOCIATED_WITH,Zinc deficiency,C0235950,en_3334,1,1,AFFECTS,General/Uncertain,6
18847,Antiviral Response,C1155328,en_5322,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
18848,Antiviral Response,C1155328,en_5322,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18849,kinase inhibitor,C1171350,en_5378,ASSOCIATED_WITH,"Lupus Erythematosus, Systemic",C0024141,en_1466,1,1,AFFECTS,General/Uncertain,3
18850,"VEGF protein, human",C1171892,en_5379,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,2,1,AFFECTS,General/Uncertain,3
18851,"VEGF protein, human",C1171892,en_5379,ASSOCIATED_WITH,Acute Lung Injury,C0242488,en_3416,3,1,AFFECTS,General/Uncertain,3
18852,natalizumab,C1172734,en_6699,ASSOCIATED_WITH,"Multiple Sclerosis, Relapsing-Remitting",C0751967,en_6680,1,1,AFFECTS,General/Uncertain,6
18853,Endocannabinoids,C1172779,en_6700,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18854,Severe Acute Respiratory Syndrome,C1175175,en_5383,ASSOCIATED_WITH,Biochemical Pathway,C1704259,en_6027,1,1,AFFECTS,General/Uncertain,6
18855,Snuffles,C1260880,en_5412,ASSOCIATED_WITH(SPEC),Disease,C0012634,en_826,2,1,AFFECTS,General/Uncertain,3
18856,Abnormal breathing,C1260922,en_5414,ASSOCIATED_WITH,"Lung Diseases, Obstructive",C0600260,en_4502,1,1,AFFECTS,General/Uncertain,3
18857,Entire nervous system,C1269560,en_6701,ASSOCIATED_WITH,Stress,C0038435,en_2165,2,1,AFFECTS,General/Uncertain,3
18858,Entire nervous system,C1269560,en_6701,ASSOCIATED_WITH,activity level,C0683317,en_4657,1,1,AFFECTS,General/Uncertain,3
18859,Inflammatory disorder,C1290884,en_5483,ASSOCIATED_WITH,Signal Pathways,C0037080,en_2104,1,1,AFFECTS,General/Uncertain,3
18860,Procoagulant,C1292267,en_5493,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18861,Body mass index,C1305855,en_5516,ASSOCIATED_WITH,Asthenia,C0004093,en_416,1,1,AFFECTS,General/Uncertain,3
18862,"HAVCR1 protein, human|HAVCR1",C1313407|26762,en_6704,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18863,cytokine production,C1327413,en_5564,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18864,negative regulation of inflammatory response,C1327441,en_6705,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,6
18865,ANP32B gene,C1332090,en_5581,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,2,1,AFFECTS,General/Uncertain,3
18866,ASK Gene,C1332118,en_5582,ASSOCIATED_WITH,Neutropenic sepsis,C0877153,en_6690,2,1,AFFECTS,General/Uncertain,3
18867,CD4 gene,C1332714,en_5583,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18868,CD4 gene,C1332714,en_5583,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18869,CD4 gene,C1332714,en_5583,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,1,1,AFFECTS,General/Uncertain,3
18870,CXCL9 gene|CXCL9,C1332821|4283,en_6706,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,7
18871,Candidate Disease Gene,C1332838,en_5587,ASSOCIATED_WITH,innate immune response,C1155265,en_5320,1,1,AFFECTS,General/Uncertain,3
18872,FIBP gene,C1333548,en_5592,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,3
18873,FSTL3 gene|FSTL3,C1333581|10272,en_6707,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
18874,HDAC2 gene,C1333892,en_5597,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,3
18875,HSPB1 gene,C1333928,en_6708,ASSOCIATED_WITH,Helicobacter Infections,C0079487,en_6572,2,1,AFFECTS,General/Uncertain,3
18876,"PTPN22 protein, human|PTPN22",C1335057|26191,en_5610,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,2,AFFECTS,General/Uncertain,15
18877,Nuclear LIM Interactor-Interacting Factor 2|CTD,C1335071|1283,en_6709,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18878,SHFM1 gene,C1335823,en_6712,ASSOCIATED_WITH,Distal bile duct stricture,C0860019,en_4988,5,1,AFFECTS,General/Uncertain,3
18879,SLC2A1 gene|SLC2A1,C1335837|6513,en_6713,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18880,STAT1 gene|STAT1,C1335872|6772,en_6714,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18881,SYK gene,C1335892,en_5628,ASSOCIATED_WITH,Acute infectious disease,C0275518,en_3563,1,1,AFFECTS,General/Uncertain,3
18882,TRIO gene,C1336674,en_6715,ASSOCIATED_WITH,Neurodevelopmental disorder,C1535926,en_5943,1,1,AFFECTS,General/Uncertain,3
18883,POMC gene,C1337111,en_5645,ASSOCIATED_WITH,Blood Coagulation Disorders,C0005779,en_485,1,1,AFFECTS,General/Uncertain,3
18884,TPO gene,C1364508,en_5651,ASSOCIATED_WITH,Sleep Apnea Syndromes,C0037315,en_2120,1,1,AFFECTS,General/Uncertain,3
18885,AVP gene|AVP,C1366535|551,en_6717,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
18886,AVP gene|AVP,C1366535|551,en_6717,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,1,1,AFFECTS,General/Uncertain,6
18887,TYMS gene,C1366824,en_5669,ASSOCIATED_WITH,"Shock, Toxic",C0600327,en_6659,1,1,AFFECTS,General/Uncertain,3
18888,CD8B1 gene,C1367471,en_5671,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,3
18889,imbalance,C1397014,en_5692,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18890,SERPING1 gene|SERPING1,C1412922|710,en_6718,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18891,CD3D gene,C1413222,en_5699,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,2,1,AFFECTS,General/Uncertain,3
18892,FOXD3 gene|FOXD3,C1414672|27022,en_6720,ASSOCIATED_WITH,METABOLIC DISTURBANCE,C0746556,en_6672,1,1,AFFECTS,General/Uncertain,7
18893,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
18894,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Diabetes,C0011847,en_797,1,1,AFFECTS,General/Uncertain,6
18895,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Diabetes Mellitus,C0011849,en_798,1,1,AFFECTS,General/Uncertain,6
18896,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
18897,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Diarrhea,C0011991,en_810,1,1,AFFECTS,General/Uncertain,6
18898,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Disease,C0012634,en_826,4,3,AFFECTS,General/Uncertain,21
18899,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Dyspnea,C0013404,en_866,1,1,AFFECTS,General/Uncertain,6.5
18900,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Fever,C0015967,en_985,1,1,AFFECTS,General/Uncertain,6
18901,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Hemoptysis,C0019079,en_6524,1,1,AFFECTS,General/Uncertain,6.5
18902,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,6
18903,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
18904,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Leukocytosis,C0023518,en_1421,1,1,AFFECTS,General/Uncertain,6
18905,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Lung diseases,C0024115,en_1462,1,1,AFFECTS,General/Uncertain,6
18906,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Lymphopenia,C0024312,en_1474,1,1,AFFECTS,General/Uncertain,6
18907,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,6
18908,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,"Stress, Psychological",C0038443,en_2168,1,1,AFFECTS,General/Uncertain,6
18909,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Myalgia,C0231528,en_3262,1,1,AFFECTS,General/Uncertain,7
18910,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Chest tightness,C0232292,en_6605,1,1,AFFECTS,General/Uncertain,6.5
18911,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Injury due to exposure to external cause,C0274281,en_3562,1,1,AFFECTS,General/Uncertain,6
18912,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Dementia,C0497327,en_4164,2,1,AFFECTS,General/Uncertain,6
18913,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,myocardium; injury,C0746730,en_4817,1,1,AFFECTS,General/Uncertain,6
18914,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
18915,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Chronic Kidney Diseases,C1561643,en_5967,1,1,AFFECTS,General/Uncertain,6
18916,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,Steatohepatitis,C2711227,en_6120,1,1,AFFECTS,General/Uncertain,6
18917,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,"Discharge, body substance",C2926602,en_6145,1,1,AFFECTS,General/Uncertain,6
18918,GJA1 gene|GJA1,C1415068|2697,en_5704,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18919,GRIN2B gene,C1415300,en_6721,ASSOCIATED_WITH,Neurodevelopmental disorder,C1535926,en_5943,1,1,AFFECTS,General/Uncertain,3
18920,MS4A1 gene,C1417326,en_5708,ASSOCIATED_WITH,HEMOPATHIES,C0744795,en_4808,1,1,AFFECTS,General/Uncertain,3
18921,SLC9A1 gene|SLC9A1,C1420232|6548,en_6724,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18922,WASF1 gene|WASF1,C1421479|8936,en_5721,ASSOCIATED_WITH,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,General/Uncertain,6
18923,WASF1 gene|WASF1,C1421479|8936,en_5721,ASSOCIATED_WITH,"Leukemia, Myelocytic, Acute",C0023467,en_1418,1,1,AFFECTS,General/Uncertain,6
18924,WASF1 gene|WASF1,C1421479|8936,en_5721,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,6
18925,B3GNT3 gene|B3GNT3,C1422039|10331,en_5722,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18926,ACE2 gene|ACE2,C1422064|59272,en_5724,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
18927,ACE2 gene|ACE2,C1422064|59272,en_5724,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,6
18928,NCKIPSD gene|NCKIPSD,C1423524|51517,en_6725,ASSOCIATED_WITH,Depressive Symptoms,C0086132,en_2702,1,1,AFFECTS,General/Uncertain,6
18929,SDCBP2 gene|SDCBP2,C1423706|27111,en_6726,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18930,TREM1 gene|TREM1,C1425066|54210,en_6727,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,6
18931,TREM1 gene|TREM1,C1425066|54210,en_6727,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,1,1,AFFECTS,General/Uncertain,6
18932,TREM2 gene,C1425067,en_136,ASSOCIATED_WITH,Membranous lipodystrophy,C0406599,en_6634,1,1,AFFECTS,General/Uncertain,3
18933,RALGAPA1 gene|RALGAPA1,C1425072|253959,en_6728,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18934,TBATA gene|TBATA,C1428114|219793,en_6729,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
18935,EXG,C1442252,en_6730,ASSOCIATED_WITH,Well adult,C0686750,en_4683,1,1,AFFECTS,General/Uncertain,3
18936,Plasma C-reactive protein,C1442972,en_6731,ASSOCIATED_WITH(INFER),Extravasation,C0015376,en_949,1,1,AFFECTS,General/Uncertain,3
18937,Resistant bacteria,C1444090,en_5742,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18938,Resistant bacteria,C1444090,en_5742,ASSOCIATED_WITH,Infectious disease of lung,C0876973,en_5058,2,2,AFFECTS,General/Uncertain,6
18939,"TNF protein, human",C1448177,en_5755,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
18940,"TNF protein, human",C1448177,en_5755,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,3
18941,"TNF protein, human",C1448177,en_5755,ASSOCIATED_WITH,Disease Progression,C0242656,en_3429,2,2,AFFECTS,General/Uncertain,6
18942,"TNF protein, human",C1448177,en_5755,ASSOCIATED_WITH,Inflammatory disorder,C1290884,en_5483,1,1,AFFECTS,General/Uncertain,3
18943,"TNF protein, human|TNF",C1448177|7124,en_5756,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,8
18944,"TNF protein, human|TNF",C1448177|7124,en_5756,ASSOCIATED_WITH,Subclinical infection,C0275522,en_3565,1,1,AFFECTS,General/Uncertain,8
18945,"MCP1 protein, human|CCL2",C1449159|6347,en_6733,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,7
18946,Amyloid Fibrils,C1449651,en_6734,ASSOCIATED_WITH,Alzheimer's Disease,C0002395,en_291,1,1,AFFECTS,General/Uncertain,3
18947,"MAPK14 protein, human",C1456380,en_5771,ASSOCIATED_WITH,Inflammatory Response,C1155266,en_5321,2,1,AFFECTS,General/Uncertain,3
18948,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Asthenopia,C0004095,en_417,1,1,AFFECTS,General/Uncertain,6
18949,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,3
18950,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Bronchiectasis,C0006267,en_6506,1,1,AFFECTS,General/Uncertain,6
18951,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,4,3,AFFECTS,General/Uncertain,9
18952,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Communicable Diseases,C0009450,en_685,2,2,AFFECTS,General/Uncertain,6
18953,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Disease,C0012634,en_826,17,15,AFFECTS,General/Uncertain,58
18954,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Encephalitis,C0014038,en_896,1,1,AFFECTS,General/Uncertain,6
18955,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Chronic Fatigue Syndrome,C0015674,en_967,2,2,AFFECTS,General/Uncertain,6
18956,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Fibromyalgia,C0016053,en_993,1,1,AFFECTS,General/Uncertain,3
18957,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Gastroesophageal reflux disease,C0017168,en_1038,1,1,AFFECTS,General/Uncertain,3
18958,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Guillain-Barre Syndrome,C0018378,en_1104,1,1,AFFECTS,General/Uncertain,6
18959,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Hypercalcemia,C0020437,en_6529,1,1,AFFECTS,General/Uncertain,3
18960,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Hypertensive disease,C0020538,en_1239,1,1,AFFECTS,General/Uncertain,6
18961,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Infection,C3714514,en_6235,3,3,AFFECTS,General/Uncertain,9
18962,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,3
18963,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,2,2,AFFECTS,General/Uncertain,6
18964,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Respiration Disorders,C0035204,en_2005,2,1,AFFECTS,General/Uncertain,3
18965,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,13,9,AFFECTS,General/Uncertain,30
18966,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Virus Diseases,C0042769,en_2362,1,1,AFFECTS,General/Uncertain,3
18967,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Vitamin D Deficiency,C0042870,en_2372,1,1,AFFECTS,General/Uncertain,3
18968,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Encephalopathies,C0085584,en_2680,1,1,AFFECTS,General/Uncertain,6
18969,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Chronic pain,C0150055,en_2816,1,1,AFFECTS,General/Uncertain,3
18970,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,6,5,AFFECTS,General/Uncertain,18
18971,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,DUMPING,C0221542,en_6601,1,1,AFFECTS,General/Uncertain,3
18972,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,"RHEUMATISM, INFLAMMATORY",C0242079,en_6613,1,1,AFFECTS,General/Uncertain,3
18973,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Rare Diseases,C0678236,en_4556,1,1,AFFECTS,General/Uncertain,3
18974,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,SYSTEMIC INFLAMMATORY PROCESS,C0749224,en_4835,1,1,AFFECTS,General/Uncertain,3
18975,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,"Stroke, Acute",C0751956,en_4854,2,1,AFFECTS,General/Uncertain,3
18976,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Critical illness myopathy,C1135188,en_5255,1,1,AFFECTS,General/Uncertain,3
18977,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Respiratory Failure,C1145670,en_5292,1,1,AFFECTS,General/Uncertain,3
18978,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,3,2,AFFECTS,General/Uncertain,9
18979,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,22,22,AFFECTS,General/Uncertain,136
18980,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,6
18981,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,postintensive care syndrome,C5391440,en_6438,1,1,AFFECTS,General/Uncertain,6
18982,Symptoms,C1457887,en_5784,ASSOCIATED_WITH,post-acute COVID-19 syndrome,C5433293,en_6463,2,1,AFFECTS,General/Uncertain,6
18983,Symptoms,C1457887,en_5784,ASSOCIATED_WITH(SPEC),Fever,C0015967,en_985,1,1,AFFECTS,General/Uncertain,3
18984,Symptoms,C1457887,en_5784,ASSOCIATED_WITH(SPEC),Chronic Obstructive Airway Disease,C0024117,en_1463,1,1,AFFECTS,General/Uncertain,3
18985,Akkermansia muciniphila,C1490590,en_6736,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,3
18986,PREDICTED,C1508497,en_6737,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,3
18987,Paraosmia,C1510410,en_5793,ASSOCIATED_WITH,Olfaction Disorders,C0553757,en_4291,1,1,AFFECTS,General/Uncertain,3
18988,Homologous Protein,C1512488,en_6739,ASSOCIATED_WITH,Severe Acute Respiratory Syndrome,C1175175,en_5383,1,1,AFFECTS,General/Uncertain,3
18989,Flare,C1517205,en_5867,ASSOCIATED_WITH,Spondylarthritis,C0949690,en_5184,3,1,AFFECTS,General/Uncertain,3
18990,Flare,C1517205,en_5867,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
18991,Respiratory secretion,C1532372,en_6741,ASSOCIATED_WITH(INFER),Asymptomatic,C0231221,en_3252,1,1,AFFECTS,General/Uncertain,3
18992,OXCT1 gene|OXCT1,C1538557|5019,en_6742,ASSOCIATED_WITH,Chronic heart failure,C0264716,en_3538,1,1,AFFECTS,General/Uncertain,6
18993,Chronic Kidney Diseases,C1561643,en_5967,ASSOCIATED_WITH,phosphate metabolism,C1158883,en_6698,1,1,AFFECTS,General/Uncertain,7
18994,Homeostatic mechanism,C1561987,en_6743,ASSOCIATED_WITH,Chronic Disease,C0008679,en_643,1,1,AFFECTS,General/Uncertain,3
18995,Catenins,C1564904,en_6744,ASSOCIATED_WITH,Malignant neoplasm of stomach,C0024623,en_1495,1,1,AFFECTS,General/Uncertain,3
18996,neutrophil elastase inhibitors,C1569711,en_6745,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,3
18997,monoclonal antibody CNTO 1275,C1608841,en_6002,ASSOCIATED_WITH,Ulcerative Colitis,C0009324,en_676,2,1,AFFECTS,General/Uncertain,6
18998,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,3
18999,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,7
19000,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,5,3,AFFECTS,General/Uncertain,12
19001,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Rheumatism,C0035435,en_2028,1,1,AFFECTS,General/Uncertain,6
19002,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Syndrome,C0039082,en_2197,1,1,AFFECTS,General/Uncertain,3
19003,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Cytokine release syndrome,C0948245,en_5163,3,2,AFFECTS,General/Uncertain,6
19004,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,Storm Syndrome,C1861452,en_6056,1,1,AFFECTS,General/Uncertain,8
19005,tocilizumab,C1609165,en_6003,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,7,6,AFFECTS,General/Uncertain,40
19006,Anti-Antibodies,C1624602,en_6015,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
19007,GNAS wt Allele|GNAS,C1706339|2778,en_6746,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,6
19008,Isolate - microorganism,C1764827,en_6747,ASSOCIATED_WITH,Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,1,1,AFFECTS,General/Uncertain,7
19009,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Appendicitis,C0003615,en_387,1,1,AFFECTS,General/Uncertain,6
19010,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,6
19011,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
19012,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
19013,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Epilepsy,C0014544,en_917,1,1,AFFECTS,General/Uncertain,6
19014,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Fatigue,C0015672,en_966,1,1,AFFECTS,General/Uncertain,8
19015,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Heart failure,C0018801,en_1135,2,2,AFFECTS,General/Uncertain,15
19016,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Parkinson Disease,C0030567,en_1753,1,1,AFFECTS,General/Uncertain,6
19017,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,"Respiratory Distress Syndrome, Adult",C0035222,en_2010,1,1,AFFECTS,General/Uncertain,6
19018,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Illness (finding),C0221423,en_3224,1,1,AFFECTS,General/Uncertain,6
19019,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Opiate Overdose,C0579142,en_6651,1,1,AFFECTS,General/Uncertain,6
19020,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Community acquired pneumonia,C0694549,en_4692,2,1,AFFECTS,General/Uncertain,7
19021,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Spondylarthritis,C0949690,en_5184,1,1,AFFECTS,General/Uncertain,6
19022,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Pressure injury,C4554531,en_6766,1,1,AFFECTS,General/Uncertain,6
19023,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,11,11,AFFECTS,General/Uncertain,69
19024,IMPACT gene,C1825598,en_6044,ASSOCIATED_WITH,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,1,1,AFFECTS,General/Uncertain,7
19025,ocrelizumab,C1882138,en_6063,ASSOCIATED_WITH,Multiple Sclerosis,C0026769,en_1598,1,1,AFFECTS,General/Uncertain,6
19026,ocrelizumab,C1882138,en_6063,ASSOCIATED_WITH,"Multiple Sclerosis, Relapsing-Remitting",C0751967,en_6680,1,1,AFFECTS,General/Uncertain,6
19027,Adipokines,C1955907,en_6066,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,1,1,AFFECTS,General/Uncertain,6
19028,Adipokines,C1955907,en_6066,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
19029,Microbiome,C1956108,en_6068,ASSOCIATED_WITH,Respiratory Tract Infections,C0035243,en_2017,1,1,AFFECTS,General/Uncertain,7
19030,Human Microbiome,C1956109,en_6748,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
19031,Human Microbiome,C1956109,en_6748,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
19032,Microglobulin,C1979927,en_6079,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,2,1,AFFECTS,General/Uncertain,6
19033,Inhibitor,C1999216,en_6749,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,8
19034,Sense of smell impaired,C2364082,en_6111,ASSOCIATED_WITH,Systemic disease,C0442893,en_4062,1,1,AFFECTS,General/Uncertain,6
19035,Smell function,C2370955,en_6750,ASSOCIATED_WITH,Luteolin,C0065264,en_2518,1,1,AFFECTS,General/Uncertain,8
19036,canakinumab,C2718773,en_6127,ASSOCIATED_WITH,Heart Injuries,C0018805,en_1137,2,1,AFFECTS,General/Uncertain,7
19037,canakinumab,C2718773,en_6127,ASSOCIATED_WITH,Inflammation,C0021368,en_1307,1,1,AFFECTS,General/Uncertain,7
19038,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Anemia,C0002871,en_316,1,1,AFFECTS,General/Uncertain,6
19039,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Asthma,C0004096,en_418,1,1,AFFECTS,General/Uncertain,6
19040,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Complication,C0009566,en_697,1,1,AFFECTS,General/Uncertain,6
19041,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Conjunctivitis,C0009763,en_704,1,1,AFFECTS,General/Uncertain,6
19042,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
19043,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Disease,C0012634,en_826,3,3,AFFECTS,General/Uncertain,19
19044,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Epilepsy,C0014544,en_917,1,1,AFFECTS,General/Uncertain,6
19045,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Exanthema,C0015230,en_938,1,1,AFFECTS,General/Uncertain,6
19046,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Hip Fractures,C0019557,en_1185,1,1,AFFECTS,General/Uncertain,6
19047,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,"Kidney Failure, Acute",C0022660,en_1382,1,1,AFFECTS,General/Uncertain,6
19048,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Septicemia,C0036690,en_2086,1,1,AFFECTS,General/Uncertain,6
19049,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Thrombus,C0087086,en_2743,1,1,AFFECTS,General/Uncertain,6
19050,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Deep Vein Thrombosis,C0149871,en_2812,1,1,AFFECTS,General/Uncertain,6
19051,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Malnutrition,C0162429,en_2910,1,1,AFFECTS,General/Uncertain,6
19052,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,"Pneumonitis, Interstitial",C0206061,en_3141,1,1,AFFECTS,General/Uncertain,7
19053,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Coronavirus Infections,C0206750,en_3176,1,1,AFFECTS,General/Uncertain,6
19054,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Single organ dysfunction,C0349410,en_3841,1,1,AFFECTS,General/Uncertain,6
19055,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Associated symptom,C0521989,en_4207,1,1,AFFECTS,General/Uncertain,8
19056,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,"Complication, hemorrhage",C0940931,en_5147,1,1,AFFECTS,General/Uncertain,6
19057,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Symptoms,C1457887,en_5784,1,1,AFFECTS,General/Uncertain,6
19058,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,Venous Thromboembolism,C1861172,en_6055,1,1,AFFECTS,General/Uncertain,6
19059,"CD69 protein, human|CD69",C2744535|969,en_6133,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,9,9,AFFECTS,General/Uncertain,59
19060,Secretory Phospholipase A2,C2756983,en_6751,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
19061,Secretory Phospholipase A2,C2756983,en_6751,ASSOCIATED_WITH,pediatric inflammatory multisystem syndrome,C5389369,en_6437,1,1,AFFECTS,General/Uncertain,6
19062,Negative Regulation of Coagulation,C2917212,en_6142,ASSOCIATED_WITH,Heparin,C0019134,en_1166,1,1,AFFECTS,General/Uncertain,7
19063,Specimen from trachea obtained by aspiration (specimen),C2919642,en_6752,ASSOCIATED_WITH,Present,C0150312,en_2833,1,1,AFFECTS,General/Uncertain,6
19064,"Discharge, body substance",C2926602,en_6145,ASSOCIATED_WITH,Cardiovascular Diseases,C0007222,en_569,1,1,AFFECTS,General/Uncertain,6
19065,"Discharge, body substance",C2926602,en_6145,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,7
19066,Cerebral Hemorrhage,C2937358,en_6154,ASSOCIATED_WITH,EHD1 wt Allele,C4284302,en_6764,1,1,AFFECTS,General/Uncertain,7
19067,Transcriptome,C3178810,en_6181,ASSOCIATED_WITH,pulmonary complications,C0281169,en_3627,1,1,AFFECTS,General/Uncertain,6
19068,"Troponin T, Cardiac Muscle",C3538889,en_6753,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
19069,UGT1A7 wt Allele,C3541329,en_6754,ASSOCIATED_WITH,Hemorrhage,C0019080,en_1161,1,1,AFFECTS,General/Uncertain,6
19070,UGT1A7 wt Allele,C3541329,en_6754,ASSOCIATED_WITH,Multiple Organ Failure,C0026766,en_1597,1,1,AFFECTS,General/Uncertain,6
19071,UGT1A7 wt Allele,C3541329,en_6754,ASSOCIATED_WITH,Thrombosis,C0040053,en_2233,1,1,AFFECTS,General/Uncertain,6
19072,Infection,C3714514,en_6235,ASSOCIATED_WITH,PER1 gene|PER1,C1418464|5187,en_6722,1,1,AFFECTS,General/Uncertain,6
19073,Weakness,C3714552,en_6236,ASSOCIATED_WITH,Critical Illness,C0010340,en_733,1,1,AFFECTS,General/Uncertain,6
19074,"Transformation, function",C3714584,en_6757,ASSOCIATED_WITH,doxifluridine,C0048808,en_6561,1,1,AFFECTS,General/Uncertain,6
19075,Pain Perception,C3714605,en_6758,ASSOCIATED_WITH,Respiratory distress,C0476273,en_4149,1,1,AFFECTS,General/Uncertain,6
19076,Central Nervous System,C3714787,en_6759,ASSOCIATED_WITH,Neurologic Manifestations,C0027854,en_1664,1,1,AFFECTS,General/Uncertain,7
19077,AKR1A1 wt Allele,C3715044,en_6239,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,7
19078,HSD11B1 wt Allele|HSD11B1,C3715113|3290,en_6760,ASSOCIATED_WITH,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,1,1,AFFECTS,General/Uncertain,6
19079,HSD11B1 wt Allele|HSD11B1,C3715113|3290,en_6760,ASSOCIATED_WITH,Obesity,C0028754,en_1699,1,1,AFFECTS,General/Uncertain,6
19080,Pathogenic,C3816499,en_6761,ASSOCIATED_WITH,Adenomatous Polyposis Coli,C0032580,en_6548,1,1,AFFECTS,General/Uncertain,8
19081,Pathogenic,C3816499,en_6761,ASSOCIATED_WITH,Pancreatic Ductal Adenocarcinoma,C1335302,en_6710,1,1,AFFECTS,General/Uncertain,8
19082,sarilumab,C3885145,en_6280,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
19083,sarilumab,C3885145,en_6280,ASSOCIATED_WITH,Pneumonia,C0032285,en_1833,2,1,AFFECTS,General/Uncertain,6
19084,avelumab,C4055417,en_6763,ASSOCIATED_WITH,refractory plasma cell neoplasm,C0278620,en_6619,1,1,AFFECTS,General/Uncertain,7
19085,Clinical Deterioration,C4505323,en_6765,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
19086,COVID-19,C5203670,en_6417,ASSOCIATED_WITH,iron metabolism,C0596803,en_4396,1,1,AFFECTS,General/Uncertain,6
19087,COVID-19,C5203670,en_6417,ASSOCIATED_WITH,Cytokine Signaling,C1511617,en_6738,1,1,AFFECTS,General/Uncertain,7
19088,Antibody to SARS-CoV-2,C5203674,en_6768,ASSOCIATED_WITH,"Diabetes Mellitus, Insulin-Dependent",C0011854,en_799,1,1,AFFECTS,General/Uncertain,6
19089,Convalescent plasma,C5383282,en_6769,ASSOCIATED_WITH,Infected,C0439663,en_4036,4,4,AFFECTS,General/Uncertain,28
19090,Convalescent plasma,C5383282,en_6769,ASSOCIATED_WITH,Moderate disease,C4740691,en_6395,1,1,AFFECTS,General/Uncertain,8
19091,COVID-19 Vaccines,C5387588,en_6436,ASSOCIATED_WITH,Autoimmune Diseases,C0004364,en_428,1,1,AFFECTS,General/Uncertain,6
19092,COVID-19 Vaccines,C5387588,en_6436,ASSOCIATED_WITH,Malignant Neoplasms,C0006826,en_545,1,1,AFFECTS,General/Uncertain,7
19093,PD-L1 Inhibitors,C5392068,en_6770,ASSOCIATED_WITH,refractory plasma cell neoplasm,C0278620,en_6619,1,1,AFFECTS,General/Uncertain,7
19094,SARS-CoV-2 IgG,C5397186,en_6771,ASSOCIATED_WITH,COVID-19,C5203670,en_6417,1,1,AFFECTS,General/Uncertain,6
19095,Ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance),C5397190,en_6772,ASSOCIATED_WITH,Disease,C0012634,en_826,1,1,AFFECTS,General/Uncertain,6
19096,Acute bacterial sinusitis,C0275556,en_3569,has_associated_morphology(Axiom),Acute inflammation,C0333361,en_3763,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19097,Acute failure,C0231176,en_3248,associated_with(Axiom),Acute respiratory failure,C0264490,en_3533,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19098,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,has_associated_morphology(Axiom),Edema,C0013604,en_877,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19099,ANP32B gene,C1332090,en_5581,gene_plays_role_in_process(Axiom),Apoptosis,C0162638,en_2922,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19100,Antiinflammatory Effect,C1516019,en_5851,biological_process_involves_gene_product(Axiom),Adiponectin,C0389071,en_6633,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19101,"ASPERGILLOSIS, INVASIVE",C0238013,en_3360,has_causative_agent(Axiom),Aspergillus,C0004034,en_411,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19102,attenuation,C0599946,en_4490,see(Axiom),transcription termination,C0597600,en_4432,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19103,Biosensors,C0600364,en_4504,see(Axiom),metabolism,C0025519,en_1547,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19104,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,C4725841,en_6387,disease_has_abnormal_cell(Axiom),Neoplastic Cell,C0597032,en_4409,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19105,cationic antimicrobial protein CAP 37,C0054878,en_6564,gene_product_plays_role_in_biological_process(Axiom),Inflammatory Response,C1155266,en_5321,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19106,cationic antimicrobial protein CAP 37,C0054878,en_6564,gene_product_has_organism_source(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19107,CD14 gene,C1367477,en_5672,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19108,CD14 gene,C1367477,en_5672,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19109,CD14 gene,C1367477,en_5672,gene_plays_role_in_process(Axiom),Apoptosis,C0162638,en_2922,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19110,CD69,C1413235,en_19,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19111,CD69,C1413235,en_19,gene_plays_role_in_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19112,CD69,C1413235,en_19,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19113,cell injury,C0599732,en_4467,see(Axiom),cytotoxicity,C0596402,en_4385,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19114,CHEST TUBE PLACEMENT,C0742344,en_4796,co-occurs_with(Axiom),PNEUMOTHORAX,C0032326,en_1838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19115,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,chemotherapy_regimen_has_component(Axiom),Doxorubicin,C0013089,en_845,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19116,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,chemotherapy_regimen_has_component(Axiom),Cisplatin,C0008838,en_648,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19117,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,chemotherapy_regimen_has_component(Axiom),Cyclophosphamide,C0010583,en_739,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19118,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,has_component(Axiom),cyclophosphamide,C0010583,en_739,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19119,cisplatin/cyclophosphamide/doxorubicin protocol,C0280547,en_3622,has_component(Axiom),cisplatin,C0008838,en_648,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19120,clazakizumab,C4077748,en_6315,has_target(Axiom),Interleukin-6,C0021760,en_1342,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19121,CLOCK gene,C1413503,en_5702,gene_found_in_organism(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19122,Consideration,C0518609,en_4179,biological_process_has_associated_location(Axiom),Brain,C0006104,en_508,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19123,COVID-19-Associated Acute Respiratory Distress Syndrome,C5419164,en_6458,disease_has_associated_anatomic_site(Axiom),Lung,C0024109,en_1460,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19124,cullin-3,C0909608,en_5097,gene_product_plays_role_in_biological_process(Axiom),Ubiquitination,C1519751,en_5891,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19125,cullin-3,C0909608,en_5097,gene_product_has_organism_source(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19126,Cyclooxygenase deficiency,C0398634,en_3950,interprets(Axiom),Hemostatic function,C0019116,en_1165,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19127,daunorubicin/prednisone/vincristine protocol,C0078144,en_2588,chemotherapy_regimen_has_component(Axiom),Prednisone,C0032952,en_1871,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19128,daunorubicin/prednisone/vincristine protocol,C0078144,en_2588,has_component(Axiom),prednisone,C0032952,en_1871,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19129,Does walk,C0600108,en_4496,interprets(Axiom),Ability to walk,C0559964,en_4318,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19130,Does walk,C0600108,en_4496,interprets(Axiom),Walking,C0080331,en_2629,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19131,DUSP3 gene,C1333258,en_5589,gene_plays_role_in_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19132,DUSP3 gene,C1333258,en_5589,gene_plays_role_in_process(Axiom),Hydrolysis,C0020291,en_1223,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19133,early/brief intervention/therapy (treatment),C1964029,en_6074,used_for(Axiom),brief intervention,C0814459,en_4914,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19134,EHD1 wt Allele,C4284302,en_6764,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19135,EHD1 wt Allele,C4284302,en_6764,gene_found_in_organism(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19136,Elastases,C0699918,en_4708,used_for(Axiom),leukocyte elastase,C0064833,en_2515,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19137,Equine influenza,C0276356,en_3577,has_causative_agent(Axiom),Orthomyxoviridae,C0029341,en_1720,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19138,FIBP gene,C1333548,en_5592,gene_plays_role_in_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19139,FIBP gene,C1333548,en_5592,gene_plays_role_in_process(Axiom),B-Cell Activation,C1155003,en_5311,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19140,FIBP gene,C1333548,en_5592,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19141,Gallstone acute pancreatitis,C0554117,en_4293,has_associated_morphology(Axiom),Acute inflammation,C0333361,en_3763,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19142,GPX1,C1415275,en_41,gene_plays_role_in_process(Axiom),Oxidative Stress,C0242606,en_3422,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19143,Hepatocarcinogenesis,C1512409,en_5818,biological_process_has_associated_location(Axiom),Liver,C0023884,en_1452,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19144,"HRH2 protein, human",C1531432,en_5926,gene_product_plays_role_in_biological_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19145,"HRH2 protein, human",C1531432,en_5926,gene_product_plays_role_in_biological_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19146,"HRH2 protein, human",C1531432,en_5926,gene_product_plays_role_in_biological_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19147,human leukocyte interferon,C0733470,en_4772,gene_product_plays_role_in_biological_process(Axiom),Cytokine Signaling,C1511617,en_6738,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19148,Interested,C0543488,en_4259,biological_process_has_associated_location(Axiom),Brain,C0006104,en_508,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19149,"Interferon Alpha, Human",C1610033,en_6007,gene_product_plays_role_in_biological_process(Axiom),Cytokine Signaling,C1511617,en_6738,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19150,intervention program,C0599917,en_4484,see(Axiom),counseling,C0010210,en_724,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19151,intervention program,C0599917,en_4484,see(Axiom),psychotherapy,C0033968,en_1921,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19152,intervention program,C0599917,en_4484,see(Axiom),behavior therapy,C0004933,en_451,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19153,Invasive Malignant Neoplasm,C0677898,en_4548,disease_has_abnormal_cell(Axiom),Neoplastic Cell,C0597032,en_4409,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19154,IRF1 gene,C1366516,en_5659,gene_found_in_organism(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19155,IRF1 gene,C1366516,en_5659,gene_encodes_gene_product(Axiom),Interferon Regulatory Factor 1,C0063700,en_2508,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19156,IRF1 gene,C1366516,en_5659,gene_plays_role_in_process(Axiom),Transcriptional Activation,C0162493,en_2911,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19157,IRF1 gene,C1366516,en_5659,gene_plays_role_in_process(Axiom),Apoptosis,C0162638,en_2922,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19158,IRF3 gene,C1334139,en_5602,gene_found_in_organism(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19159,IRF3 gene,C1334139,en_5602,gene_plays_role_in_process(Axiom),Antiviral Response,C1155328,en_5322,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19160,IRF3 gene,C1334139,en_5602,gene_plays_role_in_process(Axiom),Transcriptional Activation,C0162493,en_2911,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19161,IRF7,C1416475,en_53,gene_plays_role_in_process(Axiom),Transcriptional Activation,C0162493,en_2911,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19162,IRF7,C1416475,en_53,gene_plays_role_in_process(Axiom),Antiviral Response,C1155328,en_5322,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19163,IRF7,C1416475,en_53,gene_found_in_organism(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19164,Localized Malignant Neoplasm,C0796563,en_4884,disease_has_abnormal_cell(Axiom),Neoplastic Cell,C0597032,en_4409,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19165,LOX gene,C1334349,en_5607,gene_plays_role_in_process(Axiom),Protein-Protein Interaction,C0872079,en_5036,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19166,Major change,C3845593,en_6266,population_at_risk_for(Axiom),Anxiety,C0003467,en_380,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19167,MAS1 gene,C0812372,en_4899,gene_plays_role_in_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19168,MAS1 gene,C0812372,en_4899,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19169,MAS1 gene,C0812372,en_4899,gene_plays_role_in_process(Axiom),Cell Proliferation,C0596290,en_4384,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19170,MAS1 gene,C0812372,en_4899,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19171,Medical gases,C0358516,en_3857,has_member(Axiom),carbon dioxide,C0007012,en_556,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19172,Medical gases,C0358516,en_3857,has_member(Axiom),oxygen,C0030054,en_1736,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19173,Medical gases,C0358516,en_3857,has_member(Axiom),nitrogen,C0028158,en_1684,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19174,Microbial agent,C1445706,en_5751,active_ingredient_of(Axiom),probiotics,C0525033,en_4227,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19175,Multiple somatic complaints,C0233756,en_6607,ssc(Axiom),FEVER,C0015967,en_985,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19176,"Myocarditis, chronic",C0865681,en_4995,has_associated_morphology(Axiom),Chronic inflammation,C0021376,en_1309,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19177,narcotic use,C0240602,en_3386,associated_with(Axiom),drug abuse,C0013146,en_851,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19178,Nasotracheal intubation,C0396625,en_3942,has_direct_device(Axiom),Endotracheal tube,C0336630,en_3787,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19179,negative regulation of inflammatory response,C1327441,en_6705,negatively_regulates(Axiom),inflammatory response,C1155266,en_5321,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19180,Neonatal calf diarrhea,C0276467,en_3578,has_definitional_manifestation(Axiom),Diarrhea,C0011991,en_810,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19181,"Neuro-Oncological Ventral Antigen 2, Human",C0753802,en_6683,gene_product_plays_role_in_biological_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19182,"Neuro-Oncological Ventral Antigen 2, Human",C0753802,en_6683,gene_product_plays_role_in_biological_process(Axiom),RNA Binding,C1148846,en_5299,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19183,Normal renal function,C0232805,en_3286,interprets(Axiom),Renal function,C0232804,en_3285,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19184,"nucleoprotein, Measles virus",C0065827,en_2522,gene_product_has_organism_source(Axiom),Virus,C0042776,en_2364,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19185,Orotracheal intubation,C0396621,en_3941,has_direct_device(Axiom),Endotracheal tube,C0336630,en_3787,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19186,Outcomes of Therapy,C1518681,en_5877,has_gdc_value(Axiom),Progressive Disease,C1335499,en_6711,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19187,Peptide/MHC Complex,C1335376,en_5614,gene_product_plays_role_in_biological_process(Axiom),T-Cell Activation,C1155065,en_5315,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19188,PGP,C1418520,en_165,gene_plays_role_in_process(Axiom),Hydrolysis,C0020291,en_1223,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19189,Phosphorus intake,C0559872,en_4317,has_process_output(Axiom),Phosphorus,C0031705,en_1799,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19190,Play,C0032214,en_1830,used_for(Axiom),play therapy,C0032216,en_1831,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19191,Population at Risk,C0242444,en_3415,used_for(Axiom),High Risk Populations,C0870646,en_5008,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19192,Prenatal Testing,C1456692,en_5778,related_to(Axiom),Genetic Counseling,C0017382,en_1055,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19193,Prenatal Testing,C1456692,en_5778,related_to(Axiom),Pregnancy,C0032961,en_1872,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19194,Prenatal Testing,C1456692,en_5778,related_to(Axiom),Prenatal Care,C0033052,en_1878,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19195,Primary Neoplasm,C0677930,en_4550,disease_has_abnormal_cell(Axiom),Neoplastic Cell,C0597032,en_4409,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19196,Proton beam,C0729603,en_4764,energy_used_by(Axiom),Proton therapy,C0436226,en_4025,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19197,PSMA5 wt Allele,C3889400,en_6282,gene_plays_role_in_process(Axiom),Proteolysis,C0597304,en_4421,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19198,PSMA5 wt Allele,C3889400,en_6282,gene_plays_role_in_process(Axiom),Hydrolysis,C0020291,en_1223,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19199,QT interval:Time:Point in time:Heart:Quantitative:EKG,C0488414,en_4154,analyzes(Axiom),Heart,C0018787,en_1130,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19200,RBBP1L1 Protein,C1337094,en_5644,gene_product_plays_role_in_biological_process(Axiom),Epigenetic Process,C1516924,en_5864,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19201,receptor activity,C1152633,en_5307,exhibited_by(Axiom),Peptidylprolyl Isomerase,C0136073,en_2784,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19202,receptor expression,C0597360,en_4424,used_for(Axiom),receptor activation,C1514758,en_5837,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19203,Refractory Hematologic Malignancy,C1335724,en_5620,disease_has_abnormal_cell(Axiom),Neoplastic Cell,C0597032,en_4409,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19204,"RTN1 protein, human",C0217373,en_3194,gene_product_plays_role_in_biological_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19205,"S100A12 protein, human",C0389073,en_3907,gene_product_plays_role_in_biological_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19206,"S100A12 protein, human",C0389073,en_3907,gene_product_plays_role_in_biological_process(Axiom),Inflammatory Response,C1155266,en_5321,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19207,"S100A12 protein, human",C0389073,en_3907,gene_product_plays_role_in_biological_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19208,SCTR gene,C1335806,en_5621,gene_plays_role_in_process(Axiom),Digestion,C0012238,en_815,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19209,SCTR gene,C1335806,en_5621,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19210,SCTR gene,C1335806,en_5621,gene_associated_with_disease(Axiom),Pancreatic Carcinoma,C0235974,en_3336,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19211,SCTR gene,C1335806,en_5621,gene_plays_role_in_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19212,SCTR gene,C1335806,en_5621,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19213,Severe acute respiratory infection,C3873497,en_6279,disease_has_associated_anatomic_site(Axiom),Lung,C0024109,en_1460,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19214,"SH2D3A protein, human",C1309025,en_5526,gene_product_plays_role_in_biological_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19215,"SH2D3A protein, human",C1309025,en_5526,gene_product_plays_role_in_biological_process(Axiom),Protein-Protein Interaction,C0872079,en_5036,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19216,"SH2D3A protein, human",C1309025,en_5526,gene_product_plays_role_in_biological_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19217,Signaling Molecule,C1519315,en_5883,chemical_or_drug_initiates_biological_process(Axiom),Neuronal Transmission,C0678903,en_4583,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19218,Signaling Molecule,C1519315,en_5883,chemical_or_drug_initiates_biological_process(Axiom),Inflammatory Response,C1155266,en_5321,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19219,SKIL gene,C1335828,en_5624,gene_plays_role_in_process(Axiom),Transcriptional Repression,C0920533,en_5127,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19220,SKIL gene,C1335828,en_5624,gene_plays_role_in_process(Axiom),Signal Transduction,C0037083,en_2105,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19221,Social drinker,C0337676,en_3796,interprets(Axiom),Health-related behavior,C0237121,en_3340,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19222,SOMATIZATION,C0149779,en_2808,biological_process_has_associated_location(Axiom),Brain,C0006104,en_508,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19223,"spike protein, SARS-CoV-2",C5391442,en_6439,gene_product_has_organism_source(Axiom),Virus,C0042776,en_2364,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19224,Sun Exposure,C1456711,en_5780,related_to(Axiom),Melanoma,C0025202,en_1522,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19225,"TAL1 protein, human",C0378781,en_6632,gene_product_plays_role_in_biological_process(Axiom),Transcriptional Activation,C0162493,en_2911,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19226,targeting,C0599894,en_4482,see(Axiom),protein transport,C0599895,en_4483,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19227,Therapeutic Intervention,C0808232,en_4889,see(Axiom),behavior therapy,C0004933,en_451,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19228,"TIMP3 protein, human",C1527365,en_5924,gene_product_has_associated_anatomy(Axiom),Extracellular Matrix,C0015350,en_947,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19229,"TIMP3 protein, human",C1527365,en_5924,gene_product_has_organism_source(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19230,TLR6,C1336638,en_106,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19231,TLR6,C1336638,en_106,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19232,TLR7 gene,C1336639,en_5634,gene_plays_role_in_process(Axiom),Antiviral Response,C1155328,en_5322,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19233,TLR7 gene,C1336639,en_5634,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19234,TLR7 gene,C1336639,en_5634,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19235,TLR7 gene,C1336639,en_5634,gene_plays_role_in_process(Axiom),RNA Binding,C1148846,en_5299,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19236,TLR8 gene,C1336640,en_5635,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19237,TLR8 gene,C1336640,en_5635,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19238,TLR9,C1423633,en_135,gene_plays_role_in_process(Axiom),Immunity,C0020964,en_1273,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19239,TLR9,C1423633,en_135,gene_encodes_gene_product(Axiom),Toll-Like Receptor 9,C0963057,en_5199,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19240,TLR9,C1423633,en_135,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19241,TLR9,C1423633,en_135,gene_plays_role_in_process(Axiom),Receptor Signaling,C1514762,en_5838,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19242,TOP3B gene,C1420860,en_5720,gene_plays_role_in_process(Axiom),Cell Aging,C0007581,en_584,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19243,Tracer,C1522485,en_5902,has_gdc_value(Axiom),Acetate,C0000975,en_216,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19244,trait,C0599883,en_6658,see(Axiom),phenotype,C0031437,en_6544,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19245,Treatment duration:Time:Pt:^Patient:Qn,C3259042,en_6186,has_component(Axiom),Duration,C2926735,en_6146,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19246,TSLP gene,C1336681,en_5638,gene_plays_role_in_process(Axiom),Cytokine Signaling,C1511617,en_6738,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19247,TSLP gene,C1336681,en_5638,gene_plays_role_in_process(Axiom),T-Cell Proliferation,C1155046,en_5314,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19248,TSLP gene,C1336681,en_5638,gene_plays_role_in_process(Axiom),Immunoregulation,C0678889,en_4580,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19249,TSLP gene,C1336681,en_5638,gene_encodes_gene_product(Axiom),Thymic Stromal Lymphopoietin,C0762640,en_4865,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19250,type I collagen alpha 1,C0972255,en_5212,gene_product_plays_role_in_biological_process(Axiom),Cell Growth,C0007595,en_590,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19251,type I collagen alpha 1,C0972255,en_5212,gene_product_has_organism_source(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19252,type I collagen alpha 1,C0972255,en_5212,gene_product_has_associated_anatomy(Axiom),Extracellular Matrix,C0015350,en_947,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19253,UGT1A7 wt Allele,C3541329,en_6754,gene_plays_role_in_process(Axiom),Glycosylation,C0017982,en_1086,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19254,vaccine delivery,C1331096,en_5580,see(Axiom),vector vaccine,C0597641,en_4434,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19255,VBM protocol,C0078140,en_2587,chemotherapy_regimen_has_component(Axiom),Methotrexate,C0025677,en_1556,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19256,VBM protocol,C0078140,en_2587,chemotherapy_regimen_has_component(Axiom),Bleomycin,C0005740,en_481,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19257,VBM protocol,C0078140,en_2587,has_component(Axiom),methotrexate,C0025677,en_1556,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19258,VIP gene,C1366646,en_5668,gene_encodes_gene_product(Axiom),Vasoactive Intestinal Peptide,C0042395,en_2339,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19259,VIP gene,C1366646,en_5668,gene_plays_role_in_process(Axiom),Immunoregulation,C0678889,en_4580,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19260,VIP gene,C1366646,en_5668,gene_plays_role_in_process(Axiom),Inflammatory Response,C1155266,en_5321,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19261,WDFY2,C1426966,en_158,gene_plays_role_in_process(Axiom),Ligand Binding,C1517880,en_5869,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19262,"XRCC1 protein, human",C0250029,en_3484,gene_product_plays_role_in_biological_process(Axiom),DNA Repair,C0012899,en_836,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19263,"XRCC1 protein, human",C0250029,en_3484,gene_product_has_organism_source(Axiom),Human,C0020114,en_1210,UMLS,UMLS,AFFECTS(Axiom),Axiom,9
19264,Disease,C0012634,en_826,affects(Infered),Secondary bacterial pneumonia,C0339952,en_3811,None,None,AFFECTS(Infered),Infered,3
19265,Ability,C0085732,en_2688,affects(Infered),skills,C0678856,en_4575,None,None,AFFECTS(Infered),Infered,3
19266,Teacher,C0221457,en_3226,affects(Infered),Instructor,C0556993,en_4304,None,None,AFFECTS(Infered),Infered,3
19267,acute inflammatory response,C1817978,en_6041,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19268,acute inflammatory response,C1817978,en_6041,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19269,acute inflammatory response,C1817978,en_6041,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
19270,acute inflammatory response,C1817978,en_6041,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
19271,acute inflammatory response,C1817978,en_6041,affects(Infered),chemokine,C0282554,en_3651,None,None,AFFECTS(Infered),Infered,3
19272,acute inflammatory response,C1817978,en_6041,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
19273,acute inflammatory response,C1817978,en_6041,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19274,acute inflammatory response,C1817978,en_6041,affects(Infered),Lung diseases,C0024115,en_1462,None,None,AFFECTS(Infered),Infered,3
19275,acute inflammatory response,C1817978,en_6041,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19276,acute inflammatory response,C1817978,en_6041,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19277,acute inflammatory response,C1817978,en_6041,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
19278,acute inflammatory response,C1817978,en_6041,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
19279,acute inflammatory response,C1817978,en_6041,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
19280,acute inflammatory response,C1817978,en_6041,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
19281,acute inflammatory response,C1817978,en_6041,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
19282,acute inflammatory response,C1817978,en_6041,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
19283,acute inflammatory response,C1817978,en_6041,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
19284,acute inflammatory response,C1817978,en_6041,affects(Infered),Shock,C0036974,en_2097,None,None,AFFECTS(Infered),Infered,3
19285,acute inflammatory response,C1817978,en_6041,affects(Infered),Interleukin-1 beta,C0021753,en_1334,None,None,AFFECTS(Infered),Infered,3
19286,acute inflammatory response,C1817978,en_6041,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
19287,acute inflammatory response,C1817978,en_6041,affects(Infered),Cell Proliferation,C0596290,en_4384,None,None,AFFECTS(Infered),Infered,3
19288,acute inflammatory response,C1817978,en_6041,affects(Infered),Acute respiratory disease,C0264219,en_3527,None,None,AFFECTS(Infered),Infered,3
19289,acute inflammatory response,C1817978,en_6041,affects(Infered),"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,None,None,AFFECTS(Infered),Infered,3
19290,acute inflammatory response,C1817978,en_6041,affects(Infered),cyclooxygenase 2,C0387583,en_3904,None,None,AFFECTS(Infered),Infered,3
19291,Acetylcysteine,C0001047,en_219,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
19292,Fluimucil,C0699251,en_4700,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
19293,Fluimucil,C0699251,en_4700,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19294,Fluimucil,C0699251,en_4700,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19295,Fluimucil,C0699251,en_4700,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
19296,Fluimucil,C0699251,en_4700,affects(Infered),Adverse drug effect,C0041755,en_2312,None,None,AFFECTS(Infered),Infered,3
19297,Fluimucil,C0699251,en_4700,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
19298,Fluimucil,C0699251,en_4700,affects(Infered),Interleukin-8,C0079633,en_2608,None,None,AFFECTS(Infered),Infered,3
19299,Fluimucil,C0699251,en_4700,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
19300,Fluimucil,C0699251,en_4700,affects(Infered),"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,None,None,AFFECTS(Infered),Infered,3
19301,Fluimucil,C0699251,en_4700,affects(Infered),chemokine,C0282554,en_3651,None,None,AFFECTS(Infered),Infered,3
19302,Fluimucil,C0699251,en_4700,affects(Infered),angiotensin converting enzyme 2,C0960880,en_5195,None,None,AFFECTS(Infered),Infered,3
19303,Fluimucil,C0699251,en_4700,affects(Infered),glutathione S-transferase activity,C1152039,en_5306,None,None,AFFECTS(Infered),Infered,3
19304,Fluimucil,C0699251,en_4700,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
19305,Fluimucil,C0699251,en_4700,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
19306,Fluimucil,C0699251,en_4700,affects(Infered),Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,None,None,AFFECTS(Infered),Infered,3
19307,cytokine,C0079189,en_2593,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
19308,cytokine,C0079189,en_2593,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19309,cytokine,C0079189,en_2593,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
19310,cytokine,C0079189,en_2593,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19311,cytokine,C0079189,en_2593,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
19312,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
19313,Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,affects(Infered),cardiac arrhythmia,C0003811,en_397,None,None,AFFECTS(Infered),Infered,3
19314,Virus Diseases,C0042769,en_2362,affects(Infered),Infected,C0439663,en_4036,None,None,AFFECTS(Infered),Infered,3
19315,Armed macrophage,C0001280,en_228,affects(Infered),Tumor Necrosis Factors,C0041368,en_2300,None,None,AFFECTS(Infered),Infered,3
19316,Armed macrophage,C0001280,en_228,affects(Infered),Interferons,C0021747,en_1333,None,None,AFFECTS(Infered),Infered,3
19317,Armed macrophage,C0001280,en_228,affects(Infered),ACE2,C1422064,en_5723,None,None,AFFECTS(Infered),Infered,3
19318,Armed macrophage,C0001280,en_228,affects(Infered),attenuation,C0599946,en_4490,None,None,AFFECTS(Infered),Infered,3
19319,Armed macrophage,C0001280,en_228,affects(Infered),Metabolism,C0025519,en_1547,None,None,AFFECTS(Infered),Infered,3
19320,Armed macrophage,C0001280,en_228,affects(Infered),Nitric Oxide,C0028128,en_1682,None,None,AFFECTS(Infered),Infered,3
19321,Armed macrophage,C0001280,en_228,affects(Infered),Interleukin-1 beta,C0021753,en_1334,None,None,AFFECTS(Infered),Infered,3
19322,Armed macrophage,C0001280,en_228,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
19323,Armed macrophage,C0001280,en_228,affects(Infered),Reactive Oxygen Species,C0162772,en_2932,None,None,AFFECTS(Infered),Infered,3
19324,Armed macrophage,C0001280,en_228,affects(Infered),Retinal dehydrogenase,C0073099,en_2559,None,None,AFFECTS(Infered),Infered,3
19325,Armed macrophage,C0001280,en_228,affects(Infered),Immunoglobulins,C0021027,en_1282,None,None,AFFECTS(Infered),Infered,3
19326,Armed macrophage,C0001280,en_228,affects(Infered),Interleukins,C0021764,en_1345,None,None,AFFECTS(Infered),Infered,3
19327,Armed macrophage,C0001280,en_228,affects(Infered),Migration Inhibitory Factor,C0024429,en_1483,None,None,AFFECTS(Infered),Infered,3
19328,Armed macrophage,C0001280,en_228,affects(Infered),TNPO1|RPTOR|MAPKAP1,C1416706;C1846723;C1425758,en_193,None,None,AFFECTS(Infered),Infered,3
19329,Hospitalization,C0019993,en_1206,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
19330,C-reactive protein,C0006560,en_529,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
19331,C-reactive protein,C0006560,en_529,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19332,C-reactive protein,C0006560,en_529,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19333,C-reactive protein,C0006560,en_529,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
19334,Fibrin fragment D,C0060323,en_2484,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
19335,anti-inflammatory response,C1154987,en_5310,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
19336,pulmonary complications,C0281169,en_3627,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19337,pulmonary complications,C0281169,en_3627,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19338,pulmonary complications,C0281169,en_3627,affects(Infered),Evolution,C0015219,en_937,None,None,AFFECTS(Infered),Infered,3
19339,pulmonary complications,C0281169,en_3627,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
19340,pulmonary complications,C0281169,en_3627,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
19341,pulmonary complications,C0281169,en_3627,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
19342,pulmonary complications,C0281169,en_3627,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
19343,pulmonary complications,C0281169,en_3627,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
19344,pulmonary complications,C0281169,en_3627,affects(Infered),Male population group,C0025266,en_1533,None,None,AFFECTS(Infered),Infered,3
19345,pulmonary complications,C0281169,en_3627,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
19346,pulmonary complications,C0281169,en_3627,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
19347,pulmonary complications,C0281169,en_3627,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
19348,pulmonary complications,C0281169,en_3627,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
19349,pulmonary complications,C0281169,en_3627,affects(Infered),Acute coronary syndrome,C0948089,en_5159,None,None,AFFECTS(Infered),Infered,3
19350,pulmonary complications,C0281169,en_3627,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
19351,pulmonary complications,C0281169,en_3627,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
19352,pulmonary complications,C0281169,en_3627,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
19353,pulmonary complications,C0281169,en_3627,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
19354,pulmonary complications,C0281169,en_3627,affects(Infered),Thrombus,C0087086,en_2743,None,None,AFFECTS(Infered),Infered,3
19355,pulmonary complications,C0281169,en_3627,affects(Infered),Mothers,C0026591,en_1583,None,None,AFFECTS(Infered),Infered,3
19356,pulmonary complications,C0281169,en_3627,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
19357,pulmonary complications,C0281169,en_3627,affects(Infered),Disability NOS,C0231170,en_3247,None,None,AFFECTS(Infered),Infered,3
19358,pulmonary complications,C0281169,en_3627,affects(Infered),Birth,C0005615,en_476,None,None,AFFECTS(Infered),Infered,3
19359,pulmonary complications,C0281169,en_3627,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
19360,pulmonary complications,C0281169,en_3627,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
19361,pulmonary complications,C0281169,en_3627,affects(Infered),Abnormal Hemoglobins,C0019047,en_6523,None,None,AFFECTS(Infered),Infered,3
19362,pulmonary complications,C0281169,en_3627,affects(Infered),Pancreatic Polypeptide,C0030298,en_6541,None,None,AFFECTS(Infered),Infered,3
19363,pulmonary complications,C0281169,en_3627,affects(Infered),Troponin,C0041199,en_2287,None,None,AFFECTS(Infered),Infered,3
19364,pulmonary complications,C0281169,en_3627,affects(Infered),Weaning,C0043084,en_2386,None,None,AFFECTS(Infered),Infered,3
19365,pulmonary complications,C0281169,en_3627,affects(Infered),CARDIAC EVENT,C0741923,en_4791,None,None,AFFECTS(Infered),Infered,3
19366,pulmonary complications,C0281169,en_3627,affects(Infered),TMEM173,C4077403,en_6488,None,None,AFFECTS(Infered),Infered,3
19367,pulmonary complications,C0281169,en_3627,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
19368,pulmonary complications,C0281169,en_3627,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
19369,Adrenal Cortex Hormones,C0001617,en_247,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19370,Adrenal Cortex Hormones,C0001617,en_247,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
19371,Adrenal Cortex Hormones,C0001617,en_247,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19372,Adrenal Cortex Hormones,C0001617,en_247,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
19373,Interleukin-6,C0021760,en_1342,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
19374,Interleukin-6,C0021760,en_1342,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19375,Interleukin-6,C0021760,en_1342,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19376,Interleukin-6,C0021760,en_1342,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
19377,Lung,C0024109,en_1460,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
19378,Interleukin 6 Receptor,C0063717,en_2510,affects(Infered),Tocilizumab therapy,C4510396,en_6356,None,None,AFFECTS(Infered),Infered,3
19379,PULMONARY PROCESS,C0748169,en_4830,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
19380,PULMONARY PROCESS,C0748169,en_4830,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
19381,PULMONARY PROCESS,C0748169,en_4830,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
19382,PULMONARY PROCESS,C0748169,en_4830,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
19383,PULMONARY PROCESS,C0748169,en_4830,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
19384,ACE2,C1422064,en_5723,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
19385,Immune Cell,C4330475,en_6345,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
19386,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
19387,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
19388,Blood,C0005767,en_482,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
19389,Immune Cell,C4330475,en_6345,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
19390,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
19391,Immune system,C0020962,en_1271,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
19392,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
19393,Immune Cell,C4330475,en_6345,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
19394,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
19395,Immune system,C0020962,en_1271,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
19396,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
19397,Immune Cell,C4330475,en_6345,affects(Infered),Personal Satisfaction,C0031206,en_1780,None,None,AFFECTS(Infered),Infered,3
19398,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Personal Satisfaction,C0031206,en_1780,None,None,AFFECTS(Infered),Infered,3
19399,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Personal Satisfaction,C0031206,en_1780,None,None,AFFECTS(Infered),Infered,3
19400,Blood,C0005767,en_482,affects(Infered),Personal Satisfaction,C0031206,en_1780,None,None,AFFECTS(Infered),Infered,3
19401,Immune Cell,C4330475,en_6345,affects(Infered),Lesion,C0221198,en_3221,None,None,AFFECTS(Infered),Infered,3
19402,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Lesion,C0221198,en_3221,None,None,AFFECTS(Infered),Infered,3
19403,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Lesion,C0221198,en_3221,None,None,AFFECTS(Infered),Infered,3
19404,Immune Cell,C4330475,en_6345,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
19405,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
19406,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
19407,Blood,C0005767,en_482,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
19408,Immune Cell,C4330475,en_6345,affects(Infered),Scaling,C0237849,en_6611,None,None,AFFECTS(Infered),Infered,3
19409,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Scaling,C0237849,en_6611,None,None,AFFECTS(Infered),Infered,3
19410,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Scaling,C0237849,en_6611,None,None,AFFECTS(Infered),Infered,3
19411,Blood,C0005767,en_482,affects(Infered),Scaling,C0237849,en_6611,None,None,AFFECTS(Infered),Infered,3
19412,Immune Cell,C4330475,en_6345,affects(Infered),Duration of gestation,C0460089,en_4127,None,None,AFFECTS(Infered),Infered,3
19413,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Duration of gestation,C0460089,en_4127,None,None,AFFECTS(Infered),Infered,3
19414,Peripheral Blood Lymphocyte,C1518997,en_5878,affects(Infered),Duration of gestation,C0460089,en_4127,None,None,AFFECTS(Infered),Infered,3
19415,Blood,C0005767,en_482,affects(Infered),Duration of gestation,C0460089,en_4127,None,None,AFFECTS(Infered),Infered,3
19416,Immune Cell,C4330475,en_6345,affects(Infered),Recombinant Interferon-gamma,C0021740,en_1330,None,None,AFFECTS(Infered),Infered,3
19417,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Recombinant Interferon-gamma,C0021740,en_1330,None,None,AFFECTS(Infered),Infered,3
19418,Immune system,C0020962,en_1271,affects(Infered),Recombinant Interferon-gamma,C0021740,en_1330,None,None,AFFECTS(Infered),Infered,3
19419,Blood,C0005767,en_482,affects(Infered),Recombinant Interferon-gamma,C0021740,en_1330,None,None,AFFECTS(Infered),Infered,3
19420,Immune Cell,C4330475,en_6345,affects(Infered),Caspase-1,C0534519,en_4239,None,None,AFFECTS(Infered),Infered,3
19421,Conventional Dendritic Cell,C4085194,en_6318,affects(Infered),Caspase-1,C0534519,en_4239,None,None,AFFECTS(Infered),Infered,3
19422,Immune system,C0020962,en_1271,affects(Infered),Caspase-1,C0534519,en_4239,None,None,AFFECTS(Infered),Infered,3
19423,Blood,C0005767,en_482,affects(Infered),Caspase-1,C0534519,en_4239,None,None,AFFECTS(Infered),Infered,3
19424,Pathologic Processes,C0030660,en_1755,affects(Infered),Infected,C0439663,en_4036,None,None,AFFECTS(Infered),Infered,3
19425,Adverse event,C0877248,en_5069,affects(Infered),Tocilizumab therapy,C4510396,en_6356,None,None,AFFECTS(Infered),Infered,3
19426,Eating habit,C1266864,en_5434,affects(Infered),Health behavior,C0018687,en_1116,None,None,AFFECTS(Infered),Infered,3
19427,Ethanol,C0001962,en_271,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19428,Prevail,C3152857,en_6174,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19429,Ethanol,C0001962,en_271,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19430,Prevail,C3152857,en_6174,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19431,Povidone-Iodine,C0032857,en_1864,affects(Infered),Anxiety,C0003467,en_380,None,None,AFFECTS(Infered),Infered,3
19432,Prevail,C3152857,en_6174,affects(Infered),Anxiety,C0003467,en_380,None,None,AFFECTS(Infered),Infered,3
19433,Ethanol,C0001962,en_271,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19434,Prevail,C3152857,en_6174,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19435,Ethanol,C0001962,en_271,affects(Infered),inpatient,C0021562,en_1321,None,None,AFFECTS(Infered),Infered,3
19436,Prevail,C3152857,en_6174,affects(Infered),inpatient,C0021562,en_1321,None,None,AFFECTS(Infered),Infered,3
19437,Ethanol,C0001962,en_271,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
19438,Prevail,C3152857,en_6174,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
19439,Povidone-Iodine,C0032857,en_1864,affects(Infered),Lung,C0024109,en_1460,None,None,AFFECTS(Infered),Infered,3
19440,Prevail,C3152857,en_6174,affects(Infered),Lung,C0024109,en_1460,None,None,AFFECTS(Infered),Infered,3
19441,Povidone-Iodine,C0032857,en_1864,affects(Infered),Present,C0150312,en_2833,None,None,AFFECTS(Infered),Infered,3
19442,Prevail,C3152857,en_6174,affects(Infered),Present,C0150312,en_2833,None,None,AFFECTS(Infered),Infered,3
19443,Povidone-Iodine,C0032857,en_1864,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
19444,Prevail,C3152857,en_6174,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
19445,Povidone-Iodine,C0032857,en_1864,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
19446,Prevail,C3152857,en_6174,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
19447,Povidone-Iodine,C0032857,en_1864,affects(Infered),Blood Pressure,C0005823,en_492,None,None,AFFECTS(Infered),Infered,3
19448,Prevail,C3152857,en_6174,affects(Infered),Blood Pressure,C0005823,en_492,None,None,AFFECTS(Infered),Infered,3
19449,Povidone-Iodine,C0032857,en_1864,affects(Infered),Brain,C0006104,en_508,None,None,AFFECTS(Infered),Infered,3
19450,Prevail,C3152857,en_6174,affects(Infered),Brain,C0006104,en_508,None,None,AFFECTS(Infered),Infered,3
19451,Povidone-Iodine,C0032857,en_1864,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
19452,Prevail,C3152857,en_6174,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
19453,Povidone-Iodine,C0032857,en_1864,affects(Infered),Intestines,C0021853,en_1350,None,None,AFFECTS(Infered),Infered,3
19454,Prevail,C3152857,en_6174,affects(Infered),Intestines,C0021853,en_1350,None,None,AFFECTS(Infered),Infered,3
19455,Povidone-Iodine,C0032857,en_1864,affects(Infered),Opioid Use Disorders,C0029103,en_1711,None,None,AFFECTS(Infered),Infered,3
19456,Prevail,C3152857,en_6174,affects(Infered),Opioid Use Disorders,C0029103,en_1711,None,None,AFFECTS(Infered),Infered,3
19457,Povidone-Iodine,C0032857,en_1864,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
19458,Prevail,C3152857,en_6174,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
19459,Povidone-Iodine,C0032857,en_1864,affects(Infered),Suicide,C0038661,en_2178,None,None,AFFECTS(Infered),Infered,3
19460,Prevail,C3152857,en_6174,affects(Infered),Suicide,C0038661,en_2178,None,None,AFFECTS(Infered),Infered,3
19461,Povidone-Iodine,C0032857,en_1864,affects(Infered),Surface Tension,C0038887,en_2189,None,None,AFFECTS(Infered),Infered,3
19462,Prevail,C3152857,en_6174,affects(Infered),Surface Tension,C0038887,en_2189,None,None,AFFECTS(Infered),Infered,3
19463,Povidone-Iodine,C0032857,en_1864,affects(Infered),Unplanned pregnancy,C0041747,en_2311,None,None,AFFECTS(Infered),Infered,3
19464,Prevail,C3152857,en_6174,affects(Infered),Unplanned pregnancy,C0041747,en_2311,None,None,AFFECTS(Infered),Infered,3
19465,Povidone-Iodine,C0032857,en_1864,affects(Infered),Violence,C0042693,en_2353,None,None,AFFECTS(Infered),Infered,3
19466,Prevail,C3152857,en_6174,affects(Infered),Violence,C0042693,en_2353,None,None,AFFECTS(Infered),Infered,3
19467,Povidone-Iodine,C0032857,en_1864,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
19468,Prevail,C3152857,en_6174,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
19469,Povidone-Iodine,C0032857,en_1864,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19470,Prevail,C3152857,en_6174,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19471,Povidone-Iodine,C0032857,en_1864,affects(Infered),Homelessness,C0237154,en_3342,None,None,AFFECTS(Infered),Infered,3
19472,Prevail,C3152857,en_6174,affects(Infered),Homelessness,C0237154,en_3342,None,None,AFFECTS(Infered),Infered,3
19473,Povidone-Iodine,C0032857,en_1864,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
19474,Prevail,C3152857,en_6174,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
19475,Povidone-Iodine,C0032857,en_1864,affects(Infered),Family illness,C0344339,en_3837,None,None,AFFECTS(Infered),Infered,3
19476,Prevail,C3152857,en_6174,affects(Infered),Family illness,C0344339,en_3837,None,None,AFFECTS(Infered),Infered,3
19477,Povidone-Iodine,C0032857,en_1864,affects(Infered),Hyperactive behavior,C0424295,en_3992,None,None,AFFECTS(Infered),Infered,3
19478,Prevail,C3152857,en_6174,affects(Infered),Hyperactive behavior,C0424295,en_3992,None,None,AFFECTS(Infered),Infered,3
19479,Povidone-Iodine,C0032857,en_1864,affects(Infered),stressor,C0597530,en_4430,None,None,AFFECTS(Infered),Infered,3
19480,Prevail,C3152857,en_6174,affects(Infered),stressor,C0597530,en_4430,None,None,AFFECTS(Infered),Infered,3
19481,Povidone-Iodine,C0032857,en_1864,affects(Infered),attenuation,C0599946,en_4490,None,None,AFFECTS(Infered),Infered,3
19482,Prevail,C3152857,en_6174,affects(Infered),attenuation,C0599946,en_4490,None,None,AFFECTS(Infered),Infered,3
19483,Povidone-Iodine,C0032857,en_1864,affects(Infered),General Population,C0683971,en_4674,None,None,AFFECTS(Infered),Infered,3
19484,Prevail,C3152857,en_6174,affects(Infered),General Population,C0683971,en_4674,None,None,AFFECTS(Infered),Infered,3
19485,Povidone-Iodine,C0032857,en_1864,affects(Infered),heavy drinking,C0687132,en_4684,None,None,AFFECTS(Infered),Infered,3
19486,Prevail,C3152857,en_6174,affects(Infered),heavy drinking,C0687132,en_4684,None,None,AFFECTS(Infered),Infered,3
19487,Povidone-Iodine,C0032857,en_1864,affects(Infered),brain development,C1160340,en_5353,None,None,AFFECTS(Infered),Infered,3
19488,Prevail,C3152857,en_6174,affects(Infered),brain development,C1160340,en_5353,None,None,AFFECTS(Infered),Infered,3
19489,Ethanol,C0001962,en_271,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
19490,Prevail,C3152857,en_6174,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
19491,Ethanol,C0001962,en_271,affects(Infered),member,C0680022,en_4618,None,None,AFFECTS(Infered),Infered,3
19492,Prevail,C3152857,en_6174,affects(Infered),member,C0680022,en_4618,None,None,AFFECTS(Infered),Infered,3
19493,Ethanol,C0001962,en_271,affects(Infered),Food Consumption,C2983605,en_6164,None,None,AFFECTS(Infered),Infered,3
19494,Povidone-Iodine,C0032857,en_1864,affects(Infered),Food Consumption,C2983605,en_6164,None,None,AFFECTS(Infered),Infered,3
19495,Alkaline Phosphatase,C0002059,en_275,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
19496,Alkaline Phosphatase,C0002059,en_275,affects(Infered),Blood Coagulation Factor,C0005789,en_486,None,None,AFFECTS(Infered),Infered,3
19497,Severe asthma,C0581126,en_4345,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
19498,Severe asthma,C0581126,en_4345,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
19499,Severe asthma,C0581126,en_4345,affects(Infered),Hospitalization,C0019993,en_1206,None,None,AFFECTS(Infered),Infered,3
19500,Severe asthma,C0581126,en_4345,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
19501,Severe asthma,C0581126,en_4345,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
19502,Severe asthma,C0581126,en_4345,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
19503,Severe asthma,C0581126,en_4345,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
19504,Severe asthma,C0581126,en_4345,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
19505,Severe asthma,C0581126,en_4345,affects(Infered),Negative,C0205160,en_3126,None,None,AFFECTS(Infered),Infered,3
19506,Severe asthma,C0581126,en_4345,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19507,Severe asthma,C0581126,en_4345,affects(Infered),African race,C0027567,en_1646,None,None,AFFECTS(Infered),Infered,3
19508,Severe asthma,C0581126,en_4345,affects(Infered),Unipolar Depression,C0041696,en_2310,None,None,AFFECTS(Infered),Infered,3
19509,Severe asthma,C0581126,en_4345,affects(Infered),Hypercapnic respiratory failure,C0398353,en_3947,None,None,AFFECTS(Infered),Infered,3
19510,Severe asthma,C0581126,en_4345,affects(Infered),Respiratory distress,C0476273,en_4149,None,None,AFFECTS(Infered),Infered,3
19511,Streptococcal lymphadenitis of swine,C0275814,en_3571,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
19512,Streptococcal lymphadenitis of swine,C0275814,en_3571,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19513,AGTR1,C1439284,en_5,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
19514,Angiotensin II,C0003009,en_328,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
19515,Vascular Permeability,C0162337,en_2906,affects(Infered),Hypertensive disease,C0020538,en_1239,None,None,AFFECTS(Infered),Infered,3
19516,Capillary Permeability,C0006906,en_551,affects(Infered),Hypertensive disease,C0020538,en_1239,None,None,AFFECTS(Infered),Infered,3
19517,Acute Lung Injury,C0242488,en_3416,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19518,Acute Lung Injury,C0242488,en_3416,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19519,Acute Lung Injury,C0242488,en_3416,affects(Infered),Evolution,C0015219,en_937,None,None,AFFECTS(Infered),Infered,3
19520,Acute Lung Injury,C0242488,en_3416,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19521,Acute Lung Injury,C0242488,en_3416,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
19522,Acute Lung Injury,C0242488,en_3416,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
19523,Acute Lung Injury,C0242488,en_3416,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
19524,Acute Lung Injury,C0242488,en_3416,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
19525,Acute Lung Injury,C0242488,en_3416,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
19526,Acute Lung Injury,C0242488,en_3416,affects(Infered),Male population group,C0025266,en_1533,None,None,AFFECTS(Infered),Infered,3
19527,Acute Lung Injury,C0242488,en_3416,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
19528,Acute Lung Injury,C0242488,en_3416,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
19529,Acute Lung Injury,C0242488,en_3416,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
19530,Acute Lung Injury,C0242488,en_3416,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
19531,Acute Lung Injury,C0242488,en_3416,affects(Infered),Acute coronary syndrome,C0948089,en_5159,None,None,AFFECTS(Infered),Infered,3
19532,Acute Lung Injury,C0242488,en_3416,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
19533,Acute Lung Injury,C0242488,en_3416,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
19534,Acute Lung Injury,C0242488,en_3416,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
19535,Acute Lung Injury,C0242488,en_3416,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
19536,Acute Lung Injury,C0242488,en_3416,affects(Infered),Thrombus,C0087086,en_2743,None,None,AFFECTS(Infered),Infered,3
19537,Acute Lung Injury,C0242488,en_3416,affects(Infered),Mothers,C0026591,en_1583,None,None,AFFECTS(Infered),Infered,3
19538,Acute Lung Injury,C0242488,en_3416,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
19539,Acute Lung Injury,C0242488,en_3416,affects(Infered),Disability NOS,C0231170,en_3247,None,None,AFFECTS(Infered),Infered,3
19540,Acute Lung Injury,C0242488,en_3416,affects(Infered),Birth,C0005615,en_476,None,None,AFFECTS(Infered),Infered,3
19541,Acute Lung Injury,C0242488,en_3416,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
19542,Acute Lung Injury,C0242488,en_3416,affects(Infered),Abnormal Hemoglobins,C0019047,en_6523,None,None,AFFECTS(Infered),Infered,3
19543,Acute Lung Injury,C0242488,en_3416,affects(Infered),Pancreatic Polypeptide,C0030298,en_6541,None,None,AFFECTS(Infered),Infered,3
19544,Acute Lung Injury,C0242488,en_3416,affects(Infered),Troponin,C0041199,en_2287,None,None,AFFECTS(Infered),Infered,3
19545,Acute Lung Injury,C0242488,en_3416,affects(Infered),Weaning,C0043084,en_2386,None,None,AFFECTS(Infered),Infered,3
19546,Acute Lung Injury,C0242488,en_3416,affects(Infered),CARDIAC EVENT,C0741923,en_4791,None,None,AFFECTS(Infered),Infered,3
19547,Acute Lung Injury,C0242488,en_3416,affects(Infered),TMEM173,C4077403,en_6488,None,None,AFFECTS(Infered),Infered,3
19548,Acute Lung Injury,C0242488,en_3416,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
19549,Acute Lung Injury,C0242488,en_3416,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
19550,Angiotensins,C0003018,en_332,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
19551,Animal Viruses,C0003060,en_334,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19552,Animal Viruses,C0003060,en_334,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19553,Animal Viruses,C0003060,en_334,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
19554,Animal Viruses,C0003060,en_334,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
19555,Animal Viruses,C0003060,en_334,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
19556,Animal Viruses,C0003060,en_334,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
19557,Animal Viruses,C0003060,en_334,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19558,Animal Viruses,C0003060,en_334,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
19559,Animal Viruses,C0003060,en_334,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19560,Animal Viruses,C0003060,en_334,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19561,Animal Viruses,C0003060,en_334,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
19562,Animal Viruses,C0003060,en_334,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
19563,Animal Viruses,C0003060,en_334,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19564,Animal Viruses,C0003060,en_334,affects(Infered),Lower respiratory tract infection,C0149725,en_2806,None,None,AFFECTS(Infered),Infered,3
19565,Animal Viruses,C0003060,en_334,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
19566,Animal Viruses,C0003060,en_334,affects(Infered),"Infections, Hospital",C0205721,en_3133,None,None,AFFECTS(Infered),Infered,3
19567,Animal Viruses,C0003060,en_334,affects(Infered),Myocarditis,C0027059,en_1627,None,None,AFFECTS(Infered),Infered,3
19568,Animal Viruses,C0003060,en_334,affects(Infered),"Pneumonia, Viral",C0032310,en_1837,None,None,AFFECTS(Infered),Infered,3
19569,Animal Viruses,C0003060,en_334,affects(Infered),Acute respiratory infection NOS,C0339901,en_3809,None,None,AFFECTS(Infered),Infered,3
19570,Animal Viruses,C0003060,en_334,affects(Infered),Common Cold,C0009443,en_684,None,None,AFFECTS(Infered),Infered,3
19571,Animal Viruses,C0003060,en_334,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
19572,Animal Viruses,C0003060,en_334,affects(Infered),Dysautonomia,C0013363,en_863,None,None,AFFECTS(Infered),Infered,3
19573,Animal Viruses,C0003060,en_334,affects(Infered),cell injury,C0599732,en_4467,None,None,AFFECTS(Infered),Infered,3
19574,Animal Viruses,C0003060,en_334,affects(Infered),AIRWAY DISEASE,C0699949,en_4711,None,None,AFFECTS(Infered),Infered,3
19575,Animal Viruses,C0003060,en_334,affects(Infered),Chronic inflammatory disorder,C1290886,en_5485,None,None,AFFECTS(Infered),Infered,3
19576,Animal Viruses,C0003060,en_334,affects(Infered),"Hemorrhagic Fevers, Viral",C0019104,en_1164,None,None,AFFECTS(Infered),Infered,3
19577,Animal Viruses,C0003060,en_334,affects(Infered),"[X]Acute myocarditis, unspecified",C0155686,en_2889,None,None,AFFECTS(Infered),Infered,3
19578,Animal Viruses,C0003060,en_334,affects(Infered),"Communicable Diseases, Emerging",C0872315,en_5049,None,None,AFFECTS(Infered),Infered,3
19579,Animal Viruses,C0003060,en_334,affects(Infered),Malignant disease,C0442867,en_4059,None,None,AFFECTS(Infered),Infered,3
19580,Animal Viruses,C0003060,en_334,affects(Infered),Reception,C0544683,en_4264,None,None,AFFECTS(Infered),Infered,3
19581,Animal Viruses,C0003060,en_334,affects(Infered),Disorder of upper respiratory system,C0264221,en_3529,None,None,AFFECTS(Infered),Infered,3
19582,Animal Viruses,C0003060,en_334,affects(Infered),Anthropozoonosis,C0275535,en_3567,None,None,AFFECTS(Infered),Infered,3
19583,Animal Viruses,C0003060,en_334,affects(Infered),Infectious canine tracheobronchitis,C0276170,en_3575,None,None,AFFECTS(Infered),Infered,3
19584,Animal Viruses,C0003060,en_334,affects(Infered),Zoonotic infection NOS,C0854537,en_4961,None,None,AFFECTS(Infered),Infered,3
19585,Anti-Inflammatory Agents,C0003209,en_342,affects(Infered),Low molecular weight heparin therapy,C2733531,en_6131,None,None,AFFECTS(Infered),Infered,3
19586,Malignant Neoplasms,C0006826,en_545,affects(Infered),thymic stromal lymphopoietin,C0762640,en_4865,None,None,AFFECTS(Infered),Infered,3
19587,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
19588,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19589,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19590,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
19591,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
19592,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
19593,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Lung diseases,C0024115,en_1462,None,None,AFFECTS(Infered),Infered,3
19594,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19595,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19596,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Lung,C0024109,en_1460,None,None,AFFECTS(Infered),Infered,3
19597,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
19598,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
19599,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Pulmonary Embolism,C0034065,en_1930,None,None,AFFECTS(Infered),Infered,3
19600,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
19601,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19602,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
19603,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Acute Lung Injury,C0242488,en_3416,None,None,AFFECTS(Infered),Infered,3
19604,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Malaise,C0231218,en_3251,None,None,AFFECTS(Infered),Infered,3
19605,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Blood Clot,C0302148,en_3702,None,None,AFFECTS(Infered),Infered,3
19606,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Thromboembolism,C0040038,en_2230,None,None,AFFECTS(Infered),Infered,3
19607,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Hemorrhage,C0019080,en_1161,None,None,AFFECTS(Infered),Infered,3
19608,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Blood Platelets,C0005821,en_491,None,None,AFFECTS(Infered),Infered,3
19609,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Patient ventilated,C1299448,en_5503,None,None,AFFECTS(Infered),Infered,3
19610,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Factor V,C0015498,en_957,None,None,AFFECTS(Infered),Infered,3
19611,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Neurologic Symptoms,C0235031,en_3318,None,None,AFFECTS(Infered),Infered,3
19612,Low molecular weight heparin therapy,C2733531,en_6131,affects(Infered),Fibrin deposition,C0333565,en_3769,None,None,AFFECTS(Infered),Infered,3
19613,influenza A virus nucleoprotein,C0063529,en_2506,affects(Infered),Virion,C0042760,en_2360,None,None,AFFECTS(Infered),Infered,3
19614,influenza A virus nucleoprotein,C0063529,en_2506,affects(Infered),Receptor Binding,C0597358,en_4423,None,None,AFFECTS(Infered),Infered,3
19615,Pneumonia caused by SARS-CoV-2,C5244027,en_6427,affects(Infered),anticoagulant activity,C1148561,en_5297,None,None,AFFECTS(Infered),Infered,3
19616,"Passive immunity, function",C0678210,en_4555,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19617,"Passive immunity, function",C0678210,en_4555,affects(Infered),Predisposition,C0220898,en_3206,None,None,AFFECTS(Infered),Infered,3
19618,"Passive immunity, function",C0678210,en_4555,affects(Infered),Tuberculosis,C0041296,en_2293,None,None,AFFECTS(Infered),Infered,3
19619,Pharmaceutical Preparations,C0013227,en_856,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
19620,Pharmaceutical Preparations,C0013227,en_856,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19621,Pharmaceutical Preparations,C0013227,en_856,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
19622,Pharmaceutical Preparations,C0013227,en_856,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19623,human leukocyte interferon,C0733470,en_4772,affects(Infered),Premature Birth,C0151526,en_2860,None,None,AFFECTS(Infered),Infered,3
19624,human leukocyte interferon,C0733470,en_4772,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19625,human leukocyte interferon,C0733470,en_4772,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
19626,human leukocyte interferon,C0733470,en_4772,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
19627,human leukocyte interferon,C0733470,en_4772,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
19628,human leukocyte interferon,C0733470,en_4772,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
19629,human leukocyte interferon,C0733470,en_4772,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
19630,human leukocyte interferon,C0733470,en_4772,affects(Infered),Chronic inflammation,C0021376,en_1309,None,None,AFFECTS(Infered),Infered,3
19631,human leukocyte interferon,C0733470,en_4772,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
19632,human leukocyte interferon,C0733470,en_4772,affects(Infered),Thromboplastin,C0040048,en_2232,None,None,AFFECTS(Infered),Infered,3
19633,human leukocyte interferon,C0733470,en_4772,affects(Infered),Acute-Phase Proteins,C0001347,en_232,None,None,AFFECTS(Infered),Infered,3
19634,human leukocyte interferon,C0733470,en_4772,affects(Infered),C-reactive protein,C0006560,en_529,None,None,AFFECTS(Infered),Infered,3
19635,human leukocyte interferon,C0733470,en_4772,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
19636,human leukocyte interferon,C0733470,en_4772,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
19637,human leukocyte interferon,C0733470,en_4772,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19638,human leukocyte interferon,C0733470,en_4772,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19639,human leukocyte interferon,C0733470,en_4772,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
19640,human leukocyte interferon,C0733470,en_4772,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
19641,human leukocyte interferon,C0733470,en_4772,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
19642,human leukocyte interferon,C0733470,en_4772,affects(Infered),Storm NOS,C2905612,en_6141,None,None,AFFECTS(Infered),Infered,3
19643,human leukocyte interferon,C0733470,en_4772,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
19644,human leukocyte interferon,C0733470,en_4772,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19645,human leukocyte interferon,C0733470,en_4772,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
19646,human leukocyte interferon,C0733470,en_4772,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19647,human leukocyte interferon,C0733470,en_4772,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
19648,human leukocyte interferon,C0733470,en_4772,affects(Infered),Severe infection,C5139167,en_6407,None,None,AFFECTS(Infered),Infered,3
19649,human leukocyte interferon,C0733470,en_4772,affects(Infered),Pathologic Processes,C0030660,en_1755,None,None,AFFECTS(Infered),Infered,3
19650,human leukocyte interferon,C0733470,en_4772,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
19651,human leukocyte interferon,C0733470,en_4772,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
19652,human leukocyte interferon,C0733470,en_4772,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
19653,human leukocyte interferon,C0733470,en_4772,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
19654,human leukocyte interferon,C0733470,en_4772,affects(Infered),Brain,C0006104,en_508,None,None,AFFECTS(Infered),Infered,3
19655,human leukocyte interferon,C0733470,en_4772,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19656,human leukocyte interferon,C0733470,en_4772,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
19657,human leukocyte interferon,C0733470,en_4772,affects(Infered),Hyperactive behavior,C0424295,en_3992,None,None,AFFECTS(Infered),Infered,3
19658,human leukocyte interferon,C0733470,en_4772,affects(Infered),Shock,C0036974,en_2097,None,None,AFFECTS(Infered),Infered,3
19659,human leukocyte interferon,C0733470,en_4772,affects(Infered),Toxic effect,C0600688,en_4513,None,None,AFFECTS(Infered),Infered,3
19660,human leukocyte interferon,C0733470,en_4772,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
19661,human leukocyte interferon,C0733470,en_4772,affects(Infered),Little's Disease,C0023882,en_1451,None,None,AFFECTS(Infered),Infered,3
19662,human leukocyte interferon,C0733470,en_4772,affects(Infered),Influenza,C0021400,en_1311,None,None,AFFECTS(Infered),Infered,3
19663,human leukocyte interferon,C0733470,en_4772,affects(Infered),Permeability,C0031164,en_1779,None,None,AFFECTS(Infered),Infered,3
19664,human leukocyte interferon,C0733470,en_4772,affects(Infered),Acute Lung Injury,C0242488,en_3416,None,None,AFFECTS(Infered),Infered,3
19665,human leukocyte interferon,C0733470,en_4772,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19666,human leukocyte interferon,C0733470,en_4772,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
19667,human leukocyte interferon,C0733470,en_4772,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
19668,human leukocyte interferon,C0733470,en_4772,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
19669,human leukocyte interferon,C0733470,en_4772,affects(Infered),Matrix Metalloproteinases,C0623362,en_4521,None,None,AFFECTS(Infered),Infered,3
19670,human leukocyte interferon,C0733470,en_4772,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
19671,human leukocyte interferon,C0733470,en_4772,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
19672,human leukocyte interferon,C0733470,en_4772,affects(Infered),Inflammation Process,C1512753,en_5825,None,None,AFFECTS(Infered),Infered,3
19673,human leukocyte interferon,C0733470,en_4772,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
19674,human leukocyte interferon,C0733470,en_4772,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
19675,human leukocyte interferon,C0733470,en_4772,affects(Infered),Respiratory complication,C0161818,en_2899,None,None,AFFECTS(Infered),Infered,3
19676,human leukocyte interferon,C0733470,en_4772,affects(Infered),Antigen-Antibody Complex,C0003313,en_361,None,None,AFFECTS(Infered),Infered,3
19677,human leukocyte interferon,C0733470,en_4772,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
19678,human leukocyte interferon,C0733470,en_4772,affects(Infered),Endothelial dysfunction,C0856169,en_4968,None,None,AFFECTS(Infered),Infered,3
19679,human leukocyte interferon,C0733470,en_4772,affects(Infered),Tuberculosis,C0041296,en_2293,None,None,AFFECTS(Infered),Infered,3
19680,human leukocyte interferon,C0733470,en_4772,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
19681,human leukocyte interferon,C0733470,en_4772,affects(Infered),Homeostasis,C0019868,en_1201,None,None,AFFECTS(Infered),Infered,3
19682,human leukocyte interferon,C0733470,en_4772,affects(Infered),Lymphocyte,C0024264,en_1469,None,None,AFFECTS(Infered),Infered,3
19683,human leukocyte interferon,C0733470,en_4772,affects(Infered),Respiratory distress,C0476273,en_4149,None,None,AFFECTS(Infered),Infered,3
19684,human leukocyte interferon,C0733470,en_4772,affects(Infered),ANP32B gene,C1332090,en_5581,None,None,AFFECTS(Infered),Infered,3
19685,human leukocyte interferon,C0733470,en_4772,affects(Infered),Tissue damage,C0010957,en_756,None,None,AFFECTS(Infered),Infered,3
19686,human leukocyte interferon,C0733470,en_4772,affects(Infered),Muscular Atrophy,C0026846,en_1604,None,None,AFFECTS(Infered),Infered,3
19687,human leukocyte interferon,C0733470,en_4772,affects(Infered),Macrophage activation syndrome,C1096155,en_5233,None,None,AFFECTS(Infered),Infered,3
19688,human leukocyte interferon,C0733470,en_4772,affects(Infered),Inflammatory disorder,C1290884,en_5483,None,None,AFFECTS(Infered),Infered,3
19689,human leukocyte interferon,C0733470,en_4772,affects(Infered),Pulmonary Fibrosis,C0034069,en_1932,None,None,AFFECTS(Infered),Infered,3
19690,human leukocyte interferon,C0733470,en_4772,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
19691,human leukocyte interferon,C0733470,en_4772,affects(Infered),Organ,C0178784,en_2991,None,None,AFFECTS(Infered),Infered,3
19692,human leukocyte interferon,C0733470,en_4772,affects(Infered),Cell Communication,C0007582,en_585,None,None,AFFECTS(Infered),Infered,3
19693,human leukocyte interferon,C0733470,en_4772,affects(Infered),Reactive Oxygen Species,C0162772,en_2932,None,None,AFFECTS(Infered),Infered,3
19694,human leukocyte interferon,C0733470,en_4772,affects(Infered),Cell Growth,C0007595,en_590,None,None,AFFECTS(Infered),Infered,3
19695,human leukocyte interferon,C0733470,en_4772,affects(Infered),Acute inflammation,C0333361,en_3763,None,None,AFFECTS(Infered),Infered,3
19696,human leukocyte interferon,C0733470,en_4772,affects(Infered),Kidney Diseases,C0022658,en_1381,None,None,AFFECTS(Infered),Infered,3
19697,human leukocyte interferon,C0733470,en_4772,affects(Infered),Hematopoiesis,C0018951,en_1152,None,None,AFFECTS(Infered),Infered,3
19698,human leukocyte interferon,C0733470,en_4772,affects(Infered),"Polymorphism, Genetic",C0032529,en_1849,None,None,AFFECTS(Infered),Infered,3
19699,human leukocyte interferon,C0733470,en_4772,affects(Infered),imbalance,C1397014,en_5692,None,None,AFFECTS(Infered),Infered,3
19700,human leukocyte interferon,C0733470,en_4772,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
19701,human leukocyte interferon,C0733470,en_4772,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
19702,human leukocyte interferon,C0733470,en_4772,affects(Infered),Signal Pathways,C0037080,en_2104,None,None,AFFECTS(Infered),Infered,3
19703,human leukocyte interferon,C0733470,en_4772,affects(Infered),myocardium; injury,C0746730,en_4817,None,None,AFFECTS(Infered),Infered,3
19704,human leukocyte interferon,C0733470,en_4772,affects(Infered),Male Genital Organs,C0017422,en_1058,None,None,AFFECTS(Infered),Infered,3
19705,human leukocyte interferon,C0733470,en_4772,affects(Infered),Osteogenesis,C0029433,en_1724,None,None,AFFECTS(Infered),Infered,3
19706,human leukocyte interferon,C0733470,en_4772,affects(Infered),iron metabolism,C0596803,en_4396,None,None,AFFECTS(Infered),Infered,3
19707,human leukocyte interferon,C0733470,en_4772,affects(Infered),type 2 immune response,C3159116,en_6176,None,None,AFFECTS(Infered),Infered,3
19708,human leukocyte interferon,C0733470,en_4772,affects(Infered),biological adaptation to stress,C0149784,en_2810,None,None,AFFECTS(Infered),Infered,3
19709,human leukocyte interferon,C0733470,en_4772,affects(Infered),"NOS3 protein, human",C0669365,en_4534,None,None,AFFECTS(Infered),Infered,3
19710,human leukocyte interferon,C0733470,en_4772,affects(Infered),Subclinical infection,C0275522,en_3565,None,None,AFFECTS(Infered),Infered,3
19711,human leukocyte interferon,C0733470,en_4772,affects(Infered),NF-kappa B,C0079904,en_2615,None,None,AFFECTS(Infered),Infered,3
19712,human leukocyte interferon,C0733470,en_4772,affects(Infered),Interleukins,C0021764,en_1345,None,None,AFFECTS(Infered),Infered,3
19713,human leukocyte interferon,C0733470,en_4772,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
19714,human leukocyte interferon,C0733470,en_4772,affects(Infered),"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,None,None,AFFECTS(Infered),Infered,3
19715,human leukocyte interferon,C0733470,en_4772,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
19716,human leukocyte interferon,C0733470,en_4772,affects(Infered),Protein C,C0033621,en_1908,None,None,AFFECTS(Infered),Infered,3
19717,human leukocyte interferon,C0733470,en_4772,affects(Infered),Spermatogenesis,C0037864,en_2139,None,None,AFFECTS(Infered),Infered,3
19718,human leukocyte interferon,C0733470,en_4772,affects(Infered),Acute encephalopathy,C1306587,en_5522,None,None,AFFECTS(Infered),Infered,3
19719,human leukocyte interferon,C0733470,en_4772,affects(Infered),Microglia,C0206116,en_3147,None,None,AFFECTS(Infered),Infered,3
19720,human leukocyte interferon,C0733470,en_4772,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
19721,human leukocyte interferon,C0733470,en_4772,affects(Infered),"Toxins, Chimeric",C0085998,en_2700,None,None,AFFECTS(Infered),Infered,3
19722,human leukocyte interferon,C0733470,en_4772,affects(Infered),activin A,C0100748,en_2749,None,None,AFFECTS(Infered),Infered,3
19723,human leukocyte interferon,C0733470,en_4772,affects(Infered),Single organ dysfunction,C0349410,en_3841,None,None,AFFECTS(Infered),Infered,3
19724,human leukocyte interferon,C0733470,en_4772,affects(Infered),Severe inflammation,C0522569,en_4215,None,None,AFFECTS(Infered),Infered,3
19725,human leukocyte interferon,C0733470,en_4772,affects(Infered),metalloenzyme,C0596918,en_4402,None,None,AFFECTS(Infered),Infered,3
19726,human leukocyte interferon,C0733470,en_4772,affects(Infered),testicular function,C0678881,en_4579,None,None,AFFECTS(Infered),Infered,3
19727,human leukocyte interferon,C0733470,en_4772,affects(Infered),organic disorders,C0683324,en_4660,None,None,AFFECTS(Infered),Infered,3
19728,human leukocyte interferon,C0733470,en_4772,affects(Infered),ALLERGIC SYMPTOM,C0740903,en_4785,None,None,AFFECTS(Infered),Infered,3
19729,human leukocyte interferon,C0733470,en_4772,affects(Infered),Structure of parenchyma of lung,C0819757,en_4926,None,None,AFFECTS(Infered),Infered,3
19730,human leukocyte interferon,C0733470,en_4772,affects(Infered),Hypos,C0858246,en_6688,None,None,AFFECTS(Infered),Infered,3
19731,human leukocyte interferon,C0733470,en_4772,affects(Infered),CD14+ cell,C0947286,en_5153,None,None,AFFECTS(Infered),Infered,3
19732,human leukocyte interferon,C0733470,en_4772,affects(Infered),TNFSF13B,C1420816,en_109,None,None,AFFECTS(Infered),Infered,3
19733,human leukocyte interferon,C0733470,en_4772,affects(Infered),Alveolar,C1440080,en_5730,None,None,AFFECTS(Infered),Infered,3
19734,human leukocyte interferon,C0733470,en_4772,affects(Infered),Signaling Molecule,C1519315,en_5883,None,None,AFFECTS(Infered),Infered,3
19735,Proteins,C0033684,en_1912,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
19736,Proteins,C0033684,en_1912,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
19737,Proteins,C0033684,en_1912,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
19738,Proteins,C0033684,en_1912,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
19739,anticoagulation,C0003281,en_355,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19740,anticoagulation,C0003281,en_355,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
19741,anticoagulation,C0003281,en_355,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
19742,anticoagulation,C0003281,en_355,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19743,anticoagulation,C0003281,en_355,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19744,anticoagulation,C0003281,en_355,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
19745,anticoagulation,C0003281,en_355,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
19746,anticoagulation,C0003281,en_355,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
19747,anticoagulation,C0003281,en_355,affects(Infered),Severe infection,C5139167,en_6407,None,None,AFFECTS(Infered),Infered,3
19748,anticoagulation,C0003281,en_355,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
19749,anticoagulation,C0003281,en_355,affects(Infered),Geriatric Patients,C0870602,en_5007,None,None,AFFECTS(Infered),Infered,3
19750,anticoagulation,C0003281,en_355,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
19751,anticoagulation,C0003281,en_355,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
19752,anticoagulation,C0003281,en_355,affects(Infered),Physicians,C0031831,en_1805,None,None,AFFECTS(Infered),Infered,3
19753,anticoagulation,C0003281,en_355,affects(Infered),imbalance,C1397014,en_5692,None,None,AFFECTS(Infered),Infered,3
19754,anticoagulation,C0003281,en_355,affects(Infered),Storm Syndrome,C1861452,en_6056,None,None,AFFECTS(Infered),Infered,3
19755,anticoagulation,C0003281,en_355,affects(Infered),Middle East Respiratory Syndrome,C3694279,en_6232,None,None,AFFECTS(Infered),Infered,3
19756,anticoagulation,C0003281,en_355,affects(Infered),High risk of,C0332167,en_3748,None,None,AFFECTS(Infered),Infered,3
19757,Antigens,C0003320,en_365,affects(Infered),Toll-like receptor 9,C0963057,en_5199,None,None,AFFECTS(Infered),Infered,3
19758,Toll-like receptor 9,C0963057,en_5199,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
19759,Toll-like receptor 9,C0963057,en_5199,affects(Infered),TLR9,C1423633,en_135,None,None,AFFECTS(Infered),Infered,3
19760,Toll-like receptor 9,C0963057,en_5199,affects(Infered),Ligand Binding,C1517880,en_5869,None,None,AFFECTS(Infered),Infered,3
19761,Toll-like receptor 9,C0963057,en_5199,affects(Infered),Receptor Signaling,C1514762,en_5838,None,None,AFFECTS(Infered),Infered,3
19762,Antioxidants,C0003402,en_372,affects(Infered),Vascular Permeability,C0162337,en_2906,None,None,AFFECTS(Infered),Infered,3
19763,Complement System Proteins,C0009498,en_691,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
19764,viral genome replication,C1160701,en_5361,affects(Infered),virion attachment,C1160649,en_5359,None,None,AFFECTS(Infered),Infered,3
19765,Body Fluids,C0005889,en_496,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
19766,Dipyridamole,C0012582,en_823,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
19767,Aggrenox,C0732282,en_4771,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
19768,Dipyridamole,C0012582,en_823,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19769,Dipyridamole,C0012582,en_823,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19770,Aggrenox,C0732282,en_4771,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19771,Dipyridamole,C0012582,en_823,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19772,Aggrenox,C0732282,en_4771,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
19773,Dipyridamole,C0012582,en_823,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19774,Aggrenox,C0732282,en_4771,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19775,Dipyridamole,C0012582,en_823,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19776,Aggrenox,C0732282,en_4771,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19777,Dipyridamole,C0012582,en_823,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19778,Aggrenox,C0732282,en_4771,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19779,Dipyridamole,C0012582,en_823,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19780,Aggrenox,C0732282,en_4771,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19781,Dipyridamole,C0012582,en_823,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
19782,Aggrenox,C0732282,en_4771,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
19783,Dipyridamole,C0012582,en_823,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
19784,Aggrenox,C0732282,en_4771,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
19785,Dipyridamole,C0012582,en_823,affects(Infered),Chronic pain,C0150055,en_2816,None,None,AFFECTS(Infered),Infered,3
19786,Aggrenox,C0732282,en_4771,affects(Infered),Chronic pain,C0150055,en_2816,None,None,AFFECTS(Infered),Infered,3
19787,Dipyridamole,C0012582,en_823,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
19788,Aggrenox,C0732282,en_4771,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
19789,Dipyridamole,C0012582,en_823,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
19790,Aggrenox,C0732282,en_4771,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
19791,Aspirin,C0004057,en_414,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
19792,Aggrenox,C0732282,en_4771,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
19793,Aspirin,C0004057,en_414,affects(Infered),Blood coagulation,C0005778,en_484,None,None,AFFECTS(Infered),Infered,3
19794,Aggrenox,C0732282,en_4771,affects(Infered),Blood coagulation,C0005778,en_484,None,None,AFFECTS(Infered),Infered,3
19795,Dipyridamole,C0012582,en_823,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
19796,Aggrenox,C0732282,en_4771,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
19797,Dipyridamole,C0012582,en_823,affects(Infered),Platelet function,C1254881,en_5398,None,None,AFFECTS(Infered),Infered,3
19798,Aggrenox,C0732282,en_4771,affects(Infered),Platelet function,C1254881,en_5398,None,None,AFFECTS(Infered),Infered,3
19799,Dipyridamole,C0012582,en_823,affects(Infered),Mothers,C0026591,en_1583,None,None,AFFECTS(Infered),Infered,3
19800,Aggrenox,C0732282,en_4771,affects(Infered),Mothers,C0026591,en_1583,None,None,AFFECTS(Infered),Infered,3
19801,Dipyridamole,C0012582,en_823,affects(Infered),Hypertension induced by pregnancy,C0340274,en_3815,None,None,AFFECTS(Infered),Infered,3
19802,Aggrenox,C0732282,en_4771,affects(Infered),Hypertension induced by pregnancy,C0340274,en_3815,None,None,AFFECTS(Infered),Infered,3
19803,Dipyridamole,C0012582,en_823,affects(Infered),cyclooxygenase 1,C0389003,en_3906,None,None,AFFECTS(Infered),Infered,3
19804,Aggrenox,C0732282,en_4771,affects(Infered),cyclooxygenase 1,C0389003,en_3906,None,None,AFFECTS(Infered),Infered,3
19805,Bioenergetics,C0005486,en_464,affects(Infered),Energy Balance,C0597987,en_4440,None,None,AFFECTS(Infered),Infered,3
19806,PULMONARY INVOLVEMENT,C0748159,en_4828,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
19807,PULMONARY INVOLVEMENT,C0748159,en_4828,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
19808,PULMONARY INVOLVEMENT,C0748159,en_4828,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
19809,PULMONARY INVOLVEMENT,C0748159,en_4828,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
19810,PULMONARY INVOLVEMENT,C0748159,en_4828,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
19811,Movement,C0026649,en_1588,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
19812,Movement,C0026649,en_1588,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
19813,Movement,C0026649,en_1588,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
19814,Movement,C0026649,en_1588,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19815,Movement,C0026649,en_1588,affects(Infered),Arteriosclerosis,C0003850,en_399,None,None,AFFECTS(Infered),Infered,3
19816,Movement,C0026649,en_1588,affects(Infered),"Cardiomyopathy, Dilated",C0007193,en_566,None,None,AFFECTS(Infered),Infered,3
19817,Movement,C0026649,en_1588,affects(Infered),Immune System Diseases,C0021053,en_1284,None,None,AFFECTS(Infered),Infered,3
19818,Toddler,C0682053,en_4633,affects(Infered),Classification,C0008902,en_651,None,None,AFFECTS(Infered),Infered,3
19819,Toddler,C0682053,en_4633,affects(Infered),Study models,C0026336,en_1575,None,None,AFFECTS(Infered),Infered,3
19820,"Biological function, NOS",C0277784,en_3587,affects(Infered),Infected,C0439663,en_4036,None,None,AFFECTS(Infered),Infered,3
19821,Rheumatism,C0035435,en_2028,affects(Infered),autoimmune rheumatologic disease,C1328842,en_5574,None,None,AFFECTS(Infered),Infered,3
19822,Blood Circulation,C0005775,en_483,affects(Infered),blood pressure regulation,C0678863,en_4576,None,None,AFFECTS(Infered),Infered,3
19823,Heart,C0018787,en_1130,affects(Infered),QT interval:Time:Point in time:Heart:Quantitative:EKG,C0488414,en_4154,None,None,AFFECTS(Infered),Infered,3
19824,Blood Glucose,C0005802,en_490,affects(Infered),"Monitors, Personal, Glucose",C0872182,en_5041,None,None,AFFECTS(Infered),Infered,3
19825,Infected,C0439663,en_4036,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19826,Infected,C0439663,en_4036,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19827,Organism,C0029235,en_1717,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19828,Infected,C0439663,en_4036,affects(Infered),Gastrointestinal Diseases,C0017178,en_1039,None,None,AFFECTS(Infered),Infered,3
19829,Infected,C0439663,en_4036,affects(Infered),"Pneumonia, Ventilator-Associated",C1701940,en_6025,None,None,AFFECTS(Infered),Infered,3
19830,Brachytherapy,C0006098,en_506,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
19831,Brachytherapy,C0006098,en_506,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19832,Brachytherapy,C0006098,en_506,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19833,Brachytherapy,C0006098,en_506,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
19834,Brachytherapy,C0006098,en_506,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
19835,Brachytherapy,C0006098,en_506,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
19836,Brachytherapy,C0006098,en_506,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
19837,Brachytherapy,C0006098,en_506,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19838,Brachytherapy,C0006098,en_506,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
19839,Brachytherapy,C0006098,en_506,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
19840,Brachytherapy,C0006098,en_506,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
19841,Brachytherapy,C0006098,en_506,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
19842,Brachytherapy,C0006098,en_506,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
19843,Brachytherapy,C0006098,en_506,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19844,Brachytherapy,C0006098,en_506,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
19845,Brachytherapy,C0006098,en_506,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
19846,Brachytherapy,C0006098,en_506,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
19847,Brachytherapy,C0006098,en_506,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19848,Brachytherapy,C0006098,en_506,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
19849,Brachytherapy,C0006098,en_506,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
19850,Brachytherapy,C0006098,en_506,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19851,Brachytherapy,C0006098,en_506,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
19852,Brachytherapy,C0006098,en_506,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
19853,Brachytherapy,C0006098,en_506,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
19854,Brachytherapy,C0006098,en_506,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
19855,Brachytherapy,C0006098,en_506,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
19856,Brachytherapy,C0006098,en_506,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
19857,Brachytherapy,C0006098,en_506,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
19858,Brachytherapy,C0006098,en_506,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
19859,Brachytherapy,C0006098,en_506,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
19860,Brachytherapy,C0006098,en_506,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
19861,Brachytherapy,C0006098,en_506,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
19862,Brachytherapy,C0006098,en_506,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
19863,Brachytherapy,C0006098,en_506,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
19864,Brachytherapy,C0006098,en_506,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
19865,Brachytherapy,C0006098,en_506,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
19866,Brachytherapy,C0006098,en_506,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
19867,Brachytherapy,C0006098,en_506,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
19868,Brachytherapy,C0006098,en_506,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
19869,Brachytherapy,C0006098,en_506,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
19870,Brachytherapy,C0006098,en_506,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
19871,Brachytherapy,C0006098,en_506,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
19872,Brachytherapy,C0006098,en_506,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
19873,Brachytherapy,C0006098,en_506,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
19874,Brachytherapy,C0006098,en_506,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
19875,Brachytherapy,C0006098,en_506,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
19876,Brachytherapy,C0006098,en_506,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
19877,Brachytherapy,C0006098,en_506,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
19878,Brachytherapy,C0006098,en_506,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
19879,Brachytherapy,C0006098,en_506,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19880,Brachytherapy,C0006098,en_506,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
19881,Brachytherapy,C0006098,en_506,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
19882,Brachytherapy,C0006098,en_506,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
19883,Brachytherapy,C0006098,en_506,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
19884,Brachytherapy,C0006098,en_506,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
19885,Brachytherapy,C0006098,en_506,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
19886,Brachytherapy,C0006098,en_506,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
19887,Brachytherapy,C0006098,en_506,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
19888,Brachytherapy,C0006098,en_506,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
19889,Brachytherapy,C0006098,en_506,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
19890,Brachytherapy,C0006098,en_506,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
19891,Brachytherapy,C0006098,en_506,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
19892,Brachytherapy,C0006098,en_506,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
19893,Brachytherapy,C0006098,en_506,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
19894,Brachytherapy,C0006098,en_506,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
19895,Brachytherapy,C0006098,en_506,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
19896,Brachytherapy,C0006098,en_506,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
19897,Brachytherapy,C0006098,en_506,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
19898,Brachytherapy,C0006098,en_506,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
19899,Brachytherapy,C0006098,en_506,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
19900,Brachytherapy,C0006098,en_506,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
19901,Brachytherapy,C0006098,en_506,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
19902,Brachytherapy,C0006098,en_506,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
19903,Brachytherapy,C0006098,en_506,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
19904,Brachytherapy,C0006098,en_506,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
19905,Brachytherapy,C0006098,en_506,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
19906,Brachytherapy,C0006098,en_506,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
19907,Brachytherapy,C0006098,en_506,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
19908,Brachytherapy,C0006098,en_506,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
19909,Brachytherapy,C0006098,en_506,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
19910,Brachytherapy,C0006098,en_506,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
19911,Brachytherapy,C0006098,en_506,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
19912,Brachytherapy,C0006098,en_506,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
19913,Brachytherapy,C0006098,en_506,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
19914,Brachytherapy,C0006098,en_506,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
19915,Brachytherapy,C0006098,en_506,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
19916,Brachytherapy,C0006098,en_506,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
19917,Brachytherapy,C0006098,en_506,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
19918,Brachytherapy,C0006098,en_506,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
19919,Brachytherapy,C0006098,en_506,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
19920,Brachytherapy,C0006098,en_506,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
19921,Brachytherapy,C0006098,en_506,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
19922,Brachytherapy,C0006098,en_506,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
19923,Brachytherapy,C0006098,en_506,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
19924,Brachytherapy,C0006098,en_506,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
19925,Brachytherapy,C0006098,en_506,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
19926,Brachytherapy,C0006098,en_506,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
19927,Brachytherapy,C0006098,en_506,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
19928,Brachytherapy,C0006098,en_506,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
19929,Brachytherapy,C0006098,en_506,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
19930,Brachytherapy,C0006098,en_506,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
19931,Brachytherapy,C0006098,en_506,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
19932,Brachytherapy,C0006098,en_506,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
19933,Brachytherapy,C0006098,en_506,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
19934,Brachytherapy,C0006098,en_506,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
19935,Brachytherapy,C0006098,en_506,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
19936,Brachytherapy,C0006098,en_506,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
19937,Brachytherapy,C0006098,en_506,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
19938,Brachytherapy,C0006098,en_506,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
19939,Brachytherapy,C0006098,en_506,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
19940,Brachytherapy,C0006098,en_506,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
19941,Brachytherapy,C0006098,en_506,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
19942,Brachytherapy,C0006098,en_506,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
19943,Brachytherapy,C0006098,en_506,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
19944,Brachytherapy,C0006098,en_506,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
19945,Brachytherapy,C0006098,en_506,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
19946,Brachytherapy,C0006098,en_506,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
19947,Brachytherapy,C0006098,en_506,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
19948,Brachytherapy,C0006098,en_506,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
19949,Inflammation Mediators,C0243042,en_3453,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
19950,thymic stromal lymphopoietin,C0762640,en_4865,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
19951,thymic stromal lymphopoietin,C0762640,en_4865,affects(Infered),TSLP gene,C1336681,en_5638,None,None,AFFECTS(Infered),Infered,3
19952,thymic stromal lymphopoietin,C0762640,en_4865,affects(Infered),T-Cell Proliferation,C1155046,en_5314,None,None,AFFECTS(Infered),Infered,3
19953,thymic stromal lymphopoietin,C0762640,en_4865,affects(Infered),Cytokine Signaling,C1511617,en_6738,None,None,AFFECTS(Infered),Infered,3
19954,Tumorigenesis,C1326912,en_5561,affects(Infered),Tumor Initiation,C0598935,en_4456,None,None,AFFECTS(Infered),Infered,3
19955,Cell Growth,C0007595,en_590,affects(Infered),Cell Maturation,C1516349,en_5855,None,None,AFFECTS(Infered),Infered,3
19956,Cell Line,C0007600,en_591,affects(Infered),stable cell line,C0598091,en_4442,None,None,AFFECTS(Infered),Infered,3
19957,Cell Line,C0007600,en_591,affects(Infered),Human Cell Line,C0682523,en_4644,None,None,AFFECTS(Infered),Infered,3
19958,Tretinoin,C0040845,en_2280,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
19959,Tretinoin,C0040845,en_2280,affects(Infered),Interferon Regulatory Factor 1,C0063700,en_2508,None,None,AFFECTS(Infered),Infered,3
19960,Chloroquine,C0008269,en_631,affects(Infered),Hydroxychloroquine therapy,C5190549,en_6409,None,None,AFFECTS(Infered),Infered,3
19961,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
19962,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
19963,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
19964,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
19965,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
19966,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Adverse drug effect,C0041755,en_2312,None,None,AFFECTS(Infered),Infered,3
19967,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
19968,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
19969,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
19970,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
19971,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
19972,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
19973,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
19974,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
19975,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),inpatient,C0021562,en_1321,None,None,AFFECTS(Infered),Infered,3
19976,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
19977,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
19978,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
19979,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
19980,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
19981,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
19982,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
19983,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
19984,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
19985,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
19986,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
19987,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),General Population,C0683971,en_4674,None,None,AFFECTS(Infered),Infered,3
19988,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Signal Transduction,C0037083,en_2105,None,None,AFFECTS(Infered),Infered,3
19989,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
19990,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
19991,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
19992,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),patient state,C0683521,en_4668,None,None,AFFECTS(Infered),Infered,3
19993,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Toxic effect,C0600688,en_4513,None,None,AFFECTS(Infered),Infered,3
19994,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
19995,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
19996,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
19997,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Acute Lung Injury,C0242488,en_3416,None,None,AFFECTS(Infered),Infered,3
19998,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
19999,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Virus,C0042776,en_2364,None,None,AFFECTS(Infered),Infered,3
20000,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Anti-Infective Agents,C0003204,en_340,None,None,AFFECTS(Infered),Infered,3
20001,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
20002,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Lower respiratory tract infection,C0149725,en_2806,None,None,AFFECTS(Infered),Infered,3
20003,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
20004,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
20005,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Cardiotoxicity,C0876994,en_5060,None,None,AFFECTS(Infered),Infered,3
20006,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),viral entry,C1160648,en_5358,None,None,AFFECTS(Infered),Infered,3
20007,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,None,None,AFFECTS(Infered),Infered,3
20008,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Epidermal cGVHD Score 2,C4761314,en_6403,None,None,AFFECTS(Infered),Infered,3
20009,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
20010,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20011,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Antiviral Agents,C0003451,en_379,None,None,AFFECTS(Infered),Infered,3
20012,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Possible,C0332149,en_3747,None,None,AFFECTS(Infered),Infered,3
20013,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Worse,C1457868,en_5783,None,None,AFFECTS(Infered),Infered,3
20014,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),cardiac arrhythmia,C0003811,en_397,None,None,AFFECTS(Infered),Infered,3
20015,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Blind Vision,C0456909,en_4120,None,None,AFFECTS(Infered),Infered,3
20016,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),PULMONARY INVOLVEMENT,C0748159,en_4828,None,None,AFFECTS(Infered),Infered,3
20017,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Pregnant Women,C0033011,en_1876,None,None,AFFECTS(Infered),Infered,3
20018,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Rheumatism,C0035435,en_2028,None,None,AFFECTS(Infered),Infered,3
20019,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Infected,C0439663,en_4036,None,None,AFFECTS(Infered),Infered,3
20020,Hydroxychloroquine,C0020336,en_1226,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
20021,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
20022,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Cell division,C0007590,en_589,None,None,AFFECTS(Infered),Infered,3
20023,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Chloroquine,C0008269,en_631,None,None,AFFECTS(Infered),Infered,3
20024,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Cardiovascular event,C1320716,en_5537,None,None,AFFECTS(Infered),Infered,3
20025,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),hearing impairment,C1384666,en_5689,None,None,AFFECTS(Infered),Infered,3
20026,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Endocytosis,C0014139,en_897,None,None,AFFECTS(Infered),Infered,3
20027,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Comorbidity,C0009488,en_690,None,None,AFFECTS(Infered),Infered,3
20028,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Convulsions,C0009951,en_714,None,None,AFFECTS(Infered),Infered,3
20029,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),"Signs and Symptoms, Respiratory",C0037090,en_2107,None,None,AFFECTS(Infered),Infered,3
20030,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),High Risk Populations,C0870646,en_5008,None,None,AFFECTS(Infered),Infered,3
20031,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Pulmonary Pathology,C0748168,en_4829,None,None,AFFECTS(Infered),Infered,3
20032,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Porphyrias,C0032708,en_1852,None,None,AFFECTS(Infered),Infered,3
20033,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Asymptomatic,C0231221,en_3252,None,None,AFFECTS(Infered),Infered,3
20034,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Immune System Diseases,C0021053,en_1284,None,None,AFFECTS(Infered),Infered,3
20035,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Voluntary Workers,C0042960,en_2380,None,None,AFFECTS(Infered),Infered,3
20036,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),viral transmission,C1160716,en_5362,None,None,AFFECTS(Infered),Infered,3
20037,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Pigmentation,C0031911,en_1809,None,None,AFFECTS(Infered),Infered,3
20038,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Q Fever,C0034362,en_1943,None,None,AFFECTS(Infered),Infered,3
20039,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),risk factors,C0035648,en_2039,None,None,AFFECTS(Infered),Infered,3
20040,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Ventricular arrhythmia,C0085612,en_2682,None,None,AFFECTS(Infered),Infered,3
20041,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Homo sapiens,C0086418,en_2718,None,None,AFFECTS(Infered),Infered,3
20042,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Retinal depigmentation,C0151891,en_2870,None,None,AFFECTS(Infered),Infered,3
20043,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Porphyria Cutanea Tarda,C0162566,en_2913,None,None,AFFECTS(Infered),Infered,3
20044,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),"Dermatitis, Phototoxic",C0162830,en_2935,None,None,AFFECTS(Infered),Infered,3
20045,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Clinical infection,C0275521,en_3564,None,None,AFFECTS(Infered),Infered,3
20046,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Italians,C0337810,en_3799,None,None,AFFECTS(Infered),Infered,3
20047,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Cerebellar decompression injury,C0344191,en_3835,None,None,AFFECTS(Infered),Infered,3
20048,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Lupus Erythematosus,C0409974,en_3967,None,None,AFFECTS(Infered),Infered,3
20049,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),adverse drug interaction,C0678798,en_4569,None,None,AFFECTS(Infered),Infered,3
20050,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Study Subject,C0681850,en_4632,None,None,AFFECTS(Infered),Infered,3
20051,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),line worker,C0682215,en_4639,None,None,AFFECTS(Infered),Infered,3
20052,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Drug Interactions,C0687133,en_4685,None,None,AFFECTS(Infered),Infered,3
20053,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),QTc,C0860814,en_4993,None,None,AFFECTS(Infered),Infered,3
20054,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Retinal toxicity,C0877104,en_5063,None,None,AFFECTS(Infered),Infered,3
20055,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),6-fluoro-3-hydroxy-2-pyrazinecarboxamide,C1138226,en_5269,None,None,AFFECTS(Infered),Infered,3
20056,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Recurrent pregnancy loss,C2921106,en_6144,None,None,AFFECTS(Infered),Infered,3
20057,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Treatment duration:Time:Pt:^Patient:Qn,C3259042,en_6186,None,None,AFFECTS(Infered),Infered,3
20058,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),"Systemic lupus erythematosus, childhood onset",C3280743,en_6199,None,None,AFFECTS(Infered),Infered,3
20059,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Ventricular Repolarization,C3537202,en_6210,None,None,AFFECTS(Infered),Infered,3
20060,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),QTcF Prolongation,C3828431,en_6251,None,None,AFFECTS(Infered),Infered,3
20061,Hydroxychloroquine therapy,C5190549,en_6409,affects(Infered),Acute respiratory tract infection,C4759838,en_6402,None,None,AFFECTS(Infered),Infered,3
20062,Isotretinoin,C0022265,en_1370,affects(Infered),CD14 gene,C1367477,en_5672,None,None,AFFECTS(Infered),Infered,3
20063,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20064,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20065,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20066,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
20067,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20068,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),"Tuberculosis, Multidrug-Resistant",C0206526,en_3164,None,None,AFFECTS(Infered),Infered,3
20069,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20070,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20071,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20072,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Male population group,C0025266,en_1533,None,None,AFFECTS(Infered),Infered,3
20073,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
20074,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20075,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
20076,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
20077,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20078,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20079,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
20080,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Well adult,C0686750,en_4683,None,None,AFFECTS(Infered),Infered,3
20081,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
20082,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20083,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
20084,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
20085,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
20086,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
20087,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
20088,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
20089,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Overweight,C0497406,en_4165,None,None,AFFECTS(Infered),Infered,3
20090,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Permeability,C0031164,en_1779,None,None,AFFECTS(Infered),Infered,3
20091,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20092,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Virus,C0042776,en_2364,None,None,AFFECTS(Infered),Infered,3
20093,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Viral respiratory infection,C0729531,en_4763,None,None,AFFECTS(Infered),Infered,3
20094,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Tuberculosis,C0041296,en_2293,None,None,AFFECTS(Infered),Infered,3
20095,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Acute respiratory infection NOS,C0339901,en_3809,None,None,AFFECTS(Infered),Infered,3
20096,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Homeostasis,C0019868,en_1201,None,None,AFFECTS(Infered),Infered,3
20097,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),"Immunity, Cellular",C0020966,en_1274,None,None,AFFECTS(Infered),Infered,3
20098,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Vitamin D Deficiency,C0042870,en_2372,None,None,AFFECTS(Infered),Infered,3
20099,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Falls,C0085639,en_2684,None,None,AFFECTS(Infered),Infered,3
20100,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Ethnic group,C0015031,en_934,None,None,AFFECTS(Infered),Infered,3
20101,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Households,C0020052,en_1208,None,None,AFFECTS(Infered),Infered,3
20102,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Asymptomatic,C0231221,en_3252,None,None,AFFECTS(Infered),Infered,3
20103,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),pleiotropism,C0597257,en_4418,None,None,AFFECTS(Infered),Infered,3
20104,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),"Infections, Upper Respiratory",C0041912,en_2315,None,None,AFFECTS(Infered),Infered,3
20105,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Rickets,C0035579,en_2037,None,None,AFFECTS(Infered),Infered,3
20106,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Ultraviolet Rays,C0041625,en_2307,None,None,AFFECTS(Infered),Infered,3
20107,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Flail,C0231445,en_6603,None,None,AFFECTS(Infered),Infered,3
20108,25-hydroxyvitamin D,C0535968,en_4242,affects(Infered),Viral upper respiratory tract infection,C0339916,en_3810,None,None,AFFECTS(Infered),Infered,3
20109,Chronically Ill,C0008715,en_644,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20110,Chronically Ill,C0008715,en_644,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
20111,Chronically Ill,C0008715,en_644,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20112,Chronically Ill,C0008715,en_644,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20113,Chronically Ill,C0008715,en_644,affects(Infered),Crisis,C0231224,en_3253,None,None,AFFECTS(Infered),Infered,3
20114,Chronically Ill,C0008715,en_644,affects(Infered),Hospitalization,C0019993,en_1206,None,None,AFFECTS(Infered),Infered,3
20115,Chronically Ill,C0008715,en_644,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
20116,Chronically Ill,C0008715,en_644,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20117,Chronically Ill,C0008715,en_644,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
20118,Chronically Ill,C0008715,en_644,affects(Infered),Blood Pressure,C0005823,en_492,None,None,AFFECTS(Infered),Infered,3
20119,Chronically Ill,C0008715,en_644,affects(Infered),Voice,C0042939,en_2377,None,None,AFFECTS(Infered),Infered,3
20120,Chronically Ill,C0008715,en_644,affects(Infered),Health Care,C0086388,en_2715,None,None,AFFECTS(Infered),Infered,3
20121,Chronically Ill,C0008715,en_644,affects(Infered),Decompensation,C0231187,en_3250,None,None,AFFECTS(Infered),Infered,3
20122,Chronically Ill,C0008715,en_644,affects(Infered),Native Americans,C0282204,en_3640,None,None,AFFECTS(Infered),Infered,3
20123,Chronically Ill,C0008715,en_644,affects(Infered),Non-smoker,C0337672,en_3795,None,None,AFFECTS(Infered),Infered,3
20124,Chronically Ill,C0008715,en_644,affects(Infered),cooperation,C0392337,en_3917,None,None,AFFECTS(Infered),Infered,3
20125,Chronically Ill,C0008715,en_644,affects(Infered),"Medical care, unspecified",C0496675,en_4163,None,None,AFFECTS(Infered),Infered,3
20126,Comorbidity,C0009488,en_690,affects(Infered),concomitant disease,C0243087,en_3460,None,None,AFFECTS(Infered),Infered,3
20127,Thrombogen,C0723739,en_4749,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20128,Thrombogen,C0723739,en_4749,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
20129,Thrombogen,C0723739,en_4749,affects(Infered),Fibrin,C0015982,en_987,None,None,AFFECTS(Infered),Infered,3
20130,Thrombogen,C0723739,en_4749,affects(Infered),Thrombus,C0087086,en_2743,None,None,AFFECTS(Infered),Infered,3
20131,Thrombogen,C0723739,en_4749,affects(Infered),Arteriosclerosis,C0003850,en_399,None,None,AFFECTS(Infered),Infered,3
20132,Thrombogen,C0723739,en_4749,affects(Infered),Blood Platelets,C0005821,en_491,None,None,AFFECTS(Infered),Infered,3
20133,Thrombogen,C0723739,en_4749,affects(Infered),Thromboembolic event,C0857496,en_4977,None,None,AFFECTS(Infered),Infered,3
20134,Thrombogen,C0723739,en_4749,affects(Infered),"Receptor, PAR-1",C0668084,en_4533,None,None,AFFECTS(Infered),Infered,3
20135,Thrombogen,C0723739,en_4749,affects(Infered),Platelet Activation,C0032173,en_1827,None,None,AFFECTS(Infered),Infered,3
20136,Thrombogen,C0723739,en_4749,affects(Infered),"SELP protein, human|SELP",C2742134|6403,en_6132,None,None,AFFECTS(Infered),Infered,3
20137,Thrombogen,C0723739,en_4749,affects(Infered),Protein C,C0033621,en_1908,None,None,AFFECTS(Infered),Infered,3
20138,Thrombogen,C0723739,en_4749,affects(Infered),PROTEIN KINASE,C0033640,en_1909,None,None,AFFECTS(Infered),Infered,3
20139,Thrombogen,C0723739,en_4749,affects(Infered),Thrombomodulin,C0145779,en_2793,None,None,AFFECTS(Infered),Infered,3
20140,Thrombogen,C0723739,en_4749,affects(Infered),Carboxypeptidase U,C0255161,en_3492,None,None,AFFECTS(Infered),Infered,3
20141,Thrombogen,C0723739,en_4749,affects(Infered),"SLC6A2 protein, human|SLC6A2",C1456447|6530,en_5773,None,None,AFFECTS(Infered),Infered,3
20142,Thrombogen,C0723739,en_4749,affects(Infered),ACACA|BMS1,C1412104;C1428109,en_166,None,None,AFFECTS(Infered),Infered,3
20143,Thrombin,C0040018,en_2228,affects(Infered),P2RY12,C1425330,en_150,None,None,AFFECTS(Infered),Infered,3
20144,Complement Activation,C0009528,en_695,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20145,Complement Activation,C0009528,en_695,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20146,Complement Activation,C0009528,en_695,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20147,Complement Activation,C0009528,en_695,affects(Infered),Age,C0001779,en_257,None,None,AFFECTS(Infered),Infered,3
20148,Complement Activation,C0009528,en_695,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20149,Complement Activation,C0009528,en_695,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20150,Complement Activation,C0009528,en_695,affects(Infered),Sarcoidosis,C0036202,en_2064,None,None,AFFECTS(Infered),Infered,3
20151,Complement Activation,C0009528,en_695,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20152,Complement Activation,C0009528,en_695,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
20153,Complement Activation,C0009528,en_695,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20154,Complement Activation,C0009528,en_695,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
20155,Complement Activation,C0009528,en_695,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20156,Complement Activation,C0009528,en_695,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20157,Complement Activation,C0009528,en_695,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20158,Complement Activation,C0009528,en_695,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20159,Complement Activation,C0009528,en_695,affects(Infered),Neutralizing antibody,C0475463,en_4145,None,None,AFFECTS(Infered),Infered,3
20160,Complement Activation,C0009528,en_695,affects(Infered),Predisposition,C0220898,en_3206,None,None,AFFECTS(Infered),Infered,3
20161,Complement Activation,C0009528,en_695,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
20162,Complement Activation,C0009528,en_695,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
20163,Complement Activation,C0009528,en_695,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
20164,Complement Activation,C0009528,en_695,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
20165,Complement Activation,C0009528,en_695,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
20166,Complement Activation,C0009528,en_695,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
20167,Complement Activation,C0009528,en_695,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
20168,Complement Activation,C0009528,en_695,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
20169,Complement Activation,C0009528,en_695,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20170,Complement Activation,C0009528,en_695,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
20171,Complement Activation,C0009528,en_695,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20172,Complement Activation,C0009528,en_695,affects(Infered),Animals,C0003062,en_335,None,None,AFFECTS(Infered),Infered,3
20173,Complement Activation,C0009528,en_695,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20174,Complement Activation,C0009528,en_695,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
20175,Complement Activation,C0009528,en_695,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
20176,Complement Activation,C0009528,en_695,affects(Infered),Organ failure,C0948600,en_5171,None,None,AFFECTS(Infered),Infered,3
20177,Complement Activation,C0009528,en_695,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20178,Complement Activation,C0009528,en_695,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20179,Complement Activation,C0009528,en_695,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
20180,Complement Activation,C0009528,en_695,affects(Infered),Autophagy,C0004391,en_432,None,None,AFFECTS(Infered),Infered,3
20181,Complement Activation,C0009528,en_695,affects(Infered),Specific antibody,C0443640,en_4068,None,None,AFFECTS(Infered),Infered,3
20182,Complement Activation,C0009528,en_695,affects(Infered),"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,None,None,AFFECTS(Infered),Infered,3
20183,Complement Activation,C0009528,en_695,affects(Infered),"Mycobacterium Infections, Atypical",C0026919,en_1616,None,None,AFFECTS(Infered),Infered,3
20184,Complement Activation,C0009528,en_695,affects(Infered),Ultraviolet Rays,C0041625,en_2307,None,None,AFFECTS(Infered),Infered,3
20185,Complement Activation,C0009528,en_695,affects(Infered),Acute infectious disease,C0275518,en_3563,None,None,AFFECTS(Infered),Infered,3
20186,Complement Activation,C0009528,en_695,affects(Infered),"Hemorrhagic Fever, Ebola",C0282687,en_3666,None,None,AFFECTS(Infered),Infered,3
20187,Complement Activation,C0009528,en_695,affects(Infered),South Asian,C1519427,en_5885,None,None,AFFECTS(Infered),Infered,3
20188,Complement Activation,C0009528,en_695,affects(Infered),Hospital specialist,C0087009,en_2742,None,None,AFFECTS(Infered),Infered,3
20189,Complement Activation,C0009528,en_695,affects(Infered),Renal Insufficiency,C1565489,en_5983,None,None,AFFECTS(Infered),Infered,3
20190,TMEM173,C4077403,en_6488,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20191,malignant neoplasm of breast staging,C2216702,en_6091,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20192,malignant neoplasm of breast staging,C2216702,en_6091,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
20193,malignant neoplasm of breast staging,C2216702,en_6091,affects(Infered),hair,C0018494,en_1107,None,None,AFFECTS(Infered),Infered,3
20194,malignant neoplasm of breast staging,C2216702,en_6091,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
20195,malignant neoplasm of breast staging,C2216702,en_6091,affects(Infered),Menarche,C0025274,en_1534,None,None,AFFECTS(Infered),Infered,3
20196,Neoral,C0699605,en_4701,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20197,Cyclosporine,C0010592,en_740,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20198,Neoral,C0699605,en_4701,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20199,Neoral,C0699605,en_4701,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
20200,Neoral,C0699605,en_4701,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20201,Cyclosporine,C0010592,en_740,affects(Infered),Deep Vein Thrombosis,C0149871,en_2812,None,None,AFFECTS(Infered),Infered,3
20202,Neoral,C0699605,en_4701,affects(Infered),Cardiotoxicity,C0876994,en_5060,None,None,AFFECTS(Infered),Infered,3
20203,Neoral,C0699605,en_4701,affects(Infered),Cyclosporine,C0010592,en_740,None,None,AFFECTS(Infered),Infered,3
20204,Cyclosporine,C0010592,en_740,affects(Infered),Neoral,C0699605,en_4701,None,None,AFFECTS(Infered),Infered,3
20205,Neoral,C0699605,en_4701,affects(Infered),Keratoconjunctivitis,C0022573,en_1375,None,None,AFFECTS(Infered),Infered,3
20206,Neoral,C0699605,en_4701,affects(Infered),Peptidylprolyl Isomerase,C0136073,en_2784,None,None,AFFECTS(Infered),Infered,3
20207,Neoral,C0699605,en_4701,affects(Infered),Historical Cohort,C2348984,en_6100,None,None,AFFECTS(Infered),Infered,3
20208,Angiogenesis,C0302600,en_3709,affects(Infered),Hypertensive disease,C0020538,en_1239,None,None,AFFECTS(Infered),Infered,3
20209,Pulmonary Pathology,C0748168,en_4829,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
20210,Pulmonary Pathology,C0748168,en_4829,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
20211,Pulmonary Pathology,C0748168,en_4829,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
20212,Pulmonary Pathology,C0748168,en_4829,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
20213,Pulmonary Pathology,C0748168,en_4829,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
20214,Dioxins,C0012503,en_819,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
20215,Dioxins,C0012503,en_819,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
20216,Dioxins,C0012503,en_819,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
20217,Dioxins,C0012503,en_819,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
20218,Acute abdominal pain,C0740577,en_4779,affects(Infered),Familial Mediterranean Fever,C0031069,en_1773,None,None,AFFECTS(Infered),Infered,3
20219,"DNA, Mitochondrial",C0012929,en_837,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
20220,"DNA, Mitochondrial",C0012929,en_837,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
20221,"DNA, Mitochondrial",C0012929,en_837,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
20222,"DNA, Mitochondrial",C0012929,en_837,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
20223,"DNA, Mitochondrial",C0012929,en_837,affects(Infered),TLR9,C1423633,en_135,None,None,AFFECTS(Infered),Infered,3
20224,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20225,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20226,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20227,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20228,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),chemokine,C0282554,en_3651,None,None,AFFECTS(Infered),Infered,3
20229,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20230,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20231,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Lung diseases,C0024115,en_1462,None,None,AFFECTS(Infered),Infered,3
20232,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20233,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20234,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
20235,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
20236,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
20237,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
20238,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
20239,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
20240,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
20241,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Shock,C0036974,en_2097,None,None,AFFECTS(Infered),Infered,3
20242,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Interleukin-1 beta,C0021753,en_1334,None,None,AFFECTS(Infered),Infered,3
20243,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
20244,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Cell Proliferation,C0596290,en_4384,None,None,AFFECTS(Infered),Infered,3
20245,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),Acute respiratory disease,C0264219,en_3527,None,None,AFFECTS(Infered),Infered,3
20246,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),"Respiratory Distress Syndrome, Newborn",C0035220,en_2009,None,None,AFFECTS(Infered),Infered,3
20247,Antiinflammatory Effect,C1516019,en_5851,affects(Infered),cyclooxygenase 2,C0387583,en_3904,None,None,AFFECTS(Infered),Infered,3
20248,"Drugs, Orphan",C0013232,en_859,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20249,"Drugs, Orphan",C0013232,en_859,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20250,"Drugs, Orphan",C0013232,en_859,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20251,"Drugs, Orphan",C0013232,en_859,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20252,"Drugs, Orphan",C0013232,en_859,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
20253,"Drugs, Orphan",C0013232,en_859,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
20254,"Drugs, Orphan",C0013232,en_859,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
20255,"Drugs, Orphan",C0013232,en_859,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20256,"Drugs, Orphan",C0013232,en_859,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20257,"Drugs, Orphan",C0013232,en_859,affects(Infered),Lung diseases,C0024115,en_1462,None,None,AFFECTS(Infered),Infered,3
20258,"Drugs, Orphan",C0013232,en_859,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20259,"Drugs, Orphan",C0013232,en_859,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
20260,"Drugs, Orphan",C0013232,en_859,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20261,"Drugs, Orphan",C0013232,en_859,affects(Infered),Chronic Obstructive Airway Disease,C0024117,en_1463,None,None,AFFECTS(Infered),Infered,3
20262,"Drugs, Orphan",C0013232,en_859,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
20263,"Drugs, Orphan",C0013232,en_859,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
20264,"Drugs, Orphan",C0013232,en_859,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
20265,"Drugs, Orphan",C0013232,en_859,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
20266,"Drugs, Orphan",C0013232,en_859,affects(Infered),Pulmonary arterial hypertension,C1619734,en_6012,None,None,AFFECTS(Infered),Infered,3
20267,"Drugs, Orphan",C0013232,en_859,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
20268,"Drugs, Orphan",C0013232,en_859,affects(Infered),Acute Lung Injury,C0242488,en_3416,None,None,AFFECTS(Infered),Infered,3
20269,"Drugs, Orphan",C0013232,en_859,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20270,"Drugs, Orphan",C0013232,en_859,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
20271,"Drugs, Orphan",C0013232,en_859,affects(Infered),"Infections, Hospital",C0205721,en_3133,None,None,AFFECTS(Infered),Infered,3
20272,"Drugs, Orphan",C0013232,en_859,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
20273,"Drugs, Orphan",C0013232,en_859,affects(Infered),Rheumatism,C0035435,en_2028,None,None,AFFECTS(Infered),Infered,3
20274,"Drugs, Orphan",C0013232,en_859,affects(Infered),Autoimmune,C0443146,en_4064,None,None,AFFECTS(Infered),Infered,3
20275,"Drugs, Orphan",C0013232,en_859,affects(Infered),nervous system disorder,C0027765,en_1659,None,None,AFFECTS(Infered),Infered,3
20276,"Drugs, Orphan",C0013232,en_859,affects(Infered),Malignant neoplasm of kidney,C0740457,en_4778,None,None,AFFECTS(Infered),Infered,3
20277,"Drugs, Orphan",C0013232,en_859,affects(Infered),Hypovolemic Shock,C0020683,en_1251,None,None,AFFECTS(Infered),Infered,3
20278,"Drugs, Orphan",C0013232,en_859,affects(Infered),Renal transplant rejection,C0238217,en_3364,None,None,AFFECTS(Infered),Infered,3
20279,Clinical Management,C1516615,en_5859,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
20280,Elements,C0013879,en_885,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
20281,Embolism,C0013922,en_887,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
20282,carbapenemase,C0246081,en_3478,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
20283,carbapenemase,C0246081,en_3478,affects(Infered),RNA,C0035668,en_2040,None,None,AFFECTS(Infered),Infered,3
20284,carbapenemase,C0246081,en_3478,affects(Infered),Toxic effect,C0600688,en_4513,None,None,AFFECTS(Infered),Infered,3
20285,Stratum granulosum,C0221923,en_3231,affects(Infered),Aldosterone,C0002006,en_274,None,None,AFFECTS(Infered),Infered,3
20286,Evaluation,C0220825,en_3201,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
20287,fibrinmonomer,C0060327,en_2485,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
20288,fibrinmonomer,C0060327,en_2485,affects(Infered),Respiratory Insufficiency,C0035229,en_2012,None,None,AFFECTS(Infered),Infered,3
20289,fibrinmonomer,C0060327,en_2485,affects(Infered),Plasminogen,C0032140,en_1822,None,None,AFFECTS(Infered),Infered,3
20290,fibrinmonomer,C0060327,en_2485,affects(Infered),FRAGMENTS,C0486805,en_4153,None,None,AFFECTS(Infered),Infered,3
20291,fibrinmonomer,C0060327,en_2485,affects(Infered),Abnormal breathing,C1260922,en_5414,None,None,AFFECTS(Infered),Infered,3
20292,fibrinmonomer,C0060327,en_2485,affects(Infered),Right ventricular failure,C2939447,en_6155,None,None,AFFECTS(Infered),Infered,3
20293,Chemically-Induced Menopause,C4727713,en_6389,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
20294,Chemically-Induced Menopause,C4727713,en_6389,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20295,type 2 immune response,C3159116,en_6176,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20296,type 2 immune response,C3159116,en_6176,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20297,type 2 immune response,C3159116,en_6176,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20298,type 2 immune response,C3159116,en_6176,affects(Infered),Age,C0001779,en_257,None,None,AFFECTS(Infered),Infered,3
20299,type 2 immune response,C3159116,en_6176,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20300,type 2 immune response,C3159116,en_6176,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20301,type 2 immune response,C3159116,en_6176,affects(Infered),Sarcoidosis,C0036202,en_2064,None,None,AFFECTS(Infered),Infered,3
20302,type 2 immune response,C3159116,en_6176,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20303,type 2 immune response,C3159116,en_6176,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
20304,type 2 immune response,C3159116,en_6176,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20305,type 2 immune response,C3159116,en_6176,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
20306,type 2 immune response,C3159116,en_6176,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20307,type 2 immune response,C3159116,en_6176,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20308,type 2 immune response,C3159116,en_6176,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20309,type 2 immune response,C3159116,en_6176,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20310,type 2 immune response,C3159116,en_6176,affects(Infered),Predisposition,C0220898,en_3206,None,None,AFFECTS(Infered),Infered,3
20311,type 2 immune response,C3159116,en_6176,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
20312,type 2 immune response,C3159116,en_6176,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
20313,type 2 immune response,C3159116,en_6176,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
20314,type 2 immune response,C3159116,en_6176,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
20315,type 2 immune response,C3159116,en_6176,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
20316,type 2 immune response,C3159116,en_6176,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
20317,type 2 immune response,C3159116,en_6176,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
20318,type 2 immune response,C3159116,en_6176,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
20319,type 2 immune response,C3159116,en_6176,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20320,type 2 immune response,C3159116,en_6176,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
20321,type 2 immune response,C3159116,en_6176,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20322,type 2 immune response,C3159116,en_6176,affects(Infered),Animals,C0003062,en_335,None,None,AFFECTS(Infered),Infered,3
20323,type 2 immune response,C3159116,en_6176,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20324,type 2 immune response,C3159116,en_6176,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
20325,type 2 immune response,C3159116,en_6176,affects(Infered),Organ failure,C0948600,en_5171,None,None,AFFECTS(Infered),Infered,3
20326,type 2 immune response,C3159116,en_6176,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20327,type 2 immune response,C3159116,en_6176,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20328,type 2 immune response,C3159116,en_6176,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
20329,type 2 immune response,C3159116,en_6176,affects(Infered),Autophagy,C0004391,en_432,None,None,AFFECTS(Infered),Infered,3
20330,type 2 immune response,C3159116,en_6176,affects(Infered),Specific antibody,C0443640,en_4068,None,None,AFFECTS(Infered),Infered,3
20331,type 2 immune response,C3159116,en_6176,affects(Infered),"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,None,None,AFFECTS(Infered),Infered,3
20332,type 2 immune response,C3159116,en_6176,affects(Infered),"Mycobacterium Infections, Atypical",C0026919,en_1616,None,None,AFFECTS(Infered),Infered,3
20333,type 2 immune response,C3159116,en_6176,affects(Infered),Ultraviolet Rays,C0041625,en_2307,None,None,AFFECTS(Infered),Infered,3
20334,type 2 immune response,C3159116,en_6176,affects(Infered),Acute infectious disease,C0275518,en_3563,None,None,AFFECTS(Infered),Infered,3
20335,type 2 immune response,C3159116,en_6176,affects(Infered),"Hemorrhagic Fever, Ebola",C0282687,en_3666,None,None,AFFECTS(Infered),Infered,3
20336,type 2 immune response,C3159116,en_6176,affects(Infered),South Asian,C1519427,en_5885,None,None,AFFECTS(Infered),Infered,3
20337,type 2 immune response,C3159116,en_6176,affects(Infered),Hospital specialist,C0087009,en_2742,None,None,AFFECTS(Infered),Infered,3
20338,type 2 immune response,C3159116,en_6176,affects(Infered),Renal Insufficiency,C1565489,en_5983,None,None,AFFECTS(Infered),Infered,3
20339,"Heparin, Low-Molecular-Weight",C0019139,en_1167,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
20340,"PTH protein, human",C0020063,en_1209,affects(Infered),physiological aspects,C0031843,en_1806,None,None,AFFECTS(Infered),Infered,3
20341,PTH gene,C1419072,en_5712,affects(Infered),"PTH protein, human",C0020063,en_1209,None,None,AFFECTS(Infered),Infered,3
20342,Clinical infection,C0275521,en_3564,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20343,Clinical infection,C0275521,en_3564,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20344,Mild asthma,C0581124,en_4343,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20345,Mild asthma,C0581124,en_4343,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20346,Mild asthma,C0581124,en_4343,affects(Infered),Hospitalization,C0019993,en_1206,None,None,AFFECTS(Infered),Infered,3
20347,Mild asthma,C0581124,en_4343,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
20348,Mild asthma,C0581124,en_4343,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
20349,Mild asthma,C0581124,en_4343,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
20350,Mild asthma,C0581124,en_4343,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
20351,Mild asthma,C0581124,en_4343,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20352,Mild asthma,C0581124,en_4343,affects(Infered),Negative,C0205160,en_3126,None,None,AFFECTS(Infered),Infered,3
20353,Mild asthma,C0581124,en_4343,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20354,Mild asthma,C0581124,en_4343,affects(Infered),African race,C0027567,en_1646,None,None,AFFECTS(Infered),Infered,3
20355,Mild asthma,C0581124,en_4343,affects(Infered),Unipolar Depression,C0041696,en_2310,None,None,AFFECTS(Infered),Infered,3
20356,Mild asthma,C0581124,en_4343,affects(Infered),Hypercapnic respiratory failure,C0398353,en_3947,None,None,AFFECTS(Infered),Infered,3
20357,Mild asthma,C0581124,en_4343,affects(Infered),Respiratory distress,C0476273,en_4149,None,None,AFFECTS(Infered),Infered,3
20358,Interferon Alfa-2b,C0021735,en_1329,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
20359,Interferon Alfa-2b,C0021735,en_1329,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
20360,Interferon Alfa-2b,C0021735,en_1329,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
20361,Interferon Alfa-2b,C0021735,en_1329,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
20362,"NOS3 protein, human",C0669365,en_4534,affects(Infered),Vascular Permeability,C0162337,en_2906,None,None,AFFECTS(Infered),Infered,3
20363,"Radiation, Charged Particles",C1516444,en_5857,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20364,post operative (finding),C0241311,en_3389,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20365,CD14 Antigen,C0108768,en_2758,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20366,CD14 Antigen,C0108768,en_2758,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
20367,CD14 Antigen,C0108768,en_2758,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
20368,CD14 Antigen,C0108768,en_2758,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
20369,CD14 Antigen,C0108768,en_2758,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
20370,CD14 Antigen,C0108768,en_2758,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
20371,CD14 Antigen,C0108768,en_2758,affects(Infered),Ligand Binding,C1517880,en_5869,None,None,AFFECTS(Infered),Infered,3
20372,CD14 Antigen,C0108768,en_2758,affects(Infered),Receptor Signaling,C1514762,en_5838,None,None,AFFECTS(Infered),Infered,3
20373,CD14 Antigen,C0108768,en_2758,affects(Infered),cell activation,C1326120,en_5553,None,None,AFFECTS(Infered),Infered,3
20374,Ivermectin,C0022322,en_1371,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
20375,Ivermectin,C0022322,en_1371,affects(Infered),Negative Regulation of Coagulation,C2917212,en_6142,None,None,AFFECTS(Infered),Infered,3
20376,Nuclear Import,C0887839,en_5087,affects(Infered),Molecular Chaperones,C0243041,en_3452,None,None,AFFECTS(Infered),Infered,3
20377,anticoagulant activity,C1148561,en_5297,affects(Infered),Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2,C5397144,en_6452,None,None,AFFECTS(Infered),Infered,3
20378,anticoagulant activity,C1148561,en_5297,affects(Infered),Heparin,C0019134,en_1166,None,None,AFFECTS(Infered),Infered,3
20379,anticoagulant activity,C1148561,en_5297,affects(Infered),Low molecular weight heparin therapy,C2733531,en_6131,None,None,AFFECTS(Infered),Infered,3
20380,Negative Regulation of Coagulation,C2917212,en_6142,affects(Infered),Low molecular weight heparin therapy,C2733531,en_6131,None,None,AFFECTS(Infered),Infered,3
20381,anticoagulant activity,C1148561,en_5297,affects(Infered),Hemorrhage,C0019080,en_1161,None,None,AFFECTS(Infered),Infered,3
20382,Mannitol,C0024730,en_1499,affects(Infered),TSLP gene,C1336681,en_5638,None,None,AFFECTS(Infered),Infered,3
20383,Mastectomy,C0024881,en_1505,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20384,Mastectomy,C0024881,en_1505,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20385,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20386,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20387,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20388,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20389,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
20390,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20391,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
20392,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20393,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20394,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20395,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
20396,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
20397,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
20398,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20399,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Patient ventilated,C1299448,en_5503,None,None,AFFECTS(Infered),Infered,3
20400,Methylprednisolone pulse therapy,C0587279,en_4362,affects(Infered),Storm Syndrome,C1861452,en_6056,None,None,AFFECTS(Infered),Infered,3
20401,nicotinamide-beta-riboside,C0068711,en_2532,affects(Infered),Recovery,C0237820,en_3354,None,None,AFFECTS(Infered),Infered,3
20402,nicotinamide-beta-riboside,C0068711,en_2532,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
20403,nicotinamide-beta-riboside,C0068711,en_2532,affects(Infered),SIRT1,C1423062,en_121,None,None,AFFECTS(Infered),Infered,3
20404,nicotinamide-beta-riboside,C0068711,en_2532,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
20405,nicotinamide-beta-riboside,C0068711,en_2532,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
20406,Severe pain,C0278140,en_3598,affects(Infered),Fibromyalgia,C0016053,en_993,None,None,AFFECTS(Infered),Infered,3
20407,Severe pain,C0278140,en_3598,affects(Infered),Sickle Cell Anemia,C0002895,en_317,None,None,AFFECTS(Infered),Infered,3
20408,Severe pain,C0278140,en_3598,affects(Infered),Toxic Epidermal Necrolysis,C0014518,en_915,None,None,AFFECTS(Infered),Infered,3
20409,Severe pain,C0278140,en_3598,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
20410,Severe pain,C0278140,en_3598,affects(Infered),Caries,C0333519,en_6626,None,None,AFFECTS(Infered),Infered,3
20411,angiogenin,C0051844,en_2430,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20412,angiogenin,C0051844,en_2430,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20413,angiogenin,C0051844,en_2430,affects(Infered),Premature Birth,C0151526,en_2860,None,None,AFFECTS(Infered),Infered,3
20414,angiogenin,C0051844,en_2430,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20415,angiogenin,C0051844,en_2430,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20416,angiogenin,C0051844,en_2430,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
20417,angiogenin,C0051844,en_2430,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
20418,angiogenin,C0051844,en_2430,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20419,angiogenin,C0051844,en_2430,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
20420,angiogenin,C0051844,en_2430,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
20421,angiogenin,C0051844,en_2430,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20422,angiogenin,C0051844,en_2430,affects(Infered),Chronic inflammation,C0021376,en_1309,None,None,AFFECTS(Infered),Infered,3
20423,angiogenin,C0051844,en_2430,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
20424,angiogenin,C0051844,en_2430,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20425,angiogenin,C0051844,en_2430,affects(Infered),Thromboplastin,C0040048,en_2232,None,None,AFFECTS(Infered),Infered,3
20426,angiogenin,C0051844,en_2430,affects(Infered),Acute-Phase Proteins,C0001347,en_232,None,None,AFFECTS(Infered),Infered,3
20427,angiogenin,C0051844,en_2430,affects(Infered),C-reactive protein,C0006560,en_529,None,None,AFFECTS(Infered),Infered,3
20428,angiogenin,C0051844,en_2430,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
20429,angiogenin,C0051844,en_2430,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
20430,angiogenin,C0051844,en_2430,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20431,angiogenin,C0051844,en_2430,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20432,angiogenin,C0051844,en_2430,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20433,angiogenin,C0051844,en_2430,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
20434,angiogenin,C0051844,en_2430,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
20435,angiogenin,C0051844,en_2430,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
20436,angiogenin,C0051844,en_2430,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
20437,angiogenin,C0051844,en_2430,affects(Infered),Storm NOS,C2905612,en_6141,None,None,AFFECTS(Infered),Infered,3
20438,angiogenin,C0051844,en_2430,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
20439,angiogenin,C0051844,en_2430,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
20440,angiogenin,C0051844,en_2430,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
20441,angiogenin,C0051844,en_2430,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
20442,angiogenin,C0051844,en_2430,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
20443,angiogenin,C0051844,en_2430,affects(Infered),Severe infection,C5139167,en_6407,None,None,AFFECTS(Infered),Infered,3
20444,angiogenin,C0051844,en_2430,affects(Infered),Pathologic Processes,C0030660,en_1755,None,None,AFFECTS(Infered),Infered,3
20445,angiogenin,C0051844,en_2430,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
20446,angiogenin,C0051844,en_2430,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
20447,angiogenin,C0051844,en_2430,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
20448,angiogenin,C0051844,en_2430,affects(Infered),Brain,C0006104,en_508,None,None,AFFECTS(Infered),Infered,3
20449,angiogenin,C0051844,en_2430,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
20450,angiogenin,C0051844,en_2430,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20451,angiogenin,C0051844,en_2430,affects(Infered),Hyperactive behavior,C0424295,en_3992,None,None,AFFECTS(Infered),Infered,3
20452,angiogenin,C0051844,en_2430,affects(Infered),Shock,C0036974,en_2097,None,None,AFFECTS(Infered),Infered,3
20453,angiogenin,C0051844,en_2430,affects(Infered),Toxic effect,C0600688,en_4513,None,None,AFFECTS(Infered),Infered,3
20454,angiogenin,C0051844,en_2430,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
20455,angiogenin,C0051844,en_2430,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
20456,angiogenin,C0051844,en_2430,affects(Infered),Little's Disease,C0023882,en_1451,None,None,AFFECTS(Infered),Infered,3
20457,angiogenin,C0051844,en_2430,affects(Infered),Influenza,C0021400,en_1311,None,None,AFFECTS(Infered),Infered,3
20458,angiogenin,C0051844,en_2430,affects(Infered),Permeability,C0031164,en_1779,None,None,AFFECTS(Infered),Infered,3
20459,angiogenin,C0051844,en_2430,affects(Infered),Acute Lung Injury,C0242488,en_3416,None,None,AFFECTS(Infered),Infered,3
20460,angiogenin,C0051844,en_2430,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20461,angiogenin,C0051844,en_2430,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
20462,angiogenin,C0051844,en_2430,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20463,angiogenin,C0051844,en_2430,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
20464,angiogenin,C0051844,en_2430,affects(Infered),Matrix Metalloproteinases,C0623362,en_4521,None,None,AFFECTS(Infered),Infered,3
20465,angiogenin,C0051844,en_2430,affects(Infered),Interleukin-1 beta,C0021753,en_1334,None,None,AFFECTS(Infered),Infered,3
20466,angiogenin,C0051844,en_2430,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
20467,angiogenin,C0051844,en_2430,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
20468,angiogenin,C0051844,en_2430,affects(Infered),Inflammation Process,C1512753,en_5825,None,None,AFFECTS(Infered),Infered,3
20469,angiogenin,C0051844,en_2430,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
20470,angiogenin,C0051844,en_2430,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
20471,angiogenin,C0051844,en_2430,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
20472,angiogenin,C0051844,en_2430,affects(Infered),Respiratory complication,C0161818,en_2899,None,None,AFFECTS(Infered),Infered,3
20473,angiogenin,C0051844,en_2430,affects(Infered),Antigen-Antibody Complex,C0003313,en_361,None,None,AFFECTS(Infered),Infered,3
20474,angiogenin,C0051844,en_2430,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20475,angiogenin,C0051844,en_2430,affects(Infered),Endothelial dysfunction,C0856169,en_4968,None,None,AFFECTS(Infered),Infered,3
20476,angiogenin,C0051844,en_2430,affects(Infered),Tuberculosis,C0041296,en_2293,None,None,AFFECTS(Infered),Infered,3
20477,angiogenin,C0051844,en_2430,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
20478,angiogenin,C0051844,en_2430,affects(Infered),Homeostasis,C0019868,en_1201,None,None,AFFECTS(Infered),Infered,3
20479,angiogenin,C0051844,en_2430,affects(Infered),Lymphocyte,C0024264,en_1469,None,None,AFFECTS(Infered),Infered,3
20480,angiogenin,C0051844,en_2430,affects(Infered),Respiratory distress,C0476273,en_4149,None,None,AFFECTS(Infered),Infered,3
20481,angiogenin,C0051844,en_2430,affects(Infered),ANP32B gene,C1332090,en_5581,None,None,AFFECTS(Infered),Infered,3
20482,angiogenin,C0051844,en_2430,affects(Infered),Tissue damage,C0010957,en_756,None,None,AFFECTS(Infered),Infered,3
20483,angiogenin,C0051844,en_2430,affects(Infered),Muscular Atrophy,C0026846,en_1604,None,None,AFFECTS(Infered),Infered,3
20484,angiogenin,C0051844,en_2430,affects(Infered),Macrophage activation syndrome,C1096155,en_5233,None,None,AFFECTS(Infered),Infered,3
20485,angiogenin,C0051844,en_2430,affects(Infered),Inflammatory disorder,C1290884,en_5483,None,None,AFFECTS(Infered),Infered,3
20486,angiogenin,C0051844,en_2430,affects(Infered),Pulmonary Fibrosis,C0034069,en_1932,None,None,AFFECTS(Infered),Infered,3
20487,angiogenin,C0051844,en_2430,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
20488,angiogenin,C0051844,en_2430,affects(Infered),"Immunity, Cellular",C0020966,en_1274,None,None,AFFECTS(Infered),Infered,3
20489,angiogenin,C0051844,en_2430,affects(Infered),Organ,C0178784,en_2991,None,None,AFFECTS(Infered),Infered,3
20490,angiogenin,C0051844,en_2430,affects(Infered),Cell Communication,C0007582,en_585,None,None,AFFECTS(Infered),Infered,3
20491,angiogenin,C0051844,en_2430,affects(Infered),Reactive Oxygen Species,C0162772,en_2932,None,None,AFFECTS(Infered),Infered,3
20492,angiogenin,C0051844,en_2430,affects(Infered),Cell Growth,C0007595,en_590,None,None,AFFECTS(Infered),Infered,3
20493,angiogenin,C0051844,en_2430,affects(Infered),Acute inflammation,C0333361,en_3763,None,None,AFFECTS(Infered),Infered,3
20494,angiogenin,C0051844,en_2430,affects(Infered),Kidney Diseases,C0022658,en_1381,None,None,AFFECTS(Infered),Infered,3
20495,angiogenin,C0051844,en_2430,affects(Infered),Hematopoiesis,C0018951,en_1152,None,None,AFFECTS(Infered),Infered,3
20496,angiogenin,C0051844,en_2430,affects(Infered),Genes,C0017337,en_1052,None,None,AFFECTS(Infered),Infered,3
20497,angiogenin,C0051844,en_2430,affects(Infered),"Polymorphism, Genetic",C0032529,en_1849,None,None,AFFECTS(Infered),Infered,3
20498,angiogenin,C0051844,en_2430,affects(Infered),imbalance,C1397014,en_5692,None,None,AFFECTS(Infered),Infered,3
20499,angiogenin,C0051844,en_2430,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
20500,angiogenin,C0051844,en_2430,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
20501,angiogenin,C0051844,en_2430,affects(Infered),Signal Pathways,C0037080,en_2104,None,None,AFFECTS(Infered),Infered,3
20502,angiogenin,C0051844,en_2430,affects(Infered),myocardium; injury,C0746730,en_4817,None,None,AFFECTS(Infered),Infered,3
20503,angiogenin,C0051844,en_2430,affects(Infered),Male Genital Organs,C0017422,en_1058,None,None,AFFECTS(Infered),Infered,3
20504,angiogenin,C0051844,en_2430,affects(Infered),Osteogenesis,C0029433,en_1724,None,None,AFFECTS(Infered),Infered,3
20505,angiogenin,C0051844,en_2430,affects(Infered),iron metabolism,C0596803,en_4396,None,None,AFFECTS(Infered),Infered,3
20506,angiogenin,C0051844,en_2430,affects(Infered),type 2 immune response,C3159116,en_6176,None,None,AFFECTS(Infered),Infered,3
20507,angiogenin,C0051844,en_2430,affects(Infered),biological adaptation to stress,C0149784,en_2810,None,None,AFFECTS(Infered),Infered,3
20508,angiogenin,C0051844,en_2430,affects(Infered),"NOS3 protein, human",C0669365,en_4534,None,None,AFFECTS(Infered),Infered,3
20509,angiogenin,C0051844,en_2430,affects(Infered),Subclinical infection,C0275522,en_3565,None,None,AFFECTS(Infered),Infered,3
20510,angiogenin,C0051844,en_2430,affects(Infered),NF-kappa B,C0079904,en_2615,None,None,AFFECTS(Infered),Infered,3
20511,angiogenin,C0051844,en_2430,affects(Infered),Interleukins,C0021764,en_1345,None,None,AFFECTS(Infered),Infered,3
20512,angiogenin,C0051844,en_2430,affects(Infered),"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,None,None,AFFECTS(Infered),Infered,3
20513,angiogenin,C0051844,en_2430,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
20514,angiogenin,C0051844,en_2430,affects(Infered),Protein C,C0033621,en_1908,None,None,AFFECTS(Infered),Infered,3
20515,angiogenin,C0051844,en_2430,affects(Infered),Spermatogenesis,C0037864,en_2139,None,None,AFFECTS(Infered),Infered,3
20516,angiogenin,C0051844,en_2430,affects(Infered),Acute encephalopathy,C1306587,en_5522,None,None,AFFECTS(Infered),Infered,3
20517,angiogenin,C0051844,en_2430,affects(Infered),Microglia,C0206116,en_3147,None,None,AFFECTS(Infered),Infered,3
20518,angiogenin,C0051844,en_2430,affects(Infered),"Toxins, Chimeric",C0085998,en_2700,None,None,AFFECTS(Infered),Infered,3
20519,angiogenin,C0051844,en_2430,affects(Infered),activin A,C0100748,en_2749,None,None,AFFECTS(Infered),Infered,3
20520,angiogenin,C0051844,en_2430,affects(Infered),Single organ dysfunction,C0349410,en_3841,None,None,AFFECTS(Infered),Infered,3
20521,angiogenin,C0051844,en_2430,affects(Infered),Severe inflammation,C0522569,en_4215,None,None,AFFECTS(Infered),Infered,3
20522,angiogenin,C0051844,en_2430,affects(Infered),metalloenzyme,C0596918,en_4402,None,None,AFFECTS(Infered),Infered,3
20523,angiogenin,C0051844,en_2430,affects(Infered),testicular function,C0678881,en_4579,None,None,AFFECTS(Infered),Infered,3
20524,angiogenin,C0051844,en_2430,affects(Infered),organic disorders,C0683324,en_4660,None,None,AFFECTS(Infered),Infered,3
20525,angiogenin,C0051844,en_2430,affects(Infered),ALLERGIC SYMPTOM,C0740903,en_4785,None,None,AFFECTS(Infered),Infered,3
20526,angiogenin,C0051844,en_2430,affects(Infered),Structure of parenchyma of lung,C0819757,en_4926,None,None,AFFECTS(Infered),Infered,3
20527,angiogenin,C0051844,en_2430,affects(Infered),Hypos,C0858246,en_6688,None,None,AFFECTS(Infered),Infered,3
20528,angiogenin,C0051844,en_2430,affects(Infered),CD14+ cell,C0947286,en_5153,None,None,AFFECTS(Infered),Infered,3
20529,angiogenin,C0051844,en_2430,affects(Infered),TNFSF13B,C1420816,en_109,None,None,AFFECTS(Infered),Infered,3
20530,angiogenin,C0051844,en_2430,affects(Infered),Alveolar,C1440080,en_5730,None,None,AFFECTS(Infered),Infered,3
20531,angiogenin,C0051844,en_2430,affects(Infered),Signaling Molecule,C1519315,en_5883,None,None,AFFECTS(Infered),Infered,3
20532,TRANSCRIPTION FACTOR,C0040648,en_2264,affects(Infered),E protein,C0599561,en_6656,None,None,AFFECTS(Infered),Infered,3
20533,humoral immune response,C1155229,en_5318,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20534,humoral immune response,C1155229,en_5318,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20535,humoral immune response,C1155229,en_5318,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20536,humoral immune response,C1155229,en_5318,affects(Infered),Age,C0001779,en_257,None,None,AFFECTS(Infered),Infered,3
20537,humoral immune response,C1155229,en_5318,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20538,humoral immune response,C1155229,en_5318,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20539,humoral immune response,C1155229,en_5318,affects(Infered),Sarcoidosis,C0036202,en_2064,None,None,AFFECTS(Infered),Infered,3
20540,humoral immune response,C1155229,en_5318,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20541,humoral immune response,C1155229,en_5318,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
20542,humoral immune response,C1155229,en_5318,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20543,humoral immune response,C1155229,en_5318,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
20544,humoral immune response,C1155229,en_5318,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20545,humoral immune response,C1155229,en_5318,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20546,humoral immune response,C1155229,en_5318,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20547,humoral immune response,C1155229,en_5318,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20548,humoral immune response,C1155229,en_5318,affects(Infered),Predisposition,C0220898,en_3206,None,None,AFFECTS(Infered),Infered,3
20549,humoral immune response,C1155229,en_5318,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
20550,humoral immune response,C1155229,en_5318,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
20551,humoral immune response,C1155229,en_5318,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
20552,humoral immune response,C1155229,en_5318,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
20553,humoral immune response,C1155229,en_5318,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
20554,humoral immune response,C1155229,en_5318,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
20555,humoral immune response,C1155229,en_5318,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
20556,humoral immune response,C1155229,en_5318,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
20557,humoral immune response,C1155229,en_5318,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20558,humoral immune response,C1155229,en_5318,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
20559,humoral immune response,C1155229,en_5318,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20560,humoral immune response,C1155229,en_5318,affects(Infered),Animals,C0003062,en_335,None,None,AFFECTS(Infered),Infered,3
20561,humoral immune response,C1155229,en_5318,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20562,humoral immune response,C1155229,en_5318,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
20563,humoral immune response,C1155229,en_5318,affects(Infered),Organ failure,C0948600,en_5171,None,None,AFFECTS(Infered),Infered,3
20564,humoral immune response,C1155229,en_5318,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20565,humoral immune response,C1155229,en_5318,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20566,humoral immune response,C1155229,en_5318,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
20567,humoral immune response,C1155229,en_5318,affects(Infered),Autophagy,C0004391,en_432,None,None,AFFECTS(Infered),Infered,3
20568,humoral immune response,C1155229,en_5318,affects(Infered),Specific antibody,C0443640,en_4068,None,None,AFFECTS(Infered),Infered,3
20569,humoral immune response,C1155229,en_5318,affects(Infered),"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,None,None,AFFECTS(Infered),Infered,3
20570,humoral immune response,C1155229,en_5318,affects(Infered),"Mycobacterium Infections, Atypical",C0026919,en_1616,None,None,AFFECTS(Infered),Infered,3
20571,humoral immune response,C1155229,en_5318,affects(Infered),Ultraviolet Rays,C0041625,en_2307,None,None,AFFECTS(Infered),Infered,3
20572,humoral immune response,C1155229,en_5318,affects(Infered),Acute infectious disease,C0275518,en_3563,None,None,AFFECTS(Infered),Infered,3
20573,humoral immune response,C1155229,en_5318,affects(Infered),"Hemorrhagic Fever, Ebola",C0282687,en_3666,None,None,AFFECTS(Infered),Infered,3
20574,humoral immune response,C1155229,en_5318,affects(Infered),South Asian,C1519427,en_5885,None,None,AFFECTS(Infered),Infered,3
20575,humoral immune response,C1155229,en_5318,affects(Infered),Hospital specialist,C0087009,en_2742,None,None,AFFECTS(Infered),Infered,3
20576,humoral immune response,C1155229,en_5318,affects(Infered),Renal Insufficiency,C1565489,en_5983,None,None,AFFECTS(Infered),Infered,3
20577,Alteplase,C0032143,en_1823,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
20578,Platelet Activation,C0032173,en_1827,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
20579,Recreation,C0034872,en_1984,affects(Infered),Play,C0032214,en_1830,None,None,AFFECTS(Infered),Infered,3
20580,Secondary bacterial pneumonia,C0339952,en_3811,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20581,Secondary bacterial pneumonia,C0339952,en_3811,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20582,Secondary bacterial pneumonia,C0339952,en_3811,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20583,Secondary bacterial pneumonia,C0339952,en_3811,affects(Infered),cardiac arrhythmia,C0003811,en_397,None,None,AFFECTS(Infered),Infered,3
20584,School child,C0260267,en_3511,affects(Infered),Study models,C0026336,en_1575,None,None,AFFECTS(Infered),Infered,3
20585,Pro-Opiomelanocortin,C0033195,en_6550,affects(Infered),Mus,C0026809,en_1600,None,None,AFFECTS(Infered),Infered,3
20586,saliva,C0036087,en_2057,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
20587,paramylon,C0070074,en_2538,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20588,paramylon,C0070074,en_2538,affects(Infered),Phagocytosis,C0031308,en_1785,None,None,AFFECTS(Infered),Infered,3
20589,paramylon,C0070074,en_2538,affects(Infered),dectin 1,C0916194,en_5102,None,None,AFFECTS(Infered),Infered,3
20590,paramylon,C0070074,en_2538,affects(Infered),cytokine secretion,C1327414,en_5565,None,None,AFFECTS(Infered),Infered,3
20591,paramylon,C0070074,en_2538,affects(Infered),toll-like receptor 4,C1411976,en_5695,None,None,AFFECTS(Infered),Infered,3
20592,Protein Import,C1326471,en_5556,affects(Infered),Gene Expression,C0017262,en_1044,None,None,AFFECTS(Infered),Infered,3
20593,Struck,C0275626,en_3570,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20594,Struck,C0275626,en_3570,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20595,Physiological action,C0442687,en_4049,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
20596,Physiological action,C0442687,en_4049,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
20597,Physiological action,C0442687,en_4049,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
20598,Physiological action,C0442687,en_4049,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20599,Physiological action,C0442687,en_4049,affects(Infered),Arteriosclerosis,C0003850,en_399,None,None,AFFECTS(Infered),Infered,3
20600,Physiological action,C0442687,en_4049,affects(Infered),"Cardiomyopathy, Dilated",C0007193,en_566,None,None,AFFECTS(Infered),Infered,3
20601,Physiological action,C0442687,en_4049,affects(Infered),Immune System Diseases,C0021053,en_1284,None,None,AFFECTS(Infered),Infered,3
20602,Substance,C0439861,en_4040,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20603,Rehydration,C0034997,en_1990,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20604,Substance,C0439861,en_4040,affects(Infered),Diarrhea,C0011991,en_810,None,None,AFFECTS(Infered),Infered,3
20605,Reperfusion Therapy,C0035124,en_1998,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
20606,Advance,C0725066,en_4752,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20607,Advance,C0725066,en_4752,affects(Infered),Acute coronary syndrome,C0948089,en_5159,None,None,AFFECTS(Infered),Infered,3
20608,Advance,C0725066,en_4752,affects(Infered),Diagnosis,C0011900,en_806,None,None,AFFECTS(Infered),Infered,3
20609,Retinaldehyde,C0035331,en_2023,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
20610,Neural Development,C0814002,en_4907,affects(Infered),brain development,C1160340,en_5353,None,None,AFFECTS(Infered),Infered,3
20611,Viral life cycle,C1160638,en_5357,affects(Infered),viral genome replication,C1160701,en_5361,None,None,AFFECTS(Infered),Infered,3
20612,Viral life cycle,C1160638,en_5357,affects(Infered),virion attachment,C1160649,en_5359,None,None,AFFECTS(Infered),Infered,3
20613,Severe depression,C0588008,en_4364,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20614,Severe depression,C0588008,en_4364,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20615,Severe depression,C0588008,en_4364,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20616,Severe depression,C0588008,en_4364,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20617,Severe depression,C0588008,en_4364,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
20618,Severe depression,C0588008,en_4364,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
20619,Severe depression,C0588008,en_4364,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
20620,Severe depression,C0588008,en_4364,affects(Infered),physiological aspects,C0031843,en_1806,None,None,AFFECTS(Infered),Infered,3
20621,Severe depression,C0588008,en_4364,affects(Infered),Family,C0015576,en_961,None,None,AFFECTS(Infered),Infered,3
20622,Severe depression,C0588008,en_4364,affects(Infered),Sex Behavior,C0036864,en_2093,None,None,AFFECTS(Infered),Infered,3
20623,Severe depression,C0588008,en_4364,affects(Infered),Behavior,C0004927,en_450,None,None,AFFECTS(Infered),Infered,3
20624,Severe depression,C0588008,en_4364,affects(Infered),Sleep Disorders,C0851578,en_4954,None,None,AFFECTS(Infered),Infered,3
20625,Severe depression,C0588008,en_4364,affects(Infered),Child Development,C0008071,en_621,None,None,AFFECTS(Infered),Infered,3
20626,Severe depression,C0588008,en_4364,affects(Infered),Offspring,C0680063,en_4620,None,None,AFFECTS(Infered),Infered,3
20627,Severe depression,C0588008,en_4364,affects(Infered),Nurses,C0028661,en_1694,None,None,AFFECTS(Infered),Infered,3
20628,Severe depression,C0588008,en_4364,affects(Infered),Loss of capacity for enjoyment,C0178417,en_2983,None,None,AFFECTS(Infered),Infered,3
20629,Severe depression,C0588008,en_4364,affects(Infered),Phasis,C1067936,en_5224,None,None,AFFECTS(Infered),Infered,3
20630,Severe depression,C0588008,en_4364,affects(Infered),Negative thoughts,C1142075,en_5283,None,None,AFFECTS(Infered),Infered,3
20631,interleukin-22,C0961814,en_5197,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
20632,interleukin-22,C0961814,en_5197,affects(Infered),Expectation,C0679138,en_4589,None,None,AFFECTS(Infered),Infered,3
20633,interleukin-22,C0961814,en_5197,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
20634,interleukin-22,C0961814,en_5197,affects(Infered),Viremia,C0042749,en_2359,None,None,AFFECTS(Infered),Infered,3
20635,Thrombomodulin,C0145779,en_2793,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
20636,Tramadol,C0040610,en_2260,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
20637,Tramadol,C0040610,en_2260,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
20638,Tramadol,C0040610,en_2260,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
20639,Tramadol,C0040610,en_2260,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
20640,Interferon Regulatory Factor 1,C0063700,en_2508,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
20641,IRF1 gene,C1366516,en_5659,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20642,Interferon Regulatory Factor 1,C0063700,en_2508,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
20643,Interferon Regulatory Factor 1,C0063700,en_2508,affects(Infered),IRF1 gene,C1366516,en_5659,None,None,AFFECTS(Infered),Infered,3
20644,Interferon Regulatory Factor 1,C0063700,en_2508,affects(Infered),Transcriptional Activation,C0162493,en_2911,None,None,AFFECTS(Infered),Infered,3
20645,Longterm Follow-up,C1517942,en_5871,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20646,Longterm Follow-up,C1517942,en_5871,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20647,Longterm Follow-up,C1517942,en_5871,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
20648,Longterm Follow-up,C1517942,en_5871,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20649,Longterm Follow-up,C1517942,en_5871,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20650,Longterm Follow-up,C1517942,en_5871,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
20651,Longterm Follow-up,C1517942,en_5871,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20652,Longterm Follow-up,C1517942,en_5871,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20653,Longterm Follow-up,C1517942,en_5871,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
20654,Longterm Follow-up,C1517942,en_5871,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20655,Longterm Follow-up,C1517942,en_5871,affects(Infered),Present,C0150312,en_2833,None,None,AFFECTS(Infered),Infered,3
20656,Longterm Follow-up,C1517942,en_5871,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
20657,Longterm Follow-up,C1517942,en_5871,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20658,Longterm Follow-up,C1517942,en_5871,affects(Infered),Responsive Disease,C5236984,en_6425,None,None,AFFECTS(Infered),Infered,3
20659,Longterm Follow-up,C1517942,en_5871,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
20660,Longterm Follow-up,C1517942,en_5871,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
20661,Longterm Follow-up,C1517942,en_5871,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
20662,Longterm Follow-up,C1517942,en_5871,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
20663,Longterm Follow-up,C1517942,en_5871,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
20664,Longterm Follow-up,C1517942,en_5871,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
20665,Longterm Follow-up,C1517942,en_5871,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
20666,Longterm Follow-up,C1517942,en_5871,affects(Infered),General Population,C0683971,en_4674,None,None,AFFECTS(Infered),Infered,3
20667,Longterm Follow-up,C1517942,en_5871,affects(Infered),Maximum,C0806909,en_4887,None,None,AFFECTS(Infered),Infered,3
20668,Longterm Follow-up,C1517942,en_5871,affects(Infered),Family,C0015576,en_961,None,None,AFFECTS(Infered),Infered,3
20669,Longterm Follow-up,C1517942,en_5871,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
20670,Longterm Follow-up,C1517942,en_5871,affects(Infered),Persistent infection,C1264606,en_5429,None,None,AFFECTS(Infered),Infered,3
20671,Longterm Follow-up,C1517942,en_5871,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
20672,Longterm Follow-up,C1517942,en_5871,affects(Infered),Blind Vision,C0456909,en_4120,None,None,AFFECTS(Infered),Infered,3
20673,Longterm Follow-up,C1517942,en_5871,affects(Infered),Adolescent,C0205653,en_3132,None,None,AFFECTS(Infered),Infered,3
20674,Longterm Follow-up,C1517942,en_5871,affects(Infered),Pregnant Women,C0033011,en_1876,None,None,AFFECTS(Infered),Infered,3
20675,Longterm Follow-up,C1517942,en_5871,affects(Infered),Deglutition Disorders,C0011168,en_772,None,None,AFFECTS(Infered),Infered,3
20676,Longterm Follow-up,C1517942,en_5871,affects(Infered),Control Groups,C0009932,en_711,None,None,AFFECTS(Infered),Infered,3
20677,Longterm Follow-up,C1517942,en_5871,affects(Infered),Decompensation,C0231187,en_3250,None,None,AFFECTS(Infered),Infered,3
20678,Longterm Follow-up,C1517942,en_5871,affects(Infered),Infant,C0021270,en_1297,None,None,AFFECTS(Infered),Infered,3
20679,Longterm Follow-up,C1517942,en_5871,affects(Infered),Falls,C0085639,en_2684,None,None,AFFECTS(Infered),Infered,3
20680,Longterm Follow-up,C1517942,en_5871,affects(Infered),Diabetic ulcer,C0743150,en_4799,None,None,AFFECTS(Infered),Infered,3
20681,Longterm Follow-up,C1517942,en_5871,affects(Infered),Young adult,C0238598,en_3365,None,None,AFFECTS(Infered),Infered,3
20682,Longterm Follow-up,C1517942,en_5871,affects(Infered),Households,C0020052,en_1208,None,None,AFFECTS(Infered),Infered,3
20683,Longterm Follow-up,C1517942,en_5871,affects(Infered),Physical function,C0516981,en_4169,None,None,AFFECTS(Infered),Infered,3
20684,Longterm Follow-up,C1517942,en_5871,affects(Infered),Disease Outcome,C0679250,en_4593,None,None,AFFECTS(Infered),Infered,3
20685,Longterm Follow-up,C1517942,en_5871,affects(Infered),Voluntary Workers,C0042960,en_2380,None,None,AFFECTS(Infered),Infered,3
20686,Longterm Follow-up,C1517942,en_5871,affects(Infered),Form of muscle,C0240417,en_3384,None,None,AFFECTS(Infered),Infered,3
20687,Longterm Follow-up,C1517942,en_5871,affects(Infered),Treatment Group,C5205742,en_6422,None,None,AFFECTS(Infered),Infered,3
20688,Longterm Follow-up,C1517942,en_5871,affects(Infered),Graft-vs-Host Disease,C0018133,en_1092,None,None,AFFECTS(Infered),Infered,3
20689,Longterm Follow-up,C1517942,en_5871,affects(Infered),Psychiatrist,C0033872,en_1919,None,None,AFFECTS(Infered),Infered,3
20690,Longterm Follow-up,C1517942,en_5871,affects(Infered),Tinnitus,C0040264,en_2241,None,None,AFFECTS(Infered),Infered,3
20691,Longterm Follow-up,C1517942,en_5871,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
20692,Severe diarrhea,C1443924,en_5740,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20693,Severe diarrhea,C1443924,en_5740,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20694,Severe diarrhea,C1443924,en_5740,affects(Infered),Hospital admission,C0184666,en_3063,None,None,AFFECTS(Infered),Infered,3
20695,VIP gene,C1366646,en_5668,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20696,VIP gene,C1366646,en_5668,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20697,VIP gene,C1366646,en_5668,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20698,VIP gene,C1366646,en_5668,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20699,Vasoactive Intestinal Peptide,C0042395,en_2339,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
20700,Vasoactive Intestinal Peptide,C0042395,en_2339,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
20701,VIP gene,C1366646,en_5668,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
20702,VIP gene,C1366646,en_5668,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
20703,Vasoactive Intestinal Peptide,C0042395,en_2339,affects(Infered),Emission,C0233929,en_3301,None,None,AFFECTS(Infered),Infered,3
20704,VIP gene,C1366646,en_5668,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
20705,VIP gene,C1366646,en_5668,affects(Infered),cytokine biosynthesis,C1155099,en_5317,None,None,AFFECTS(Infered),Infered,3
20706,VIP gene,C1366646,en_5668,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
20707,Vasoactive Intestinal Peptide,C0042395,en_2339,affects(Infered),VIP gene,C1366646,en_5668,None,None,AFFECTS(Infered),Infered,3
20708,Infectious canine tracheobronchitis,C0276170,en_3575,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20709,Infectious canine tracheobronchitis,C0276170,en_3575,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20710,Infectious canine tracheobronchitis,C0276170,en_3575,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20711,Vitamin A,C0042839,en_2368,affects(Infered),Thrombogen,C0723739,en_4749,None,None,AFFECTS(Infered),Infered,3
20712,Warfarin,C0043031,en_2383,affects(Infered),Negative Regulation of Coagulation,C2917212,en_6142,None,None,AFFECTS(Infered),Infered,3
20713,1-(1-(2-thienyl)cyclohexyl)piperidine,C0044091,en_2411,affects(Infered),Alzheimer's Disease,C0002395,en_291,None,None,AFFECTS(Infered),Infered,3
20714,4-aminoquinoline,C0048060,en_2420,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20715,4-aminoquinoline,C0048060,en_2420,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20716,4-aminoquinoline,C0048060,en_2420,affects(Infered),uptake,C0243144,en_3467,None,None,AFFECTS(Infered),Infered,3
20717,4-aminoquinoline,C0048060,en_2420,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20718,4-aminoquinoline,C0048060,en_2420,affects(Infered),Death (finding),C1306577,en_5521,None,None,AFFECTS(Infered),Infered,3
20719,4-aminoquinoline,C0048060,en_2420,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
20720,4-aminoquinoline,C0048060,en_2420,affects(Infered),Cardiac rhythm type,C0232187,en_3273,None,None,AFFECTS(Infered),Infered,3
20721,4-aminoquinoline,C0048060,en_2420,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
20722,4-aminoquinoline,C0048060,en_2420,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20723,4-aminoquinoline,C0048060,en_2420,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
20724,doxifluridine,C0048808,en_6561,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20725,doxifluridine,C0048808,en_6561,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20726,doxifluridine,C0048808,en_6561,affects(Infered),"Abortion, Habitual",C0000809,en_207,None,None,AFFECTS(Infered),Infered,3
20727,doxifluridine,C0048808,en_6561,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20728,doxifluridine,C0048808,en_6561,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
20729,doxifluridine,C0048808,en_6561,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20730,doxifluridine,C0048808,en_6561,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
20731,doxifluridine,C0048808,en_6561,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
20732,doxifluridine,C0048808,en_6561,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20733,doxifluridine,C0048808,en_6561,affects(Infered),Tissue damage,C0010957,en_756,None,None,AFFECTS(Infered),Infered,3
20734,doxifluridine,C0048808,en_6561,affects(Infered),Autoimmune,C0443146,en_4064,None,None,AFFECTS(Infered),Infered,3
20735,doxifluridine,C0048808,en_6561,affects(Infered),Inflammatory disorder,C1290884,en_5483,None,None,AFFECTS(Infered),Infered,3
20736,doxifluridine,C0048808,en_6561,affects(Infered),Psoriasis,C0033860,en_1918,None,None,AFFECTS(Infered),Infered,3
20737,doxifluridine,C0048808,en_6561,affects(Infered),Undifferentiated connective tissue disease,C0409999,en_3968,None,None,AFFECTS(Infered),Infered,3
20738,doxifluridine,C0048808,en_6561,affects(Infered),organ rejection,C0815080,en_4921,None,None,AFFECTS(Infered),Infered,3
20739,doxifluridine,C0048808,en_6561,affects(Infered),Rodent Model,C1519106,en_5880,None,None,AFFECTS(Infered),Infered,3
20740,doxifluridine,C0048808,en_6561,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
20741,doxifluridine,C0048808,en_6561,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
20742,apolipoprotein E-4,C0052201,en_2434,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
20743,Azithromycin,C0052796,en_2439,affects(Infered),Hydroxychloroquine therapy,C5190549,en_6409,None,None,AFFECTS(Infered),Infered,3
20744,boswellic acid,C0053959,en_2444,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
20745,boswellic acid,C0053959,en_2444,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20746,boswellic acid,C0053959,en_2444,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
20747,boswellic acid,C0053959,en_2444,affects(Infered),Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,None,None,AFFECTS(Infered),Infered,3
20748,boswellic acid,C0053959,en_2444,affects(Infered),Angiotensin Receptor,C0034787,en_1963,None,None,AFFECTS(Infered),Infered,3
20749,boswellic acid,C0053959,en_2444,affects(Infered),Eicosanoids,C0013725,en_880,None,None,AFFECTS(Infered),Infered,3
20750,boswellic acid,C0053959,en_2444,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
20751,boswellic acid,C0053959,en_2444,affects(Infered),Polyamine Catabolism,C1156778,en_5331,None,None,AFFECTS(Infered),Infered,3
20752,Acute bacterial sinusitis,C0275556,en_3569,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20753,Acute bacterial sinusitis,C0275556,en_3569,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
20754,iproplatin,C0057856,en_2469,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20755,iproplatin,C0057856,en_2469,affects(Infered),Mus,C0026809,en_1600,None,None,AFFECTS(Infered),Infered,3
20756,iproplatin,C0057856,en_2469,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
20757,iproplatin,C0057856,en_2469,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20758,iproplatin,C0057856,en_2469,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
20759,iproplatin,C0057856,en_2469,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20760,iproplatin,C0057856,en_2469,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20761,iproplatin,C0057856,en_2469,affects(Infered),POLDIP2,C1428254,en_122,None,None,AFFECTS(Infered),Infered,3
20762,iproplatin,C0057856,en_2469,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
20763,iproplatin,C0057856,en_2469,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
20764,ebselen,C0058903,en_2476,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20765,ebselen,C0058903,en_2476,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
20766,ebselen,C0058903,en_2476,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20767,ebselen,C0058903,en_2476,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
20768,ebselen,C0058903,en_2476,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
20769,ebselen,C0058903,en_2476,affects(Infered),Alzheimer's Disease,C0002395,en_291,None,None,AFFECTS(Infered),Infered,3
20770,ebselen,C0058903,en_2476,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
20771,ebselen,C0058903,en_2476,affects(Infered),Interferons,C0021747,en_1333,None,None,AFFECTS(Infered),Infered,3
20772,ebselen,C0058903,en_2476,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
20773,ebselen,C0058903,en_2476,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20774,ebselen,C0058903,en_2476,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
20775,ebselen,C0058903,en_2476,affects(Infered),Alveolar ventilation function,C0231940,en_3269,None,None,AFFECTS(Infered),Infered,3
20776,ebselen,C0058903,en_2476,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
20777,ebselen,C0058903,en_2476,affects(Infered),Vascular Permeability,C0162337,en_2906,None,None,AFFECTS(Infered),Infered,3
20778,ebselen,C0058903,en_2476,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
20779,ebselen,C0058903,en_2476,affects(Infered),Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,None,None,AFFECTS(Infered),Infered,3
20780,ebselen,C0058903,en_2476,affects(Infered),Angiotensin Receptor,C0034787,en_1963,None,None,AFFECTS(Infered),Infered,3
20781,ebselen,C0058903,en_2476,affects(Infered),Eicosanoids,C0013725,en_880,None,None,AFFECTS(Infered),Infered,3
20782,ebselen,C0058903,en_2476,affects(Infered),Sphingolipids,C0037900,en_2142,None,None,AFFECTS(Infered),Infered,3
20783,ebselen,C0058903,en_2476,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
20784,ebselen,C0058903,en_2476,affects(Infered),Polyamine Catabolism,C1156778,en_5331,None,None,AFFECTS(Infered),Infered,3
20785,ebselen,C0058903,en_2476,affects(Infered),Platelet aggregation,C0032176,en_1828,None,None,AFFECTS(Infered),Infered,3
20786,ebselen,C0058903,en_2476,affects(Infered),Pathological accumulation of air in tissues,C0013990,en_891,None,None,AFFECTS(Infered),Infered,3
20787,ebselen,C0058903,en_2476,affects(Infered),Lipid Peroxidation,C0023775,en_1440,None,None,AFFECTS(Infered),Infered,3
20788,ebselen,C0058903,en_2476,affects(Infered),Lipopolysaccharides,C0023810,en_1443,None,None,AFFECTS(Infered),Infered,3
20789,ebselen,C0058903,en_2476,affects(Infered),Adverse reaction to antitussives,C0261908,en_3514,None,None,AFFECTS(Infered),Infered,3
20790,ebselen,C0058903,en_2476,affects(Infered),Neuropathic pain,C0423716,en_3989,None,None,AFFECTS(Infered),Infered,3
20791,ebselen,C0058903,en_2476,affects(Infered),TNF gene,C0812246,en_4896,None,None,AFFECTS(Infered),Infered,3
20792,ebselen,C0058903,en_2476,affects(Infered),ROS1,C0812281,en_74,None,None,AFFECTS(Infered),Infered,3
20793,ebselen,C0058903,en_2476,affects(Infered),Endothelial dysfunction,C0856169,en_4968,None,None,AFFECTS(Infered),Infered,3
20794,ebselen,C0058903,en_2476,affects(Infered),cellular metabolism,C1523924,en_5913,None,None,AFFECTS(Infered),Infered,3
20795,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20796,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20797,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
20798,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20799,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
20800,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
20801,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
20802,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Interferons,C0021747,en_1333,None,None,AFFECTS(Infered),Infered,3
20803,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
20804,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20805,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
20806,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Alveolar ventilation function,C0231940,en_3269,None,None,AFFECTS(Infered),Infered,3
20807,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Agitation,C0085631,en_2683,None,None,AFFECTS(Infered),Infered,3
20808,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
20809,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
20810,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Gout,C0018099,en_1091,None,None,AFFECTS(Infered),Infered,3
20811,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
20812,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Tendinitis,C0039503,en_2213,None,None,AFFECTS(Infered),Infered,3
20813,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),"Diabetes Insipidus, Nephrogenic",C0162283,en_2902,None,None,AFFECTS(Infered),Infered,3
20814,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Vascular Permeability,C0162337,en_2906,None,None,AFFECTS(Infered),Infered,3
20815,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
20816,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,None,None,AFFECTS(Infered),Infered,3
20817,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Angiotensin Receptor,C0034787,en_1963,None,None,AFFECTS(Infered),Infered,3
20818,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Eicosanoids,C0013725,en_880,None,None,AFFECTS(Infered),Infered,3
20819,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Sphingolipids,C0037900,en_2142,None,None,AFFECTS(Infered),Infered,3
20820,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
20821,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Polyamine Catabolism,C1156778,en_5331,None,None,AFFECTS(Infered),Infered,3
20822,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Platelet aggregation,C0032176,en_1828,None,None,AFFECTS(Infered),Infered,3
20823,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Pathological accumulation of air in tissues,C0013990,en_891,None,None,AFFECTS(Infered),Infered,3
20824,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Lipid Peroxidation,C0023775,en_1440,None,None,AFFECTS(Infered),Infered,3
20825,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Lipopolysaccharides,C0023810,en_1443,None,None,AFFECTS(Infered),Infered,3
20826,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Adverse reaction to antitussives,C0261908,en_3514,None,None,AFFECTS(Infered),Infered,3
20827,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Neuropathic pain,C0423716,en_3989,None,None,AFFECTS(Infered),Infered,3
20828,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),TNF gene,C0812246,en_4896,None,None,AFFECTS(Infered),Infered,3
20829,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),ROS1,C0812281,en_74,None,None,AFFECTS(Infered),Infered,3
20830,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),Endothelial dysfunction,C0856169,en_4968,None,None,AFFECTS(Infered),Infered,3
20831,"enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,en_2479,affects(Infered),cellular metabolism,C1523924,en_5913,None,None,AFFECTS(Infered),Infered,3
20832,"enterotoxin B, staphylococcal",C0059386,en_2480,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
20833,"enterotoxin B, staphylococcal",C0059386,en_2480,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
20834,"enterotoxin B, staphylococcal",C0059386,en_2480,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
20835,"TXN protein, human",C1504637,en_5790,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20836,"TXN protein, human",C1504637,en_5790,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20837,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20838,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20839,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
20840,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
20841,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20842,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20843,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20844,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
20845,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
20846,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
20847,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
20848,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
20849,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),physiological aspects,C0031843,en_1806,None,None,AFFECTS(Infered),Infered,3
20850,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Blood coagulation,C0005778,en_484,None,None,AFFECTS(Infered),Infered,3
20851,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,None,None,AFFECTS(Infered),Infered,3
20852,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Epidermal cGVHD Score 2,C4761314,en_6403,None,None,AFFECTS(Infered),Infered,3
20853,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Atrial Fibrillation,C0004238,en_423,None,None,AFFECTS(Infered),Infered,3
20854,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
20855,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
20856,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Proteins,C0033684,en_1912,None,None,AFFECTS(Infered),Infered,3
20857,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Pulmonary thrombosis,C0151946,en_2875,None,None,AFFECTS(Infered),Infered,3
20858,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),"Receptor, PAR-2",C0259628,en_3498,None,None,AFFECTS(Infered),Infered,3
20859,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Blood Clot,C0302148,en_3702,None,None,AFFECTS(Infered),Infered,3
20860,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
20861,glucuronyl glucosamine glycan sulfate,C0061450,en_2493,affects(Infered),"Stroke, Acute",C0751956,en_4854,None,None,AFFECTS(Infered),Infered,3
20862,leflunomide,C0063041,en_2502,affects(Infered),Immune,C0439662,en_4035,None,None,AFFECTS(Infered),Infered,3
20863,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20864,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20865,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20866,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Evolution,C0015219,en_937,None,None,AFFECTS(Infered),Infered,3
20867,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
20868,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20869,Tocilizumab therapy,C4510396,en_6356,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
20870,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
20871,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
20872,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
20873,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
20874,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
20875,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
20876,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20877,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Acute-Phase Proteins,C0001347,en_232,None,None,AFFECTS(Infered),Infered,3
20878,Tocilizumab therapy,C4510396,en_6356,affects(Infered),C-reactive protein,C0006560,en_529,None,None,AFFECTS(Infered),Infered,3
20879,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Malignant neoplasm of breast,C0006142,en_511,None,None,AFFECTS(Infered),Infered,3
20880,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
20881,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
20882,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
20883,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
20884,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
20885,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
20886,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Interleukin 6 Receptor,C0063717,en_2510,None,None,AFFECTS(Infered),Infered,3
20887,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
20888,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20889,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
20890,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Storm NOS,C2905612,en_6141,None,None,AFFECTS(Infered),Infered,3
20891,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Severe infection,C5139167,en_6407,None,None,AFFECTS(Infered),Infered,3
20892,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
20893,Tocilizumab therapy,C4510396,en_6356,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
20894,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
20895,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Death (finding),C1306577,en_5521,None,None,AFFECTS(Infered),Infered,3
20896,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
20897,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Malaise,C0231218,en_3251,None,None,AFFECTS(Infered),Infered,3
20898,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Inflammation Process,C1512753,en_5825,None,None,AFFECTS(Infered),Infered,3
20899,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Myocarditis,C0027059,en_1627,None,None,AFFECTS(Infered),Infered,3
20900,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
20901,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
20902,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Worse,C1457868,en_5783,None,None,AFFECTS(Infered),Infered,3
20903,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Respiratory distress,C0476273,en_4149,None,None,AFFECTS(Infered),Infered,3
20904,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Rheumatism,C0035435,en_2028,None,None,AFFECTS(Infered),Infered,3
20905,Tocilizumab therapy,C4510396,en_6356,affects(Infered),receptor,C0597357,en_4422,None,None,AFFECTS(Infered),Infered,3
20906,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Control Groups,C0009932,en_711,None,None,AFFECTS(Infered),Infered,3
20907,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Patient ventilated,C1299448,en_5503,None,None,AFFECTS(Infered),Infered,3
20908,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Lethality,C5203340,en_6416,None,None,AFFECTS(Infered),Infered,3
20909,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Storm Syndrome,C1861452,en_6056,None,None,AFFECTS(Infered),Infered,3
20910,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Complement factor,C1305959,en_5520,None,None,AFFECTS(Infered),Infered,3
20911,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Intubated,C4698386,en_6376,None,None,AFFECTS(Infered),Infered,3
20912,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Structure of parenchyma of lung,C0819757,en_4926,None,None,AFFECTS(Infered),Infered,3
20913,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Ligand Binding,C1517880,en_5869,None,None,AFFECTS(Infered),Infered,3
20914,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Sepsis Syndrome,C0242966,en_3446,None,None,AFFECTS(Infered),Infered,3
20915,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Hyperinflammatory state,C4014463,en_6290,None,None,AFFECTS(Infered),Infered,3
20916,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Mild inflammation,C0522567,en_4214,None,None,AFFECTS(Infered),Infered,3
20917,Tocilizumab therapy,C4510396,en_6356,affects(Infered),"Pulmonary involvement, severe",C1843376,en_6050,None,None,AFFECTS(Infered),Infered,3
20918,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Actual Adequate Hydration,C2364300,en_6113,None,None,AFFECTS(Infered),Infered,3
20919,Tocilizumab therapy,C4510396,en_6356,affects(Infered),Complete Response with Incomplete Platelet Recovery,C3890735,en_6283,None,None,AFFECTS(Infered),Infered,3
20920,Tissue neutrophil,C0229611,en_3243,affects(Infered),5'-NUCLEOTIDASE,C0000530,en_202,None,None,AFFECTS(Infered),Infered,3
20921,Tissue neutrophil,C0229611,en_3243,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
20922,Tissue neutrophil,C0229611,en_3243,affects(Infered),"CD79A,LOC102723407",C1413238,en_191,None,None,AFFECTS(Infered),Infered,3
20923,Tissue neutrophil,C0229611,en_3243,affects(Infered),Reactive Oxygen Species,C0162772,en_2932,None,None,AFFECTS(Infered),Infered,3
20924,Tissue neutrophil,C0229611,en_3243,affects(Infered),Enzymes,C0014442,en_912,None,None,AFFECTS(Infered),Infered,3
20925,Tissue neutrophil,C0229611,en_3243,affects(Infered),Chromatin,C0008546,en_642,None,None,AFFECTS(Infered),Infered,3
20926,Tissue neutrophil,C0229611,en_3243,affects(Infered),ELK3 gene,C0812375,en_4900,None,None,AFFECTS(Infered),Infered,3
20927,Tissue neutrophil,C0229611,en_3243,affects(Infered),Transferrin,C0040679,en_2269,None,None,AFFECTS(Infered),Infered,3
20928,Tissue neutrophil,C0229611,en_3243,affects(Infered),Immunoglobulins,C0021027,en_1282,None,None,AFFECTS(Infered),Infered,3
20929,Listerine,C0065081,en_2516,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20930,Listerine,C0065081,en_2516,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
20931,Listerine,C0065081,en_2516,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
20932,Listerine,C0065081,en_2516,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20933,Listerine,C0065081,en_2516,affects(Infered),exacerbation acute,C0743630,en_4804,None,None,AFFECTS(Infered),Infered,3
20934,Listerine,C0065081,en_2516,affects(Infered),Death (finding),C1306577,en_5521,None,None,AFFECTS(Infered),Infered,3
20935,Listerine,C0065081,en_2516,affects(Infered),Respiratory complication,C0161818,en_2899,None,None,AFFECTS(Infered),Infered,3
20936,Listerine,C0065081,en_2516,affects(Infered),Death in hospital,C0277608,en_3586,None,None,AFFECTS(Infered),Infered,3
20937,Listerine,C0065081,en_2516,affects(Infered),Professional guide,C0181090,en_3019,None,None,AFFECTS(Infered),Infered,3
20938,zaprinast,C0065432,en_2519,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
20939,"nucleoprotein, Measles virus",C0065827,en_2522,affects(Infered),Virion,C0042760,en_2360,None,None,AFFECTS(Infered),Infered,3
20940,"nucleoprotein, Measles virus",C0065827,en_2522,affects(Infered),Receptor Binding,C0597358,en_4423,None,None,AFFECTS(Infered),Infered,3
20941,mometasone furoate,C0066700,en_2525,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20942,mometasone furoate,C0066700,en_2525,affects(Infered),Keratoconjunctivitis,C0022573,en_1375,None,None,AFFECTS(Infered),Infered,3
20943,mometasone furoate,C0066700,en_2525,affects(Infered),"Dermatitis, Atopic",C0011615,en_791,None,None,AFFECTS(Infered),Infered,3
20944,monoferrous acid citrate,C0066752,en_2526,affects(Infered),Common Cold,C0009443,en_684,None,None,AFFECTS(Infered),Infered,3
20945,monoferrous acid citrate,C0066752,en_2526,affects(Infered),"Biological function, NOS",C0277784,en_3587,None,None,AFFECTS(Infered),Infered,3
20946,piperaquine,C0071105,en_2544,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20947,piperaquine,C0071105,en_2544,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20948,piperaquine,C0071105,en_2544,affects(Infered),uptake,C0243144,en_3467,None,None,AFFECTS(Infered),Infered,3
20949,piperaquine,C0071105,en_2544,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20950,piperaquine,C0071105,en_2544,affects(Infered),Death (finding),C1306577,en_5521,None,None,AFFECTS(Infered),Infered,3
20951,piperaquine,C0071105,en_2544,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
20952,piperaquine,C0071105,en_2544,affects(Infered),Cardiac rhythm type,C0232187,en_3273,None,None,AFFECTS(Infered),Infered,3
20953,piperaquine,C0071105,en_2544,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
20954,piperaquine,C0071105,en_2544,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20955,piperaquine,C0071105,en_2544,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
20956,protoporphyrin IX,C0072497,en_2552,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
20957,protoporphyrin IX,C0072497,en_2552,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
20958,protoporphyrin IX,C0072497,en_2552,affects(Infered),acetonitrile,C0050456,en_2422,None,None,AFFECTS(Infered),Infered,3
20959,pyronaridine,C0072768,en_2553,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
20960,pyronaridine,C0072768,en_2553,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20961,pyronaridine,C0072768,en_2553,affects(Infered),uptake,C0243144,en_3467,None,None,AFFECTS(Infered),Infered,3
20962,pyronaridine,C0072768,en_2553,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
20963,pyronaridine,C0072768,en_2553,affects(Infered),Death (finding),C1306577,en_5521,None,None,AFFECTS(Infered),Infered,3
20964,pyronaridine,C0072768,en_2553,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
20965,pyronaridine,C0072768,en_2553,affects(Infered),Cardiac rhythm type,C0232187,en_3273,None,None,AFFECTS(Infered),Infered,3
20966,pyronaridine,C0072768,en_2553,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
20967,pyronaridine,C0072768,en_2553,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
20968,pyronaridine,C0072768,en_2553,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
20969,resveratrol,C0073096,en_2558,affects(Infered),Antiinflammatory Effect,C1516019,en_5851,None,None,AFFECTS(Infered),Infered,3
20970,RNA primers,C0073429,en_2564,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
20971,RNA primers,C0073429,en_2564,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
20972,RNA primers,C0073429,en_2564,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
20973,RNA primers,C0073429,en_2564,affects(Infered),Cell physiology,C0007613,en_594,None,None,AFFECTS(Infered),Infered,3
20974,RNA primers,C0073429,en_2564,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
20975,RNA primers,C0073429,en_2564,affects(Infered),Signal Transduction,C0037083,en_2105,None,None,AFFECTS(Infered),Infered,3
20976,RNA primers,C0073429,en_2564,affects(Infered),physiological aspects,C0031843,en_1806,None,None,AFFECTS(Infered),Infered,3
20977,RNA primers,C0073429,en_2564,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
20978,RNA primers,C0073429,en_2564,affects(Infered),"Infections, Hospital",C0205721,en_3133,None,None,AFFECTS(Infered),Infered,3
20979,RNA primers,C0073429,en_2564,affects(Infered),small molecule,C1328819,en_5573,None,None,AFFECTS(Infered),Infered,3
20980,RNA primers,C0073429,en_2564,affects(Infered),Diffusion,C0012222,en_814,None,None,AFFECTS(Infered),Infered,3
20981,RNA primers,C0073429,en_2564,affects(Infered),Gene Expression Regulation,C0017263,en_1045,None,None,AFFECTS(Infered),Infered,3
20982,RNA primers,C0073429,en_2564,affects(Infered),Toll-like receptors,C0670896,en_4538,None,None,AFFECTS(Infered),Infered,3
20983,RNA primers,C0073429,en_2564,affects(Infered),Cytokinesis of the fertilized ovum,C1330957,en_5579,None,None,AFFECTS(Infered),Infered,3
20984,RNA primers,C0073429,en_2564,affects(Infered),genetic aspects,C0017399,en_1057,None,None,AFFECTS(Infered),Infered,3
20985,RNA primers,C0073429,en_2564,affects(Infered),Crossbreeding,C0020202,en_1217,None,None,AFFECTS(Infered),Infered,3
20986,RNA primers,C0073429,en_2564,affects(Infered),Viremia,C0042749,en_2359,None,None,AFFECTS(Infered),Infered,3
20987,RNA primers,C0073429,en_2564,affects(Infered),Transcription Termination,C0597600,en_4432,None,None,AFFECTS(Infered),Infered,3
20988,RNA primers,C0073429,en_2564,affects(Infered),Escape,C0870509,en_5004,None,None,AFFECTS(Infered),Infered,3
20989,RNA primers,C0073429,en_2564,affects(Infered),"TLR7 protein, human",C0971207,en_5210,None,None,AFFECTS(Infered),Infered,3
20990,RNA primers,C0073429,en_2564,affects(Infered),Viral life cycle,C1160638,en_5357,None,None,AFFECTS(Infered),Infered,3
20991,bucillamine,C0073917,en_2566,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
20992,bucillamine,C0073917,en_2566,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
20993,bucillamine,C0073917,en_2566,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
20994,bucillamine,C0073917,en_2566,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
20995,bucillamine,C0073917,en_2566,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
20996,bucillamine,C0073917,en_2566,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
20997,bucillamine,C0073917,en_2566,affects(Infered),Interferons,C0021747,en_1333,None,None,AFFECTS(Infered),Infered,3
20998,bucillamine,C0073917,en_2566,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
20999,bucillamine,C0073917,en_2566,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21000,bucillamine,C0073917,en_2566,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
21001,bucillamine,C0073917,en_2566,affects(Infered),Alveolar ventilation function,C0231940,en_3269,None,None,AFFECTS(Infered),Infered,3
21002,bucillamine,C0073917,en_2566,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
21003,bucillamine,C0073917,en_2566,affects(Infered),Vascular Permeability,C0162337,en_2906,None,None,AFFECTS(Infered),Infered,3
21004,bucillamine,C0073917,en_2566,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
21005,bucillamine,C0073917,en_2566,affects(Infered),Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,None,None,AFFECTS(Infered),Infered,3
21006,bucillamine,C0073917,en_2566,affects(Infered),Angiotensin Receptor,C0034787,en_1963,None,None,AFFECTS(Infered),Infered,3
21007,bucillamine,C0073917,en_2566,affects(Infered),Eicosanoids,C0013725,en_880,None,None,AFFECTS(Infered),Infered,3
21008,bucillamine,C0073917,en_2566,affects(Infered),Sphingolipids,C0037900,en_2142,None,None,AFFECTS(Infered),Infered,3
21009,bucillamine,C0073917,en_2566,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
21010,bucillamine,C0073917,en_2566,affects(Infered),Polyamine Catabolism,C1156778,en_5331,None,None,AFFECTS(Infered),Infered,3
21011,bucillamine,C0073917,en_2566,affects(Infered),Platelet aggregation,C0032176,en_1828,None,None,AFFECTS(Infered),Infered,3
21012,bucillamine,C0073917,en_2566,affects(Infered),Pathological accumulation of air in tissues,C0013990,en_891,None,None,AFFECTS(Infered),Infered,3
21013,bucillamine,C0073917,en_2566,affects(Infered),Lipid Peroxidation,C0023775,en_1440,None,None,AFFECTS(Infered),Infered,3
21014,bucillamine,C0073917,en_2566,affects(Infered),Lipopolysaccharides,C0023810,en_1443,None,None,AFFECTS(Infered),Infered,3
21015,bucillamine,C0073917,en_2566,affects(Infered),Adverse reaction to antitussives,C0261908,en_3514,None,None,AFFECTS(Infered),Infered,3
21016,bucillamine,C0073917,en_2566,affects(Infered),Neuropathic pain,C0423716,en_3989,None,None,AFFECTS(Infered),Infered,3
21017,bucillamine,C0073917,en_2566,affects(Infered),TNF gene,C0812246,en_4896,None,None,AFFECTS(Infered),Infered,3
21018,bucillamine,C0073917,en_2566,affects(Infered),ROS1,C0812281,en_74,None,None,AFFECTS(Infered),Infered,3
21019,bucillamine,C0073917,en_2566,affects(Infered),Endothelial dysfunction,C0856169,en_4968,None,None,AFFECTS(Infered),Infered,3
21020,bucillamine,C0073917,en_2566,affects(Infered),cellular metabolism,C1523924,en_5913,None,None,AFFECTS(Infered),Infered,3
21021,bucillamine,C0073917,en_2566,affects(Infered),Arteriosclerosis,C0003850,en_399,None,None,AFFECTS(Infered),Infered,3
21022,Salazopyrine,C0073966,en_2567,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21023,Salazopyrine,C0073966,en_2567,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
21024,Salazopyrine,C0073966,en_2567,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21025,Salazopyrine,C0073966,en_2567,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21026,Salazopyrine,C0073966,en_2567,affects(Infered),Respiratory complication,C0161818,en_2899,None,None,AFFECTS(Infered),Infered,3
21027,Salazopyrine,C0073966,en_2567,affects(Infered),Death in hospital,C0277608,en_3586,None,None,AFFECTS(Infered),Infered,3
21028,Salazopyrine,C0073966,en_2567,affects(Infered),Professional guide,C0181090,en_3019,None,None,AFFECTS(Infered),Infered,3
21029,tetrandrine,C0076316,en_2575,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21030,tetrandrine,C0076316,en_2575,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21031,tetrandrine,C0076316,en_2575,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21032,tetrandrine,C0076316,en_2575,affects(Infered),"Abortion, Habitual",C0000809,en_207,None,None,AFFECTS(Infered),Infered,3
21033,tetrandrine,C0076316,en_2575,affects(Infered),RNA Viruses,C0035691,en_2044,None,None,AFFECTS(Infered),Infered,3
21034,tetrandrine,C0076316,en_2575,affects(Infered),uptake,C0243144,en_3467,None,None,AFFECTS(Infered),Infered,3
21035,tetrandrine,C0076316,en_2575,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21036,tetrandrine,C0076316,en_2575,affects(Infered),Anxiety,C0003467,en_380,None,None,AFFECTS(Infered),Infered,3
21037,tetrandrine,C0076316,en_2575,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21038,tetrandrine,C0076316,en_2575,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21039,tetrandrine,C0076316,en_2575,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
21040,tetrandrine,C0076316,en_2575,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
21041,tetrandrine,C0076316,en_2575,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
21042,tetrandrine,C0076316,en_2575,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
21043,tetrandrine,C0076316,en_2575,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
21044,tetrandrine,C0076316,en_2575,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21045,tetrandrine,C0076316,en_2575,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21046,tetrandrine,C0076316,en_2575,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
21047,tetrandrine,C0076316,en_2575,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21048,tetrandrine,C0076316,en_2575,affects(Infered),Hypertensive disease,C0020538,en_1239,None,None,AFFECTS(Infered),Infered,3
21049,tetrandrine,C0076316,en_2575,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
21050,tetrandrine,C0076316,en_2575,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21051,tetrandrine,C0076316,en_2575,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21052,tetrandrine,C0076316,en_2575,affects(Infered),Relative (related person),C0080103,en_2623,None,None,AFFECTS(Infered),Infered,3
21053,tetrandrine,C0076316,en_2575,affects(Infered),Blood Pressure,C0005823,en_492,None,None,AFFECTS(Infered),Infered,3
21054,tetrandrine,C0076316,en_2575,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
21055,tetrandrine,C0076316,en_2575,affects(Infered),Opioid Use Disorders,C0029103,en_1711,None,None,AFFECTS(Infered),Infered,3
21056,tetrandrine,C0076316,en_2575,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21057,tetrandrine,C0076316,en_2575,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
21058,tetrandrine,C0076316,en_2575,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
21059,tetrandrine,C0076316,en_2575,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
21060,tetrandrine,C0076316,en_2575,affects(Infered),Influenza,C0021400,en_1311,None,None,AFFECTS(Infered),Infered,3
21061,tetrandrine,C0076316,en_2575,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21062,tetrandrine,C0076316,en_2575,affects(Infered),Animal Viruses,C0003060,en_334,None,None,AFFECTS(Infered),Infered,3
21063,tetrandrine,C0076316,en_2575,affects(Infered),Virus,C0042776,en_2364,None,None,AFFECTS(Infered),Infered,3
21064,tetrandrine,C0076316,en_2575,affects(Infered),Death (finding),C1306577,en_5521,None,None,AFFECTS(Infered),Infered,3
21065,tetrandrine,C0076316,en_2575,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
21066,tetrandrine,C0076316,en_2575,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21067,tetrandrine,C0076316,en_2575,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
21068,tetrandrine,C0076316,en_2575,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
21069,tetrandrine,C0076316,en_2575,affects(Infered),Superinfection,C0038826,en_2184,None,None,AFFECTS(Infered),Infered,3
21070,tetrandrine,C0076316,en_2575,affects(Infered),Cardiac rhythm type,C0232187,en_3273,None,None,AFFECTS(Infered),Infered,3
21071,tetrandrine,C0076316,en_2575,affects(Infered),"Translation, Genetic",C0040711,en_2274,None,None,AFFECTS(Infered),Infered,3
21072,tetrandrine,C0076316,en_2575,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
21073,tetrandrine,C0076316,en_2575,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
21074,tetrandrine,C0076316,en_2575,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
21075,tetrandrine,C0076316,en_2575,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
21076,tetrandrine,C0076316,en_2575,affects(Infered),Complement System Proteins,C0009498,en_691,None,None,AFFECTS(Infered),Infered,3
21077,tetrandrine,C0076316,en_2575,affects(Infered),Hepatitis C,C0019196,en_1177,None,None,AFFECTS(Infered),Infered,3
21078,tetrandrine,C0076316,en_2575,affects(Infered),Peptide Hydrolases,C0030940,en_1769,None,None,AFFECTS(Infered),Infered,3
21079,tetrandrine,C0076316,en_2575,affects(Infered),"Pneumonia, Viral",C0032310,en_1837,None,None,AFFECTS(Infered),Infered,3
21080,tetrandrine,C0076316,en_2575,affects(Infered),RNA-Directed RNA Polymerase,C0035685,en_2042,None,None,AFFECTS(Infered),Infered,3
21081,tetrandrine,C0076316,en_2575,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
21082,tetrandrine,C0076316,en_2575,affects(Infered),Hepatitis C virus,C0220847,en_3204,None,None,AFFECTS(Infered),Infered,3
21083,tetrandrine,C0076316,en_2575,affects(Infered),Clinical Syndromes,C0221444,en_3225,None,None,AFFECTS(Infered),Infered,3
21084,tetrandrine,C0076316,en_2575,affects(Infered),Possible,C0332149,en_3747,None,None,AFFECTS(Infered),Infered,3
21085,tetrandrine,C0076316,en_2575,affects(Infered),Acute respiratory infection NOS,C0339901,en_3809,None,None,AFFECTS(Infered),Infered,3
21086,tetrandrine,C0076316,en_2575,affects(Infered),viral genome replication,C1160701,en_5361,None,None,AFFECTS(Infered),Infered,3
21087,tetrandrine,C0076316,en_2575,affects(Infered),Polymerase,C1335439,en_5615,None,None,AFFECTS(Infered),Infered,3
21088,tetrandrine,C0076316,en_2575,affects(Infered),Worse,C1457868,en_5783,None,None,AFFECTS(Infered),Infered,3
21089,tetrandrine,C0076316,en_2575,affects(Infered),Tissue damage,C0010957,en_756,None,None,AFFECTS(Infered),Infered,3
21090,tetrandrine,C0076316,en_2575,affects(Infered),Autoimmune,C0443146,en_4064,None,None,AFFECTS(Infered),Infered,3
21091,tetrandrine,C0076316,en_2575,affects(Infered),Inflammatory disorder,C1290884,en_5483,None,None,AFFECTS(Infered),Infered,3
21092,tetrandrine,C0076316,en_2575,affects(Infered),Psoriasis,C0033860,en_1918,None,None,AFFECTS(Infered),Infered,3
21093,tetrandrine,C0076316,en_2575,affects(Infered),Undifferentiated connective tissue disease,C0409999,en_3968,None,None,AFFECTS(Infered),Infered,3
21094,tetrandrine,C0076316,en_2575,affects(Infered),organ rejection,C0815080,en_4921,None,None,AFFECTS(Infered),Infered,3
21095,tetrandrine,C0076316,en_2575,affects(Infered),Rodent Model,C1519106,en_5880,None,None,AFFECTS(Infered),Infered,3
21096,tetraphenylporphine,C0076327,en_2576,affects(Infered),Lysis,C0024348,en_1476,None,None,AFFECTS(Infered),Infered,3
21097,tetraphenylporphine,C0076327,en_2576,affects(Infered),Acquired porphyria,C0948592,en_5170,None,None,AFFECTS(Infered),Infered,3
21098,tetraphenylporphine,C0076327,en_2576,affects(Infered),luminescence,C1450275,en_5763,None,None,AFFECTS(Infered),Infered,3
21099,VBM protocol,C0078140,en_2587,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21100,VBM protocol,C0078140,en_2587,affects(Infered),Mus,C0026809,en_1600,None,None,AFFECTS(Infered),Infered,3
21101,VBM protocol,C0078140,en_2587,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
21102,VBM protocol,C0078140,en_2587,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
21103,VBM protocol,C0078140,en_2587,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21104,VBM protocol,C0078140,en_2587,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
21105,VBM protocol,C0078140,en_2587,affects(Infered),Chronic Childhood Arthritis,C0553662,en_4288,None,None,AFFECTS(Infered),Infered,3
21106,VBM protocol,C0078140,en_2587,affects(Infered),Pulmonary Fibrosis,C0034069,en_1932,None,None,AFFECTS(Infered),Infered,3
21107,daunorubicin/prednisone/vincristine protocol,C0078144,en_2588,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21108,daunorubicin/prednisone/vincristine protocol,C0078144,en_2588,affects(Infered),Community acquired pneumonia,C0694549,en_4692,None,None,AFFECTS(Infered),Infered,3
21109,daunorubicin/prednisone/vincristine protocol,C0078144,en_2588,affects(Infered),Recurrent pregnancy loss,C2921106,en_6144,None,None,AFFECTS(Infered),Infered,3
21110,Signaling Molecule,C1519315,en_5883,affects(Infered),Antiinflammatory Effect,C1516019,en_5851,None,None,AFFECTS(Infered),Infered,3
21111,Basic life support,C0085873,en_2696,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21112,Basic life support,C0085873,en_2696,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21113,Basic life support,C0085873,en_2696,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
21114,Basic life support,C0085873,en_2696,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21115,Basic life support,C0085873,en_2696,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
21116,Basic life support,C0085873,en_2696,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21117,Basic life support,C0085873,en_2696,affects(Infered),Dementia,C0497327,en_4164,None,None,AFFECTS(Infered),Infered,3
21118,Basic life support,C0085873,en_2696,affects(Infered),Childbirth,C1148523,en_5296,None,None,AFFECTS(Infered),Infered,3
21119,Basic life support,C0085873,en_2696,affects(Infered),parent,C0030551,en_1750,None,None,AFFECTS(Infered),Infered,3
21120,Basic life support,C0085873,en_2696,affects(Infered),Atrophic,C0333641,en_3770,None,None,AFFECTS(Infered),Infered,3
21121,Therapeutic procedure,C0087111,en_2744,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
21122,camostate-mesilate,C0108225,en_2756,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21123,camostate-mesilate,C0108225,en_2756,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21124,camostate-mesilate,C0108225,en_2756,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21125,camostate-mesilate,C0108225,en_2756,affects(Infered),Cell Proliferation,C0596290,en_4384,None,None,AFFECTS(Infered),Infered,3
21126,camostate-mesilate,C0108225,en_2756,affects(Infered),Angiogenesis,C0302600,en_3709,None,None,AFFECTS(Infered),Infered,3
21127,Curosurf,C0111318,en_2761,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21128,Curosurf,C0111318,en_2761,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21129,ibudilast,C0123047,en_2769,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21130,ibudilast,C0123047,en_2769,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
21131,ibudilast,C0123047,en_2769,affects(Infered),Angiotensin Receptor,C0034787,en_1963,None,None,AFFECTS(Infered),Infered,3
21132,ibudilast,C0123047,en_2769,affects(Infered),ESAM gene,C1424976,en_5726,None,None,AFFECTS(Infered),Infered,3
21133,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21134,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21135,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21136,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Platelet aggregation,C0032176,en_1828,None,None,AFFECTS(Infered),Infered,3
21137,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Complement System Proteins,C0009498,en_691,None,None,AFFECTS(Infered),Infered,3
21138,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Cell Proliferation,C0596290,en_4384,None,None,AFFECTS(Infered),Infered,3
21139,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Angiogenesis,C0302600,en_3709,None,None,AFFECTS(Infered),Infered,3
21140,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Peptic Esophagitis,C0014869,en_930,None,None,AFFECTS(Infered),Infered,3
21141,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),"Hemoglobin, Glycosylated",C0017853,en_1078,None,None,AFFECTS(Infered),Infered,3
21142,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Glycine Receptors,C0061605,en_2496,None,None,AFFECTS(Infered),Infered,3
21143,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
21144,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Kininogenase,C0022478,en_1374,None,None,AFFECTS(Infered),Infered,3
21145,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),"Pancreatitis, Chronic",C0149521,en_2802,None,None,AFFECTS(Infered),Infered,3
21146,"N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid",C0130137,en_2780,affects(Infered),Postoperative esophagitis,C0267058,en_3543,None,None,AFFECTS(Infered),Infered,3
21147,"auR protein, Staphylococcus aureus",C0143595,en_2791,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
21148,"auR protein, Staphylococcus aureus",C0143595,en_2791,affects(Infered),RNA,C0035668,en_2040,None,None,AFFECTS(Infered),Infered,3
21149,"auR protein, Staphylococcus aureus",C0143595,en_2791,affects(Infered),Toxic effect,C0600688,en_4513,None,None,AFFECTS(Infered),Infered,3
21150,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21151,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21152,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Neurodegenerative Disorders,C0524851,en_4220,None,None,AFFECTS(Infered),Infered,3
21153,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Up-Regulation (Physiology),C0041904,en_2313,None,None,AFFECTS(Infered),Infered,3
21154,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
21155,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
21156,"TAL1 protein, human",C0378781,en_6632,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
21157,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
21158,"TAL1 protein, human",C0378781,en_6632,affects(Infered),Pluripotent Stem Cells,C0872076,en_5035,None,None,AFFECTS(Infered),Infered,3
21159,"TAL1 protein, human",C0378781,en_6632,affects(Infered),E protein,C0599561,en_6656,None,None,AFFECTS(Infered),Infered,3
21160,Organizing thrombus,C1318539,en_5532,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
21161,Organizing thrombus,C1318539,en_5532,affects(Infered),Organ failure,C0948600,en_5171,None,None,AFFECTS(Infered),Infered,3
21162,Organizing thrombus,C1318539,en_5532,affects(Infered),Endothelial dysfunction,C0856169,en_4968,None,None,AFFECTS(Infered),Infered,3
21163,Organizing thrombus,C1318539,en_5532,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
21164,Organizing thrombus,C1318539,en_5532,affects(Infered),Obstruction,C0028778,en_1702,None,None,AFFECTS(Infered),Infered,3
21165,Organizing thrombus,C1318539,en_5532,affects(Infered),Oxidation-Reduction,C0030012,en_1733,None,None,AFFECTS(Infered),Infered,3
21166,Organizing thrombus,C1318539,en_5532,affects(Infered),Intracranial Hemorrhages,C0151699,en_2864,None,None,AFFECTS(Infered),Infered,3
21167,Telemedicine,C0162648,en_2924,affects(Infered),telecare,C0872369,en_5052,None,None,AFFECTS(Infered),Infered,3
21168,bivalirudin,C0168273,en_2955,affects(Infered),anticoagulant activity,C1148561,en_5297,None,None,AFFECTS(Infered),Infered,3
21169,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
21170,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Cell physiology,C0007613,en_594,None,None,AFFECTS(Infered),Infered,3
21171,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21172,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
21173,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Epithelial Cells,C0014597,en_919,None,None,AFFECTS(Infered),Infered,3
21174,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Peptidyl-Dipeptidase A,C0022709,en_1387,None,None,AFFECTS(Infered),Infered,3
21175,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
21176,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
21177,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Peptides,C0030956,en_1771,None,None,AFFECTS(Infered),Infered,3
21178,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Antibody-Dependent Enhancement,C0282632,en_3660,None,None,AFFECTS(Infered),Infered,3
21179,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Lymphocyte,C0024264,en_1469,None,None,AFFECTS(Infered),Infered,3
21180,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Reproduction,C0035150,en_2001,None,None,AFFECTS(Infered),Infered,3
21181,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Signal Pathways,C0037080,en_2104,None,None,AFFECTS(Infered),Infered,3
21182,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),enzyme activity,C0243102,en_3464,None,None,AFFECTS(Infered),Infered,3
21183,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Viral life cycle,C1160638,en_5357,None,None,AFFECTS(Infered),Infered,3
21184,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Serum,C0229671,en_3244,None,None,AFFECTS(Infered),Infered,3
21185,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),"Complement Pathway, Mannose-Binding Lectin",C1138407,en_5270,None,None,AFFECTS(Infered),Infered,3
21186,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),enzyme binding,C1149286,en_5303,None,None,AFFECTS(Infered),Infered,3
21187,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),IL1B,C1334112,en_49,None,None,AFFECTS(Infered),Infered,3
21188,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Plasmid Cloning Vector,C1514152,en_5831,None,None,AFFECTS(Infered),Infered,3
21189,interleukin-1beta-converting enzyme inhibitor,C0168318,en_2956,affects(Infered),Ubiquitination,C1519751,en_5891,None,None,AFFECTS(Infered),Infered,3
21190,PTX3 protein,C0174234,en_2965,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21191,PTX3 protein,C0174234,en_2965,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21192,PTX3 protein,C0174234,en_2965,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21193,PTX3 protein,C0174234,en_2965,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
21194,PTX3 protein,C0174234,en_2965,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21195,PTX3 protein,C0174234,en_2965,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
21196,PTX3 protein,C0174234,en_2965,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
21197,PTX3 protein,C0174234,en_2965,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
21198,PTX3 protein,C0174234,en_2965,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
21199,PTX3 protein,C0174234,en_2965,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
21200,PTX3 protein,C0174234,en_2965,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21201,PTX3 protein,C0174234,en_2965,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21202,PTX3 protein,C0174234,en_2965,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
21203,PTX3 protein,C0174234,en_2965,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21204,PTX3 protein,C0174234,en_2965,affects(Infered),Plethora,C0232370,en_3277,None,None,AFFECTS(Infered),Infered,3
21205,PTX3 protein,C0174234,en_2965,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21206,PTX3 protein,C0174234,en_2965,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
21207,PTX3 protein,C0174234,en_2965,affects(Infered),PULMONARY INVOLVEMENT,C0748159,en_4828,None,None,AFFECTS(Infered),Infered,3
21208,PTX3 protein,C0174234,en_2965,affects(Infered),Lymphopenia,C0024312,en_1474,None,None,AFFECTS(Infered),Infered,3
21209,PTX3 protein,C0174234,en_2965,affects(Infered),Lactate Dehydrogenase,C0022917,en_1395,None,None,AFFECTS(Infered),Infered,3
21210,PTX3 protein,C0174234,en_2965,affects(Infered),Prealbumin,C0032923,en_1868,None,None,AFFECTS(Infered),Infered,3
21211,PTX3 protein,C0174234,en_2965,affects(Infered),Skeletal muscle structure,C0242692,en_3432,None,None,AFFECTS(Infered),Infered,3
21212,PTX3 protein,C0174234,en_2965,affects(Infered),Infiltration,C0332448,en_3749,None,None,AFFECTS(Infered),Infered,3
21213,PTX3 protein,C0174234,en_2965,affects(Infered),Severe disorder,C1836348,en_6048,None,None,AFFECTS(Infered),Infered,3
21214,Oral medication,C0175795,en_2972,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21215,Oral medication,C0175795,en_2972,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21216,Oral medication,C0175795,en_2972,affects(Infered),Extravasation,C0015376,en_949,None,None,AFFECTS(Infered),Infered,3
21217,Oral medication,C0175795,en_2972,affects(Infered),Predisposition,C0220898,en_3206,None,None,AFFECTS(Infered),Infered,3
21218,Oral medication,C0175795,en_2972,affects(Infered),Recovery,C0237820,en_3354,None,None,AFFECTS(Infered),Infered,3
21219,Oral medication,C0175795,en_2972,affects(Infered),Bacterial Abscess,C0549483,en_4283,None,None,AFFECTS(Infered),Infered,3
21220,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21221,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21222,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
21223,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21224,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21225,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
21226,Acute hypoxemic respiratory failure,C4039867,en_6301,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21227,Surgical Helmet Systems,C0180797,en_3011,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21228,Surgical Helmet Systems,C0180797,en_3011,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
21229,Surgical Helmet Systems,C0180797,en_3011,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
21230,"Filters, Blood",C0180863,en_3014,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21231,"Filters, Blood",C0180863,en_3014,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
21232,"Filters, Blood",C0180863,en_3014,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
21233,"Filters, Blood",C0180863,en_3014,affects(Infered),Secondary transmission,C0948191,en_5161,None,None,AFFECTS(Infered),Infered,3
21234,Surgical face mask,C0181758,en_3028,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21235,Surgical face mask,C0181758,en_3028,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21236,Surgical face mask,C0181758,en_3028,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21237,Surgical face mask,C0181758,en_3028,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
21238,Surgical face mask,C0181758,en_3028,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21239,Surgical face mask,C0181758,en_3028,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
21240,Surgical face mask,C0181758,en_3028,affects(Infered),Extravasation,C0015376,en_949,None,None,AFFECTS(Infered),Infered,3
21241,Surgical face mask,C0181758,en_3028,affects(Infered),"Lung Diseases, Interstitial",C0206062,en_3142,None,None,AFFECTS(Infered),Infered,3
21242,Surgical face mask,C0181758,en_3028,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
21243,Surgical face mask,C0181758,en_3028,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21244,Surgical face mask,C0181758,en_3028,affects(Infered),disease transmission,C0242781,en_3438,None,None,AFFECTS(Infered),Infered,3
21245,Surgical face mask,C0181758,en_3028,affects(Infered),General Population,C0683971,en_4674,None,None,AFFECTS(Infered),Infered,3
21246,Surgical face mask,C0181758,en_3028,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
21247,Surgical face mask,C0181758,en_3028,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
21248,Surgical face mask,C0181758,en_3028,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
21249,Surgical face mask,C0181758,en_3028,affects(Infered),Community,C0009462,en_687,None,None,AFFECTS(Infered),Infered,3
21250,Surgical face mask,C0181758,en_3028,affects(Infered),"Personnel, Hospital",C0031228,en_1781,None,None,AFFECTS(Infered),Infered,3
21251,Surgical face mask,C0181758,en_3028,affects(Infered),Protection,C1545588,en_5951,None,None,AFFECTS(Infered),Infered,3
21252,Surgical face mask,C0181758,en_3028,affects(Infered),Macrophage activation syndrome,C1096155,en_5233,None,None,AFFECTS(Infered),Infered,3
21253,Surgical face mask,C0181758,en_3028,affects(Infered),Leak NOS,C1608322,en_6001,None,None,AFFECTS(Infered),Infered,3
21254,Surgical face mask,C0181758,en_3028,affects(Infered),Chief complaint (finding),C0277786,en_3589,None,None,AFFECTS(Infered),Infered,3
21255,Surgical face mask,C0181758,en_3028,affects(Infered),Nurses,C0028661,en_1694,None,None,AFFECTS(Infered),Infered,3
21256,Surgical face mask,C0181758,en_3028,affects(Infered),Acne,C0702166,en_4736,None,None,AFFECTS(Infered),Infered,3
21257,Surgical face mask,C0181758,en_3028,affects(Infered),athlete,C0238703,en_3368,None,None,AFFECTS(Infered),Infered,3
21258,Surgical face mask,C0181758,en_3028,affects(Infered),Heat Stroke,C0018843,en_1144,None,None,AFFECTS(Infered),Infered,3
21259,Surgical face mask,C0181758,en_3028,affects(Infered),skin disorder,C0037274,en_2115,None,None,AFFECTS(Infered),Infered,3
21260,Surgical face mask,C0181758,en_3028,affects(Infered),Urban Population,C0041935,en_2316,None,None,AFFECTS(Infered),Infered,3
21261,Surgical face mask,C0181758,en_3028,affects(Infered),Hearing normal,C0234725,en_3312,None,None,AFFECTS(Infered),Infered,3
21262,Surgical face mask,C0181758,en_3028,affects(Infered),Infantile Neuroaxonal Dystrophy,C0270724,en_3553,None,None,AFFECTS(Infered),Infered,3
21263,Surgical face mask,C0181758,en_3028,affects(Infered),Air leakage,C0333257,en_3758,None,None,AFFECTS(Infered),Infered,3
21264,Surgical face mask,C0181758,en_3028,affects(Infered),Anesthesiologist,C0334910,en_3779,None,None,AFFECTS(Infered),Infered,3
21265,Surgical face mask,C0181758,en_3028,affects(Infered),Encounter due to sterilization,C0362065,en_3865,None,None,AFFECTS(Infered),Infered,3
21266,Surgical face mask,C0181758,en_3028,affects(Infered),professional occupation status,C0679924,en_4617,None,None,AFFECTS(Infered),Infered,3
21267,Surgical face mask,C0181758,en_3028,affects(Infered),Static sitting,C4270719,en_6324,None,None,AFFECTS(Infered),Infered,3
21268,Face Shields,C0183255,en_3043,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21269,Face Shields,C0183255,en_3043,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
21270,Face Shields,C0183255,en_3043,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
21271,Mental health promotion,C0184645,en_3060,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21272,Mental health promotion,C0184645,en_3060,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21273,Mental health promotion,C0184645,en_3060,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21274,Mental health promotion,C0184645,en_3060,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
21275,Mental health promotion,C0184645,en_3060,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21276,Mental health promotion,C0184645,en_3060,affects(Infered),Chronic pain,C0150055,en_2816,None,None,AFFECTS(Infered),Infered,3
21277,Mental health promotion,C0184645,en_3060,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
21278,Mental health promotion,C0184645,en_3060,affects(Infered),African race,C0027567,en_1646,None,None,AFFECTS(Infered),Infered,3
21279,Mental health promotion,C0184645,en_3060,affects(Infered),Youth,C0087178,en_2748,None,None,AFFECTS(Infered),Infered,3
21280,Mental health promotion,C0184645,en_3060,affects(Infered),Provider,C1138603,en_5273,None,None,AFFECTS(Infered),Infered,3
21281,Mental health promotion,C0184645,en_3060,affects(Infered),Nurses,C0028661,en_1694,None,None,AFFECTS(Infered),Infered,3
21282,Mental health promotion,C0184645,en_3060,affects(Infered),Drug abuse,C0013146,en_851,None,None,AFFECTS(Infered),Infered,3
21283,Mental health promotion,C0184645,en_3060,affects(Infered),CANADIAN,C0238884,en_3371,None,None,AFFECTS(Infered),Infered,3
21284,Mental health promotion,C0184645,en_3060,affects(Infered),Fit and well,C0424576,en_3995,None,None,AFFECTS(Infered),Infered,3
21285,Mental health promotion,C0184645,en_3060,affects(Infered),Public Health Nurses,C0034022,en_1926,None,None,AFFECTS(Infered),Infered,3
21286,Mental health promotion,C0184645,en_3060,affects(Infered),Teens,C1521910,en_5899,None,None,AFFECTS(Infered),Infered,3
21287,Mental health promotion,C0184645,en_3060,affects(Infered),Latinas,C0949335,en_5179,None,None,AFFECTS(Infered),Infered,3
21288,Mental health promotion,C0184645,en_3060,affects(Infered),Older people,C3826770,en_6248,None,None,AFFECTS(Infered),Infered,3
21289,Mental health treatment,C0184647,en_3061,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21290,Mental health treatment,C0184647,en_3061,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21291,Mental health treatment,C0184647,en_3061,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21292,Mental health treatment,C0184647,en_3061,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
21293,Mental health treatment,C0184647,en_3061,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
21294,Mental health treatment,C0184647,en_3061,affects(Infered),Social fear,C0424166,en_3991,None,None,AFFECTS(Infered),Infered,3
21295,Mental health treatment,C0184647,en_3061,affects(Infered),Research Personnel,C0035173,en_2002,None,None,AFFECTS(Infered),Infered,3
21296,Mental health treatment,C0184647,en_3061,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
21297,Mental health treatment,C0184647,en_3061,affects(Infered),Addictive Behavior,C0085281,en_2658,None,None,AFFECTS(Infered),Infered,3
21298,Emergency operation,C0184893,en_3065,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
21299,Massive hemorrhage,C0333279,en_3761,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21300,Massive hemorrhage,C0333279,en_3761,affects(Infered),AKR1A1 wt Allele,C3715044,en_6239,None,None,AFFECTS(Infered),Infered,3
21301,Cytokine therapy,C0199974,en_3102,affects(Infered),tumor necrosis factor therapy,C0279936,en_3618,None,None,AFFECTS(Infered),Infered,3
21302,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21303,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21304,Auditory rehabilitation,C0200323,en_3104,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21305,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21306,Auditory rehabilitation,C0200323,en_3104,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21307,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
21308,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21309,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
21310,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Chronic pain,C0150055,en_2816,None,None,AFFECTS(Infered),Infered,3
21311,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
21312,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21313,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Sequela of disorder,C0543419,en_4257,None,None,AFFECTS(Infered),Infered,3
21314,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Parkinson Disease,C0030567,en_1753,None,None,AFFECTS(Infered),Infered,3
21315,Auditory rehabilitation,C0200323,en_3104,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
21316,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Malignant Childhood Neoplasm,C0278704,en_3604,None,None,AFFECTS(Infered),Infered,3
21317,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Pinnipedia,C0031944,en_1812,None,None,AFFECTS(Infered),Infered,3
21318,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Physiological action,C0442687,en_4049,None,None,AFFECTS(Infered),Infered,3
21319,Auditory rehabilitation,C0200323,en_3104,affects(Infered),Peripheral Arterial Diseases,C1704436,en_6030,None,None,AFFECTS(Infered),Infered,3
21320,Psychiatric follow-up,C0204511,en_3115,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21321,Psychiatric follow-up,C0204511,en_3115,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
21322,Isolation procedure,C0204727,en_3120,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
21323,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
21324,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),Heart failure,C0018801,en_1135,None,None,AFFECTS(Infered),Infered,3
21325,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),cardiac arrhythmia,C0003811,en_397,None,None,AFFECTS(Infered),Infered,3
21326,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),Child syndrome,C0265267,en_3542,None,None,AFFECTS(Infered),Infered,3
21327,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),"Death, Sudden, Cardiac",C0085298,en_2661,None,None,AFFECTS(Infered),Infered,3
21328,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),"Death, Sudden",C0011071,en_763,None,None,AFFECTS(Infered),Infered,3
21329,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
21330,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),Myocardial fibrosis,C0151654,en_2862,None,None,AFFECTS(Infered),Infered,3
21331,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),"[X]Acute myocarditis, unspecified",C0155686,en_2889,None,None,AFFECTS(Infered),Infered,3
21332,"Myocarditis, chronic",C0865681,en_4995,affects(Infered),Cardiomyopathies,C0878544,en_5074,None,None,AFFECTS(Infered),Infered,3
21333,nafamostat,C0207683,en_3180,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21334,nafamostat,C0207683,en_3180,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21335,nafamostat,C0207683,en_3180,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21336,nafamostat,C0207683,en_3180,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21337,nafamostat,C0207683,en_3180,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
21338,nafamostat,C0207683,en_3180,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21339,nafamostat,C0207683,en_3180,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21340,nafamostat,C0207683,en_3180,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
21341,nafamostat,C0207683,en_3180,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21342,nafamostat,C0207683,en_3180,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
21343,nafamostat,C0207683,en_3180,affects(Infered),Exocytosis,C0015283,en_943,None,None,AFFECTS(Infered),Infered,3
21344,nafamostat,C0207683,en_3180,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21345,nafamostat,C0207683,en_3180,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21346,nafamostat,C0207683,en_3180,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
21347,nafamostat,C0207683,en_3180,affects(Infered),Cerebrovascular accident,C0038454,en_2169,None,None,AFFECTS(Infered),Infered,3
21348,nafamostat,C0207683,en_3180,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
21349,nafamostat,C0207683,en_3180,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21350,nafamostat,C0207683,en_3180,affects(Infered),physiological aspects,C0031843,en_1806,None,None,AFFECTS(Infered),Infered,3
21351,nafamostat,C0207683,en_3180,affects(Infered),Angiotensin-Converting Enzyme Inhibitors,C0003015,en_330,None,None,AFFECTS(Infered),Infered,3
21352,nafamostat,C0207683,en_3180,affects(Infered),Angiotensin Receptor,C0034787,en_1963,None,None,AFFECTS(Infered),Infered,3
21353,nafamostat,C0207683,en_3180,affects(Infered),Eicosanoids,C0013725,en_880,None,None,AFFECTS(Infered),Infered,3
21354,nafamostat,C0207683,en_3180,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
21355,nafamostat,C0207683,en_3180,affects(Infered),Polyamine Catabolism,C1156778,en_5331,None,None,AFFECTS(Infered),Infered,3
21356,nafamostat,C0207683,en_3180,affects(Infered),Blood coagulation,C0005778,en_484,None,None,AFFECTS(Infered),Infered,3
21357,nafamostat,C0207683,en_3180,affects(Infered),American College of Cardiology/American Heart Association Lesion Complexity Score C,C3272283,en_6190,None,None,AFFECTS(Infered),Infered,3
21358,nafamostat,C0207683,en_3180,affects(Infered),Epidermal cGVHD Score 2,C4761314,en_6403,None,None,AFFECTS(Infered),Infered,3
21359,nafamostat,C0207683,en_3180,affects(Infered),Atrial Fibrillation,C0004238,en_423,None,None,AFFECTS(Infered),Infered,3
21360,nafamostat,C0207683,en_3180,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
21361,nafamostat,C0207683,en_3180,affects(Infered),Proteins,C0033684,en_1912,None,None,AFFECTS(Infered),Infered,3
21362,nafamostat,C0207683,en_3180,affects(Infered),Thrombus,C0087086,en_2743,None,None,AFFECTS(Infered),Infered,3
21363,nafamostat,C0207683,en_3180,affects(Infered),Pulmonary thrombosis,C0151946,en_2875,None,None,AFFECTS(Infered),Infered,3
21364,nafamostat,C0207683,en_3180,affects(Infered),"Receptor, PAR-2",C0259628,en_3498,None,None,AFFECTS(Infered),Infered,3
21365,nafamostat,C0207683,en_3180,affects(Infered),Blood Clot,C0302148,en_3702,None,None,AFFECTS(Infered),Infered,3
21366,nafamostat,C0207683,en_3180,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
21367,nafamostat,C0207683,en_3180,affects(Infered),Complement System Proteins,C0009498,en_691,None,None,AFFECTS(Infered),Infered,3
21368,nafamostat,C0207683,en_3180,affects(Infered),Cell Proliferation,C0596290,en_4384,None,None,AFFECTS(Infered),Infered,3
21369,nafamostat,C0207683,en_3180,affects(Infered),Angiogenesis,C0302600,en_3709,None,None,AFFECTS(Infered),Infered,3
21370,nafamostat,C0207683,en_3180,affects(Infered),Peptic Esophagitis,C0014869,en_930,None,None,AFFECTS(Infered),Infered,3
21371,nafamostat,C0207683,en_3180,affects(Infered),Kininogenase,C0022478,en_1374,None,None,AFFECTS(Infered),Infered,3
21372,nafamostat,C0207683,en_3180,affects(Infered),"Pancreatitis, Chronic",C0149521,en_2802,None,None,AFFECTS(Infered),Infered,3
21373,nafamostat,C0207683,en_3180,affects(Infered),Postoperative esophagitis,C0267058,en_3543,None,None,AFFECTS(Infered),Infered,3
21374,secretoneurin,C0216115,en_6596,affects(Infered),Chronic pain,C0150055,en_2816,None,None,AFFECTS(Infered),Infered,3
21375,secretoneurin,C0216115,en_6596,affects(Infered),Migraine Disorders,C0149931,en_2813,None,None,AFFECTS(Infered),Infered,3
21376,sargramostim,C0216231,en_3191,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21377,sargramostim,C0216231,en_3191,affects(Infered),Alveolar ventilation function,C0231940,en_3269,None,None,AFFECTS(Infered),Infered,3
21378,Leukine,C0701500,en_4732,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
21379,sargramostim,C0216231,en_3191,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21380,Entresto,C4033616,en_6297,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21381,Entresto,C4033616,en_6297,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21382,Entresto,C4033616,en_6297,affects(Infered),Hypertensive disease,C0020538,en_1239,None,None,AFFECTS(Infered),Infered,3
21383,Entresto,C4033616,en_6297,affects(Infered),Pathologic Processes,C0030660,en_1755,None,None,AFFECTS(Infered),Infered,3
21384,Entresto,C4033616,en_6297,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21385,Entresto,C4033616,en_6297,affects(Infered),Ejection Fraction Decreased,C0743400,en_4802,None,None,AFFECTS(Infered),Infered,3
21386,Agammaglobulinaemia tyrosine kinase,C0218158,en_3196,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
21387,Agammaglobulinaemia tyrosine kinase,C0218158,en_3196,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
21388,Agammaglobulinaemia tyrosine kinase,C0218158,en_3196,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
21389,Agammaglobulinaemia tyrosine kinase,C0218158,en_3196,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
21390,Multiple somatic complaints,C0233756,en_6607,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21391,"ASPERGILLOSIS, INVASIVE",C0238013,en_3360,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21392,"ASPERGILLOSIS, INVASIVE",C0238013,en_3360,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21393,Invasive pulmonary aspergillosis,C0276653,en_3581,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21394,Invasive pulmonary aspergillosis,C0276653,en_3581,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21395,Invasive pulmonary aspergillosis,C0276653,en_3581,affects(Infered),Aspergillus,C0004034,en_411,None,None,AFFECTS(Infered),Infered,3
21396,"Myositis, Inclusion Body",C0238190,en_3362,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
21397,Headache Severe,C0239889,en_3376,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21398,Headache Severe,C0239889,en_3376,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21399,Headache Severe,C0239889,en_3376,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21400,Headache Severe,C0239889,en_3376,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
21401,Headache Severe,C0239889,en_3376,affects(Infered),Systemic disease,C0442893,en_4062,None,None,AFFECTS(Infered),Infered,3
21402,Headache Severe,C0239889,en_3376,affects(Infered),Bleeding tendency,C1458140,en_6735,None,None,AFFECTS(Infered),Infered,3
21403,Formaldehyde dehydrogenase (glutathione),C0243628,en_3472,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21404,Formaldehyde dehydrogenase (glutathione),C0243628,en_3472,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21405,CARE protocol,C0250336,en_3485,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21406,CARE protocol,C0250336,en_3485,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21407,CARE protocol,C0250336,en_3485,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
21408,CARE protocol,C0250336,en_3485,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21409,CARE protocol,C0250336,en_3485,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21410,CARE protocol,C0250336,en_3485,affects(Infered),Chronic Childhood Arthritis,C0553662,en_4288,None,None,AFFECTS(Infered),Infered,3
21411,arbidol,C0254211,en_3489,affects(Infered),Atrophic,C0333641,en_3770,None,None,AFFECTS(Infered),Infered,3
21412,proadrenomedullin,C0257634,en_3496,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21413,proadrenomedullin,C0257634,en_3496,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
21414,proadrenomedullin,C0257634,en_3496,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
21415,proadrenomedullin,C0257634,en_3496,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
21416,proadrenomedullin,C0257634,en_3496,affects(Infered),Muscle,C0026845,en_1603,None,None,AFFECTS(Infered),Infered,3
21417,proadrenomedullin,C0257634,en_3496,affects(Infered),"Enterocolitis, Necrotizing",C0520459,en_4186,None,None,AFFECTS(Infered),Infered,3
21418,proadrenomedullin,C0257634,en_3496,affects(Infered),Neonatal necrotizing enterocolitis,C1442826,en_5733,None,None,AFFECTS(Infered),Infered,3
21419,Equine influenza,C0276356,en_3577,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21420,Equine influenza,C0276356,en_3577,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21421,Human immunodeficiency virus I infection,C0276500,en_3579,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21422,Human immunodeficiency virus I infection,C0276500,en_3579,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21423,Hormone replacement therapy,C0282402,en_3645,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21424,Hormone replacement therapy,C0282402,en_3645,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21425,Hormone replacement therapy,C0282402,en_3645,affects(Infered),Alveolar ventilation function,C0231940,en_3269,None,None,AFFECTS(Infered),Infered,3
21426,Hormone replacement therapy,C0282402,en_3645,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21427,Hormone replacement therapy,C0282402,en_3645,affects(Infered),Age related macular degeneration,C0242383,en_3409,None,None,AFFECTS(Infered),Infered,3
21428,tumor necrosis factor therapy,C0279936,en_3618,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
21429,tumor necrosis factor therapy,C0279936,en_3618,affects(Infered),Macrophage activation syndrome,C1096155,en_5233,None,None,AFFECTS(Infered),Infered,3
21430,brequinar,C0280509,en_3621,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21431,brequinar,C0280509,en_3621,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21432,brequinar,C0280509,en_3621,affects(Infered),"Abortion, Habitual",C0000809,en_207,None,None,AFFECTS(Infered),Infered,3
21433,brequinar,C0280509,en_3621,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21434,brequinar,C0280509,en_3621,affects(Infered),Mus,C0026809,en_1600,None,None,AFFECTS(Infered),Infered,3
21435,brequinar,C0280509,en_3621,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
21436,brequinar,C0280509,en_3621,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
21437,brequinar,C0280509,en_3621,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
21438,brequinar,C0280509,en_3621,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21439,brequinar,C0280509,en_3621,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21440,brequinar,C0280509,en_3621,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
21441,brequinar,C0280509,en_3621,affects(Infered),Rheumatoid Arthritis,C0003873,en_402,None,None,AFFECTS(Infered),Infered,3
21442,brequinar,C0280509,en_3621,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21443,brequinar,C0280509,en_3621,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21444,brequinar,C0280509,en_3621,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
21445,brequinar,C0280509,en_3621,affects(Infered),POLDIP2,C1428254,en_122,None,None,AFFECTS(Infered),Infered,3
21446,brequinar,C0280509,en_3621,affects(Infered),Tissue damage,C0010957,en_756,None,None,AFFECTS(Infered),Infered,3
21447,brequinar,C0280509,en_3621,affects(Infered),Autoimmune,C0443146,en_4064,None,None,AFFECTS(Infered),Infered,3
21448,brequinar,C0280509,en_3621,affects(Infered),Inflammatory disorder,C1290884,en_5483,None,None,AFFECTS(Infered),Infered,3
21449,brequinar,C0280509,en_3621,affects(Infered),Psoriasis,C0033860,en_1918,None,None,AFFECTS(Infered),Infered,3
21450,brequinar,C0280509,en_3621,affects(Infered),Undifferentiated connective tissue disease,C0409999,en_3968,None,None,AFFECTS(Infered),Infered,3
21451,brequinar,C0280509,en_3621,affects(Infered),organ rejection,C0815080,en_4921,None,None,AFFECTS(Infered),Infered,3
21452,brequinar,C0280509,en_3621,affects(Infered),Rodent Model,C1519106,en_5880,None,None,AFFECTS(Infered),Infered,3
21453,brequinar,C0280509,en_3621,affects(Infered),Immune,C0439662,en_4035,None,None,AFFECTS(Infered),Infered,3
21454,brequinar,C0280509,en_3621,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
21455,brequinar,C0280509,en_3621,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
21456,educational intervention,C0281163,en_3626,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21457,antibody therapy,C0281176,en_3628,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21458,antibody therapy,C0281176,en_3628,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
21459,antibody therapy,C0281176,en_3628,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21460,antibody therapy,C0281176,en_3628,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
21461,antibody therapy,C0281176,en_3628,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
21462,antibody therapy,C0281176,en_3628,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21463,antibody therapy,C0281176,en_3628,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
21464,antibody therapy,C0281176,en_3628,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21465,antibody therapy,C0281176,en_3628,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
21466,antibody therapy,C0281176,en_3628,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
21467,antibody therapy,C0281176,en_3628,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21468,antibody therapy,C0281176,en_3628,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
21469,antibody therapy,C0281176,en_3628,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
21470,antibody therapy,C0281176,en_3628,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
21471,antibody therapy,C0281176,en_3628,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
21472,antibody therapy,C0281176,en_3628,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
21473,antibody therapy,C0281176,en_3628,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
21474,antibody therapy,C0281176,en_3628,affects(Infered),Solid tumor,C0280100,en_3619,None,None,AFFECTS(Infered),Infered,3
21475,antibody therapy,C0281176,en_3628,affects(Infered),Advanced cancer,C0877373,en_5070,None,None,AFFECTS(Infered),Infered,3
21476,antibody therapy,C0281176,en_3628,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
21477,Palliative Surgery,C0282282,en_3642,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21478,Palliative Surgery,C0282282,en_3642,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21479,Palliative Surgery,C0282282,en_3642,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21480,Palliative Surgery,C0282282,en_3642,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21481,Palliative Surgery,C0282282,en_3642,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
21482,Palliative Surgery,C0282282,en_3642,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21483,Palliative Surgery,C0282282,en_3642,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
21484,Palliative Surgery,C0282282,en_3642,affects(Infered),Family,C0015576,en_961,None,None,AFFECTS(Infered),Infered,3
21485,Palliative Surgery,C0282282,en_3642,affects(Infered),Nurses,C0028661,en_1694,None,None,AFFECTS(Infered),Infered,3
21486,Palliative Surgery,C0282282,en_3642,affects(Infered),"Pneumonitis, Interstitial",C0206061,en_3141,None,None,AFFECTS(Infered),Infered,3
21487,Palliative Surgery,C0282282,en_3642,affects(Infered),Frail Older Adults,C0079379,en_2599,None,None,AFFECTS(Infered),Infered,3
21488,Palliative Surgery,C0282282,en_3642,affects(Infered),Latinos,C0086528,en_2724,None,None,AFFECTS(Infered),Infered,3
21489,Palliative Surgery,C0282282,en_3642,affects(Infered),Malignant Childhood Neoplasm,C0278704,en_3604,None,None,AFFECTS(Infered),Infered,3
21490,"2,4-thiazolidinedione",C0289779,en_3676,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21491,Ritonavir,C0292818,en_3680,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
21492,ran-binding protein 2,C0299456,en_3686,affects(Infered),cytokine biosynthesis,C1155099,en_5317,None,None,AFFECTS(Infered),Infered,3
21493,ran-binding protein 2,C0299456,en_3686,affects(Infered),Crossbreeding,C0020202,en_1217,None,None,AFFECTS(Infered),Infered,3
21494,ran-binding protein 2,C0299456,en_3686,affects(Infered),adenosinetriphosphatase activity,C1148926,en_5300,None,None,AFFECTS(Infered),Infered,3
21495,ran-binding protein 2,C0299456,en_3686,affects(Infered),strand displacement,C1158517,en_5340,None,None,AFFECTS(Infered),Infered,3
21496,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21497,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21498,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Neurodegenerative Disorders,C0524851,en_4220,None,None,AFFECTS(Infered),Infered,3
21499,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Up-Regulation (Physiology),C0041904,en_2313,None,None,AFFECTS(Infered),Infered,3
21500,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
21501,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
21502,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
21503,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
21504,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),Pluripotent Stem Cells,C0872076,en_5035,None,None,AFFECTS(Infered),Infered,3
21505,Interferon Regulatory Factor 4,C0299544,en_3687,affects(Infered),E protein,C0599561,en_6656,None,None,AFFECTS(Infered),Infered,3
21506,Steroid hormone,C0301818,en_3694,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
21507,Steroid hormone,C0301818,en_3694,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
21508,Steroid hormone,C0301818,en_3694,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
21509,Steroid hormone,C0301818,en_3694,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
21510,Primary immune response,C0301875,en_3697,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21511,Primary immune response,C0301875,en_3697,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21512,Primary immune response,C0301875,en_3697,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21513,Primary immune response,C0301875,en_3697,affects(Infered),Age,C0001779,en_257,None,None,AFFECTS(Infered),Infered,3
21514,Primary immune response,C0301875,en_3697,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21515,Primary immune response,C0301875,en_3697,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21516,Primary immune response,C0301875,en_3697,affects(Infered),Sarcoidosis,C0036202,en_2064,None,None,AFFECTS(Infered),Infered,3
21517,Primary immune response,C0301875,en_3697,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
21518,Primary immune response,C0301875,en_3697,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
21519,Primary immune response,C0301875,en_3697,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
21520,Primary immune response,C0301875,en_3697,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
21521,Primary immune response,C0301875,en_3697,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
21522,Primary immune response,C0301875,en_3697,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21523,Primary immune response,C0301875,en_3697,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
21524,Primary immune response,C0301875,en_3697,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21525,Primary immune response,C0301875,en_3697,affects(Infered),Predisposition,C0220898,en_3206,None,None,AFFECTS(Infered),Infered,3
21526,Primary immune response,C0301875,en_3697,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
21527,Primary immune response,C0301875,en_3697,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21528,Primary immune response,C0301875,en_3697,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21529,Primary immune response,C0301875,en_3697,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21530,Primary immune response,C0301875,en_3697,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21531,Primary immune response,C0301875,en_3697,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
21532,Primary immune response,C0301875,en_3697,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
21533,Primary immune response,C0301875,en_3697,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
21534,Primary immune response,C0301875,en_3697,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21535,Primary immune response,C0301875,en_3697,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
21536,Primary immune response,C0301875,en_3697,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21537,Primary immune response,C0301875,en_3697,affects(Infered),Animals,C0003062,en_335,None,None,AFFECTS(Infered),Infered,3
21538,Primary immune response,C0301875,en_3697,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21539,Primary immune response,C0301875,en_3697,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
21540,Primary immune response,C0301875,en_3697,affects(Infered),Organ failure,C0948600,en_5171,None,None,AFFECTS(Infered),Infered,3
21541,Primary immune response,C0301875,en_3697,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
21542,Primary immune response,C0301875,en_3697,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
21543,Primary immune response,C0301875,en_3697,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
21544,Primary immune response,C0301875,en_3697,affects(Infered),Autophagy,C0004391,en_432,None,None,AFFECTS(Infered),Infered,3
21545,Primary immune response,C0301875,en_3697,affects(Infered),Specific antibody,C0443640,en_4068,None,None,AFFECTS(Infered),Infered,3
21546,Primary immune response,C0301875,en_3697,affects(Infered),"Lymphohistiocytosis, Hemophagocytic",C0024291,en_1470,None,None,AFFECTS(Infered),Infered,3
21547,Primary immune response,C0301875,en_3697,affects(Infered),"Mycobacterium Infections, Atypical",C0026919,en_1616,None,None,AFFECTS(Infered),Infered,3
21548,Primary immune response,C0301875,en_3697,affects(Infered),Ultraviolet Rays,C0041625,en_2307,None,None,AFFECTS(Infered),Infered,3
21549,Primary immune response,C0301875,en_3697,affects(Infered),Acute infectious disease,C0275518,en_3563,None,None,AFFECTS(Infered),Infered,3
21550,Primary immune response,C0301875,en_3697,affects(Infered),"Hemorrhagic Fever, Ebola",C0282687,en_3666,None,None,AFFECTS(Infered),Infered,3
21551,Primary immune response,C0301875,en_3697,affects(Infered),South Asian,C1519427,en_5885,None,None,AFFECTS(Infered),Infered,3
21552,Primary immune response,C0301875,en_3697,affects(Infered),Hospital specialist,C0087009,en_2742,None,None,AFFECTS(Infered),Infered,3
21553,Primary immune response,C0301875,en_3697,affects(Infered),Renal Insufficiency,C1565489,en_5983,None,None,AFFECTS(Infered),Infered,3
21554,Lead compound,C0303231,en_3716,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
21555,Lead compound,C0303231,en_3716,affects(Infered),Distress,C0231303,en_3256,None,None,AFFECTS(Infered),Infered,3
21556,Psychostimulant,C0304403,en_3722,affects(Infered),Vascular Permeability,C0162337,en_2906,None,None,AFFECTS(Infered),Infered,3
21557,Reporter,C0335038,en_3782,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21558,Reporter,C0335038,en_3782,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
21559,Reporter,C0335038,en_3782,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21560,Reporter,C0335038,en_3782,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
21561,Reporter,C0335038,en_3782,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
21562,Reporter,C0335038,en_3782,affects(Infered),Study models,C0026336,en_1575,None,None,AFFECTS(Infered),Infered,3
21563,Reporter,C0335038,en_3782,affects(Infered),"Recipient, Transplant",C0376387,en_3875,None,None,AFFECTS(Infered),Infered,3
21564,Reporter,C0335038,en_3782,affects(Infered),Detectors,C0180392,en_3008,None,None,AFFECTS(Infered),Infered,3
21565,Reporter,C0335038,en_3782,affects(Infered),Advance,C0725066,en_4752,None,None,AFFECTS(Infered),Infered,3
21566,Reporter,C0335038,en_3782,affects(Infered),Surgical Patients,C0871463,en_5023,None,None,AFFECTS(Infered),Infered,3
21567,Hot water,C0337023,en_3789,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21568,Hot water,C0337023,en_3789,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21569,Hot water,C0337023,en_3789,affects(Infered),Influenza,C0021400,en_1311,None,None,AFFECTS(Infered),Infered,3
21570,Hot water,C0337023,en_3789,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21571,Non-tuberculous mycobacterial pneumonia,C0349650,en_3843,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21572,Non-tuberculous mycobacterial pneumonia,C0349650,en_3843,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21573,Human immunoglobulin,C0358321,en_3855,affects(Infered),TSLP gene,C1336681,en_5638,None,None,AFFECTS(Infered),Infered,3
21574,H-Cadherin,C0390690,en_3911,affects(Infered),Permeability,C0031164,en_1779,None,None,AFFECTS(Infered),Infered,3
21575,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21576,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21577,Nasotracheal intubation,C0396625,en_3942,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21578,Nasotracheal intubation,C0396625,en_3942,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21579,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
21580,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
21581,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21582,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21583,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Alveolar ventilation function,C0231940,en_3269,None,None,AFFECTS(Infered),Infered,3
21584,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
21585,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21586,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21587,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
21588,Nasotracheal intubation,C0396625,en_3942,affects(Infered),"Infections, Hospital",C0205721,en_3133,None,None,AFFECTS(Infered),Infered,3
21589,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Organ failure,C0948600,en_5171,None,None,AFFECTS(Infered),Infered,3
21590,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
21591,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Inspired fraction of oxygen,C0428167,en_4012,None,None,AFFECTS(Infered),Infered,3
21592,Nasotracheal intubation,C0396625,en_3942,affects(Infered),"Pneumonitis, Interstitial",C0206061,en_3141,None,None,AFFECTS(Infered),Infered,3
21593,Nasotracheal intubation,C0396625,en_3942,affects(Infered),viral transmission,C1160716,en_5362,None,None,AFFECTS(Infered),Infered,3
21594,Nasotracheal intubation,C0396625,en_3942,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
21595,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Respiratory failure without hypercapnia,C0340194,en_3812,None,None,AFFECTS(Infered),Infered,3
21596,Nasotracheal intubation,C0396625,en_3942,affects(Infered),Intubated,C4698386,en_6376,None,None,AFFECTS(Infered),Infered,3
21597,Interval appendectomy,C0399995,en_3952,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21598,Interval appendectomy,C0399995,en_3952,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21599,Interval appendectomy,C0399995,en_3952,affects(Infered),Acute appendicitis NOS,C0085693,en_2687,None,None,AFFECTS(Infered),Infered,3
21600,Interval appendectomy,C0399995,en_3952,affects(Infered),World,C2700280,en_6119,None,None,AFFECTS(Infered),Infered,3
21601,Advanced life support,C0419055,en_3978,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21602,Advanced life support,C0419055,en_3978,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21603,Advanced life support,C0419055,en_3978,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21604,Advanced life support,C0419055,en_3978,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
21605,Advanced life support,C0419055,en_3978,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21606,Advanced life support,C0419055,en_3978,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
21607,Advanced life support,C0419055,en_3978,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21608,Advanced life support,C0419055,en_3978,affects(Infered),Dementia,C0497327,en_4164,None,None,AFFECTS(Infered),Infered,3
21609,Advanced life support,C0419055,en_3978,affects(Infered),Childbirth,C1148523,en_5296,None,None,AFFECTS(Infered),Infered,3
21610,Advanced life support,C0419055,en_3978,affects(Infered),parent,C0030551,en_1750,None,None,AFFECTS(Infered),Infered,3
21611,Advanced life support,C0419055,en_3978,affects(Infered),Atrophic,C0333641,en_3770,None,None,AFFECTS(Infered),Infered,3
21612,Follow-up consultation,C0422322,en_3987,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21613,Follow-up consultation,C0422322,en_3987,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21614,Follow-up consultation,C0422322,en_3987,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21615,Follow-up consultation,C0422322,en_3987,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
21616,Follow-up consultation,C0422322,en_3987,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
21617,Follow-up consultation,C0422322,en_3987,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21618,Follow-up consultation,C0422322,en_3987,affects(Infered),Ageusia,C0001800,en_259,None,None,AFFECTS(Infered),Infered,3
21619,Follow-up consultation,C0422322,en_3987,affects(Infered),Low Back Pain,C0024031,en_1458,None,None,AFFECTS(Infered),Infered,3
21620,Follow-up consultation,C0422322,en_3987,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
21621,Follow-up consultation,C0422322,en_3987,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
21622,Follow-up consultation,C0422322,en_3987,affects(Infered),Hydranencephaly with Renal Aplasia-Dysplasia,C1856053,en_6053,None,None,AFFECTS(Infered),Infered,3
21623,Follow-up consultation,C0422322,en_3987,affects(Infered),Research Personnel,C0035173,en_2002,None,None,AFFECTS(Infered),Infered,3
21624,Follow-up consultation,C0422322,en_3987,affects(Infered),Teams,C0871489,en_5024,None,None,AFFECTS(Infered),Infered,3
21625,Follow-up consultation,C0422322,en_3987,affects(Infered),Otitis Media with Effusion,C0029883,en_1728,None,None,AFFECTS(Infered),Infered,3
21626,Follow-up consultation,C0422322,en_3987,affects(Infered),Vertigo,C0042571,en_2350,None,None,AFFECTS(Infered),Infered,3
21627,Follow-up consultation,C0422322,en_3987,affects(Infered),Ear discharge,C0155540,en_2887,None,None,AFFECTS(Infered),Infered,3
21628,Follow-up consultation,C0422322,en_3987,affects(Infered),Acute otitis media,C0271429,en_3555,None,None,AFFECTS(Infered),Infered,3
21629,Follow-up consultation,C0422322,en_3987,affects(Infered),Chief complaint (finding),C0277786,en_3589,None,None,AFFECTS(Infered),Infered,3
21630,Follow-up consultation,C0422322,en_3987,affects(Infered),CHEST SYMPTOM,C0742337,en_4794,None,None,AFFECTS(Infered),Infered,3
21631,Follow-up consultation,C0422322,en_3987,affects(Infered),Diabetic ulcer,C0743150,en_4799,None,None,AFFECTS(Infered),Infered,3
21632,Follow-up consultation,C0422322,en_3987,affects(Infered),Psychiatric inpatient,C0748064,en_4827,None,None,AFFECTS(Infered),Infered,3
21633,Follow-up consultation,C0422322,en_3987,affects(Infered),Provider,C1138603,en_5273,None,None,AFFECTS(Infered),Infered,3
21634,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
21635,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
21636,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
21637,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Nitric Oxide,C0028128,en_1682,None,None,AFFECTS(Infered),Infered,3
21638,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Digestion,C0012238,en_815,None,None,AFFECTS(Infered),Infered,3
21639,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Dizziness,C0012833,en_833,None,None,AFFECTS(Infered),Infered,3
21640,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),heart rate,C0018810,en_1138,None,None,AFFECTS(Infered),Infered,3
21641,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Sleep Apnea Syndromes,C0037315,en_2120,None,None,AFFECTS(Infered),Infered,3
21642,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Baroreflex,C0206162,en_3150,None,None,AFFECTS(Infered),Infered,3
21643,Pulmonary artery pressure,C0428642,en_4013,affects(Infered),Cardiac function,C0232164,en_3272,None,None,AFFECTS(Infered),Infered,3
21644,Transcranial magnetic stimulation,C0436548,en_4029,affects(Infered),"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,None,None,AFFECTS(Infered),Infered,3
21645,Apolipoprotein E isoform,C0443526,en_4066,affects(Infered),Delirium,C0011206,en_774,None,None,AFFECTS(Infered),Infered,3
21646,Apolipoprotein E isoform,C0443526,en_4066,affects(Infered),Dementia,C0497327,en_4164,None,None,AFFECTS(Infered),Infered,3
21647,Liver enzyme,C0443764,en_6638,affects(Infered),Blood Coagulation Factor,C0005789,en_486,None,None,AFFECTS(Infered),Infered,3
21648,Inspiratory muscle training,C0454511,en_4107,affects(Infered),Sequela of disorder,C0543419,en_4257,None,None,AFFECTS(Infered),Infered,3
21649,Positive pressure therapy,C0454517,en_4108,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21650,Positive pressure therapy,C0454517,en_4108,affects(Infered),Sequela of disorder,C0543419,en_4257,None,None,AFFECTS(Infered),Infered,3
21651,Intravenous therapy,C0455142,en_4110,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
21652,Contents,C0456205,en_4116,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21653,Contents,C0456205,en_4116,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21654,Contents,C0456205,en_4116,affects(Infered),Diarrhea,C0011991,en_810,None,None,AFFECTS(Infered),Infered,3
21655,Renal disease diet,C0457987,en_4124,affects(Infered),Malignant neoplasm of breast,C0006142,en_511,None,None,AFFECTS(Infered),Infered,3
21656,Renal disease diet,C0457987,en_4124,affects(Infered),Recovery,C0237820,en_3354,None,None,AFFECTS(Infered),Infered,3
21657,Renal disease diet,C0457987,en_4124,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
21658,Renal disease diet,C0457987,en_4124,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
21659,Renal disease diet,C0457987,en_4124,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21660,Renal disease diet,C0457987,en_4124,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21661,Renal disease diet,C0457987,en_4124,affects(Infered),brain function,C0678908,en_4584,None,None,AFFECTS(Infered),Infered,3
21662,Renal disease diet,C0457987,en_4124,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21663,Renal disease diet,C0457987,en_4124,affects(Infered),Insulin Resistance,C0021655,en_1325,None,None,AFFECTS(Infered),Infered,3
21664,Renal disease diet,C0457987,en_4124,affects(Infered),Periodontal Diseases,C0031090,en_1774,None,None,AFFECTS(Infered),Infered,3
21665,Renal disease diet,C0457987,en_4124,affects(Infered),Reproduction,C0035150,en_2001,None,None,AFFECTS(Infered),Infered,3
21666,Renal disease diet,C0457987,en_4124,affects(Infered),"Steatohepatitis, non-alcoholic",C0878674,en_5075,None,None,AFFECTS(Infered),Infered,3
21667,Renal disease diet,C0457987,en_4124,affects(Infered),Metabolic syndrome,C0948265,en_5164,None,None,AFFECTS(Infered),Infered,3
21668,RyR1,C0524965,en_4225,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
21669,RyR1,C0524965,en_4225,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
21670,RyR1,C0524965,en_4225,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
21671,RyR1,C0524965,en_4225,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
21672,Cell Maturation,C1516349,en_5855,affects(Infered),Clonal Expansion,C1516670,en_5861,None,None,AFFECTS(Infered),Infered,3
21673,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
21674,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
21675,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
21676,vitamin D-binding protein-macrophage activating factor,C0530774,en_4236,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
21677,tissue inhibitor of metalloproteinase 4,C0532028,en_4237,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21678,tissue inhibitor of metalloproteinase 4,C0532028,en_4237,affects(Infered),Matrix Metalloproteinases,C0623362,en_4521,None,None,AFFECTS(Infered),Infered,3
21679,tissue inhibitor of metalloproteinase 4,C0532028,en_4237,affects(Infered),"Tuberculosis, Pulmonary",C0041327,en_2297,None,None,AFFECTS(Infered),Infered,3
21680,tissue inhibitor of metalloproteinase 4,C0532028,en_4237,affects(Infered),"Tuberculosis, Lymph Node",C0041316,en_2296,None,None,AFFECTS(Infered),Infered,3
21681,xanthohumol,C0536128,en_4243,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21682,xanthohumol,C0536128,en_4243,affects(Infered),Mus,C0026809,en_1600,None,None,AFFECTS(Infered),Infered,3
21683,xanthohumol,C0536128,en_4243,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
21684,xanthohumol,C0536128,en_4243,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21685,xanthohumol,C0536128,en_4243,affects(Infered),pulmonary complications,C0281169,en_3627,None,None,AFFECTS(Infered),Infered,3
21686,xanthohumol,C0536128,en_4243,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
21687,xanthohumol,C0536128,en_4243,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21688,xanthohumol,C0536128,en_4243,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
21689,xanthohumol,C0536128,en_4243,affects(Infered),POLDIP2,C1428254,en_122,None,None,AFFECTS(Infered),Infered,3
21690,xanthohumol,C0536128,en_4243,affects(Infered),Cell membrane,C0007603,en_592,None,None,AFFECTS(Infered),Infered,3
21691,xanthohumol,C0536128,en_4243,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
21692,xanthohumol,C0536128,en_4243,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
21693,xanthohumol,C0536128,en_4243,affects(Infered),Oral Dysplasia,C4330858,en_6347,None,None,AFFECTS(Infered),Infered,3
21694,Renal Cell,C0553257,en_4286,affects(Infered),Transferrin,C0040679,en_2269,None,None,AFFECTS(Infered),Infered,3
21695,Close supervision,C0557988,en_4312,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21696,Close supervision,C0557988,en_4312,affects(Infered),Neck Pain,C0007859,en_609,None,None,AFFECTS(Infered),Infered,3
21697,Close supervision,C0557988,en_4312,affects(Infered),Relapsing Fever,C0035021,en_1991,None,None,AFFECTS(Infered),Infered,3
21698,Moderate asthma,C0581125,en_4344,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21699,Moderate asthma,C0581125,en_4344,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21700,Moderate asthma,C0581125,en_4344,affects(Infered),Hospitalization,C0019993,en_1206,None,None,AFFECTS(Infered),Infered,3
21701,Moderate asthma,C0581125,en_4344,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
21702,Moderate asthma,C0581125,en_4344,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21703,Moderate asthma,C0581125,en_4344,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21704,Moderate asthma,C0581125,en_4344,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
21705,Moderate asthma,C0581125,en_4344,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21706,Moderate asthma,C0581125,en_4344,affects(Infered),Negative,C0205160,en_3126,None,None,AFFECTS(Infered),Infered,3
21707,Moderate asthma,C0581125,en_4344,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21708,Moderate asthma,C0581125,en_4344,affects(Infered),African race,C0027567,en_1646,None,None,AFFECTS(Infered),Infered,3
21709,Moderate asthma,C0581125,en_4344,affects(Infered),Unipolar Depression,C0041696,en_2310,None,None,AFFECTS(Infered),Infered,3
21710,Moderate asthma,C0581125,en_4344,affects(Infered),Hypercapnic respiratory failure,C0398353,en_3947,None,None,AFFECTS(Infered),Infered,3
21711,Moderate asthma,C0581125,en_4344,affects(Infered),Respiratory distress,C0476273,en_4149,None,None,AFFECTS(Infered),Infered,3
21712,Percutaneous dilational tracheostomy,C1301722,en_5510,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21713,Percutaneous dilational tracheostomy,C1301722,en_5510,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21714,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21715,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21716,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21717,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21718,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
21719,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21720,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21721,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
21722,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
21723,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
21724,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21725,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
21726,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
21727,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21728,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
21729,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
21730,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
21731,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21732,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
21733,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
21734,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21735,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
21736,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
21737,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
21738,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21739,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21740,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
21741,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
21742,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21743,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
21744,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21745,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21746,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21747,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21748,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
21749,Antihypertensive therapy,C0585941,en_4355,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
21750,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
21751,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21752,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21753,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
21754,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
21755,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
21756,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
21757,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
21758,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
21759,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
21760,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
21761,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
21762,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
21763,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21764,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
21765,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21766,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
21767,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
21768,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
21769,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
21770,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
21771,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
21772,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
21773,Antihypertensive therapy,C0585941,en_4355,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
21774,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
21775,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
21776,Antihypertensive therapy,C0585941,en_4355,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
21777,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
21778,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
21779,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
21780,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
21781,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
21782,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
21783,Antihypertensive therapy,C0585941,en_4355,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
21784,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
21785,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
21786,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
21787,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
21788,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
21789,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
21790,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
21791,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
21792,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
21793,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
21794,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
21795,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
21796,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
21797,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
21798,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
21799,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
21800,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
21801,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
21802,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
21803,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
21804,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
21805,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
21806,Antihypertensive therapy,C0585941,en_4355,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
21807,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
21808,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
21809,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
21810,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
21811,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
21812,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
21813,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
21814,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
21815,Antihypertensive therapy,C0585941,en_4355,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
21816,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
21817,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
21818,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
21819,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
21820,Antihypertensive therapy,C0585941,en_4355,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
21821,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
21822,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
21823,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
21824,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
21825,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
21826,Antihypertensive therapy,C0585941,en_4355,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
21827,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
21828,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
21829,Antihypertensive therapy,C0585941,en_4355,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
21830,Antihypertensive therapy,C0585941,en_4355,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
21831,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
21832,Antihypertensive therapy,C0585941,en_4355,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
21833,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21834,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21835,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21836,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21837,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
21838,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21839,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21840,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Sarcoidosis,C0036202,en_2064,None,None,AFFECTS(Infered),Infered,3
21841,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
21842,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
21843,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
21844,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21845,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
21846,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
21847,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21848,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
21849,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
21850,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
21851,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21852,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
21853,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
21854,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21855,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
21856,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
21857,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
21858,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21859,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21860,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
21861,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
21862,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21863,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
21864,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21865,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21866,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21867,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21868,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
21869,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
21870,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
21871,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21872,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21873,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
21874,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
21875,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
21876,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
21877,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
21878,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Shock,C0036974,en_2097,None,None,AFFECTS(Infered),Infered,3
21879,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
21880,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
21881,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
21882,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Family,C0015576,en_961,None,None,AFFECTS(Infered),Infered,3
21883,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
21884,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
21885,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
21886,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
21887,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
21888,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
21889,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Vital signs,C0518766,en_4182,None,None,AFFECTS(Infered),Infered,3
21890,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
21891,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
21892,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
21893,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
21894,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
21895,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
21896,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
21897,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
21898,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
21899,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
21900,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
21901,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
21902,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
21903,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
21904,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
21905,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
21906,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
21907,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
21908,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
21909,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
21910,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
21911,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
21912,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
21913,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
21914,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
21915,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
21916,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
21917,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
21918,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
21919,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
21920,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
21921,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
21922,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
21923,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
21924,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
21925,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
21926,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Households,C0020052,en_1208,None,None,AFFECTS(Infered),Infered,3
21927,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
21928,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
21929,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
21930,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
21931,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
21932,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
21933,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
21934,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
21935,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
21936,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
21937,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
21938,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
21939,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
21940,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
21941,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
21942,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
21943,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
21944,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
21945,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
21946,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
21947,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
21948,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
21949,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
21950,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
21951,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
21952,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
21953,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
21954,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
21955,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
21956,Lipid-lowering therapy,C0585943,en_4356,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
21957,Metabolic therapy,C0587059,en_4360,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
21958,Metabolic therapy,C0587059,en_4360,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
21959,Metabolic therapy,C0587059,en_4360,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
21960,Metabolic therapy,C0587059,en_4360,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
21961,Metabolic therapy,C0587059,en_4360,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
21962,Metabolic therapy,C0587059,en_4360,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
21963,Metabolic therapy,C0587059,en_4360,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
21964,Metabolic therapy,C0587059,en_4360,affects(Infered),Sarcoidosis,C0036202,en_2064,None,None,AFFECTS(Infered),Infered,3
21965,Metabolic therapy,C0587059,en_4360,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
21966,Metabolic therapy,C0587059,en_4360,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
21967,Metabolic therapy,C0587059,en_4360,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
21968,Metabolic therapy,C0587059,en_4360,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
21969,Metabolic therapy,C0587059,en_4360,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
21970,Metabolic therapy,C0587059,en_4360,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
21971,Metabolic therapy,C0587059,en_4360,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
21972,Metabolic therapy,C0587059,en_4360,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
21973,Metabolic therapy,C0587059,en_4360,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
21974,Metabolic therapy,C0587059,en_4360,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
21975,Metabolic therapy,C0587059,en_4360,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
21976,Metabolic therapy,C0587059,en_4360,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
21977,Metabolic therapy,C0587059,en_4360,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
21978,Metabolic therapy,C0587059,en_4360,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
21979,Metabolic therapy,C0587059,en_4360,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
21980,Metabolic therapy,C0587059,en_4360,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
21981,Metabolic therapy,C0587059,en_4360,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
21982,Metabolic therapy,C0587059,en_4360,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
21983,Metabolic therapy,C0587059,en_4360,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
21984,Metabolic therapy,C0587059,en_4360,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
21985,Metabolic therapy,C0587059,en_4360,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
21986,Metabolic therapy,C0587059,en_4360,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
21987,Metabolic therapy,C0587059,en_4360,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
21988,Metabolic therapy,C0587059,en_4360,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
21989,Metabolic therapy,C0587059,en_4360,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
21990,Metabolic therapy,C0587059,en_4360,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
21991,Metabolic therapy,C0587059,en_4360,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
21992,Metabolic therapy,C0587059,en_4360,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
21993,Metabolic therapy,C0587059,en_4360,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
21994,Metabolic therapy,C0587059,en_4360,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
21995,Metabolic therapy,C0587059,en_4360,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
21996,Metabolic therapy,C0587059,en_4360,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
21997,Metabolic therapy,C0587059,en_4360,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
21998,Metabolic therapy,C0587059,en_4360,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
21999,Metabolic therapy,C0587059,en_4360,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
22000,Metabolic therapy,C0587059,en_4360,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
22001,Metabolic therapy,C0587059,en_4360,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
22002,Metabolic therapy,C0587059,en_4360,affects(Infered),Shock,C0036974,en_2097,None,None,AFFECTS(Infered),Infered,3
22003,Metabolic therapy,C0587059,en_4360,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22004,Metabolic therapy,C0587059,en_4360,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22005,Metabolic therapy,C0587059,en_4360,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
22006,Metabolic therapy,C0587059,en_4360,affects(Infered),Family,C0015576,en_961,None,None,AFFECTS(Infered),Infered,3
22007,Metabolic therapy,C0587059,en_4360,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22008,Metabolic therapy,C0587059,en_4360,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
22009,Metabolic therapy,C0587059,en_4360,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22010,Metabolic therapy,C0587059,en_4360,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
22011,Metabolic therapy,C0587059,en_4360,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
22012,Metabolic therapy,C0587059,en_4360,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
22013,Metabolic therapy,C0587059,en_4360,affects(Infered),Vital signs,C0518766,en_4182,None,None,AFFECTS(Infered),Infered,3
22014,Metabolic therapy,C0587059,en_4360,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22015,Metabolic therapy,C0587059,en_4360,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
22016,Metabolic therapy,C0587059,en_4360,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
22017,Metabolic therapy,C0587059,en_4360,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22018,Metabolic therapy,C0587059,en_4360,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
22019,Metabolic therapy,C0587059,en_4360,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
22020,Metabolic therapy,C0587059,en_4360,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
22021,Metabolic therapy,C0587059,en_4360,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22022,Metabolic therapy,C0587059,en_4360,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
22023,Metabolic therapy,C0587059,en_4360,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
22024,Metabolic therapy,C0587059,en_4360,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
22025,Metabolic therapy,C0587059,en_4360,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
22026,Metabolic therapy,C0587059,en_4360,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
22027,Metabolic therapy,C0587059,en_4360,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22028,Metabolic therapy,C0587059,en_4360,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
22029,Metabolic therapy,C0587059,en_4360,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
22030,Metabolic therapy,C0587059,en_4360,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
22031,Metabolic therapy,C0587059,en_4360,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
22032,Metabolic therapy,C0587059,en_4360,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
22033,Metabolic therapy,C0587059,en_4360,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
22034,Metabolic therapy,C0587059,en_4360,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
22035,Metabolic therapy,C0587059,en_4360,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
22036,Metabolic therapy,C0587059,en_4360,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
22037,Metabolic therapy,C0587059,en_4360,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
22038,Metabolic therapy,C0587059,en_4360,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
22039,Metabolic therapy,C0587059,en_4360,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
22040,Metabolic therapy,C0587059,en_4360,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
22041,Metabolic therapy,C0587059,en_4360,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
22042,Metabolic therapy,C0587059,en_4360,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
22043,Metabolic therapy,C0587059,en_4360,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
22044,Metabolic therapy,C0587059,en_4360,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
22045,Metabolic therapy,C0587059,en_4360,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
22046,Metabolic therapy,C0587059,en_4360,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
22047,Metabolic therapy,C0587059,en_4360,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22048,Metabolic therapy,C0587059,en_4360,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
22049,Metabolic therapy,C0587059,en_4360,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
22050,Metabolic therapy,C0587059,en_4360,affects(Infered),Households,C0020052,en_1208,None,None,AFFECTS(Infered),Infered,3
22051,Metabolic therapy,C0587059,en_4360,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
22052,Metabolic therapy,C0587059,en_4360,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
22053,Metabolic therapy,C0587059,en_4360,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
22054,Metabolic therapy,C0587059,en_4360,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
22055,Metabolic therapy,C0587059,en_4360,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
22056,Metabolic therapy,C0587059,en_4360,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
22057,Metabolic therapy,C0587059,en_4360,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
22058,Metabolic therapy,C0587059,en_4360,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
22059,Metabolic therapy,C0587059,en_4360,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
22060,Metabolic therapy,C0587059,en_4360,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
22061,Metabolic therapy,C0587059,en_4360,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
22062,Metabolic therapy,C0587059,en_4360,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
22063,Metabolic therapy,C0587059,en_4360,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
22064,Metabolic therapy,C0587059,en_4360,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
22065,Metabolic therapy,C0587059,en_4360,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
22066,Metabolic therapy,C0587059,en_4360,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
22067,Metabolic therapy,C0587059,en_4360,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
22068,Metabolic therapy,C0587059,en_4360,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
22069,Metabolic therapy,C0587059,en_4360,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
22070,Metabolic therapy,C0587059,en_4360,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
22071,Metabolic therapy,C0587059,en_4360,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
22072,Metabolic therapy,C0587059,en_4360,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
22073,Metabolic therapy,C0587059,en_4360,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
22074,Metabolic therapy,C0587059,en_4360,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
22075,Metabolic therapy,C0587059,en_4360,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
22076,Metabolic therapy,C0587059,en_4360,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
22077,Metabolic therapy,C0587059,en_4360,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
22078,Metabolic therapy,C0587059,en_4360,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
22079,Metabolic therapy,C0587059,en_4360,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
22080,Active Ingredients,C1372955,en_5682,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22081,Aptamer,C0599013,en_4460,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22082,Aptamer,C0599013,en_4460,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22083,Aptamer,C0599013,en_4460,affects(Infered),Encephalitis,C0014038,en_896,None,None,AFFECTS(Infered),Infered,3
22084,Aptamer,C0599013,en_4460,affects(Infered),Prions,C0033164,en_1888,None,None,AFFECTS(Infered),Infered,3
22085,Late pregnancy,C0878751,en_5077,affects(Infered),Spontaneous abortion,C0000786,en_206,None,None,AFFECTS(Infered),Infered,3
22086,Late pregnancy,C0878751,en_5077,affects(Infered),Ability,C0085732,en_2688,None,None,AFFECTS(Infered),Infered,3
22087,Late pregnancy,C0878751,en_5077,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22088,Late pregnancy,C0878751,en_5077,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22089,Late pregnancy,C0878751,en_5077,affects(Infered),Breast Feeding,C0006147,en_512,None,None,AFFECTS(Infered),Infered,3
22090,Late pregnancy,C0878751,en_5077,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22091,Late pregnancy,C0878751,en_5077,affects(Infered),Male population group,C0025266,en_1533,None,None,AFFECTS(Infered),Infered,3
22092,Late pregnancy,C0878751,en_5077,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22093,Late pregnancy,C0878751,en_5077,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
22094,Late pregnancy,C0878751,en_5077,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22095,Late pregnancy,C0878751,en_5077,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
22096,Late pregnancy,C0878751,en_5077,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22097,Late pregnancy,C0878751,en_5077,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22098,Late pregnancy,C0878751,en_5077,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22099,Late pregnancy,C0878751,en_5077,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22100,Late pregnancy,C0878751,en_5077,affects(Infered),Mothers,C0026591,en_1583,None,None,AFFECTS(Infered),Infered,3
22101,Late pregnancy,C0878751,en_5077,affects(Infered),"Infant, Newborn",C0021289,en_1299,None,None,AFFECTS(Infered),Infered,3
22102,Late pregnancy,C0878751,en_5077,affects(Infered),Birth Weight,C0005612,en_475,None,None,AFFECTS(Infered),Infered,3
22103,Late pregnancy,C0878751,en_5077,affects(Infered),Birth,C0005615,en_476,None,None,AFFECTS(Infered),Infered,3
22104,Late pregnancy,C0878751,en_5077,affects(Infered),Child Development,C0008071,en_621,None,None,AFFECTS(Infered),Infered,3
22105,Late pregnancy,C0878751,en_5077,affects(Infered),Infant,C0021270,en_1297,None,None,AFFECTS(Infered),Infered,3
22106,Late pregnancy,C0878751,en_5077,affects(Infered),Offspring,C0680063,en_4620,None,None,AFFECTS(Infered),Infered,3
22107,Late pregnancy,C0878751,en_5077,affects(Infered),Pregnancy Complications,C0032962,en_1873,None,None,AFFECTS(Infered),Infered,3
22108,Late pregnancy,C0878751,en_5077,affects(Infered),Fetal Death,C0015927,en_982,None,None,AFFECTS(Infered),Infered,3
22109,Late pregnancy,C0878751,en_5077,affects(Infered),"Diabetes, Gestational",C0085207,en_2652,None,None,AFFECTS(Infered),Infered,3
22110,Late pregnancy,C0878751,en_5077,affects(Infered),Pre-Eclampsia,C0032914,en_1867,None,None,AFFECTS(Infered),Infered,3
22111,Late pregnancy,C0878751,en_5077,affects(Infered),[V]Other behavioral problems,C0260657,en_3512,None,None,AFFECTS(Infered),Infered,3
22112,Late pregnancy,C0878751,en_5077,affects(Infered),neurodevelopment,C0599855,en_4477,None,None,AFFECTS(Infered),Infered,3
22113,Late pregnancy,C0878751,en_5077,affects(Infered),Fetal complications,C0851390,en_4953,None,None,AFFECTS(Infered),Infered,3
22114,Late pregnancy,C0878751,en_5077,affects(Infered),Acute viral disease,C1443953,en_6732,None,None,AFFECTS(Infered),Infered,3
22115,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22116,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22117,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),Blood coagulation,C0005778,en_484,None,None,AFFECTS(Infered),Infered,3
22118,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),Arteriosclerosis,C0003850,en_399,None,None,AFFECTS(Infered),Infered,3
22119,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),Basophils,C0004827,en_447,None,None,AFFECTS(Infered),Infered,3
22120,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),"Signs and Symptoms, Respiratory",C0037090,en_2107,None,None,AFFECTS(Infered),Infered,3
22121,cysteinyl-leukotriene,C0675175,en_4543,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
22122,prenatal alcohol exposure,C0678807,en_4571,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22123,Human Cell Line,C0682523,en_4644,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
22124,Human Cell Line,C0682523,en_4644,affects(Infered),Vaccines,C0042210,en_2329,None,None,AFFECTS(Infered),Infered,3
22125,Human Cell Line,C0682523,en_4644,affects(Infered),Viral Genome,C0042720,en_2355,None,None,AFFECTS(Infered),Infered,3
22126,Human Cell Line,C0682523,en_4644,affects(Infered),stable cell line,C0598091,en_4442,None,None,AFFECTS(Infered),Infered,3
22127,Mullerian duct inhibiting substance,C0687670,en_4688,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
22128,Mullerian duct inhibiting substance,C0687670,en_4688,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
22129,Mullerian duct inhibiting substance,C0687670,en_4688,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
22130,Mullerian duct inhibiting substance,C0687670,en_4688,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
22131,Electrocardiographic axis,C0728839,en_4759,affects(Infered),QT interval:Time:Point in time:Heart:Quantitative:EKG,C0488414,en_4154,None,None,AFFECTS(Infered),Infered,3
22132,dialysis chronic,C0743165,en_4800,affects(Infered),Autoantibodies,C0004358,en_426,None,None,AFFECTS(Infered),Infered,3
22133,RESPIRATORY ISOLATION,C0748359,en_4832,affects(Infered),Interleukin-6,C0021760,en_1342,None,None,AFFECTS(Infered),Infered,3
22134,RESPIRATORY ISOLATION,C0748359,en_4832,affects(Infered),Interleukin-10,C0085295,en_2659,None,None,AFFECTS(Infered),Infered,3
22135,RESPIRATORY ISOLATION,C0748359,en_4832,affects(Infered),Pulmonary Surfactants,C0034085,en_1935,None,None,AFFECTS(Infered),Infered,3
22136,RESPIRATORY ISOLATION,C0748359,en_4832,affects(Infered),"TNF protein, human",C1448177,en_5755,None,None,AFFECTS(Infered),Infered,3
22137,RESPIRATORY ISOLATION,C0748359,en_4832,affects(Infered),Lung volume,C0231953,en_3270,None,None,AFFECTS(Infered),Infered,3
22138,WORK UP,C0750430,en_4841,affects(Infered),Health Services,C0018747,en_1125,None,None,AFFECTS(Infered),Infered,3
22139,COLLOIDAL SILVER,C0772313,en_4875,affects(Infered),Parkinson Disease,C0030567,en_1753,None,None,AFFECTS(Infered),Infered,3
22140,Hyaluronan,C0813622,en_4905,affects(Infered),Epidermis,C0014520,en_916,None,None,AFFECTS(Infered),Infered,3
22141,Radiation,C0851346,en_4952,affects(Infered),Radioprotective drug,C1318473,en_5531,None,None,AFFECTS(Infered),Infered,3
22142,Deterioration,C0868945,en_4997,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22143,Deterioration,C0868945,en_4997,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
22144,Deterioration,C0868945,en_4997,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
22145,Deterioration,C0868945,en_4997,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22146,Deterioration,C0868945,en_4997,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
22147,Deterioration,C0868945,en_4997,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22148,Deterioration,C0868945,en_4997,affects(Infered),"Translation, Genetic",C0040711,en_2274,None,None,AFFECTS(Infered),Infered,3
22149,Deterioration,C0868945,en_4997,affects(Infered),Appendicitis,C0003615,en_387,None,None,AFFECTS(Infered),Infered,3
22150,Deterioration,C0868945,en_4997,affects(Infered),Blind Vision,C0456909,en_4120,None,None,AFFECTS(Infered),Infered,3
22151,Deterioration,C0868945,en_4997,affects(Infered),Microorganism,C0445623,en_4075,None,None,AFFECTS(Infered),Infered,3
22152,Deterioration,C0868945,en_4997,affects(Infered),humoral defense mechanism (sensu Vertebrata),C1155250,en_5319,None,None,AFFECTS(Infered),Infered,3
22153,Deterioration,C0868945,en_4997,affects(Infered),Nucleocapsid Proteins,C0524816,en_4219,None,None,AFFECTS(Infered),Infered,3
22154,Institutional care,C0868975,en_4999,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
22155,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22156,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22157,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22158,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
22159,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
22160,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22161,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22162,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22163,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22164,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
22165,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22166,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
22167,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22168,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22169,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22170,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22171,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
22172,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22173,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22174,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
22175,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22176,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
22177,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
22178,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
22179,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22180,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22181,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
22182,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
22183,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22184,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
22185,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22186,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
22187,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
22188,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
22189,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
22190,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
22191,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
22192,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
22193,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22194,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
22195,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
22196,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
22197,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
22198,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
22199,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22200,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22201,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
22202,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22203,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
22204,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22205,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
22206,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
22207,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
22208,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22209,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
22210,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
22211,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22212,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
22213,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
22214,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
22215,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22216,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
22217,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
22218,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
22219,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
22220,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
22221,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
22222,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
22223,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
22224,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
22225,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
22226,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
22227,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
22228,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
22229,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
22230,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
22231,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
22232,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
22233,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
22234,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
22235,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
22236,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
22237,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
22238,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
22239,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
22240,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22241,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
22242,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
22243,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
22244,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
22245,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
22246,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
22247,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
22248,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
22249,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
22250,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
22251,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
22252,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
22253,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
22254,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
22255,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
22256,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
22257,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
22258,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
22259,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
22260,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
22261,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
22262,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
22263,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
22264,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
22265,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
22266,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
22267,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
22268,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
22269,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
22270,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
22271,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
22272,"Transcranial Magnetic Stimulation, Repetitive",C0872259,en_5043,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
22273,Alvesco,C1174745,en_5380,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22274,Alvesco,C1174745,en_5380,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22275,Alvesco,C1174745,en_5380,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22276,Alvesco,C1174745,en_5380,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22277,ciclesonide,C0907850,en_5095,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22278,Alvesco,C1174745,en_5380,affects(Infered),"Signs and Symptoms, Respiratory",C0037090,en_2107,None,None,AFFECTS(Infered),Infered,3
22279,Leukocyte L1 Antigen Complex,C0950624,en_5192,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
22280,"CD274 protein, human|CD274",C0965245|29126,en_5203,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
22281,"CD274 protein, human|CD274",C0965245|29126,en_5203,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
22282,"CD274 protein, human|CD274",C0965245|29126,en_5203,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
22283,"CD274 protein, human|CD274",C0965245|29126,en_5203,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
22284,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
22285,type I collagen alpha 1,C0972255,en_5212,affects(Infered),cytokine,C0079189,en_2593,None,None,AFFECTS(Infered),Infered,3
22286,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22287,type I collagen alpha 1,C0972255,en_5212,affects(Infered),macrophage,C0024432,en_1484,None,None,AFFECTS(Infered),Infered,3
22288,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Endothelial Cells,C0225336,en_3237,None,None,AFFECTS(Infered),Infered,3
22289,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
22290,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Pulmonary Fibrosis,C0034069,en_1932,None,None,AFFECTS(Infered),Infered,3
22291,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Fibroblasts,C0016030,en_992,None,None,AFFECTS(Infered),Infered,3
22292,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Gelatin,C0017237,en_1042,None,None,AFFECTS(Infered),Infered,3
22293,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Oxidants,C0085403,en_2667,None,None,AFFECTS(Infered),Infered,3
22294,type I collagen alpha 1,C0972255,en_5212,affects(Infered),"Tumor cells, malignant",C0334227,en_3774,None,None,AFFECTS(Infered),Infered,3
22295,type I collagen alpha 1,C0972255,en_5212,affects(Infered),Pericytes,C0598800,en_4453,None,None,AFFECTS(Infered),Infered,3
22296,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22297,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22298,Aspirin 150 MG,C0983851,en_5216,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22299,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22300,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22301,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22302,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22303,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
22304,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
22305,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Chronic pain,C0150055,en_2816,None,None,AFFECTS(Infered),Infered,3
22306,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22307,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22308,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
22309,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Blood coagulation,C0005778,en_484,None,None,AFFECTS(Infered),Infered,3
22310,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
22311,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Platelet function,C1254881,en_5398,None,None,AFFECTS(Infered),Infered,3
22312,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Mothers,C0026591,en_1583,None,None,AFFECTS(Infered),Infered,3
22313,Aspirin 150 MG,C0983851,en_5216,affects(Infered),Hypertension induced by pregnancy,C0340274,en_3815,None,None,AFFECTS(Infered),Infered,3
22314,Aspirin 150 MG,C0983851,en_5216,affects(Infered),cyclooxygenase 1,C0389003,en_3906,None,None,AFFECTS(Infered),Infered,3
22315,Dapsone 100 MG,C0985298,en_5217,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22316,Dapsone 100 MG,C0985298,en_5217,affects(Infered),pulmonary complications,C0281169,en_3627,None,None,AFFECTS(Infered),Infered,3
22317,Dapsone 100 MG,C0985298,en_5217,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22318,Dapsone 100 MG,C0985298,en_5217,affects(Infered),Elderly,C0001792,en_258,None,None,AFFECTS(Infered),Infered,3
22319,Dapsone 100 MG,C0985298,en_5217,affects(Infered),Leprosy,C0023343,en_1412,None,None,AFFECTS(Infered),Infered,3
22320,Dapsone 100 MG,C0985298,en_5217,affects(Infered),High Risk Populations,C0870646,en_5008,None,None,AFFECTS(Infered),Infered,3
22321,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22322,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22323,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),network,C0679670,en_4604,None,None,AFFECTS(Infered),Infered,3
22324,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22325,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22326,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
22327,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
22328,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22329,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22330,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22331,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Adrenal Cortex,C0001613,en_246,None,None,AFFECTS(Infered),Infered,3
22332,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22333,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
22334,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Lung,C0024109,en_1460,None,None,AFFECTS(Infered),Infered,3
22335,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
22336,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
22337,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
22338,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22339,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22340,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
22341,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
22342,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Virus,C0042776,en_2364,None,None,AFFECTS(Infered),Infered,3
22343,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Malaise,C0231218,en_3251,None,None,AFFECTS(Infered),Infered,3
22344,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Borg Category-Ratio 10 Perceived Exertion Score 5,C4050466,en_6309,None,None,AFFECTS(Infered),Infered,3
22345,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
22346,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Possible,C0332149,en_3747,None,None,AFFECTS(Infered),Infered,3
22347,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Arthritis,C0003864,en_400,None,None,AFFECTS(Infered),Infered,3
22348,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Pregnant Women,C0033011,en_1876,None,None,AFFECTS(Infered),Infered,3
22349,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Histone Deacetylase,C0019643,en_1188,None,None,AFFECTS(Infered),Infered,3
22350,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Muscle,C0026845,en_1603,None,None,AFFECTS(Infered),Infered,3
22351,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),T-Cell Lymphoma,C0079772,en_2610,None,None,AFFECTS(Infered),Infered,3
22352,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
22353,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Thromboembolic event,C0857496,en_4977,None,None,AFFECTS(Infered),Infered,3
22354,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Patient ventilated,C1299448,en_5503,None,None,AFFECTS(Infered),Infered,3
22355,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Brain Edema,C1527311,en_5920,None,None,AFFECTS(Infered),Infered,3
22356,Dexamethasone 6 MG,C0985347,en_5218,affects(Infered),Lethality,C5203340,en_6416,None,None,AFFECTS(Infered),Infered,3
22357,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
22358,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
22359,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22360,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22361,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22362,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
22363,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),Carrier of disorder,C0560175,en_4319,None,None,AFFECTS(Infered),Infered,3
22364,Ritonavir 100 MG,C0992889,en_5219,affects(Infered),"Hepatitis C, Chronic",C0524910,en_4224,None,None,AFFECTS(Infered),Infered,3
22365,Spironolactone 50 MG,C0992989,en_5220,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22366,Spironolactone 50 MG,C0992989,en_5220,affects(Infered),Pulmonary Fibrosis,C0034069,en_1932,None,None,AFFECTS(Infered),Infered,3
22367,Spironolactone 50 MG,C0992989,en_5220,affects(Infered),Control Groups,C0009932,en_711,None,None,AFFECTS(Infered),Infered,3
22368,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22369,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22370,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Fever,C0015967,en_985,None,None,AFFECTS(Infered),Infered,3
22371,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22372,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22373,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
22374,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22375,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
22376,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Immunoregulation,C0678889,en_4580,None,None,AFFECTS(Infered),Infered,3
22377,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22378,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22379,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),pulmonary complications,C0281169,en_3627,None,None,AFFECTS(Infered),Infered,3
22380,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
22381,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
22382,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22383,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Duration,C2926735,en_6146,None,None,AFFECTS(Infered),Infered,3
22384,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Severe infection,C5139167,en_6407,None,None,AFFECTS(Infered),Infered,3
22385,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
22386,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
22387,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
22388,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
22389,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),patient state,C0683521,en_4668,None,None,AFFECTS(Infered),Infered,3
22390,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22391,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Coughing,C0010200,en_723,None,None,AFFECTS(Infered),Infered,3
22392,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22393,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Cardiotoxicity,C0876994,en_5060,None,None,AFFECTS(Infered),Infered,3
22394,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),cardiac arrhythmia,C0003811,en_397,None,None,AFFECTS(Infered),Infered,3
22395,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Antiviral Response,C1155328,en_5322,None,None,AFFECTS(Infered),Infered,3
22396,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Vesicle,C0333262,en_3759,None,None,AFFECTS(Infered),Infered,3
22397,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Hydroxychloroquine,C0020336,en_1226,None,None,AFFECTS(Infered),Infered,3
22398,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Hydroxychloroquine therapy,C5190549,en_6409,None,None,AFFECTS(Infered),Infered,3
22399,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Dyspnea,C0013404,en_866,None,None,AFFECTS(Infered),Infered,3
22400,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Escherichia coli,C0014834,en_929,None,None,AFFECTS(Infered),Infered,3
22401,Azithromycin 500 MG,C1126333,en_5252,affects(Infered),Ventricular Repolarization,C3537202,en_6210,None,None,AFFECTS(Infered),Infered,3
22402,Sexual transmission,C1519279,en_5882,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
22403,Sexual transmission,C1519279,en_5882,affects(Infered),Pregnant Women,C0033011,en_1876,None,None,AFFECTS(Infered),Infered,3
22404,"Recorders, Electronic Storage, Data, Physical Activity",C1139952,en_5278,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22405,Dialysis care,C1161201,en_5364,affects(Infered),Native Americans,C0282204,en_3640,None,None,AFFECTS(Infered),Infered,3
22406,Sexual behavior analysis,C1171217,en_5375,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22407,Sexual behavior analysis,C1171217,en_5375,affects(Infered),Relative (related person),C0080103,en_2623,None,None,AFFECTS(Infered),Infered,3
22408,Sexual behavior analysis,C1171217,en_5375,affects(Infered),Staff,C0851286,en_4950,None,None,AFFECTS(Infered),Infered,3
22409,"VEGF protein, human",C1171892,en_5379,affects(Infered),Capillary Permeability,C0006906,en_551,None,None,AFFECTS(Infered),Infered,3
22410,Cutaneous muscle,C1184459,en_5390,affects(Infered),15-Hydroxyprostaglandin dehydrogenase (NAD+),C0044894,en_2415,None,None,AFFECTS(Infered),Infered,3
22411,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22412,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Anxiety,C0003467,en_380,None,None,AFFECTS(Infered),Infered,3
22413,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22414,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),inpatient,C0021562,en_1321,None,None,AFFECTS(Infered),Infered,3
22415,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22416,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Lung,C0024109,en_1460,None,None,AFFECTS(Infered),Infered,3
22417,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Present,C0150312,en_2833,None,None,AFFECTS(Infered),Infered,3
22418,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22419,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
22420,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Blood Pressure,C0005823,en_492,None,None,AFFECTS(Infered),Infered,3
22421,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Brain,C0006104,en_508,None,None,AFFECTS(Infered),Infered,3
22422,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
22423,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Intestines,C0021853,en_1350,None,None,AFFECTS(Infered),Infered,3
22424,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Opioid Use Disorders,C0029103,en_1711,None,None,AFFECTS(Infered),Infered,3
22425,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
22426,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Suicide,C0038661,en_2178,None,None,AFFECTS(Infered),Infered,3
22427,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Surface Tension,C0038887,en_2189,None,None,AFFECTS(Infered),Infered,3
22428,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Unplanned pregnancy,C0041747,en_2311,None,None,AFFECTS(Infered),Infered,3
22429,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Violence,C0042693,en_2353,None,None,AFFECTS(Infered),Infered,3
22430,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Virus Replication,C0042774,en_2363,None,None,AFFECTS(Infered),Infered,3
22431,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
22432,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Homelessness,C0237154,en_3342,None,None,AFFECTS(Infered),Infered,3
22433,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22434,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Family illness,C0344339,en_3837,None,None,AFFECTS(Infered),Infered,3
22435,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Hyperactive behavior,C0424295,en_3992,None,None,AFFECTS(Infered),Infered,3
22436,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),stressor,C0597530,en_4430,None,None,AFFECTS(Infered),Infered,3
22437,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),attenuation,C0599946,en_4490,None,None,AFFECTS(Infered),Infered,3
22438,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),General Population,C0683971,en_4674,None,None,AFFECTS(Infered),Infered,3
22439,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),heavy drinking,C0687132,en_4684,None,None,AFFECTS(Infered),Infered,3
22440,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),brain development,C1160340,en_5353,None,None,AFFECTS(Infered),Infered,3
22441,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22442,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),member,C0680022,en_4618,None,None,AFFECTS(Infered),Infered,3
22443,Povidone-Iodine Mouthwash,C1251768,en_5394,affects(Infered),Food Consumption,C2983605,en_6164,None,None,AFFECTS(Infered),Infered,3
22444,laquinimod,C1260208,en_5409,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22445,laquinimod,C1260208,en_5409,affects(Infered),Corrected Prolonged QT Interval by ECG Finding,C0855333,en_4966,None,None,AFFECTS(Infered),Infered,3
22446,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22447,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22448,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22449,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22450,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22451,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22452,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Social fear,C0424166,en_3991,None,None,AFFECTS(Infered),Infered,3
22453,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Research Personnel,C0035173,en_2002,None,None,AFFECTS(Infered),Infered,3
22454,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22455,Solution-Focused Brief Therapy,C1276047,en_5463,affects(Infered),Addictive Behavior,C0085281,en_2658,None,None,AFFECTS(Infered),Infered,3
22456,Procoagulant,C1292267,en_5493,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
22457,Procoagulant,C1292267,en_5493,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
22458,Procoagulant,C1292267,en_5493,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
22459,Procoagulant,C1292267,en_5493,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
22460,Empirical antibiotic therapy,C1299622,en_5505,affects(Infered),Secondary infection,C0442886,en_4061,None,None,AFFECTS(Infered),Infered,3
22461,Empirical antibiotic therapy,C1299622,en_5505,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22462,Empirical antibiotic therapy,C1299622,en_5505,affects(Infered),Bacterial Infections,C0004623,en_441,None,None,AFFECTS(Infered),Infered,3
22463,Empirical antibiotic therapy,C1299622,en_5505,affects(Infered),Immunocompromised Host,C0085393,en_2665,None,None,AFFECTS(Infered),Infered,3
22464,Problem solving therapy,C1303140,en_5513,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22465,Problem solving therapy,C1303140,en_5513,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22466,Problem solving therapy,C1303140,en_5513,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22467,Problem solving therapy,C1303140,en_5513,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22468,Problem solving therapy,C1303140,en_5513,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22469,Problem solving therapy,C1303140,en_5513,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22470,Problem solving therapy,C1303140,en_5513,affects(Infered),Social fear,C0424166,en_3991,None,None,AFFECTS(Infered),Infered,3
22471,Problem solving therapy,C1303140,en_5513,affects(Infered),Research Personnel,C0035173,en_2002,None,None,AFFECTS(Infered),Infered,3
22472,Problem solving therapy,C1303140,en_5513,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22473,Problem solving therapy,C1303140,en_5513,affects(Infered),Addictive Behavior,C0085281,en_2658,None,None,AFFECTS(Infered),Infered,3
22474,"SH2D3A protein, human",C1309025,en_5526,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
22475,Dual Specificity Phosphatase 3,C1333317,en_5590,affects(Infered),Signal Transduction,C0037083,en_2105,None,None,AFFECTS(Infered),Infered,3
22476,Dual Specificity Phosphatase 3,C1333317,en_5590,affects(Infered),small molecule,C1328819,en_5573,None,None,AFFECTS(Infered),Infered,3
22477,DUSP3 gene,C1333258,en_5589,affects(Infered),innate immune response,C1155265,en_5320,None,None,AFFECTS(Infered),Infered,3
22478,Dual Specificity Phosphatase 3,C1333317,en_5590,affects(Infered),Hydrolysis,C0020291,en_1223,None,None,AFFECTS(Infered),Infered,3
22479,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22480,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22481,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Neurodegenerative Disorders,C0524851,en_4220,None,None,AFFECTS(Infered),Infered,3
22482,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Up-Regulation (Physiology),C0041904,en_2313,None,None,AFFECTS(Infered),Infered,3
22483,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
22484,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
22485,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
22486,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Symptom aggravating factors,C0436331,en_4027,None,None,AFFECTS(Infered),Infered,3
22487,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),Pluripotent Stem Cells,C0872076,en_5035,None,None,AFFECTS(Infered),Infered,3
22488,Forkhead Box Protein O4,C1333634,en_5595,affects(Infered),E protein,C0599561,en_6656,None,None,AFFECTS(Infered),Infered,3
22489,TIMP3 gene,C1336630,en_5631,affects(Infered),"TIMP3 protein, human",C1527365,en_5924,None,None,AFFECTS(Infered),Infered,3
22490,IFNA1,C1415900,en_46,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
22491,Hypermethylation,C1512554,en_5821,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22492,Hypermethylation,C1512554,en_5821,affects(Infered),Gene Expression,C0017262,en_1044,None,None,AFFECTS(Infered),Infered,3
22493,Hypermethylation,C1512554,en_5821,affects(Infered),TMPRSS2 gene|TMPRSS2,C1336641|7113,en_5637,None,None,AFFECTS(Infered),Infered,3
22494,Rintatolimod,C1434913,en_5728,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22495,Rintatolimod,C1434913,en_5728,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22496,Rintatolimod,C1434913,en_5728,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22497,Rintatolimod,C1434913,en_5728,affects(Infered),RNA Viruses,C0035691,en_2044,None,None,AFFECTS(Infered),Infered,3
22498,Rintatolimod,C1434913,en_5728,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22499,Rintatolimod,C1434913,en_5728,affects(Infered),Anxiety,C0003467,en_380,None,None,AFFECTS(Infered),Infered,3
22500,Rintatolimod,C1434913,en_5728,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22501,Rintatolimod,C1434913,en_5728,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22502,Rintatolimod,C1434913,en_5728,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
22503,Rintatolimod,C1434913,en_5728,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22504,Rintatolimod,C1434913,en_5728,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22505,Rintatolimod,C1434913,en_5728,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22506,Rintatolimod,C1434913,en_5728,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22507,Rintatolimod,C1434913,en_5728,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22508,Rintatolimod,C1434913,en_5728,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
22509,Rintatolimod,C1434913,en_5728,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22510,Rintatolimod,C1434913,en_5728,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22511,Rintatolimod,C1434913,en_5728,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
22512,Rintatolimod,C1434913,en_5728,affects(Infered),Opioid Use Disorders,C0029103,en_1711,None,None,AFFECTS(Infered),Infered,3
22513,Rintatolimod,C1434913,en_5728,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22514,Rintatolimod,C1434913,en_5728,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
22515,Rintatolimod,C1434913,en_5728,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
22516,Rintatolimod,C1434913,en_5728,affects(Infered),Influenza,C0021400,en_1311,None,None,AFFECTS(Infered),Infered,3
22517,Rintatolimod,C1434913,en_5728,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22518,Rintatolimod,C1434913,en_5728,affects(Infered),Animal Viruses,C0003060,en_334,None,None,AFFECTS(Infered),Infered,3
22519,Rintatolimod,C1434913,en_5728,affects(Infered),Virus,C0042776,en_2364,None,None,AFFECTS(Infered),Infered,3
22520,Rintatolimod,C1434913,en_5728,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
22521,Rintatolimod,C1434913,en_5728,affects(Infered),"Kidney Failure, Acute",C0022660,en_1382,None,None,AFFECTS(Infered),Infered,3
22522,Rintatolimod,C1434913,en_5728,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22523,Rintatolimod,C1434913,en_5728,affects(Infered),Superinfection,C0038826,en_2184,None,None,AFFECTS(Infered),Infered,3
22524,Rintatolimod,C1434913,en_5728,affects(Infered),Cardiac rhythm type,C0232187,en_3273,None,None,AFFECTS(Infered),Infered,3
22525,Rintatolimod,C1434913,en_5728,affects(Infered),"Translation, Genetic",C0040711,en_2274,None,None,AFFECTS(Infered),Infered,3
22526,Rintatolimod,C1434913,en_5728,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22527,Rintatolimod,C1434913,en_5728,affects(Infered),Complement System Proteins,C0009498,en_691,None,None,AFFECTS(Infered),Infered,3
22528,Rintatolimod,C1434913,en_5728,affects(Infered),Hepatitis C,C0019196,en_1177,None,None,AFFECTS(Infered),Infered,3
22529,Rintatolimod,C1434913,en_5728,affects(Infered),Peptide Hydrolases,C0030940,en_1769,None,None,AFFECTS(Infered),Infered,3
22530,Rintatolimod,C1434913,en_5728,affects(Infered),"Pneumonia, Viral",C0032310,en_1837,None,None,AFFECTS(Infered),Infered,3
22531,Rintatolimod,C1434913,en_5728,affects(Infered),RNA-Directed RNA Polymerase,C0035685,en_2042,None,None,AFFECTS(Infered),Infered,3
22532,Rintatolimod,C1434913,en_5728,affects(Infered),"Transcription, Genetic",C0040649,en_2265,None,None,AFFECTS(Infered),Infered,3
22533,Rintatolimod,C1434913,en_5728,affects(Infered),Hepatitis C virus,C0220847,en_3204,None,None,AFFECTS(Infered),Infered,3
22534,Rintatolimod,C1434913,en_5728,affects(Infered),Clinical Syndromes,C0221444,en_3225,None,None,AFFECTS(Infered),Infered,3
22535,Rintatolimod,C1434913,en_5728,affects(Infered),Possible,C0332149,en_3747,None,None,AFFECTS(Infered),Infered,3
22536,Rintatolimod,C1434913,en_5728,affects(Infered),Acute respiratory infection NOS,C0339901,en_3809,None,None,AFFECTS(Infered),Infered,3
22537,Rintatolimod,C1434913,en_5728,affects(Infered),viral genome replication,C1160701,en_5361,None,None,AFFECTS(Infered),Infered,3
22538,Rintatolimod,C1434913,en_5728,affects(Infered),Polymerase,C1335439,en_5615,None,None,AFFECTS(Infered),Infered,3
22539,Rintatolimod,C1434913,en_5728,affects(Infered),Worse,C1457868,en_5783,None,None,AFFECTS(Infered),Infered,3
22540,B VARIANT NOS,C1440117,en_5731,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
22541,B VARIANT NOS,C1440117,en_5731,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
22542,B VARIANT NOS,C1440117,en_5731,affects(Infered),Immune system,C0020962,en_1271,None,None,AFFECTS(Infered),Infered,3
22543,B VARIANT NOS,C1440117,en_5731,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
22544,Adenovirus Vector,C1510800,en_5801,affects(Infered),Mucous Membrane,C0026724,en_1594,None,None,AFFECTS(Infered),Infered,3
22545,Detection,C1511790,en_5814,affects(Infered),Health Services,C0018747,en_1125,None,None,AFFECTS(Infered),Infered,3
22546,Harvest,C1512335,en_5817,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22547,Harvest,C1512335,en_5817,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22548,Harvest,C1512335,en_5817,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
22549,Harvest,C1512335,en_5817,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22550,Harvest,C1512335,en_5817,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22551,Harvest,C1512335,en_5817,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22552,Harvest,C1512335,en_5817,affects(Infered),Mycoses,C0026946,en_1620,None,None,AFFECTS(Infered),Infered,3
22553,Harvest,C1512335,en_5817,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
22554,Harvest,C1512335,en_5817,affects(Infered),Antibiotic-associated diarrhea,C0578159,en_4340,None,None,AFFECTS(Infered),Infered,3
22555,Harvest,C1512335,en_5817,affects(Infered),Primary infection NOS,C0948192,en_5162,None,None,AFFECTS(Infered),Infered,3
22556,Harvest,C1512335,en_5817,affects(Infered),"Bladder, Neurogenic",C0005697,en_480,None,None,AFFECTS(Infered),Infered,3
22557,Harvest,C1512335,en_5817,affects(Infered),"Hepatitis, Alcoholic",C0019187,en_1176,None,None,AFFECTS(Infered),Infered,3
22558,Harvest,C1512335,en_5817,affects(Infered),UNDERLYING INFECTION,C0749769,en_4837,None,None,AFFECTS(Infered),Infered,3
22559,Harvest,C1512335,en_5817,affects(Infered),organ rejection,C0815080,en_4921,None,None,AFFECTS(Infered),Infered,3
22560,Harvest,C1512335,en_5817,affects(Infered),"Obesity, Morbid",C0028756,en_1700,None,None,AFFECTS(Infered),Infered,3
22561,Harvest,C1512335,en_5817,affects(Infered),Systemic Scleroderma,C0036421,en_2071,None,None,AFFECTS(Infered),Infered,3
22562,Harvest,C1512335,en_5817,affects(Infered),muscle injury,C0410256,en_3969,None,None,AFFECTS(Infered),Infered,3
22563,Harvest,C1512335,en_5817,affects(Infered),Intraoperative hemorrhage,C0475026,en_4143,None,None,AFFECTS(Infered),Infered,3
22564,Surgical Management,C1515089,en_5845,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22565,Surgical Management,C1515089,en_5845,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22566,Surgical Management,C1515089,en_5845,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22567,Surgical Management,C1515089,en_5845,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22568,Surgical Management,C1515089,en_5845,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22569,Surgical Management,C1515089,en_5845,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22570,Surgical Management,C1515089,en_5845,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22571,Surgical Management,C1515089,en_5845,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
22572,Surgical Management,C1515089,en_5845,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
22573,Surgical Management,C1515089,en_5845,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22574,Surgical Management,C1515089,en_5845,affects(Infered),Severe infection,C5139167,en_6407,None,None,AFFECTS(Infered),Infered,3
22575,Surgical Management,C1515089,en_5845,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22576,Surgical Management,C1515089,en_5845,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
22577,Surgical Management,C1515089,en_5845,affects(Infered),Geriatric Patients,C0870602,en_5007,None,None,AFFECTS(Infered),Infered,3
22578,Surgical Management,C1515089,en_5845,affects(Infered),Pneumonia caused by SARS-CoV-2,C5244027,en_6427,None,None,AFFECTS(Infered),Infered,3
22579,Surgical Management,C1515089,en_5845,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
22580,Surgical Management,C1515089,en_5845,affects(Infered),Physicians,C0031831,en_1805,None,None,AFFECTS(Infered),Infered,3
22581,Surgical Management,C1515089,en_5845,affects(Infered),imbalance,C1397014,en_5692,None,None,AFFECTS(Infered),Infered,3
22582,Surgical Management,C1515089,en_5845,affects(Infered),Storm Syndrome,C1861452,en_6056,None,None,AFFECTS(Infered),Infered,3
22583,Surgical Management,C1515089,en_5845,affects(Infered),Middle East Respiratory Syndrome,C3694279,en_6232,None,None,AFFECTS(Infered),Infered,3
22584,Surgical Management,C1515089,en_5845,affects(Infered),High risk of,C0332167,en_3748,None,None,AFFECTS(Infered),Infered,3
22585,Systemic Therapy,C1515119,en_5846,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22586,Systemic Therapy,C1515119,en_5846,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22587,Systemic Therapy,C1515119,en_5846,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22588,Systemic Therapy,C1515119,en_5846,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
22589,Systemic Therapy,C1515119,en_5846,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
22590,Systemic Therapy,C1515119,en_5846,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22591,Systemic Therapy,C1515119,en_5846,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22592,Systemic Therapy,C1515119,en_5846,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22593,Systemic Therapy,C1515119,en_5846,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
22594,Systemic Therapy,C1515119,en_5846,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22595,Systemic Therapy,C1515119,en_5846,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
22596,Systemic Therapy,C1515119,en_5846,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22597,Systemic Therapy,C1515119,en_5846,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22598,Systemic Therapy,C1515119,en_5846,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22599,Systemic Therapy,C1515119,en_5846,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22600,Systemic Therapy,C1515119,en_5846,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
22601,Systemic Therapy,C1515119,en_5846,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22602,Systemic Therapy,C1515119,en_5846,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22603,Systemic Therapy,C1515119,en_5846,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
22604,Systemic Therapy,C1515119,en_5846,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22605,Systemic Therapy,C1515119,en_5846,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
22606,Systemic Therapy,C1515119,en_5846,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
22607,Systemic Therapy,C1515119,en_5846,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
22608,Systemic Therapy,C1515119,en_5846,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22609,Systemic Therapy,C1515119,en_5846,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22610,Systemic Therapy,C1515119,en_5846,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
22611,Systemic Therapy,C1515119,en_5846,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
22612,Systemic Therapy,C1515119,en_5846,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22613,Systemic Therapy,C1515119,en_5846,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
22614,Systemic Therapy,C1515119,en_5846,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22615,Systemic Therapy,C1515119,en_5846,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
22616,Systemic Therapy,C1515119,en_5846,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
22617,Systemic Therapy,C1515119,en_5846,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
22618,Systemic Therapy,C1515119,en_5846,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
22619,Systemic Therapy,C1515119,en_5846,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
22620,Systemic Therapy,C1515119,en_5846,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
22621,Systemic Therapy,C1515119,en_5846,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
22622,Systemic Therapy,C1515119,en_5846,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22623,Systemic Therapy,C1515119,en_5846,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
22624,Systemic Therapy,C1515119,en_5846,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
22625,Systemic Therapy,C1515119,en_5846,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
22626,Systemic Therapy,C1515119,en_5846,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
22627,Systemic Therapy,C1515119,en_5846,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22628,Systemic Therapy,C1515119,en_5846,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22629,Systemic Therapy,C1515119,en_5846,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
22630,Systemic Therapy,C1515119,en_5846,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22631,Systemic Therapy,C1515119,en_5846,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
22632,Systemic Therapy,C1515119,en_5846,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
22633,Systemic Therapy,C1515119,en_5846,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
22634,Systemic Therapy,C1515119,en_5846,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22635,Systemic Therapy,C1515119,en_5846,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
22636,Systemic Therapy,C1515119,en_5846,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
22637,Systemic Therapy,C1515119,en_5846,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22638,Systemic Therapy,C1515119,en_5846,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
22639,Systemic Therapy,C1515119,en_5846,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
22640,Systemic Therapy,C1515119,en_5846,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
22641,Systemic Therapy,C1515119,en_5846,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22642,Systemic Therapy,C1515119,en_5846,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
22643,Systemic Therapy,C1515119,en_5846,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
22644,Systemic Therapy,C1515119,en_5846,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
22645,Systemic Therapy,C1515119,en_5846,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
22646,Systemic Therapy,C1515119,en_5846,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
22647,Systemic Therapy,C1515119,en_5846,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22648,Systemic Therapy,C1515119,en_5846,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
22649,Systemic Therapy,C1515119,en_5846,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
22650,Systemic Therapy,C1515119,en_5846,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
22651,Systemic Therapy,C1515119,en_5846,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
22652,Systemic Therapy,C1515119,en_5846,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
22653,Systemic Therapy,C1515119,en_5846,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
22654,Systemic Therapy,C1515119,en_5846,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
22655,Systemic Therapy,C1515119,en_5846,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
22656,Systemic Therapy,C1515119,en_5846,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
22657,Systemic Therapy,C1515119,en_5846,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
22658,Systemic Therapy,C1515119,en_5846,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
22659,Systemic Therapy,C1515119,en_5846,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
22660,Systemic Therapy,C1515119,en_5846,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
22661,Systemic Therapy,C1515119,en_5846,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
22662,Systemic Therapy,C1515119,en_5846,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
22663,Systemic Therapy,C1515119,en_5846,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
22664,Systemic Therapy,C1515119,en_5846,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
22665,Systemic Therapy,C1515119,en_5846,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
22666,Systemic Therapy,C1515119,en_5846,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
22667,Systemic Therapy,C1515119,en_5846,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22668,Systemic Therapy,C1515119,en_5846,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
22669,Systemic Therapy,C1515119,en_5846,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
22670,Systemic Therapy,C1515119,en_5846,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
22671,Systemic Therapy,C1515119,en_5846,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
22672,Systemic Therapy,C1515119,en_5846,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
22673,Systemic Therapy,C1515119,en_5846,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
22674,Systemic Therapy,C1515119,en_5846,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
22675,Systemic Therapy,C1515119,en_5846,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
22676,Systemic Therapy,C1515119,en_5846,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
22677,Systemic Therapy,C1515119,en_5846,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
22678,Systemic Therapy,C1515119,en_5846,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
22679,Systemic Therapy,C1515119,en_5846,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
22680,Systemic Therapy,C1515119,en_5846,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
22681,Systemic Therapy,C1515119,en_5846,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
22682,Systemic Therapy,C1515119,en_5846,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
22683,Systemic Therapy,C1515119,en_5846,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
22684,Systemic Therapy,C1515119,en_5846,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
22685,Systemic Therapy,C1515119,en_5846,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
22686,Systemic Therapy,C1515119,en_5846,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
22687,Systemic Therapy,C1515119,en_5846,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
22688,Systemic Therapy,C1515119,en_5846,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
22689,Systemic Therapy,C1515119,en_5846,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
22690,Systemic Therapy,C1515119,en_5846,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
22691,Systemic Therapy,C1515119,en_5846,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
22692,Systemic Therapy,C1515119,en_5846,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
22693,Systemic Therapy,C1515119,en_5846,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
22694,Systemic Therapy,C1515119,en_5846,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
22695,Systemic Therapy,C1515119,en_5846,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
22696,Systemic Therapy,C1515119,en_5846,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
22697,Systemic Therapy,C1515119,en_5846,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
22698,Systemic Therapy,C1515119,en_5846,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
22699,Systemic Therapy,C1515119,en_5846,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
22700,Clonal Expansion,C1516670,en_5861,affects(Infered),Cytokine release syndrome,C0948245,en_5163,None,None,AFFECTS(Infered),Infered,3
22701,Clonal Expansion,C1516670,en_5861,affects(Infered),Cell Maturation,C1516349,en_5855,None,None,AFFECTS(Infered),Infered,3
22702,Local Therapy,C1517925,en_5870,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22703,Local Therapy,C1517925,en_5870,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22704,Local Therapy,C1517925,en_5870,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
22705,Local Therapy,C1517925,en_5870,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
22706,Local Therapy,C1517925,en_5870,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22707,Local Therapy,C1517925,en_5870,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22708,Local Therapy,C1517925,en_5870,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22709,Local Therapy,C1517925,en_5870,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22710,Local Therapy,C1517925,en_5870,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
22711,Local Therapy,C1517925,en_5870,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22712,Local Therapy,C1517925,en_5870,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
22713,Local Therapy,C1517925,en_5870,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22714,Local Therapy,C1517925,en_5870,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22715,Local Therapy,C1517925,en_5870,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22716,Local Therapy,C1517925,en_5870,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22717,Local Therapy,C1517925,en_5870,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
22718,Local Therapy,C1517925,en_5870,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22719,Local Therapy,C1517925,en_5870,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22720,Local Therapy,C1517925,en_5870,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
22721,Local Therapy,C1517925,en_5870,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22722,Local Therapy,C1517925,en_5870,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
22723,Local Therapy,C1517925,en_5870,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
22724,Local Therapy,C1517925,en_5870,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
22725,Local Therapy,C1517925,en_5870,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22726,Local Therapy,C1517925,en_5870,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
22727,Local Therapy,C1517925,en_5870,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
22728,Local Therapy,C1517925,en_5870,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22729,Local Therapy,C1517925,en_5870,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
22730,Local Therapy,C1517925,en_5870,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22731,Local Therapy,C1517925,en_5870,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
22732,Local Therapy,C1517925,en_5870,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
22733,Local Therapy,C1517925,en_5870,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
22734,Local Therapy,C1517925,en_5870,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
22735,Local Therapy,C1517925,en_5870,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
22736,Local Therapy,C1517925,en_5870,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
22737,Local Therapy,C1517925,en_5870,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
22738,Local Therapy,C1517925,en_5870,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22739,Local Therapy,C1517925,en_5870,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
22740,Local Therapy,C1517925,en_5870,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
22741,Local Therapy,C1517925,en_5870,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
22742,Local Therapy,C1517925,en_5870,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
22743,Local Therapy,C1517925,en_5870,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
22744,Local Therapy,C1517925,en_5870,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22745,Local Therapy,C1517925,en_5870,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22746,Local Therapy,C1517925,en_5870,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
22747,Local Therapy,C1517925,en_5870,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22748,Local Therapy,C1517925,en_5870,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
22749,Local Therapy,C1517925,en_5870,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22750,Local Therapy,C1517925,en_5870,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
22751,Local Therapy,C1517925,en_5870,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
22752,Local Therapy,C1517925,en_5870,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
22753,Local Therapy,C1517925,en_5870,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22754,Local Therapy,C1517925,en_5870,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
22755,Local Therapy,C1517925,en_5870,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
22756,Local Therapy,C1517925,en_5870,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22757,Local Therapy,C1517925,en_5870,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
22758,Local Therapy,C1517925,en_5870,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
22759,Local Therapy,C1517925,en_5870,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
22760,Local Therapy,C1517925,en_5870,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22761,Local Therapy,C1517925,en_5870,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
22762,Local Therapy,C1517925,en_5870,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
22763,Local Therapy,C1517925,en_5870,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
22764,Local Therapy,C1517925,en_5870,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
22765,Local Therapy,C1517925,en_5870,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
22766,Local Therapy,C1517925,en_5870,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22767,Local Therapy,C1517925,en_5870,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
22768,Local Therapy,C1517925,en_5870,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
22769,Local Therapy,C1517925,en_5870,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
22770,Local Therapy,C1517925,en_5870,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
22771,Local Therapy,C1517925,en_5870,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
22772,Local Therapy,C1517925,en_5870,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
22773,Local Therapy,C1517925,en_5870,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
22774,Local Therapy,C1517925,en_5870,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
22775,Local Therapy,C1517925,en_5870,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
22776,Local Therapy,C1517925,en_5870,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
22777,Local Therapy,C1517925,en_5870,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
22778,Local Therapy,C1517925,en_5870,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
22779,Local Therapy,C1517925,en_5870,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
22780,Local Therapy,C1517925,en_5870,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
22781,Local Therapy,C1517925,en_5870,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
22782,Local Therapy,C1517925,en_5870,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
22783,Local Therapy,C1517925,en_5870,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
22784,Local Therapy,C1517925,en_5870,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
22785,Local Therapy,C1517925,en_5870,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
22786,Local Therapy,C1517925,en_5870,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22787,Local Therapy,C1517925,en_5870,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
22788,Local Therapy,C1517925,en_5870,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
22789,Local Therapy,C1517925,en_5870,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
22790,Local Therapy,C1517925,en_5870,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
22791,Local Therapy,C1517925,en_5870,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
22792,Local Therapy,C1517925,en_5870,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
22793,Local Therapy,C1517925,en_5870,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
22794,Local Therapy,C1517925,en_5870,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
22795,Local Therapy,C1517925,en_5870,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
22796,Local Therapy,C1517925,en_5870,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
22797,Local Therapy,C1517925,en_5870,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
22798,Local Therapy,C1517925,en_5870,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
22799,Local Therapy,C1517925,en_5870,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
22800,Local Therapy,C1517925,en_5870,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
22801,Local Therapy,C1517925,en_5870,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
22802,Local Therapy,C1517925,en_5870,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
22803,Local Therapy,C1517925,en_5870,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
22804,Local Therapy,C1517925,en_5870,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
22805,Local Therapy,C1517925,en_5870,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
22806,Local Therapy,C1517925,en_5870,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
22807,Local Therapy,C1517925,en_5870,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
22808,Local Therapy,C1517925,en_5870,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
22809,Local Therapy,C1517925,en_5870,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
22810,Local Therapy,C1517925,en_5870,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
22811,Local Therapy,C1517925,en_5870,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
22812,Local Therapy,C1517925,en_5870,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
22813,Local Therapy,C1517925,en_5870,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
22814,Local Therapy,C1517925,en_5870,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
22815,Local Therapy,C1517925,en_5870,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
22816,Local Therapy,C1517925,en_5870,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
22817,Local Therapy,C1517925,en_5870,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
22818,Low Dose Radiation,C1518010,en_5872,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22819,Low Dose Radiation,C1518010,en_5872,affects(Infered),Mus,C0026809,en_1600,None,None,AFFECTS(Infered),Infered,3
22820,Low Dose Radiation,C1518010,en_5872,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22821,Low Dose Radiation,C1518010,en_5872,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22822,Low Dose Radiation,C1518010,en_5872,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22823,Low Dose Radiation,C1518010,en_5872,affects(Infered),Malignant neoplasm of breast,C0006142,en_511,None,None,AFFECTS(Infered),Infered,3
22824,Low Dose Radiation,C1518010,en_5872,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22825,Low Dose Radiation,C1518010,en_5872,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
22826,Low Dose Radiation,C1518010,en_5872,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22827,Low Dose Radiation,C1518010,en_5872,affects(Infered),Malignant neoplasm of lung,C0242379,en_3408,None,None,AFFECTS(Infered),Infered,3
22828,Low Dose Radiation,C1518010,en_5872,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
22829,Low Dose Radiation,C1518010,en_5872,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
22830,Low Dose Radiation,C1518010,en_5872,affects(Infered),Cardiotoxicity,C0876994,en_5060,None,None,AFFECTS(Infered),Infered,3
22831,Low Dose Radiation,C1518010,en_5872,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
22832,Low Dose Radiation,C1518010,en_5872,affects(Infered),"Pneumonia, Viral",C0032310,en_1837,None,None,AFFECTS(Infered),Infered,3
22833,Low Dose Radiation,C1518010,en_5872,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
22834,Low Dose Radiation,C1518010,en_5872,affects(Infered),Malignant neoplasm of tongue,C0153349,en_2882,None,None,AFFECTS(Infered),Infered,3
22835,Low Dose Radiation,C1518010,en_5872,affects(Infered),"Carcinoma, Non-Small-Cell Lung",C0007131,en_563,None,None,AFFECTS(Infered),Infered,3
22836,Low Dose Radiation,C1518010,en_5872,affects(Infered),Gene Expression,C0017262,en_1044,None,None,AFFECTS(Infered),Infered,3
22837,Low Dose Radiation,C1518010,en_5872,affects(Infered),Asymptomatic,C0231221,en_3252,None,None,AFFECTS(Infered),Infered,3
22838,Low Dose Radiation,C1518010,en_5872,affects(Infered),"Pneumonitis, Interstitial",C0206061,en_3141,None,None,AFFECTS(Infered),Infered,3
22839,Low Dose Radiation,C1518010,en_5872,affects(Infered),Female,C0015780,en_977,None,None,AFFECTS(Infered),Infered,3
22840,Low Dose Radiation,C1518010,en_5872,affects(Infered),Glioma,C0017638,en_1063,None,None,AFFECTS(Infered),Infered,3
22841,Low Dose Radiation,C1518010,en_5872,affects(Infered),Bury,C1390944,en_5691,None,None,AFFECTS(Infered),Infered,3
22842,Low Dose Radiation,C1518010,en_5872,affects(Infered),Radiation Injuries,C0034530,en_1953,None,None,AFFECTS(Infered),Infered,3
22843,Low Dose Radiation,C1518010,en_5872,affects(Infered),Mucositis,C0333355,en_3762,None,None,AFFECTS(Infered),Infered,3
22844,Recombinant Interferon,C1522537,en_5903,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
22845,Recombinant Interferon,C1522537,en_5903,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
22846,Recombinant Interferon,C1522537,en_5903,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
22847,"TIMP3 protein, human",C1527365,en_5924,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
22848,"TIMP3 protein, human",C1527365,en_5924,affects(Infered),Matrix Metalloproteinases,C0623362,en_4521,None,None,AFFECTS(Infered),Infered,3
22849,"TIMP3 protein, human",C1527365,en_5924,affects(Infered),"Tuberculosis, Pulmonary",C0041327,en_2297,None,None,AFFECTS(Infered),Infered,3
22850,"TIMP3 protein, human",C1527365,en_5924,affects(Infered),"Tuberculosis, Lymph Node",C0041316,en_2296,None,None,AFFECTS(Infered),Infered,3
22851,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22852,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
22853,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
22854,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
22855,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),Myocardial Infarction,C0027051,en_1625,None,None,AFFECTS(Infered),Infered,3
22856,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22857,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),Thrombosis,C0040053,en_2233,None,None,AFFECTS(Infered),Infered,3
22858,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
22859,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),STEMI,C1536220,en_5944,None,None,AFFECTS(Infered),Infered,3
22860,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),"Fatty Streak, Arterial",C0015697,en_974,None,None,AFFECTS(Infered),Infered,3
22861,Emergency percutaneous coronary intervention,C1532297,en_5931,affects(Infered),Infarction,C0021308,en_1301,None,None,AFFECTS(Infered),Infered,3
22862,Homeostatic mechanism,C1561987,en_6743,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22863,Homeostatic mechanism,C1561987,en_6743,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22864,Homeostatic mechanism,C1561987,en_6743,affects(Infered),Apoptosis,C0162638,en_2922,None,None,AFFECTS(Infered),Infered,3
22865,Homeostatic mechanism,C1561987,en_6743,affects(Infered),physiological aspects,C0031843,en_1806,None,None,AFFECTS(Infered),Infered,3
22866,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,affects(Infered),Fatty Acids,C0015684,en_969,None,None,AFFECTS(Infered),Infered,3
22867,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22868,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C1568094,en_5987,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22869,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
22870,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22871,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
22872,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
22873,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
22874,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
22875,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
22876,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
22877,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
22878,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
22879,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
22880,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
22881,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
22882,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
22883,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
22884,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
22885,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
22886,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
22887,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
22888,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
22889,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22890,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
22891,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
22892,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
22893,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22894,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
22895,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
22896,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
22897,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
22898,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
22899,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
22900,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
22901,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
22902,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
22903,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
22904,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
22905,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
22906,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
22907,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
22908,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
22909,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
22910,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
22911,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
22912,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
22913,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
22914,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
22915,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
22916,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
22917,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
22918,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
22919,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
22920,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
22921,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
22922,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
22923,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
22924,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
22925,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
22926,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
22927,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
22928,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
22929,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
22930,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
22931,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
22932,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
22933,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
22934,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
22935,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
22936,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
22937,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
22938,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
22939,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
22940,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
22941,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
22942,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
22943,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
22944,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
22945,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
22946,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
22947,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
22948,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
22949,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
22950,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
22951,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
22952,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
22953,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
22954,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
22955,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
22956,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
22957,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
22958,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
22959,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
22960,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
22961,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
22962,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
22963,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
22964,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
22965,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
22966,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
22967,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
22968,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
22969,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
22970,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
22971,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
22972,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
22973,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
22974,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
22975,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
22976,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
22977,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
22978,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
22979,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
22980,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
22981,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
22982,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
22983,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
22984,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
22985,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
22986,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
22987,nebulization-mediated drug administration,C1659427,en_6019,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
22988,cytoflavin,C1701400,en_6024,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
22989,cytoflavin,C1701400,en_6024,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
22990,cytoflavin,C1701400,en_6024,affects(Infered),Recovery,C0237820,en_3354,None,None,AFFECTS(Infered),Infered,3
22991,cytoflavin,C1701400,en_6024,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
22992,cytoflavin,C1701400,en_6024,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
22993,cytoflavin,C1701400,en_6024,affects(Infered),Respiratory complication,C0161818,en_2899,None,None,AFFECTS(Infered),Infered,3
22994,cytoflavin,C1701400,en_6024,affects(Infered),Death in hospital,C0277608,en_3586,None,None,AFFECTS(Infered),Infered,3
22995,cytoflavin,C1701400,en_6024,affects(Infered),Professional guide,C0181090,en_3019,None,None,AFFECTS(Infered),Infered,3
22996,cytoflavin,C1701400,en_6024,affects(Infered),SIRT1,C1423062,en_121,None,None,AFFECTS(Infered),Infered,3
22997,Lyso-Thermosensitive Liposome Doxorubicin,C1831903,en_6047,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
22998,Lyso-Thermosensitive Liposome Doxorubicin,C1831903,en_6047,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
22999,Lyso-Thermosensitive Liposome Doxorubicin,C1831903,en_6047,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
23000,Internet-Based Intervention,C3898714,en_6287,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
23001,Microbiome,C1956108,en_6068,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23002,Microbiome,C1956108,en_6068,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23003,Microbiome,C1956108,en_6068,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
23004,Microbiome,C1956108,en_6068,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23005,Microbiome,C1956108,en_6068,affects(Infered),Legionellosis,C0023240,en_1407,None,None,AFFECTS(Infered),Infered,3
23006,Inhibitor,C1999216,en_6749,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23007,Inhibitor,C1999216,en_6749,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23008,Inhibitor,C1999216,en_6749,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23009,Inhibitor,C1999216,en_6749,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
23010,Inhibitor,C1999216,en_6749,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23011,Inhibitor,C1999216,en_6749,affects(Infered),Cardiovascular Diseases,C0007222,en_569,None,None,AFFECTS(Infered),Infered,3
23012,Inhibitor,C1999216,en_6749,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23013,Inhibitor,C1999216,en_6749,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23014,Inhibitor,C1999216,en_6749,affects(Infered),Lung diseases,C0024115,en_1462,None,None,AFFECTS(Infered),Infered,3
23015,Inhibitor,C1999216,en_6749,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23016,Inhibitor,C1999216,en_6749,affects(Infered),Asthma,C0004096,en_418,None,None,AFFECTS(Infered),Infered,3
23017,Inhibitor,C1999216,en_6749,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23018,Inhibitor,C1999216,en_6749,affects(Infered),Chronic Obstructive Airway Disease,C0024117,en_1463,None,None,AFFECTS(Infered),Infered,3
23019,Inhibitor,C1999216,en_6749,affects(Infered),Chronic lung disease,C0746102,en_4815,None,None,AFFECTS(Infered),Infered,3
23020,Inhibitor,C1999216,en_6749,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23021,Inhibitor,C1999216,en_6749,affects(Infered),Adverse event,C0877248,en_5069,None,None,AFFECTS(Infered),Infered,3
23022,Inhibitor,C1999216,en_6749,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23023,Inhibitor,C1999216,en_6749,affects(Infered),Pulmonary arterial hypertension,C1619734,en_6012,None,None,AFFECTS(Infered),Infered,3
23024,Inhibitor,C1999216,en_6749,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23025,Inhibitor,C1999216,en_6749,affects(Infered),Acute Lung Injury,C0242488,en_3416,None,None,AFFECTS(Infered),Infered,3
23026,Inhibitor,C1999216,en_6749,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23027,Inhibitor,C1999216,en_6749,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23028,Inhibitor,C1999216,en_6749,affects(Infered),"Infections, Hospital",C0205721,en_3133,None,None,AFFECTS(Infered),Infered,3
23029,Inhibitor,C1999216,en_6749,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23030,Inhibitor,C1999216,en_6749,affects(Infered),Rheumatism,C0035435,en_2028,None,None,AFFECTS(Infered),Infered,3
23031,Inhibitor,C1999216,en_6749,affects(Infered),Autoimmune,C0443146,en_4064,None,None,AFFECTS(Infered),Infered,3
23032,Inhibitor,C1999216,en_6749,affects(Infered),nervous system disorder,C0027765,en_1659,None,None,AFFECTS(Infered),Infered,3
23033,Inhibitor,C1999216,en_6749,affects(Infered),Malignant neoplasm of kidney,C0740457,en_4778,None,None,AFFECTS(Infered),Infered,3
23034,Inhibitor,C1999216,en_6749,affects(Infered),Hypovolemic Shock,C0020683,en_1251,None,None,AFFECTS(Infered),Infered,3
23035,Inhibitor,C1999216,en_6749,affects(Infered),Renal transplant rejection,C0238217,en_3364,None,None,AFFECTS(Infered),Infered,3
23036,Influenza A,C2062441,en_6088,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23037,Influenza A,C2062441,en_6088,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23038,Influenza A,C2062441,en_6088,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23039,Influenza A,C2062441,en_6088,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23040,Influenza A,C2062441,en_6088,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23041,Influenza A,C2062441,en_6088,affects(Infered),Lung diseases,C0024115,en_1462,None,None,AFFECTS(Infered),Infered,3
23042,Influenza A,C2062441,en_6088,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23043,Influenza A,C2062441,en_6088,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23044,Influenza A,C2062441,en_6088,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23045,Influenza A,C2062441,en_6088,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23046,Influenza A,C2062441,en_6088,affects(Infered),Lower respiratory tract infection,C0149725,en_2806,None,None,AFFECTS(Infered),Infered,3
23047,Influenza A,C2062441,en_6088,affects(Infered),human leukocyte interferon,C0733470,en_4772,None,None,AFFECTS(Infered),Infered,3
23048,Influenza A,C2062441,en_6088,affects(Infered),Viral respiratory infection,C0729531,en_4763,None,None,AFFECTS(Infered),Infered,3
23049,Influenza A,C2062441,en_6088,affects(Infered),Infectious disease of lung,C0876973,en_5058,None,None,AFFECTS(Infered),Infered,3
23050,Influenza A,C2062441,en_6088,affects(Infered),Blood Circulation,C0005775,en_483,None,None,AFFECTS(Infered),Infered,3
23051,Influenza A,C2062441,en_6088,affects(Infered),Fertility,C0015895,en_981,None,None,AFFECTS(Infered),Infered,3
23052,Influenza A,C2062441,en_6088,affects(Infered),"Tuberculosis, Pulmonary",C0041327,en_2297,None,None,AFFECTS(Infered),Infered,3
23053,Influenza A,C2062441,en_6088,affects(Infered),Acute myocardial infarction,C0155626,en_2888,None,None,AFFECTS(Infered),Infered,3
23054,Influenza A,C2062441,en_6088,affects(Infered),modern society,C0680319,en_4622,None,None,AFFECTS(Infered),Infered,3
23055,ciclesonide Metered Dose Inhaler,C2344604,en_6096,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23056,ciclesonide Metered Dose Inhaler,C2344604,en_6096,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23057,ciclesonide Metered Dose Inhaler,C2344604,en_6096,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23058,ciclesonide Metered Dose Inhaler,C2344604,en_6096,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23059,ciclesonide Metered Dose Inhaler,C2344604,en_6096,affects(Infered),"Signs and Symptoms, Respiratory",C0037090,en_2107,None,None,AFFECTS(Infered),Infered,3
23060,Myobacterium w (attenuated),C2349988,en_6102,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
23061,Myobacterium w (attenuated),C2349988,en_6102,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
23062,Myobacterium w (attenuated),C2349988,en_6102,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
23063,"CD69 protein, human|CD69",C2744535|969,en_6133,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
23064,"CD69 protein, human|CD69",C2744535|969,en_6133,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
23065,"CD69 protein, human|CD69",C2744535|969,en_6133,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
23066,"CD69 protein, human|CD69",C2744535|969,en_6133,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
23067,Current Therapy,C2827774,en_6138,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23068,Current Therapy,C2827774,en_6138,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23069,Current Therapy,C2827774,en_6138,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23070,Current Therapy,C2827774,en_6138,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23071,Current Therapy,C2827774,en_6138,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
23072,Current Therapy,C2827774,en_6138,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23073,Current Therapy,C2827774,en_6138,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23074,Current Therapy,C2827774,en_6138,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
23075,Current Therapy,C2827774,en_6138,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23076,Current Therapy,C2827774,en_6138,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23077,Current Therapy,C2827774,en_6138,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23078,Current Therapy,C2827774,en_6138,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23079,Current Therapy,C2827774,en_6138,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23080,Current Therapy,C2827774,en_6138,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23081,Current Therapy,C2827774,en_6138,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
23082,Current Therapy,C2827774,en_6138,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
23083,Current Therapy,C2827774,en_6138,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23084,Current Therapy,C2827774,en_6138,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23085,Current Therapy,C2827774,en_6138,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23086,Current Therapy,C2827774,en_6138,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23087,Current Therapy,C2827774,en_6138,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23088,Current Therapy,C2827774,en_6138,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
23089,Current Therapy,C2827774,en_6138,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
23090,Current Therapy,C2827774,en_6138,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23091,Current Therapy,C2827774,en_6138,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23092,Current Therapy,C2827774,en_6138,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
23093,Current Therapy,C2827774,en_6138,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
23094,Current Therapy,C2827774,en_6138,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
23095,Current Therapy,C2827774,en_6138,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23096,Current Therapy,C2827774,en_6138,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
23097,Current Therapy,C2827774,en_6138,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23098,Current Therapy,C2827774,en_6138,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23099,Current Therapy,C2827774,en_6138,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
23100,Current Therapy,C2827774,en_6138,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23101,Current Therapy,C2827774,en_6138,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
23102,Current Therapy,C2827774,en_6138,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23103,Current Therapy,C2827774,en_6138,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23104,Current Therapy,C2827774,en_6138,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23105,Current Therapy,C2827774,en_6138,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
23106,Current Therapy,C2827774,en_6138,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23107,Current Therapy,C2827774,en_6138,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
23108,Current Therapy,C2827774,en_6138,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23109,Current Therapy,C2827774,en_6138,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
23110,Current Therapy,C2827774,en_6138,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
23111,Current Therapy,C2827774,en_6138,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23112,Current Therapy,C2827774,en_6138,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23113,Current Therapy,C2827774,en_6138,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
23114,Current Therapy,C2827774,en_6138,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23115,Current Therapy,C2827774,en_6138,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
23116,Current Therapy,C2827774,en_6138,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23117,Current Therapy,C2827774,en_6138,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
23118,Current Therapy,C2827774,en_6138,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23119,Current Therapy,C2827774,en_6138,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23120,Current Therapy,C2827774,en_6138,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23121,Current Therapy,C2827774,en_6138,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
23122,Current Therapy,C2827774,en_6138,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23123,Current Therapy,C2827774,en_6138,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
23124,Current Therapy,C2827774,en_6138,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
23125,Current Therapy,C2827774,en_6138,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
23126,Current Therapy,C2827774,en_6138,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
23127,Current Therapy,C2827774,en_6138,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23128,Current Therapy,C2827774,en_6138,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23129,Current Therapy,C2827774,en_6138,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
23130,Current Therapy,C2827774,en_6138,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
23131,Current Therapy,C2827774,en_6138,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
23132,Current Therapy,C2827774,en_6138,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
23133,Current Therapy,C2827774,en_6138,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
23134,Current Therapy,C2827774,en_6138,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
23135,Current Therapy,C2827774,en_6138,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
23136,Current Therapy,C2827774,en_6138,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
23137,Current Therapy,C2827774,en_6138,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
23138,Current Therapy,C2827774,en_6138,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23139,Current Therapy,C2827774,en_6138,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
23140,Current Therapy,C2827774,en_6138,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
23141,Current Therapy,C2827774,en_6138,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
23142,Current Therapy,C2827774,en_6138,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
23143,Current Therapy,C2827774,en_6138,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
23144,Current Therapy,C2827774,en_6138,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
23145,Current Therapy,C2827774,en_6138,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
23146,Current Therapy,C2827774,en_6138,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
23147,Current Therapy,C2827774,en_6138,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
23148,Current Therapy,C2827774,en_6138,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
23149,Current Therapy,C2827774,en_6138,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23150,Current Therapy,C2827774,en_6138,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
23151,Current Therapy,C2827774,en_6138,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
23152,Current Therapy,C2827774,en_6138,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
23153,Current Therapy,C2827774,en_6138,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
23154,Current Therapy,C2827774,en_6138,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
23155,Current Therapy,C2827774,en_6138,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23156,Current Therapy,C2827774,en_6138,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
23157,Current Therapy,C2827774,en_6138,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
23158,Current Therapy,C2827774,en_6138,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
23159,Current Therapy,C2827774,en_6138,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
23160,Current Therapy,C2827774,en_6138,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
23161,Current Therapy,C2827774,en_6138,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
23162,Current Therapy,C2827774,en_6138,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
23163,Current Therapy,C2827774,en_6138,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
23164,Current Therapy,C2827774,en_6138,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
23165,Current Therapy,C2827774,en_6138,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
23166,Current Therapy,C2827774,en_6138,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
23167,Current Therapy,C2827774,en_6138,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
23168,Current Therapy,C2827774,en_6138,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
23169,Current Therapy,C2827774,en_6138,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
23170,Current Therapy,C2827774,en_6138,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
23171,Current Therapy,C2827774,en_6138,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
23172,Current Therapy,C2827774,en_6138,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
23173,Current Therapy,C2827774,en_6138,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
23174,Current Therapy,C2827774,en_6138,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
23175,Current Therapy,C2827774,en_6138,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
23176,Current Therapy,C2827774,en_6138,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
23177,Current Therapy,C2827774,en_6138,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
23178,Current Therapy,C2827774,en_6138,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
23179,Current Therapy,C2827774,en_6138,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
23180,Current Therapy,C2827774,en_6138,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
23181,Current Therapy,C2827774,en_6138,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
23182,Current Therapy,C2827774,en_6138,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
23183,Current Therapy,C2827774,en_6138,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
23184,Current Therapy,C2827774,en_6138,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
23185,Current Therapy,C2827774,en_6138,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
23186,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23187,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),ACE2,C1422064,en_5723,None,None,AFFECTS(Infered),Infered,3
23188,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),Signal Transduction,C0037083,en_2105,None,None,AFFECTS(Infered),Infered,3
23189,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),Cells,C0007634,en_596,None,None,AFFECTS(Infered),Infered,3
23190,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),Antigens,C0003320,en_365,None,None,AFFECTS(Infered),Infered,3
23191,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),Vaccines,C0042210,en_2329,None,None,AFFECTS(Infered),Infered,3
23192,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),Coronet,C0222033,en_3233,None,None,AFFECTS(Infered),Infered,3
23193,Recombinant Human Deoxyribonuclease 1 [EPC],C2917414,en_6143,affects(Infered),ELK3 gene,C0812375,en_4900,None,None,AFFECTS(Infered),Infered,3
23194,ruxolitinib,C2931926,en_6148,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
23195,Conventional Treatment,C2945704,en_6157,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23196,Conventional Treatment,C2945704,en_6157,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23197,Conventional Treatment,C2945704,en_6157,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23198,Conventional Treatment,C2945704,en_6157,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23199,Conventional Treatment,C2945704,en_6157,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
23200,Conventional Treatment,C2945704,en_6157,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23201,Conventional Treatment,C2945704,en_6157,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
23202,Conventional Treatment,C2945704,en_6157,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23203,Conventional Treatment,C2945704,en_6157,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23204,Conventional Treatment,C2945704,en_6157,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23205,Conventional Treatment,C2945704,en_6157,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23206,Conventional Treatment,C2945704,en_6157,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23207,Conventional Treatment,C2945704,en_6157,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23208,Conventional Treatment,C2945704,en_6157,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
23209,Conventional Treatment,C2945704,en_6157,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
23210,Conventional Treatment,C2945704,en_6157,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23211,Conventional Treatment,C2945704,en_6157,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23212,Conventional Treatment,C2945704,en_6157,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23213,Conventional Treatment,C2945704,en_6157,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23214,Conventional Treatment,C2945704,en_6157,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23215,Conventional Treatment,C2945704,en_6157,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
23216,Conventional Treatment,C2945704,en_6157,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
23217,Conventional Treatment,C2945704,en_6157,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23218,Conventional Treatment,C2945704,en_6157,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23219,Conventional Treatment,C2945704,en_6157,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
23220,Conventional Treatment,C2945704,en_6157,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
23221,Conventional Treatment,C2945704,en_6157,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
23222,Conventional Treatment,C2945704,en_6157,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23223,Conventional Treatment,C2945704,en_6157,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
23224,Conventional Treatment,C2945704,en_6157,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23225,Conventional Treatment,C2945704,en_6157,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23226,Conventional Treatment,C2945704,en_6157,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
23227,Conventional Treatment,C2945704,en_6157,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23228,Conventional Treatment,C2945704,en_6157,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
23229,Conventional Treatment,C2945704,en_6157,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23230,Conventional Treatment,C2945704,en_6157,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23231,Conventional Treatment,C2945704,en_6157,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23232,Conventional Treatment,C2945704,en_6157,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
23233,Conventional Treatment,C2945704,en_6157,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23234,Conventional Treatment,C2945704,en_6157,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
23235,Conventional Treatment,C2945704,en_6157,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23236,Conventional Treatment,C2945704,en_6157,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
23237,Conventional Treatment,C2945704,en_6157,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
23238,Conventional Treatment,C2945704,en_6157,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23239,Conventional Treatment,C2945704,en_6157,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23240,Conventional Treatment,C2945704,en_6157,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
23241,Conventional Treatment,C2945704,en_6157,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23242,Conventional Treatment,C2945704,en_6157,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
23243,Conventional Treatment,C2945704,en_6157,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23244,Conventional Treatment,C2945704,en_6157,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
23245,Conventional Treatment,C2945704,en_6157,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23246,Conventional Treatment,C2945704,en_6157,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23247,Conventional Treatment,C2945704,en_6157,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23248,Conventional Treatment,C2945704,en_6157,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
23249,Conventional Treatment,C2945704,en_6157,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23250,Conventional Treatment,C2945704,en_6157,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
23251,Conventional Treatment,C2945704,en_6157,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
23252,Conventional Treatment,C2945704,en_6157,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
23253,Conventional Treatment,C2945704,en_6157,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23254,Conventional Treatment,C2945704,en_6157,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23255,Conventional Treatment,C2945704,en_6157,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
23256,Conventional Treatment,C2945704,en_6157,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
23257,Conventional Treatment,C2945704,en_6157,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
23258,Conventional Treatment,C2945704,en_6157,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
23259,Conventional Treatment,C2945704,en_6157,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
23260,Conventional Treatment,C2945704,en_6157,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
23261,Conventional Treatment,C2945704,en_6157,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
23262,Conventional Treatment,C2945704,en_6157,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
23263,Conventional Treatment,C2945704,en_6157,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
23264,Conventional Treatment,C2945704,en_6157,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23265,Conventional Treatment,C2945704,en_6157,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
23266,Conventional Treatment,C2945704,en_6157,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
23267,Conventional Treatment,C2945704,en_6157,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
23268,Conventional Treatment,C2945704,en_6157,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
23269,Conventional Treatment,C2945704,en_6157,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
23270,Conventional Treatment,C2945704,en_6157,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
23271,Conventional Treatment,C2945704,en_6157,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
23272,Conventional Treatment,C2945704,en_6157,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
23273,Conventional Treatment,C2945704,en_6157,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
23274,Conventional Treatment,C2945704,en_6157,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
23275,Conventional Treatment,C2945704,en_6157,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23276,Conventional Treatment,C2945704,en_6157,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
23277,Conventional Treatment,C2945704,en_6157,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
23278,Conventional Treatment,C2945704,en_6157,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
23279,Conventional Treatment,C2945704,en_6157,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
23280,Conventional Treatment,C2945704,en_6157,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
23281,Conventional Treatment,C2945704,en_6157,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23282,Conventional Treatment,C2945704,en_6157,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
23283,Conventional Treatment,C2945704,en_6157,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
23284,Conventional Treatment,C2945704,en_6157,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
23285,Conventional Treatment,C2945704,en_6157,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
23286,Conventional Treatment,C2945704,en_6157,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
23287,Conventional Treatment,C2945704,en_6157,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
23288,Conventional Treatment,C2945704,en_6157,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
23289,Conventional Treatment,C2945704,en_6157,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
23290,Conventional Treatment,C2945704,en_6157,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
23291,Conventional Treatment,C2945704,en_6157,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
23292,Conventional Treatment,C2945704,en_6157,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
23293,Conventional Treatment,C2945704,en_6157,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
23294,Conventional Treatment,C2945704,en_6157,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
23295,Conventional Treatment,C2945704,en_6157,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
23296,Conventional Treatment,C2945704,en_6157,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
23297,Conventional Treatment,C2945704,en_6157,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
23298,Conventional Treatment,C2945704,en_6157,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
23299,Conventional Treatment,C2945704,en_6157,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
23300,Conventional Treatment,C2945704,en_6157,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
23301,Conventional Treatment,C2945704,en_6157,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
23302,Conventional Treatment,C2945704,en_6157,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
23303,Conventional Treatment,C2945704,en_6157,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
23304,Conventional Treatment,C2945704,en_6157,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
23305,Conventional Treatment,C2945704,en_6157,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
23306,Conventional Treatment,C2945704,en_6157,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
23307,Conventional Treatment,C2945704,en_6157,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
23308,Conventional Treatment,C2945704,en_6157,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
23309,Conventional Treatment,C2945704,en_6157,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
23310,Conventional Treatment,C2945704,en_6157,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
23311,Conventional Treatment,C2945704,en_6157,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
23312,danoprevir,C2973564,en_6160,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23313,danoprevir,C2973564,en_6160,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23314,danoprevir,C2973564,en_6160,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23315,danoprevir,C2973564,en_6160,affects(Infered),Cell Proliferation,C0596290,en_4384,None,None,AFFECTS(Infered),Infered,3
23316,danoprevir,C2973564,en_6160,affects(Infered),Angiogenesis,C0302600,en_3709,None,None,AFFECTS(Infered),Infered,3
23317,Intestinal Microbiome,C2985398,en_6166,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23318,Intestinal Microbiome,C2985398,en_6166,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23319,Intestinal Microbiome,C2985398,en_6166,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
23320,Intestinal Microbiome,C2985398,en_6166,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
23321,Intestinal Microbiome,C2985398,en_6166,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23322,Intestinal Microbiome,C2985398,en_6166,affects(Infered),Legionellosis,C0023240,en_1407,None,None,AFFECTS(Infered),Infered,3
23323,Targeted Therapy,C2985566,en_6168,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23324,Targeted Therapy,C2985566,en_6168,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23325,Targeted Therapy,C2985566,en_6168,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23326,Targeted Therapy,C2985566,en_6168,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23327,Targeted Therapy,C2985566,en_6168,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
23328,Targeted Therapy,C2985566,en_6168,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23329,Targeted Therapy,C2985566,en_6168,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23330,Targeted Therapy,C2985566,en_6168,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
23331,Targeted Therapy,C2985566,en_6168,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23332,Targeted Therapy,C2985566,en_6168,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23333,Targeted Therapy,C2985566,en_6168,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23334,Targeted Therapy,C2985566,en_6168,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23335,Targeted Therapy,C2985566,en_6168,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23336,Targeted Therapy,C2985566,en_6168,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23337,Targeted Therapy,C2985566,en_6168,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
23338,Targeted Therapy,C2985566,en_6168,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
23339,Targeted Therapy,C2985566,en_6168,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23340,Targeted Therapy,C2985566,en_6168,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23341,Targeted Therapy,C2985566,en_6168,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23342,Targeted Therapy,C2985566,en_6168,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23343,Targeted Therapy,C2985566,en_6168,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23344,Targeted Therapy,C2985566,en_6168,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
23345,Targeted Therapy,C2985566,en_6168,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
23346,Targeted Therapy,C2985566,en_6168,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23347,Targeted Therapy,C2985566,en_6168,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23348,Targeted Therapy,C2985566,en_6168,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
23349,Targeted Therapy,C2985566,en_6168,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
23350,Targeted Therapy,C2985566,en_6168,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
23351,Targeted Therapy,C2985566,en_6168,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23352,Targeted Therapy,C2985566,en_6168,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
23353,Targeted Therapy,C2985566,en_6168,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23354,Targeted Therapy,C2985566,en_6168,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23355,Targeted Therapy,C2985566,en_6168,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
23356,Targeted Therapy,C2985566,en_6168,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23357,Targeted Therapy,C2985566,en_6168,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
23358,Targeted Therapy,C2985566,en_6168,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23359,Targeted Therapy,C2985566,en_6168,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23360,Targeted Therapy,C2985566,en_6168,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23361,Targeted Therapy,C2985566,en_6168,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
23362,Targeted Therapy,C2985566,en_6168,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23363,Targeted Therapy,C2985566,en_6168,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
23364,Targeted Therapy,C2985566,en_6168,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23365,Targeted Therapy,C2985566,en_6168,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
23366,Targeted Therapy,C2985566,en_6168,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
23367,Targeted Therapy,C2985566,en_6168,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23368,Targeted Therapy,C2985566,en_6168,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23369,Targeted Therapy,C2985566,en_6168,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
23370,Targeted Therapy,C2985566,en_6168,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23371,Targeted Therapy,C2985566,en_6168,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
23372,Targeted Therapy,C2985566,en_6168,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23373,Targeted Therapy,C2985566,en_6168,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
23374,Targeted Therapy,C2985566,en_6168,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23375,Targeted Therapy,C2985566,en_6168,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23376,Targeted Therapy,C2985566,en_6168,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23377,Targeted Therapy,C2985566,en_6168,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
23378,Targeted Therapy,C2985566,en_6168,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23379,Targeted Therapy,C2985566,en_6168,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
23380,Targeted Therapy,C2985566,en_6168,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
23381,Targeted Therapy,C2985566,en_6168,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
23382,Targeted Therapy,C2985566,en_6168,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
23383,Targeted Therapy,C2985566,en_6168,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23384,Targeted Therapy,C2985566,en_6168,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23385,Targeted Therapy,C2985566,en_6168,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
23386,Targeted Therapy,C2985566,en_6168,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
23387,Targeted Therapy,C2985566,en_6168,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
23388,Targeted Therapy,C2985566,en_6168,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
23389,Targeted Therapy,C2985566,en_6168,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
23390,Targeted Therapy,C2985566,en_6168,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
23391,Targeted Therapy,C2985566,en_6168,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
23392,Targeted Therapy,C2985566,en_6168,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
23393,Targeted Therapy,C2985566,en_6168,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
23394,Targeted Therapy,C2985566,en_6168,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23395,Targeted Therapy,C2985566,en_6168,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
23396,Targeted Therapy,C2985566,en_6168,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
23397,Targeted Therapy,C2985566,en_6168,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
23398,Targeted Therapy,C2985566,en_6168,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
23399,Targeted Therapy,C2985566,en_6168,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
23400,Targeted Therapy,C2985566,en_6168,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
23401,Targeted Therapy,C2985566,en_6168,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
23402,Targeted Therapy,C2985566,en_6168,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
23403,Targeted Therapy,C2985566,en_6168,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
23404,Targeted Therapy,C2985566,en_6168,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
23405,Targeted Therapy,C2985566,en_6168,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23406,Targeted Therapy,C2985566,en_6168,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
23407,Targeted Therapy,C2985566,en_6168,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
23408,Targeted Therapy,C2985566,en_6168,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
23409,Targeted Therapy,C2985566,en_6168,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
23410,Targeted Therapy,C2985566,en_6168,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
23411,Targeted Therapy,C2985566,en_6168,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23412,Targeted Therapy,C2985566,en_6168,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
23413,Targeted Therapy,C2985566,en_6168,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
23414,Targeted Therapy,C2985566,en_6168,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
23415,Targeted Therapy,C2985566,en_6168,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
23416,Targeted Therapy,C2985566,en_6168,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
23417,Targeted Therapy,C2985566,en_6168,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
23418,Targeted Therapy,C2985566,en_6168,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
23419,Targeted Therapy,C2985566,en_6168,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
23420,Targeted Therapy,C2985566,en_6168,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
23421,Targeted Therapy,C2985566,en_6168,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
23422,Targeted Therapy,C2985566,en_6168,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
23423,Targeted Therapy,C2985566,en_6168,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
23424,Targeted Therapy,C2985566,en_6168,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
23425,Targeted Therapy,C2985566,en_6168,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
23426,Targeted Therapy,C2985566,en_6168,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
23427,Targeted Therapy,C2985566,en_6168,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
23428,Targeted Therapy,C2985566,en_6168,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
23429,Targeted Therapy,C2985566,en_6168,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
23430,Targeted Therapy,C2985566,en_6168,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
23431,Targeted Therapy,C2985566,en_6168,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
23432,Targeted Therapy,C2985566,en_6168,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
23433,Targeted Therapy,C2985566,en_6168,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
23434,Targeted Therapy,C2985566,en_6168,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
23435,Targeted Therapy,C2985566,en_6168,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
23436,Targeted Therapy,C2985566,en_6168,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
23437,Targeted Therapy,C2985566,en_6168,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
23438,Targeted Therapy,C2985566,en_6168,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
23439,Targeted Therapy,C2985566,en_6168,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
23440,Targeted Therapy,C2985566,en_6168,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
23441,Targeted Therapy,C2985566,en_6168,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
23442,Tailored Intervention,C2986593,en_6172,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23443,Tailored Intervention,C2986593,en_6172,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23444,Tailored Intervention,C2986593,en_6172,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23445,Tailored Intervention,C2986593,en_6172,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23446,Tailored Intervention,C2986593,en_6172,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
23447,Tailored Intervention,C2986593,en_6172,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23448,Tailored Intervention,C2986593,en_6172,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23449,Tailored Intervention,C2986593,en_6172,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
23450,Tailored Intervention,C2986593,en_6172,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23451,Tailored Intervention,C2986593,en_6172,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23452,Tailored Intervention,C2986593,en_6172,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23453,Tailored Intervention,C2986593,en_6172,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23454,Tailored Intervention,C2986593,en_6172,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23455,Tailored Intervention,C2986593,en_6172,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23456,Tailored Intervention,C2986593,en_6172,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
23457,Tailored Intervention,C2986593,en_6172,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
23458,Tailored Intervention,C2986593,en_6172,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23459,Tailored Intervention,C2986593,en_6172,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23460,Tailored Intervention,C2986593,en_6172,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23461,Tailored Intervention,C2986593,en_6172,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23462,Tailored Intervention,C2986593,en_6172,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23463,Tailored Intervention,C2986593,en_6172,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
23464,Tailored Intervention,C2986593,en_6172,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
23465,Tailored Intervention,C2986593,en_6172,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23466,Tailored Intervention,C2986593,en_6172,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23467,Tailored Intervention,C2986593,en_6172,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
23468,Tailored Intervention,C2986593,en_6172,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
23469,Tailored Intervention,C2986593,en_6172,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23470,Tailored Intervention,C2986593,en_6172,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
23471,Tailored Intervention,C2986593,en_6172,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23472,Tailored Intervention,C2986593,en_6172,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23473,Tailored Intervention,C2986593,en_6172,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
23474,Tailored Intervention,C2986593,en_6172,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23475,Tailored Intervention,C2986593,en_6172,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
23476,Tailored Intervention,C2986593,en_6172,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23477,Tailored Intervention,C2986593,en_6172,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23478,Tailored Intervention,C2986593,en_6172,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23479,Tailored Intervention,C2986593,en_6172,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
23480,Tailored Intervention,C2986593,en_6172,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23481,Tailored Intervention,C2986593,en_6172,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
23482,Tailored Intervention,C2986593,en_6172,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23483,Tailored Intervention,C2986593,en_6172,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
23484,Tailored Intervention,C2986593,en_6172,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
23485,Tailored Intervention,C2986593,en_6172,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23486,Tailored Intervention,C2986593,en_6172,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23487,Tailored Intervention,C2986593,en_6172,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
23488,Tailored Intervention,C2986593,en_6172,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23489,Tailored Intervention,C2986593,en_6172,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
23490,Tailored Intervention,C2986593,en_6172,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23491,Tailored Intervention,C2986593,en_6172,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
23492,Tailored Intervention,C2986593,en_6172,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23493,Tailored Intervention,C2986593,en_6172,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23494,Tailored Intervention,C2986593,en_6172,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23495,Tailored Intervention,C2986593,en_6172,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
23496,Tailored Intervention,C2986593,en_6172,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23497,Tailored Intervention,C2986593,en_6172,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
23498,Tailored Intervention,C2986593,en_6172,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
23499,Tailored Intervention,C2986593,en_6172,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
23500,Tailored Intervention,C2986593,en_6172,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
23501,Tailored Intervention,C2986593,en_6172,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23502,Tailored Intervention,C2986593,en_6172,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23503,Tailored Intervention,C2986593,en_6172,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
23504,Tailored Intervention,C2986593,en_6172,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
23505,Tailored Intervention,C2986593,en_6172,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
23506,Tailored Intervention,C2986593,en_6172,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
23507,Tailored Intervention,C2986593,en_6172,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
23508,Tailored Intervention,C2986593,en_6172,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
23509,Tailored Intervention,C2986593,en_6172,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
23510,Tailored Intervention,C2986593,en_6172,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
23511,Tailored Intervention,C2986593,en_6172,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
23512,Tailored Intervention,C2986593,en_6172,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23513,Tailored Intervention,C2986593,en_6172,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
23514,Tailored Intervention,C2986593,en_6172,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
23515,Tailored Intervention,C2986593,en_6172,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
23516,Tailored Intervention,C2986593,en_6172,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
23517,Tailored Intervention,C2986593,en_6172,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
23518,Tailored Intervention,C2986593,en_6172,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
23519,Tailored Intervention,C2986593,en_6172,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
23520,Tailored Intervention,C2986593,en_6172,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
23521,Tailored Intervention,C2986593,en_6172,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
23522,Tailored Intervention,C2986593,en_6172,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
23523,Tailored Intervention,C2986593,en_6172,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23524,Tailored Intervention,C2986593,en_6172,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
23525,Tailored Intervention,C2986593,en_6172,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
23526,Tailored Intervention,C2986593,en_6172,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
23527,Tailored Intervention,C2986593,en_6172,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
23528,Tailored Intervention,C2986593,en_6172,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
23529,Tailored Intervention,C2986593,en_6172,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23530,Tailored Intervention,C2986593,en_6172,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
23531,Tailored Intervention,C2986593,en_6172,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
23532,Tailored Intervention,C2986593,en_6172,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
23533,Tailored Intervention,C2986593,en_6172,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
23534,Tailored Intervention,C2986593,en_6172,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
23535,Tailored Intervention,C2986593,en_6172,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
23536,Tailored Intervention,C2986593,en_6172,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
23537,Tailored Intervention,C2986593,en_6172,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
23538,Tailored Intervention,C2986593,en_6172,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
23539,Tailored Intervention,C2986593,en_6172,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
23540,Tailored Intervention,C2986593,en_6172,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
23541,Tailored Intervention,C2986593,en_6172,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
23542,Tailored Intervention,C2986593,en_6172,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
23543,Tailored Intervention,C2986593,en_6172,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
23544,Tailored Intervention,C2986593,en_6172,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
23545,Tailored Intervention,C2986593,en_6172,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
23546,Tailored Intervention,C2986593,en_6172,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
23547,Tailored Intervention,C2986593,en_6172,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
23548,Tailored Intervention,C2986593,en_6172,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
23549,Tailored Intervention,C2986593,en_6172,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
23550,Tailored Intervention,C2986593,en_6172,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
23551,Tailored Intervention,C2986593,en_6172,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
23552,Tailored Intervention,C2986593,en_6172,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
23553,Tailored Intervention,C2986593,en_6172,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
23554,Tailored Intervention,C2986593,en_6172,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
23555,Tailored Intervention,C2986593,en_6172,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
23556,Tailored Intervention,C2986593,en_6172,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
23557,Tailored Intervention,C2986593,en_6172,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
23558,Tailored Intervention,C2986593,en_6172,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
23559,Tailored Intervention,C2986593,en_6172,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
23560,Urgent Procedure,C3272275,en_6188,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23561,Urgent Procedure,C3272275,en_6188,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23562,Urgent Procedure,C3272275,en_6188,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23563,Urgent Procedure,C3272275,en_6188,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23564,Urgent Procedure,C3272275,en_6188,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
23565,Urgent Procedure,C3272275,en_6188,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23566,Urgent Procedure,C3272275,en_6188,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23567,Urgent Procedure,C3272275,en_6188,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
23568,Urgent Procedure,C3272275,en_6188,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23569,Urgent Procedure,C3272275,en_6188,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23570,Urgent Procedure,C3272275,en_6188,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23571,Urgent Procedure,C3272275,en_6188,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23572,Urgent Procedure,C3272275,en_6188,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23573,Urgent Procedure,C3272275,en_6188,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23574,Urgent Procedure,C3272275,en_6188,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
23575,Urgent Procedure,C3272275,en_6188,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
23576,Urgent Procedure,C3272275,en_6188,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23577,Urgent Procedure,C3272275,en_6188,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23578,Urgent Procedure,C3272275,en_6188,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23579,Urgent Procedure,C3272275,en_6188,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23580,Urgent Procedure,C3272275,en_6188,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23581,Urgent Procedure,C3272275,en_6188,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
23582,Urgent Procedure,C3272275,en_6188,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
23583,Urgent Procedure,C3272275,en_6188,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23584,Urgent Procedure,C3272275,en_6188,affects(Infered),Hospitalized Patients,C0870668,en_5010,None,None,AFFECTS(Infered),Infered,3
23585,Urgent Procedure,C3272275,en_6188,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
23586,Urgent Procedure,C3272275,en_6188,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
23587,Urgent Procedure,C3272275,en_6188,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
23588,Urgent Procedure,C3272275,en_6188,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23589,Urgent Procedure,C3272275,en_6188,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
23590,Urgent Procedure,C3272275,en_6188,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23591,Urgent Procedure,C3272275,en_6188,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23592,Urgent Procedure,C3272275,en_6188,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
23593,Urgent Procedure,C3272275,en_6188,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23594,Urgent Procedure,C3272275,en_6188,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
23595,Urgent Procedure,C3272275,en_6188,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23596,Urgent Procedure,C3272275,en_6188,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23597,Urgent Procedure,C3272275,en_6188,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23598,Urgent Procedure,C3272275,en_6188,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
23599,Urgent Procedure,C3272275,en_6188,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23600,Urgent Procedure,C3272275,en_6188,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
23601,Urgent Procedure,C3272275,en_6188,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23602,Urgent Procedure,C3272275,en_6188,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
23603,Urgent Procedure,C3272275,en_6188,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
23604,Urgent Procedure,C3272275,en_6188,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23605,Urgent Procedure,C3272275,en_6188,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23606,Urgent Procedure,C3272275,en_6188,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
23607,Urgent Procedure,C3272275,en_6188,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23608,Urgent Procedure,C3272275,en_6188,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
23609,Urgent Procedure,C3272275,en_6188,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23610,Urgent Procedure,C3272275,en_6188,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
23611,Urgent Procedure,C3272275,en_6188,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23612,Urgent Procedure,C3272275,en_6188,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23613,Urgent Procedure,C3272275,en_6188,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23614,Urgent Procedure,C3272275,en_6188,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
23615,Urgent Procedure,C3272275,en_6188,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23616,Urgent Procedure,C3272275,en_6188,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
23617,Urgent Procedure,C3272275,en_6188,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
23618,Urgent Procedure,C3272275,en_6188,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
23619,Urgent Procedure,C3272275,en_6188,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
23620,Urgent Procedure,C3272275,en_6188,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23621,Urgent Procedure,C3272275,en_6188,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23622,Urgent Procedure,C3272275,en_6188,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
23623,Urgent Procedure,C3272275,en_6188,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
23624,Urgent Procedure,C3272275,en_6188,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
23625,Urgent Procedure,C3272275,en_6188,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
23626,Urgent Procedure,C3272275,en_6188,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
23627,Urgent Procedure,C3272275,en_6188,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
23628,Urgent Procedure,C3272275,en_6188,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
23629,Urgent Procedure,C3272275,en_6188,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
23630,Urgent Procedure,C3272275,en_6188,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
23631,Urgent Procedure,C3272275,en_6188,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23632,Urgent Procedure,C3272275,en_6188,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
23633,Urgent Procedure,C3272275,en_6188,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
23634,Urgent Procedure,C3272275,en_6188,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
23635,Urgent Procedure,C3272275,en_6188,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
23636,Urgent Procedure,C3272275,en_6188,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
23637,Urgent Procedure,C3272275,en_6188,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
23638,Urgent Procedure,C3272275,en_6188,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
23639,Urgent Procedure,C3272275,en_6188,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
23640,Urgent Procedure,C3272275,en_6188,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
23641,Urgent Procedure,C3272275,en_6188,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
23642,Urgent Procedure,C3272275,en_6188,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23643,Urgent Procedure,C3272275,en_6188,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
23644,Urgent Procedure,C3272275,en_6188,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
23645,Urgent Procedure,C3272275,en_6188,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
23646,Urgent Procedure,C3272275,en_6188,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
23647,Urgent Procedure,C3272275,en_6188,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
23648,Urgent Procedure,C3272275,en_6188,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23649,Urgent Procedure,C3272275,en_6188,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
23650,Urgent Procedure,C3272275,en_6188,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
23651,Urgent Procedure,C3272275,en_6188,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
23652,Urgent Procedure,C3272275,en_6188,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
23653,Urgent Procedure,C3272275,en_6188,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
23654,Urgent Procedure,C3272275,en_6188,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
23655,Urgent Procedure,C3272275,en_6188,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
23656,Urgent Procedure,C3272275,en_6188,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
23657,Urgent Procedure,C3272275,en_6188,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
23658,Urgent Procedure,C3272275,en_6188,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
23659,Urgent Procedure,C3272275,en_6188,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
23660,Urgent Procedure,C3272275,en_6188,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
23661,Urgent Procedure,C3272275,en_6188,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
23662,Urgent Procedure,C3272275,en_6188,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
23663,Urgent Procedure,C3272275,en_6188,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
23664,Urgent Procedure,C3272275,en_6188,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
23665,Urgent Procedure,C3272275,en_6188,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
23666,Urgent Procedure,C3272275,en_6188,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
23667,Urgent Procedure,C3272275,en_6188,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
23668,Urgent Procedure,C3272275,en_6188,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
23669,Urgent Procedure,C3272275,en_6188,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
23670,Urgent Procedure,C3272275,en_6188,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
23671,Urgent Procedure,C3272275,en_6188,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
23672,Urgent Procedure,C3272275,en_6188,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
23673,Urgent Procedure,C3272275,en_6188,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
23674,Urgent Procedure,C3272275,en_6188,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
23675,Urgent Procedure,C3272275,en_6188,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
23676,Urgent Procedure,C3272275,en_6188,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
23677,Urgent Procedure,C3272275,en_6188,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
23678,Urgent Procedure,C3272275,en_6188,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
23679,"Transformation, function",C3714584,en_6757,affects(Infered),Adolescent,C0205653,en_3132,None,None,AFFECTS(Infered),Infered,3
23680,"Transformation, function",C3714584,en_6757,affects(Infered),Staff,C0851286,en_4950,None,None,AFFECTS(Infered),Infered,3
23681,SUCLA2,C3811915,en_97,affects(Infered),Immune Cell,C4330475,en_6345,None,None,AFFECTS(Infered),Infered,3
23682,SUCLA2,C3811915,en_97,affects(Infered),Conventional Dendritic Cell,C4085194,en_6318,None,None,AFFECTS(Infered),Infered,3
23683,SUCLA2,C3811915,en_97,affects(Infered),Peripheral Blood Lymphocyte,C1518997,en_5878,None,None,AFFECTS(Infered),Infered,3
23684,SUCLA2,C3811915,en_97,affects(Infered),Blood,C0005767,en_482,None,None,AFFECTS(Infered),Infered,3
23685,Pathogenic,C3816499,en_6761,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23686,Pathogenic,C3816499,en_6761,affects(Infered),Alzheimer's Disease,C0002395,en_291,None,None,AFFECTS(Infered),Infered,3
23687,Pathogenic,C3816499,en_6761,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23688,Pathogenic,C3816499,en_6761,affects(Infered),Respiratory Tract Infections,C0035243,en_2017,None,None,AFFECTS(Infered),Infered,3
23689,Pathogenic,C3816499,en_6761,affects(Infered),"Heart Septal Defects, Atrial",C0018817,en_1139,None,None,AFFECTS(Infered),Infered,3
23690,Severe acute respiratory infection,C3873497,en_6279,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23691,Severe acute respiratory infection,C3873497,en_6279,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23692,Recurrent thromboembolism,C4025286,en_6296,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23693,Recurrent thromboembolism,C4025286,en_6296,affects(Infered),Evolution,C0015219,en_937,None,None,AFFECTS(Infered),Infered,3
23694,Recurrent thromboembolism,C4025286,en_6296,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23695,Recurrent thromboembolism,C4025286,en_6296,affects(Infered),LDLR gene,C1366529,en_6716,None,None,AFFECTS(Infered),Infered,3
23696,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23697,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23698,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23699,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
23700,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23701,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23702,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23703,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),Kidney Diseases,C0022658,en_1381,None,None,AFFECTS(Infered),Infered,3
23704,Maintenance hemodialysis,C4040576,en_6302,affects(Infered),End stage renal failure,C1261469,en_5418,None,None,AFFECTS(Infered),Infered,3
23705,Cell-Free DNA,C4289789,en_6334,affects(Infered),anticoagulant activity,C1148561,en_5297,None,None,AFFECTS(Infered),Infered,3
23706,abrocitinib,C5139788,en_6408,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
23707,ravidasvir,C4508633,en_6355,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23708,ravidasvir,C4508633,en_6355,affects(Infered),Insulin Resistance,C0021655,en_1325,None,None,AFFECTS(Infered),Infered,3
23709,Proactive Therapy,C4744673,en_6397,affects(Infered),Inflammation,C0021368,en_1307,None,None,AFFECTS(Infered),Infered,3
23710,Proactive Therapy,C4744673,en_6397,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23711,Proactive Therapy,C4744673,en_6397,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23712,Proactive Therapy,C4744673,en_6397,affects(Infered),Chronic liver disease NOS,C0341439,en_3823,None,None,AFFECTS(Infered),Infered,3
23713,Proactive Therapy,C4744673,en_6397,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23714,Proactive Therapy,C4744673,en_6397,affects(Infered),"Respiratory Distress Syndrome, Adult",C0035222,en_2010,None,None,AFFECTS(Infered),Infered,3
23715,Proactive Therapy,C4744673,en_6397,affects(Infered),Outpatients,C0029921,en_1729,None,None,AFFECTS(Infered),Infered,3
23716,Proactive Therapy,C4744673,en_6397,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23717,Proactive Therapy,C4744673,en_6397,affects(Infered),Acquired Immunodeficiency Syndrome,C0001175,en_226,None,None,AFFECTS(Infered),Infered,3
23718,Proactive Therapy,C4744673,en_6397,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23719,Proactive Therapy,C4744673,en_6397,affects(Infered),Cessation of life,C0011065,en_762,None,None,AFFECTS(Infered),Infered,3
23720,Proactive Therapy,C4744673,en_6397,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23721,Proactive Therapy,C4744673,en_6397,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23722,Proactive Therapy,C4744673,en_6397,affects(Infered),Inflammatory Response,C1155266,en_5321,None,None,AFFECTS(Infered),Infered,3
23723,Proactive Therapy,C4744673,en_6397,affects(Infered),Critical Illness,C0010340,en_733,None,None,AFFECTS(Infered),Infered,3
23724,Proactive Therapy,C4744673,en_6397,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23725,Proactive Therapy,C4744673,en_6397,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23726,Proactive Therapy,C4744673,en_6397,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23727,Proactive Therapy,C4744673,en_6397,affects(Infered),Complication,C0009566,en_697,None,None,AFFECTS(Infered),Infered,3
23728,Proactive Therapy,C4744673,en_6397,affects(Infered),Syndrome,C0039082,en_2197,None,None,AFFECTS(Infered),Infered,3
23729,Proactive Therapy,C4744673,en_6397,affects(Infered),Woman,C0043210,en_2396,None,None,AFFECTS(Infered),Infered,3
23730,Proactive Therapy,C4744673,en_6397,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23731,Proactive Therapy,C4744673,en_6397,affects(Infered),Cytokine storm,C0919747,en_5119,None,None,AFFECTS(Infered),Infered,3
23732,Proactive Therapy,C4744673,en_6397,affects(Infered),Tachycardia,C0039231,en_2203,None,None,AFFECTS(Infered),Infered,3
23733,Proactive Therapy,C4744673,en_6397,affects(Infered),Survivors,C0206194,en_3154,None,None,AFFECTS(Infered),Infered,3
23734,Proactive Therapy,C4744673,en_6397,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23735,Proactive Therapy,C4744673,en_6397,affects(Infered),"Lupus Erythematosus, Systemic",C0024141,en_1466,None,None,AFFECTS(Infered),Infered,3
23736,Proactive Therapy,C4744673,en_6397,affects(Infered),Obesity,C0028754,en_1699,None,None,AFFECTS(Infered),Infered,3
23737,Proactive Therapy,C4744673,en_6397,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23738,Proactive Therapy,C4744673,en_6397,affects(Infered),Chronic Disease,C0008679,en_643,None,None,AFFECTS(Infered),Infered,3
23739,Proactive Therapy,C4744673,en_6397,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23740,Proactive Therapy,C4744673,en_6397,affects(Infered),Respiration,C0035203,en_2004,None,None,AFFECTS(Infered),Infered,3
23741,Proactive Therapy,C4744673,en_6397,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23742,Proactive Therapy,C4744673,en_6397,affects(Infered),Human,C0020114,en_1210,None,None,AFFECTS(Infered),Infered,3
23743,Proactive Therapy,C4744673,en_6397,affects(Infered),Injury,C0175677,en_2968,None,None,AFFECTS(Infered),Infered,3
23744,Proactive Therapy,C4744673,en_6397,affects(Infered),Disease Progression,C0242656,en_3429,None,None,AFFECTS(Infered),Infered,3
23745,Proactive Therapy,C4744673,en_6397,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23746,Proactive Therapy,C4744673,en_6397,affects(Infered),Alopecia Areata,C0002171,en_283,None,None,AFFECTS(Infered),Infered,3
23747,Proactive Therapy,C4744673,en_6397,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23748,Proactive Therapy,C4744673,en_6397,affects(Infered),Orthomyxoviridae,C0029341,en_1720,None,None,AFFECTS(Infered),Infered,3
23749,Proactive Therapy,C4744673,en_6397,affects(Infered),Virus Shedding,C0162633,en_2921,None,None,AFFECTS(Infered),Infered,3
23750,Proactive Therapy,C4744673,en_6397,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23751,Proactive Therapy,C4744673,en_6397,affects(Infered),Respiration Disorders,C0035204,en_2005,None,None,AFFECTS(Infered),Infered,3
23752,Proactive Therapy,C4744673,en_6397,affects(Infered),"Depression, Postpartum",C0221074,en_3212,None,None,AFFECTS(Infered),Infered,3
23753,Proactive Therapy,C4744673,en_6397,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23754,Proactive Therapy,C4744673,en_6397,affects(Infered),Fibrosis,C0016059,en_994,None,None,AFFECTS(Infered),Infered,3
23755,Proactive Therapy,C4744673,en_6397,affects(Infered),Coronavirus Infections,C0206750,en_3176,None,None,AFFECTS(Infered),Infered,3
23756,Proactive Therapy,C4744673,en_6397,affects(Infered),Tropical Disease,C1336827,en_5642,None,None,AFFECTS(Infered),Infered,3
23757,Proactive Therapy,C4744673,en_6397,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23758,Proactive Therapy,C4744673,en_6397,affects(Infered),Multiple Sclerosis,C0026769,en_1598,None,None,AFFECTS(Infered),Infered,3
23759,Proactive Therapy,C4744673,en_6397,affects(Infered),Septicemia,C0036690,en_2086,None,None,AFFECTS(Infered),Infered,3
23760,Proactive Therapy,C4744673,en_6397,affects(Infered),Epidemic disease,C0277548,en_3584,None,None,AFFECTS(Infered),Infered,3
23761,Proactive Therapy,C4744673,en_6397,affects(Infered),Adverse effects,C0879626,en_5081,None,None,AFFECTS(Infered),Infered,3
23762,Proactive Therapy,C4744673,en_6397,affects(Infered),Growth,C0018270,en_1098,None,None,AFFECTS(Infered),Infered,3
23763,Proactive Therapy,C4744673,en_6397,affects(Infered),Neoplasm,C0027651,en_1651,None,None,AFFECTS(Infered),Infered,3
23764,Proactive Therapy,C4744673,en_6397,affects(Infered),Stress,C0038435,en_2165,None,None,AFFECTS(Infered),Infered,3
23765,Proactive Therapy,C4744673,en_6397,affects(Infered),PATIENT SYMPTOMS,C1317600,en_5529,None,None,AFFECTS(Infered),Infered,3
23766,Proactive Therapy,C4744673,en_6397,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23767,Proactive Therapy,C4744673,en_6397,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23768,Proactive Therapy,C4744673,en_6397,affects(Infered),HIV Infections,C0019693,en_1192,None,None,AFFECTS(Infered),Infered,3
23769,Proactive Therapy,C4744673,en_6397,affects(Infered),Blood Coagulation Disorders,C0005779,en_485,None,None,AFFECTS(Infered),Infered,3
23770,Proactive Therapy,C4744673,en_6397,affects(Infered),Cystic Fibrosis,C0010674,en_745,None,None,AFFECTS(Infered),Infered,3
23771,Proactive Therapy,C4744673,en_6397,affects(Infered),Patient in hospital,C0701159,en_4731,None,None,AFFECTS(Infered),Infered,3
23772,Proactive Therapy,C4744673,en_6397,affects(Infered),Depressive disorder,C0011581,en_788,None,None,AFFECTS(Infered),Infered,3
23773,Proactive Therapy,C4744673,en_6397,affects(Infered),Generalized Anxiety Disorder,C0270549,en_3551,None,None,AFFECTS(Infered),Infered,3
23774,Proactive Therapy,C4744673,en_6397,affects(Infered),Treatment Resistant Depression,C0871546,en_5026,None,None,AFFECTS(Infered),Infered,3
23775,Proactive Therapy,C4744673,en_6397,affects(Infered),high-risk group,C0684030,en_4676,None,None,AFFECTS(Infered),Infered,3
23776,Proactive Therapy,C4744673,en_6397,affects(Infered),Genus: Coronavirus,C0206419,en_3158,None,None,AFFECTS(Infered),Infered,3
23777,Proactive Therapy,C4744673,en_6397,affects(Infered),Malaria,C0024530,en_1493,None,None,AFFECTS(Infered),Infered,3
23778,Proactive Therapy,C4744673,en_6397,affects(Infered),Parasitic Diseases,C0030499,en_1748,None,None,AFFECTS(Infered),Infered,3
23779,Proactive Therapy,C4744673,en_6397,affects(Infered),Fatigue,C0015672,en_966,None,None,AFFECTS(Infered),Infered,3
23780,Proactive Therapy,C4744673,en_6397,affects(Infered),Sjogren's Syndrome,C1527336,en_5921,None,None,AFFECTS(Infered),Infered,3
23781,Proactive Therapy,C4744673,en_6397,affects(Infered),Autism spectrum disorder,C1510586,en_5799,None,None,AFFECTS(Infered),Infered,3
23782,Proactive Therapy,C4744673,en_6397,affects(Infered),"Hypertension, Pulmonary",C0020542,en_1240,None,None,AFFECTS(Infered),Infered,3
23783,Proactive Therapy,C4744673,en_6397,affects(Infered),Inflammatory Bowel Diseases,C0021390,en_1310,None,None,AFFECTS(Infered),Infered,3
23784,Proactive Therapy,C4744673,en_6397,affects(Infered),Multiple Organ Failure,C0026766,en_1597,None,None,AFFECTS(Infered),Infered,3
23785,Proactive Therapy,C4744673,en_6397,affects(Infered),"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,en_800,None,None,AFFECTS(Infered),Infered,3
23786,Proactive Therapy,C4744673,en_6397,affects(Infered),Cerebral Palsy,C0007789,en_605,None,None,AFFECTS(Infered),Infered,3
23787,Proactive Therapy,C4744673,en_6397,affects(Infered),Substance Use Disorders,C0038586,en_2176,None,None,AFFECTS(Infered),Infered,3
23788,Proactive Therapy,C4744673,en_6397,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23789,Proactive Therapy,C4744673,en_6397,affects(Infered),Vertical Disease Transmission,C0242648,en_3427,None,None,AFFECTS(Infered),Infered,3
23790,Proactive Therapy,C4744673,en_6397,affects(Infered),Chiroptera,C0008139,en_625,None,None,AFFECTS(Infered),Infered,3
23791,Proactive Therapy,C4744673,en_6397,affects(Infered),Lymphoma,C0024299,en_1471,None,None,AFFECTS(Infered),Infered,3
23792,Proactive Therapy,C4744673,en_6397,affects(Infered),"Stress Disorders, Post-Traumatic",C0038436,en_2166,None,None,AFFECTS(Infered),Infered,3
23793,Proactive Therapy,C4744673,en_6397,affects(Infered),Dengue Fever,C0011311,en_778,None,None,AFFECTS(Infered),Infered,3
23794,Proactive Therapy,C4744673,en_6397,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23795,Proactive Therapy,C4744673,en_6397,affects(Infered),Co-morbid conditions,C1275743,en_5462,None,None,AFFECTS(Infered),Infered,3
23796,Proactive Therapy,C4744673,en_6397,affects(Infered),Seizures,C0036572,en_2076,None,None,AFFECTS(Infered),Infered,3
23797,Proactive Therapy,C4744673,en_6397,affects(Infered),Diabetic complications,C0271672,en_3556,None,None,AFFECTS(Infered),Infered,3
23798,Proactive Therapy,C4744673,en_6397,affects(Infered),host-pathogen interaction,C1154482,en_5309,None,None,AFFECTS(Infered),Infered,3
23799,Proactive Therapy,C4744673,en_6397,affects(Infered),Ebola virus,C0013480,en_872,None,None,AFFECTS(Infered),Infered,3
23800,Proactive Therapy,C4744673,en_6397,affects(Infered),Ischemic stroke,C0948008,en_5158,None,None,AFFECTS(Infered),Infered,3
23801,Proactive Therapy,C4744673,en_6397,affects(Infered),Acute Ischemic Stroke,C5392833,en_6450,None,None,AFFECTS(Infered),Infered,3
23802,Proactive Therapy,C4744673,en_6397,affects(Infered),Erectile dysfunction,C0242350,en_3407,None,None,AFFECTS(Infered),Infered,3
23803,Proactive Therapy,C4744673,en_6397,affects(Infered),Glomerulonephritis,C0017658,en_1065,None,None,AFFECTS(Infered),Infered,3
23804,Proactive Therapy,C4744673,en_6397,affects(Infered),Viral hepatitis,C0042721,en_2356,None,None,AFFECTS(Infered),Infered,3
23805,Proactive Therapy,C4744673,en_6397,affects(Infered),"Hyperostosis, Diffuse Idiopathic Skeletal",C0020498,en_1234,None,None,AFFECTS(Infered),Infered,3
23806,Proactive Therapy,C4744673,en_6397,affects(Infered),Neutrophil Infiltration,C0751982,en_4855,None,None,AFFECTS(Infered),Infered,3
23807,Proactive Therapy,C4744673,en_6397,affects(Infered),pulmonary function,C0231921,en_3268,None,None,AFFECTS(Infered),Infered,3
23808,Proactive Therapy,C4744673,en_6397,affects(Infered),Leg Ulcer,C0023223,en_1406,None,None,AFFECTS(Infered),Infered,3
23809,Proactive Therapy,C4744673,en_6397,affects(Infered),Malignant neoplasm of stomach,C0024623,en_1495,None,None,AFFECTS(Infered),Infered,3
23810,Proactive Therapy,C4744673,en_6397,affects(Infered),Mucocutaneous Lymph Node Syndrome,C0026691,en_1592,None,None,AFFECTS(Infered),Infered,3
23811,Proactive Therapy,C4744673,en_6397,affects(Infered),Neuromyelitis Optica,C0027873,en_1669,None,None,AFFECTS(Infered),Infered,3
23812,Proactive Therapy,C4744673,en_6397,affects(Infered),RNA Virus Infections,C0035690,en_2043,None,None,AFFECTS(Infered),Infered,3
23813,Proactive Therapy,C4744673,en_6397,affects(Infered),"Tachycardia, Sinus",C0039239,en_2204,None,None,AFFECTS(Infered),Infered,3
23814,Proactive Therapy,C4744673,en_6397,affects(Infered),Unemployment,C0041674,en_2309,None,None,AFFECTS(Infered),Infered,3
23815,Proactive Therapy,C4744673,en_6397,affects(Infered),Uterine Fibroids,C0042133,en_2324,None,None,AFFECTS(Infered),Infered,3
23816,Proactive Therapy,C4744673,en_6397,affects(Infered),Sense of smell impaired,C2364082,en_6111,None,None,AFFECTS(Infered),Infered,3
23817,Proactive Therapy,C4744673,en_6397,affects(Infered),Chronic infectious disease,C0151317,en_2857,None,None,AFFECTS(Infered),Infered,3
23818,Proactive Therapy,C4744673,en_6397,affects(Infered),"[X]Chronic viral hepatitis, unspecified",C0276623,en_3580,None,None,AFFECTS(Infered),Infered,3
23819,Proactive Therapy,C4744673,en_6397,affects(Infered),Infectious disorder of bronchus,C0340238,en_3813,None,None,AFFECTS(Infered),Infered,3
23820,Proactive Therapy,C4744673,en_6397,affects(Infered),Feeling suicidal,C0424000,en_3990,None,None,AFFECTS(Infered),Infered,3
23821,Proactive Therapy,C4744673,en_6397,affects(Infered),commune,C0598781,en_4451,None,None,AFFECTS(Infered),Infered,3
23822,Proactive Therapy,C4744673,en_6397,affects(Infered),HEART PROBLEM,C0795691,en_4879,None,None,AFFECTS(Infered),Infered,3
23823,Proactive Therapy,C4744673,en_6397,affects(Infered),Old tuberculosis,C0857427,en_4976,None,None,AFFECTS(Infered),Infered,3
23824,Proactive Therapy,C4744673,en_6397,affects(Infered),Neurologic Diseases,C1456669,en_5777,None,None,AFFECTS(Infered),Infered,3
23825,Pharmacological Ascorbate,C4744839,en_6399,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
23826,Pharmacological Ascorbate,C4744839,en_6399,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
23827,Pharmacological Ascorbate,C4744839,en_6399,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
23828,Bemcentinib,C4763383,en_6404,affects(Infered),INFECTIOUS PROCESS,C0745283,en_4812,None,None,AFFECTS(Infered),Infered,3
23829,Bemcentinib,C4763383,en_6404,affects(Infered),Neonatal Jaundice,C0022353,en_1372,None,None,AFFECTS(Infered),Infered,3
23830,Bemcentinib,C4763383,en_6404,affects(Infered),"FRAP1 protein, human",C1307407,en_5524,None,None,AFFECTS(Infered),Infered,3
23831,Single Agent Therapy,C4763675,en_6405,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23832,Single Agent Therapy,C4763675,en_6405,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23833,Single Agent Therapy,C4763675,en_6405,affects(Infered),Infection,C3714514,en_6235,None,None,AFFECTS(Infered),Infered,3
23834,Single Agent Therapy,C4763675,en_6405,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23835,Single Agent Therapy,C4763675,en_6405,affects(Infered),Communicable Diseases,C0009450,en_685,None,None,AFFECTS(Infered),Infered,3
23836,Single Agent Therapy,C4763675,en_6405,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23837,Single Agent Therapy,C4763675,en_6405,affects(Infered),Malignant neoplasm of breast,C0006142,en_511,None,None,AFFECTS(Infered),Infered,3
23838,Single Agent Therapy,C4763675,en_6405,affects(Infered),Anosmia,C0003126,en_337,None,None,AFFECTS(Infered),Infered,3
23839,Single Agent Therapy,C4763675,en_6405,affects(Infered),Diabetes,C0011847,en_797,None,None,AFFECTS(Infered),Infered,3
23840,Single Agent Therapy,C4763675,en_6405,affects(Infered),Hypoxia,C0242184,en_3396,None,None,AFFECTS(Infered),Infered,3
23841,Single Agent Therapy,C4763675,en_6405,affects(Infered),Individual,C0237401,en_3343,None,None,AFFECTS(Infered),Infered,3
23842,Single Agent Therapy,C4763675,en_6405,affects(Infered),Immunologic function,C1268930,en_5445,None,None,AFFECTS(Infered),Infered,3
23843,Single Agent Therapy,C4763675,en_6405,affects(Infered),alcohol use disorder,C0001956,en_270,None,None,AFFECTS(Infered),Infered,3
23844,Single Agent Therapy,C4763675,en_6405,affects(Infered),brain development,C1160340,en_5353,None,None,AFFECTS(Infered),Infered,3
23845,Single Agent Therapy,C4763675,en_6405,affects(Infered),Cancer Patient,C1516213,en_5852,None,None,AFFECTS(Infered),Infered,3
23846,Single Agent Therapy,C4763675,en_6405,affects(Infered),Mycoses,C0026946,en_1620,None,None,AFFECTS(Infered),Infered,3
23847,Single Agent Therapy,C4763675,en_6405,affects(Infered),Pain,C0030193,en_1741,None,None,AFFECTS(Infered),Infered,3
23848,Single Agent Therapy,C4763675,en_6405,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23849,Single Agent Therapy,C4763675,en_6405,affects(Infered),Anorexia,C0003123,en_336,None,None,AFFECTS(Infered),Infered,3
23850,Single Agent Therapy,C4763675,en_6405,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23851,Single Agent Therapy,C4763675,en_6405,affects(Infered),Malaise,C0231218,en_3251,None,None,AFFECTS(Infered),Infered,3
23852,Single Agent Therapy,C4763675,en_6405,affects(Infered),Mental disorders,C0004936,en_452,None,None,AFFECTS(Infered),Infered,3
23853,Single Agent Therapy,C4763675,en_6405,affects(Infered),Antibody Formation,C0003261,en_352,None,None,AFFECTS(Infered),Infered,3
23854,Single Agent Therapy,C4763675,en_6405,affects(Infered),Edema,C0013604,en_877,None,None,AFFECTS(Infered),Infered,3
23855,Single Agent Therapy,C4763675,en_6405,affects(Infered),Sleeplessness,C0917801,en_5108,None,None,AFFECTS(Infered),Infered,3
23856,Single Agent Therapy,C4763675,en_6405,affects(Infered),Solid tumor,C0280100,en_3619,None,None,AFFECTS(Infered),Infered,3
23857,Single Agent Therapy,C4763675,en_6405,affects(Infered),Hyperglycemia,C0020456,en_1232,None,None,AFFECTS(Infered),Infered,3
23858,Single Agent Therapy,C4763675,en_6405,affects(Infered),Digestion,C0012238,en_815,None,None,AFFECTS(Infered),Infered,3
23859,Single Agent Therapy,C4763675,en_6405,affects(Infered),Hematologic Neoplasms,C0376545,en_3883,None,None,AFFECTS(Infered),Infered,3
23860,Single Agent Therapy,C4763675,en_6405,affects(Infered),Malignant tumor of colon,C0007102,en_559,None,None,AFFECTS(Infered),Infered,3
23861,Single Agent Therapy,C4763675,en_6405,affects(Infered),"Carcinoma, Non-Small-Cell Lung",C0007131,en_563,None,None,AFFECTS(Infered),Infered,3
23862,Single Agent Therapy,C4763675,en_6405,affects(Infered),Target Population,C0039309,en_2207,None,None,AFFECTS(Infered),Infered,3
23863,Single Agent Therapy,C4763675,en_6405,affects(Infered),Overdose,C4018909,en_6291,None,None,AFFECTS(Infered),Infered,3
23864,Single Agent Therapy,C4763675,en_6405,affects(Infered),Teams,C0871489,en_5024,None,None,AFFECTS(Infered),Infered,3
23865,Single Agent Therapy,C4763675,en_6405,affects(Infered),Prognosis bad,C0278252,en_3600,None,None,AFFECTS(Infered),Infered,3
23866,Single Agent Therapy,C4763675,en_6405,affects(Infered),Diabetic,C0241863,en_3392,None,None,AFFECTS(Infered),Infered,3
23867,Single Agent Therapy,C4763675,en_6405,affects(Infered),Addictive Behavior,C0085281,en_2658,None,None,AFFECTS(Infered),Infered,3
23868,Single Agent Therapy,C4763675,en_6405,affects(Infered),Hematological Disease,C0018939,en_1150,None,None,AFFECTS(Infered),Infered,3
23869,Single Agent Therapy,C4763675,en_6405,affects(Infered),hypoglycemia,C0020615,en_1245,None,None,AFFECTS(Infered),Infered,3
23870,Single Agent Therapy,C4763675,en_6405,affects(Infered),Nerve Degeneration,C0027746,en_1657,None,None,AFFECTS(Infered),Infered,3
23871,Single Agent Therapy,C4763675,en_6405,affects(Infered),Peripheral Neuropathy,C0031117,en_1776,None,None,AFFECTS(Infered),Infered,3
23872,Single Agent Therapy,C4763675,en_6405,affects(Infered),"Tuberculosis, Pulmonary",C0041327,en_2297,None,None,AFFECTS(Infered),Infered,3
23873,Single Agent Therapy,C4763675,en_6405,affects(Infered),Acute leukemia,C0085669,en_2685,None,None,AFFECTS(Infered),Infered,3
23874,Single Agent Therapy,C4763675,en_6405,affects(Infered),Benign Neoplasm,C0086692,en_2732,None,None,AFFECTS(Infered),Infered,3
23875,Single Agent Therapy,C4763675,en_6405,affects(Infered),Esophageal carcinoma,C0152018,en_2876,None,None,AFFECTS(Infered),Infered,3
23876,Single Agent Therapy,C4763675,en_6405,affects(Infered),Pulmonary circulation disease NOS,C0178272,en_2980,None,None,AFFECTS(Infered),Infered,3
23877,Single Agent Therapy,C4763675,en_6405,affects(Infered),Former smoker,C0337671,en_3794,None,None,AFFECTS(Infered),Infered,3
23878,Single Agent Therapy,C4763675,en_6405,affects(Infered),Prolonged periods,C0425945,en_4005,None,None,AFFECTS(Infered),Infered,3
23879,Single Agent Therapy,C4763675,en_6405,affects(Infered),advanced disease,C0679246,en_4592,None,None,AFFECTS(Infered),Infered,3
23880,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23881,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Symptoms,C1457887,en_5784,None,None,AFFECTS(Infered),Infered,3
23882,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Septic Shock,C0036983,en_2101,None,None,AFFECTS(Infered),Infered,3
23883,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Severe Acute Respiratory Syndrome,C1175175,en_5383,None,None,AFFECTS(Infered),Infered,3
23884,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),"Acidosis, Respiratory",C0001127,en_224,None,None,AFFECTS(Infered),Infered,3
23885,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Pneumonia,C0032285,en_1833,None,None,AFFECTS(Infered),Infered,3
23886,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Acute respiratory failure,C0264490,en_3533,None,None,AFFECTS(Infered),Infered,3
23887,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Respiratory Failure,C1145670,en_5292,None,None,AFFECTS(Infered),Infered,3
23888,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Hypoxemia,C0700292,en_4719,None,None,AFFECTS(Infered),Infered,3
23889,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Thromboembolism,C0040038,en_2230,None,None,AFFECTS(Infered),Infered,3
23890,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Hemorrhage,C0019080,en_1161,None,None,AFFECTS(Infered),Infered,3
23891,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Kidney Diseases,C0022658,en_1381,None,None,AFFECTS(Infered),Infered,3
23892,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),"Pneumonitis, Interstitial",C0206061,en_3141,None,None,AFFECTS(Infered),Infered,3
23893,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),"Shock, Cardiogenic",C0036980,en_2098,None,None,AFFECTS(Infered),Infered,3
23894,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Arterial thrombosis,C0151942,en_2873,None,None,AFFECTS(Infered),Infered,3
23895,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Refractory shock,C0349412,en_3842,None,None,AFFECTS(Infered),Infered,3
23896,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Clinicians,C0871685,en_5028,None,None,AFFECTS(Infered),Infered,3
23897,Venovenous extracorporeal membrane oxygenation,C5192099,en_6411,affects(Infered),Author,C3812881,en_6243,None,None,AFFECTS(Infered),Infered,3
23898,Convalescent plasma,C5383282,en_6769,affects(Infered),Organism,C0029235,en_1717,None,None,AFFECTS(Infered),Infered,3
23899,sotrovimab,C5433947,en_6465,affects(Infered),"spike protein, SARS-CoV-2",C5391442,en_6439,None,None,AFFECTS(Infered),Infered,3
23900,SARS-CoV-2 IgG,C5397186,en_6771,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
23901,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Patients,C0030705,en_1762,None,None,AFFECTS(Infered),Infered,3
23902,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Disease,C0012634,en_826,None,None,AFFECTS(Infered),Infered,3
23903,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Persons,C0027361,en_1635,None,None,AFFECTS(Infered),Infered,3
23904,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
23905,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23906,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Immune response,C0301872,en_3696,None,None,AFFECTS(Infered),Infered,3
23907,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Virus Diseases,C0042769,en_2362,None,None,AFFECTS(Infered),Infered,3
23908,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Immunity,C0020964,en_1273,None,None,AFFECTS(Infered),Infered,3
23909,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Participant,C0679646,en_4602,None,None,AFFECTS(Infered),Infered,3
23910,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Well adult,C0686750,en_4683,None,None,AFFECTS(Infered),Infered,3
23911,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Rheumatic Fever,C0035436,en_2029,None,None,AFFECTS(Infered),Infered,3
23912,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),cohort,C0599755,en_4470,None,None,AFFECTS(Infered),Infered,3
23913,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23914,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Pregnancy,C0032961,en_1872,None,None,AFFECTS(Infered),Infered,3
23915,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
23916,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23917,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
23918,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23919,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
23920,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Adolescent,C0205653,en_3132,None,None,AFFECTS(Infered),Infered,3
23921,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Solid tumor,C0280100,en_3619,None,None,AFFECTS(Infered),Infered,3
23922,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Hematologic Neoplasms,C0376545,en_3883,None,None,AFFECTS(Infered),Infered,3
23923,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Fertility,C0015895,en_981,None,None,AFFECTS(Infered),Infered,3
23924,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Tretinoin,C0040845,en_2280,None,None,AFFECTS(Infered),Infered,3
23925,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Isotretinoin,C0022265,en_1370,None,None,AFFECTS(Infered),Infered,3
23926,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Human Age Group,C0027362,en_1636,None,None,AFFECTS(Infered),Infered,3
23927,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),"Tuberculosis, Pulmonary",C0041327,en_2297,None,None,AFFECTS(Infered),Infered,3
23928,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),"Myeloid Leukemia, Chronic",C0023473,en_1419,None,None,AFFECTS(Infered),Infered,3
23929,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Multiple Myeloma,C0026764,en_1596,None,None,AFFECTS(Infered),Infered,3
23930,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Voluntary Workers,C0042960,en_2380,None,None,AFFECTS(Infered),Infered,3
23931,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),gamma-interferon|IFNA1,C3539881|3439,en_6213,None,None,AFFECTS(Infered),Infered,3
23932,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),"Recipient, Transplant",C0376387,en_3875,None,None,AFFECTS(Infered),Infered,3
23933,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Immunocompromised Host,C0085393,en_2665,None,None,AFFECTS(Infered),Infered,3
23934,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Pre-existing disease,C1112199,en_5242,None,None,AFFECTS(Infered),Infered,3
23935,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Urinary hesitation,C0152032,en_2878,None,None,AFFECTS(Infered),Infered,3
23936,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Hypercoagulability disease,C0543671,en_4260,None,None,AFFECTS(Infered),Infered,3
23937,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Well child,C0686744,en_4681,None,None,AFFECTS(Infered),Infered,3
23938,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),Autoimmune disease (systemic) NOS,C2895206,en_6140,None,None,AFFECTS(Infered),Infered,3
23939,SARS-CoV-2 inactivated vaccines,C5416836,en_6455,affects(Infered),"spike protein, SARS-CoV-2",C5391442,en_6439,None,None,AFFECTS(Infered),Infered,3
23940,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),COVID-19,C5203670,en_6417,None,None,AFFECTS(Infered),Infered,3
23941,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Child,C0008059,en_620,None,None,AFFECTS(Infered),Infered,3
23942,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Well adult,C0686750,en_4683,None,None,AFFECTS(Infered),Infered,3
23943,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Rheumatic Fever,C0035436,en_2029,None,None,AFFECTS(Infered),Infered,3
23944,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Adult,C0001675,en_252,None,None,AFFECTS(Infered),Infered,3
23945,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),2019 novel coronavirus,C5203676,en_6420,None,None,AFFECTS(Infered),Infered,3
23946,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Health Personnel,C0018724,en_1121,None,None,AFFECTS(Infered),Infered,3
23947,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Autoimmune Diseases,C0004364,en_428,None,None,AFFECTS(Infered),Infered,3
23948,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Malignant Neoplasms,C0006826,en_545,None,None,AFFECTS(Infered),Infered,3
23949,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Antibodies,C0003241,en_347,None,None,AFFECTS(Infered),Infered,3
23950,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Adolescent,C0205653,en_3132,None,None,AFFECTS(Infered),Infered,3
23951,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Solid tumor,C0280100,en_3619,None,None,AFFECTS(Infered),Infered,3
23952,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Hematologic Neoplasms,C0376545,en_3883,None,None,AFFECTS(Infered),Infered,3
23953,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Human Age Group,C0027362,en_1636,None,None,AFFECTS(Infered),Infered,3
23954,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),"Myeloid Leukemia, Chronic",C0023473,en_1419,None,None,AFFECTS(Infered),Infered,3
23955,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Multiple Myeloma,C0026764,en_1596,None,None,AFFECTS(Infered),Infered,3
23956,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),gamma-interferon|IFNA1,C3539881|3439,en_6213,None,None,AFFECTS(Infered),Infered,3
23957,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),"Recipient, Transplant",C0376387,en_3875,None,None,AFFECTS(Infered),Infered,3
23958,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Immunocompromised Host,C0085393,en_2665,None,None,AFFECTS(Infered),Infered,3
23959,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Urinary hesitation,C0152032,en_2878,None,None,AFFECTS(Infered),Infered,3
23960,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Hypercoagulability disease,C0543671,en_4260,None,None,AFFECTS(Infered),Infered,3
23961,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Well child,C0686744,en_4681,None,None,AFFECTS(Infered),Infered,3
23962,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),Autoimmune disease (systemic) NOS,C2895206,en_6140,None,None,AFFECTS(Infered),Infered,3
23963,recombinant SARS-CoV-2 vaccine NVX-cov2373,C5416844,en_6456,affects(Infered),"spike protein, SARS-CoV-2",C5391442,en_6439,None,None,AFFECTS(Infered),Infered,3
23964,CA2|SLC25A20,C1413043;C1413076,en_172,affects(Infered),anticoagulant activity,C1148561,en_5297,None,None,AFFECTS(Infered),Infered,3
